Next Previous Article
73 FR 84 pgs. 23528-23938 - Medicare Program; Proposed Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2009 Rates; Proposed Changes to Disclosure of Physician Ownership in Hospitals and Physician Self-Referral Rules; Proposed Collection of Information Regarding Financial Relationships Between Hospitals and Physicians

Type: PRORULEVolume: 73Number: 84Pages: 23528 - 23938
Docket number: [CMS-1390-P]
FR document: [FR Doc. 08-1135 Filed 4-14-08; 9:19 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Medicare Medicaid Services
Official PDF Version:  PDF Version

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare Medicaid Services

42 CFR Parts 411, 412, 413, 422, and 489

[CMS-1390-P]

RIN 0938-AP15

Medicare Program; Proposed Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2009 Rates; Proposed Changes to Disclosure of Physician Ownership in Hospitals and Physician Self-Referral Rules; Proposed Collection of Information Regarding Financial Relationships Between Hospitals and Physicians

AGENCY:

Centers for Medicare and Medicaid Services (CMS), HHS.

ACTION:

Proposed rule.

SUMMARY:

We are proposing to revise the Medicare hospital inpatient prospective payment systems (IPPS) for operating and capital-related costs to implement changes arising from our continuing experience with these systems, and to implement certain provisions made by the Deficit Reduction Act of 2005, the Medicare Improvements and Extension Act, Division B, Title I of the Tax Relief and Health Care Act of 2006, and the TMA, Abstinence Education, and QI Programs Extension Act of 2007. In addition, in the Addendum to this proposed rule, we describe the proposed changes to the amounts and factors used to determine the rates for Medicare hospital inpatient services for operating costs and capital-related costs. These proposed changes would be applicable to discharges occurring on or after October 1, 2008. We also are setting forth the proposed update to the rate-of-increase limits for certain hospitals and hospital units excluded from the IPPS that are paid on a reasonable cost basis subject to these limits. The proposed updated rate-of-increase limits would be effective for cost reporting periods beginning on or after October 1, 2008.

Among the other policy decisions and changes that we are proposing to make are changes related to: Limited proposed revisions of the classification of cases to Medicare severity diagnosis-related groups (MS-DRGs), proposals to address charge compression issues in the calculation of MS-DRG relative weights, the proposed revisions to the classifications and relative weights for the Medicare severity long-term care diagnosis-related groups (MS-LTC-DRGs); applications for new medical services and technologies add-on payments; wage index reform changes and the wage data, including the occupational mix data, used to compute the proposed FY 2009 wage indices; submission of hospital quality data; proposed changes to the postacute care transfer policy relating to transfers to home for the furnishing of home health services; and proposed policy changes relating to the requirements for furnishing hospital emergency services under the Emergency Medical Treatment and Labor Act of 1986 (EMTALA).

In addition, we are proposing policy changes relating to disclosure to patients of physician ownership or investment interests in hospitals and soliciting public comments on a proposed collection of information regarding financial relationships between hospitals and physicians. We are also proposing changes or soliciting comments on issues relating to policies on physician self-referrals.

DATES:

To be assured consideration, comments must be received at one of the addresses provide below, no later than 5 p.m. E.S.T. on June 13, 2008.

ADDRESSES:

When commenting on issues presented in this proposed rule, please refer to filecode CMS-1390-P. Because of staff and resource limitations, we cannot accept comments by facsimile (FAX) transmission.

You may submit comments in one of four ways (please choose only one of the ways listed):

1. Electronically . You may submit electronic comments on this regulation to http://www.regulations.gov . Follow the instructions for "Comment or Submission" and enter the file code CMS-1390-P to submit comments on this proposed rule.

2. By regular mail . You may mail written comments (one original and two copies) to the following address ONLY: Centers for Medicare Medicaid Services, Department of Health and Human Services, Attention: CMS-1390-P, P.O. Box 8011, Baltimore, MD 21244-1850.

Please allow sufficient time for mailed comments to be received before the close of the comment period.

3. By express or overnight mail . You may send written comments (one original and two copies) to the following address ONLY: Centers for Medicare Medicaid Services, Department of Health and Human Services, Attention: CMS-1390-P, Mail Stop C4-26-05, 7500 Security Boulevard,Baltimore, MD 21244-1850.

4. By hand or courier . If you prefer, you may deliver (by hand or courier) your written comments (one original and two copies) before the close of the comment period to either of the following addresses:

a. Room 445-G, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201.

(Because access to the interior of the HHH Building is not readily available to persons without Federal Government identification, commenters are encouraged to leave their comments in the CMS drop slots located in the main lobby of the building. A stamp-in clock is available for persons wishing to retain a proof of filing by stamping in and retaining an extra copy of the comments being filed.)

b. 7500 Security Boulevard, Baltimore, MD 21244-1850.

If you intend to deliver your comments to the Baltimore address, please call telephone number (410) 786-7195 in advance to schedule your arrival with one of our staff members.

Comments mailed to the addresses indicated as appropriate for hand or courier delivery may be delayed and received after the comment period.

Submission of comments on paperwork requirements . You may submit comments on this document's paperwork requirements by following the instructions at the end of the "Collection of Information Requirements" section in this document.

For information on viewing public comments, see the beginning of the SUPPLEMENTARY INFORMATION section.

FOR FURTHER INFORMATION, CONTACT:

Michele Hudson, (410) 786-4487, Operating Prospective Payment, MS-DRGs, Wage Index, New Medical Service and Technology Add-On Payments, Hospital Geographic Reclassifications, and Postacute Care Transfer Issues.

Tzvi Hefter, (410) 786-4487, Capital Prospective Payment, Excluded Hospitals, Direct and Indirect Graduate Medical Education, MS-LTC-DRGs, EMTALA, Hospital Emergency Services, and Hospital-within-Hospital Issues.

Siddhartha Mazumdar, (410) 786-6673, Rural Community Hospital Demonstration Program Issues.

Sheila Blackstock, (410) 786-3502, Quality Data for Annual Payment Update Issues.

Thomas Valuck, (410) 786-7479, Hospital Value-Based Purchasing and Readmissions to Hospital Issues.

Anne Hornsby, (410) 786-1181, Collection of Managed Care Encounter Data Issues.

Jacqueline Proctor, (410) 786-8852, Disclosure of Physician Ownership in Hospitals and Financial Relationships between Hospitals and Physicians Issues.

Lisa Ohrin, (410) 786-4565, and Don Romano, (410) 786-1404, Physician Self-Referral Issues.

SUPPLEMENTARY INFORMATION:

Inspection of Public Comments: All comments received before the close of the comment period are available for viewing by the public, including any personally identifiable or confidential business information that is included in a comment. We post all comments received before the close of the comment period on the following Web site as soon as possible after they have been received: http://www.regulations.gov . Follow the search instructions on that Web site to view public comments.

Comments received timely will also be available for public inspection, generally beginning approximately 3 weeks after publication of a document, at the headquarters of the Centers for Medicare Medicaid Services, 7500 Security Boulevard, Baltimore, Maryland 21244, Monday through Friday of each week from 8:30 a.m. to 4 p.m. To schedule an appointment to view public comments, phone 1-800-743-3951.

Electronic Access

This Federal Register document is also available from the Federal Register online database through GPO Access , a service of the U.S. Government Printing Office. Free public access is available on a Wide Area Information Server (WAIS) through the Internet and via asynchronous dial-in. Internet users can access the database by using the World Wide Web (the Superintendent of Documents' home page address is http://www.gpoaccess.gov/ ), by using local WAIS client software, or by telnet to swais.access.gpo.gov , then login as guest (no password required). Dial-in users should use communications software and modem to call (202) 512-1661; type swais, then login as guest (no password required).

Acronyms

AARPAmerican Association of Retired Persons

AAHKSAmerican Association of Hip and Knee Surgeons

AAMCAssociation of American Medical Colleges

ACGMEAccreditation Council for Graduate Medical Education

AFArtrial fibrillation

AHAAmerican Hospital Association

AICDAutomatic implantable cardioverter defibrillator

AHIMAAmerican Health Information Management Association

AHICAmerican Health Information Community

AHRQAgency for Healthcare Research and Quality

AMAAmerican Medical Association

AMGAAmerican Medical Group Association

AMIAcute myocardial infarction

AOAAmerican Osteopathic Association

APR DRGAll Patient Refined Diagnosis Related Group System

ASCAmbulatory surgical center

ASITNAmerican Society of Interventional and Therapeutic Neuroradiology

BBABalanced Budget Act of 1997, Pub. L. 105-33

BBRAMedicare, Medicaid, and SCHIP [State Children's Health Insurance Program] Balanced Budget Refinement Act of 1999, Pub. L. 106-113

BIPAMedicare, Medicaid, and SCHIP [State Children's Health Insurance Program] Benefits Improvement and Protection Act of 2000, Pub. L. 106-554

BLSBureau of Labor Statistics

CAHCritical access hospital

CARE[Medicare] Continuity Assessment Record Evaluation [Instrument]

CARTCMS Abstraction Reporting Tool

CBSAsCore-based statistical areas

CCComplication or comorbidity

CCRCost-to-charge ratio

CDAC[Medicare] Clinical Data Abstraction Center

CDAD Clostridium difficile -associated disease

CIPICapital input price index

CMICase-mix index

CMSCenters for Medicare Medicaid Services

CMSAConsolidated Metropolitan Statistical Area

COBRAConsolidated Omnibus Reconciliation Act of 1985, Pub. L. 99-272

CoP[Hospital] condition of participation

CPIConsumer price index

CYCalendar year

DFRRDisclosure of financial relationship report

DRADeficit Reduction Act of 2005, Pub. L. 109-171

DRGDiagnosis-related group

DSHDisproportionate share hospital

DVTDeep vein thrombosis

ECIEmployment cost index

EMRElectronic medical record

EMTALAEmergency Medical Treatment and Labor Act of 1986, Pub. L. 99-272

FAHFederation of Hospitals

FDAFood and Drug Administration

FHAFederal Health Architecture

FIPSFederal information processing standards

FQHCFederally qualified health center

FTEFull-time equivalent

FYFiscal year

GAAPGenerally Accepted Accounting Principles

GAFGeographic Adjustment Factor

GMEGraduate medical education

HACsHospital-acquired conditions

HCAHPSHospital Consumer Assessment of Healthcare Providers and Systems

HCFAHealth Care Financing Administration

HCRISHospital Cost Report Information System

HHAHome health agency

HHSDepartment of Health and Human Services

HICHealth insurance card

HIPAAHealth Insurance Portability and Accountability Act of 1996, Pub. L. 104-191

HIPCHealth Information Policy Council

HISHealth information system

HITHealth information technology

HMOHealth maintenance organization

HPMPHospital Payment Monitoring Program

HSAHealth savings account

HSCRC[Maryland] Health Services Cost Review Commission

HSRVHospital-specific relative value

HSRVccHospital-specific relative value cost center

HQAHospital Quality Alliance

HQIHospital Quality Initiative

HWHHospital-within-a hospital

ICD-9-CMInternational Classification of Diseases, Ninth Revision,Clinical Modification

ICD-10-PCSInternational Classification of Diseases, Tenth Edition,Procedure Coding System

ICRInformation collection requirement

IHSIndian Health Service

IMEIndirect medical education

IOMInstitute of Medicine

IPFInpatient psychiatric facility

IPPS[Acute care hospital] inpatient prospective payment system

IRFInpatient rehabilitation facility

LAMCsLarge area metropolitan counties

LTC-DRGLong-term care diagnosis-related group

LTCHLong-term care hospital

MAMedicare Advantage

MACMedicare Administrative Contractor

MCCMajor complication or comorbidity

MCEMedicare Code Editor

MCOManaged care organization

MCVMajor cardiovascular condition

MDCMajor diagnostic category

MDHMedicare-dependent, small rural hospital

MedPACMedicare Payment Advisory Commission

MedPARMedicare Provider Analysis and Review File

MEIMedicare Economic Index

MGCRBMedicare Geographic Classification Review Board

MIEA-TRHCAMedicare Improvements and Extension Act, Division B of the Tax Relief and Health Care Act of 2006, Pub. L. 109-432

MMAMedicare Prescription Drug, Improvement, and Modernization Act of 2003, Pub. L. 108-173

MPNMedicare provider number

MRHFPMedicare Rural Hospital Flexibility Program

MRSAMethicillin-resistant Staphylococcus aureus

MSAMetropolitan Statistical Area

MS-DRGMedicare severity diagnosis-related group

MS-LTC-DRGMedicare severity long-term care diagnosis-related group

NAICS North American Industrial Classification System

NCD National coverage determination

NCHSNational Center for Health Statistics

NCQANational Committee for Quality Assurance

NCVHSNational Committee on Vital and Health Statistics

NECMANew England County Metropolitan Areas

NQFNational Quality Forum

NTISNational Technical Information Service

NVHRINational Voluntary Hospital Reporting Initiative

OESOccupational employment statistics

OIGOffice of the Inspector General

OMBExecutive Office of Management and Budget

O.R.Operating room

OSCAROnline Survey Certification and Reporting [System]

PEPulmonary embolism

PMSAsPrimary metropolitan statistical areas

POAPresent on admission

PPIProducer price index

PPSProspective payment system

PRMProvider Reimbursement Manual

ProPACProspective Payment Assessment Commission

PRRBProvider Reimbursement Review Board

PSFProvider-Specific File

PSRProvider Statistical and Reimbursement (System)

QIGQuality Improvement Group, CMS

QIOQuality Improvement Organization

RCEReasonable compensation equivalent

RHCRural health clinic

RHQDAPUReporting hospital quality data for annual payment update

RNHCIReligious nonmedical health care institution

RRCRural referral center

RUCAsRural-urban commuting area codes

RYRate year

SAFStandard Analytic File

SCHSole community hospital

SFYState fiscal year

SICStandard Industrial Classification

SNFSkilled nursing facility

SOCsStandard occupational classifications

SOMState Operations Manual

TEFRATax Equity and Fiscal Responsibility Act of 1982, Pub. L. 97-248

TMATMA [Transitional Medical Assistance], Abstinence Education, and QI [Qualifying Individuals] Programs Extension Act of 2007, Pub. L. 110-09

TJATotal joint arthroplasty

UHDDSUniform hospital discharge data set

VAPVentilator-associated pneumonia

VBPValue-based purchasing

Table of Contents

I. Background

A. Summary

1. Acute Care Hospital Inpatient Prospective Payment System (IPPS)

2. Hospitals and Hospital Units Excluded From the IPPS

a. Inpatient Rehabilitation Facilities (IRFs)

b. Long-Term Care Hospitals (LTCHs)

c. Inpatient Psychiatric Facilities (IPFs)

3. Critical Access Hospitals (CAHs)

4. Payments for Graduate Medical Education (GME)

B. Provisions of the Deficit Reduction Act of 2005 (DRA)

C. Provisions of the Medicare Improvements and Extension Act under Division B, Title I of the Tax Relief and Health Care Act of 2006 (MIEA-TRHCA)

D. Provision of the TMA, Abstinence Education, and QI Programs Extension Act of 2007

E. Major Contents of this Proposed Rule

1. Proposed Changes to MS-DRG Classifications and Recalibrations of Relative Weights

2. Proposed Changes to the Hospital Wage Index

3. Other Decisions and Proposed Changes to the IPPS for Operating Costs and GME Costs

4. Proposed Changes to the IPPS for Capital-Related Costs

5. Proposed Changes to the Payment Rates for Excluded Hospitals and Hospital Units: Rate-of-Increase Percentages

6. Proposed Changes Relating to Disclosure of Physician Ownership in Hospitals

7. Proposed Changes and Solicitation of Comments on Physician Self-Referral Provisions

8. Proposed Collection of Information Regarding Financial Relationships between Hospitals and Physicians

9. Determining Proposed Prospective Payment Operating and Capital Rates and Rate-of-Increase Limits

10. Impact Analysis

11. Recommendation of Update Factors for Operating Cost Rates of Payment for Inpatient Hospital Services

12. Disclosure of Financial Relationships Report (DFRR) Form

13. Discussion of Medicare Payment Advisory Commission Recommendations

F. Public Comments Received on Issues in Related Rules

1. Comments on Phase-Out of the Capital Teaching Adjustment under the IPPS Included in the FY 2008 IPPS Final Rule with Comment Period

2. Policy Revisions Related to Medicare GME Group Affiliations for Hospitals in Certain Declared Emergency Areas

II. Proposed Changes to Medicare Severity DRG (MS-DRG) Classifications and Relative Weights

A. Background

B. MS-DRG Reclassifications

1. General

2. Yearly Review for Making MS-DRG Changes

C. Adoption of the MS-DRGs in FY 2008

D. MS-DRG Documentation and Coding Adjustment, Including the Applicability to the Hospital-Specific Rates and the Puerto Rico-Specific Standardized Amount

1. MS-DRG Documentation and Coding Adjustment

2. Application of the Documentation and Coding Adjustment to the Hospital-Specific Rates

3. Application of the Documentation and Coding Adjustment to Puerto Rico-Specific Standardized Amount

4. Potential Additional Payment Adjustments in FYs 2010 through 2012

E. Refinement of the MS-DRG Relative Weight Calculation

1. Background

2. Refining the Medicare Cost Report

3. Timeline for Revising the Medicare Cost Report

4. Revenue Codes used in the MedPAR File

F. Preventable Hospital-Acquired Conditions (HACs), Including Infections

1. General

2. Statutory Authority

3. Public Input

4. Collaborative Process

5. Selection Criteria for HACs

6. HACs Selected in FY 2008 and Proposed Changes to Certain Codes

a. Foreign Object Retained After Surgery: Proposed Inclusion of ICD-9-CM Code 998.7 (CC)

b. Pressure Ulcers: Proposed Changes in Code Assignments

7. HACs Under Consideration as Additional Candidates

a. Surgical Site Infections Following Elective Surgeries

b. Legionnaires' Disease

c. Glycemic Control

d. Iatrogenic Pneumothorax

e. Delirium

f. Ventilator-Associated Pneumonia (VAP)

g. Deep Vein Thrombosis (DVT)/Pulmonary Embolism (PE)

h. Staphylococcus aureus Septicemia

i. Clostridium Difficile -Associated Disease (CDAD)

j. Methicillin-Resistant Staphylococcus aureus (MRSA)

8. Present on Admission (POA) Indicator Reporting

9. Enhancement and Future Issues

a. Risk Adjustment

b. Rates of HACs

c. Use of POA Information

d. Transition to ICD-10-PCS

e. Application of Nonpayment for HACs to Other Settings

f. Relationship to NQF's Serious Reportable Adverse Events

G. Proposed Changes to Specific MS-DRG Classifications

1. Pre-MDCs: Artificial Heart Devices

2. MDC 1 (Diseases and Disorders of the Nervous System)

a. Transferred Stroke Patients Receiving Tissue Plasminogen Activator (tPA)

b. Intractable Epilepsy with Video Electroencephalogram (EEG)

3. MDC 5 (Diseases and Disorders of the Circulatory System)

a. Automatic Implantable Cardioverter-Defibrillators (AICD) Lead and Generator Procedures

b. Left Atrial Appendage Device

4. MDC 8 (Diseases and Disorders of the Musculoskeletal System and Connective Tissue): Hip and Knee Replacements and Revisions

a. Brief History of Development of Hip and Knee Replacement Codes

b. Prior Recommendations of the AAHKS

c. Adoption of MS-DRGs for Hip and Knee Replacements for FY 2008 and AAHKS' Recommendations

d. AAHKS' Recommendations for FY 2009

e. CMS' Response to AAHKS' Recommendations

f. Conclusion

5. MDC 18 (Infections and Parasitic Diseases Systemic or Unspecified Sites): Severe Sepsis

6. MDC 21 (Injuries, Poisonings and Toxic Effects of Drugs): Traumatic Compartment Syndrome

7. Medicare Code Editor (MCE) Changes

a. List of Unacceptable Principal Diagnoses in MCE

b. Diagnoses Allowed for Male Only Edit c. Limited Coverage Edit

8. Surgical Hierarchies

9. CC Exclusions List

a. Background

b. CC Exclusions List for FY 2009

10. Review of Procedure Codes in MS-DRGs 981, 982, and 983; 984, 985, and 986; and 987, 988, and 989

a. Moving Procedure Codes from MS-DRG 981 through 983 or MS-DRG 987 through 989 to MDCs

b. Reassignment of Procedures among MS-DRGs 981 through 983, 984 through 986, and 987 through 989

c. Adding Diagnosis or Procedure Codes to MDCs

11. Changes to the ICD-9-CM Coding System

H. Recalibration of MS-DRG Weights

I. Proposed Medicare Severity Long-Term Care Diagnosis-Related Group (MS-LTC-DRG) Reclassifications and Relative Weights for LTCHs for FY 2009

1. Background

2. Proposed Changes in the MS-LTC-DRG Classifications

a. Background

b. Patient Classifications into MS-LTC-DRGs

3. Development of the Proposed FY 2009 MS-LTC-DRG Relative Weights

a. General Overview of Development of the MS-LTC-DRG Relative Weights

b. Data

c. Hospital-Specific Relative Value (HSRV) Methodology

d. Treatment of Severity Levels in Developing Proposed Relative Weights

e. Proposed Low-Volume MS-LTC-DRGs

4. Steps for Determining the Proposed FY 2009 MS-LTC-DRG Relative Weights

J. Proposed Add-On Payments for New Services and Technologies

1. Background

2. Public Input Before Publication of a Notice of Proposed Rulemaking on Add-On Payments

3. FY 2009 Status of Technologies Approved for FY 2008 Add-On Payments

4. FY 2009 Applications for New Technology Add-On Payments

a. CardioWest TM Temporary Total Artificial Heart System (CardioWest TM TAH-t)

b. Emphasys Medical Zephyr® Endobronchial Valve (Zephyr® EBV)

c. Oxiplex®

d. TherOx Downstream® System

5. Proposed Regulatory Change

III. Proposed Changes to the Hospital Wage Index

A. Background

B. Requirements of Section 106 of the MIEA-TRHCA

1. Wage Index Study Required Under the MIEA-TRHCA

2. CMS Proposals in Response to Requirements Under Section 106(b) of the MIEA-TRHCA

a. Proposed Revision of the Reclassification Average Hourly Wage Comparison Criteria

b. Within-State Budget Neutrality Adjustment for the Rural and Imputed Floors

c. Within-State Budget Neutrality Adjustment for Geographic Reclassification

C. Core-Based Statistical Areas for the Hospital Wage Index

D. Proposed Occupational Mix Adjustment to the Proposed FY 2009 Wage Index

1. Development of Data for the Proposed FY 2009 Occupational Mix Adjustment

2. Calculation of the Proposed Occupational Mix Adjustment for FY 2009

3. 2007-2008 Occupational Mix Survey for the FY 2010 Wage Index

E. Worksheet S-3 Wage Data for the Proposed FY 2009 Wage Index

1. Included Categories of Costs

2. Excluded Categories of Costs

3. Use of Wage Index Data by Providers Other Than Acute Care Hospitals Under the IPPS

F. Verification of Worksheet S-3 Wage Data

1. Wage Data for Multicampus Hospitals

2. New Orleans' Post-Katrina Wage Index

G. Method for Computing the Proposed FY 2009 Unadjusted Wage Index

H. Analysis and Implementation of the Proposed Occupational Mix Adjustment and the Proposed FY 2009 Occupational Mix Adjustment Wage Index

I. Proposed Revisions to the Wage Index Based on Hospital Redesignations

1. General

2. Effects of Reclassification/Redesignation

3. FY 2009 MGCRB Reclassifications

4. FY 2008 Policy Clarifications and Revisions

5. Redesignations of Hospitals under Section 1886(d)(8)(B) of the Act

6. Reclassifications under Section 1886(d)(8)(B) of the Act

J. Proposed FY 2009 Wage Index Adjustment Based on Commuting Patterns of Hospital Employees

K. Process for Requests for Wage Index Data Corrections

L. Labor-Related Share for the Proposed Wage Index for FY 2009

IV. Other Decisions and Proposed Changes to the IPPS for Operating Costs and GME Costs

A. Proposed Changes to the Postacute Care Transfer Policy

1. Background

2. Proposed Policy Change Relating to Transfers to Home with a Written Plan for the Provision of Home Health Services

3. Evaluation of MS-DRGs under Postacute Care Transfer Policy for FY 2009

B. Reporting of Hospital Quality Data for Annual Hospital Payment Update

1. Background

a. Overview

b. Voluntary Hospital Quality Data Reporting

c. Hospital Quality Data Reporting under Section 501(b) of Pub. L. 108-173

d. Hospital Quality Data Reporting under Section 5001(a) of Pub. L. 109-171

2. Proposed Quality Measures for FY 2010 and Subsequent Years

a. Proposed Quality Measures for FY 2010

b. Possible New Quality Measures, Measure Sets, and Program Requirements for FY 2011 and Subsequent Years

c. Considerations in Expanding and Updating Quality Measures Under the RHQDAPU Program

3. Form and Manner and Timing of Quality Data Submission

4. Current and Proposed RHQDAPU Program Procedures

a. RHQDAPU Program Procedures for FY 2009

b. Proposed RHQDAPU Program Procedures for FY 2010

5. Current and Proposed HCAHPS Requirements

a. FY 2009 HCAHPS Requirements

b. Proposed FY 2010 HCAHPS Requirements

6. Current and Proposed Chart Validation Requirements

a. Chart Validation Requirements for FY 2009

b. Proposed Chart Validation Requirements for FY 2010

c. Chart Validation Methods and Requirements Under Consideration for FY 2011 and Subsequent Years

7. Data Attestation Requirements

a. Proposed Change to Requirements for FY 2009

b. Proposed Requirements for FY 2010

8. Public Display Requirements

9. Proposed Reconsideration and Appeal Procedures

10. Proposed RHQDAPU Program Withdrawal Deadline for FYs 2009 and 2010

11. Requirements for New Hospitals

12. Electronic Medical Records

C. Medicare Hospital Value-Based Purchasing (VBP)

1. Medicare Hospital VBP Plan Report to Congress

2. Testing and Further Development of the Medicare Hospital VBP Plan

D. Sole Community Hospitals (SCHs) and Medicare-Dependent, Small Rural Hospitals (MDHs): Volume Decrease Adjustment

1. Background

2. Volume Decrease Adjustment for SCHs and MDHs: Data Sources for Determining Core Staff Values

a. Occupational Mix Survey

b. AHA Annual Survey

E. Rural Referral Centers (RRCs)

1. Case-Mix Index

2. Discharges

F. Indirect Medical Education (IME) Adjustment

1. Background

2. IME Adjustment Factor for FY 2009

G. Medicare GME Affiliation Provisions for Teaching Hospitals in Certain Emergency Situations; Technical Correction

1. Background

2. Technical Correction

H. Payments to Medicare Advantage Organizations: Collection of Risk Adjustment Data

I. Hospital Emergency Services under EMTALA

1. Background

2. EMTALA Technical Advisory Group (TAG): Recommendations

3. Proposed Changes Relating to Applicability of EMTALA Requirements to Hospital Inpatients

4. Proposed Changes to the EMTALA Physician On-Call Requirements

a. Relocation of Regulatory Provisions

b. Shared/Community Call

5. Proposed Technical Change to Regulations

J. Application of Incentives To Reduce Avoidable Readmissions to Hospitals

1. Introduction

2. Measurement

3. Accountability

4. Interventions

5. Financial Incentive: Direct Payment Adjustment

6. Financial Incentive: Performance-Based Payment Adjustment

7. Nonfinancial Incentive: Public Reporting

8. Conclusion

K. Rural Community Hospital Demonstration Program

V. Proposed Changes to the IPPS for Capital-Related Costs

A. Background

1. Exception Payments

2. New Hospitals

3. Hospitals Located in Puerto Rico

B. Revisions to the Capital IPPS Based on Data on Hospitals Medicare Capital Margins

1. Elimination of the Large Add-On Payment Adjustment

2. Changes to the Capital IME Adjustment

a. Background and Changes Made for FY 2008

b. Public Comments Received on Phase Out of Capital IPPS Teaching Adjustment Provisions Included in the FY 2008 Final Rule With Comment Period and Further Solicitation of Public Comments

VI. Proposed Changes for Hospitals and Hospital Units Excluded From the IPPS

A. Proposed Payments to Excluded Hospitals and Hospital Units

B. IRF PPS

C. LTCH PPS

D. IPF PPS

E. Determining Proposed LTCH Cost-to-Charge Ratios (CCRs) under the LTCH PPS

F. Proposed Change to the Regulations Governing Hospitals-Within-Hospitals

VII. Disclosure Required of Certain Hospitals and Critical Access Hospitals Regarding Physician Ownership

VIII. Physician Self-Referrals Provisions

A. Stand in the Shoes Provisions

1. Physician "Stand in the Shoes" Provisions

a. Background

b. Proposals

2. DHS Entity "Stand in the Shoes" Provisions

3. Application of the Physician "Stand in the Shoes" and the Entity "Stand in the Shoes" Provisions

4. Definitions: "Physician" and "Physician Organization"

B. Period of Disallowance

C. Gainsharing Arrangements

1. Background

2. Statutory Impediments to Gainsharing Arrangements

3. Office of Inspector General (OIG) Approach Towards Gainsharing Arrangements

4. MedPAC Recommendation

5. Demonstration Programs

6. Solicitation of Comments

D. Physician-Owned Implant and Other Medical Device Companies

1. Background

2. Solicitation of Comments

IX. Financial Relationships between Hospitals and Physicians

A. Background

B. Section 5006 of the Deficit Reduction Act (DRA) of 2005

C. Disclosure of Financial Relationships Report (DFRR)

D. Civil Monetary Penalties

E. Uses of Information Captured by the DFRR

F. Solicitation of Comments

X. MedPAC Recommendations

XI. Other Required Information

A. Requests for Data from the Public

B. Collection of Information Requirements

1. Legislative Requirement for Solicitation of Comments

2. Solicitation of Comments on Proposed Requirements in Regulatory Text

a. ICRs Regarding Physician Reporting Requirements

b. ICRs Regarding Risk Adjustment Data

c. ICRs Regarding Basic Commitments of Providers

3. Associated Information Collections Not Specified in Regulatory Text

a. Present on Admission (POA) Indicator Reporting

b. Proposed Add-On Payments for New Services and Technologies

c. Reporting of Hospital Quality Data for Annual Hospital Payment Update

d. Occupational Mix Adjustment to the FY 2009 Index (Hospital Wage Index Occupational Mix Survey)

4. Addresses for Submittal of Comments on Information Collection Requirements

C. Response to Public Comments

Regulation Text

Addendum-Proposed Schedule of Standardized Amounts, Update Factors, and Rate-of-Increase Percentages Effective With Cost Reporting Periods Beginning On or After October 1, 2008

I. Summary and Background

II. Proposed Changes to the Prospective Payment Rates for Hospital Inpatient Operating Costs for FY 2009

A. Calculation of the Adjusted Standardized Amount

B. Proposed Adjustments for Area Wage Levels and Cost-of-Living

C. Proposed MS-DRG Relative Weights

D. Calculation of the Proposed Prospective Payment Rates

III. Proposed Changes of Payment Rates for Acute Care Hospital Inpatient Capital-Related Costs for FY 2009

A. Determination of Proposed Federal Hospital Inpatient Capital-Related Prospective Payment Rate Update

B. Calculation of the Proposed Inpatient Capital-Related Prospective Payments for FY 2009

C. Capital Input Price Index

IV. Proposed Changes to Payment Rates for Excluded Hospitals and Hospital Units: Rate-of-Increase Percentages

V. Tables

Table 1A.-National Adjusted Operating Standardized Amounts, Labor/Nonlabor (69.7 Percent Labor Share/30.3 Percent Nonlabor Share If Wage Index Is Greater Than 1)

Table 1B.-National Adjusted Operating Standardized Amounts, Labor/Nonlabor (62 Percent Labor Share/38 Percent Nonlabor Share If Wage Index Is Less Than or Equal to 1)

Table 1C.-Adjusted Operating Standardized Amounts for Puerto Rico, Labor/Nonlabor

Table 1D.-Capital Standard Federal Payment Rate

Table 2.-Hospital Case-Mix Indexes for Discharges Occurring in Federal Fiscal Year 2007; Hospital Wage Indexes for Federal Fiscal Year 2009; Hospital Average Hourly Wages for Federal Fiscal Years 2007 (2003 Wage Data), 2008 (2004 Wage Data), and 2009 (2005 Wage Data); and 3-Year Average of Hospital Average Hourly Wages

Table 3A.-FY 2009 and 3-Year Average Hourly Wage for Urban Areas by CBSA

Table 3B.-FY 2009 and 3-Year Average Hourly Wage for Rural Areas by CBSA

Table 4A.-Wage Index and Capital Geographic Adjustment Factor (GAF) for Urban Areas by CBSA and by State-FY 2009

Table 4B.-Wage Index and Capital Geographic Adjustment Factor (GAF) for Rural Areas by CBSA and by State-FY 2009

Table 4C.-Wage Index and Capital Geographic Adjustment Factor (GAF) for Hospitals That Are Reclassified by CBSA and by State-FY 2009

Table 4D-1.-Rural Floor Budget Neutrality Factors-FY 2009

Table 4D-2.-Urban Areas with Hospitals Receiving the Statewide Rural Floor or Imputed Floor Wage Index-FY 2009

Table 4E.-Urban CBSAs and Constituent Counties-FY 2009

Table 4F.-Puerto Rico Wage Index and Capital Geographic Adjustment Factor (GAF) by CBSA-FY 2009

Table 4J.-Out-Migration Wage Adjustment-FY 2009

Table 5.-List of Medicare Severity Diagnosis-Related Groups (MS-DRGs), Relative Weighting Factors, and Geometric and Arithmetic Mean Length of Stay

Table 6A.-New Diagnosis Codes

Table 6B.-New Procedure Codes

Table 6C.-Invalid Diagnosis Codes

Table 6D.-Invalid Procedure Codes

Table 6E.-Revised Diagnosis Code Titles

Table 6F.-Revised Procedure Code Titles

Table 6G.-Additions to the CC Exclusions List (Available through the Internet on the CMS Web site at: http://www.cms.hhs.gov/AcuteInpatientPPS/ )

Table 6H.-Deletions From the CC Exclusions List (Available Through the Internet on the CMS Web site at: http://www.cms.hhs.gov/AcuteInpatientPPS/ )

Table 6I.-Complete List of Complication and Comorbidity (CC) Exclusions (Available Only Through the Internet on the CMS Web site at: http:/www.cms.hhs.gov/AcuteInpatientPPS/ )

Table 6J.-Major Complication and Comorbidity (MCC) List (Available Through the Internet on the CMS Web Site at: http://www.cms.hhs.gov/AcuteInpatientPPS/ )

Table 6K.-Complication and Comorbidity (CC) List (Available Through the Internet on the CMS Web site at: http://www.cms.hhs.gov/AcuteInpatientPPS/ )

Table 7A.-Medicare Prospective Payment System Selected Percentile Lengths of Stay: FY 2007 MedPAR Update-December 2007 GROUPER V25.0 MS-DRGs

Table 7B.-Medicare Prospective Payment System Selected Percentile Lengths of Stay: FY 2007 MedPAR Update-December 2007 GROUPER V26.0 MS-DRGs

Table 8A.-Proposed Statewide Average Operating Cost-to-Charge Ratios-March 2008

Table 8B.-Proposed Statewide Average Capital Cost-to-Charge Ratios-March 2008

Table 8C.-Proposed Statewide Average Total Cost-to-Charge Ratios for LTCHs-March 2008

Table 9A.-Hospital Reclassifications and Redesignations-FY 2009

Table 9B.-Hospitals Redesignated as Rural under Section 1886(d)(8)(E) of the Act-FY 2009

Table 10.-Geometric Mean Plus the Lesser of .75 of the National Adjusted Operating Standardized Payment Amount (Increased to Reflect the Difference Between Costs and Charges) or .75 of One Standard Deviation of Mean Charges by Medicare Severity Diagnosis-Related Groups (MS-DRGs)-March 2008

Table 11.-Proposed FY 2009 MS-LTC-DRGs, Proposed Relative Weights, Proposed Geometric Average Length of Stay, and Proposed Short-Stay Outlier Threshold

Appendix A-Regulatory Impact Analysis

I. Overall Impact

II. Objectives

III. Limitations on Our Analysis

IV. Hospitals Included in and Excluded From the IPPS

V. Effects on Excluded Hospitals and Hospital Units

VI. Quantitative Effects of the Proposed Policy Changes Under the IPPS for Operating Costs

A. Basis and Methodology of Estimates

B. Analysis of Table I

C. Effects of the Proposed Changes to the MS-DRG Reclassifications and Relative Cost-Based Weights (Column 2)

D. Effects of Proposed Wage Index Changes (Column 3)

E. Combined Effects of Proposed MS-DRG and Wage Index Changes (Column 4)

F. Effects of MGCRB Reclassifications (Column 5)

G. Effects of the Proposed Rural Floor and Imputed Rural Floor, Including the Proposed Application of Budget Neutrality at the State Level (Column 6)

H. Effects of the Proposed Wage Index Adjustment for Out-Migration (Column 7)

I. Effects of All Proposed Changes with CMI Adjustment Prior to Estimated Growth (Column 8)

J. Effects of All Proposed Changes with CMI Adjustment and Estimated Growth(Column 9)

K. Effects of Policy on Payment Adjustment for Low-Volume Hospitals

L. Impact Analysis of Table II

VII. Effects of Other Proposed Policy Changes

A. Effects of Proposed Policy on HACs, Including Infections

B. Effects of Proposed MS-LTC-DRG Reclassifications and Relative Weights for LTCHs

C. Effects of Proposed Policy Change Relating to New Medical Service and Technology Add-On Payments

D. Effects of Proposed Policy Change Regarding Postacute Care Transfers to Home Health Services

E. Effects of Proposed Requirements for Hospital Reporting of Quality Data for Annual Hospital Payment Update

F. Effects of Proposed Policy Change to Methodology for Computing Core Staffing Factors for Volume Decrease Adjustment for SCHs and MDHs

G. Effects of Proposed Clarification of Policy for Collection of Risk Adjustment Data From MA Organizations

H. Effects of Proposed Policy Changes Relating to Hospital Emergency Services under EMTALA

I. Effects of Implementation of Rural Community Hospital Demonstration Program

J. Effects of Proposed Policy Changes Relating to Payments to Hospitals-Within-Hospitals

K. Effects of Proposed Policy Changes Relating to Requirements for Disclosure of Physician Ownership in Hospitals

L. Effects of Proposed Changes Relating to Physician Self-Referral Provisions

M. Effects of Proposed Changes Relating to Reporting of Financial Relationships Between Hospitals and Physicians

VIII. Effects of Proposed Changes in the Capital IPPS

A. General Considerations

B. Results

IX. Alternatives Considered

X. Overall Conclusion

XI. Accounting Statement

XII. Executive Order 12866

Appendix B-Recommendation of Update Factors for Operating Cost Rates of Payment for Inpatient Hospital Services

I. Background

II. Inpatient Hospital Update for FY 2009

III. Secretary's Recommendation

IV. MedPAC Recommendation for Assessing Payment Adequacy and Updating Payments in Traditional Medicare

Appendix C-Disclosure of Financial Relationships Report (DFRR) Form

I. Background

A. Summary

1. Acute Care Hospital Inpatient Prospective Payment System (IPPS)

Section 1886(d) of the Social Security Act (the Act) sets forth a system of payment for the operating costs of acute care hospital inpatient stays under Medicare Part A (Hospital Insurance) based on prospectively set rates. Section 1886(g) of the Act requires the Secretary to pay for the capital-related costs of hospital inpatient stays under a prospective payment system (PPS). Under these PPSs, Medicare payment for hospital inpatient operating and capital-related costs is made at predetermined, specific rates for each hospital discharge. Discharges are classified according to a list of diagnosis-related groups (DRGs).

The base payment rate is comprised of a standardized amount that is divided into a labor-related share and a nonlabor-related share. The labor-related share is adjusted by the wage index applicable to the area where the hospital is located. If the hospital is located in Alaska or Hawaii, the nonlabor-related share is adjusted by a cost-of-living adjustment factor. This base payment rate is multiplied by the DRG relative weight.

If the hospital treats a high percentage of low-income patients, it receives a percentage add-on payment applied to the DRG-adjusted base payment rate. This add-on payment, known as the disproportionate share hospital (DSH) adjustment, provides for a percentage increase in Medicare payments to hospitals that qualify under either of two statutory formulas designed to identify hospitals that serve a disproportionate share of low-income patients. For qualifying hospitals, the amount of this adjustment may vary based on the outcome of the statutory calculations.

If the hospital is an approved teaching hospital, it receives a percentage add-on payment for each case paid under the IPPS, known as the indirect medical education (IME) adjustment. This percentage varies, depending on the ratio of residents to beds.

Additional payments may be made for cases that involve new technologies or medical services that have been approved for special add-on payments. To qualify, a new technology or medical service must demonstrate that it is a substantial clinical improvement over technologies or services otherwise available, and that, absent an add-on payment, it would be inadequately paid under the regular DRG payment.

The costs incurred by the hospital for a case are evaluated to determine whether the hospital is eligible for an additional payment as an outlier case. This additional payment is designed to protect the hospital from large financial losses due to unusually expensive cases. Any outlier payment due is added to the DRG-adjusted base payment rate, plus any DSH, IME, and new technology or medical service add-on adjustments.

Although payments to most hospitals under the IPPS are made on the basis of the standardized amounts, some categories of hospitals are paid in whole or in part based on their hospital-specific rate based on their costs in a base year. For example, sole community hospitals (SCHs) receive the higher of a hospital-specific rate based on their costs in a base year (the higher of FY 1982, FY 1987, or FY 1996) or the IPPS rate based on the standardized amount. Until FY 2007, a Medicare-dependent, small rural hospital (MDH) has received the IPPS rate plus 50 percent of the difference between the IPPS rate and its hospital-specific rate if the hospital-specific rate based on their costs in a base year (the higher of FY 1982, FY 1987, or FY 2002) is higher than the IPPS rate. As discussed below, for discharges occurring on or after October 1, 2007, but before October 1, 2011, an MDH will receive the IPPS rate plus 75 percent of the difference between the IPPS rate and its hospital-specific rate, if the hospital-specific rate is higher than the IPPS rate. SCHs are the sole source of care in their areas, and MDHs are a major source of care for Medicare beneficiaries in their areas. Both of these categories of hospitals are afforded this special payment protection in order to maintain access to services for beneficiaries.

Section 1886(g) of the Act requires the Secretary to pay for the capital-related costs of inpatient hospital services "in accordance with a prospective payment system established by the Secretary." The basic methodology for determining capital prospective payments is set forth in our regulations at 42 CFR 412.308 and 412.312. Under the capital IPPS, payments are adjusted by the same DRG for the case as they are under the operating IPPS. Capital IPPS payments are also adjusted for IME and DSH, similar to the adjustments made under the operating IPPS. However, as discussed in section V.B.2. of this preamble, we are phasing out the IME adjustment beginning with FY 2008. In addition, hospitals may receive outlier payments for those cases that have unusually high costs.

The existing regulations governing payments to hospitals under the IPPS are located in 42 CFR Part 412, Subparts A through M.

2. Hospitals and Hospital Units Excluded From the IPPS

Under section 1886(d)(1)(B) of the Act, as amended, certain specialty hospitals and hospital units are excluded from the IPPS. These hospitals and units are: Rehabilitation hospitals and units; long-term care hospitals (LTCHs); psychiatric hospitals and units; children's hospitals; and cancer hospitals. Religious nonmedical health care institutions (RNHCIs) are also excluded from the IPPS. Various sections of the Balanced Budget Act of 1997 (Pub. L. 105-33), the Medicare, Medicaid and SCHIP [State Children's Health Insurance Program] Balanced Budget Refinement Act of 1999 (Pub. L. 106-113), and the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000 (Pub. L. 106-554) provide for the implementation of PPSs for rehabilitation hospitals and units (referred to as inpatient rehabilitation facilities (IRFs)), LTCHs, and psychiatric hospitals and units (referred to as inpatient psychiatric facilities (IPFs)), as discussed below. Children's hospitals, cancer hospitals, and RNHCIs continue to be paid solely under a reasonable cost-based system.

The existing regulations governing payments to excluded hospitals and hospital units are located in 42 CFR Parts 412 and 413.

a. Inpatient Rehabilitation Facilities (IRFs)

Under section 1886(j) of the Act, as amended, rehabilitation hospitals and units (IRFs) have been transitioned from payment based on a blend of reasonable cost reimbursement subject to a hospital-specific annual limit under section 1886(b) of the Act and the adjusted facility Federal prospective payment rate for cost reporting periods beginning on or after January 1, 2002 through September 30, 2002, to payment at 100 percent of the Federal rate effective for cost reporting periods beginning on or after October 1, 2002. IRFs subject to the blend were also permitted to elect payment based on 100 percent of the Federal rate. The existing regulations governing payments under the IRF PPS are located in 42 CFR Part 412, Subpart P.

b. Long-Term Care Hospitals (LTCHs)

Under the authority of sections 123(a) and (c) of Pub. L. 106-113 and section 307(b)(1) of Pub. L. 106-554, the LTCH PPS was effective for a LTCH's first cost reporting period beginning on or after October 1, 2002. LTCHs that do not meet the definition of "new" under § 412.23(e)(4) are paid, during a 5-year transition period, a LTCH prospective payment that is comprised of an increasing proportion of the LTCH Federal rate and a decreasing proportion based on reasonable cost principles. Those LTCHs that did not meet the definition of "new" under § 412.23(e)(4) could elect to be paid based on 100 percent of the Federal prospective payment rate instead of a blended payment in any year during the 5-year transition. For cost reporting periods beginning on or after October 1, 2006, all LTCHs are paid 100 percent of the Federal rate. The existing regulations governing payment under the LTCH PPS are located in 42 CFR Part 412, Subpart O.

c. Inpatient Psychiatric Facilities (IPFs)

Under the authority of sections 124(a) and (c) of Pub. L. 106-113, inpatient psychiatric facilities (IPFs) (formerly psychiatric hospitals and psychiatric units of acute care hospitals) are paid under the IPF PPS. For cost reporting periods beginning on or after January 1, 2008, all IPFs are paid 100 percent of the Federal per diem payment amount established under the IPF PPS. (For cost reporting periods beginning on or after January 1, 2005, and ending on or before December 31, 2007, some IPFs received transitioned payments for inpatient hospital services based on a blend of reasonable cost-based payment and a Federal per diem payment rate.) The existing regulations governing payment under the IPF PPS are located in 42 CFR part 412, Subpart N.

3. Critical Access Hospitals (CAHs)

Under sections 1814, 1820, and 1834(g) of the Act, payments are made to critical access hospitals (CAHs) (that is, rural hospitals or facilities that meet certain statutory requirements) for inpatient and outpatient services are based on 101 percent of reasonable cost. Reasonable cost is determined under the provisions of section 1861(v)(1)(A) of the Act and existing regulations under 42 CFR Parts 413 and 415.

4. Payments for Graduate Medical Education (GME)

Under section 1886(a)(4) of the Act, costs of approved educational activities are excluded from the operating costs of inpatient hospital services. Hospitals with approved graduate medical education (GME) programs are paid for the direct costs of GME in accordance with section 1886(h) of the Act. The amount of payment for direct GME costs for a cost reporting period is based on the hospital's number of residents in that period and the hospital's costs per resident in a base year. The existing regulations governing payments to the various types of hospitals are located in 42 CFR Part 413.

B. Provisions of the Deficit Reduction Act of 2005 (DRA)

Section 5001(b) of the Deficit Reduction Act of 2005 (DRA), Pub. L. 109-171, requires the Secretary to develop a plan to implement, beginning with FY 2009, a value-based purchasing plan for section 1886(d) hospitals defined in the Act. In section IV.C. of the preamble of this proposed rule, we discuss the report to Congress on the Medicare value-based purchasing plan and the current testing of the plan.

C. Provisions of the Medicare Improvements and Extension Act Under Division B, Title I of the Tax Relief and Health Care Act of 2006 (MIEA-TRHCA)

Section 106(b)(2) of the MIEA-TRHCA instructs the Secretary of Health and Human Services to include in the FY 2009 IPPS proposed rule one or more proposals to revise the wage index adjustment applied under section 1886(d)(3)(E) of the Act for purposes of the IPPS. The Secretary was also instructed to consider MedPAC's recommendations on the Medicare wage index classification system in developing these proposals. In section III. of the preamble of this proposed rule, we discuss MedPAC's recommendations in a report to Congress and present our proposed changes to the FY 2009 wage index in response to those recommendations.

D. Provision of the TMA, Abstinence Education, and QI Programs Extension Act of 2007

Section 7 of the TMA [Transitional Medical Assistance], Abstinence Education, and QI [Qualifying Individuals] Programs Extension Act of 2007 (Pub. L. 110-90) provides for a 0.9 percent prospective documentation and coding adjustment in the determination of standardized amounts under the IPPS (except for MDHs and SCHs) for discharges occurring during FY 2009. The prospective documentation and coding adjustment was established in FY 2008 in response to the implementation of an MS-DRG system under the IPPS that resulted in changes in coding and classification that did not reflect real changes in case-mix under section 1886(d) of the Act. We discuss our proposed implementation of this provision in section II.D. of the preamble of this proposed rule and in the Addendum and in Appendix A to this proposed rule.

E. Major Contents of This Proposed Rule

In this proposed rule, we are setting forth proposed changes to the Medicare IPPS for operating costs and for capital-related costs in FY 2009. We also are setting forth proposed changes relating to payments for IME costs and payments to certain hospitals and units that continue to be excluded from the IPPS and paid on a reasonable cost basis. In addition, we are presenting proposed changes relating to disclosure to patients of physician ownership and investment interests in hospitals, proposed changes to our physician self-referral regulations, and a solicitation of public comments on a proposed collection of information regarding financial relationships between hospitals and physicians.

The following is a summary of the major changes that we are proposing to make:

1. Proposed Changes to MS-DRG Classifications and Recalibrations of Relative Weights

In section II. of the preamble to this proposed rule, we are including-

• Proposed changes to MS-DRG reclassifications based on our yearly review.

• Proposed application of the documentation and coding adjustment to hospital-specific rates resulting from implementation of the MS-DRG system.

• Proposed changes to address the RTI reporting recommendations on charge compression.

• Proposed recalibrations of the MS-DRG relative weights.

We also are proposing to refine the hospital cost reports so that charges for relatively inexpensive medical supplies are reported separately from the costs and charges for more expensive medical devices. This proposal would be applied to the determination of both the IPPS and the OPPS relative weights as well as the calculation of the ambulatory surgical center payment rates.

We are presenting a listing and discussion of additional hospital-acquired conditions (HACs), including infections, that are being proposed to be subject to the statutorily required quality adjustment in MS-DRG payments for FY 2009.

We are presenting our evaluation and analysis of the FY 2009 applicants for add-on payments for high-cost new medical services and technologies (including public input, as directed by Pub. L. 108-173, obtained in a town hall meeting).

We are proposing the annual update of the MS-LTC-DRG classifications and relative weights for use under the LTCH PPS for FY 2009.

2. Proposed Changes to the Hospital Wage Index

In section III. of the preamble to this proposed rule, we are proposing revisions to the wage index and the annual update of the wage data. Specific issues addressed include the following:

• Proposed wage index reform changes in response to recommendations made to Congress as a result of the wage index study required under Pub. L. 109-432. We discuss changes related to reclassifications criteria, application of budget neutrality in reclassifications, and the rural floor and imputed floor budget neutrality at the State level.

• Changes to the CBSA designations.

• The methodology for computing the proposed FY 2009 wage index.

• The proposed FY 2009 wage index update, using wage data from cost reporting periods that began during FY 2006.

• Analysis and implementation of the proposed FY 2009 occupational mix adjustment to the wage index.

• Proposed revisions to the wage index based on hospital redesignations and reclassifications.

• The proposed adjustment to the wage index for FY 2009 based on commuting patterns of hospital employees who reside in a county and work in a different area with a higher wage index.

• The timetable for reviewing and verifying the wage data used to compute the proposed FY 2009 wage index.

• The proposed labor-related share for the FY 2009 wage index, including the labor-related share for Puerto Rico.

3. Other Decisions and Proposed Changes to the IPPS for Operating Costs and GME Costs

In section IV. of the preamble to this proposed rule, we discuss a number of the provisions of the regulations in 42 CFR Parts 412, 413, and 489, including the following:

• Proposed changes to the postacute care transfer policy as it relates to transfers to home with the provision of home health services.

• The reporting of hospital quality data as a condition for receiving the full annual payment update increase.

• Proposed changes in the collection of Medicare Advantage (MA) encounter data that are used for computing the risk payment adjustment made to MA organizations.

• Discussion of the report to Congress on the Medicare value-based purchasing plan and current testing and further development of the plan.

• Proposed changes to the methodology for determining core staff values for the volume decrease payment adjustment for SCHs and MDHs.

• The proposed updated national and regional case-mix values and discharges for purposes of determining RRC status.

• The statutorily-required IME adjustment factor for FY 2009 and technical changes to the GME payment policies.

• Proposed changes to policies on hospital emergency services under EMTALA to address EMTALA Technical Advisory Group (TAG) recommendations.

• Solicitation of public comments on Medicare policies relating to incentives for avoidable readmissions to hospitals.

• Discussion of the fifth year of implementation of the Rural Community Hospital Demonstration Program.

4. Proposed Changes to the IPPS for Capital-Related Costs

In section V. of the preamble to this proposed rule, we discuss the payment policy requirements for capital-related costs and capital payments to hospitals. We acknowledge the public comments that we received on the phase-out of the capital teaching adjustment included in the FY 2008 IPPS final rule with comment period, and again are soliciting public comments on this phase-out in this proposed rule.

5. Proposed Changes to the Payment Rates for Excluded Hospitals and Hospital Units: Rate-of-Increase Percentages

In section VI. of the preamble to this proposed rule, we discuss proposed changes to payments to excluded hospitals and hospital units, proposed changes for determining LTCH CCRs under the LTCH PPS, including a discussion regarding changing the annual payment rate update schedule for the LTCH PPS, and proposed changes to the regulations on hospitals-within-hospitals.

6. Proposed Changes Relating to Disclosure of Physician Ownership in Hospitals

In section VII. of the preamble of this proposed rule, we present proposed changes to the regulations relating to the disclosure to patients of physician ownership or investment interests in hospitals.

7. Proposed Changes and Solicitation of Comments on Physician Self-Referrals Provisions

In section VIII. of the preamble of this proposed rule, we present proposed changes to the policies on physician self-referrals relating to the "Stand in Shoes" provision, In addition, we solicit public comments regarding physician-owned implant companies and gainsharing arrangements.

8. Proposed Collection of Information Regarding Financial Relationships Between Hospitals and Physicians

In section IX. of the preamble of this proposed rule, we solicit public comments on our proposed collection of information regarding financial relationships between hospitals and physicians.

9. Determining Proposed Prospective Payment Operating and Capital Rates and Rate-of-Increase Limits

In the Addendum to this proposed rule, we set forth proposed changes to the amounts and factors for determining the FY 2009 prospective payment rates for operating costs and capital-related costs. We also establish the proposed threshold amounts for outlier cases. In addition, we address the proposed update factors for determining the rate-of-increase limits for cost reporting periods beginning in FY 2009 for hospitals and hospital units excluded from the PPS.

10. Impact Analysis

In Appendix A of this proposed rule, we set forth an analysis of the impact that the proposed changes would have on affected hospitals.

11. Recommendation of Update Factors for Operating Cost Rates of Payment for Inpatient Hospital Services

In Appendix B of this proposed rule, as required by sections 1886(e)(4) and (e)(5) of the Act, we provided our recommendations of the appropriate percentage changes for FY 2009 for the following:

• A single average standardized amount for all areas for hospital inpatient services paid under the IPPS for operating costs (and hospital-specific rates applicable to SCHs and MDHs).

• Target rate-of-increase limits to the allowable operating costs of hospital inpatient services furnished by hospitals and hospital units excluded from the IPPS.

12. Disclosure of Financial Relationships Report (DFRR) Form

In Appendix C of this proposed rule, we present the reporting form that we are proposing to use for the proposed collection of information on financial relationships between hospitals and physicians discussed in section IX, of the preamble of this proposed rule.

13. Discussion of Medicare Payment Advisory Commission Recommendations

Under section 1805(b) of the Act, MedPAC is required to submit a report to Congress, no later than March 1 of each year, in which MedPAC reviews and makes recommendations on Medicare payment policies. MedPAC's March 2008 recommendations concerning hospital inpatient payment policies address the update factor for inpatient hospital operating costs and capital-related costs under the IPPS and for hospitals and distinct part hospital units excluded from the IPPS. We address these recommendations in Appendix B of this proposed rule. For further information relating specifically to the MedPAC March 2008 reports or to obtain a copy of the reports, contact MedPAC at (202) 220-3700 or visit MedPAC's Web site at: www.medpac.gov .

F. Public Comments Received on Issues in Related Rules

1. Comments on Phase-Out of the Capital Teaching Adjustment Under the IPPS Included in the FY 2008 IPPS Final Rule With Comment Period

In the FY 2008 IPPS final rule with comment period, we solicited public comments on our policy changes related to phase-out of the capital teaching adjustment to the capital payment update under the IPPS (72 FR 47401). We received approximately 90 timely pieces of correspondence in response to our solicitation. (These public comments may be viewed on the following Web site: http://www.cms.hhs.gov/eRulemaking/ECCMSR/list.asp under file code CMS-1533-FC.) In section V. of the preamble of this proposed rule, we acknowledge receipt of these public comments and again solicit public comments on the phase-out in this proposed rule. We will respond to the public comments received in response to both the FY 2008 IPPS final rule with comment period and this proposed rule in the FY 2009 IPPS final rule, which is scheduled to be published in August 2008.

2. Policy Revisions Related to Medicare GME Group Affiliations for Hospitals in Certain Declared Emergency Areas

We have issued two interim final rules with comment periods in the Federal Register that modified the GME regulations as they apply to Medicare GME affiliated groups to provide for greater flexibility in training residents in approved residency programs during times of disasters: on April 12, 2006 (71 FR 18654) and on November 27, 2007 (72 FR 66892). We received a number of timely pieces of correspondence in response to these interim final rules with comment period. (The public comments that we received may be viewed on the Web site at: http://www.cms.hhs.gov/eRulemaking/ECCMSR/list.asp under the file codes CMS-1531-IFC1 and CMS-1531-IFC2, respectively.) We will summarize and address these public comments in the FY 2009 IPPS final rule, which is scheduled to be published in August 2008.

II. Proposed Changes to Medicare Severity DRG (MS-DRG) Classifications and Relative Weights

A. Background

Section 1886(d) of the Act specifies that the Secretary shall establish a classification system (referred to as DRGs) for inpatient discharges and adjust payments under the IPPS based on appropriate weighting factors assigned to each DRG. Therefore, under the IPPS, we pay for inpatient hospital services on a rate per discharge basis that varies according to the DRG to which a beneficiary's stay is assigned. The formula used to calculate payment for a specific case multiplies an individual hospital's payment rate per case by the weight of the DRG to which the case is assigned. Each DRG weight represents the average resources required to care for cases in that particular DRG, relative to the average resources used to treat cases in all DRGs.

Congress recognized that it would be necessary to recalculate the DRG relative weights periodically to account for changes in resource consumption. Accordingly, section 1886(d)(4)(C) of the Act requires that the Secretary adjust the DRG classifications and relative weights at least annually. These adjustments are made to reflect changes in treatment patterns, technology, and any other factors that may change the relative use of hospital resources.

B. MS-DRG Reclassifications

1. General

As discussed in the preamble to the FY 2008 IPPS final rule with comment period (72 FR 47138), we focused our efforts in FY 2008 on making significant reforms to the IPPS consistent with the recommendations made by MedPAC in its "Report to the Congress, Physician-Owned Specialty Hospitals" in March 2005. MedPAC recommended that the Secretary refine the entire DRG system by taking into account severity of illness and applying hospital-specific relative value (HSRV) weights to DRGs.1We began this reform process by adopting cost-based weights over a 3-year transition period beginning in FY 2007 and making interim changes to the DRG system for FY 2007 by creating 20 new CMS DRGs and modifying 32 others across 13 different clinical areas involving nearly 1.7 million cases. As described below in more detail, these refinements were intermediate steps towards comprehensive reform of both the relative weights and the DRG system that is occurring as we undertook further study. For FY 2008, we adopted 745 new Medicare Severity DRGs (MS-DRGs) to replace the CMS DRGs. We refer readers to section II.D. of the FY 2008 IPPS final rule with comment period for a full detailed discussion of how the MS-DRG system was established based on severity levels of illness (72 FR 47141).

Footnotes:

1 Medicare Payment Advisory Commission: Report to the Congress, Physician-Owned Specialty Hospitals, March 25, page viii.

Currently, cases are classified into MS-DRGs for payment under the IPPS based on the principal diagnosis, up to eight additional diagnoses, and up to six procedures performed during the stay. In a small number of MS-DRGs, classification is also based on the age, sex, and discharge status of the patient. The diagnosis and procedure information is reported by the hospital using codes from the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).

The process of forming the MS-DRGs was begun by dividing all possible principal diagnoses into mutually exclusive principal diagnosis areas, referred to as Major Diagnostic Categories (MDCs). The MDCs were formed by physician panels to ensure that the DRGs would be clinically coherent. The diagnoses in each MDC correspond to a single organ system or etiology and, in general, are associated with a particular medical specialty. Thus, in order to maintain the requirement of clinical coherence, no final MS-DRG could contain patients in different MDCs. Most MDCs are based on a particular organ system of the body. For example, MDC 6 is Diseases and Disorders of the Digestive System. This approach is used because clinical care is generally organized in accordance with the organ system affected. However, some MDCs are not constructed on this basis because they involve multiple organ systems (for example, MDC 22 (Burns)). For FY 2008, cases are assigned to one of 745 MS-DRGs in 25 MDCs. The table below lists the 25 MDCs.

1 Diseases and Disorders of the Nervous System.
2 Diseases and Disorders of the Eye.
3 Diseases and Disorders of the Ear, Nose, Mouth, and Throat.
4 Diseases and Disorders of the Respiratory System.
5 Diseases and Disorders of the Circulatory System.
6 Diseases and Disorders of the Digestive System.
7 Diseases and Disorders of the Hepatobiliary System and Pancreas.
8 Diseases and Disorders of the Musculoskeletal System and Connective Tissue.
9 Diseases and Disorders of the Skin, Subcutaneous Tissue and Breast.
10 Endocrine, Nutritional and Metabolic Diseases and Disorders.
11 Diseases and Disorders of the Kidney and Urinary Tract.
12 Diseases and Disorders of the Male Reproductive System.
13 Diseases and Disorders of the Female Reproductive System.
14 Pregnancy, Childbirth, and the Puerperium.
15 Newborns and Other Neonates with Conditions Originating in the Perinatal Period.
16 Diseases and Disorders of the Blood and Blood Forming Organs and Immunological Disorders.
17 Myeloproliferative Diseases and Disorders and Poorly Differentiated Neoplasms.
18 Infectious and Parasitic Diseases (Systemic or Unspecified Sites).
19 Mental Diseases and Disorders.
20 Alcohol/Drug Use and Alcohol/Drug Induced Organic Mental Disorders.
21 Injuries, Poisonings, and Toxic Effects of Drugs.
22 Burns.
23 Factors Influencing Health Status and Other Contacts with Health Services.
24 Multiple Significant Trauma.
25 Human Immunodeficiency Virus Infections.

In general, cases are assigned to an MDC based on the patient's principal diagnosis before assignment to an MS-DRG. However, under the most recent version of the Medicare GROUPER (Version 26.0), there are 9 MS-DRGs to which cases are directly assigned on the basis of ICD-9-CM procedure codes. These MS-DRGs are for heart transplant or implant of heart assist systems, liver and/or intestinal transplants, bone marrow transplants, lung transplants, simultaneous pancreas/kidney transplants, pancreas transplants, and for tracheostomies. Cases are assigned to these MS-DRGs before they are classified to an MDC. The table below lists the nine current pre-MDCs.

MS-DRG 103 Heart Transplant or Implant of Heart Assist System.
MS-DRG 480 Liver Transplant and/or Intestinal Transplant.
MS-DRG 481 Bone Marrow Transplant.
MS-DRG 482 Tracheostomy for Face, Mouth, and Neck Diagnoses.
MS-DRG 495 Lung Transplant.
MS-DRG 512 Simultaneous Pancreas/Kidney Transplant.
MS-DRG 513 Pancreas Transplant.
MS-DRG 541 ECMO or Tracheostomy with Mechanical Ventilation 96+ Hours or Principal Diagnosis Except for Face, Mouth, and Neck Diagnosis with Major O.R.
MS-DRG 542 Tracheostomy with Mechanical Ventilation 96+ Hours or Principal Diagnosis Except for Face, Mouth, and Neck Diagnosis without Major O.R.

Once the MDCs were defined, each MDC was evaluated to identify those additional patient characteristics that would have a consistent effect on the consumption of hospital resources. Because the presence of a surgical procedure that required the use of the operating room would have a significant effect on the type of hospital resources used by a patient, most MDCs were initially divided into surgical DRGs and medical DRGs. Surgical DRGs are based on a hierarchy that orders operating room (O.R.) procedures or groups of O.R. procedures by resource intensity. Medical DRGs generally are differentiated on the basis of diagnosis and age (0 to 17 years of age or greater than 17 years of age). Some surgical and medical DRGs are further differentiated based on the presence or absence of a complication or comorbidity (CC) or a major complication or comorbidity (MCC).

Generally, nonsurgical procedures and minor surgical procedures that are not usually performed in an operating room are not treated as O.R. procedures. However, there are a few non-O.R. procedures that do affect MS-DRG assignment for certain principal diagnoses. An example is extracorporeal shock wave lithotripsy for patients with a principal diagnosis of urinary stones. Lithotripsy procedures are not routinely performed in an operating room. Therefore, lithotripsy codes are not classified as O.R. procedures. However, our clinical advisors believe that patients with urinary stones who undergo extracorporeal shock wave lithotripsy should be considered similar to other patients who undergo O.R. procedures. Therefore, we treat this group of patients similar to patients undergoing O.R. procedures.

Once the medical and surgical classes for an MDC were formed, each diagnosis class was evaluated to determine if complications or comorbidities would consistently affect the consumption of hospital resources. Each diagnosis was categorized into one of three severity levels. These three levels include a major complication or comorbidity (MCC), a complication or comorbidity (CC), or a non-CC. Physician panels classified each diagnosis code based on a highly iterative process involving a combination of statistical results from test data as well as clinical judgment. As stated earlier, we refer readers to section II.D. of the FY 2008 IPPS final rule with comment period for a full detailed discussion of how the MS-DRG system was established based on severity levels of illness (72 FR 47141).

A patient's diagnosis, procedure, discharge status, and demographic information is entered into the Medicare claims processing systems and subjected to a series of automated screens called the Medicare Code Editor (MCE). The MCE screens are designed to identify cases that require further review before classification into an MS-DRG.

After patient information is screened through the MCE and any further development of the claim is conducted, the cases are classified into the appropriate MS-DRG by the Medicare GROUPER software program. The GROUPER program was developed as a means of classifying each case into an MS-DRG on the basis of the diagnosis and procedure codes and, for a limited number of MS-DRGs, demographic information (that is, sex, age, and discharge status).

After cases are screened through the MCE and assigned to an MS-DRG by the GROUPER, the PRICER software calculates a base MS-DRG payment. The PRICER calculates the payment for each case covered by the IPPS based on the MS-DRG relative weight and additional factors associated with each hospital, such as IME and DSH payment adjustments. These additional factors increase the payment amount to hospitals above the base MS-DRG payment.

The records for all Medicare hospital inpatient discharges are maintained in the Medicare Provider Analysis and Review (MedPAR) file. The data in this file are used to evaluate possible MS-DRG classification changes and to recalibrate the MS-DRG weights. However, in the FY 2000 IPPS final rule (64 FR 41500), we discussed a process for considering non-MedPAR data in the recalibration process. In order for us to consider using particular non-MedPAR data, we must have sufficient time to evaluate and test the data. The time necessary to do so depends upon the nature and quality of the non-MedPAR data submitted. Generally, however, a significant sample of the non-MedPAR data should be submitted by mid-October for consideration in conjunction with the next year's proposed rule. This date allows us time to test the data and make a preliminary assessment as to the feasibility of using the data. Subsequently, a complete database should be submitted by early December for consideration in conjunction with the next year's proposed rule.

As we indicated above, for FY 2008, we made significant improvement in the DRG system to recognize severity of illness and resource usage by adopting MS-DRGs. The changes we adopted were reflected in the FY 2008 GROUPER, Version 25.0, and were effective for discharges occurring on or after October 1, 2007. Our DRG analysis for the FY 2008 final rule with comment period was based on data from the March 2007 update of the FY 2006 MedPAR file, which contained hospital bills received through March 31, 2007, for discharges occurring through September 30, 2006. For this proposed rule, for FY 2009, our DRG analysis is based on data from the September 2007 update of the FY 2007 MedPAR file, which contains hospital bills received through September 30, 2007, for discharges through September 30, 2007.

2. Yearly Review for Making MS-DRG Changes

Many of the changes to the MS-DRG classifications we make annually are the result of specific issues brought to our attention by interested parties. We encourage individuals with concerns about MS-DRG classifications to bring those concerns to our attention in a timely manner so they can be carefully considered for possible inclusion in the annual proposed rule and, if included, may be subjected to public review and comment. Therefore, similar to the timetable for interested parties to submit non-MedPAR data for consideration in the MS-DRG recalibration process, concerns about MS-DRG classification issues should be brought to our attention no later than early December in order to be considered and possibly included in the next annual proposed rule updating the IPPS.

The actual process of forming the MS-DRGs was, and will likely continue to be, highly iterative, involving a combination of statistical results from test data combined with clinical judgment. In the FY 2008 IPPS final rule (72 FR 47140 through 47189), we described in detail the process we used to develop the MS-DRGs that we adopted for FY 2008. In addition, in deciding whether to make further modification to the MS-DRGs for particular circumstances brought to our attention, we considered whether the resource consumption and clinical characteristics of the patients with a given set of conditions are significantly different than the remaining patients in the MS-DRG. We evaluated patient care costs using average charges and lengths of stay as proxies for costs and relied on the judgment of our medical advisors to decide whether patients are clinically distinct or similar to other patients in the MS-DRG. In evaluating resource costs, we considered both the absolute and percentage differences in average charges between the cases we selected for review and the remainder of cases in the MS-DRG. We also considered variation in charges within these groups; that is, whether observed average differences were consistent across patients or attributable to cases that were extreme in terms of charges or length of stay, or both. Further, we considered the number of patients who will have a given set of characteristics and generally preferred not to create a new MS-DRG unless it would include a substantial number of cases.

C. Adoption of the MS-DRGs in FY 2008

In the FY 2006, FY 2007, and FY 2008 IPPS final rules, we discussed a number of recommendations made by MedPAC regarding revisions to the DRG system used under the IPPS (70 FR 47473 through 47482; 71 FR 47881 through 47939; and 72 FR 47140 through 47189). As we noted in the FY 2006 IPPS final rule, we had insufficient time to complete a thorough evaluation of these recommendations for full implementation in FY 2006. However, we did adopt severity-weighted cardiac DRGs in FY 2006 to address public comments on this issue and the specific concerns of MedPAC regarding cardiac surgery DRGs. We also indicated that we planned to further consider all of MedPAC's recommendations and thoroughly analyze options and their impacts on the various types of hospitals in the FY 2007 IPPS proposed rule.

For FY 2007, we began this process. In the FY 2007 IPPS proposed rule, we proposed to adopt Consolidated Severity DRGs (CS DRGs) for FY 2008 (if not earlier). However, based on public comments received on the FY 2007 IPPS proposed rule, we decided not to adopt the CS DRGs. Rather, we decided to make interim changes to the existing DRGs for FY 2007 by creating 20 new DRGs involving 13 different clinical areas that would significantly improve the CMS DRG system's recognition of severity of illness. We also modified 32 DRGs to better capture differences in severity. The new and revised DRGs were selected from 40 existing CMS DRGs that contained 1,666,476 cases and represent a number of body systems. In creating these 20 new DRGs, we deleted 8 and modified 32 existing DRGs. We indicated that these interim steps for FY 2007 were being taken as a prelude to more comprehensive changes to better account for severity in the DRG system by FY 2008.

In the FY 2007 IPPS final rule, we indicated our intent to pursue further DRG reform through two initiatives. First, we announced that we were in the process of engaging a contractor to assist us with evaluating alternative DRG systems that were raised as potential alternatives to the CMS DRGs in the public comments. Second, we indicated our intent to review over 13,000 ICD-9-CM diagnosis codes as part of making further refinements to the current CMS DRGs to better recognize severity of illness based on the work that CMS (then HCFA) did in the mid-1990's in connection with adopting severity DRGs. We describe below the progress we have made on these two initiatives, our actions for FY 2008, and our proposals for FY 2009 based on our continued analysis of reform of the DRG system. We note that the adoption of the MS-DRGs to better recognize severity of illness has implications for the outlier threshold, the application of the postacute care transfer policy, the measurement of real case-mix versus apparent case-mix, and the IME and DSH payment adjustments. We discuss these implications for FY 2009 in other sections of this preamble and in the Addendum to this proposed rule.

In the FY 2007 IPPS proposed rule, we discussed MedPAC's recommendations to move to a cost-based HSRV weighting methodology using HSRVs beginning with the FY 2007 IPPS proposed rule for determining the DRG relative weights. Although we proposed to adopt the HSRV weighting methodology for FY 2007, we decided not to adopt the proposed methodology in the final rule after considering the public comments we received on the proposal. Instead, in the FY 2007 IPPS final rule, we adopted a cost-based weighting methodology without the HSRV portion of the proposed methodology. The cost-based weights are being adopted over a 3-year transition period in 13 increments between FY 2007 and FY 2009. In addition, in the FY 2007 IPPS final rule, we indicated our intent to further study the HSRV-based methodology as well as other issues brought to our attention related to the cost-based weighting methodology adopted in the FY 2007 final rule. There was significant concern in the public comments that our cost-based weighting methodology does not adequately account for charge compression-the practice of applying a higher percentage charge markup over costs to lower cost items and services and a lower percentage charge markup over costs to higher cost items and services. Further, public commenters expressed concern about potential inconsistencies between how costs and charges are reported on the Medicare cost reports and charges on the Medicare claims. In the FY 2007 IPPS final rule, we used costs and charges from the cost report to determine departmental level cost-to-charge ratios (CCRs) which we then applied to charges on the Medicare claims to determine the cost-based weights. The commenters were concerned about potential distortions to the cost-based weights that would result from inconsistent reporting between the cost reports and the Medicare claims. After publication of the FY 2007 IPPS final rule, we entered into a contract with RTI International (RTI) to study both charge compression and to what extent our methodology for calculating DRG relative weights is affected by inconsistencies between how hospitals report costs and charges on the cost reports and how hospitals report charges on individual claims. Further, as part of its study of alternative DRG systems, the RAND Corporation analyzed the HSRV cost-weighting methodology. We refer readers to section II.E. of the preamble of this proposed rule for our proposals for addressing the issue of charge compression and the HSRV cost-weighting methodology for FY 2009.

We believe that revisions to the DRG system to better recognize severity of illness and changes to the relative weights based on costs rather than charges are improving the accuracy of the payment rates in the IPPS. We agree with MedPAC that these refinements should be pursued. Although we continue to caution that any prospective payment system based on grouping cases will always present some opportunities for providers to specialize in cases they believe have higher margins, we believe that the changes we have adopted and the continuing reforms we are proposing in this proposed rule for FY 2009 will improve payment accuracy and reduce financial incentives to create specialty hospitals.

We refer readers to section II.D. of the FY 2008 IPPS final rule with comment period for a full discussion of how the MS-DRG system was established based on severity levels of illness (72 FR 47141).

D. MS-DRG Documentation and Coding Adjustment, Including the Applicability to the Hospital-Specific Rates and the Puerto Rico-Specific Standardized Amount

1. MS-DRG Documentation and Coding Adjustment

As stated above, we adopted the new MS-DRG patient classification system for the IPPS, effective October 1, 2007, to better recognize severity of illness in Medicare payment rates. Adoption of the MS-DRGs resulted in the expansion of the number of DRGs from 538 in FY 2007 to 745 in FY 2008. By increasing the number of DRGs and more fully taking into account severity of illness in Medicare payment rates, the MS-DRGs encourage hospitals to improve their documentation and coding of patient diagnoses. In the FY 2008 IPPS final rule with comment period (72 FR 47175 through 47186), which appeared in the Federal Register on August 22, 2007, we indicated that we believe the adoption of the MS-DRGs had the potential to lead to increases in aggregate payments without a corresponding increase in actual patient severity of illness due to the incentives for improved documentation and coding. In that final rule with comment period, using the Secretary's authority under section 1886(d)(3)(A)(vi) of the Act to maintain budget neutrality by adjusting the standardized amount to eliminate the effect of changes in coding or classification that do not reflect real change in case-mix, we established prospective documentation and coding adjustments of -1.2 percent for FY 2008, -1.8 percent for FY 2009, and -1.8 percent for FY 2010.

On September 29, 2007, the TMA, Abstinence Education, and QI Programs Extension Act of 2007, Pub. L. 110-90, was enacted. Section 7 of Pub. L. 110-90 included a provision that reduces the documentation and coding adjustment for the MS-DRG system that we adopted in the FY 2008 IPPS final rule with comment period to -0.6 percent for FY 2008 and -0.9 percent for FY 2009. To comply with the provision of section 7 of Pub. L. 110-90, in a final rule that appeared in the Federal Register on November 27, 2007 (72 FR 66886), we changed the IPPS documentation and coding adjustment for FY 2008 to -0.6 percent, and revised the FY 2008 payment rates, factors, and thresholds accordingly, with these revisions effective October 1, 2007.

For FY 2009, Pub. L. 110-90 requires a documentation and coding adjustment of -0.9 percent instead of the -1.8 percent adjustment specified in the FY 2008 IPPS final rule with comment period. As required by statute, we are applying a documentation and coding adjustment of -0.9 percent to the FY 2009 IPPS national standardized amounts. The documentation and coding adjustments established in the FY 2008 IPPS final rule with comment period are cumulative. As a result, the -0.9 percent documentation and coding adjustment in FY 2009 is in addition to the -0.6 percent adjustment in FY 2008, yielding a combined effect of -1.5 percent.

2. Application of the Documentation and Coding Adjustment to the Hospital-Specific Rates

Under section 1886(d)(5)(D)(i) of the Act, SCHs are paid based on whichever of the following rates yields the greatest aggregate payment: The Federal national rate; the updated hospital-specific rate based on FY 1982 costs per discharge; the updated hospital-specific rate based on FY 1987 costs per discharge; or the updated hospital-specific rate based on FY 1996 costs per discharge. Under section 1886(d)(5)(G) of the Act, MDHs are paid based on the Federal national rate or, if higher, the Federal national rate plus 75 percent of the difference between the Federal national rate and the updated hospital-specific rate based on the greater of either the FY 1982, 1987, or 2002 costs per discharge. In the FY 2008 IPPS final rule with comment period, we established a policy of applying the documentation and coding adjustment to the hospital-specific rates. In that rule, we indicated that because SCHs and MDHs use the same DRG system as all other hospitals, we believe they should be equally subject to the budget neutrality adjustment that we are applying for adoption of the MS-DRGs to all other hospitals. In establishing this policy, we cited our authority under section 1886(d)(3)(A)(vi) of the Act, which provides the authority to adjust "the standardized amount" to eliminate the effect of changes in coding or classification that do not reflect real change in case-mix. However, in a final rule that appeared in the Federal Register on November 27, 2007 (72 FR 66886), we rescinded the application of the documentation and coding adjustment to the hospital-specific rates retroactive to October 1, 2007. In that final rule, we indicated that, while we still believe it would be appropriate to apply the documentation and coding adjustment to the hospital-specific rates, upon further review we decided that application of the documentation and coding adjustment to the hospital-specific rates is not consistent with the plain meaning of section 1886(d)(3)(A)(vi) of the Act, which only mentions adjusting "the standardized amount" and does not mention adjusting the hospital-specific rates.

We continue to have concerns about this issue. Because hospitals paid based on the hospital-specific rate use the same MS-DRG system as other hospitals, we believe they have the potential to realize increased payments from coding improvements that do not reflect real increases in patients' severity of illness. In section 1886(d)(3)(A)(vi) of the Act, Congress stipulated that hospitals paid based on the standardized amount should not receive additional payments based on the effect of documentation and coding changes that do not reflect real changes in case-mix. Similarly, we believe that hospitals paid based on the hospital-specific rate should not have the potential to realize increased payments due to documentation and coding improvements that do not reflect real increases in patients' severity of illness. While we continue to believe that section 1886(d)(3)(A)(vi) of the Act does not provide explicit authority for application of the documentation and coding adjustment to the hospital-specific rates, we believe that we have the authority to apply the documentation and coding adjustment to the hospital-specific rates using our special exceptions and adjustment authority under section 1886(d)(5)(I)(i) of the Act. The special exceptions and adjustment authority authorizes us to provide "for such other exceptions and adjustments to [IPPS] payment amounts * * * as the Secretary deems appropriate." In light of this authority, for the FY 2010 rulemaking, we plan to examine our FY 2008 claims data for hospitals paid based on the hospital-specific rate. If we find evidence of significant increases in case-mix for patients treated in these hospitals, we would consider proposing application of the documentation and coding adjustments to the FY 2010 hospital-specific rates under our authority in section 1886(d)(5)(I)(i) of the Act. As noted previously, the documentation and coding adjustments established in the FY 2008 IPPS final rule with comment period are cumulative. For example, the -0.9 percent documentation and coding adjustment to the national standardized amount in FY 2009 is in addition to the -0.6 percent adjustment made in FY 2008, yielding a combined effect of -1.5 percent in FY 2009. Given the cumulative nature of the documentation and coding adjustments, if we were to propose to apply the documentation and coding adjustment to the FY 2010 hospital-specific rates, it may involve applying the FY 2008 and FY 2009 documentation and coding adjustments (-1.5 percent combined) plus the FY 2010 documentation and coding adjustment, discussed in the FY 2008 IPPS final rule with comment period, to the FY 2010 hospital-specific rates.

3. Application of the Documentation and Coding Adjustment to the Puerto Rico-Specific Standardized Amount

Puerto Rico hospitals are paid based on 75 percent of the national standardized amount and 25 percent of the Puerto Rico-specific standardized amount. As noted previously, the documentation and coding adjustment we adopted in the FY 2008 IPPS final rule with comment period relied upon our authority under section 1886(d)(3)(A)(vi) of the Act, which provides the authority to adjust "the standardized amounts computed under this paragraph" to eliminate the effect of changes in coding or classification that do not reflect real change in case-mix. Section 1886(d)(3)(A)(vi) of the Act applies to the national standardized amounts computed under section 1886(d)(3) of the Act, but does not apply to the Puerto Rico-specific standardized amount computed under section 1886(d)(9)(C) of the Act. In calculating the FY 2008 payment rates, we made an inadvertent error and applied the FY 2008 -0.6 percent documentation and coding adjustment to the Puerto Rico-specific standardized amount, relying on our authority under section 1886(d)(3)(A)(vi) of the Act. We are currently in the process of developing a Federal Register notice to correct that error in the Puerto Rico-specific standardized amount for FY 2008 retroactive to October 1, 2007.

While section 1886(d)(3)(A)(vi) of the Act is not applicable to the Puerto Rico-specific standardized amount, we believe that we have the authority to apply the documentation and coding adjustment to the Puerto Rico-specific standardized amount using our special exceptions and adjustment authority under section 1886(d)(5)(I)(i) of the Act. Similar to SCHs and MDHs that are paid based on the hospital-specific rate, discussed in section II.D.2. of this preamble, we believe that Puerto Rico hospitals that are paid based on the Puerto Rico-specific standardized amount should not have the potential to realize increased payments due to documentation and coding improvements that do not reflect real increases in patients' severity of illness. Consistent with the approach described for SCHs and MDHs in section II.D.2. of the preamble of this proposed rule, for the FY 2010 rulemaking, we plan to examine our FY 2008 claims data for hospitals in Puerto Rico. If we find evidence of significant increases in case-mix for patients treated in these hospitals, we would consider proposing application of the documentation and coding adjustments to the FY 2010 Puerto Rico-specific standardized amount under our authority in section 1886(d)(5)(I)(i) of the Act. As noted previously, the documentation and coding adjustments established in the FY 2008 IPPS final rule with comment period are cumulative. Given the cumulative nature of the documentation and coding adjustments, if we were to propose to apply the documentation and coding adjustment to the FY 2010 Puerto Rico-specific standardized amount, it may involve applying the FY 2008 and FY 2009 documentation and coding adjustments (-1.5 percent combined) plus the FY 2010 documentation and coding adjustment, discussed in the FY 2008 IPPS final rule with comment period, to the FY 2010 Puerto Rico-specific standardized amount.

4. Potential Additional Payment Adjustments in FYs 2010 Through 2012

Section 7 of Pub. L.110-90 also provides for payment adjustments in FYs 2010 through 2012 based upon a retrospective evaluation of claims data from the implementation of the MS-DRG system. If, based on this retrospective evaluation, the Secretary finds that in FY 2008 and FY 2009, the actual amount of change in case-mix that does not reflect real change in underlying patient severity differs from the statutorily mandated documentation and coding adjustments implemented in those years, the law requires the Secretary to adjust payments for discharges occurring in FYs 2010 through 2012 to offset the estimated amount of increase or decrease in aggregate payments that occurred in FY 2008 and FY 2009 as a result of that difference, in addition to making an appropriate adjustment to the standardized amount under section 1886(d)(3)(A)(vi) of the Act.

In order to implement these requirements of section 7 of Pub. L. 110-90, we are planning a thorough retrospective evaluation of our claims data. Results of this evaluation would be used by our actuaries to determine any necessary payment adjustments in FYs 2010 through 2012 to ensure the budget neutrality of the MS-DRG implementation for FY 2008 and FY 2009, as required by law. We are currently developing our analysis plans for this effort.

We intend to measure and corroborate the extent of the overall national average changes in case-mix for FY 2008 and FY 2009. We expect part of this overall national average change would be attributable to underlying changes in actual patient severity and part would be attributable to documentation and coding improvements under the MS-DRG system. In order to separate the two effects, we plan to isolate the effect of shifts in cases among base DRGs from the effect of shifts in the types of cases within base DRGs. The shifts among base DRGs are the result of changes in principal diagnoses while the shifts within base DRGs are the result of changes in secondary diagnoses. Because we expect most of the documentation and coding improvements under the MS-DRG system will occur in the secondary diagnoses, the shifts among base DRGs are less likely to be the result of the MS-DRG system and the shifts within base DRGs are more likely to be the result of the MS-DRG system. We also anticipate evaluating data to identify the specific MS-DRGs and diagnoses that contributed significantly to the improved documentation and coding payment effect and to quantify their impact. This step would entail analysis of the secondary diagnoses driving the shifts in severity within specific base DRGs.

While we believe that the data analysis plan described previously will produce an appropriate estimate of the extent of case-mix changes resulting from documentation and coding improvements, we may also decide, if feasible, to use historical data from our Hospital Payment Monitoring Program (HPMP) to corroborate the within base DRG shift analysis. The HPMP is supported by the Medicare Clinical Data Abstraction Center (CDAC). From 1999 to 2007, the CDAC obtained medical records for a sample of discharges as part of our hospital monitoring activities. These data were collected on a random sample of between 30,000 to 50,000 hospital discharges per year. The historical CDAC data could be used to develop an upper bound estimate of the trend in real case-mix growth (that is, real change in underlying patient severity) prior to implementation of the MS-DRGs.

We welcome public comments on our analysis plans, as well as suggestions on other possible approaches for conducting a retrospective analysis to identify the amount of case-mix changes that occurred in FY 2008 and FY 2009 that did not reflect real increases in patients' severity of illness. Our analysis, findings, and any resulting proposals to adjust payments for discharges occurring in FYs 2010 through 2012 to offset the estimated amount of increase or decrease in aggregate payments that occurred in FY 2008 and FY 2009 will be discussed in future years' rulemakings.

E. Refinement of the MS-DRG Relative Weight Calculation

1. Background

In the FY 2008 IPPS final rule with comment period (72 FR 47188), we continued to implement significant revisions to Medicare's inpatient hospital rates by basing relative weights on hospitals' estimated costs rather than on charges. We continued our 3-year transition from charge-based relative weights to cost-based relative weights. Beginning in FY 2007, we implemented relative weights based on cost report data instead of based on charge information. We had initially proposed to develop cost-based relative weights using the hospital-specific relative value cost center (HSRVcc) methodology as recommended by MedPAC. However, after considering concerns raised in the public comments, we modified MedPAC's methodology to exclude the hospital-specific relative weight feature. Instead, we developed national CCRs based on distinct hospital departments and engaged a contractor to evaluate the HSRVcc methodology for future consideration. To mitigate payment instability due to the adoption of cost-based relative weights, we decided to transition cost-based weights over 3 years by blending them with charge-based weights beginning in FY 2007. In FY 2008, we continued our transition by blending the relative weights with one-third charge-based weights and two-thirds cost-based weights.

Also, in FY 2008, we adopted severity-based MS-DRGs, which increased the number of DRGs from 538 to 745. Many commenters raised concerns as to how the transition from charge-based weights to cost-based weights would continue with the introduction of new MS-DRGs. We decided to implement a 2-year transition for the MS-DRGs to coincide with the remainder of the transition to cost-based relative weights. In FY 2008, 50 percent of the relative weight for each DRG was based on the CMS DRG relative weight and 50 percent was based on the MS-DRG relative weight. We refer readers to the FY 2007 IPPS final rule (71 FR 47882) for more detail on our final policy for calculating the cost-based DRG relative weights and to the FY 2008 IPPS final rule with comment period (72 FR 47199) for information on how we blended relative weights based on the CMS DRGs and MS-DRGs.

As we transitioned to cost-based relative weights, some commenters raised concerns about potential bias in the weights due to "charge compression," which is the practice of applying a higher percentage charge markup over costs to lower cost items and services, and a lower percentage charge markup over costs to higher cost items and services. As a result, the cost-based weights would undervalue high cost items and overvalue low cost items if a single CCR is applied to items of widely varying costs in the same cost center. To address this concern, in August 2006, we awarded a contract to RTI to study the effects of charge compression in calculating the relative weights and to consider methods to reduce the variation in the CCRs across services within cost centers. RTI issued an interim draft report in March 2007 which was posted on the CMS Web site with its findings on charge compression. In that report, RTI found that a number of factors contribute to charge compression and affect the accuracy of the relative weights. RTI found inconsistent matching of charges in the Medicare cost report and their corresponding charges in the MedPAR claims for certain cost centers. In addition, there was inconsistent reporting of costs and charges among hospitals. For example, some hospitals would report costs and charges for devices and medical supplies in the Medical Supplies Charged to Patients cost center, while other hospitals would report those costs and charges in their related ancillary departments such as Operating Room or Radiology. RTI also found evidence that certain revenue codes within the same cost center had significantly different markup rates. For example, within the Medicare Supplies Charged to Patients cost center, revenue codes for devices, implantables, and prosthetics had different markup rates than the other medical supplies in that cost center. RTI's findings demonstrated that charge compression exists in several CCRs, most notably in the Medical Supplies and Equipment CCR.

RTI offered short-term, medium-term, and long-term recommendations to mitigate the effects of charge compression. RTI's short-term recommendations included expanding the distinct hospital CCRs to 19 by disaggregating the "Emergency Room" and "Blood and Blood Products" from the Other Services cost center and by estimating regression-based CCRs to disaggregate Medical Supplies, Drugs, and Radiology cost centers. RTI recommended, for the medium-term, to expand the MedPAR file to include separate fields that disaggregate several existing charge departments. In addition, RTI recommended improving hospital cost reporting instructions so that hospitals can properly report costs in the appropriate cost centers. RTI's long-term recommendations included adding new cost centers to the Medicare cost report, such as adding a "Devices, Implants and Prosthetics" line under "Medical Supplies Charged to Patients" and a "CT Scanning and MRI" subscripted line under "Radiology-Diagnostics".

Among RTI's short-term recommendations, for FY 2008, we expanded the number of distinct hospital department CCRs from 13 to 15 by disaggregating "Emergency Room" and "Blood and Blood Products" from the Other Services cost center as these lines already exist on the hospital cost report. Furthermore, in an effort to improve consistency between costs and their corresponding charges in the MedPAR file, we moved the costs for cases involving electroencephalography (EEG) from the Cardiology cost center to the Laboratory cost center group which corresponds with the EEG MedPAR claims categorized under the Laboratory charges. We also agreed with RTI's recommendations to revise the Medicare cost report and the MedPAR file as a long-term solution for charge compression. We stated that, in the upcoming year, we would consider additional lines to the cost report and additional revenue codes for the MedPAR file.

We did not adopt RTI's short-term recommendation to create four additional regression-based CCRs for several reasons, even though we had received comments in support of the regression-based CCRs as a means to immediately resolve the problem of charge compression, particularly within the Medical Supplies and Equipment CCR. We were concerned that RTI's analysis was limited to charges on hospital inpatient claims while typically hospital cost report CCRs combine both inpatient and outpatient services. Further, because both the IPPS and OPPS rely on cost-based weights, we preferred to introduce any methodological adjustments to both payment systems at the same time. We have since expanded RTI's analysis of charge compression to incorporate outpatient services. RTI has been evaluating the cost estimation process for the OPPS cost-based weights, including a reassessment of the regression-based CCR models using both outpatient and inpatient charge data. The RTI report was finalized at the conclusion of our proposed rule development process and is expected to be posted on the CMS Web site in the near future. We welcome comments on this report.

A second reason that we did not implement regression-based CCRs at the time of the FY 2008 IPPS final rule with comment period was our inability to investigate how regression-based CCRs would interact with the implementation of MS-DRGs. We stated that we would consider the results of the second phase of the RAND study as we prepared for the FY 2009 IPPS rulemaking process. The purpose of the RAND study was to analyze how the relative weights would change if we were to adopt regression-based CCRs to address charge compression while simultaneously adopting an HSRV methodology using fully phased-in MS-DRGs. We had intended to include a detailed discussion of RAND's study in this FY 2009 IPPS proposed rule. However, due to some delays in releasing identifiable data to the contractor under revised data security rules, the report on this second stage of RAND's analysis was not completed in time for the development of this proposed rule. Therefore, we continue to have the same concerns with respect to uncertainty about how regression-based CCRs would interact with the MS-DRGs or an HSRV methodology. Therefore, we are not proposing to adopt the regression-based CCRs or an HSRV methodology in this FY 2009 IPPS proposed rule. Nevertheless, we welcome public comments on our proposals not to adopt regression-based CCRs or an HSRV methodology at this time or in the future. The RAND report on regression-based CCRs and the HSRV methodology was finalized at the conclusion of our proposed rule development process and is expected to be posted on the CMS Web site in the near future. Although we are unable to include a discussion of the results of the RAND study in this proposed rule, we welcome public comment on the report.

Finally, we received public comments on the FY 2008 IPPS proposed rule raising concerns on the accuracy of using regression-based CCR estimates to determine the relative weights rather than the Medicare cost report. Commenters noted that regression-based CCRs would not fix the underlying mismatch of hospital reporting of costs and charges. Instead, the commenters suggested that the impact of charge compression might be mitigated through an educational initiative that would encourage hospitals to improve their cost reporting. Commenters recommended that hospitals be educated to report costs and charges in a way that is consistent with how charges are grouped in the MedPAR file. In an effort to achieve this goal, hospital associations have launched an educational campaign to encourage consistent reporting, which would result in consistent groupings of the cost centers used to establish the cost-based relative weights. The commenters requested that CMS communicate to the fiscal intermediaries/MACs that such action is appropriate. In the FY 2008 IPPS final rule with comment period, we stated that we were supportive of the educational initiative of the industry, and we encouraged hospitals to report costs and charges consistently with how the data are used to determine relative weights (72 FR 47196). We would also like to affirm that the longstanding Medicare principles of cost apportionment at 42 CFR 413.53 convey that, under the departmental method of apportionment, the cost of each ancillary department is to be apportioned separately rather than being combined with another ancillary department (for example, combining the cost of Medical Supplies Charged to Patients with the costs of Operating Room or any other ancillary cost center. (We note that, effective for cost reporting periods starting on or after January 1, 1979, the departmental method of apportionment replaced the combination method of apportionment where all the ancillary departments were apportioned in the aggregate (Section 2200.3 of the Provider Reimbursement Manual (PRM), Part I).)

Furthermore, longstanding Medicare cost reporting policy has been that hospitals must include the cost and charges of separately "chargeable medical supplies" in the Medical Supplies Charged to Patients cost center (line 55 of Worksheet A), rather than in the Operating Room, Emergency Room, or other ancillary cost centers. Routine services, which can include "minor medical and surgical supplies" (Section 2202.6 of the PRM, Part 1), and items for which a separate charge is not customarily made, may be directly assigned through the hospital's accounting system to the department in which they were used, or they may be included in the Central Services and Supply cost center (line 15 of Worksheet A). Conversely, the separately chargeable medical supplies should be assigned to the Medical Supplies Charged to Patients cost center on line 55.

We note that not only is accurate cost reporting important for IPPS hospitals to ensure that accurate relative weights are computed, but hospitals that are still paid on the basis of cost, such as CAHs and cancer hospitals, and SCHs and MDHs must adhere to Medicare cost reporting principles as well.

The CY 2008 OPPS/ASC final rule with comment period (72 FR 66601) also discussed the issue of charge compression and regression-based CCRs, and noted that RTI is currently evaluating the cost estimation process underpinning the OPPS cost-based weights, including a reassessment of the regression models using both outpatient and inpatient charges, rather than inpatient charges only. In responding to comments in the CY 2008 OPPS/ASC final rule with comment period, we emphasized that we "fully support" the educational initiatives of the industry and that we would "examine whether the educational activities being undertaken by the hospital community to improve cost reporting accuracy under the IPPS would help to mitigate charge compression under the OPPS, either as an adjunct to the application of regression-based CCRs or in lieu of such an adjustment" (72 FR 66601). However, as we stated in the FY 2008 IPPS final rule with comment period that we would consider the results of the RAND study before considering whether to adopt regression-based CCRs, in the CY 2008 OPPS/ASC final rule with comment period, we stated that we would determine whether refinements should be proposed, after reviewing the results of the RTI study.

On February 29, 2008, we issued Transmittal 321, Change Request 5928, to inform the fiscal intermediaries/ MACs of the hospital associations' initiative to encourage hospitals to modify their cost reporting practices with respect to costs and charges in a manner that is consistent with how charges are grouped in the MedPAR file. We noted that the hospital cost reports submitted for FY 2008 may have costs and charges grouped differently than in prior years, which is allowable as long as the costs and charges are properly matched and the Medicare cost reporting instructions are followed. Furthermore, we recommended that fiscal intermediaries/MACs remain vigilant to ensure that the costs of items and services are not moved from one cost center to another without moving their corresponding charges. Due to a time lag in submittal of cost reporting data, the impact of changes in providers' cost reporting practices occurring during FY 2008 would be reflected in the FY 2011 IPPS relative weights.

2. Refining the Medicare Cost Report

In developing this FY 2009 proposed rule, we considered whether there were concrete steps we could take to mitigate the bias introduced by charge compression in both the IPPS and OPPS relative weights in a way that balance hospitals' desire to focus on improving the cost reporting process through educational initiatives with device industry interest in adopting regression-adjusted CCRs. Although RTI recommended adopting regression-based CCRs, particularly for medical supplies and devices, as a short-term solution to address charge compression, RTI also recommended refinements to the cost report as a long-term solution. RTI's draft interim March 2007 report discussed a number of options that could improve the accuracy and precision of the CCRs currently being derived from the Medicare cost report and also reduce the need for statistically-based adjustments. As mentioned in the FY 2008 IPPS final rule with comment period (72 FR 47193), we believe that RTI and many of the public commenters on the FY 2008 IPPS proposed rule concluded that, ultimately, improved and more precise cost reporting is the best way to minimize charge compression and improve the accuracy of cost weights. Therefore, in this proposed rule, we are proposing to begin making cost report changes geared to improving the accuracy of the IPPS and OPPS relative weights. However, we also received comments last year asking that we proceed cautiously with changing the Medicare cost report to avoid unintended consequences for hospitals that are paid on a cost basis (such as CAHs and, to some extent, SCHs and MDHs), and to consider the administrative burden associated with adapting to new cost reporting forms and instructions. Accordingly, we are proposing to focus at this time on the CCR for Medical Supplies and Equipment because RTI found that the largest impact on the relative weights could result from correcting charge compression for devices and implants. When examining markup differences within the Medical Supplies Charged to Patients cost center, RTI found that its "regression results provide solid evidence that if there were distinct cost centers for items, cost ratios for devices and implants would average about 17 points higher than the ratios for other medical supplies" (January 2007 RTI report, page 59). This suggests that much of the charge compression within the Medical Supplies CCR results from inclusion of medical devices that have significantly different markups than the other supplies in that CCR. Furthermore, in the FY 2007 final rule and FY 2008 IPPS final rule with comment period, the Medical Supplies and Equipment CCR received significant attention by the public commenters.

Although we are proposing to make improvements to lessen the effects of charge compression only on the Medical Supplies and Equipment CCR as a first step, we are inviting public comments as to whether to make other changes to the Medicare cost report to refine other CCRs. In addition, we are open to making further refinements to other CCRs in the future. Therefore, we are proposing at this time to add only one cost center to the cost report, such that, in general, the costs and charges for relatively inexpensive medical supplies would be reported separately from the costs and charges of more expensive devices (such as pacemakers and other implantable devices). We will consider public comments submitted on this proposed rule for purposes of both the IPPS and the OPPS relative weights and, by extension, the calculation of the ambulatory surgical center (ASC) payment rates.

Under the IPPS for FY 2007 and FY 2008, the aggregate CCR for supplies and equipment was computed based on line 55 for Medical Supplies Charged to Patients and lines 66 and 67 for DME Rented and DME Sold, respectively. To compute the 15 national CCRs used in developing the cost-based weights under the IPPS (explained in more detail under section II.H. of the preamble of this proposed rule), we take the costs and charges for the 15 cost groups from Worksheet C, Part I of the Medicare cost report for all hospital patients and multiply each of these 15 CCRs by the Medicare charges on Worksheet D-4 for those same cost centers to impute the Medicare cost for each of the 15 cost groups. Under this proposal, the goal would be to split the current CCR for Medical Supplies and Equipment into one CCR for medical supplies, and another CCR for devices and DME Rented and DME Sold.

In considering how to instruct hospitals on what to report in the cost center for supplies and the cost center for devices, we looked at the existing criteria for what type of device qualifies for payment as a transitional pass-through device category in the OPPS. (There are no such existing criteria for devices under the IPPS.) The provisions of the regulations under § 419.66(b) state that for a medical device to be eligible for pass-through payment under the OPPS, the medical device must meet the following criteria:

a. If required by the FDA, the device must have received FDA approval or clearance (except for a device that has received an FDA investigational device exemption (IDE) and has been classified as a Category B device by the FDA in accordance with §§ 405.203 through 405.207 and 405.211 through 405.215 of the regulations) or another appropriate FDA exemption.

b. The device is determined to be reasonable and necessary for the diagnosis or treatment of an illness or injury or to improve the functioning of a malformed body part (as required by section 1862(a)(1)(A) of the Act).

c. The device is an integral and subordinate part of the service furnished, is used for one patient only, comes in contact with human tissues, and is surgically implanted or inserted whether or not it remains with the patient when the patient is released from the hospital.

d. The device is not any of the following:

• Equipment, an instrument, apparatus, implement, or item of this type for which depreciation and financing expenses are recovered as depreciable assets as defined in Chapter 1 of the Medicare Provider Reimbursement Manual (CMS Pub. 15-1).

• A material or supply furnished incident to a service (for example, a suture, customized surgical kit, or clip, other than a radiological site marker).

• Material that may be used to replace human skin (for example, a biological or synthetic material).

These requirements are the OPPS criteria used to define a device for pass-through payment purposes and do not include additional criteria that are used under the OPPS to determine if a candidate device is new and represents a substantial clinical improvement, two other requirements for qualifying for pass-through payment.

For purposes of applying the eligibility criteria, we interpret "surgical insertion or implantation" to include devices that are surgically inserted or implanted via a natural or surgically created orifice as well as those devices that are inserted or implanted via a surgically created incision (70 FR 68630).

In proposing to modify the cost report to have one cost center for medical supplies and one cost center for devices, we are proposing that hospitals would determine what should be reported in the Medical Supplies cost center and what should be reported in the Medical Devices cost center using criteria consistent with those listed above that are included under § 419.66(b), with some modification. Specifically, for purposes of the cost reporting instructions, we are proposing that an item would be reported in the device cost center if it meets the following criteria:

a. If required by the FDA, the device must have received FDA approval or clearance (except for a device that has received an FDA investigational device exemption (IDE) and has been classified as a Category B device by the FDA in accordance with §§ 405.203 through 405.207 and 405.211 through 405.215 of the regulations) or another appropriate FDA exemption.

b. The device is reasonable and necessary for the diagnosis or treatment of an illness or injury or to improve the functioning of a malformed body part (as required by section 1862(a)(1)(A) of the Act).

c. The device is an integral and subordinate part of the service furnished, is used for one patient only, comes in contact with human tissue, is surgically implanted or inserted through a natural or surgically created orifice or surgical incision in the body, and remains in the patient when the patient is discharged from the hospital.

d. The device is not any of the following:

• Equipment, an instrument, apparatus, implement, or item of this type for which depreciation and financing expenses are recovered as depreciable assets as defined in Chapter 1 of the Medicare Provider Reimbursement Manual (CMS Pub. 15-1).

• A material or supply furnished incident to a service (for example, a surgical staple, a suture, customized surgical kit, or clip, other than a radiological site marker).

• Material that may be used to replace human skin (for example, a biological or synthetic material).

• A medical device that is used during a procedure or service and does not remain in the patient when the patient is released from the hospital.

We are proposing to select the existing criteria for what type of device qualifies for payment as a transitional pass-through device under the OPPS as a basis for instructing hospitals on what to report in the cost center for Medical Supplies Charged to Patients or the cost center for Medical Devices Charged to Patients because these criteria are concrete and already familiar to the hospital community. However, the key difference between the existing criteria for devices that are eligible for pass-through payment under the OPPS at § 419.66(b) and our proposed criteria stated above to be used for cost reporting purposes is that the device that is implanted remains in the patient when the patient is discharged from the hospital . Essentially, we are proposing to instruct hospitals to report only implantable devices that remain in the patient at discharge in the cost center for devices. All other devices and non-routine supplies which are separately chargeable would be reported in the medical supplies cost center. We believe that defining a device for cost reporting purposes based on criteria that specify implantation and adding that the device must remain in the patient upon discharge would have the benefit of capturing virtually all costly implantable devices (for example, implantable cardioverter defibrillators (ICDs), pacemakers, and cochlear implants) for which charge compression is a significant concern.

However, we acknowledge that a definition of device based on whether an item is implantable and remains in the patient could, in some cases, include items that are relatively inexpensive (for example, urinary catheters, fiducial markers, vascular catheters, and drainage tubes), and which many would consider to be supplies. Thus, some modest amount of charge compression could still be present in the cost center for devices if the hospital does not have a uniform markup policy. In addition, requiring as a cost reporting criterion that the device is to remain in the patient at discharge could exclude certain technologies that are moderately expensive (for example, cryoablation probes, angioplasty catheters, and cardiac echocardiography catheters, which do not remain in the patient upon discharge). Therefore, some charge compression could continue for these technologies. We believe this limited presence of charge compression is acceptable, given that the proposed definition of device for cost reporting purposes would isolate virtually all of the expensive items, allowing them to be separately reported from most inexpensive supplies.

The criteria we are proposing above for instructing hospitals as to what to report in the device cost center specify that a device is not a material or supply furnished incident to a service (for example, a surgical staple, a suture, customized surgical kit , or clip, other than a radiological site marker) (emphasis added). We understand that hospitals may sometimes receive surgical kits from device manufacturers that consist of a high-cost primary implantable device, external supplies required for operation of the device, and other disposable surgical supplies required for successful device implantation. Often the device and the attending supplies are included on a single invoice from the manufacturer, making it difficult for the hospital to determine the cost of each item in the kit. In addition, manufacturers sometimes include with the primary device other free or "bonus" items or supplies that are not an integral and necessary part of the device (that is, not actually required for the safe surgical implantation and subsequent operation of that device). (We note that arrangements involving free or bonus items or supplies may implicate the Federal anti-kickback statue, depending on the circumstances.) One option is for the hospital to split the total combined charge on the invoice in a manner that the hospital believes best identifies the cost of the device alone. However, because it may be difficult for hospitals to determine the respective costs of the actual device and the attending supplies (whether they are required for the safe surgical implantation and subsequent operation of that device or not), we are soliciting comments with respect to how supplies, disposable or otherwise, that are part of surgical kits should be reported. We are distinguishing between such supplies that are an integral and necessary part of the primary device (that is, required for the safe surgical implantation and subsequent operation of that device) from other supplies that are not directly related to the implantation of that device, but may be included by the device manufacturer with or without charge as "perks" along with the kit. If it is difficult to break out the costs and charges of these lower cost items that are an integral and necessary part of the primary device, we would consider allowing hospitals to report the costs and charges of these lower cost supplies along with the costs and charges of the more expensive primary device in the cost report cost center for implantable devices. However, to the extent that device manufacturers could be encouraged to refine their invoicing practices to break out the charges and costs for the lower cost supplies and the higher cost primary device separately, so that hospitals need not "guesstimate" the cost of the device, this would facilitate more accurate cost reporting and, therefore, the calculation of more accurate cost-based weights. Under either scenario, even for an aggregated invoice that contains an expensive device, we believe that RTI's findings of significant differences in supply CCRs for hospitals with a greater percentage of charges in device revenue codes demonstrate that breaking the Medical Supplies Charged to Patients cost center into two cost centers and using appropriate revenue codes for devices, and walking those costs to the new Implantable Devices Charged to Patients cost center, will result in an increase in estimated device costs.

In summary, we are proposing to modify the cost report to have one cost center for Medical Supplies Charged to Patients and one cost center for Implantable Devices Charged to Patients. We are proposing to instruct hospitals to report only devices that meet the four criteria listed above (specifically including that the device is implantable and remains in the patient at discharge) in the cost center for Implantable Devices Charged to Patients. All other devices and nonchargeable supplies would be reported in the Medical Supplies cost center. This would allow for two distinct CCRs, one for medical supplies and one for implantable devices and DME rented and DME sold.

However, we are also soliciting comments on alternative approaches that could be used in conjunction with or in lieu of the four proposed criteria for distinguishing between what should be reported in the cost center for Implantable Devices and Medical Supplies, respectively. Another option we are considering would distinguish between high-cost and low-cost items based on a cost threshold. Under this methodology, we would also have one cost center for Medical Supplies and one cost center for Devices, but we would instruct hospitals to report items that are not movable equipment or a capital expense but are above a certain cost threshold in the cost center for Devices. Items costing below that threshold would be reported in the cost center for Medical Supplies.

Establishing a cost threshold for cost reporting purposes would directly address the problem of charge compression and would enable hospitals to easily determine whether an item should be reported in the supply or the device cost center. A cost threshold would also potentially allow a broader variety of expensive, single use devices that do not remain in the patient at discharge to be reported in the device cost center (such as specialized catheters or ablation probes). While we have a number of concerns with the cost threshold approach, we are nevertheless soliciting public comments on whether such an approach would be worthwhile to pursue. Specifically, we are concerned that establishing a single cost threshold for pricing devices could possibly be inaccurate across hospitals. Establishing a threshold would require identifying a cost at which hospitals would begin applying reduced markup policies. Currently, we do not have data from which to derive a threshold. We have anecdotal reports that hospitals change their markup thresholds between $15,000 and $20,000 in acquisition costs. Recent research on this issue indicated that hospitals with average inpatient discharges in DRGs with supply charges greater than $15,000, $20,000, and $30,000 have higher supply CCRs (Advamed March 2006).

Furthermore, although a cost threshold directly addresses charge compression, it may not eliminate all charge compression from the device cost center because a fixed cost threshold may not accurately capture differential markup policies for an individual hospital. At the same time, we are also concerned that establishing a cost threshold may interfere with the pricing practices of device manufacturers in that the prices for certain devices or surgical kits could be inflated to ensure that the devices met the cost threshold. We believe our proposed approach of identifying a group of items that are relatively expensive based on the existing criteria for OPPS device pass-through payment status, rather than adopting a cost threshold, would not influence pricing by the device industry. In addition, if a cost threshold were adopted for distinguishing between high-cost devices and low-cost supplies on the cost report, we would need to periodically reassess the threshold for changes in markup policies and price inflation over time.

Another option for distinguishing between high-cost and low-cost items for purposes of the cost report would be to divide the Medical Supplies cost center based on markup policies by placing items with lower than average markups in a separate cost center. This approach would center on documentation requirements for differential charging practices that would lead hospitals to distinguish between the reporting of supplies and devices on different cost report lines. That is, because charge compression results from the different markup policies that hospitals apply to the supplies and devices they use based on the estimated costs of those supplies and devices, isolating supplies and devices with different markup policies mitigates aggregation in markup policies that cause charge compression and is specific to a hospital's internal accounting and pricing practices. If requested by the fiscal intermediaries/MACs at audit, hospitals could be required to submit documentation of their markup policies to justify the way they have reported relatively inexpensive supplies on one line and more expensive devices on the other line. We believe that it should not be too difficult for hospitals to document their markup practices because, as was pointed out by many commenters since the implementation of cost-based weights, the source of charge compression is varying markup practices. Greater knowledge of the specifics of hospital markup practices may allow ultimately for development of standard cost reporting instructions that instruct hospitals to report an item as a device or a supply based on the type of markup applied to that item. This option related to markup practices, the proposal to define devices based on four specific criteria, and the third alternative that would establish a cost threshold for purposes of distinguishing between high-cost and low-cost items, could be utilized separately or in some combination for purposes of cost report modification. Again, we are soliciting comments on these alternative approaches. We are also interested in other recommendations forappropriate cost reporting improvements that address charge compression.

3. Timeline for Revising the Medicare Cost Report

As mentioned in the FY 2008 IPPS final rule with comment period (72 FR 47198), we have begun a comprehensive review of the Medicare hospital cost report, and the proposed splitting of the current cost center for Medical Supplies Charged to Patients into one line for Medical Supplies Charged to Patients and another line for Implantable Devices Charged to Patients, is part of our initiative to update and revise the hospital cost report. Under an effort initiated by CMS to update the Medicare hospital cost report to eliminate outdated requirements in conjunction with the Paperwork Reduction Act, we plan to propose the actual changes to the cost reporting form, the attending cost reporting software, and the cost report instructions in Chapter 36 of the Medicare Provider Reimbursement Manual (PRM), Part II. We expect the proposed revision to the Medicare hospital cost report to be issued after publication of this IPPS proposed rule. If we were to adopt as final our proposal to create one cost center for Medical Supplies Charged to Patients and one cost center for Implantable Devices Charged to Patients in the FY 2009 IPPS final rule, the cost report forms and instructions would reflect those changes. We expect the revised cost report would be available for hospitals to use when submitting cost reports during FY 2009 (that is, for cost reporting periods beginning on or after October 1, 2008). Because there is approximately a 3-year lag between the availability of cost report data for IPPS and OPPS ratesetting purposes and a given fiscal year, we may be able to derive two distinct CCRs, one for medical supplies and one for devices, for use in calculating the FY 2012 IPPS relative weights and the CY 2012 OPPS relative weights.

4. Revenue Codes Used in the MedPAR File

An important first step in RTI's study (as explained in its draft interim March 2007 report) was determining how well the cost report charges used to compute CCRs matched to the charges in the MedPAR file. This match (or lack thereof) directly affects the accuracy of the DRG cost estimates because MedPAR charges are multiplied by CCRs to estimate cost. RTI found inconsistent reporting between the cost reports and the claims data for charges in several ancillary departments (Medical Supplies, Operating Room, Cardiology, and Radiology). For example, the data suggested that some hospitals often include costs and charges for devices and other medical supplies within the Medicare cost report cost centers for Operating Room, Radiology, or Cardiology, while other hospitals include them in the Medical Supplies Charged to Patients cost center. While the educational initiative undertaken by the national hospital associations is encouraging hospitals to consistently report costs and charges for devices and other medical supplies only in the Medical Supplies Charged to Patients cost center, equal attention must be paid to the way in which charges are grouped by hospitals in the MedPAR file. Several commenters on the FY 2008 IPPS proposed rule supported RTI's recommendation of including additional fields in the MedPAR file to disaggregate certain cost centers. One commenter stated that the assignment of revenue codes and charges to revenue centers in the MedPAR file should be reviewed and changed to better reflect hospital accounting practices as reflected on the cost report (72 FR 47198).

In an effort to improve the match between the costs and charges included on the cost report and the charges in the MedPAR file, we are recommending that certain revenue codes be used for items reported in the proposed Medical Supplies Charged to Patients cost center and the proposed Implantable Devices Charged to Patients cost center, respectively. Specifically, under the proposal to create a cost center for implantable devices that remain in the patient upon discharge, revenue codes 0275 (Pacemaker), 0276 (Intraocular Lens), and 0278 (Other Implants) would correspond to implantable devices reported in the proposed Implantable Devices Charged to Patients cost center. Items for which a hospital may have previously used revenue code 0270 (General Classification), but actually meet the proposed definition of an implantable device that remains in the patient upon discharge should instead be billed with the 0278 revenue code. Conversely, relatively inexpensive items and supplies that are not implantable and do not remain in the patient at discharge would be reported in the proposed Medical Supplies Charged to Patients cost center on the cost report, and should be billed with revenue codes 0271 (nonsterile supply), 0272 (sterile supply), and 0273 (take-home supplies), as appropriate. Revenue code 0274 (Prosthetic/Orthotic devices) and revenue code 0277 (Oxygen-Take Home) should be associated with the costs reported on lines 66 and 67 for DME-Rented and DME-Sold on the cost report. Charges associated with supplies used incident to radiology or to other diagnostic services (revenue codes 0621 and 0622 respectively) should match those items used incident to those services on the Medical Supplies Charged to Patients cost center of the cost report, because, under this proposal, supplies furnished incident to a service would be reported in the Medical Supplies Charged to Patients cost center (see item b. listed above, in the proposed definition of a device). A revenue code of 0623 for surgical dressings would similarly be associated with the costs and charges of items reported in the proposed Medical Supplies Charged to Patients cost center, while a revenue code of 0624 for FDA investigational device, if that device does not remain in the patient upon discharge, could be associated with items reported on the Medical Supplies Charged to Patients cost center as well.

In general, if an item is reported as an implantable device on the cost report, the associated charges should be recorded in the MedPAR file with either revenue codes 0275 (Pacemaker), 0276 (Intraocular Lens), or 0278 (Other Implants). Likewise, items reported as Medical Supplies should receive an appropriate revenue code indicative of supplies. We understand that many of these revenue codes have been in existence for many years and have been added for purposes unrelated to the goal of refining the calculation of cost-based weights. Accordingly, we acknowledge that additional instructions relating to the appropriate use of these revenue codes may need to be issued. In addition, CMS or the hospital associations may need to request new revenue codes from the National Uniform Billing Committee (NUBC). In either case, we do not believe either should delay use of the new Medical Supplies and Implantable Devices CCRs in setting payment rates. However, in light of our proposal to create two separate cost centers for Medical Supplies Charged to Patients and Implantable Devices Charged to Patients, respectively, we are soliciting comments on how the existing revenue codes or additional revenue codes could best be used in conjunction with the revised cost centers on the cost report.

F. Preventable Hospital-Acquired Conditions (HACs), Including Infections

1. General

In its landmark 1999 report "To Err is Human: Building a Safer Health System," the Institute of Medicine found that medical errors, particularly hospital-acquired conditions (HACs) caused by medical errors, are a leading cause of morbidity and mortality in the United States. The report noted that the number of Americans who die each year as a result of medical errors that occur in hospitals may be as high as 98,000. The cost burden of HACs is also high. Total national costs of these errors due to lost productivity, disability, and health care costs were estimated at $17 billion to $29 billion.2In 2000, the CDC estimated that hospital-acquired infections added nearly $5 billion to U.S. health care costs every year.3A 2007 study found that, in 2002, 1.7 million hospital-acquired infections were associated with 99,000 deaths4Research has also shown that hospitals are not following recommended guidelines to avoid preventable hospital-acquired infections. A 2007 Leapfrog Group survey of 1,256 hospitals found that 87 percent of those hospitals do not follow recommendations to prevent many of the most common hospital-acquired infections.5

Footnotes:

2 Institute of Medicine: To Err Is Human: Building a Safer Health System, November 1999. Available at: http://www.iom.edu/Object.File/Master/4/117/ToErr-8pager.pdf.

3 Centers for Disease Control and Prevention: Press Release, March 2000. Available at: http://www.cdc.gov/od/oc/media/pressrel/r2k0306b.htm.

4 Klevens et al. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002. Public Health Reports. March-April 2007. Volume 122.

5 2007 Leapfrog Group Hospital Survey. The Leapfrog Group 2007. Available at: http://www.leapfroggroup.org/media/file/Leapfrog_hospital_acquired_infections_release.pdf

As one approach to combating HACs, including infections, in 2005 Congress authorized CMS to adjust for Medicare IPPS hospital payments to encourage the prevention of these conditions. The preventable HAC provision at section 1886(d)(4)(D) of the Act is part of an array of Medicare value-based purchasing (VBP) tools that CMS is using to promote increased quality and efficiency of care. Those tools include measuring performance, using payment incentives, publicly reporting performance results, applying national and local coverage policy decisions, enforcing conditions of participation, and providing direct support for providers through Quality Improvement Organization (QIO) activities. CMS' application of VBP tools through various initiatives, such as this HAC provision, is transforming Medicare from a passive payer to an active purchaser of higher value health care services. We are applying these strategies for inpatient hospital care and across the continuum of care for Medicare beneficiaries.

The President's FY 2009 Budget outlines another approach for addressing serious preventable adverse events ("never events"), including HACs. The President's Budget proposal would: (1) Prohibit hospitals from billing the Medicare program for "never events" and prohibit Medicare payment for these events; and (2) require hospitals to report occurrence of these events or receive a reduced annual payment update.

Medicare's IPPS encourages hospitals to treat patients efficiently. Hospitals receive the same DRG payment for stays that vary in length and in the services provided, which gives hospitals an incentive to avoid unnecessary costs in the delivery of care. In many cases, complications acquired in the hospital do not generate higher payments than the hospital would otherwise receive for uncomplicated cases paid under the same DRG. To this extent, the IPPS encourages hospitals to avoid complications. However, complications, such as infections, acquired in the hospital can generate higher Medicare payments in two ways. First, the treatment of complications can increase the cost of a hospital stay enough to generate an outlier payment. However, the outlier payment methodology requires that a hospital experience a large loss on an outlier case, which serves as an incentive for hospitals to prevent outliers. Second, under the MS-DRGs that took effect in FY 2008, there are currently 258 sets of MS-DRGs that are split into 2 or 3 subgroups based on the presence or absence of a CC or an MCC. If a condition acquired during a hospital stay is one of the conditions on the CC or MCC list, the hospital currently receives a higher payment under the MS-DRGs (prior to the October 1, 2008 effective date of the HAC payment provision). (We refer readers to section II.D. of the FY 2008 IPPS final rule with comment period for a discussion of DRG reforms (72 FR 47141).) The following is an example of how an MS-DRG may be paid.

Service: MS-DRG Assignment* (Examples below with CC/MCC indicate a single secondary diagnosis only) Present on admission (status of secondary diagnosis) Average payment (based on 50th percentile)
Principal Diagnosis $5,347.98
• Intracranial hemorrhage or cerebral infarction (stroke) without CC/MCC-MS-DRG 066
Principal Diagnosis Y 6,177.43
• Intracranial hemorrhage or cerebral infarction (stroke) with CC-MS-DRG 065
Example Secondary Diagnosis
• Dislocation of patella-open due to a fall (code 836.4 (CC))
Principal Diagnosis N 5,347.98
• Intracranial hemorrhage or cerebral infarction (stroke) with CC-MS-DRG 065
Example Secondary Diagnosis
• Dislocation of patella-open due to a fall (code 836.4 (CC))
Principal Diagnosis Y 8,030.28
• Intracranial hemorrhage or cerebral infarction (stroke) with MCC-MS-DRG 064
Example Secondary Diagnosis
• Stage III pressure ulcer (code 707.23 (MCC))
Principal Diagnosis N 5,347.98
• Intracranial hemorrhage or cerebral infarction (stroke) with MCC-MS-DRG 064
Example Secondary Diagnosis
• Stage III pressure ulcer (code 707.23 (MCC))
* Operating amounts for a hospital whose wage index is equal to the national average.

2. Statutory Authority

Section 1886(d)(4)(D) of the Act required the Secretary to select at least two conditions by October 1, 2007, that are: (a) High cost, high volume, or both; (b) assigned to a higher paying DRG when present as a secondary diagnosis; and (c) could reasonably have been prevented through the application of evidence-based guidelines. Beginning October 1, 2008, Medicare can no longer assign an inpatient hospital discharge to a higher paying MS-DRG if a selected HAC was not present on admission. That is, the case will be paid as though the secondary diagnosis was not present. (Medicare will continue to assign a discharge to a higher paying MS-DRG if the selected condition was present on admission.) Section 1886(d)(4)(D) of the Act provides that the list of conditions can be revised from time to time, as long as the list contains at least two conditions. Beginning October 1, 2007, we required hospitals to begin submitting information on Medicare claims specifying whether diagnoses were present on admission (POA).

The POA indicator reporting requirement and the HACs payment provision apply to IPPS hospitals only. At this time, non-IPPS hospitals such as CAHs, LTCHs, IRFs, and hospitals in Maryland operating under waivers, among others, are exempt from POA reporting and the HAC payment provision. Throughout this section, "hospital" refers to IPPS hospitals.

3. Public Input

In the FY 2007 IPPS proposed rule (71 FR 24100), we sought public input regarding conditions with evidence-based prevention guidelines that should be selected in implementing section 1886(d)(4)(D) of the Act. The public comments we received were summarized in the FY 2007 IPPS final rule (71 FR 48051 through 48053). In the FY 2008 IPPS proposed rule (72 FR 24716), we again sought formal public comment on conditions that we proposed to select. In the FY 2008 IPPS final rule with comment period (72 FR 47200 through 47218), we summarized the public comments we received on the FY 2008 IPPS proposed rule, presented our responses, selected eight conditions to which the HAC provision will initially apply, and noted that we would be seeking comments on additional HAC candidates in this proposed rule.

4. Collaborative Process

CMS experts worked with public health and infectious disease professionals from the CDC to identify the candidate preventable HACs. CMS and CDC staff also collaborated on the process for hospitals to submit a POA indicator for each diagnosis listed on IPPS hospital Medicare claims.

On December 17, 2007, CMS and CDC hosted a jointly sponsored HAC and POA Listening Session to receive input from interested organizations and individuals. The agenda, presentations, audio file, and written transcript of the listening session are available on the Web site at: http://www.cms.hhs.gov/HospitalAcqCond/07_EducationalResources.asp. CMS and CDC also received informal comments during the listening session and subsequently received numerous written comments.

5. Selection Criteria for HACs

CMS and CDC staff evaluated each candidate condition against the criteria established by section 1886(d)(4)(D)(iv) of the Act.

• Cost or Volume-Medicare data6must support that the selected conditions are high cost, high volume, or both. At this point, there are no Medicare claims data indicating which secondary diagnoses were POA because POA indicator reporting began only recently; therefore, the currently available data for candidate conditions includes all secondary diagnoses.

Footnotes:

6 For this FY 2009 IPPS proposed rule, the DRG analysis is based on data from the September 2007 update of the FY 2007 MedPAR file, which contains hospital bills received through September 30, 2007, for discharges through September 30, 2007.

• Complicating Condition (CC) or Major Complicating Condition (MCC)-Selected conditions must be represented by ICD-9-CM diagnosis codes that clearly identify the condition, are designated as a CC or an MCC, and result in the assignment of the case to an MS-DRG that has a higher payment when the code is reported as a secondary diagnosis. That is, selected conditions must be a CC or an MCC that would, in the absence of this provision, result in assignment to a higher paying MS-DRG.

• Evidence-Based Guidelines-Selected conditions must be reasonably preventable through the application of evidence-based guidelines. By reviewing guidelines from professional organizations, academic institutions, and entities such as the Healthcare Infection Control Practices Advisory Committee (HICPAC), we evaluated whether guidelines are available that hospitals should follow to prevent the condition from occurring in the hospital.

• Reasonably Preventable-Selected conditions must be reasonably preventable through the application of evidence-based guidelines.

6. HACs Selected in FY 2008 and Proposed Changes to Certain Codes

The HACs that were selected for the HAC payment provision through the FY 2008 IPPS final rule with comment period are listed below. The payment provision for these selected HACs will take effect on October 1, 2008. We refer readers to section II.F.6. of the FY 2008 IPPS final rule with comment period (72 FR 47202 through 47218) for a detailed analysis supporting the selection of each of these HACs.

BILLING CODE 4120-01-P

[Federal Register graphic "EP30AP08.000" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.001" is not available. Please view the graphic in the PDF version of this document.]

BILLING CODE 4120-01-C

We are seeking public comments on the following refinements to two of the previously selected HACs:

a. Foreign Object Retained After Surgery: Proposed Inclusion of ICD-9-CM Code 998.7 (CC)

In the FY 2008 IPPS final rule with comment period (72 FR 47206), we indicated that a foreign body accidentally left in the patient during a procedure (ICD-9-CM code 998.4) was one of the conditions selected. It has come to our attention that ICD-9-CM diagnosis code 998.7 (Acute reaction to foreign substance accidentally left during a procedure) should also be included. ICD-9-CM code 998.7 describes instances in which a patient developed an acute reaction due to a retained foreign substance. Therefore, we are proposing to make this code subject to the HAC payment provision.

b. Pressure Ulcers: Proposed Changes in Code Assignments

As discussed in the FY 2008 IPPS final rule with comment period (72 FR 47205-47206), we referred the need for more detailed ICD-9-CM pressure ulcer codes to the CDC. The topic of expanding pressure ulcer codes to capture the stage of the ulcer was addressed at the September 27-28, 2007, meeting of the ICD-9-CM Coordination and Maintenance Committee. A summary report of this meeting is available on the Web site at: http://www.cdc.gov/nchs/about/otheract/icd9/maint/maint.htm.

Numerous wound care professionals supported modifying the pressure ulcer codes to capture staging information. The stage of the pressure ulcer is a powerful predictor of severity and resource utilization. At its September 27-28, 2007 meeting, the ICD-9-CM Coordination and Maintenance Committee discussed the creation of pressure ulcer codes to capture this information. The new codes, along with their proposed CC/MCC classifications, are shown in Table 6A of the Addendum to this proposed rule. The new codes are as follows:

• 707.20 (Pressure ulcer, unspecified stage).

• 707.21 (Pressure ulcer stage I).

• 707.22 (Pressure ulcer stage II).

• 707.23 (Pressure ulcer stage III).

• 707.24 (Pressure ulcer stage IV).

While the code titles are final, we are soliciting comment on the proposed MS-DRG classifications of these codes, as indicated in Table 6A of the Addendum to this proposed rule. We are proposing to remove the CC/MCC classifications from the current pressure ulcer codes that show the site of the ulcer (ICD-9-CM codes 707.00 through 707.09). Therefore, the following codes would no longer be a CC:

• 707.00 (Decubitus ulcer, unspecified site).

• 707.01 (Decubitus ulcer, elbow).

• 707.09 (Decubitus ulcer, other site).The following codes would no longer be an MCC:

• 707.02 (Decubitus ulcer, upper back).

• 707.03 (Decubitus ulcer, lower back).

• 707.04 (Decubitus ulcer, hip).

• 707.05 (Decubitus ulcer, buttock).

• 707.06 (Decubitus ulcer, ankle).

• 707.07 (Decubitus ulcer, heel).

We are proposing to instead assign the CC/MCC classifications to the stage of the pressure ulcer as shown in Table 6A of the Addendum to this proposed rule. We are proposing to classify ICD-9-CM codes 707.23 and 707.24 as MCCs. We are proposing to classify codes 707.20, 707.21, and 707.22 as non-CCs.

Therefore, we are proposing that, beginning October 1, 2008, the codes used to make MS-DRG adjustments for pressure ulcers under the HAC provision would include the proposed MCC codes 707.23 and 707.24.

7. HACs Under Consideration as Additional Candidates

CMS and CDC have diligently worked together and with other stakeholders to identify additional HACs that might appropriately be subject to the HAC payment provision. If the additional candidate HACs are selected in the FY 2009 IPPS final rule, the payment provision will take effect for these candidate HACS on October 1, 2008. The statutory criteria for each HAC candidate are presented in tabular format. Each table contains the following:

• HAC Candidate-We are seeking public comment on all HAC candidates.

• Medicare Data-We are seeking public comment on the statutory criterion of high cost, high volume, or both as it applies to the HAC candidate.

• CC/MCC-We are seeking public comment on the statutory criterion that an ICD-9-CM diagnosis code(s) clearly identifies the HAC candidate.

• Selected Evidence-Based Guidelines-We are seeking public comment on the degree to which the HAC candidate is reasonably preventable through the application of the identified evidence-based guidelines.

a. Surgical Site Infections Following Elective Surgeries

[Federal Register graphic "EP30AP08.002" is not available. Please view the graphic in the PDF version of this document.]

In the FY 2008 IPPS final rule with comment period (72 FR 47213), surgical site infections were identified as a broad category for consideration, and we selected mediastinitis after coronary artery bypass graft (CABG) as one of the initial eight HACs for implementation. We are now considering the addition of other surgical site infections, particularly those following elective procedures. In most cases, patients selected as candidates for elective surgeries should have a relatively low-risk profile for surgical site infections.

The following elective surgical procedures are under consideration:

• Total Knee Replacement (81.54): ICD-9-CM codes 996.66 (CC) and 998.59 (CC)

• Laparoscopic Gastric Bypass (44.38) and Laparoscopic Gastroenterostomy (44.39): ICD-9-CM code 998.59 (CC)

• Ligation and Stripping of Varicose Veins (38.50 through 38.53, 38.55, 38.57, and 38.59): ICD-9-CM code 998.59 (CC)

Evidence-based guidelines for preventing surgical site infections emphasize the importance of appropriately using prophylactic antibiotics, using clippers rather than razors for hair removal and tightly controlling postoperative glucose.

While we are seeking public comments on the applicability of each of the statutory criteria to surgical site infections following elective procedures, we are particularly interested in receiving comments on the degree of preventability of surgical site infections following elective procedures generally, as well as specifically for those listed above. We also are seeking public comments on additional elective surgical procedures that would qualify for the HAC provision by meeting all of the statutory criteria. Based on the public comments we receive, we may select some combination of the four procedures presented here along with additional conditions that qualify and are supported by the comments.

b. Legionnaires' Disease

[Federal Register graphic "EP30AP08.003" is not available. Please view the graphic in the PDF version of this document.]

We discussed Legionnaires' Disease in the FY 2008 IPPS final rule with comment period (72 FR 47216). Legionnaires' Disease is a type of pneumonia caused by the bacterium Legionella pneumophila. It is contracted by inhaling contaminated water vapor or droplets. It is not spread person to person. Individuals at risk include those who are elderly, immunocompromised, smokers, or persons with underlying lung disease. The bacterium thrives in warm aquatic environments and infections have been linked to large industrial water systems, including hospital water systems such as air conditioning cooling towers and potable water plumbing systems. Prevention depends primarily on regular monitoring and decontamination of these water systems. While we are seeking public comments regarding the applicability of each of the statutory criteria to Legionnaires' Disease, we are particularly interested in receiving comments on the degree of preventability of Legionnaires' Disease through the application of hospital water system maintenance guidelines.

Legionnaires' Disease is typically acquired outside of the hospital setting and may be difficult to diagnose as present on admission. We are seeking comments on the degree to which hospital-acquired Legionnaires' Disease can be distinguished from community-acquired cases.

We also are seeking public comments on additional water-borne pathogens that would qualify for the HAC provision by meeting the statutory criteria. Based on the public comments we receive, we may finalize some combination of Legionnaires' Disease and additional conditions that qualify and are supported by the public comments.

c. Glycemic Control

[Federal Register graphic "EP30AP08.004" is not available. Please view the graphic in the PDF version of this document.]

During the December 17, 2007 HAC and POA Listening Session, one of the commenters suggested that we explore hyperglycemia and hypoglycemia as HACs for selection. NQF's list of Serious Reportable Adverse Events includes death or serious disability associated with hypoglycemia that occurs during hospitalization.

Hyperglycemia and hypoglycemia are extremely common laboratory findings in hospitalized patients and can be complicating features of underlying diseases and some therapies. However, we believe that extreme forms of poor glycemic control should not occur while under medical care in the hospital setting. Thus, we are considering whether the following forms of extreme glucose derangement should be subject to the HAC payment provision:

• Diabetic Ketoacidosis: ICD-9-CM codes 250.10-250.13 (CC)

• Nonketotic Hyperosmolar Coma: ICD-9-CM code 251.0 (CC)

• Diabetic Coma: ICD-9-CM codes 250.30-250.33 (CC)

• Hypoglycemic Coma: ICD-9-CM codes 250.30-251.0 (CC)

While we are seeking public comments regarding the applicability of each of the statutory criteria to these extreme aberrations in glycemic control, we are particularly interested in receiving comments on the degree to which these extreme aberrations in glycemic control are reasonably preventable, in the hospital setting, through the application of evidence-based guidelines. Based on the public comments we receive, we may select some combination of these glycemic control-related conditions as HACs.

d. Iatrogenic Pneumothorax

[Federal Register graphic "EP30AP08.005" is not available. Please view the graphic in the PDF version of this document.]

Iatrogenic pneumothorax refers to the accidental introduction of air into the pleural space, which is the space between the lung and the chest wall. When air is introduced into this space it partially or completely collapses the lung. Iatrogenic pneumothorax can occur during any procedure where there is the possibility of air entering pleural space, including needle biopsy of the lung, thoracentesis, central venous catheter placement, pleural biopsy, tracheostomy, and liver biopsy. Iatrogenic pneumothorax can occur secondary to positive pressure mechanical ventilation when an air sac in the lung ruptures allowing air into the pleural space.

While we are seeking public comments on the applicability of each of the statutory criteria to iatrogenic pneumothorax, we are particularly interested in receiving comments on the degree to which iatrogenic pneumothorax is reasonably preventable through the application of evidence-based guidelines. Based on the public comments we receive, we may select iatrogenic pneumothorax as an HAC.

e. Delirium

[Federal Register graphic "EP30AP08.006" is not available. Please view the graphic in the PDF version of this document.]

Delirium is a relatively abrupt deterioration in a patient's ability to sustain attention, learn, or reason. Delirium is strongly associated with aging and treatment of illnesses that are associated with hospitalizations. Delirium affects nearly half of hospital patient days for individuals age 65 and older, and approximately three-quarters of elderly individuals in intensive care units have delirium. About 14 to 24 percent of hospitalized elderly individuals have delirium at the time of admission. Having delirium is a very serious risk factor, with 1-year mortality of 35 to 40 percent, a rate as high as those associated with heart attacks and sepsis. The adverse effects of delirium routinely last for months. Delirium is a clinical diagnosis, commonly assisted by screening tests such as the Confusion Assessment Method.

Well-established practices, such as reducing certain medications, reorienting the patient, assuring sensory input and sleep, and avoiding malnutrition and dehydration, prevent 30 to 40 percent of the possible cases. While we are seeking public comments on the applicability of each of the statutory criteria to delirium, we are particularly interested in receiving comments on the degree to which delirium is reasonably preventable through the application of evidence-based guidelines. Based upon the public comments we receive, we may select delirium as an HAC.

f. Ventilator-Associated Pneumonia (VAP)

[Federal Register graphic "EP30AP08.007" is not available. Please view the graphic in the PDF version of this document.]

We discussed ventilator-associated pneumonia (VAP) in the FY 2008 IPPS final rule with comment period (72 FR 47209-47210). VAP is a serious hospital-acquired infection associated with high mortality, significantly increased hospital length of stay, and high cost. It is typically caused by the aspiration of contaminated gastric and/or oropharyngeal secretions. The presence of an endotracheal tube facilitates both the contamination of secretions as well as aspiration.

During the past year, the ICD-9-CM Coordination and Maintenance Committee discussed the creation of a new ICD-9-CM code 997.31 to identify VAP. This new code is shown in Table 6A of the Addendum to this proposed rule. The lack of a specific code was one of the barriers to including VAP as an HAC that we discussed in the FY 2008 IPPS final rule with comment period. We also discussed the degree to which VAP may be reasonably preventable through the application of evidence-based guidelines. Specifically, the FY 2008 IPPS final rule with comment period referenced the American Association for Respiratory Care's Clinical Practice Guidelines at the Web site: http://www.rcjournal.com/cpgs/09.03.0869.html.

To further investigate the extent to which VAP is reasonably preventable, we reviewed published clinical research. The literature, including recommendations by CDC and the HICPAC, from 2003 shows numerous prevention guidelines that can significantly reduce the incidence of VAP in the hospital setting. These guidelines include interventions such as educating staff, hand washing, using gowns and gloves, properly positioning the patient, elevating the head of the bed, changing ventilator tubing, sterilizing reusable equipment, applying chlorhexadine solution for oral decontamination, monitoring sedation daily, administering stress ulcer prophylaxis, and administering pneumococcal vaccinations. Further review of the literature, specifically regarding the proportion of VAP cases that might be preventable, revealed two large-scale analyses that were completed recently. One study concluded that an estimated 40 percent of VAP cases are preventable. A second study concluded that at least 20 percent of nosocomial infections in general (not just VAP) are preventable.7

Footnotes:

7 American Association for Respiratory Care Clinical Practice: Guideline: Care of the Ventilator Circuit and Its Relation to Ventilator Associated Pneumonia. Available at the Web site: http://www.rcjournal.com/cpgs/09.03.0869.html.

During the December 17, 2007 HAC and POA Listing Session, we also received comments on evidence-based guidelines for preventing VAP.Commenters referenced two articles8 9 that both state there is a high degree of risk associated with endotracheal tube insertions, suggesting that VAP may not always be preventable.

Footnotes:

8 Ramirez et al.: Prevention Measures for Ventilator-Associated Pneumonia: A New Focus on the Endotracheal Tube. Current Opinion in Infectious Disease, April 2007, Vol.20 (2), pp. 190-197.

9 Safdar et al.: The Pathogenesis of Ventilator-Associated Pneumonia: Its Relevance to Developing Effective Strategies for Prevention. Respiratory Care, June 2005, Vol. 50, No. 6, pp.725-741.

While we are seeking public comments on the applicability of each of the statutory criteria to VAP, we are particularly interested in receiving comment on the degree to which VAP is reasonably preventable through the application of evidence-based guidelines. Based on the public comments we receive, we may select VAP as an HAC.

g. Deep Vein Thrombosis (DVT)/Pulmonary Embolism (PE)

[Federal Register graphic "EP30AP08.008" is not available. Please view the graphic in the PDF version of this document.]

We discussed deep vein thrombosis (DVT) and pulmonary embolism (PE) in the FY 2008 IPPS final rule with comment period (72 FR 47215). DVT and PE are common events. DVT occurs when a blood clot forms in the deep veins of the leg and causes local swelling and inflammation. PE occurs when a clot or a piece of a clot migrates from its original site into the lungs, causing the death of lung tissue, which can be fatal. Risk factors for DVTs and PEs include inactivity, smoking, use of oral contraceptives, prolonged bed rest, prolonged sitting with bent knees, certain types of cancer and other disease states, certain blood clotting disorders, and certain types of orthopedic and other surgical procedures. DVT is not always clinically apparent because the manifestations of pain, redness, and swelling may develop some time after the venous clot forms.

As we discussed in the FY 2008 IPPS final rule with comment period, DVTs and PEs may be preventable in certain circumstances, but it is possible that a patient may have a DVT that is difficult to detect on admission. We also received comments during the December 17, 2007 HAC and POA Listening Session reiterating that not all cases of DVTs and PEs are preventable. For example, common patient characteristics such as immobility, obesity, severe vessel trauma, and venous stasis put certain trauma and joint replacement surgery patients at high risk for these conditions.

In our review of the literature, we found that there are definite pharmacologic and nonpharmacologic interventions that may reduce the likelihood of developing DVTs and PEs, including exercise, compression stockings, intermittent pneumatic boots, aspirin, enoxaparin, dalteparin, heparin, coumadin, clopidogrel, and fondaparinux. However, the evidencepbased guidelines indicate that some patients may still develop clots despite these therapies.

While we are seeking public comments on the applicability of each of the statutory criteria to DVTs and PEs, we are particularly interested in receiving comments on the degree of preventability of DVTs and PEs. We are also interested in comments on determining the presence of DVT and PE at admission. Based on the public comments we receive, we may select DVTs and PEs as HACs.

h. Staphylococcus aureus Septicemia

[Federal Register graphic "EP30AP08.009" is not available. Please view the graphic in the PDF version of this document.]

We discuss Staphylococcus aureus Septicemia in the FY 2008 IPPS final rule with comment period (72 FR 47208). Staphylococcus aureus is a bacterium that lives in the nose and on the skin of a large percentage of the population. It usually does not cause physical illness, but it can cause infections ranging from superficial boils to cellulitis to pneumonia to life threatening bloodstream infections (septicemia). It usually enters the body through traumatized tissue, such as cuts or abrasions, or at the time of invasive procedures. Staphylococcus aureus Septicemia can also be a late effect of an injury or a surgical procedure. Risk factors for developing Staphylococcus aureus Septicemia include advanced age, debilitated state, immunocompromised status, and a history of an invasive medical procedure.

CDC has developed evidence-based guidelines for the prevention of the Staphylococcus aureus Septicemia. Most preventable cases of septicemia are primarily related to the presence of a central venous or vascular catheter. During the December 17, 2007 HAC and POA Listening Session, commenters noted that intravascular catheter-associated infections are only one cause of septicemia. Therefore, catheter-oriented evidence-based guidelines would not cover all cases of Staphylococcus aureus Septicemia.10

Footnotes:

10 Jensen, A.G. Importance of Focus Identification in the Treatment of Staphylococcus aureus Bacteremia. 2002. Vol. 52, pp. 29-36.

We identified evidence-based guidelines that suggest Staphylococcus aureus Septicemia is reasonably preventable. These guidelines emphasize the importance of effective and fastidious hand washing by both staff and visitors, using gloves and gowns where appropriate, applying proper decontamination techniques, and exercising contact isolation where clinically indicated.

While we are seeking public comments on the applicability of each of the statutory criteria to Staphylococcus aureus infections generally, we are particularly interested in receiving comments on the degree of preventability of Staphylococcus aureus infections generally, and specifically Staphylococcus aureus Septicemia. Based on the public comments we receive, we may select Staphylococcus aureus Septicemia as an HAC.

i. Clostridium Difficile -Associated Disease (CDAD)

[Federal Register graphic "EP30AP08.010" is not available. Please view the graphic in the PDF version of this document.]

We discussed Clostridium difficile -associated disease (CDAD) in the FY 2008 IPPS final rule with comment period. Clostridium difficile is a bacterium that colonizes the gastrointestinal (GI) tract of a certain number of healthy people. Under conditions where the normal flora of the gastrointestinal tract is altered, Clostridium difficile can flourish and release large enough amounts of a toxin to cause severe diarrhea or even life threatening colitis. Risk factors for CDAD include prolonged use of broad spectrum antibiotics, gastrointestinal surgery, prolonged nasogastric tube insertion, and repeated enemas. CDAD can be acquired in the hospital or in the community. Its spores can live outside of the body for months and thus can be spread to other patients in the absence of meticulous hand washing by care providers and others who contact the infected patient.

We continue to receive strong support in favor of selecting CDAD as an HAC. During the December 17, 2007 HAC and POA Listening Session, representatives of consumers and purchasers advocated to include CDAD as an HAC.

The evidence-based guidelines for CDAD prevention emphasize that hand washing by staff and visitors and effective decontamination of environmental surfaces prevent the spread of Clostridium difficile. While we are seeking public comments on the applicability of each of the statutory criteria to CDADs, we are particularly interested in receiving comments on the degree of preventability of CDAD. Based on the public comments we receive, we may select CDAD as an HAC.

j. Methicillin-Resistant Staphylococcus aureus (MRSA)

[Federal Register graphic "EP30AP08.011" is not available. Please view the graphic in the PDF version of this document.]

We discussed the special case of methicillin-resistant Staphylococcus aureus (MRSA) in the FY 2008 IPPS final rule with comment period (72 FR 47212). In October 2007, the CDC published in the Journal of the American Medical Association an article citing high mortality rates from MRSA, an antibiotic-resistant "superbug." The article estimates 19,000 people died from MRSA infections in the United States in 2005. The majority of invasive MRSA cases are health care-related-contracted in hospitals or nursing homes-though community-acquired MRSA also poses a significant public health concern. Hospitals have been focused for years on controlling MRSA through the application of CDC's evidence-based guidelines outlining best practices for combating the bacterium in that setting.

MRSA is currently addressed by the HAC payment provision. For every infectious condition selected, MRSA could be the etiology of that infection. For example, if MRSA were the cause of a vascular catheter-associated infection (one of the eight conditions selected in the FY 2008 IPPS final rule with comment period), the HAC payment provision would apply to that MRSA infection.

As we noted in the FY 2008 IPPS final rule with comment period, colonization by MRSA is not a reasonably preventable HAC according to the current evidence-based guidelines; therefore, MRSA does not meet the reasonably preventable statutory criterion for an HAC. An estimated 32.4 percent of Americans are colonized with MRSA, which may reside in the nose or on the skin of asymptomatic carriers.11In addition, in last year's final rule with comment period, we noted that there is no CC/MCC code available for MRSA, and therefore it also does not meet the codeable CC/MCC statutory criterion for an HAC. Only when MRSA causes an infection does a codeable condition occur. However, we referenced the possibility that new codes for MRSA were being considered by the ICD-9-CM Coordination and Maintenance Committee. The creation of unique codes to capture MRSA was discussed during the March 19-20, 2008 Committee meeting. While these codes will enhance the data available and our understanding of MRSA, the availability and use of these codes will not change the fact that the mere presence of MRSA as a colonizing bacterium does not constitute an HAC.

Footnotes:

11 Kuehnert, M.J., et al.: Prevalence of Staphylococcusa aureus Nasal Colonization in the United States, 2001-2002. The Journal of Infectious Disease, January 15, 2006; Vol. 193.

Because MRSA as a bacterium does not meet two of our statutory criteria, codeable CC/MCC and reasonably preventable through evidence-based guidelines, we are not proposing MRSA as an HAC. However, we recognize the significant public health concerns that were raised by representatives of consumers and purchasers at the HAC and POA Listening Session, and we are committed to reducing the spread of multi-drug resistant organisms, such as MRSA.

In addition, we are pursuing collaborative efforts with other HHS agencies to combat MRSA. The Agency for Healthcare Research and Quality (AHRQ) has launched a new initiative in collaboration with CDC and CMS to identify and suppress the spread of MRSA and related infections. In support of this work, Congress has appropriated $5 million to fund research, implementation, management, and evaluation practices that mitigate such infections.

CDC has carried out extensive research on the epidemiology of MRSA and effective techniques that could be used to treat the infection and reduce its spread. The following Web sites contain information that reflect CDC's commitment: (1) http://www.cdc.gov/ncidod/dhqp/ar_mrsa.html (health care-associated MRSA); (2) http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca_public.html (community-acquired MRSA); (3) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4908a1.htm; and (4) http://www.cdc.gov/handhygiene/.

AHRQ has made previous investments in systems research to help monitor MRSA and related infections in hospital settings, as reflected in material on the Web site at: http://www.guideline.gov/browse/guideline_index.aspx and http://www.ahrq.gov/clinic/ptsafety/pdf/ptsafety.pdf.

8. Present on Admission (POA) Indicator Reporting

POA indicator information is necessary to identify which conditions were acquired during hospitalization for the HAC payment provision and for broader public health uses of Medicare data. Through Change Request No. 5679 (released June 20, 2007), CMS issued instructions requiring IPPS hospitals to submit the POA indicator data for all diagnosis codes on Medicare claims. Specific instructions on how to select the correct POA indicator for each diagnosis code are included in the ICD-9-CM Official Guidelines for Coding and Reporting, available at the Web site: http://www.cdc.gov/nchs/datawh/ftpserv/ftpicd9/icdguide07.pdf (POA reporting guidelines begin on page 92). Additional instructions, including information regarding CMS's phased implementation of POA indicator reporting and application of the POA reporting options, are available at the Web site: http://www.cms.hhs.gov/HospitalAcqCond.

There are five POA indicator reporting options: "Y," "N," "W," "U," and "1." Under the HAC payment provision, we are proposing to pay the CC/MCC MS-DRGs only for those HACs coded as "Y" and "W" indicators. The "Y" option indicates that the condition was present on admission. The "W" indicator affirms that the provider has determined, based on data and clinical judgment, that it is not possible to document when the onset of the condition occurred. We expect that this approach will encourage better documentation and promote the public health goals of POA reporting by providing more accurate data about the occurrence of HACs in the Medicare population. We anticipate that true clinical uncertainty will occur in only a very small number of cases. We plan to analyze how frequently the "W" indicator is used, and we leave open the possibility of proposing in future IPPS rulemaking not paying the CC/MCC MS-DRGs for HACs coded with the "W" indicator. In addition, we plan to analyze whether both the "Y" and "W" indicators are being used appropriately. Medicare program integrity initiatives closely monitor for inaccurate coding and coding that is inconsistent with medical record documentation. We are seeking public comments regarding the proposed treatment of the "Y" and "W" POA reporting options under the HAC payment provision.

We are proposing to not pay the CC/MMC MS-DRGs for HACs coded with the "N" indicator. The "N" option indicates that the condition was not present on admission. We are also proposing to not pay the CC/MCC MS-DRGs for HACs coded with the "U" indicator. The "U" option indicates that the medical record documentation is insufficient to determine whether the condition was present at the time of admission. Not paying for the CC/MCC MS-DRGs for HACs that are coded with the "U" indicator is expected to foster better medical record documentation.

Although we are proposing not paying the CC/MCC MS-DRG for HACs coded with the "U" indicator, we do recognize there may be some exceptional circumstances under which payment might be made. Death, elopement (leaving against medical advice), and transfers out of a hospital may preclude making an informed determination of whether an HAC was present on admission. We are seeking public comments on the potential use of the following current patient discharge status codes to identify the exceptional circumstances:

Form locator code Code descriptor
Exception for Patient Death
20 Expired.
Exception for Patient Elopement (Leaving Against Medical Device)
7 Left against medical advice or discontinued care.
Exception for Transfer
02 Discharged/transferred to a short-term general hospital for inpatient care.
03 Discharged/transferred to a skilled nursing facility (SNF) with Medicare certification in anticipation of skilled care.
04 Discharged/transferred to an intermediate care facility (ICF).
05 Discharged/transferred to a designated cancer center or children's hospital.
06 Discharged/transferred to home under care of organized home health service organization.
43 Discharged/transferred to a Federal health care facility.
50 Hospice-home.
51 Hospice-medical facility (certified) providing hospice level of care.
61 Discharged/transferred to a hospital-based Medicare approved swing bed.
62 Discharged/transferred to an inpatient rehabilitation facility (IRF) including rehabilitation distinct part units of a hospital.
63 Discharged/transferred to a Medicare certified long term care hospital (LTCH).
64 Discharged/transferred to a nursing facility certified under Medicaid but not certified under Medicare.
65 Discharged/transferred to a psychiatric hospital or psychiatric distinct part unit of a hospital.
66 Discharged/transferred to a critical access hospital (CAH).
70 Discharged/transferred to another type of health care institution not otherwise defined in this code list.

We plan to analyze whether both the "N" and "U" POA reporting options are being used appropriately. The American Health Information Management Association (AHIMA) has promulgated Standards of Ethical Coding that require accurate coding regardless of the payment implications of the diagnoses. That is, diagnoses must be reported accurately regardless of their effect on payment. Medicare program integrity initiatives closely monitor for inaccurate coding and coding inconsistent with medical record documentation. We are seeking public comments regarding the proposal to not pay the CC/MCC MS-DRGs for HACs coded with "N" and "U" indicators.

9. Enhancement and Future Issues

The preventable HAC payment provision is one of CMS' VBP initiatives, as noted earlier in this section. VBP ties payment to performance through the use of incentives based on quality measures and cost of care. The implementation of VBP is rapidly transforming CMS from being a passive payer of claims to an active purchaser of higher quality, more efficient health care for Medicare beneficiaries. Other VBP initiatives include hospital pay for reporting (the RHQDAPU program discussed in section IV.B. of the preamble of this proposed rule), physician pay for reporting (the Physician Quality Reporting Initiative), home health pay for reporting, the Hospital VBP Plan Report to Congress (discussed in section IV.C. of the preamble of this proposed rule), and various VBP demonstration programs across payment settings, including the Premier Hospital Quality Incentive Demonstration and the Physician Group Practice Demonstration.

The success of CMS' VBP initiatives depends in large part on the validity of the performance measures and on the effectiveness of incentives in driving desired changes in behavior that will result in greater quality and efficiency. We are committed to enhancing the Medicare VBP programs, in close collaboration with stakeholders, to fulfill VBP's potential to promise of promoting higher value health care for Medicare beneficiaries. It is in this spirit that we seek public comment on enhancements to the preventable HACs payment policy and to concomitant POA indicator reporting.

We welcome all public comments presenting ideas and models for combating preventable HACs through the application of VBP principles. To stimulate reflection and creativity, we present several options:

• Risk adjustment could be applied to make the HAC payment provision more precise.

• Rates of HACs could be collected to obtain a more robust longitudinal measure of a hospital's incidence of these conditions.

• POA information could be used in various ways to decrease the incidence of preventable HACs.

• The adoption of ICD-10-PCS could facilitate more precise identification of HACs.

• The principle behind the HAC payment provision (Medicare not paying more for preventable HACs) could be applied to Medicare payments in settings of care other than the IPPS.

• CMS is using authority other than the HAC payment provision to address other events on the NQF's list of Serious Reportable Adverse Events.

We note that we are not proposing new Medicare policy in this Enhancements and Future Issues discussion, as some of these approaches may require new statutory authority.

a. Risk Adjustment

To make the HAC payment provision more precise, the adjustments to payment made when one of the selected HACs occurs during the hospitalization could be further adjusted to account for patient-specific risk factors. The expected occurrence of an HAC may be greater or lesser depending on the health status of the patient, as reflected by severity of illness, presence of comorbidities, or other factors. Rather than not paying any additional amount for the complication, the additional payment for the complication could range from zero for the lowest risk patient to the full amount for the highest risk patient. An option may be individualized adjustment for every hospitalization based on the patient's unique characteristics, but state-of-the-art risk adjustment currently precludes such individualized adjustment.

b. Rates of HACs

Given our limited capability at present for precise patient-level risk adjustment, adding a consideration of risk to the criteria for selecting HACs could be an alternative. If primarily high-risk patients are acquiring a certain condition during hospitalization, that condition could be considered a less-fit candidate for selection. Other alternatives to precise individualized risk adjustment could be adjustment for overall facility case mix or facility case-mix by condition. At the highest level, national Medicare program data could be used to make adjustments to the payment implications for the selected HACs based on expected rates of complications. Another option could be to designate certain patient risk factors as exemptions that would prohibit or mitigate the application of the HAC payment policy to the claims of patients with those risk factors.

The Medicare Hospital VBP Plan was submitted in a Report to Congress on November 21, 2007. The plan includes a performance assessment model that scores a hospital's attainment or improvement on various measures. The scores for each measure would be summed within each domain, such as the clinical process of care domain or the patient experience domain, and then the domains would be weighted and summed to yield a total performance score. The total performance score would then be translated into an incentive payment, proposed to be a certain percentage of each MS-DRG payment, using an exchange function. The plan also calls for public reporting of hospitals' performance scores by domain and in total. (Section IV.C. of this preamble included a related discussion of the Hospital VBP Plan Report to Congress.)

In accordance with this hospital VBP model, a hospital's rates of HACs could be included as a domain within each hospital's total performance score. The measurement of rates over time could be a more meaningful, actionable, and fair way to adjust a hospital's MS-DRG payments for the incidence of HACs. The consequence of a higher incidence of measured conditions would be a lower VBP incentive payment. Public reporting of the measured rates of HACs would give hospitals an additional, nonfinancial incentive to prevent occurrence of the conditions to avoid lower public ratings.

c. Use of POA Information

Information obtained from hospitals' reporting of POA data could be used in various ways to better understand and prevent the occurrence of HACs. The POA information could be provided to health services researchers to analyze factors that lead to HACs and disseminate the best practices for prevention of HACs. At least two states, New York and California, already collect POA data from their hospitals. Comparison of the State POA data with the Medicare data could fill in gaps in the databases and yield valuable insights about POA data validity.

POA data could also be used to calculate the incidence of HACs by hospital. This application of the POA data would be particularly powerful if the Medicare POA data were combined with state or private sector payer POA data. The Medicare-only or combined quality of care information could be initially shared with hospitals and thereafter publicly reported to support better healthcare decision making by Medicare beneficiaries, other health care consumers, professionals, and caregivers.

d. Transition to ICD-10-PCS

Accurate identification of HACs requires unambiguous and precise diagnosis codes. The current ICD-9-CM diagnosis coding system is three decades old. It is outdated and contains numerous instances of broad and vague codes. Attempts to add necessary detail to the ICD-9-CM system are inhibited by lack of expansion capacity. These factors negatively affect CMS' attempts to identify HAC cases.

ICD-10-PCS codes are more precise and capture information using more current medical terminology. For example, ICD-9-CM codes for pressure ulcers do not provide information about the size, depth, or exact location of the ulcer, while ICD-10-PCS has 60 codes to capture this information. ICD-10-PCS would also provide codes, beyond the current ICD-9-CM codes, that would enable the selection of additional surgical complications and adverse drug events.

e. Application of Nonpayment for HACs to Other Settings

The broad principle of Medicare not paying for preventable health care-associated conditions could potentially be applied to Medicare payment settings other than IPPS hospitals. Other possible settings of care might include hospital outpatient departments, SNFs, HHAs, end-stage renal disease facilities, and physician practices. The implications would be different for each setting, as each payment system is different and the reasonable preventability through the application of evidence-based guidelines would vary for candidate conditions over the different settings. However, alignment of incentives across settings of care is an important goal for all of CMS' VBP initiatives, including the HAC provision.

A related application of the broad principle behind the HAC payment could be accomplished through modification to the Medicare secondary payer policy which would allow us to directly recoup from the provider that failed to prevent the occurrence of a preventable condition in one setting to pay for all or part of the necessary followup care in a second setting. This would help shield the Medicare program from inappropriately paying for the downstream effects of a preventable condition acquired in the first setting but treated in the second setting.

f. Relationship to NQF's Serious Reportable Adverse Events

CMS is applying its authority to address the events on the NQF's list of Serious Reportable Adverse Events (also known as "never events"). In May 2006 testimony before the Senate Finance Committee, the CMS Administrator noted that paying hospitals for serious preventable events is contrary to the promise that hospital payments should support higher quality and efficiency. There is growing consensus that health care purchasers should not be paying for these events when they occur during a hospitalization. In January 2005, HealthPartners, a Minnesota-based not-for-profit HMO, announced that it would no longer reimburse hospitals for services associated with events enumerated in the Minnesota Adverse Health Care Events Reporting Act (essentially the NQF's list of Serious Reportable Adverse Events). Further, HealthPartners' contracts preclude hospitals from seeking reimbursement from the patient for these costs. During 2007, several State hospital associations adopted policies stating that their members will not bill payers or patients when these events occur in their hospitals.

In the FY 2008 IPPS final rule with comment period, we adopted several items from the NQF's list of events as HACs, including retained foreign object after surgery, air embolism, blood incompatibility, stage III and IV pressure ulcers, falls, electric shock, and burns. In this proposed rule, we are seeking public comments regarding adding hypoglycemic coma, which is closely related to NQF's listing of death or serious disability associated with hypoglycemia. However, as we discussed in the FY 2008 IPPS final rule with comment period, the HAC payment provision is not ideally suited to address every condition on the NQF's list of Serious Reportable Adverse Events. To address the events on the NQF's list beyond the effect of the HAC policy, CMS is exploring the application of Medicare authority, including other payment provisions, coverage policy, conditions of participation, and Quality Improvement Organization (QIO) retrospective review.

We note that we are not proposing new Medicare policy in this discussion of the HAC payment provision for IPPS hospitals, as some of these approaches may require new statutory authority. We are seeking public comments on these and other options for enhancing the preventable HACs payment provision and maximizing the use of POA indicator reporting data. We look forward to working with stakeholders in the fight against HACs.

G. Proposed Changes to Specific MS-DRG Classifications

1. Pre-MDCs: Artificial Heart Devices

Heart failure affects more than 5 million patients in the United States with 550,000 new cases each year, and causes more than 55,000 deaths annually. It is a progressive disease that is medically managed at all stages, but over time leads to continued deterioration of the heart's ability to pump sufficient amounts of adequately oxygenated blood throughout the body. When medical management becomes inadequate to continue to support the patient, the patient's heart failure would be considered to be the end stage of the disease. At this point, the only remaining treatment options are a heart transplant or mechanical circulatory support. A device termed an artificial heart has been used only for severe failure of both the right and left ventricles, also known as biventricular failure. Relatively small numbers of patients suffer from biventricular failure, but the exact numbers are unknown. There are about 4,000 patients approved and waiting to receive heart transplants in the United States at any given time, but only about 2,000 hearts per year are transplanted due to a scarcity of donated organs. There are a number of mechanical devices that may be used to support the ventricles of a failing heart on either a temporary or permanent basis. When it is apparent that a patient will require long-term support, a ventricular support device is generally implanted and may be considered either as a bridge to recovery or a bridge to transplantation. Sometimes a patient's prognosis is uncertain, and with device support the native heart may recover its function. However when recovery is not likely, the patient may qualify as a transplant candidate and require mechanical circulatory support until a donor heart becomes available. This type of support is commonly supplied by ventricular assist devices, (VADs), which are surgically attached to the native ventricles but do not replace them.

Devices commonly called artificial hearts are biventricular heart replacement systems that differ from VADs in that a substantial part of the native heart, including both ventricles, is removed. When the heart remains intact, it remains possible for the native heart to recover its function after being assisted by a VAD. However, because the artificial heart device requires the resection of the ventricles, the native heart is no longer intact and such recovery is not possible. The designation "artificial heart" is somewhat of a misnomer because some portion of the native heart remains and there is no current mechanical device that fully replaces all four chambers of the heart. Over time, better descriptive language for these devices may be adopted.

In 1986, CMS made a determination that the use of artificial hearts was not covered under the Medicare program. To conform to that decision, we placed ICD-9-CM procedure code 37.52 (Implantation of total replacement heart system) on the GROUPER program's MCE in the noncovered procedure list.

On August 1, 2007, CMS began a national coverage determination process for artificial hearts. SynCardia Systems, Inc. submitted a request for reconsideration of the longstanding noncoverage policy when its device, the CardioWest Temporary Total Artificial Heart (TAH-t) System, is used for "bridge to transplantation" in accordance with the FDA-labeled indication for the device. "Bridge to transplantation" is a phrase meaning that a patient in end-stage heart failure may qualify as a heart transplant candidate, but will require mechanical circulatory support until a donor heart becomes available. The CardioWest TAH-t System is indicated for use as a bridge to transplantation in cardiac transplant-eligible candidates at risk of imminent death from biventricular failure. The system is intended for use inside the hospital as the patient awaits a donor heart. The ultimate desired outcome for insertion of the TAH-t is a successful heart transplant, along with the potential that offers for cure from heart failure.

CMS determined that a broader analysis of artificial heart coverage was deemed appropriate, as another manufacturer, Abiomed, Inc. has developed an artificial heart device, AbioCor® Implantable Replacement Heart Device, with different indications. SynCardia Systems, Inc has received approval of its device from the FDA for humanitarian use as destination therapy for patients in end-stage biventricular failure who cannot qualify as transplant candidates. The AbioCor® Implantable Replacement Heart Device is indicated for use in severe biventricular end-stage heart disease patients who are not cardiac transplant candidates and who are less than 75 years old, who require multiple inotropic support, who are not treatable by VAD destination therapy, and who cannot be weaned from biventricular support if they are on such support. The desired outcome for this device is prolongation of life and discharge to home.

On February 1, 2008, CMS published a proposed coverage decision memorandum for artificial hearts which stated, in part, that while the evidence is inadequate to conclude that the use of an artificial heart is reasonable and necessary for Medicare beneficiaries, the evidence is promising for the uses of artificial heart devices as described above. CMS supports additional research for these devices, and therefore proposed that the artificial heart will be covered by Medicare when performed under the auspices of a clinical study. The study must meet all of the criteria listed in the proposed decision memorandum. This proposed coverage decision memorandum may be found on the CMS Web site at: http://www.cms.hhs.gov/mcd/viewdraftdecisionmemo.asp?id=211. Following consideration of the public comments received, CMS expects to make a final decision on or about May 1, 2008.

The topic of coding of artificial heart devices was discussed at the September 27-28, 2007 ICD-9-CM Coordination and Maintenance Committee meeting held at CMS in Baltimore, MD. We note that this topic was placed on the Committee's agenda because any proposed changes to the ICD-9-CM coding system must be discussed at a Committee meeting, with opportunity for comment from the public. At the September 2007 Committee meeting, the Committee accepted oral comments from participants and encouraged attendees or anyone with an interest in the topic to comment on proposed changes to the code, inclusion terms, or exclusion terms. We accepted written comments until October 12, 2007. As a result of discussion and comment from the Committee meeting, the Committee revised the title of procedure code 37.52 for artificial hearts to read "Implantation of internal biventricular heart replacement system." In addition, the Committee created new code 37.55 (Removal of internal biventricular heart replacement system) to identify explantation of the artificial heart prior to heart transplantation.

To make conforming changes to the IPPS system with regard to the proposed revision to the coverage decision for artificial hearts, in this proposed rule, we are proposing to remove procedure code 37.52 from MS-DRG 215 (Other Heart Assist System Implant) and assign it to MS-DRG 001 (Heart Transplant or Implant of Heart Assist System with Major Comorbidity or Complication (MCC)) and MS-DRG 002 (Heart Transplant or Implant of Heart Assist System without Major Comorbidity or Complication (MCC)). In addition, we are proposing to remove procedure code 37.52 from the MCE "Non-Covered Procedure" edit and assign it to the "Limited Coverage" edit. We are proposing to include in this proposed edit the requirement that ICD-9-CM diagnosis code V70.7 (Examination of participant in clinical trial) also be present on the claim. We are proposing that claims submitted without both procedure code 37.52 and diagnosis code V70.7 would be denied because they would not be in compliance with the proposed coverage policy.

During FY 2008, we are making mid-year changes to portions of the GROUPER program that do not affect MS-DRG assignment or ICD-9-CM coding. However, as the proposed coverage decision memorandum for artificial hearts was published after the CMS contractor's testing and release of the mid-year product, the above proposed changes to the MCE will not be included in that revision of the GROUPER Version 25.0. GROUPER Version 26.0, which will be in use for FY 2009, will contain the proposed changes if they are approved. If the proposed revisions to the MCE are accepted, the edits in the MCE Version 25.0 will be effective retroactive to May 1, 2008. (To reduce confusion, we note that the version number of the MCE is one digit lower than the current GROUPER version number; that is, Version 26.0 of the GROUPER uses Version 25.0 of the MCE.)

2. MDC 1 (Diseases and Disorders of the Nervous System)

a. Transferred Stroke Patients Receiving Tissue Plasminogen Activator (tPA)

In 1996, the FDA approved the use of tissue plasminogen activator (tPA), one type of thrombolytic agent that dissolves blood clots. In 1998, the ICD-9-CM Coordination and Maintenance Committee created code 99.10 (Injection or infusion of thrombolytic agent) in order to be able to uniquely identify the administration of these agents. Studies have shown that tPA can be effective in reducing the amount of damage the brain sustains during an ischemic stroke, which is caused by blood clots that block blood flow to the brain. tPA is approved for patients who have blood clots in the brain, but not for patients who have a bleeding or hemorrhagic stroke. Thrombolytic therapy has been shown to be most effective when used within the first 3 hours after the onset of an embolic stroke, but it is contraindicated in hemorrhagic strokes.

For FY 2006, we modified the structure of CMS DRGs 14 (Intracranial Hemorrhage or Cerebral Infarction) and 15 (Nonspecific CVA and Precerebral Occlusion without Infarction) by removing the diagnostic ischemic (embolic) stroke codes. We created a new CMS DRG 559 (Acute Ischemic Stroke with Use of Thrombolytic Agent) which increased reimbursement for patients who sustained an ischemic or embolic stroke and who also had administration of tPA. The intent of this DRG was not to award higher payment for a specific drug but to recognize the need for better overall care for this group of patients. Even though tPA is indicated only for a small proportion of stroke patients, that is, those patients experiencing ischemic strokes treated within 3 hours of the onset of symptoms, our data suggested that there was a sufficient quantity of patients to support the DRG change. While our goal is to make payment relate more closely to resource use, we also note that use of tPA in a carefully selected patient population may lead to better outcomes and overall care and may lessen the need for postacute care.

For FY 2008, with the adoption of MS-DRGs, CMS DRG 559 became MS-DRGs 061 (Acute Ischemic Stroke with Use of Thrombolytic Agent with MCC), 062 (Acute Ischemic Stroke with Use of Thrombolytic Agent with CC), and 063 (Acute Ischemic Stroke with Use of Thrombolytic Agent without CC/MCC). Stroke cases in which no thrombolytic agent was administered were grouped to MS-DRGs 064 (Intracranial Hemorrhage or Cerebral Infarction with MCC), 065 (Intracranial Hemorrhage or Cerebral Infarction with CC), or 066 (Intracranial Hemorrhage or Cerebral Infarction without CC/MCC). The MS-DRGs that reflect use of a thrombolytic agent, that is, MS-DRGs 061, 062, and 063, have higher relative weights than the hemorrhagic or cerebral infarction MS-DRGs 064, 065, and 066.

The American Society of Interventional and Therapeutic Neuroradiology (ASITN) has made us aware of a treatment issue that is of concern to the stroke provider's community. In some instances, patients suffering an embolytic or thrombolytic stroke are evaluated and given tPA in a community hospital's emergency department, and then are transferred to a larger facility's stroke center that is able to provide the level of services required by the increased severity of these cases. The facility providing the administration of tPA in its emergency department does not realize increased reimbursement, as the patient is often transferred as soon a possible to a stroke center. The facility to which the patient is transferred does not realize increased reimbursement, as the tPA was not administered there. The ASITN has requested that CMS give permission to code the administration of tPA as if it had been given in the receiving facility. This would result in the receiving facility being paid the higher weighted MS-DRGs 061, 062, or 063 instead of MS-DRGs 064, 065, or 066. The ASITN's rationale is that the patients who received tPA in another facility (even though administration of tPA may have alleviated some of the worst consequences of their strokes) are still extremely compromised and require increased health care services that are much more resource consumptive than patients with less severe types of stroke. We have advised the ASITN that hospitals may not report services that were not performed in their facility.

We recognize that the ASITN's concerns potentially have merit but the quantification of the increased resource consumption of these patients is not currently possible in the existing ICD-9-CM coding system. Without specific length of stay and average charges data, we are unable to determine an appropriate MS-DRG for these cases. Therefore, we have advised the ASITN to present a request at the diagnostic portion of the ICD-9-CM Coordination and Maintenance Committee meeting on March 20, 2008, for a code that would recognize the fact that the patient had received a thrombolytic agent for treatment of the current stroke. If this request is presented at the March 20, 2008 meeting, it will not be approved in time to be published as a final code in this proposed rule. However, if a diagnosis code is created by the National Centers for Health Statistics as a result of that meeting, it can be added to the list of codes published in the FY 2009 IPPS final rule that will go into effect on October 1, 2008. With such information appearing on subsequent claims, we will have a better idea of how to classify these cases within the MS-DRGs. Therefore, because we lack the data to identify these patients, we are not proposing an MS-DRG modification for the stroke patients receiving tPA in one facility prior to being transferred to another facility.

b. Intractable Epilepsy With Video Electroencephalogram (EEG)

As we did for FY 2008, we received a request from an individual representing the National Association of Epilepsy Centers to consider further refinements to the MS-DRGs describing seizures. Specifically, the representative recommended that a new MS-DRG be established for patients with intractable epilepsy who receive an electroencephalogram with video monitoring (vEEG) during their hospital stay. Similar to the initial recommendation, the representative stated that patients who suffer from uncontrolled seizures or intractable epilepsy are admitted to an epilepsy center for a comprehensive evaluation to identify the epilepsy seizure type, the cause of the seizure, and the location of the seizure. These patients are admitted to the hospital for 4 to 6 days with 24-hour monitoring that includes the use of EEG video monitoring along with cognitive testing and brain imaging procedures.

Effective October 1, 2007, MS-DRG 100 (Seizures with MCC) and MS-DRG 101 (Seizures without MCC) were implemented as a result of refinements to the DRG system to better recognize severity of illness and resource utilization. Once again, the representative applauded CMS for making changes in the DRG structure to better recognize differences in patient severity. However, the representative stated that a subset of patients in MS-DRG 101 who have a primary diagnosis of intractable epilepsy and are treated with vEEG are substantially more costly to treat than other patients in this MS-DRG and represent the majority of patients being evaluated by specialized epilepsy centers. Alternatively, the representative stated that he was not requesting any change in the structure of MS-DRG 100. According to the representative, the number of cases that would fall into this category is not significant. The representative further noted that this is a change from last year's request.

Epilepsy is currently identified by ICD-9-CM diagnosis codes 345.0x through 345.9x. There are two fifth digits that may be assigned to a subset of the epilepsy codes depending on the physician documentation:

• "0" for without mention of intractable epilepsy.

• "1" for with intractable epilepsy.

With the assistance of an outside reviewer, the representative analyzed cost data for MS-DRGs 100 and 101, which focused on three subsets of patients identified with a primary diagnosis of epilepsy or convulsions who also received vEEG (procedure code 89.19):

• Patients with a primary diagnosis of epilepsy with intractability specified (codes 345.01 through 345.91).

• Patients with a primary diagnosis of epilepsy without intractability specified (codes 345.00 through 345.90).

• Patients with a primary diagnosis of convulsions (codes 780.39).

The representative acknowledged that the association did not include any secondary diagnoses in its analyses. Based on its results, the representative recommended that CMS further refine MS-DRG 101 by subdividing cases with a primary diagnosis of intractable epilepsy (codes 345.01 through 345.91) when vEEG (code 89.19) is also performed into a separate MS-DRG that would be defined as "MS-DRG XXX" (Epilepsy Evaluation without MCC).

According to the representative, these cases are substantially more costly than the other cases within MS-DRG 101 and are consistent with the criteria for dividing MS-DRGs on the basis of CCs and MCCs. In addition, the representative stated that the request would have a minimal impact on most hospitals but would substantially improve the accuracy of payment to hospitals specializing in epilepsy care.

We performed an analysis using FY 2007 MedPAR data. As shown in the table below, we found a total of 54,060 cases in MS-DRG 101 with average charges of $14,508 and an average length of stay of 3.69 days. There were 879 cases with intractable epilepsy and vEEG with average charges of $19,227 and an average length of stay of 5 days.

MS-DRG Number of cases Average length of stay Average charges
MS-DRG 100-All Cases 16,142 6.34 $27,623
MS-DRG 100-Cases with Intractable Epilepsy with vEEG (Codes 345.01, 345.11, 345.41, 345.51, 345.61, 345.71, 345.81, 345.91) 69 6.6 26,990
MS-DRG 100-Cases with Intractable Epilepsy without vEEG 328 7.81 32,539
MS-DRG 101-All cases 54,060 3.69 14,508
MS-DRG 101-Cases with Intractable Epilepsy with vEEG (Codes 345.01, 345.11, 345.41, 345.51, 345.61, 345.71, 345.81, 345.91) 879 5.0 19,227
MS-DRG 101-Cased with Intractable Epilepsy without vEEG 1,351 4.25 14,913

In applying the criteria to establish subgroups, the data do not support the creation of a new subdivision for MS-DRG 101 for cases with intractable epilepsy and vEEG nor does the data support moving the 879 cases from MS-DRG 101 to MS-DRG 100. Moving the 879 cases to MS-DRG 100 would mean moving cases with average charges of approximately $19,000 into an MS-DRG with average charges of $28,000. Therefore, we are not proposing to refine MS-DRG 101 by subdividing cases with a primary diagnosis of intractable epilepsy (codes 345.01 through 345.91) when vEEG (code 89.19) is also performed into a separate MS-DRG.

3. MDC 5 (Diseases and Disorders of the Circulatory System)

a. Automatic Implantable Cardioverter-Defibrillators (AICD) Lead and Generator Procedures

In the FY 2008 IPPS final rule with comment period (72 FR 47257), we created a separate, stand alone DRG for automatic implantable cardioverter-defibrillator (AICD) generator replacements and defibrillator lead replacements. The new MS-DRG 245 (AICD lead and generator procedures) contains the following codes:

• 00.52, Implantation or replacement of transvenous lead [electrode] into left ventricular coronary venous system.

• 00.54, Implantation or replacement of cardiac resynchronization defibrillator pulse generator device only [CRT-D].

• 37.95, Implantation of automatic cardioverter/defibrillator leads(s) only.

• 37.96, Implantation of automatic cardioverter/defibrillator pulse generator only.

• 37.97, Replacement of automatic cardioverter/defibrillator leads(s) only.

• 37.98, Replacement of automatic cardioverter/defibrillator pulse generator only.

Commenters on the FY 2008 IPPS proposed rule supported this new MS-DRG, which recognizes the distinct differences in resource utilization between pacemaker and defibrillator generators and leads, but suggested that CMS should consider additional refinements for the defibrillator generator and leads. In reviewing the standardized charges for the AICD leads, the commenter believed that the leads may be more appropriately assigned to another DRG such as MS-DRG 243 (Permanent Cardiac Pacemaker Implant with CC) or MS-DRG 258 (Cardiac Pacemaker Device Replacement with MCC). The commenter recommended that CMS consider moving the defibrillator leads back into a pacemaker DRG, either MS-DRG 243 or MS-DRG 258.

In response to the commenters, we indicated that the data supported separate DRGs for these very different devices (72 FR 47257). We indicated that moving the defibrillator leads back into a pacemaker MS-DRG defeated the purpose of creating separate MS-DRGs for defibrillators and pacemakers. Therefore, we finalized MS-DRG 245 as proposed with the leads and generator codes listed above.

After publication of the FY 2008 IPPS final rule with comment period, we received a request from a manufacturer that recommended a subdivision for MS-DRG 245 (AICD Lead and Generator Procedures). The requestor suggested creating a new MS-DRG to separate the implantation or replacement of the AICD leads from the implantation or replacement of the AICD pulse generators to better recognize the differences in resource utilization for these distinct procedures.

The requestor applauded CMS' decision to create separate MS-DRGs for the pacemaker device procedures from the AICD procedures in the FY 2008 IPPS final rule (72 FR 47257). The requestor further acknowledged its support of the clinically distinct MS-DRGs for pacemaker devices. Currently, MS-DRGs 258 and 259 (Cardiac Pacemaker Device Replacement with MCC and without MCC, respectively) describe the implantation or replacement of pacemaker generators while MS-DRGs 260, 261, and 262 (Cardiac Pacemaker Revision Except Device Replacement with MCC, with CC, without CC/MCC, respectively) describe the insertion or replacement of pacemaker leads.

The requestor believed that the IPPS "needs to continue to evolve to accurately reflect clinical differences and costs of services." As such, the requestor recommended that CMS follow the same structure as it did with the pacemaker MS-DRGs for MS-DRG 245 to separately identify the implantation or replacement of the defibrillator leads (codes 37.95, 37.97, and 00.52) from the implantation or replacement of the pulse generators (codes 37.96, 37.98, 00.54).

In our analysis of the FY 2007 MedPAR data, we found a total of 5,546 cases in MS-DRG 245 with average charges of $62,631 and an average length of stay of 3.3 days. We found 1,894 cases with implantation or replacement of the defibrillator leads (codes 37.95, 37.97, and 00.52) with average charges of $42, 896 and an average length of stay of 3.4 days. We also found a total of 3,652 cases with implantation or replacement of the pulse generator (codes 37.96, 37.98, 00.54) with average charges of $72, 866 and an average length of stay of 3.2 days.

We agree with the requestor that the IPPS should accurately recognize differences in resource utilization for clinically distinct procedures. As the data demonstrate, average charges for the implantation or replacement of the AICD pulse generators are significantly higher than for the implantation or replacement of the AICD leads. Therefore, we are proposing to create a new MS-DRG 265 to separately identify these distinct procedures. The proposed new MS-DRG 265 would be titled "AICD Lead Procedures" and would include procedure codes that identify the AICD leads (codes 37.95, 37.97 and 00.52). The title for MS-DRG 245 would be revised to "AICD Generator Procedures" and include procedure codes 37.96, 37.98, 00.54. We believe these changes would better reflect the clinical differences and resources utilized for these distinct procedures.

b. Left Atrial Appendage Device

Atrial fibrillation (AF) is the primary cardiac abnormality associated with ischemic or embolytic stroke. Most ischemic strokes associated with AF are possibly due to an embolism or thrombus that has formed in the left atrial appendage. Evidence from studies such as transesophageal echocardiography shows left atrial thrombi to be more frequent in AF patients with ischemic stroke as compared to AF patients without stroke. While anticoagulation medication can be efficient in ischemic stroke prevention, there can be problems of safety and tolerability in many patients, especially those older than 75 years. Chronic warfarin therapy has been proven to reduce the risk of embolism but there can be difficulties concerning its administration. Frequent blood tests to monitor warfarin INR are required at some cost and patient inconvenience. In addition, because warfarin INR is affected by a large number of drug and dietary interactions, it can be unpredictable in some patients and difficult to manage. The efficacy of aspirin for stroke prevention in AF patients is less clear and remains controversial. With the known disutility of warfarin and the questionable effectiveness of aspirin, a device-based solution may provide added protection against thromboembolism in certain patients with AF.

At the April 1, 2004 ICD-9-CM Coordination and Maintenance Committee meeting, a proposal was presented for the creation of a unique procedure code describing insertion of the left atrial appendage filter system. Subsequently, ICD-9-CM code 37.90 (Insertion of left atrial appendage device) was created for use beginning October 1, 2004. This code was designated as a non-operating room (non-O.R.) procedure, and had an effect only on cases in MDC 5, CMS DRG 518 (Percutaneous Cardiovascular Procedure without Coronary Artery Stent or Acute Myocardial Infarction). With the adoption of MS-DRGs in FY 2008, CMS DRG 518 was divided into MS-DRGs 250 and 251 (Percutaneous Cardiovascular Procedure without Coronary Artery Stent or AMI with MCC, and without MCC, respectively).

We have reviewed the data concerning this procedure code annually. Using FY 2005 MedPAR data for the FY 2007 IPPS final rule, 24 cases were reported, and the average charges ($27,620) closely mimicked the average charges of the other 22,479 cases in CMS DRG 518 ($28,444). As the charges were comparable, we made no recommendations to change the CMS DRG assignment for FY 2007.

Using FY 2006 MedPAR data for the FY 2008 final rule with comment period, we divided CMS DRG 518 into the cases that would be reflected in the MS-DRG configuration; that is, we divided the cases based on the presence or absence of an MCC. There were 35 cases without an MCC with average charges of $24,436, again mimicking the 38,002 cases with average charges of $32,546. There were 3 cases with MCC with average charges of $62,337, compared to the 5,458 cases also with an MCC with average charges of $53,864. Again it was deemed that cases with code 37.90 were comparable to the rest of the cases in CMS DRG 518, and the decision was made not to make any changes in the DRG assignment for this procedure code. As noted above, CMS DRG 518 became MS-DRGs 250 and 251 in FY 2008.

We have received a request regarding code 37.90, and its placement within the MS-DRG system for FY 2009. The requestor asked for either the reassignment of code 37.90 to an MS-DRG that would adequately cover the costs associated with the complete procedure or the creation of a new MS-DRG that would reimburse hospitals adequately for the cost of the device. The requestor, a manufacturer's representative, reported that the device's IDE clinical trial is nearing completion, with the conclusion of study enrollment in May 2008. The requestor will continue to enroll patients in a Continued Use Registry following completion of the trial. The requestor reported that it did not charge hospitals for the atrial appendage device, estimated to cost $6,000, during the trial period, but it will begin to charge hospitals upon the completion of the trial in May. The requestor provided us with its data showing what it believed to be a differential of $107 more per case than the payment average for MS-DRG 250, and a shortfall of $3,808 per case than the payment average for MS-DRG 251.

The requestor pointed out that code 37.90 is assigned to both MS-DRGs 250 and 251, but stated that the final MS-DRG assignment would be MS-DRG 251 when the patient has a principal diagnosis of atrial fibrillation (code 427.31) because AF is not presently listed as a CC or an MCC. We would take this opportunity to note that the principal diagnosis is used to determine assignment of a case to the correct MDC. Secondary or additional diagnosis codes are the only codes that can be used to determine the presence of a CC or an MCC.

With regard to the request to create a specific DRG for the insertion of this device entitled "Percutaneous Cardiovascular Procedures with Implantation of a Left Atrial Appendage Device without CC/MCC", we would point out that the payments under a prospective payment system are predicated on averages. The device is already assigned to MS-DRGs containing other percutaneous cardiovascular devices; to create a new MS-DRG specific to this device would be to remove all other percutaneously inserted devices and base the MS-DRG assignment solely on the presence of code 37.90. This approach negates our longstanding method of grouping like procedures, and removes the concept of averaging. Further, to ignore the structure of the MS-DRG system solely for the purpose of increasing payment for one device would set an unwelcome precedent for defining all of the other MS-DRGs in the system. We would also point out that the final rule establishing the MS-DRGs set forth five criteria, all five of which are required to be met, in order to warrant creation of a CC or an MCC subgroup within a base MS-DRG. The criteria can be found in the FY 2008 IPPS final rule with comment period (72 FR 47169). One of the criteria specifies that there will be at least 500 cases in the CC or MCC subgroup. To date, there are not enough cases of code 37.90 reported within the MedPAR data.

Using FY 2007 MedPAR data, for this FY 2009 IPPS proposed rule, we reviewed MS-DRGs 250 and 251 for the presence of the left atrial appendage device. The following table displays our results:

MS-DRG Number of cases Average length of stay Average charges
250-All Cases 6,424 7.72 $60,597.58
250-Cases with code 37.90 4 6.50 65,829.51
250-Cases without code 37.90 6,420 7.72 60,594.32
251-All Cases 39,456 2.84 35,719.81
251-Cases with code 37.90 101 1.30 20,846.09
251-Cases without code 37.90 39,335 2.85 35,757.98

There were a total of 105 cases with code 37.90 reported for Medicare beneficiaries in the 2007 MedPAR data. There are 4 cases with an atrial appendage device in MS-DRG 250 that have higher average charges than the other 6,420 cases in the MS-DRG, and that have slightly shorter lengths of stay by 1.25 days. However, the more telling data are located in MS-DRG 251, which shows that the 101 cases in which an atrial appendage device was implanted have much lower average charges ($20,846.09) than the other 39,355 cases in the MS-DRG, with average charges of $35,758.98. The difference in the average charges is approximately $14,912, so even when the manufacturer begins charging the hospitals the estimated $6,000 for the device, there is still a difference of approximately $8,912 in average charges based on the comparison within the total MS-DRG 251. Interestingly, the 101 cases also have an average length of stay of less than half of the average length of stay compared to the other cases assigned to that MS-DRG.

Because the data do not support either the creation of a unique MS-DRG or the assignment of procedure code 37.90 to another higher-weighted MS-DRG, we are not proposing any change to MS-DRGs 250 and 251, or to code 37.90 for FY 2009. We believe, based on the past 3 year's comparisons, that this code is appropriately located within the MS-DRG structure.

4. MDC 8 (Diseases and Disorders of the Musculoskeletal System and Connective Tissue): Hip and Knee Replacements and Revisions

For FY 2009, we again received a request from the American Association of Hip and Knee Surgeons (AAHKS), a specialty group within the American Academy of Orthopedic Surgeons (AAOS), concerning modifications of the lower joint procedure MS-DRGs. The request is similar, in some respects, to the AAHKS's request in FY 2008, particularly as it relates to separating routine and complex procedures. For the benefit of the reader, we are republishing a history of the development of DRGs for hip and knee replacements and a summary of the AAHKS FY 2008 request that were included in the FY 2008 IPPS final rule with comment period (72 FR 47222 through 47224) before we discuss the AAHKS's more recent request.

a. Brief History of Development of Hip and Knee Replacement Codes

In the FY 2006 IPPS final rule (70 FR 47303), we deleted CMS DRG 209 (Major Joint and Limb Reattachment Procedures of Lower Extremity) and created two new CMS DRGs: 544 (Major Joint Replacement or Reattachment of Lower Extremity) and 545 (Revision of Hip or Knee Replacement). The two new CMS DRGs were created because revisions of joint replacement procedures are significantly more resource intensive than original hip and knee replacements procedures. CMS DRG 544 included the following procedure code assignments:

• 81.51, Total hip replacement.

• 81.52, Partial hip replacement.

• 81.54, Total knee replacement.

• 81.56, Total ankle replacement.

• 84.26, Foot reattachment.

• 84.27, Lower leg or ankle reattachment.

• 84.28, Thigh reattachment.

CMS DRG 545 included the following procedure code assignments:

• 00.70, Revision of hip replacement, both acetabular and femoral components.

• 00.71, Revision of hip replacement, acetabular component.

• 00.72, Revision of hip replacement, femoral component.

• 00.73, Revision of hip replacement, acetabular liner and/or femoral head only.

• 00.80, Revision of knee replacement, total (all components).

• 00.81, Revision of knee replacement, tibial component.

• 00.82, Revision of knee replacement, femoral component.

• 00.83, Revision of knee replacement, patellar component.

• 00.84, Revision of knee replacement, tibial insert (liner).

• 81.53, Revision of hip replacement, not otherwise specified

• 81.55, Revision of knee replacement, not otherwise specified

Further, we created a number of new ICD-9-CM procedure codes effective October 1, 2005, that better distinguish the many different types of joint replacement procedures that are being performed. In the FY 2006 IPPS final rule (70 FR 47305), we indicated a commenter had requested that, once we receive claims data using the new procedure codes, we closely examine data from the use of the codes under the two new CMS DRGs to determine if future additional DRG modifications are needed.

b. Prior Recommendations of the AAHKS

Prior to this year, the AAHKS had recommended that we make further refinements to the CMS DRGs for knee and hip arthroplasty procedures. The AAHKS previously presented data to CMS on the important differences in clinical characteristics and resource utilization between primary and revision total joint arthroplasty procedures. The AAHKS stated that CMS's decision to create a separate DRG for revision of total joint arthroplasty (TJA) in October 2005 resulted in more equitable reimbursement for hospitals that perform a disproportionate share of complex revision of TJA procedures, recognizing the higher resource utilization associated with these cases. The AAHKS stated that this important payment policy change led to increased access to care for patients with failed total joint arthroplasties, and ensured that high volume TJA centers could continue to provide a high standard of care for these challenging patients.

The AAHKS further stated that the addition of new, more descriptive ICD-9-CM diagnosis and procedure codes for TJA in October 2005 gave it the opportunity to further analyze differences in clinical characteristics and resource intensity among TJA patients and procedures. Inclusive of the preparatory work to submit its recommendations, the AAHKS compiled, analyzed, and reviewed detailed clinical and resource utilization data from over 6,000 primary and revision TJA procedure codes from 4 high volume joint arthroplasty centers located within different geographic regions of the United States: University of California, San Francisco, CA; Mayo Clinic, Rochester, MN; Massachusetts General Hospital, Boston, MA; and the Hospital for Special Surgery, New York, NY. Based on its analysis, the AAHKS recommended that CMS examine Medicare claims data and consider the creation of separate DRGs for total hip and total knee arthroplasty procedures. The AAHKS stated that based on the differences between patient characteristics, procedure characteristics, resource utilization, and procedure code payment rates between total hip and total knee replacements, separate DRGs were warranted. Furthermore, the AAHKS recommended that CMS create separate base DRGs for routine versus complex joint revision or replacement procedures as shown below.

Routine Hip Replacements

• 00.73, Revision of hip replacement, acetabular liner and/or femoral head only.

• 00.85, Resurfacing hip, total, acetabulum and femoral head.

• 00.86, Resurfacing hip, partial, femoral head.

• 00.87, Resurfacing hip, partial, acetabulum.

• 81.51, Total hip replacement.

• 81.52, Partial hip replacement.

• 81.53, Revision of hip replacement, not otherwise specified.

Complex Hip Replacements

• 00.70, Revision of hip replacement, both acetabular and femoral components.

• 00.71, Revision of hip replacement, acetabular component.

• 00.72, Revision of hip replacement, femoral component.

Routine Knee Replacements and Ankle Procedures

• 00.83, Revision of knee replacement, patellar component.

• 00.84, Revision of knee replacement, tibial insert (liner).

• 81.54, Revision of knee replacement, not otherwise specified.

• 81.55, Revision of knee replacement, not otherwise specified.

• 81.56, Total ankle replacement.

Complex Knee Replacements and Other Reattachments

• 00.80, Revision of knee replacement, total (all components).

• 00.81, Revision of knee replacement, tibial component.

• 00.82, Revision of knee replacement, femoral component.

• 84.26, Foot reattachment.

• 84.27, Lower leg or ankle reattachment.

• 84.28, Thigh reattachment.

The AAHKS also recommended the continuation of CMS DRG 471 (Bilateral or Multiple Major Joint Procedures of Lower Extremity) without modifications. CMS DRG 471 included any combination of two or more of the following procedure codes:

• 00.70, Revision of hip replacement, both acetabular and femoral components.

• 00.80, Revision of knee replacement, total (all components).

• 00.85, Resurfacing hip, total, acetabulum and femoral head.

• 00.86, Resurfacing hip, partial, femoral head.

• 00.87, Resurfacing hip, partial, acetabulum.

• 81.51, Total hip replacement.

• 81.52, Partial hip replacement.

• 81.54, Total knee replacement.

• 81.56, Total ankle replacement.

c. Adoption of MS-DRGs for Hip and Knee Replacements for FY 2008 and AAHKS's Recommendations

In the FY 2008 IPPS final rule with comment period (72 FR 47222 through 47226), we adopted MS-DRGs to better recognize severity of illness for FY 2008. The MS-DRGs include two new severity of illness levels under the then current base DRG 544. We also added three new severity of illness levels to the base DRG for Revision of Hip or Knee Replacement. The new MS-DRGs are as follows:

• MS-DRG 466 (Revision of Hip or Knee Replacement with MCC)

• MS-DRG 467 (Revision of Hip or Knee Replacement with CC)

• MS-DRG 468 (Revision of Hip or Knee Replacement without CC/MCC)

• MS-DRG 469 (Major Joint Replacement or Reattachment of Lower Extremity with MCC)

• MS-DRG 470 (Major Joint Replacement or Reattachment of Lower Extremity without MCC)

We found that the MS-DRGs greatly improved our ability to identify joint procedures with higher resource costs. In the final rule, we presented data indicating the average charges for each new MS-DRG for the joint procedures.

In the FY 2008 IPPS final rule with comment period, we acknowledged the valuable assistance the AAHKS had provided to CMS in creating the new joint replacement procedure codes and modifying the joint replacement DRGs beginning in FY 2006. These efforts greatly improved our ability to categorize significantly different groups of patients according to severity of illness. Commenters on the FY 2008 proposed rule had encouraged CMS to continue working with the orthopedic community, including the AAHKS, to monitor the need for additional new DRGs. The commenters stated that MS-DRGs 466 through 470 are a good first step. However, they stated that CMS should continue to evaluate the data for these procedures and consider additional refinements to the MS-DRGs, including the need for additional severity levels. AAHKS stated that its data suggest that all three base DRGs (primary replacement, revision of major joint replacement, and bilateral joint replacement) should be separated into three severity levels (that is, MCC, CC, and non-CC). (We had proposed three severity levels for revision of hip and knee replacement (MS-DRGs 466, 467, and 468), and AAHKS agreed with this 3-level subdivision.)

The AAHKS recommended that the base DRG for the proposed two severity subdivision MS-DRGs for major joint replacement or reattachment of lower extremity with and without CC/MCC (MS-DRGs 483 and 484) be subdivided into three severity levels, as was the case for the revision of hip and knee replacement MS-DRGs. AAHKS also recommended that the two severity subdivision MS-DRGs for bilateral or multiple major joint procedures of lower extremity with and without MCC (MS-DRGs 461 and 462) be subdivided three ways for this base DRG. AAHKS acknowledged that the three way split would not meet all five of the criteria for establishing a subgroup, and stated that these criteria were too restrictive, lack face validity, and create perverse admission selection incentives for hospitals by significantly overpaying for cases without a CC and underpaying for cases with a CC. It recommended that the existing five criteria be modified for low volume subgroups to assure materiality. For higher volume MS-DRG subgroups, the AAHKS recommended that two other criteria be considered, particularly for nonemergency, elective admissions:

• Is the per-case underpayment amount significant enough to affect admission vs. referral decisions on a case-by-case basis?

• Is the total level of underpayments sufficient to encourage systematic admission vs. referral policies, procedures, and marketing strategies?

The AAHKS also recommended refining the five existing criteria for MCC/CC/without subgroups as follows:

• Create subgroups if they meet the five existing criteria, with cost difference between subgroups ($1,350) substituted for charge difference between subgroups ($4,000);

• If a proposed subgroup meets criteria number 2 and 3 (at least 5 percent and at least 500 cases) but fails one of the others, then create the subgroup if either of the following criteria are met:

? At least $1,000 cost difference per case between subgroups; or

? At least $1 million overall cost should be shifted to cases with a CC (or MCC) within the base DRG for payment weight calculations.

In response, we indicated that we did not believe it was appropriate to modify our five criteria for creating severity subgroups. Our data did not support creating additional subdivisions based on the criteria. At that time, we believed the criteria we established to create subdivisions within a base DRG were reasonable and establish the appropriate balance between better recognition of severity of illness, sufficient differences between the groups, and a reasonable number of cases in each subgroup. However, we indicated that we may consider further modifications to the criteria at a later date once we have had some experience with MS-DRGs created using the proposed criteria.

The AAHKS indicated in its response to the FY 2008 proposed rule that it continued to support the separation of routine and complex joint procedures. It believed that certain joint replacement procedures have significantly lower average charges than do other joint replacements. The AAKHS's data suggest that more routine joint replacements are associated with substantially less resource utilization than other more complex revision procedures. The AAHKS stated that leaving these procedures in the revision MS-DRGs results in substantial overpayment for these relatively simple, less costly revision procedures, which in turn results in a relative underpayment for the more complex revision procedures.

In response, we examined data on this issue and identified two procedure codes for partial knee revisions that had significantly lower average charges than did other joint revisions. The two codes are as follows:

• 00.83 Revision of knee replacement, patellar component

• 00.84 Revision of total knee replacement, tibial insert (liner)

The data suggest that these less complex partial knee revisions are less resource intensive than other cases assigned to MS-DRGs 466, 467, or 468. We examined other orthopedic DRGs to which these two codes could be assigned. We found that these cases have very similar average charges to those in MS-DRG 485 (Knee Procedures with Principal Diagnosis of Infection with MCC), MS-DRG 486 (Knee Procedures with Principal Diagnosis of Infection with CC), MS-DRG 487 (Knee Procedures with Principal Diagnosis of Infection without CC), MS-DRG 488 (Knee Procedures without Principal Diagnosis of Infection with CC or MCC), and MS-DRG 489 (Knee Procedures without Principal Diagnosis of Infection without CC).

Given the very similar resource requirements of MS-DRG 485 and the fact that these DRGs also contain knee procedures, we moved codes 00.83 and 00.84 out of MS-DRGs 466, 467, and 468 and into MS-DRGs 485, 486, 487, 488, and 489. We also indicated that we would continue to monitor the revision DRGs to determine if additional modifications are needed.

d. AAHKS' Recommendations for FY 2009

The AAHKS' current request involves the following recommendations:

• That CMS consolidate and reassign certain joint procedures that have a diagnosis of an infection or malignancy into MS-DRGs that are similar in terms of clinical characteristics and resource utilization. The AAKHS further identifies groups called Stage 1 and 2 procedures that it believes require significant differences in resource utilization.

• That CMS reclassify certain specific joint procedures, which AAHKS refers to as "routine," out of their current MS-DRG assignments. The three joint procedures that AAHKS classifies as "routine" are codes 00.73 (Revision of hip replacement, acetabular liner and/or femoral head only), 00.83 (Revision of knee replacement, patellar component), and 00.84 (Revision of total knee replacement, tibial insert (liner)). The AAHKS advocated removing these three "routine" procedures from the following DRGs: MS-DRGs 466, 467, and 468, MS-DRGs 485, 486, and 487, and MS-DRGs 488 and 489. The AAHKS refers to MS-DRGs 466, 467, and 468 as "complex" revision DRGs, and recommended that the three "routine" procedures be moved out of MS-DRGs 466, 467, and 468 and MS-DRGs 485, 486, and 489 and into MS-DRGs 469 and 470 (Major Joint Replacement or Reattachment of Lower Extremity with and without MCC, respectively). The AAHKS contended that the three "routine" procedures have similar clinical characteristics and resource utilization to those in MS-DRGs 469.

The recommendations suggested by AAHKS are quite complex and involve a number of specific code lists and MS-DRG assignment changes. We discuss each of these requests in detail below.

(1) AAHKS Recommendation 1: Consolidate and reassign patients with hip and knee prosthesis related infections or malignancies.

The AAHKS pointed out that deep infection is one of the most devastating complications associated with hip and knee replacements. These infections have been reported to occur in approximately 0.5 percent to 3 percent of primary and 4 percent to 6 percent of revision total joint replacement procedures. These infections often result in the need for multiple reoperations, prolonged use of intravenous and oral antibiotics, extended inpatient and outpatient rehabilitation, and frequent followup visits. Furthermore, clinical outcomes following single- and two-stage revision total joint arthroplasty procedures have been less favorable than revision for other causes of failure not associated with infection.

In addition to the clinical impact, the AAHKS stated that infected total joint replacement procedures also have substantial economic implications for patients, payers, hospitals, physicians, and society in terms of direct medical costs, resource utilization, and the indirect costs associated with lost wages and productivity. The AAHKS stated that the considerable resources required to care for these patients has resulted in a strong financial disincentive for physicians and hospitals to provide care for patients with infected total joint replacements, an increased economic burden on the high volume tertiary care referral centers where patients with infected hip replacement procedures are frequently referred for definitive management. The AAHKS further stated that, in some cases, there are compromised patient outcomes due to treatment delays as patients with infected joint replacements seek providers who are willing to care for them.

Once a deep infection of a total joint prosthesis is identified, the first stage of treatment involves a hospital admission for removal of the infected prosthesis and debridement of the involved bone and surrounding tissue. During the same procedure, an antibiotic-impregnated cement spacer is typically inserted to maintain alignment of the limb during the course of antibiotic therapy. The patient is then discharged to a rehabilitation facility/nursing home (or to home if intravenous therapy can be safely arranged for the patient) for a 6-week course of IV antibiotic treatment until the infection has cleared.

After the completion of antibiotic therapy, the hip or knee may be reaspirated to look for evidence of persistent infection or eradication of infection. A second stage procedure is then undertaken, where the patient is readmitted, the hip or knee is reexplored, and the cement spacer removed. If there are no signs of persistent infection, a hip or knee prosthesis is reimplanted, often using bone graft and costly revision implants in order to address extensive bone loss and distorted anatomy. Thus, the entire course of treatment for patients with infected joint replacements is 4 to 6 months, with an additional 6 to 12 months of rehabilitation. Furthermore, clinical outcomes following revision for infection are poor relative to outcomes following revision for other, aseptic causes. The AAHKS noted that patients with bone malignancy have a similar treatment focus-surgery to remove diseased tissue, chemotherapy to treat the malignancy, and implantation of the new prosthesis. They also have similar resource use. For simplicity, the AAHKS' discussion focused on infected joint prostheses, but it suggested that the issues it raises would apply to patients with a malignancy as well.

The AAHKS stated that these patients are currently grouped in multiple MS-DRGs, and the cases are often "outliers" in each one. AAHKS proposed to consolidate these patients with similar clinical characteristics and treatment into MS-DRGs reflective of their resource utilization.

The AAHKS states that these more severe patients are currently classified into the following MS-DRGs:

• MS-DRGs 463, 463, and 465 (Wound Debridement and Skin Graft Excluding Hand, for Musculoskeletal-Connective Tissue Disease with MCC, with CC, without CC/MCC, respectively).

• MS-DRGs 480, 481, and 482 (Hip and Femur Procedures Except Major Joint with MCC, with CC, without CC/MCC, respectively).

• MS-DRGs 485, 486, and 487 (Knee Procedures with Principal Diagnosis of Infection and with MCC, with CC, and without CC/MCC, respectively).

• MS-DRGs 488 and 489 (Knee Procedures without Principal Diagnosis of Infection and with CC/MCC and without CC/MCC, respectively).

• MS-DRGs 495, 496, and 497 (Local Excision and Removal of Internal Fixation Devices Except Hip and Femur with MCC, with CC, and without CC/MCC, respectively).

• Other MS-DRGs (The AAHKS did not specify what these other MS-DRGs were.).

The AAHKS indicated that cases with the severe diagnoses of infections, neoplasms, and structural defects have similarities. These similarities are due to an overlap of a severe diagnosis (including a principal diagnosis of code 996.66 (Infected joint prosthesis) and the resulting need for more extensive surgical procedures. The AAHKS stated that currently these patients are grouped into MS-DRGs by major procedure alone. AAHKS recommended that these cases be grouped into what it refers to as Stages 1 and 2 as follows:

• Stage 1 would include the removal of an infected prosthesis and includes cases in MS-DRGs 463, 464, and 465, 480, 481, and 482, 485 through 489, and 495, 496, and 497. Stage 1 joint procedure codes would include codes 80.05 (Arthrotomy for removal of prosthesis, hip), 80.06 (Arthrotomy for removal of prosthesis, knee), 00.73 (Revision of hip replacement, acetabular liner and/or femoral head only), and 00.84 (Revision of knee replacement, tibial insert (liner)).

• Stage 2 would include the implant of a new prosthesis and includes cases in MS-DRGs 461 and 462, 463, 464, and 465, 466, 467, and 468, and 469 and 470. Stage 2 joint procedure codes would include codes 00.70 (Revision of hip replacement, both acetabular and femoral components), 00.71 (Revision of hip replacement, acetabular component), 00.72 (Revision of hip replacement, femoral component), 00.80 (Revision of knee replacement, total (all components)), 00.81 (Revision of knee replacement, tibial component), 00.82 (Revision of knee replacement, femoral component), 00.85 (Resurfacing hip, total, acetabulum and femoral head), 00.86 (Resurfacing hip, partial, femoral head), 00.87 (Resurfacing hip, partial, acetabulum), 81.51 (Total hip replacement), 81.52 (Partial hip replacement), 81.53 (Revise hip replacement), 81.54 (Total knee replacement), 81.55 (Revise knee replacement), and 81.56 (Total ankle replacement).

As stated earlier, the AAHKS recommended patients with certain more severe diagnoses be grouped into a higher severity level. While most of AAHKS' comments focused on joint replacement patients with infections, the AAHKS also believed that patients with certain neoplasms require greater resources. To this group of infections and neoplasms, the AAHKS recommended the addition of four codes that capture acquired deformities. The AAHKS believed that these codes would capture admissions for the second stage of the treatment for an infected joint. The AAHKS stated that the significance of these diagnoses when they are reported as the principal code position was significant in predicting resource utilization. However, the impact was not as significant when the diagnosis was reported as a secondary diagnosis. The AAHKS recommended that patients with one of the following infection/neoplasm/defect principal diagnosis codes be segregated into a higher severity level.

Stage 1Infection/Neoplasm/Defect Principal Diagnosis Codes

• 170.7 (Malignant neoplasm of long bones of lower limb).

• 171.3 (Malignant neoplasm of soft tissue, lower limb, including hip).

• 711.05 (Pyogenic arthritis, pelvic region and thigh).

• 711.06 (Pyogenic arthritis, lower leg).

• 730.05 (Acute osteomyelitis, pelvic region and thigh).

• 730.06 (Acute osteomyelitis, lower leg).

• 730.15 (Chronic osteomyelitis, pelvic region and thigh).

• 730.16 (Chronic osteomyelitis, lower leg).

• 730.25 (Unspecified osteomyelitis, pelvic region and thigh).

• 730.26 (Unspecified osteomyelitis, lower leg).

• 996.66 (Infection and inflammatory reaction due to internal joint prosthesis).

• 996.67 (Infection and inflammatory reaction due to other internal orthopedic device, implant, and graft).

Stage 2Infection/Neoplasm/Defect Principal Diagnosis Codes (an Asterisk * Shows the Diagnoses Included in Stage 2 That Were Not Listed in Stage 1)

• 170.7 (Malignant neoplasm of long bones of lower limb).

• 171.3 (Malignant neoplasm of soft tissue, lower limb, including hip).

• 198.5 (Secondary malignant neoplasm of bone and bone marrow) .*

• 711.05 (Pyogenic arthritis, pelvic region and thigh).

• 711.06 (Pyogenic arthritis, lower leg).

• 730.05 (Acute osteomyelitis, pelvic region and thigh).

• 730.06 (Acute osteomyelitis, lower leg).

• 730.15 (Chronic osteomyelitis, pelvic region and thigh).

• 730.16 (Chronic osteomyelitis, lower leg).

• 730.25 (Unspecified osteomyelitis, pelvic region and thigh).

• 730.26 (Unspecified osteomyelitis, lower leg).

• 736.30 (Acquired deformities of hip, unspecified deformity).

• 736.39 (Other acquired deformities of hip) .*

• 736.6 (Other acquired deformities of knee) .*

• 736.89 (Other acquired deformities of other parts of limbs). *

• 996.66 (Infection and inflammatory reaction due to internal joint prosthesis). *

• 996.67 (Infection and inflammatory reaction due to other internal orthopedic device, implant, andgraft). *

For the Stage 2 procedures, AAHKS also suggested the use of the following secondary diagnosis codes to assign the cases to a higher severity level. These conditions would not be the reason the patient was admitted to the hospital. They would instead represent secondary conditions that were also present on admission or conditions that were diagnosed after admission.

Stage 2Infection/Neoplasm/Defect SecondaryDiagnosis Codes

• 170.7 (Malignant neoplasm of long bones of lower limb).

• 171.3 (Malignant neoplasm of soft tissue, lower limb, including hip).

• 711.05 (Pyogenic arthritis, pelvic region and thigh).

• 711.06 (Pyogenic arthritis, lower leg).

• 730.05 (Acute osteomyelitis, pelvic region and thigh).

• 730.06 (Acute osteomyelitis, lower leg).

• 730.15 (Chronic osteomyelitis, pelvic region and thigh).

• 730.16 (Chronic osteomyelitis, lower leg).

• 730.25 (Unspecified osteomyelitis, pelvic region and thigh).

• 730.26 (Unspecified osteomyelitis, lower leg).

• 996.66 (Infection and inflammatory reaction due to internal joint prosthesis).

• 996.67 (Infection and inflammatory reaction due to other internal orthopedic device, implant,and graft).

(2) AAHKS Recommendation 2: Reclassify certain specific joint procedures.

The AAHKS suggested that cases with the infection/neoplasm/defect diagnoses listed above be segregated according to the Stage 1 and 2 groups listed above. The AAHKS made one final recommendation concerning joint procedure cases with infections. It identified a subset of patients who had a principal diagnosis of 996.66 (Infection and inflammatory reaction due to internal joint prosthesis) and who also had a secondary diagnosis of sepsis or septicemia. The AAHKS believed that these patients are for the most part admitted with both the joint infection and sepsis/septicemia present at the time of admission. The codes for sepsis/septicemia are classified as MCCs underMS-DRGs. The AAHKS believed it is inappropriate to count the secondary diagnosis of sepsis/septicemia as a MCC when it is reported with code 996.66. The AAHKS believed that counting sepsis and septicemia as a MCC results in double counting the infections. It believed that the joint infection and septicemia are the same infection. The AAHKS recommended that the following sepsis and septicemia codes not count as a MCC when reported with code 996.66:

• 038.0 (Streptococcal septicemia).

• 038.10 (Staphylococcal septicemia, unspecified).

• 038.11 (Staphylococcal aureus septicemia).

• 038.19 (Other staphylococcal septicemia).

• 038.2 (Pneumococcal septicemia [streptococcus pneumonia septicemia]).

• 038.3 (Septicemia due anaerobes).

• 038.40 (Septicemia due to gram-negative organisms).

• 038.41 (Hemophilus influenzae [H. Influenzae]).

• 038.42 (Escherichia coli [E. Coli]).

• 038.43 (Pseudomonas).

• 038.44 (Serratia).

• 038.49 (Other septicemia due to gram-negative organisms).

• 038.8 (Other specified septicemias).

• 038.9 (Unspecified septicemia).

• 995.91 (Sepsis).

• 995.92 (Severe sepsis).

e. CMS' Response to AAHKS' Recommendations

The MS-DRG modifications proposed by the AAHKS are quite complex and have many separate parts. We made changes to the MS-DRGs in FY 2008 as a result of a request by the AAHKS as discussed above, to recognize two types of partial knee replacements as less complex procedures. We have no data on how effective the new MS-DRGs for joint procedures are in differentiating patients with varying degrees of severity. Therefore, we analyzed data reported prior to the adoption of MS-DRGs to analyze each of the recommendations made. We begin our analysis by focusing first on the more simple aspects of the recommendations made by the AAHKS.

(1) Changing the MS-DRG Assignment for Codes 00.73, 00.83, and 00.84

As discussed previously, in FY 2008, the AAHKS recommended that CMS classify certain joint procedures as either routine or complex. We examined the data for these cases and found that the following two codes had significantly lower charges than the other joint revisions: 00.83 (Revision of knee replacement, patellar component) and 00.84 (Revision of knee replacement, tibial insert (liner)). Therefore, we moved these two codes to MS-DRGs 485, 486, and 487, and MS-DRGs 488 and 489.

As a result of AAHKS' most recent recommendations, we once again examined claims data for these two knee procedures (codes 00.83 and 00.84) as well as its request that we move code 00.73 (Revision of hip replacement, acetabular liner and/or femoral head only). Code 00.73 is assigned to MS-DRGs 466, 467, and 468. The following tables show our findings.

MS-DRG Number of cases Average length of stay Average charges
485-All Cases 1,122 12.20 $64,672.47
485-Cases with Code 00.83 or 00.84 179 11.83 64,446.68
485-Cases without Code 00.83 or 00.84 943 12.27 64,715.33
486-All Cases 2,061 8.03 40,758.55
486-Cases with Code 00.83 or 00.84 464 7.34 39,864.39
486-Cases without Code 00.83 or 00.84 1,597 8.23 41,018.34
487-All Cases 1,236 5.67 29,180.88
487-Cases with Code 00.83 or 00.84 284 5.61 31,231.79
487-Cases without Code 00.83 or 00.84 952 5.68 28,569.06
488-All Cases 2,374 5.17 30,180.80
488-Cases with code 00.83 or 00.84 754 4.09 28,432.06
488-Cases without code 00.83 or 00.84 1,620 5.67 30,994.73
489-All Cases 5,493 3.04 21,385.67
489-Cases with code 00.83 or 00,.84 2,154 3.07 23,122.18
489-Cases without code 00.83 or 00.84 3,339 3.03 20,265.44
469-All cases 29,030 8.17 56,681.64
470-All Cases 385,123 3.93 36,126.23
466-All Cases 3,888 9.18 76,015.66
466-Cases with Code 00.73 273 10.02 71,293.33
466-Cases without Code 00.73 3,616 9.12 76,372.06
467-All Cases 13,551 5.50 53,431.63
467-Cases with Code 00.73 1,078 5.94 43,635.63
467-Cases without Code 00.73 12,484 5.47 54,284.13
468-All Cases 19,917 3.94 44,055.62
468-Cases with Code 00.73 1,688 3.93 33,449.22
468-Cases without Code 00.73 18,232 3.94 45,037.09
469-All Cases 29,030 8.17 56,681.64
470-All Cases 385,123 3.93 36,126.23

The tables show that codes 00.73, 00.83, and 00.84 are appropriately assigned to their current MS-DRGs. The data do not support moving these three codes to MS-DRGs 469 and 470. Therefore, we are not proposing a change of MS-DRG assignment for codes 00.73, 00.83, and 00.84.

(2) Excluding Sepsis and Septicemia From Being a MCC With Code 996.66

There are cases where a patient may be admitted with an infection of a joint prosthesis (code 996.66) and also have sepsis. In these cases, it may be possible to perform joint procedures as suggested by AAHKS. However, in other cases, a patient may be admitted with an infection of a joint prosthesis and then develop sepsis during the stay. Because our current data do not indicate whether a condition is present on admission, we could not determine whether or not the sepsis occurred after admission. Our data have consistently shown that cases of sepsis and septicemia require significant resources. Therefore, we classified the sepsis and septicemia codes as MCCs. Our clinical advisors do not believe it is appropriate to exclude all cases of sepsis and septicemia that are reported as a secondary diagnosis with code 996.66 from being classified as a MCC. We discuss septicemia as part of hospital acquired conditions provision under section II.F. of the preamble of this proposed rule. For the purposes of classifying sepsis and septicemia as non-CCs when reported with code 996.66, we do not support this recommendation. Therefore, we are not proposing that the sepsis and septicemia codes be added to the CC exclusion list for code 996.66.

(3) Differences Between Stage 1 and 2 Cases With Severe Diagnoses

We next examined data on AAHKS' suggestion that there are significantly differences in resource utilization for cases they refer to as Stage 1 and 2. AAHKS stated that this is particularly true for those with infections, neoplasms, or structural defects. We used the list of procedure codes listed above that AAHKS describes as Stage 1 and 2 procedures. We also used AAHKS' designated lists of Stage 1 and 2 principal diagnosis codes to examine this proposal. This proposal entails moving cases with a Stage 1 or 2 principal diagnosis and procedure out of their current MS-DRG assignment in the following 19 MS-DRGs and into a newly consolidated set of MS-DRGs:MS-DRGs 463, 464, and 465, 480, 481, and 482, 485 through 489, and 495, 496, and 497.

As can be seen from the information below, there was not a significant difference in average charges between these Stage 1 and Stage 2 cases that have an MCC.

Stage 1 Total cases Average length of stay Average charges
With MCC 1,306 14.1 $79,232
Without MCC 4,115 7.6 44,716

Stage 2 Total cases Average length of stay Average charges
With MCC 1,072 10.9 $80,781
Without MCC 5,413 6.0 57,355

Average charges for Stage 1 cases with an MCC was $79,232 compared to $80,781 for Stage 2. Stage 1 cases without an MCC had average charges of $44,716 compared to $57,355. These data do not support reconfiguring the current MS-DRGs based on this new subdivision.

(4) Moving Joint Procedure Cases to New MS-DRGs Based on Secondary Diagnoses of Infection

We examined AAHKS' recommendation that Stage 2 joint cases with specific secondary diagnoses of infection or neoplasm be moved out of their current MS-DRG assignments and into a newly constructed MS-DRG.

We are reluctant to make this type of significant DRG change to the joint MS-DRGs based on the presence of a secondary diagnosis. This results in the movement of cases out of MS-DRGs which were configured based on the reason for the admission (for example, principal diagnosis) and surgery. The cases would instead be assigned based on conditions that are reported as secondary diagnoses. In some cases, the infection may have developed or be diagnosed during the admission. This would be a significant logic change to the MS-DRGs for joint procedures. We have not had an opportunity to examine claims data based on hospital discharges under the MS-DRGs which began October 1, 2008. Our clinical advisors believe it would be more appropriate to wait for data under the new MS-DRG system to determine how well the new severity levels are addressing accurate payment for these cases before considering this approach to assigning cases to a MS-DRG.

(5) Moving Cases With Infection, Neoplasms, or Structural Defects Out of 19 MS-DRGs and Into Two Newly Developed MS-DRGs

The last recommended by AAHKS that we considered was moving cases with a principal diagnosis of infection, neoplasm, or structural defect from their list of Stage 1 and 2 diagnoses and consolidated them into newly constructed and modified MS-DRGs. AAHKS could not identify an existing set of MS-DRGs with similar resource utilizations into which the Stage 1 cases could be assigned. Therefore, the AAHKS recommended that CMS create three new MS-DRGs for Stage 1 cases with infections, neoplasms and structural defects which would be titled "Arthrotomy/Removal/Component exchange of Infected Hip or Knee Prosthesis with MCC, with CC, and without CC/MCC", respectively.

The AAHKS recommended moving Stage 2 cases out of MS-DRGs 466, 467, and 468, and 469 and 470 and into MS-DRGs 461 and 462. AAHKS recommended that MS-DRGs 461 and 462 be renamed "Major Joint Procedures of Lower Extremity-Bilateral/Multiple/Infection/Malignancy".

In reviewing these proposed changes, we had a number of concerns. The first concern was that these proposed changes would result in the removal of cases with varying average charges from 19 current MS-DRGs and consolidating them into two separate sets of MS-DRGs. As the data below indicate, the average charges vary from as low as $29,181 in MS-DRG 487 to $81,089 in MS-DRG 463. Furthermore, the average charges for these infection/neoplasm/structural defect cases are very similar to other cases in their respective MS-DRG assignments for many of these MS-DRGs. There are cases where the average charges are higher. In MS-DRG 469 and 470, the infection/neoplasm/structural defect cases are significantly higher. However, there are only 136 cases in MS-DRG 469 out of a total of 29,030 cases with these diagnoses. There are only 673 cases in MS-DRG 470 out of a total of 385,123 cases with one of these diagnoses. The table below clearly demonstrates the wide variety of charges for cases with these diagnoses.

MS-DRGs Number of cases Average length of stay Average charges
463-All Cases 4,747 16.25 $73,405.46
463-Cases with PDX of Infection/Malignancy/React 1,009 17.79 81,089.07
464-All Cases 5,499 10.21 44,387.73
464-Cases with PDX of Infection/Malignancy/React 1,420 10.59 46,800.60
465-All Cases 2,271 5.95 26,631.57
465-Cases with PDX of Infection/Malignancy/React 557 10.59 29,816.40
466-All Cases 3,888 9.18 76,015.66
466-Cases with PDX of Infection/Malignancy/React 890 10.67 79,334.69
467-All Cases 13,551 5.50 53,431.63
467-Cases with PDX of Infection/Malignancy/React 2,401 6.71 58,506.86
468-All Cases 19,917 3.94 44,055.62
468-Cases with PDX of Infection/Malignancy/React 1,994 4.76 54,322.03
469-All Cases 29,030 8.17 56,681.64
469-Cases with PDX of Infection/Malignancy/React 136 11.74 85,256.07
470-All Cases 385,123 3.93 36,126.23
470-Cases with PDX of Infection/Malignancy/React 673 6.44 59,676.31
480-All Cases 25,391 9.32 52,281.65
480-Cases with PDX of Infection/Malignancy/React 880 14.53 76,355.15
481-All Cases 68,655 5.94 32,963.64
481-Cases with PDX of Infection/Malignancy/React 878 8.78 48,655.30
482-All Cases 45,832 4.86 27,266.20
482-Cases with PDX of Infection/Malignancy/React 577 6.19 37,572.38
485-All Cases 1,122 12.20 64,672.47
485-Cases with PDX of Infection/Malignancy/React 1,122 12.20 64,672.47
486-All Cases 2,061 8.03 40,758.55
486-Cases with PDX of Infection/Malignancy/React 2,061 8.03 40,758.55
487-All Cases 1,236 5.67 29,180.88
487-Cases with PDX of Infection/Malignancy/React 1,236 5.67 29,180.88
488-All Cases 2,374 5.17 30,180.80
488-Cases with PDX of Infection/Malignancy/React 31 7.13 50,155.42
489-All Cases 5,493 3.04 21,385.67
489-Cases with PDX of Infection/Malignancy/React 36 3.72 35,313.84
495-All Cases 1,860 10.94 55,103.91
495-Cases with PDX of Infection/Malignancy/React 1,025 11.74 59,453.69
496-All Cases 5,203 5.95 32,177.29
496-Cases with PDX of Infection/Malignancy/React 2,759 6.98 36,940.99
497-All Cases 6,259 3.01 21,445.60
497-Cases with PDX of Infection/Malignancy/React 1,500 5.18 29,966.98

Given the wide variety of charges and the small number of cases where there are differences in charges, we do not believe the data support the AAHKS' recommendations. The data do not support removing these cases from the 19 MS-DRGs above and consolidating them into a new set of MS-DRGs, either newly created, or by adding them to MS-DRG 461 or 462, which have average charges of $80,718 and $57,355, respectively.

A second major concern involves redefining MS-DRGs 461 and 462 is that these MS-DRG currently captures bilateral and multiple joint procedures. These MS-DRGs were specifically created to capture a unique set of patients who undergo procedures on more than one lower joint. Redefining these MS-DRGs to include both single and multiple joints undermines the clinical coherence of this MS-DRG. It would create a widely diverse group of patients based on either a list of specific diagnoses or the fact that the patient had multiple lower joint procedures.

f. Conclusion

The AAHKS recommended a number of complicated, interrelated MS-DRG changes to the joint procedure MS-DRGs. We have not yet had the opportunity to review data for these cases under the new MS-DRGs. We did analyze the impact of these recommendations using cases prior to the implementation of MS-DRGs. The recommendations were difficult to analyze because there were so many separate logic changes that impacted a number of MS-DRGs. We did examine each major suggestion separately, and found that our data and clinical analysis did not support making these changes. Therefore, we are not proposing any revisions to the joint procedure MS-DRGs for FY 2009. We look forward to examining these issues once we receive data under the MS-DRG system. We also welcome additional recommendations from the AAHKS and others on a more incremental approach to resolving its concerns about the ability of the current MS-DRGs to adequately capture differences in severity levels for joint procedure patients.

5. MDC 18 (Infections and Parasitic Diseases (Systemic or Unspecified Sites)): Severe Sepsis

We received a request from a manufacturer to modify the titles for three MS-DRGs with the most significant concentration of severe sepsis patients. The manufacturer stated that modification of the titles will assist in quality improvement efforts and provide a better reflection on the types of patients included in these MS-DRGs. Specifically, the manufacturer urged CMS to incorporate the term "severe sepsis" into the titles of the following MS-DRGs that became effective October 1, 2007 (FY 2008)

• MS-DRG 870 (Septicemia with Mechanical Ventilation 96+ Hours).

• MS-DRG 871 (Septicemia without Mechanical Ventilation 96+ Hours with MCC).

• MS-DRG 872 (Septicemia without Mechanical Ventilation 96+ Hours without MCC).

These MS-DRGs were created to better recognize severity of illness among patients diagnosed with conditions including septicemia, severe sepsis, septic shock, and systemic inflammatory response syndrome (SIRS) who are also treated with mechanical ventilation for a specified duration of time.

According to the manufacturer, "severe sepsis is a common, deadly and costly disease, yet the number of patients impacted and the outcomes associated with their care remain largely hidden within the administrative data set." The manufacturer further noted that, although improvements have been made in the ICD-9-CM coding of severe sepsis (diagnosis code 995.92) and septic shock (diagnosis code 785.52), results of an analysis demonstrated an unacceptably high mortality rate for patients reported to have those conditions. The manufacturer believed that revising the titles to incorporate "severe sepsis" will provide various clinicians and researchers the opportunity to improve outcomes for these patients. Therefore, the manufacturer recommended revising the current MS-DRG titles as follows:

• Proposed Revised MS-DRG 870 (Septicemia or Severe Sepsis with Mechanical Ventilation 96+ Hours).

• Proposed Revised MS-DRG 871 (Septicemia or Severe Sepsis without Mechanical Ventilation 96+ Hours with MCC).

• Proposed Revised MS-DRG 872 (Septicemia or Severe Sepsis without Mechanical Ventilation 96+ Hours without MCC).

We agree with the manufacturer that revising the current MS-DRG titles to include the term "severe sepsis" would better assist in the recognition and identification of this disease, which could lead to better clinical outcomes and quality improvement efforts. In addition, both severe sepsis (diagnosis code 995.92) and septic shock (diagnosis code 785.52) are currently already assigned to these three MS-DRGs. Therefore, we are proposing to revise the titles of MS-DRGs 870, 871, and 872 to reflect severe sepsis in the titles as suggested by the manufacturer and listed above for FY 2009.

6. MDC 21 (Injuries, Poisonings and Toxic Effects of Drugs): Traumatic Compartment Syndrome

Traumatic compartment syndrome is a condition in which increased pressure within a confined anatomical space that contains blood vessels, muscles, nerves, and bones causes a decrease in blood flow and may lead to tissue necrosis.

There are five ICD-9-CM diagnosis codes that were created effective October 1, 2006, to identify traumatic compartment syndrome of various sites.

• 958.90 (Compartment syndrome, unspecified).

• 958.91 (Traumatic compartment syndrome of upper extremity).

• 958.92 (Traumatic compartment syndrome of lower extremity).

• 958.93 (Traumatic compartment syndrome of abdomen).

• 958.99 (Traumatic compartment syndrome of other sites) .

Cases with one of the diagnosis codes listed above reported as the principal diagnosis and no operating room procedure are assigned to either MS-DRG 922 (Other Injury, Poisoning and Toxic Effect Diagnosis with MCC) or MS-DRG 923 (Other Injury, Poisoning and Toxic Effect Diagnosis without MCC) in MDC 21.

In the FY 2008 IPPS final rule with comment period when we adopted the MS-DRGs, we inadvertently omitted the addition of these traumatic compartment syndrome codes 958.90 through 958.99 to the multiple trauma MS-DRGs 963 (Other Multiple Significant Trauma with MCC), MS-DRG 964 (Other Multiple Significant Trauma with CC), and MS-DRG 965 (Other Multiple Significant Trauma without CC/MCC) in MDC 24 (Multiple Significant Trauma). Cases are assigned to MDC 24 based on the principal diagnosis of trauma and at least two significant trauma diagnosis codes (either as principal or secondary diagnoses) from different body site categories. There are eight different body site categories as follows:

• Significant head trauma.

• Significant chest trauma.

• Significant abdominal trauma.

• Significant kidney trauma.

• Significant trauma of the urinary system.

• Significant trauma of the pelvis or spine.

• Significant trauma of the upper limb.

• Significant trauma of the lower limb.

Therefore, we are proposing to add traumatic compartment syndrome codes 958.90 through 958.99 to MS-DRGs 963 and MS-DRG 965 in MDC 24. Under this proposal, codes 958.90 through 958.99 would be added to the list of principal diagnosis of significant trauma. In addition, code 958.91 would be added to the list of significant trauma of upper limb, code 958.92 would be added to the list of significant trauma of lower limb, and code 958.93 would be added to the list of significant abdominal trauma.

7. Medicare Code Editor (MCE) Changes

As explained under section II.B.1. of the preamble of this proposed rule, the Medicare Code Editor (MCE) is a software program that detects and reports errors in the coding of Medicare claims data. Patient diagnoses, procedure(s), and demographic information are entered into the Medicare claims processing systems and are subjected to a series of automated screens. The MCE screens are designed to identify cases that require further review before classification into a DRG. For FY 2009, we are proposing to make the following changes to the MCE edits:

a. List of Unacceptable Principal Diagnoses in MCE

Diagnosis code V62.84 (Suicidal ideation) was created for use beginning October 1, 2005. At the time the diagnosis code was created, it was not clear that the creation of this code was requested in order to describe the principal reason for admission to a facility or the principal reason for treatment. The NCHS Official ICD-9-CM Coding Guidelines therefore categorized the group of codes in V62.X for use only as additional or secondary diagnoses. It has been brought to the government's attention that the use of this code is hampered by its designation as an additional-only diagnosis. NCHS has therefore modified the Official Coding Guidelines for FY 2009 by making this code acceptable as a principal diagnosis as well as an additional diagnosis. In order to conform to this change by NCHS, we are proposing to remove code V62.84 from the MCE list of "Unacceptable Principal Diagnoses" for FY 2009.

b. Diagnoses Allowed for Males Only Edit

There are four diagnosis codes that were inadvertently left off of the MCE edit titled "Diagnoses Allowed for Males Only." These codes are located in the chapter of the ICD-9-CM diagnosis codes entitled "Diseases of Male Genital Organs." We are proposing to add the following four codes to this MCE edit: 603.0 (Encysted hydrocele), 603.1 (Infected hydrocele), 603.8 (Other specified types of hydrocele), and 603.9 (Hydrocele, unspecified). We have had no reported problems or confusion with the omission of these codes from this section of the MCE, but in order to have an accurate product, we are proposing that these codes be added for FY 2009.

c. Limited Coverage Edit

As explained in section II.G.1. of the preamble of this proposed rule, we are proposing to remove procedure code 37.52 (Implantation of internal biventricular heart replacement system) from the MCE "Non-Covered Procedure" edit and to assign it to the "Limited Coverage" edit. We are proposing to include in this proposed edit the requirement that ICD-9-CM diagnosis code V70.7 (Examination of participant in clinical trial) also be present on the claim. We are proposing that claims submitted without both procedure code 37.52 and diagnosis code V70.7 would be denied because they would not be in compliance with the proposed coverage policy explained in section II.G.1. of this preamble.

8. Surgical Hierarchies

Some inpatient stays entail multiple surgical procedures, each one of which, occurring by itself, could result in assignment of the case to a different MS-DRG within the MDC to which the principal diagnosis is assigned. Therefore, it is necessary to have a decision rule within the GROUPER by which these cases are assigned to a single MS-DRG. The surgical hierarchy, an ordering of surgical classes from most resource-intensive to least resource-intensive, performs that function. Application of this hierarchy ensures that cases involving multiple surgical procedures are assigned to the MS-DRG associated with the most resource-intensive surgical class.

Because the relative resource intensity of surgical classes can shift as a function of MS-DRG reclassification and recalibrations, we reviewed the surgical hierarchy of each MDC, as we have for previous reclassifications and recalibrations, to determine if the ordering of classes coincides with the intensity of resource utilization.

A surgical class can be composed of one or more MS-DRGs. For example, in MDC 11, the surgical class "kidney transplant" consists of a single MS-DRG (MS-DRG 652) and the class "kidney, ureter and major bladder procedures" consists of three MS-DRGs (MS-DRGs 653, 654, and 655). Consequently, in many cases, the surgical hierarchy has an impact on more than one MS-DRG. The methodology for determining the most resource-intensive surgical class involves weighting the average resources for each MS-DRG by frequency to determine the weighted average resources for each surgical class. For example, assume surgical class A includes MS-DRGs 1 and 2 and surgical class B includes MS-DRGs 3, 4, and 5. Assume also that the average charge of MS-DRG 1 is higher than that of MS-DRG 3, but the average charges of MS-DRGs 4 and 5 are higher than the average charge of MS-DRG 2. To determine whether surgical class A should be higher or lower than surgical class B in the surgical hierarchy, we would weight the average charge of each MS-DRG in the class by frequency (that is, by the number of cases in the MS-DRG) to determine average resource consumption for the surgical class. The surgical classes would then be ordered from the class with the highest average resource utilization to that with the lowest, with the exception of "other O.R. procedures" as discussed below.

This methodology may occasionally result in assignment of a case involving multiple procedures to the lower-weighted MS-DRG (in the highest, most resource-intensive surgical class) of the available alternatives. However, given that the logic underlying the surgical hierarchy provides that the GROUPER search for the procedure in the most resource-intensive surgical class, in cases involving multiple procedures, this result is sometimes unavoidable.

We note that, notwithstanding the foregoing discussion, there are a few instances when a surgical class with a lower average charge is ordered above a surgical class with a higher average charge. For example, the "other O.R. procedures" surgical class is uniformly ordered last in the surgical hierarchy of each MDC in which it occurs, regardless of the fact that the average charge for the MS-DRG or MS-DRGs in that surgical class may be higher than that for other surgical classes in the MDC. The "other O.R. procedures" class is a group of procedures that are only infrequently related to the diagnoses in the MDC, but are still occasionally performed on patients in the MDC with these diagnoses. Therefore, assignment to these surgical classes should only occur if no other surgical class more closely related to the diagnoses in the MDC is appropriate.

A second example occurs when the difference between the average charges for two surgical classes is very small. We have found that small differences generally do not warrant reordering of the hierarchy because, as a result of reassigning cases on the basis of the hierarchy change, the average charges are likely to shift such that the higher-ordered surgical class has a lower average charge than the class ordered below it.

For FY 2009, we are proposing a revision of the surgical hierarchy for MDC 5 (Diseases and Disorders of the Circulatory System) by placing MS-DRG 245 (AICD Generator Procedures) above proposed new MS-DRG 265 (AICD Lead Procedures).

9. CC Exclusions List

a. Background

As indicated earlier in the preamble of this proposed rule, under the IPPS DRG classification system, we have developed a standard list of diagnoses that are considered CCs. Historically, we developed this list using physician panels that classified each diagnosis code based on whether the diagnosis, when present as a secondary condition, would be considered a substantial complication or comorbidity. A substantial complication or comorbidity was defined as a condition that, because of its presence with a specific principal diagnosis, would cause an increase in the length of stay by at least 1 day in at least 75 percent of the patients. We refer readers to section II.D.2. and 3. of the preamble of the FY 2008 IPPS final rule with comment period for a discussion of the refinement of CCs in relation to the MS-DRGs we adopted for FY-2008 (72 FR 47152 through 47121).

b. CC Exclusions List for FY 2009

In the September 1, 1987 final notice (52-FR-33143) concerning changes to the DRG classification system, we modified the GROUPER logic so that certain diagnoses included on the standard list of CCs would not be considered valid CCs in combination with a particular principal diagnosis. We created the CC Exclusions List for the following reasons: (1) To preclude coding of CCs for closely related conditions; (2) to preclude duplicative or inconsistent coding from being treated as CCs; and (3) to ensure that cases are appropriately classified between the complicated and uncomplicated DRGs in a pair. As we indicated above, we developed a list of diagnoses, using physician panels, to include those diagnoses that, when present as a secondary condition, would be considered a substantial complication or comorbidity. In previous years, we have made changes to the list of CCs, either by adding new CCs or deleting CCs already on the list.

In the May 19, 1987 proposed notice (52 FR 18877) and the September 1, 1987 final notice (52 FR 33154), we explained that the excluded secondary diagnoses were established using the following five principles:

• Chronic and acute manifestations of the same condition should not be considered CCs for one another.

• Specific and nonspecific (that is, not otherwise specified (NOS)) diagnosis codes for the same condition should not be considered CCs for one another.

• Codes for the same condition that cannot coexist, such as partial/total, unilateral/bilateral, obstructed/unobstructed, and benign/malignant, should not be considered CCs for one another.

• Codes for the same condition in anatomically proximal sites should not be considered CCs for one another.

• Closely related conditions should not be considered CCs for one another.

The creation of the CC Exclusions List was a major project involving hundreds of codes. We have continued to review the remaining CCs to identify additional exclusions and to remove diagnoses from the master list that have been shown not to meet the definition of a CC.12

Footnotes:

12 See the FY 1989 final rule (53 FR 38485, September 30, 1988), for the revision made for the discharges occurring in FY 1989; the FY 1990 final rule (54 FR 36552, September 1, 1989), for the FY 1990 revision; the FY 1991 final rule (55 FR 36126, September 4, 1990), for the FY 1991 revision; the FY 1992 final rule (56 FR 43209, August 30, 1991) for the FY 1992 revision; the FY 1993 final rule (57 FR 39753, September 1, 1992), for the FY 1993 revision; the FY 1994 final rule (58 FR 46278, September 1, 1993), for the FY 1994 revisions; the FY 1995 final rule (59 FR 45334, September 1, 1994), for the FY 1995 revisions; the FY 1996 final rule (60 FR 45782, September 1, 1995), for the FY 1996 revisions; the FY 1997 final rule (61 FR 46171, August 30, 1996), for the FY 1997 revisions; the FY 1998 final rule (62 FR 45966, August 29, 1997) for the FY 1998 revisions; the FY 1999 final rule (63 FR 40954, July 31, 1998), for the FY 1999 revisions; the FY 2001 final rule (65 FR 47064, August 1, 2000), for the FY 2001 revisions; the FY 2002 final rule (66 FR 39851, August 1, 2001), for the FY 2002 revisions; the FY 2003 final rule (67 FR 49998, August 1, 2002), for the FY 2003 revisions; the FY 2004 final rule (68 FR 45364, August 1, 2003), for the FY 2004 revisions; the FY 2005 final rule (69 FR 49848, August 11, 2004), for the FY 2005 revisions; the FY 2006 final rule (70 FR 47640, August 12, 2005), for the FY 2006 revisions; the FY 2007 final rule (71 FR 47870) for the FY 2007 revisions; and the FY 2008 final rule (72 FR 47130) for the FY 2008 revisions. In the FY 2000 final rule (64 FR 41490, July 30, 1999, we did not modify the CC Exclusions List because we did not make any changes to the ICD-9-CM codes for FY 2000.

For FY 2009, we are proposing to make limited revisions to the CC Exclusions List to take into account the changes that will be made in the ICD-9-CM diagnosis coding system effective October 1, 2008. (See section II.G.11. of the preamble of this proposed rule with comment period for a discussion of ICD-9-CM changes.) We are proposing to make these changes in accordance with the principles established when we created the CC Exclusions List in 1987. In addition, as discussed in section II.D.3. of the preamble of this proposed rule, we are indicating on the CC exclusion list some updates to reflect the exclusion of a few codes from being an MCC under the MS-DRG system that we adopted for FY 2008.

Tables 6G and 6H, Additions to and Deletions from the CC Exclusion List, respectively, which will be effective for discharges occurring on or after October 1, 2008, are not being published in this proposed rule because of the length of the two tables. Instead, we are making them available through the Internet on the CMS Web site at: http://www.cms.hhs.gov/AcuteInpatientPPS . Each of these principal diagnoses for which there is a CC exclusion is shown in Tables 6G and 6H with an asterisk, and the conditions that will not count as a CC, are provided in an indented column immediately following the affected principal diagnosis.

A complete updated MCC, CC, and Non-CC Exclusions List is also available through the Internet on the CMS Web site at: http:/www.cms.hhs.gov/AcuteInpatientPPS . Beginning with discharges on or after October 1, 2008, the indented diagnoses will not be recognized by the GROUPER as valid CCs for the asterisked principal diagnosis.

To assist readers in the review of changes to the MCC and CC lists that occurred as a result of updates to the ICD-9-CM codes, as described in Tables 6A, 6C, and 6E, we are providing the following summaries of those MCC and CC changes.

Code Description
249.10 Secondary diabetes mellitus with ketoacidosis, not stated as uncontrolled, or unspecified.
249.11 Secondary diabetes mellitus with ketoacidosis, uncontrolled.
249.20 Secondary diabetes mellitus with hyperosmolarity, not stated as uncontrolled, or unspecified.
249.21 Secondary diabetes mellitus with hyperosmolarity, uncontrolled.
249.30 Secondary diabetes mellitus with other coma, not stated as uncontrolled, or unspecified.
249.31 Secondary diabetes mellitus with other coma, uncontrolled.
707.23 Pressure ulcer, stage III.
707.24 Pressure ulcer, stage IV.
777.50 Necrotizing enterocolitis in newborn, unspecified.
777.51 Stage I necrotizing enterocolitis in newborn.
777.52 Stage II necrotizing enterocolitis in newborn.
777.53 Stage III necrotizing enterocolitis in newborn.
780.72 Functional quadriplegia.

Code Description
136.2 Specific infections by free-living amebae.
511.8 Other specified forms of pleural effusion, except tuberculous.
707.02 Pressure ulcer, upper back.
707.03 Pressure ulcer, lower back.
707.04 Pressure ulcer, hip.
707.05 Pressure ulcer, buttock.
707.06 Pressure ulcer, ankle.
707.07 Pressure ulcer, heel.
777.5 Necrotizing enterocolitis in fetus or newborn.

Code Description
046.11 Variant Creutzfeldt-Jakob disease.
046.19 Other and unspecified Creutzfeldt-Jakob disease.
046.71 Gerstmann-Sträussler-Scheinker syndrome.
046.72 Fatal familial insomnia.
046.79 Other and unspecified prion disease of central nervous system.
059.01 Monkeypox.
059.21 Tanapox.
136.29 Other specific infections by free-living amebae.
199.2 Malignant neoplasm associated with transplant organ.
203.02 Multiple myeloma, in relapse.
203.12 Plasma cell leukemia, in relapse.
203.82 Other immunoproliferative neoplasms, in relapse.
204.02 Acute lymphoid leukemia, in relapse.
204.12 Chronic lymphoid leukemia, in relapse.
204.22 Subacute lymphoid leukemia, in relapse.
204.82 Other lymphoid leukemia, in relapse.
204.92 Unspecified lymphoid leukemia, in relapse.
205.02 Acute myeloid leukemia, in relapse.
205.12 Chronic myeloid leukemia, in relapse.
205.22 Subacute myeloid leukemia, in relapse.
205.32 Myeloid sarcoma, in relapse.
205.82 Other myeloid leukemia, in relapse.
205.92 Unspecified myeloid leukemia, in relapse.
206.02 Acute monocytic leukemia, in relapse.
206.12 Chronic monocytic leukemia, in relapse.
206.22 Subacute monocytic leukemia, in relapse.
206.82 Other monocytic leukemia, in relapse.
206.92 Unspecified monocytic leukemia, in relapse.
207.02 Acute erythremia and erythroleukemia, in relapse.
207.12 Chronic erythremia, in relapse.
207.22 Megakaryocytic leukemia, in relapse.
207.82 Other specified leukemia, in relapse.
208.02 Acute leukemia of unspecified cell type, in relapse.
208.12 Chronic leukemia of unspecified cell type, in relapse.
208.22 Subacute leukemia of unspecified cell type, in relapse.
208.82 Other leukemia of unspecified cell type, in relapse.
208.92 Unspecified leukemia, in relapse.
209.00 Malignant carcinoid tumor of the small intestine, unspecified portion.
209.01 Malignant carcinoid tumor of the duodenum.
209.02 Malignant carcinoid tumor of the jejunum.
209.03 Malignant carcinoid tumor of the ileum.
209.10 Malignant carcinoid tumor of the large intestine, unspecified portion.
209.11 Malignant carcinoid tumor of the appendix.
209.12 Malignant carcinoid tumor of the cecum.
209.13 Malignant carcinoid tumor of the ascending colon.
209.14 Malignant carcinoid tumor of the transverse colon.
209.15 Malignant carcinoid tumor of the descending colon.
209.16 Malignant carcinoid tumor of the sigmoid colon.
209.17 Malignant carcinoid tumor of the rectum.
209.20 Malignant carcinoid tumor of unknown primary site.
209.21 Malignant carcinoid tumor of the bronchus and lung.
209.22 Malignant carcinoid tumor of the thymus.
209.23 Malignant carcinoid tumor of the stomach.
209.24 Malignant carcinoid tumor of the kidney.
209.25 Malignant carcinoid tumor of foregut, not otherwise specified.
209.26 Malignant carcinoid tumor of midgut, not otherwise specified.
209.27 Malignant carcinoid tumor of hindgut, not otherwise specified.
209.29 Malignant carcinoid tumor of other sites.
209.30 Malignant poorly differentiated neuroendocrine carcinoma, any site.
238.77 Post-transplant lymphoproliferative disorder (PTLD).
279.50 Graft-versus-host disease, unspecified.
279.51 Acute graft-versus-host disease.
279.52 Chronic graft-versus-host disease.
279.53 Acute on chronic graft-versus-host disease.
346.60 Persistent migraine aura with cerebral infarction, without mention of intractable migraine without mention of status migrainosus.
346.61 Persistent migraine aura with cerebral infarction, with intractable migraine, so stated, without mention of status migrainosus.
346.62 Persistent migraine aura with cerebral infarction, without mention of intractable migraine with status migrainosus.
346.63 Persistent migraine aura with cerebral infarction, with intractable migraine, so stated, with status migrainosus.
511.81 Malignant pleural effusion.
511.89 Other specified forms of effusion, except tuberculous.
649.70 Cervical shortening, unspecified as to episode of care or not applicable.
649.71 Cervical shortening, delivered, with or without mention of antepartum condition.
649.73 Cervical shortening, antepartum condition or complication.
695.12 Erythema multiforme major.
695.13 Stevens-Johnson syndrome.
695.14 Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome.
695.15 Toxic epidermal necrolysis.
695.53 Exfoliation due to erythematous condition involving 30-39 percent of body surface.
695.54 Exfoliation due to erythematous condition involving 40-49 percent of body surface.
695.55 Exfoliation due to erythematous condition involving 50-59 percent of body surface.
695.56 Exfoliation due to erythematous condition involving 60-69 percent of body surface.
695.57 Exfoliation due to erythematous condition involving 70-79 percent of body surface.
695.58 Exfoliation due to erythematous condition involving 80-89 percent of body surface.
695.59 Exfoliation due to erythematous condition involving 90 percent or more of body surface.
997.31 Ventilator associated pneumonia.
997.39 Other respiratory complications.
998.30 Disruption of wound, unspecified.
998.33 Disruption of traumatic wound repair.
999.81 Extravasation of vesicant chemotherapy.
999.82 Extravasation of other vesicant agent.

Code Description
046.1 Jakob-Creutzfeldt disease.
337.0 Idiopathic peripheral autonomic neuropathy.
695.1 Erythema multiforme.
707.00 Pressure ulcer, unspecified site.
707.01 Pressure ulcer, elbow.
707.09 Pressure ulcer, other site.
997.3 Respiratory complications.
999.8 Other transfusion reaction.

Alternatively, the complete documentation of the GROUPER logic, including the current CC Exclusions List, is available from 3M/Health Information Systems (HIS), which, under contract with CMS, is responsible for updating and maintaining the GROUPER program. The current DRG Definitions Manual, Version 25.0, is available for $225.00, which includes $15.00 for shipping and handling. Version 26.0 of this manual, which will include the final FY 2009 DRG changes, will be available in hard copy for $250.00. Version 26.0 of the manual is also available on a CD for $200.00; a combination hard copy and CD is available for $400.00. These manuals may be obtained by writing 3M/HIS at the following address: 100 Barnes Road, Wallingford, CT 06492; or by calling (203) 949-0303. Please specify the revision or revisions requested.

10. Review of Procedure Codes in MS DRGs 981, 982, and 983; 984, 985, and 986; and 987, 988, and 989

Each year, we review cases assigned to former CMS DRG 468 (Extensive O.R. Procedure Unrelated to Principal Diagnosis), CMS DRG 476 (Prostatic O.R. Procedure Unrelated to Principal Diagnosis), and CMS DRG 477 (Nonextensive O.R. Procedure Unrelated to Principal Diagnosis) to determine whether it would be appropriate to change the procedures assigned among these CMS DRGs. Under the MS-DRGs that we adopted for FY 2008, CMS DRG 468 was split three ways and became MS-DRGs 981, 982, and 983 (Extensive O.R. Procedure Unrelated to Principal Diagnosis with MCC, with CC, and without CC/MCC). CMS DRG 476 became MS-DRGs 984, 985, and 986 (Prostatic O.R. Procedure Unrelated to Principal Diagnosis with MCC, with CC, and without CC/MCC). CMS DRG 477 became MS-DRGs 987, 988, and 989 (Nonextensive O.R. Procedure Unrelated to Principal Diagnosis with MCC, with CC, and without CC/MCC).

MS-DRGs 981 through 983, 984 through 986, and 987 through 989 (formerly CMS DRGs 468, 476, and 477, respectively) are reserved for those cases in which none of the O.R. procedures performed are related to the principal diagnosis. These DRGs are intended to capture atypical cases, that is, those cases not occurring with sufficient frequency to represent a distinct, recognizable clinical group. MS-DRGs 984 through 986 (previously CMS DRG 476) are assigned to those discharges in which one or more of the following prostatic procedures are performed and are unrelated to the principal diagnosis:

• 60.0, Incision of prostate.

• 60.12, Open biopsy of prostate.

• 60.15, Biopsy of periprostatic tissue.

• 60.18, Other diagnostic procedures on prostate and periprostatic tissue.

• 60.21, Transurethral prostatectomy.

• 60.29, Other transurethral prostatectomy.

• 60.61, Local excision of lesion of prostate.

• 60.69, Prostatectomy, not elsewhere classified.

• 60.81, Incision of periprostatic tissue.

• 60.82, Excision of periprostatic tissue.

• 60.93, Repair of prostate.

• 60.94, Control of (postoperative) hemorrhage of prostate.

• 60.95, Transurethral balloon dilation of the prostatic urethra.

• 60.96, Transurethral destruction of prostate tissue by microwave thermotherapy.

• 60.97, Other transurethral destruction of prostate tissue by other thermotherapy.

• 60.99, Other operations on prostate.

All remaining O.R. procedures are assigned to MS-DRGs 981 through 983 and 987 through 989, with MS-DRGs 987 through 989 assigned to those discharges in which the only procedures performed are nonextensive procedures that are unrelated to the principal diagnosis.13

Footnotes:

13 The original list of the ICD-9-CM procedure codes for the procedures we consider nonextensive procedures, if performed with an unrelated principal diagnosis, was published in Table 6C in section IV. of the Addendum to the FY 1989 final rule (53 FR 38591). As part of the FY 1991 final rule (55 FR 36135), the FY 1992 final rule (56 FR 43212), the FY 1993 final rule (57 FR 23625), the FY 1994 final rule (58 FR 46279), the FY 1995 final rule (59 FR 45336), the FY 1996 final rule (60 FR 45783), the FY 1997 final rule (61 FR 46173), and the FY 1998 final rule (62 FR 45981), we moved several other procedures from DRG 468 to DRG 477, and some procedures from DRG 477 to DRG 468. No procedures were moved in FY 1999, as noted in the final rule (63 FR 40962); in FY 2000 (64 FR 41496); in FY 2001 (65 FR 47064); or in FY 2002 (66 FR 39852). In the FY 2003 final rule (67 FR 49999) we did not move any procedures from DRG 477. However, we did move procedure codes from DRG 468 and placed them in more clinically coherent DRGs. In the FY 2004 final rule (68 FR 45365), we moved several procedures from DRG 468 to DRGs 476 and 477 because the procedures are nonextensive. In the FY 2005 final rule (69 FR 48950), we moved one procedure from DRG 468 to 477. In addition, we added several existing procedures to DRGs 476 and 477. In the FY 2006 (70 FR 47317), we moved one procedure from DRG 468 and assigned it to DRG 477. In FY 2007, we moved one procedure from DRG 468 and assigned it to DRGs 479, 553, and 554. In FY 2008, no procedures were moved, as noted in the final rule with comment period (72 FR 46241).

For FY 2009, we are not proposing to change the procedures assigned among these DRGs.

a. Moving Procedure Codes From MS-DRGs 981 Through 983 or MS-DRGs 987 Through 989 to MDCs

We annually conduct a review of procedures producing assignment to MS-DRGs 981 through 983 (formerly CMS DRG 468) or MS-DRGs 987 through 989 (formerly CMS DRG 477) on the basis of volume, by procedure, to see if it would be appropriate to move procedure codes out of these DRGs into one of the surgical DRGs for the MDC into which the principal diagnosis falls. The data are arrayed in two ways for comparison purposes. We look at a frequency count of each major operative procedure code. We also compare procedures across MDCs by volume of procedure codes within each MDC.

We identify those procedures occurring in conjunction with certain principal diagnoses with sufficient frequency to justify adding them to one of the surgical DRGs for the MDC in which the diagnosis falls. For FY 2009, we are not proposing to remove any procedures from MS-DRGs 981 through 983 or MS-DRGs 987 through 989.

b. Reassignment of Procedures Among MS-DRGs 981 Through 983, 984 Through 986, and 987 Through 989)

We also annually review the list of ICD-9-CM procedures that, when in combination with their principal diagnosis code, result in assignment to MS-DRGs 981 through 983, 984 through 986, and 987 through 989 (formerly, CMS DRGs 468, 476, and 477, respectively), to ascertain whether any of those procedures should be reassigned from one of these three DRGs to another of the three DRGs based on average charges and the length of stay. We look at the data for trends such as shifts in treatment practice or reporting practice that would make the resulting DRG assignment illogical. If we find these shifts, we would propose to move cases to keep the DRGs clinically similar or to provide payment for the cases in a similar manner. Generally, we move only those procedures for which we have an adequate number of discharges to analyze the data.

For FY 2009, we are not proposing to move any procedure codes among these DRGs.

c. Adding Diagnosis or Procedure Codes to MDCs

Based on our review this year, we are not proposing to add any diagnosis codes to MDCs for FY 2009.

11. Changes to the ICD-9-CM Coding System

As described in section II.B.1. of the preamble of this proposed rule, the ICD-9-CM is a coding system used for the reporting of diagnoses and procedures performed on a patient. In September 1985, the ICD-9-CM Coordination and Maintenance Committee was formed. This is a Federal interdepartmental committee, co-chaired by the National Center for Health Statistics (NCHS), the Centers for Disease Control and Prevention, and CMS, charged with maintaining and updating the ICD-9-CM system. The Committee is jointly responsible for approving coding changes, and developing errata, addenda, and other modifications to the ICD-9-CM to reflect newly developed procedures and technologies and newly identified diseases. The Committee is also responsible for promoting the use of Federal and non-Federal educational programs and other communication techniques with a view toward standardizing coding applications and upgrading the quality of the classification system.

The Official Version of the ICD-9-CM contains the list of valid diagnosis and procedure codes. (The Official Version of the ICD-9-CM is available from the Government Printing Office on CD-ROM for $27.00 by calling (202) 512-1800.) Complete information on ordering the CD-ROM is also available at: http://www.cdc.gov/nchs/products/prods/subject/icd96ed.htm. The Official Version of the ICD-9-CM is no longer available in printed manual form from the Federal Government; it is only available on CD-ROM. Users who need a paper version are referred to one of the many products available from publishing houses.

The NCHS has lead responsibility for the ICD-9-CM diagnosis codes included in the Tabular List and Alphabetic Index for Diseases , while CMS has lead responsibility for the ICD-9-CM procedure codes included in the Tabular List and Alphabetic Index for Procedures.

The Committee encourages participation in the above process by health-related organizations. In this regard, the Committee holds public meetings for discussion of educational issues and proposed coding changes. These meetings provide an opportunity for representatives of recognized organizations in the coding field, such as the American Health Information Management Association (AHIMA), the American Hospital Association (AHA), and various physician specialty groups, as well as individual physicians, health information management professionals, and other members of the public, to contribute ideas on coding matters. After considering the opinions expressed at the public meetings and in writing, the Committee formulates recommendations, which then must be approved by the agencies.

The Committee presented proposals for coding changes for implementation in FY 2009 at a public meeting held on September 27-28, 2007 and finalized the coding changes after consideration of comments received at the meetings and in writing by December 3, 2007. Those coding changes are announced in Tables 6A through 6F in the Addendum to this proposed rule. The Committee held its 2008 meeting on March 19-20, 2008. Proposed new codes for which there was a consensus of public support and for which complete tabular and indexing changes can be made by May 2008 will be included in the October 1, 2008 update to ICD-9-CM. Code revisions that were discussed at the March 19-20, 2008 Committee meeting but that could not be finalized in time to include them in the Addendum to this proposed rule are not included in Tables 6A through 6F. These additional codes will be included in Tables 6A through 6F of the final rule with comment period and are marked with an asterisk (*).

Copies of the minutes of the procedure codes discussions at the Committee's September 27-28, 2007 meeting can be obtained from the CMS Web site at: http://cms.hhs.gov/ICD9ProviderDiagnosticCodes/03_meetings.asp . The minutes of the diagnosis codes discussions at the September 27-28, 2007 meeting are found at: http://www.cdc.gov/nchs/icd9.htm . Paper copies of these minutes are no longer available and the mailing list has been discontinued. These Web sites also provide detailed information about the Committee, including information on requesting a new code, attending a Committee meeting, and timeline requirements and meeting dates.

We encourage commenters to address suggestions on coding issues involving diagnosis codes to: Donna Pickett, Co-Chairperson, ICD-9-CM Coordination and Maintenance Committee, NCHS, Room 2402, 3311 Toledo Road, Hyattsville, MD 20782. Comments may be sent by E-mail to: dfp4@cdc.gov .

Questions and comments concerning the procedure codes should be addressed to: Patricia E. Brooks, Co-Chairperson, ICD-9-CM Coordination and Maintenance Committee, CMS, Center for Medicare Management, Hospital and Ambulatory Policy Group, Division of Acute Care, C4-08-06, 7500 Security Boulevard, Baltimore, MD 21244-1850. Comments may be sent by E-mail to: patricia.brooks2@cms.hhs.gov .

The ICD-9-CM code changes that have been approved will become effective October 1, 2008. The new ICD-9-CM codes are listed, along with their DRG classifications, in Tables 6A and 6B (New Diagnosis Codes and New Procedure Codes, respectively) in the Addendum to this proposed rule. As we stated above, the code numbers and their titles were presented for public comment at the ICD-9-CM Coordination and Maintenance Committee meetings. Both oral and written comments were considered before the codes were approved. In this proposed rule, we are only soliciting comments on the proposed classification of these new codes.

For codes that have been replaced by new or expanded codes, and the corresponding new or expanded diagnosis codes are included in Table 6A. New procedure codes are shown in Table 6B. Diagnosis codes that have been replaced by expanded codes or other codes or have been deleted are in Table 6C (Invalid Diagnosis Codes). These invalid diagnosis codes will not be recognized by the GROUPER beginning with discharges occurring on or after October 1, 2008. Table 6D contains invalid procedure codes. These invalid procedure codes will not be recognized by the GROUPER beginning with discharges occurring on or after October 1, 2008. Revisions to diagnosis code titles are in Table 6E (Revised Diagnosis Code Titles), which also includes the MS-DRG assignments for these revised codes. Table 6F includes revised procedure code titles for FY 2009.

In the September 7, 2001 final rule implementing the IPPS new technology add-on payments (66 FR 46906), we indicated we would attempt to include proposals for procedure codes that would describe new technology discussed and approved at the Spring meeting as part of the code revisions effective the following October. As stated previously, ICD-9-CM codes discussed at the March 19-20, 2008 Committee meeting that received consensus and that are finalized by May 2008, will be included in Tables 6A through 6F of the Addendum to the final rule.

Section 503(a) of Pub. L. 108-173 included a requirement for updating ICD-9-CM codes twice a year instead of a single update on October 1 of each year. This requirement was included as part of the amendments to the Act relating to recognition of new technology under the IPPS. Section 503(a) amended section 1886(d)(5)(K) of the Act by adding a clause (vii) which states that the "Secretary shall provide for the addition of new diagnosis and procedure codes on April 1 of each year, but the addition of such codes shall not require the Secretary to adjust the payment (or diagnosis-related group classification) * * * until the fiscal year that begins after such date." This requirement improves the recognition of new technologies under the IPPS system by providing information on these new technologies at an earlier date. Data will be available 6 months earlier than would be possible with updates occurring only once a year on October 1.

While section 1886(d)(5)(K)(vii) of the Act states that the addition of new diagnosis and procedure codes on April 1 of each year shall not require the Secretary to adjust the payment, or DRG classification, under section 1886(d) of the Act until the fiscal year that begins after such date, we have to update the DRG software and other systems in order to recognize and accept the new codes. We also publicize the code changes and the need for a mid-year systems update by providers to identify the new codes. Hospitals also have to obtain the new code books and encoder updates, and make other system changes in order to identify and report the new codes.

The ICD-9-CM Coordination and Maintenance Committee holds its meetings in the spring and fall in order to update the codes and the applicable payment and reporting systems by October 1 of each year. Items are placed on the agenda for the ICD-9-CM Coordination and Maintenance Committee meeting if the request is received at least 2 months prior to the meeting. This requirement allows time for staff to review and research the coding issues and prepare material for discussion at the meeting. It also allows time for the topic to be publicized in meeting announcements in the Federal Register as well as on the CMS Web site. The public decides whether or not to attend the meeting based on the topics listed on the agenda. Final decisions on code title revisions are currently made by March 1 so that these titles can be included in the IPPS proposed rule. A complete addendum describing details of all changes to ICD-9-CM, both tabular and index, is published on the CMS and NCHS Web sites in May of each year. Publishers of coding books and software use this information to modify their products that are used by health care providers. This 5-month time period has proved to be necessary for hospitals and other providers to update their systems.

A discussion of this timeline and the need for changes are included in the December 4-5, 2005 ICD-9-CM Coordination and Maintenance Committee minutes. The public agreed that there was a need to hold the fall meetings earlier, in September or October, in order to meet the new implementation dates. The public provided comment that additional time would be needed to update hospital systems and obtain new code books and coding software. There was considerable concern expressed about the impact this new April update would have on providers.

In the FY 2005 IPPS final rule, we implemented section 1886(d)(5)(K)(vii) of the Act, as added by section 503(a) of Pub. L. 108-173, by developing a mechanism for approving, in time for the April update, diagnosis and procedure code revisions needed to describe new technologies and medical services for purposes of the new technology add-on payment process. We also established the following process for making these determinations. Topics considered during the Fall ICD-9-CM Coordination and Maintenance Committee meeting are considered for an April 1 update if a strong and convincing case is made by the requester at the Committee's public meeting. The request must identify the reason why a new code is needed in April for purposes of the new technology process. The participants at the meeting and those reviewing the Committee meeting summary report are provided the opportunity to comment on this expedited request. All other topics are considered for the October 1 update. Participants at the Committee meeting are encouraged to comment on all such requests. There were no requests approved for an expedited April l, 2008 implementation of an ICD-9-CM code at the September 27-28, 2007 Committee meeting. Therefore, there were no new ICD-9-CM codes implemented on April 1, 2008.

We believe that this process captures the intent of section 1886(d)(5)(K)(vii) of the Act. This requirement was included in the provision revising the standards and process for recognizing new technology under the IPPS. In addition, the need for approval of new codes outside the existing cycle (October 1) arises most frequently and most acutely where the new codes will identify new technologies that are (or will be) under consideration for new technology add-on payments. Thus, we believe this provision was intended to expedite data collection through the assignment of new ICD-9-CM codes for new technologies seeking higher payments.

Current addendum and code title information is published on the CMS Web site at: www.cms.hhs.gov/icd9ProviderDiagnosticCodes/01_overview.asp#TopofPage. Information on ICD-9-CM diagnosis codes, along with the Official ICD-9-CM Coding Guidelines, can be found on the Web site at: www.cdc.gov/nchs/icd9.htm. Information on new, revised, and deleted ICD-9-CM codes is also provided to the AHA for publication in the Coding Clinic for ICD-9-CM. AHA also distributes information to publishers and software vendors.

CMS also sends copies of all ICD-9-CM coding changes to its contractors for use in updating their systems and providing education to providers.

These same means of disseminating information on new, revised, and deleted ICD-9-CM codes will be used to notify providers, publishers, software vendors, contractors, and others of any changes to the ICD-9-CM codes that are implemented in April. The code titles are adopted as part of the ICD-9-CM Coordination and Maintenance Committee process. Thus, although we publish the code titles in the IPPS proposed and final rules, they are not subject to comment in the proposed or final rules. We will continue to publish the October code updates in this manner within the IPPS proposed and final rules. For codes that are implemented in April, we will assign the new procedure code to the same DRG in which its predecessor code was assigned so there will be no DRG impact as far as DRG assignment. Any midyear coding updates will be available through the Web sites indicated above and through the Coding Clinic for ICD-9-CM. Publishers and software vendors currently obtain code changes through these sources in order to update their code books and software systems. We will strive to have the April 1 updates available through these Web sites 5 months prior to implementation (that is, early November of the previous year), as is the case for the October 1 updates.

H. Recalibration of MS-DRG Weights

In section II.E. of the preamble of this proposed rule, we state that we are proposing to fully implement the cost-based DRG relative weights for FY 2009, which is the third year in the 3-year transition period to calculate the relative weights at 100 percent based on costs. In the FY 2008 IPPS final rule with comment period (72 FR 47267), as recommended by RTI, for FY 2008, we added two new CCRs for a total of 15 CCRs: one for "Emergency Room" and one for "Blood and Blood Products," both of which can be derived directly from the Medicare cost report.

In developing the FY 2009 proposed system of weights, we used two data sources: claims data and cost report data. As in previous years, the claims data source is the MedPAR file. This file is based on fully coded diagnostic and procedure data for all Medicare inpatient hospital bills. The FY 2007 MedPAR data used in this proposed rule include discharges occurring on October 1, 2006, through September 30, 2007, based on bills received by CMS through December 2007, from all hospitals subject to the IPPS and short-term, acute care hospitals in Maryland (which are under a waiver from the IPPS under section 1814(b)(3) of the Act). The FY 2007 MedPAR file used in calculating the relative weights includes data for approximately 11,433,806 Medicare discharges from IPPS providers. Discharges for Medicare beneficiaries enrolled in a Medicare Advantage managed care plan are excluded from this analysis. The data exclude CAHs, including hospitals that subsequently became CAHs after the period from which the data were taken. The second data source used in the cost-based relative weighting methodology is the FY 2006 Medicare cost report data files from HCRIS (that is, cost reports beginning on or after October 1, 2005, and before October 1, 2006), which represents the most recent full set of cost report data available. We used the December 31, 2007 update of the HCRIS cost report files for FY 2006 in setting the relative cost-based weights.

The methodology we used to calculate the DRG cost-based relative weights from the FY 2007 MedPAR claims data and FY 2006 Medicare cost report data is as follows:

• To the extent possible, all the claims were regrouped using the proposed FY 2009 MS-DRG classifications discussed in sections II.B. and G. of the preamble of this proposed rule.

• The transplant cases that were used to establish the relative weights for heart and heart-lung, liver and/or intestinal, and lung transplants (MS-DRGs 001, 002, 005, 006, and 007, respectively) were limited to those Medicare-approved transplant centers that have cases in the FY 2007 MedPAR file. (Medicare coverage for heart, heart-lung, liver and/or intestinal, and lung transplants is limited to those facilities that have received approval from CMS as transplant centers.)

• Organ acquisition costs for kidney, heart, heart-lung, liver, lung, pancreas, and intestinal (or multivisceral organs) transplants continue to be paid on a reasonable cost basis. Because these acquisition costs are paid separately from the prospective payment rate, it is necessary to subtract the acquisition charges from the total charges on each transplant bill that showed acquisition charges before computing the average cost for each DRG and before eliminating statistical outliers.

• Claims with total charges or total length of stay less than or equal to zero were deleted. Claims that had an amount in the total charge field that differed by more than $10.00 from the sum of the routine day charges, intensive care charges, pharmacy charges, special equipment charges, therapy services charges, operating room charges, cardiology charges, laboratory charges, radiology charges, other service charges, labor and delivery charges, inhalation therapy charges, emergency room charges, blood charges, and anesthesia charges were also deleted.

• At least 96.1 percent of the providers in the MedPAR file had charges for 10 of the 15 cost centers. Claims for providers that did not have charges greater than zero for at least 10 of the 15 cost centers were deleted.

• Statistical outliers were eliminated by removing all cases that were beyond 3.0 standard deviations from the mean of the log distribution of both the total charges per case and the total charges per day for each DRG.

Once the MedPAR data were trimmed and the statistical outliers were removed, the charges for each of the 15 cost groups for each claim were standardized to remove the effects of differences in area wage levels, IME and DSH payments, and for hospitals in Alaska and Hawaii, the applicable cost-of-living adjustment. Because hospital charges include charges for both operating and capital costs, we standardized total charges to remove the effects of differences in geographic adjustment factors, cost-of-living adjustments, DSH payments, and IME adjustments under the capital IPPS as well. Charges were then summed by DRG for each of the 15 cost groups so that each DRG had 15 standardized charge totals. These charges were then adjusted to cost by applying the national average CCRs developed from the FY 2006 cost report data.

The 15 cost centers that we used in the relative weight calculation are shown in the following table. The table shows the lines on the cost report and the corresponding revenue codes that we used to create the 15 national cost center CCRs.

BILLING CODE 4120-01-P

[Federal Register graphic "EP30AP08.012" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.013" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.014" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.015" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.016" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.017" is not available. Please view the graphic in the PDF version of this document.]

BILLING CODE 4120-01-C

We developed the national average CCRs as follows:

Taking the FY 2006 cost report data, we removed CAHs, Indian Health Service hospitals, all-inclusive rate hospitals, and cost reports that represented time periods of less than 1 year (365 days). We included hospitals located in Maryland as we are including their charges in our claims database. We then created CCRs for each provider for each cost center (see prior table for line items used in the calculations) and removed any CCRs that were greater than 10 or less than 0.01. We normalized the departmental CCRs by dividing the CCR for each department by the total CCR for the hospital for the purpose of trimming the data. We then took the logs of the normalized cost center CCRs and removed any cost center CCRs where the log of the cost center CCR was greater or less than the mean log plus/minus 3 times the standard deviation for the log of that cost center CCR. Once the cost report data were trimmed, we calculated a Medicare-specific CCR. The Medicare-specific CCR was determined by taking the Medicare charges for each line item from Worksheet D-4 and deriving the Medicare-specific costs by applying the hospital-specific departmental CCRs to the Medicare-specific charges for each line item from Worksheet D-4. Once each hospital's Medicare-specific costs were established, we summed the total Medicare-specific costs and divided by the sum of the total Medicare-specific charges to produce national average, charge-weighted CCRs.

After we multiplied the total charges for each DRG in each of the 15 cost centers by the corresponding national average CCR, we summed the 15 "costs" across each DRG to produce a total standardized cost for the DRG. The average standardized cost for each DRG was then computed as the total standardized cost for the DRG divided by the transfer-adjusted case count for the DRG. The average cost for each DRG was then divided by the national average standardized cost per case to determine the relative weight.

The new cost-based relative weights were then normalized by an adjustment factor of 1.50612 so that the average case weight after recalibration was equal to the average case weight before recalibration. The normalization adjustment is intended to ensure that recalibration by itself neither increases nor decreases total payments under the IPPS, as required by section 1886(d)(4)(C)(iii) of the Act.

The 15 proposed national average CCRs for FY 2009 are as follows:

Group CCR
Routine Days 0.527
Intensive Days 0.476
Drugs 0.205
Supplies Equipment 0.341
Therapy Services 0.419
Laboratory 0.166
Operating Room 0.293
Cardiology 0.186
Radiology 0.171
Emergency Room 0.291
Blood and Blood Products 0.449
Other Services 0.419
Labor Delivery 0.482
Inhalation Therapy 0.198
Anesthesia 0.150

As we explained in section II.E. of the preamble of this proposed rule, we are proposing to complete our 2-year transition to the MS-DRGs. For FY 2008, the first year of the transition, 50 percent of the relative weight for an MS-DRG was based on the two-thirds cost-based weight/one-third charge-based weight calculated using FY 2006 MedPAR data grouped to the Version 24.0 (FY 2007) DRGs. The remaining 50 percent of the FY 2008 relative weight for an MS-DRG was based on the two-thirds cost-based weight/one-third charge-based weight calculated using FY 2006 MedPAR grouped to the Version 25.0 (FY 2008) MS-DRGs. In FY 2009, we are proposing that the relative weights will be based on 100 percent cost weights computed using the Version 26.0 (FY 2009) MS-DRGs.

When we recalibrated the DRG weights for previous years, we set a threshold of 10 cases as the minimum number of cases required to compute a reasonable weight. We are proposing to use that same case threshold in recalibrating the MS-DRG weights for FY 2009. Using the FY 2007 MedPAR data set, there are 8 MS-DRGs that contain fewer than 10 cases. Under the MS-DRGs, we have fewer low-volume DRGs than under the CMS DRGs because we no longer have separate DRGs for patients age 0 to 17 years. With the exception of newborns, we previously separated some DRGs based on whether the patient was age 0 to 17 years or age 17 years and older. Other than the age split, cases grouping to these DRGs are identical. The DRGs for patients age 0 to 17 years generally have very low volumes because children are typically ineligible for Medicare. In the past, we have found that the low volume of cases for the pediatric DRGs could lead to significant year-to-year instability in their relative weights. Although we have always encouraged non-Medicare payers to develop weights applicable to their own patient populations, we have heard frequent complaints from providers about the use of the Medicare relative weights in the pediatric population. We believe that eliminating this age split in the MS-DRGs will provide more stable payment for pediatric cases by determining their payment using adult cases that are much higher in total volume. All of the low-volume MS-DRGs listed below are for newborns. Newborns are unique and require separate DRGs that are not mirrored in the adult population. Therefore, it remains necessary to retain separate DRGs for newborns. In FY 2009, because we do not have sufficient MedPAR data to set accurate and stable cost weights for these low-volume MS-DRGs, we are proposing to compute weights for the low-volume MS-DRGs by adjusting their FY 2008 weights by the percentage change in the average weight of the cases in other MS-DRGs. The crosswalk table is shown below:

Low-volume MS-DRG MS-DRG title Crosswalk to MS-DRG
768 Vaginal Delivery with O.R. Procedure Except Sterilization and/or DC FY 2008 FR weight (adjusted by percent change in average weight of the cases in other MS-DRGs).
789 Neonates, Died or Transferred to Another Acute Care Facility FY 2008 FR weight (adjusted by percent change in average weight of the cases in other MS-DRGs).
790 Extreme Immaturity or Respiratory Distress Syndrome, Neonate FY 2008 FR weight (adjusted by percent change in average weight of the cases in other MS-DRGs).
791 Prematurity with Major Problems FY 2008 FR weight (adjusted by percent change in average weight of the cases in other MS-DRGs).
792 Prematurity without Major Problems FY 2008 FR weight (adjusted by percent change in average weight of the cases in other MS-DRGs).
793 Full-Term Neonate with Major Problems FY 2008 FR weight (adjusted by percent change in average weight of the cases in other MS-DRGs).
794 Neonate with Other Significant Problems FY 2008 FR weight(adjusted by percent change in average weight of the cases in other MS-DRGs).
795 Normal Newborn FY 2008 FR weight (adjusted by percent change in average weight of the cases in other MS-DRGs).

I. Proposed Medicare Severity Long-Term Care (MS-LTC-DRG) Reclassifications and Relative Weights for LTCHs for FY 2009

1. Background

Section 123 of the BBRA requires that the Secretary implement a PPS for LTCHs (that is, a per discharge system with a diagnosis-related group (DRG)-based patient classification system reflecting the differences in patient resources and costs). Section 307(b)(1) of the BIPA modified the requirements of section 123 of the BBRA by requiring that the Secretary examine "the feasibility and the impact of basing payment under such a system [the long-term care hospital (LTCH) PPS] on the use of existing (or refined) hospital DRGs that have been modified to account for different resource use of LTCH patients, as well as the use of the most recently available hospital discharge data."

When the LTCH PPS was implemented for cost reporting periods beginning on or after October 1, 2002, we adopted the same DRG patient classification system (that is, the CMS DRGs) that was utilized at that time under the IPPS. As a component of the LTCH PPS, we refer to the patient classification system as the "long-term care diagnosis-related groups (LTC-DRGs)." As discussed in greater detail below, although the patient classification system used under both the LTCH PPS and the IPPS are the same, the relative weights are different. The established relative weight methodology and data used under the LTCH PPS result in LTC-DRG relative weights that reflect "the differences in patient resource use * * *" of LTCH patients (section 123(a)(1) of the BBRA (Pub. L. 106-113). As part of our efforts to better recognize severity of illness among patients, in the FY 2008 IPPS final rule with comment period (72 FR 47130), the MS-DRGs and the Medicare severity long-term care diagnosis related groups (MS-LTC-DRGs) were adopted for the IPPS and the LTCH PPS, respectively, effective October 1, 2007 (FY 2008). For a full description of the development and implementation of the MS-DRGs and MS-LTC-DRGs, we refer readers to the FY 2008 IPPS final rule with comment period (72 FR 47141 through 47175 and 47277 through 47299). (We note that, in that same final rule, we revised the regulations at § 412.503 to specify that for LTCH discharges occurring on or after October 1, 2007, when applying the provisions of 42 CFR Part 412, Subpart O applicable to LTCHs for policy descriptions and payment calculations, all references to LTC-DRGs would be considered a reference to MS-LTC-DRGs. For the remainder of this section, we present the discussion in terms of the current MS-LTC-DRG patient classification unless specifically referring to the previous LTC-DRG patient classification system (that was in effect before October 1, 2007).) We believe the MS-DRGs (and by extension, the MS-LTC-DRGs) represent a substantial improvement over the previous CMS DRGs in their ability to differentiate cases based on severity of illness and resource consumption.

The MS-DRGs represent an increase in the number of DRGs by 207 (that is, from 538 to 745) (72 FR 47171). In addition to improving the DRG system's recognition of severity of illness, we believe the MS-DRGs are responsive to the public comments that were made on the FY 2007 IPPS proposed rule with respect to how we should undertake further DRG reform. The MS-DRGs use the CMS DRGs as the starting point for revising the DRG system to better recognize resource complexity and severity of illness. We have generally retained all of the refinements and improvements that have been made to the base DRGs over the years that recognize the significant advancements in medical technology and changes to medical practice.

Consistent with section 123 of the BBRA as amended by section 307(b)(1) of the BIPA and § 412.515, we use information derived from LTCH PPS patient records to classify LTCH discharges into distinct MS-LTC-DRGs based on clinical characteristics and estimated resource needs. We then assign an appropriate weight to the MS-LTC-DRGs to account for the difference in resource use by patients exhibiting the case complexity and multiple medical problems characteristic of LTCHs.

Generally, under the LTCH PPS, a Medicare payment is made at a predetermined specific rate for each discharge; and that payment varies by the MS-LTC-DRG to which a beneficiary's stay is assigned. Cases are classified into MS-LTC-DRGs for payment based on the following six data elements:

• Principal diagnosis.

• Up to eight additional diagnoses.

• Up to six procedures performed.

• Age.

• Sex.

• Discharge status of the patient.

Upon the discharge of the patient from a LTCH, the LTCH must assign appropriate diagnosis and procedure codes from the most current version of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). HIPAA Transactions and Code Sets Standards regulations at 45 CFR Parts 160 and 162 require that no later than October 16, 2003, all covered entities must comply with the applicable requirements of Subparts A and I through R of Part 162. Among other requirements, those provisions direct covered entities to use the ASC X12N 837 Health Care Claim: Institutional, Volumes 1 and 2, Version 4010, and the applicable standard medical data code sets for the institutional health care claim or equivalent encounter information transaction (see 45 CFR 162.1002 and 45 CFR 162.1102). For additional information on the ICD-9-CM Coding System, we refer readers to the FY 2008 IPPS final rule with comment period (72 FR 47241 through 47243 and 47277 through 47281). We also refer readers to the detailed discussion on correct coding practices in the August 30, 2002 LTCH PPS final rule (67 FR 55981 through 55983). Additional coding instructions and examples are published in the Coding Clinic for ICD-9-CM , a product of the American Hospital Association.

Medicare contractors (that is, fiscal intermediaries or MACs) enter the clinical and demographic information into their claims processing systems and subject this information to a series of automated screening processes called the Medicare Code Editor (MCE). These screens are designed to identify cases that require further review before assignment into a MS-LTC-DRG can be made. During this process, the following types of cases are selected for further development:

• Cases that are improperly coded. (For example, diagnoses are shown that are inappropriate, given the sex of the patient. Code 68.69 (Other and unspecified radical abdominal hysterectomy) would be an inappropriate code for a male.)

• Cases including surgical procedures not covered under Medicare. (For example, organ transplant in a nonapproved transplant center.)

• Cases requiring more information. (For example, ICD-9-CM codes are required to be entered at their highest level of specificity. There are valid 3-digit, 4-digit, and 5-digit codes. That is, code 262 (Other severe protein-calorie malnutrition) contains all appropriate digits, but if it is reported with either fewer or more than 3 digits, the claim will be rejected by the MCE as invalid.)

After screening through the MCE, each claim is classified into the appropriate MS-LTC-DRG by the Medicare LTCH GROUPER software. The Medicare GROUPER software, which is used under the LTCH PPS, is specialized computer software, and is the same GROUPER software program used under the IPPS. The GROUPER software was developed as a means of classifying each case into a MS-LTC-DRG on the basis of diagnosis and procedure codes and other demographic information (age, sex, and discharge status). Following the MS-LTC-DRG assignment, the Medicare contractor determines the prospective payment amount by using the Medicare PRICER program, which accounts for hospital-specific adjustments. Under the LTCH PPS, we provide an opportunity for the LTCH to review the MS-LTC-DRG assignments made by the Medicare contractor and to submit additional information within a specified timeframe as specified in § 412.513(c).

The GROUPER software is used both to classify past cases to measure relative hospital resource consumption to establish the DRG weights and to classify current cases for purposes of determining payment. The records for all Medicare hospital inpatient discharges are maintained in the MedPAR file. The data in this file are used to evaluate possible MS-DRG classification changes and to recalibrate the MS-DRG and MS-LTC-DRG relative weights during our annual update under both the IPPS (§ 412.60(e)) and the LTCH PPS (§ 412.517), respectively.

In the June 6, 2003 LTCH PPS final rule (68 FR 34122), we changed the LTCH PPS annual payment rate update cycle to be effective July 1 through June 30 instead of October 1 through September 30. In addition, because the patient classification system utilized under the LTCH PPS uses the same DRGs as those used under the IPPS for acute care hospitals, in that same final rule, we explained that the annual update of the LTC-DRG classifications and relative weights will continue to remain linked to the annual reclassification and recalibration of the DRGs used under the IPPS. Therefore, we specified that we will continue to update the LTC-DRG classifications and relative weights to be effective for discharges occurring on or after October 1 through September 30 each year. We further stated that we will publish the annual proposed and final update of the LTC-DRGs in same notice as the proposed and final update for the IPPS (69 FR 34125).

In the RY 2009 LTCH PPS proposed rule (73 FR 5351-5352), due to administrative considerations as well as in response to numerous comments urging CMS to establish one rulemaking cycle that would encompass the update of the LTCH PPS payment rates (currently updated on a rate year basis, effective July 1) as well as the development of the LTC-DRG weights (currently updated on a fiscal year basis, effective October 1), we proposed to amend the regulations at § 412.535 in order to consolidate the rate year and fiscal year rulemaking cycles. Specifically, we proposed that the annual update of the LTCH PPS payment rates (and description of the methodology and data used to calculate these payment rates) and the annual update of the MS-LTC-DRG classifications and associated weighting factors for LTCHs would be effective on October 1 each Federal fiscal year. In order to revise the payment rate update (currently on a rate year cycle of July 1 through June 30) to an October 1 through September 30 cycle, we proposed to extend the 2009 rate period to September 30, 2009, so that RY 2009 would be 15 months. This proposed 15-month rate period would extend from July 1, 2008, through September 30, 2009. We believe that extending RY 2009 by 3 months (July, August, and September) would provide for a smooth transition to a consolidated annual update for both the LTCH PPS payment rates and the LTCH PPS MS-LTC-DRG classifications and weighting factors. (We believe that proposing to shorten the 2009 rate year period to an October 1 through September 30 period so that RY 2009 would only be 3 months (that is, July 1, 2008 through September 30, 2008) would exacerbate the current time-consuming, biannual update process by resulting in two payment rate changes within a very short period of time.) Consequently, under the proposal to extend RY 2009 to a 15-month rate period, after September 30, 2009, when the RY 2009 cycle ends, the LTCH PPS payment rates and other policy changes would subsequently be updated on an October 1 through September 30 cycle in conjunction with the annual update to the MS-LTC-DRG classifications and relative weights. Accordingly, the next update to the LTCH PPS payment rates, after the proposed 15-month RY 2009, would begin October 1, 2009, coinciding with the 2010 Federal fiscal year.

In the past, the annual update to the DRGs used under the IPPS has been based on the annual revisions to the ICD-9-CM codes and was effective each October 1. As discussed in the RY 2009 LTCH PPS proposed rule (73 FR 5348-5349), with the implementation of section 503(a) of Pub. L. 108-173, there is the possibility that one feature of the GROUPER software program may be updated twice during a Federal fiscal year (October 1 and April 1) as required by the statute for the IPPS. Section 503(a) of Pub. L. 108-173 amended section 1886(d)(5)(K) of the Act by adding a new clause (vii) which states that "the Secretary shall provide for the addition of new diagnosis and procedure codes in [sic] April 1 of each year, but the addition of such codes shall not require the Secretary to adjust the payment (or diagnosis-related group classification) * * * until the fiscal year that begins after such date." This requirement improves the recognition of new technologies under the IPPS by accounting for those ICD-9-CM codes in the MedPAR claims data earlier than the agency had accounted for new technology in the past. In implementing the statutory change, the agency has provided that ICD-9-CM diagnosis and procedure codes for new medical technology may be created and assigned to existing DRGs in the middle of the Federal fiscal year, on April 1. However, this policy change will not impact the DRG relative weights in effect for that year, which will continue to be updated only once a year (October 1). The use of the ICD-9-CM code set is also compliant with the current requirements of the Transactions and Code Sets Standards regulations at 45 CFR Parts 160 and 162, promulgated in accordance with HIPAA.

As noted above, the patient classification system used under the LTCH PPS is the same patient classification system that is used under the IPPS. Therefore, the ICD-9-CM codes currently used under both the IPPS and the LTCH PPS have the potential of being updated twice a year. This requirement is included as part of the amendments to the Act relating to recognition of new medical technology under the IPPS.

Because we do not publish a midyear IPPS rule, any April 1 ICD-9-CM coding update will not be published in the Federal Register . Rather, we will assign any new diagnosis or procedure codes to the same DRG in which its predecessor code was assigned, so that there will be no impact on the DRG assignments (as also discussed in section II.G.11. of the preamble of this proposed rule). Any coding updates will be available through the Web sites provided in section II.G.11. of the preamble of this proposed rule and through the Coding Clinic for ICD-9-CM . Publishers and software vendors currently obtain code changes through these sources in order to update their code books and software system. If new codes are implemented on April 1, revised code books and software systems, including the GROUPER software program, will be necessary because the most current ICD-9-CM codes must be reported. Therefore, for purposes of the LTCH PPS, because each ICD-9-CM code must be included in the GROUPER algorithm to classify each case under the correct LTCH PPS, the GROUPER software program used under the LTCH PPS would need to be revised to accommodate any new codes.

In implementing section 503(a) of Pub. L. 108-173, there will only be an April 1 update if new technology diagnosis and procedure code revisions are requested and approved. We note that any new codes created for April 1 implementation will be limited to those primarily needed to describe new technologies and medical services. However, we reiterate that the process of discussing updates to the ICD-9-CM is an open process through the ICD-9-CM Coordination and Maintenance Committee. Requestors will be given the opportunity to present the merits for a new code and to make a clear and convincing case for the need to update ICD-9-CM codes for purposes of the IPPS new technology add-on payment process through an April 1 update (as also discussed in section II.G.11. of the preamble of this proposed rule).

At the September 27, 2007 ICD-9-CM Coordination and Maintenance Committee meeting, there were no requests for an April 1, 2008 implementation of ICD-9-CM codes. Therefore, the next update to the ICD-9-CM coding system will occur on October 1, 2008 (FY 2009). Because there were no coding changes suggested for an April 1, 2008 update, the ICD-9-CM coding set implemented on October 1, 2008, will continue through September 30, 2009 (FY 2009). The update to the ICD-9-CM coding system for FY 2009 is discussed in section II.G.11. of the preamble of this proposed rule. Accordingly, in this proposed rule, as discussed in greater detail below, we are proposing to modify and revise the MS-LTC-DRG classifications and relative weights to be effective October 1, 2008 through September 30, 2009 (FY 2009). As discussed in greater detail below, the MS-LTC-DRGs for FY 2009 in this proposed rule are the same as the MS-DRGs proposed for the IPPS for FY 2009 (GROUPER Version 26.0) discussed in section II.B. of the preamble to this proposed rule.

2. Proposed Changes in the MS-LTC-DRG Classifications

a. Background

As discussed earlier, section 123 of Pub. L. 106-113 specifically requires that the agency implement a PPS for LTCHs that is a per discharge system with a DRG-based patient classification system reflecting the differences in patient resources and costs in LTCHs. Section 307(b)(1) of Pub. L. 106-554 modified the requirements of section 123 of Pub. L. 106-113 by specifically requiring that the Secretary examine "the feasibility and the impact of basing payment under such a system [the LTCH PPS] on the use of existing (or refined) hospital diagnosis-related groups (DRGs) that have been modified to account for different resource use of long-term care hospital patients as well as the use of the most recently available hospital discharge data."

Consistent with section 123 of Pub. L. 106-113 as amended by section 307(b)(1) of Pub. L. 106-554 and § 412.515 of our existing regulations, the LTCH PPS uses information from LTCH patient records to classify patient cases into distinct LTC-DRGs based on clinical characteristics and expected resource needs. As described in section II.D. of the preamble of this proposed rule, for FY 2008, we adopted MS-DRGs under the IPPS because we believe that this system results in a significant improvement in the DRG system's recognition of severity of illness and resource usage. We stated that we believe these improvements in the DRG system are equally applicable to the LTCH PPS. The changes we are proposing to make for the FY 2009 IPPS are reflected in the proposed FY 2009 GROUPER, Version 26.0, that would be effective for discharges occurring on or after October 1, 2008 through September 30, 2009.

Consistent with our historical practice of having LTC-DRGs correspond to the DRGs applicable under the IPPS, under the broad authority of section 123(a) of Pub. L. 106-113, as modified by section 307(b) of Pub. L. 106-554, under the LTCH PPS for FY 2008, we adopted the use of MS-LTC-DRGs, which correspond to the MS-DRGs we adopted under the IPPS. In addition, as stated above, we are proposing to use the FY 2009 GROUPER Version 26.0 to classify cases effective for LTCH discharges occurring on or after October 1, 2008, through September 30, 2009. The changes to the MS-DRG classification system that we are proposing to use under the IPPS for FY 2009 (GROUPER Version 26.0) are discussed in section II.B. of the preamble to this proposed rule.

Under the LTCH PPS, as described in greater detail below, we determine relative weights for each of the MS-LTC-DRGs to account for the difference in resource use by patients exhibiting the case complexity and multiple medical problems characteristic of LTCH patients. (Unless otherwise noted in this proposed rule, our MS-LTC-DRG analysis is based on LTCH data from the December 2007 update of the FY 2007 MedPAR file, which contains hospital bills received through December 31, 2007, for discharges occurring in FY 2007.)

LTCHs do not typically treat the full range of diagnoses as do acute care hospitals. Therefore, as we discussed in the August 30, 2002 LTCH PPS final rule (67 FR 55985), which implemented the LTCH PPS, and the FY 2008 IPPS final rule with comment period (72 FR 47283), we use low-volume quintiles in determining the DRG relative weights for DRGs with less than 25 LTCH cases (low-volume MS-LTC-DRGs). Specifically, we group those low-volume DRGs into 5 quintiles based on average charges per discharge. (A listing of the composition of low-volume quintiles for the FY 2008 MS-LTC-DRGs (based on FY 2006 MedPAR data) appears in section II.I.3. of the FY 2008 IPPS final rule with comment period (72 FR 47281 through 47288).) We also adjust for cases in which the stay at the LTCH is less than or equal to five-sixths of the geometric average length of stay; that is, short-stay outlier cases, as discussed below in section II.I.4. of the preamble of this proposed rule.

b. Patient Classifications Into MS-LTC-DRGs

Generally, under the LTCH PPS, Medicare payment is made at a predetermined specific rate for each discharge; that is, payment varies by the DRG to which a beneficiary's stay is assigned. Just as cases have been classified into the MS-DRGs for acute care hospitals under the IPPS (section II.B. of the preamble of this proposed rule), cases have been classified into MS-LTC-DRGs for payment under the LTCH PPS based on the principal diagnosis, up to eight additional diagnoses, and up to six procedures performed during the stay, as well as demographic information about the patient. The diagnosis and procedure information is reported by the hospital using the ICD-9-CM coding system. Under the MS-DRGs for the IPPS and the MS-LTC-DRGs for the LTCH PPS, these factors will not change.

Section II.B. of the preamble of this proposed rule discusses the organization of the existing MS-DRGs, which we are maintaining under the MS-LTC-DRG system. As noted above, the patient classification system for the LTCH PPS is derived from the IPPS DRGs and is similarly organized into 25 major diagnostic categories (MDCs). Most of these MDCs are based on a particular organ system of the body and the remainder involves multiple organ systems (such as MDC 22, Burns). Accordingly, the principal diagnosis determines MDC assignment. Within most MDCs, cases are then divided into surgical DRGs and medical DRGs. Under the MS-DRGs, some surgical and medical DRGs are further defined for severity purposes based on the presence or absence of MCCs or CCs. The existing MS-LTC-DRGs are similarly categorized. (We refer readers to section II.B. of the preamble of this proposed rule for further discussion of surgical DRGs and medical DRGs.)

Therefore, consistent with the MS-DRGs, a base MS-LTC-DRG may be subdivided according to three alternatives. The first alternative includes division of the DRG into one, two, or three severity levels. The most severe level has cases with at least one code that is a major CC, referred to as "with MCC". The next lower severity level contains cases with at least one CC, referred to as "with CC". Those DRGs without an MCC or a CC are referred to as "without CC/MCC". When data do not support the creation of three severity levels, the base DRG is divided into either two levels or the base is not subdivided.

The two-level subdivisions consist of one of the following subdivisions: "with CC/MCC" or "without CC/MCC." In this type of subdivision, cases with at least one code that is on the CC or MCC list are assigned to the " CC/MCC" DRG. Cases without a CC or an MCC are assigned to the "without CC/MCC" DRG.

The other type of two-level subdivision is as follows: "with MCC" and "without MCC." In this type of subdivision, cases with at least one code that is on the MCC list are assigned to the "with MCC" DRG. Cases that do not have an MCC are assigned to the "without MCC" DRG. This type of subdivision could include cases with a CC code, but no MCC.

3. Development of the Proposed FY 2009 MS-LTC-DRG Relative Weights

a. General Overview of Development of the MS-LTC-DRG Relative Weights

As we stated in the August 30, 2002 LTCH PPS final rule (67 FR 55981), one of the primary goals for the implementation of the LTCH PPS is to pay each LTCH an appropriate amount for the efficient delivery of medical care to Medicare patients. The system must be able to account adequately for each LTCH's case-mix in order to ensure both fair distribution of Medicare payments and access to adequate care for those Medicare patients whose care is more costly. To accomplish these goals, we have annually adjusted the LTCH PPS standard Federal prospective payment system rate by the applicable relative weight in determining payment to LTCHs for each case. (As we have noted above, in last year's final rule, we adopted the MS-LTC-DRGs for the LTCH PPS beginning in FY 2008. However, this change in the patient classification system does not affect the basic principles of the development of relative weights under a DRG-based prospective payment system.

Although the adoption of the MS-LTC-DRGs resulted in some modifications of existing procedures for assigning weights in cases of zero volume and/or nonmonotonicity, as discussed in the FY 2008 IPPS final rule with comment period (72 FR 47289 through 47295) and discussed in detail in the following sections, the basic methodology for developing the proposed FY 2009 MS-LTC-DRG relative weights in this proposed rule continue to be determined in accordance with the general methodology established in the August 30, 2002 LTCH PPS final rule (67 FR 55989 through 55991). Under the LTCH PPS, relative weights for each MS-LTC-DRG are a primary element used to account for the variations in cost per discharge and resource utilization among the payment groups (§ 412.515). To ensure that Medicare patients classified to each MS-LTC-DRG have access to an appropriate level of services and to encourage efficiency, we calculate a relative weight for each MS-LTC-DRG that represents the resources needed by an average inpatient LTCH case in that MS-LTC-DRG. For example, cases in an MS-LTC-DRG with a relative weight of 2 will, on average, cost twice as much to treat as cases in an MS-LTC-DRG with a weight of 1.

b. Data

To calculate the proposed MS-LTC-DRG relative weights for FY 2009, we obtained total Medicare allowable charges from FY 2007 Medicare LTCH bill data from the December 2007 update of the MedPAR file, which are the best available data at this time, and we used the proposed Version 26.0 of the CMS GROUPER that is also proposed for use under the IPPS to classify cases for FY 2009. We also are proposing that if more recent data are available, we will use those data and the finalized Version 26.0 of the CMS GROUPER in establishing the FY 2009 MS-LTC-DRG relative weights in the final rule.

Consistent with our historical methodology, we have excluded the data from LTCHs that are all-inclusive rate providers and LTCHs that are reimbursed in accordance with demonstration projects authorized under section 402(a) of Pub. L. 90-248 or section 222(a) of Pub. L. 92-603 (We refer readers to the FY 2008 IPPS final rule with comment period (72 FR 47282)). Therefore, in the development of the proposed FY 2009 MS-LTC-DRG relative weights in this proposed rule, we have excluded the data of the 17 all-inclusive rate providers and the 2 LTCHs that are paid in accordance with demonstration projects that had claims in the FY 2007 MedPAR file.

c. Hospital-Specific Relative Value (HSRV) Methodology

By nature, LTCHs often specialize in certain areas, such as ventilator-dependent patients and rehabilitation and wound care. Some case types (DRGs) may be treated, to a large extent, in hospitals that have, from a perspective of charges, relatively high (or low) charges. This nonarbitrary distribution of cases with relatively high (or low) charges in specific MS-LTC-DRGs has the potential to inappropriately distort the measure of average charges. To account for the fact that cases may not be randomly distributed across LTCHs, we are proposing to use a hospital-specific relative value (HSRV) methodology to calculate the MS-LTC-DRG relative weights instead of the methodology used to determine the MS-DRG relative weights under the IPPS described in section II.H. of the preamble of this proposed rule. We believe this method will remove this hospital-specific source of bias in measuring LTCH average charges. Specifically, we are proposing to reduce the impact of the variation in charges across providers on any particular MS-LTC-DRG relative weight by converting each LTCH's charge for a case to a relative value based on that LTCH's average charge.

Under the HSRV methodology, we standardize charges for each LTCH by converting its charges for each case to hospital-specific relative charge values and then adjusting those values for the LTCH's case-mix. The adjustment for case-mix is needed to rescale the hospital-specific relative charge values (which, by definition, average 1.0 for each LTCH). The average relative weight for a LTCH is its case-mix, so it is reasonable to scale each LTCH's average relative charge value by its case-mix. In this way, each LTCH's relative charge value is adjusted by its case-mix to an average that reflects the complexity of the cases it treats relative to the complexity of the cases treated by all other LTCHs (the average case-mix of all LTCHs).

In accordance with the methodology established in the August 30, 2002 LTCH PPS final rule (67 FR 55989 through 55991), we continue to standardize charges for each case by first dividing the adjusted charge for the case (adjusted for short-stay outliers under § 412.529 as described in section II.I.4. (step 3) of the preamble of this proposed rule) by the average adjusted charge for all cases at the LTCH in which the case was treated. Short-stay outliers are cases with a length of stay that is less than or equal to five-sixths the average length of stay of the MS-LTC-DRG (§ 412.529 and § 412.503). The average adjusted charge reflects the average intensity of the health care services delivered by a particular LTCH and the average cost level of that LTCH. The resulting ratio is multiplied by that LTCH's case-mix index to determine the standardized charge for the case.

Multiplying by the LTCH's case-mix index accounts for the fact that the same relative charges are given greater weight at a LTCH with higher average costs than they would at a LTCH with low average costs, which is needed to adjust each LTCH's relative charge value to reflect its case-mix relative to the average case-mix for all LTCHs. Because we standardize charges in this manner, we count charges for a Medicare patient at a LTCH with high average charges as less resource intensive than they would be at a LTCH with low average charges. For example, a $10,000 charge for a case at a LTCH with an average adjusted charge of $17,500 reflects a higher level of relative resource use than a $10,000 charge for a case at a LTCH with the same case-mix, but an average adjusted charge of $35,000. We believe that the adjusted charge of an individual case more accurately reflects actual resource use for an individual LTCH because the variation in charges due to systematic differences in the markup of charges among LTCHs is taken into account.

d. Treatment of Severity Levels in Developing Proposed Relative Weights

Under the proposed MS-LTC-DRGs, for purposes of the proposed setting of the relative weights, there would be three different categories of DRGs based on volume of cases within specific MS-LTC-DRGs. MS-LTC-DRGs with at least 25 cases are each assigned a unique relative weight; low-volume MS-LTC-DRGs (that is, MS-LTC-DRGs that contain between one and 24 cases annually) are grouped into quintiles (described below) and assigned the weight of the quintile. No-volume MS-LTC-DRGs (that is, no cases in the database were assigned to those MS-LTC-DRGs) are crosswalked to other MS-LTC-DRGs based on the clinical similarities and assigned the relative weight of the crosswalked MS-LTC-DRG. (We provide in-depth discussions of our proposed policy regarding weight setting for low-volume MS-LTC-DRGs in section II.I.3.e. of the preamble of this proposed rule and for no-volume MS-LTC-DRGs, under Step 5 in section II.I.4. of the preamble of this proposed rule.)

As described above, in response to the need to account for severity and pay appropriately for cases, we developed a severity-adjusted patient classification system which we adopted for both the IPPS and the LTCH PPS in FY 2008. As described in greater detail above, the MS-LTC-DRG system can accommodate three severity levels: "with MCC" (most severe); "with CC," and "without CC/MCC" (the least severe) with each level assigned an individual MS-LTC-DRG number. In cases with two subdivisions, the levels are either "with CC/MCC" and "without CC/MCC" or "with MCC" and "without MCC". For example, under the MS-LTC-DRG system, multiple sclerosis and cerebellar ataxia with MCC is MS-LTC-DRG 58; multiple sclerosis and cerebellar ataxia with CC is MS-LTC-DRG 59; and multiple sclerosis and cerebellar ataxia without CC/MCC is MS-LTC-DRG 60. For purposes of discussion in this section, the term "base DRG" is used to refer to the DRG category that encompasses all levels of severity for that DRG. For example, when referring to the entire DRG category for multiple sclerosis and cerebellar ataxia, which includes the above three severity levels, we would use the term "base-DRG."

As noted above, while the LTCH PPS and the IPPS use the same patient classification system, the methodology that is used to set the DRG weights for use in each payment system differs because the overall volume of cases in the LTCH PPS is much less than in the IPPS. As a general rule, consistent with the methodology we used when we adopted the MS-LTC-DRGs in the FY 2008 IPPS final rule with comment period (72 FR 47278 through 47281), we are proposing to determine the FY 2009 relative weights for the MS-LTC-DRGs using the following steps: (1) if an MS-LTC-DRG has at least 25 cases, it is assigned its own relative weight; (2) if an MS-LTC-DRG has between 1 and 24 cases, it is assigned to a quintile for which we will compute a relative weight; and (3) if an MS-LTC-DRG has no cases, it is crosswalked to another MS-LTC-DRG based upon clinical similarities to assign an appropriate relative weight (as described below in detail in Step 5 of the Steps for Determining the proposed FY 2009 MS-LTC-DRG Relative Weights). Furthermore, in determining the proposed FY 2009 MS-LTC-DRG relative weights, when necessary, we are proposing to make adjustments to account for nonmonotonicity, as explained below.

Theoretically, cases under the MS-LTC-DRG system that are more severe require greater expenditure of medical care resources and will result in higher average charges. Therefore, in the three severity levels, weights should increase with severity, from lowest to highest. If the weights do not increase (that is, if based on the relative weight methodology outlined above, the MS-LTC-DRG with MCC would have a lower relative weight than one with CC, or the MS-LTC-DRG without CC/MCC would have a higher relative weight than either of the others), there is a problem with monotonicity. Since the start of the LTCH PPS for FY 2003 (67 FR 55990), we have adjusted the setting of the LTC-DRG relative weights in order to maintain monotonicity by grouping both sets of cases together and establishing a new relative weight for both LTC-DRGs. We continue to believe that utilizing nonmonotonic relative weights to adjust Medicare payments would result in inappropriate payments because, in a nonmonotonic system, cases that are more severe and require greater expenditure of medical care resources would be paid based on a lower relative weight than cases that are less severe and require lower resource use. The procedure for dealing with nonmonotonicity under the MS-LTC-DRG classification system is discussed in greater detail below in section II.I.4. (Step 6) of the preamble of this proposed rule.

e. Proposed Low-Volume MS-LTC-DRGs

In order to account for MS-LTC-DRGs with low volume (that is, with fewer than 25 LTCH cases), consistent with the methodology we established when we implemented the LTCH PPS (August 30, 2002; 67 FR 55984 through 55995), we group those "low-volume MS-LTC-DRGs" (that is, MS-LTC-DRGs that contained between 1 and 24 cases annually) into one of five categories (quintiles) based on average charges, for the purposes of determining relative weights (72 FR 47283 through 47288). In determining the proposed FY 2009 MS-LTC-DRG relative weights in this proposed rule, we are proposing to continue to employ this quintile methodology for proposed low-volume MS-LTC-DRGs. In addition, in cases where the initial assignment of a low-volume MS-LTC-DRG to quintiles results in nonmonotonicity within a base DRG, in order to ensure appropriate Medicare payments, consistent with our historical methodology, we are proposing to make adjustments to the treatment of low-volume MS-LTC-DRGs to preserve monotonicity, as discussed in detail below in section II.I.4 (Step 6 of the methodology for determining the proposed FY 2009 MS-LTC-DRG relative weights). In this proposed rule, using LTCH cases from the December 2007 update of the FY 2007 MedPAR file, we identified 290 MS-LTC-DRGs that contained between 1 and 24 cases. This list of proposed MS-LTC-DRGs was then divided into one of the proposed 5 low-volume quintiles, each containing 58 MS-LTC-DRGs (290/5 = 58). We are proposing to make the assignment of a low-volume MS-LTC-DRG to a specific low-volume quintile by sorting the proposed low-volume MS-LTC-DRGs in ascending order by average charge in accordance with our established methodology. Specifically, for this proposed rule, the 290 proposed low-volume MS-LTC-DRGs are sorted by ascending order by average charge and assigned to a specific proposed low-volume quintile (as described below). After sorting the 290 proposed low-volume MS-LTC-DRGs by average charge in ascending order, we are proposing to group the first fifth (1st through 58th) of proposed low-volume MS-LTC-DRGs (with the lowest average charge) into Quintile 1. This process is repeated through the remaining proposed low-volume MS-LTC-DRGs so that each of the 5 proposed low-volume quintiles contains 58 proposed MS-LTC-DRGs. The highest average charge cases would be grouped into Quintile 5. (We note that, consistent with our historical methodology, if the number of proposed low-volume MS-LTC-DRGs had not been evenly divisible by 5, we would have used the average charge of the proposed low-volume MS-LTC-DRG to determine which proposed low-volume quintile would have received the additional proposed low-volume MS-LTC-DRG.)

Accordingly, in order to determine the proposed relative weights for the proposed MS-LTC-DRGs with low-volume for FY 2009, we are proposing to use the five low-volume quintiles described above. The composition of each of the proposed five low-volume quintiles shown in the chart below was used in determining the proposed MS-LTC-DRG relative weights for FY 2009 (Table 11 of the Addendum of this proposed rule). We would determine a proposed relative weight and (geometric) average length of stay for each of the proposed five low-volume quintiles using the methodology that we are proposing to apply to the regular MS-LTC-DRGs (25 or more cases), as described in section II.I.4. of the preamble of this proposed rule. We are proposing to assign the same relative weight and average length of stay to each of the proposed low-volume MS-LTC-DRGs that make up an individual low-volume quintile. We note that, as this system is dynamic, it is possible that the number and specific type of MS-LTC-DRGs with a low volume of LTCH cases will vary in the future. We use the best available claims data in the MedPAR file to identify low-volume MS-LTC-DRGs and to calculate the relative weights based on our methodology.

Proposed MS-LTC-DRG (version 26.0) Proposed MS-LTC-DRG description (version 26.0)
PROPOSED QUINTILE 1
66 Intracranial hemorrhage or cerebral infarction w/o CC/MCC.
67 Nonspecific cva precerebral occlusion w/o infarct w MCC.
68 Nonspecific cva precerebral occlusion w/o infarct w/o MCC.
69 Transient ischemia.
72 Nonspecific cerebrovascular disorders w/o CC/MCC.
79 Hypertensive encephalopathy w/o CC/MCC.
87 Traumatic stupor coma, coma 1 hr w/o CC/MCC.
89 Concussion w CC.
125 Other disorders of the eye w/o MCC.
135 Sinus mastoid procedures w CC/MCC.
136 Sinus mastoid procedures w/o CC/MCC.**
148 Ear, nose, mouth throat malignancy w/o CC/MCC.
149 Dysequilibrium.
159 Dental Oral Diseases w/o CC/MCC.
183 Major chest trauma w MCC.
184 Major chest trauma w CC.
185 Major chest trauma w/o CC/MCC.
201 Pneumothorax w/o CC/MCC.
257 Upper limb toe amputation for circ system disorders w/o CC/MCC.
261 Cardiac pacemaker revision except device replacement w CC.***
263 Vein ligation stripping.
304 Hypertension w MCC.
305 Hypertension w/o MCC.
311 Angina pectoris.
313 Chest pain.
382 Complicated peptic ulcer w/o CC/MCC.
387 Inflammatory bowel disease w/o CC/MCC.
437 Malignancy of hepatobiliary system or pancreas w/o CC/MCC.
443 Disorders of liver except malig, cirr, alc hepa w/o CC/MCC.
468 Revision of hip or knee replacement w/o CC/MCC.
510 Shoulder, elbow or forearm proc, exc major joint proc w MCC.***
537 Sprains, strains, dislocations of hip, pelvis thigh w CC/MCC.
544 Pathological fractures musculoskelet conn tiss malig w/o CC/MCC.
547 Connective tissue disorders w/o CC/MCC.
556 Signs symptoms of musculoskeletal system conn tissue w/o MCC.
563 Fx, sprn, strn disl except femur, hip, pelvis thigh w/o MCC.
601 Non-malignant breast disorders w/o CC/MCC.
618 Amputat of lower limb for endocrine, nutrit, metabol dis w/o CC/MCC.
642 Inborn errors of metabolism
645 Endocrine disorders w/o CC/MCC.
694 Urinary stones w/o esw lithotripsy w/o MCC.
723 Malignancy, male reproductive system w CC.
726 Benign prostatic hypertrophy w/o MCC.
730 Other male reproductive system diagnoses w/o CC/MCC.
756 Malignancy, female reproductive system w/o CC/MCC.
781 Other antepartum diagnoses w medical complications.
810 Major hematol/immun diag exc sickle cell crisis coagul w/o CC/MCC.
816 Reticuloendothelial immunity disorders w/o CC/MCC.
864 Fever of unknown origin.
869 Other infectious parasitic diseases diagnoses w/o CC/MCC.
880 Acute adjustment reaction psychosocial dysfunction.
882 Neuroses except depressive.
886 Behavioral developmental disorders.
895 Alcohol/drug abuse or dependence w rehabilitation therapy.
897 Alcohol/drug abuse or dependence w/o rehabilitation therapy w/o MCC.
917 Poisoning toxic effects of drugs w MCC.
918 Poisoning toxic effects of drugs w/o MCC.
958 Other O.R. procedures for multiple significant trauma w CC.
965 Other multiple significant trauma w/o CC/MCC.
PROPOSED QUINTILE 2
59 Multiple sclerosis cerebellar ataxia w CC.
60 Multiple sclerosis cerebellar ataxia w/o CC/MCC.
75 Viral meningitis w CC/MCC.
78 Hypertensive encephalopathy w CC.
83 Traumatic stupor coma, coma 1 hr w CC.
84 Traumatic stupor coma, coma 1 hr w/o CC/MCC.
99 Non-bacterial infect of nervous sys exc viral meningitis w/o CC/MCC.
102 Headaches w MCC.
103 Headaches w/o MCC.
121 Acute major eye infections w CC/MCC.
122 Acute major eye infections w/o CC/MCC.
124 Other disorders of the eye w MCC.
153 Otitis media URI w/o MCC.
156 Nasal trauma deformity w/o CC/MCC.
157 Dental Oral Diseases w MCC.
158 Dental Oral Diseases w CC.
182 Respiratory neoplasms w/o CC/MCC.*
188 Pleural effusion w/o CC/MCC.*
203 Bronchitis asthma w/o CC/MCC.
254 Other vascular procedures w/o CC/MCC.
294 Deep vein thrombophlebitis w CC/MCC.
354 Hernia procedures except inguinal femoral w CC.
376 Digestive malignancy w/o CC/MCC.
379 G.I. hemorrhage w/o CC/MCC.
381 Complicated peptic ulcer w CC.
390 G.I. obstruction w/o CC/MCC.
409 Biliary tract proc except only cholecyst w or w/o c.d.e. w CC.
433 Cirrhosis alcoholic hepatitis w CC.
440 Disorders of pancreas except malignancy w/o CC/MCC.
446 Disorders of the biliary tract w/o CC/MCC.*
489 Knee procedures w/o pdx of infection w/o CC/MCC.
533 Fractures of femur w MCC.
534 Fractures of femur w/o MCC.
553 Bone diseases arthropathies w MCC.
578 Skin graft /or debrid exc for skin ulcer or cellulitis w/o CC/MCC.
584 Breast biopsy, local excision other breast procedures w CC/MCC.
624 Skin grafts wound debrid for endoc, nutrit metab dis w/o CC/MCC.
661 Kidney ureter procedures for non-neoplasm w/o CC/MCC.
663 Minor bladder procedures w CC.
665 Prostatectomy w MCC.***
669 Transurethral procedures w CC.
671 Urethral procedures w CC/MCC.
688 Kidney urinary tract neoplasms w/o CC/MCC.
696 Kidney urinary tract signs symptoms w/o MCC.
722 Malignancy, male reproductive system w MCC.
759 Infections, female reproductive system w/o CC/MCC.*
815 Reticuloendothelial immunity disorders w CC.
835 Acute leukemia w/o major O.R. procedure w CC.***
842 Lymphoma non-acute leukemia w/o CC/MCC.
844 Other myeloprolif dis or poorly diff neopl diag w CC.
845 Other myeloprolif dis or poorly diff neopl diag w/o CC/MCC.
866 Viral illness w/o MCC.
876 O.R. procedure w principal diagnoses of mental illness.
881 Depressive neuroses
923 Other injury, poisoning toxic effect diag w/o MCC.
929 Full thickness burn w skin graft or inhal inj w/o CC/MCC.
964 Other multiple significant trauma w CC.
976 HIV w major related condition w/o CC/MCC.
PROPOSED QUINTILE 3
23 Craniotomy w major device implant or acute complex CNS PDX w MCC.***
27 Craniotomy endovascular intracranial procedures w/o CC/MCC.
53 Spinal disorders injuries w/o CC/MCC.
58 Multiple sclerosis cerebellar ataxia w MCC.
82 Traumatic stupor coma, coma 1 hr w MCC.
98 Non-bacterial infect of nervous sys exc viral meningitis w CC.
113 Orbital procedures w CC/MCC.
116 Intraocular procedures w CC/MCC.
136 Sinus mastoid procedures w/o CC/MCC.***
152 Otitis media URI w MCC.
165 Major chest procedures w/o CC/MCC.
168 Other resp system O.R. procedures w/o CC/MCC.
238 Major cardiovascular procedures w/o MCC.
241 Amputation for circ sys disorders exc upper limb toe w/o CC/MCC.
261 Cardiac pacemaker revision except device replacement w CC.**
262 Cardiac pacemaker revision except device replacement w/o CC/MCC.**
284 Circulatory disorders w AMI, expired w CC.*
287 Circulatory disorders except AMI, w card cath w/o MCC.
369 Major esophageal disorders w CC.
370 Major esophageal disorders w/o CC/MCC.
380 Complicated peptic ulcer w MCC.
384 Uncomplicated peptic ulcer w/o MCC.
424 Other hepatobiliary or pancreas O.R. procedures w CC.
471 Cervical spinal fusion w MCC.
472 Cervical spinal fusion w CC.
476 Amputation for musculoskeletal sys conn tissue dis w/o CC/MCC.
482 Hip femur procedures except major joint w/o CC/MCC.
494 Lower extrem humer proc except hip, foot, femur w/o CC/MCC.
497 Local excision removal int fix devices exc hip femur w/o CC/MCC.*
502 Soft tissue procedures w/o CC/MCC.
504 Foot procedures w CC.
505 Foot procedures w/o CC/MCC.
510 Shoulder, elbow or forearm proc, exc major joint proc w MCC.**
511 Shoulder, elbow or forearm proc, exc major joint proc w CC.**
535 Fractures of hip pelvis w MCC.
542 Pathological fractures musculoskelet conn tiss malig w MCC.
555 Signs symptoms of musculoskeletal system conn tissue w MCC.
562 Fx, sprn, strn disl except femur, hip, pelvis thigh w MCC.
598 Malignant breast disorders w CC.
599 Malignant breast disorders w/o CC/MCC.**
600 Non-malignant breast disorders w CC/MCC.
626 Thyroid, parathyroid thyroglossal procedures w CC.
630 Other endocrine, nutrit metab O.R. proc w/o CC/MCC.
665 Prostatectomy w MCC.**
666 Prostatectomy w CC.**
668 Transurethral procedures w MCC.
686 Kidney urinary tract neoplasms w MCC.
687 Kidney urinary tract neoplasms w CC.
693 Urinary stones w/o esw lithotripsy w MCC.
725 Benign prostatic hypertrophy w MCC.
744 DC, conization, laparoscopy tubal interruption w CC/MCC.
755 Malignancy, female reproductive system w CC.
800 Splenectomy w CC.
809 Major hematol/immun diag exc sickle cell crisis coagul w CC.
814 Reticuloendothelial immunity disorders w MCC.
824 Lymphoma non-acute leukemia w other O.R. proc w CC.
834 Acute leukemia w/o major O.R. procedure w MCC.
835 Acute leukemia w/o major O.R. procedure w CC.**
836 Acute leukemia w/o major O.R. procedure w/o CC/MCC.**
843 Other myeloprolif dis or poorly diff neopl diag w MCC.
883 Disorders of personality impulse control.
903 Wound debridements for injuries w/o CC/MCC.
905 Skin grafts for injuries w/o CC/MCC.
922 Other injury, poisoning toxic effect diag w MCC.
941 O.R. proc w diagnoses of other contact w health services w/o CC/MCC.
963 Other multiple significant trauma w MCC.
989 Non-extensive O.R. proc unrelated to principal diagnosis w/o CC/MCC.
PROPOSED QUINTILE 4
23 Craniotomy w major device implant or acute complex CNS PDX w MCC.**
24 Craniotomy w major device implant or acute complex CNS PDX w/o MCC.**
28 Spinal procedures w MCC.
29 Spinal procedures w CC.
30 Spinal procedures w/o CC/MCC.
37 Extracranial procedures w MCC.
38 Extracranial procedures w CC.**
42 Periph cranial nerve other nerv syst proc w/o CC/MCC.*
77 Hypertensive encephalopathy w MCC.
133 Other ear, nose, mouth throat O.R. procedures w CC/MCC.
164 Major chest procedures w CC.
237 Major cardiovascular procedures w MCC.
242 Permanent cardiac pacemaker implant w MCC.***
246 Percutaneous cardiovascular proc w drug-eluting stent w MCC.
247 Percutaneous cardiovascular proc w drug-eluting stent w/o MCC.
248 Percutaneous cardiovasc proc w non-drug-eluting stent w MCC.
249 Percutaneous cardiovasc proc w non-drug-eluting stent w/o MCC.**
259 Cardiac pacemaker device replacement w/o MCC.
260 Cardiac pacemaker revision except device replacement w MCC.
262 Cardiac pacemaker revision except device replacement w/o CC/MCC.***
286 Circulatory disorders except AMI, w card cath w MCC.
327 Stomach, esophageal duodenal proc w CC.
328 Stomach, esophageal duodenal proc w/o CC/MCC.**
348 Anal stomal procedures w CC.
358 Other digestive system O.R. procedures w/o CC/MCC.*
405 Pancreas, liver shunt procedures w MCC.
406 Pancreas, liver shunt procedures w CC.**
417 Laparoscopic cholecystectomy w/o c.d.e. w MCC.***
466 Revision of hip or knee replacement w MCC.
467 Revision of hip or knee replacement w CC.
469 Major joint replacement or reattachment of lower extremity w MCC.***
478 Biopsies of musculoskeletal system connective tissue w CC.
481 Hip femur procedures except major joint w CC.
485 Knee procedures w pdx of infection w MCC.
486 Knee procedures w pdx of infection w CC.
487 Knee procedures w pdx of infection w/o CC/MCC.**
490 Back neck procedures except spinal fusion w CC/MCC or disc devices.
492 Lower extrem humer proc except hip, foot, femur w MCC.
493 Lower extrem humer proc except hip, foot, femur w CC.
503 Foot procedures w MCC.
511 Shoulder, elbow or forearm proc, exc major joint proc w CC.***
513 Hand or wrist proc, except major thumb or joint proc w CC/MCC.
514 Hand or wrist proc, except major thumb or joint proc w/o CC/MCC.**
597 Malignant breast disorders w MCC.
599 Malignant breast disorders w/o CC/MCC.***
625 Thyroid, parathyroid thyroglossal procedures w MCC.
659 Kidney ureter procedures for non-neoplasm w MCC.
660 Kidney ureter procedures for non-neoplasm w CC.
666 Prostatectomy w CC.***
695 Kidney urinary tract signs symptoms w MCC.
711 Testes procedures w CC/MCC.
717 Other male reproductive system O.R. proc exc malignancy w CC/MCC.
739 Uterine, adnexa proc for non-ovarian/adnexal malig w MCC.
749 Other female reproductive system O.R. procedures w CC/MCC.
754 Malignancy, female reproductive system w MCC.
802 Other O.R. proc of the blood blood forming organs w MCC.
808 Major hematol/immun diag exc sickle cell crisis coagul w MCC.
823 Lymphoma non-acute leukemia w other O.R. proc w MCC.
896 Alcohol/drug abuse or dependence w/o rehabilitation therapy w MCC.
909 Other O.R. procedures for injuries w/o CC/MCC.*
928 Full thickness burn w skin graft or inhal inj w CC/MCC.
933 Extensive burns or full thickness burns w MV 96+ hrs w/o skin graft.
957 Other O.R. procedures for multiple significant trauma w MCC.
969 HIV w extensive O.R. procedure w MCC.
970 HIV w extensive O.R. procedure w/o MCC.**
984 Prostatic O.R. procedure unrelated to principal diagnosis w MCC.
985 Prostatic O.R. procedure unrelated to principal diagnosis w CC.
PROPOSED QUINTILE 5
11 Tracheostomy for face, mouth neck diagnoses w MCC.
12 Tracheostomy for face, mouth neck diagnoses w CC.
24 Craniotomy w major device implant or acute complex CNS PDX w/o MCC.***
25 Craniotomy endovascular intracranial procedures w MCC.
26 Craniotomy endovascular intracranial procedures w CC.
31 Ventricular shunt procedures w MCC.
32 Ventricular shunt procedures w CC.
38 Extracranial procedures w CC.***
132 Cranial/facial procedures w/o CC/MCC.
137 Mouth procedures w CC/MCC.
226 Cardiac defibrillator implant w/o cardiac cath w MCC.
227 Cardiac defibrillator implant w/o cardiac cath w/o MCC.
242 Permanent cardiac pacemaker implant w MCC.**
243 Permanent cardiac pacemaker implant w CC.
244 Permanent cardiac pacemaker implant w/o CC/MCC.
249 Percutaneous cardiovasc proc w non-drug-eluting stent w/o MCC.***
250 Perc cardiovasc proc w/o coronary artery stent or AMI w MCC.
326 Stomach, esophageal duodenal proc w MCC.
328 Stomach, esophageal duodenal proc w/o CC/MCC.***
330 Major small large bowel procedures w CC.
331 Major small large bowel procedures w/o CC/MCC.
335 Peritoneal adhesiolysis w MCC.
344 Minor small large bowel procedures w MCC.
347 Anal stomal procedures w MCC.
353 Hernia procedures except inguinal femoral w MCC.
406 Pancreas, liver shunt procedures w CC.***
411 Cholecystectomy w c.d.e. w MCC.
414 Cholecystectomy except by laparoscope w/o c.d.e. w MCC.
415 Cholecystectomy except by laparoscope w/o c.d.e. w CC.
417 Laparoscopic cholecystectomy w/o c.d.e. w MCC.**
418 Laparoscopic cholecystectomy w/o c.d.e. w CC.
423 Other hepatobiliary or pancreas O.R. procedures w MCC.
456 Spinal fusion exc cerv w spinal curv, malig or 9+ fusions w MCC.
457 Spinal fusion exc cerv w spinal curv, malig or 9+ fusions w CC.
459 Spinal fusion except cervical w MCC.
469 Major joint replacement or reattachment of lower extremity w MCC.**
470 Major joint replacement or reattachment of lower extremity w/o MCC.
477 Biopsies of musculoskeletal system connective tissue w MCC.
480 Hip femur procedures except major joint w MCC.
487 Knee procedures w pdx of infection w/o CC/MCC.***
488 Knee procedures w/o pdx of infection w CC/MCC.
496 Local excision removal int fix devices exc hip femur w CC.*
498 Local excision removal int fix devices of hip femur w CC/MCC.
507 Major shoulder or elbow joint procedures w CC/MCC.
514 Hand or wrist proc, except major thumb or joint proc w/o CC/MCC.***
582 Mastectomy for malignancy w CC/MCC.
619 O.R. procedures for obesity w MCC.
653 Major bladder procedures w MCC.
656 Kidney ureter procedures for neoplasm w MCC.
662 Minor bladder procedures w MCC.
709 Penis procedures w CC/MCC.
713 Transurethral prostatectomy w CC/MCC.
746 Vagina, cervix vulva procedures w CC/MCC.
826 Myeloprolif disord or poorly diff neopl w maj O.R. proc w MCC.
827 Myeloprolif disord or poorly diff neopl w maj O.R. proc w CC.
829 Myeloprolif disord or poorly diff neopl w other O.R. proc w CC/MCC.
836 Acute leukemia w/o major O.R. procedure w/o CC/MCC.***
855 Infectious parasitic diseases w O.R. procedure w/o CC/MCC.*
906 Hand procedures for injuries.
927 Extensive burns or full thickness burns w MV 96+ hrs w skin graft.
970 HIV w extensive O.R. procedure w/o MCC.***
*One of the original 290 proposed low-volume MS-LTC-DRGs initially assigned to this proposed low-volume quintile; removed from this proposed low-volume quintile in addressing nonmonotonicity (refer to step 6 in section II.I.4..of the preamble of this proposed rule).
**One of the original 290 proposed low-volume MS-LTC-DRGs initially assigned to a different proposed low-volume quintile but moved to this proposed low-volume quintile in addressing nonmonotonicity (refer to step 6 in section II.I.4. of the preamble of this proposed rule).
***One of the original 290 proposed low-volume MS-LTC-DRGs initially assigned to this proposed low-volume quintile but moved to a different proposed low-volume quintile in addressing nonmonotonicity (refer to step 6 in section II.I.4. of the preamble of this proposed rule).

We note that we will continue to monitor the volume (that is, the number of LTCH cases) in the low-volume quintiles to ensure that our proposed quintile assignment results in appropriate payment for such cases and does not result in an unintended financial incentive for LTCHs to inappropriately admit these types of cases.

4. Steps for Determining the Proposed FY 2009 MS-LTC-DRG Relative Weights

In general, the proposed FY 2009 MS-LTC-DRG relative weights in this proposed rule were determined based on the methodology established in the August 30, 2002 LTCH PPS final rule (67 FR 55989 through 55991). In summary, for FY 2009, we are proposing to group LTCH cases to the appropriate proposed MS-LTC-DRG, while taking into account the proposed low-volume MS-LTC-DRGs (as described above), before the proposed FY 2009 MS-LTC-DRG relative weights are determined. After grouping the cases to the appropriate proposed MS-LTC-DRG (or proposed low-volume quintile), we would calculate the proposed relative weights for FY 2009 by first removing statistical outliers and cases with a length of stay of 7 days or less (as discussed in greater detail below). Next, we would adjust the number of cases in each proposed MS-LTC-DRG (or proposed low-volume quintile) for the effect of short-stay outlier cases (as also discussed in greater detail below). The short-stay adjusted discharges and corresponding charges are used to calculate "relative adjusted weights" in each proposed MS-LTC-DRG (or proposed low-volume quintile) using the HSRV method (described above). In general, to determine the proposed FY 2009 MS-LTC-DRG relative weights in this proposed rule, we are proposing to use the same methodology we used in determining the FY 2008 MS-LTC-DRG relative weights in the FY 2008 IPPS final rule with comment period (72 FR 47281 through 47299). However, we are proposing to make a modification to our methodology for determining proposed relative weights for MS-LTC-DRGs with no LTCH cases (as discussed in greater detail in Step 5 below). Also, we note that, although we are generally proposing to use the same methodology in this proposed rule (with the exception noted above) as the methodology used in the FY 2008 IPPS final rule with comment, the discussion presented below of the steps for determining the proposed FY 2009 MS-LTC-DRG relative weights varies slightly from the discussion of the steps for determining the FY 2008 MS-LTC-DRG relative weights (presented in the FY 2008 IPPS final rule with comment) because we are taking this opportunity to refine our description to more precisely explain our methodology for determining the MS-LTC-DRG relative weights.

As discussed in the FY 2008 IPPS final rule with comment when we adopted the MS-LTC-DRGs, the adoption of the MS-LTC-DRGs with either two or three severity levels resulted in some slight modifications of procedures for assigning relative weights in cases of zero volume and/or nonmonotonicity (described in detail below) from the methodology we established when we implemented the LTCH PPS in the August 30, 2002 LTCH PPS final rule. As also discussed in the FY 2008 IPPS final rule with comment when we adopted the MS-LTC-DRGs, we implemented the MS-LTC-DRGs with a 2-year transition beginning in FY 2008. For FY 2008, the first year of the transition, 50 percent of the relative weight for a MS-LTC-DRG was based on the average LTC-DRG relative weight under Version 24.0 of the LTC-DRG GROUPER. The remaining 50 percent of the relative weight was based on the MS-LTC-DRG relative weight under Version 25.0 of the MS-LTC-DRG GROUPER. In FY 2009, the MS-LTC-DRG relative weights are based on 100 percent of the MS-LTC-DRG relative weights. Accordingly, in determining the proposed FY 2009 MS-LTC-DRG relative weights in this proposed rule, there is no longer a need to include a step to calculate MS-LTC-DRG transition blended relative weights (see Step 7 in the FY 2008 IPPS final rule with comment period (72 FR 47295)). Therefore, in this proposed rule, we determined the proposed FY 2009 MS-LTC-DRG relative weights based solely on the proposed MS-LTC-DRG relative weight under proposed Version 26.0 of the MS-LTC-DRG GROUPER, which is discussed in section II.B. of the preamble of this proposed rule. Furthermore, we are proposing that we would determine the final FY 2009 MS-LTC-DRG relative weights in the final rule based on the final Version 26.0 of the MS-LTC-DRG GROUPER that will be presented in that same final rule.

Below we discuss in detail the steps for calculating the proposed FY 2009 MS-LTC-DRG relative weights. We note that, as we stated above in section II.I.3.b. of the preamble of this proposed rule, we have excluded the data of all-inclusive rate LTCHs and LTCHs that are paid in accordance with demonstration projects that had claims in the FY 2007 MedPAR file.

Step 1 -Remove statistical outliers.

The first step in the calculation of the proposed FY 2009 MS-LTC-DRG relative weights is to remove statistical outlier cases. Consistent with our historical relative weight methodology, we are proposing to continue to define statistical outliers as cases that are outside of 3.0 standard deviations from the mean of the log distribution of both charges per case and the charges per day for each proposed MS-LTC-DRG. These statistical outliers are removed prior to calculating the proposed relative weights because we believe that they may represent aberrations in the data that distort the measure of average resource use. Including those LTCH cases in the calculation of the proposed relative weights could result in an inaccurate proposed relative weight that does not truly reflect relative resource use among the proposed MS-LTC-DRGs.

Step 2 -Remove cases with a length of stay of 7 days or less.

The MS-LTC-DRG relative weights reflect the average of resources used on representative cases of a specific type. Generally, cases with a length of stay of 7 days or less do not belong in a LTCH because these stays do not fully receive or benefit from treatment that is typical in a LTCH stay, and full resources are often not used in the earlier stages of admission to a LTCH. If we were to include stays of 7 days or less in the computation of the proposed FY 2009 MS-LTC-DRG relative weights, the value of many relative weights would decrease and, therefore, payments would decrease to a level that may no longer be appropriate. We do not believe that it would be appropriate to compromise the integrity of the payment determination for those LTCH cases that actually benefit from and receive a full course of treatment at a LTCH, by including data from these very short-stays. Therefore, consistent with our historical relative weight methodology, in determining the proposed FY 2009 MS-LTC-DRG relative weights, we are proposing to remove LTCH cases with a length of stay of 7 days or less.

Step 3 -Adjust charges for the effects of short-stay outliers.

After removing cases with a length of stay of 7 days or less, we are left with cases that have a length of stay of greater than or equal to 8 days. As the next step in the calculation of the proposed FY 2009 MS-LTC-DRG relative weights, consistent with our historical relative weight methodology, we are proposing to adjust each LTCH's charges per discharge for those remaining cases for the effects of short-stay outliers (as defined in § 412.529(a) in conjunction with § 412.503 for LTCH discharges occurring on or after October 1, 2008). (We note that even if a case was removed in Step 2 (that is, cases with a length of stay of 7 days or less), it was paid as a short-stay outlier if its length of stay was less than or equal to five-sixths of the average length of stay of the MS-LTC-DRG.)

We would make this adjustment by counting a short-stay outlier as a fraction of a discharge based on the ratio of the length of stay of the case to the average length of stay for the proposed MS-LTC-DRG for nonshort-stay outlier cases. This has the effect of proportionately reducing the impact of the lower charges for the short-stay outlier cases in calculating the average charge for the proposed MS-LTC-DRG. This process produces the same result as if the actual charges per discharge of a short-stay outlier case were adjusted to what they would have been had the patient's length of stay been equal to the average length of stay of the proposed MS-LTC-DRG.

Counting short-stay outlier cases as full discharges with no adjustment in determining the proposed FY 2009 MS-LTC-DRG relative weights would lower the proposed FY 2009 MS-LTC-DRG relative weight for affected proposed MS-LTC-DRGs because the relatively lower charges of the short-stay outlier cases would bring down the average charge for all cases within a proposed MS-LTC-DRG. This would result in an "underpayment" for nonshort-stay outlier cases and an "overpayment" for short-stay outlier cases. Therefore, we are proposing to adjust for short-stay outlier cases under § 412.529 in this manner because it results in more appropriate payments for all LTCH cases.

Step 4 -Calculate the proposed FY 2009 MS-LTC-DRG relative weights on an iterative basis.

Consistent with our historical relative weight methodology, we are proposing to calculate the proposed MS-LTC-DRG relative weights using the HSRV methodology, which is an iterative process. First, for each LTCH case, we calculate a hospital-specific relative charge value by dividing the short-stay outlier adjusted charge per discharge (see step 3) of the LTCH case (after removing the statistical outliers (see step 1)) and LTCH cases with a length of stay of 7 days or less (see step 2) by the average charge per discharge for the LTCH in which the case occurred. The resulting ratio is then multiplied by the LTCH's case-mix index to produce an adjusted hospital-specific relative charge value for the case. An initial case-mix index value of 1.0 is used for each LTCH.

For each proposed MS-LTC-DRG, the proposed FY 2009 relative weight is calculated by dividing the average of the adjusted hospital-specific relative charge values (from above) for the MS-LTC-DRG by the overall average hospital-specific relative charge value across all cases for all LTCHs. Using these recalculated MS-LTC-DRG relative weights, each LTCH's average relative weight for all of its cases (that is, its case-mix) is calculated by dividing the sum of all the LTCH's MS-LTC-DRG relative weights by its total number of cases. The LTCH's hospital-specific relative charge values above are multiplied by these hospital-specific case-mix indexes. These hospital-specific case-mix adjusted relative charge values are then used to calculate a new set of MS-LTC-DRG relative weights across all LTCHs. This iterative process is continued until there is convergence between the weights produced at adjacent steps, for example, when the maximum difference is less than 0.0001.

Step 5 -Determine a proposed FY 2009 relative weight for proposed MS-LTC-DRGs with no LTCH cases.

As we stated above, we determine the proposed FY 2009 relative weight for each proposed MS-LTC-DRG using total Medicare allowable charges reported in the best available LTCH claims data (that is, the December 2007 update of the FY 2007 MedPAR file for this proposed rule). Of the proposed FY 2009 MS-LTC-DRGs, we identified a number of proposed MS-LTC-DRGs for which there were no LTCH cases in the database. That is, based on data from the FY 2007 MedPAR file used for this proposed rule, no patients who would have been classified to those proposed MS-LTC-DRGs were treated in LTCHs during FY 2007 and, therefore, no charge data are available for those proposed MS-LTC-DRGs. Thus, in the process of determining the proposed MS-LTC-DRG relative weights, we are unable to calculate proposed relative weights for these proposed MS-LTC-DRGs with no LTCH cases using the methodology described in Steps 1 through 4 above. However, because patients with a number of the diagnoses under these proposed MS-LTC-DRGs may be treated at LTCHs, consistent with our historical methodology, we are proposing to assign relative weights to each of the proposed no-volume MS-LTC-DRGs based on clinical similarity and relative costliness (with the exception of proposed "transplant" MS-LTC-DRGs and proposed "error" MS-LTC-DRGs as discussed below). In general, we are proposing to determine proposed FY 2009 relative weights for the proposed MS-LTC-DRGs with no LTCH cases in the FY 2007 MedPAR file used in this proposed rule (that is, proposed "no-volume MS-LTC-DRGs) by cross-walking each proposed no-volume MS-LTC-DRG to another proposed MS-LTC-DRG with a proposed relative weight (determined in accordance with the proposed methodology described above). Then, under our proposed methodology presented in this proposed rule, the proposed "no-volume" MS-LTC-DRG would be assigned the same proposed relative weight of the proposed MS-LTC-DRG to which it would be cross-walked (as described in greater detail below). As noted above, we are proposing to make a modification to our methodology for determining proposed relative weights for MS-LTC-DRGs with no LTCH cases in this proposed rule, which is discussed in greater detail below. As also noted above, even where we are not proposing changes to our existing methodology, we are taking this opportunity to refine our description to more precisely explain our proposed methodology for determining the MS-LTC-DRG relative weights in this proposed rule.

Specifically, in this proposed rule, we are proposing to determine the relative weight for each proposed MS-LTC-DRG using total Medicare allowable charges reported in the December 2007 update of the FY 2007 MedPAR file. Of the 746 proposed MS-LTC-DRGs for FY 2009, we identified 203 proposed MS-LTC-DRGs for which there were no LTCH cases in the database (including the 8 proposed "transplant" MS-LTC-DRGs and 2 proposed "error" MS-LTC-DRGs). For this proposed rule, as noted above, we are proposing to assign proposed relative weights for each of the 203 proposed no-volume MS-LTC-DRGs (with the exception of the 8 proposed "transplant" proposed MS-LTC-DRGs and the 2 proposed "error" MS-LTC-DRGs, which are discussed below) based on clinical similarity and relative costliness to one of the remaining 543 (746 - 203 = 543) proposed MS-LTC-DRGs for which we are able to determine relative weights, based on FY 2007 LTCH claims data. (For the remainder of this discussion, we refer to one of the 543 proposed MS-LTC-DRGs for which we are able to determine relative weight as the proposed "cross-walked" MS-LTC-DRG.) Then we are proposing to assign the proposed no-volume MS-LTC-DRG the proposed relative weight of the proposed cross-walked MS-LTC-DRG. This proposed approach differs from the one we used to determine the FY 2008 MS-LTC-DRG relative weights when there were no LTCH cases (see 72 FR 47290). Specifically, in determining the FY 2008 MS-LTC-DRG relative weights in the FY 2008 IPPS final rule with comment period, if the no volume MS-LTC-DRG was cross-walked to a MS-LTC-DRG that had 25 or more cases and, therefore, was not in a low-volume quintile, we assigned the relative weight of a quintile to a no-volume MS-LTC-DRG (rather than assigning the relative weight of the cross-walked MS-LTC-DRG). While we believe this approach would result in appropriate LTCH PPS payments (because it is consistent with our methodology for determining relative weights for MS-LTC-DRGs that have a low volume of LTCH cases (which is discussed above in section II.I.3.e. of this preamble)), upon further review during the development of the proposed FY 2009 MS-LTC-DRG relative weights in this proposed rule, we now believe that proposing to assign the proposed relative weight of the proposed cross-walked MS-LTC-DRG to the proposed no-volume MS-LTC-DRG would result in more appropriate LTCH PPS payments because those cases generally require equivalent relative resource (and therefore should generally have the same LTCH PPS payment). The relative weight of each MS-LTC-DRG should reflect relative resource of the LTCH cases grouped to that MS-LTC-DRG. Because the proposed no-volume MS-LTC-DRGs would be cross-walked to other proposed MS-LTC-DRGs based on clinical similarity and relative costliness, which usually require equivalent relative resource use, we believe that assigning the proposed no-volume MS-LTC-DRG the proposed relative weight of the proposed cross-walked MS-LTC-DRG would result in appropriate LTCH PPS payments. (As explained below in Step 6, when necessary, we are proposing to make adjustments to account for nonmonotonicity.)

Our proposed methodology for determining the proposed relative weights for the proposed no-volume MS-LTC-DRGs is as follows: We cross-walk the proposed no-volume MS-LTC-DRG to a proposed MS-LTC-DRG for which there are LTCH cases in the FY 2007 MedPAR file and to which it is similar clinically in intensity of use of resources and relative costliness as determined by criteria such as care provided during the period of time surrounding surgery, surgical approach (if applicable), length of time of surgical procedure, postoperative care, and length of stay. We then assign the proposed relative weight of the proposed cross-walked MS-LTC-DRG as the proposed relative weight for the proposed no-volume MS-LTC-DRG such that both of these proposed MS-LTC-DRGs (that is, the proposed no-volume MS-LTC-DRG and the proposed cross-walked MS-LTC-DRG) would have the same proposed relative weight. We note that if the proposed cross-walked MS-LTC-DRG had 25 cases or more, its proposed relative weight, which was calculated using the proposed methodology described in steps 1 through 4 above, would be assigned to the proposed no-volume MS-LTC-DRG as well. Similarly, if the proposed MS-LTC-DRG to which the proposed no-volume MS-LTC-DRG is cross-walked has 24 or less cases, and therefore was designated to one of the proposed low-volume quintiles for purposes of determining the proposed relative weights, we would assign the proposed relative weight of the applicable proposed low-volume quintile to the proposed no-volume MS-LTC-DRG such that both of these proposed MS-LTC-DRGs (that is, the proposed no-volume MS-LTC-DRG and the proposed cross-walked MS-LTC-DRG) would have the same proposed relative weight. (As we noted above, in the infrequent case where nonmonotonicity involving a proposed no-volume MS-LTC-DRG results, additional measures as described in Step 6 would be required in order to maintain monotonically increasing relative weights.)

For this proposed rule, a list of the proposed no-volume FY 2009 MS-LTC-DRGs and the proposed FY 2009 MS-LTC-DRG to which it is cross-walked (that is, the proposed cross-walked MS-LTC-DRG) is shown in the chart below.

Proposed MS-LTC-DRG (Version 26.0) Proposed MS-LTC-DRG description (version 26.0) Proposed cross-walked MS-LTC-DRG
9 Bone marrow transplant 823
13 Tracheostomy for face, mouth neck diagnoses w/o CC/MCC 12
20 Intracranial vascular procedures w PDX hemorrhage w MCC 31
21 Intracranial vascular procedures w PDX hemorrhage w CC 32
22 Intracranial vascular procedures w PDX hemorrhage w/o CC/MCC 32
33 Ventricular shunt procedures w/o CC/MCC 32
34 Carotid artery stent procedure w MCC 37
35 Carotid artery stent procedure w CC 38
36 Carotid artery stent procedure w/o CC/MCC 38
39 Extracranial procedures w/o CC/MCC 38
61 Acute ischemic stroke w use of thrombolytic agent w MCC 70
62 Acute ischemic stroke w use of thrombolytic agent w CC 71
63 Acute ischemic stroke w use of thrombolytic agent w/o CC/MCC 72
76 Viral meningitis w/o CC/MCC 75
88 Concussion w MCC 89
90 Concussion w/o CC/MCC 89
114 Orbital procedures w/o CC/MCC 113
115 Extraocular procedures except orbit 125
117 Intraocular procedures w/o CC/MCC 125
123 Neurological eye disorders 125
129 Major head neck procedures w CC/MCC or major device 146
130 Major head neck procedures w/o CC/MCC 148
131 Cranial/facial procedures w CC/MCC 132
134 Other ear, nose, mouth throat O.R. procedures w/o CC/MCC 133
138 Mouth procedures w/o CC/MCC 137
139 Salivary gland procedures 137
150 Epistaxis w MCC 152
151 Epistaxis w/o MCC 153
215 Other heart assist system implant 238
216 Cardiac valve oth maj cardiothoracic proc w card cath w MCC 237
217 Cardiac valve oth maj cardiothoracic proc w card cath w CC 238
218 Cardiac valve oth maj cardiothoracic proc w card cath w/o CC/MCC 238
219 Cardiac valve oth maj cardiothoracic proc w/o card cath w MCC 237
220 Cardiac valve oth maj cardiothoracic proc w/o card cath w CC 238
221 Cardiac valve oth maj cardiothoracic proc w/o card cath w/o CC/MCC 238
222 Cardiac defib implant w cardiac cath w AMI/HF/shock w MCC 242
223 Cardiac defib implant w cardiac cath w AMI/HF/shock w/o MCC 243
224 Cardiac defib implant w cardiac cath w/o AMI/HF/shock w MCC 242
225 Cardiac defib implant w cardiac cath w/o AMI/HF/shock w/o MCC 243
228 Other cardiothoracic procedures w MCC 252
229 Other cardiothoracic procedures w CC 253
230 Other cardiothoracic procedures w/o CC/MCC 254
231 Coronary bypass w PTCA w MCC 237
232 Coronary bypass w PTCA w/o MCC 238
233 Coronary bypass w cardiac cath w MCC 237
234 Coronary bypass w cardiac cath w/o MCC 238
235 Coronary bypass w/o cardiac cath w MCC 237
236 Coronary bypass w/o cardiac cath w/o MCC 238
245 AICD generator procedures 244
251 Perc cardiovasc proc w/o coronary artery stent or AMI w/o MCC 250
258 Cardiac pacemaker device replacement w MCC 259
265 AICD lead procedures 259
285 Circulatory disorders w AMI, expired w/o CC/MCC 284
295 Deep vein thrombophlebitis w/o CC/MCC 294
296 Cardiac arrest, unexplained w MCC 283
297 Cardiac arrest, unexplained w CC 284
298 Cardiac arrest, unexplained w/o CC/MCC 284
332 Rectal resection w MCC 356
333 Rectal resection w CC 357
334 Rectal resection w/o CC/MCC 358
336 Peritoneal adhesiolysis w CC 335
337 Peritoneal adhesiolysis w/o CC/MCC 335
338 Appendectomy w complicated principal diag w MCC 371
339 Appendectomy w complicated principal diag w CC 372
340 Appendectomy w complicated principal diag w/o CC/MCC 373
341 Appendectomy w/o complicated principal diag w MCC 371
342 Appendectomy w/o complicated principal diag w CC 372
343 Appendectomy w/o complicated principal diag w/o CC/MCC 373
345 Minor small large bowel procedures w CC 344
346 Minor small large bowel procedures w/o CC/MCC 344
349 Anal stomal procedures w/o CC/MCC 348
350 Inguinal femoral hernia procedures w MCC 348
351 Inguinal femoral hernia procedures w CC 348
352 Inguinal femoral hernia procedures w/o CC/MCC 348
355 Hernia procedures except inguinal femoral w/o CC/MCC 354
383 Uncomplicated peptic ulcer w MCC 384
407 Pancreas, liver shunt procedures w/o CC/MCC 406
408 Biliary tract proc except only cholecyst w or w/o c.d.e. w MCC 409
410 Biliary tract proc except only cholecyst w or w/o c.d.e. w/o CC/MCC 409
412 Cholecystectomy w c.d.e. w CC 411
413 Cholecystectomy w c.d.e. w/o CC/MCC 411
416 Cholecystectomy except by laparoscope w/o c.d.e. w/o CC/MCC 415
419 Laparoscopic cholecystectomy w/o c.d.e. w/o CC/MCC 418
420 Hepatobiliary diagnostic procedures w MCC 424
421 Hepatobiliary diagnostic procedures w CC 424
422 Hepatobiliary diagnostic procedures w/o CC/MCC 424
425 Other hepatobiliary or pancreas O.R. procedures w/o CC/MCC 424
434 Cirrhosis alcoholic hepatitis w/o CC/MCC 433
453 Combined anterior/posterior spinal fusion w MCC 457
454 Combined anterior/posterior spinal fusion w CC 457
455 Combined anterior/posterior spinal fusion w/o CC/MCC 457
458 Spinal fusion exc cerv w spinal curv, malig or 9+ fusions w/o CC/MCC 457
460 Spinal fusion except cervical w/o MCC 459
461 Bilateral or multiple major joint procs of lower extremity w MCC 480
462 Bilateral or multiple major joint procs of lower extremity w/o MCC 482
473 Cervical spinal fusion w/o CC/MCC 472
479 Biopsies of musculoskeletal system connective tissue w/o CC/MCC 478
483 Major joint limb reattachment proc of upper extremity w CC/MCC 480
484 Major joint limb reattachment proc of upper extremity w/o CC/MCC 482
491 Back neck procedures except spinal fusion w/o CC/MCC 490
499 Local excision removal int fix devices of hip femur w/o CC/MCC 498
506 Major thumb or joint procedures 514
508 Major shoulder or elbow joint procedures w/o CC/MCC 507
509 Arthroscopy 505
512 Shoulder, elbow or forearm proc, exc major joint proc w/o CC/MCC 511
517 Other musculoskelet sys conn tiss O.R. proc w/o CC/MCC 516
538 Sprains, strains, dislocations of hip, pelvis thigh w/o CC/MCC 537
583 Mastectomy for malignancy w/o CC/MCC 582
585 Breast biopsy, local excision other breast procedures w/o CC/MCC 584
614 Adrenal pituitary procedures w CC/MCC 629
615 Adrenal pituitary procedures w/o CC/MCC 630
620 O.R. procedures for obesity w CC 619
621 O.R. procedures for obesity w/o CC/MCC 619
627 Thyroid, parathyroid thyroglossal procedures w/o CC/MCC 626
654 Major bladder procedures w CC 653
655 Major bladder procedures w/o CC/MCC 653
657 Kidney ureter procedures forneoplasm w CC 656
658 Kidney ureter procedures for neoplasm w/o CC/MCC 656
664 Minor bladder procedures w/o CC/MCC 663
667 Prostatectomy w/o CC/MCC 666
670 Transurethral procedures w/o CC/MCC 669
672 Urethral procedures w/o CC/MCC 671
675 Other kidney urinary tract procedures w/o CC/MCC 674
691 Urinary stones w esw lithotripsy w CC/MCC 694
692 Urinary stones w esw lithotripsy w/o CC/MCC 694
697 Urethral stricture 688
707 Major male pelvic procedures w CC/MCC 660
708 Major male pelvic procedures w/o CC/MCC 661
710 Penis procedures w/o CC/MCC 709
712 Testes procedures w/o CC/MCC 711
714 Transurethral prostatectomy w/o CC/MCC 713
715 Other male reproductive system O.R. proc for malignancy w CC/MCC 717
716 Other male reproductive system O.R. proc for malignancy w/o CC/MCC 717
718 Other male reproductive system O.R. proc exc malignancy w/o CC/MCC 717
724 Malignancy, male reproductive system w/o CC/MCC 723
734 Pelvic evisceration, rad hysterectomy rad vulvectomy w CC/MCC 717
735 Pelvic evisceration, rad hysterectomy rad vulvectomy w/o CC/MCC 717
736 Uterine adnexa proc for ovarian or adnexal malignancy w MCC 754
737 Uterine adnexa proc for ovarian or adnexal malignancy w CC 755
738 Uterine adnexa proc for ovarian or adnexal malignancy w/o CC/MCC 756
740 Uterine, adnexa proc for non-ovarian/adnexal malig w CC 739
741 Uterine, adnexa proc for non-ovarian/adnexal malig w/o CC/MCC 739
742 Uterine adnexa proc for non-malignancy w CC/MCC 755
743 Uterine adnexa proc for non-malignancy w/o CC/MCC 756
745 DC, conization, laparascopy tubal interruption w/o CC/MCC 744
747 Vagina, cervix vulva procedures w/o CC/MCC 746
748 Female reproductive system reconstructive procedures 749
750 Other female reproductive system O.R. procedures w/o CC/MCC 749
760 Menstrual other female reproductive system disorders w CC/MCC 744
761 Menstrual other female reproductive system disorders w/o CC/MCC 744
765 Cesarean section w CC/MCC 744
766 Cesarean section w/o CC/MCC 744
767 Vaginal delivery w sterilization /or DC 744
768 Vaginal delivery w O.R. proc except steril /or DC 744
769 Postpartum post abortion diagnoses w O.R. procedure 744
770 Abortion w DC, aspiration curettage or hysterotomy 744
774 Vaginal delivery w complicating diagnoses 744
775 Vaginal delivery w/o complicating diagnoses 744
776 Postpartum post abortion diagnoses w/o O.R. procedure 744
777 Ectopic pregnancy 744
778 Threatened abortion 759
779 Abortion w/o DC 759
780 False labor 759
782 Other antepartum diagnoses w/o medical complications 781
789 Neonates, died or transferred to another acute care facility 781
790 Extreme immaturity or respiratory distress syndrome, neonate 781
791 Prematurity w major problems 781
792 Prematurity w/o major problems 781
793 Full term neonate w major problems 781
794 Neonate w other significant problems 781
795 Normal newborn 781
799 Splenectomy w MCC 800
801 Splenectomy w/o CC/MCC 800
803 Other O.R. proc of the blood blood forming organs w CC 802
804 Other O.R. proc of the blood blood forming organs w/o CC/MCC 802
820 Lymphoma leukemia w major O.R. procedure w MCC 823
821 Lymphoma leukemia w major O.R. procedure w CC 824
822 Lymphoma leukemia w major O.R. procedure w/o CC/MCC 824
825 Lymphoma non-acute leukemia w other O.R. proc w/o CC/MCC 824
828 Myeloprolif disord or poorly diff neopl w maj O.R. proc w/o CC/MCC 827
830 Myeloprolif disord or poorly diff neopl w other O.R. proc w/o CC/MCC 829
837 Chemo w acute leukemia as sdx or w high dose chemo agent w MCC 829
838 Chemo w acute leukemia as sdx or w high dose chemo agent w CC 829
839 Chemo w acute leukemia as sdx or w high dose chemo agent w/o CC/MCC 829
848 Chemotherapy w/o acute leukemia as secondary diagnosis w/o CC/MCC 847
887 Other mental disorder diagnoses 881
894 Alcohol/drug abuse or dependence, left ama 881
915 Allergic reactions w MCC 918
916 Allergic reactions w/o MCC 918
955 Craniotomy for multiple significant trauma 26
956 Limb reattachment, hip femur proc for multiple significant trauma 482
959 Other O.R. procedures for multiple significant trauma w/o CC/MCC 958
986 Prostatic O.R. procedure unrelated to principal diagnosis w/o CC/MCC 985

To illustrate this methodology for determining the proposed relative weights for the proposed MS-LTC-DRGs with no LTCH cases, we are providing the following example, which refers to the proposed no-volume MS-LTC-DRGs crosswalk information for FY 2009 provided in the chart above.

Example: There were no cases in the FY 2007 MedPAR file used for this proposed rule for proposed MS-LTC-DRG 61 (Acute ischemic stroke w use of thrombolytic agent w MCC). We determined that MS-LTC-DRG 70 (Nonspecific cebrovascular disorders w MCC) is similar clinically and based on resource use to proposed MS-LTC-DRG 61. Therefore, we are proposing to assign the same proposed relative weight of proposed MS-LTC-DRG 70 of 0.8718 for FY 2009 to proposed MS-LTC-DRG 61 (Table 11 of the Addendum of this proposed rule).

Furthermore, for FY 2009, consistent with our historical relative weight methodology, we are proposing to establish MS-LTC-DRG relative weights of 0.0000 for the following proposed transplant MS-LTC-DRGs: Heart Transplant or Implant of Heart Assist System with MCC (MS-LTC-DRG 1); Heart Transplant or Implant of Heart Assist System without MCC (MS-LTC-DRG 2); Liver Transplant with MCC or Intestinal Transplant (MS-LTC-DRG 5); Liver Transplant without MCC (MS-LTC-DRG 6); Lung Transplant (MS-LTC-DRG 7); Simultaneous Pancreas/Kidney Transplant (MS-LTC-DRG 8); Pancreas Transplant (MS-LTC-DRG 10); and Kidney Transplant (MS-LTC-DRG 652). This is because Medicare will only cover these procedures if they are performed at a hospital that has been certified for the specific procedures by Medicare and presently no LTCH has been so certified. Based on our research, we found that most LTCHs only perform minor surgeries, such as minor small and large bowel procedures, to the extent any surgeries are performed at all. Given the extensive criteria that must be met to become certified as a transplant center for Medicare, we believe it is unlikely that any LTCHs will become certified as a transplant center. In fact, in the more than 20 years since the implementation of the IPPS, there has never been a LTCH that even expressed an interest in becoming a transplant center.

If in the future a LTCH applies for certification as a Medicare-approved transplant center, we believe that the application and approval procedure would allow sufficient time for us to determine appropriate weights for the MS-LTC-DRGs affected. At the present time, we would only include these eight proposed transplant MS-LTC-DRGs in the GROUPER program for administrative purposes only. Because we use the same GROUPER program for LTCHs as is used under the IPPS, removing these proposed MS-LTC-DRGs would be administratively burdensome.

Again, we note that, as this system is dynamic, it is entirely possible that the number of proposed MS-LTC-DRGs with no volume of LTCH cases based on the system will vary in the future. We used the most recent available claims data in the MedPAR file to identify no-volume proposed MS-LTC-DRGs and to determine the proposed relative weights in this proposed rule.

Step 6 -Adjust the proposed FY 2009 MS-LTC-DRG relative weights to account for nonmonotonically increasing relative weights.

As discussed in section II.B. of the preamble of this proposed rule, the MS-DRGs (used under the IPPS) on which the MS-LTC-DRGs are based provide a significant improvement in the DRG system's recognition of severity of illness and resource usage. The proposed MS-DRGs contain base DRGs that have been subdivided into one, two, or three severity levels. Where there are three severity levels, the most severe level has at least one code that is referred to as an MCC. The next lower severity level contains cases with at least one code that is a CC. Those cases without a MCC or a CC are referred to as without CC/MCC. When data did not support the creation of three severity levels, the base was divided into either two levels or the base was not subdivided. The two-level subdivisions could consist of the CC/MCC and the without CC/MCC. Alternatively, the other type of two level subdivision could consist of the MCC and without MCC.

In those base MS-LTC-DRGs that are split into either two or three severity levels, cases classified into the "without CC/MCC" MS-LTC-DRG are expected to have a lower resource use (and lower costs) than the "with CC/MCC" MS-LTC-DRG (in the case of a two-level split) or the "with CC" and "with MCC" MS-LTC-DRGs (in the case of a three-level split). That is, theoretically, cases that are more severe typically require greater expenditure of medical care resources and will result in higher average charges. Therefore, in the three severity levels, relative weights should increase by severity, from lowest to highest. If the relative weights do not increase (that is, if within a base MS-LTC-DRG, a MS-LTC-DRG with MCC has a lower relative weight than one with CC, or the MS-LTC-DRG without CC/MCC has a higher relative weight than either of the others, they are nonmonotonic). We continue to believe that utilizing nonmonotonic relative weights to adjust Medicare payments would result in inappropriate payments. Consequently, in general, we are proposing to combine proposed MS-LTC-DRG severity levels within a base MS-LTC-DRG for the purpose of computing a relative weight when necessary to ensure that monotonicity is maintained. In determining the proposed FY 2009 MS-LTC-DRG relative weights in this proposed rule, in general, we are proposing to use the same methodology to adjust for nonmonotonicity that we used to determine the FY 2008 MS-LTC-DRG relative weights in the FY 2008 IPPS final rule with comment (72 FR 47293 through 47295). However, as noted above, we are taking this opportunity to refine our description to more precisely explain our methodology for determining the MS-LTC-DRG relative weights in this proposed rule. Specifically, in determining the proposed FY 2009 MS-LTC-DRG relative weights in this proposed rule, under each of the example scenarios provided below, we would combine severity levels within a base MS-LTC-DRG as follows:

The first example of nonmonotonically increasing relative weights for a MS-LTC-DRG pertains to a base MS-LTC-DRG with a three-level split and each of the three levels has 25 or more LTCH cases and, therefore, none of those MS-LTC-DRGs is assigned to one of the five low-volume quintiles. In this proposed rule, if nonmonotonicity is detected in the proposed relative weights of the proposed MS-LTC-DRGs in adjacent severity levels (for example, the proposed relative weight of the "with MCC" (the highest severity level) is less than the "with CC" (the middle level), or the "with CC" is less than the "without CC/MCC"), we would combine the nonmonotonic adjacent proposed MS-LTC-DRGs and re-determine a proposed relative weight based on the case-weighted average of the combined LTCH cases of the nonmonotonic proposed MS-LTC-DRGs. The case-weighted average charge is calculated by dividing the total charges for all LTCH cases in both severity levels by the total number of LTCH cases for both proposed MS-LTC-DRGs. The same proposed relative weight would be assigned to both affected levels of the base MS-LTC-DRG. If nonmonotonicity remains an issue because the above process results in a proposed relative weight that is still nonmonotonic to the remaining proposed MS-LTC-DRG relative weight within the base MS-LTC-DRG, we would combine all three of the severity levels to redetermine the proposed relative weights based on the case-weighted average charge of the combined severity levels. This same proposed relative weight is then assigned to each of the proposed MS-LTC-DRGs in that base MS-LTC-DRG.

A second example of nonmonotonically increasing relative weights for a base MS-LTC-DRG pertains to the situation where there are three severity levels and one or more of the severity levels within a base MS-LTC-DRG has less than 25 LTCH cases (that is, low-volume). In this proposed rule, if nonmonotonicity occurs in the case where either the highest or lowest severity level ("with MCC" or "without CC/MCC") has 25 LTCH cases or more and the other two severity levels are low-volume (and therefore the other two severity levels would otherwise be assigned the proposed relative weight of the applicable proposed low-volume quintile(s)), we would combine the data for the cases in the two adjacent proposed low-volume MS-LTC-DRGs for the purpose of determining a proposed relative weight. If the combination results in at least 25 cases, we re-determine one proposed relative weight based on the case-weighted average charge of the combined severity levels and assign this same proposed relative weight to each of the severity levels. If the combination results in less than 25 cases, based on the case-weighted average charge of the combined proposed low-volume MS-LTC-DRGs, both proposed MS-LTC-DRGs would be assigned to the appropriate proposed low-volume quintile (discussed above in section II.I.3.e. of this preamble) based on the case-weighted average charge of the combined proposed low-volume MS-LTC-DRGs. Then the proposed relative weight of the affected proposed low-volume quintile would be redetermined and that proposed relative weight would be assigned to each of the affected severity levels (and all of the proposed MS-LTC-DRGs in the affected proposed low-volume quintile). If nonmonotonicity persists, we would combine all three severity levels and redetermine one proposed relative weight based on the case-weighted average charge of the combined severity levels and this same proposed relative weight would be assigned to each of the three levels.

Similarly, in nonmonotonic cases where the middle level has 25 cases or more but either or both of the lowest or highest severity level has less than 25 cases (that is, low volume), we would combine the nonmonotonic proposed low-volume MS-LTC-DRG with the middle level proposed MS-LTC-DRG of the base MS-LTC-DRG. We would redetermine one proposed relative weight based on the case-weighted average charge of the combined severity levels and assign this same proposed relative weight to each of the affected proposed MS-LTC-DRGs. If nonmonotonicity persists, we would combine all three levels for the purpose of redetermining a proposed relative weight based on the case-weighted average charge of the combined severity levels, and assign that proposed relative weight to each of the three severity levels.

In the case where all three severity levels in the base MS-LTC-DRGs are proposed low-volume MS-LTC-DRGs and two of the severity levels are nonmonotonic in relation to each other, we would combine the two adjacent nonmonotonic severity levels. If that combination results in less than 25 cases, both proposed low-volume MS-LTC-DRGs would be assigned to the appropriate proposed low-volume quintile (discussed above in section II.I.3.e. of this preamble) based on the case-weighted average charge of the combined proposed low-volume MS-LTC-DRGs. Then the proposed relative weight of the affected proposed low-volume quintile would be redetermined and that proposed relative weight would be assigned to each of the affected severity levels (and all of the proposed MS-LTC-DRGs in the affected proposed low-volume quintile). If the nonmonotonicity persists, we would combine all three levels of that base MS-LTC-DRG for the purpose of redetermining a proposed relative weight based on the case-weighted average charge of the combined severity levels, and assign that proposed relative weight to each of the three severity levels. If that combination of all three severity levels results in less than 25 cases, we would assign that "combined" base MS-LTC-DRG to the appropriate proposed low-volume quintile based on the case-weighted average charge of the combined proposed low-volume MS-LTC-DRGs. Then the proposed relative weight of the affected proposed low-volume quintile would be redetermined and that proposed relative weight would be assigned to each of the affected severity levels (and all of the proposed MS-LTC-DRGs in the affected proposed low-volume quintile).

Another example of nonmonotonicity involves a base MS-LTC-DRG with three severity levels where at least one of the severity levels has no cases. As discussed above in greater detail in Step 5, based on resource use intensity and clinical similarity, we propose to cross-walk a proposed no-volume MS-LTC-DRG to a proposed MS-LTC-DRG that has at least one case. Under our proposed methodology for the treatment of proposed no-volume MS-LTC-DRGs, the proposed no-volume MS-LTC-DRG would be assigned the same proposed relative weight as the proposed MS-LTC-DRG to which the proposed no-volume MS-LTC-DRG is cross-walked. For many proposed no-volume MS-LTC-DRGs, as shown in the chart above in Step 5, the application of our proposed methodology results in a proposed cross-walk MS-LTC-DRG that is the adjacent severity level in the same base MS-LTC-DRG. Consequently, in most instances, the proposed no-volume MS-LTC-DRG and the adjacent proposed MS-LTC-DRG to which it is cross-walked would not result in nonmonotonicity because both of these severity levels would have the same proposed relative weight. (In this proposed rule, under our proposed methodology for the treatment of proposed no-volume MS-LTC-DRGs, in the case where the proposed no-volume MS-LTC-DRG is either the highest or lowest severity level, the proposed cross-walk MS-LTC-DRG would be the middle level ("with CC") within the same base MS-LTC-DRG, and therefore the proposed no-volume MS-LTC-DRG (either the "with MCC" or the "without CC/MCC") and the proposed cross-walk MS-LTC-DRG (the "with CC") would have the same proposed relative weight. Consequently, no adjustment for monotonicity would be necessary.) However, if our proposed methodology for determining proposed relative weights for proposed no-volume MS-LTC-DRGs results in nonmonotonicity with the third severity level in the base-MS-LTC-DRG, all three severity levels would be combined for the purpose of redetermining one proposed relative weight based on the case-weighted average charge of the combined severity levels. This same proposed relative weight would be assigned to each of the three severity levels in the base MS-LTC-DRG.

Thus far in the discussion, we have presented examples of nonmonotonicity in a base MS-LTC-DRG that has three severity levels. We would apply the same process where the base MS-LTC-DRG contains only two severity levels. For example, if nonmonotonicity occurs in a base MS-LTC-DRG with two severity levels (that is, the proposed relative weight of the higher severity level is less than the lower severity level), where both of the proposed MS-LTC-DRGs have at least 25 cases or where one or both of the proposed MS-LTC-DRGs is low volume (that is, less than 25 cases), we would combine the two proposed MS-LTC-DRGs of that base MS-LTC-DRG for the purpose of redetermining a proposed relative weight based on the combined case-weighted average charge for both severity levels. This same proposed relative weight would be assigned to each of the two severity levels in the base MS-LTC-DRG. Specifically, if the combination of the two severity levels would result in at least 25 cases, we would redetermine one proposed relative weight based on the case-weighted average charge and assign that proposed relative weight to each of the two proposed MS-LTC-DRGs. If the combination results in less than 25 cases, we would assign both proposed MS-LTC-DRGs to the appropriate proposed low-volume quintile (discussed above in section II.I.3.e. of this preamble) based on their combined case-weighted average charge. Then the proposed relative weight of the affected proposed low-volume quintile would be redetermined and that proposed relative weight would be assigned to each of the affected severity levels.

Step 7 -Calculate the proposed FY 2009 budget neutrality factor.

As we established in the RY 2008 LTCH PPS final rule (72 FR 26882), under the broad authority conferred upon the Secretary under section 123 of Pub. L. 106-113 as amended by section 307(b) of Pub. L. 106-554 to develop the LTCH PPS, beginning with the MS-LTC-DRG update for FY 2008, the annual update to the MS-LTC-DRG classifications and relative weights will be done in a budget neutral manner such that estimated aggregate LTCH PPS payments would be unaffected, that is, would be neither greater than nor less than the estimated aggregate LTCH PPS payments that would have been made without the MS-LTC-DRG classification and relative weight changes. Specifically, in that same final rule, we established under § 412.517(b) that the annual update to the MS-LTC-DRG classifications and relative weights be done in a budget neutral manner. For a detailed discussion on the establishment of the requirement to update the MS-LTC-DRG classifications and relative weights in a budget neutral manner, we refer readers to the RY 2008 LTCH PPS final rule (72 FR 26880 through 26884). Updating the MS-LTC-DRGs in a budget neutral manner results in an annual update to the individual MS-LTC-DRG classifications and relative weights based on the most recent available data to reflect changes in relative LTCH resource use. To accomplish this, the MS-LTC-DRG relative weights are uniformly adjusted to ensure that estimated aggregate payments under the LTCH PPS would not be affected (that is, decreased or increased). Consistent with that provision, we are proposing to update the MS-LTC-DRG classifications and relative weights for FY 2009 based on the most recent available data and include a proposed budget neutrality adjustment that would be applied in determining the proposed MS-LTC-DRG relative weights.

To ensure budget neutrality in updating the proposed MS-LTC-DRG classifications and proposed relative weights under § 412.517(b), consistent with the budget neutrality methodology we established in the FY 2008 IPPS final rule with comment period (72 FR 47295 through 47296), in determining the proposed budget neutrality adjustment for FY 2009 in this proposed rule, we are proposing to use a method that is similar to the methodology used under the IPPS. Specifically, for FY 2009, after recalibrating the proposed MS-LTC-DRG relative weights as we do under the methodology as described in detail in Steps 1 through 6 above, we would calculate and apply a normalization factor to those relative weights to ensure that estimated payments are not influenced by changes in the composition of case types or the changes being proposed to the classification system. That is, the proposed normalization adjustment is intended to ensure that the recalibration of the proposed MS-LTC-DRG relative weights (that is, the process itself) neither increases nor decreases total estimated payments.

To calculate the proposed normalization factor for FY 2009, we would use the following steps: (1) We use the most recent available claims data (FY 2007) and the proposed MS-LTC-DRG relative weights (determined above in Steps 1 through 6 above) to calculate the average CMI; (2) we group the same claims data (FY 2007) using the FY 2008 GROUPER (Version 25.0) and FY 2008 relative weights (established in the FY 2008 IPPS final rule with comment period (72 FR 47295 through 47296)) and calculate the average CMI; and (3), we compute the ratio of these average CMIs by dividing the average CMI determined in step (2) by the average CMI determined in step (1). In determining the proposed MS-LTC-DRG relative weights for FY 2009, based on the latest available LTCH claims data, the normalization factor is estimated as 1.038266, which would be applied in determining each proposed MS-LTC-DRG relative weight. That is, each proposed MS-LTC-DRG relative weight would be multiplied by 1.038266 in the first step of the budget neutrality process. Accordingly, the proposed relative weights in Table 11 in the Addendum of this proposed rule reflect this proposed normalization factor. We also ensure that estimated aggregate LTCH PPS payments (based on the most recent available LTCH claims data) after reclassification and recalibration (the new proposed FY 2009 MS-LTC-DRG classifications and relative weights) are equal to estimated aggregate LTCH PPS payments (for the same most recent available LTCH claims data) before reclassification and recalibration (the existing FY 2008 MS-DRG classifications and relative weights). Therefore, we would calculate the proposed budget neutrality adjustment factor by simulating estimated total payments under both sets of GROUPERs and relative weights using current LTCH PPS payment policies (RY 2008) and the most recent available claims data (from the FY 2007 MedPAR file).

Accordingly, we are proposing to use RY 2008 LTCH PPS rates and policies in determining the proposed FY 2009 budget neutrality adjustment in this proposed rule, using the following steps: (1) We simulate estimated total payments using the normalized proposed relative weights under GROUPER Version 26.0 (as described above); (2) we simulate estimated total payments using the FY 2008 GROUPER (Version 25.0) and FY 2008 MS-LTC-DRG relative weights (as established in the FY 2008 IPPS final rule (72 FR 47295 through 47296)); (3) we calculate the ratio of these estimated total payments by dividing the estimated total payments determined in step (2) by the estimated total payments determined in step (1). Then, each of the normalized proposed relative weights is multiplied by the proposed budget neutrality factor to determine the budget neutral proposed relative weight for each proposed MS-LTC-DRG.

Accordingly, in determining the proposed MS-LTC-DRG relative weights for FY 2009 in this proposed rule, based on the most recent available LTCH claims data, we are proposing a budget neutrality factor of 0.99965, which would be applied to the normalized proposed relative weights (described above). The proposed FY 2009 MS-LTC-DRG relative weights in Table 11 in the Addendum of this proposed rule reflect this proposed budget neutrality factor. Furthermore, we expect that we will have established payments rates and policies for RY 2009 prior to the development of the FY 2009 IPPS final rule. Therefore, for purposes of determining the FY 2009 budget neutrality factor in the final rule, we are proposing that we would simulate estimated total payments using the most recent LTCH PPS payment policies and LTCH claims data that are available at that time.

Table 11 in the Addendum to this proposed rule lists the proposed MS-LTC-DRGs and their respective proposed budget neutral relative weights, geometric mean length of stay, and five-sixths of the geometric mean length of stay (used in the determination of short-stay outlier payments under § 412.529) for FY 2009.

J. Proposed Add-On Payments for New Services and Technologies

1. Background

Sections 1886(d)(5)(K) and (L) of the Act establish a process of identifying and ensuring adequate payment for new medical services and technologies (sometimes collectively referred to in this section as "new technologies") under the IPPS. Section 1886(d)(5)(K)(vi) of the Act specifies that a medical service or technology will be considered new if it meets criteria established by the Secretary after notice and opportunity for public comment. Section 1886(d)(5)(K)(ii)(I) of the Act specifies that the process must apply to a new medical service or technology if, "based on the estimated costs incurred with respect to discharges involving such service or technology, the DRG prospective payment rate otherwise applicable to such discharges under this subsection is inadequate."

The regulations implementing this provision establish three criteria for new medical services and technologies to receive an additional payment. First, 42CFR412.87(b)(2) states that a specific medical service or technology will be considered new for purposes of new medical service or technology add-on payments until such time as Medicare data are available to fully reflect the cost of the technology in the DRG weights through recalibration. Typically, there is a lag of 2 to 3 years from the point a new medical service or technology is first introduced on the market (generally on the date that the technology receives FDA approval/clearance) and when data reflecting the use of the medical service or technology are used to calculate the DRG weights. For example, data from discharges occurring during FY 2007 are used to calculate the FY 2009 DRG weights in this proposed rule. Section 412.87(b)(2) of our existing regulations provides that "a medical service or technology may be considered new within 2 or 3 years after the point at which data begin to become available reflecting the ICD-9-CM code assigned to the new medical service or technology (depending on when a new code is assigned and data on the new medical service or technology become available for DRG recalibration). After CMS has recalibrated the DRGs based on available data to reflect the costs of an otherwise new medical service or technology, the medical service or technology will no longer be considered "new" under the criterion for this section."

The 2-year to 3-year period during which a medical service or technology can be considered new would ordinarily begin on the date on which the medical service or technology received FDA approval or clearance. (We note that, for purposes of this section of the proposed rule, we refer to both FDA approval and FDA clearance as FDA "approval.") However, in some cases, initially there may be no Medicare data available for the new service or technology following FDA approval. For example, the newness period could extend beyond the 2-year to 3-year period after FDA approval is received in cases where the product initially was generally unavailable to Medicare patients following FDA approval, such as in the case of a national noncoverage determination, or if there was some documented delay in bringing the product onto the market after that approval (for instance, component production or drug production has been postponed following FDA approval due to shelf life concerns or manufacturing issues). After the DRGs have been recalibrated to reflect the costs of an otherwise new medical service or technology, the medical service or technology is no longer eligible for special add-on payment for new medical services or technologies (§ 412.87(b)(2)). For example, an approved new technology that received FDA approval in October 2007 and entered the market at that time may be eligible to receive add-on payments as a new technology for discharges occurring before October 1, 2010 (the start of FY 2011). Because the FY 2011 DRG weights would be calculated using FY 2009 MedPAR data, the costs of such a new technology would be fully reflected in the FY 2011 DRG weights. Therefore, the new technology would no longer be eligible to receive add-on payments as a new technology for discharges occurring in FY 2011 and thereafter.

Section 412.87(b)(3) further provides that, to be eligible for the add-on payment for new medical services or technologies, the DRG prospective payment rate otherwise applicable to the discharge involving the new medical services or technologies must be assessed for adequacy. Under the cost criterion, to assess whether a new technology would be inadequately paid under the applicable DRG-prospective payment rate, we evaluate whether the charges for cases involving the new technology exceed certain threshold amounts. In the FY 2004 IPPS final rule (68 FR 45385), we established the threshold at the geometric mean standardized charge for all cases in the DRG plus 75 percent of 1 standard deviation above the geometric mean standardized charge (based on the logarithmic values of the charges and converted back to charges) for all cases in the DRG to which the new medical service or technology is assigned (or the case-weighted average of all relevant DRGs, if the new medical service or technology occurs in more than one DRG).

However, section 503(b)(1) of Pub. L. 108-173 amended section 1886(d)(5)(K)(ii)(I) of the Act to provide that, beginning in FY 2005, CMS will apply "a threshold * * * that is the lesser of 75 percent of the standardized amount (increased to reflect the difference between cost and charges) or 75 percent of one standard deviation for the diagnosis-related group involved." (We refer readers to section IV.D. of the preamble to the FY 2005 IPPS final rule (69 FR 49084) for a discussion of the revision of the regulations to incorporate the change made by section 503(b)(1) of Pub. L. 108-173.) Table 10 in section XIX. of the interim final rule with comment period published in the Federal Register on November 27, 2007, contained the final thresholds that are being used to evaluate applications for new technology add-on payments for FY 2009 (72 FR 66888 through 66892). An applicant must demonstrate that the cost threshold is met using information from inpatient hospital claims.

With regard to the issue of whether the HIPAA Privacy Rule at 45 CFR Parts 160 and 164 applies to claims information that providers submit with applications for new technology add-on payments, we addressed this issue in the September 7, 2001 final rule that established the new technology add-on payment regulations (66 FR 46917). In the preamble to that final rule, we explained that health plans, including Medicare, and providers that conduct certain transactions electronically, including the hospitals that would be receiving payment under the FY 2001 IPPS final rule, are required to comply with the HIPAA Privacy Rule. We further explained how such entities could meet the applicable HIPAA requirements by discussing how the HIPAA Privacy Rule permitted providers to share with health plans information needed to ensure correct payment, if they had obtained consent from the patient to use that patient's data for treatment, payment, or health care operations. We also explained that because the information to be provided within applications for new technology add-on payment would be needed to ensure correct payment, no additional consent would be required. The HHS Office of Civil Rights has since amended the HIPAA Privacy Rule, but the results remain. The HIPAA Privacy Rule no longer requires covered entities to obtain consent from patients to use or disclose protected health information for treatment, payment, or health care operations, and expressly permits such entities to use or to disclose protected health information for any of these purposes. (We refer readers to 45 CFR 164.502(a)(1)(ii), and 164.506(c)(1) and (c)(3), and the Standards for Privacy of Individually Identifiable Health Information published in the Federal Register on August 14, 2002, for a full discussion of changes in consent requirements.)

Section 412.87(b)(1) of our existing regulations provides that a new technology is an appropriate candidate for an additional payment when it represents "an advance that substantially improves, relative to technologies previously available, the diagnosis or treatment of Medicare beneficiaries." For example, a new technology represents a substantial clinical improvement when it reduces mortality, decreases the number of hospitalizations or physician visits, or reduces recovery time compared to the technologies previously available. (We refer readers to the September 7, 2001 final rule for a complete discussion of this criterion (66 FR 46902).)

The new medical service or technology add-on payment policy under the IPPS provides additional payments for cases with relatively high costs involving eligible new medical services or technologies while preserving some of the incentives inherent under an average-based prospective payment system. The payment mechanism is based on the cost to hospitals for the new medical service or technology. Under § 412.88, if the costs of the discharge (determined by applying CCRs as described in § 412.84(h)) exceed the full DRG payment, Medicare will make an add-on payment equal to the lesser of: (1) 50 percent of the estimated costs of the new technology (if the estimated costs for the case including the new technology exceed Medicare's payment) or (2) 50 percent of the difference between the full DRG payment and the hospital's estimated cost for the case. If the amount by which the actual costs of a new medical service or technology case exceeds the full DRG payment (including payments for IME and DSH, but excluding outlier payments) by more than the 50-percent marginal cost factor, Medicare payment is limited to the full DRG payment plus 50 percent of the estimated costs of the new technology.

Section 1886(d)(4)(C)(iii) of the Act requires that the adjustments to annual DRG classifications and relative weights must be made in a manner that ensures that aggregate payments to hospitals are not affected. Therefore, in the past, we accounted for projected payments under the new medical service and technology provision during the upcoming fiscal year at the same time we estimated the payment effect of changes to the DRG classifications and recalibration. The impact of additional payments under this provision was then included in the budget neutrality factor, which was applied to the standardized amounts and the hospital-specific amounts. However, section 503(d)(2) of Pub. L. 108-173 provides that there shall be no reduction or adjustment in aggregate payments under the IPPS due to add-on payments for new medical services and technologies. Therefore, add-on payments for new medical services or technologies for FY 2005 and later years have not been budget neutral.

Applicants for add-on payments for new medical services or technologies for FY 2010 must submit a formal request, including a full description of the clinical applications of the medical service or technology and the results of any clinical evaluations demonstrating that the new medical service or technology represents a substantial clinical improvement, along with a significant sample of data to demonstrate the medical service or technology meets the high-cost threshold. Complete application information, along with final deadlines for submitting a full application, will be available on our Web site at: http://www.cms.hhs.gov/AcuteInpatientPPS/08_newtech.asp#TopOfPage. To allow interested parties to identify the new medical services or technologies under review before the publication of the proposed rule for FY 2010, the Web site will also list the tracking forms completed by each applicant.

The Council on Technology and Innovation (CTI) at CMS oversees the agency's cross-cutting priority on coordinating coverage, coding and payment processes for Medicare with respect to new technologies and procedures, including new drug therapies, as well as promoting the exchange of information on new technologies between CMS and other entities. The CTI, composed of senior CMS staff and clinicians, was established under section 942(a) of Pub. L. 108-173. It is co-chaired by the Director of the Center for Medicare Management (CMM), who is also designated as the CTI's Executive Coordinator, and the Director of the Office of Clinical Standards and Quality (OCSQ).

The specific processes for coverage, coding, and payment are implemented by CMM, OCSQ, and the local claims-payment contractors (in the case of local coverage and payment decisions). The CTI supplements rather than replaces these processes by working to assure that all of these activities reflect the agency-wide priority to promote high-quality, innovative care, and at the same time to streamline, accelerate, and improve coordination of these processes to ensure that they remain up to date as new issues arise. To achieve its goals, the CTI works to streamline and create a more transparent coding and payment process, improve the quality of medical decisions, and speed patient access to effective new treatments. It is also dedicated to supporting better decisions by patients and doctors in using Medicare-covered services through the promotion of better evidence development, which is critical for improving the quality of care for Medicare beneficiaries.

The agency plans to continue its Open Door forums with stakeholders who are interested in CTI's initiatives. In addition, to improve understanding of CMS processes for coverage, coding, and payment and how to access them, the CTI is developing an "innovator's guide" to these processes. This guide will, for example, outline regulation cycles and application deadlines. The intent is to consolidate this information, much of which is already available in a variety of CMS documents and in various places on CMS's Web site, in a user-friendly format. In the meantime, we invite any product developers with specific issues involving the agency to contact us early in the process of product development if they have questions or concerns about the evidence that would be needed later in the development process for the agency's coverage decisions for Medicare.

The CTI aims to provide information on CTI activities to stakeholders, including Medicare beneficiaries, advocates, medical product manufacturers, providers, and health policy experts, and other stakeholders with useful information on CTI initiatives. Stakeholders with further questions about Medicare's coverage, coding, and payment processes, or who want further guidance about how they can navigate these processes, can contact the CTI at CTI@cms.hhs.gov or from the "Contact Us" section of the CTI home page ( http://www.cms.hhs.gov/CouncilonTechInnov/ ).

2. Public Input Before Publication of a Notice of Proposed Rulemaking on Add-On Payments

Section 1886(d)(5)(K)(viii) of the Act, as amended by section 503(b)(2) of Pub. L. 108-173, provides for a mechanism for public input before publication of a notice of proposed rulemaking regarding whether a medical service or technology represents a substantial clinical improvement or advancement. The process for evaluating new medical service and technology applications requires the Secretary to-

•Provide, before publication of a proposed rule, for public input regarding whether a new service or technology represents an advance in medical technology that substantially improves the diagnosis or treatment of Medicare beneficiaries;

•Make public and periodically update a list of the services and technologies for which applications for add-on payments are pending;

•Accept comments, recommendations, and data from the public regarding whether a service or technology represents a substantial clinical improvement; and

•Provide, before publication of a proposed rule, for a meeting at which organizations representing hospitals, physicians, manufacturers, and any other interested party may present comments, recommendations, and data regarding whether a new medical service or technology represents a substantial clinical improvement to the clinical staff of CMS.

In order to provide an opportunity for public input regarding add-on payments for new medical services and technologies for FY 2009 before publication of the FY 2009 IPPS proposed rule, we published a notice in the Federal Register on December 28, 2007 (72 FR 73845 through 73847), and held a town hall meeting at the CMS Headquarters Office in Baltimore, MD, on February 21, 2008. In the announcement notice for the meeting, we stated that the opinions and alternatives provided during the meeting would assist us in our evaluations of applications by allowing public discussion of the substantial clinical improvement criterion for each of the FY 2009 new medical service and technology add-on payment applications before the publication of the FY 2009 IPPS proposed rule.

Approximately 70 individuals attended the town hall meeting in person, while approximately 20 additional participants listened over an open telephone line. Each of the four FY 2009 applicants presented information on its technology, including a focused discussion of data reflecting the substantial clinical improvement aspect of the technology. We received two comments during the town hall meeting, which are summarized below. We considered each applicant's presentation made at the town hall meeting, as well as written comments submitted on each applicant's application, in our evaluation of the new technology add-on applications for FY 2009 in this proposed rule. We have summarized these comments below or, if applicable, indicated that no comments were received at the end of the discussion of each application.

Comment: One commenter addressed the substantial clinical improvement criterion. A medical device association stated that CMS' interpretation of the statutory criteria for new technology add-on payments is narrow and makes it difficult for potential applicants, especially small manufacturing companies, to qualify for new technology add-on payments. The commenter urged CMS to "deem a device to satisfy the substantial clinical improvement criteria if it was granted a humanitarian device exemption or priority review based on the fact that it represents breakthrough technologies, which offer significant advantages over existing approved alternatives, for which no alternatives exist, or the availability of which is in the best interests of the patients." In addition, the commenter remarked that this process would simplify CMS' evaluation of applications for new technology add-on payments and would promote access to innovative treatments, as intended by Congress. Although the commenter also made remarks that were unrelated to substantial clinical improvement, because the purpose of the town hall meeting was specifically to discuss substantial clinical improvement of pending new technology applications, those comments are not summarized in this proposed rule.

Response: With respect to the comment that CMS has a narrow interpretation of the statute that makes it difficult for applicants to meet the statutory criteria for a new technology add-on payment, we note that we have already specifically addressed the issue in the past (71 FR 47997 and 72 FR 47301). In addition, we addressed the comment concerning automatically deeming technologies granted a humanitarian device exemption (HDE) at 72 FR 47302. Further, because the purpose of the new technology town hall meeting was to discuss substantial clinical improvement of pending applications, we are not providing a response to the unrelated comments in this proposed rule.

Comment: One commenter, a medical technology association, submitted comments in reference to the MS-DRGs and the need to account for complexity as well as severity in making refinements to the DRG classification system. The commenter also made the following comments: CMS should raise the new technology marginal cost factor, adjust the newness policy to begin with the issuance of an ICD-9-CM code instead of the FDA approval date, provide access to the quarterly MedPAR updates, and allow for the use of external data for determining new technology payments (when CMS determines that the external data are unbiased and valid).

Response: Section 1886(d)(5)(K)(viii) of the Act requires that CMS accept comments, recommendations, and data from the public regarding whether a service or technology represents a substantial clinical improvement. Because the comments above are not related to the substantial clinical improvement criterion of pending applications, we are not providing a response to them in this proposed rule.

3. FY 2009 Status of Technologies Approved for FY 2008 Add-On Payments

We did not approve any applications for new technology add-on payments for FY 2008. For additional information, refer to the FY 2008 IPPS final rule with comment period (72 FR 47305 through 47307).

4. FY 2009 Applications for New Technology Add-On Payments

We received four applications to be considered for new technology add-on payment for FY 2009. A discussion of each of these applications is presented below. We note that, in the past, we have considered applications that had not yet received FDA approval, but were anticipating FDA approval prior to publication of the IPPS final rule. In such cases, we generally provide a more limited discussion of those technologies in the proposed rule because it is not known if these technologies will meet the newness criterion in time for us to conduct a complete analysis in the final rule. This year, three out of four applicants do not yet have FDA approval. Consequently, we have presented a limited analysis of them in this proposed rule.

a. CardioWest TM Temporary Total Artificial Heart System (CardioWest TM TAH-t)

SynCardia Systems, Inc. submitted an application for approval of the CardioWest TM temporary Total Artificial Heart system (TAH-t) for new technology add-on payments for FY 2009. The TAH-t is a technology that is used as a bridge to heart transplant device for heart transplant-eligible patients with end-stage biventricular failure. The TAH-t pumps up to 9.5 liters of blood per minute. This high level of perfusion helps improve hemodynamic function in patients, thus making them better heart transplant candidates.

The TAH-t was approved by the FDA on October 15, 2004, for use as a bridge to transplant device in cardiac transplant-eligible candidates at risk of imminent death from biventricular failure. The TAH-t is intended to be used in hospital inpatients. Some of the FDA's post-approval requirements include that the manufacturer agree to provide a post-approval study demonstrating that the success of the device at one center can be reproduced at other centers. The study was to include at least 50 patients who will be followed up to 1 year, including (but not limited to) the following endpoints; survival to transplant, adverse events, and device malfunction.

Presently, Medicare does not cover artificial heart devices, including the TAH-t. However, on February 01, 2008, CMS proposed to reverse a national noncoverage determination that would extend coverage to this technology within the confines of an FDA-approved clinical study. (To view the proposed National Coverage Determination (NCD), we refer readers to the CMS Web site at http://www.cms.hhs.gov/mcd/viewdraftdecisionmemo.asp?from2=viewdraftdecisionmemo.aspid=211. ) Should this proposal be finalized, it would become effective on May 01, 2008. Because Medicare's existing coverage policy with respect to this device has precluded it from being paid for by Medicare, we would not expect the costs associated with this technology to be currently reflected in the data used to determine MS-DRGs relative weights. As we have indicated in the past, although we generally believe that the newness period would begin on the date that FDA approval was granted, in cases where the applicant can demonstrate a documented delay in market availability subsequent to FDA approval, we would consider delaying the start of the newness period. This technology's situation represents one such case. We also note that section 1886(d)(5)(K)(ii)(II) of the Act requires that we provide for the collection of cost data for a new medical service or technology for a period of at least 2 years and no more than 3 years "beginning on the date on which an inpatient hospital code is issued with respect to the service or technology." Furthermore, the statute specifies that the term "inpatient hospital code" means any code that is used with respect to inpatient hospital services for which payment may be made under the IPPS and includes ICD-9-CM codes and any subsequent revisions. Although the TAH-t has been described by the ICD-9-CM code(s) (described below in the cost threshold discussion) since the time of its FDA approval, because the TAH-t has not been covered under the Medicare program (and, therefore, no Medicare payment has been made for this technology), this code is not "used with respect to inpatient hospital services for which payment" is made under the IPPS, and thus we assume that none of the costs associated with this technology would be reflected in the Medicare claims data used to recalibrate the MS-DRG weights. For this reason, despite its FDA approval date, it appears that this technology would still be eligible to be considered "new" for purposes of the new technology add-on payment if and when the proposal to reverse the national noncoverage determination concerning this technology is finalized. Therefore, based on this information, it appears that the TAH-t would meet the newness criterion on the date that Medicare coverage begins, should the proposed NCD be finalized.

In an effort to demonstrate that TAH-t would meet the cost criterion, the applicant submitted data based on 28 actual cases of the TAH-t. The data included 6 cases (or 21.4 percent of cases) from 2005, 13 cases (or 46.5 percent of cases) from 2006, 7 cases (or 25 percent of cases) from 2007, and 2 cases (or 7.1 percent of cases) from 2008. Currently, cases involving the TAH-t are assigned to MS-DRG 215 (Other Heart Assist System Implant). As discussed below in this section, we are proposing to remove the TAH-t from MS-DRG 215 and reassign the TAH-t to MS-DRGs 001 (Heart Transplant or Implant of Heart Assist System with MCC) and 002 (Heart Transplant or Implant of Heart Assist System without MCC). Therefore, to determine if the technology meets the cost criterion, it is appropriate to compare the average standardized charge per case to the thresholds for MS-DRGs 001, 002, and 215 included in Table 10 of the November 27, 2007 interim final rule (72 FR 66888 through 66889). The thresholds for MS-DRGs 001, 002, and 215 from Table 10 are $345,031, $178,142, and $151,824, respectively. Based on the 28 cases the applicant submitted, the average standardized charge per case was $731,632. Because the average standardized charge per case is much greater than the thresholds cited above for MS-DRG 215 (and MS-DRGs 001 and 002, should the proposal to reassign the TAH-t be finalized), the applicant asserted that the TAH-t meets the cost criterion whether or not the costs were analyzed by using either a case-weighted threshold or case-weighted standardized charge per case.

In addition to analyzing the costs of actual cases involving the TAH-t, the applicant searched the FY 2006 MedPAR file to identify cases involving patients who would have potentially been eligible to receive the TAH-t. The applicant submitted three different MedPAR analyses. The first MedPAR analysis involved a search for cases using ICD-9-CM diagnosis code 428.0 (Congestive heart failure) in combination with ICD-9-CM procedure code 37.66 (Insertion of implantable heart assist system), and an inpatient hospital length of stay greater than or equal to 60 days. The applicant found two cases that met this criterion, which had an average standardized charge per case of $821,522. The second MedPAR analysis searched for cases with ICD-9-CM diagnosis code 428.0 (Congestive heart failure) and one or more of the following ICD-9-CM procedure codes: 37.51 (Heart transplant), 37.52 (Implantation of total heart replacement system), 37.64 (Removal of heart assist system), 37.66 (Insertion of implantable heart assist system), or 37.68 (Insertion of percutaneous external heart assist device), and a length of stay greater than or equal to 60 days. The applicant found 144 cases that met this criterion, which had an average standardized charge per case of $841,827. The final MedPAR analysis searched for cases with ICD-9-CM procedure code 37.51 (Heart transplant) in combination with one of the following ICD-9-CM procedure codes: 37.52 (Implantation of total heart replacement system), 37.65 (Implantation of external heart system), or 37.66 (Insertion of implantable heart assist system). The applicant found 37 cases that met this criterion, which had an average standardized charge per case of $896,601. Because only two cases met the criterion for the first analysis, consistent with historical practice, we would not consider it to be of statistical significance and, therefore, would not rely upon it to demonstrate whether the TAH-t would meet the cost threshold. However, both of the additional analyses seem to provide an adequate number of cases to demonstrate whether the TAH-t would meet the cost threshold. We assume that none of the costs associated with this technology would be reflected in the MedPAR analyses that the applicant used to demonstrate that the technology would meet the cost criterion. We note that, under all three of the analyses the applicant performed, it identified cases that would have been eligible for the TAH-t, but did not remove charges that were unrelated to the TAH-t, nor did the applicant insert a proxy of charges related to the TAH-t. However, as stated above, the average standardized charge per case is much greater than any of the thresholds for MS-DRGs 001, 002, and 215. Therefore, even if the applicant were to approximate what the costs of cases eligible to receive the TAH-t would have been by removing non-TAH-t associated charges and inserting charges related to the TAH-t, it appears that the average standardized charges per case for cases eligible for the TAH-t would exceed the relevant thresholds from Table 10 (as discussed above) and would therefore appear to meet the cost criterion. We invite public comment on whether TAH-t meets the cost criterion.

As noted in section II.G. of this preamble, we are proposing to remove the TAH-t from MS-DRG 215 and reassign the TAH-t to MS-DRGs 001 and 002. As stated earlier, CMS is proposing to reverse a national noncoverage determination that would extend coverage to artificial heart devices within the confines of an FDA-approved clinical study, effective May 1, 2008. If this proposal is finalized, the MCE will require both the procedure code 37.52 (Implantation of total replacement heart system) and the diagnosis code reflecting clinical trial-V70.7 (Examination of participant in clinical trial). As we have previously mentioned, the TAH-t appears to meet the cost thresholds for MS-DRGs 001, 002, and 215. Therefore, its proposed reassignment from MS-DRG 215 to MS-DRGs 001 and 002 should have no material effect on meeting the cost thresholds in MS-DRGs 001 and 002 should the reassignment proposal be finalized.

The manufacturer states that the TAH-t is the only mechanical circulatory support device intended as a bridge-to-transplant for patients with irreversible biventricular failure. It also asserts that the TAH-t improves clinical outcomes because it has been shown to reduce mortality in patients who are otherwise in end-stage heart failure. In addition, the manufacturer claims that the TAH-t provides greater hemodynamic stability and end-organ perfusion, thus making patients who receive it better candidates for eventual heart transplant. We welcome comments from the public regarding whether the TAH-t represents a substantial clinical improvement.

We did not receive any written comments or public comments at the town hall meeting regarding the substantial clinical improvement aspects of this technology.

b. Emphasys Medical Zephyr® Endobronchial Valve (Zephyr® EBV)

Emphasys Medical submitted an application for new technology add-on payments for FY 2009 for the Emphasys Medical Zephyr® Endobronchial Valve (Zephyr® EBV). The Zephyr® EBV is intended to treat patients with emphysema by reducing volume in the diseased, hyperinflated portion of the emphysematous lung with fewer risks and complications than with more invasive surgical alternatives. Zephyr® EBV therapy involves placing small, one-way valves in the patients' airways to allow air to flow out of, but not into, the diseased portions of the lung thus reducing the hyperinflation. A typical procedure involves placing three to four valves in the target lobe using a bronchoscope, and the procedure takes approximately 20 to 40 minutes to complete. The Zephyr® EBVs are designed to be relatively easy to place, and are intended to be removable so that, unlike more risky surgical alternatives such as Lung Volume Reduction Surgery (LVRS) or Lung Transplant, the procedure has the potential to be fully reversible.

Currently, the Zephyr® EBV has yet to receive approval from the FDA, but the manufacturer indicated to CMS that it expects to receive its FDA approval in the second or third quarter of 2008. Because the technology is not yet approved by the FDA, we will limit our discussion of this technology to data that the applicant submitted, rather than make specific proposals with respect to whether the device would meet the new technology add-on criteria.

In an effort to demonstrate that the Zephyr® EBV would meet the cost criterion, the applicant searched the FY 2006 MedPAR file for cases with one of the following ICD-9-CM diagnosis codes: 492.0 (Emphysematous bleb), 492.8 (Other emphysema, NEC), or 496 (Chronic airway obstruction, NEC). Based on the diagnosis codes searched by the applicant, cases of the Zephyr® EBV would be most prevalent in MS-DRGs 190 (Chronic Obstructive Pulmonary Disease with MCC), 191 (Chronic Obstructive Pulmonary Disease with CC), and 192 (Chronic Obstructive Pulmonary Disease without CC/MCC). The applicant found 1,869 cases (or 12.8 percent of cases) in MS-DRG 190, 5,789 cases (or 39.5 percent of cases) in MS-DRG 191, and 6,995 cases (or 47.7 percent of cases) in MS-DRG 192 (which equals a total of 14,653 cases). The average standardized charge per case was $21,567 for MS-DRG 190, $15,494 for MS-DRG 191, and $11,826 for MS-DRG 192. The average standardized charge per case does not include charges related to the Zephyr® EBV; therefore, it is necessary to add the charges related to the device to the average standardized charge per case in evaluating the cost threshold criteria. Although the applicant submitted data related to the estimated cost of the Zephyr® EBV per case, the applicant noted that the cost of the device was proprietary information because the device is not yet available on the open market. The applicant estimates $23,920 in charges related to the Zephyr® EBV (based on a 100 percent charge markup of the cost of the device). In addition to case-weighting the data based on the amount of cases that the applicant found in the FY 2006 MedPAR file, the applicant case-weighted the data based on its own projections of how many Medicare cases it would expect to map to MS-DRGs 190, 191, and 192 in FY 2009. The applicant projects that, 5 percent of the cases would map to MS-DRG 190, 15 percent of the cases would map to MS-DRG 191, and 80 percent of the cases would map to MS-DRG 192. Adding the charges related to the device to the average standardized charge per case (based on the applicant's projected case distribution) resulted in a case-weighted average standardized charge per case of $36,782 ($12,862 plus $23,920). Using the thresholds published in Table 10 (72 FR 66889), the case-weighted threshold for MS-DRGs 190, 191, and 192 was $18,394. Because the case-weighted average standardized charge per case for the applicable MS-DRGs exceed the case-weighted threshold amount, the applicant maintains that the Zephyr® EBV would meet the cost criterion. As noted above, the applicant also performed a case-weighted analysis of the data based on the 14,653 cases the applicant found in the FY 2006 MedPAR file. Based on this analysis, the applicant found that the case-weighted average standardized charge per case ($38,441 based on the 14,653 cases) exceeded the case-weighted threshold ($20,606 based on the 14,653 cases). Based on both analyses described above, it appears that the applicant would meet the cost criterion. We invite public comment on whether Zephyr® EBV meets the cost criterion.

The applicant asserts that the Zephyr® EBV is a substantial clinical improvement because it provides a new therapy along the continuum of care for patients with emphysema that offers improvement in lung function over standard medical therapy while incurring significantly less risk than more invasive treatments such as LVRS and lung transplant. Specifically, the applicant submitted data from the ongoing pivotal Endobronchial Valve for Emphysema Palliation (VENT) trial,14which compared 220 patients who received EBV treatment to 101 patients who received standard medical therapy, including bronchodilators, steroids, mucolytics, and supplemental oxygen. At 6 months, patients who received the Zephyr® EBV had an average of 7.2 percent and 5.8 percent improvement (compared to standard medical therapy) in the primary effectiveness endpoints of the Forced Expiratory Volume in 1 second test (FEV1), and the 6 Minute Walk Test (6MWT), respectively. Both results were determined by the applicant to be statistically significant. The FEV1 results were determined using the t-test parametric confidence intervals (the p value determined using the one-side t-test adjusted for unequal variance) and the 6MWT results were determined using the Mann-Whitney nonparametric confidence intervals (the p value was calculated using the one-sided Wilcoxon rank sum test). However, the data also showed that patients who received the Zephyr® EBV experienced a number of adverse events, including hemoptyis, pneumonia, respiratory failure, pneumothorax, and COPD exacerbations, as well as valve migrations and expectorations that, in some cases, required repeat bronchoscopy. The manufacturer also submitted the VENT pivotal trial 1-year follow-up data, but has requested that the data not be disclosed because it has not yet been presented publicly nor published in a peer-reviewed journal.

Footnotes:

14 Strange, Charlie., et al., design of the Endobronchial Valve for Emphysema Palliation trial (VENT): A Nonsurgical Method of Lung Volume Reduction, BMC Pulmonary Medicine. 2007; 7:10.

While CMS recognizes that the Zephyr® EBV therapy is significantly less risky than LVRS and lung transplant, we are concerned that the benefits as shown in the VENT pivotal trial may not outweigh the risks when compared with medical therapy alone. Further, we note that, according to the applicant, the Zephyr® EBV is intended for use in many patients who are ineligible for LVRS and/or lung transplant (including those too sick to undergo more invasive surgery and those with lower lobe predominant disease distribution), but that certain patients (that is, those with upper lobe predominant disease distribution) could be eligible for either surgery or the Zephyr® EBV. We welcome comments from the public on both the patient population who would be eligible for the technology, and whether the Zephyr® EBV represents a substantial clinical improvement in the treatment of patients with emphysema.

We received written comments from the manufacturer and its presenters at the town hall meeting clarifying some questions that were raised at the town hall meeting. Specifically, these commenters explained that, in general, the target population for the Zephyr® EBV device was the same population that could benefit from LVRS, and also includes some patients who were too sick to undergo surgery. The commenters also explained that patients with emphysema with more heterogeneous lung damage were more likely to benefit from the device.

We welcome public comments regarding where exactly this technology falls in the continuum of care of patients with emphysema, and for whom the risk/benefit ratio is most favorable.

c. Oxiplex®

FzioMed, Inc. submitted an application for new technology add-on payments for FY 2009 for Oxiplex®. Oxiplex® is an absorbable, viscoelastic gel made of carboxymethylcellulose (CMC) and polyethylene oxide (PEO) that is intended to be surgically implanted during a posterior discectomy, laminotomy, or laminectomy. The manufacturer asserts that the gel reduces the potential for inflammatory mediators that injure, tether, or antagonize the nerve root in the epidural space by creating an acquiescent, semi-permeable environment to protect against localized debris. These proinflammatory mediators (phospholipase A and nitric oxide), induced or extruded by intervertebral discs, may be responsible for increased pain during these procedures. The manufacturer also asserts that Oxiplex® is a unique material in that it coats tissue, such as the nerve root in the epidural space, to protect the nerve root from the effects of inflammatory mediators originating from either the nucleus pulposus, from blood derived inflammatory cells, or cytokines during the healing process.

Oxiplex® is expecting to receive premarket approval from the FDA by June 2008. Because the technology is not yet approved by the FDA, we will limit our discussion of this technology to data that the applicant submitted, rather than make specific proposals with respect to whether the device would meet the new technology add-on payment criteria.

With regard to the newness criterion, we are concerned that Oxiplex® may be substantially similar to adhesion barriers that have been on the market for several years. We also note that Oxiplex® has been marketed as an adhesion barrier in other countries outside of the United States. The manufacturer maintains that Oxiplex® is different from adhesion barriers in several ways, including chemical composition, method of action, surgical application (that is, it is applied liberally to the nerve root and surrounding neural tissues as opposed to minimally only to nerve elements), and tissue response (noninflammatory as opposed to inflammatory). We welcome comments from the public on this issue.

In an effort to demonstrate that the technology meets the cost criterion, the applicant searched the FY 2006 MedPAR file for cases with ICD-9-CM procedure codes 03.09 (Other exploration and decompression of spinal canal) or 80.51 (Excision of interveterbral disc) that mapped to CMS DRGs 499 and 500 (CMS DRGs 499 and 500 are crosswalked to MS-DRGs 490 and 491 (Back and Neck Procedures except Spinal Fusion with or without CC)). Because these cases do not include charges associated with the technology, the applicant determined it was necessary to add an additional $7,143 in charges to the average standardized charge per case of cases that map to MS-DRGs 490 and 491. (To do this, the applicant used a methodology of inflating the costs of the technology by the average CCR computed by using the average costs and charges for supplies for cases with ICD-9-CM procedure codes 03.09 and 80.51 that map to MS-DRGs 490 and 491). Of the 221,505 cases the applicant found, 95,340 cases (or 43 percent of cases) would map to MS-DRG 490, which has an average standardized charge of $60,301, and 126,165 cases (or 57 percent of cases) would map to MS-DRG 491, which has an average standardized charge per case of $43,888. This resulted in a case-weighted average standardized charge per case of $50,952. The case-weighted threshold for MS-DRGs 490 and 491 was $27,481. Because the case-weighted average standardized charge per case exceeds the case-weighted threshold in MS-DRGs 490 and 491, the applicant maintains that Oxiplex® would meet the cost criterion. We invite public comment on whether Oxiplex® meets the cost criterion.

The manufacturer maintains that Oxiplex® is a substantial clinical improvement because it "creates a protective environment around the neural tissue that limits nerve root exposure to post-surgical irritants and damage and thus reduces adverse outcomes associated with Failed Back Surgery Syndrome (FBSS) following surgery." The manufacturer also claims that theOxiplex® gel reduces leg and back pain after discectomy, laminectomy, and laminotomy. The manufacturer also asserts that the use of Oxiplex® is consistent with fewer revision surgeries. (During the FDA Investigational Device Exemption (IDE) trial, one Oxiplex® patient required revision surgery compared to six control patients.) However, as we noted previously in this section, we are concerned that Oxiplex® may be substantially similar to adhesion barriers that have been on the market for several years. We are also concerned that even if we were to determine that Oxiplex is not substantially similar to existing adhesion barriers, there may still be insufficient evidence to support the manufacturer's claims that Oxiplex® reduces pain associated with spinal surgery. In addition, we have found no evidence to support the manufacturer's claims regarding mode of action, degree of dural healing, degree of wound healing, and local tissue response such as might be shown in animal studies. We welcome comments from the public regarding whether Oxiplex® represents a substantial clinical improvement.

We did not receive any written comments or public comments at the town hall meeting regarding the substantial clinical improvement aspects of this technology.

d. TherOx Downstream® System

TherOx, Inc. submitted an application for new technology add-on payments for FY 2009 for the TherOx Downstream® System (Downstream® System). The Downstream® System uses SuperSaturatedOxygen Therapy (SSO2) that is designed to limit myocardial necrosis by minimizing microvascular damage in acute myocardial infarction (AMI) patients following intervention with Percutaneous Transluminal Coronary Angioplasty (PTCA), and coronary stent placement by perfusing the affected myocardium with blood that has been supersaturated with oxygen. SSO2 therapy refers to the delivery of superoxygenated arterial blood directly to areas of myocardial tissue that have been reperfused using PTCA and stent placement, but which may still be at risk. The desired effect of SSO2 therapy is to reduce infarct size and thus preserve heart muscle and function. The DownStream® System is the console portion of a disposable cartridge-based system that withdraws a small amount of the patient's arterial blood, mixes it with a small amount of saline, and supersaturates it with oxygen to create highly oxygen-enriched blood. The superoxygenated blood is delivered directly to the infarct-related artery via the TherOx infusion catheter. SSO2 therapy is a catheter laboratory-based procedure. Additional time in the catheter lab area is an average of 100 minutes. The manufacturer claims that the SSO2 therapy duration lasts 90 minutes and requires an additional 10 minutes post-procedure preparation for transfer time. The TherOx Downstream® System is currently not FDA approved; however, the manufacturer states that it expects to receive FDA approval in the second quarter of 2008. Because the technology is not yet approved by the FDA, we will limit our discussion of this technology to data that the applicant submitted, rather than make specific proposals with respect to whether the device would meet the new technology add-on criteria.

In an effort to demonstrate that it would meet the cost criterion, the applicant submitted two analyses. The applicant believes that cases that would be eligible for the Downstream® System would most frequently group to MS-DRGs 246 (Percutaneous Cardiovascular Procedure with Drug-Eluting Stent with MCC or 4+Vessels/Stents), 247 (Percutaneous Cardiovascular Procedure with Drug-Eluting Stent without MCC), 248 (Percutaneous Cardiovascular Procedure with Non-Drug-Eluting Stent with MCC or 4+Vessels/Stents), and 249 (Percutaneous Cardiovascular Procedure with Non-Drug-Eluting Stent without MCC). The first analysis used data based on 83 clinical trial patients from 10 clinical sites. Of the 83 cases, 78 were assigned to MS-DRGs 246, 247, 248, or 249. The data showed that 32 of these patients were 65 years old or older. There were 12 cases (or 15.4 percent of cases) in MS-DRG 246, 56 cases (or 71.8 percent of cases) in MS-DRG 247, 2 cases (or 2.6 percent of cases) in MS-DRG 248, and 8 cases (or 10.3 percent of cases) in MS-DRG 249. (The remaining five cases grouped to MS-DRGs that the technology would not frequently group to and therefore are not included in this analysis.) The average standardized charge per case for MS-DRGs 246, 247, 248, and 249 was $66,730, $53,963, $54,977, and $41,594, respectively. The case-weighted average standardized charge per case for the four MS-DRGs listed above is $54,665. Based on the threshold from Table 10 (72 FR 66890), the case-weighted threshold for the four MS-DRGs listed above was $49,303. The applicant also searched the FY 2006 MedPAR file to identify cases that would be eligible for theDownstream® System. The applicant specifically searched for cases with primary ICD-9-CM diagnosis code 410.00 (Acute myocardial infarction of anterolateral wall with episode of care unspecified), 410.01 (Acute myocardial infarction of anterolateral wall with initial episode of care), 410.10 (Acute myocardial infarction of other anterior wall with episode of care unspecified), or 410.11 (Acute myocardial infarction of other anterior wall with initial episode of care) in combination with ICD-9-CM procedure code of 36.06 (Insertion of non-drug-eluting coronary artery stent(s)) or 36.07 (Insertion of drug-eluting coronary artery stent(s)). The applicant's search found 13,527 cases within MS-DRGs 246, 247, 248, and 249 distributed as follows: 2,287 cases (or 16.9 percent of cases) in MS-DRG 246; 9,691 cases (or 71.6 percent of cases) in MS-DRG 247; 402 cases (or 3 percent of cases) in MS-DRG 248; and 1,147 cases (or 8.5 percent of cases) in MS-DRG 249. Not including the charges associated with the technology, the geometric mean standardized charge per case for MS-DRGs 246, 247, 248, and 249 was $59,631, $42,357, $49,718 and $37,446, respectively. Therefore, based on this analysis, the total case-weighted geometric mean standardized charge per case across these MS-DRGs was $45,080. The applicant estimated that it was necessary to add an additional $21,620 in charges to the total case-weighted geometric mean standardized charge per case. The applicant included charges for supplies and tests related to the technology, charges for 100 minutes of additional procedure time in the catheter laboratory and charges for the technology itself in the additional charge amount referenced above. The inclusion of these charges would result in a total case-weighted geometric mean standardized charge per case of $66,700. The case-weighted threshold for MS-DRGs 246, 247, 248, and 249 (from Table 10 (72 FR 66889)) was $49,714. Because the total case-weighted average standardized charge per case from the first analysis and the case-weighted geometric mean standardized charge per case from the second analysis exceeds the applicable case-weighted threshold, the applicant maintains the Downstream® System would meet the cost criterion. We invite public comment on whether Downstream® System meets the cost criterion.

The applicant asserts that the Downstream® System is a substantial clinical improvement because it reduces infarct size in acute AMI where PTCA and stent placement have also been performed. Data was submitted from the Acute Myocardial Infarction Hyperbaric Oxygen Treatment (AMIHOT) II trial, which was presented at the October 2007 Transcatheter Cardiovascular Therapeutics conference, but has not been published in peer reviewed literature, that showed an average of 6.5 percent reduction in infarct size as measured with Tc-99m Sestamibi imaging in patients who received supersaturated oxygen therapy. We note that those patients also showed a significantly higher incidence of bleeding complications. While we recognize that a reduction of infarct size may correlate with improved clinical outcomes, we question whether the degree of infarct size reduction found in the trial represents a substantial clinical improvement, particularly in light of the apparent increase in bleeding complications. We welcome comments from the public on this matter.

We received one written comment from the manufacturer clarifying questions that were raised at the town hall meeting. Specifically, the commenter explained the methodology of Tc-99m Sestamibi scanning and interpretation in the AMIHOT II trial. In addition, the commenter explained that the AMIHOT15and AMIHOT II trials did not attempt to measure differences in heart failure outcomes nor mortality outcomes.

Footnotes:

15 Oneill, WW., et al., Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): A Prospective Randomized Trial of Intracoronary Hyperoxemic Reperfusion after Percutaneous Coronary Intervention. Journal of the American College of Cardiology , Vol. 50, No. 5, 2007, pp. 397-405.

5. Proposed Regulatory Change

Section 1886(d)(5)(K)(i) of the Act directs us to establish a mechanism to recognize the cost of new medical services and technologies under the IPPS, with such mechanism established after notice and opportunity for public comment. In accordance with this authority, we established at § 412.87(b) of our regulations criteria that a medical service or technology must meet in order to qualify for the additional payment for new medical services and technologies. Specifically, we evaluate applications for new medical service or technology add-on payment by determining whether they meet the criteria of newness, adequacy of payment, and substantial clinical improvement.

As stated in section III.J.1. of the preamble of this proposed rule, § 412.87(b)(2) of our existing regulations provides that a specific medical service or technology will be considered new for purposes of new medical service or technology add-on payments after the point at which data begin to become available reflecting the ICD-9-CM code assigned to the new service or technology. The point at which these data become available typically begins when the new medical service or technology is first introduced on the market, generally on the date that the medical service or technology receives FDA approval. Accordingly, for purposes of the new medical service or technology add-on payment, a medical service or technology cannot be considered new prior to the date on which FDA approval is granted.

In addition, as stated in section III.J.1. of the preamble of this proposed rule, § 412.87(b)(3) of our existing regulations provides that, to be eligible for the add-on payment for new medical services or technologies, the DRG prospective payment rate otherwise applicable to the discharge involving the new medical service or technology must be assessed for adequacy. Under the cost criterion, to assess the adequacy of payment for a new medical service or technology paid under the applicable DRG prospective payment rate, we evaluate whether the charges for cases involving the new medical service or technology exceed certain threshold amounts.

Section 412.87(b)(1) of our existing regulations provides that, to be eligible for the add-on payment for new medical services or technologies, the new medical service or technology must represent an advance that substantially improves, relative to technologies previously available, the diagnosis or treatment of Medicare beneficiaries. In addition, § 412.87(b)(1) states that CMS will announce its determination as to whether a new medical service or technology meets the substantial clinical improvement criteria in the Federal Register as part of the annual updates and changes to the IPPS.

Since the implementation of the policy on add-on payments for new medical services and technologies, we accept applications for add-on payments for new medical services and technologies on an annual basis by a specified deadline. For example, applications for FY 2009 were submitted in November 2007. After accepting applications, CMS then evaluates them in the annual IPPS proposed and final rules to determine whether the medical service or technology is eligible for the new medical service or technology add-on payment. If an application meets each of the eligibility criteria, the medical service or technology is eligible for new medical service or technology add-on payments beginning on the first day of the new fiscal year (that is, October 1).

We have advised prior and potential applicants that we evaluate whether a medical service or technology is eligible for the new medical service or technology add-on payments prior to publication of the final rule setting forth the annual updates and changes to the IPPS, with the results of our determination announced in the final rule. We announce our results in the final rule for each fiscal year because we believe predictability is an important aspect of the IPPS and that it is important to apply a consistent payment methodology for new medical services or technologies throughout the entire fiscal year. For example, hospitals must train their billing and other staff after publication of the final rule to properly implement the coding and payment changes for the upcoming fiscal year set forth in the final rule. In addition, hospitals' budgetary process and clinical decisions regarding whether to utilize new technologies are based in part on the applicable payment rates under the IPPS for the upcoming fiscal year, including whether the new medical services or technologies qualify for the new medical service or technology add-on payment. If CMS were to make multiple payment changes under the IPPS during a fiscal year, these changes could adversely affect the decisions hospitals implement at the beginning of the fiscal year. For these reasons, we believe applications for new medical service or technology add-on payments should be evaluated prior to publication of the final IPPS rule for each fiscal year. Therefore, if an application does not meet the new medical service or technology add-on payment criteria prior to publication of the final rule, it will not be eligible for the new medical service or technology add-on payments for the fiscal year for which it applied for the add-on payments.

Because we make our determination regarding whether a medical service or technology meets the eligibility criteria for the new medical service or technology add-on payments prior to publication of the final rule, we have advised both past and potential applicants that their medical service or technology must receive FDA approval early enough in the IPPS rulemaking cycle to allow CMS enough time to fully evaluate the application prior to the publication of the IPPS final rule. Moreover, because new medical services or technologies that have not received FDA approval do not meet the newness criterion, it would not be necessary or prudent for us to make a final determination regarding whether a new medical service or technology meets the cost threshold and substantial clinical improvement criteria prior to the medical service or technology receiving FDA approval. In addition, we do not believe it is appropriate for CMS to determine whether a medical service or technology represents a substantial clinical improvement over existing technologies before the FDA makes a determination as to whether the medical service or technology is safe and effective. For these reasons, we first determine whether a medical service or technology meets the newness criteria, and only if so, do we then make a determination as to whether the technology meets the cost threshold and represents a substantial clinical improvement over existing medical services or technologies. For example, even if an application has FDA approval, if the medical service or technology is beyond the timeline of 2-3 years to be considered new, in the past we have not made a determination on the cost threshold and substantial clinical improvement. Further, as we have discussed in prior final rules (69 FR 49018-49019 and 70 FR 47344), it is our past and present practice to analyze the new medical service or technology add-on payment criteria in the following sequence: Newness, cost threshold, and finally substantial clinical improvement. Under our proposal in this proposed rule, we would continue this practice of analyzing the eligibility criteria in this sequence and announce in the annual Federal Register as part of the annual updates and changes to the IPPS our determination on whether a medical service or technology meets the eligibility criteria in § 412.87(b).

In the interest of more clearly defining the parameters under which CMS can fully and completely evaluate new medical service or technology add-on payment applications, we are proposing to amend the regulations at § 412.87 by adding a new paragraph (c) to codify our current policy and specify that CMS will consider whether a new medical service or technology meets the eligibility criteria in § 412.87(b) and announce the results in the Federal Register as part of the annual updates and changes to the IPPS. As a result, we are proposing to remove the duplicative text in § 412.87(b)(1) that specifies that CMS will determine whether a new medical service or technology meets the substantial clinical improvement criteria and announce the results of its determination in the Federal Register as part of the annual updates and changes to the IPPS. We note that this proposal is not a change to our current policy, as we have always given consideration to whether an application meets the new medical service or technology eligibility criteria in the annual IPPS proposed and final rules. Rather, this proposal simply codifies our current practice of fully evaluating new medical service or technology add-on payment applications prior to publication of the final rule in order to maintain predictability within the IPPS for the upcoming fiscal year.

In addition, we are proposing in new paragraph (c) of § 412.87 to set July 1 of each year as the deadline by which IPPS new medical service or technology add-on payment applications must receive FDA approval. This proposed deadline should provide us with enough time to fully consider all of the new medical service or technology add-on payment criteria for each application and maintain predictability in the IPPS for the coming fiscal year.

Finally, under this proposal, applications that have not received FDA approval by July 1 would not be considered in the final rule, even if they were summarized in the corresponding IPPS proposed rule. However, applications that receive FDA approval of the medical service or technology after July 1 would be able to reapply for the new medical service or technology add-on payment the following year (at which time they would be given full consideration in both the IPPS proposed and final rules).

In summary, for the reasons cited above, we are proposing to revise § 412.87 to remove the second sentence of (b)(1) and add a new paragraph (c) to codify our current practice of how CMS evaluates new medical service or technology add-on payment applications and establish in paragraph (c) a deadline of July 1 of each year as the deadline by which IPPS new medical service or technology add-on payment applications must receive FDA approval in order to be fully evaluated in the applicable IPPS final rule each year.

III. Proposed Changes to the Hospital Wage Index

A. Background

Section 1886(d)(3)(E) of the Act requires that, as part of the methodology for determining prospective payments to hospitals, the Secretary must adjust the standardized amounts "for area differences in hospital wage levels by a factor (established by the Secretary) reflecting the relative hospital wage level in the geographic area of the hospital compared to the national average hospital wage level." In accordance with the broad discretion conferred under the Act, we currently define hospital labor market areas based on the definitions of statistical areas established by the Office of Management and Budget (OMB). A discussion of the proposed FY 2009 hospital wage index based on the statistical areas, including OMB's revised definitions of Metropolitan Areas, appears under section III.C. of this preamble.

Beginning October 1, 1993, section 1886(d)(3)(E) of the Act requires that we update the wage index annually. Furthermore, this section provides that the Secretary base the update on a survey of wages and wage-related costs of short-term, acute care hospitals. The survey must exclude the wages and wage-related costs incurred in furnishing skilled nursing services. This provision also requires us to make any updates or adjustments to the wage index in a manner that ensures that aggregate payments to hospitals are not affected by the change in the wage index. The proposed adjustment for FY 2009 is discussed in section II.B. of the Addendum to this proposed rule.

As discussed below in section III.I. of this preamble, we also take into account the geographic reclassification of hospitals in accordance with sections 1886(d)(8)(B) and 1886(d)(10) of the Act when calculating IPPS payment amounts. Under section 1886(d)(8)(D) of the Act, the Secretary is required to adjust the standardized amounts so as to ensure that aggregate payments under the IPPS after implementation of the provisions of sections 1886(d)(8)(B) and (C) and 1886(d)(10) of the Act are equal to the aggregate prospective payments that would have been made absent these provisions. The proposed budget neutrality adjustment for FY 2009 is discussed in section II.A.4.b. of the Addendum to this proposed rule.

Section 1886(d)(3)(E) of the Act also provides for the collection of data every 3 years on the occupational mix of employees for short-term, acute care hospitals participating in the Medicare program, in order to construct an occupational mix adjustment to the wage index. A discussion of the occupational mix adjustment that we are proposing to apply beginning October 1, 2008 (the FY 2009 wage index) appears under section III.D. of this preamble.

B. Requirements of Section 106 of the MIEA-TRHCA

1. Wage Index Study Required Under the MIEA-TRHCA

Section 106(b)(1) of the MIEA-TRHCA (Pub. L. 109-432) required MedPAC to submit to Congress, not later than June 30, 2007, a report on the Medicare wage index classification system applied under the Medicare IPPS. Section 106(b) of MIEA-TRHCA required the report to include any alternatives that MedPAC recommends to the method to compute the wage index under section 1886(d)(3)(E) of the Act.

In addition, section 106(b)(2) of the MIEA-TRHCA instructed the Secretary of Health and Human Services, taking into account MedPAC's recommendations on the Medicare wage index classification system, to include in this FY 2009 IPPS proposed rule one or more proposals to revise the wage index adjustment applied under section 1886(d)(3)(E) of the Act for purposes of the IPPS. The proposal (or proposals) must consider each of the following:

• Problems associated with the definition of labor markets for the wage index adjustment.

• The modification or elimination of geographic reclassifications and other adjustments.

• The use of Bureau of Labor of Statistics data or other data or methodologies to calculate relative wages for each geographic area.

• Minimizing variations in wage index adjustments between and within MSAs and statewide rural areas.

• The feasibility of applying all components of CMS' proposal to other settings.

• Methods to minimize the volatility of wage index adjustments while maintaining the principle of budget neutrality.

• The effect that the implementation of the proposal would have on health care providers on each region of the country.

• Methods for implementing the proposal(s) including methods to phase in such implementations.

• Issues relating to occupational mix such as staffing practices and any evidence on quality of care and patient safety including any recommendation for alternative calculations to the occupational mix.

In its June 2007 Report to Congress, "Report to the Congress: Promoting Greater Efficiency in Medicare" (Chapter 6 with Appendix), MedPAC made three broad recommendations regarding the wage index:

(1) Congress should repeal the existing hospital wage index statute, including reclassifications and exceptions, and give the Secretary authority to establish a new wage index system;

(2) The Secretary should establish a hospital compensation index that-

• Uses wage data from all employers and industry-specific occupational weights;

• Is adjusted for geographic differences in the ratio of benefits to wages;

• Is adjusted at the county level and smoothes large differences between counties; and

• Is implemented so that large changes in wage index values are phased in over a transition period; and

(3) The Secretary should use the hospital compensation index for the home health and skilled nursing facility prospective payment systems and evaluate its use in the other Medicare fee-for-service prospective payment systems.

The full June 2007 Report to Congress is available at the Web site: http://www.medpac.gov/documents/Jun07_EntireReport.pdf) .

In the presentation and analysis of its alternative wage index system, MedPAC addressed almost all of the nine points for consideration under section 106(b)(2) of Pub. L. 109-432. Following are the highlights of the alternative wage index system recommended by MedPAC:

• Although the MedPAC recommended wage index generally retains the current labor market definitions, it supplements the metropolitan areas with county-level adjustments and eliminates single wage index values for rural areas.

• In the MedPAC recommended wage index, the county-level adjustments, together with a smoothing process that constrains the magnitude of differences between and within contiguous wage areas, serve as a replacement for geographical reclassifications.

• The MedPAC recommended wage index uses BLS data instead of the CMS hospital wage data collected on the Medicare cost report. MedPAC adjusts the BLS data for geographic differences in the ratio of benefits to wages using Medicare cost report data.

• The BLS data are collected from a sample of all types of employers, not just hospitals. The MedPAC recommended wage index could be adapted to other providers such as HHAs and SNFs by replacing hospital occupational weights with occupational weights appropriate for other types of providers.

• In the MedPAC recommended wage index, volatility over time is addressed by the use of BLS data, which is based on a 3-year rolling sample design.

• MedPAC recommends a phased implementation for its recommended wage index in order to cushion the effect of large wage index changes on individual hospitals.

• MedPAC suggests that using BLS data automatically addresses occupational mix differences, because the BLS data are specific to health care occupations, and national industry-wide occupational weights are applied to all geographic areas.

• The MedPAC report does not provide any evidence of the impact of its wage index on staffing practices or the quality of care and patient safety.

To assist CMS in meeting the requirements of section 106(b)(2) of Pub. L. 109-432, in February 2008, CMS awarded a Task Order under its Expedited Research and Demonstration Contract, to Acumen, LLC. The two general responsibilities of the Task Order are to (1) conduct a detailed impact analysis that compares the effects of MedPAC's wage and hospital compensation indexes with the CMS wage index and (2) assist CMS in developing a proposal (or proposals) that addresses the nine points for consideration under section 106(b)(2) of Pub. L. 109-432. Specifically, the tasks under the Task Order include, but are not limited to, an evaluation of whether differences between the two types of wage data (that is, CMS cost report and occupational mix data and BLS data) produce significant differences in wage index values among labor market areas, a consideration of alternative methods of incorporating benefit costs into the construction of the wage index, a review of past and current research on alternative labor market area definitions, and a consideration of how aspects of the MedPAC recommended wage index can be applied to the CMS wage data in constructing a new methodology for the wage index. We will present any analyses and proposals resulting from this Task Order in the FY 2009 IPPS final rule or in a special Federal Register notice issued after the final rule is published.

2. CMS Proposals in Response to Requirements Under Section 106(b) of the MIEA-TRHCA

As discussed in section III.A. of this preamble, the purpose of the hospital wage index is to adjust the IPPS standardized payment to reflect labor market area differences in wage levels. The geographic reclassification system exists in order to assist "hospitals which are disadvantaged by their current geographic classification because they compete with hospitals that are located in the geographic area to which they seek to be reclassified" (56 FR 25469). Geographic reclassification is established under section 1886(d)(10) of the Act and is implemented through 42 CFR Part 412, Subpart L. (We refer readers to section III.I. of this preamble for a detailed discussion of the geographic reclassification system and other area wage index exceptions.)

In its June 2007 Report to Congress, MedPAC discussed its findings that geographic reclassification, and numerous other area wage index exceptions added to the system over the years, have created major complexities and "troubling anomalies" in the hospital wage index. A review of the IPPS final rules reveals a long history of legislative changes that have permitted certain hospitals, that otherwise would not be able to reclassify under section 1886(d)(10) of the Act, to receive a higher wage index than calculated for their geographic area. MedPAC reports that more than one-third of hospitals now receive a higher wage index due to geographic reclassification or other wage index exceptions. We are concerned about the integrity of the current system, and agree with MedPAC that the process has become burdensome.

As noted above, MedPAC recommended the elimination of geographic reclassification and other wage index exceptions. In addition, the President's FY 2009 Budget included a proposal to apply the geographic reclassification budget neutrality requirement at the State level rather than by adjusting the standardized rate for hospitals nationwide. Given the language in section 1886(d)(10) of the Act establishing the MGCRB, we believe a statutory change would be required to make these changes. However, we do have the authority to make some regulatory changes to the reclassification system as discussed below. We note that these proposals do not preclude future consideration of MedPAC's recommendations that could be implemented through additional changes to our regulations, once our analysis of those recommendations is complete (after the publication of the FY 2009 IPPS proposed rule).

a. Proposed Revision of the Reclassification Average Hourly Wage Comparison Criteria

Regulations at 42 CFR 413.230(d)(1) set forth the average hourly wage comparison criteria that an individual hospital must meet in order for the MGCRB to approve a geographic reclassification application. Our current criteria (requiring an urban hospital to demonstrate that its average hourly wage is at least 108 percent of the average hourly wage of hospitals in the area in which the hospital is located and at least 84 percent of the average hourly wage of hospitals in the area to which it seeks redesignation) were adopted in the FY 1993 IPPS final rule (57 FR 39825). In that final rule, we explained that the 108 percent threshold "is based on the national average hospital wage as a percentage of its area wage (96 percent) plus one standard deviation (12 percent)." We also explained that we would use the 84-percent threshold to reflect the average hospital wage of the hospital as a percentage of its area wage less one standard deviation. We stated that "to qualify for a wage index reclassification, a hospital must have an average hourly wage that is more than one national standard deviation above its original labor market area and not less than one national standard deviation below its new labor market area" (57 FR 39770). In response to numerous public comments we received, we expressed our policy and legal justifications for adopting the specific thresholds. Among other things, we stated that geographic reclassifications must be viewed not just in terms of those hospitals that are reclassifying, but also in terms of the nonreclassifying hospitals that, through a budget neutrality adjustment, are required to bear a financial burden associated with the higher wage indices received by those hospitals that reclassify. We also indicated that the Secretary has ample legal authority under section 1886(d)(10) of the Act to set the wage comparison thresholds and to revise such thresholds upon further review. We refer readers to that final rule for a full discussion of our justifications for the standards.

In the FY 2000 IPPS final rule (65 FR 47089 through 47090), the wage comparison criteria for rural hospitals seeking individual hospital reclassifications were reduced to 82 percent and 106 percent to compensate for the historic economic underperformance of rural hospitals. The 2-percent drop in both thresholds was determined to allow a significant benefit to some hospitals that were close to meeting the existing criteria but would not make the reclassification standards overly liberal for rural hospitals.

CMS has not evaluated or recalibrated the average hourly wage criteria for geographic reclassification since they were established in FY 1993. In consideration of the MIEA-TRHCA requirements and MedPAC's finding that over one-third of hospitals are receiving a reclassified wage index or other wage index adjustment, we decided to reevaluate the average hourly wage criteria for geographic reclassification. We ran simulations with more recent wage data to determine what would be the appropriate average hourly wage criteria. We found that the average hospital average hourly wage as a percentage of its area's wage has increased from approximately 96 percent in FY 1993 to closer to 98 percent over FYs 2006, 2007, and 2008 (97.8, 98.2, and 98 percent, respectively). We also determined that the standard deviation has been reduced from approximately 12 percent in FY 1993 to closer to 10 percent over the same 3-year period (10.7, 10.4, and 10.4 percent, respectively); that is, assuming normal distributions, approximately 68 percent of all hospitals would have an average hourly wage that deviates less than 10 percentage points above or below the mean. This assessment indicates that the new baseline criteria for reclassification should be set to 88/108 percent. While the 108 criterion appears not to require adjustment, the current 84 percent standard appears to be too low a threshold to serve the purpose of establishing wage comparability with a proximate labor market area.

To assess the impact that these changes would have had on hospitals that reclassified in FY 2008, we ran models that set urban individual reclassification standards to 88/108 percent and the county group reclassification standard to 88 percent. We retained the 2-percent benefit for rural hospitals by setting an 86/106 percent standard. We used 3-year average hourly wage figures from the 2005, 2006, and 2007 wage surveys and compared them to 3-year average hourly wage figures for CBSAs over the same 3-year period.

Of the 295 hospitals that applied for and received individual reclassifications in FY 2008, 45 of them (15.3 percent) would not meet the proposed 88/86 percent threshold. Of the 66 hospitals that applied for and received county group reclassification in FY 2008, 6 hospitals (9.1 percent) in 3 groups would not have qualified with the new standards. We also ran comparisons for hospitals that reclassified in FY 2006 and FY 2007 to determine if they would have been able to reclassify in FY 2008, using 3-year averages available in FY 2008. We found that, of all hospitals that were reclassified in FY 2008 (that is, applications approved for FYs 2006 through 2008), 14.7 percent of individual reclassifications and 8.5 percent of county group reclassification would not have qualified to reclassify in FY 2008.

Section 106 of MIEA-TRHCA requires us to propose revisions to the hospital wage index system after considering the recommendations of MedPAC. To address this requirement, we are proposing that the 84/108 criteria for urban hospital reclassifications and the 82/106 criteria for rural hospital reclassifications be recalibrated using the methodology published in the FY 1993 final rule and more recent wage data (that is, data used in computing the FYs 2006, 2007, 2008 wage indices). We believe that hospitals that are seeking to reclassify to another area should be required to demonstrate more similarity to the area than the current criteria permit, and our recent analysis demonstrates that those criteria are no longer appropriate. Therefore, we are proposing to change the criterion for the comparison of a hospital's average hourly wage to that of the area to which the hospital seeks reclassification to 88 percent for urban hospitals and 86 percent for rural hospitals for new reclassifications beginning with the FY 2010 wage index and, accordingly, revise our regulations at 42 CFR 412.230 to reflect these changes. The criterion for the comparison of a hospital's average hourly wage to that of its geographic area would be unchanged (108 percent for urban hospitals and 106 percent for rural hospitals). We also are proposing that, when there are significant changes in labor market area definitions, such as CMS' adoption of new OMB CBSA definitions based upon the decennial census (69 FR 49027), we would again reevaluate and, if warranted, recalibrate these criteria. This would allow CMS to consider the effects of periodic changes in labor market boundaries and provide a regular timeline for updating and validating the reclassification criteria. Finally, we are proposing to adjust the 85 percent criterion for both urban and rural county group reclassifications to be equal to the proposed 88 percent standard for urban reclassifications, and to revise the regulations at 42 CFR 412.232 and 412.234 to reflect the change. The urban and rural county group average hourly wage standard has always been equivalent for both urban and rural county groups and has always been 1 percent higher than the 84 percent urban area individual reclassification standard. We would continue the policy of having an equivalent wage comparison criterion for both urban and rural county groups, as these groups have always used the same wage comparison criteria. We also would use the individual urban hospital reclassification standard of 88 percent because this threshold would ensure that the hospitals in the county group are at least as comparable to the proximate area as are individual hospitals within their own areas. Also, we do not believe it would be appropriate to have a group reclassification standard lower than the individual reclassification standards, thus potentially creating a situation where all of the hospitals in a county could reclassify, even though no single hospital within such county would be able to meet any average hourly wage-related comparisons for an individual reclassification.

We considered raising the group reclassification criterion to 89 percent in order to preserve the historical policy of the standard being set at 1 percent higher than the individual reclassification standard. However, we determined that making the group standard equal to the individual standard would adequately address our stated concerns.

We note that the proposed changes in the reclassification criteria apply only to new reclassifications beginning with the FY 2010 wage index. Any hospital or county group that is in the midst of a 3-year reclassification in FY 2010 will not be affected by the proposed criteria change until they reapply for a geographic reclassification. Therefore, we are proposing the effective date for these changes would be September 1, 2008, the deadline for hospitals to submit applications for reclassification for the FY 2010 wage index.

b. Within-State Budget Neutrality Adjustment for the Rural and Imputed Floors

Section 4410 of the Balanced Budget Act of 1997 (BBA) established the rural floor by requiring that the wage index for a hospital in an urban area of a State cannot be less than the area wage index determined for that State's rural area. Section 4410(b) of the BBA imposed the budget neutrality requirement and stated that the Secretary shall "adjust the area wage index referred to in subsection (a) for hospitals not described in such subsection." Therefore, in order to compensate for the increased wage indices of urban hospitals receiving the rural floor, a nationwide budget neutrality adjustment is applied to the wage index to account for the additional payment to these hospitals. As a result, urban hospitals that qualify for their State's rural floor wage index receive enhanced payments at the expense of all rural hospitals nationwide and all other urban hospitals that do not receive their State's rural floor. In the FY 2009 proposed wage index, 266 hospitals in 27 States benefit from the rural floor. The first chart below lists the percentage of total payments each State either received or contributed to fund the current rural floor and imputed floor provisions with national budget neutrality adjustments (as indicated in the discussion of the imputed floor below in this section III.B.2.b.). The second chart below provides a graphical depiction of the proposed FY 2009 impacts.

State Current policy application of national rural floor and imputed floor budget neutrality Proposed policy application of rural floor and imputed floor budget neutrality within each state
Alabama -0.1 0.3
Alaska 0.0 -0.2
Arizona -0.2 0.3
Arkansas -0.1 0.3
California 0.7 -0.8
Colorado 0.0 -0.1
Connecticut 2.1 -2.2
Delaware -0.2 0.3
Washington, DC -0.2 0.3
Florida 0.0 0.0
Georgia -0.1 0.3
Hawaii -0.1 0.3
Idaho -0.1 0.3
Illinois -0.2 0.1
Indiana -0.1 0.0
Iowa 0.1 -0.1
Kansas -0.1 0.3
Kentucky -0.1 0.3
Louisiana -0.1 0.0
Maine -0.1 0.3
Massachusetts -0.2 0.3
Michigan -0.2 0.3
Minnesota -0.2 0.3
Mississippi -0.1 0.3
Missouri -0.1 0.0
Montana -0.1 0.2
Nebraska -0.1 0.3
Nevada -0.2 0.3
New Hampshire 1.1 -1.2
New Jersey 0.7 -0.8
New Mexico -0.1 0.0
New York -0.2 0.3
North Carolina -0.1 0.1
North Dakota 0.1 -0.1
Ohio -0.1 0.1
Oklahoma -0.1 0.1
Oregon -0.1 0.0
Pennsylvania -0.1 0.1
Rhode Island -0.2 0.3
South Carolina -0.1 0.0
South Dakota -0.1 0.3
Tennessee 0.0 0.0
Texas -0.1 0.1
Utah -0.1 0.3
Vermont 3.5 -3.4
Virginia -0.1 0.0
Washington -0.1 -0.1
West Virginia 0.0 -0.1
Wisconsin -0.1 -0.1
Wyoming 0.0 0.1

[Federal Register graphic "EP30AP08.018" is not available. Please view the graphic in the PDF version of this document.]

The above charts demonstrate how, at a State-by-State level, the rural floor is creating a benefit for a minority of States that is then funded by a majority of States, including States that are overwhelmingly rural in character. The intent behind the rural floor seems to have been to address anomalous occurrences where certain urban areas in a State have unusually depressed wages when compared to the State's rural areas. However, because these comparisons occur at the State level, we believe it also would be sound policy to make the budget neutrality adjustment specific to the State, redistributing payments among hospitals within the State, rather than adjusting payments to hospitals in other States.

In addition, a statewide budget neutrality adjustment would address the situation we discussed in the FY 2008 IPPS final rule with comment period (72 FR 47324) in which rural CAHs were converting to IPPS status, apparently to raise the State's rural wage index to a level whereby all urban hospitals in the State would receive the rural floor. Medicare payments to CAHs are based on 101 percent of reasonable costs while the IPPS pays hospitals a fixed rate per discharge. In addition, as a CAH, a hospital is guaranteed to recover its costs, while an IPPS hospital is provided with incentives to increase efficiency to cover its costs. Thus, we stated that the identified CAHs were converting back to IPPS, even though the conversion would not directly benefit them. Because these hospitals' wage levels are higher than most, if not all, of the urban hospitals in the State, the wage indices for most, if not all, of the State's urban hospitals would increase as a result of the rural floor provision if the CAHs convert to IPPS status. In simulating the effect of the hospitals setting the State's rural floor, we estimated that payment to hospitals in the State would increase in excess of $220 million in a single year. The MedPAC, in its June 2007 Report to the Congress stated, "The fact that the movement of one or two CAHs in or out of the [I]PPS system can increase (or decrease) Medicare payments by $220 million suggests there is a flaw in the design of the wage index system." (We refer readers to page 131 of the report.)

For the above reasons, we are proposing to apply a State level rural floor budget neutrality adjustment to the wage index beginning in FY 2009. States that have no hospitals receiving a rural floor wage index would no longer have a negative budget neutrality adjustment applied to their wage indices. Conversely, hospitals in States with hospitals receiving a rural floor would have their wage indices downwardly adjusted to achieve budget neutrality within the State. All hospitals within each State would, in effect, be responsible for funding the rural floor adjustment applicable within that specific State.

In the FY 2005 IPPS final rule and the FY 2008 IPPS final rule with comment period (69 FR 49109 and 72 FR 47321, respectively), we temporarily adopted an "imputed" floor measure to address a concern by some individuals that hospitals in all-urban States were disadvantaged by the absence of rural hospitals. Because no rural wage index could be calculated, no rural floor could be applied within such States. We originally limited application of the policy to FYs 2005 through 2007 and then extended it one additional year, through FY 2008. We are proposing to extend the imputed floor for 3 additional years, through FY 2011, and to revise the introductory text of § 412.64(h)(4) of our regulations to reflect this extension. For FY 2009, 26 hospitals in New Jersey (33.8 percent) would receive the imputed floor. Rhode Island, the only other all-urban State, has no hospitals that would receive the imputed floor. In past years, we applied a national budget neutrality adjustment to the standardized amount to ensure that payments remained constant to payments that would have occurred in the absence of the imputed floor policy. As a result, payments to all other hospitals in the Nation were adjusted downward to subsidize the higher payments to New Jersey hospitals receiving the imputed floor. As the intent of the imputed floor is to create a protection to all-urban States similar to the protection offered to urban-rural mixed States by the rural floor, and the effect of the measure is also State-specific like the rural floor, we believe that the budget neutrality adjustments for the imputed floor and the rural floor should be applied in the same manner. Therefore, beginning with FY 2009, we are also proposing to apply the imputed floor budget neutrality adjustment to the wage index and at the State level.

Based on our impact analysis of these proposals for FY 2009, of the 49 States (Maryland is excluded because it is under a State waiver), the District of Columbia, and Puerto Rico, 39 would see either no change or an increase in total Medicare payments as a result of applying a budget neutrality adjustment to the wage index for the rural and imputed floors at the State level rather than the national level. The total payments of the remaining 12 States would decrease 0.1 percent to 3.4 percent compared to continuing our prior national adjustment policy. The full impact analysis is reflected in the two charts presented earlier in this section III.B.2.b. of the preamble of this proposed rule. Tables 4D-1 and 4D-2 in the Addendum to this proposed rule reflect the proposed FY 2009 State level budget neutrality adjustments for the rural and imputed floors. We are specifically requesting public comments from national and State hospital associations regarding these proposals, particularly the national associations, as they represent member hospitals that are both positively and negatively affected by our proposed policies, and are, therefore, in the best position to comment on the policy merits of these proposals. We will view the absence of any comments from the national hospital associations as a sign that they do not object to our proposed policies.

c. Within-State Budget Neutrality Adjustment for Geographic Reclassification

Currently, section 1886(d)(8)(D) of the Act requires us to adjust the standardized amount to ensure that the effects of geographic reclassification do not increase aggregate IPPS payments. This means that, in the case of a reclassification, budget neutrality is achieved by reducing the standardized amount for all hospitals nationwide. The FY 2009 President's Budget includes a legislative proposal to apply geographic reclassification budget neutrality at the State level (available at the Web site: www.hhs.gov/budget/09budget/2009BudgetInBrief.pdf under FY 2009 Medicare Proposals, page 54). If this proposal is enacted by the Congress, budget neutrality would be achieved by adjusting the wage index for all hospitals within the State rather than reducing the standardized amount for all hospitals nationwide.

As noted also in MedPAC's June 2007 Report to Congress, over the years, there have been many changes to the Medicare law that are intended to broaden the ability for a hospital to receive a wage index that is higher than the value that is calculated for its geographic area and not be subject to the proximity or wage level criteria for geographic reclassification established under section 1886(d)(10) of the Act. These more targeted geographic reclassification provisions are creating inequities in the wage index by sometimes allowing hospitals to be reclassified to areas where other hospitals that are closer in proximity are ineligible to reclassify. Applying budget neutrality at the State level would focus the costs of geographic reclassification closer to the areas where hospitals that benefit from the reclassification are located. We expect that a legislative provision on applying geographic reclassification budget neutrality at the State level would be applied to all reclassifications and wage index exceptions that are implemented through 42 CFR Part 412, Subpart L, and certain provisions of the Social Security Act that permit hospitals to receive a higher wage index than is calculated for their geographic area. (As discussed above, as a proposed regulatory matter, there also would be a separate within-State budget neutrality adjustment for the imputed and rural floors.) We expect that reclassification budget neutrality at the State level would operate through adjustments to the IPPS payments to hospitals in the State in which the reclassifying hospital is geographically located.

We are seeking public comments regarding MedPAC's recommendations for reforming the wage index, our plan for our contractor's review of the wage index, and the regulatory proposals for modifying the current hospital wage index system. We also welcome additional suggestions for reforming the hospital wage index.

C. Core-Based Statistical Areas for the Hospital Wage Index

The wage index is calculated and assigned to hospitals on the basis of the labor market area in which the hospital is located. In accordance with the broad discretion under section 1886(d)(3)(E) of the Act, beginning with FY 2005, we define hospital labor market areas based on the Core-Based Statistical Areas (CBSAs) established by OMB and announced in December 2003 (69 FR 49027). For a discussion of OMB's revised definitions of CBSAs and our implementation of the CBSA definitions, we refer readers to the preamble of the FY 2005 IPPS final rule (69 FR 49026 through 49032).

As with the FY 2008 final rule, for FY 2009 we are proposing to provide that hospitals receive 100 percent of their wage index based upon the CBSA configurations. Specifically, for each hospital, we will determine a wage index for FY 2009 employing wage index data from FY 2005 hospital cost reports and using the CBSA labor market definitions. We consider CBSAs that are MSAs to be urban, and CBSAs that are Micropolitan Statistical Areas as well as areas outside of CBSAs to be rural. In addition, it has been our longstanding policy that where an MSA has been divided into Metropolitan Divisions, we consider the Metropolitan Division to comprise the labor market areas for purposes of calculating the wage index (69 FR 49029). We are proposing to codify this longstanding policy into our regulations at § 412.64(b)(1)(ii)(A).

On November 20, 2007, OMB announced the revision of titles for eight urban areas (OMB Bulletin No. 08-01). The revised titles are as follows:

• Hammonton, New Jersey qualifies as a new principal city of the Atlantic City, New Jersey CBSA. The new title is Atlantic City-Hammonton, New Jersey CBSA;

• New Brunswick, New Jersey, located in the Edison, New Jersey Metropolitan Division, qualifies as a new principal city of the New York-Northern New Jersey-Long Island, New York, New Jersey, Pennsylvania CBSA. The new title for the Metropolitan Division is Edison-New Brunswick, New Jersey CBSA;

• Summerville, South Carolina qualifies as a new principal city of the Charleston-North Charleston, South Carolina CBSA. The new title is Charleston-North Charleston-Summerville, South Carolina;

• Winter Haven, Florida qualifies as a new principal city of the Lakeland, Florida CBSA. The new title is Lakeland-Winter Haven, Florida;

• Bradenton, Florida replaces Sarasota, Florida as the most populous principal city of the Sarasota-Bradenton-Venice, Florida CBSA. The new title is Bradenton-Sarasota-Venice, Florida. The new CBSA code is 14600;

• Frederick, Maryland replaces Gaithersburg, Maryland as the second most populous principal city in the Bethesda-Gaithersburg-Frederick, Maryland CBSA. The new title is Bethesda-Frederick-Gaithersburg, Maryland;

• North Myrtle Beach, South Carolina replaces Conway, South Carolina as the second most populous principal city of the Myrtle Beach-Conway-North Myrtle Beach, South Carolina CBSA. The new title is Myrtle Beach-North Myrtle Beach-Conway, South Carolina;

• Pasco, Washington replaces Richland, Washington as the second most populous principal city of the Kennewick-Richland-Pasco, Washington CBSA. The new title is Kennewick-Pasco-Richland, Washington.

The OMB bulletin is available on the OMB Web site at https://www.whitehouse.gov/OMB- go to "Bulletins" or "Statistical Programs and Standards." CMS will apply these changes to the IPPS beginning October 1, 2008.

D. Proposed Occupational Mix Adjustment to the Proposed FY 2009 Wage Index

As stated earlier, section 1886(d)(3)(E) of the Act provides for the collection of data every 3 years on the occupational mix of employees for each short-term, acute care hospital participating in the Medicare program, in order to construct an occupational mix adjustment to the wage index, for application beginning October 1, 2004 (the FY 2005 wage index). The purpose of the occupational mix adjustment is to control for the effect of hospitals' employment choices on the wage index. For example, hospitals may choose to employ different combinations of registered nurses, licensed practical nurses, nursing aides, and medical assistants for the purpose of providing nursing care to their patients. The varying labor costs associated with these choices reflect hospital management decisions rather than geographic differences in the costs of labor.

1. Development of Data for the Proposed FY 2009 Occupational Mix Adjustment

On October 14, 2005, we published a notice in the Federal Register (70 FR 60092) proposing to use a new survey, the 2006 Medicare Wage Index Occupational Mix Survey (the 2006 survey) to apply an occupational mix adjustment to the FY 2008 wage index. In the proposed 2006 survey, we included several modifications based on the comments and recommendations we received on the 2003 survey, including (1) allowing hospitals to report their own average hourly wage rather than using BLS data; (2) extending the prospective survey period; and (3) reducing the number of occupational categories but refining the subcategories for registered nurses.

We made the changes to the occupational categories in response to MedPAC comments to the FY 2005 IPPS final rule (69 FR 49036). Specifically, MedPAC recommended that CMS assess whether including subcategories of registered nurses would result in a more accurate occupational mix adjustment. MedPAC believed that including all registered nurses in a single category may obscure significant wage differences among the subcategories of registered nurses, for example, the wages of surgical registered nurses and floor registered nurses may differ. Also, to offset additional reporting burden for hospitals, MedPAC recommended that CMS should combine the general service categories that account for only a small percentage of a hospital's total hours with the "all other occupations" category because most of the occupational mix adjustment is correlated with the nursing general service category.

In addition, in response to the public comments on the October 14, 2005 notice, we modified the 2006 survey. On February 10, 2006, we published a Federal Register notice (71 FR 7047) that solicited comments and announced our intent to seek OMB approval on the revised occupational mix survey (Form CMS-10079 (2006)). OMB approved the survey on April 25, 2006.

The 2006 survey provides for the collection of hospital-specific wages and hours data, a 6-month prospective reporting period (that is, January 1, 2006, through June 30, 2006), the transfer of each general service category that comprised less than 4 percent of total hospital employees in the 2003 survey to the "all other occupations" category (the revised survey focuses only on the mix of nursing occupations), additional clarification of the definitions for the occupational categories, an expansion of the registered nurse category to include functional subcategories, and the exclusion of average hourly rate data associated with advance practice nurses.

The 2006 survey included only two general occupational categories: nursing and "all other occupations." The nursing category has four subcategories: Registered nurses, licensed practical nurses, aides, orderlies, attendants, and medical assistants. The registered nurse subcategory includes two functional subcategories: management personnel and staff nurses or clinicians. As indicated above, the 2006 survey provided for a 6-month data collection period, from January 1, 2006 through June 30, 2006. However, we allowed flexibility for the reporting period beginning and ending dates to accommodate some hospitals' biweekly payroll and reporting systems. That is, the 6-month reporting period had to begin on or after December 25, 2005, and end before July 9, 2006.

We are proposing to use the entire 6-month 2006 survey data to calculate the occupational mix adjustment for the FY 2009 wage index. The original timelines for the collection, review, and correction of the 2006 occupational mix data were discussed in detail in the FY 2007 IPPS final rule (71 FR 48008). The revision and correction process for all of the data, including the 2006 occupational mix survey data to be used for computing the FY 2009 wage index, is discussed in detail in section III.K. of the preamble of this proposed rule.

2. Calculation of the Proposed Occupational Mix Adjustment for FY 2009

For FY 2009 (as we did for FY 2008), we are proposing to calculate the occupational mix adjustment factor using the following steps:

Step 1 -For each hospital, determine the percentage of the total nursing category attributable to a nursing subcategory by dividing the nursing subcategory hours by the total nursing category's hours (registered nurse management personnel and registered nurse staff nurses or clinicians are treated as separate nursing subcategories). Repeat this computation for each of the five nursing subcategories: registered nurse management personnel; registered nurse staff nurses or clinicians; licensed practical nurses; nursing aides, orderlies, and attendants; and medical assistants.

Step 2 -Determine a national average hourly rate for each nursing subcategory by dividing a subcategory's total salaries for all hospitals in the occupational mix survey database by the subcategory's total hours for all hospitals in the occupational mix survey database.

Step 3 -For each hospital, determine an adjusted average hourly rate for each nursing subcategory by multiplying the percentage of the total nursing category (from Step 1) by the national average hourly rate for that nursing subcategory (from Step 2). Repeat this calculation for each of the five nursing subcategories.

Step 4 -For each hospital, determine the adjusted average hourly rate for the total nursing category by summing the adjusted average hourly rate (from Step 3) for each of the nursing subcategories.

Step 5 -Determine the national average hourly rate for the total nursing category by dividing total nursing category salaries for all hospitals in the occupational mix survey database by total nursing category hours for all hospitals in the occupational mix survey database.

Step 6 -For each hospital, compute the occupational mix adjustment factor for the total nursing category by dividing the national average hourly rate for the total nursing category (from Step 5) by the hospital's adjusted average hourly rate for the total nursing category (from Step 4).

If the hospital's adjusted average hourly rate is less than the national average hourly rate (indicating the hospital employs a less costly mix of nursing employees), the occupational mix adjustment factor would be greater than 1.0000. If the hospital's adjusted average hourly rate is greater than the national average hourly rate, the occupational mix adjustment factor would be less than 1.0000.

Step 7 -For each hospital, calculate the occupational mix adjusted salaries and wage-related costs for the total nursing category by multiplying the hospital's total salaries and wage-related costs (from Step 5 of the unadjusted wage index calculation in section III.G. of this preamble) by the percentage of the hospital's total workers attributable to the total nursing category (using the occupational mix survey data, this percentage is determined by dividing the hospital's total nursing category salaries by the hospital's total salaries for "nursing and all other") and by the total nursing category's occupational mix adjustment factor (from Step 6 above).

The remaining portion of the hospital's total salaries and wage-related costs that is attributable to all other employees of the hospital is not adjusted by the occupational mix. A hospital's all other portion is determined by subtracting the hospital's nursing category percentage from 100 percent.

Step 8 -For each hospital, calculate the total occupational mix adjusted salaries and wage-related costs for a hospital by summing the occupational mix adjusted salaries and wage-related costs for the total nursing category (from Step 7) and the portion of the hospital's salaries and wage-related costs for all other employees (from Step 7).

To compute a hospital's occupational mix adjusted average hourly wage, divide the hospital's total occupational mix adjusted salaries and wage-related costs by the hospital's total hours (from Step 4 of the unadjusted wage index calculation in section III.G. of this preamble).

Step 9 -To compute the occupational mix adjusted average hourly wage for an urban or rural area, sum the total occupational mix adjusted salaries and wage-related costs for all hospitals in the area, then sum the total hours for all hospitals in the area. Next, divide the area's occupational mix adjusted salaries and wage-related costs by the area's hours.

Step 10 -To compute the national occupational mix adjusted average hourly wage, sum the total occupational mix adjusted salaries and wage-related costs for all hospitals in the Nation, then sum the total hours for all hospitals in the Nation. Next, divide the national occupational mix adjusted salaries and wage-related costs by the national hours. The proposed FY 2009 occupational mix adjusted national average hourly wage is $32.2252.

Step 11 -To compute the occupational mix adjusted wage index, divide each area's occupational mix adjusted average hourly wage (Step 9) by the national occupational mix adjusted average hourly wage (Step 10).

Step 12 -To compute the Puerto Rico specific occupational mix adjusted wage index, follow Steps 1 through 11 above. The proposed FY 2009 occupational mix adjusted Puerto Rico specific average hourly wage is $13.7851.

The table below is an illustrative example of the proposed occupational mix adjustment.

BILLING CODE 4120-01-P

[Federal Register graphic "EP30ap08.019" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30ap08.020" is not available. Please view the graphic in the PDF version of this document.]

BILLING CODE 4120-01-C

Because the occupational mix adjustment is required by statute, all hospitals that are subject to payments under the IPPS, or any hospital that would be subject to the IPPS if not granted a waiver, must complete the occupational mix survey, unless the hospital has no associated cost report wage data that are included in the proposed FY 2009 wage index.

For the FY 2008 wage index, if a hospital did not respond to the occupational mix survey, or if we determined that a hospital's submitted data were too erroneous to include in the wage index, we assigned the hospital the average occupational mix adjustment for the labor market area (72 FR 47314). We believed this method had the least impact on the wage index for other hospitals in the area. For areas where no hospital submitted data for purposes of calculating the occupational mix adjustment, we applied the national occupational mix factor of 1.0000 in calculating the area's FY 2008 occupational mix adjusted wage index. We indicated in the FY 2008 IPPS final rule that we reserve the right to apply a different approach in future years, including potentially penalizing nonresponsive hospitals (72 FR 47314).

For the FY 2009 wage index, we are proposing to handle the data for hospitals that did not respond to the occupational mix survey (neither the 1st quarter nor 2nd quarter data) in the same manner as discussed above for the FY 2008 wage index. In addition, if a hospital submits survey data for either the 1st quarter or 2nd quarter, but not for both quarters, we are proposing to use the data the hospital submitted for one quarter to calculate the hospital's proposed FY 2009 occupational mix adjustment factor. Lastly, if a hospital submits a survey(s), but that survey data can not be used because we determine it to be aberrant, we will also assign the hospital the average occupational mix adjustment for its labor market area. For example, if a hospital's individual nurse category average hourly wages are out of range (that is, unusually high or low), and the hospital does not provide sufficient documentation to explain the aberrancy, or the hospital does not submit any registered nurse staff salaries or hours data, we will assign the hospital the average occupational mix adjustment for the labor market area in which it is located.

In calculating the average occupational mix adjustment factor for a labor market area, we replicated Steps 1 through 6 of the calculation for the occupational mix adjustment. However, instead of performing these steps at the hospital level, we aggregated the data at the labor market area level. In following these steps, for example, for CBSAs that contain providers that did not submit occupational mix survey data, the occupational mix adjustment factor ranged from a low of 0.8968 (CBSA 39820, Redding, CA), to a high of 1.0775 (CBSA 43300, Sherman-Denison, TX). Also, in computing a hospital's occupational mix adjusted salaries and wage-related costs for nursing employees (Step 7 of the calculation), in the absence of occupational mix survey data, we multiplied the hospital's total salaries and wage-related costs by the percentage of the area's total workers attributable to the area's total nursing category. For FY 2009, there was one CBSA for which we did not have occupational mix data for any of its providers (CBSA 12020, Athens-Clark County, GA). In the absence of any data in this labor market area, we applied an occupational mix adjustment factor of 1.0 to all provider(s).

In the FY 2007 IPPS final rule, we also indicated that we would give serious consideration to applying a hospital-specific penalty if a hospital does not comply with regulations requiring submission of occupational mix survey data in future years. We stated that we believe that section 1886(d)(5)(I)(i) of the Act provides us with the authority to penalize hospitals that do not submit occupational mix survey data. That section authorizes us to provide for exceptions and adjustments to the payment amounts under IPPS as the Secretary deems appropriate. We also indicated that we would address this issue in the FY 2008 IPPS proposed rule.

In the FY 2008 IPPS proposed rule, we solicited comments and suggestions for a hospital-specific penalty for hospitals that do not submit occupational mix survey data. In response to the FY 2008 IPPS proposed rule, some commenters suggested a 1-percent to 2-percent reduction in the hospital's wage index value or a set percentage of the standardized amount. We noted that any penalty that we would determine for nonresponsive hospitals would apply to a future wage index, not the FY 2008 wage index.

In the FY 2008 final rule with comment period, we assigned nonresponsive hospitals the average occupational mix adjustment for the labor market area. For areas where no hospital submitted survey data, we applied the national occupational mix adjustment factor of 1.0000 in calculating the area's FY 2008 occupational mix adjusted wage index. We appreciate the suggestions we received regarding future penalties for hospitals that do not submit occupational mix survey data. We stated in the FY 2008 final rule with comment period that we may consider proposing a policy to penalize hospitals that do not submit occupational mix survey data for FY 2010, the first year of the application of the new 2007-2008 occupational mix survey, and that we expected that any such penalty would be proposed in the FY 2009 IPPS proposed rule so hospitals would be aware of the policy before the deadline for submitting the data to the fiscal intermediaries/MAC. At this time, however, we are not proposing a penalty for FY 2010. Rather, we are reserving the right to propose a penalty in the FY 2010 IPPS proposed rule, once we collect and analyze the FY 2007-2008 occupational mix survey data. Hospitals are still on notice that any failure to submit occupational mix data for the FY 2007-2008 survey year may result in a penalty in FY 2010, thus achieving our policy goal of ensuring that hospitals are aware of the consequences of failure to submit data in response to the most recent survey.

3. 2007-2008 Occupational Mix Survey for the FY 2010 Wage Index

As stated earlier, section 304(c) of Pub. L. 106-554 amended section 1886(d)(3)(E) of the Act to require CMS to collect data every 3 years on the occupational mix of employees for each short-term, acute care hospital participating in the Medicare program. We used occupational mix data collected on the 2006 survey to compute the proposed occupational mix adjustment for FY 2009. In the FY 2008 IPPS final rule with comment period (72 FR 47315), we discussed how we modified the occupational mix survey. The revised 2007-2008 occupational mix survey provides for the collection of hospital-specific wages and hours data for the 1-year period of July 1, 2007, through June 30, 2008, additional clarifications to the survey instructions, the elimination of the registered nurse subcategories, some refinements to the definitions of the occupational categories, and the inclusion of additional cost centers that typically provide nursing services. The revised 2007-2008 occupational mix survey will be applied beginning with the FY 2010 wage index.

On February 2, 2007, we published in the Federal Register a notice soliciting comments on the proposed revisions to the occupational mix survey (72 FR 5055). The comment period for the notice ended on April 3, 2007. After considering the comments we received, we made a few minor editorial changes and published the final 2007-2008 occupational mix survey on September 14, 2007 (72 FR 52568). OMB approved the survey without change on February 1, 2008 (OMB Control Number 0938 0907). The 2007-2008 Medicare occupational mix survey (Form CMS-10079 (2008)) is available on the CMS Web site at: http://www.cms.hhs.gov/AcuteInpatientPPS/WIFN/list.asp#TopOfPage , and through the fiscal intermediaries/MAC. Hospitals must submit their completed surveys to their fiscal intermediaries/MAC by September 1, 2008. The preliminary, unaudited 2007-2008 occupational mix survey data will be released in early October 2008, along with the FY 2006 Worksheet S-3 wage data, for the FY 2010 wage index review and correction process.

E. Worksheet S-3 Wage Data for the Proposed FY 2009 Wage Index

The proposed FY 2009 wage index values (to be effective for hospital discharges occurring on or after October 1, 2008, and before October 1, 2009) in section II.B. of the Addendum to this proposed rule are based on the data collected from the Medicare cost reports submitted by hospitals for cost reporting periods beginning in FY 2005 (the FY 2008 wage index was based on FY 2004 wage data).

1. Included Categories of Costs

The proposed FY 2009 wage index includes the following categories of data associated with costs paid under the IPPS (as well as outpatient costs):

• Salaries and hours from short-term, acute care hospitals (including paid lunch hours and hours associated with military leave and jury duty).

• Home office costs and hours.

• Certain contract labor costs and hours (which includes direct patient care, certain top management, pharmacy, laboratory, and nonteaching physician Part A services, and certain contract indirect patient care services (as discussed in the FY 2008 final rule with comment period (72 FR 47315).

• Wage-related costs, including pensions and other deferred compensation costs. We note that, on March 28, 2008, CMS published a technical clarification to the cost reporting instructions for pension and deferred compensation costs (sections 2140 through 2142.7 of the Provider Reimbursement Manual, Part I). These instructions are used for developing pension and deferred compensation costs for purposes of the wage index, as discussed in the instructions for Worksheet S-3, Part II, Lines 13 through 20 and in the FY 2006 final rule (70 FR 47369).

2. Excluded Categories of Costs

Consistent with the wage index methodology for FY 2008, the proposed wage index for FY 2009 also excludes the direct and overhead salaries and hours for services not subject to IPPS payment, such as SNF services, home health services, costs related to GME (teaching physicians and residents) and certified registered nurse anesthetists (CRNAs), and other subprovider components that are not paid under the IPPS. The proposed FY 2009 wage index also excludes the salaries, hours, and wage-related costs of hospital-based rural health clinics (RHCs), and Federally qualified health centers (FQHCs) because Medicare pays for these costs outside of the IPPS (68 FR 45395). In addition, salaries, hours, and wage-related costs of CAHs are excluded from the wage index, for the reasons explained in the FY 2004 IPPS final rule (68 FR 45397).

3. Use of Wage Index Data by Providers Other Than Acute Care Hospitals Under the IPPS

Data collected for the IPPS wage index are also currently used to calculate wage indices applicable to other providers, such as SNFs, home health agencies, and hospices. In addition, they are used for prospective payments to IRFs, IPFs, and LTCHs, and for hospital outpatient services. We note that, in the IPPS rules, we do not address comments pertaining to the wage indices for non-IPPS providers. Such comments should be made in response to separate proposed rules for those providers.

F. Verification of Worksheet S-3 Wage Data

The wage data for the proposed FY 2009 wage index were obtained from Worksheet S-3, Parts II and III of the FY 2005 Medicare cost reports. Instructions for completing Worksheet S-3, Parts II and III are in the Provider Reimbursement Manual (PRM), Part II, sections 3605.2 and 3605.3. The data file used to construct the proposed wage index includes FY 2005 data submitted to us as of February 29, 2008. As in past years, we performed an intensive review of the wage data, mostly through the use of edits designed to identify aberrant data.

We asked our fiscal intermediaries/MAC to revise or verify data elements that resulted in specific edit failures. For the proposed FY 2009 wage index, we identified and excluded 37 providers with data that was too aberrant to include in the proposed wage index, although if data elements for some of these providers are corrected, we intend to include some of these providers in the FY 2009 final wage index. We instructed fiscal intermediaries/MACs to complete their data verification of questionable data elements and to transmit any changes to the wage data no later than April 14, 2008. We believe all unresolved data elements will be resolved by the date the final rule is issued. The revised data will be reflected in the FY 2009 IPPS final rule.

In constructing the proposed FY 2009 wage index, we included the wage data for facilities that were IPPS hospitals in FY 2005; inclusive of those facilities that have since terminated their participation in the program as hospitals, as long as those data did not fail any of our edits for reasonableness. We believe that including the wage data for these hospitals is, in general, appropriate to reflect the economic conditions in the various labor market areas during the relevant past period and to ensure that the current wage index represents the labor market area's current wages as compared to the national average of wages. However, we excluded the wage data for CAHs as discussed in the FY 2004 IPPS final rule (68 FR 45397). For this proposed rule, we removed 20 hospitals that converted to CAH status between February 16, 2007, the cut-off date for CAH exclusion from the FY 2008 wage index, and February 18, 2008, the cut-off date for CAH exclusion from the FY 2009 wage index. After removing hospitals with aberrant data and hospitals that converted to CAH status, the proposed FY 2009 wage index is calculated based on 3,533 hospitals.

1. Wage Data for Multicampus Hospitals

In the FY 2008 final rule with comment period (72 FR 47317), we discussed our policy for allocating a multicampus hospital's wages and hours data, by full-time equivalent (FTE) staff, among the different labor market areas where its campuses are located. During the FY 2009 wage index desk review process, we requested fiscal intermediaries/MACs to contact multicampus hospitals that had campuses in different labor market areas to collect the data for the allocation. The proposed FY 2009 wage index in this proposed rule includes separate wage data for campuses of three multicampus hospitals.

As with the FY 2008 wage index, we allowed hospitals the option of allocating their wages and hours for the FY 2009 wage index based on either FTE staff or discharge data. Again, we are providing this option until a revised cost report is available that will allow a multicampus hospital to report the number of FTEs by location of its different campuses. Two of the three multicampus hospitals chose to have their wage data allocated by their Medicare discharge data. One of the hospitals provided FTE staff data for the allocation. The average hourly wage associated with each geographical location of a multicampus hospital is reflected in Table 2 of the Addendum to this proposed rule.

2. New Orleans' Post-Katrina Wage Index

Since 2005 when Hurricane Katrina devastated the Gulf States, we have received numerous comments suggesting that current Medicare payments to hospitals in New Orleans, Louisiana are inadequate, and the wage index does not accurately reflect the increase in labor costs experienced by the city after the storm. The post-Katrina effects on the New Orleans wage index will not be realized in the wage index until FY 2010, when the wage index will be based on cost reporting periods beginning during FY 2006 (that is, beginning on or after October 1, 2005 and before October 1, 2006).

In responding to the health-related needs of people affected by the hurricane, the Federal Government, through the Deficit Reduction Act of 2005 (DRA), appropriated $2 billion in FY 2006. These funds allowed the Secretary to make available $160 million in February 2007 to Louisiana, Mississippi, and Alabama for payments to hospitals and skilled nursing facilities facing financial stress because of changing wage rates not yet reflected in Medicare payment methodologies. In March and May 2007, the Department provided two additional DRA grants of $15 million and $35 million, respectively, to Louisiana for professional health care workforce recruitment and sustainability in the greater New Orleans area, namely the Orleans, Jefferson, St. Bernard, and Plaquemines Parishes. In addition, the Department issued a supplemental award of $60 million in provider stabilization grant funding to Louisiana, Mississippi, and Alabama to continue to help health care providers meet changing wage rates not yet reflected by Medicare's payment policies. On July 23, 2007, HHS awarded to Louisiana a new $100 million Primary Care Grant to help increase access to primary care in the Greater New Orleans area. The resulting stabilization and expansion of the community based primary care infrastructure, post Katrina, helps provide a viable alternative to local hospital emergency rooms for all citizens of New Orleans, especially those who are poor and uninsured. In other Department efforts, the OIG has performed an in-depth review of the post-Katrina infrastructure of five New Orleans hospitals, including the hospitals' staffing levels and wage costs. The OIG's final reports and recommendations are scheduled to be published in Spring 2008.

G. Method for Computing the Proposed FY 2009 Unadjusted Wage Index

The method used to compute the proposed FY 2009 wage index without an occupational mix adjustment follows:

Step 1 -As noted above, we based the proposed FY 2009 wage index on wage data reported on the FY 2005 Medicare cost reports. We gathered data from each of the non-Federal, short-term, acute care hospitals for which data were reported on the Worksheet S-3, Parts II and III of the Medicare cost report for the hospital's cost reporting period beginning on or after October 1, 2004, and before October 1, 2005. In addition, we included data from some hospitals that had cost reporting periods beginning before October 2004 and reported a cost reporting period covering all of FY 2004. These data are included because no other data from these hospitals would be available for the cost reporting period described above, and because particular labor market areas might be affected due to the omission of these hospitals. However, we generally describe these wage data as FY 2005 data. We note that, if a hospital had more than one cost reporting period beginning during FY 2005 (for example, a hospital had two short cost reporting periods beginning on or after October 1, 2004, and before October 1, 2005), we included wage data from only one of the cost reporting periods, the longer, in the wage index calculation. If there was more than one cost reporting period and the periods were equal in length, we included the wage data from the later period in the wage index calculation.

Step 2-Salaries-The method used to compute a hospital's average hourly wage excludes certain costs that are not paid under the IPPS. (We note that, beginning with FY 2008 (72 FR 47315), we include lines 22.01, 26.01, and 27.01 of Worksheet S-3, Part II for overhead services in the wage index. However, we note that the wages and hours on these lines are not incorporated into line 101, column 1 of Worksheet A, which, through the electronic cost reporting software, flows directly to line 1 of Worksheet S-3, Part II. Therefore, the first step in the wage index calculation for FY 2009 is to compute a "revised" Line 1, by adding to the Line 1 on Worksheet S-3, Part II (for wages and hours respectively) the amounts on Lines 22.01, 26.01, and 27.01.) In calculating a hospital's average salaries plus wage-related costs, we subtract from Line 1 (total salaries) the GME and CRNA costs reported on Lines 2, 4.01, 6, and 6.01, the Part B salaries reported on Lines 3, 5 and 5.01, home office salaries reported on Line 7, and exclude salaries reported on Lines 8 and 8.01 (that is, direct salaries attributable to SNF services, home health services, and other subprovider components not subject to the IPPS). We also subtract from Line 1 the salaries for which no hours were reported. To determine total salaries plus wage-related costs, we add to the net hospital salaries the costs of contract labor for direct patient care, certain top management, pharmacy, laboratory, and nonteaching physician Part A services (Lines 9 and 10), home office salaries and wage-related costs reported by the hospital on Lines 11 and 12, and nonexcluded area wage-related costs (Lines 13, 14, and 18).

We note that contract labor and home office salaries for which no corresponding hours are reported are not included. In addition, wage-related costs for nonteaching physician Part A employees (Line 18) are excluded if no corresponding salaries are reported for those employees on Line 4.

Step 3 -Hours-With the exception of wage-related costs, for which there are no associated hours, we compute total hours using the same methods as described for salaries in Step 2.

Step 4 -For each hospital reporting both total overhead salaries and total overhead hours greater than zero, we then allocate overhead costs to areas of the hospital excluded from the wage index calculation. First, we determine the ratio of excluded area hours (sum of Lines 8 and 8.01 of Worksheet S-3, Part II) to revised total hours (Line 1 minus the sum of Part II, Lines 2, 3, 4.01, 5, 5.01, 6, 6.01, 7, and Part III, Line 13 of Worksheet S-3). We then compute the amounts of overhead salaries and hours to be allocated to excluded areas by multiplying the above ratio by the total overhead salaries and hours reported on Line 13 of Worksheet S-3, Part III. Next, we compute the amounts of overheadwage-related costs to be allocated to excluded areas using three steps: (1) We determine the ratio of overhead hours (Part III, Line 13 minus the sum of lines 22.01, 26.01, and 27.01) to revised hours excluding the sum of lines 22.01, 26.01, and 27.01 (Line 1 minus the sum of Lines 2, 3, 4.01, 5, 5.01, 6, 6.01, 7, 8, 8.01, 22.01, 26.01, and 27.01). (We note that for the FY 2008 and subsequent wage index calculations, we are excluding the sum of lines 22.01, 26.01, and 27.01 from the determination of the ratio of overhead hours to revised hours, since hospitals typically do not provide fringe benefits (wage-related costs) to contract personnel. Therefore, it is not necessary for the wage index calculation to exclude overhead wage-related costs for contract personnel. Further, if a hospital does contribute to wage-related costs for contracted personnel, the instructions for lines 22.01, 26.01, and 27.01 require that associated wage-related costs be combined with wages on the respective contract labor lines.); (2) we compute overhead wage-related costs by multiplying the overhead hours ratio by wage-related costs reported on Part II, Lines 13, 14, and 18; and (3) we multiply the computed overhead wage-related costs by the above excluded area hours ratio. Finally, we subtract the computed overhead salaries,wage-related costs, and hours associated with excluded areas from the total salaries (plus wage-related costs) and hours derived in Steps 2 and 3.

Step 5 -For each hospital, we adjust the total salaries plus wage-related costs to a common period to determine total adjusted salaries plus wage-related costs. To make the wage adjustment, we estimate the percentage change in the employment cost index (ECI) for compensation for each 30-day increment from October 14, 2003, through April 15, 2005, for private industry hospital workers from the BLS' Compensation and Working Conditions. We use the ECI because it reflects the price increase associated with total compensation (salaries plus fringes) rather than just the increase in salaries. In addition, the ECI includes managers as well as other hospital workers. This methodology to compute the monthly update factors uses actual quarterly ECI data and assures that the update factors match the actual quarterly and annual percent changes. We also note that, since April 2006 with the publication of March 2006 data, the BLS' ECI uses a different classification system, the North American Industrial Classification System (NAICS), instead of the Standard Industrial Codes (SICs), which no longer exist. We have consistently used the ECI as the data source for our wages and salaries and other price proxies in the IPPS market basket and are not proposing to make any changes to the usage at this time. The factors used to adjust the hospital's data were based on the midpoint of the cost reporting period, as indicated below.

After Before Adjustment factor
10/14/2004 11/15/2004 1.05390
11/14/2004 12/15/2004 1.05035
12/14/2004 01/15/2005 1.04690
01/14/2005 02/15/2005 1.04342
02/14/2005 03/15/2005 1.03992
03/14/2005 04/15/2005 1.03641
04/14/2005 05/15/2005 1.03291
05/14/2005 06/15/2005 1.02940
06/14/2005 07/15/2005 1.02596
07/14/2005 08/15/2005 1.02264
08/14/2005 09/15/2005 1.01943
09/14/2005 10/15/2005 1.01627
10/14/2005 11/15/2005 1.01308
11/14/2005 12/15/2005 1.00987
12/14/2005 01/15/2006 1.00661
01/14/2006 02/15/2006 1.00333
02/14/2006 03/15/2006 1.00000
03/14/2006 04/15/2006 0.99670

For example, the midpoint of a cost reporting period beginning January 1, 2005, and ending December 31, 2005, is June 30, 2005. An adjustment factor of 1.02596 would be applied to the wages of a hospital with such a cost reporting period. In addition, for the data for any cost reporting period that began in FY 2005 and covered a period of less than 360 days or more than 370 days, we annualize the data to reflect a 1-year cost report. Dividing the data by the number of days in the cost report and then multiplying the results by 365 accomplishes annualization.

Step 6- Each hospital is assigned to its appropriate urban or rural labor market area before any reclassifications under section 1886(d)(8)(B), section 1886(d)(8)(E), or section 1886(d)(10) of the Act. Within each urban or rural labor market area, we add the total adjusted salaries plus wage-related costs obtained in Step 5 for all hospitals in that area to determine the total adjusted salaries plus wage-related costs for the labor market area.

Step 7- We divide the total adjusted salaries plus wage-related costs obtained under both methods in Step 6 by the sum of the corresponding total hours (from Step 4) for all hospitals in each labor market area to determine an average hourly wage for the area.

Step 8- We add the total adjusted salaries plus wage-related costs obtained in Step5 for all hospitals in the Nation and then divide the sum by the national sum of total hours from Step 4 to arrive at a national average hourly wage. Using the data as described above, the proposed national average hourly wage (unadjusted for occupational mix) is $32.2489.

Step 9- For each urban or rural labor market area, we calculate the hospital wage index value, unadjusted for occupational mix, by dividing the area average hourly wage obtained in Step 7 by the national average hourly wage computed in Step 8.

Step 10- Following the process set forth above, we develop a separate Puerto Rico-specific wage index for purposes of adjusting the Puerto Rico standardized amounts. (The national Puerto Rico standardized amount is adjusted by a wage index calculated for all Puerto Rico labor market areas based on the national average hourly wage as described above.) We add the total adjusted salaries plus wage-related costs (as calculated in Step 5) for all hospitals in Puerto Rico and divide the sum by the total hours for Puerto Rico (as calculated in Step 4) to arrive at an overall proposed average hourly wage (unadjusted for occupational mix) of $13.7956 for Puerto Rico. For each labor market area in Puerto Rico, we calculate the Puerto Rico-specific wage index value by dividing the area average hourly wage (as calculated in Step 7) by the overall Puerto Rico average hourly wage.

Step 11- Section 4410 of Pub. L. 105-33 provides that, for discharges on or after October 1, 1997, the area wage index applicable to any hospital that is located in an urban area of a State may not be less than the area wage index applicable to hospitals located in rural areas in that State. For FY 2009, this proposed change would affect 266 hospitals in 69 urban areas. The areas affected by this provision are identified by a footnote in Table 4A in the Addendum of this proposed rule.

In the FY 2005 IPPS final rule (69 FR 49109), we adopted the "imputed" floor as a temporary 3-year measure to address a concern by some individuals that hospitals in all-urban States were disadvantaged by the absence of rural hospitals to set a wage index floor in those States. The imputed floor was originally set to expire in FY 2007, but we extended it an additional year in the FY 2008 IPPS final rule with comment period (72FR47321). As explained in section III.B.2.b. of the preamble of this proposed rule, we are proposing to extend the imputed floor for an additional 3 years, through FY 2011.

H. Analysis and Implementation of the Proposed Occupational Mix Adjustment and the Proposed FY 2009 Occupational Mix Adjusted Wage Index

As discussed in section III.D. of this preamble, for FY 2009, we are proposing to apply the occupational mix adjustment to 100 percent of the FY 2009 wage index. We calculated the occupational mix adjustment using data from the 2006 occupational mix survey data, using the methodology described in section III.D.3. of this preamble.

Using the 1st and 2nd quarter occupational mix survey data and applying the occupational mix adjustment to 100 percent of the proposed FY2009 wage index results in a proposed national average hourly wage of $32.2252 and a proposed Puerto-Rico specific average hourly wage of $13.7851. After excluding data of hospitals that either submitted aberrant data that failed critical edits, or that do not have FY 2005 Worksheet S-3 cost report data for use in calculating the proposed FY2009 wage index, we calculated the proposed FY 2009 wage index using the occupational mix survey data from 3,364 hospitals. Using the Worksheet S-3 cost report data of 3,533 hospitals and occupational mix 1st and/or 2nd quarter survey data from 3,364 hospitals represents a 95.2 percent survey response rate. The proposed FY2009 national average hourly wages for each occupational mix nursing subcategory as calculated in Step 2 of the occupational mix calculation are as follows:

Occupational mix nursing subcategory Average hourly wage
National RN Management $38.6341
National RN Staff $33.4795
National LPN $19.2316
National Nurse Aides, Orderlies, and Attendants $13.6954
National Medical Assistants $15.7714
National Nurse Category $28.7291

The proposed national average hourly wage for the entire nurse category as computed in Step 5 of the occupational mix calculation is $28.7291. Hospitals with a nurse category average hourly wage (as calculated in Step 4) of greater than the national nurse category average hourly wage receive an occupational mix adjustment factor (as calculated in Step 6) of less than 1.0. Hospitals with a nurse category average hourly wage (as calculated in Step 4) of less than the national nurse category average hourly wage receive an occupational mix adjustment factor (as calculated in Step 6) of greater than 1.0.

Based on the January through June 2006 occupational mix survey data, we determined (in Step 7 of the occupational mix calculation) that the proposed national percentage of hospital employees in the Nurse category is 42.99 percent, and the proposed national percentage of hospital employees in the All Other Occupations category is 57.01 percent. At the CBSA level, the percentage of hospital employees in the Nurse category ranged from a low of 27.26 percent in one CBSA, to a high of 85.30 percent in another CBSA.

The proposed wage index values for FY 2009 (except those for hospitals receiving wage index adjustments under section 1886(d)(13) of the Act) are shown in Tables 4A, 4B, 4C, and 4F in the Addendum to this proposed rule.

Tables 3A and 3B in the Addendum to this proposed rule list the 3-year average hourly wage for each labor market area before the redesignation of hospitals based on FYs 2007, 2008, and 2009 cost reporting periods. Table 3A lists these data for urban areas and Table 3B lists these data for rural areas. In addition, Table 2 in the Addendum to this proposed rule includes the adjusted average hourly wage for each hospital from the FY 2003 and FY 2004 cost reporting periods, as well as the FY 2005 period used to calculate the proposed FY 2009 wage index. The 3-year averages are calculated by dividing the sum of the dollars (adjusted to a common reporting period using the method described previously) across all 3 years, by the sum of the hours. If a hospital is missing data for any of the previous years, its average hourly wage for the 3-year period is calculated based on the data available during that period.

The proposed wage index values in Tables 2, 4A, 4B, 4C, and 4F and the average hourly wages in Tables 2, 3A, and 3B in the Addendum to this proposed rule include the proposed occupational mix adjustment. The proposed wage index values in Tables 2, 4A, 4B, and 4C also include the proposed State-specific rural floor and imputed floor budget neutrality adjustments that are discussed in section III.B.2. of this preamble. The proposed State budget neutrality adjustments for the rural and imputed floors are included in Tables 4D-1 and 4D-2 in the Addendum to this proposed rule.

I. Proposed Revisions to the Wage Index Based on Hospital Redesignations

1. General

Under section 1886(d)(10) of the Act, the MGCRB considers applications by hospitals for geographic reclassification for purposes of payment under the IPPS. Hospitals must apply to the MGCRB to reclassify 13 months prior to the start of the fiscal year for which reclassification is sought (generally by September 1). Generally, hospitals must be proximate to the labor market area to which they are seeking reclassification and must demonstrate characteristics similar to hospitals located in that area. The MGCRB issues its decisions by the end of February for reclassifications that become effective for the following fiscal year (beginning October 1). The regulations applicable to reclassifications by the MGCRB are located in 42 CFR 412.230 through 412.280.

Section 1886(d)(10)(D)(v) of the Act provides that, beginning with FY 2001, a MGCRB decision on a hospital reclassification for purposes of the wage index is effective for 3 fiscal years, unless the hospital elects to terminate the reclassification. Section 1886(d)(10)(D)(vi) of the Act provides that the MGCRB must use average hourly wage data from the 3 most recently published hospital wage surveys in evaluating a hospital's reclassification application for FY 2003 and any succeeding fiscal year.

Section 304(b) of Pub. L. 106-554 provides that the Secretary must establish a mechanism under which a statewide entity may apply to have all of the geographic areas in the State treated as a single geographic area for purposes of computing and applying a single wage index, for reclassifications beginning in FY 2003. The implementing regulations for this provision are located at 42 CFR 412.235.

Section 1886(d)(8)(B) of the Act requires the Secretary to treat a hospital located in a rural county adjacent to one or more urban areas as being located in the MSA to which the greatest number of workers in the county commute, if the rural county would otherwise be considered part of an urban area under the standards for designating MSAs and if the commuting rates used in determining outlying counties were determined on the basis of the aggregate number of resident workers who commute to (and, if applicable under the standards, from) the central county or counties of all contiguous MSAs. In light of the CBSA definitions and the Census 2000 data that we implemented for FY 2005 (69 FR 49027), we undertook to identify those counties meeting these criteria. Eligible counties are discussed and identified under section III.I.5. of this preamble.

2. Effects of Reclassification/Redesignation

Section 1886(d)(8)(C) of the Act provides that the application of the wage index to redesignated hospitals is dependent on the hypothetical impact that the wage data from these hospitals would have on the wage index value for the area to which they have been redesignated. These requirements for determining the wage index values for redesignated hospitals are applicable both to the hospitals deemed urban under section 1886(d)(8)(B) of the Act and hospitals that were reclassified as a result of the MGCRB decisions under section 1886(d)(10) of the Act. Therefore, as provided in section 1886(d)(8)(C) of the Act, the wage index values were determined by considering the following:

• If including the wage data for the redesignated hospitals would reduce the wage index value for the area to which the hospitals are redesignated by 1 percentage point or less, the area wage index value determined exclusive of the wage data for the redesignated hospitals applies to the redesignated hospitals.

• If including the wage data for the redesignated hospitals reduces the wage index value for the area to which the hospitals are redesignated by more than 1 percentage point, the area wage index determined inclusive of the wage data for the redesignated hospitals (the combined wage index value) applies to the redesignated hospitals.

• If including the wage data for the redesignated hospitals increases the wage index value for the urban area to which the hospitals are redesignated, both the area and the redesignated hospitals receive the combined wage index value. Otherwise, the hospitals located in the urban area receive a wage index excluding the wage data of hospitals redesignated into the area.

Rural areas whose wage index values would be reduced by excluding the wage data for hospitals that have been redesignated to another area continue to have their wage index values calculated as if no redesignation had occurred (otherwise, redesignated rural hospitals are excluded from the calculation of the rural wage index). The wage index value for a redesignated rural hospital cannot be reduced below the wage index value for the rural areas of the State in which the hospital is located.

CMS has also adopted the following policies:

• The wage data for a reclassified urban hospital is included in both the wage index calculation of the area to which the hospital is reclassified (subject to the rules described above) and the wage index calculation of the urban area where the hospital is physically located.

• In cases where urban hospitals have reclassified to rural areas under 42 CFR 412.103, the urban hospital wage data are: (a) Included in the rural wage index calculation, unless doing so would reduce the rural wage index; and (b) included in the urban area where the hospital is physically located.

3. FY 2009 MGCRB Reclassifications

Under section 1886(d)(10) of the Act, the MGCRB considers applications by hospitals for geographic reclassification for purposes of payment under the IPPS. The specific procedures and rules that apply to the geographic reclassification process are outlined in 42 CFR 412.230 through 412.280.

At the time this proposed rule was constructed, the MGCRB had completed its review of FY 2009 reclassification requests. There were 314 hospitals approved for wage index reclassifications by the MGCRB for FY 2009. Because MGCRB wage index reclassifications are effective for 3 years, hospitals reclassified during FY 2007 or FY 2008 are eligible to continue to be reclassified based on prior reclassifications to current MSAs during FY 2009. There were 175 hospitals approved for wage index reclassifications in FY 2007 and 324 hospitals approved for wage index reclassifications in FY 2008. Of all of the hospitals approved for reclassification for FY 2007, FY 2008, and FY 2009, 813 hospitals are in a reclassification status for FY 2009.

Under 42 CFR 412.273, hospitals that have been reclassified by the MGCRB are permitted to withdraw their applications within 45 days of the publication of a proposed rule. The request for withdrawal of an application for reclassification or termination of an existing 3-year reclassification that would be effective in FY 2009 must be received by the MGCRB within 45 days of the publication of this proposed rule. If a hospital elects to withdraw its wage index application after the MGCRB has issued its decision, but within 45 days of publication of this proposed rule date, it may later cancel its withdrawal in a subsequent year and request the MGCRB to reinstate its wage index reclassification for the remaining fiscal year(s) of the 3-year period (42 CFR 412.273(b)(2)(i)). The request to cancel a prior withdrawal or termination must be in writing to the MGCRB no later than the deadline for submitting reclassification applications for the following fiscal year (42 CFR 412.273(d)). For further information about withdrawing, terminating, or canceling a previous withdrawal or termination of a 3-year reclassification for wage index purposes, we refer the reader to 42 CFR 412.273, as well as the August 1, 2002 IPPS final rule (67 FR 50065), and the August 1, 2001 IPPS final rule (66 FR 39887).

Changes to the wage index that result from withdrawals of requests for reclassification, wage index corrections, appeals, and the Administrator's review process will be incorporated into the wage index values published in the FY 2009 final rule. These changes may affect not only the wage index value for specific geographic areas, but also the wage index value redesignated hospitals receive; that is, whether they receive the wage index that includes the data for both the hospitals already in the area and the redesignated hospitals. Further, the wage index value for the area from which the hospitals are redesignated may be affected.

Applications for FY 2010 reclassifications are due to the MGCRB by September 2, 2008 (the first working day of September 2008). We note that this is also the deadline for canceling a previous wage index reclassification withdrawal or termination under 42 CFR 412.273(d). Applications and other information about MGCRB reclassifications may be obtained, beginning in mid-July 2008, via the CMS Internet Web site at: http://cms.hhs.gov/providers/prrb/mgcinfo.asp, or by calling the MGCRB at (410) 786-1174. The mailing address of the MGCRB is: 2520 Lord Baltimore Drive, Suite L, Baltimore, MD 21244-2670.

4. FY 2008 Policy Clarifications and Revisions

We note below several policies related to geographic reclassification that were clarified or revised in the FY 2008 IPPS final rule with comment period (72 FR 47333):

Reinstating Reclassifications -As provided for in 42 CFR 412.273(b)(2), once a hospital (or hospital group) accepts a newly approved reclassification, any previous reclassification is permanently terminated.

Geographic Reclassification for Multicampus Hospitals -Because campuses of a multicampus hospital can now have their wages and hours data allocated by FTEs or discharge data, a hospital campus located in a geographic area distinct from the geographic area associated with the provider number of the multicampus hospital will have official wage data to supplement an individual or group reclassification application (§ 412.230(d)(2)(v)).

New England Deemed Counties -Hospitals in New England deemed counties are treated the same as Lugar hospitals in calculating the wage index. That is, the area is considered rural, but the hospitals within the area are deemed to be urban (§ 412.64(b)(3)(ii)).

"Fallback" Reclassifications -A hospital will automatically be given its most recently approved reclassification (thereby permanently terminating any previously approved reclassifications) unless it provides written notice to the MGCRB within 45 days of publication of the notice of proposed rulemaking that it wishes to withdraw its most recently approved reclassification and "fall back" to either its prior reclassification or its home area wage index for the following fiscal year.

5. Redesignations of Hospitals Under Section 1886(d)(8)(B) of the Act

Section 1886(d)(8)(B) of the Act requires us to treat a hospital located in a rural county adjacent to one or more urban areas as being located in the MSA if certain criteria are met. Effective beginning FY 2005, we use OMB's 2000 CBSA standards and the Census 2000 data to identify counties in which hospitals qualify under section 1886(d)(8)(B) of the Act to receive the wage index of the urban area. Hospitals located in these counties have been known as "Lugar" hospitals and the counties themselves are often referred to as "Lugar" counties. We provide the proposed FY 2009 chart below with the listing of the rural counties containing the hospitals designated as urban under section 1886(d)(8)(B) of the Act. For discharges occurring on or after October 1, 2008, hospitals located in the rural county in the first column of this chart will be redesignated for purposes of using the wage index of the urban area listed in the second column.

Rural county CBSA
Cherokee, AL Rome, GA
Macon, AL Auburn-Opelika, AL
Talladega, AL Anniston-Oxford, AL
Hot Springs, AR Hot Springs, AR
Windham, CT Hartford-West Hartford-East Hartford, CT
Bradford, FL Gainesville, FL
Hendry, FL West Palm Beach-Boca Raton-Boynton, FL
Levy, FL Gainesville, FL
Walton, FL Fort Walton Beach-Crestview-Destin, FL
Banks, GA Gainesville, GA
Chattooga, GA Chattanooga, TN-GA
Jackson, GA Atlanta-Sandy Springs-Marietta, GA
Lumpkin, GA Atlanta-Sandy Springs-Marietta, GA
Morgan, GA Atlanta-Sandy Springs-Marietta, GA
Peach, GA Macon, GA
Polk, GA Atlanta-Sandy Springs-Marietta, GA
Talbot, GA Columbus, GA-AL
Bingham, ID Idaho Falls, ID
Christian, IL Springfield, IL
DeWitt, IL Bloomington-Normal, IL
Iroquois, IL Kankakee-Bradley, IL
Logan, IL Springfield, IL
Mason, IL Peoria, IL
Ogle, IL Rockford, IL
Clinton, IN Lafayette, IN
Henry, IN Indianapolis-Carmel, IN
Spencer, IN Evansville, IN-KY
Starke, IN Gary, IN
Warren, IN Lafayette, IN
Boone, IA Ames, IA
Buchanan, IA Waterloo-Cedar Falls, IA
Cedar, IA Iowa City, IA
Allen, KY Bowling Green, KY
Assumption Parish, LA Baton Rouge, LA
St. James Parish, LA Baton Rouge, LA
Allegan, MI Holland-Grand Haven, MI
Montcalm, MI Grand Rapids-Wyoming, MI
Oceana, MI Muskegon-Norton Shores, MI
Shiawassee, MI Lansing-East Lansing, MI
Tuscola, MI Saginaw-Saginaw Township North, MI
Fillmore, MN Rochester, MN
Dade, MO Springfield, MO
Pearl River, MS Gulfport-Biloxi, MS
Caswell, NC Burlington, NC
Davidson, NC Greensboro-High Point, NC
Granville, NC Durham, NC
Harnett, NC Raleigh-Cary, NC
Lincoln, NC Charlotte-Gastonia-Concord, NC-SC
Polk, NC Spartanburg, NC
Los Alamos, NM Santa Fe, NM
Lyon, NV Carson City, NV
Cayuga, NY Syracuse, NY
Columbia, NY Albany-Schenectady-Troy, NY
Genesee, NY Rochester, NY
Greene, NY Albany-Schenectady-Troy, NY
Schuyler, NY Ithaca, NY
Sullivan, NY Poughkeepsie-Newburgh-Middletown, NY
Wyoming, NY Buffalo-Niagara Falls, NY
Ashtabula, OH Cleveland-Elyria-Mentor, OH
Champaign, OH Springfield, OH
Columbiana, OH Youngstown-Warren-Boardman, OH-PA
Cotton, OK Lawton, OK
Linn, OR Corvallis, OR
Adams, PA York-Hanover, PA
Clinton, PA Williamsport, PA
Greene, PA Pittsburgh, PA
Monroe, PA Allentown-Bethlehem-Easton, PA-NJ
Schuylkill, PA Reading, PA
Susquehanna, PA Binghamton, NY
Clarendon, SC Sumter, SC
Lee, SC Sumter, SC
Oconee, SC Greenville, SC
Union, SC Spartanburg, SC
Meigs, TN Cleveland, TN
Bosque, TX Waco, TX
Falls, TX Waco, TX
Fannin, TX Dallas-Plano-Irving, TX
Grimes, TX College Station-Bryan, TX
Harrison, TX Longview, TX
Henderson, TX Dallas-Plano-Irving, TX
Milam, TX Austin-Round Rock, TX
Van Zandt, TX Dallas-Plano-Irving, TX
Willacy, TX Brownsville-Harlingen, TX
Buckingham, VA Charlottesville, VA
Floyd, VA Blacksburg-Christiansburg-Radford, VA
Middlesex, VA Virginia Beach-Norfolk-Newport News, VA
Page, VA Harrisonburg, VA
Shenandoah, VA Winchester, VA-WV
Island, WA Seattle-Bellevue-Everett, WA
Mason, WA Olympia, WA
Wahkiakum, WA Longview, WA
Jackson, WV Charleston, WV
Roane, WV Charleston, WV
Green, WI Madison, WI
Green Lake, WI Fond du Lac, WI
Jefferson, WI Milwaukee-Waukesha-West Allis, WI
Walworth, WI Milwaukee-Waukesha-West Allis, WI

As in the past, hospitals redesignated under section 1886(d)(8)(B) of the Act are also eligible to be reclassified to a different area by the MGCRB. Affected hospitals are permitted to compare the reclassified wage index for the labor market area in Table 4C in the Addendum to this proposed rule into which they have been reclassified by the MGCRB to the wage index for the area to which they are redesignated under section 1886(d)(8)(B) of the Act. Hospitals may withdraw from an MCGRB reclassification within 45 days of the publication of this proposed rule.

6. Reclassifications Under Section 1886(d)(8)(B) of the Act

As discussed in last year's FY 2008 IPPS final rule with comment period (72 FR 47336-47337), Lugar hospitals are treated like reclassified hospitals for purposes of determining their applicable wage index and receive the reclassified wage index (Table 4C in the Addendum to this proposed rule) for the urban area to which they have been redesignated. Because Lugar hospitals are treated like reclassified hospitals, when they are seeking reclassification by the MCGRB, they are subject to the rural reclassification rules set forth at 42 CFR 412.230. The procedural rules set forth at § 412.230 list the criteria that a hospital must meet in order to reclassify as a rural hospital. Lugar hospitals are subject to the proximity criteria and payment thresholds that apply to rural hospitals. Specifically, the hospital must be no more than 35 miles from the area to which it seeks reclassification (§ 412.230(b)(1)); and the hospital must show that its average hourly wage is at least 106 percent of the average hourly wage of all other hospitals in the area in which the hospital is located (§ 412.230(d)(1)(iii)(C)). Under current rules, the hospital must also demonstrate that its average hourly wage is equal to at least 82 percent of the average hourly wage of hospitals in the area to which it seeks redesignation (§ 412.230(d)(1)(iv)(C)). However, we are proposing to increase this threshold to 86 percent (as discussed in section III.B.2.a. of this preamble).

Hospitals not located in a Lugar County seeking reclassification to the urban area where the Lugar hospitals have been redesignated are not permitted to measure to the Lugar County to demonstrate proximity (no more than 15 miles for an urban hospital, and no more than 35 miles for a rural hospital or the closest urban or rural area for RRCs or SCHs) in order to be reclassified to such urban area. These hospitals must measure to the urban area exclusive of the Lugar County to meet the proximity or nearest urban or rural area requirement. As discussed in the FY 2008 final rule with comment period, we treat New England deemed counties in a manner consistent with how we treat Lugar counties. (We refer readers to 72 FR 47337 for a discussion of this policy.)

J. Proposed FY 2009 Wage Index Adjustment Based on Commuting Patterns of Hospital Employees

In accordance with the broad discretion under section 1886(d)(13) of the Act, as added by section 505 of Pub. L. 108-173, beginning with FY 2005, we established a process to make adjustments to the hospital wage index based on commuting patterns of hospital employees (the "out-migration" adjustment). The process, outlined in the FY 2005 IPPS final rule (69 FR 49061), provides for an increase in the wage index for hospitals located in certain counties that have a relatively high percentage of hospital employees who reside in the county but work in a different county (or counties) with a higher wage index. Such adjustments to the wage index are effective for 3 years, unless a hospital requests to waive the application of the adjustment. A county will not lose its status as a qualifying county due to wage index changes during the 3-year period, and counties will receive the same wage index increase for those three years. However, a county that qualifies in any given year may no longer qualify after the 3-year period, or it may qualify but receive a different adjustment to the wage index level. Hospitals that receive this adjustment to their wage index are not eligible for reclassification under section 1886(d)(8) or section 1886(d)(10) of the Act. Adjustments under this provision are not subject to the budget neutrality requirements under section 1886(d)(3)(E) of the Act.

Hospitals located in counties that qualify for the wage index adjustment are to receive an increase in the wage index that is equal to the average of the differences between the wage indices of the labor market area(s) with higher wage indices and the wage index of the resident county, weighted by the overall percentage of hospital workers residing in the qualifying county who are employed in any labor market area with a higher wage index. Beginning with the FY 2008 wage index, we use post-reclassified wage indices when determining the out-migration adjustment (72 FR 47339).

For the proposed FY 2009 wage index, we calculated the out-migration adjustment using the same formula described in the FY 2005 IPPS final rule (69 FR 49064), with the addition of using the post-reclassified wage indices, to calculate the out-migration adjustment. This adjustment is calculated as follows:

Step 1. Subtract the wage index for the qualifying county from the wage index of each of the higher wage area(s) to which hospital workers commute.

Step 2. Divide the number of hospital employees residing in the qualifying county who are employed in such higher wage index area by the total number of hospital employees residing in the qualifying county who are employed in any higher wage index area. For each of the higher wage index areas, multiply this result by the result obtained in Step 1.

Step 3. Sum the products resulting from Step 2 (if the qualifying county has workers commuting to more than one higher wage index area).

Step 4. Multiply the result from Step 3 by the percentage of hospital employees who are residing in the qualifying county and who are employed in any higher wage index area.

These adjustments will be effective for each county for a period of 3 fiscal years. For example, hospitals that received the adjustment for the first time in FY 2008 will be eligible to retain the adjustment for FY 2009. For hospitals in newly qualified counties, adjustments to the wage index are effective for 3 years, beginning with discharges occurring on or after October 1, 2008.

Hospitals receiving the wage index adjustment under section 1886(d)(13)(F) of the Act are not eligible for reclassification under sections 1886(d)(8) or (d)(10) of the Act unless they waive the out-migration adjustment. Consistent with our FY 2005, 2006, 2007, and 2008 IPPS final rules, we are proposing that hospitals redesignated under section 1886(d)(8) of the Act or reclassified under section 1886(d)(10) of the Act will be deemed to have chosen to retain their redesignation or reclassification. Section 1886(d)(10) hospitals that wish to receive the out-migration adjustment, rather than their reclassification, should follow the termination/withdrawal procedures specified in 42 CFR 412.273 and section III.I.3. of the preamble of this proposed rule. Otherwise, they will be deemed to have waived the out-migration adjustment. Hospitals redesignated under section 1886(d)(8) of the Act will be deemed to have waived the out-migration adjustment, unless they explicitly notify CMS within 45 days from the publication of this proposed rule that they elect to receive the out-migration adjustment instead. These notifications should be sent to the following address: Centers for Medicare and Medicaid Services, Center for Medicare Management, Attention: Wage Index Adjustment Waivers, Division of Acute Care, Room C4-08-06, 7500 Security Boulevard, Baltimore, MD 21244-1850.

Table 4J in the Addendum to this proposed rule lists the proposed out-migration wage index adjustments for FY 2009. Hospitals that are not otherwise reclassified or redesignated under section 1886(d)(8) or section 1886(d)(10) of the Act will automatically receive the listed adjustment. In accordance with the procedures discussed above, redesignated/reclassified hospitals would be deemed to have waived the out-migration adjustment unless CMS is otherwise notified. Hospitals that are eligible to receive the out-migration wage index adjustment and that withdraw their application for reclassification would automatically receive the wage index adjustment listed in Table 4J in the Addendum to this proposed rule.

K. Process for Requests for Wage Index Data Corrections

The preliminary, unaudited Worksheet S-3 wage data and occupational mix survey data files for the FY 2009 wage index were made available on October 5, 2007, through the Internet on the CMS Web site at: http://www.cms.hhs.gov/AcuteInpatientPPS/WIFN/list.asp#TopOfPage.

In the interest of meeting the data needs of the public, beginning with the proposed FY 2009 wage index, we posted an additional public use file on our Web site that reflects the actual data that are used in computing the proposed wage index. The release of this new file does not alter the current wage index process or schedule. We notified the hospital community of the availability of these data as we do with the current public use wage data files through our Hospital Open Door forum. We encourage hospitals to sign up for automatic notifications of information about hospital issues and the scheduling of the Hospital Open Door forums at: http://www.cms.hhs.gov/OpenDoorForums/.

In a memorandum dated October 5, 2007, we instructed all fiscal intermediaries/MACs to inform the IPPS hospitals they service of the availability of the wage index data files and the process and timeframe for requesting revisions (including the specific deadlines listed below). We also instructed the fiscal intermediaries/MACs to advise hospitals that these data were also made available directly through their representative hospital organizations.

If a hospital wished to request a change to its data as shown in the October 5, 2007 wage and occupational mix data files, the hospital was to submit corrections along with complete, detailed supporting documentation to its fiscal intermediary/MAC by December 7, 2007. Hospitals were notified of this deadline and of all other possible deadlines and requirements, including the requirement to review and verify their data as posted on the preliminary wage index data files on the Internet, through the October 5, 2007 memorandum referenced above.

In the October 5, 2007 memorandum, we also specified that a hospital requesting revisions to its 1st and/or 2nd quarter occupational mix survey data was to copy its record(s) from the CY 2006 occupational mix preliminary files posted to our Web site in October, highlight the revised cells on its spreadsheet, and submit its spreadsheet(s) and complete documentation to its fiscal intermediary/MAC no later than December 7, 2007.

The fiscal intermediaries (or, if applicable, the MACs) notified the hospitals by mid-February 2008 of any changes to the wage index data as a result of the desk reviews and the resolution of the hospitals' early-December revision requests. The fiscal intermediaries/MACs also submitted the revised data to CMS by mid-February 2008. CMS published the proposed wage index public use files that included hospitals' revised wageindex data on February 25, 2008. In a memorandum also dated February 25, 2008, we instructed fiscal intermediaries/MACs to notify all hospitals regarding the availability of the proposed wage index public use files and the criteria and process for requesting corrections and revisions to the wage index data. Hospitals had until March 11, 2008 to submit requests to the fiscal intermediaries/MACs for reconsideration of adjustments made by the fiscal intermediaries/MACs as a result of the desk review, and to correct errors due to CMS's or the fiscal intermediary's (or, if applicable, the MAC's) mishandling of the wage index data. Hospitals were also required to submit sufficient documentation to support their requests.

After reviewing requested changes submitted by hospitals, fiscal intermediaries/MACs are to transmit any additional revisions resulting from the hospitals' reconsideration requests by April 14, 2008. The deadline for a hospital to request CMS intervention in cases where the hospital disagreed with the fiscal intermediary's (or, if applicable, the MAC's) policy interpretations is April 21, 2008.

Hospitals should also examine Table 2 in the Addendum to this proposed rule. Table 2 in the Addendum to this proposed rule contains each hospital's adjusted average hourly wage used to construct the wage index values for the past 3 years, including the FY 2005 data used to construct the proposed FY 2009 wage index. We note that the hospital average hourly wages shown in Table 2 only reflect changes made to a hospital's data and transmitted to CMS by February 29, 2008.

We will release the final wage index data public use files in early May 2008 on the Internet at http://www.cms.hhs.gov/AcuteInpatientPPS/WIFN/list.asp#TopOfPage. The May 2008 public use files will be made available solely for the limited purpose of identifying any potential errors made by CMS or the fiscal intermediary/MAC in the entry of the final wage index data that result from the correction process described above (revisions submitted to CMS by the fiscal intermediaries/MACs by April 14, 2008). If, after reviewing the May 2008 final files, a hospital believes that its wage or occupational mix data are incorrect due to a fiscal intermediary or MAC or CMS error in the entry or tabulation of the final data, the hospital should send a letter to both its fiscal intermediary or MAC and CMS that outlines why the hospital believes an error exists and to provide all supporting information, including relevant dates (for example, when it first became aware of the error). CMS and the fiscal intermediaries (or, if applicable, the MACs) must receive these requests no later than June 9, 2008. Requests mailed to CMS should be sent to: Centers for Medicare Medicaid Services, Center for Medicare Management, Attention: Wage Index Team, Division of Acute Care, C4-08-06, 7500 Security Boulevard, Baltimore, MD 21244-1850.

Each request also must be sent to the fiscal intermediary or the MAC. The fiscal intermediary or the MAC will review requests upon receipt and contact CMS immediately to discuss its findings.

At this point in the process, that is, after the release of the May 2008 wage index data files, changes to the wage and occupational mix data will only be made in those very limited situations involving an error by the fiscal intermediary or the MAC or CMS that the hospital could not have known about before its review of the final wage index data files. Specifically, neither the fiscal intermediary or the MAC nor CMS will approve the following types of requests:

• Requests for wage index data corrections that were submitted too late to be included in the data transmitted to CMS by fiscal intermediaries or the MACs on or before April 21, 2008.

• Requests for correction of errors that were not, but could have been, identified during the hospital's review of the February 25, 2008 wage index public use files.

• Requests to revisit factual determinations or policy interpretations made by the fiscal intermediary or the MAC or CMS during the wage index data correction process.

Verified corrections to the wage index data received timely by CMS and the fiscal intermediaries or the MACs (that is, by June 9, 2008) will be incorporated into the final wage index in the FY 2009 IPPS final rule, which will be effective October 1, 2008.

We created the processes described above to resolve all substantive wage index data correction disputes before we finalize the wage and occupational mix data for the FY 2009 payment rates. Accordingly, hospitals that do not meet the procedural deadlines set forth above will not be afforded a later opportunity to submit wage index data corrections or to dispute the fiscal intermediary's (or, if applicable the MAC's) decision with respect to requested changes. Specifically, our policy is that hospitals that do not meet the procedural deadlines set forth above will not be permitted to challenge later, before the Provider Reimbursement Review Board, the failure of CMS to make a requested data revision. (See W. A. Foote Memorial Hospital v. Shalala , No. 99-CV-75202-DT (E.D. Mich. 2001) and Palisades General Hospital v. Thompson , No. 99-1230 (D.D.C. 2003).) We refer the reader also to the FY 2000 final rule (64 FR 41513) for a discussion of the parameters for appealing to the PRRB for wage index data corrections.

Again, we believe the wage index data correction process described above provides hospitals with sufficient opportunity to bring errors in their wage and occupational mix data to the fiscal intermediary's (or, if applicable, the MAC's) attention. Moreover, because hospitals will have access to the final wage index data by early May 2008, they have the opportunity to detect any data entry or tabulation errors made by the fiscal intermediary or the MAC or CMS before the development and publication of the final FY 2009 wage index by August 1, 2008, and the implementation of the FY 2009 wage index on October 1, 2008. If hospitals availed themselves of the opportunities afforded to provide and make corrections to the wage and occupational mix data, the wage index implemented on October 1 should be accurate. Nevertheless, in the event that errors are identified by hospitals and brought to our attention after June 9, 2008, we retain the right to make midyear changes to the wage index under very limited circumstances.

Specifically, in accordance with 42 CFR 412.64(k)(1) of our existing regulations, we make midyear corrections to the wage index for an area only if a hospital can show that: (1) The fiscal intermediary or the MAC or CMS made an error in tabulating its data; and (2) the requesting hospital could not have known about the error or did not have an opportunity to correct the error, before the beginning of the fiscal year. For purposes of this provision, "before the beginning of the fiscal year" means by the June deadline for making corrections to the wage data for the following fiscal year's wage index. This provision is not available to a hospital seeking to revise another hospital's data that may be affecting the requesting hospital's wage index for the labor market area. As indicated earlier, since CMS makes the wage index data available to hospitals on the CMS Web site prior to publishing both the proposed and final IPPS rules, and the fiscal intermediaries or the MAC notify hospitals directly of any wage index data changes after completing their desk reviews, we do not expect that midyear corrections will be necessary. However, under our current policy, if the correction of a data error changes the wage index value for an area, the revised wage index value will be effective prospectively from the date the correction is made.

In the FY 2006 IPPS final rule (70 FR 47385), we revised 42 CFR 412.64(k)(2) to specify that, effective on October 1, 2005, that is beginning with the FY 2006 wage index, a change to the wage index can be made retroactive to the beginning of the Federal fiscal year only when: (1) The fiscal intermediary (or, if applicable, the MAC) or CMS made an error in tabulating data used for the wage index calculation; (2) the hospital knew about the error and requested that the fiscal intermediary (or if applicable the MAC) and CMS correct the error using the established process and within the established schedule for requesting corrections to the wage index data, before the beginning of the fiscal year for the applicable IPPS update (that is, by the June 9, 2008 deadline for the FY 2009 wage index); and (3) CMS agreed that the fiscal intermediary (or if applicable, the MAC) or CMS made an error in tabulating the hospital's wage index data and the wage index should be corrected.

In those circumstances where a hospital requested a correction to its wage index data before CMS calculates the final wage index (that is, by the June deadline), and CMS acknowledges that the error in the hospital's wage index data was caused by CMS's or the fiscal intermediary's (or, if applicable, the MAC's) mishandling of the data, we believe that the hospital should not be penalized by our delay in publishing or implementing the correction. As with our current policy, we indicated that the provision is not available to a hospital seeking to revise another hospital's data. In addition, the provision cannot be used to correct prior years' wage index data; it can only be used for the current Federal fiscal year. In other situations where our policies would allow midyear corrections, we continue to believe that it is appropriate to make prospective-only corrections to the wage index.

We note that, as with prospective changes to the wage index, the final retroactive correction will be made irrespective of whether the change increases or decreases a hospital's payment rate. In addition, we note that the policy of retroactive adjustment will still apply in those instances where a judicial decision reverses a CMS denial of a hospital's wage index data revision request.

L. Labor-Related Share for the Proposed Wage Index for FY 2009

Section 1886(d)(3)(E) of the Act directs the Secretary to adjust the proportion of the national prospective payment system base payment rates that are attributable to wages and wage-related costs by a factor that reflects the relative differences in labor costs among geographic areas. It also directs the Secretary to estimate from time to time the proportion of hospital costs that are labor-related: "The Secretary shall adjust the proportion (as estimated by the Secretary from time to time) of hospitals' costs which are attributable to wages and wage-related costs of the DRG prospective payment rates * * *" We refer to the portion of hospital costs attributable to wages and wage-related costs as the labor-related share. The labor-related share of the prospective payment rate is adjusted by an index of relative labor costs, which is referred to as the wage index.

Section 403 of Pub. L. 108-173 amended section 1886(d)(3)(E) of the Act to provide that the Secretary must employ 62 percent as the labor-related share unless this "would result in lower payments to a hospital than would otherwise be made." However, this provision of Pub. L. 108-173 did not change the legal requirement that the Secretary estimate "from time to time" the proportion of hospitals costs that are "attributable to wages and wage-related costs." We interpret this to mean that hospitals receive payment based on either a 62-percent labor-related share, or the labor-related share estimated from time to time by the Secretary, depending on which labor-related share resulted in a higher payment.

We have continued our research into the assumptions employed in calculating the labor-related share. Our research involves analyzing the compensation share separately for urban and rural hospitals, using regression analysis to determine the proportion of costs influenced by the area wage index, and exploring alternative methodologies to determine whether all or only a portion of professional fees and nonlabor intensive services should be considered labor-related.

In the FY 2006 IPPS final rule (70 FR 47392), we presented our analysis and conclusions regarding the methodology for updating the labor-related share for FY 2006. We also recalculated a labor-related share of 69.731 percent, using the FY 2002-based PPS market basket for discharges occurring on or after October 1, 2005. In addition, we implemented this revised and rebased labor-related share in a budget neutral manner, but consistent with section 1886(d)(3)(E) of the Act, we did not take into account the additional payments that would be made as a result of hospitals with a wage index less than or equal to 1.0 being paid using a labor-related share lower than the labor-related share of hospitals with a wage index greater than 1.0.

The labor-related share is used to determine the proportion of the national PPS base payment rate to which the area wage index is applied. In this proposed rule, we are not proposing to make any changes to the national average proportion of operating costs that are attributable to wages and salaries, fringe benefits, professional fees, contract labor, and labor intensive services. Therefore, we are proposing to continue to use a labor-related share of 69.731 percent for discharges occurring on or after October 1, 2008. Tables 1A and 1B in the Addendum to this proposed rule reflect this proposed labor-related share. We note that section 403 of Pub. L. 108-173 amended sections 1886(d)(3)(E) and 1886(d)(9)(C)(iv) of the Act to provide that the Secretary must employ 62 percent as the labor-related share unless this employment "would result in lower payments to a hospital than would otherwise be made."

We also are proposing to continue to use a labor-related share for the Puerto Rico-specific standardized amounts of 58.7 percent for discharges occurring on or after October 1, 2008. Consistent with our methodology for determining the national labor-related share, we added the Puerto Rico-specific relative weights for wages and salaries, fringe benefits, contract labor, nonmedical professional fees, and other labor-intensive services to determine the labor-related share. Puerto Rico hospitals are paid based on 75 percent of the national standardized amounts and 25 percent of the Puerto Rico-specific standardized amounts. For Puerto Rico hospitals, the national labor-related share will always be 62 percent because the wage index for all Puerto Rico hospitals is less than 1.0. A Puerto Rico-specific wage index is applied to the Puerto Rico-specific portion of payments to the hospitals. The labor-related share of a hospital's Puerto Rico-specific rate will be either 62 percent or the Puerto Rico-specific labor-related share depending on which results in higher payments to the hospital. If the hospital has a Puerto Rico-specific wage index of greater than 1.0, we will set the hospital's rates using a labor-related share of 62 percent for the 25 percent portion of the hospital's payment determined by the Puerto Rico standardized amounts because this amount will result in higher payments. Conversely, a hospital with a Puerto Rico-specific wage index of less than 1.0 will be paid using the Puerto Rico-specific labor-related share of 58.7 percent of the Puerto Rico-specific rates because the lower labor-related share will result in higher payments. The proposed Puerto Rico labor-related share of 58.7 percent for FY 2008 is reflected in the Table 1C of the Addendum to this proposed rule.

IV. Other Decisions and Proposed Changes to the IPPS for Operating Costs and GME Costs

A. Proposed Changes to the Postacute Care Transfer Policy (§ 412.4)

1. Background

Existing regulations at § 412.4(a) define discharges under the IPPS as situations in which a patient is formally released from an acute care hospital or dies in the hospital. Section 412.4(b) defines transfers from one acute care hospital to another. Section 412.4(c) establishes the conditions under which we consider a discharge to be a transfer for purposes of our postacute care transfer policy. In transfer situations, the transferring hospital is paid based on a per diem rate for each day of the stay, not to exceed the full MS-DRG payment that would have been made if the patient had been discharged without being transferred.

The per diem rate paid to a transferring hospital is calculated by dividing the full MS-DRG payment by the geometric mean length of stay for the MS-DRG. Based on an analysis that showed that the first day of hospitalization is the most expensive (60 FR 5804), our policy generally provides for payment that is double the per diem amount for the first day, with each subsequent day paid at the per diem amount up to the full DRG payment (§ 412.4(f)(1)). Transfer cases are also eligible for outlier payments. The outlier threshold for transfer cases is equal to the fixed-loss outlier threshold for nontransfer cases (adjusted for geographic variations in costs), divided by the geometric mean length of stay for the MS-DRG, multiplied by the length of stay for the case plus one day. The purpose of the IPPS postacute care transfer payment policy is to avoid providing an incentive for a hospital to transfer patients to another hospital, a SNF, or home under a written plan of care for home health services early in the patients" stay in order to minimize costs while still receiving the full MS-DRG payment. The transfer policy adjusts the payments to approximate the reduced costs of transfer cases.

Beginning with the FY 2006 IPPS, the regulations at § 412.4 specified that, effective October 1, 2005, a DRG would be subject to the postacute care transfer policy if, based on Version 23.0 of the DRG Definitions Manual (FY 2006), using data from the March 2005 update of FY 2004 MedPAR file, the DRG meets the following criteria:

• The DRG had a geometric mean length of stay of at least 3 days;

• The DRG had at least 2,050 postacute care transfer cases; and

• At least 5.5 percent of the cases in the DRG were discharged to postacute care prior to the geometric mean length of stay for the DRG.

In addition, if the DRG was one of a paired set of DRGs based on the presence or absence of a CC or major cardiovascular condition (MCV), both paired DRGs would be included if either one met the three criteria above.

If a DRG met the above criteria based on the Version 23.0 DRG Definitions Manual and FY 2004 MedPAR data, we made the DRG subject to the postacute care transfer policy. We noted in the FY 2006 final rule that we would not revise the list of DRGs subject to the postacute care transfer policy annually unless we made a change to a specific CMS DRG. We established this policy to promote certainty and stability in the postacute care transfer payment policy. Annual reviews of the list of CMS DRGs subject to the policy would likely lead to great volatility in the payment methodology with certain DRGs qualifying for the policy in one year, deleted the next year, only to be reinstated the following year. However, we noted that, over time, as treatment practices change, it was possible that some CMS DRGs that qualified for the policy will no longer be discharged with great frequency to postacute care. Similarly, we explained that there may be other CMS DRGs that at that time had a low rate of discharges to postacute care, but which might have very high rates in the future.

The regulations at § 412.4 further specify that if a DRG did not exist in Version 23.0 of the DRG Definitions Manual or a DRG included in Version 23.0 of the DRG Definitions Manual is revised, the DRG will be a qualifying DRG if it meets the following criteria based on the version of the DRG Definitions Manual in use when the new or revised DRG first became effective, using the most recent complete year of MedPAR data:

• The total number of discharges to postacute care in the DRG must equal or exceed the 55th percentile for all DRGs; and

• The proportion of short-stay discharges to postacute care to total discharges in the DRG exceeds the 55th percentile for all DRGs. A short-stay discharge is a discharge before the geometric mean length of stay for the DRG.

A DRG also is a qualifying DRG if it is paired with another DRG based on the presence or absence of a CC or MCV that meets either of the above two criteria.

The MS-DRGs that we adopted for FY 2008 were a significant revision to the CMS DRG system (72 FR 47141). Because the MS-DRGs were not reflected in Version 23.0 of the DRG Definitions Manual, consistent with § 412.4, we established policy to recalculate the 55th percentile thresholds in order to determine which MS-DRGs would be subject to the postacute care transfer policy (72 FR 47186 through 47188). Further, under the MS-DRGs, the subdivisions within the base DRGs are different than those under the previous CMS DRGs. Unlike the CMS DRGs, the MS-DRGs are not divided based on the presence or absence of a CC or MCV. Rather, the MS-DRGs have up to three subdivisions based on: (1) The presence of a MCC; (2) the presence of a CC; or (3) the absence of either an MCC or CC. Consistent with our previous policy under which both CMS DRGs in a CC/non-CC pair were qualifying DRGs if one of the pair qualified, we established that each MS-DRG that shared a base MS-DRG will be a qualifying DRG if one of the MS-DRGs that shared the base DRG qualifies. We revised § 412.4(d)(3)(ii) to codify this policy.

Similarly, the adoption of the MS-DRGs also necessitated a revision to one of the criteria used in § 412.4(f)(5) of the regulations to determine whether a DRG meets the criteria for payment under the "special payment methodology." Under the special payment methodology, a case subject to the special payment methodology that is transferred early to a postacute care setting will be paid 50 percent of the total IPPS payment plus the average per diem for the first day of the stay. In addition, the hospital will receive 50 percent of the per diem amount for each subsequent day of the stay, up to the full MS-DRG payment amount. A CMS DRG was subject to the special payment methodology if it met the criteria of § 412.4(f)(5). Section 412.4(f)(5)(iv) specifies that, for discharges occurring on or after October 1, 2005, and prior to October 1, 2007, if a DRG meets the criteria specified under § 412.4(f)(5)(i) through (f)(5)(iii), any DRG that is paired with it based on the presence or absence of a CC or MCV is also subject to the special payment methodology. Given that this criterion was no longer applicable under the MS-DRG system, in the FY 2008 final rule with comment period, we added a new § 412.4(f)(6) (42 FR 47188 and 47410). Section 412.4(f)(6) provides that, for discharges on or after October 1, 2007, if an MS-DRG meets the criteria specified under §§ 412.4(f)(6)(i) through (f)(6)(iii), any other MS-DRG that is part of the same MS-DRG group is also subject to the special payment methodology. We updated this criterion so that it conformed to the changes associated with adopting MS-DRGs for FY 2008. The revision makes an MS-DRG subject to the special payment methodology if it shares a base MS-DRG with an MS-DRG that meets the criteria for receiving the special payment methodology.

Section 1886(d)(5)(J) of the Act provides that, effective for discharges on or after October 1, 1998, a "qualified discharge" from one of DRGs selected by the Secretary to a postacute care provider would be treated as a transfer case. This section required the Secretary to define and pay as transfers all cases assigned to one of the DRGs selected by the Secretary, if the individuals are discharged to one of the following postacute care settings:

• A hospital or hospital unit that is not a subsection 1886(d) hospital. (Section 1886(d)(1)(B) of the Act identifies the hospitals and hospital units that are excluded from the term "subsection (d) hospital" as psychiatric hospitals and units, rehabilitation hospitals and units, children's hospitals, long-term care hospitals, and cancer hospitals.)

• A SNF (as defined at section1819(a) of the Act).

• Home health services provided by a home health agency, if the services relate to the condition or diagnosis for which the individual received inpatient hospital services, and if the home health services are provided within an appropriate period (as determined by the Secretary). In the FY 1999 IPPS final rule (63 FR 40975 through 40976 and 40979 through 40981), we specified that a patient discharged to home would be considered transferred to postacute care if the patient received home health services within 3 days after the date of discharge. In addition, in the FY 1999 IPPS final rule, we did not include patients transferred to a swing-bed for skilled nursing care in the definition of postacute care transfer cases (63 FR 40977).

2. Proposed Policy Change Relating to Transfers to Home with a Written Plan for the Provision of Home Health Services

As noted above, in the FY 1999 IPPS final rule (63 FR 40975 through 40976 and 40979 through 40981), we determined that 3 days is an appropriate period within which home health services should begin following a beneficiary's discharge to the home in order for the discharge to be considered a "qualified discharge" subject to the payment adjustment for postacute care transfer cases. In that same final rule, we noted that we would monitor whether 3 days would remain an appropriate timeframe.

Section 1886(d)(5)(J)(ii)(III) of the Act provides that the discharge of an individual who receives home health services upon discharge will be treated as a transfer if "such services are provided within an appropriate period as determined by the Secretary * * *". The statute thus confers upon the Secretary the authority to determine an appropriate timeframe for the application of the postacute care transfer policy in cases where home health services commence subsequent to discharge from an acute care hospital. In the FY 1999 final IPPS rule, we established the policy that the postacute care transfer policy would apply to cases in which the home health care begins within 3 days of the discharge from an acute care policy. We noted in that rule that we did not believe that it was appropriate to limit the transfer definition to cases in which home health care begins on the same day as the patient is discharged from the hospital. We observed that data indicated that less than 8 percent of discharged patients who receive home health care begin receiving those services on the date of discharge. It is unreasonable to expect that patients who are discharged later in the day would receive a home health visit that same day. Furthermore, we believed that the financial incentive to delay needed home health care for only a matter of hours would be overwhelming if we limited the timeframe to one day. At the time of that final rule, we explained that we believed that 3 days would be a more appropriate timeframe because it would mitigate the incentive to delay home health services to avoid the application of the postacute care transfer policy, and because a 3-day timeframe was consistent with existing patterns of care.

In that final rule, we also noted that a number of commenters had raised issues and questions concerning the proposal to adopt 3 days as the appropriate timeframe for the application of the postacute care transfer policy in these cases. While most of the commenters advocated shorter timeframes, on the grounds that postacute care beginning 3 days after a discharge should not be considered a substitute for inpatient hospital care, others suggested that a 3-day window might still allow for needlessly prolonged hospital care or delayed home health in order to avoid the application of the postacute care transfer policy. Although MedPAC agreed with the commenters who asserted that home health care services furnished after a delay of more than one day may not necessarily be regarded as substituting for inpatient acute care, they also noted that a 3-day window allows for the fact that most home health patients do not receive care every day, as well as for those occasions in which there may be a delay in arranging for the provision of planned care (for example, an intervening weekend). The commission also stated that a shorter period may create a stronger incentive to delay the provision of necessary care beyond the window so that the hospital will receive the full DRG payment. In the light of these comments and, in particular, of the concern that a 3-day timeframe still allowed for some incentive to delay necessary home health services in order to avoid the application of the postacute care transfer policy, we indicated that we would continue to monitor this policy in order to track any changes in practices that may indicate the need for revising the window.

Since the adoption of this policy in FY 1999, we have continued to receive reports that some providers discharge patients prior to the geometric mean length of stay but intentionally delay home health services beyond 3 days after the acute hospital discharge in order to avoid the postacute care transfer payment adjustment policy. These reports, and the concerns expressed by some commenters in FY 1999 about the adequacy of a 3-day window to reduce such incentives, have prompted us to examine the available data concerning the initiation and program payments for home health care subsequent to discharge from postacute care.

We merged the FY 2004 MedPAR file with postacute care bill files matching beneficiary identification numbers and discharge and admission dates and looked at the 10 DRGs that were subject to the postacute care transfer policy from FYs 1999 through 2003 (DRG 14 (Intracranial Hemorrhage and Stroke with Infarction (formerly "Specific Cerebrovascular Disorders Except Transient Ischemic Attack")); DRG 113 (Amputation for Circulatory System Disorders Except Upper Limb and Toe); DRG 209 (Major Joint Limb Reattachment Procedures of Lower Extremity); DRG 210 (Hip and Femur Procedures Except Major Joint Procedures =17 with CC); DRG 211 (Hip and Femur Procedures Except Major Joint Procedures Age =17 without CC); DRG 236 (Fractures of Hip and Pelvis); DRG 263 (Skin Graft and/or Debridement for Skin Ulcer or Cellulitis with CC); DRG 264 (Skin Graft and/or Debridement for Skin Ulcer or Cellulitis without CC); DRG 429 (Organic Disturbances and Mental Retardation); and DRG 483 (Tracheostomy with Mechanical Ventiliation 96+ Hours or Principal Diagnosis Except Face, Mouth, and Neck Diagnoses (formerly "Tracheostomy Except for Face, Mouth, and Neck Diagnoses")). We selected the original 10 "qualified DRGs" because they were the DRGs to which the postacute care transfer policy applied for FYs 1999 through 2003 and because we expect that trends that we found in the data with those DRGs would be likely to accurately reflect provider practices after the inception of the postacute care transfer policy. We expect that provider practices for the original 10 DRGs would be consistent even with the expansion of the DRGs that are subject to the postacute care transfer policy. We note that providers may have even a greater incentive to delay the initiation of home health care in an effort to avoid the postacute care transfer policy now that there are more DRGs to which the policy applies. We compared data on home health services provided to patients who were discharged prior to the geometric mean length of stay to patients who were discharged at or beyond the geometric mean length of stay. For purposes of this analysis, we assumed that home health was the first discharge designation from the acute care hospital setting.

The data showed that, on average, the Medicare payment per home health visit was higher for patients who were discharged prior to the geometric mean length of stay (as compared to patients who were discharged at or beyond the geometric mean length of stay). Additionally, we found some evidence in the data suggesting that, for patients discharged prior to the geometric mean length of stay for many DRGs, hospitals may indeed be discharging patients earlier than advisable, providing less than the optimal amount of acute inpatient care, and are instead substituting home health care for inpatient services, resulting in higher home health care payments under the Medicare program. One generally would expect that patients discharged prior to the geometric mean length of stay are genuinely less severely ill than patients discharged at or after the geometric mean length of stay because patients in the former group are judged to be appropriate for discharge after less acute inpatient care. However, our data paint a different picture. For example, the data on the average per day Medicare payments for home health care for those patients who are discharged from the hospital prior to the geometric mean length of stay in the DRGs to which the postacute care transfer policy applies, as compared to Medicare payments for patients discharged from the hospital at or after the geometric mean length of stay, show patterns other than what might be expected if hospitals are generally discharging patients for home health care only after the full amount of acute inpatient care. Specifically, average Medicare payments per home health care visit are consistently higher for patients discharged prior to the geometric mean length of stay than for patients discharged at or after the geometric mean length of stay. The average home health care per visit payments for patients treated for the relevant DRGs and discharged before the geometric mean length of stay are $204 when the initiation of home health care began on the second day after discharge, $199 on the third day, and $182 on the sixth day, compared to $177, $163, and $171, respectively for patients discharged on or after the geometric mean length of stay. Furthermore, the ratio of the payments for these two groups actually increases from 1.16 on the third day after discharge to 1.22 on the fourth day, before falling again to 1.04, 1.07, and 1.08 on the fifth, sixth, and seventh days. This suggests the possibility that home health care for some relatively sicker patients is being delayed until just beyond the 3-day window during which the postacute care transfer policy applies. In the light of these data, we believe that it is appropriate to propose extending the applicable timeframe in order to reduce the incentive for providers to delay home health care when discharging patients from the acute care setting. Further examination of the data indicates that the average per day Medicare payments for home health care for those patients, in the DRGs to which the postacute care transfer policy applies, who are discharged from the hospital prior to the geometric mean length of stay, stabilizes at a somewhat lower amount when the initiation of home health visits begins on the seventh and subsequent days after discharge. Specifically, average payments per visit for this group fall from $182 when home health services began on the sixth day after the acute care hospital discharge to $174 on the seventh day, and then remain relatively steady at $171, $177, and $172 on the eighth, ninth, and tenth days. This suggests that a 7-day period would be an appropriate point at which to establish a new timeframe. The stabilization of average home health care visit payments at and after the seventh day suggests that this may be the point at which the incentives to delay the start of home health care in order to avoid the application of the postacute care transfer policy are reduced. As a consequence of this analysis, in this proposed rule, we are proposing to revise § 412.4(c)(3) to extend the timeframe to within 7 days of discharge to home under a written plan for the provision of home health services, effective October 1, 2008. We believe that extending the applicable timeframe will lessen the incentive for providers to delay the start of home health care after discharging patients from the acute care hospital setting. During the comment period on this proposed rule, we plan to continue to search our data on postacute care discharges to home health services. We welcome comments and suggestions on other data analyses that can be performed to determine an appropriate timeframe for which the postacute care transfer policy would apply.

In addition to the reasons noted above, we believe that 7 days is currently an appropriate timeframe because we believe that accommodates current practices and it is sufficiently long enough to lessen the likelihood that providers would delay the initiation of necessary home health services. At the same time, we believe that 7 days is narrow enough that we would still expect the majority of the home health services to be related to the condition to which the acute inpatient hospital stay was necessary. Further, we note that there may be some cases for which it is not clinically appropriate to begin home health services immediately following an acute care discharge, and that even when home health services are clinically appropriate sooner than within 7 days of acute care discharge, home health services may not be immediately available.

We note that, as we stated in the FY 2000 IPPS final rule (65 FR 47081), if the hospital's continuing care plan for the patient is not related to the purpose of the inpatient hospital admission, a condition code 42 must be entered on the claim. If the continuing care plan is related to the purpose of the inpatient hospital admission but begins after 7 days (formerly after 3 days) of discharge, a condition code 43 must be entered on the claim. The presence of either of these condition codes in conjunction with patient status discharge code 06 (Discharged/Transferred to Home under Care of Organized Home Health Service Organization in Anticipation of Covered Skilled Care) will result in full payment rather than the transfer payment amount.

3. Evaluation of MS-DRGs Under Postacute Care Transfer Policy for FY 2009

For FY 2009, we are not proposing to make any changes to the criteria by which an MS-DRG would qualify for inclusion in the postacute care transfer policy. However, because we are proposing to revise some existing MS-DRGs and to add one new MS-DRG (discussed under section II.G. of this preamble), we are proposing to evaluate those MS-DRGs under our existing postacute care transfer criteria in order to determine whether any of the revised or new MS-DRGs will meet the postacute care transfer criteria for FY 2009. Therefore, for 2009, we are evaluating MS-DRGs 001, 002, 215, 245, 901 through 909, 913 through 923, 955 through 959, and 963 through 965. Any revisions made would not constitute a change to the application of the postacute care transfer policy. A list indicating which MS-DRGs would be subject to the postacute care transfer policy for FY 2009 can be found in Table 5 in the Addendum to this proposed rule.

B. Reporting of Hospital Quality Data for Annual Hospital Payment Update (§ 412.64(d)(2))

1. Background

a. Overview

CMS is transforming the Medicare program from a passive payer to an active purchaser of higher quality, more efficient health care. Such care will contribute to the sustainability of the Medicare program, encourage the delivery of high quality care while avoiding unnecessary costs, and help ensure high value for beneficiaries. To support this transformation, CMS has worked with stakeholders to develop and implement quality measures, make provider and plan performance public, link payment incentives to reporting on measures, and ultimately is working to link payment to actual performance on these measures. Commonly referred to as value-based purchasing, this policy aligns payment incentives with the quality of care as well as the resources used to deliver care to encourage the delivery of high-value health care.

The success of this transformation is supported by and dependent upon an increasing number of widely-agreed upon quality measures. The Medicare program has defined measures of quality in almost every setting and measures some aspect of care for almost all Medicare beneficiaries. These measures include clinical processes, patient perception of their care experience, and, increasingly, outcomes.

The Medicare program has established mechanisms for collecting information on these measures, such as QualityNet, an Internet-based process that hospitals use to report all-payer information. Initial voluntary efforts were supplemented beginning in FY 2005 by a provision in the Medicare Prescription Drug Improvement and Modernization Act (MMA), which provided the full annual payment update only to "subsection (d) hospitals" (that is, hospitals paid under the IPPS) that successfully reported on a set of widely-agreed upon quality measures. Since FY 2007, as required by subsequent legislation (the Deficit Reduction Act (DRA)) the number of quality measures and the amount of the financial incentive have increased.

As a result, the great majority of hospitals now report on quality measures for heart failure, heart disease, pneumonia, and surgical infection and received the full annual update for FY 2008. The number of measures has continued to grow and the types of measures have grown as well, with the addition of outcomes measures, such as heart attack and heart failure mortality measures, and the HCAHPS measure of patient satisfaction. In section IV.B.2. of this preamble, we are seeking public comments on proposed additional quality measures.

Reporting on these measures provides hospitals a greater awareness of the quality of care they provide and provides actionable information for consumers to make more informed decisions about their health care providers and treatments.

Moving beyond reporting to performance, CMS has designed a Hospital Value-Based Purchasing Plan that would link hospital payments to their actual performance on quality measures. In accordance with the DRA, the Plan was submitted to Congress in November 2007. We discuss the Plan more fully in section IV.C. of this preamble.

The ongoing CMS Premier Hospital Quality Incentive Demonstration project is another effort linking payments to quality performance. Launched in 2003, the Premier Hospital Quality Incentive Demonstration project promotes measurable improvements in the quality of care, examining whether economic incentives to hospitals are effective at improving the quality of care. Early evidence from the project indicates that linking payments to quality performance can be effective.

As required by section 5001(c) the DRA, CMS also has implemented a program intended to encourage the prevention of certain avoidable or preventable hospital-acquired conditions (HACs), including infections, that may occur during a hospital stay. Beginning October 1, 2007, CMS required hospitals to begin reporting information on Medicare claims specifying whether certain diagnoses were present on admission (POA). Beginning October 1, 2008, CMS will no longer pay hospitals for a DRG using the higher-paying CC or MCC associated with one or more of these conditions (if no other condition meeting the higher paying CC or MCC criteria is present) unless the condition was POA (that is, not acquired during the hospital stay). Linking a payment incentive to hospitals' prevention of avoidable or preventable HACs is a strong approach for encouraging high quality care. Combating these HACs can reduce morbidity and mortality as well as reducing unnecessary costs. In the FY 2008 IPPS final rule with comment period (72 FR 47217), CMS identified eight HACs. In section II.F. of this preamble, CMS is seeking comment on additional proposed conditions.

CMS is committed to enhancing these value-based purchasing programs, in close collaboration with stakeholders, through the development and use of new measures for quality reporting, expanded public reporting, greater and more widespread incentives in the payment system for reporting on such measures, and ultimately performance on those measures. These initiatives hold the potential to transform the delivery of health care by rewarding quality of care and delivering higher value to Medicare beneficiaries.

A critical element of value-based purchasing is well-accepted measures. Hospitals can then measure their performance relative to other hospitals. Further, this information can be posted for consumers to use to make more informed choices about their care. In this section IV.B. of this preamble, we describe past and current efforts to make this information available and proposals to expand these efforts and make even more useful hospital quality information available to the public.

b. Voluntary Hospital Quality Data Reporting

In December 2002, the Secretary announced a partnership with several collaborators intended to promote hospital quality improvement and public reporting of hospital quality information. These collaborators included the American Hospital Association (AHA), the Federation of American Hospitals (FAH), the Association of American Medical Colleges (AAMC), the Joint Commission on Accreditation of Healthcare Organizations (the Joint Commission), the National Quality Forum (NQF), the American Medical Association (AMA), the Consumer-Purchaser Disclosure Project, the American Association of Retired Persons (AARP), the American Federation of Labor-Congress of Industrial Organizations (AFL-CIO), the Agency for Healthcare Research and Quality (AHRQ), as well as CMS and others. In July 2003, CMS began the National Voluntary Hospital Reporting Initiative. This initiative is now known as the Hospital Quality Alliance: Improving Care through Information (HQA).

We established the following "starter set" of 10 quality measures for voluntary reporting as of November 1, 2003:

Heart Attack (Acute Myocardial Infarction or AMI)

• Was aspirin given to the patient upon arrival to the hospital?

• Was aspirin prescribed when the patient was discharged?

• Was a beta blocker given to the patient upon arrival to the hospital?

• Was a beta blocker prescribed when the patient was discharged?

• Was an Angiotensin Converting Enzyme (ACE) Inhibitor given for the patient with heart failure?

Heart Failure (HF)

• Did the patient get an assessment of his or her heart function?

• Was an Angiotensin Converting Enzyme (ACE) Inhibitor given to the patient?

Pneumonia (PN)

• Was an antibiotic given to the patient in a timely way?

• Had the patient received a pneumococcal vaccination?

• Was the patient's oxygen level assessed?

This starter set of 10 quality measures was endorsed by the NQF. The NQF is a voluntary consensus standard-setting organization established to standardize health care quality measurement and reporting through its consensus development process. In addition, this starter set is a subset of measures currently collected for the Joint Commission as part of its hospital inpatient certification program.

We chose these 10 quality measures in order to collect data that would: (1) Provide useful and valid information about hospital quality to the public; (2) provide hospitals with a sense of predictability about public reporting expectations; (3) begin to standardize data and data collection mechanisms; and (4) foster hospital quality improvement.

Hospitals submit quality data through the QualityNet secure Web site (formerly known as QualityNet Exchange) (www.qualitynet.org). This Web site meets or exceeds all current Health Insurance Portability and Accountability Act requirements for security of personal health information. Data from this initiative are used to populate the Hospital Compare Web site, www.hospitalcompare.hhs.gov. This Web site assists beneficiaries and the general public by providing information on hospital quality of care for consumers who need to select a hospital. It further serves to encourage consumers to work with their doctors and hospitals to discuss the quality of care hospitals provide to patients, thereby providing an additional incentive to improve the quality of care that they furnish.

c. Hospital Quality Data Reporting Under Section 501(b) of Pub. L. 108-173

Section 1886(b)(3)(B)(vii) of the Act, as added by section 501(b) of Pub. L. 108-173, revised the mechanism used to update the standardized amount of payment for inpatient hospital operating costs. Specifically, the statute provided for a reduction of 0.4 percentage points to the update percentage increase (also known as the market basket update) for each of FYs 2005 through 2007 for any subsection (d) hospital that does not submit data on a set of 10 quality indicators established by the Secretary as of November 1, 2003. The statute also provided that any reduction would apply only to the fiscal year involved, and would not be taken into account in computing the applicable percentage increase for a subsequent fiscal year. This measure established an incentive for IPPS hospitals to submit data on the quality measures established by the Secretary.

We initially implemented section 1886(b)(3)(B)(vii) of the Act in the FY 2005 IPPS final rule (69 FR 49078). In addition, we established the Reporting Hospital Quality Data for Annual Payment Update (RHQDAPU) program and added 42 CFR 412.64(d)(2) to our regulations. We adopted additional requirements under the RHQDAPU program in the FY 2006 IPPS final rule (70 FR 47420).

d. Hospital Quality Data Reporting Under Section 5001(a) of Pub. L. 109-171

Section 5001(a) of the Deficit Reduction Act of 2005, Pub. L. 109-171 (DRA), further amended section 1886(b)(3)(B) of the Act to revise the mechanism used to update the standardized amount for payment for hospital inpatient operating costs. Specifically, sections 1886(b)(3)(B)(viii)(I) and (II) of the Act provide that the payment update for FY 2007 and each subsequent fiscal year be reduced by 2.0 percentage points for any subsection (d) hospital that does not submit certain quality data in a form and manner, and at a time, specified by the Secretary. Section 1886(b)(3)(B)(viii)(III) of the Act requires that the Secretary expand the "starter set" of 10 quality measures that were established by the Secretary as of November 1, 2003, as the Secretary determines to be appropriate for the measurement of the quality of care furnished by a hospital in inpatient settings. In expanding this set of measures, section 1886(b)(3)(B)(viii)(IV) of the Act requires that, effective for payments beginning with FY 2007, the Secretary begin to adopt the baseline set of performance measures as set forth in a December 2005 report issued by the Institute of Medicine (IOM) of the National Academy of Sciences under section 238(b) of the MMA.16

Footnotes:

16 Institute of Medicine, "Performance Measurement: Accelerating Improvement," December 1, 2005, available at: www.iom.edu/CMS/3809/19805/31310.aspx.

The IOM measures include: 21 HQA quality measures (including the "starter set" of 10 quality measures); the HCAHPS patient experience of care survey; and 3 structural measures. The structural measures are: (1) Implementation of computerized provider order entry for prescriptions; (2) staffing of intensive care units with intensivists; and (3) evidence-based hospital referrals. These structural measures constitute the Leapfrog Group's original "three leaps," and are part of the NQF's 30 Safe Practices for Better Healthcare.

Sections 1886(b)(3)(B)(viii)(V) and (VI) of the Act require that, effective for payments beginning with FY 2008, the Secretary add other quality measures that reflect consensus among affected parties, and to the extent feasible and practicable, have been set forth by one or more national consensus building entities, and provide the Secretary with the discretion to replace any quality measures or indicators in appropriate cases, such as where all hospitals are effectively in compliance with a measure, or the measures or indicators have been subsequently shown to not represent the best clinical practice. Thus, the Secretary is granted broad discretion to replace measures that are no longer appropriate for the RHQDAPU program.

Section 1886(b)(3)(B)(viii)(VII) of the Act requires that the Secretary establish procedures for making quality data available to the public after ensuring that a hospital would have the opportunity to review its data before these data are made public. In addition, this section requires that the Secretary report quality measures of process, structure, outcome, patients' perspective of care, efficiency, and costs of care that relate to services furnished in inpatient settings on the CMS Web site.

Section 1886(b)(3)(B)(viii)(I) of the Act also provides that any reduction in a hospital's payment update will apply only with respect to the fiscal year involved, and will not be taken into account for computing the applicable percentage increase for a subsequent fiscal year.

In the FY 2007 IPPS final rule (71 FR 48045), we amended our regulations at 42 CFR 412.64(d)(2) to reflect the 2.0 percentage point reduction in the payment update for FY 2007 and subsequent fiscal years for subsection (d) hospitals that do not comply with requirements for reporting quality data, as provided for under section 1886(b)(3)(B)(viii) of the Act. In the FY 2007 IPPS final rule, we also added 11 additional quality measures to the 10-measure starter set to establish an expanded set of 21 quality measures (71 FR 48033 through 48037).

Commenters on the FY 2007 IPPS proposed rule requested that we notify the public as far in advance as possible of any proposed expansions of the measure set and program procedures in order to encourage broad collaboration and to give hospitals time to prepare for any anticipated change. Taking these concerns into account, in the CY 2007 OPPS/ASC final rule with comment period (71 FR 68201), we adopted six additional quality measures for the FY 2008 IPPS update, for a total of 27 measures. The measure set that we adopted for the FY 2008 payment determination was as follows:

Topic Quality measure
Heart Attack (Acute Myocardial Infarction). • Aspirin at arrival.*
• Aspirin prescribed at discharge.*
• Angiotensin Converting Enzyme Inhibitor (ACE-I) or Angiotensin II Receptor Blocker (ARB) for left ventricular systolic dysfunction.*
• Beta blocker at arrival.*
• Beta blocker prescribed at discharge.*
• Fibrinolytic (thrombolytic) agent received within 30 minutes of hospital arrival.**
• Percutaneous Coronary Intervention (PCI) received within 120 minutes of hospital arrival.**
• Adult smoking cessation advice/counseling.**
Heart Failure (HF) • Left ventricular function assessment.*
• Angiotensin Converting Enzyme Inhibitor (ACE-I) or Angiotensin II Receptor Blocker (ARB) for left ventricular systolic dysfunction.
• Discharge instructions.**
• Adult smoking cessation advice/counseling.**
Pneumonia (PN) • Initial antibiotic received within 4 hours of hospital arrival *
• Oxygenation assessment.*
• Pneumococcal vaccination status.*
• Blood culture performed before first antibiotic received in hospital.**
• Adult smoking cessation advice/counseling.**
• Appropriate initial antibiotic selection.**
• Influenza vaccination status.**
Surgical Care Improvement Project (SCIP)-named SIP for discharges prior to July 2006 (3Q06) • Prophylactic antibiotic received within 1 hour prior to surgical incision.**
• Prophylactic antibiotics discontinued within 24 hours after surgery end time.**
• SCIP-VTE-1: Venous thromboembolism (VTE) prophylaxis ordered for surgery patients.***
• SCIP-VTE-2: VTE prophylaxis within 24 hours pre/post surgery.***
• SCIP Infection 2: Prophylactic antibiotic selection for surgical patients.***
Mortality Measures (Medicare patients) • Acute Myocardial Infarction 30-day mortality Medicare patients***
• Heart Failure 30-day mortality Medicare patients.***
Patients' Experience of Care. HCAHPS patient survey.***
*Measure included in 10 measure starter set.
**Measure included in 21 measure expanded set.
***Measure added in CY 2007 OPPS/ASC final rule with comment period (data submission required as of January 2007 for three additional SCIP measures).

For FY 2008, hospitals were required to submit data on 25 of the 27 measures. No data submission was required for the two mortality outcome measures (30-Day Risk Standardized Mortality Rates for Heart Failure and AMI), because they were calculated using existing administrative Medicare claims data. The measures used for the payment determination included, for the first time, the HCAHPS patient experience of care survey as well as two outcome measures. These measures expanded the types of measures available for public reporting as required under section 1886(b)(3)(B)(viii) of the Act. In addition, the outcome measures, which are claims-based measures, did not increase the data submission requirements for hospitals, thereby reducing the burden associated with collection of data for quality reporting.

In the FY 2008 IPPS proposed rule (72 FR 24805), we proposed to add 1 outcome measure and 4 process measures to the existing 27-measure set to establish a new set of 32 quality measures to be used under the RHQDAPU program for the FY 2009 IPPS annual payment determination. We proposed to add the following five measures for the FY 2009 IPPS annual payment determination:

• PN 30-day mortality measure (Medicare patients)

• SCIP Infection 4: Cardiac Surgery Patients with Controlled 6AM Postoperative

Serum Glucose

• SCIP Infection 6: Surgery Patients with Appropriate Hair Removal

• SCIP Infection 7: Colorectal Patients with Immediate Postoperative

Normothermia

• SCIP Cardiovascular 2: Surgery Patients on a Beta Blocker Prior to Arrival Who Received a Beta Blocker During the Perioperative Period

We stated that we planned to formally adopt these measures a year in advance in order to provide time for hospitals to prepare for changes related to the RHQDAPU program. We also stated that we anticipated that the proposed measures would be endorsed by the NQF, as a national consensus building entity. Finally, we stated that any proposed measure that was not endorsed by the NQF by the time that we published the FY 2008 IPPS final rule with comment period would not be finalized in that final rule.

At the time we published the FY 2008 IPPS final rule with comment period, only the PN 30-day mortality measure had been endorsed by the NQF. Therefore, we finalized only that measure as part of the FY 2009 IPPS measure set and stated that we would further address adding additional measures in the CY 2008 OPPS/ASC final rule and, if necessary, in the FY 2009 IPPS proposed and final rules. We also responded to comments we had received on the five proposed measures (72 FR 47348 through 47351).

In the CY 2008 OPPS/ASC final rule with comment period (72 FR 66875), we noted that the NQF had endorsed the following additional process measures that we had proposed to include in the FY 2009 RHQDAPU program measure set:

• SCIP Infection 4: Cardiac Surgery Patients with Controlled 6AM Postoperative

Serum Glucose

• SCIP Infection 6: Surgery Patients with Appropriate Hair Removal

As we stated in the FY 2008 IPPS proposed rule (72 FR 24805), these measures reflect our continuing commitment to quality improvement in both clinical care and quality. These quality measures reflect consensus among affected parties as demonstrated by endorsement by a national consensus building entity. The addition of these two measures for the FY 2009 measure set bring the total number of measures in that measure set to 30 (72 FR 66876).

The measure set to be used for FY 2009 annual payment determination is as follows:

Topic Quality measure
Heart Attack (Acute Myocardial Infarction) • Aspirin at arrival*.
• Aspirin prescribed at discharge*.
• Angiotensin Converting Enzyme Inhibitor (ACE-I) or Angiotensin II Receptor Blocker (ARB) for left ventricular systolic dysfunction*.
• Beta blocker at arrival*.
• Beta blocker prescribed at discharge*.
• Fibrinolytic (thrombolytic) agent received within 30 minutes of hospital arrival**.
• Primary Percutaneous Coronary Intervention (PCI) received within 120 minutes of hospital arrival**.
• Adult smoking cessation advice/counseling**.
Heart Failure (HF) • Left ventricular function assessment*.
• Angiotensin Converting Enzyme Inhibitor (ACE-I) or Angiotensin II Receptor Blocker (ARB) for left ventricular systolic dysfunction*.
• Discharge instructions**.
• Adult smoking cessation advice/counseling**.
Pneumonia (PN) • Initial antibiotic received within 4 hours of hospital arrival*.
• Oxygenation assessment*.
• Pneumococcal vaccination status*.
• Blood culture performed before first antibiotic received in hospital**.
• Adult smoking cessation advice/counseling**.
• Appropriate initial antibiotic selection**.
• Influenza vaccination status**.
Surgical Care Improvement Project (SCIP)-named SIP for discharges prior to July 2006 (3Q06) • Prophylactic antibiotic received within 1 hour prior to surgical incision**.
• Prophylactic antibiotics discontinued within 24 hours after surgery end time**.
• SCIP-VTE-1: Venous thromboembolism (VTE) prophylaxis ordered for surgery patients***.
• SCIP-VTE-2: VTE prophylaxis within 24 hours pre/post surgery***.
• SCIP Infection 2: Prophylactic antibiotic selection for surgical patients***.
• SCIP-Infection 4: Cardiac Surgery Patients with Controlled 6AM Postoperative Serum Glucose*****.
• SCIP Infection 6: Surgery Patients with Appropriate Hair Removal*****.
Mortality Measures (Medicare patients) • Acute Myocardial Infarction 30-day mortality Medicare patients***.
• Heart Failure 30-day mortality Medicare patients***.
• Pneumonia 30-day mortality Medicare patients****.
Patients' Experience of Care • HCAHPS patient survey***.
* Measure included in 10 measure starter set.
** Measure included in 21 measure expanded set.
*** Measure added in CY 2007 OPPS/ASC final rule with comment period.
**** Measure added in FY 2008 IPPS final rule with comment period.
***** Measure added in CY 2008 OPPS/ASC final rule with comment period (data submission required effective with discharges starting January 1, 2008).

We also stated in the FY 2008 IPPS final rule with comment period and the CY 2008 OPPS/ASC final rule with comment period that the RHQDAPU program participation requirements for the FY 2009 program would apply to additional measures we adopt for the FY 2009 program (72 FR 47361; 72 FR 66877).

Therefore, hospitals are required to start submitting data for SCIP Infection 4 and SCIP Infection 6 starting with first quarter calendar year 2008 discharges and subsequent quarters until further notice. Hospitals must submit their aggregate population and sample size counts for Medicare and non-Medicare patients. These requirements are consistent with the requirements for the other AMI, HF, PN, and SCIP process measures included in the FY 2009 measure set. The complete list of procedures for participating in the RHQDAPU program for FY 2009 are provided in the FY 2008 IPPS final rule with comment period (72 FR 47359 through 47361).

Because SCIP Cardiovascular 2 and SCIP Infection 7 had not been endorsed by a national consensus building entity by the publishing deadline for the CY 2008 OPPS/ASC final rule with comment period, we did not adopt these measures as part of the FY 2009 IPPS measure set.

In the FY 2008 IPPS proposed rule, we also solicited public comments on 18 measures and 8 measure sets that could be selected for future inclusion in the RHQDAPU program (72 FR 24805). These measures and measure sets highlight our interest in improving patient safety and outcomes of care, with a particular focus on the quality of surgical care and patient outcomes. In order to engender a broad review of potential performance measures, the list included measures that have not yet received endorsement by a national consensus review process for public reporting. The list also included measures developed by organizations other than CMS as well as measures that can be calculated using administrative data (such as claims).

We solicited public comment not only on the measures and measure sets that were listed, but also on whether there were any critical gaps or "missing" measures or measure sets. We specifically requested input concerning the following issues:

• Which of the measures or measure sets should be included in the FY 2009 RHQDAPU program or in subsequent years?

• What challenges for data collection and reporting are posed by the identified measures and measure sets?

• What improvements could be made to data collection or reporting that might offset or otherwise address those challenges?

In the FY 2008 IPPS final rule with comment period (72 FR 47351), after consideration of the public comments received, we decided not to adopt any of these measures or measure sets for FY 2009. We indicated that we will continue to consider some of these measures and measure sets for subsequent years.

2. Proposed Quality Measures for FY 2010 and Subsequent Years

a. Proposed Quality Measures for FY 2010

For FY 2010, we are proposing to require continued submission of data on 26 of the 30 existing AMI, Heart Failure, Pneumonia, HCAHPS, and SCIP measures adopted for FY 2009. As noted above, the three outcome measures do not require hospitals to submit data. In addition, we are proposing to remove the Pneumonia Oxygenation Assessment measure from the RHQDAPU program measure set. We are proposing to discontinue requiring hospitals to submit data on the Pneumonia Oxygenation Assessment measure, effective with discharges beginning January 1, 2009. Section 1886(b)(3)(B)(viii)(VI) of the Act provides the Secretary with the discretion to replace any quality measures or indicators in appropriate cases, such as where all hospitals are effectively in compliance with a measure. We interpret this to authorize the Secretary to remove or retire measures from the RHQDAPU program.

In the case of the Pneumonia Oxygenation Assessment measure, the vast majority of hospitals are performing near 100 percent. In addition, oxygenation assessment is routinely performed by hospitals for admitted patients without regard to the specific diagnosis. Thus, the measure is topped out so completely across virtually all hospitals as to provide no significant opportunity for improvement. We believe that the burden to hospitals to abstract and report these data outweighs the benefit in publicly reporting hospital level data with very little variation among hospitals. We do not expect that the retirement of the Pneumonia Oxygenation Assessment measure will result in the deterioration of care. However, if we determine otherwise, we may seek to reintroduce the measure.

The proposed removal of the Pneumonia Oxygenation Assessment measure for FY 2010 represents the first instance of retiring a measure. We intend to review other existing chart-abstracted measures recognizing the significant burden to hospitals that chart abstraction requires. In this way, we seek to maximize the value of the RHQDAPU program to promote quality improvement by hospitals and to report information that the public will find beneficial in choosing inpatient hospital services. We invite comment on the retirement of the Pneumonia Oxygenation Assessment measure. In addition, we invite comment on other measures that may be suitable for retirement from the RHQDAPU program measure set. Finally, we invite comment on the following general considerations relevant to retiring measures:

• Should CMS retire a RHQDAPU program measure when hospital performance on the measure has reached a high threshold (that is, performance on the measure has topped out) even if the measure still reflects best practice?

• Are there reasons to consider retiring a measure other than high overall performance?

• When a measure is retired on the basis of substantially complete compliance by hospitals, should data collection on the measure again be required after 1 or 2 years to assure that a high compliance level remains, or should some other way of monitoring continued hospital compliance be used?

The specifications for two of the existing measures have been updated by the NQF, effective May 2007, with respect to the applicable timing interval. For the measures previously identified as:

• AMI-Primary Percutaneous Coronary Intervention (PCI) received within 120 minutes of hospital arrival, the NQF has revised its endorsement of the specifications to reflect that the timing interval has been changed to PCI within 90 minutes of arrival.

• Pneumonia-Initial antibiotic received within 4 hours of hospital arrival, the NQF has revised its endorsement of the specifications to reflect that the initial antibiotic must be received within 6 hours of arrival.

In the FY 2008 IPPS final rule with comment period, one commenter "urged CMS to develop a policy to harmonize measures that related to payment, such as the NQF's move from a 4-hour timeframe for initial antibiotic administration for pneumonia patients to a 6-hour timeframe (72 FR 47357)." Another commenter raised the issue of the timing for PCI in the AMI topic (72 FR 47347-8). In response to these comments, we responded that if we believe that a change is an appropriate change for the RHQDAPU program, we would expect to adopt it.

Because the NQF is now endorsing different timing intervals with respect to these measures, we are proposing to also update these measures for the purposes of the FY 2010 RHQDAPU program. The updated measures are as follows:

• AMI-Timing of Receipt of Primary Percutaneous Coronary Intervention (PCI); and

• Pneumonia-Timing of receipt of initial antibiotic following hospital arrival.

We note that the technical specifications for these measures will not change, and hospitals will continue to submit the same data that they currently submit. However, beginning with discharges on or after January 1, 2009, CMS will calculate the measures using the updated timing intervals.

The NQF updated these two measures to reflect the most current consensus standards effective May 2007. Because this was after we issued the FY 2008 IPPS proposed rule, we could not adopt the updated measures in the FY 2008 IPPS final rule with comment period or CY 2008 OPPS/ASC final rule with comment period. We also recognized that we did not have in place a subregulatory process that would have permitted us to update the measures. Therefore, we announced that hospitals could suppress the public reporting of the quality data for the two measures for hospital discharges starting with April 1, 2007 discharges. We did this because we believe that hospitals should not be held to out-of-date consensus standards for public reporting pending the next regulatory cycle.

We propose, in the future, to act on updates to existing RHQDAPU program measures made by a consensus building entity such as the NQF through a subregulatory process. This is necessary to be able to utilize the most up-to-date consensus standards in the RHQDAPU program, and recognizes that neither scientific advances nor consensus building entity standard updates are linked to the timing of regulatory actions. We propose to implement updates to existing RHQDAPU program measures and provide notification through the Qualitynet Web site, and additionally in the CMS/Joint Commission Specifications Manual for National Hospital Inpatient Quality Measures where data collection and measure specifications changes are necessary. We invite comment on this proposal.

Under section 1886(b)(3)(B)(viii)(III) of the Act, the Secretary shall expand the RHQDAPU program measures beyond the measures specified as of November 1, 2003. Under section 1886(b)(3)(B)(viii)(V) of the Act, these measures, to the extent feasible and practicable, shall include measures set forth by one or more national consensus building entities.

We are proposing to add the following 43 measures for the FY 2010 payment determination: a SCIP measure that we proposed last year; 4 nursing sensitive measures; 3 readmission measures; 6 Venous Thromboembolism measures; 5 stroke measures; 9 AHRQ measures; and 15 cardiac surgery measures.

We are proposing to add SCIP Cardiovascular 2, Surgery Patients on a Beta Blocker Prior to Arrival Who Received a Beta Blocker During the Perioperative Period. This measure was initially proposed last year in the FY 2008 IPPS proposed rule, but because the NQF had not endorsed this measure at the time we issued the FY 2008 IPPS final rule with comment period or the CY 2008 OPPS/ASC final rule with comment period, we did not adopt it. For the purposes of proposing the FY 2010 RHQDAPU program measure set, CMS believes that NQF endorsement of a measure represents a standard for consensus among affected parties as specified in section 1886(b)(3)(B)(viii)(V) of the Act. The NQF is an independent health care quality endorsement organization with a diverse representation of consumer, purchaser, provider, academic, clinical, and other health care stakeholder organizations.

In November 2007, the NQF endorsed SCIP Cardiovascular 2. CMS believes that this measure targets an important process of care, beta blocker administration for noncardiac surgery patients. Therefore, we are now proposing to add SCIP Cardiovascular 2 to the RHQDAPU program measures for FY 2010. The specifications and data collection tools are currently available through the Qualitynet Web site and in the CMS/Joint Commission Specifications Manual for National Hospital Inpatient Quality Measures for hospitals to utilize and submit data for this measure. We are proposing that hospitals be required to submit data on this measure beginning with January 1, 2009 discharges.

We also are proposing to add four nursing sensitive measures to the RHQDAPU program measure set for FY 2010. The four measures are:

• Failure to Rescue

• Pressure Ulcer Prevalence and Incidence by Severity (Joint Commission developed measure; all patient data from chart abstraction)

• Patient Falls Prevalence

• Patient Falls with Injury

These measures broaden the ability of the RHQDAPU program measure set to assess care generally associated with nursing staff. In addition, these measures are directed toward outcomes that are underrepresented among the RHQDAPU program measures. These measures apply to the vast majority of inpatient stays and provide a great deal of critical information about hospital quality to consumers and stakeholders. The specifications and data collection tools are scheduled to be available in the specifications manual by December 2008 for hospitals to utilize and submit data for these measures. We are proposing that hospitals be required to submit data on these four measures effective with discharges beginning April 1, 2009. While these measures are endorsed by NQF, the Joint Commission has initiated rigorous field testing of the measures, which may not be completed until late 2008. Therefore, it is possible that the endorsement status of these measures may change in the next several months. If this rigorous field testing results in uncertainty as to the NQF endorsement status at the time we issue the FY 2009 IPPS final rule, we will defer our final decision on whether to require these measures for the RHQDAPU program for FY 2010 until the time that we issue the CY 2009 OPPS/ASC final rule with comment period. This deferral is consistent with our measure expansion during the past 2 years, when we finalized some RHQDAPU program measures in the annual OPPS/ASC final rules.

We are proposing to adopt three readmission measures for FY 2010 that will be calculated using Medicare administrative claims data. The proposed measures are:

• Pneumonia (PN) 30-Day Risk Standardized Readmission Measure (Medicare patients)

• Heart Attack (AMI) 30-Day Risk Standardized Readmission Measure (Medicare patients)

• Heart Failure (HF) 30-Day Risk Standardized Readmission Measure (Medicare patients)

These readmission measures assess both quality of care and efficiency of care. They also promote coordination of care among hospitals and other providers. They compliment the existing 30-Day Risk Standardized Mortality Measures for Pneumonia, Heart Attack, and Heart Failure. These measures require no additional data collection from hospitals. The measures are risk adjusted to account for differences between hospitals in the characteristics of their patient populations.

These three claims-based readmission measures are pending NQF endorsement. The NQF endorsement decision on these three measures is expected before we issue the FY 2009 IPPS final rule. We are proposing to add these three measures contingent upon NQF endorsement. We are also proposing to defer our decision on whether to include these measures until we issue the CY 2009 OPPS/ASC final rule, in the event that NQF endorsement status is still pending when we issue the FY 2009 IPPS final rule. This deferral is consistent with our measure expansion during the past 2 years, when we finalized some RHQDAPU program measures in the annual OPPS/ASC final rules.

We are also proposing to add six Venous Thromboembolism (VTE) measures. These measures comprehensively address a major cause of morbidity and mortality among hospitalized patients.

• VTE-1: VTE Prophylaxis

• VTE-2: VTE Prophylaxis in the ICU

• VTE-4: Patients with overlap in anticoagulation therapy

• VTE-5/6: (as combined measure) Patients with UFH dosages who have platelet count monitoring and adjustment of medication per protocol or nomogram

• VTE-7: Discharge instructions to address: follow-up monitoring, compliance, dietary restrictions and adverse drug reactions/interactions

• VTE-8: Incidence of preventable VTE

These VTE measures are pending NQF endorsement. The NQF endorsement decision on these measures is expected before we issue the FY 2009 IPPS final rule. We are proposing to add these measures contingent upon NQF endorsement. We also are proposing to defer our decision on whether to include these measures until we issue the CY 2009 OPPS/ASC final rule with comment period, in the event that NQF endorsement status is still pending when we issue the FY 2009 IPPS final rule. This deferral is consistent with our measure expansion during the past 2 years, when we finalized some RHQDAPU program measures in the annual OPPS/ASC final rules. We are proposing that hospitals be required to submit data on these six measures effective with discharges beginning January 1, 2009.

We also are proposing to add five Stroke measures that will apply only to certain identified groups under specific ICD-9-CM codes as specified in the specifications manual. These measures comprehensively address an important condition not currently covered by the RHQDAPU program that is associated with significant morbidity and mortality.

• STK-1 DVT Prophylaxis

• STK-2 Discharged on Antithrombotic Therapy

• STK-3 Patients with Atrial Fibrillation Receiving Anticoagulation Therapy

• STK-5 Antithrombotic Medication By End of Hospital Day Two

• STK-7 Dysphasia Screening

These Stroke measures are pending NQF endorsement. The NQF endorsement decision on these measures is expected before we issue the FY 2009 IPPS final rule. We are proposing to add these measures contingent upon NQF endorsement. We also are proposing to defer our adoption of these measures until we issue the CY 2009 OPPS/ASC final rule with comment period in the event that NQF endorsement status is still pending as of the time we issue the FY 2009 IPPS final rule. This approach is consistent with our measure expansion during the past 2 years, when CMS finalized some RHQDAPU program measures in the annual OPPS/ASC final rules. We are proposing that hospitals be required to submit data on these five measures effective with discharges beginning July 1, 2009.

We also are proposing to add the following nine AHRQ Patient Safety Indicators (PSI) and Inpatient Quality Indicators (IQI) that have been endorsed by the NQF:

• Patient Safety Indicator (PSI) 4-Death among surgical patients with treatable serious complications

• PSI 6-Iatrogenic pneumothorax, adult

• PSI 14-Postoperative wound dehiscence

• PSI 15-Accidental puncture or laceration

• Inpatient Quality Indicator (IQI) 4 and 11-Abdominal aortic aneurysm (AAA) mortality rate (with or without volume)

• IQI 19-Hip fracture morality rate

• IQI Mortality for selected medical conditions (composite)

• IQI Mortality for selected surgical procedures (composite)

• IQI Complication/patient safety for selected indicators (composite)

These are claims-based outcome measures. They are important additional measures that can be calculated for hospital inpatients without the burden of additional chart abstraction. Hospitals currently collect and submit these data to CMS and other insurers for reimbursement. These measures will be calculated using all-payer claims data that hospitals currently collect with respect to each patient discharge. We are proposing to require hospitals to submit to CMS the all-payer claims data that we specify in the technical specifications manual as necessary to calculate the AHRQ PSI/IQI measures. We are proposing that hospitals begin submitting data on a quarterly basis on these measures to CMS by April 1, 2010 beginning with October 1, 2009 discharges.

However, we are aware that a large number of hospitals already submit these data on a voluntary basis to third party data aggregators such as State health agencies or State hospital associations. We seek comments on whether a hospital that already submits the data necessary to calculate these measures to such entities should be permitted to authorize such an entity to transmit these data to CMS, in accordance with applicable confidentiality laws, on their behalf. This would relieve the hospital of the burden of having to submit the same data directly to CMS via the QIO Clinical Warehouse.

As an alternative to requiring that hospitals submit all-payer claims data for purposes of calculating the AHRQ PSI/IQI measures, CMS is considering whether it should initially calculate the AHRQ PSI/IQI measures using Medicare claims data only, and at a subsequent date require submission of all-payer claims data. We also seek comment on this alternative.

We also are proposing to add 15 cardiac surgery measures. Cardiac surgical procedures carry a significant risk of morbidity and mortality. We believe that the nationwide public reporting of these cardiac surgery measures would provide highly meaningful information for the public.

Currently, over 85 percent of hospitals with a cardiac surgery program submit data on the proposed cardiac surgery measures listed below to the Society of Thoracic Surgeons (STS) Cardiac Surgery Clinical Data Registry. We are proposing to accept these data from the STS registry beginning on July 1, 2009, on a quarterly basis for discharges on or after January 1, 2009. Hospitals that participate in the RHQDAPU program, but that do not submit data on the proposed cardiac surgery measures to the STS registry for discharges on or after January 1, 2009, would need to submit such data to CMS. Although we would accept cardiac surgery data from other clinical data registries, we are unaware of any other registries that collect all of the data necessary to support calculation of the proposed cardiac surgery measures. Hospitals and CMS would need to establish appropriate legal arrangements, to the extent such arrangements are necessary, to ensure that the transfer of these data from the STS registry to CMS complies with all applicable laws. By accepting these registry-based data, only those hospitals with cardiac surgery programs that do not already collect such data to submit to the STS registry will have any additional data submission burden. All of the proposed measures are currently NQF-endorsed. We are proposing that hospitals begin submitting data by July 1, 2009, on a quarterly basis on the following 15 cardiac surgery measures to the STS data registry or CMS for 1st quarter calendar year 2009 discharges:

• Participation in a Systematic Database for Cardiac Surgery

• Pre-Operative Beta Blockade

• Prolonged Intubation

• Deep Sternal Wound Infection Rate

• Stroke/CVA

• Post-Operative Renal Insufficiency

• Surgical Reexploration

• Anti-Platelet Medication at Discharge

• Beta Blockade Therapy at Discharge

• Anti-Lipid Treatment at Discharge

• Risk-Adjusted Operative Mortality for CABG

• Risk-Adjusted Operative Mortality for Aortic Valve Replacement

• Risk-Adjusted Operative Mortality for Mitral Valve Replacement/Repair

• Risk-Adjusted Mortality for Mitral Valve Replacement and CABG Surgery

• Risk-Adjusted Mortality for Aortic Valve Replacement and CABG Surgery

The following table lists the 72 proposed measures for FY 2010:

Topic Quality measure
Heart Attack (Acute Myocardial Infarction) • AMI-1 Aspirin at arrival *.
• AMI-2 Aspirin prescribed at discharge *.
• AMI-3 Angiotensin Converting Enzyme Inhibitor (ACE-I) or Angiotensin II Receptor Blocker (ARB) for left ventricular systolic dysfunction *.
• AMI 6 Beta blocker at arrival *.
• AMI-5 Beta blocker prescribed at discharge *.
• AMI-7a Fibrinolytic (thrombolytic) agent received within 30 minutes of hospital arrival**.
• AMI-4 Adult smoking cessation advice/counseling**.
• AMI-8a Timing of Receipt of Primary Percutaneous Coronary Intervention (PCI).
Heart Failure (HF) • HF-2 Left ventricular function assessment *.
• HF-3 Angiotensin Converting Enzyme Inhibitor (ACE-I) or Angiotensin II Receptor Blocker (ARB) for left ventricular systolic dysfunction *.
• HF-1 Discharge instructions**.
• HF-4 Adult smoking cessation advice/counseling**.
Pneumonia (PN) • PN-2 Pneumococcal vaccination status *.
• PN-3b Blood culture performed before first antibiotic received in hospital**.
• PN-4 Adult smoking cessation advice/counseling**.
• PN-6 Appropriate initial antibiotic selection**.
• PN-7 Influenza vaccination status**.
• PN-5c Timing of receipt of initial antibiotic following hospital arrival******.
Surgical Care Improvement Project (SCIP)-named SIP for discharges prior to July 2006 (3Q06) • SCIP-1 Prophylactic antibiotic received within 1 hour prior to surgical incision**.
• SCIP-3 Prophylactic antibiotics discontinued within 24 hours after surgery end time**.
• SCIP-VTE-1: Venous thromboembolism (VTE) prophylaxis ordered for surgery patients***.
• SCIP-VTE-2: VTE prophylaxis within 24 hours pre/post surgery***.
• SCIP Infection 2: Prophylactic antibiotic selection for surgical patients***.
• SCIP-Infection 4: Cardiac Surgery Patients with Controlled 6AM Postoperative Serum Glucose*****.
• SCIP Infection 6: Surgery Patients with Appropriate Hair Removal*****.
• SCIP Cardiovascular 2: Surgery Patients on a Beta Blocker Prior to Arrival Who Received a Beta Blocker During the Perioperative Period******.
Mortality Measures (Medicare patients) • MORT-30-AMI Acute Myocardial Infarction 30-day mortality Medicare patients***.
• MORT-30-HF Heart Failure 30-day mortality Medicare patients***.
• MORT-30-PN Pneumonia 30-day mortality Medicare patients****.
Patients' Experience of Care • HCAHPS patient survey***.
Readmission Measures (Medicare patients) • Heart Attack (AMI) 30-Day Risk Standardized Readmission Measure (Medicare patients)******.
• Heart Failure (HF) 30-Day Risk Standardized Readmission Measure (Medicare patients)******.
• Pneumonia (PN) 30-Day Risk Standardized Readmission Measure (Medicare patients) ******.
Inpatient Stroke Care • STK-1 DVT Prophylaxis******.
• STK-2 Discharged on Antithrombotic Therapy******.
• STK-3 Patients with Atrial Fibrillation Receiving Anticoagulation Therapy******.
• STK-5 Antithrombotic Medication By End of Hospital Day Two******.
• STK-7 Dysphasia Screening******.
Venous Thromboembolic Care • VTE-1: VTE Prophylaxis******.
• VTE-2: VTE Prophylaxis in the ICU******.
• VTE-4: Patients with overlap in anticoagulation therapy******.
• VTE-5/6: (as combined measure) patients with UFH dosages who have platelet count monitoring and adjustment of medication per protocol or nomagram******.
• VTE-7: Discharge instructions to address: followup monitoring, compliance, dietary restrictions, and adverse drug reactions/interactions******.
• VTE-8: Incidence of preventable VTE******.
AHRQ Patient Safety Indicators • Death among surgical patients with treatable serious complications******.
• Iatrogenic pneumothorax, adult******.
• Postoperative wound dehiscence******.
• Accidental puncture or laceration******.
AHRQ Inpatient Quality Indicators (IQI) • Abdominal aortic aneurysm (AAA) mortality rate (with or without volume) ******.
• Hip fracture morality rate******.
AHRQ IQI Composite Measures • Mortality for selected surgical procedures (composite) ******.
• Complication/patient safety for selected indicators (composite) ******.
• Mortality for selected medical conditions (composite) ******.
Nursing Sensitive Measures • Failure to Rescue******.
• Pressure Ulcer Prevalence and Incidence by Severity ******.
• Patient Falls Prevalence******.
• Patient Falls with Injury******.
Cardiac Surgery Measures • Participation in a Systematic Database for Cardiac Surgery ******.
• Pre-operative Beta Blockade******.
• Prolonged Intubation******.
• Deep Sternal Wound Infection Rate******.
• Stroke/CVA******.
• Postoperative Renal Insufficiency******.
• Surgical Reexploration******.
• Anti-platelet Medication at Discharge******.
• Beta Blockade Therapy at Discharge******.
• Anti-lipid Treatment at Discharge******.
• Risk-Adjusted Operative Mortality for CABG******.
• Risk-Adjusted Operative Mortality for Aortic Valve Replacement******.
• Risk-Adjusted Operative Mortality for Mitral Valve Replacement/Repair******.
• Risk-Adjusted Mortality for Mitral Valve Replacement and CABG Surgery******.
• Risk-Adjusted Mortality for Aortic Valve Replacement and CABG Surgery ******.
*Measure included in 10 measure starter set.
**Measure included in 21 measure expanded set.
***Measure added in CY 2007 OPPS/ASC final rule with comment period.
****Measure added in FY 2008 IPPS final rule with comment period.
*****Measure added in CY 2008 OPPS/ASC final rule with comment period.
******Measure proposed in FY 2009 IPPS proposed rule.

In summary, we are proposing to increase the RHQDAPU program measures from 30 measures for FY 2009 to a total of 72 measures for FY 2010. The following table lists the increase in the RHQDAPU program measure set since the program's inception:

IPPS payment year Number of RHQDAPU program quality measures Topics covered
2005-2006 10 AMI, HF, PN.
2007 21 AMI, HF, PN, SCIP.
2008 27 AMI, HF, PN, SCIP, Mortality, HCAHPS.
2009 30 AMI, HF, PN, SCIP, Mortality, HCAHPS.
2010 72 AMI, HF, PN, SCIP, Mortality, HCAHPS, Nursing Sensitive, Readmission, VTE, Stroke, AHRQ IQI/PSI measures and composites, Cardiac Surgery.

The above measures reflect our continuing commitment to quality improvement in both clinical care and patient safety. These additional measures also demonstrate our commitment to include in the RHQDAPU program only those quality measures that reflect consensus among the affected parties and that have been reviewed by a consensus building process.

To the extent that the proposed measures have not already been endorsed by a consensus building entity such as the NQF, we anticipate that they will be endorsed prior to the time that we issue the FY 2009 IPPS final rule. We intend to finalize the FY 2010 RHQDAPU program measure set in the FY 2009 IPPS final rule, contingent on the endorsement status of the proposed measures. However, to the extent that a measure has not received NQF endorsement by the time we issue the FY 2009 IPPS final rule, we intend to finalize that measure for the FY 2010 RHQDAPU program measure set in the CY 2009 OPPS/ASC final rule with comment period if the measure is endorsed prior to the time we issue the CY-2009-OPPS/ASC final rule with comment period. We are requesting public comment on these measures.

b. Possible New Quality Measures, Measure Sets, and Program Requirements for FY 2011 and Subsequent Years

The following table contains a list of 59 measures and 4 measure sets from which additional quality measures could be selected for inclusion in the RHQDAPU program. It includes measures and measure sets that highlight CMS' interest in improving patient safety and outcomes of care, with a particular focus on the quality of surgical care and patient outcomes. In order to engender a broad review of potential performance measures, the list includes measures that have not yet been considered for approval by the HQA or endorsed by a consensus review process such as the NQF. It also includes measures developed by organizations other than CMS as well as measures that are to be derived from administrative data (such as claims) that may need to be modified for specific use by the Medicare program if implemented under the RHQDAPU program.

We are seeking public comment on the measures and measure sets that are listed as well as any critical gaps or missing measures or measure sets. We specifically request input concerning the following:

• Which of the measures or measure sets should be included in the RHQDAPU program for FY 2011 or in subsequent years?

• What challenges for data collection and reporting are posed by the identified measures and measure sets? What improvements could be made to data collection or reporting that might offset or otherwise address those challenges?

We are soliciting public comment on the following measure sets for consideration in FY 2011 and subsequent years:

Topic Quality measure
Chronic Pulmonary Obstructive Disease Measures:
Complications of Vascular Surgery AAA stratified by open and endovascular methods.
Carotid Endarterectomy.
Lower extremity bypass.
Inpatient Diabetes Care Measures:
Healthcare Associated Infection Central Line-Associated Blood Stream Infections.
Surgical Site Infections.
Timeliness of Emergency Care Measures, including Timeliness Median Time from ED Arrival to ED Departure for Admitted ED Patients.
Median Time from ED Arrival to ED Departure for Discharged ED Patients.
Admit Decision Time to ED Departure Time for Admitted Patients.
Surgical Care Improvement Project (SCIP)-named SIP for discharges prior to July 2006 (3Q06) SCIP Infection 8-Short Half-life Prophylactic Administered Preoperatively Redosed Within 4 Hours After Preoperative Dose.
SCIP Cardiovascular 3-Surgery Patients on a Beta Blocker Prior to Arrival Receiving a Beta Blocker on Postoperative Days 1 and 2.
Complication Measures (Medicare patients):
Healthcare Acquired Conditions Serious reportable events in healthcare (never events).
Pressure ulcer prevalence and incidence by severity.
Catheter-associated UTI.
Hospital Inpatient Cancer Care Measures Patients with early stage breast cancer who have evaluation of the axilla.
College of American Pathologists breast cancer protocol.
Surgical resection includes at least 12 nodes.
College of American Pathologists Colon and rectum protocol.
Completeness of pathologic reporting.
Serious Reportable Events in Healthcare ("Never Events") Surgery performed on the wrong body part.
Surgery performed on the wrong patient.
Wrong surgical procedure on a patient.
Retention of a foreign object in a patient after surgery or other procedure.
Intraoperative or immediately post-operative death in a normal health patient (defined as a Class 1 patient for purposes of the American Society of Anesthesiologists patient safety initiative).
Patient death or serious disability associated with the use of contaminated drugs, devices, or biologics provided by the healthcare facility.
Patient death or serious disability associated with the use or function of a device in patient care in which the device is used or functions other than as intended.
Patient death or serious disability associated with intravascular air embolism that occurs while being cared for in a healthcare facility.
Patient death or serious disability associated with patient elopement (disappearance) for more than four hours.
Patient suicide, or attempted suicide resulting in serious disability, while being cared for in a healthcare facility.
Patient death or serious disability associated with a medication error (e.g., error involving the wrong drug, wrong dose, wrong patient, wrong time, wrong rate, wrong preparation, or wrong route of administration).
Patient death or serious disability associated with a hemolytic reaction due to the administration of ABO-incompatible blood or blood products.
Patient death or serious disability associated with hypoglycemia, the onset of which occurs while the patient is being cared for in a health care facility.
Stage 3 or 4 pressure ulcers acquired after admission to a health care facility.
Patient death or serious disability due to spinal manipulative therapy.
Patient death or serious disability associated with an electric shock while being cared for in a healthcare facility.
Any incident in which a line designated for oxygen or other gas to be delivered to a patient contains the wrong gas or is contaminated by toxic substances.
Patient death or serious disability associated with a burn incurred from any source while being cared for in a health care facility.
Patient death associated with a fall while being cared for in a health care facility.
Patient death or serious disability associated with the use of restraints or bedrails while being cared for in a health care facility.
Any instance of care ordered by or provided by someone impersonating a physician, nurse, pharmacist, or other licensed health care provider.
Abduction of a patient of any age.
Sexual assault on a patient within or on the grounds of a health care facility.
Death or significant injury of a patient or staff member resulting from a physical assault (i.e., battery) that occurs within or on the grounds of a health care facility.
Average Length of Stay Coupled with Global Readmission Measure:
Preventable Hospital-Acquired Conditions (HACs) Catheter-Associated Urinary Tract Infection (UTI).
Vascular Catheter-Associated Infection.
Surgical Site Infections-Mediastinitis after Coronary Artery Bypass Graft (CABG).
Surgical Site Infections following Elective Procedures-Total Knee Replacement, Laparoscopic Gastric Bypass, Litigation and Stripping of Varicose Veins.
Legionnaires' Disease.
Glycemic Control-Diabetic Ketoacidosis, Nonketotic Hypersmolar Coma, Hypoglycemic Coma.
Iatrogenic pneumothorax.
Delirium.
Ventilator-Associated Pneumonia (VAP).
Deep Vein Thrombosis (DVT)/Pulmonary Embolism (PE).
Staphylococcus aureus Septicemia.
Clostridium-Difficile Associated Disease (CDAD).
Methicillin-Resistant Staphylococcus aureus (MRSA).

c. Considerations in Expanding and Updating Quality Measures Under the RHQDAPU Program

The RHQDAPU program has significantly expanded from an initial set of 10 measures to 30 measures for the FY 2009 payment determination. Initially, the conditions covered by the RHQDAPU program measures were limited to Acute Myocardial Infarction, Heart Failure, and Pneumonia, three high-cost and high-volume conditions. In expanding the process measures, Surgical Infection Prevention was the first additional focus, now supplemented by the two Venous Thromboembolism SCIP measures SCIP VTE-1 and SCIP VTE-2 for surgical patients. Of the 30 current measures, 27 require data collection from chart abstraction and surveying patients and submission of detailed data elements.

In looking forward to further expansion of the RHQDAPU program, we believe it is important to take several goals into consideration. These include: (a) Expanding the types of measures beyond process of care measures to include an increased number of outcome measures, efficiency measures, and experience-of-care measures; (b) expanding the scope of hospital services to which the measures apply; (c) considering the burden on hospitals in collecting chart-abstracted data; (d) harmonizing the measures used in the RHQDAPU program with other CMS quality programs to align incentives and promote coordinated efforts to improve quality; (e) seeking to use measures based on alternative sources of data that do not require chart abstraction or that utilize data already being broadly reported by hospitals, such as clinical data registries or all-payer claims data bases; and (f) weighing the meaningfulness and utility of the measures compared to the burden on hospitals in submitting data under the RHQDAPU program.

We request comments on how to reduce burden on the hospitals participating in the RHQDAPU program. We realize that our proposal to expand the RHQDAPU program measure set from submission of 30 measures in FY 2009 to 72 measures in FY 2010 is potentially burdensome. However, to minimize hospitals' burden, the proposed expansion uses many existing data sources, including Medicare claims and registry data. We also request comment about which measures would be most useful while minimizing burden.

(1) Expanding the Types of Measures

Section 1886(b)(3)(B)(viii)(III) of the Act requires the Secretary to add other quality measures that the Secretary determines to be appropriate for the measurement of the quality of care furnished by hospitals in inpatient settings. We intend to expand outcome measures such as mortality measures and measures of complications. For FY 2010, the proposed measure set includes:

• Patient Experience of Care. HCAHPS collects data regarding a patient's experience of care in the hospital and provides a very meaningful perspective from the patient standpoint.

• Efficiency. Efficiency is a Quality Domain, as defined by the IOM, that relates Quality and Cost. The three proposed readmission measures address hospital efficiency. These are considered efficiency measures because higher hospital readmission rates are linked to higher costs and also to lower quality of care received during hospitalization and after the initial hospital stay. We are also seeking additional ways in which to address efficiency.

• Outcomes. The three 30-day mortality measures, the STS cardiac surgery measures, the AHRQ PSI/IQI measures, and the four outcome-related nursing sensitive measures represent significant expansion of the RHQDAPU program outcome measures. Additional outcome measures are provided in the list under consideration for inclusion in the RHQDAPU program for FY 2010 and beyond.

(2) Expanding the Scope of Hospital Services To Which Measures Apply

Many of the most common and high-cost Medicare DRGs were posted on the Hospital Compare Web site in March 2008 as part of the President's transparency initiative. We have assessed these DRGs and have found that the FY 2009 RHQDAPU program measure set does not capture data regarding care in important areas such as Inpatient Diabetes Care, Chronic Obstructive Pulmonary Disease (COPD), and Chest Pain. These are areas for which we currently do not have quality measures but which constitute a significant portion of the top paying DRGs for Medicare beneficiaries. We intend to develop measures in these areas in order to provide additional quality information on the most common and high-cost conditions that affect Medicare beneficiaries. In the proposed FY 2010 measure set, measures have been expanded to comprehensively address services related to preventing Venous Thromboembolism, treatment of stroke, and nursing services.

(3) Considering the Burden on Hospitals in Collecting Chart-Abstracted Data for Measures

Although we are proposing to add additional chart-abstracted measures for FY 2010, we also are proposing to stagger the dates for which data collection for these measures must begin, which we believe will lessen the burden on hospitals as they incorporate these new measures into their systems. We also intend to work to simplify the data abstraction specifications that add to the burden of data collection.

(4) Harmonizing With Other CMS Programs

We intend to harmonize measures across settings and other CMS programs as evidenced by the implementation of the readmission measures not only for the RHQDAPU program but also for the QIOs' 9th Scope of Work (SOW) Patient Pathways/Care Transitions Theme, which also uses the 30-Day Readmission Measures and will provide assistance to engage hospitals in improving care. The 9th SOW also focuses on disparities in health care, which is another important area of interest for CMS. We plan to analyze current RHQDAPU measures to identify particular RHQDAPU program measures needed to evaluate the existence of health care disparities, to require data elements that would support better identification of health care disparities, and to find more efficient ways to ascertain this information from claims data. In addition, at least some of the CY 2008 Physician Quality Reporting Initiative (PQRI) measures align with the current RHQDAPU program AMI and SCIP measures reported starting with the FY 2007 RHQDAPU measure set. In other words, there are financial incentives that cover the same clinical processes of care across different providers and settings. For example, Aspirin for Heart Attack corresponds to PQRI measure number 28, and Surgical Infection Antibiotic Timing corresponds to PQRI measure number 20. Outpatient quality measures under the Hospital Outpatient Data Quality Data Reporting Program (HOP QDRP) are also aligned with the RHQDAPU program measures. For example, the HOP QDRP addresses Acute Myocardial Infarction treatment for transferred patients and surgical infection prevention for outpatient surgery.

(5) Using Alternative Data Sources Not Requiring Chart Abstraction

We are actively pursuing alternative data sources, including data sources that are electronically maintained. Alternative data submission methodologies that we are proposing in this rule include:

• Use of registry-collected clinical data for which there is broad existing hospital participation as previously described with the STS registry.

• Use of data collected by State data organizations, State hospital associations, Federal entities such as AHRQ, and/or other data warehouses.

In addition, we are considering adopting the following methods of data collection in the future and request comments on these methods:

• Use of the CMS Continuity Assessment Record Evaluation (CARE) tool, a standardized data collection instrument, which would allow data to be transmitted in "real time." This recently developed, Internet-based, quality data collection tool was developed as a part of the Post Acute Care Reform Demonstration Program mandated by section 5008 of the DRA. The CARE tool consists of a core set of assessment items, common to all patients and all care settings (meeting criteria of being predictive of cost, utilization, outcomes, among others), organized under five major domains: Medical, Functional, Social, Environmental, and Cognitive-Continuity of Care. The Internet-based CARE tool will communicate critical information across settings accurately, quickly, and efficiently with reduced time burden to providers and is intended to enhance beneficiaries' safe transitions between settings to prevent avoidable, costly events such as unnecessary rehospitalizations or medication errors. We believe that the CARE tool may provide a vehicle for collection of data elements to be used for calculating RHQDAPU program quality measures. CMS is considering utilizing the CARE tool in this manner. The Care tool is available at: www.cms.hhs.gov/PaperworkReductionActof1995/PRAL/list.asp#TopOfPage . (Viewers should select "Show only items with the word "10243", click on show items, select CMS-10243, click on downloads, and open Appendices A B, pdf files.)

We are particularly interested in receiving public comment on this tool. Our goal is to have a standardized, efficient, effective, interoperable, common assessment tool to capture key patient characteristics that will help CMS capture information related to resource utilization; expected costs as well as clinical outcomes; and post-discharge disposition. The CARE tool will also be useful for guiding payment and quality policies.

Specifically, we are interested in receiving public comments on how CARE might advance the use of health information technology in automating the process for collecting and submitting quality data.

• Submission of data derived from electronic versions of laboratory test reports that are issued by the laboratory in accordance with CLIA to the ordering provider and maintained by the hospital as part of the patient's medical record during and after the patient's course of treatment at the hospital. We are considering using these data to support risk adjustment for claims-based outcome measures (for example, mortality measures) and to develop other outcomes measures. This would support use of electronically maintained data and our goal of reducing manual data collection burden on hospitals.

• Submission of data currently being collected by clinical data registries in addition to the STS registry. This would support and leverage existing clinical data registries and existing voluntary clinical data collection efforts, such as:

• American College of Cardiology (ACC) data registry for Cardiac Measures.

• ACC data registry for ICD.

• ACC data registry for Carotid Stents.

• Vascular Surgery Registry for Vascular Surgical Procedures.

• ACC-sponsored "Get with the Guidelines" registry for Stroke Care.

(6) Weighing the Meaningfulness and Utility of the Measures Compared to the Burden on Hospitals in Submitting Data Under the RHQDAPU Program

We are proposing to retire one measure from the RHQDAPU program for FY 2010 because we have determined that the burden on hospitals in abstracting the data outweighs the meaningful benefit that we can ascertain from the measure. As we explained more fully above, we are seeking comments on the applicability to the RHQDAPU program of criteria currently described in the Hospital VBP Issues Paper for inclusion and retirement of measures. The Hospital VBP Issues Paper is located on the CMS Web site at the following location: http://www.cms.hhs.gov/AcuteInpatientPPS/downloads/hospital_VBP_plan_issues_paper.pdf .

3. Form and Manner and Timing of Quality Data Submission

In the FY 2007 IPPS final rule (71 FR 48031 through 48045), we set out RHQDAPU program procedures for data submission, program withdrawal, data validation, attestation, public display of hospitals" quality data, and reconsiderations. Section 1886(b)(3)(B)(viii)(I) of the Act requires that subsection (d) hospitals submit data on measures selected under that clause with respect to the applicable fiscal year. In addition, section 1886(b)(3)(B)(viii)(II) of the Act requires that each subsection (d) hospital submit data on measures selected under that clause to the Secretary in a form and manner, and at a time, specified by the Secretary. The technical specifications for each RHQDAPU program measure are listed in the CMS/Joint Commission Specifications Manual for National Inpatient Hospital Quality Measures (Specifications Manual). We update this manual semiannually or more frequently in unusual cases, and include detailed instructions and calculation algorithms for hospitals to collect and submit the data for the required measures.

The maintenance of the specifications for the measures selected by the Secretary occurs through publication of the Specifications Manual. Thus, measure selection by the Secretary occurs through the rulemaking process; whereas the maintenance of the technical specifications for the selected measures occurs through a subregulatory process so as to best maintain the specifications consistent with current science and consensus. The data submission, Specifications Manual, and submission deadlines are posted on the QualityNet Web site at www.qualitynet.org . We require that hospitals submit data in accordance with the specifications for the appropriate discharge periods. When measure specifications are updated, we are proposing to require that hospitals submit all of the data required to calculate the required measures as outlined in the Specifications Manual current as of the patient discharge date.

4. Current and Proposed RHQDAPU Program Procedures

a. RHQDAPU Program Procedures for FY 2009

In the FY 2008 IPPS final rule with comment period, we stated that the requirements for FY 2008 would continue to apply for FY 2009 (72 FR 47361). The "Reporting Hospital Quality Data for Annual Payment Update Reference Checklist" section of the QualityNet Web site contains all of the forms to be completed by hospitals participating in the RHQDAPU program.

Under these requirements hospitals must-

• Register with QualityNet, before participating hospitals initially begin reporting data, regardless of the method used for submitting data.

¦ Identify a QualityNet Administrator who follows the registration process located on the QualityNet Web site ( www.qualitynet.org ).

¦ Complete the revised RHQDAPU program Notice of Participation form (only for hospitals that did not submit a form prior to August 15, 2007). For hospitals that share the same Medicare Provider Number (now CMS Certification Number (CCN)), report the name and address of each hospital on this form.

¦ Collect and report data for each of the required measures except the Medicare mortality measures (AMI, HF, and PN 30-day Mortality for Medicare Patients). Hospitals must continuously report these data. Hospitals must submit the data to the QIO Clinical Warehouse using the CMS Abstraction Reporting Tool (CART), The Joint Commission ORYX® Core Measures Performance Measurement System, or another third-party vendor tool that has met the measurement specification requirements for data transmission to QualityNet. All submissions will be executed through QualityNet. Because the information in the QIO Clinical Warehouse is considered QIO information, it is subject to the stringent QIO confidentiality regulations in 42 CFR Part 480. The QIO Clinical Warehouse will submit the data to CMS on behalf of the hospitals.

• Submit complete data regarding the quality measures in accordance with the joint CMS/Joint Commission sampling requirements located on the QualityNet Web site for each quality measure that requires hospitals to collect and report data. These requirements specify that hospitals must submit a random sample or complete population of cases for each of the topics covered by the quality measures. Hospitals must meet the sampling requirements for these quality measures for discharges in each quarter.

• Submit to CMS on a quarterly basis aggregate population and sample size counts for Medicare and non-Medicare discharges for the four topic areas (AMI, HF, PN, and SCIP).

• Continuously collect and submit HCAHPS data in accordance with the HCAHPS Quality Assurance Guidelines, Version 3.0, located at the Web site: www.hcahpsonline.org. The QIO Clinical Warehouse has been modified to accept zero HCAHPS-eligible discharges. We remind the public to refer to the QualityNet Web site for any questions about how to submit "zero cases" information.

For the AMI 30-day, HF 30-day, and PN 30-day mortality measures, CMS uses Part A and Part B claims for Medicare fee-for-service patients to calculate the mortality measures. For FY 2009, hospital inpatient claims (Part A) from July 1, 2006 to June 30, 2007, will be used to identify the relevant patients and the index hospitalizations. Inpatient claims for the index hospitalizations and Part A and Part B claims for all inpatient, outpatient, and physician services received one year prior to the index hospitalizations are used to determine patient comorbidity, which is used in the risk adjustment calculation (see the Web site: www.qualitynet.org/dcs/ContentServer?cid=1163010398556pagename=QnetPublic%2FPage%2FQnetTier2c=Page ). No other hospital data submission is required to calculate the mortality rates.

b. Proposed RHQDAPU Program Procedures for FY 2010

We are proposing to continue requiring the FY 2009 RHQDAPU program procedures for FY 2010 for hospitals participating in the RHQDAPU program, with the following modifications:

• Notice of Participation. New subsection (d) hospitals and existing hospitals that wish to participate in RHQDAPU for the first time must complete a revised "Reporting Hospital Quality Data for Annual Payment Update Notice of Participation" that includes the name and address of each hospital that shares the same CCN.

• Data Submission. In order to reduce the burden on hospitals that treat a low number of patients who are covered by the submission requirements, we are proposing the following:

¦ AMI. We are proposing that a hospital that has five or fewer AMI discharges (both Medicare and non-Medicare combined) in a quarter will not be required to submit AMI patient level data for that quarter. We are proposing to begin implementing this requirement with discharges on or after January 1, 2009. However, the hospital must still submit its aggregate AMI population and sample size counts to CMS for that quarter as part of its quarterly RHQDAPU data submission.

¦ HCAHPS. We are proposing that a hospital that has five or fewer HCAHPS-eligible discharges in any month will not be required to submit HCAHPS surveys for that month. However, the hospital must still submit its total number of HCAHPS-eligible cases for that month as part of its quarterly HCAHPS data submission. We are proposing to begin implementing this requirement with discharges on or after January 1, 2009.

¦ HF. We are proposing that a hospital that has five or fewer HF discharges (both Medicare and non-Medicare combined) in a quarter will not be required to submit HF patient level data for that quarter. However, the hospital must still submit its aggregate HF population and sample size counts to CMS for that quarter as part of its quarterly RHQDAPU data submission. We are proposing to begin implementing this requirement with discharges on or after January 1, 2009.

¦ PN. We are proposing that a hospital that has five or fewer PN discharges (both Medicare and non-Medicare combined) in a quarter will not be required to submit PN patient level data for that quarter. However, the hospital must still submit its aggregate PN population and sample size counts to CMS for that quarter as part of its quarterly RHQDAPU data submission. We are proposing to begin implementing this requirement with discharges on or after January 1, 2009.

¦ SCIP. We are proposing that a hospital that has five or fewer SCIP discharges (both Medicare and non-Medicare combined) in a quarter will not be required to submit SCIP patient level data for that quarter. However, the hospital must still submit its aggregate SCIP population and sample size counts to CMS for that quarter as part of its quarterly RHQDAPU data submission. We are proposing to begin implementing this requirement with discharges on or after January 1, 2009.

In addition, we are proposing the following quarterly deadlines for hospitals to submit the FY 2010 AMI, HF, SCIP, PN, Stroke, VTE, and nursing sensitive measure data:

• The data submission deadline for hospitals to submit the patient level measure data for 1st calendar quarter of 2009 discharges would be August 15, 2009. Data must be submitted for each of these measures 4.5 months after the end of the preceding quarter. The specific deadlines will be listed on the QualityNet Web site.

• Even though data on applicable measures will not be due until 4.5 months after the end of the preceding quarter, hospitals must submit their aggregate population and sample size counts no later than 4 months after the end of the preceding quarter (the exact dates will be posted on the QualityNet Web site). This deadline falls approximately 15 days before the data submission deadline for the clinical process measures, and we are proposing it so that we can inform hospitals about their data submission status for the quarter before the 4.5 month clinical process measure deadline. We have found from past experience that hospitals need sufficient time to submit additional data when their counts differ from Medicare claims counts generated by CMS. We will provide hospitals with these Medicare claims counts and submitted patient level data counts on the QualityNet Web site approximately 2 weeks before the quarterly submission deadline. We plan to use the aggregate population and sample size data to assess submission completeness and adherence to sampling requirements for Medicare and non-Medicare patients.

We propose the following quarterly deadlines for hospitals to submit cardiac surgery and the AHRQ PSI/IQI measure data to CMS or other entities:

• The data submission deadline for hospitals to submit cardiac surgery patient level measure data to CMS or STS data registry for 1st calendar quarter of 2009 discharges would be June 1, 2009. Data must be submitted for each of these measures 2 months after the end of the preceding quarter. The specific deadlines will be listed on the QualityNet Web site.

• The data submission deadline for hospitals to submit the AHRQ PSI/IQI measure data to CMS for 4th calendar quarter of 2009 discharges would be April 1, 2010. Data must be submitted for each of these measures 3 months after the end of the preceding quarter. The specific deadlines will be listed on the QualityNet Web site.

We are proposing these quarterly submission deadlines for cardiac surgery and AHRQ PSI/IQI measure data to coordinate submission deadlines with external data registries and provide more timely information to the consumers. We are proposing this quarterly submission deadline for cardiac surgery measure data to coincide with the STS quarterly submission deadline that is approximately 2 months following the discharge quarter. We also propose to shorten the time lag between the date of discharge and the public reporting of these quality measures to provide more timely consumer information.

5. Current and Proposed HCAHPS Requirements

a. FY 2009 HCAHPS Requirements

For FY 2009, hospitals must continuously collect and submit HCAHPS data to the QIO Clinical Warehouse by the data submission deadlines posted on the Web site at: www.hcahpsonline.org. The data submission deadline for first quarter CY 2008 (January through March) discharges is July 9, 2008. To collect HCAHPS data, a hospital can either contract with an approved HCAHPS survey vendor that will conduct the survey and submit data on the hospital's behalf to the QIO Clinical Warehouse, or a hospital can self-administer the survey without using a survey vendor, provided that the hospital meets Minimum Survey Requirements as specified on the Web site at: www.hcahpsonline.org. A current list of approved HCAHPS survey vendors can be found on the Web site at: www.hcahpsonline.org.

Every hospital choosing to contract with a survey vendor should provide the sample frame of hospital-eligible discharges to its survey vendor with sufficient time to allow the survey vendor to begin contacting each sampled patient within 6 weeks of discharge from the hospital (see the Quality Assurance Guidelines for details about HCAHPS eligibility and sample frame creation) and must authorize the survey vendor to submit data via QualityNet on the hospital's behalf. CMS strongly recommends that the hospitals employing a survey vendor promptly review the two HCAHPS Feedback Reports (the Provider Survey Status Summary Report and the Data Submission Detail Report) that are available after the survey vendor submits the data to the QIO Clinical Warehouse. These reports enable a hospital to ensure that its survey vendor has submitted the data on time and it has been accepted into the Warehouse.

In the FY 2008 IPPS final rule with comment period (72 FR 47362), we stated that hospitals and survey vendors must participate in a quality oversight process conducted by the HCAHPS project team. Starting in July 2007, we began asking hospitals/survey vendors to correct any problems that were found and provide followup documentation of corrections for review within a defined time period. If the HCAHPS project team finds that the hospital has not made these corrections, CMS may determine that the hospital is not submitting HCAHPS data that meet the requirements for the RHQDAPU program. As part of these activities, HCAHPS project staff reviews and discusses with survey vendors and hospitals self-administering the survey their specific Quality Assurance Plans, survey management procedures, sampling and data collection protocols, and data preparation and submission procedures.

b. Proposed FY 2010 HCAHPS Requirements

For FY 2010, we are proposing continuous collection of HCAHPS in accordance with the Quality Assurance Guidelines located at the Web site: www.hcahpsonline.org , by the quarterly data submission deadlines posted on the Web site: www.hcahpsonline.org . As stated above, starting with January 1, 2009 discharges, we are proposing that hospitals that have five or fewer HCAHPS-eligible discharges in a month would not be required to submit HCAHPS patient-level data for that month as part of the quarterly data submission that includes that month, but they would still be required to submit the number of HCAHPS-eligible cases for that month as part of their HCAHPS quarterly data submission.

With respect to HCAHPS oversight, we are proposing that the HCAHPS Project Team will continue to conduct site visits and/or conference calls with hospitals/survey vendors to ensure the hospital's compliance with the HCAHPS requirements. During the onsite visit or conference call, the HCAHPS Project Team will review the hospital's/survey vendor's survey systems and will assess protocols based upon the most recent Quality Assurance Guidelines. All materials relevant to survey administration will be subject to review. The systems and program review includes, but it is not necessarily limited to: (a) survey management and data systems; (b) printing and mailing materials and facilities; (c) telephone/IVR materials and facilities; (d) data receipt, entry and storage facilities; and (e) written documentation of survey processes. Organizations will be given a defined time period in which to correct any problems and provide followup documentation of corrections for review. Hospitals/survey vendors will be subject to followup site visits and/or conference calls, as needed. If CMS determines that a hospital is noncompliant with HCAHPS program requirements, CMS may determine that the hospital is not submitting HCAHPS data that meet the requirements of the RHQDAPU program.

6. Current and Proposed Chart Validation Requirements

a. Chart Validation Requirements for FY 2009

In the FY 2008 IPPS final rule with comment period (72 FR 47361), we stated that, until further notice, we would continue to require that hospitals meet the chart validation requirements that we implemented in the FY 2006 IPPS final rule (70 FR 47421 and 47422). These requirements, as well as additional information on validation requirements, continue and are being placed on the QualityNet Web site.

We also stated in the FY 2008 IPPS final rule with comment period that, until further notice, hospitals must pass our validation requirement that requires a minimum of 80-percent reliability, based upon our chart-audit validation process (72 FR 47361).

In the FY 2008 IPPS final rule with comment period (72 FR 47362), we indicated that, for the FY 2009 update, all FY 2008 validation requirements would apply, except for the following modifications. We would modify the validation requirement to pool the quarterly validation estimates for 4th quarter CY 2006 through 3rd quarter 2007 discharges. We would also expand the list of validated measures in the FY 2009 update to add SCIP Infection-2, SCIP VTE-1, and SCIP VTE-2 (starting with 4th quarter CY 2006 discharges). We would also drop the current two-step process to determine if the hospital is submitting validated data. For the FY 2009 update, we stated that we will pool validation estimates covering the four quarters (4th quarter CY 2006 discharges through 3rd quarter 2007 discharges) in a similar manner to the current 3rd quarter pooled confidence interval.

In summary, the following chart validation requirements apply for the FY 2009 RHQDAPU program:

• The 21-measure expanded set will be validated using 4th quarter CY 2006 (4Q06) through 3rd quarter CY 2007 (3Q07) discharges.

• SCIP VTE-1, VTE-2, and SCIP Infection 2 will be validated using 2nd quarter CY 2007 and 3rd quarter CY 2007 discharges.

• SCIP Infection 4 and SCIP Infection 6 must be submitted starting with 1st quarter CY 2008 discharges but will not be validated.

• HCAHPS data must continuously be submitted and will be reviewed as discussed above.

• AMI, HF, and PN 30-day mortality measures will be calculated as discussed below.

In the FY 2008 IPPS final rule with comment period (72 FR 47364), we stated that, for the FY 2008 update and in subsequent years, we would revise and post up-to-date confidence interval information on the QualityNet Web site explaining the application of the confidence interval to the overall validation results. The data are being validated at several levels. There are consistency and internal edit checks to ensure the integrity of the submitted data; there are external edit checks to verify expectations about the volume of the data received.

b. Proposed Chart Validation Requirements for FY 2010

For FY 2010, we are proposing the following chart validation requirements to reflect the proposed 72-measure set:

• The following 21 measures from the FY 2009 RHQDAPU program measure set will be validated using data from 4th quarter 2007 through 3rd quarter 2008 discharges.

Topic Quality measure validated from 4th quarter 2007 through 3rd quarter 2008 discharges
Heart Attack (Acute Myocardial Infarction) Aspirin at arrival
Aspirin prescribed at discharge
Angiotensin Converting Enzyme Inhibitor (ACE-I) or Angiotensin II Receptor Blocker (ARB) for left ventricular systolic dysfunction
Beta blocker at arrival
Beta blocker prescribed at discharge
Fibrinolytic (thrombolytic) agent received within 30 minutes of hospital arrival
Adult smoking cessation advice/counseling
Heart Failure (HF) Left ventricular function assessment
Angiotensin Converting Enzyme Inhibitor (ACE-I) or Angiotensin II Receptor Blocker (ARB) for left ventricular systolic dysfunction
Discharge instructions
Adult smoking cessation advice/counseling
Pneumonia (PN) Pneumococcal vaccination status
Blood culture performed before first antibiotic received in hospital
Adult smoking cessation advice/counseling
Appropriate initial antibiotic selection
Influenza vaccination status
Surgical Care Improvement Project (SCIP)-named SIP for discharges prior to July 2006 (3Q06) Prophylactic antibiotic received within 1 hour prior to surgical incision
SCIP-VTE-1: Venous thromboembolism (VTE) prophylaxis ordered for surgery patients***
SCIP-VTE-2: VTE prophylaxis within 24 hours pre/post surgery***
SCIP Infection 2: Prophylactic antibiotic selection for surgical patients***
SCIP-Infection 3: Prophylactic antibiotics discontinued within 24 hours after surgery end time

• SCIP Infection 4 and Infection 6 will be validated using data from 2nd and 3rd quarter CY 2008 discharges.

In addition, we are proposing to include the following three measures in the FY 2010 RHQDAPU program validation process that are included the FY 2009 RHQDAPU program measure set but have been updated or deleted for the FY 2010 measure set:

• Pneumonia antibiotic prophylaxis timing within 4 hours will be validated using data from 4th quarter 2007 through 3rd quarter 2008 discharges.

• Percutaneous Coronary Intervention (PCI) Timing within 120 minutes will be validated using data from 4th quarter 2007 through 3rd quarter 2008 discharges.

• Pneumonia Oxygenation Assessment will be validated using data from 4th quarter through 3rd quarter 2008 discharges.

These measures will be submitted by hospitals during 2008 and early 2009, and are available to be validated by CMS in time for the FY 2010 RHQDAPU program payment eligibility determination.

As explained above, will also revise and post up-to-date confidence interval information on the QualityNet Web site explaining the application of the confidence interval to the overall validation results.

c. Chart Validation Methods and Requirements Under Consideration for FY 2011 and Subsequent Years

Under the current and proposed RHQDAPU program chart validation process, we validate measures by reabstracting on a quarterly basis a random sample of five patient records for each hospital. This quarterly sample results in an annual combined sample of 20 patient records across 4 calendar quarters, but because the samples are random, they do not necessarily include patient records covering each of the clinical topics.

We anticipate that the proposed expansion of the RHQDAPU program measure set to include additional clinical topics will decrease the percentage of RHQDAPU clinical topics, as well as the total number of measures, covered in many hospitals' annual chart validation. In addition to the measures for which hospitals must submit data for FY 2009 (with the exception of the Pneumonia Oxygenation Assessment measure), we have proposed that hospitals will submit data on the proposed five stroke measures, six VTE measures, and four nursing sensitive measures for FY 2010 using chart abstraction. CMS is considering the addition of these measures to the current RHQDAPU program validation process for FY 2011 and future years.

However, we are considering whether registries and other external parties that may be collecting data on proposed RHQDAPU program measures could validate the accuracy of those measures beginning in FY 2011. In addition, we note that the proposed readmission measures are calculated using Medicare claims information and do not require chart validation.

We are interested in receiving public comments from a broad set of stakeholders on the impact of adding measures to the validation process, as well as modifications to the current validation process that could improve the reliability and validity of the methodology. We specifically request input concerning the following:

• Which of the measures or measure sets should be included in the FY 2010 RHQDAPU program chart validation process or in the chart validation process for subsequent years?

• What validation challenges are posed by the RHQDAPU program measures and measure sets? What improvements could be made to validation or reporting that might offset or otherwise address those challenges?

• Should CMS switch from its current quarterly validation sample of five charts per hospital to randomly selecting a sample of hospitals, and selecting more charts on an annual basis to improve reliability of hospital level validation estimates?

• Should CMS select the validation sample by clinical topic to ensure that all publicly reported measures are covered by the validation sample?

7. Data Attestation Requirements

a. Proposed Change to Requirements for FY 2009

In the FY 2008 IPPS final rule with comment period (72 FR 47364), we stated that we would require for FY 2008 and subsequent years that hospitals attest each quarter to the completeness and accuracy of their data, including the volume of data, submitted to the QIO Clinical Warehouse in order to improve aspects of the validation checks. We stated that we would provide additional information to explain this attestation requirement, as well as provide the relevant form to be completed on the QualityNet Web site, at the same time as the publication of the FY 2008 IPPS final rule with comment period.

We are now proposing to defer the requirement in FY 2009 for hospitals to separately attest to the accuracy and completeness of their submitted data due to the burden placed on hospitals to report paper attestation forms on a quarterly basis. We continue to expect that hospitals will submit quality data that are accurate to the best of their knowledge and ability.

b. Proposed Requirements for FY 2010

For FY 2010 and subsequent years, we are soliciting public comment on the electronic implementation of the attestation requirement at the point of data submission to the QIO Clinical Warehouse. Hospitals would electronically pledge to CMS that their submitted data are accurate and complete to the best of their knowledge. Hospitals would be required to designate an authorized contact to CMS for attestation in their patient-level data submission.

Resubmissions would continue to be allowed before the quarterly submission deadline, and hospitals would be required to electronically update their pledges about data accuracy at the time of resubmission. We welcome comments on this approach.

8. Public Display Requirements

Section 1886(b)(3)(B)(viii)(VII) of the Act provides that the Secretary shall establish procedures for making data submitted under the RHQDAPU program available to the public. The RHQDAPU program quality measures are posted on the Hospital Compare Web site ( http://www.hospitalcompare.hhs.gov ). CMS requires that hospitals sign a "Reporting Hospital Quality Data for Annual Payment Update Notice of Participation" form when they first register to participate in the RHQDAPU program. Once a hospital has submitted a form, the hospital is considered to be an active RHQDAPU program participant until such time as the hospital submits a withdrawal form to CMS (72 FR 47360). Hospitals signing this form agree that they will allow CMS to publicly report the quality measures as required in the applicable year's RHQDAPU program requirements.

We are proposing to continue to display quality information for public viewing as required by section 1886(b)(3)(B)(viii)(VII) of the Act. Before we display this information, hospitals will be permitted to review their information as recorded in the QIO Clinical Warehouse.

Currently, hospitals that share the same CCN (formerly known as Medicare Provider Number (MPN)) must combine data collection and submission across their multiple campuses (for both clinical measures and for HCAHPS). These measures are then publicly reported as if they apply to a single hospital. We estimate that approximately 5 to 10 percent of the hospitals reported on the Hospital Compare Web site share CCNs. Beginning with the FY 2008 RHQDAPU program, hospitals must report the name and address of each hospital that shares the same CCN. This information will be gathered through the RHQDAPU program Notice of Participation form for new hospitals participating in the RHQDAPU program. To increase transparency in public reporting and improve the usefulness of the Hospital Compare Web site, we will note on the Web site where publicly reported measures combine results from two or more hospitals.

9. Proposed Reconsideration and Appeal Procedures

For FY 2009, we are proposing to continue the current RHQDAPU program reconsideration and appeal procedures finalized in the FY 2008 IPPS final rule with comment period. The deadline for submitting a request for reconsideration in connection with the FY 2009 payment determination is November 1, 2008. We also are proposing to use the same procedural rules finalized in the FY 2008 IPPS final rule with comment period (72 FR 47365). We posted these rules on the QualityNet Web site for the FY 2008 RHQDAPU program reconsideration process.

Under the procedural rules, in order to receive reconsideration for FY 2009, the hospital must-

• Submit to CMS, via QualityNet, a Reconsideration Request form (available on the QualityNet Web site) containing the following information:

? Hospital Medicare ID number.

? Hospital Name.

? CMS-identified reason for failure (as provided in the CMS notification of failure letter to the hospital).

? Hospital basis for requesting reconsideration. (This must identify the hospital's specific reason(s) for believing it met the RHQDAPU program requirements and should receive the full FY 2009 IPPS annual payment update.)

? CEO contact information, including name, e-mail address, telephone number, and mailing address (must include physical address, not just the post office box).

? QualityNet System Administrator contact information, including name, e-mail address, telephone number, and mailing address (must include physical address, not just the post office box).

• The request must be signed by the hospital's CEO.

• Following receipt of a request for reconsideration, CMS will-

• Provide an e-mail acknowledgement, using the contact information provided in the reconsideration request, to the CEO and the QualityNet Administrator that the letter has been received.

• Provide a formal response to the hospital CEO, using the contact information provided in the reconsideration request, notifying the facility of the outcome of the reconsideration process. CMS expects the process to take 60 to 90 days from the due date of November 1, 2008.

If a hospital is dissatisfied with the result of a RHQDAPU program reconsideration decision, the hospital may file a claim under 42 CFR part 405, subpart R (a Provider Reimbursement Review Board (PRRB) appeal).

10. Proposed RHQDAPU Program Withdrawal Deadline for FYs 2009 and 2010

We propose to accept RHQDAPU program withdrawal forms for FY 2009 from hospitals through August 15, 2008. We are proposing this deadline to provide CMS with sufficient time to update the RHQDAPU FY 2009 payment to hospitals starting on October 1, 2008. If a hospital withdraws from the program for FY 2009, it will receive a 2.0 percentage point reduction in its FY 2009 annual payment update.

We also propose to accept RHQDAPU program withdrawal forms for FY 2010 from hospitals through August 15, 2009. If a hospital withdraws from the program for FY 2010, it will receive a 2.0 percentage point reduction in its FY 2010 annual payment update.

11. Requirements for New Hospitals

In the FY 2008 IPPS final rule with comment period (72 FR 47366), we stated that a new hospital that receives a provider number on or after October 1 of each year (beginning with October 1, 2007) will be required to report RHQDAPU program data beginning with the first day of the quarter following the date the hospital registers to participate in the RHQDAPU program. For example, a hospital that receives its CCN on October 2, 2008, and signs up to participate in the RHQDAPU program on November 1, 2007, will be expected to meet all of the data submission requirements for discharges on or after January 1, 2009.

In addition, we strongly recommend that each new hospital participate in an HCAHPS dry run, if feasible, prior to beginning to collect HCAHPS data on an ongoing basis to meet RHQDAPU program requirements. We refer readers to the Web site at www.hcahpsonline.org for a schedule of upcoming dry runs. The dry run will give newly participating hospitals the opportunity to gain first-hand experience collecting and transmitting HCAHPS data without the public reporting of results. Using the official survey instrument and the approved modes of administration and data collection protocols, hospitals/survey vendors will collect HCAHPS data and submit the data to QualityNet.

12. Electronic Medical Records

In the FY 2006 IPPS final rule, we encouraged hospitals to take steps toward the adoption of electronic medical records (EMRs) that will allow for reporting of clinical quality data from the EMRs directly to a CMS data repository (70 FR 47420). We intend to begin working toward creating measures' specifications, and a system or mechanism, or both, that will accept the data directly without requiring the transfer of the raw data into an XML file as is currently done. The Department continues to work cooperatively with other Federal agencies in the establishment of Federal Health Architecture (FHA) data standards. We encouraged hospitals that are developing systems to conform them to industry standards, and in particular to FHA data standards, once identified, taking measures to ensure that the data necessary for quality measures are captured. Ideally, such systems will also provide point-of-care decision support that enables detection of high levels of performance on the measures. Hospitals using EMRs to produce data on quality measures will be held to the same performance expectations as hospitals not using EMRs.

Due to the low volume of comments we received on this issue in response to the FY 2006 proposed IPPS rule, in the FY 2007 IPPS proposed (71 FR 24095), we again invited public comment on these requirements and related options. In the FY 2007 IPPS final rule (71 FR 48045), we summarized and addressed the additional comments we received. In the FY 2008 IPPS proposed rule (72 FR 24809), we noted that we would welcome additional comments on this issue.

In the FY 2008 IPPS final rule with comment period (72 FR 47366), we responded to the additional comments we received and noted that CMS plans to continue working with the American Health Information Community (AHIC) and other entities to explore processes through which an EMR could speed the collection and minimize the resources necessary for quality reporting. (The AHIC is a Federal advisory body, chartered in 2005 to make recommendations to the Secretary on how to accelerate the development and adoption of health information technology.) In addition, we noted that we will continue to participate in appropriate HHS studies and workgroups, as mentioned by a GAO report (GAO-07-320) about hospital quality data and their use of information technology. As appropriate, CMS will inform interested parties regarding progress in the implementation of HIT for the collection and submission of hospital quality data as specific steps, including timeframes and milestones, are identified. Current mechanisms include publication in the Federal Register as well as ongoing collaboration with external stakeholders such as the HQA, the AHA, the FAH, the AAMC, and the Joint Commission. We further anticipate that as HIT is implemented, a formal plan, including training, will be developed to assist providers in understanding and utilizing HIT in reporting quality data. In addition, we will assess the effectiveness of our communications with providers and stakeholders as it relates to all information dissemination pertinent to collecting hospital quality data as part of an independent and comprehensive external evaluation of the RHQDAPU program.

We are again soliciting comments on the issues and challenges associated with EMRs. Specifically, we invite comment on our proposed changes to our data submission requirements to be more aligned with currently implemented HIT systems, including data collection from registries and laboratory data.

We recognize the potential burden on hospitals of increased data reporting requirements for process measures that require chart abstraction. In FY 2007 IPPS rulemaking, we listed a variety of additional possible measures for future years. The measures included and emphasized additional outcomes measures. Additional measures were included for which the data sources are claims. For these, no additional data abstraction or submission would be required for reporting hospitals beyond the claims data. In proposing measures for FY 2010, we seek to emphasize outcome measures and to minimize any additional data collection burden. In addition, as provided in section 1886(b)(3)(B)(viii)(VI) and discussed in section IV.B.2.a. of this proposed rule, we are proposing to retire one measure where there is no meaningful difference among hospitals as a means of reducing data collection burden.

C. Medicare Hospital Value-Based Purchasing (VBP)

1. Medicare Hospital VBP Plan Report to Congress

Through section 5001(b) of the Deficit Reduction Act of 2005, Congress authorized the development of a plan to implement value-based purchasing (VBP) beginning FY 2009 for IPPS hospital services. By statute, the plan must address: (a) The ongoing development, selection, and modification process for measures of quality and efficiency in hospital inpatient settings; (b) reporting, collection, and validation of quality data; (c) the structure, size, and source of value-based payment adjustments; and (d) public disclosure of hospital performance data.

To develop the plan, CMS created a Hospital VBP Workgroup with members from various CMS components and the Office of the Assistant Secretary for Planning and Evaluation. The Workgroup completed an environmental scan of existing hospital VBP programs, an issue paper outlining the topics to be addressed in the plan, and an options paper presenting design alternatives for the plan.

CMS hosted two public Listening Sessions in early 2007 to solicit comments from interested parties on outstanding design questions associated with development of the plan. The perspectives expressed by stakeholders (including hospitals, consumers, and purchasers) during these sessions and in writing assisted the Workgroup in creating the Medicare Hospital VBP Plan Report to Congress. The Report was submitted to Congress on November 21, 2007.

The Medicare Hospital VBP Plan builds on the foundation of Medicare's current RHQDAPU program (discussed in section IV.B. of the preamble of this proposed rule), which, since FY 2005, has provided differential payments to hospitals that report their performance on a defined set of inpatient measures for public posting on the Hospital Compare Web site. If authorized by Congress, the VBP Plan would replace the current quality reporting program with a new program that would include both public reporting and financial incentives to drive improvements in clinical quality, patient-centeredness, and efficiency.

The proposed plan contains the following key components: (a) A performance assessment model that incorporates measures from different quality domains (that is, clinical process of care, patient experience of care, outcomes, among others) to calculate a hospital's total performance score; (b) options for translating this score into an incentive payment that would make a portion of the hospital's base DRG payment contingent on its total performance score; (c) criteria for selecting performance measures for the financial incentive and candidate measures for FY 2009 and beyond; (d) a phased approach for transitioning from the RHQDAPU program to the VBP plan; (e) proposed enhancements to the current data transmission and validation infrastructure to support VBP program requirements; (f) refinements to the Hospital Compare Web site to support expanded public reporting; and (g) an approach to monitoring VBP impacts.

The Medicare Hospital VBP Plan Report to Congress is available on the CMS Web site at: http://www.cms.hhs.gov/AcuteInpatientPPS/downloads/HospitalVBPPlanRTCFINALSUBMITTED2007.pdf.

2. Testing and Further Development of the Medicare Hospital VBP Plan

The Hospital VBP Workgroup has undertaken testing of the VBP Plan. This "dry run" or "simulation" of the Plan will use the most recent clinical process-of-care and HCAHPS measurement data available from the RHQDAPU program. New information generated by the VBP Plan testing will include: (a) Performance scores by domain; (b) total performance scores; and (c) financial impacts. Following a process similar to that used in developing the Plan, CMS will analyze this information by individual IPPS hospital, by segment of the hospital industry (that is, geographic location, size, teaching status, among others), and in aggregate for all IPPS hospitals.

The results of VBP Plan testing will be used to further develop the Plan. Priorities for Plan completion include addressing the small numbers issue (described on pages 74 and 75 of the Hospital VBP Plan Report to Congress) and developing a scoring methodology for the outcomes domain (pages 57-58 of the Hospital VBP Plan Report to Congress), which will become an additional aspect of the performance model. After completion, the Plan will be retested.

We are seeking public comments on how to take full advantage of the new information generated through this testing and further Plan development. For example: Should the testing and retesting results be publicly posted? If the testing results were to be posted, would the best location be the Hospital Compare Web site or the CMS Web site at: http://www.cms.hhs.gov ? In what format would public posting be most useful to potential audiences? At what level would the data be posted-individual hospital or some higher level? Which data elements from the testing results would be most useful to share?

D. Sole Community Hospitals (SCHs) and Medicare-Dependent, Small Rural Hospitals (MDHs): Volume Decrease Adjustment (§§ 412.92 and 412.108)

1. Background

Under the IPPS, special payment protections are provided to a sole community hospital (SCH). Section 1886(d)(5)(D)(iii) of the Act defines an SCH as a hospital that, by reason of factors such as isolated location, weather conditions, travel conditions, absence of other like hospitals (as determined by the Secretary), or historical designation by the Secretary as an essential access community hospital, is the sole source of inpatient hospital services reasonably available to Medicare beneficiaries. The regulations that set forth the criteria that a hospital must meet to be classified as an SCH are located in 42 CFR 412.92 of the regulations.

Under the IPPS, separate special payment protections also are provided to a Medicare-dependent, small rural hospital (MDH). Section 1886(d)(5)(G)(iv) of the Act defines an MDH as a hospital that is located in a rural area, has not more than 100 beds, is not an SCH, and has a high percentage of Medicare discharges (not less than 60 percent in its 1987 cost reporting year or in 2 of its most recent 3 audited and settled Medicare cost reporting years). The regulations that set forth the criteria that a hospital must meet to be classified as an MDH are located in 42 CFR 412.108.

Although SCHs and MDHs are paid under special payment methodologies, they are hospitals that are paid under section 1886(d) of the Act. Like all IPPS hospitals paid under section 1886(d) of the Act, SCHs and MDHs are paid for their discharges based on the DRG weights calculated under section 1886(d)(4) of the Act.

Effective with hospital cost reporting periods beginning on or after October 1, 2000, section 1886(d)(5)(D)(i) of the Act (as amended by section 6003(e) of Pub. L. 101-239) and section 1886(b)(3)(I) of the Act (as added by section 405 of Pub. L. 106-113 and further amended by section 213 of Pub. L. 106-554), provide that SCHs are paid based on whichever of the following rates yields the greatest aggregate payment to the hospital for the cost reporting period:

• The Federal rate applicable to the hospital;

• The updated hospital-specific rate based on FY 1982 costs per discharge;

• The updated hospital-specific rate based on FY 1987 costs per discharge; or

• The updated hospital-specific rate based on FY 1996 costs per discharge.

For purposes of payment to SCHs for which the FY 1996 hospital-specific rate yields the greatest aggregate payment, payments for discharges during FYs 2001, 2002, and 2003 were based on a blend of the FY 1996 hospital-specific rate and the greater of the Federal rate or the updated FY 1982 or FY 1987 hospital-specific rate. For discharges during FY 2004 and subsequent fiscal years, payments based on the FY 1996 hospital-specific rate are 100 percent of the updated FY 1996 hospital-specific rate.

Through and including FY 2006, under section 1886(d)(5)(G) of the Act, MDHs are paid based on the Federal rate or, if higher, the Federal rate plus 50 percent of the difference between the Federal rate and the updated hospital-specific rate based on FY 1982 or FY 1987 costs per discharge, whichever is higher. However, section 5003 of Pub. L. 109-171 (DRA) modified these rules for discharges occurring on or after October 1, 2006. Section 5003(c) changed the 50 percent adjustment to 75 percent. Section 5003(b) requires that an MDH use the 2002 cost reporting year as its base year (that is, the FY 2002 updated hospital-specific rate), if that use results in a higher payment. MDHs do not have the option to use their FY 1996 hospital-specific rate.

For each cost reporting period, the fiscal intermediary/MAC determines which of the payment options will yield the highest aggregate payment. Interim payments are automatically made at the highest rate using the best data available at the time the fiscal intermediary/MAC makes the determination. However, it may not be possible for the fiscal intermediary/MAC to determine in advance precisely which of the rates will yield the highest aggregate payment by year's end. In many instances, it is not possible to forecast the outlier payments, the amount of the DSH adjustment, or the IME adjustment, all of which are applicable only to payments based on the Federal rate and not to payments based on the hospital-specific rate. The fiscal intermediary/MAC makes a final adjustment at the close of the cost reporting period after it determines precisely which of the payment rates would yield the highest aggregate payment to the hospital.

If a hospital disagrees with the fiscal intermediary's or MAC's determination regarding the final amount of program payment to which it is entitled, it has the right to appeal the fiscal intermediary's or MAC's decision in accordance with the procedures set forth in 42 CFR Part 405, Subpart R, which concern provider payment determinations and appeals.

2. Volume Decrease Adjustment for SCHs and MDHs: Data Sources for Determining Core Staff Values

Section 1886(d)(5)(D)(ii) of the Act requires that the Secretary make a payment adjustment to an SCH that experiences a decrease of more than 5 percent in its total number of inpatient discharges from one cost reporting period to the next, if the circumstances leading to the decline in discharges were beyond the SCH's control. Section 1886(d)(5)(G)(iii) of the Act requires that the Secretary make a payment adjustment to an MDH that experiences a decrease of more than 5 percent in its total number of inpatient discharges from one cost reporting period to the next, if the circumstances leading to the decline in discharges were beyond the MDH's control. These adjustments were designed to compensate an SCH or MDH for the fixed costs it incurs in the year in which the reduction in discharges occurred, which it may be unable to reduce. Such costs include the maintenance of necessary core staff and services. Our records indicate that less than 10 SCHs/MDHs request and receive this payment adjustment each year.

We believe that not all staff costs can be considered fixed costs. Using a standardized formula specified by us, the SCH or MDH must demonstrate that it appropriately adjusted the number of staff in inpatient areas of the hospital based on the decrease in the number of inpatient days. This formula examines nursing staff in particular. If an SCH or MDH has an excess number of nursing staff, the cost of maintaining those staff members is deducted from the total adjustment. One exception to this policy is that no SCH or MDH may reduce its number of staff to a level below what is required by State or local law. In other words, an SCH or MDH will not be penalized for maintaining a level of staff that is consistent with State or local requirements.

The process for determining the amount of the volume decrease adjustment can be found in Section 2810.1 of the Provider Reimbursement Manual, Part 1 (PRM-1). Fiscal intermediaries/MACs are responsible for establishing whether an SCH or MDH is eligible for a volume decrease adjustment and, if so, the amount of the adjustment. To qualify for this adjustment, the SCH or MDH must demonstrate that: (a) a decrease of more than 5 percent in total number of inpatient discharges has occurred; and (b) the circumstance that caused the decrease in discharges was beyond the control of the hospital. Once the fiscal intermediary/MAC has established that the SCH or MDH satisfies these two requirements, it will calculate the adjustment. The adjustment amount is determined by subtracting the second year's DRG payment from the lesser of: (a) the second year's costs minus any adjustment for excess staff; or (b) the previous year's costs multiplied by the appropriate IPPS update factor minus any adjustment for excess staff. The SCH or MDH receives the difference in a lump-sum payment.

In order to determine whether or not the hospital's nurse staffing level is appropriate, the fiscal intermediary/MAC compares the hospital's actual number of nursing staff in each area with the staffing of like-size hospitals in the same census region. If a hospital employs more than the reported average number of nurses for hospitals of its size and census region, the fiscal intermediary/MAC reduces the amount of the adjustment by the cost of maintaining the additional staff. The amount of the reduction is calculated by multiplying the actual number of nursing staff above the reported average by the average nurse salary for that hospital as reported on the Medicare cost report. The complete process for determining the amount of the adjustment can be found at Section 2810.1 of the PRM-1.

Prior to FY 2007, our policy was for fiscal intermediaries/MACs to obtain average nurse staffing data from the AHA HAS/Monitrend Data Book. However, in light of concerns that the Data Book had been published in 1989 and is no longer updated, in the FY 2007 IPPS rule, we proposed and finalized our policy to update the data sources and methodology used to determine the core staffing factors (that is, the average nursing staff for similar bed size and census region) for purposes of calculating the volume decrease adjustment (71 FR 48056 through 48060). We specified that for adjustment requests for decreases in discharges beginning with FY 2007 (that is, a decrease in discharges in 2007 as compared to 2006), an SCH or MDH could opt to use one of two data sources: the AHA Annual Survey or the Occupational Mix Survey, but could not use the HAS/Monitrend Data Book. (For any open adjustment requests prior to FY 2007, we allowed SCHs and MDHs the option of using the results of any of three sources: (1) The 2006 Occupational Mix Survey for cost reporting periods beginning in FY 2006; (2) the AHA Annual Survey (where available); or (3) the AHA HAS/Monitrend Data Book. We also specified a methodology for calculating those core staffing factors. For purposes of explaining the methodology, we applied it to the 2003 Occupational Mix Survey data. In our explanation, we recognized that some of the 2003 data seemed anomalous, and we solicited comments on a possible alternative methodology. However, there were no suggested alternative methodologies from the commenters. We also explained that, while we used the 2003 Occupational Mix Survey data "for purposes of describing how we would implement this methodology," the final policy was to use FY 2006 Occupational Mix Survey data going forward. At the time we published the proposed and final rules, however, we had not yet processed the FY 2006 data, and could not present the core staffing figures that resulted from such data.

We have now processed the 2006 Occupational Mix Survey data using the methodology specified in the FY 2007 IPPS final rule and continue to see some results that cause us to believe that the methodology for calculating the core staffing factors should be slightly revised from the methodology discussed in the FY 2007 IPPS final rule (71 FR 48056 through 48060). The new methodology uses a revised formula to remove outliers from the core staffing values.

a. Occupational Mix Survey

In the FY 2007 IPPS final rule (71 FR 48055), we explained the methodology we would use for calculating core staffing values from the Occupational Mix Survey. We stated that we would calculate the nursing hours per patient day for each SCH or MDH by dividing the number of paid nursing hours (for registered nurses, licensed practical nurses and nursing aides) reported on the Occupational Mix Survey by the number of patients days reported on the Medicare cost report. The results would be grouped in the same bed-size groups and census regions as were used in the HAS/Monitrend Data Book.

We indicated that we would publish the mean number of nursing hours per patient day, for each census region and bed-size group, in the Federal Register and on the CMS Web site. For purposes of the volume decrease adjustment, the published data would be utilized in the same way as the HAS/Monitrend data: The fiscal intermediary/MAC would multiply the SCH's and MDH's number of patient days by the applicable published hours per patient day. This figure would be divided by the average number of worked hours per year per nurse (for example, 2,080 for a standard 40-hour week). The result would be the target number of core nursing staff for the particular SCH or MDH. If necessary, the cost of any excess staff (number of FTEs that exceed the published number) would be removed from the second year's costs or, if applicable, the previous year's costs multiplied by the IPPS update factor when determining the volume decrease adjustment.

In the FY 2007 IPPS final rule (71 FY 48057), we stated that we would use the results of the FY 2006 Occupational Mix Survey and begin applying the methodology for adjustments resulting from a decrease in discharges in FY 2007. Because the occupational mix survey is conducted once every 3 years, we would update the data set every 3 years. However, at the time of the FY 2007 IPPS final rule, the FY 2006 Occupational Mix Survey data were not available. In that final rule, we described our methodology using the FY 2003 occupational mix data and the FY 2003 Medicare cost report file. However, these data were used only in order to present an example of how our methodology would work. Our final policy was to use FY 2006 occupational mix and cost report data when actually processing adjustment requests.

In the FY 2007 IPPS final rule, to illustrate how we would calculate the average number of nursing hours per patient day by bed size and region, we first merged the FY 2003 Occupational Mix Survey data with the FY 2003 Medicare cost report file. We eliminated all observations for non-IPPS providers, providers who failed to complete the occupational mix survey and the providers for which provider numbers, bed counts, and/or days counts were missing.

For each provider in the pool, we calculated the number of nursing hours by adding the number of registered nurses, licensed practical nurses, and nursing aide hours reported on the Occupational Mix Survey. We divided the result of this calculation by the total number of inpatient days reported on the cost report to determine the number of nursing hours per patient day. For purposes of calculating the census regional averages for the various bed-size groups, we finalized our rule to only include observations that fell within three standard deviations of the mean of all observations, thus removing potential outliers in the data.

When the FY 2006 Occupational Mix Survey data became available, our analysis of the results indicated that the methodology for computing core staffing factors should be further revised in order to further eliminate outlier data.

After consulting with the Office of the Actuary on appropriate statistical methods to remove outlier data, we are proposing to modify our methodology for calculating the average nursing hours per patient day using the FY 2006 Occupational Mix Survey data and FY 2006 Medicare cost report data. Similar to what was finalized in the FY 2007 IPPS rule, we are proposing to merge the FY 2006 Occupational Mix Survey data with the FY 2006 Medicare cost report file. We would then eliminate all observations for non-IPPS providers, providers who failed to complete the occupational mix survey and the providers for which provider numbers, bed counts and/or days counts were missing. We would annualize the results so that the nursing hours from the Occupational Mix Survey and the patient days reported on the Medicare cost report is representative of one year.

For each provider in the pool, we would calculate the number of nursing hours by adding the number of registered nurses, licensed practical nurses, and nursing aide hours reported on the Occupational Mix Survey. We would divide the result of this calculation by the total number of patient days reported on line 12 on Worksheet S-3, Part I, Column 6 of the Medicare cost report. This includes patient days in the general acute care area and the intensive care unit area. The result is the number of nursing hours per patient day.

For purposes of calculating the census regional averages for the various bed-size groups, we are proposing a different method to remove outliers in the data. First, we would calculate the difference between the observations in the 75th percentile and the 25th percentile, which is the inter-quartile range. We would remove observations that are greater than the 75th percentile plus 1.5 times the inter-quartile range and less than the 25th percentile minus 1.5 times the inter-quartile range. This methodology, known as the Tukey method, is a common statistical method used by the Office of the Actuary. Under the standard deviation method described in the FY 2007 IPPS final rule, the mean and standard deviation can be influenced by extreme values (because the standard deviation is increased by the very observations that would otherwise be discarded from the analysis). Our proposed methodology is a more robust technique because it uses the quartile values instead of variance to describe the spread of the data, and quartiles are less influenced by extreme outlier values that may be present in the data.

Our proposed method would prevent the mean from being influenced by extreme observations and assumes that the middle 50 percent of the data has no outlier observations. The application of this methodology would result in a pool of approximately 2,578 providers. Each census region and bed group category required at least three providers in order for their average to be published. The results of the average nursing hours per patient day by bed size and region using the FY 2006 Occupational Mix Survey Data and the FY 2006 hospital cost report data are shown in the table below. As stated in the FY 2007 IPPS final rule (71 FR 48059), the results of the FY 2006 Occupational Mix Survey may be used for the volume decrease adjustment calculations for decreases in discharges beginning with cost reporting periods beginning in FYs 2006, 2007, and 2008.

Number of beds Census Region New England Middle Atlantic South Atlantic East North Central East South Central West North Central West South Central Mountain Pacific
(1) (2) (3) (4) (5) (6) (7) (8) (9)
0-49 25.47 20.60 21.08 24.52 20.27 25.92 22.16 24.52 20.99
50-99 20.99 18.51 20.36 23.44 19.00 22.44 20.44 22.54 18.89
100-199 18.12 16.31 17.31 18.87 17.43 19.50 17.01 18.70 16.25
200-399 16.92 13.80 16.23 17.79 16.06 18.66 14.56 16.82 16.63
400+ 17.52 14.43 16.68 18.41 14.14 16.90 16.25 15.50 18.15

b. AHA Annual Survey

In the FY 2007 IPPS final rule (71 FR 48058), we also allowed SCHs or MDHs that experienced a greater than 5 percent reduction in the number of discharges in a cost reporting period the option of using the AHA Annual Survey results, where available, to compare the number of hospital's core staff with other like-sized hospitals in its geographic area. Our methodology for calculating the nursing hours per patient day using the AHA Annual Survey data and the Medicare hospital cost report was similar to the methodology using the Occupational Mix Survey data (eliminating outliers outside of three standard deviations from the mean). For this reason, as with the occupational mix data, both standard deviations and the mean could be influenced by extreme values. Therefore, we are proposing to refine our methodology to calculate the core staffing factors using the AHA Annual Survey data as well. The AHA Annual Survey contains FTE counts for registered nurses, practical and vocational nurses, nursing assistive personnel, and other personnel in both inpatient and outpatient areas of the hospital. This is consistent with the Occupational Mix Survey which collects data on both the inpatient and outpatient areas of the hospital.

In the FY 2007 IPPS final rule, we stated we would calculate the nursing hours per patient day using the AHA Annual Survey data in a similar method to the Occupational Mix Survey. Consistent with the HAS/Monitrend Data book, we would only calculate the average number of nursing staff for a bed-size/census group if there are data available for three or more hospitals. First, we would merge the AHA Annual Survey Data with the corresponding Medicare cost report. We would eliminate all observations for non-IPPS providers, providers with hospital-based SNFs, and the providers for which provider numbers, bed counts, and/or days counts were missing. We would multiply the number of nurse, licensed practical nurse, and nursing aide FTEs reported on the AHA Annual Survey by 2,080 hours to derive the number of nursing hours per year (based on a 40-hour work week). We would then divide this number by the total number of patient days reported on line 12 on Worksheet S-3, Part I, Column 6 of the Medicare cost report. In the FY 2007 IPPS final rule (71 FR 48060), we had stated that we would eliminate all providers with results beyond three standard deviations from the mean. However, to be consistent with our methodology with the Occupational Mix Survey data, we are also proposing that we would remove outliers from the AHA Annual Survey data by calculating the difference between the observations in the 75th percentile and the 25th percentile, which is the inter-quartile range. Then, we are proposing to remove observations that are greater than the 75th percentile plus 1.5 times the inter-quartile range and less than the 25th percentile minus 1.5 times the inter-quartile range. After removing the outliers, we would group the hospitals by bed size and census area to calculate the average number of nursing hours per patient day for each category. Using the 2006 AHA Annual Survey data as an example, this would result in a pool of approximately 1,205 providers. The results of the nursing hours per patient day using the 2006 AHA Annual Survey data and the Medicare cost report data are shown below. The 2006 Survey would be used for the volume decrease adjustment calculations for decreases in discharges occurring during cost reporting periods beginning in FY 2006. As we stated in the FY 2007 IPPS final rule, for other years, the corresponding AHA Annual Survey would be used for the year in which the decreased occurred. For example, if a hospital experienced a decrease between its 2004 and 2005 cost reporting periods, the fiscal intermediary/MAC would compare the hospital's 2005 staffing with the results of the 2005 AHA Annual Survey, using the methodology discussed above.

Number of beds Census Region New England Middle Atlantic South Atlantic East North Central East South Central West North Central West South Central Mountain Pacific
(1) (2) (3) (4) (5) (6) (7) (8) (9)
0-49 25.82 23.48 21.77 26.12 17.25 24.75 23.66 25.44 24.50
50-99 23.42 19.40 20.69 23.47 22.06 23.28 20.55 19.28 19.91
100-199 18.89 17.46 18.43 20.08 19.64 20.23 19.02 18.80 18.71
200-399 18.89 14.96 15.75 17.02 15.07 19.81 15.85 18.17 18.01
400+ 18.98 16.66 17.39 21.59 16.47 17.71 15.06 17.76 21.11

E. Rural Referral Centers (RRCs) (§ 412.96)

Under the authority of section 1886(d)(5)(C)(i) of the Act, the regulations at § 412.96 set forth the criteria that a hospital must meet in order to qualify under the IPPS as an RRC. For discharges occurring before October 1, 1994, RRCs received the benefit of payment based on the other urban standardized amount rather than the rural standardized amount. Although the other urban and rural standardized amounts are the same for discharges occurring on or after October 1, 1994, RRCs continue to receive special treatment under both the DSH payment adjustment and the criteria for geographic reclassification.

Section 402 of Pub. L. 108-173 raised the DSH adjustment for other rural hospitals with less than 500 beds and RRCs. Other rural hospitals with less than 500 beds are subject to a 12-percent cap on DSH payments. RRCs are not subject to the 12-percent cap on DSH payments that is applicable to other rural hospitals (with the exception of rural hospitals with 500 or more beds). RRCs are not subject to the proximity criteria when applying for geographic reclassification, and they do not have to meet the requirement that a hospital's average hourly wage must exceed the average hourly wage of the labor market area where the hospital is located by a certain percentage (106/108 percent in FY 2008).

Section 4202(b) of Pub. L. 105-33 states, in part, "[a]ny hospital classified as an RRC by the Secretary * * * for fiscal year 1991 shall be classified as such an RRC for fiscal year 1998 and each subsequent year." In the August 29, 1997 final rule with comment period (62 FR 45999), we reinstated RRC status for all hospitals that lost the status due to triennial review or MGCRB reclassification, but did not reinstate the status of hospitals that lost RRC status because they were now urban for all purposes because of the OMB designation of their geographic area as urban. However, subsequently, in the August 1, 2000 final rule (65 FR 47089), we indicated that we were revisiting that decision. Specifically, we stated that we would permit hospitals that previously qualified as an RRC and lost their status due to OMB redesignation of the county in which they are located from rural to urban to be reinstated as an RRC. Otherwise, a hospital seeking RRC status must satisfy the applicable criteria. We used the definitions of "urban" and "rural" specified in Subpart D of 42 CFR Part 412.

One of the criteria under which a hospital may qualify as a RRC is to have 275 or more beds available for use (§ 412.96(b)(1)(ii)). A rural hospital that does not meet the bed size requirement can qualify as an RRC if the hospital meets two mandatory prerequisites (a minimum CMI and a minimum number of discharges), and at least one of three optional criteria (relating to specialty composition of medical staff, source of inpatients, or referral volume) (§ 412.96(c)(1) through (c)(5) and the September 30, 1988 Federal Register (53 FR 38513)). With respect to the two mandatory prerequisites, a hospital may be classified as an RRC if-

• The hospital's CMI is at least equal to the lower of the median CMI for urban hospitals in its census region, excluding hospitals with approved teaching programs, or the median CMI for all urban hospitals nationally; and

• The hospital's number of discharges is at least 5,000 per year, or, if fewer, the median number of discharges for urban hospitals in the census region in which the hospital is located. (The number of discharges criterion for an osteopathic hospital is at least 3,000 discharges per year, as specified in section 1886(d)(5)(C)(i) of the Act.)

1. Case-Mix Index

Section 412.96(c)(1) provides that CMS establish updated national and regional CMI values in each year's annual notice of prospective payment rates for purposes of determining RRC status. The methodology we used to determine the national and regional CMI values is set forth in the regulations at § 412.96(c)(1)(ii). The proposed national median CMI value for FY 2009 includes all urban hospitals nationwide, and the proposed regional values for FY 2009 are the median CMI values of urban hospitals within each census region, excluding those hospitals with approved teaching programs (that is, those hospitals that train residents in an approved GME program as provided in § 413.75). These values are based on discharges occurring during FY 2007 (October 1, 2006 through September 30, 2007), and include bills posted to CMS' records through December 2007.

We are proposing that, in addition to meeting other criteria, if rural hospitals with fewer than 275 beds are to qualify for initial RRC status for cost reporting periods beginning on or after October 1, 2008, they must have a CMI value for FY 2007 that is at least-

• 1.4285; or

• The median CMI value (nottransfer-adjusted) for urban hospitals (excluding hospitals with approved teaching programs as identified in § 413.75) calculated by CMS for the census region in which the hospital is located.

The proposed median CMI values by region are set forth in the following table:

Region Case-mix index value
1. New England (CT, ME, MA, NH, RI, VT) 1.2515
2. Middle Atlantic (PA, NJ, NY) 1.2691
3. South Atlantic (DE, DC, FL, GA, MD, NC, SC, VA, WV) 1.3589
4. East North Central (IL, IN, MI, OH, WI) 1.3572
5. East South Central (AL, KY, MS, TN) 1.3040
6. West North Central (IA, KS, MN, MO, NE, ND, SD) 1.3557
7. West South Central (AR, LA, OK, TX) 1.4405
8. Mountain (AZ, CO, ID, MT, NV, NM, UT, WY) 1.4692
9. Pacific (AK, CA, HI, OR, WA) 1.3872

The preceding numbers will be revised in the FY 2009 IPPS final rule to the extent required to reflect the updated FY 2007 MEDPAR file, which will contain data from additional bills received through March 2008.

Hospitals seeking to qualify as RRCs or those wishing to know how their CMI value compares to the criteria should obtain hospital-specific CMI values (not transfer-adjusted) from their fiscal intermediaries. Data are available on the Provider Statistical and Reimbursement (PSR) System. In keeping with our policy on discharges, these CMI values are computed based on all Medicare patient discharges subject to the IPPS DRG-based payment.

2. Discharges

Section 412.96(c)(2)(i) provides that CMS set forth the national and regional numbers of discharges in each year's annual notice of prospective payment rates for purposes of determining RRC status. As specified in section 1886(d)(5)(C)(ii) of the Act, the national standard is set at 5,000 discharges. We are proposing to update the regional standards based on discharges for urban hospitals' cost reporting periods that began during FY 2006 (that is, October 1, 2005 through September 30, 2006), which is the latest cost report data available at the time this proposed rule was developed.

Therefore, we are proposing that, in addition to meeting other criteria, a hospital, if it is to qualify for initial RRC status for cost reporting periods beginning on or after October 1, 2008, must have as the number of discharges for its cost reporting period that began during FY 2006 a figure that is at least-

• 5,000 (3,000 for an osteopathic hospital); or

• The median number of discharges for urban hospitals in the census region in which the hospital is located, as indicated in the following table.

Region Number of discharges
1. New England (CT, ME, MA, NH, RI, VT) 8,158
2. Middle Atlantic (PA, NJ, NY) 10,443
3. South Atlantic (DE, DC, FL, GA, MD, NC, SC, VA, WV) 10,344
4. East North Central (IL, IN, MI, OH, WI) 8,900
5. East South Central (AL, KY, MS, TN) 7,401
6. West North Central (IA, KS, MN, MO, NE, ND, SD) 7,988
7. West South Central (AR, LA, OK, TX) 5,816
8. Mountain (AZ, CO, ID, MT, NV, NM, UT, WY) 9,919
9. Pacific (AK, CA, HI, OR, WA) 8,600

These numbers will be revised in the FY 2009 IPPS final rule based on the latest available cost reports.

We note that the median number of discharges for hospitals in each census region is greater than the national standard of 5,000 discharges. Therefore, 5,000 discharges is the minimum criterion for all hospitals.

We reiterate that, if an osteopathic hospital is to qualify for RRC status for cost reporting periods beginning on or after October 1, 2008, the hospital would be required to have at least 3,000 discharges for its cost reporting period that began during FY 2005.

F. Indirect Medical Education (IME) Adjustment (§ 412.105)

1. Background

Section 1886(d)(5)(B) of the Act provides for an additional payment amount under the IPPS for hospitals that have residents in an approved graduate medical education (GME) program in order to reflect the higher indirect patient care costs of teaching hospitals relative to nonteaching hospitals. The regulations regarding the calculation of this additional payment, known as the indirect medical education (IME) adjustment, are located at § 412.105.

The Balanced Budget Act of 1997 (Pub. L. 105-33) established a limit on the number of allopathic and osteopathic residents that a hospital may include in its full-time equivalent (FTE) resident count for direct GME and IME payment purposes. Under section 1886(h)(4)(F) of the Act, for cost reporting periods beginning on or after October 1, 1997, a hospital's unweighted FTE count of residents for purposes of direct GME may not exceed the hospital's unweighted FTE count for its most recent cost reporting period ending on or before December 31, 1996. Under section 1886(d)(5)(B)(v) of the Act, a similar limit on the FTE resident count for IME purposes is effective for discharges occurring on or after October 1, 1997.

2. IME Adjustment Factor for FY 2009

The IME adjustment to the MS-DRG payment is based in part on the applicable IME adjustment factor. The IME adjustment factor is calculated by using a hospital's ratio of residents to beds, which is represented as r , and a formula multiplier, which is represented as c , in the following equation: c x [{1 + r } .405 - 1]. The formula is traditionally described in terms of a certain percentage increase in payment for every 10-percent increase in the resident-to-bed ratio.

Section 502(a) of Pub. L. 108-173 modified the formula multiplier (c) to be used in the calculation of the IME adjustment. Prior to the enactment of Pub. L. 108-173, the formula multiplier was fixed at 1.35 for discharges occurring during FY 2003 and thereafter. In the FY 2005 IPPS final rule, we announced the schedule of formula multipliers to be used in the calculation of the IME adjustment and incorporated the schedule in our regulations at § 412.105(d)(3)(viii) through (d)(3)(xii). Section 502(a) modifies the formula multiplier beginning midway through FY 2004 and provides for a new schedule of formula multipliers for FYs 2005 and thereafter as follows:

• For discharges occurring on or after April 1, 2004, and before October 1, 2004, the formula multiplier is 1.47.

• For discharges occurring during FY 2005, the formula multiplier is 1.42.

• For discharges occurring during FY 2006, the formula multiplier is 1.37.

• For discharges occurring during FY 2007, the formula multiplier is 1.32.

• For discharges occurring during FY 2008 and fiscal years thereafter, the formula multiplier is 1.35.

Accordingly, for discharges occurring during FY 2009, the formula multiplier would be 1.35. We estimate that application of this formula multiplier for FY 2009 IME adjustment will result in an increase in IME payment of 5.5 percent for every approximately 10-percent increase in the hospital's resident-to-bed ratio.

G. Medicare GME Affiliation Provisions for Teaching Hospitals in Certain Emergency Situations; Technical Correction (§ 413.79(f)(6)(iv))

1. Background

Under section 1886(h) of the Act, as amended by section 9202 of the Consolidated Omnibus Budget Reconciliation Act (COBRA) of 1985 (Pub. L. 99-272), the Secretary is authorized to make payments to hospitals for the direct costs of approved GME programs. Section 1886(d)(5)(B) of the Act provides that prospective payment acute care hospitals that have residents in an approved GME program receive an additional payment for a Medicare discharge to reflect the higher patient care costs of teaching hospitals, that is, IME costs. Sections 1886(h)(4)(F) and 1886(d)(5)(B)(v) of the Act establish limits on the number of allopathic and osteopathic residents that hospitals may count for purposes of calculating direct GME payments and the IME adjustment, respectively, establishing hospital-specific direct GME and IME FTE resident caps. Under the authority granted by section 1886(h)(4)(H)(ii) of the Act, the Secretary issued rules to allow institutions that are members of the same affiliated group to apply their direct GME and IME FTE resident caps on an aggregate basis through a Medicare GME affiliation agreement. The Medicare regulations at §§ 413.75 and 413.76 permit hospitals, through a Medicare GME affiliation agreement, to adjust IME and direct GME FTE resident caps to reflect the rotation of residents among affiliated hospitals.

In response to circumstances in the aftermath of Hurricanes Katrina and Rita, we supplemented regulations in the April 12, 2006 interim final rule with comment period published in the Federal Register (71 FR 18654). The regulatory changes allowed certain hospitals to engage in emergency Medicare GME affiliations so that Medicare funding for GME is maintained while there are displaced residents training at various host hospitals even as the hurricane-affected hospitals are rebuilding their training programs. The modifications to the regulations at § 413.75(b) and § 413.76(f) provided flexibility for home hospitals whose residency programs have been disrupted due to an emergency to enter into emergency Medicare GME affiliation agreements with host hospitals where the hospitals may not otherwise meet the regulatory requirements to form Medicare GME affiliations. (We note that on November 27, 2007, we issued a second interim final rule with comment period providing further flexibility relating to emergency Medicare GME affiliation agreements (72 FR 66893 through 66898). We expect to address the public comments received on both interim final rules with comment period and finalize our policies in the FY 2009 IPPS final rule scheduled to be published in August 2008.)

2. Technical Correction

In the April 12, 2006 interim final rule, we revised § 413.79(f) by adding a new paragraph (6) to provide for more flexibility in Medicare GME affiliations for home hospitals located in section 1135 emergency areas to allow the home hospitals to efficiently find training sites for displaced residents. We have discovered that, under § 413.79(f)(6)(iv), in our provisions on the host hospital exception from the rolling average for the period from August 29, 2005 to June 30, 2006, we included an incorrect cross-reference to the rolling average requirements for direct GME as "§ 413.75(d)." The correct citation to the rolling average requirements for direct GME is § 413.79(d). We are proposing to correct the cross-reference under § 413.79(f)(6)(iv) to read "paragraph (d) of this section".

H. Payments to Medicare Advantage Organizations: Collection of Risk Adjustment Data (§ 422.310)

Section 1853 of the Act requires CMS to make advance monthly payments to a Medicare Advantage (MA) organization for each beneficiary enrolled in an MA plan offered by the organization for coverage of Medicare Part A and Part B benefits. Section 1853(a)(1)(C) of the Act requires CMS to adjust the monthly payment amount for each enrollee to take into account the health status of the MA plan's enrollees. Under the CMS-Hierarchical Condition Category (HCC) risk adjustment payment methodology, CMS determines risk scores for MA enrollees for a year and adjusts the monthly payment amount using the appropriate enrollee risk score.

Under section 1853(a)(3)(B) of the Act, MA organizations are required to "submit data regarding inpatient hospital services . . . and data regarding other services and other information as the Secretary deems necessary" in order to implement a methodology for "risk adjusting" payments made to MA organizations. Risk adjustments to payments are made in order to take into account "variations in per capita costs based on [the] health status" of the Medicare beneficiaries enrolled in an MA plan offered by the organization. Submission of data on inpatient hospital services has been required with respect to services beginning on or after July 1, 1997. Submission of data on other services has been required since July 1, 1998.

While we initially required the submission of comprehensive data regarding services provided by MA organizations, including comprehensive inpatient hospital encounter data, we subsequently permitted MA organizations to submit an "abbreviated" set of data. Our regulations at 42 CFR 422.310(d)(1) currently explicitly provide MA organizations with the option of submitting an abbreviated data set. Under this provision, we currently collect limited risk adjustment data from MA organizations, primarily diagnosis data.

From calendar years 2000 through 2006, application of risk adjustment to MA payments was "phased in" with an increasing percentage of the monthly capitation payment subjected to risk adjustment. Beginning with calendar year 2007, 100 percent of payments to MA organizations are risk-adjusted. Given the increased importance of the accuracy of our risk adjustment methodology, we are proposing to amend § 422.310 to provide that CMS will collect data from MA organizations regarding each item and service provided to an MA plan enrollee. This will allow us to include utilization data and other factors that CMS can use in developing the CMS-HCC risk adjustment models in order to reflect patterns of diagnoses and expenditures in the MA program.

Specifically, we are proposing to revise § 422.310(a) to clarify that risk adjustment data are data used not only in the application of risk adjustment to MA payments, but also in the development of risk adjustment models. For example, once encounter data for MA enrollees are available, CMS would have beneficiary-specific information on the utilization of services by MA plan enrollees. These data could be used to calibrate the CMS-HCC risk adjustment models using MA patterns of diagnoses and expenditures.

We are proposing to revise §§ 422.310(b), (c), (d)(3), and (g) to clarify that the term "services" includes items and services.

We are proposing to revise § 422.310(d) to clarify that CMS has the authority to require MA organizations to submit encounter data for each item and service provided to an MA plan enrollee. The proposed revision also would clarify that CMS will determine the formats for submitting encounter data, which may be more abbreviated than those used for the fee-for-service claims data submission process.

We are proposing to revise § 422.310(f) to clarify that one of the "other" purposes for which CMS may use risk adjustment data collected under this section would be to update risk adjustment models with data from MA enrollees. In addition, when providing that CMS may use risk adjustment data for purposes other than adjusting payments as described at §§ 422.304(a) and (c), we are proposing to delete the phrase "except for medical records data" from paragraph (f). Any use of medical records data collected under paragraph (e) of § 422.310 is governed by the Privacy Act and the privacy provisions in the HIPAA. Furthermore, there may be occasions when we learn from analysis of medical record review data that some organizations have misunderstood our guidance on how to implement an operational instruction. We want to be able to provide improved guidance to MA organizations based on any insights that may emerge during analysis of the medical record review data.

In addition, we are proposing a technical correction to § 422.310(f) to clarify that risk adjustment data are used not only to adjust payments to plans described at §§ 422.301(a)(1), (a)(2), and (a)(3) (which refer to coordinated care plans and private fee-for-service plans), but also to adjust payments for ESRD enrollees and payments to MSA plans and Religious Fraternal Benefit society plans, as described at § 422.301(c).

Under § 422.310(g), we would continue to provide that data that CMS receives after the final deadline for a payment year will not be accepted for purposes of the reconciliation. However, we are proposing to revise paragraph (g)(2) of § 422.310 to change the deadline from "December 31" of the payment year to "January 31" of the year following the payment year. We are also proposing to add language to provide that CMS may adjust deadlines as appropriate.

I. Hospital Emergency Services under EMTALA (§ 489.24)

1. Background

Sections 1866(a)(1)(I), 1866(a)(1)(N), and 1867 of the Act impose specific obligations on certain Medicare-participating hospitals and CAHs. (Throughout this section of this proposed rule, when we reference the obligation of a "hospital" under these sections of the Act and in our regulations, we mean to include CAHs as well.) These obligations concern individuals who come to a hospital emergency department and request examination or treatment for a medical condition, and apply to all of these individuals, regardless of whether they are beneficiaries of any program under the Act.

The statutory provisions cited above are frequently referred to as the Emergency Medical Treatment and Labor Act (EMTALA), also known as the patient antidumping statute. EMTALA was passed in 1986 as part of the Consolidated Omnibus Budget Reconciliation Act of 1985 (COBRA), Pub. L. 99-272. Congress incorporated these antidumping provisions within the Social Security Act to ensure that individuals with emergency medical conditions are not denied essential lifesaving services. Under section 1866(a)(1)(I)(i) of the Act, a hospital that fails to fulfill its EMTALA obligations under these provisions may be subject to termination of its Medicare provider agreement, which would result in loss of all Medicare and Medicaid payments.

Section 1867 of the Act sets forth requirements for medical screening examinations for individuals who come to the hospital and request examination or treatment for a medical condition. The section further provides that if a hospital finds that such an individual has an emergency medical condition, it is obligated to provide that individual with either necessary stabilizing treatment or an appropriate transfer to another medical facility where stabilization can occur.

The EMTALA statute also outlines the obligation of hospitals to receive appropriate transfers from other hospitals. Section 1867(g) of the Act states that a participating hospital that has specialized capabilities or facilities (such as burn units, shock-trauma units, neonatal intensive care units, or, with respect to rural areas, regional referral centers as identified by the Secretary in regulation) shall not refuse to accept an appropriate transfer of an individual who requires these specialized capabilities or facilities if the hospital has the capacity to treat the individual. The regulations implementing section 1867 of the Act are found at 42 CFR 489.24. The regulations at 42 CFR 489.20(l), (m), (q), and (r) also refer to certain EMTALA requirements. The Interpretive Guidelines concerning EMTALA are found at Appendix V of the CMS State Operations Manual.

2. EMTALA Technical Advisory Group (TAG) Recommendations

Section 945 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), Pub. L. 108-173, required the Secretary to establish a Technical Advisory Group (TAG) to advise the Secretary on issues related to the regulations and implementation of EMTALA. The MMA specified that the EMTALA TAG be composed of 19 members, including the Administrator of CMS, the Inspector General of HHS, hospital representatives and physicians representing specific specialties, patient representatives, and representatives of organizations involved in EMTALA enforcement.

The EMTALA TAG's functions, as identified in the charter for the EMTALA TAG, were as follows: (1) Review EMTALA regulations; (2) provide advice and recommendations to the Secretary concerning these regulations and their application to hospitals and physicians; (3) solicit comments and recommendations from hospitals, physicians, and the public regarding the implementation of such regulations; and (4) disseminate information concerning the application of these regulations to hospitals, physicians, and the public. The TAG met 7 times during its 30-month term, which ended on September 30, 2007. At its meetings, the TAG heard testimony from representatives of physician groups, hospital associations, and others regarding EMTALA issues and concerns. During each meeting, the three subcommittees established by the TAG (the On-Call Subcommittee, the Action Subcommittee, and the Framework Subcommittee) developed recommendations, which were then discussed and voted on by members of the TAG. In total, the TAG submitted 55 recommendations to the Secretary. If implemented, some of the recommendations would require regulatory changes. Of the 55 recommendations developed by the TAG, 5 have already been implemented by CMS. A complete list of TAG recommendations will be available shortly in the Emergency Medical Treatment and Labor Act Technical Advisory Group final report available at the Web site: http://www.cms.hhs.gov/FACA/07_emtalatag.asp. The following recommendations have already been implemented by CMS:

• That CMS revise, in the EMTALA regulations [42 CFR 489.24(b)], the following sentence contained in the definition of "labor": "A woman experiencing contractions is in true labor unless a physician certifies that, after a reasonable time of observation, the woman is in false labor."

This recommendation was adopted with modification in the FY 2007 IPPS final rule (71 FR 48143). We revised the definition of "labor" in the regulations at § 489.24(b) to permit a physician, certified nurse-midwife, or other qualified medical person, acting within his or her scope of practice in accordance with State law and hospital bylaws, to certify that a woman is experiencing false labor. We issued Survey and Certification Letter SC-06-32 on September 29, 2006, to clarify the regulation change. (The Survey and Certification Letter can be found at the following Web site: http://www.cms.hhs.gov/SurveyCertificationGenInfo/PMSR/list.asp ).

• That hospitals with specialized capabilities (as defined in the EMTALA regulations) that do not have a dedicated emergency department be bound by the same responsibilities under EMTALA as hospitals with specialized capabilities that do have a dedicated emergency department.

This recommendation was adopted in the FY 2007 IPPS final rule (71 FR 48143). We added language at § 489.24(f) that makes explicit the current policy that all Medicare-participating providers with specialized capabilities are required to accept an appropriate transfer if they have the capacity to treat the individual. We issued Survey and Certification Letter SC-06-32 on September 29, 2006, to clarify the regulation change. (The Survey and Certification Letter can be found at the following Web site: http://www.cms.hhs.gov/SurveyCertificationGenInfo/PMSR/list.asp ).

• That CMS clarify the intent of regulations regarding obligations under EMTALA to receive individuals who arrive by ambulance. Specifically, the TAG recommended that CMS revise a letter of guidance that had been issued by the agency to clarify its position on the practice of delaying the transfer of an individual from an emergency medical service provider's stretcher to a bed in a hospital's emergency department.

This recommendation was adopted with modification by CMS in Survey and Certification Letter SC-07-20, which was released on April 27, 2007. (The Survey and Certification Letter can be found at the following Web site: http://www.cms.hhs.gov/SurveyCertificationGenInfo/PMSR/list.asp).

• That CMS clarify that a hospital may not refuse to accept an individual appropriately transferred under EMTALA on the grounds that it (the receiving hospital) does not approve the method of transfer arranged by the attending physician at the sending hospital (for example, a receiving hospital may not require the sending hospital to use an ambulance transport designated by the receiving hospital). In addition, CMS should improve its communication of such clarifications with its regional offices.

This recommendation was adopted and implemented by CMS in Survey and Certification Letter SC-07-20, which was released on April 27, 2007. (The Survey and Certification Letter can be found at the following Web site: http://www.cms.hhs.gov/SurveyCertificationGenInfo/PMSR/list.asp ).

• That CMS strike the language in the Interpretive Guidelines (CMS State Operations Manual, Appendix V) that addresses telehealth/telemedicine (relating to the regulations at § 489.24(j)(1)) and replace it with language that clarifies that the treating physician ultimately determines whether an on-call physician should come to the emergency department and that the treating physician may use a variety of methods to communicate with the on-call physician. A potential violation occurs only if the treating physician requests that the on-call physician come to the emergency department and the on-call physician refuses.

This recommendation was adopted and implemented by CMS in Survey and Certification Letter SC-07-23, which was released on June 22, 2007. (The Survey and Certification Letter can be found at the following Web site: http://www.cms.hhs.gov/SurveyCertificationGenInfo/PMSR/list.asp).

We are considering the remaining recommendations of the EMTALA TAG and may address them through future changes to or clarifications of the existing regulations or the Interpretive Guidelines, or both.

At the end of its term, the EMTALA TAG compiled a final report to the Secretary. This report includes, among other materials, minutes from each TAG meeting as well as a comprehensive list of all of the TAG's recommendations. The final report will be available shortly at the following Web site: http://www.cms.hhs.gov/FACA/07_emtalatag.asp.

3. Proposed Changes Relating to Applicability of EMTALA Requirements to Hospital Inpatients

While many issues pertaining to EMTALA involve individuals presenting to a hospital's dedicated emergency department, questions have been raised regarding the applicability of the EMTALA requirements to inpatients. We have previously discussed the applicability of the EMTALA requirements to hospital inpatients in both the May 9, 2002 IPPS proposed rule (67 FR 31475) and the September 9, 2003 stand alone final rule on EMTALA (68 FR 53243). As we stated in both of the aforementioned rules, in 1999, the United States Supreme Court considered a case ( Roberts v. Galen of Virginia , 525 U.S. 249 (1999)) that involved, in part, the question of whether EMTALA applies to inpatients in a hospital. In the context of that case, the United States Solicitor General advised the Court that HHS would develop a regulation clarifying its position on that issue. In the 2003 final rule, CMS took the position that a hospital's obligation under EMTALA ends when that hospital, in good faith, admits an individual with an unstable emergency medical condition as an inpatient to that hospital. In that rule, CMS noted that other patient safeguards protected inpatients, including the CoPs as well as State malpractice law. However, in the 2003 final rule, CMS did not directly address the question of whether EMTALA's "specialized care" requirements (section 1867(g) of the Act) applied to inpatients.

As noted in section IV.I.2. of this preamble, the EMTALA TAG has developed a set of recommendations to the Secretary. One of those recommendations calls for CMS to revise its regulations to address the situation of an individual who: (1) Presents to a hospital that has a dedicated emergency department and is determined to have an unstabilized emergency medical condition; (2) is admitted to the hospital as an inpatient; and (3) the hospital subsequently determines that stabilizing the individual's emergency medical condition requires specialized care only available at another hospital.

We believe that the obligation of EMTALA does not end for all hospitals once an individual has been admitted as an inpatient to the hospital where the individual first presented with a medical condition that was determined to be an emergency medical condition. Rather, once the individual is admitted, admission only impacts on the EMTALA obligation of the hospital where the individual first presented. (Throughout this section of the preamble of this proposed rule, we will refer to the hospital where the individual first presented as the "admitting hospital.") Section 1867(g) of the Act states: "Nondiscrimination-A participating hospital that has specialized capabilities or facilities (such as burn units, shock-trauma units, neonatal intensive care units, or (with respect to rural areas) regional referral centers as identified by the Secretary in regulation) shall not refuse to accept an appropriate transfer of an individual who requires such specialized capabilities or facilities if the hospital has the capacity to treat the individual." Section 1867(g) of the Act therefore requires a receiving hospital with specialized capabilities to accept a request to transfer an individual with an unstable emergency medical condition as long as the hospital has the capacity to treat that individual, regardless of whether the individual had been an inpatient at the admitting hospital. Furthermore, in the September 9, 2003 final rule (68 FR 53263), we amended the regulations at § 489.24(d)(2)(i) to state: "If a hospital has screened an individual under paragraph (a) of this section and found the individual to have an emergency medical condition, and admits that individual in good faith in order to stabilize the emergency medical condition, the hospital has satisfied its special responsibilities under this section with respect to that individual" (emphasis added). We did not intend for the regulation to end the EMTALA obligation for any other hospital to which the individual may appropriately be transferred to stabilize his or her emergency medical condition. Permitting inpatient admission at the admitting hospital to end EMTALA obligations for another hospital to which an unstabilized individual is being appropriately transferred to receive specialized care would seemingly contradict the intent of section 1867(g) of the Act to ensure that hospitals with specialized capabilities provide medical treatment to individuals with emergency medical conditions to stabilize their conditions.

We also note that, as we discussed in the preamble of the September 9, 2003 stand alone final rule, once a hospital has admitted an individual as an inpatient, the individual is protected under the Medicare CoPs and may also have additional protections under State law. Accordingly, we believe it is consistent with the intent of EMTALA to limit its protections to individuals who need them most; for example, individuals who present to a hospital but may not have been formally admitted as patients and thus are not covered by other protections applicable to inpatients of the hospital. As noted above, once the individual is admitted, the CoPs apply to the admitting hospital's care of that individual. A hospital that fails to provide treatment to such individuals could face termination of its Medicare provider agreement for a violation of the CoPs. However, these CoPs do not, of course, apply to a hospital with specialized capabilities to which the individual might be transferred unless and until the individual is formally admitted as a patient at that hospital. Therefore, in order to ensure an individual the protections intended by the EMTALA statute, especially section 1867(g) of the Act (obligating a hospital with specialized capabilities to accept an appropriately transferred individual if it has the capacity to treat that individual), we believe it is appropriate to propose to clarify that section 1867(g) of the Act continues to apply so as to protect even an individual who has been admitted as an inpatient to the admitting hospital who has not been stable since becoming an inpatient. We believe that this proposed clarification is necessary to ensure that EMTALA protections are continued for individuals who are not otherwise protected by the hospital CoPs. (We note that this proposed clarification is consistent with the EMATLA TAG's recommendation that EMTALA does not apply when an individual is admitted to the hospital for an elective procedure and subsequently develops an emergency medical condition.)

We recognize that this proposed clarification that EMTALA applies to a hospital with specialized capabilities when an inpatient (who presented to the admitting hospital under EMTALA) is in need of specialized care to stabilize his or her emergency medical condition may raise concerns among the provider community that such a clarification in policy could hypothetically result in an increase in the number of transfers. However, the intention of this proposed clarification is not to encourage patient dumping to hospitals with specialized capabilities. Rather, even if the hospital with specialized capabilities has an EMTALA obligation to accept an individual who was an inpatient at the admitting hospital, the admitting hospital transferring the individual should take all steps necessary to ensure that it is providing needed treatment within its capabilities prior to transferring the individual. This means that an individual with an unstabilized emergency medical condition should be transferred only when the capabilities of the admitting hospital have been exceeded.

Accordingly, we are proposing to revise § 489.24(f) by adding to the existing text a provision that specifies that paragraph (f) also applies to an individual who has been admitted under paragraph (d)(2)(i) of the section and who has not been stabilized.

While we are not including the following in our proposed clarification, we are seeking public comments on whether the EMTALA obligation imposed on hospitals with specialized capabilities to accept appropriate transfers should apply to a hospital with specialized capabilities in the case of an individual who had a period of stability during his or her stay at the admitting hospital and is in need of specialized care available at the hospital with specialized capabilities. CMS takes seriously its duty to protect patients with emergency medical conditions as required by EMTALA. Thus, we are seeking public comments as to whether, with respect to the EMTALA obligation on the hospital with specialized capabilities, it should or should not matter if an individual who currently has an unstabilized emergency medical condition (which is beyond the capability of the admitting hospital) (1) remained unstable after coming to the hospital emergency department or (2) subsequently had a period of stability after coming to the hospital emergency department.

In summary, to implement the recommendation by the EMTALA TAG and clarify our policy regarding the applicability of EMTALA to hospital inpatients, we are proposing to amend § 489.24(f) to add a provision to state that when an individual covered by EMTALA was admitted as an inpatient and remains unstabilized with an emergency medical condition, a receiving hospital with specialized capabilities has an EMTALA obligation to accept that individual, assuming that the transfer of the individual is an appropriate transfer and the participating hospital with specialized capabilities has the capacity to treat the individual.

4. Proposed Changes to the EMTALA Physician On-Call Requirements

a. Relocation of Regulatory Provisions

During its term, the EMTALA TAG dedicated a significant portion of its discussion to a hospital's physician on-call obligations under EMTALA and made several recommendations to the Secretary regarding physician on-call requirements that are included in its final report (will be available shortly at the Web site: http://www.cms.hhs/gov/FACA/07_emtalatag.asp). The TAG recommended that CMS move the regulation discussing the obligation to maintain an on-call list from the EMTALA regulations at § 489.24(j)(1) to the regulations implementing provider agreements at § 489.20(r)(2). We agree with the TAG's recommendation. The requirement to maintain an on-call list is found at section 1866(a)(1)(I)(iii) of the Act, the section of the Act that refers to provider agreements. Section 1867 of the Act, which outlines the EMTALA requirements, makes no mention of the requirement to maintain an on-call list.

To implement the EMTALA TAG's recommendation, we are proposing to delete the provision relating to maintaining a list of on-call physicians from § 489.24(j)(1). We note that a provision for an on-call physician list is already included in the regulations as a hospital provider agreement requirement at § 489.20(r)(2). We are proposing to incorporate the language of § 489.24(j)(1) as replacement language for the existing § 489.20(r)(2) and amend the regulatory language to make it more consistent with the statutory language found at section 1866(a)(1)(I)(iii) of the Act. Proposed revised § 489.20(r)(2) would read: "An on-call list of physicians on its medical staff available to provide treatment necessary after the initial examination to stabilize individuals with emergency medical conditions who are receiving services required under § 489.24 in accordance with the resources available to the hospital; and". These proposed changes would make the regulations consistent with the statutory basis for maintaining an on-call list.

The EMTALA TAG made additional recommendations regarding how a hospital would satisfy its on-call list obligations, including calling for an annual plan by the hospital and medical staff for on-call coverage that would include an assessment of factors such as the hospital's capabilities and services, community need for emergency department services as indicated by emergency department visits, emergent transfers, physician resources, and past performance of previous on-call plans. The TAG also recommended that a hospital have a backup plan for viable patient care options when an on-call physician is not available, including such factors as telemedicine, other staff physicians, transfer agreements, and regional or community call arrangements. While community call arrangements are discussed below, we intend to address the remainder of the TAG recommendations at a later date.

b. Shared/Community Call

As noted in the previous section, section 1866(a)(1)(I)(iii) of the Act states, as a requirement for participation in the Medicare program, that a hospital must keep a list of physicians who are on call for duty after the initial examination to provide treatment necessary to stabilize an individual with an emergency medical condition. If a physician on the list is called by a hospital to provide stabilizing treatment and either fails or refuses to appear within a reasonable period of time, the hospital and that physician may be in violation of EMTALA as provided for under section 1867(d)(1)(C) of the Act. Thus, hospitals are required to maintain a list of on-call physicians, and physicians or hospitals, or both, may be held responsible under the EMTALA statute if a physician who is on call fails or refuses to appear within a reasonable period of time.

In the May 9, 2002 proposed rule (67 FR 31471), we stated that we were aware of hospitals' increasing concerns regarding their physician on-call requirements. Specifically, we noted that we were aware of reports of physicians, particularly specialty physicians, severing their relationships with hospitals because of on-call obligations, especially when those physicians belong to more than one hospital medical staff. We further noted that physician attrition from these medical staffs could result in hospitals having no specialty physician service coverage for their patients. In the September 9, 2003 final rule (68 FR 53264), we clarified the regulations at § 489.24(j) to permit on-call physicians to schedule elective surgery during the time that they are on call and to permit on-call physicians to have simultaneous on-call duties. We also specified that physicians, including specialists and subspecialists, are not required to be on call at all times, and that the hospital must have policies and procedures to be followed when a particular specialty is not available or the on-call physician cannot respond because of situations beyond his or her control. We expected these clarifications would help to improve access to physician services for all hospital patients by permitting hospitals flexibility to determine how best to maximize their available physician resources. Furthermore, we expected that these clarifications would permit hospitals to continue to attract physicians to serve on their medical staffs, thereby continuing to provide services to all patients, including those individuals who are covered by EMTALA.

As part of its recommendations concerning physician on-call requirements, the EMTALA TAG recommended that hospitals be permitted to participate in "community call." Specifically, the language of the recommendation states: "The TAG recommends that CMS clarify its position regarding shared or community call: that such community call arrangements are acceptable if the hospitals involved have formal agreements recognized in their policies and procedures, as well as backup plans. It should also be clarified that a community call arrangement does not remove a hospital's obligation to perform an MSE [medical screening examination]." The TAG also recommended in a subsequent recommendation that "A hospital may satisfy its on-call coverage obligation by participation in an approved community/regional call coverage program. (CMS to determine appropriate approval process)."

We believe that community call (as described below) would afford additional flexibility to hospitals providing on-call services and improve access to specialty physician services for individuals in an emergency department. Therefore, we are proposing to amend our regulations at § 489.24(j) to provide that hospitals may comply with the on-call list requirement specified at § 489.20(r)(2) (under our proposed revision), by participating in a formal community call plan so long as the plan meets the elements outlined below. We are further proposing to revise the regulations to state that, notwithstanding participation in a community call plan, hospitals are still required to perform medical screening examinations on individuals who present seeking treatment and to provide for an appropriate transfer when appropriate.

We propose "community call," to be a formal on-call plan that permits a specific hospital in a region to be designated as the on-call facility for a specific time period, or for a specific service, or both. For example, if there are two hospitals that choose to participate in community call, Hospital A could be designated as the on-call facility for the first 15 days of each month and Hospital B could be designated as the on-call facility for the rest of each month. Alternatively, Hospital A could be designated as on-call for cases requiring specialized interventional cardiac care, while Hospital B could be designated as on-call for neurosurgical cases. We anticipate that hospitals and their communities would have the flexibility to develop a plan that reflects their local resources and needs. Such a community on-call plan will allow various physicians in a certain specialty in the aggregate to be on continuous call (24 hours a day, 7 days a week), without putting a continuous call obligation on any one physician. We note that generally if an individual arrives at a hospital other than the designated on-call facility, is determined to have an unstabilized emergency medical condition, and requires the services of an on-call specialist, the individual would be transferred to the designated on-call facility in accordance with the community call plan.

As noted above, we are proposing that a community call plan must be a formal plan among the participating hospitals. While we do not believe it is necessary for the formal community call plan to be subject to preapproval by CMS, if an EMTALA complaint investigation is initiated, the plan will be subject to review and enforcement by CMS. We are proposing that, at a minimum, hospitals must include the following elements when devising a formal community call plan:

• The community call plan would include a clear delineation of on-call coverage responsibilities, that is, when each hospital participating in the plan is responsible for on-call coverage.

• The community call plan would define the specific geographic area to which the plan applies.

• The community call plan would be signed by an appropriate representative of each hospital participating in the plan.

• The community call plan would ensure that any local and regional EMS system protocol formally includes information on community on-call arrangements.

• Hospitals participating in the community call plan would engage in an analysis of the specialty on-call needs of the community for which the plan is effective.

• The community call plan would include a statement specifying that even if an individual arrives at the hospital that is not designated as the on-call hospital, that hospital still has an EMTALA obligation to provide a medical screening examination and stabilizing treatment within its capability, and hospitals participating in community call must abide by the EMTALA regulations governing appropriate transfers.

• There would be an annual reassessment of the community call plan by the participating hospitals.

Proposed revised § 489.24(j) would read "Availability of on-call physicians. In accordance with the on-call list requirements specified in § 489.20(r)(2), a hospital must have written policies and procedures in place-(1) To respond to situations in which a particular specialty is not available or the on-call physician cannot respond because of circumstances beyond the physician's control; and (2) To provide that emergency services are available to meet the needs of individuals with emergency medical conditions if a hospital elects to-(i) Permit on-call physicians to schedule elective surgery during the time that they are on call; (ii) Permit on-call physicians to have simultaneous on-call duties; and (iii) Participate in a formal community call plan. Notwithstanding participation in a community call plan, hospitals are still required to perform medical screening examinations on individuals who present seeking treatment and to conduct appropriate transfers. The formal community call plan must include the following elements: [proposed elements noted above in the bullets are included in regulations text]."

We welcome public comments on the proposed elements of the formal community call plan noted above. We are also soliciting public comments on whether individuals believe it is important that, in situations where there is a governing State or local agency that would have authority over the development of a formal community call plan, the plan be approved by that agency. In summary, we are proposing that, as part of the obligation to have an on-call list, hospitals may choose to participate in community call, provided that the formal community call plan includes, at a minimum, the elements noted in bullets above. Additionally, each hospital participating in the community call plan must have written policies and procedures in place to respond to situations in which the on-call physician is unable to respond due to situations beyond his or her control. We are further proposing that a hospital would still be responsible for performing medical screening examinations on individuals who present to the hospital seeking treatment and conducting appropriate transfers, regardless of which hospital has on-call responsibilities on a particular day.

5. Proposed Technical Change to Regulations

In the FY 2008 IPPS final rule with comment period (72 FR 47413), we revised § 489.24(a)(2) (which refers to the nonapplicability of the EMTALA provisions in an emergency area during an emergency period) to conform it to the changes made to section 1135 of the Act by the Pandemic and All-Hazards Preparedness Act. When we made the change to the regulations, we inadvertently left out language consistent with the following statutory language found in section 1135: "pursuant to an appropriate State emergency preparedness plan; or in the case of a public health emergency described in subsection (g)(1)(B) that involves a pandemic infectious disease, pursuant to a State pandemic preparedness plan or a plan referred to in clause (i), whichever is applicable in the State." We also inadvertently left out the phrase in section 1135 "during an emergency period" when we state the nonapplicability of the sanctions in an emergency area. We are proposing to revise the language at § 489.24(a)(2) to include the aforementioned language to conform the regulation text to the statutory language. Proposed revised § 489.24(a)(2) would read as follows: "Nonapplicability of provisions of this section. Sanctions under this section for an inappropriate transfer during a national emergency or for the direction or relocation of an individual to receive medical screening at an alternate location pursuant to an appropriate State emergency preparedness plan or, in the case of a public health emergency that involves a pandemic infectious disease, pursuant to a State pandemic preparedness plan do not apply to a hospital with a dedicated emergency department located in an emergency area during an emergency period, as specified in section 1135(g)(1) of the Act. A waiver of these sanctions is limited to a 72-hour period beginning upon the implementation of a hospital disaster protocol, except that, if a public health emergency involves a pandemic infectious disease (such as pandemic influenza), the waiver will continue in effect until the termination of the applicable declaration of a public health emergency, as provided for by section 1135(e)(1)(B) of the Act."

J. Application of Incentives To Reduce Avoidable Readmissions to Hospitals

1. Introduction

A significant portion of Medicare spending-$15 billion each year-is related to hospital readmissions. According to a 2005 MedPAC analysis ,17nearly 18 percent of beneficiaries who are discharged from the hospital are readmitted within 30 days, resulting in approximately 2 million readmissions. By MedPAC's method, over 13 percent of 30-day hospital readmissions and an associated $12 billion in spending ( 45 of all Medicare spending for readmissions) were found to be potentially avoidable. Beyond cost considerations, readmissions may reflect poor quality of care and affect beneficiaries" quality of life. Though not all readmissions are avoidable, hospitals should share accountability for readmission rates that could be much lower through the application of evidence-based best practices. Interventions that have been shown to reduce readmissions include better quality of care during the hospitalization, more complete care plans, emphasis on coordination of care at the point of transitions to home or postacute care, better use of after-hospital care, and more active involvement of patients and caregivers in decision making.

Footnotes:

17 Medicare Payment Advisory Commission: Report to Congress: Promoting Greater Efficiency in Medicare. June 2007, Chapter 5, page 103.

The application of incentives to reduce hospital readmissions, including payment and public reporting approaches, could promote the adoption and development of best practice interventions for averting avoidable readmissions, resulting in higher quality of care for Medicare beneficiaries and reduction in unnecessary costs for the program. Under the current payment system, readmissions are financially rewarding for hospitals. Application of payment incentives to encourage reduction of avoidable readmissions could help address unintended incentives in the current payment system.

In this section, following discussion of readmission issues related to measurement, accountability, and interventions, we are presenting three approaches to applying incentives to reduce avoidable readmissions for public comment: (1) Direct adjustment to hospital DRG payments for avoidable readmissions, (2) adjustments to hospital DRG payments through a performance-based payment methodology, and (3) public reporting of readmission rates. We note that either type of adjustment to hospital payments for readmissions would likely require new statutory authority for the Medicare program. We are seeking public comments on all of the ideas presented in this section.

2. Measurement

Routine, valid, and reliable measurement of hospital-specific rates of readmissions would be a prerequisite to any method of applying incentives for reducing hospital readmissions. Measurement data should be meaningful and actionable for hospitals and should be fair to encourage trust and engagement in the effort. Risk adjustment of measurement data is necessary to account for patientpspecific factors that influence the likelihood of readmission, such as age, disease severity, and comorbidities.

Another important consideration in measurement of readmission rates is the time period from discharge to readmission (for example, 7, 15, 30, or 90 days). In section IV.B. of the preamble of this proposed rule, measures of risk-adjusted 30-day readmission rates are proposed for the RHQDAPU program. The 9th Scope of Work for Medicare Quality Improvement Organizations (QIO 9th SOW) also includes 30-day readmission measures for communities.

Measures should be aligned across settings of care. Hospitals are not the only providers that affect the occurrence of readmissions. For example, the care delivered by SNFs and HHAs also has an important impact on whether a beneficiary is readmitted. Data from aligned readmissions measures, applicable to various settings of care, would provide better information about care coordination problems within and between settings. Alignment of readmissions measures would also facilitate more powerful application of incentives across Medicare's payment systems.

Another consideration is whether to focus on all readmissions or to focus on those that are known to be higher cost, more easily preventable, or most frequently occurring. For example, numerous hospitals have successfully implemented programs to reduce readmissions of heart failure patients, so more is known about the prevention of heart failure readmissions. Further, heart failure readmissions may be more costly than readmissions for other conditions. Another focus of efforts to prevent readmissions could be patients with multiple chronic conditions, who may be at the highest risk to experience readmissions.

3. Accountability

In the assignment of accountability for readmissions, risk adjustment of measurement data is one consideration of fairness; however, other factors must also be considered, including avoidability and shared accountability. Most clinicians would agree that a goal of zero readmissions may not be appropriate, as an extremely low rate of readmissions could indicate restricted access to needed medical services, overuse of hospital resources during the initial hospitalization (for example, prolonged length of stay), or excessive intensity of post-acute care services. Adequate risk adjustment could help to elucidate the avoidability of readmissions by identifying an expected readmission rate for a given patient or patient population.

Shared accountability is another important consideration. Hospitals are clearly accountable for the care provided during hospitalization and can also affect the quality of care provided after the hospitalization, but hospitals are not the only accountable entity. Both during and after hospitalization,physicians and other health professionals share accountability for the quality of care. Other provider entities, including skilled nursing facilities, rehabilitation facilities, home health agencies, and end-stage renal disease facilities, also share accountability for avoidable readmissions.Medicare beneficiaries themselves and their caregivers and social support systems play important roles in avoiding readmissions, particularly when beneficiaries have been discharged to home.

Assignment of accountability also requires consideration of situations where the patient presents for readmission with a different diagnosis or presents to a different hospital.If the locus of accountability were at the hospital level, a second hospital should not be held accountable for a readmission resulting from a first hospital's lack of adherence to evidence-based best practices for averting readmissions.If the locus of accountability were at the community level, then shared accountability could encourage hospitals to work together to reduce readmissions.

4. Interventions

A number of interventions have been identified as best practices for averting avoidable readmissions.18,19,20,21,22,23,24,25,26 Some of these evidence-based interventions are listed below:

Footnotes:

18 Coleman, E.A., C. Parry, S. Chalmers, et al. 2006. The care transitions intervention: Results of a randomized controlled trial. Archives of Internal Medicine, 166 (September 25): 1822-1828.

19 Coleman, E.A., J.D. Smith, R. Devbani, et al. 2005. Posthospital medication discrepancies: Prevalence and contributing factors. Archives of Internal Medicine 165, (September 12): 1842-1847.

20 Coleman, E., and R. Berenson. 2004. Lost in transition: Challenges and opportunities for improving the quality of transitional care. Annals of Internal Medicine, 141, no. 7 (October 5): 533-536.

21 Institute for Healthcare Improvement. 2004a. Reducing readmissions for heart failure patients:Hackensack University Medical Center. Available at http://www.ihi.org.

22 Institute for Healthcare Improvement. 2004b. The MedProvider inpatient care unit-congestive heart failure project. Available at: http://www.ihi.org.

23 Lappe, J.M., J.B. Muhlestein, D.L. Lappe, et al. 2004. Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program. Annals of Internal Medicine, 141, no.6 (September 21): 446-453.

24 Naylor, M.D., D. Brooton, R. Campbell, et al. 1999. Comprehensive discharge planning and home follow-up of hospitalized elders. Journal of the American Medical Association, 281, no.7 (February 17): 613-620.

25 VanSuch, M., J.M. Naessens, R.J. Stroebel, et al. 2006. Effect of discharge instructions on readmission of hospitalized patients with heart failure: Do all of the Joint Commission on Accreditation of Healthcare Organizations heart failure core measures reflect better care? Quality and Safety in Healthcare, 15: 414-417.

26 Weinberg D.B., J.H. Gittell, R.W. Lusenhop, et al. 2007. Beyond our walls: Impact of patient and provider coordination across the continuum on outcomes for surgical patients. Health Services Research, 42, no. 1, pt. 1 (February): 7-24.

• Better, safer care during the hospitalization.

• Improved communication among providers and with the patient and caregivers.

• Care planning that begins with assessment at admission.

• Clear discharge instructions, with specific attention to medication management.

• Shared accountability for care coordination, with attention to transitions and hand-offs.

• Discharge to a proper setting of care.

• Better, safer care in the post-acute setting of care.

• Appropriate use of palliative care and honest planning for the likely course.

• Timely physician follow up visits.

• Active involvement of patients and their caregivers.

Interventions such as these have been employed by several participants in CMS Physician Group Practice Demonstration and have contributed to improvements in the quality and cost-efficiency of care provided to Medicare beneficiaries. For example, the University of Michigan Faculty Group Practice's transitional care call-back program contacts Medicare patients discharged from the emergency department and acute care hospital to address gaps in care during the transition between care settings. The program provides short-term care coordination with linkages to visiting nurse and community services, as well as coordination with primary care and specialty clinics. The Everett Clinic utilizes hospital coaches to guide patients and caregivers through complicated care processes during hospital stays and on discharge. The clinic proactively reaches out to recently hospitalized patients to assure that they have a physician followup visit within 10 days after discharge to address any unresolved or new health problems.

CMS is considering strategies for distributing a discharge checklist that the agency developed to help beneficiaries and their caregivers prepare for discharge from a hospital or nursing home. The checklist includes a range of issues to consider and address with physicians and other health care providers to facilitate a smooth transition to home or postacute care setting. In addition, the checklist provides information about supportive home and community-based services.

The QIO 9th SOW includes a theme entitled Patient Pathways (Care Transitions). The goal of this theme is to measurably improve the quality of care for Medicare beneficiaries who transition among care settings, resulting in reduced readmissions and replicable strategies to sustain reduced readmission rates. The QIO 8th SOW included initiatives to reduce avoidable readmissions of home health patients.

5. Financial Incentive: Direct Payment Adjustment

The first of three approaches presented for comment is direct adjustment to hospital DRG payments for readmissions. This approach would likely require new statutory authority for the Medicare program. In section II.F. of the preamble of this

proposed rule, we discuss direct adjustments to MS-DRG payment for selected preventable HACs. Similarly, a payment adjustment could be applied for readmissions determined to be avoidable because the hospital did not follow evidence-based best practices for averting readmissions. The magnitude of the payment adjustment could be based on patient-specific risk factors and on the apportionment of shared accountability among the involved entities.

A variation of this approach could be adjustment of all hospital payments for readmissions, nationwide or by some regional designation, based on aggregate information about avoidable readmissions for the entire relevant Medicare population (national or regional) under typical circumstances. Under this approach, hospitals would receive less Medicare payment for readmissions for conditions with lower expected rates of readmission and less shared accountability.

Potential unintended consequences resulting from a financial incentive to avert readmissions also need to be considered. For example, hospitals could begin discharging patients to settings that provide more intensive postacute care to avoid readmissions, thereby potentially driving up total costs for episodes of care and total Medicare spending. As another example of potential unintended consequences, hospitals could begin to resist medically necessary readmissions from postacute care providers, creating an access problem.

6. Financial Incentive: Performance-Based Payment Adjustment

The second approach presented for comment is adjustment to hospital MS-DRG payments using a performance-based payment methodology, such as the Medicare Hospital VBP Plan referenced in section IV.C. of the preamble of this proposed rule and available at: http://www.cms.hhs.gov/AcuteInpatientPPS/downloads/HospitalVBPPlanRTCFINALSUBMITTED2007.pdf. The intent of the VBP Plan methodology is to promote adherence to evidence-based best practices in the delivery of care and to provide rewards for those who are successful in improving their measured performance. Implementation of the VBP methodology would require new statutory authority for the Medicare program.

Under the VBP Plan, measures of clinical processes of care, patient experience (HCAHPS), and outcomes (30-day mortality) would be scored and translated into an incentive payment. These measures of process, outcome, and patient-centeredness address areas of quality that are important to reducing readmissions; however, other measures could be added to more fully adjust payments for readmissions. Direct measures of hospital-specific, risk adjusted readmission rates could be included in the VBP Plan performance assessment model. In addition, other measures of care coordination that indirectly address readmissions could also be included.

The direct adjustment approach and the VBP Plan approaches for applying financial incentives to the reduction of avoidable readmissions could be implemented separately or in combination.

7. Nonfinancial Incentive: Public Reporting

A third approach presented for comment is public reporting of hospital-specific, risk adjusted readmission rates. The Administration's Value-Driven Health Care initiative, which stems from the President's Executive Order Promoting Quality and Efficient Health Care in Federal Government Health Care Programs, calls for Federal agencies to make health care quality and cost information more transparent. Health care consumers, including Medicare beneficiaries, and their providers and caregivers need better information to support more informed decision making about their care. The public reporting of readmission rates would likely not require new statutory authority for the Medicare program.

The Hospital Compare Web site could be used to report readmission rates along with the other quality and cost of care parameters displayed on that site. Public reporting has been demonstrated to be a strong non-financial incentive with a competitive effect, as hospitals appropriately focus on maintaining and enhancing their reputations as providers of high quality of care. The VBP Plan envisions public reporting in concert with the VBP financial incentive, but the public reporting incentive could be applied regardless of statutory authority to implement the VBP Plan.

8. Conclusion

The purpose of this section is to solicit and encourage public comments on considerations and options for applying incentives to reduce avoidable hospital readmissions. We welcome public comments on readmission issues related to measurement, accountability, and interventions, as well as on potential approaches to applying financial and nonfinancial incentives to reduce avoidable readmissions.

K. Rural Community Hospital Demonstration Program

In accordance with the requirements of section 410A(a) of Pub. L. 108-173, the Secretary has established a 5-year demonstration program (beginning with selected hospitals' first cost reporting period beginning on or after October 1, 2004) to test the feasibility and advisability of establishing "rural community hospitals" for Medicare payment purposes for covered inpatient hospital services furnished to Medicare beneficiaries. A rural community hospital, as defined in section 410A(f)(1), is a hospital that-

• Is located in a rural area (as defined in section 1886(d)(2)(D) of the Act) or is treated as being located in a rural area under section 1886(d)(8)(E) of the Act;

• Has fewer than 51 beds (excluding beds in a distinct part psychiatric or rehabilitation unit) as reported in its most recent cost report;

• Provides 24-hour emergency care services; and

• Is not designated or eligible for designation as a CAH.

Section 410A(a)(4) of Pub. L. 108-173 states that no more than 15 such hospitals may participate in the demonstration program.

As we indicated in the FY 2005 IPPS final rule (69 FR 49078), in accordance with sections 410A(a)(2) and (a)(4) of Pub. L. 108-173 and using 2002 data from the U.S. Census Bureau, we identified 10 States with the lowest population density from which to select hospitals: Alaska, Idaho, Montana, Nebraska, Nevada, New Mexico, North Dakota, South Dakota, Utah, and Wyoming (Source: U.S. Census Bureau Statistical Abstract of the United States: 2003 ). Nine rural community hospitals located within these States are currently participating in the demonstration program. (Of the 13 hospitals that participated in the first 2 years of the demonstration program, 4 hospitals located in Nebraska have become CAHs and have withdrawn from the program.)

In a notice published in the Federal Register on February 6, 2008 (73 FR 6971 through 6973), we announced a solicitation for up to six additional hospitals to participate in the demonstration program. Hospitals that enter the demonstration under this solicitation will be able to participate for no more than 2 years. The February 6, 2008 notice specifies the eligibility requirements for the demonstration program.

Under the demonstration program, participating hospitals are paid the reasonable costs of providing covered inpatient hospital services (other than services furnished by a psychiatric or rehabilitation unit of a hospital that is a distinct part), applicable for discharges occurring in the first cost reporting period beginning on or after the October 1, 2004 implementation date of the demonstration program. Payments to the participating hospitals will be the lesser amount of the reasonable cost or a target amount in subsequent cost reporting periods. The target amount in the second cost reporting period is defined as the reasonable costs of providing covered inpatient hospital services in the first cost reporting period, increased by the inpatient prospective payment update factor (as defined in section 1886(b)(3)(B) of the Act) for that particular cost reporting period. The target amount in subsequent cost reporting periods is defined as the preceding cost reporting period's target amount, increased by the inpatient prospective payment update factor (as defined in section 1886(b)(3)(B) of the Act) for that particular cost reporting period.

Covered inpatient hospital services are inpatient hospital services (defined in section 1861(b) of the Act), and include extended care services furnished under an agreement under section 1883 of the Act.

Section 410A of Pub. L. 108-173 requires that, "in conducting the demonstration program under this section, the Secretary shall ensure that the aggregate payments made by the Secretary do not exceed the amount which the Secretary would have paid if the demonstration program under this section was not implemented." Generally, when CMS implements a demonstration program on a budget neutral basis, the demonstration program is budget neutral in its own terms; in other words, the aggregate payments to the participating providers do not exceed the amount that would be paid to those same providers in the absence of the demonstration program. This form of budget neutrality is viable when, by changing payments or aligning incentives to improve overall efficiency, or both, a demonstration program may reduce the use of some services or eliminate the need for others, resulting in reduced expenditures for the demonstration program's participants. These reduced expenditures offset increased payments elsewhere under the demonstration program, thus ensuring that the demonstration program as a whole is budget neutral or yields savings. However, the small scale of this demonstration program, in conjunction with the payment methodology, makes it extremely unlikely that this demonstration program could be viable under the usual form of budget neutrality. Specifically, cost-based payments to participating small rural hospitals are likely to increase Medicare outlays without producing any offsetting reduction in Medicare expenditures elsewhere. Therefore, a rural community hospital's participation in this demonstration program is unlikely to yield benefits to the participant if budget neutrality were to be implemented by reducing other payments for these providers.

In order to achieve budget neutrality for this demonstration program for FY 2009, we are proposing to adjust the national inpatient PPS rates by an amount sufficient to account for the added costs of this demonstration program. We are proposing to apply budget neutrality across the payment system as a whole rather than merely across the participants in this demonstration program. As we discussed in the FY 2005, FY 2006, FY 2007 and FY 2008 IPPS final rules (69 FR 49183; 70 FR 47462; 71 FR 48100; and 72 FR 47392), we believe that the language of the statutory budget neutrality requirements permits the agency to implement the budget neutrality provision in this manner. For FY 2009, using data from the cost reports from each of the nine hospitals' first year of participation in the demonstration program, that is, cost reports for years beginning in CY 2005, and estimating the cost of six additional hospitals based on these data, we estimate that the additional cost would be $32,011,849. (In the final rule, we should know the exact number of hospitals participating in the demonstration program and would revise our estimates accordingly.) This estimated adjusted amount reflects the estimated difference between the participating hospitals costs and the IPPS payment based on data from the hospitals' cost reports. We discuss the payment rate adjustment that is required to ensure the budget neutrality of the demonstration program for FY 2009 in section II.A.4. of the Addendum to this proposed rule.

V. Proposed Changes to the IPPS for Capital-Related Costs

A. Background

Section 1886(g) of the Act requires the Secretary to pay for the capital-related costs of inpatient acute hospital services "in accordance with a prospective payment system established by the Secretary." Under the statute, the Secretary has broad authority in establishing and implementing the IPPS for acute care hospital inpatient capital-related costs. We initially implemented the IPPS for capital-related costs in the Federal fiscal year (FY) 1992 IPPS final rule (56 FR 43358), in which we established a 10-year transition period to change the payment methodology for Medicare hospital inpatient capital-related costs from a reasonable cost-based methodology to a prospective methodology (based fully on the Federal rate).

FY 2001 was the last year of the 10-year transition period established to phase in the IPPS for hospital inpatient capital-related costs. For cost reporting periods beginning in FY 2002, capital IPPS payments are based solely on the Federal rate for most acute care hospitals (other than hospitals receiving certain exception payments and certain new hospitals). The basic methodology for determining capital prospective payments using the Federal rate is set forth in § 412.312. For the purpose of calculating payments for each discharge, the standard Federal rate is adjusted as follows:

(Standard Federal Rate) × (DRG Weight) × (Geographic Adjustment Factor (GAF)) × (Large Urban Add-on, if applicable) × (COLA for hospitals located in Alaska and Hawaii) × (1 + Capital DSH Adjustment Factor + Capital IME Adjustment Factor, if applicable).

Hospitals also may receive outlier payments for those cases that qualify under the threshold established for each fiscal year as specified in § 412.312(c) of the regulations.

1. Exception Payments

The regulations at § 412.348(f) provide that a hospital may request an additional payment if the hospital incurs unanticipated capital expenditures in excess of $5 million due to extraordinary circumstances beyond the hospital's control. This policy was originally established for hospitals during the 10-year transition period, but as we discussed in the FY 2003 IPPS final rule (67 FR 50102), we revised the regulations at § 412.312 to specify that payments for extraordinary circumstances are also made for cost reporting periods after the transition period (that is, cost reporting periods beginning on or after October 1, 2001). Additional information on the exception payment for extraordinary circumstances in § 412.348(f) can be found in the FY 2005 IPPS final rule (69 FR 49185 and 49186).

During the transition period, under §§ 412.348(b) through (e), eligible hospitals could receive regular exception payments. These exception payments guaranteed a hospital a minimum payment percentage of its Medicare allowable capital-related costs depending on the class of the hospital (§ 412.348(c)), but were available only during the 10-year transition period. After the end of the transition period, eligible hospitals can no longer receive this exception payment. However, even after the transition period, eligible hospitals receive additional payments under the special exceptions provisions at § 412.348(g), which guarantees all eligible hospitals a minimum payment of 70 percent of its Medicare allowable capital-related costs provided that special exceptions payments do not exceed 10 percent of total capital IPPS payments. Special exceptions payments may be made only for the 10 years from the cost reporting year in which the hospital completes its qualifying project, and the hospital must have completed the project no later than the hospital's cost reporting period beginning before October 1, 2001. Thus, an eligible hospital may receive special exceptions payments for up to 10 years beyond the end of the capital IPPS transition period. Hospitals eligible for special exceptions payments are required to submit documentation to the intermediary indicating the completion date of their project. (For more detailed information regarding the special exceptions policy under § 412.348(g), we refer readers to the FY 2002 IPPS final rule (66 FR 39911 through 39914) and the FY 2003 IPPS final rule (67 FR 50102).)

2. New Hospitals

Under the IPPS for capital-related costs, § 412.300(b) of the regulations defines a new hospital as a hospital that has operated (under current or previous ownership) for less than 2 years. (For more detailed information, we refer readers to the FY 1992 IPPS final rule (56 FR 43418).) During the 10-year transition period, a new hospital was exempt from the capital IPPS for its first 2 years of operation and was paid 85 percent of its reasonable costs during that period. Originally, this provision was effective only through the transition period and, therefore, ended with cost reporting periods beginning in FY 2002. Because, as discussed in the FY 2003 IPPS final rule (67 FR 50101), we believe that special protection to new hospitals is also appropriate even after the transition period, we revised the regulations at § 412.304(c)(2) to provide that, for cost reporting periods beginning on or after October 1, 2002, a new hospital (defined under § 412.300(b)) is paid 85 percent of its Medicare allowable capital-related costs through its first 2 years of operation, unless the new hospital elects to receive fully prospective payment based on 100 percent of the Federal rate. (We refer readers to the FY 2002 IPPS final rule (66 FR 39910) for a detailed discussion of the statutory basis for the system, the development and evolution of the system, the methodology used to determine capital-related payments to hospitals both during and after the transition period, and the policy for providing exception payments.)

3. Hospitals Located in Puerto Rico

Section 412.374 provides for the use of a blended payment amount for prospective payments for capital-related costs to hospitals located in Puerto Rico. Accordingly, under the capital IPPS, we compute a separate payment rate specific to Puerto Rico hospitals using the same methodology used to compute the national Federal rate for capital-related costs. In general, hospitals located in Puerto Rico are paid a blend of the applicable capital IPPS Puerto Rico rate and the applicable capital IPPS Federal rate.

Prior to FY 1998, hospitals in Puerto Rico were paid a blended capital IPPS rate that consisted of 75 percent of the capital IPPS Puerto Rico specific rate and 25 percent of the capital IPPS Federal rate. However, effective October 1, 1997 (FY 1998), in conjunction with the change to the operating IPPS blend percentage for hospitals located in Puerto Rico required by section 4406 of Pub. L. 105-33, we revised the methodology for computing capital IPPS payments to hospitals in Puerto Rico to be based on a blend of 50 percent of the capital IPPS Puerto Rico rate and 50 percent of the capital IPPS Federal rate. Similarly, in conjunction with the change in operating IPPS payments to hospitals located in Puerto Rico for FY 2005 required by section 504 of Pub. L. 108-173, we again revised the methodology for computing capital IPPS payments to hospitals located in Puerto Rico to be based on a blend of 25 percent of the capital IPPS Puerto Rico rate and 75 percent of the capital IPPS Federal rate effective for discharges occurring on or after October 1, 2004.

B. Revisions to the Capital IPPS Based on Data on Hospital Medicare Capital Margins

As noted above, under the Secretary's broad authority under the statute in establishing and implementing the IPPS for hospital inpatient capital-related costs, we have established a standard Federal payment rate for capital-related costs, as well as the mechanism for updating that rate each year. For FY 1992, we computed the standard Federal payment rate for capital-related costs under the IPPS by updating the FY 1989 Medicare inpatient capital cost per case by an actuarial estimate of the increase in Medicare inpatient capital costs per case. Each year after FY 1992, we update the capital standard Federal rate, as provided at § 412.308(c)(1), to account for capital input price increases and other factors. The regulations at § 412.308(c)(2) provide that the capital Federal rate is adjusted annually by a factor equal to the estimated proportion of outlier payments under the capital Federal rate to total capital payments under the capital Federal rate. In addition, § 412.308(c)(3) requires that the capital Federal rate be reduced by an adjustment factor equal to the estimated proportion of payments for (regular and special) exceptions under § 412.348. Section 412.308(c)(4)(ii) requires that the capital standard Federal rate be adjusted so that the effects of the annual DRG reclassification and the recalibration of DRG weights, and changes in the geographic adjustment factor are budget neutral.

In the FY 2008 IPPS final rule with comment period (72 FR 47398 through 47401), based on our analysis of data on inpatient hospital Medicare capital margins that we obtained through our monitoring and comprehensive review of the adequacy of the standard Federal payment rate forcapital-related costs and the updates provided under the existing regulations, we made changes in the payment structure under the capital IPPS beginning with FY 2008. We summarize these changes below. We refer readers to section V.B. of the preamble of the FY 2008 final rule with comment period (72 FR 47393 through 47401) for a detailed discussion of the data used as a basis for these changes. These data showed that hospital inpatient Medicare capital margins were very high across all hospitals during the period from FY 1996 through FY 2004.

In the FY 2008 IPPS final rule with comment period, as background, we noted that, in general, under a PPS, standard payment rates should reflect the costs that an average, efficient provider would bear to provide the services required for quality patient care. Payment rate updates should also account for the changes necessary to continue providing such services. Updates should reflect, for example, the increased costs that are necessary to provide for the introduction of new technology that improves patient care. Updates should also take into account the productivity gains that, over time, allow providers to realize the same, or even improved, quality outcomes with reduced inputs and lower costs. Hospital margins, the difference between the costs of actually providing services and the payments received under a particular system, thus provide some evidence concerning whether payment rates have been established and updated at an appropriate level over time for efficient providers to provide necessary services. All other factors being equal, sustained substantial positive margins demonstrate that payment rates and updates have exceeded what is required to provide those services. It is to be expected, under a PPS, that highly efficient providers might regularly realize positive margins, while less efficient providers might regularly realize negative margins. However, a PPS that is correctly calibrated should not necessarily experience sustained periods in which providers generally realize substantial positive Medicare margins. Under the capital IPPS in particular, it seems especially appropriate that there should not be sustained significant positive margins across the system as a whole. Prior to the implementation of the capital IPPS, Congress mandated that the Medicare program pay only 85 percent of hospitals' inpatient Medicare capital costs. During the first 5 years of the capital IPPS, Congress also mandated a budget neutrality adjustment, under which the standard Federal capital rate was set each year so that payments under the system as a whole equaled 90 percent of estimated hospitals' inpatient Medicare capital costs for the year. Finally, Congress has twice adjusted the standard Federal capital rate (a 7.4 percent reduction beginning in FY 1994, followed by a 17.78 percent reduction beginning in FY 1998). On the second occasion in particular, the specific congressional mandate was "to apply the budget neutrality factor used to determine the Federal capital payment rate in effect on September 30, 1995 * * * to the unadjusted standard Federal capital payment rate" for FY 1998 and beyond. (The designated budget neutrality factor constituted a 17.78 percent reduction.) This statutory language indicates that Congress considered the payment levels in effect during FYs1992 through 1995, established under the budget neutrality provision to pay 90 percent of hospitals' inpatient Medicare capital costs in the aggregate, appropriate for the capital IPPS. The statutory history of the capital IPPS thus suggests that the system in the aggregate should not provide for continuous, large positive margins.

As we also discussed in the FY 2008 IPPS final rule with comment period, we believed that there could be a number of reasons for the relatively high margins that most IPPS hospitals have realized under the capital IPPS. One possibility is that the updates to the capital IPPS rates have been higher than the actual increases in Medicare inpatient capital costs that hospitals have experienced in recent years. Another possible reason for the relatively high margins of most capital IPPS hospitals may be that the payment adjustments provided under the system are too high, or perhaps even unnecessary. Specifically, the adjustments for teaching hospitals, disproportionate share hospitals, and large urban hospitals appear to be contributing to excessive payment levels for these classes of hospitals. Since the inception of the capital IPPS in FY 1992, the system has provided adjustments for teaching hospitals (the IME adjustment factor, under § 412.322 of the regulations), disproportionate share hospitals (the DSH adjustment factor, under § 412.320), and large urban hospitals (the large urban location adjustment factor, under § 412.316(b)). The classes of hospitals eligible for these adjustments have been realizing much higher margins than other hospitals under the system. Specifically, teaching hospitals (11.6 percent for FYs 1998 through 2004), disproportionate share hospitals (8.4 percent), and urban hospitals (8.3 percent) have had significant positive margins. Other classes of hospitals have experienced much lower margins, especially rural hospitals (0.3 percent for FYs 1998 through 2004) and nonteaching hospitals (1.3 percent). The three groups of hospitals that have been realizing especially high margins under the capital IPPS are, therefore, classes of hospitals that are eligible to receive one or more specific payment adjustment under the system. We believed that the evidence indicates that these adjustments have been contributing to the significantly large positive margins experienced by the classes of hospitals eligible for these adjustments.

Therefore, in the FY 2008 IPPS final rule with comment period, we made two changes to the structure of payments under the capital IPPS, as discussed under items 1. and 2. below.

1. Elimination of the Large Add-On Payment Adjustment

In the FY 2008 IPPS final rule with comment period, we determined that the data we had gathered on inpatient hospital Medicare capital margins provided sufficient evidence to warrant elimination of the large urban add-on payment adjustment starting in FY 2008 under the capital IPPS. Therefore, for FYs 2008 and beyond, we discontinued the 3.0 percent additional payment that had been provided to hospitals located in large urban areas (72 FR 24822). This decision was supported by comments from MedPAC.

2. Changes to the Capital IME Adjustment

a. Background and Changes Made for FY 2008

In the FY 2008 IPPS proposed rule, we noted that margin analysis indicated that several classes of hospitals had experienced continuous, significant positive margins. The analysis indicated that the existing payment adjustments for teaching hospitals and disproportionate share hospitals were contributing to excessive payment levels for these classes of hospitals. Therefore, we stated that it may be appropriate to reduce these adjustments significantly, or even to eliminate them altogether, within the capital IPPS. These payment adjustments, unlike parallel adjustments under the operating IPPS, were not mandated by the Act. Rather, they were included within the original design of the capital IPPS under the Secretary's broad authority in section 1886(g)(1) of the Act to include appropriate adjustments and exceptions within a capital IPPS. In the FY 2008 final rule with comment period, we also noted a MedPAC recommendation that we seriously reexamine the appropriateness of the existing capital IME adjustment, that the margin analysis indicated such adjustment may be too high, and that MedPAC's previous analysis also suggested the adjustment may be too high. In light of MedPAC's recommendation, we extended the margin analysis discussed in the FY 2008 IPPS proposed rule in order to distinguish the experience of teaching hospitals from the experience of urban and rural hospitals generally. Specifically, we isolated the margins of urban, large urban, and rural teaching hospitals, as opposed to urban, large urban, and rural nonteaching hospitals. In conducting this analysis, we employed updated cost report information, which allowed us to incorporate the margins for an additional year, FY 2005, into the analysis. The data on the experience of urban, large urban, and rural teaching hospitals as opposed to nonteaching hospitals provided significant new information. As the analysis demonstrated, teaching hospitals in each class (urban, large urban, and rural) performed significantly better than comparable nonteaching hospitals. For the period covering FYs 1998 through 2005, urban teaching hospitals realized aggregate positive margins of 11.9 percent, compared to a positive margin of 0.9 percent for urban nonteaching hospitals. Similarly, large urban teaching hospitals realized an aggregate positive margin of 12.8 percent during that period, while large urban nonteaching hospitals had an aggregate positive margin of only 2.9 percent. Finally, rural teaching hospitals experienced an aggregate positive margin of 4.5 percent, as compared to a negative 1.3 percent margin for nonteaching rural hospitals. We noted that the positive margins for teaching hospitals did not exhibit a decline to the same degree as the margins for all hospitals. For example, the positive margins for all IPPS hospitals declined from 8.7 percent in FY 2002 to 5.3 percent in FY 2004 and 3.7 percent in FY 2005. For urban hospitals, aggregate margins decreased from 10.3 percent in FY 2002 to 6.4 percent in FY 2004 and 4.8 percent in FY 2005. Rural hospitals experienced a decrease from 1.5 percent in FY 2001 to a negative margin of -4.2 percent in FY 2005. In comparison, the aggregate margin for teaching hospitals was 12.1 percent in FY 2001 and 10.6 percent in FY 2005. For urban teaching hospitals, margins were 12.5 percent in FY 2001, 14.0 percent in FY 2002, 13.6 percent in FY 2003, 11.9 percent in FY 2004, and 10.9 percent in FY 2005. Rural teaching hospital margins were more variable, but did not exhibit a pattern of significant decline. In FY 2001, rural teaching hospitals had a positive margin of 3.2 percent; in FY 2002, 8.2 percent; in FY 2003, 4.7 percent; in FY 2004, 5.7 percent; and in FY 2005, 4.0 percent. We are reprinting below the table found in the FY 2008 IPPS final rule with comment period showing our analysis (72 FR 47400).

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 Aggregate 1996-2005 Aggregate 1998-2005
U.S. 17.6 13.4 7.0 6.8 7.3 8.1 8.7 7.6 5.3 3.7 8.5 6.8
URBAN 17.7 13.8 7.8 7.5 8.4 9.2 10.3 9.0 6.4 4.8 9.4 7.9
RURAL 16.8 11.0 2.1 2.4 1.0 1.5 -1.7 -1.4 -2.3 -4.2 2.6 -0.4
No DSH Payments 16.2 11.7 4.2 4.3 5.6 5.5 4.7 4.4 -1.3 -4.7 5.9 3.2
Has DSH Payments 18.5 14.4 8.6 8.1 8.2 9.0 10.0 8.5 7.0 5.9 9.5 8.1
$1-$249,999 14.5 12.9 -0.4 3.1 1.6 4.1 3.2 1.4 -1.7 -4.8 3.2 1.9
$250,000-$999,999 15.5 9.0 2.3 1.6 2.8 2.7 -2.4 -1.5 -4.3 -7.3 1.5 -0.9
$1,000,000-$2,999,999 16.8 13.0 8.7 9.0 8.7 7.0 10.1 5.2 3.2 2.0 8.2 6.6
$3,000,000 or more 20.3 16.6 10.4 9.3 9.7 12.1 13.2 12.5 10.6 9.5 12.2 11.0
TEACHING 19.5 15.7 9.8 9.7 11.2 12.1 13.8 13.2 11.7 10.6 12.7 11.6
Urban 19.7 15.9 10.2 10.0 11.4 12.5 14.0 13.6 11.9 10.9 13.0 11.9
Large Urban 20.5 16.8 11.0 10.1 12.5 13.9 15.2 14.7 12.0 11.9 13.9 12.8
Rural 13.9 8.5 1.0 2.9 5.8 3.2 8.2 4.7 5.7 4.0 5.7 4.5
NONTEACHING 15.3 10.5 3.4 2.8 2.2 2.6 1.7 0.0 -3.2 -5.1 2.8 0.3
Urban 14.4 10.1 3.8 3.0 3.0 3.1 3.6 0.9 -2.9 -4.9 3.1 0.9
Large Urban 15.5 11.3 6.2 6.1 5.7 5.2 5.3 1.7 -0.9 -3.2 5.1 2.9
Rural 17.3 11.4 2.3 2.4 0.2 1.2 -3.7 -2.6 -3.9 -6.0 2.0 -1.3
Census Division:
New England (1) 27.9 25.9 17.1 15.1 18.2 20.7 21.3 21.1 20.5 20.3 21.0 19.5
Middle Atlantic (2) 19.1 15.5 11.1 11.6 14.1 16.5 18.7 18.0 14.7 16.0 15.6 15.2
South Atlantic (3) 18.1 13.9 5.9 4.0 6.0 5.0 6.6 6.9 5.8 2.8 7.4 5.4
East North Central (4) 18.2 12.7 6.4 7.1 8.8 8.5 6.1 7.1 6.6 3.2 8.4 6.7
East South Central (5) 14.9 11.1 3.3 4.1 3.8 3.8 3.8 -0.9 -3.4 -5.8 3.2 0.9
West North Central (6) 14.3 7.0 0.1 --0.3 -1.5 2.0 1.9 3.4 1.6 -0.4 2.8 0.9
West South Central (7) 13.2 8.3 3.3 2.6 -0.7 0.0 1.2 -2.0 -4.0 -6.5 1.2 -1.0
Mountain (8) 17.2 14.7 8.5 7.7 7.2 6.4 2.9 3.3 0.8 -4.7 5.8 3.6
Pacific (9) 20.4 16.1 12.3 11.3 11.9 13.3 14.7 12.1 9.8 8.8 13.0 11.7
Code 99 23.7 24.1 14.5 16.8 19.8 20.7 20.5 25.1 21.6 24.8 21.4 20.8
Bed Size:
100 beds 17.7 13.0 4.6 3.5 2.7 2.5 -1.8 -1.2 -6.1 -9.6 2.0 -0.9
100-249 beds 15.1 10.5 3.7 4.5 4.3 6.1 6.0 4.2 1.5 0.8 5.6 3.8
250-499 beds 18.9 14.1 8.9 8.3 10.6 10.7 12.1 11.6 10.3 7.7 11.4 10.1
500-999 beds 19.9 17.1 10.7 10.4 11.3 10.8 12.6 10.1 7.3 7.8 11.6 10.1
= 1000 beds 8.2 14.0 2.2 -1.3 -6.6 -3.6 6.5 8.1 6.5 2.1 3.5 2.3
Notes:
Based on Medicare Cost Report hospital data updated as of the 1st quarter of 2007.
Medicare payments are from Worksheet E, Part A, Lines 9 and 10.
Expenses are from Worksheet D, Part I, columns 10 and 12 and Part II, columns 6 and 8.
We apply the outlier trimming methodology developed with MedPAC.
Code 99 applies when census division information was not specified in the Medicare Cost Report hospital data.

As we indicated in the FY 2008 IPPS final rule with comment period (72 FR 47401), the statutory history of the capital IPPS suggests that the system in the aggregate should not provide for continuous, large positive margins. As we also indicated, a possible reason for the relatively high margins of many capital IPPS hospitals may be that the payment adjustments provided under the system are too high, or perhaps even unnecessary. We agreed with MedPAC's recommendation and reexamined the appropriateness of the teaching adjustment. We concluded that the record of relatively high and persistent positive margins for teaching hospitals under the capital IPPS indicated that the teaching adjustment is unnecessary, and that it was therefore appropriate to exercise our discretion under the capital IPPS to eliminate this adjustment. At the same time, we believed that we should mitigate abrupt changes in payment policy and that we should provide time for hospitals to adjust to changes in the payments that they can expect under the program.

Therefore, in the FY 2008 IPPS final rule with comment period, we adopted a policy to phase out the capital teaching adjustment over a 3-year period beginning in FY 2008. Specifically, we maintained the adjustment for FY 2008, in order to give teaching hospitals an opportunity to plan and make adjustments to the change. During the second year of the transition, FY 2009, the formula for determining the amount of the teaching adjustment was revised so that adjustment amounts will be half of the amounts provided under the current formula. For FY 2010 and after, hospitals will no longer receive an adjustment for teaching activity under the capital IPPS.

b. Public Comments Received on Phase Out of Capital IPPS Teaching Adjustment Provisions Included in the FY 2008 Final Rule With Comment Period and Further Solicitation of Public Comments

As indicated above, in the FY 2008 IPPS final rule with comment period, we formally adopted as final policy a phase out of the capital IPPS teaching adjustment over a 3-year period, maintaining the current adjustment for FY 2008, making a 50-percent reduction in FY 2009, and eliminating the adjustment for FY 2010 and subsequent years. However, because we concluded that this change to the structure of payments under the capital IPPS was significant, we provided the public with an opportunity for further comment on these provisions through a 90-day comment period after publication of the FY 2008 IPPS final rule with comment period (72 FR 47401). In addition, as we indicated in that final rule with comment period, to provide a more than adequate opportunity for hospitals, associations, and other interested parties to raise issues and concerns related to our policy, we are providing additional opportunity for public comment during this FY 2009 proposed rulemaking cycle for the IPPS.

We received numerous timely pieces of correspondence that commented on the policy of phasing out the capital IPPS teaching adjustment as described in the FY 2008 IPPS final rule with comment period. These comments are available on our e-rulemaking Web site, at http://www.cms.hhs.gov/eRulemaking/ECCMSR/list.asp . We will also accept public comments on this policy during the comment period for this proposed rule. We will respond to both sets of public comments when we issue the FY 2009 IPPS final rule, which is scheduled for publication in August 2008.

VI. Proposed Changes for Hospitals and Hospital Units Excluded From the IPPS

A. Proposed Payments to Excluded Hospitals and Hospital Units

Historically, hospitals and hospital units excluded from the prospective payment system received payment for inpatient hospital services they furnished on the basis of reasonable costs, subject to a rate-of-increase ceiling. An annual per discharge limit (the target amount as defined in § 413.40(a)) was set for each hospital or hospital unit based on the hospital's own cost experience in its base year. The target amount was multiplied by the Medicare discharges and applied as an aggregate upper limit (the ceiling as defined in § 413.40(a)) on total inpatient operating costs for a hospital's cost reporting period. Prior to October 1, 1997, these payment provisions applied consistently to all categories of excluded providers, which include rehabilitation hospitals and units (now referred to as IRFs), psychiatric hospitals and units (now referred to as IPFs), LTCHs, children's hospitals, and cancer hospitals.

Payment for children's hospitals and cancer hospitals that are excluded from the IPPS continues to be subject to the rate-of-increase ceiling based on the hospital's own historical cost experience. (We note that, in accordance with § 403.752(a) of the regulations, RNHCIs are also subject to the rate-of-increase limits established under § 413.40 of the regulations.)

In this FY 2009 IPPS proposed rule, we are proposing that the percentage increase in the rate-of-increase limits for cancer and children's hospitals and RNHCIs would be the proposed percentage increase in the FY 2009 IPPS operating market basket, which is estimated to be 3.0 percent. Consistent with our historical approach, we calculated the proposed IPPS operating market basket for FY 2009 using the most recent data available. However, if more recent data are available for the final rule, we will use them to calculate the IPPS operating market basket. For cancer and children's hospitals and RNHCIs, the proposed FY 2009 rate-of-increase percentage that is applied to FY 2008 target amounts in order to calculate FY 2009 target amounts is 3.0 percent, based on Global Insight, Inc.'s 2008 first quarter forecast of the IPPS operating market basket increase, in accordance with the applicable regulations in 42 CFR 413.40.

IRFs, IPFs, and LTCHs were paid previously under the reasonable cost methodology. However, the statute was amended to provide for the implementation of prospective payment systems for IRFs, IPFs, and LTCHs. In general, the prospective payment systems for IRFs, IPFs, and LTCHs provided transition periods of varying lengths during which time a portion of the prospective payment was based on cost-based reimbursement rules under Part 413 (certain providers do not receive a transition period or may elect to bypass the transition period as applicable under 42 CFR Part 412, Subparts N, O, and P). We note that the various transition periods provided for under the IRF PPS, the IPF PPS, and the LTCH PPS have ended.

For cost reporting periods beginning on or after October 1, 2002, all IRFs are paid 100 percent of the adjusted Federal rate under the IRF PPS. Therefore, for cost reporting periods beginning on or after October 1, 2002, no portion of an IRF PPS payment is subject to 42 CFR Part 413. Similarly, for cost reporting periods beginning on or after October 1, 2006, all LTCHs are paid 100 percent of the adjusted Federal prospective payment rate under the LTCH PPS. Therefore, for cost reporting periods beginning on or after October 1, 2006, no portion of the LTCH PPS payment is subject to 42 CFR Part 413. (We note that, to the extent a portion of a LTCH's PPS payment was subject to reasonable cost principles, the Secretary utilized his broad authority under section 123 of the BBRA, as amended by section 307 of the BIPA, to make such portion subject to 42 CFR Part 413 and various provisions in section 1886(b) of the Act.) Likewise, for cost reporting periods beginning on or after January 1, 2008, all IPFs are paid 100 percent of the Federal per diem amount under the IPF PPS. Therefore, for cost reporting periods beginning on or after January 1, 2008, no portion of an IPF PPS payment is subject to 42 CFR Part 413.

B. IRF PPS

Section 1886(j) of the Act, as added by section 4421(a) of Pub. L. 105-33, provided for a phase-in of a case-mix adjusted PPS for inpatient hospital services furnished by IRFs for cost reporting periods beginning on or after October 1, 2000, and before October 1, 2002, with payments based entirely on the adjusted Federal prospective payment for cost reporting periods beginning on or after October 1, 2002. Section 1886(j) of the Act was amended by section 125 of Pub. L. 106-113 to require the Secretary to use a discharge as the payment unit for services furnished under the PPS for inpatient rehabilitation hospitals and inpatient rehabilitation units of hospitals (referred to as IRFs), and to establish classes of patient discharges by functional-related groups. Section 305 of Pub. L. 106-554 further amended section 1886(j) of the Act to allow IRFs, subject to the blended methodology, to elect to be paid the full Federal prospective payment rather than the transitional period payments specified in the Act.

On August 7, 2001, we issued a final rule in the Federal Register (66 FR 41316) establishing the PPS for IRFs, effective for cost reporting periods beginning on or after January 1, 2002. There was a transition period for cost reporting periods beginning on or after January 1, 2002, and ending before October 1, 2002. For cost reporting periods beginning on or after October 1, 2002, payments are based entirely on the adjusted Federal prospective payment rate determined under the IRF PPS.

C. LTCH PPS

On August 30, 2002, we issued a final rule in the Federal Register (67 FR 55954) establishing the PPS for LTCHs, effective for cost reporting periods beginning on or after October 1, 2002. Except for a LTCH that made an election under § 412.533(c) or a LTCH that is defined as new under § 412.23(e)(4), there was a transition period under § 412.533(a) for LTCHs. For cost reporting periods beginning on or after October 1, 2006, all LTCHs are paid 100 percent of the adjusted Federal prospective payment rate.

D. IPF PPS

In accordance with section 124 of Pub. L. 106-113 and section 405(g)(2) of Pub. L. 108-173, we established a PPS for inpatient hospital services furnished in IPFs. On November 15, 2004, we issued in the Federal Register a final rule (69 FR 66922) that established the IPF PPS, effective for IPF cost reporting periods beginning on or after January 1, 2005. Under the requirements of that final rule, we computed a Federal per diem base rate to be paid to all IPFs for inpatient psychiatric services based on the sum of the average routine operating, ancillary, and capital costs for each patient day of psychiatric care in an IPF, adjusted for budget neutrality. The Federal per diem base rate is adjusted to reflect certain patient characteristics, including age, specified DRGs, selected high-cost comorbidities, days of the stay, and certain facility characteristics, including a wage index adjustment, rural location, indirect teaching costs, the presence of a full-service emergency department, and COLAs for IPFs located in Alaska and Hawaii.

We established a 3-year transition period during which IPFs whose cost reporting periods began on or after January 1, 2005, and before January 1, 2008, would be paid a PPS payment, a portion of which was based on reasonable cost principles and a portion of which was the Federal per diem payment amount. For cost reporting periods beginning on or after January 1, 2008, all IPFs are paid 100 percent of the Federal per diem payment amount.

E. Determining Proposed LTCH Cost-to-Charge Ratios (CCRs) Under the LTCH PPS

In general, we use a LTCH's overall CCR, which is computed based on either the most recently settled cost report or the most recent tentatively settled cost report, whichever is from the latest cost reporting period, in accordance with § 412.525(a)(4)(iv)(B) and § 412.529(c)(4)(iv)(B) for high cost outliers and short-stay outliers, respectively. (We note that, in some instances, we use an alternative CCR, such as the statewide average CCR in accordance with the regulations at § 412.525(a)(4)(iv)(C) and § 412.529(c)(4)(iv)(C), or a CCR that is specified by CMS or that is requested by the hospital under the provisions of the regulations at § 412.525(a)(4)(iv)(A) and § 412.529(c)(4)(iv)(A).) Under the LTCH PPS, a single prospective payment per discharge is made for both inpatient operating and capital-related costs. Therefore, we compute a single "overall" or "total" LTCH-specific CCR based on the sum of LTCH operating and capital costs (as described in Chapter 3, section 150.24, of the Medicare Claims Processing Manual (CMS Pub. 100-4)) as compared to total charges. Specifically, a LTCH's CCR is calculated by dividing a LTCH's total Medicare costs (that is, the sum of its operating and capital inpatient routine and ancillary costs) by its total Medicare charges (that is, the sum of its operating and capital inpatient routine and ancillary charges).

Generally, a LTCH is assigned the applicable statewide average CCR if, among other things, a LTCH's CCR is found to be in excess of the applicable maximum CCR threshold (that is, the LTCH CCR ceiling). This is because CCRs above this threshold are most likely due to faulty data reporting or entry, and, therefore, these CCRs should not be used to identify and make payments for outlier cases. Such data are clearly errors and should not be relied upon. Thus, under our established policy, generally, if a LTCH's calculated CCR is above the applicable ceiling, the applicable LTCH PPS statewide average CCR is assigned to the LTCH instead of the CCR computed from its most recent (settled or tentatively settled) cost report data.

In the FY 2008 IPPS final rule with comment period, in accordance with § 412.525(a)(4)(iv)(C)( 2 ) for high-cost outliers and § 412.529(c)(4)(iv)(C)( 2 ) for short-stay outliers, using our established methodology for determining the LTCH total CCR ceiling, based on IPPS total CCR data from the March 2007 update to the Provider-Specific File (PSF), we established a total CCR ceiling of 1.284 under the LTCH PPS effective October 1, 2007, through September 30, 2008. (For further detail on our methodology for annually determining the LTCH total CCR ceiling, we refer readers to the FY 2007 IPPS final rule (71 FR 48117 through 48121) and the FY 2008 IPPS final rule with comment period (72 FR 47403 through 47404).)

Our general methodology established for determining the statewide average CCRs used under the LTCH PPS is similar to our established methodology for determining the LTCH total CCR ceiling (described above) because it is based on "total" IPPS CCR data. Under the LTCH PPS high-cost outlier policy at § 412.525(a)(4)(iv)(C) and the short-stay outlier policy at § 412.529(c)(4)(iv)(C), the fiscal intermediary (or MAC) may use a statewide average CCR, which is established annually by CMS, if it is unable to determine an accurate CCR for a LTCH in one of the following circumstances: (1) A new LTCH that has not yet submitted its first Medicare cost report (for this purpose, a new LTCH is defined as an entity that has not accepted assignment of an existing hospital's provider agreement in accordance with § 489.18); (2) a LTCH whose CCR is in excess of the LTCH CCR ceiling (as discussed above); and (3) any other LTCH for whom data with which to calculate a CCR are not available (for example, missing or faulty data). (Other sources of data that the fiscal intermediary (or MAC) may consider in determining a LTCH's CCR include data from a different cost reporting period for the LTCH, data from the cost reporting period preceding the period in which the hospital began to be paid as a LTCH (that is, the period of at least 6 months that it was paid as a short-term acute care hospital), or data from other comparable LTCHs, such as LTCHs in the same chain or in the same region.)

In this proposed rule, in accordance with § 412.525(a)(4)(iv)(C)( 2 ) for high-cost outliers and § 412.529(c)(4)(iv)(C)( 2 ) for short-stay outliers, using our established methodology for determining the LTCH total CCR ceiling (described above), based on IPPS total CCR data from the December 2007 update to the PSF), we are proposing a total CCR ceiling of 1.262 under the LTCH PPS, effective for discharges occurring on or after October 1, 2008, and before October 1, 2009. If more recent data become available before publication of the final rule, we will use such data to determine the final total CCR ceiling under the LTCH PPS for FY 2009.

In this FY 2009 IPPS proposed rule, in accordance with § 412.525(a)(4)(iv)(C) for high-cost outliers and § 412.529(c)(4)(iv)(C) for short-stay outliers, using our established methodology for determining the LTCH statewide average CCRs (described above), based on the most recent complete IPPS total CCR data from the December 2007 update of the PSF, we are proposing LTCH PPS statewide average total CCRs for urban and rural hospitals that would be effective for discharges occurring on or after October 1, 2008, and before October 1, 2009, presented in Table 8C of the Addendum to this proposed rule. If more recent data become available before publication of the final rule, we will use such data to determine the final statewide average total CCRs for urban and rural hospitals under the LTCH PPS for FY 2009 using our established methodology described above.

We note that, for this proposed rule, as we established when we revised our methodology for determining the applicable LTCH statewide average CCRs in the FY 2007 IPPS final rule (71 FR 48119 through 48121), and as is the case under the IPPS, all areas in the District of Columbia, New Jersey, Puerto Rico, and Rhode Island are classified as urban, and, therefore, there are no proposed rural statewide average total CCRs listed for those jurisdictions in Table 8C of the Addendum to this proposed rule. In addition, as we established when we revised our methodology for determining the applicable LTCH statewide average CCRs in that same final rule, and as is the case under the IPPS, although Massachusetts has areas that are designated as rural, there were no short-term acute care IPPS hospitals or LTCHs located in those areas as of December 2007. Therefore, for this proposed rule, there is no proposed rural statewide average total CCR listed for rural Massachusetts in Table 8C of the Addendum of this proposed rule. As we also established when we revised our methodology for determining the applicable LTCH statewide average CCRs in the FY 2007 IPPS final rule (71 FR 48120 through 48121), in determining the urban and rural statewide average total CCRs for Maryland LTCHs paid under the LTCH PPS, we use, as a proxy, the national average total CCR for urban IPPS hospitals and the national average total CCR for rural IPPS hospitals, respectively. We use this proxy because we believe that the CCR data on the PSF for Maryland hospitals may not be accurate (as discussed in greater detail in that same final rule (71 FR 48120)).

F. Proposed Change to the Regulations Governing Hospitals-Within-Hospitals

On September 1, 1994, we published hospital-within-hospital (HwH) regulations for LTCHs to address inappropriate Medicare payments to entities that were effectively units of other hospitals (59 FR 45330). There was concern that the HwH model was being used by some acute care hospitals paid under the IPPS as a way of inappropriately receiving higher payments for a subset of their cases. Moreover, IPPS-exclusion of long-term care "units" was and remains inconsistent with the statutory scheme.

Therefore, we established the HwH regulations at 42 CFR 412.23 (currently at § 412.22) for a LTCH HwH that is co-located with another hospital. A co-located hospital is a hospital that occupies space in the same building or on the same campus as another hospital. The regulations at § 412.23(e) required that, to be excluded from the IPPS, long-term care HwHs must have a separate governing body, chief medical officer, medical staff, and chief executive officer from that of the co-located hospital. In addition, the HwH must meet either of the following two criteria: The HwH must perform certain specified basic hospital functions on its own and not receive them from the host hospital or a third entity that controls both hospitals; or the HwH must receive at least 75 percent of its inpatients from sources other than the co-located hospital. A third option was added to the regulations on September 1, 1995 (60 FR 45778) that allowed HwHs to demonstrate their separateness by showing that the cost of the services that the hospital obtains under contracts or other agreements with the co-located hospital or a third entity that controls both hospitals is no more than 15 percent. In 1997, we extended application of the HwH rules at § 412.22 to all classes of IPPS excluded hospitals. Therefore, effective for cost reporting periods beginning on or after October 1, 1997, psychiatric, rehabilitation, cancer, and children's hospitals that are co-located with another hospital are also required to meet the "separateness" criteria at § 412.22(e).

In addition, a "grandfathering" provision was added to the regulations at § 412.22(f), as provided for under section 4417 of the Balanced Budget Act (BBA) of 1997 (Pub. L. 105-33). This provision of the regulations allowed a LTCH that was excluded from the IPPS on or before September 30, 1995, and at that time occupied space in a building also used by another hospital, or in one or more buildings located on the same campus as buildings used by another hospital, to retain its IPPS-excluded status even if the HwH criteria at § 412.22(e) could not be met, as long as the hospital continued to operate under the same terms and conditions as were in effect on September 30, 1995. Consistent with the grandfathering provision under the BBA, which only applied to LTCHs, we extended the application of the grandfathering rule to the other classes of IPPS-excluded hospitals that are HwHs but did not meet the criteria at § 412.22(e). (We subsequently expanded this provision to allow for a grandfathered hospital to make specified changes during particular timeframes.)

Despite our efforts to allow those HwHs for whom the IPPS-exclusion status is appropriate to meet the HwH criteria, it appears that there may be a gap in our regulations. There remain certain HwHs under current rules that may be unnecessarily restricted from expanding their bed size. These HwHs are State hospitals that are co-located with another State hospital and that are grandfathered under § 412.22(f). Where a State law defines the structure and authority of the State's agencies and institutions, and the State hospital is co-located with another hospital that is under State governance, each hospital may have control over the day-to-day operations of its respective facility and have separate management, patient intake, and billing systems and medical staff, as well as a governing board. However, State law may require that the legal accountability for the budgets and activities of entities operating within a State-run institution rests with the State. Therefore, the co-located State hospitals may also be governed by a common governing body. Because of State law requirements, these HwHs are, therefore, precluded from meeting the HwH criteria at § 412.22(e)(1)(i) that requires the governing body of a co-located hospital to be separate from the governing body of the hospital with which it shares space. The excluded hospital's governing body cannot be under the control of the hospital occupying space in the same building or on the same campus, or of any third entity that controls both hospitals. Currently, there are State HwHs in these types of arrangements that have been able to retain their IPPS-excluded status solely because of the grandfathering provision in § 412.22(f). These HwHs were IPPS-excluded even before the HwH criteria were implemented and only remain excluded HwHs under § 412.22(f) as long as they continue to meet the requirements specified under § 412.22(f)(1), (f)(2), and (f)(3). Because they are grandfathered, these HwHs cannot increase their bed size without losing their IPPS-excluded status under the grandfathering provisions (§ 412.22(f)). Furthermore, if a grandfathered State-run HwH increased its bed size, it would be unable to qualify as an IPPS-excluded HwH under § 412.22(e) because it cannot meet the HwH criteria at § 412.22(e)(1)(i) as a result of State law requirements regarding its organizational structure and governance. These HwHs are precluded from the flexibility to expand their bed size, which is available to other HwHs whose organizational structure is not bound by State law.

As discussed in the previous paragraph, the organizational arrangements were in place for these State-operated HwHs before the HwH regulations were adopted. To the extent the arrangements are required by State law, we believe they do not reflect attempts by entities to establish a nominal hospital and, in turn, seek inappropriate exclusions. We also believe it may be unnecessary to prevent hospitals that were created before the HwH requirements, and that because of State statutory requirements cannot meet the subsequently issued separate governing body requirements, from being excluded from the IPPS. Accordingly, we are proposing to add a provision to the regulations that would apply only to State hospitals that were in existence when the HwH regulations were established. This proposed provision would not apply to other State hospitals that chose to open as a HwH subsequent to the establishment of the HwH regulations in FY 1994, under an organizational structure the same as or similar to the one described in this section. These hospitals knew, in advance of becoming a HwH, the requirements that had to be met in order to be an IPPS-excluded HwH, unlike those hospitals that existed before the HwH regulations were established.

Accordingly, we are proposing to add a new paragraph (e)(1)(vi) to § 412.22 to provide that if a hospital cannot meet the criteria in § 412.22(e)(1)(i) solely because it is a State hospital occupying space with another State hospital, the HwH can nevertheless qualify for an exclusion from the IPPS if that hospital meets the other applicable criteria in § 412.22(e) and-

• Both State hospitals share the same building or same campus and have been continuously owned and operated by the State since October 1, 1995;

• Is required by State law to be subject to the governing authority of the State hospital with which it shares space or the governing authority of a third entity that controls both hospitals; and

• Was excluded from the inpatient prospective payment system before October 1, 1995, and continues to be excluded from the IPPS through September 30, 2008.

We believe the proposed criteria capture the segment of grandfathered, State-operated HwHs that are unable to increase their bed size because of State law regarding governance. We emphasize that we intend to allow an exception to the criteria in § 412.22 (e)(1)(i) only if the hospital that meets the proposed criteria above cannot meet the separate governing body requirement because of State law. We do not intend to provide similar treatment for hospitals that are not subject to State statutory requirements regarding governance but have chosen not to organize in a manner that would allow them to be an IPPS-excluded hospital that meets the HwH criteria at § 412.22(e)(1)(i).

VII. Disclosure Required of Certain Hospitals and Critical Access Hospitals Regarding Physician Ownership (§ 489.2(u) and (v))

Section 1866 of the Act states that any provider of services (except a fund designated for purposes of sections 1814(g) and 1835(e) of the Act) shall be qualified to participate in the Medicare program and shall be eligible for Medicare payments if it files with the Secretary a Medicare provider agreement and abides by the requirements applicable to Medicare provider agreements. These requirements are incorporated into our regulations in 42 CFR Part 489, Subparts A and B. Section 1861(e) of the Act defines the term "hospital." Section 1861(e)(9) of the Act authorizes the Secretary to establish requirements for hospitals as he finds necessary in the interest of patient health and safety. Section 1820(e)(3) of the Act authorizes the Secretary to establish criteria necessary for an institution to be certified as a "critical access hospital."

In the FY 2008 IPPS final rule with comment period, we revised our regulations governing Medicare provider agreements, specifically § 489.20(u), to require a hospital to disclose to all patients whether it is physician-owned and, if so, the names of its physician owners (72 FR 47385 through 47387). In addition, we added a definition of physician-owned hospital at § 489.3. The disclosure requirement in current § 489.20(u) is applicable only to those hospitals with physician ownership. (For purposes of this proposal, the term "hospital" also includes "critical access hospital" (CAH).) We neglected to include those hospitals in which no physician held an ownership or investment interest, but in which an immediate family member of a physician held an ownership or investment interest. However, it was always our intent to have consistency between the disclosure requirements and the physician self-referral statute and regulations. The physician self-referral statute and regulations, which recognize the potential for program and patient abuse where a financial relationship exists, are applicable to both a physician and the immediate family member of the physician. We believe that it is necessary to revise our definition of physician-owned hospital because a physician's potential conflict of interest occurs not only in those instances where he or she has a financial relationship in the form of an ownership or investment interest, but also where his or her immediate family member has a similar interest, and patients should be informed of this as part of making an informed decision concerning treatment. Therefore, we are proposing to revise the language in § 489.3 to define a "physician-owned hospital" as a participating hospital in which a physician, or an immediate family member of a physician (as defined at § 411.351), has an ownership or investment interest in the hospital.

To effectuate the changes made in the FY 2008 IPPS final rule with comment period, we relied on our authority in sections 1861(e)(9), 1820(e)(3) and 1866 of the Act, and on our general rulemaking authority in sections 1871 and 1102 of the Act. Following publication of the FY 2008 IPPS final rule with comment period, we became aware that some physician-owned hospitals have no physician owners who refer patients to the hospital (for example, in the case of a hospital whose physician-owners have retired from the practice of medicine). We believe that requiring a hospital with no referring physician owners to disclose to all patients that it is physician-owned and to provide the patients with a list of the (nonreferring) physician owners would be an unnecessary burden on the hospital and of no value in assisting a patient in making an informed decision as to where to seek treatment. Similarly, we do not believe that it is useful to require a hospital to make such disclosures when no referring physician has an immediate family member who has an ownership or investment interest in the hospital. Accordingly, we are proposing to include in § 489.20(v) new language to provide for an exception to the disclosure requirements for a physician-owned hospital (as defined at § 489.3) that does not have any physician owners who refer patients to the hospital (and that has no referring physicians (as defined at § 411.351) who have an immediate family member with an ownership or investment interest in the hospital), provided that the hospital attests, in writing, to that effect and maintains such attestation in its files for review by State and Federal surveyors or other government officials. (We note that, as explained below, we are proposing to redesignate the existing paragraphs (v) and (w) of § 489.20 as paragraphs (w) and (x), respectively.)

We are proposing to revise § 489.20(u) to specify that a hospital must furnish to patients the list of owners and investors who are physicians (or immediate family members of physicians) at the time the list is requested by or on behalf of the patient. In response to the FY 2008 IPPS proposed rule, we received public comments that noted that our proposal did not establish a timeframe within which the hospital must furnish to patients the required list of the hospital's physician owners or investors. These commenters suggested that we require that the list be provided to the patient at the time the request for the list is made by or on behalf of the patient. We stated in the preamble of the FY 2008 IPPS final rule with comment period that we would not revise the provision to include any specific timeframe for making the list available because we believed that it was important to allow hospitals some degree of flexibility regarding the manner and form in which it notified patients of the identity of its physician owners and investors (72 FR 47386). However, we also stated later in the preamble that we were revising proposed § 489.20(u) to specify that the hospital should furnish a list of physician owners to a patient at the beginning of his or her hospital stay or outpatient visit, but the regulation text did not reflect this change (72 FR 47387).

We have reconsidered the issue and are proposing in § 489.20(u)(1) that the list of the hospital's owners or investors who are physicians or immediate family members of physicians (as defined at § 411.351) must be furnished at the time the patient or someone on the patient's behalf requests it. We are proposing this change for two reasons. First, in the FY 2008 IPPS final rule with comment period, in response to public comments received on the FY 2008 IPPS proposed rule, we stated that we believed that the physician ownership disclosure proposal would permit an individual to make more informed decisions regarding his or her treatment and to evaluate whether the existence of a financial relationship, in the form of an ownership interest, suggests a conflict of interest that is not in his or her best interest. However, we maintain that the provision of a generic notice that the hospital is owned by physicians or immediate family members of physicians is insufficient to permit an individual to make a truly informed decision. We believe that it is critical that the patient receives the list of names of the relevant owners or investors at the time the request is made by or on behalf of the patient so that the patient may make a determination as to whether his or her admitting or referring physician has a potential conflict of interest. Second, furnishing the list at the time the request is made by the patient or on behalf of the patient is crucial to affording the patient an opportunity to make an informed decision before treatment is furnished at the hospital. We are not specifying a form to be used for the list; rather, we are addressing the timeframe for the hospital to furnish the list to the patient.

In addition, we are proposing to add new § 489.20(u)(2) to require a hospital to require all physicians who are members of the hospital's medical staff to agree, as a condition of continued medical staff membership or admitting privileges, to disclose in writing to all patients who they refer to the hospital any ownership or investment interest in the hospital held by themselves or by an immediate family member. We would require that physicians agree to make such disclosures at the time they refer patients to the hospital. We proposed a similar requirement in the FY 2008 IPPS proposed rule, but decided not to adopt it as final. In response to a public comment, we stated that we would not finalize the proposal because we believed that it would not provide any additional protections for patients that would not already be offered by the requirement for hospitals to disclose their physician ownership to patients. We have revisited this issue.

In the FY 2008 IPPS final rule with comment period, we stated that the scheduling of most hospital inpatient or outpatient services is performed by a staff member in the physician's office, often weeks, or even months, in advance of the furnishing of the service. As discussed previously, we believe that early notification of physician ownership or investment in the hospital is beneficial to the patient's decisionmaking concerning his or her treatment. Currently, under § 489.20(u), scheduling of inpatient stays and outpatient visits at physician-owned hospitals would be permitted without notification to the patient of the referring physician's ownership or investment interest in the hospital. If a patient were notified of the physician ownership or investment at the time of the referral, he or she would have an opportunity to discuss the physician's ownership or investment in the hospital and make a more informed decision. We believe that it would be in the best interests of the patient and the physician owner or investor to disclose the physician's (or his or her immediate family member's) ownership in the hospital at the time the physician is referring the patient to the hospital. We are revising § 489.20(u) accordingly.

We note that notification of physician ownership or investment in a hospital may not be viewed negatively by all interested parties. For instance, some physician owners or investors in hospitals believe that disclosing their ownership or investment interests in the hospital to their patients at the time of the referral is extremely beneficial for both the physician and the patient. They communicate to patients their belief that their ownership in the hospital permits them to have total control over scheduling, staffing, and quality mechanisms. Section 5006 of the Medicare, Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) required, among other things, that HHS study the quality of care and patient satisfaction with specialty hospitals. HHS concluded that specialty hospital patients have very favorable perceptions of the clinical quality of care they receive, and that overall patient satisfaction is very high.

We are also proposing to revise § 489.53 to permit CMS to terminate the Medicare provider agreement if the hospital fails to comply with the provisions of proposed § 489.20(u)(1) or (u)(2). We believe that these revisions would be necessary to enforce the proposed disclosure requirements set forth in § 489.20.

We are not inclined to make a corresponding change to the medical staff bylaws condition of participation (CoP) in § 482.22(c). We believe that the proposed disclosure requirement is appropriate for inclusion in the regulations governing Medicare provider agreements for the following reasons. As stated in the FY 2008 IPPS final rule with comment period, each participating provider must comply with all applicable provisions of the provider agreement regulations found in 42 CFR Part 489, and CMS may terminate a provider agreement if the provider is not in substantial compliance with these requirements (72 FR 47391). A provider's compliance with applicable provider agreement regulations is reviewed through a variety of means, including onsite investigation of complaints. Thus, compliance with this proposed requirement could be easily monitored. We also note that any revisions to the medical staff bylaws concerning the requirement that the disclosure be given at the time of the referral would be difficult to enforce as a CoP because the required notification generally would be given outside of the hospital's or CAH's premises. However, we are considering whether these proposed changes would be better effectuated through changes to our regulations governing the CoPs applicable to hospitals and CAHs, which appear at 42 CFR Part 482 and 42 CFR Part 485, Subpart F, respectively, and, therefore, we are soliciting public comments on this issue.

In the FY 2008 IPPS final rule with comment period, we added a new provision at § 489.20(v) to require that hospitals and CAHs: (1) Furnish all patients written notice at the beginning of their inpatient hospital stay or outpatient service if a doctor of medicine or a doctor of osteopathy is not present in the hospital 24 hours per day, 7 days per week; and (2) describe how the hospital or CAH will meet the medical needs of any patient who develops an emergency medical condition at a time when no physician is present in the hospital (72 FR 47387). (We are proposing to redesignate existing § 489.20(v) and (w) as § 489.20(w) and (x), respectively, to accommodate the addition of the proposed exception to the requirements in § 489.20(v) discussed above.) We stated that it is important to ensure that consumers are provided accurate information on the availability of physician services at the point when they are about to become patients of a hospital or CAH. In order to be fully informed, consumers should be made aware of whether a hospital or CAH has a physician on-site 24 hours per day, 7 days per week, and should be made aware of the hospital's or CAH's processes for addressing medical emergencies that may occur when a physician is not on site. Given the patient safety measures addressed by these provisions, we are proposing to set forth penalties for failure to comply with these requirements. Specifically, we are proposing to revise § 489.53 to permit CMS to terminate the provider agreement of any hospital or CAH that fails to comply with the requirements set forth in proposed redesignated § 489.20(w).

We are also soliciting public comments on whether hospitals and CAHs should educate patients about the availability of information regarding physician ownership under the proposed disclosure requirements and, if so, by what means (for example, by a posting in the admissions office or in a patient brochure).

VIII. Physician Self-Referral Provisions (§§ 411.351, 411.352 and 411.354)

A. Stand in the Shoes Provisions

1. Physician "Stand in the Shoes" Provisions

a. Background

Section 1877 of the Act, also known as the physician self-referral law: (1) Prohibits a physician from making referrals for certain designated health services ("DHS") payable by Medicare to an entity with which he or she (or an immediate family member) has a financial relationship (ownership, investment or compensation), unless an exception applies; and (2) prohibits the entity from filing claims with Medicare (or billing another individual, entity, or third party payor) for those referred services. The statute establishes a number of specific exceptions and grants the Secretary the authority to create regulatory exceptions for financial relationships that pose no risk of program or patient abuse. Determining whether DHS entities and referring physicians (or their immediate family members) have direct or indirect financial relationships is a key step in applying the statute.

In the final rule entitled "Medicare Program; Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships (Phase III)," published in the Federal Register on September 5, 2007 (72 FR 51012) ("Phase III"), we interpreted certain provisions of section 1877 of the Act, including provisions relating to direct and indirect compensation arrangements. Specifically, the Phase III final rule included provisions under which referring physicians are treated as standing in the shoes of their physician organizations for purposes of applying the rules that describe direct and indirect compensation arrangements in § 411.354 (72 FR 51026 through 51030). A "physician organization" is defined at § 411.351 as "a physician (including a professional corporation of which the physician is the sole owner), a physician practice, or a group practice that complies with the requirements of § 411.352." Therefore, when determining whether a direct or indirect compensation arrangement exists between a physician and an entity to which the physician refers Medicare patients for DHS, the referring physician stands in the shoes of: (1) Another physician who employs the referring physician; (2) his or her wholly-owned professional corporation ("PC"); (3) a physician practice (that is, a medical practice) that employs or contracts with the referring physician or in which the physician has an ownership interest; or (4) a group practice of which the referring physician is a member or independent contractor. The referring physician is considered to have the same compensation arrangements (with the same parties and on the same terms) as the physician organization in whose shoes the referring physician stands.

Subsequent to the publication of Phase III, industry stakeholders, including academic medical centers ("AMCs"), integrated tax-exempt health care delivery systems, and their representatives, expressed concern about the application of the Phase III "stand in the shoes" provisions to compensation arrangements involving "mission support payments" and "similar payments" (referred to in this proposed rule generally as "support payments"). The stakeholders believed that certain payments did not previously trigger application of the physician self-referral law but, after Phase III, need to satisfy the requirements of an exception. One example offered was a DHS entity component (such as a hospital) of an AMC that transfers funds to the faculty practice plan component of the AMC. If a referring physician stands in the shoes of his or her faculty practice plan, the compensation arrangement between the hospital providing the support payment and the faculty practice plan will be considered to be a direct compensation arrangement between the hospital and the physician and would need to satisfy the requirements of a direct compensation arrangement exception, if the physician is to continue referring Medicare patients to the component for DHS. According to the industry stakeholders, before Phase III, such arrangements would have been analyzed under the rules regarding indirect compensation arrangements and would, in their view, have been permitted. After Phase III, in their view, it is unlikely that the requirements of an available exception could be satisfied given the nature of support payments; that is, support payments usually are not tied to specific items or services provided by the faculty practice plan (or group practice within an integrated health care delivery system), but rather are intended to support the overall mission of the AMC or maintain operations in an integrated health care delivery system. For this reason, support payments likely do not satisfy the requirement, present in many exceptions, that the compensation be fair market value for items or services provided. Similarly, some stakeholders raised concerns about support payments made from faculty practice plans to AMC components. Although AMCs are free to use the exception for services provided by an AMC in § 411.355(e) (which would protect support payments made among AMC components if all of the conditions of the exception are met), industry stakeholders explained that many AMCs do not do so, preferring instead to rely on other available exceptions and the rules regarding indirect compensation arrangements (especially prior to Phase III).

To provide CMS sufficient time to study the "stand in the shoes" provisions as they relate to compensation arrangements involving support payments, seek additional public comment, and develop an approach for addressing this issue, on November 15, 2007, we issued a final rule entitled "Medicare Program; Delay of the Date of Applicability for Certain Provisions of Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships (Phase III)" (72 FR 64164) that delayed the effective date of the provisions in § 411.354(c)(1)(ii), § 411.354(c)(2)(iv), and § 411.354(c)(3) for 12 months after the effective date of Phase III (that is, until December 4, 2008). That final rule was applicable to the following compensation arrangements between the following physician organizations and entities ONLY:

• With respect to an AMC as described in § 411.355(e)(2), compensation arrangements between a faculty practice plan and another component of the same AMC; and

• With respect to an integrated section 501(c)(3) health care system, compensation arrangements between an affiliated DHS entity and an affiliated physician practice in the same integrated section 501(c)(3) health care system.

Following the publication of the November 15, 2007 final rule, other industry stakeholders asserted that, in addition to section 501(c)(3) health care systems, most integrated health care delivery systems, including ones involving for-profit entities, make support payments. The stakeholders further asserted that, although under the "stand in the shoes" provisions such payments must now satisfy a direct compensation arrangement exception, there is, in fact, no applicable exception. These stakeholders urged that any approach to addressing the impact of the Phase III "stand in the shoes" provisions on support payments and other monetary transfers within integrated health care delivery systems should have universal applicability that is not dependent on whether the system meets the definition of an AMC or has a particular status under the rules of the Internal Revenue Service.

b. Proposals

Given the potential widespread impact of the "stand in the shoes" provisions, as well as the considerable industry interest in their application, we are revisiting the "stand in the shoes" policy and regulations issued in Phase III. We believe that a more refined approach to the "stand in the shoes" provisions would accomplish our goals of simplifying the analysis of many financial arrangements and reducing program abuse by bringing more financial relationships within the scope of the physician self-referral law (such as certain potentially abusive arrangements between DHS entities and physician organizations that may not have met the definition of an "indirect compensation arrangement"). We note that we are not suggesting that support payments and other similar compensation arrangements are without risk of program or patient abuse, nor are we endorsing such payments and arrangements.

We are proposing here two alternative ways to address the "stand in the shoes" issues described above, and are seeking industry input on each proposal, as well as on other possible approaches. The first is a multi-faceted approach to revising the Phase III "stand in the shoes" provisions. The second proposal would leave the Phase III "stand in the shoes" provisions as promulgated and would, instead, create a new exception using our authority under section 1877(b)(4) of the Act for nonabusive arrangements that warrant protection not available under existing exceptions. We are also interested in public comments on other approaches and on whether changes to the existing "stand in the shoes" provisions are needed at all.

For the first proposal, we propose revising § 411.354(c)(2)(iv) to provide that a physician would be deemed not to stand in the shoes of his or physician organization if the compensation arrangement between the physician organization and the physician satisfies the requirements of the exception in § 411.357(c) (for bona fide employment relationships), the exception in § 411.357(d) (for personal service arrangements), or the exception in § 411.357(l) (for fair market value compensation). Currently, all physicians stand in the shoes of their physician organizations, regardless of the nature of the compensation they receive from the physician organization. Under our proposal, the first step in the analysis would be to look at the compensation a referring physician receives from his or her physician organization. A compensation arrangement between a physician organization and a physician that satisfies the requirements of § 411.357(c), (d), or (l) would be consistent with fair market value by design and not determined in a manner that takes into account (directly or indirectly) the volume or value of any referrals by the physician to the physician organization . Although such compensation could, in some circumstances, be determined in a manner that takes into account (directly or indirectly) the volume or value of the physician's referrals to the DHS entity (see 66 FR 869), we believe that the risk of program or patient abuse will be addressed sufficiently by analyzing such arrangements between DHS entities and referring physicians who do not stand in the shoes of their physician organizations using the rules regarding indirect compensation arrangements. Therefore, under this proposal, if the compensation arrangement between a physician organization and one of its referring physicians satisfies the requirements of one of the exceptions noted above, the referring physician would be deemed not to stand in the shoes of the physician organization for purposes of applying the definitions of, and provisions related to, direct and indirect compensation arrangements in § 411.354(c). Arrangements between DHS entities and physician organizations whose physicians do not stand in their shoes may still create indirect compensation arrangements that would need to satisfy the requirements of the exception for indirect compensation arrangements in § 411.357(p).

Under this first proposed approach, physician owners and investors would continue to stand in the shoes of their physician organizations. However, we are concerned that considering all physician owners of, or physician investors in, a physician organization to stand in the shoes of the physician organization, as they currently do under the Phase III "stand in the shoes" provisions, might be over-inclusive. For example, in a State that prohibits the corporate practice of medicine, a physician owner of a captive or "friendly" PC who has no right to the distribution of profits would stand in the shoes of his or her physician organization, even though his or her employment arrangement with the group satisfies the requirements of the exception for bona fide employment relationships in § 411.357(c). We are considering whether these and similarly situated physician owners should have to stand in the shoes of their physician organizations when their ownership interest is nominal in nature and their compensation arrangement with the physician organization satisfies the requirements of one of the exceptions in § 411.357(c), (d), or (l). We are soliciting public comments on this issue.

As described above, a physician-employee or contractor whose compensation arrangement with a physician organization does not satisfy the requirements of § 411.357(c), (d), or (l) would stand in the shoes of the physician organization. This is necessary to address our concern that an arrangement between a DHS entity and a physician organization that compensates its physicians in a manner that does not satisfy the requirements of an exception may be particularly prone to abuse. For example, where a physician-employee's compensation arrangement with his or her group practice exceeds fair market value for services provided to the group practice employer (and, thus, does not satisfy the requirements of the exception in § 411.357(c)), and the physician-employee's DHS referrals to the group practice instead are protected under the exception for in-office ancillary services in § 411.355(b), there is risk that the physician-employee's above-fair-market-value compensation may reflect the volume or value of referrals to the DHS entity. This could be the result of a support or other payment between the DHS entity and the group practice that is designed to channel compensation to the physician-employee for referrals to the DHS entity.

We are also considering, and solicit comments on, an approach under which only owners of a physician organization would stand in the shoes of that physician organization (in which case, a physician would not stand in the shoes of a physician organization unless he or she holds an ownership or investment interest, even if the physician's compensation arrangement with that physician organization does not satisfy the requirements of § 411.357(c), (d), or (l)). In conjunction with this approach, we are interested in receiving comments on whether and under what circumstances the "stand in the shoes" provisions should apply to a physician organization that has no physician owners.

In this first approach, we also propose to revise § 411.354(c)(3)(ii) to provide that the provisions of §§ 411.354(c)(1)(ii) and (c)(2)(iv) do not apply when the requirements of § 411.355(e) are satisfied. In other words, a physician would not stand in the shoes of his or her physician organization (for example, a faculty practice plan) when his or her referral for DHS is protected under the exception in § 411.355(e) for services provided by an AMC. We note that, if all of the requirements of the exception in § 411.355(e) are not satisfied, a physician would stand in the shoes of his or her physician organization unless, as discussed above with respect to proposed revised § 411.354(c)(2)(iv), the compensation from the physician organization to the physician satisfies the requirements of the exception for bona fide employment relationships, the exception for personal service arrangements, or the exception for fair market value compensation in § 411.357(c), (d), and (l), respectively. We are proposing to include a specific revision to the regulation in § 411.354(c)(2)(iv); however, we are seeking public comment as to whether this policy is better achieved by revising § 411.354(c)(3) to delete the reference to applying the exceptions in § 411.355, and thereby providing that the "stand in the shoes" provisions do not apply where the prohibition on referrals is not applicable because all of the requirements of any of the exceptions in § 411.355 are satisfied.

In this first approach, we also propose to revise § 411.354(c)(3)(ii) to provide that the provisions of § 411.354(c)(1)(ii) and (c)(2)(iv) do not apply when compensation is provided by a component of an AMC to a physician organization affiliated with that AMC through a written contract to provide services required to satisfy the AMC's obligations under the Medicare graduate medical education (GME) rules where the contract is limited to only services necessary to fulfill the GME obligations as set forth in 42 CFR, Part 413, Subpart F. We have in mind certain arrangements between a hospital component of an AMC and a community physician group to serve as a teaching site for the AMC's residents, as required by the GME rules. If adopted, this proposal would not mean that such arrangements necessarily are lawful, but rather that they would be analyzed by applying the rules regarding indirect compensation arrangements.

Under this first proposal, if adopted, some referring physicians would no longer stand in the shoes of their physician organizations as they currently do under the Phase III "stand in the shoes" provisions. In such circumstances, the rules regarding direct and indirect compensation arrangements would still apply, and financial relationships would still need to be analyzed for compliance with the statute and regulations. We are concerned that, where physicians do not stand in the shoes of their physician organizations, some potentially abusive arrangements between DHS entities and physician organizations might be viewed incorrectly as falling outside the definition of an "indirect compensation arrangement" at § 411.354(c)(2) and, therefore, as not within the scope of the physician self-referral law. The definition of "indirect compensation arrangement" generally requires that three elements be present: (1) An unbroken chain of financial relationships between the DHS entity and the referring physician; (2) aggregate compensation to the referring physician (from the entity in the chain closest to the physician) that varies with or takes into account in any manner the volume or value of referrals to, or other business generated for, the DHS entity; and (3) knowledge by the DHS entity that the referring physician receives such compensation. (We refer readers to 66 FR 864 through 870, 69 FR 16057 through 16063, and 72 FR 51026 through 51031 for further explanation.) We believe that some parties may be construing these elements (particularly the second and the third) too narrowly. For example, we believe that aggregate compensation can vary with or take into account the volume or value of referrals to, or business generated for, DHS entities in a wide range of circumstances, including, without limitation, arrangements involving: variable, per-click, or percentage-based compensation; exclusive contracts; inflated fixed payments; or explicit or implicit tying of compensation to other referrals. To address this issue, we may provide additional guidance on the application of the three elements of the definition of "indirect compensation arrangement" in the FY 2009 IPPS final rule. We are interested in public comments regarding ways in which we can ensure that the full range of potentially abusive arrangements between DHS entities and physician organizations are appropriately addressed in situations where physicians do not stand in the shoes of their physician organizations.

As discussed above, we are proposing an alternative approach to addressing the Phase III "stand in the shoes" provisions. (However, we are proposing regulation text for the first proposal only.) Our alternative proposal is to make no revisions to the Phase III "stand in the shoes" provisions in §§ 411.354(c)(1)(ii), (c)(2)(iv), and, (c)(3) and, to the extent necessary to protect nonabusive arrangements, promulgate a separate exception using our authority under section 1877(b)(4) of the Act to create exceptions for arrangements that do not pose a risk of program or patient abuse. The new exception would apply to specific types of nonabusive payments or arrangements that are not otherwise covered by existing exceptions (for example, certain support payments, as described above), subject to conditions necessary to protect against program and patient abuse, similar to those conditions incorporated into the existing exception for services provided by an AMC in § 411.355(e). Specifically, we are considering establishing a new exception, using our authority under section 1877(b)(4) of the Act, for compensation arrangements between DHS entities and physician organizations and physicians for "mission support" payments (or similar compensation arrangements) and, if so, how we should define those payments (or similar compensation arrangements), and what criteria such an exception should include to protect against program or patient abuse. We are soliciting comments about this proposal, including whether an exception should be limited to "mission support" payments, whether other specific types of payments or compensation arrangements should be eligible for such an exception, the types of parties that should be permitted to use the exception (for example, AMC components, physician practices), and the conditions that should apply to such an exception to ensure that a protected compensation arrangement poses no risk of program or patient abuse. We are concerned that some "mission support" payments or similar payments are subject to fraud and abuse. We are interested in public comments that identify with specificity the types of compensation agreements that should be permitted under an applicable exception.

Under this approach, the proposed exception might address compensation arrangements between components of certain well-defined integrated delivery systems, perhaps with tightly-crafted conditions similar to those in the existing exception for services provided by an AMC in § 411.355(e). For example, some industry stakeholders have recommended that we establish an exception for compensation arrangements between a DHS entity component of an integrated health care delivery system and a physician organization component of the same integrated health care delivery system. We are concerned that the term "integrated health care delivery system" is loosely used in the industry to describe a wide variety of systems, with varying degrees of actual integration, and that it may prove infeasible to craft a sufficiently circumscribed definition. In many circumstances, payment arrangements between components of "integrated health care delivery systems," as well as payments from "integrated health care delivery systems" to physicians affiliated with those systems are susceptible to fraud and abuse. However, we are soliciting public comments defining a fully integrated health care delivery system, what types of compensation arrangements should be protected (for example, support payments), and what conditions should be included in an exception that would ensure no risk of program or patient abuse. We note that any exception established using our authority under section 1877(b)(4) of the Act would include documentation requirements and a requirement that the arrangement not violate the anti-kickback statute or any Federal or State law or regulation governing billing or claims submission, consistent with the existing exceptions created under this authority.

According to some industry stakeholders, an "integrated health care delivery system" could be defined, for example, as a health care delivery system comprised of two or more entities that are related and substantially integrated by common ownership or control, and which includes at least one hospital and one physician organization that has no physician owners or investors who make referrals for DHS to any component of the health care delivery system. Entities that file consolidated financial statements could be deemed to be substantially integrated for purposes of this definition. For purposes of this approach, ownership could exist if an individual or individuals possess 50 percent ownership or equity in the component of the integrated health care delivery system, and control would exist if an individual or an organization has the power, directly or indirectly, significantly to influence or direct the actions or policies of the component of the integrated health care delivery system. As noted above, it would be necessary to define "integrated health care delivery system," as well as "ownership" and "control," and to determine whether to permit integrated health care delivery systems to include entities related through written contractual affiliation agreements and, if so, what limitations (if any) should be placed on the types of contractually affiliated entities we would permit to be included as components of an integrated health care delivery system. We would need also to determine what characteristics indicate substantial integration and identify the types of compensation arrangements that exist between components of integrated health care delivery systems. We are seeking public comments regarding this possible approach (including the specific issues noted), as well as public comments on other alternative approaches to addressing the concerns regarding support payments and similar monetary transfers noted by industry stakeholders and described above.

2. DHS Entity "Stand in the Shoes" Provisions

On July 12, 2007, we published in the Federal Register a proposed rule entitled "Medicare Program; Proposed Revisions to Payment Policies Under the Physician Fee Schedule, and Other Part B Payment Policies for CY 2008; Proposed Revisions to the Payment Policies of Ambulance Services Under the Ambulance Fee Schedule for CY 2008; and the Proposed Elimination of the E-Prescribing Exemption for Computer-Generated Facsimile Transmissions; Proposed Rule" (the "CY 2008 PFS proposed rule") (72 FR 38122). In that rule, we proposed a corollary provision to the Phase III "stand in the shoes" provisions that addressed the DHS entity side of physician-DHS entity financial relationships. Specifically, we proposed to amend § 411.354(c) to provide that, where a DHS entity owns or controls an entity to which a physician refers Medicare patients for DHS, the DHS entity would stand in the shoes of the entity that it owns or controls and would be deemed to have the same compensation arrangements with the same parties and on the same terms as does the entity that it owns or controls. For example, a hospital would stand in the shoes of a medical foundation that it owns or controls (such as where the hospital is the sole member of a nonprofit corporation). Thus, under the CY 2008 PFS proposed rule proposal, if a hospital owns or controls a medical foundation that contracts with a physician to provide physician services at a clinic owned by the medical foundation, the hospital would stand in the shoes of the medical foundation and would be deemed to have a direct compensation relationship with the contractor physician. We solicited public comments as to whether and how we would employ a "stand in the shoes" approach for these types of relationships, as well as for other types of financial relationships.

In response to the CY 2008 PFS proposed rule, we received comments from a variety of industry stakeholders, including physicians, medical associations, and their representatives. Although several commenters supported the proposed entity "stand in the shoes" provisions because they share our concerns regarding parties ability to avoid application of the physician self-referral law by simply inserting an entity in the chain of financial relationships linking a DHS entity and a referring physician, many commenters expressed concern that the proposal was unclear and potentially overly broad. Commenters requested guidance regarding the level of ownership or control that would trigger the application of the entity "stand in the shoes" provisions. One commenter recommended that, instead of finalizing the entity "stand in the shoes" provisions, we issue, through a notice of proposed rulemaking, a more detailed proposal that would give industry stakeholders the opportunity to provide more meaningful comments.

We did not finalize the DHS entity "stand in the shoes" provisions in the CY 2008 PFS final rule published in the Federal Register on November 27, 2007 (72 FR 66222, 66306). Because the DHS entity "stand in the shoes" provisions are integrally related to the physician "stand in the shoes" provisions that we finalized in Phase III and for which we are proposing the regulatory revisions described above, we are re-proposing here the DHS entity "stand in the shoes" provisions, with some modification. We believe that a comprehensive approach to the "stand in the shoes" provisions that addresses both physicians and physician organizations, as well as DHS entities and other entities that they own or control, is the best vehicle to address the goals outlined in the Phase III final rule, namely: (1) Simplifying the analysis of many financial arrangements; and (2) reducing program abuse by bringing more financial relationships within the ambit of the physician self-referral law.

We are proposing to revise § 411.354(a) to provide that an entity that furnishes DHS would be deemed to stand in the shoes of an organization in which it has a 100 percent ownership interest and would be deemed to have the same compensation arrangements with the same parties and on the same terms as does the organization that it owns. We believe this approach is straightforward and can be readily applied. We note that, under this approach (as compared to our CY 2008 PFS proposal), a DHS entity would stand in the shoes of any wholly-owned organization, not merely a wholly-owned DHS entity. An organization may be in any legal form (for example, a limited liability company, partnership, or corporation, regardless of status as nonprofit or exempt from taxation). We are seeking public comments specifically as to whether we should consider a DHS entity to stand in the shoes of another organization in which the DHS entity holds less than a 100 percent ownership interest and, if so, what amount of ownership should trigger application of the entity "stand in the shoes" provisions. In addition, we are seeking public comments as to whether we should deem a DHS entity to stand in the shoes of an organization that it controls (for example, an entity would stand in the shoes of a nonprofit organization of which it is the sole member); we would consider a DHS entity to control an organization if the DHS entity has the power, directly or indirectly, significantly to influence or direct the actions or policies of the organization. We are seeking public comments as to what level of control should trigger the application of the entity "stand in the shoes" provisions.

3. Application of the Physician "Stand in the Shoes" and the Entity "Stand in the Shoes" Provisions

In order to protect against program and patient abuse when multiple links involving various corporate and other entities exist in a chain of financial relationships between a DHS entity and a referring physician, we are proposing that, when applying the physician "stand in the shoes" provisions and the entity "stand in the shoes" provisions to a chain of financial relationships between a physician and a DHS entity, the following conventions would apply:

• First, parties would apply the physician "stand in the shoes" provisions and deem the physician to stand in the shoes of his or her physician organization (in those instances where the physician "stand in the shoes" provisions apply to the particular physician and physician organization).

• However, if applying the physician "stand in the shoes" provisions would result in only one financial relationship remaining between the DHS entity and the "collapsed" physician/physician organization and that relationship is an ownership interest, the physician "stand in the shoes" provisions would not be applied, and the entity "stand in the shoes" provisions instead would be applied first.

• If more than two organizations remain after first "collapsing" the physician and the physician organization (that is, if at least two links remain in the chain of financial relationships between the physician who is standing in the shoes of his or her physician organization and the DHS entity), the next step would be to apply the entity "stand in the shoes" provisions.

These conventions ensure that at least one compensation arrangement remains between the DHS entity and the referring physician for purposes of analyzing the chain of relationships under the physician-self referral rules. For example, if a chain of financial relationships runs: hospital-wholly-owned home health agency-group practice-physician owner of the group practice, the first step would be to apply the physician "stand in the shoes provisions" such that the physician owner would stand in the shoes of the group practice. The next step would be to apply the entity "stand in the shoes" provisions and deem the hospital to stand in the shoes of its wholly-owned home health agency. Assuming that the financial relationship between the home health agency and the group practice is a compensation arrangement, the remaining financial relationship would be deemed to be a direct compensation arrangement between the hospital (standing in the shoes of the home health agency) and the physician (standing in the shoes of the group practice). By contrast, the example of a chain of financial relationships that runs: hospital-group practice wholly-owned by the hospital-employed physician of the group practice (whose compensation does not satisfy the requirements of the exception in § 411.357(c)), is illustrative. If the relationship between the hospital and the group practice is solely an ownership interest (that is, there is no separate compensation arrangement between them), applying the physician "stand in the shoes" provisions first, so that the physician-employee stands in the shoes of the group practice, would result in one remaining financial link between the group practice and the hospital, and that relationship would be an ownership interest. In those circumstances, the entity "stand in the shoes" provisions would be applied first and the hospital would stand in the shoes of its wholly-owned group practice. The physician would not stand in the shoes of the group practice. The remaining financial relationship would be deemed to be a direct compensation arrangement between the hospital (standing in the shoes of the group practice) and the physician. (We note that, in this example, the physician's compensation from the group practice does not satisfy the requirements of the exception for bona fide employment relationships in § 411.357(c) and, thus, no direct exception would apply to that compensation arrangement.) Using the same chain of financial relationships, but assuming instead that the hospital has a compensation arrangement with (in addition to being the sole owner of) the group practice (for example, an office space rental agreement), under the proposals described above, the physician would stand in the shoes of the group practice, but the hospital would not stand in the shoes of the group practice because, after first applying the physician "stand in the shoes" provisions, only two organizations would remain (that is, only one link in the chain of financial relationships remains). The remaining financial relationship created by the rental agreement would be deemed to be a direct compensation arrangement between the hospital and the physician, which would need to satisfy the requirements of an exception.

We are not proposing regulation text at this time with respect to the application of the physician and entity "stand in the shoes" provisions. At such time as these provisions are finalized, we would amend the regulation text, as appropriate, to codify requirements related to the application of the provisions.

4. Definitions: "Physician" and "Physician Organization"

In an interim final rule with comment period entitled "Medicare Program; Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships (Phase II); Interim Final Rule," published in the Federal Register on March 26, 2004 (72 FR 16054) ("Phase II"), we revised the definition of "referring physician" at § 411.351 to provide that a referring physician is deemed to stand in the shoes of his or her wholly-owned PC (69 FR 16060). In that rule, we stated that it is not necessary to treat a referring physician as separate from his or her wholly-owned PC. In the Phase III final rule, for purposes of implementing the physician "stand in the shoes" provisions, the term "physician organization" was newly defined at § 411.351 as "a physician (including a professional corporation of which the physician is the sole owner), a physician practice, or a group practice that complies with the requirements of § 411.352." Our intent was that, when applying the physician "stand in the shoes" provisions in § 411.354, a physician would stand in the shoes of: (1) Another physician who employs the physician; (2) his or her wholly-owned PC; (3) a physician practice that employs or contracts with the physician or in which the physician has an ownership interest; or (4) a group practice of which the physician is a member or independent contractor.

Essentially, we intended this definition to incorporate the Phase II policy that a physician stands in the shoes of, or is considered the same as, the PC of which he or she is the sole owner. In determining whether a direct or indirect compensation arrangement exists between a DHS entity and a referring physician, we intended that parties should first "collapse" the physician into his or her wholly-owned PC, and then deem that "collapsed" physician/PC unit to stand in the shoes of the physician organization (if one exists). However, we are concerned that parties may interpret the rules, using the definition of "physician organization" exclusive of the definition of "referring physician," as requiring only that they deem a physician to stand in the shoes of his or her wholly-owned PC without further deeming the "collapsed" physician/PC unit to stand in the shoes of the physician organization. That is, with respect to a chain of financial relationships that runs: hospital-group practice-PC-physician, parties might interpret our rules as requiring only that the physician stand in the shoes of the PC and not in the shoes of the group practice, so that the resulting chain of financial relationships (after the application of the "stand in the shoes" provisions) would run: hospital-group practice-PC/physician. However, our intention was that, after application of the "stand in the shoes" provisions, the chain of financial relationships would run: hospital-group practice/PC/physician.

Therefore, we are proposing revisions to the definitions of "physician" and "physician organization" to clarify that: (1) A physician and the PC of which he or she is the sole owner are always treated the same for purposes of applying the physician self-referral rules; and (2) a physician who stands in the shoes of his or her wholly-owned PC also stands in the shoes of his or her physician organization in accordance with § 411.354(c)(1)(ii) and (c)(2)(iv).

B. Period of Disallowance

In response to the Phase II interim final rule with comment period, several commenters questioned what the time period would be for which the physician could not refer patients for DHS to an entity and for which the entity could not bill Medicare (the "period of disallowance") where a financial relationship between a referring physician and an entity failed to satisfy the requirements of an exception to the general prohibition on self-referral. ( See 72 FR 51024 through 51025; and 72 FR 38183.) In the Phase III final rule, in response to these inquiries, we stated that the statute provides no explicit limitation on the billing and claims submission prohibition (72 FR 51025). In the CY 2008 PFS proposed rule, we stated that the statute contemplates that the period of disallowance begins with the date that a financial relationship failed to comply with the statute and the regulations, and ends with the date that the arrangement came into compliance or ended (72 FR 38183). We noted that, in some cases, it may not be clear when a financial relationship has ended. We provided the example of an entity leasing space to a physician at a rental price that is substantially below fair market value. We stated that such an arrangement may raise the inference that the below-market rent was in exchange for future referrals, including referrals made beyond the expiration of the lease. We solicited comments with respect to: (1) The types of noncompliance for which it is not clear when a financial relationship ended; and (2) whether we should always employ a case-by-case approach or deem certain types of financial relationships to continue for a prescribed period of time. We also solicited public comments as to whether we should allow a prescribed period of disallowance to terminate where the parties have returned (or paid back the value of) any excess compensation. For example, if we were to impose a period of disallowance for a prescribed period of time because it would not be clear when a noncompliant compensation arrangement ended, we stated that we might allow the parties to terminate the period of disallowance sooner than the prescribed period if the prohibited compensation were returned. In the CY 2008 PFS proposed rule, we cautioned that we did not envision allowing such an option where the parties knew or, in our judgment, reasonably should have known, that the arrangement did not satisfy the requirements of an exception. Finally, we sought public comments as to whether we should impose a period of disqualification, prohibiting the parties from using an exception where an arrangement has failed to satisfy the requirements of that exception. We gave the example of nonmonetary compensation provided by an entity to a physician that greatly exceeded the permissible limit prescribed in § 411.357(k), and questioned whether, in addition to whatever period of disallowance would apply, the parties should be disqualified, for some period of time, from using this exception.

We received few public comments in response to the CY 2008 PFS proposed rule solicitation of comments; however, with respect to the length of the period of disallowance, one commenter asserted that the appropriate period of disallowance should match the period that the financial relationship did not satisfy the requirements of an exception, but that the period should be limited to a maximum term. In addition, commenters asserted that, if the parties unwind the relationship and return the prohibited compensation, the period of disallowance should end. Another commenter suggested that the period of disallowance should end once the hospital corrects or terminates the arrangement and the physician repays to the hospital any compensation in excess of what is permitted. Alternatively, according to the commenter, if the physician does not repay the excess compensation, the period of disallowance should end once the hospital repays to Medicare the excess compensation, and the hospital should be prohibited from paying any further compensation to the physician until the physician reimburses the hospital for the excess compensation. One commenter asserted that certain circumstances warrant no period of disallowance. For instance, according to the commenter, if parties to an arrangement were unaware that the arrangement violates the physician self-referral law but later were notified by CMS or its contractor of the possible violation, they should be able to amend the arrangement so that it satisfies the requirements of an exception without any period of disallowance. The commenter also asserted that there should be no period of disqualification preventing the parties from using an exception in light of the onerous penalties under the physician self-referral law.

At this time, we are proposing to amend § 411.353(c) to provide that, where the reason(s) a financial relationship does not meet any applicable exception is not related to compensation (for example, a signature is missing or an agreement is not in writing as required by the applicable exception), the period of disallowance would begin on the date the arrangement first was out of compliance and end no later than the date the arrangement was brought into compliance (for example, by obtaining a missing signature on an agreement or executing a written agreement as required by the applicable exception). For example, where a hospital and a physician enter into a personal service arrangement for medical director services and begin performing under the arrangement on January 1, but do not execute a written agreement until January 31, provided that all of the requirements of § 411.357(d) (the exception for personal service arrangements) are satisfied as of January 31, the period of disallowance would begin on January 1 and end no later than January 31. As discussed below, we believe that it is possible that a financial arrangement may end prior to the arrangement being brought into compliance. In such circumstances, a determination as to the duration of the period of disallowance necessarily would be made on a case-by-case basis considering the facts and circumstances, and we are not proposing a prescribed period of disallowance for such a situation.

We are also proposing that, where the reason a financial relationship does not meet any applicable exception is related to the payment or receipt of excess compensation (for example, the compensation paid to a physician is greater than fair market value or exceeds the limits in § 411.357(k) or (m)), the period of disallowance would begin on the date the arrangement first was out of compliance and end no later than the date the excess compensation (including interest, as appropriate) was returned by the party receiving it to the party that provided it and all other requirements of the applicable exception are met. For example, if a hospital provided nonmonetary compensation totaling $100 in excess of the limits in § 411.357(k) on February 1 and the parties did not discover the noncompliance until October 1 (and, therefore, could not avail themselves of the provisions in § 411.357(k)(3) permitting parties to remain in compliance with the exception if excess nonmonetary compensation (within certain limits) provided inadvertently is discovered and returned with 180 days of its receipt), the period of disallowance would begin on February 1 and end no later than the date that the physician returned the excess nonmonetary compensation or its value ($100 plus interest, as appropriate) to the hospital. Assuming that the physician paid the hospital $100 (plus interest, as appropriate) on October 15, the period of disallowance would run from February 1 through no later than October 15.

Our proposal would also prescribe a period of disallowance where the reason a financial relationship does not meet any applicable exception is related to the payment or receipt of compensation that is insufficient to satisfy the requirements of an exception (for example, office space or equipment rental payments that are below fair market value). We are proposing that the period of disallowance would begin on the date the arrangement first was out of compliance and end no later than the date the shortfall was paid to the party to which it is owed and all other requirements of the applicable exception are met. The "shortfall" would be that amount (including interest, as appropriate) necessary to bring the arrangement into compliance from the date of its inception. For example, assume a hospital and physician entered into a 2-year office space rental agreement on January 1 (of Year 1) which specified rental charges (consistent with fair market value) of $20 per square foot during Year 1 and automatically adjusted upward each January 1 by any increase in the CPI-U. If, on January 1 of Year 2 of the agreement, the rental charges increased to $21 per square foot based on the amount of increase in the CPI-U, but the physician continued to pay $20 per square foot until the compliance failure was identified on June 30 of Year 2, the period of disallowance would run from January 1 of Year 2 until no later than June 30 of Year 2, provided that the physician paid the hospital on June 30 of Year 2 the shortfall of $1 per square foot for the 6-month shortfall period (plus interest, as appropriate) and, as of July 1 through the term of the agreement, the physician paid $21 per square foot for the office space, and the arrangement otherwise satisfied the requirements of the exception in § 411.357(d). As discussed below, we believe that it is possible that an arrangement may end prior to excess compensation being returned or a shortfall being paid; however, such a determination as to the duration of the period of disallowance necessarily would be made on a case-by-case basis considering the facts and circumstances, and we are not proposing a prescribed period of disallowance for such a situation.

We also note that an arrangement may be noncompliant for reasons that are related to compensation, but which do not involve the payment or receipt of excess compensation or a shortfall in compensation paid or received. For example, many of our exceptions require that the compensation not take into account the volume or value of referrals or other business generated between the parties and that the compensation be commercially reasonable, even if no referrals were made between the parties. It is possible that the amount of compensation provided under an arrangement is fair market value or is consistent with a prescribed limit in one of the exceptions (such as in § 411.357(k)), but, for example, takes into account the volume or value of referrals and this results in a noncompliant arrangement. We are not proposing a prescribed period of disallowance for arrangements that are noncompliant for reasons that are related to compensation but which do not involve only the payment or receipt of excess compensation or a shortfall in compensation paid or received. Rather, the appropriate period of disallowance for such arrangements would need to be determined on a case-by-case basis.

Essentially, our proposals place an outside limit on the period of disallowance in certain circumstances. That is, where the reason(s) for noncompliance does not relate to compensation, the latest the period of disallowance would end would be the date the arrangement was brought into compliance. Where the reason for noncompliance is the fact that excess compensation was provided or too little compensation was paid, the latest the period of disallowance would end would be the date that the party receiving the excess compensation returned it to the party that provided it or the party owing the shortfall in compensation paid it to the party to which it was owed (assuming the arrangement otherwise satisfies the requirements of an applicable exception).

We recognize, of course, that parties to a financial relationship that is noncompliant may never bring the relationship into compliance with an applicable exception. The financial relationship may expire according to the terms of the underlying agreement (such as the date of expiration of a personal service contract), or it may end earlier or later than the expiration date provided in the underlying agreement. However, we do not propose to prescribe with specificity when such a noncompliant financial relationship (and, thus, the period of disallowance) might end. Likewise, if a party that receives excess compensation never repays the excess compensation, or a party who owes additional compensation (the shortfall) never pays it, the question arises as to when the financial relationship ends. To return to the example that we gave in the CY 2008 PFS proposed rule and that we reference above, if an entity leases space to a physician at a rental price that is substantially below fair market value, the inference may be raised that the below-market rent was in exchange for future referrals, including referrals made beyond the expiration of the lease agreement. Therefore, in such a situation, if the physician does not pay the rental charges shortfall, the financial relationship may not end at the expiration of the written lease agreement, but rather could extend for some period beyond the expiration of the written lease agreement. We are not proposing to establish any specific time period or even guidelines for when the financial relationship in the above example would be deemed to end (so that future referrals would not be tainted); rather the determination of when the financial relationship ends must depend on the facts and circumstances. We note that our proposals pertain only to placing an outside limit on the period of disallowance for making referrals and billing the Medicare program in the case of certain noncompliant financial relationships; they do not address whether the anti-kickback statute is implicated and/or whether civil monetary penalties under the physician self-referral statute are potentially applicable due to noncompliant financial relationships.

We are not proposing, as one commenter suggested, that, in a situation involving noncompliance due to excess compensation paid by an entity to a physician (or the physician's immediate relative), the period of disallowance would end no later than the date the entity repays the excess compensation to the Medicare program, should the physician not repay the excess compensation to the entity. This approach is not consistent with the statute. We are also not proposing, as another commenter suggested, to impose no period of disallowance for the situation in which parties allegedly were unaware of the noncompliant nature of a financial relationship. We do not have the authority under section 1877 of the Act to waive violations of the physician self-referral law. We note also that there would be practical problems in determining whether parties were unaware of the noncompliant nature of the arrangement and that we would be discouraging parties from carefully structuring arrangements and monitoring them. In the CY 2008 PFS proposed rule, we proposed an alternative method of compliance that may address some of the commenter's concerns, and that proposal is still under consideration for final rulemaking. Finally, we are not proposing to impose a period of disqualification during which the parties to a noncompliant financial relationship would be prohibited from using a particular exception due to that relationship. We may propose rulemaking on this subject in the future.

C. Gainsharing Arrangements

1. Background

The term "gainsharing" typically refers to an arrangement under which a hospital gives physicians a share of the reduction in the hospital's costs (that is, the hospital's cost savings) attributable in part to the physicians' efforts. Gainsharing may take several forms. Some arrangements are narrowly targeted, giving the physician a financial incentive to select specific medical devices and products that are less expensive or to adopt specific clinical practices or protocols that reduce costs. Other, more problematic arrangements are not targeted at utilization of specific supplies or specific clinical practices, but instead offer the physician payments to reduce total average costs per case below target amounts.

Gainsharing arrangements seek to align physician incentives with those of hospitals by offering physicians a share of the hospital's variable cost savings attributable to the physicians' efforts in controlling the cost of providing patient care. Following the institution of the Medicare Part A DRG system of hospital reimbursement and with the growth of managed care, hospitals have experienced significant financial pressure to reduce costs. However, because physicians are paid separately under Medicare Part B and Medicaid, physicians do not share necessarily a hospital's incentive to control the hospital's patient care costs. Gainsharing arrangements are designed to align hospital and physician incentives by offering physicians a portion of the hospital's cost savings in exchange for identifying and implementing cost-saving strategies.

2. Statutory Impediments to Gainsharing Arrangements

Whereas gainsharing promotes hospital cost reductions by aligning physician incentives with those of the hospital, these arrangements also implicate the physician self-referral statute (section 1877 of the Act). Section 1877(a)(1) of the Act states that, except as provided in section 1877(b) of the Act, if a physician (or an immediate family member of such physician) has a financial relationship with an entity, the physician may not make a referral to the entity for the furnishing of DHS for which payment otherwise may be made under title XVIII of the Act. The provision of monetary or nonmonetary remuneration by a hospital to a physician through a gainsharing arrangement would constitute a financial relationship with an entity for purposes of the physician self-referral statute.

Gainsharing arrangements also implicate two specific fraud and abuse statutes. First, sections 1128A(b)(1) and (b)(2) of the Act, commonly referred to as the Civil Monetary Penalty, or CMP, statute, prohibit a hospital from knowingly making a payment directly or indirectly to a physician as an inducement to reduce or limit items or services furnished to Medicare or Medicaid beneficiaries, and a physician from knowingly accepting such payment. Second, gainsharing arrangements implicate section 1128B(b) of the Act (the "anti-kickback statute") if one purpose of the cost savings payment is to influence referrals of Federal health care program business.

3. Office of Inspector General (OIG) Approach Towards Gainsharing Arrangements

The HHS Office of Inspector General ("OIG") historically has been wary of gainsharing arrangements. In July 1999, OIG issued a Special Advisory Bulletin that addressed the application of sections 1128A(b)(1) and (2) of the Act to gainsharing arrangements. Although OIG recognized that appropriately structured gainsharing arrangements may offer significant benefits where there is no adverse impact on the quality of care received by patients, section 1128A(b) of the Act clearly prohibits arrangements that are intended as an inducement to limit or reduce services to Medicare or Medicaid patients. In addition, OIG stated that regulatory relief from the CMP prohibition would require statutory authorization.

OIG has issued several favorable advisory opinions regarding individual gainsharing arrangements, although the opinions (like all OIG advisory opinions) do not have general applicability. When evaluating the risks posed by a gainsharing arrangement, OIG has generally looked for three types of safeguards, namely: (1) Measures that promote accountability and transparency; (2) adequate quality controls; and (3) controls on payments related to referrals. Properly structured, gainsharing arrangements may offer opportunities for hospitals to reduce costs without causing inappropriate reductions in medical services or rewarding referrals of Federal health care program patients. In a number of specific cases involving limited proposed arrangements, OIG has issued advisory opinions in which it concluded that the proposed arrangement presents a low risk of abuse and, therefore, it would exercise its prosecutorial discretion not to impose sanctions. In these cases, OIG has concluded, based on the totality of facts and circumstances and the presence of adequate safeguards, that: (1) The proposed arrangement would constitute an improper payment to induce the reduction or limitation of services as prohibited by sections 1128A(b)(1) and (2) of the Act, but that OIG would not impose sanctions on the requestors of the advisory opinion; and (2) the proposed arrangement would potentially generate prohibited remuneration under the anti-kickback statute if the requisite intent to induce or reward referrals of Federal health care program business were present, but that OIG would not impose administrative sanctions on the requestors under section 1128A(a), or under section 1128(b)(7) or section 1128A(a)(7), as those sections relate to the commission of acts described in the anti-kickback statute.

4. MedPAC Recommendation

MedPAC, in its March 2005 Report to Congress, "Physician-owned Specialty Hospitals," recommended that gainsharing arrangements between physicians and hospitals be permitted. Specifically, MedPAC stated that, "[t]he Congress should grant the Secretary the authority to allow gainsharing arrangements between physicians and hospitals and to regulate those arrangements to protect the quality of care and minimize financial incentives that could affect physician referrals." (See http://www.medpac.gov/publications/congressional repots/Mar05EntireReport.pdf, at page 47). In addition, MedPAC stated that, drawing on OIG's work, the Secretary could require that gainsharing arrangements:

• Identify specific actions that would produce savings, such as limiting the inappropriate use of supplies;

• Are transparent and disclosed to patients;

• Include periodic reviews of quality of care by an independent organization;

• Limit the amount of time during which physicians can share cost savings in order to prevent hospitals from using these agreements as a mechanism to induce physician referrals;

• Avoid rewarding physicians for increasing referrals to the hospitals, such as capping potential savings based on the number of prior year admissions; and

• Monitor changes in the severity, age, and insurance coverage of patients affected by the gainsharing arrangement.

5. Demonstration Programs

CMS has long been interested in evaluating the association between payments and the quality of care. In 1991, CMS initiated a demonstration program entitled the "Medicare Participating Heart Bypass Center Demonstration." This demonstration was conducted to assess the feasibility and cost effectiveness of a negotiated all-inclusive bundled payment arrangement for coronary artery bypass graft (CABG) surgery while maintaining high quality care. CMS originally negotiated contracts with four applicants. In 1993, the demonstration was expanded to include three more participants. The results of the demonstration showed that an all-inclusive bundled payment arrangement can provide an incentive to physicians and hospitals to work together to provide services more efficiently, improve quality, and reduce costs. The bundling of the physician and hospital payments did not have a negative impact on the post-discharge health improvements of the demonstration patients. Three of the four original hospitals were able to make major changes in physician practice patterns and operations that generated significant cost savings. A hospital's participation in the demonstration appeared to have little or no effect on physician referral patterns.

A second demonstration project that involves gainsharing arrangements is authorized by section 646 of the MMA, which added a new section 1866C of the Act and established the Medicare Health Care Quality MHCQ Demonstration Program. MHCQ demonstration projects are intended to "* * * examine health delivery factors that encourage the delivery of improved quality in patient care." Using the authority provided by section 1866C of the Act, CMS decided to implement a 3-year demonstration that would test gainsharing models involving physicians and collaborations between hospitals working with physicians in a single geographic area to improve the quality of inpatient hospital care. In contrast to traditional models of gainsharing, the proposed demonstration approaches must be across single or multiple organizations and involve long-term followup to ensure both documented improvements in quality and reductions in the overall costs of care. CMS is particularly interested in demonstration designs that: (1) Track patients well beyond a hospital episode to determine the impact of hospital-physician collaborations on preventing short and longer-term complications, duplication of services, and coordination of care across settings; and (2) offer other quality improvements for eliminating preventable complications and unnecessary costs.

A third series of demonstration projects was authorized by section 5007 of the Deficit Reduction Act of 2005 (the "DRA") (Pub. L. 109-171). This provision requires the Secretary to establish a qualified gainsharing demonstration under which the Secretary shall approve up to six demonstration projects. Section 5007 demonstration projects would involve arrangements between a hospital and physicians and practitioners under which the hospital provides for remuneration (that is, gainsharing payments) to certain physicians and to certain practitioners (as defined in 1842(b)(18)(C) of the Act) that represents solely a share of the savings incurred directly as a result of collaborative efforts between the hospital and a particular physician (or practitioner) to improve overall quality and efficiency. Each demonstration project must also provide measures to monitor quality and efficiency in the participating project hospital(s).

6. Solicitation of Comments

In the CY 2008 PFS proposed rule, we noted that we are concerned about compensation arrangements between entities and physicians under which compensation is determined on a percentage basis (for example, rental charges for office space that are determined based on a percentage of a group practice's revenues) (72 FR 38184). We proposed to clarify that percentage-based compensation arrangements may be used only for paying for personally performed physician services and that such arrangements must be based on the revenues directly resulting from the physician services rather than based on some other factor such as a percentage of the savings by the hospital department. The proposed changes, if finalized, might prevent typical gainsharing arrangements between physicians and hospitals to which they refer for DHS. We have not yet finalized our proposal in the CY 2008 PFS final rule; however, it remains under active consideration.

Notwithstanding our general concern with arrangements that involve the use of a percentage-based compensation formula (other than payment to a physician for work personally performed by the physician), we recognize the value to the Medicare program and its beneficiaries where the alignment of hospital and physician incentives results in improvements in quality of care. Therefore, we are considering whether to issue an exception specific to gainsharing arrangements. Under section 1877(b)(4) of the Act, we may issue additional exceptions (that is, exceptions not specified in the statute) only where doing so would create no risk of program or patient abuse. At this time, we decline to issue a specific proposal concerning an exception for gainsharing arrangements, but rather are soliciting comments as to whether we should establish an exception for gainsharing arrangements, and, if so, what safeguards should be included in the exception. Specifically, we are interested in receiving comments on: (1) What types of requirements and safeguards should be included in any exception for gainsharing arrangements; and (2) whether certain services, clinical protocols, or other arrangements should not qualify for the exception.

D. Physician-Owned Implant and Other Medical Device Companies

1. Background

We have recently become aware of an increase in physician investment in implant and other medical device manufacturing, distribution, and purchasing companies. We recognize that physician involvement often adds value to device manufacturing companies and that many physicians may have legitimate investment interests in these companies. Physicians participate in the research, development, and testing involved in creating and producing many lifesaving and quality-of-life enhancing medical devices. The added value of physician involvement in distribution and purchasing companies, essentially middlemen companies, is less clear. When physicians profit from the referrals they make to hospitals through physician-owned implant and medical device companies ("POCs"), we are concerned about possible program or patient abuse. POCs exist in three primary forms: manufacturers, distributors, and group purchasing organizations ("GPOs"). Our understanding, however, is that many POCs are not manufacturers, but rather are companies that profit from the purchase and resale of products made by another organization (that is, they act as distributors) or from GPO fees paid by device vendors. In many cases, the physician investors bear little, if any, economic risk with respect to the medical devices. It is also our understanding that some physicians are offered investment interests in "private label" or similar manufacturing entities when the physicians have provided little, if any, necessary research, design, or testing services. We are concerned that some physician-owned organizations may serve little purpose other than providing physicians the opportunity to earn economic benefits in exchange for nothing more than ordering medical devices or other products that the physician-investors use on their own patients. The financial incentives paid to the physicians may foster an anti-competitive climate, raise quality of care concerns, and lead to overutilization of the device or other product to which the physician is linked. Physicians are responsible for selecting or recommending the devices ordered for the hospital's patients. It is reasonable to believe that medical device or implant companies without physician investment will have difficulty finding referral sources in areas where many physicians are invested in a POC that offers competing products.

In response to our proposed change to the definition of "entity" at § 411.351 in the CY 2008 PFS proposed rule, we received public comments regarding whether a physician-owned implant or other medical device company should or should not be considered to be an "entity." One commenter noted that orthopedic surgeons may have an ownership interest in a manufacturer of spinal implants that sells its implants to the hospital where the surgeon performs his or her surgeries. According to the commenter, because the proposed definition of "entity" would extend to an entity that "performs the DHS," the manufacturer arguably could be considered to be an "entity" under § 411.351. This commenter urged us to exclude such manufacturers from the definition of "entity." The commenter stated that indirect arrangements involving spinal implants would trigger the self-referral prohibition if they are not at fair market value. Comments submitted on behalf of a manufacturer of spinal implants asserted that, despite superficial similarities, joint ventures involving medical devices differ in many material ways from the types of arrangements about which we expressed concern. This commenter also asserted that the meaning of "has performed the DHS" is unclear and that we should clarify that the proposal applied only to "true" "under arrangement" relationships with hospitals, but that, in any event, implantable devices are not DHS. According to the commenter, even if implantable devices were deemed to be DHS, the rigorous physician self-referral exceptions (for example, the exception for indirect compensation arrangements in § 411.357(p)) are still available to protect the arrangement and against program or patient abuse.

In an October 6, 2006 letter response to a request for guidance regarding certain physician investments in the medical device industry, OIG stated that it was aware of an apparent proliferation of physician investments in medical device and distribution companies, including GPOs, and that, given the strong potential for improper inducements between and among the physician investors, the companies, device vendors, and medical device purchasers, it believed that all of these ventures should be closely scrutinized under the fraud and abuse laws. OIG also clarified that its 1989 Special Fraud Alert on Joint Ventures applies to all physician joint ventures and would, therefore, apply to physician investments in medical device manufacturing and distribution companies, as well as GPOs. OIG confirmed that the fact that a substantial portion of a venture's gross revenues is derived from participant-driven referrals is a potential indicator of a problematic joint venture. The October 6, 2006 letter response is available at http://oig.hhs.gov/fraud/docs/alertsandbulletins/GuidanceMedicalDevice%20(2).pdf. See also http://oig.hhs.gov/testimony/docs/2008/demske_testimony022708.pdf.

A medical device company requested that we take a closer look at the current prevalence of POCs and the impact that these companies may have on program or patient abuse, as well as the negative impact on competition among POCs and nonphysician owned medical device companies. This company noted that, in the CY2008 PFS proposed rule, we proposed revising the definition of "entity" to include, among other things, an entity that causes a claim to be submitted to Medicare. It suggested that we finalize our proposal and that we deem POCs to be DHS entities under certain circumstances. It also suggested that, in certain circumstances, physician investors in POCs should be deemed to have a direct compensation relationship with the hospitals that order and use implantable devices furnished by the POCs. The company suggested that a POC should not be considered to have caused a claim to be presented where the referring physician is named as an inventor on an issued patent for the implantable item, provided that the physician does not receive any remuneration from the POC based on the volume or value of his or her referrals, or where the physician's investment interest satisfies the requirements of the exception in § 411.356(a) for large, publicly traded entities. We note that it is not clear to us under what circumstances a patent holder physician, who presumably receives royalty payments from the POC, would receive remuneration that does not relate to the volume or value of referrals or other business generated by the physician. In the Phase II final rule with comment period, we noted that we received a comment that questioned whether the payment of a royalty by an equipment manufacturer to a physician inventor for a device implanted during surgeries performed by the physician inventor is permitted or whether that arrangement would create an indirect compensation relationship with the hospital that purchased the device. We stated, in response, that the physician inventor would have an indirect compensation arrangement with the hospital in which the surgeries are performed but, provided the royalty payment was fair market value, the relationship should satisfy the exception for indirect compensation arrangements in § 411.357(p) (69FR 16060).

2. Solicitation of Comments

At this time, we are not issuing a specific proposal regarding POCs. The statute and our existing regulations, specifically those related to indirect compensation arrangements, address many POCs. In some problematic circumstances, an unbroken chain of financial relationships will connect the physician owner of a POC to a DHS entity to which the physician makes referrals, and the other elements of an indirect compensation arrangement contained in § 411.354(c)(2) will also be present, including the requisite knowledge by the DHS entity of the physician's interest in the POC. In many instances, the arrangement would not satisfy the requirements of the exception for indirect compensation arrangements in § 411.357(p), and would, therefore, run afoul of the physician self-referral statute. However, we are soliciting public comments as to whether our physician self-referral rules should address POCs and similar physician owned companies more specifically, or whether the concerns surrounding POCs and similar organizations, to the extent that they are not addressed by the statute and our current rules, are better addressed through enforcement of the False Claims Act, the anti-kickback statute and similar fraud and abuse laws, other public laws, and through other applicable Federal, State, and local regulations. In this regard, we are seeking comments as to whether, and to what degree, physician investment in POCs and similar organizations presents risks of overutilization, substandard care, and increased costs to the Medicare program and its beneficiaries, or whether the risk is confined to possible anti-competitive behavior. To the extent that commenters believe that certain physician investment in POCs and similar organizations should be addressed more specifically under our physician self-referral rules, commenters are encouraged to provide us with suggestions as to specific actions we should take (for example, considering POCs to be DHS entities under certain circumstances, considering physician investors in POCs who influence hospitals as to the ordering of medical devices to have direct compensation relationships with the hospitals, excepting certain investment interests from coverage under our rules, etc.).

IX. Financial Relationships Between Hospitals and Physicians

A. Background

As stated earlier, under section 1877 of the Act, a physician is prohibited from referring a Medicare patient for DHS to an entity (including an individual) with which the physician (or an immediate family member of the physician) has a financial relationship, unless an exception applies. In addition, section 1877 of the Act provides that an entity may not present or cause to be presented a claim or bill to Medicare or any individual, third party payor, or other entity for DHS furnished as a result of a prohibited referral. Also, section 1877 of the Act prohibits us from making payment for DHS furnished pursuant to a prohibited referral. The statute contains several exceptions for certain types of compensation arrangements and ownership or investment interests, including the exception in section 1877(d)(3) of the Act for ownership or investment by a physician in the hospital itself and not merely in a subdivision of the hospital (that is, the "whole" hospital). Section 1877(b)(4) of the Act authorizes us to create additional exceptions, provided that they do not create a risk of program or patient abuse. As a result of the statutory exceptions in section 1877 of the Act, and the exceptions we have created using our authority under section 1877(b)(4) of the Act, our regulations contain approximately 40 exceptions to the prohibition on physician self-referrals. (We refer readers to 42 CFR 411.351 through 411.357 of our regulations and the September 5, 2007 "Phase III" final rule (72 FR 51012).)

Section 1877(f) of the Act provides that: "Each entity providing covered items or services for which payment may be made under this title [42 USCS 1395 et seq.] shall provide the Secretary with the information concerning the entity's ownership, investment, and compensation arrangements, including: (1) The covered items and services provided by the entity, and (2) the names and unique physician identification numbers of all physicians with an ownership or investment interest (as described in subsection (a)(2)(A)), or with a compensation arrangement (as described in subsection (a)(2)(B)), in the entity, or whose immediate relatives have such an ownership or investment interest or who have a compensation relationship with the entity. Such information shall be provided in such form, manner, and at such times as the Secretary shall specify." (Emphasis added)

Some industry representatives have argued that the reference to financial relationships as described in section 1877(a)(2)(A) and (a)(2)(B) of the Act limits our ability to obtain information on financial relationships that do not satisfy one of the statutory or regulatory exceptions. We disagree. The statute clearly contains a broad authorization for the Secretary to obtain information concerning an entity's financial relationships, "including," but not limited to, financial relationships that satisfy an exception. We believe that there would have been little point to the Congress providing us with the authority to compel information on excepted arrangements only, because, as we have noted previously, "an entity could decide that one or more of its financial relationships falls within an exception, fail to retain data concerning those financial relationships, and thereby prevent the government from reviewing the arrangements to determine if they qualify for an exception." (72 FR 51069.) Accordingly, our regulation in § 411.361 requires entities to report " any ownership or investment interest, as defined at § 411.354(b), or any compensation arrangement, as defined at § 411.354(c), except for ownership or investment interests that satisfy the exceptions set forth in § 411.356(a) and § 411.356(b) regarding publicly-traded securities and mutual funds" (emphasis added). The statute provides that an ownership or investment interest in the entity may be through equity, debt, or other means, and includes an interest in an entity that holds an ownership or investment interest in any entity that furnishes DHS.

Our regulations have been drafted to reflect clearly our commonsense interpretation of the statutory reporting requirements. In the proposed rule entitled "Medicare and Medicaid Programs; Physicians" Referrals to Health Care Entities With Which They Have Financial Relationships," published in the Federal Register on January 9, 1998 (63 FR 1703), we proposed to modify § 411.361 to require that entities report information concerning their reportable financial relationships to us on a prescribed form and thereafter report annually all changes to the submitted information that occurred in the previous 12 months. In addition, we revisited the statute and interpreted the opening paragraph of section 1877(f) of the Act to permit us to gather any data on financial relationships, including, but not necessarily limited to, financial relationships for which there are no exceptions under section 1877(a)(2)(A) or (a)(2)(B) of the Act. Therefore, we proposed to amend § 411.361 to reflect explicitly our authority to ask for a broader scope of information than the regulation permitted at that time.

In the Phase II final rule with comment period (69 FR 16121), we modified the reporting requirement in § 411.361 to remove all references to the use of a prescribed form, to require entities to make information available only upon request, and to maintain the information only for the length of time specified by the applicable regulatory requirements for the information (that is, the rules of the Internal Revenue Service, Securities and Exchange Commission, Medicare, Medicaid, or other programs). In addition, we modified § 411.361 to provide that entities need not report ownership or investment interests that satisfy the exceptions in § 411.356(a) and (b) for publicly-traded securities and mutual funds.

Most, if not all, hospitals have financial relationships with referring physicians. These financial relationships may involve ownership or investment interests, compensation arrangements, or both. The financial relationships can be direct or they may be indirect (such as through a physician group practice or limited liability company). The physician self-referral statute was first enacted in 1989, and the reporting requirements in the regulations in § 411.361 were first implemented in our December 3, 1991 interim final rule with comment period, published in the Federal Register at 56 FR 61374. Since that time, CMS has not engaged in a comprehensive reporting initiative to examine financial relationships between hospitals and physicians. Consistent with congressional intent in enacting the physician self-referral statute, we believe it is important to query hospitals concerning their financial relationships with physicians.

B. Section 5006 of the Deficit Reduction Act (DRA) of 2005

Section 5006 of the DRA required the Secretary to develop a strategic and implementing plan to address certain issues relating to physician-owned specialty hospitals. The specific issues the Secretary was required to address were: (1) Proportionality of investment return; (2) bona fide investment; (3) annual disclosure of investment information; (4) the provision by specialty hospitals of (i) care to patients who are eligible for Medicaid (or who are not eligible for Medicaid but who are regarded as such because they receive benefits under a section 1115 waiver) and (ii) charity care; and (5) appropriate enforcement. In order to assist us in preparing the report and implementing plan required by section 5006 of the DRA, we sent a voluntary survey to 130 specialty hospitals and 220 competitor hospitals, which sought information regarding, among other things, the hospitals' ownership and investment relationships, and their compensation arrangements with physicians. In the enforcement section of the strategic and implementing plan that was included in our "Final Report to the Congress and Strategic and Implementing Plan Required under Section 5006 of the Deficit Reduction Act of 2005" issued on August 8, 2006, available on our Web site at http://www.cms.hhs.gov/PhysicianSelfReferral/06a_DRA_Reports.asp (hereinafter referred to as the "DRA Report to Congress"), we stated that we would require all hospitals (that is, not just specialty hospitals) to provide us information on a periodic basis concerning the investment interests in the hospital of physicians and the hospital's compensation arrangements with physicians (DRA Report to Congress 69). We stated that we would not limit our requirement to information concerning physician investments in specialty hospitals for two reasons. First, physician investments in any type of hospital raise potential issues concerning compensation arrangements that can be associated with the investment. For example, a disproportionate return on investment or non- bona fide investment (through, for example, a sham loan), creates a prohibited compensation arrangement under the physician self-referral law and raises the possibility of an illegal kickback scheme. Second, other types of compensation arrangements (that is, those that are not associated with an investment interest), implicate the physician self-referral law, such as leasing, employment, and personal service arangements. It is also important to note that, although a physician may be highly motivated to refer patients to a hospital in which he or she has an ownership interest, the physician may be just as likely to refer patients to a hospital with which he or she has a compensation relationship, given that the physician may see a more direct and immediate financial benefit from the compensation arrangement. In the DRA Report to Congress, we stated that we would implement a regular disclosure process, but that we had not designed the process at that point, and that we would consider such issues as whether we should: (1) Survey all hospitals annually; (2) stagger our survey so that all hospitals are queried but not all in the same year; and/or (3) focus our inquiry on certain types of relationships or certain hospitals. We stated that we would also consider whether, having once provided information, hospitals need only submit updated information on a yearly or other periodic basis.

C. Disclosure of Financial Relationships Report (DFRR)

Following up on our commitment to capture information concerning financial relationships between all types of hospitals and physicians, and to assist in enforcement of the physician self-referral statute and implementing regulations, we created an information collection instrument, referred to as the Disclosure of Financial Relationships Report ("DFRR"). The DFRR is designed to collect information concerning the ownership and investment interests and compensation arrangements between hospitals and physicians. (Appendix C of this proposed rule contains the DFRR instrument and instructions for public comment.) We believe information submitted by hospitals would permit us to analyze the types of financial relationships involving hospitals and physicians, the structure of various compensation arrangements and trends therein, and potentially whether the hospitals are in compliance with the physician self-referral law and implementing regulations. Using our authority under section 1877(f) of the Act and 42 CFR 411.361, we are proposing to send the DFRR to 500 hospitals, a number that we believe is necessary to provide us with sufficient information: (1) To determine compliance; and (2) to assist us in any future rulemaking concerning the reporting requirements and other physician self-referral provisions.

We intend for our sample size to be a significant percentage of the total number of Medicare-participating hospitals. The 2007 CMS Statistics Handbook determined that, as of December 2006, there were approximately 6,200 Medicare-participating hospitals. Our goal is to begin by sending the DFRR to 8 to 10 percent of the Medicare-participating hospitals (496 to 620 hospitals). We reviewed our available funding and determined that our resources would permit us to review data from 500 hospitals (both general acute care hospitals and specialty hospitals).

As discussed further below, the DFRR also may assist us in making an informed decision as to whether to propose rulemaking for an annual (or other periodic) disclosure requirement for all hospitals. By posing a comprehensive set of questions to a significant number of hospitals, we believe that we will be informed not only as to whether we should engage in such rulemaking, but also as to what the design of the proposed information collection should look like.

Originally, we had planned to pilot this information collection request in advance of rulemaking. Thus, we prepared a proposed information collection request in accordance with the Paperwork Reduction Act. We announced and sought public comment on the information collection request in a 60-day Federal Register notice (CMS-10236) that was published on May 18, 2007 (72 FR 28056). On September 14, 2007, we published in the Federal Register a revised information collection request in which we increased the time estimate for completing the DFRR and increased the time for submission of the DFRR from 45 days to 60 days (72 FR 52568). (For additional information, we refer the reader to 72 FR 28056 and 72 FR 52568.)

In this proposed rule, we are providing a discussion of the potential burden associated with completing the DFRR, including an analysis that provides estimates of the burden for small, medium, and large hospitals. To better understand the potential burden for completing the DFRR collection, we reviewed the bed size of Medicare-participating hospitals and developed three categories of hospitals (small, medium, and large hospitals). We randomly selected 20 hospitals from each category and requested that these 60 hospitals estimate the aggregate number of hours it would take them to complete and submit the entire DFRR collection. The 33 hospitals that responded included 11 small, 11 medium, and 11 large hospitals. We reviewed the responses from the 33 hospitals and determined that the average number of hours to complete the DFRR was 31 hours. This figure represents a significant increase from our most recent time and burden estimate. Therefore, we believe it would be beneficial to seek further comments on the accuracy of the time and burden estimates associated with this information collection instrument. Because the information that we seek is that which hospitals should already be keeping in the normal course of their business activities (even apart from the need to document compliance with the physician self-referral law), we anticipate that the majority of the time spent completing the DFRR will be spent by administrative staff. We believe that the tasks involved would include retrieving the information and printing it from electronic files or copy it from hard files, which largely should involve administrative personnel. In addition, the review and organization of the materials would also impose burden on the respondent. Nevertheless, in order to err on the side of more potential burden rather than less, we have calculated costs using an hourly rate for accountants.

D. Civil Monetary Penalties

We are proposing that the DFRR be completed, certified by the appropriate officer of the hospital, and received by CMS within 60 days of the date that appears on the cover letter or e-mail transmission of the DFRR. We are soliciting comment on the proposed 60-day timeframe for completing the DFRR.

Section 411.361(f) provides that failure to timely submit the requested information concerning an entity's ownership, investment, and compensation arrangements may result in civil monetary penalties of up to $10,000 for each day beyond the deadline established for disclosure. Although we have the authority to impose civil monetary penalties, we seek not to invoke this authority and will work with entities to comply with the reporting requirements. Prior to imposing a civil monetary penalty in any amount, we would issue a letter to any hospital that does not return the completed DFRR, inquiring as to why the hospital did not return timely the completed DFRR. In addition, a hospital may, upon a demonstration of good cause, receive an extension of time to submit the requested information.

E. Uses of Information Captured by the DFRR

As noted above, we anticipate that the DFRR will be useful in determining whether the financial relationships between 500 hospitals and the physicians associated with those hospitals are in compliance with the physician self-referral statute and regulations. In addition, the results of the DFRR may assist us in other rulemaking efforts.

In the CY 2008 PFS proposed rule, we proposed certain changes to our physician self-referral rules (72 FR 38179 through 38187). With the exception of the anti-markup provisions, however, we have not yet finalized any of the proposals. We are actively working on the proposals, and although we expect to finalize the proposals before receiving and analyzing the completed DFRRs, information gleaned from the completed DFRRs may shape our final rulemaking if that rulemaking is delayed. Our analysis of the DFRRs may affect subsequent proposals on these and other related issues.

F. Solicitation of Comments

We are soliciting comments on the DFRR information collection instrument through this proposed rule as follows:

• Whether the collection effort should be recurring, and, if so, whether it should be implemented on an annual or some other periodic basis.

• Whether we are collecting too much or not enough information, and whether we are collecting the correct (or incorrect) type of information.

• The amount of time it will take hospitals to complete the DFRR and the costs associated with completing the DFRR; the amount of time we should give hospitals to complete and return their responses to us.

• Whether we should direct the collection instrument to all hospitals, and, if so, whether we should stagger the collection so that only a certain number of hospitals are subject to it in any given year.

• Whether hospitals, once having completed the DFRR, should have to send in yearly updates and report only changed information.

X. MedPAC Recommendations

We are required by section 1886(e)(4)(B) of the Act to respond to MedPAC's recommendations regarding hospital inpatient payments in our annual proposed and final IPPS rules. We have reviewed MedPAC's March 2008 "Report to the Congress: Medicare Payment Policy" and have given it careful consideration in conjunction with the proposed policies set forth in this document. MedPAC's Recommendation 2A-1 states that "The Congress should increase payment rates for the acute inpatient and outpatient prospective payment systems in 2009 by the projected rate of increase in the hospital market basket index, concurrent with implementation of a quality incentive payment program." This recommendation is discussed in Appendix B to this proposed rule.

Recommendation 2A-2: MedPAC recommended that "The Congress should reduce the indirect medical education adjustment in 2009 by 1 percentage point to 4.5 percent per 10 percent increment in the resident-to-bed ratio. The funds obtained by reducing the indirect medical education adjustment should be used to fund a quality incentive payment program."

Response: Redirecting funds obtained by reducing the IME adjustment to fund a quality incentive payment program is consistent with the VBP initiatives to improve the quality of care and, therefore, merits consideration. However, section 502(a) of Pub. L. 108-173 modified the formula multiplier (c) to be used in the calculation of the IME adjustment beginning midway through FY 2004 and provided for a new schedule of formula multipliers for FYs 2005 and thereafter. Consequently, CMS could not implement MedPAC's recommendation to reduce the IME adjustment in 2009 without a statutory change. We note that included in the President's FY 2009 budget proposal was a proposal to reduce the IME adjustment from 5.5 percent to 2.2 percent over 3 years, starting in FY 2009, in order to better align IME payments with the estimated costs per case that teaching hospitals may face.

In its June 2007 "Report to Congress: Promoting Greater Efficiency in Medicare," MedPAC made recommendations concerning the Medicare hospital wage index. Section 106(b)(1) of the MIEA-TRHCA (Pub. L. 109-432) required MedPAC to submit to Congress, not later than June 30, 2007, a report on the Medicare hospital wage index classification system applied under the Medicare IPPS, including any alternatives that MedPAC recommended to the method to compute the wage index under section 1886(d)(3)(E) of the Act. In addition, section 106(b)(2) of the MIEA-TRHCA instructed the Secretary taking into account MedPAC's recommendations on the Medicare hospital wage index classification system, to include in this FY 2009 IPPS proposed rule one or more proposals to revise the wage index adjustment applied under section 1886(d)(3)(E) of the Act for purposes of the IPPS. The MedPAC recommendations and our proposals concerning the Medicare hospital wage index are discussed in section III.B. of the preamble of this proposed rule.

For further information relating specifically to the MedPAC reports or to obtain a copy of the reports, contact MedPAC at (202) 653-7220, or visit MedPAC's Web site at: http://www.medpac.gov.

XI. Other Required Information

A. Requests for Data From the Public

In order to respond promptly to public requests for data related to the prospective payment system, we have established a process under which commenters can gain access to raw data on an expedited basis. Generally, the data are available in computer tape or cartridge format. However, some files are available on diskette as well as on the Internet at: http://www.cms.hhs.gov/providers/hipps. Data files and the cost for each file, if applicable, are listed below. Anyone wishing to purchase data tapes, cartridges, or diskettes should submit a written request along with a company check or money order (payable to CMS-PUF) to cover the cost to the following address: Centers for Medicare Medicaid Services, Public Use Files, Accounting Division, P.O. Box 7520, Baltimore, MD 21207-0520, (410)-786-3691. Files on the Internet may be downloaded without charge.

1. CMS Wage Data

This file contains the hospital hours and salaries for FY 2005 used to create the proposed FY 2009 prospective payment system wage index. The file is currently available for the NPRM and will be available by the beginning of May for the final rule.

Processing year Wage data year PPS fiscal year
2008 2005 2009
2007 2004 2008
2006 2003 2007
2005 2002 2006
2004 2001 2005
2003 2000 2004
2002 1999 2003
2001 1998 2002
2000 1997 2001
1999 1996 2000
1998 1995 1999
1997 1994 1998
1996 1993 1997
1995 1992 1996
1994 1991 1995
1993 1990 1994
1992 1989 1993
1991 1988 1992

These files support the following:

• Notice of proposed rulemaking published in the Federal Register .

• Final rule published in the Federal Register .

Media: Diskette/most recent year on the Internet.

File Cost: $165.00 per year.

Periods Available: FY 2009 PPS Update.

2. CMS Hospital Wages Indices (Formerly: Urban and Rural Wage Index Values Only)

This file contains a history of all wage indices since October 1, 1983.

Media: Diskette/most recent year on the Internet.

File Cost: $165.00 per year.

Periods Available: FY 2009 PPS Update.

3. FY 2009 Proposed Rule Occupational Mix Adjusted and Unadjusted AHW by Provider

This file includes each hospital's adjusted and unadjusted average hourly wage.

Media: Internet.

Periods Available: FY 2009 PPS Update.

4. FY 2009 Proposed Rule Occupational Mix Adjusted and Unadjusted AHW and Pre-Reclassified Wage Index by CBSA

This file includes each CBSA's adjusted and unadjusted average hourly wage.

Media: Internet.

Periods Available: FY 2009 PPS Update.

5. Provider Occupational Mix Adjustment Factors for Each Occupational Category

This file contains each hospital's occupational mix adjustment factors by occupational category.

Media: Internet.

Periods Available: FY 2009 PPS Update.

6. PPS SSA/FIPS MSA State and County Crosswalk

This file contains a crosswalk of State and county codes used by the Social Security Administration (SSA) and the Federal Information Processing Standards (FIPS), county name, and a historical list of Metropolitan Statistical Areas (MSAs).

Media: Diskette/Internet.

File Cost: $165.00 per year.

Periods Available: FY 2009 PPS Update.

7. Reclassified Hospitals New Wage Index (Formerly: Reclassified Hospitals by Provider Only)

This file contains a list of hospitals that were reclassified for the purpose of assigning a new wage index. Two versions of these files are created each year. They support the following:

• Notice of proposed rulemaking published in the Federal Register .

• Final rule published in the Federal Register .

Media: Diskette/Internet.

File Cost: $165.00 per year.

Periods Available: FY 2009 PPS Update.

8. PPS-IV to PPS-XII Minimum Data Set

The Minimum Data Set contains cost, statistical, financial, and other information from Medicare hospital cost reports. The data set includes only the most current cost report (as submitted, final settled, or reopened) submitted for a Medicare participating hospital by the Medicare fiscal intermediary to CMS. This data set is updated at the end of each calendar quarter and is available on the last day of the following month.

Media: Tape/Cartridge.

File Cost: $770.00 per year.

Periods beginning on or after and before
PPS-IV 10/01/86 10/01/87
PPS-V 10/01/87 10/01/88
PPS-VI 10/01/88 10/01/89
PPS-VII 10/01/89 10/01/90
PPS-VIII 10/01/90 10/01/91
PPS-IX 10/01/91 10/01/92
PPS-X 10/01/92 10/01/93
PPS-XI 10/01/93 10/01/94
PPS-XII 10/01/94 10/01/95
( Note: The PPS-XIII, PPS-XIV, PPS-XV, PPS-XVI, PPS-XVII, PPS-XVIII, PPS-XIX PPS-XX, PPS-XXI, PPS-XXII, and PPS-XXIII Minimum Data Sets are part of the PPS-XIII, PPS-XIV, PPS-XV, PPS-XVI, PPS-XVII, PPS-XVIII, PPS-XIX, PPS-XX, PPS-XXI, PPS-XXII, and PPS-XXIII Hospital Data Set Files (refer to item 10 below).)

9. PPS-IX to PPS-XII Capital Data Set

The Capital Data Set contains selected data for capital-related costs, interest expense and related information and complete balance sheet data from the Medicare hospital cost report. The data set includes only the most current cost report (as submitted, final settled or reopened) submitted for a Medicare certified hospital by the Medicare fiscal intermediary to CMS. This data set is updated at the end of each calendar quarter and is available on the last day of the following month.

Media: Tape/Cartridge.

File Cost: $770.00 per year.

Periods beginning on or after and before
PPS-IX 10/01/91 10/01/92
PPS-X 10/01/92 10/01/93
PPS-XI 10/01/93 10/01/94
PPS-XII 10/01/94 10/01/95

(Note: The PPS-XIII, PPS-XIV, PPS-XV, PPS-XVI, PPS-XVII, PPS-XVIII, PPS-XIX PPS-XX, PPS-XXI, PPS-XXII, and PPS-XXIII Capital Data Sets are part of the PPS-XIII, PPS-XIV, PPS-XV, PPS-XVI, PPS-XVII, PPS-XVIII, PPS-XIX, PPS-XX, PPS-XXI, PPS-XXII, and PPS-XXIII Hospital Data Set Files (refer to item 10 below).)

10. PPS-XIII to PPS-XXIII Hospital Data Set

The file contains cost, statistical, financial, and other data from the Medicare Hospital Cost Report. The data set includes only the most current cost report (as submitted, final settled, or reopened) submitted for a Medicare-certified hospital by the Medicare fiscal intermediary to CMS. The data set is updated at the end of each calendar quarter and is available on the last day of the following month.

Media: Diskette/Internet.

File Cost: $2,500.00.

Periods beginning on or after and before
PPS-XIII 10/01/95 10/01/96
PPS-XIV 10/01/96 10/01/97
PPS-XV 10/01/97 10/01/98
PPS-XVI 10/01/98 10/01/99
PPS-XVII 10/01/99 10/01/00
PPS-XVIII 10/01/00 10/01/01
PPS-XIX 10/01/01 10/01/02
PPS-XX 10/01/02 10/01/03
PPS-XXI 10/01/03 10/01/04
PPS-XXII 10/01/04 10/01/05
PPS-XXIII 10/01/05 10/01/06

11. Provider-Specific File

This file is a component of the PRICER program used in the fiscal intermediary's or the MAC's system to compute DRG payments for individual bills. The file contains records for all prospective payment system eligible hospitals, including hospitals in waiver States, and data elements used in the prospective payment system recalibration processes and related activities. Beginning with December 1988, the individual records were enlarged to include pass-through per diems and other elements.

Media: Diskette/Internet.

File Cost: $265.00.

Periods Available: FY 2009 PPS Update.

12. CMS Medicare Case-Mix Index File

This file contains the Medicare case-mix index by provider number as published in each year's update of the Medicare hospital inpatient prospective payment system. The case-mix index is a measure of the costliness of cases treated by a hospital relative to the cost of the national average of all Medicare hospital cases, using DRG weights as a measure of relative costliness of cases. Two versions of this file are created each year. They support the following:

• Notice of proposed rulemaking published in the Federal Register .

• Final rule published in the Federal Register .

Media: Diskette/most recent year on Internet.

Price: $165.00 per year/per file.

Periods Available: FY 1985 through FY 2009.

13. MS-DRG Relative Weights (Formerly Table 5 DRG)

This file contains a listing of MS-DRGs, MS-DRG narrative descriptions, relative weights, and geometric and arithmetic mean lengths of stay as published in the Federal Register . The hard copy image has been copied to diskette. There are two versions of this file as published in the Federal Register:

• Notice of proposed rulemaking.

• Final rule.

Media: Diskette/Internet.

File Cost: $165.00.

Periods Available: FY 2009 PPS Update.

14. PPS Payment Impact File

This file contains data used to estimate payments under Medicare's hospital inpatient prospective payment systems for operating and capital-related costs. The data are taken from various sources, including the Provider-Specific File, Minimum Data Sets, and prior impact files. The data set is abstracted from an internal file used for the impact analysis of the changes to the prospective payment systems published in the Federal Register . This file is available for release 1 month after the proposed and final rules are published in the Federal Register .

Media: Diskette/Internet.

File Cost: $165.00.

Periods Available: FY 2009 PPS Update.

15. AOR/BOR Tables

This file contains data used to develop the MS-DRG relative weights. It contains mean, maximum, minimum, standard deviation, and coefficient of variation statistics by MS-DRG for length of stay and standardized charges. The BOR tables are "Before Outliers Removed" and the AOR is "After Outliers Removed." (Outliers refer to statistical outliers, not payment outliers.)

Two versions of this file are created each year. They support the following:

• Notice of proposed rulemaking published in the Federal Register .

• Final rule published in the Federal Register .

Media: Diskette/Internet.

File Cost: $165.00.

Periods Available: FY 2009 PPS Update.

16. Prospective Payment System (PPS) Standardizing File

This file contains information that standardizes the charges used to calculate relative weights to determine payments under the prospective payment system. Variables include wage index, cost-of-living adjustment (COLA), case-mix index, disproportionate share, and the Metropolitan Statistical Area (MSA). The file supports the following:

• Notice of proposed rulemaking published in the Federal Register .

• Final rule published in the Federal Register .

Media: Internet.

File Cost: No charge.

Periods Available: FY 2009 PPS Update.

For further information concerning these data tapes, contact the CMS Public Use Files Hotline at (410) 786-3691.

Commenters interested in discussing any data used in constructing this proposed rule should contact Nisha Bhat at (410) 786-5320.

B. Collection of Information Requirements

1. Legislative Requirement for Solicitation of Comments

Under the Paperwork Reduction Act of 1995, we are required to provide 60-day notice in the Federal Register and solicit public comment before a collection of information requirement is submitted to the Office of Management and Budget (OMB) for review and approval. In order to fairly evaluate whether an information collection should be approved by OMB, section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 requires that we solicit comment on the following issues:

• The need for the information collection and its usefulness in carrying out the proper functions of our agency.

• The accuracy of our estimate of the information collection burden.

• The quality, utility, and clarity of the information to be collected.

• Recommendations to minimize the information collection burden on the affected public, including automated collection techniques.

2. Solicitation of Comments on Proposed Requirements in Regulatory Text

We are soliciting public comment on each of the issues listed under section XI.B.1. of this preamble for the following sections of this document that contain information collection requirements (ICRs):

a. ICRs Regarding Physician Reporting Requirements (§ 411.361)

Section 411.361(a) of the regulations states that except for entities that furnish 20 or fewer Part A and Part B services during a calendar year or for Medicare covered services furnished outside the United States, all entities furnishing services for which payment may be made under Medicare must submit information to CMS or to the Office of the Inspector General (OIG) concerning their reportable financial relationships (any ownership or investment interest, or compensation arrangement) in the form, manner, and at times that CMS or OIG specifies. As described in section IX. of the preamble of this proposed rule, and in accordance with its authority under 42 CFR 411.361(e), CMS is requiring that hospitals provide information concerning their ownership, investment and compensation arrangements with physicians by completing the DFRR instrument.

An information collection request concerning the DFRR was previously submitted to OMB for approval. We announced and sought public comment on the information collection request in both 60-day and 30-day Federal Register notices that published on May 18, 2007 (72 FR 28056), and September 14, 2007 (72 FR 52568), respectively. As further discussed in section IX. of this preamble, we have decided to obtain additional input from the public concerning the time and cost burden associated with completing and submitting the DFRR instrument. (The instrument is included as Appendix C to this proposed rule.) We believe that hospital accounting personnel would be responsible for: (1) Ensuring that the appropriate data or supporting documentation is retrieved; (2) completing the DFRR; and (3) submitting the DFRR to the Chief Executive Officer, Chief Financial Officer, or comparable officer of the hospital for his or her signature on the certification statement.

Initially, CMS would require 500 hospitals to complete and submit the DFRR instrument. We estimate that these tasks would require 31 hours for each of the 500 hospitals to complete the DFRR. Thus, the total number of burden hours required for 500 hospitals to complete the DFRR instrument is 15,500 hours.

b. ICRs Regarding Risk Adjustment Data (§ 422.310)

As discussed in section IV.H. of the preamble of this proposed rule, § 422.310(b) states that each MA organization must submit to CMS (in accordance with CMS instructions) the data necessary to characterize the context and purposes of each item and service provided to a Medicare enrollee by a provider, supplier, physician, or other practitioner. In addition, § 422.310(b) states that CMS may collect data necessary to characterize the functional limitations of enrollees of each MA organization. Section 422.310(c) lists the nature of the data elements to be submitted to CMS.

The burden associated with these requirements is the time and effort necessary for the MA organization to submit the necessary data to CMS. These requirements are subject to the PRA and the associated burden is currently approved under OMB control number 0938-0878. However, under notice and comment periods separate from this proposed rule, we intend to revise the currently approved information collection to include burden estimates as they pertain to § 422.310. The preliminary burden estimate for this proposed rule is as follows: Currently, there are 676 MA organizations. Assuming that 99 percent of encounter data claims are submitted electronically and 1 percent are submitted manually, we estimate that it will take 1,089 hours annually for submission of electronic claims and 73,335 hours annually for submission of manual claims. The estimated annual burden associated with these requirements is an annual average of 110 hours per MA organization.

c. ICRs Regarding Basic Commitments of Providers (§ 489.20)

As discussed in section IV.I. of the preamble of this proposed rule, proposed § 489.20(r)(2) states that a hospital, as defined in § 489.24(b), must maintain an on-call list of physicians on its medical staff to provide treatment necessary to stabilize patients who are receiving services required under § 489.24 in accordance with the resources available to the hospital. The burden associated with this requirement is the time and effort necessary to draft, maintain, and periodically update the list of on-call physicians. We estimate that it will take 3 hours for each of the 100 Medicare-participating hospitals to comply with this recordkeeping requirement. The estimated annual burden associated with this requirement is 300 hours.

As discussed in section VII. of the preamble of this proposed rule, proposed § 489.20(u)(1) states that, in the case of a physician-owned hospital as defined in § 489.3, the hospital must furnish written notice to all patients at the beginning of their hospital stay or outpatient visit that the hospital is a physician-owned facility. In addition, patients must be advised that a list of the hospital's owners or investors who are physicians (or immediate family members of physicians) is available upon request. Upon receiving the request of the patient or an individual on behalf of the patient, a hospital must immediately disseminate the list to the requesting patient.

The burden associated with the requirements in this section is the time and effort necessary for a hospital to furnish written notice to all patients that the hospital is a physician-owned hospital. Whereas this requirement is subject to the PRA, the associated burden is currently approved under OMB control number 0938-1034, with an expiration date of February 28, 2011.

In addition, there is burden associated with furnishing a patient with the list of the hospital's owners or investors who are physicians (or immediate family members of physicians) at the time of the patient request. However, CMS has no way to accurately quantify the burden because we cannot estimate the number of this type of request that a hospital may receive. We are soliciting public comments on the annual number of requests a hospital may receive for lists of physician-owners and investors, and will reevaluate this issue in the final rule stage of rulemaking.

Proposed § 489.20(u)(2) would require disclosure of physician ownership as a condition of continued medical staff membership or admitting privileges. The burden associated with this requirement is the time and effort required for a hospital to develop, draft, and implement changes to its medical staff bylaws and other policies governing admitting privileges. Approximately 175 physician-owned hospitals would be required to comply with this requirement. We estimate that it will require a hospital's general counsel 4 hours to revise a hospital's medical staff bylaws and policies governing admitting privileges. Therefore, the total annual hospital burden would be 700 hours.

In addition, the proposed § 489.20(u)(2) imposes a burden on physicians. As stated earlier, all physicians who are also members of the hospital's medical staff must agree, as a condition of continued medical staff membership or admitting privileges, to disclose, in writing, to all patients they refer to the hospital any ownership or investment interest in the hospital held by themselves or by an immediate family member. The disclosure must be made at the time the referral is made. The burden associated with this requirement is the time and effort necessary for a physician to draft a disclosure and to provide it to the patient at the time the referral is made to the physician-owned hospital. We estimate that it will take each physician, or designated office staff member, 1 hour to develop a disclosure notice and make copies that will be distributed to patients. In addition, we estimate 30 seconds to provide the disclosure to each patient and an additional 30 seconds to record the proof of disclosure into each patient's medical record.

Although we can estimate the number of physician-owned hospitals, we are unable to quantify the number of physicians that possess an ownership or investment interest in hospitals. There is limited data available concerning physician ownership in hospitals. The studies to date, including those by CMS and the Government Accountability Office, pertain to physician ownership in specialty hospitals (cardiac, orthopedic, and surgical hospitals). These specialty hospital studies published data concerning the average percentage of shares of direct ownership by physicians (less than 2 percent), indirect ownership through group practices, and the aggregate percentage of physician ownership, but did not publish the number of physician owners in these types of hospitals. More importantly, proposed § 489.20(u)(2) would apply to physician ownership in any type of hospital. Our other research involved a review of enrollment data. However, the CMS enrollment application (CMS-855) requires the reporting of ownership interests that exceed 5 percent or greater, and, thus, most physician ownership is not captured. In summary, because we are unable to estimate the total physician burden associated with this reporting requirement, we are seeking public comment pertaining to this burden and will reevaluate this issue in the final rule stage of rulemaking.

Proposed § 489.20(v) states that the aforementioned requirements in § 489.20(u)(1) and (u)(2) do not apply to a physician-owned hospital that does not have at least one referring physician who has an ownership or investment interest in the hospital or who has an immediate family member who has an ownership or investment interest in the hospital. To comply with this exception, an eligible hospital must sign an attestation to that effect and maintain the document in its records. Therefore, the number of hospitals that are now subject to the disclosure requirement would be slightly reduced. However, there may be a minimal burden attributable to the proposed requirement that the hospital maintain an attestation statement in its records.

The burden associated with this requirement will be limited to those physician-owned hospitals that do not have at least one referring physician who has an ownership or investment interest in the hospital or who has an immediate family member who has an ownership or investment interest in the hospital. The burden would include the time and effort for these hospitals to develop, sign, and maintain the attestations in their records. We estimate that 10 percent, or approximately 18, of the estimated 175 physician-owned hospitals would be subject to this requirement. We estimate that it would take each of these physician-owned hospitals an average of 1 hour to develop, sign, and maintain the attestation in its records. The estimated annual burden associated with this requirement is 18 hours. However, because we have no way of knowing for certain the number of physician-owned hospitals that do not have at least one referring physician who has an ownership or investment interest in the hospital or who has an immediate family member who has an ownership or investment interest in the hospital, we are requesting public comment regarding the accuracy of our estimate and the associated burden with the attestation requirement.

Section 489.20(w) requires all hospitals, as defined in § 489.24(b), to furnish all patients notice, in accordance with § 482.13(b)(2), at the beginning of their hospital stay or outpatient visit if a doctor of medicine or a doctor of osteopathy is not present in the hospital 24 hours per day, 7 days per week. The notice must indicate how the hospital will meet the medical needs of any inpatient who develops an emergency medical condition, as defined in § 489.24(b), at a time when there is no physician present in the hospital. The burden associated with this requirement is the time and effort necessary for each hospital to develop a standard notice to furnish to its patients. Whereas this requirement is subject to the PRA, the associated burden is approved under OMB control number 0938-1034 with a current expiration date of February 28, 2011.

Regulation section(s) OMB control No. Respondents Responses Burden per response (hours) Total annual burden (hours)
§ 411.361 0938-New 500 500 31 15,500
§ 422.310(b) 0938-0878 676 676 110 * 74,424
§ 489.20(r) 0938-New 100 100 3 300
§ 489.20(u)(1) and (w) 0938-1034 2,679 49,735,635 ** 839,599
§ 489.20(u)(2) 0938-New 175 175 4 700
§ 489.20(v) 0938-New 18 18 1 18
Total 930,541
* Burden estimate is based on proposed revisions to the currently approved OMB control number.
** There are multiple requirements associated with the regulation section approved under this OMB control number. There is no uniform estimate of the burden per response.

3. Associated Information Collections Not Specified in Regulatory Text

This proposed rule imposes collection of information requirements as outlined in the regulation text and specified above. However, this proposed rule also makes reference to several associated information collections that are not discussed in the regulation text. The following is a discussion of these collections, which have already received OMB approval.

a. Present on Admission (POA) Indicator Reporting

Section II.F.8 of the preamble of this proposed rule discusses the present on admission indicator (POA) reporting requirements. As stated earlier, POA indicator information is necessary to identify which conditions were acquired during hospitalization for the hospital-acquired condition (HAC) payment provision and for broader public health uses of Medicare data. Through Change Request No. 5499 (released May 11, 2007), CMS issued instructions requiring IPPS hospitals to submit the POA indicator data for all diagnosis codes on Medicare claims.

The burden associated with this requirement is the time and effort necessary to place the appropriate POA codes on Medicare claims. While the requirement is subject to the PRA; the associated burden is approved under 0938-0997 with an expiration date of August 31, 2009.

b. Proposed Add-On Payments for New Services and Technologies

Section II.J. of the preamble of this proposed rule discusses proposed add-on payments for new services and technologies. Specifically, this section states that applicants for add-on payments for new medical services or technologies for FY 2010 must submit a formal request. A formal request includes a full description of the clinical applications of the medical service or technology and the results of any clinical evaluations demonstrating that the new medical service or technology represents a substantial clinical improvement. In addition, the request must contain a significant sample of the data to demonstrate that the medical service or technology meets the high-cost threshold.

We detailed the burden associated with this requirement in a final rule published in the Federal Register on September 7, 2001 (66 FR 46902). As stated in that final rule, we believe the associated burden is exempt from the PRA as stipulated under 5 CFR 1320.3(h)(6). Collection of the information for this requirement will be conducted on an individual case-by-case basis.

c. Reporting of Hospital Quality Data for Annual Hospital Payment Update

As noted in section IV.B. of the preamble of this proposed rule, the RHQDAPU program was originally established to implement section 501(b) of Pub. L. 108-173, thereby expanding our voluntary Hospital Quality Initiative. The RHQDAPU program originally consisted of a "starter set" of 10 quality measures. OMB approved the collection of data associated with the original starter set of quality measures under OMB control number 0938-0918, with a current expiration date of January 31, 2010.

We added additional quality measures to the RHQDAPU program and submitted the information collection request to OMB for approval. This expansion of the RHQDAPU measures was part of our implementation of section 5001(a) of the DRA. Section 1886(b)(3)(B)(viii)(III) of the Act, added by section 5001(a) of the DRA, requires that the Secretary expand the "starter set" of 10 quality measures that were established by the Secretary as of November 1, 2003, to include measures "that the Secretary determines to be appropriate for the measurement of the quality of care furnished by hospitals in inpatient settings." The burden associated with these reporting requirements is currently approved under OMB control number 0938-1022 with a current expiration date of December 31, 2008.

However, for FY 2009, we submitted to OMB for approval a revised information collection request using the same OMB control number (0938-1022). In the revised request, we proposed to add three new RHQDAPU quality measures that we adopted for the FY 2009 RHADAPU program to the PRA process. These three measures are as follows:

• Pneumonia 30-day Mortality (Medicare patients);

• SCIP Infection 4: Cardiac Surgery Patients with Controlled 6AM Postoperative Serum Glucose; and

• SCIP Infection 6: Surgery Patients with Appropriate Hair Removal.

The revised information collection request was announced in the Federal Register via an emergency notice on January 28, 2008 (73 FR 4868). The information collection request is currently under review by OMB. Once approved, we will submit another revision of the information collection request to obtain approval for the new measures contained in this proposed rule.

Section IV.B.5. of the preamble of this proposed rule also discusses the requirements for the continuous collection of HCAHPS quality data. The HCAHPS survey is designed to produce comparable data on the patient's perspective on care that allows objective and meaningful comparisons between hospitals on domains that are important to consumers. We also added the HCAHPS survey to the PRA process in the information collection request currently approved under OMB control number 0938-1022 with a current expiration date of December 31, 2008.

Section IV.B.9. of the preamble of this proposed rule addresses the reconsideration and appeal procedures for a hospital that we believe did not meet the RHQDAPU program requirements. If a hospital disagrees with our determination, it may submit a written request to us requesting that we reconsider our decision. The hospital's letter must explain the reasons it believes it did meet the RHQDAPU program requirements. While this is a reporting requirement, the burden associated with it is not subject to the PRA under 5 CFR 1320.4(a)(2). The burden associated with information collection requirements imposed subsequent to an administrative action is not subject to the PRA.

d. Occupational Mix Adjustment to the FY 2009 Index (Hospital Wage Index Occupational Mix Survey)

Section III. of the preamble of this proposed rule details the proposed changes to the hospital wage index. Specifically, section III.D. addresses the proposed occupational mix adjustment to the proposed FY 2009 index. While the preamble does not contain any new information collection requirements, it is important to note that there is an OMB approved collection associated with the hospital wage index.

Section 304(c) of Pub. L. 106-554 amended section 1886(d)(3)(E) of the Act to require CMS to collect data at least once every 3 years on the occupational mix of employees for each short-term, acute care hospital participating in the Medicare program, in order to construct an occupational mix adjustment to the wage index. We collect the data via the occupational mix survey.

The burden associated with this information collection request is the time and effort required to collect and submit the data in the Hospital Wage Index Occupational Mix Survey to CMS. While this burden is subject to the PRA, it is already approved under OMB control number 0938-0907, with an expiration date of February 28, 2011.

4. Addresses for Submittal of Comments on Information Collection Requirements

If you comment on these information collection and recordkeeping requirements, please do either of the following:

1. Submit your comments electronically as specified in the ADDRESSES section of this proposed rule; or

2. Mail copies to the address specified in the ADDRESSES section of this proposed rule and to- Office of Information and Regulatory Affairs, Office of Management and Budget, Room 10235, New Executive Office Building, Washington, DC 20503, Attn: Carolyn L. Raffaelli, CMS Desk Officer, CMS-1390-P; E-mail: Carolyn_L._Raffaelli@omb.eop.gov. Fax (202) 395-6974.

C. Response to Comments

Because of the large number of public comments we normally receive on Federal Register documents, we are not able to acknowledge or respond to them individually. We will consider all comments we receive by the date and time specified in the DATES section of this preamble, and, when we proceed with a subsequent document, we will respond to the comments in the preamble to that document.

List of Subjects

42 CFR Part 411

Kidney diseases, Medicare, Physician referral, Reporting and recordkeeping requirements.

42 CFR Part 412

Administrative practice and procedure, Health facilities, Medicare, Puerto Rico, Reporting and recordkeeping requirements.

42 CFR Part 413

Health facilities, Kidney diseases, Medicare, Puerto Rico, Reporting and recordkeeping requirements.

42 CFR Part 422

Administrative practice and procedure, Grant programs-health, Health care, Health insurance, Health maintenance organizations (HMO), Loan programs-health, Medicare, Reporting and recordkeeping requirements.

42 CFR Part 489

Health facilities, Medicare, Reporting and recordkeeping requirements.

For the reasons stated in the preamble of this proposed rule, the Centers for Medicare Medicaid Services is proposing to amend 42 CFR Chapter IV as follows:

PART 411-EXCLUSIONS FROM MEDICARE AND LIMITATIONS ON MEDICARE PAYMENT

1. The authority citation for part 411 continues to read as follows:

Authority:

Secs. 1102, 1860D-1 through 1860D-42, 1871, and 1877 of the Social Security Act (42 U.S.C. 1302, 1395w-101 through 1395w-152, 1395hh, and 1395nn).

2. Section 411.351 is amended by-

a. Revising the definition of "physician".

b. Revising the definition of "physician organization".

The revisions read as follows:

§ 411.351 Definitions.

Physician means a doctor of medicine or osteopathy, a doctor of dental surgery or dental medicine, a doctor of podiatric medicine, a doctor of optometry, or a chiropractor, as defined in section 1861(r) of the Act. A physician and the professional corporation of which he or she is a sole owner are the same for purposes of this subpart.

Physician organization means a physician, a physician practice, or a group practice that complies with the requirements of § 411.352.

3. Section 411.353 is amended by revising paragraph (c) to read as follows:

§ 411.353 Prohibition on certain referrals by physicians and limitations on billing.

(c) Denial of payment. Except as provided in paragraph (e) of this section, no Medicare payment may be made for a designated health service that is furnished pursuant to a prohibited referral. The period during which referrals are prohibited is the period of disallowance. For purposes of this section, with respect to the following types of noncompliance, the period of disallowance begins at the time the financial relationship fails to satisfy the requirements of an applicable exception and ends no later than-

(1) Where the noncompliance is unrelated to compensation, the date that the financial relationship satisfies all of the requirements of an applicable exception;

(2) Where the noncompliance is due to the payment of excess compensation, the date on which the excess compensation is returned to the party that paid it and the financial relationship satisfies all of the requirements of an applicable exception; or

(3) Where the noncompliance is due to the payment of compensation that is of an amount insufficient to satisfy the requirements of an applicable exception, the date on which the additional required compensation is paid to the party to which it is owed such that the financial relationship would satisfy all of the requirements of the exception as of its date of inception.

4. Section 411.354 is amended by-

a. Adding a new paragraph (a)(1)(iii).

b. Revising paragraph (c)(2)(iv).

c. Revising paragraph (c)(3)(ii).

The addition and revisions read as follows:

§ 411.354 Financial relationship, compensation, and ownership or investment interest.

(a) * * *

(1) * * *

(iii) For purposes of paragraph (c) of this section, an entity that furnishes DHS is deemed to stand in the shoes of an organization in which it has a 100 percent ownership interest.

(c) * * *

(2) * * *

(iv) For purposes of paragraph (c)(2)(i) of this section, a physician is deemed to "stand in the shoes" of his or her physician organization unless the total compensation from the physician organization to the physician satisfies the requirements of § 411.357(c), (d), or (l).

(3) * * *

(ii) The provisions of paragraphs (c)(1)(ii) and (c)(2)(iv) of this section-

(A) Need not apply during the original term or current renewal term of an arrangement that satisfied the requirements of § 411.357(p) as of September 5, 2007 (42 CFR parts 400-413, revised as of October 1, 2007);

(B) Do not apply to an arrangement that satisfies the requirements of § 411.355(e); and

(C) Do not apply with respect to an arrangement between a physician organization and a component of an academic medical center listed in § 411.355(e)(2) for the provision to that academic medical center of only services required to satisfy the academic medical center's obligations under the Medicare graduate medical education (GME) rules in part 413, subpart F of this chapter.

PART 412-PROSPECTIVE PAYMENT SYSTEMS FOR INPATIENT HOSPITAL SERVICES

5. The authority citation for part 412 continues to read as follows:

Authority:

Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh), and sec. 124 of Pub. L. 106-113 (113 Stat. 1501A-332).

6. Section 412.4 is amended by revising paragraph (c)(3) to read as follows:

§ 412.4 Discharges and transfers.

(c) * * *

(3) To home under a written plan of care for the provision of home health services from a home health agency and those services begin-

(i) Effective for fiscal years prior to FY 2009, within 3 days after the date of discharge; and

(ii) Effective FY 2009, within 7 days after the date of discharge.

7. Section 412.22 is amended by-

a. In the introductory text of paragraph (e), removing the phrase "paragraph (f) of this section" and adding in its place "paragraphs (e)(1) (vi) and (f) of this section".

b. Adding a new paragraph (e)(1)(vi).

The addition reads as follows:

§ 412.22 Excluded hospitals and hospital units: General rules.

(e) * * *

(1) * * *

(vi) Effective October 1, 2008, if a State hospital that is occupying space in the same building or on the same campus as another State hospital cannot meet the criterion under paragraph (e)(1)(i) of this section solely because its governing body is under the control of the State hospital with which it shares a building or a campus, or is under the control of a third entity that also controls the State hospital with which it shares a building or a campus, the State hospital can nevertheless qualify for an exclusion if it meets the other applicable criteria in this section and-

(A) Both State hospitals occupy space in the same building or on the same campus and have been continuously owned and operated by the State since October 1, 1995;

(B) Is required by State law to be subject to the governing authority of the State hospital with which it shares space or the governing authority of a third entity that controls both hospitals; and

(C) Was excluded from the inpatient prospective payment system before October 1, 1995, and continues to be excluded from the inpatient prospective payment system through September 30, 2008.

8. Section 412.64 is amended by-

a. Republishing the introductory text of paragraph (b)(1)(ii) and revising paragraph (b)(1)(ii)(A).

b. In the introductory text of paragraph (h)(4), removing the date "September 30, 2008" and adding in its place "September 30, 2011".

The revision reads as follows:

§ 412.64 Federal rates for inpatient operating costs for Federal fiscal year 2005 and subsequent fiscal years.

(b) * * *

(1) * * *

(ii) The term urban area means-

(A) A Metropolitan Statistical Area or a Metropolitan division (in the case where a Metropolitan Statistical Area is divided into Metropolitan Divisions), as defined by the Executive Office of Management and Budget; or

9. Section 412.87 is amended by-

a. Revising paragraph (b)(1).

b. Adding a new paragraph (c).

The revision and addition read as follows:

§ 412.87 Additional payment for new medical services and technologies: General provisions.

(b) * * *

(1) A new medical service or technology represents an advance that substantially improves, relating to technologies previously available, the diagnosis or treatment of Medicare beneficiaries.

(c) Announcement of determinations and deadline for consideration of new medical service or technology applications. CMS will consider whether a new medical service or technology meets the eligibility criteria specified in paragraph (b) of this section and announce the results in the Federal Register as part of its annual updates and changes to the IPPS. CMS will only consider, for add-on payments for a particular fiscal year, an application for which the new medical service or technology has received FDA approval or clearance by July 1 prior to the particular fiscal year.

10. Section 412.230 is amended by-

a. Revising paragraph (d)(1)(iv)(C).

b. Adding a new paragraph (d)(1)(iv)(D).

The addition and revision read as follows:

§ 412.230 Criteria for an individual hospital seeking redesignation to another rural area or an urban area.

(d) * * *

(1) * * *

(iv) * * *

(C) With respect to redesignations for fiscal years 2002 through 2009, the hospital's average hourly wage is equal to, in the case of a hospital located in a rural area, at least 82 percent, and in the case of a hospital located in an urban area, at least 84 percent of the average hourly wage of hospitals in the area to which it seeks redesignation.

(D) With respect to redesignations for fiscal year 2010 and later fiscal years, the hospital's average hourly wage is equal to, in the case of a hospital located in a rural area, at least 86 percent, and in the case of a hospital located in an urban area, at least 88 percent of the average hourly wage of hospitals in the area to which it seeks redesignation.

11. Section 412.232 is amended by revising paragraphs (c)(1) and (c)(2) to read as follows:

§ 412.232 Criteria for all hospitals in a rural county seeking urban redesignation.

(c) * * *

(1) Aggregate hourly wage for fiscal years before fiscal year 2010 -(i) Aggregate hourly wage. With respect to redesignations effective beginning fiscal year 1999 and before fiscal year 2010, the aggregate average hourly wage for all hospitals in the rural county must be equal to at least 85 percent of the average hourly wage in the adjacent urban area.

(ii) Aggregate hourly wage weighted for occupational mix. For redesignations effective before fiscal year 1999, the aggregate hourly wage for all hospitals in the rural county, weighed for occupational categories, is at least 90 percent of the average hourly wage in the adjacent urban area.

(2) Aggregate hourly wage for fiscal year 2010 and later fiscal years. With respect to redesignations effective for fiscal year 2010 and later fiscal years, the aggregate average hourly wage for all hospitals in the rural county must be equal to at least 88 percent of the average hourly wage in the adjacent urban area.

12. Section 412.234 is amended by revising paragraphs (b)(1) and (b)(2) to read as follows:

§ 412.234 Criteria for all hospitals in an urban county seeking redesignation to another urban area.

(b) * * *

(1) Aggregate hourly wage for fiscal years before fiscal year 2010 -(i) Aggregate hourly wage. With respect to redesignations effective beginning fiscal year 1999 and before fiscal year 2010, the aggregate average hourly wage for all hospitals in the urban county must be at least 85 percent of the average hourly wage in the urban area to which the hospitals in the county seek reclassification.

(ii) Aggregate hourly wage weighted for occupational mix. For redesignations effective before fiscal year 1999, the aggregate hourly wage for all hospitals in the county, weighed for occupational categories, is at least 90 percent of the average hourly wage in the adjacent urban area.

(2) Aggregate hourly wage for fiscal year 2010 and later fiscal years. With respect to redesignations effective for fiscal year 2010 and later fiscal years, the aggregate average hourly wage for all hospitals in the urban county must be at least 88 percent of the average hourly wage in the urban area to which the hospitals in the county seek reclassification.

PART 413-PRINCIPLES OF REASONABLE COST REIMBURSEMENT; PAYMENT FOR END-STAGE RENAL DISEASE SERVICES; PROSPECTIVELY DETERMINED PAYMENT RATES FOR SKILLED NURSING FACILITIES

13. The authority citation for Part 413 continues to read as follows:

Authority:

Secs. 1102, 1812(d), 1814(b), 1815, 1833(a), (i), and (n), 1861(v), 1871, 1881, 1883, and 1886 of the Social Security Act (42 U.S.C. 1302, 1395d(d), 1395f(b), 1395g, 1395l(a), (i), and (n), 1395x(v), 1395hh, 1395rr, 1395tt, and 1395ww); and sec. 124 of Pub. L. 106-133 (113 Stat. 1501A-332).

§ 413.79 [Amended]

14. In § 413.79(f)(6)(iv), remove the cross-reference "§ 413.75(d)" and add the cross-reference "paragraph (d) of this section" in its place.

PART 422-MEDICARE ADVANTAGE PROGRAM

15. The authority citation for Part 422 continues to read as follows:

Authority:

Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh).

16. Section 422.310 is revised to read as follows:

§ 422.310 Risk adjustment data.

(a) Definition of risk adjustment data. Risk adjustment data are all data that are used in the development and application of a risk adjustment payment model.

(b) Data collection: Basic rule. Each MA organization must submit to CMS (in accordance with CMS instructions) the data necessary to characterize the context and purposes of each item and service provided to a Medicare enrollee by a provider, supplier, physician, or other practitioner. CMS may also collect data necessary to characterize the functional limitations of enrollees of each MA organization.

(c) Sources and extent of data. (1) To the extent required by CMS, risk adjustment data must account for the following:

(i) Items and services covered under the original Medicare program.

(ii) Medicare-covered items and services for which Medicare is not the primary payer.

(iii) Other additional or supplemental benefits that the MA organization may provide.

(2) The data must account separately for each provider, supplier, physician, or other practitioner that would be permitted to bill separately under the original Medicare program, even if they participate jointly in the same service.

(d) Other data requirements. (1) MA organizations must submit data that conform to CMS' requirements for data equivalent to Medicare fee-for-service data, when appropriate, and to all relevant national standards. CMS may specify abbreviated formats for data submission required of MA organizations.

(2) The data must be submitted electronically to the appropriate CMS contractor.

(3) MA organizations must obtain the risk adjustment data required by CMS from the provider, supplier, physician, or other practitioner that furnished the item or service.

(4) MA organizations may include in their contracts with providers, suppliers, physicians, and other practitioners, provisions that require submission of complete and accurate risk adjustment data as required by CMS. These provisions may include financial penalties for failure to submit complete data.

(e) Validation of risk adjustment data. MA organizations and their providers and practitioners will be required to submit a sample of medical records for the validation of risk adjustment data, as required by CMS. There may be penalties for submission of false data.

(f) Use of data. CMS uses the data obtained under this section to determine the risk adjustment factors used to adjust payments, as required under §§ 422.304(a) and (c). CMS may also use the data for other purposes, including updating of risk adjustment models.

(g) Deadlines for submission of risk adjustment data. Risk adjustment factors for each payment year are based on risk adjustment data submitted for items and services furnished during the 12-month period before the payment year that is specified by CMS. As determined by CMS, this 12-month period may include a 6-month data lag that may be changed or eliminated as appropriate. CMS may adjust these deadlines, as appropriate.

(1) The annual deadline for risk adjustment data submission is the first Friday in September for risk adjustment data reflecting items and services furnished during the 12-month period ending the prior June 30, and the first Friday in March for data reflecting services furnished during the 12-month period ending the prior December 31.

(2) CMS allows a reconciliation process to account for late data submissions. CMS continues to accept risk adjustment data submitted after the March deadline until January 31 of the year following the payment year. After the payment year is completed, CMS recalculates the risk factors for affected individuals to determine if adjustments to payments are necessary. Risk adjustment data that are received after the annual January 31 late data submission deadline will not be accepted for the purposes of reconciliation.

PART 489-PROVIDER AGREEMENTS AND SUPPLIER APPROVAL

17. The authority citation for part 489 continues to read as follows:

Authority:

Secs. 1102, 1819, 1820(e), 1861, 1864(m), 1866, 1869, and 1871 of the Social Security Act (42 U.S.C. 1302, 1395i-3, 1395x, 1395aa(m), 1395cc, 1395ff, and 1395hh).

18. Section 489.3 is amended by revising the definition of "physician-owned hospital" to read as follows:

§ 489.3 Definitions.

Physician-owned hospital means any participating hospital (as defined in § 489.24) in which a physician, or an immediate family member of a physician (as defined in § 411.351 of this chapter), has an ownership or investment interest. The ownership or investment interest may be through equity, debt, or other means, and includes an interest in an entity that holds an ownership or investment interest in the hospital. This definition does not include a hospital with physician ownership or investment interests that satisfy the requirements at § 411.356(a) or (b) of this chapter.

19. Section 489.20 is amended by-

a. Revising paragraph (r)(2).

b. Revising paragraph (u).

c. Redesignating paragraphs (v) and (w) as paragraphs (w) and (x), respectively.

d. Adding a new paragraph (v).

The revisions and addition read as follows:

§ 489.20 Basic commitments.

(r) * * *

(2) An on-call list of physicians on its medical staff available to provide treatment necessary after the initial examination to stabilize individuals with emergency medical conditions who are receiving services required under § 489.24 in accordance with the resources available to the hospital; and

(u) Except as provided in paragraph (v) of this section, in the case of a physician-owned hospital as defined in § 489.3-

(1) To furnish written notice to all patients at the beginning of their hospital stay or outpatient visit that the hospital is a physician-owned hospital, in order to assist the patients in making an informed decision regarding their care, in accordance with § 482.13(b)(2) of this subchapter. The notice should disclose, in a manner reasonably designed to be understood by all patients, the fact that the hospital meets the Federal definition of a physician-owned hospital specified in § 489.3 and that the list of the hospital's owners or investors who are physicians or immediate family members of physicians (as defined at § 411.351 of this chapter) must be provided to the patients at the time the request for the list is made by or on behalf of the patient. For purposes of this paragraph (u)(1), the hospital stay or outpatient visit begins with the provision of a package of information regarding scheduled preadmission testing and registration for a planned hospital admission for inpatient care or outpatient service.

(2) To require all physicians who are members of the hospital's medical staff to agree, as a condition of continued medical staff membership or admitting privileges, to disclose, in writing, to all patients they refer to the hospital any ownership or investment interest in the hospital that is held by themselves or by an immediate family member (as defined in § 411.351 of this chapter). Disclosure must be required at the time the referral is made.

(v) The requirements of paragraph (u) of this section do not apply to any physician-owned hospital that does not have at least one referring physician (as defined at § 411.351 of this chapter) who has an ownership or investment interest in the hospital or who has an immediate family member who has an ownership or investment interest in the hospital, provided that such hospital signs an attestation statement to that effect and maintain such a notice in its records.

20. Section 489.24 is amended by-

a. Revising paragraph (a)(2).

b. Revising paragraph (f).

c. Revising paragraph (j).

The revisions read as follows:

§ 489.24 Special responsibilities of Medicare hospitals in emergency cases.

(a) * * *

(2) Nonapplicability of provisions of this section. Sanctions under this section for an inappropriate transfer during a national emergency or for the direction or relocation of an individual to receive medical screening at an alternate location pursuant to an appropriate State emergency preparedness plan or, in the case of a public health emergency that involves a pandemic infectious disease, pursuant to a State pandemic preparedness plan do not apply to a hospital with a dedicated emergency department located in an emergency area during an emergency period, as specified in section 1135(g)(1) of the Act. A waiver of these sanctions is limited to a 72-hour period beginning upon the implementation of a hospital disaster protocol, except that, if a public health emergency involves a pandemic infectious disease (such as pandemic influenza), the waiver will continue in effect until the termination of the applicable declaration of a public health emergency, as provided for by section 135(e)(1)(B) of the Act.

(f) Recipient hospital responsibilities. A participating hospital that has specialized capabilities or facilities (including, but not limited to, facilities such as burn units, shock-trauma units, neonatal intensive case units, or, with respect to rural areas, regional referral centers (which, for purposes of this subpart, mean hospitals meeting the requirements of referral centers found at § 412.96 of this chapter)) may not refuse to accept from a referring hospital within the boundaries of the United States an appropriate transfer of an individual who requires such specialized capabilities or facilities if the receiving hospital has the capacity to treat the individual. This provision applies to-

(1) Any participating hospital with specialized capabilities, regardless of whether the hospital has a dedicated emergency department; and

(2) An individual who has been admitted under paragraph (d)(2)(i) of this section and who has not been stabilized.

(j) Availability of on-call physicians . In accordance with the on-call list requirements specified in § 489.20(r)(2), a hospital must have written policies and procedures in place-

(1) To respond to situations in which a particular specialty is not available or the on-call physician cannot respond because of circumstances beyond the physician's control; and

(2) To provide that emergency services are available to meet the needs of individuals with emergency medical conditions if a hospital elects to-

(i) Permit on-call physicians to schedule elective surgery during the time that they are on call;

(ii) Permit on-call physicians to have simultaneous on-call duties; and

(iii) Participate in a formal community call plan. Notwithstanding participation in a community call plan, hospitals are still required to perform medical screening examinations on individuals who present seeking treatment and to conduct appropriate transfers. The formal community plan must include the following elements:

(A) A clear delineation of on-call coverage responsibilities; that is, when each hospital participating in the plan is responsible for on-call coverage.

(B) A description of the specific geographic area to which the plan applies.

(C) A signature by an appropriate representative of each hospital participating in the plan.

(D) Assurances that any local and regional EMS system protocol formally includes information on community on-call arrangements.

(E) Evidence of engagement of the hospitals participating in the community call plan in an analysis of the specialty on-call needs of the community for which the plan is effective.

(F) A statement specifying that even if an individual arrives at a hospital that is not designated as the on-call hospital, that hospital still has an obligation under § 489.24 to provide a medical screening examination and stabilizing treatment within its capability, and that hospitals participating in the community call plan must abide by the regulations under § 489.24 governing appropriate transfers.

(G) An annual assessment of the community call plan by the participating hospitals.

21. Section 489.53 is amended by revising paragraph (c) to read as follows:

§ 489.53 Termination by CMS.

(c) Termination of agreements with physician-owned hospitals . In the case of a physician-owned hospital, as defined at § 489.3, CMS may terminate the provider agreement if the hospital failed to comply with the requirements of § 489.20(u) or (w).

(Catalog of Federal Domestic Assistance Program No. 93.773, Medicare-Hospital Insurance; and Program No. 93.774, Medicare-Supplementary Medical Insurance Program)

Dated: April 1, 2008.

Kerry Weems,

Acting Administrator, Centers for Medicare Medicaid Services.

Dated: April 10, 2008.

Michael O. Leavitt,

Secretary.

[Editorial Note:

The following Addendum and appendixes will not appear in the Code of Federal Regulations.]

Addendum-Proposed Schedule of Standardized Amounts, Update Factors, and Rate-of-Increase Percentages Effective With Cost Reporting Periods Beginning On or After October 1, 2008

I. Summary and Background

In this Addendum, we are setting forth the methods and data we used to determine the proposed prospective payment rates for Medicare hospital inpatient operating costs and Medicare hospital inpatient capital-related costs. We are also setting forth the proposed rate-of-increase percentages for updating the target amounts for certain hospitals and hospital units excluded from the IPPS. In general, except for SCHs, MDHs, and hospitals located in Puerto Rico, each hospital's payment per discharge under the IPPS is based on 100 percent of the Federal national rate, also known as the national adjusted standardized amount. This amount reflects the national average hospital cost per case from a base year, updated for inflation.

SCHs are paid based on whichever of the following rates yields the greatest aggregate payment: The Federal national rate; the updated hospital-specific rate based on FY 1982 costs per discharge; the updated hospital-specific rate based on FY 1987 costs per discharge; or the updated hospital-specific rate based on FY 1996 costs per discharge.

Under section 1886(d)(5)(G) of the Act, MDHs historically have been paid based on the Federal national rate or, if higher, the Federal national rate plus 50 percent of the difference between the Federal national rate and the updated hospital-specific rate based on FY 1982 or FY 1987 costs per discharge, whichever was higher. (MDHs did not have the option to use their FY 1996 hospital-specific rate.) However, section 5003(a)(1) of Pub. L. 109-171 extended and modified the MDH special payment provision that was previously set to expire on October 1, 2006, to include discharges occurring on or after October 1, 2006, but before October 1, 2011. Under section 5003(b) of Pub. L. 109-171, if the change results in an increase to an MDH's target amount, an MDH must rebase its hospital-specific rates to its FY 2002 cost report. Section 5003(c) of Pub. L. 109-171 further required that MDHs be paid based on the Federal national rate or, if higher, the Federal national rate plus 75 percent of the difference between the Federal national rate and the updated hospital-specific rate. Further, based on the provisions of section 5003(d) of Pub. L. 109-171, MDHs are no longer subject to the 12-percent cap on their DSH payment adjustment factor.

For hospitals located in Puerto Rico, the payment per discharge is based on the sum of 25 percent of an updated Puerto Rico-specific rate based on average costs per case of Puerto Rico hospitals for the base year and 75 percent of the Federal national rate. (We refer readers to section II.D.3. of this Addendum for a complete description.)

As discussed below in section II. of this Addendum, we are proposing to make changes in the determination of the prospective payment rates for Medicare inpatient operating costs for FY 2009. In section III. of this Addendum, we discuss our proposed policy changes for determining the prospective payment rates for Medicare inpatient capital-related costs for FY 2009. Section IV. of this Addendum sets forth our proposed changes for determining the rate-of-increase limits for certain hospitals excluded from the IPPS for FY 2009. The tables to which we refer in the preamble of this proposed rule are presented in section V. of this Addendum of this proposed rule.

II. Proposed Changes to Prospective Payment Rates for Hospital Inpatient Operating Costs for FY 2009

The basic methodology for determining prospective payment rates for hospital inpatient operating costs for FY 2005 and subsequent fiscal years is set forth at § 412.64. The basic methodology for determining the prospective payment rates for hospital inpatient operating costs for hospitals located in Puerto Rico for FY 2005 and subsequent fiscal years is set forth at §§ 412.211 and 412.212. Below we discuss the factors used for determining the prospective payment rates.

In summary, the proposed standardized amounts set forth in Tables 1A, 1B, and 1C, of section VI. of this Addendum reflect-

• Equalization of the standardized amounts for urban and other areas at the level computed for large urban hospitals during FY 2004 and onward, as provided for under section 1886(d)(3)(A)(iv) of the Act, updated by the applicable percentage increase required under sections 1886(b)(3)(B)(i)(XX) and 1886(b)(3)(B)(viii) of the Act.

• The labor-related share that is applied to the standardized amounts and Puerto Rico-specific standardized amounts to give the hospital the highest payment, as provided for under sections 1886(d)(3)(E), and 1886(d)(9)(C)(iv) of the Act.

• Proposed updates of 3.0 percent for all areas (that is, the estimated full market basket percentage increase of 3.0 percent), as required by section 1886(b)(3)(B)(i)(XX) of the Act, as amended by section 5001(a)(1) of Pub. L. 109-171, and reflecting the requirements of section 1886(b)(3)(B)(viii) of the Act, as added by section 5001(a)(3) of Pub. L. 109-171, to reduce the applicable percentage increase by 2.0 percentage points for a hospital that fails to submit data, in a form and manner specified by the Secretary, relating to the quality of inpatient care furnished by the hospital.

• A proposed update of 3.0 percent to the Puerto Rico-specific standardized amount (that is, the full estimated rate-of-increase in the hospital market basket for IPPS hospitals), as provided for under § 412.211(c), which states that we update the Puerto Rico-specific standardized amount using the percentage increase specified in § 412.64(d)(1), or the percentage increase in the market basket index for prospective payment hospitals for all areas.

• An adjustment to the standardized amount to ensure budget neutrality for DRG recalibration and reclassification, as provided for under section 1886(d)(4)(C)(iii) of the Act.

• An adjustment to ensure the wage index update and changes are budget neutral, as provided for under section 1886(d)(3)(E) of the Act.

• An adjustment to ensure the effects of geographic reclassification are budget neutral, as provided for in section 1886(d)(8)(D) of the Act, by removing the FY 2008 budget neutrality factor and applying a revised factor.

• An adjustment to remove the FY 2008 outlier offset and apply an offset for FY 2009.

• An adjustment to ensure the effects of the rural community hospital demonstration required under section 410A of Pub. L. 108-173 are budget neutral, as required under section 410A(c)(2) of Pub. L. 108-173.

• An adjustment to eliminate the effect of coding or classification changes that do not reflect real changes in case-mix, as discussed below and in section II.D. of the preamble to this proposed rule.

We note that, beginning in FY 2008, we applied the budget neutrality adjustment for the rural floor to the hospital wage indices rather than the standardized amount. For FY 2009, we are proposing to continue to apply the rural floor budget neutrality adjustment to hospital wage indices rather than the standardized amount. In addition, instead of applying the budget neutrality adjustment for the imputed rural floor adopted under section 1886(d)(3)(E) of the Act to the standardized amounts, beginning with FY 2009, we are proposing to apply the imputed rural floor budget neutrality adjustment to the wage indices. Beginning in FY 2009, we are also proposing to apply the budget neutrality adjustments for the rural floor and imputed rural floor at the State level rather than the national level. For a complete discussion of the budget neutrality proposals concerning the rural floor and the imputed rural floor, including the proposal for a within-State budget neutrality adjustment, we refer readers to section III.B.2.b. of the preamble to this proposed rule.

A. Calculation of the Adjusted Standardized Amount

1. Standardization of Base-Year Costs or Target Amounts

In general, the national standardized amount is based on per discharge averages of adjusted hospital costs from a base period (section 1886(d)(2)(A) of the Act) or, for Puerto Rico, adjusted target amounts from a base period (section 1886(d)(9)(B)(i) of the Act), updated and otherwise adjusted in accordance with the provisions of section 1886(d) of the Act. The September 1, 1983 interim final rule (48 FR 39763) contained a detailed explanation of how base-year cost data (from cost reporting periods ending during FY 1981) were established for urban and rural hospitals in the initial development of standardized amounts for the IPPS. The September 1, 1987 final rule (52 FR 33043 and 33066) contains a detailed explanation of how the target amounts were determined and how they are used in computing the Puerto Rico rates.

Sections 1886(d)(2)(B) and (d)(2)(C) of the Act require us to update base-year per discharge costs for FY 1984 and then standardize the cost data in order to remove the effects of certain sources of cost variations among hospitals. These effects include case-mix, differences in area wage levels, cost-of-living adjustments for Alaska and Hawaii, indirect medical education costs, and costs to hospitals serving a disproportionate share of low-income patients.

In accordance with section 1886(d)(3)(E) of the Act, the Secretary estimates, from time-to-time, the proportion of hospitals' costs that are attributable to wages and wage-related costs. In general, the standardized amount is divided into labor-related and nonlabor-related amounts; only the proportion considered to be the labor-related amount is adjusted by the wage index. Section 1886(d)(3)(E) of the Act requires that 62 percent of the standardized amount be adjusted by the wage index, unless doing so would result in lower payments to a hospital than would otherwise be made. (Section 1886(d)(9)(C)(iv)(II) of the Act extends this provision to the labor-related share for hospitals located in Puerto Rico.)

For FY 2009, we are not proposing to change the national and Puerto Rico-specific labor-related and nonlabor-related shares from the percentages established for FY 2008. Therefore, the labor-related share continues to be 69.7 percent for the national standardized amounts and 58.7 percent for the Puerto Rico-specific standardized amount. Consistent with section 1886(d)(3)(E) of the Act, we are applying the wage index to a labor-related share of 62 percent for all non-Puerto Rico hospitals whose wage indexes are less than or equal to 1.0000. For all non-Puerto Rico hospitals whose wage indices are greater than 1.0000, we are applying the wage index to a labor-related share of 69.7 percent of the national standardized amount. For hospitals located in Puerto Rico, we are applying a labor-related share of 58.7 percent if its Puerto Rico-specific wage index is less than or equal to 1.0000. For hospitals located in Puerto Rico whose Puerto Rico-specific wage index values are greater than 1.0000, we are applying a labor share of 62 percent.

The standardized amounts for operating costs appear in Table 1A, 1B, and 1C of the Addendum to this proposed rule.

2. Computing the Average Standardized Amount

Section 1886(d)(3)(A)(iv)(II) of the Act requires that, beginning with FY-2004 and thereafter, an equal standardized amount be computed for all hospitals at the level computed for large urban hospitals during FY 2003, updated by the applicable percentage update. Section 1886(d)(9)(A)(ii)(II) of the Act equalizes the Puerto Rico-specific urban and rural area rates. Accordingly, we are calculating FY 2009 national and Puerto Rico standardized amounts irrespective of whether a hospital is located in an urban or rural location.

3. Updating the Average Standardized Amount

In accordance with section 1886(d)(3)(A)(iv)(II) of the Act, we are updating the equalized standardized amount for FY 2008 by the full estimated market basket percentage increase for hospitals in all areas, as specified in section 1886(b)(3)(B)(i)(XX) of the Act, as amended by section 5001(a)(1) of Pub. L. 109-171. The percentage change in the market basket reflects the average change in the price of goods and services purchased by hospitals to furnish inpatient care. The most recent forecast of the hospital market basket increase for FY 2009 is 3.0 percent. Thus, for FY 2009, the proposed update to the average standardized amount is 3.0 percent for hospitals in all areas. The estimated market basket increase of 3.0 percent is based on the 2008 first quarter forecast of the hospital market basket increase (as discussed in Appendix B of this proposed rule).

Section 1886(b)(3)(B) of the Act specifies the mechanism to be used to update the standardized amount for payment for inpatient hospital operating costs. Section 1886(b)(3)(B)(viii) of the Act, as added by section 5001(a)(3) of Pub. L. 109-171, provides for a reduction of 2.0 percentage points from the update percentage increase (also known as the market basket update) for FY 2007 and each subsequent fiscal year for any "subsection (d) hospital" that does not submit quality data, as discussed in section IV.A. of the preamble of this proposed rule. The standardized amounts in Tables 1A through 1C of section V. of the Addendum to this proposed rule reflect these differential amounts.

Section 412.211(c) states that we update the Puerto Rico-specific standardized amount using the percentage increase specified in § 412.64(d)(1) or the percentage increase in the market basket index for prospective payment hospitals for all areas. We are proposing to apply the full rate-of-increase in the hospital market basket for IPPS hospitals to the Puerto Rico-specific standardized amount. Therefore, the proposed update to the Puerto Rico-specific standardized amount is estimated to be 3.0 percent.

Although the update factors for FY 2009 are set by law, we are required by section 1886(e)(4) of the Act to recommend, taking into account MedPAC's recommendations, appropriate update factors for FY 2009 for both IPPS hospitals and hospitals and hospital units excluded from the IPPS. Our recommendation on the update factors (which is required by sections 1886(e)(4)(A) and (e)(5)(A) of the Act) is set forth in Appendix B of this proposed rule.

4. Other Adjustments to the Average Standardized Amount

As in the past, we are adjusting the FY 2009 standardized amount to remove the effects of the FY 2008 geographic reclassifications and outlier payments before applying the FY 2009 updates. We then applied budget neutrality offsets for outliers and geographic reclassifications to the standardized amount based on proposed FY 2009 payment policies.

We do not remove the prior year's budget neutrality adjustments for reclassification and recalibration of the DRG weights and for updated wage data because, in accordance with sections 1886(d)(4)(C)(iii) and 1886(d)(3)(E) of the Act, estimated aggregate payments after updates in the DRG relative weights and wage index should equal estimated aggregate payments prior to the changes. If we removed the prior year's adjustment, we would not have satisfied these conditions.

Budget neutrality is determined by comparing aggregate IPPS payments before and after making changes that are required to be budget neutral (for example, changes to DRG classifications, recalibration of the DRG relative weights, updates to the wage index, and different geographic reclassifications). We included outlier payments in the simulations because they may be affected by changes in these parameters.

We are also proposing to adjust the standardized amount this year by an estimated amount to ensure that aggregate IPPS payments did not exceed the amount of payments that would have been made in the absence of the rural community hospital demonstration program, as required under section 410A of Pub. L. 108-173. This demonstration is required to be budget neutral under section 410A(c)(2) of Pub. L. 108-173. For FY 2009, we are proposing to no longer apply budget neutrality for the imputed rural floor to the standardized amount, and to apply it instead to the wage index, as discussed in section of II.B.2. of the preamble to this proposed rule. For FY 2009, we are also proposing an adjustment to eliminate the effect of coding or classification changes that did not reflect real changes in case-mix using the Secretary's authority under section 1886(d)(3)(A)(vi) of the Act, by the percentage specified in section 7 of Pub. L. 110-90.

a. Proposed Recalibration of DRG Weights and Updated Wage Index-Budget Neutrality Adjustment

Section 1886(d)(4)(C)(iii) of the Act specifies that, beginning in FY 1991, the annual DRG reclassification and recalibration of the relative weights must be made in a manner that ensures that aggregate payments to hospitals are not affected. As discussed in section II. of the preamble of this proposed rule, we normalized the recalibrated DRG weights by an adjustment factor so that the average case weight after recalibration is equal to the average case weight prior to recalibration. However, equating the average case weight after recalibration to the average case weight before recalibration does not necessarily achieve budget neutrality with respect to aggregate payments to hospitals because payments to hospitals are affected by factors other than average case weight. Therefore, as we have done in past years, we made a budget neutrality adjustment to ensure that the requirement of section 1886(d)(4)(C)(iii) of the Act is met.

Section 1886(d)(3)(E) of the Act requires us to update the hospital wage index on an annual basis beginning October 1, 1993. This provision also requires us to make any updates or adjustments to the wage index in a manner that ensures that aggregate payments to hospitals are not affected by the change in the wage index. Consistent with current policy, for FY 2009, we are adjusting 100 percent of the wage index factor for occupational mix. We describe the occupational mix adjustment in section III.D. of the preamble to this proposed rule.

To comply with the requirement that DRG reclassification and recalibration of the relative weights and the updated wage index be budget neutral, we used FY 2007 discharge data to simulate payments and compared aggregate payments using the FY 2008 relative weights and wage indices to aggregate payments using the proposed FY 2009 relative weights and wage indices. The same methodology was used for the FY 2008 budget neutrality adjustment. Based on this comparison, we computed a proposed budget neutrality adjustment factor equal to 0.999525 to be applied to the national standardized amount. We are also adjusting the Puerto Rico-specific standardized amount for the effect of DRG reclassification and recalibration. We computed a proposed budget neutrality adjustment factor of 0.998700 to be applied to the Puerto Rico-specific standardized amount. These proposed budget neutrality adjustment factors are applied to the standardized amounts for FY 2008 without removing the prior year's budget neutrality adjustments. In addition, as discussed in section IV. of this Addendum, we are applying the same proposed DRG reclassification and recalibration budget neutrality factor of 0.998700 to the hospital-specific rates that would be effective for cost reporting periods beginning on or after October 1, 2008.

b. Reclassified Hospitals-Budget Neutrality Adjustment

Section 1886(d)(8)(B) of the Act provides that, effective with discharges occurring on or after October 1, 1988, certain rural hospitals are deemed urban. In addition, section 1886(d)(10) of the Act provides for the reclassification of hospitals based on determinations by the MGCRB. Under section 1886(d)(10) of the Act, a hospital may be reclassified for purposes of the wage index.

Under section 1886(d)(8)(D) of the Act, the Secretary is required to adjust the standardized amount to ensure that aggregate payments under the IPPS after implementation of the provisions of sections 1886(d)(8)(B) and (C) and 1886(d)(10) of the Act are equal to the aggregate prospective payments that would have been made absent these provisions. We note that the wage index adjustments provided under section 1886(d)(13) of the Act are not budget neutral. Section 1886(d)(13)(H) of the Act provides that any increase in a wage index under section 1886(d)(13) shall not be taken into account "in applying any budget neutrality adjustment with respect to such index" under section 1886(d)(8)(D) of the Act. To calculate the proposed budget neutrality factor for FY 2009, we used FY 2007 discharge data to simulate payments, and compared total IPPS payments prior to any reclassifications under sections 1886(d)(8)(B) and (C) and 1886(d)(10) of the Act to total IPPS payments after such reclassifications. Based on these simulations, we calculated a proposed adjustment factor of 0.992333 to ensure that the effects of these provisions are budget neutral, consistent with the statute.

The proposed adjustment factor is applied to the standardized amount after removing the effects of the FY 2008 budget neutrality adjustment factor. We note that the FY 2009 adjustment reflects FY 2009 wage index reclassifications approved by the MGCRB or the Administrator. (Section 1886(d)(10)(D)(v) of the Act makes wage index reclassifications effective for 3 years. Therefore, the FY 2009 geographic reclassification could either be the continuation of a 3-year reclassification that began in FY 2007 or FY 2008, or a new one beginning in FY 2009.)

c. Case-Mix Budget Neutrality Adjustment

As stated earlier, beginning in FY 2008, we adopted the new MS-DRG patient classification system for the IPPS to better recognize severity of illness in Medicare payment rates. In the FY 2008 IPPS final rule with comment period, we indicated that we believe the adoption of the MS-DRGs had the potential to lead to increases in aggregate payments without a corresponding increase in actual patient severity of illness due to the incentives for improved documentation and coding. In that final rule, using the Secretary's authority under section 1886(d)(3)(A)(vi) of the Act to maintain budget neutrality by adjusting the national standardized amounts to eliminate the effect of changes in coding or classification that do not reflect real change in case-mix, we established prospective documentation and coding adjustments of -1.2 percent for FY 2008, -1.8 percent for FY 2009, and -1.8 percent for FY 2010. On September 29, 2007, Pub. L. 110-90 was enacted. Section 7 of Pub. L. 110-90 included a provision that reduces the documentation and coding adjustment for the MS-DRG system that we adopted in the FY 2008 IPPS final rule with comment period to -0.6 percent for FY 2008 and -0.9 percent for FY 2009. To comply with the provision of section 7 of Pub. L. 110-90, in a final rule that appeared in the Federal Register on November 27, 2007 (72 FR 66886), we changed the IPPS documentation and coding adjustment for FY 2008 to -0.6 percent, and revised the FY 2008 national standardized amounts (as well as other payment factors and thresholds) accordingly, with these revisions effective October 1, 2007. For FY 2009, section 7 of Pub. L. 110-90 requires a documentation and coding adjustment of -0.9 percent instead of the -1.8 percent adjustment specified in the FY 2008 IPPS final rule with comment period. As required by statute, we are applying a documentation and coding adjustment of -0.9 percent to the FY 2009 IPPS national standardized amounts. The documentation and coding adjustments established in the FY 2008 IPPS final rule with comment period are cumulative. As a result, the -0.9 percent documentation and coding adjustment in FY 2009 is in addition to the -0.6 percent adjustment in FY 2008, yielding a combined effect of -1.5 percent.

As discussed in more detail in section II.D. of the preamble of this proposed rule, in calculating the FY 2008 Puerto Rico standardized amount, we made an inadvertent error and applied the documentation and coding adjustment established using our authority in section 1886(d)(3)(A)(vi) of the Act (which only applies to the national standardized amounts) to the Puerto Rico-specific standardized amount. We are currently in the process of developing a Federal Register notice to remove the -0.6 percent documentation and coding adjustment from the FY 2008 Puerto Rico-specific standardized amount retroactive to October 1, 2007. As discussed in section II.D. of the preamble of this proposed rule, we are not applying the documentation and coding adjustment to the Puerto Rico-specific standardized amount for FY 2009, but we may consider doing so for the FY 2010 Puerto Rico-specific standardized amount in the FY 2010 rulemaking. In calculating the FY 2009 Puerto Rico-specific standardized amount for this proposed rule, we have removed the -0.6 percent documentation and coding adjustment that was inadvertently applied to the FY 2008 Puerto Rico-specific standardized amount.

d. Outliers

Section 1886(d)(5)(A) of the Act provides for payments in addition to the basic prospective payments for "outlier" cases involving extraordinarily high costs. To qualify for outlier payments, a case must have costs greater than the sum of the prospective payment rate for the DRG, any IME and DSH payments, any new technology add-on payments, and the "outlier threshold" or "fixed loss" amount (a dollar amount by which the costs of a case must exceed payments in order to qualify for an outlier payment). We refer to the sum of the prospective payment rate for the DRG, any IME and DSH payments, any new technology add-on payments, and the outlier threshold as the outlier "fixed-loss cost threshold." To determine whether the costs of a case exceed the fixed-loss cost threshold, a hospital's CCR is applied to the total covered charges for the case to convert the charges to estimated costs. Payments for eligible cases are then made based on a marginal cost factor, which is a percentage of the estimated costs above the fixed-loss cost threshold. The marginal cost factor for FY 2009 is 80 percent, the same marginal cost factor we have used since FY 1995 (59 FR 45367).

In accordance with section 1886(d)(5)(A)(iv) of the Act, outlier payments for any year are projected to be not less than 5 percent nor more than 6 percent of total operating DRG payments plus outlier payments. Section 1886(d)(3)(B) of the Act requires the Secretary to reduce the average standardized amount by a factor to account for the estimated proportion of total DRG payments made to outlier cases. Similarly, section 1886(d)(9)(B)(iv) of the Act requires the Secretary to reduce the average standardized amount applicable to hospitals located in Puerto Rico to account for the estimated proportion of total DRG payments made to outlier cases. More information on outlier payments may be found on the CMS Web site at http://www.cms.hhs.gov/AcuteInpatientPPS/04_outlier.asp#TopOfPage.

(1) Proposed FY 2009 Outlier Fixed-Loss Cost Threshold

For FY 2009, we are proposing to use the same methodology used for FY 2008 (72 FR 47417) to calculate the outlier threshold. Similar to the methodology used in the FY 2008 final rule with comment period, for FY 2009, we are applying an adjustment factor to the CCRs to account for cost and charge inflation (as explained below). As we have done in the past, to calculate the proposed FY 2009 outlier threshold, we simulated payments by applying FY 2009 rates and policies using cases from the FY 2007 MedPAR files. Therefore, in order to determine the proposed FY 2009 outlier threshold, we inflate the charges on the MedPAR claims by 2 years, from FY 2007 to FY 2009.

We are proposing to continue using a refined methodology that takes into account the lower inflation in hospital charges that are occurring as a result of the outlier final rule (68 FR 34494), which changed our methodology for determining outlier payments by implementing the use of more current CCRs. Our refined methodology uses more recent data that reflect the rate-of-change in hospital charges under the new outlier policy.

Using the most recent data available, we calculated the 1-year average annualized rate-of-change in charges-per-case from the last quarter of FY 2006 in combination with the first quarter of FY 2007 (July 1, 2006 through December 31, 2006) to the last quarter of FY 2007 in combination with the first quarter of FY 2008 (July 1, 2007 through December 31, 2007). This rate of change was 5.84 percent (1.0585) or 12.03 percent (1.1204) over 2 years.

As we have done in the past, we are proposing to establish the proposed FY 2009 outlier threshold using hospital CCRs from the December 2007 update to the Provider-Specific File (PSF)-the most recent available data at the time of this proposed rule. This file includes CCRs that reflected implementation of the changes to the policy for determining the applicable CCRs that became effective August 8, 2003 (68 FR 34494).

As discussed in the FY 2007 final rule (71 FR 48150), we worked with the Office of Actuary to derive the methodology described below to develop the CCR adjustment factor. For FY 2009, we are proposing to use the same methodology to calculate the CCR adjustment by using the FY 2007 operating cost per discharge increase in combination with the actual FY 2007 operating market basket increase determined by Global Insight, Inc., as well as the charge inflation factor described above to estimate the adjustment to the CCRs. (We note that the FY 2007 actual (otherwise referred to as "final") operating market basket increase reflects historical data whereas the published FY 2007 operating market basket update factor was based on Global Insight, Inc.'s 2006 second quarter forecast with historical data through the first quarter of 2007.) By using the operating market basket rate-of-increase and the increase in the average cost per discharge from hospital cost reports, we are using two different measures of cost inflation. For FY 2009, we determined the adjustment by taking the percentage increase in the operating costs per discharge from FY 2005 to FY 2006 (1.0538) from the cost report and dividing it by the final operating market basket increase from FY 2006 (1.0420). We repeated this calculation for 2 prior years to determine the 3-year average of the rate of adjusted change in costs between the operating market basket rate-of-increase and the increase in cost per case from the cost report (FY 2003 to FY 2004 percentage increase of operating costs per discharge of 1.0629 divided by FY 2004 final operating market basket increase of 1.0400, FY 2004 to FY 2005 percentage increase of operating costs per discharge of 1.0565 divided by FY 2005 final operating market basket increase of 1.0430). For FY 2009, we averaged the differentials calculated for FY 2004, FY 2005, and FY 2006, which resulted in a mean ratio of 1.0154. We multiplied the 3-year average of 1.0154 by the 2007 operating market basket percentage increase of 1.0340, which resulted in an operating cost inflation factor of 5.0 percent or 1.05. We then divided the operating cost inflation factor by the 1-year average change in charges (1.058474) and applied an adjustment factor of 0.9920 to the operating CCRs from the PSF.

As stated in the FY 2008 final rule with comment period, we continue to believe it is appropriate to apply only a 1-year adjustment factor to the CCRs. On average, it takes approximately 9 months for fiscal intermediaries (or, if applicable, the MAC) to tentatively settle a cost report from the fiscal year end of a hospital's cost reporting period. The average "age" of hospitals' CCRs from the time the fiscal intermediary or the MAC inserts the CCR in the PSF until the beginning of FY 2008 is approximately 1 year. Therefore, as stated above, we believe a 1-year adjustment factor to the CCRs is appropriate.

We used the same methodology for the capital CCRs and determined the adjustment by taking the percentage increase in the capital costs per discharge from FY 2005 to FY 2006 (1.0462) from the cost report and dividing it by the final capital market basket increase from FY 2006 (1.0090). We repeated this calculation for 2 prior years to determine the 3-year average of the rate of adjusted change in costs between the capital market basket rate-of-increase and the increase in cost per case from the cost report (FY 2003 to FY 2004 percentage increase of capital costs per discharge of 1.0315 divided by FY 2004 final capital market basket increase of 1.0050, FY 2004 to FY 2005 percentage increase of capital costs per discharge of 1.0311 divided by FY 2005 final capital market basket increase of 1.0060). For FY 2009, we averaged the differentials calculated for FY 2004, FY 2005, and FY 2006, which resulted in a mean ratio of 1.0294. We multiplied the 3-year average of 1.0294 by the 2007 capital market basket percentage increase of 1.0120, which resulted in a capital cost inflation factor of 4.17 percent or 1.0417. We then divided the capital cost inflation factor by the 1-year average change in charges (1.058474) and applied an adjustment factor of 0.9842 to the capital CCRs from the PSF. We are using the same charge inflation factor for the capital CCRs that was used for the operating CCRs. The charge inflation factor is based on the overall billed charges. Therefore, we believe it is appropriate to apply the charge factor to both the operating and capital CCRs.

For purposes of estimating the proposed outlier threshold for FY 2009, we assume 3.0 percent case-mix growth in FY 2009 compared with our FY 2007 claims data (that is, a 1.2 percent increase in FY 2008 and an additional 1.8 percent increase in FY 2009). The 3 percent case-mix growth was projected by the Office of the Actuary as the amount case-mix is expected to increase in response to adoption of the MS-DRGs as a result of improvements in documentation and coding that do not reflect real changes in patient severity of illness. It is necessary to take the 3 percent expected case-mix growth into account when calculating the outlier threshold that results in outlier payments being 5.1 percent of total payments for FY 2009. If we did not take this 3 percent projected case-mix growth into account, our estimate of total payments would be too low, and as a result, our estimate of the outlier threshold would be too high. While we assume 3 percent case-mix growth for all hospitals in our outlier threshold calculations, the FY 2009 national standardized amounts used to calculate the outlier threshold reflect the statutorily mandated documentation and coding adjustment of -0.9 percent for FY 2009, on top of the -0.6 percent adjustment for FY 2008.

Using this methodology, we are proposing an outlier fixed-loss cost threshold for FY 2009 equal to the prospective payment rate for the DRG, plus any IME and DSH payments, and any add-on payments for new technology, plus $21,025.

As we did in establishing the FY 2008 outlier threshold (72 FR 47417), in our projection of FY 2009 outlier payments, we are not making any adjustments for the possibility that hospitals' CCRs and outlier payments may be reconciled upon cost report settlement. We continue to believe that, due to the policy implemented in the outlier final rule (68 FR 34494, June 9, 2003), CCRs will no longer fluctuate significantly and, therefore, few hospitals will actually have these ratios reconciled upon cost report settlement. In addition, it is difficult to predict the specific hospitals that will have CCRs and outlier payments reconciled in any given year. We also noted that reconciliation occurs because hospitals' actual CCRs for the cost reporting period are different than the interim CCRs used to calculate outlier payments when a bill is processed. Our simulations assume that CCRs accurately measure hospital costs based on information available to us at the time we set the outlier threshold. For these reasons, we are not making any assumptions about the effects of reconciliation on the outlier threshold calculation.

We also note that there are some factors that contributed to a proposed lower fixed loss outlier threshold for FY 2009 compared to FY 2008. First, the case-weighted national average operating CCR declined by approximately an additional 1 percentage point from the March 2007 update (used to calculate the FY 2008 outlier threshold) to the December 2007 update of the PSF (used to calculate the proposed FY 2009 outlier threshold). In addition, as discussed in sections II.C. and II.H. of the preamble of this proposed rule, we began a 2-year phase-in of the MS-DRGs in FY 2008, with the DRG relative weights based on a 50 percent blend of the CMS DRGs and MS-DRGs in FY 2008 and based on 100 percent of the MS-DRGs beginning in FY 2009. Better recognition of severity of illnesses with the MS-DRGs means that nonoutlier payments will compensate hospitals for the higher costs of some cases that previously received outlier payments. As cases are paid more accurately, in order to meet the 5.1 percent target, we need to decrease the fixed-loss outlier threshold so that more cases qualify for outlier payments. In addition, as noted previously, in our modeling of the outlier threshold, we included a 3-percent adjustment for expected case-mix growth between FY 2007 and FY 2009. Together, we believe that the above factors cumulatively contributed to a lower proposed fixed-loss outlier threshold in FY 2009 compared to FY 2008.

(2) Other Proposed Changes Concerning Outliers

As stated in the FY 1994 IPPS final rule (58 FR 46348), we establish an outlier threshold that is applicable to both hospital inpatient operating costs and hospital inpatient capital-related costs. When we modeled the combined operating and capital outlier payments, we found that using a common threshold resulted in a lower percentage of outlier payments for capital-related costs than for operating costs. We are projecting that the proposed thresholds for FY 2009 will result in outlier payments that will equal 5.1 percent of operating DRG payments and 5.73 percent of capital payments based on the Federal rate.

In accordance with section 1886(d)(3)(B) of the Act, we are reducing the FY 2009 standardized amount by the same percentage to account for the projected proportion of payments paid as outliers.

The outlier adjustment factors that are applied to the standardized amount for the proposed FY 2009 outlier threshold are as follows:

Operating standardized amounts Capital federal rate
National 0.948928 0.942711
Puerto Rico 0.955988 0.925627

Consistent with current policy, we are applying the outlier adjustment factors to FY 2009 rates after removing the effects of the FY 2008 outlier adjustment factors on the standardized amount.

To determine whether a case qualifies for outlier payments, we apply hospital-specific CCRs to the total covered charges for the case. Estimated operating and capital costs for the case are calculated separately by applying separate operating and capital CCRs. These costs are then combined and compared with the outlier fixed-loss cost threshold.

The outlier final rule (68 FR 34494) eliminated the application of the statewide average CCRs for hospitals with CCRs that fell below 3 standard deviations from the national mean CCR. However, for those hospitals for which the fiscal intermediary or MAC computes operating CCRs greater than 1.213 or capital CCRs greater than 0.148, or hospitals for whom the fiscal intermediary or MAC is unable to calculate a CCR (as described at § 412.84(i)(3) of our regulations), we still use statewide average CCRs to determine whether a hospital qualifies for outlier payments.27Table 8A in this Addendum contains the statewide average operating CCRs for urban hospitals and for rural hospitals for which the fiscal intermediary or MAC is unable to compute a hospital-specific CCR within the above range. Effective for discharges occurring on or after October 1, 2008, these statewide average ratios would replace the ratios published in the IPPS final rule for FY 2008 (72 FR 48126-48127). Table 8B in this Addendum contains the comparable statewide average capital CCRs. Again, the CCRs in Tables 8A and 8B would be used during FY 2009 when hospital-specific CCRs based on the latest settled cost report are either not available or are outside the range noted above. For an explanation of Table 8C, we refer readers to section V. of this Addendum.

Footnotes:

27 These figures represent 3.0 standard deviations from the mean of the log distribution of CCRs for all hospitals.

We finally note that we published a manual update (Change Request 3966) to our outlier policy on October 12, 2005, which updated Chapter 3, Section 20.1.2 of the Medicare Claims Processing Manual. The manual update covered an array of topics, including CCRs, reconciliation, and the time value of money. We encourage hospitals that are assigned the statewide average operating and/or capital CCRs to work with their fiscal intermediaries (or MAC if applicable) on a possible alternative operating and/or capital CCR as explained in Change Request 3966. Use of an alternative CCR developed by the hospital in conjunction with the fiscal intermediary or MAC can avoid possible overpayments or underpayments at cost report settlement, thus ensuring better accuracy when making outlier payments and negating the need for outlier reconciliation. We also note that a hospital may request an alternative operating or capital CCR ratio at any time as long as the guidelines of Change Request 3966 are followed. To download and view the manual instructions on outlier and cost-to-charge ratios, visit the Web site: http://www.cms.hhs.gov/manuals/downloads/clm104c03.pdf .

(3) FY 2007 and FY 2008 Outlier Payments

In the FY 2008 IPPS final rule (72 FR 47420), we stated that, based on available data, we estimated that actual FY 2007 outlier payments would be approximately 4.6 percent of actual total DRG payments. This estimate was computed based on simulations using the FY 2006 MedPAR file (discharge data for FY 2006 bills). That is, the estimate of actual outlier payments did not reflect actual FY 2007 bills, but instead reflected the application of FY 2007 rates and policies to available FY 2006 bills.

Our current estimate, using available FY 2007 bills, is that actual outlier payments for FY 2007 were approximately 4.64 percent of actual total DRG payments. Thus, the data indicate that, for FY 2007, the percentage of actual outlier payments relative to actual total payments is lower than we projected before FY 2007. Consistent with the policy and statutory interpretation we have maintained since the inception of the IPPS, we do not plan to make retroactive adjustments to outlier payments to ensure that total outlier payments for FY 2007 are equal to 5.1 percent of total DRG payments.

We currently estimate that actual outlier payments for FY 2008 will be approximately 4.8 percent of actual total DRG payments, 0.3 percentage points lower than the 5.1 percent we projected in setting the outlier policies for FY 2008. This estimate is based on simulations using the FY 2007 MedPAR file (discharge data for FY 2007 bills). We used these data to calculate an estimate of the actual outlier percentage for FY 2008 by applying FY 2008 rates and policies, including an outlier threshold of $22,185 to available FY 2007 bills.

e. Proposed Rural Community Hospital Demonstration Program Adjustment (Section 410A of Pub. L. 108-173)

Section 410A of Pub. L. 108-173 requires the Secretary to establish a demonstration that will modify reimbursement for inpatient services for up to 15 small rural hospitals. Section 410A(c)(2) of Pub. L. 108-173 requires that "in conducting the demonstration program under this section, the Secretary shall ensure that the aggregate payments made by the Secretary do not exceed the amount which the Secretary would have paid if the demonstration program under this section was not implemented." As discussed in section IV.K. of the preamble to this proposed rule, we have satisfied this requirement by adjusting national IPPS rates by a factor that is sufficient to account for the added costs of this demonstration. There are currently nine hospitals participating in the demonstration program. CMS is currently conducting a solicitation for up to six additional hospitals to participate in the demonstration program. For this proposed rule, we used data from the cost reports of the 9 currently participating hospitals to estimate a total cost number for 15 hospitals that could potentially participate in the demonstration program in FY 2009. (In the final rule, we will know the exact number of hospitals participating in the demonstration program, and we will revise our estimates accordingly.) We estimate that the average additional annual payment that will be made to each participating hospital under the demonstration will be approximately $2,134,123. We based this estimate on the recent historical experience of the difference between inpatient cost and payment for hospitals that are participating in the demonstration program. As an estimate of the cost for a total of 15 hospitals that may participate, the total annual impact of the demonstration program for FY 2009 is projected to be $32,011,849. The required adjustment to the Federal rate used in calculating Medicare inpatient prospective payments as a result of the demonstration is 0.999666.

In order to achieve budget neutrality, we are adjusting the national IPPS rates by an amount sufficient to account for the added costs of this demonstration. In other words, we are applying budget neutrality across the payment system as a whole rather than merely across the participants of this demonstration, consistent with past practice. We believe that the language of the statutory budget neutrality requirement permits the agency to implement the budget neutrality provision in this manner. The statutory language requires that "aggregate payments made by the Secretary do not exceed the amount which the Secretary would have paid if the demonstration * * * was not implemented," but does not identify the range across which aggregate payments must be held equal.

5. Proposed FY 2009 Standardized Amount

The adjusted proposed standardized amount is divided into labor-related and nonlabor-related portions. Tables 1A and 1B of this Addendum contain the national standardized amounts that we are proposing to apply to all hospitals, except hospitals located in Puerto Rico, for FY 2009. The proposed Puerto Rico-specific amounts are shown in Table 1C of this Addendum. The proposed amounts shown in Tables 1A and 1B differ only in that the labor-related share applied to the standardized amounts in Table 1A is 69.7 percent, and Table 1B is 62 percent. In accordance with sections 1886(d)(3)(E) and 1886(d)(9)(C)(iv) of the Act, we are applying a labor-related share of 62 percent, unless application of that percentage would result in lower payments to a hospital than would otherwise be made. In effect, the statutory provision means that we apply a labor-related share of 62 percent for all hospitals (other than those in Puerto Rico) whose wage indexes are less than or equal to 1.0000.

In addition, Tables 1A and 1B include proposed standardized amounts reflecting the full 3.0 percent update for FY 2009, and proposed standardized amounts reflecting the 2.0 percentage point reduction to the update (a 1.0 percent update) applicable for hospitals that fail to submit quality data consistent with section 1886(b)(3)(B)(viii) of the Act.

Under section 1886(d)(9)(A)(ii) of the Act, the Federal portion of the Puerto Rico payment rate is based on the discharge-weighted average of the national large urban standardized amount (this proposed amount is set forth in Table 1A). The proposed labor-related and nonlabor-related portions of the national average standardized amounts for Puerto Rico hospitals for FY 2009 are set forth in Table 1C of this Addendum. This table also includes the proposed Puerto Rico standardized amounts. The labor-related share applied to the Puerto Rico specific standardized amount is 58.7 percent, or 62 percent, depending on which provides higher payments to the hospital. (Section 1886(d)(9)(C)(iv) of the Act, as amended by section 403(b) of Pub. L. 108-173, provides that the labor-related share for hospitals located in Puerto Rico be 62 percent, unless the application of that percentage would result in lower payments to the hospital.)

The following table illustrates the proposed changes from the FY 2008 national average standardized amount. The second and third columns show the proposed changes from the FY 2008 standardized amounts for hospitals that satisfy the quality data submission requirement for receiving the full update (3.0 percent) with the different labor-related shares that apply to hospitals. The fourth and fifth columns show the proposed changes for hospitals receiving the reduced update (1.0 percent) with the different labor-related shares that apply to hospitals. The first row of the table shows the updated (through FY 2008) average standardized amount after restoring the FY 2008 offsets for outlier payments, demonstration budget neutrality, the New Jersey imputed floor budget neutrality, and the geographic reclassification budget neutrality. The DRG reclassification and recalibration and wage index budget neutrality factor is cumulative. Therefore, the FY 2008 factor is not removed from this table. Also, in order to properly apply the documentation and coding adjustment, it was necessary to first remove the FY 2008 adjustment from the FY 2008 rate in the first row of the table and then later in the table to cumulatively apply the sum of the FY 2008 and FY 2009 adjustments (that is, 1-(.006 + .009)) to the FY 2009 rate. (For a complete discussion on the documentation and coding adjustment, we refer readers to section II.D of the preamble to this proposed rule.)

Full update (3.0 percent); wage index is greater than 1.0000 Full update (3.0 percent); wage index is less than 1.0000 Reduced update (1.0 percent); wage index is greater than 1.0000 Reduced update (1.0 percent); wage index is less than 1.0000
FY 2008 Base Rate, after removing geographic reclassification budget neutrality, demonstration budget neutrality, documentation and coding adjustment, NJ imputed floor budget neutrality and outlier offset (based on the labor and market share percentage for FY 2009) Labor: $3,723.07 Nonlabor: $1,618.50 Labor: $3,311.77 Nonlabor: $2,029.80 Labor: $3,723.07 Nonlabor: $1,618.50 Labor: $3,311.77 Nonlabor: $2,029.80
FY 2009 Update Factor 1.030 1.030 1.010 1.010
FY 2009 DRG Recalibrations and Wage Index Budget Neutrality Factor 0.999525 0.999525 0.999525 0.999525
FY 2009 Reclassification Budget Neutrality Factor 0.992333 0.992333 0.992333 0.992333
FY 2009 Outlier Factor 0.948928 0.948928 0.948928 0.948928
Rural Demonstration Budget Neutrality Factor 0.999666 0.999666 0.999666 0.999666
FY 2009 Documentation and Coding Adjustment and Actual FY 2008 Adjustment 0.985 0.985 0.985 0.985
Proposed Rate for FY 2009 Labor: $3,553.98 Nonlabor: $1,544.98 Labor: $3,161.36 Nonlabor: $1,937.60 Labor: $3,484.97 Nonlabor: $1,514.98 Labor: $3,099.97 Nonlabor: $1,899.98

Under section 1886(d)(9)(A)(ii) of the Act, the Federal portion of the Puerto Rico payment rate is based on the national average standardized amounts. The labor-related and nonlabor-related portions of the national average standardized amounts for hospitals located in Puerto Rico are set forth in Table 1C of this Addendum. This table also includes the Puerto Rico standardized amounts. The labor-related share applied to the Puerto Rico standardized amount is 58.7 percent, or 62 percent, depending on which results in higher payments to the hospital. (Section 1886(d)(9)(C)(iv) of the Act, as amended by section 403(b) of Pub. L. 108-173, provides that the labor-related share for hospitals located in Puerto Rico be 62 percent, unless the application of that percentage would result in lower payments to the hospital.)

B. Proposed Adjustments for Area Wage Levels and Cost-of-Living

Tables 1A through 1C, as set forth in this Addendum, contain the proposed labor-related and nonlabor-related shares that we are using to calculate the proposed prospective payment rates for hospitals located in the 50 States, the District of Columbia, and Puerto Rico for FY 2009. This section addresses two types of adjustments to the standardized amounts that were made in determining the prospective payment rates as described in this Addendum.

1. Proposed Adjustment for Area Wage Levels

Sections 1886(d)(3)(E) and 1886(d)(9)(C)(iv) of the Act require that we make an adjustment to the labor-related portion of the national and Puerto Rico prospective payment rates, respectively, to account for area differences in hospital wage levels. This adjustment is made by multiplying the labor-related portion of the adjusted standardized amounts by the appropriate wage index for the area in which the hospital is located. In section III. of the preamble to this proposed rule, we discuss the data and methodology for the FY 2009 wage index.

2. Proposed Adjustment for Cost-of-Living in Alaska and Hawaii

Section 1886(d)(5)(H) of the Act authorizes the Secretary to make an adjustment to take into account the unique circumstances of hospitals in Alaska and Hawaii. Higher labor-related costs for these two States are taken into account in the adjustment for area wages described above. For FY 2009, we are proposing to adjust the payments for hospitals in Alaska and Hawaii by multiplying the nonlabor-related portion of the standardized amount by the applicable adjustment factor contained in the table below.

Area Cost of living adjustment factor
Alaska:
City of Anchorage and 80-kilometer (50-mile) radius by road 1.24
City of Fairbanks and 80-kilometer (50-mile) radius by road 1.24
City of Juneau and 80-kilometer (50-mile) radius by road 1.24
Rest of Alaska 1.25
Hawaii:
City and County of Honolulu 1.25
County of Hawaii 1.17
County of Kauai 1.25
County of Maui and County of Kalawao 1.25
(The above factors are based on data obtained from the U.S. Office of Personnel Management.)

C. Proposed MS-DRG Relative Weights

As discussed in section II.H. of the preamble of this proposed rule, we have developed proposed relative weights for each MS-DRG that reflect the resource utilization of cases in each MS-DRG relative to Medicare cases in other MS-DRGs. Table 5 of this Addendum contains the proposed relative weights that we will apply to discharges occurring in FY 2009. These factors have been recalibrated as explained in section II. of the preamble of this proposed rule.

D. Calculation of the Proposed Prospective Payment Rates

General Formula for Calculation of the Proposed Prospective Payment Rates for FY 2009

In general, the operating prospective payment rate for all hospitals paid under the IPPS located outside of Puerto Rico, except SCHs and MDHs, for FY 2009 equals the Federal rate.

The prospective payment rate for SCHs for FY 2009 equals the higher of the applicable Federal rate, or the hospital-specific rate as described below. The prospective payment rate for MDHs for FY 2009 equals the higher of the Federal rate, or the Federal rate plus 75 percent of the difference between the Federal rate and the hospital-specific rate as described below. The prospective payment rate for hospitals located in Puerto Rico for FY 2009 equals 25 percent of the Puerto Rico rate plus 75 percent of the applicable national rate.

1. Federal Rate

The Federal rate is determined as follows:

Step 1-Select the applicable average standardized amount depending on whether the hospital submitted qualifying quality data (full update for qualifying hospitals, update minus 2.0 percentage points for nonqualifying hospitals).

Step 2-Multiply the labor-related portion of the standardized amount by the applicable wage index for the geographic area in which the hospital is located or the area to which the hospital is reclassified.

Step 3-For hospitals in Alaska and Hawaii, multiply the nonlabor-related portion of the standardized amount by the applicable cost-of-living adjustment factor.

Step 4-Add the amount from Step 2 and the nonlabor-related portion of the standardized amount (adjusted, if applicable, under Step 3).

Step 5-Multiply the final amount from Step 4 by the relative weight corresponding to the applicable MS-DRG (see Table 5 of this Addendum).

The Federal rate as determined in Step 5 is then further adjusted if the hospital qualifies for either the IME or DSH adjustment. In addition, for hospitals that qualify for a low-volume payment adjustment under section 1886(d)(12) of the Act and 42 CFR 412.101(b), the payment in Step 5 is increased by 25 percent.

2. Hospital-Specific Rate (Applicable Only to SCHs and MDHs)

a. Calculation of Hospital-Specific Rate

Section 1886(b)(3)(C) of the Act provides that SCHs are paid based on whichever of the following rates yields the greatest aggregate payment: the Federal rate; the updated hospital-specific rate based on FY 1982 costs per discharge; the updated hospital-specific rate based on FY 1987 costs per discharge; or the updated hospital-specific rate based on FY 1996 costs per discharge.

As discussed previously, MDHs are required to rebase their hospital-specific rates to their FY 2002 cost reports if doing so results in higher payments. In addition, effective for discharges occurring on or after October 1, 2006, MDHs are to be paid based on the Federal national rate or, if higher, the Federal national rate plus 75 percent (changed from 50 percent) of the difference between the Federal national rate and the greater of the updated hospital-specific rates based on either FY 1982, FY 1987 or FY 2002 costs per discharge. Further, MDHs are no longer subject to the 12-percent cap on their DSH payment adjustment factor.

Hospital-specific rates have been determined for each of these hospitals based on the FY 1982 costs per discharge, the FY 1987 costs per discharge, or, for SCHs, the FY 1996 costs per discharge and for MDHs, the FY 2002 cost per discharge. For a more detailed discussion of the calculation of the hospital-specific rates, we refer the reader to the FY 1984 IPPS interim final rule (48 FR 39772); the April 20, 1990 final rule with comment (55 FR 15150); the FY 1991 IPPS final rule (55 FR 35994); and the FY 2001 IPPS final rule (65 FR 47082). In addition, for both SCHs and MDHs, the hospital-specific rate is adjusted by the budget neutrality adjustment factor as discussed in section III. of this Addendum. The resulting rate will be used in determining the payment rate an SCH or MDH will receive for its discharges beginning on or after October 1, 2007.

b. Updating the FY 1982, FY 1987, FY 1996, and FY 2002 Hospital-Specific Rates for FY 2009

We are proposing to increase the hospital-specific rates by 3.0 percent (the proposed estimated hospital market basket percentage increase) for FY 2009 for those SCHs and MDHs that submit qualifying quality data and by 1.0 percent for SCHs and MDHs that fail to submit qualifying quality data. Section 1886(b)(3)(C)(iv) of the Act provides that the update factor applicable to the hospital-specific rates for SCHs is equal to the update factor provided under section 1886(b)(3)(B)(iv) of the Act, which, for SCHs in FY 2008, is the market basket rate-of-increase for hospitals that submit qualifying quality data and the market basket rate-of-increase minus 2 percent for hospitals that fail to submit qualifying quality data. Section 1886(b)(3)(D) of the Act provides that the update factor applicable to the hospital-specific rates for MDHs also equals the update factor provided for under section 1886(b)(3)(B)(iv) of the Act, which, for FY 2009, is the market basket rate-of-increase for hospitals that submit qualifying quality data and the market basket rate-of-increase minus 2 percent for hospitals that fail to submit qualifying quality data.

3. General Formula for Calculation of Proposed Prospective Payment Rates for Hospitals Located in Puerto Rico Beginning On or After October 1, 2008, and Before October 1, 2009

Section 1886(d)(9)(E)(iv) of the Act provides that, effective for discharges occurring on or after October 1, 2004, hospitals located in Puerto Rico are paid based on a blend of 75 percent of the national prospective payment rate and 25 percent of the Puerto Rico-specific rate.

a. Puerto Rico Rate

The Puerto Rico prospective payment rate is determined as follows:

Step 1 -Select the applicable average standardized amount considering the applicable wage index (Table 1C of this Addendum).

Step 2 -Multiply the labor-related portion of the standardized amount by the applicable Puerto Rico-specific wage index.

Step 3 -Add the amount from Step 2 and the nonlabor-related portion of the standardized amount.

Step 4 -Multiply the amount from Step 3 by the applicable MS-DRG relative weight (Table 5 of this Addendum).

Step 5 -Multiply the result in Step 4 by 25 percent.

b. National Rate

The national prospective payment rate is determined as follows:

Step 1 -Select the applicable average standardized amount.

Step 2 -Multiply the labor-related portion of the standardized amount by the applicable wage index for the geographic area in which the hospital is located or the area to which the hospital is reclassified.

Step 3 -Add the amount from Step 2 and the nonlabor-related portion of the national average standardized amount.

Step 4 -Multiply the amount from Step 3 by the applicable MS-DRG relative weight (Table 5 of this Addendum).

Step 5 -Multiply the result in Step 4 by 75 percent.

The sum of the Puerto Rico rate and the national rate computed above equals the prospective payment for a given discharge for a hospital located in Puerto Rico. This rate is then further adjusted if the hospital qualifies for either the IME or DSH adjustment.

III. Proposed Changes to Payment Rates for Acute Care Hospital Inpatient Capital-Related Costs for FY 2009

The PPS for acute care hospital inpatient capital-related costs was implemented for cost reporting periods beginning on or after October 1, 1991. Effective with that cost reporting period, hospitals were paid during a 10-year transition period (which extended through FY 2001) to change the payment methodology for Medicare acute care hospital inpatient capital-related costs from a reasonable cost-based methodology to a prospective methodology (based fully on the Federal rate).

The basic methodology for determining Federal capital prospective rates is set forth in the regulations at 42 CFR 412.308 through 412.352. Below we discuss the factors that we are proposing to use to determine the capital Federal rate for FY 2009, which would be effective for discharges occurring on or after October 1, 2008.

The 10-year transition period ended with hospital cost reporting periods beginning on or after October 1, 2001 (FY 2002). Therefore, for cost reporting periods beginning in FY 2002, all hospitals (except "new" hospitals under § 412.304(c)(2)) are paid based on the capital Federal rate. For FY 1992, we computed the standard Federal payment rate for capital-related costs under the IPPS by updating the FY 1989 Medicare inpatient capital cost per case by an actuarial estimate of the increase in Medicare inpatient capital costs per case. Each year after FY 1992, we update the capital standard Federal rate, as provided at § 412.308(c)(1), to account for capital input price increases and other factors. The regulations at § 412.308(c)(2) provide that the capital Federal rate be adjusted annually by a factor equal to the estimated proportion of outlier payments under the capital Federal rate to total capital payments under the capital Federal rate. In addition, § 412.308(c)(3) requires that the capital Federal rate be reduced by an adjustment factor equal to the estimated proportion of payments for (regular and special) exceptions under § 412.348. Section 412.308(c)(4)(ii) requires that the capital standard Federal rate be adjusted so that the effects of the annual DRG reclassification and the recalibration of DRG weights and changes in the geographic adjustment factor (GAF) are budget neutral.

For FYs 1992 through 1995, § 412.352 required that the capital Federal rate also be adjusted by a budget neutrality factor so that aggregate payments for inpatient hospital capital costs were projected to equal 90 percent of the payments that would have been made for capital-related costs on a reasonable cost basis during the respective fiscal year. That provision expired in FY 1996. Section 412.308(b)(2) describes the 7.4 percent reduction to the capital Federal rate that was made in FY 1994, and § 412.308(b)(3) describes the 0.28 percent reduction to the capital Federal rate made in FY 1996 as a result of the revised policy for paying for transfers. In FY 1998, we implemented section 4402 of Pub. L. 105-33, which required that, for discharges occurring on or after October 1, 1997, the budget neutrality adjustment factor in effect as of September 30, 1995, be applied to the unadjusted capital standard Federal rate and the unadjusted hospital-specific rate. That factor was 0.8432, which was equivalent to a 15.68 percent reduction to the unadjusted capital payment rates. An additional 2.1 percent reduction to the rates was effective from October 1, 1997 through September 30, 2002, making the total reduction 17.78 percent. As we discussed in the FY 2003 IPPS final rule (67 FR 50102) and implemented in § 412.308(b)(6), the 2.1 percent reduction was restored to the unadjusted capital payment rates effective October 1, 2002.

To determine the appropriate budget neutrality adjustment factor and the regular exceptions payment adjustment during the 10-year transition period, we developed a dynamic model of Medicare inpatient capital-related costs; that is, a model that projected changes in Medicare inpatient capital-related costs over time. With the expiration of the budget neutrality provision, the capital cost model was only used to estimate the regular exceptions payment adjustment and other factors during the transition period. As we explained in the FY 2002 IPPS final rule (66 FR 39911), beginning in FY 2002, an adjustment for regular exception payments is no longer necessary because regular exception payments were only made for cost reporting periods beginning on or after October 1, 1991, and before October 1, 2001 (see § 412.348(b)). Because payments are no longer made under the regular exception policy effective with cost reporting periods beginning in FY 2002, we discontinued use of the capital cost model. The capital cost model and its application during the transition period are described in Appendix B of the FY 2002 IPPS final rule (66 FR 40099).

Section 412.374 provides for the use of a blended payment system for payments to hospitals located in Puerto Rico under the IPPS for acute care hospital inpatient capital-related costs. Accordingly, under the capital PPS, we compute a separate payment rate specific to hospitals located in Puerto Rico using the same methodology used to compute the national Federal rate for capital-related costs. In accordance with section 1886(d)(9)(A) of the Act, under the IPPS for acute care hospital operating costs, hospitals located in Puerto Rico are paid for operating costs under a special payment formula. Prior to FY 1998, hospitals located in Puerto Rico were paid a blended operating rate that consisted of 75 percent of the applicable standardized amount specific to Puerto Rico hospitals and 25 percent of the applicable national average standardized amount. Similarly, prior to FY 1998, hospitals located in Puerto Rico were paid a blended capital rate that consisted of 75 percent of the applicable capital Puerto Rico-specific rate and 25 percent of the applicable capital Federal rate. However, effective October 1, 1997, in accordance with section 4406 of Pub. L. 105-33, the methodology for operating payments made to hospitals located in Puerto Rico under the IPPS was revised to make payments based on a blend of 50 percent of the applicable standardized amount specific to Puerto Rico hospitals and 50 percent of the applicable national average standardized amount. In conjunction with this change to the operating blend percentage, effective with discharges occurring on or after October 1, 1997, we also revised the methodology for computing capital payments to hospitals located in Puerto Rico to be based on a blend of 50 percent of the Puerto Rico capital rate and 50 percent of the capital Federal rate.

As we discussed in the FY 2005 IPPS final rule (69 FR 49185), section 504 of Pub. L. 108-173 increased the national portion of the operating IPPS payments for hospitals located in Puerto Rico from 50 percent to 62.5 percent and decreased the Puerto Rico portion of the operating IPPS payments from 50 percent to 37.5 percent for discharges occurring on or after April 1, 2004 through September 30, 2004 (see the March 26, 2004 One-Time Notification (Change Request 3158)). In addition, section 504 of Pub. L. 108-173 provided that the national portion of operating IPPS payments for hospitals located in Puerto Rico is equal to 75 percent and the Puerto Rico portion of operating IPPS payments is equal to 25 percent for discharges occurring on or after October 1, 2004. Consistent with that change in operating IPPS payments to hospitals located in Puerto Rico, for FY 2005 (as we discussed in the FY 2005 IPPS final rule), we revised the methodology for computing capital payments to hospitals located in Puerto Rico to be based on a blend of 25 percent of the Puerto Rico capital rate and 75 percent of the capital Federal rate for discharges occurring on or after October 1, 2004.

A. Determination of Proposed Federal Hospital Inpatient Capital-Related Prospective Payment Rate Update

In the FY 2008 IPPS final rule with comment period (72 FR 66886 through 66888), we established a capital Federal rate of $426.14 for FY 2008. In the discussion that follows, we explain the factors that we are proposing to use to determine the proposed FY 2009 capital Federal rate. In particular, we explain why the proposed FY 2009 capital Federal rate would decrease approximately 1.14 percent, compared to the FY 2008 capital Federal rate. However, taking into account an estimated increase in Medicare fee-for-service discharges in FY 2009 as compared to FY 2008, as well as the estimated increase in payments due to documentation and coding (discussed in section VIII. of Appendix A to this proposed rule), we estimate that the increase in aggregate capital payments would be negligible during this same period (approximately $6 million). Total payments to hospitals under the IPPS are relatively unaffected by changes in the capital prospective payments. Because capital payments constitute about 10 percent of hospital payments, a 1-percent change in the capital Federal rate yields only about a 0.1 percent change in actual payments to hospitals. As noted above, aggregate payments under the capital IPPS are projected to increase in FY 2009 compared to FY 2008.

1. Projected Capital Standard Federal Rate Update

a. Description of the Update Framework

Under § 412.308(c)(1), the capital standard Federal rate is updated on the basis of an analytical framework that takes into account changes in a capital input price index (CIPI) and several other policy adjustment factors. Specifically, we have adjusted the projected CIPI rate-of-increase as appropriate each year for case-mix index-related changes, for intensity, and for errors in previous CIPI forecasts. The proposed update factor for FY 2009 under that framework is 0.7 percent based on the best data available at this time. The proposed update factor under that framework is based on a projected 1.2 percent increase in the CIPI, a 0.0 percent adjustment for intensity, a 0.0 percent adjustment for case-mix, a -0.5 percent adjustment for the FY 2007 DRG reclassification and recalibration, and a forecast error correction of 0.0 percent. As discussed below in section III.C. of the Addendum to this proposed rule, we continue to believe that the CIPI is the most appropriate input price index for capital costs to measure capital price changes in a given year. We also explain the basis for the FY 2009 CIPI projection in that same section of this Addendum. In addition, as also noted below, the proposed capital rates would be further adjusted to account for documentation and coding improvements under the MS-DRGs discussed in section II.D. of the preamble of this proposed rule. Below we describe the policy adjustments that we are proposing to apply in the update framework for FY 2009.

The case-mix index is the measure of the average MS-DRG weight for cases paid under the IPPS. Because the MS-DRG weight determines the prospective payment for each case, any percentage increase in the case-mix index corresponds to an equal percentage increase in hospital payments.

The case-mix index can change for any of several reasons:

• The average resource use of Medicare patients changes ("real" case-mix change);

• Changes in hospital coding of patient records result in higher weight MS-DRG assignments ("coding effects"); and

• The annual MS-DRG reclassification and recalibration changes may not be budget neutral ("reclassification effect").

We define real case-mix change as actual changes in the mix (and resource requirements) of Medicare patients as opposed to changes in coding behavior that result in assignment of cases to higher weighted MS-DRGs but do not reflect higher resource requirements. The capital update framework includes the same case-mix index adjustment used in the former operating IPPS update framework (as discussed in the May 18, 2004 IPPS proposed rule for FY 2005 (69 FR 28816)). (We no longer use an update framework to make a recommendation for updating the operating IPPS standardized amounts as discussed in section II. of Appendix B in the FY 2006 IPPS final rule (70 FR 47707).)

Absent the projected increase in case-mix resulting from documentation and coding improvements under the recently adopted MS-DRGs, for FY 2009, we are projecting a 1.0 percent total increase in the case-mix index. We estimate that the real case-mix increase will also equal 1.0 percent for FY 2009. The net adjustment for change in case-mix is the difference between the projected real increase in case-mix and the projected total increase in case-mix. Therefore, the net adjustment for case-mix change in FY 2009 is 0.0 percentage points.

The capital update framework also contains an adjustment for the effects of DRG reclassification and recalibration. This adjustment is intended to remove the effect on total payments of prior year's changes to the DRG classifications and relative weights, in order to retain budget neutrality for all case-mix index-related changes other than those due to patient severity. Due to the lag time in the availability of data, there is a 2-year lag in data used to determine the adjustment for the effects of DRG reclassification and recalibration. For example, we are adjusting for the effects of the FY 2007 DRG reclassification and recalibration as part of our proposed update for FY 2009. We estimate that FY 2007 DRG reclassification and recalibration resulted in a 0.5 percent change in the case-mix when compared with the case-mix index that would have resulted if we had not made the reclassification and recalibration changes to the DRGs. Therefore, we are proposing to make a -0.5 percent adjustment for DRG reclassification in the proposed update for FY 2009 to maintain budget neutrality.

The capital update framework also contains an adjustment for forecast error. The input price index forecast is based on historical trends and relationships ascertainable at the time the update factor is established for the upcoming year. In any given year, there may be unanticipated price fluctuations that may result in differences between the actual increase in prices and the forecast used in calculating the update factors. In setting a prospective payment rate under the framework, we make an adjustment for forecast error only if our estimate of the change in the capital input price index for any year is off by 0.25 percentage points or more. There is a 2-year lag between the forecast and the availability of data to develop a measurement of the forecast error. A forecast error of 0.10 percentage point was calculated for the FY 2007 update. That is, current historical data indicate that the forecasted FY 2007 CIPI (1.1 percent) used in calculating the FY 2007 update factor slightly understated the actual realized price increases (1.2 percent) by 0.10 percentage point. This slight underprediction was mostly due to the incorporation of newly available source data for fixed asset prices and moveable asset prices into the market basket. However, because this estimation of the change in the CIPI is less than 0.25 percentage points, it is not reflected in the update recommended under this framework. Therefore, we are proposing to make a 0.0 percent adjustment for forecast error in the update for FY 2009.

Under the capital IPPS update framework, we also make an adjustment for changes in intensity. We calculate this adjustment using the same methodology and data that were used in the past under the framework for operating IPPS. The intensity factor for the operating update framework reflects how hospital services are utilized to produce the final product, that is, the discharge. This component accounts for changes in the use of quality-enhancing services, for changes within DRG severity, and for expected modification of practice patterns to remove noncost-effective services.

We calculate case-mix constant intensity as the change in total charges per admission, adjusted for price level changes (the CPI for hospital and related services) and changes in real case-mix. The use of total charges in the calculation of the intensity factor makes it a total intensity factor; that is, charges for capital services are already built into the calculation of the factor. Therefore, we have incorporated the intensity adjustment from the operating update framework into the capital update framework. Without reliable estimates of the proportions of the overall annual intensity increases that are due, respectively, to ineffective practice patterns and the combination of quality-enhancing new technologies and complexity within the DRG system, we assume that one-half of the annual increase is due to each of these factors. The capital update framework thus provides an add-on to the input price index rate of increase of one-half of the estimated annual increase in intensity, to allow for increases within DRG severity and the adoption of quality-enhancing technology.

We have developed a Medicare-specific intensity measure based on a 5-year average. Past studies of case-mix change by the RAND Corporation ( Has DRG Creep Crept Up? Decomposing the Case Mix Index Change Between 1987 and 1988 by G. M. Carter, J. P. Newhouse, and D. A. Relles, R-4098-HCFA/ProPAC (1991)) suggest that real case-mix change was not dependent on total change, but was usually a fairly steady increase of 1.0 to 1.5 percent per year. However, we used 1.4 percent as the upper bound because the RAND study did not take into account that hospitals may have induced doctors to document medical records more completely in order to improve payment.

We calculate case-mix constant intensity as the change in total charges per admission, adjusted for price level changes (the CPI for hospital and related services), and changes in real case-mix. As we noted above, in accordance with § 412.308(c)(1)(ii), we began updating the capital standard Federal rate in FY 1996 using an update framework that takes into account, among other things, allowable changes in the intensity of hospital services. For FYs 1996 through 2001, we found that case-mix constant intensity was declining, and we established a 0.0 percent adjustment for intensity in each of those years. For FYs 2002 and 2003, we found that case-mix constant intensity was increasing, and we established a 0.3 percent adjustment and 1.0 percent adjustment for intensity, respectively. For FYs 2004 and 2005, we found that the charge data appeared to be skewed (as discussed in greater detail below), and we established a 0.0 percent adjustment in each of those years. Furthermore, we stated that we would continue to apply a 0.0 percent adjustment for intensity until any increase in charges can be tied to intensity rather than attempts to maximize outlier payments.

As noted above, our intensity measure is based on a 5-year average, and therefore, the intensity adjustment for FY 2009 is based on data from the 5-year period beginning with FY 2003 and extending through FY 2007. There continues to be a substantial increase in hospital charges for three of those 5 years without a corresponding increase in the hospital case-mix index. Most dramatically, for FY 2003, the change in hospitals' charges is over 16 percent, which is reflective of the large increases in charges that we found in the 4 years prior to FY 2003 and before our revisions to the outlier policy in 2003 (discussed below). For FY 2004 and FY 2005, the change in hospitals' charges is somewhat lower in comparison to FY 2003, but is still significantly large. For FY 2006 and FY 2007, the change in hospitals' charges appears to be slightly moderating. However, the change in hospitals' charges for FYs 2003 and 2004 and to a somewhat lesser extent FY 2005 remains similar to the considerable increase in hospitals' charges that we found when examining hospitals' charge data in determining the intensity factor in the update recommendations for the past few years, as discussed in the FY 2004 IPPS final rule (68 FR 45482), the FY 2005 IPPS final rule (69 FR 49285), the FY 2006 IPPS final rule (70 FR 47500), the FY 2007 IPPS final rule (72 FR 47500), and the FY 2008 IPPS final rule with comment period (72 FR 47426). If hospitals were treating new or different types of cases, which would result in an appropriate increase in charges per discharge, then we would expect hospitals' case-mix to increase proportionally. As we discussed most recently in the FY 2008 IPPS final rule with comment period (72 FR 47426), because our intensity calculation relies heavily upon charge data and we believe that these charge data may be inappropriately skewed, we established a 0.0 percent adjustment for intensity for FY 2008 just as we did for FYs 2004 through 2007.

On June 9, 2003, we published in the Federal Register revisions to our outlier policy for determining the additional payment for extraordinarily high-cost cases (68 FR 34494 through 34515). These revised policies were effective on August 8, 2003, and October 1, 2003. While it does appear that a response to these policy changes is beginning to occur, that is, the increase in charges for FYs 2004 and 2005 are somewhat less than the previous 4 years, they still show a significant annual increase in charges without a corresponding increase in hospital case-mix. Specifically, the increases in charges in FY 2004 and FY 2005 (approximately 12 percent and 8 percent, respectively), for example, which, while less than the increase in the previous 3 years, are still much higher than increases in years prior to FY 2001. In addition, these increases in charges for FYs 2003, FY 2004, and FY 2005 significantly exceed the respective case-mix increases for the same period. Based on the significant increases in charges for FYs 2003 through 2005 that remain in the 5-year average used for the intensity adjustment, we believe residual effects of hospitals' charge practices prior to the implementation of the outlier policy revisions established in the June 9, 2003 final rule continue to appear in the data, because it may have taken hospitals some time to adopt changes in their behavior in response to the new outlier policy. Thus, we believe that the FY 2003, FY 2004, FY 2005 charge data may still be skewed. Although it appears that the change in hospitals' charges is more reasonable because the intensity adjustment is based on a 5-year average, and although the new outlier policy was generally effective in FY 2004, we believe the effects of hospitals attempting to maximize outlier payments, while lessening costs, continue to skew the charge data.

Therefore, we are proposing to make a 0.0 percent adjustment for intensity for FY 2009. In the past (FYs 1996 through 2001) when we found intensity to be declining, we believed a zero (rather than negative) intensity adjustment was appropriate. Similarly, we believe that it is appropriate to apply a zero intensity adjustment for FY 2009 until any increase in charges during the 5-year period upon which the intensity adjustment is based can be tied to intensity rather than to attempts to maximize outlier payments.

Above, we described the basis of the components used to develop the proposed 0.7 percent capital update factor for all hospitals under the capital update framework for FY 2009 as shown in the table below.

Capital Input Price Index 1.2
Intensity 0.0
Case-Mix Adjustment Factors:
Real Across DRG Change -1.0
Projected Case-Mix Change 1.0
Subtotal 1.2
Effect of FY 2007 Reclassification and Recalibration -0.5
Forecast Error Correction 0.0
Total Update for Hospitals 0.7

b. Comparison of CMS and MedPAC Update Recommendation

In its March 2008 Report to Congress, MedPAC did not make a specific update recommendation for capital IPPS payments for FY 2009. However, in that same report, in assessing the adequacy of current payments and costs, MedPAC recommended an update to the hospital inpatient and outpatient PPS rates equal to the increase in the hospital market basket in FY 2009, concurrent with a quality incentive program. (MedPAC's Report to the Congress: Medicare Payment Policy, March 2008, Section 2A.)

2. Proposed Outlier Payment Adjustment Factor

Section 412.312(c) establishes a unified outlier payment methodology for inpatient operating and inpatient capital-related costs. A single set of thresholds is used to identify outlier cases for both inpatient operating and inpatient capital-related payments. Section 412.308(c)(2) provides that the standard Federal rate for inpatient capital-related costs be reduced by an adjustment factor equal to the estimated proportion of capital-related outlier payments to total inpatient capital-related PPS payments. The outlier thresholds are set so that operating outlier payments are projected to be 5.1 percent of total operating DRG payments.

In the FY 2008 IPPS final rule with comment (72 FR 66887), we estimated that outlier payments for capital would equal 4.77 percent of inpatient capital-related payments based on the capital Federal rate in FY 2008. Based on the proposed thresholds as set forth in section II.A. of this Addendum, we estimate that proposed outlier payments for capital-related costs would equal 5.73 percent for inpatient capital-related payments based on the proposed capital Federal rate in FY 2009. Therefore, we are proposing to apply an outlier adjustment factor of 0.9427 to the capital Federal rate. Thus, we estimate that the percentage of capital outlier payments to total capital standard payments for FY 2009 will be higher than the percentages for FY 2008. This increase is primarily due to the proposed decrease to the fixed-loss amount, which is discussed section II.A. of this Addendum.

The outlier reduction factors are not built permanently into the capital rates; that is, they are not applied cumulatively in determining the capital Federal rate. The proposed FY 2009 outlier adjustment of 0.9427 is a -1.01percent change from the FY 2008 outlier adjustment of 0.9523. Therefore, the net change in the proposed outlier adjustment to the capital Federal rate for FY 2009 is 0.9899 (0.9427/0.9523). Thus, the proposed outlier adjustment decreases the FY 2009 capital Federal rate by 1.01 percent compared with the FY 2008 outlier adjustment.

3. Proposed Budget Neutrality Adjustment Factor for Changes in DRG Classifications and Weights and the GAF

Section 412.308(c)(4)(ii) requires that the capital Federal rate be adjusted so that aggregate payments for the fiscal year based on the capital Federal rate after any changes resulting from the annual DRG reclassification and recalibration and changes in the GAF are projected to equal aggregate payments that would have been made on the basis of the capital Federal rate without such changes. Because we implemented a separate GAF for Puerto Rico, we apply separate budget neutrality adjustments for the national GAF and the Puerto Rico GAF. We apply the same budget neutrality factor for DRG reclassifications and recalibration nationally and for Puerto Rico. Separate adjustments were unnecessary for FY 1998 and earlier because the GAF for Puerto Rico was implemented in FY 1998.

In the past, we used the actuarial capital cost model (described in Appendix B of the FY 2002 IPPS final rule (66 FR 40099)) to estimate the aggregate payments that would have been made on the basis of the capital Federal rate with and without changes in the DRG classifications and weights and in the GAF to compute the adjustment required to maintain budget neutrality for changes in DRG weights and in the GAF. During the transition period, the capital cost model was also used to estimate the regular exception payment adjustment factor. As we explain in section III.A. of this Addendum, beginning in FY 2002, an adjustment for regular exception payments is no longer necessary. Therefore, we will no longer use the capital cost model. Instead, we are using historical data based on hospitals' actual cost experiences to determine the exceptions payment adjustment factor for special exceptions payments.

To determine the proposed factors for FY 2009, we compared (separately for the national capital rate and the Puerto Rico capital rate) estimated aggregate capital Federal rate payments based on the FY 2008 DRG relative weights and the FY 2008 GAF to estimated aggregate capital Federal rate payments based on the proposed FY 2009 relative weights and the proposed FY 2009 GAFs. We established the final FY 2008 budget neutrality factors of 0.9902 for the national capital rate and 0.9955 for the Puerto Rico capital rate. In making the comparison, we set the exceptions reduction factor to 1.00. To achieve budget neutrality for the changes in the national GAFs, based on calculations using updated data, we are proposing to apply an incremental budget neutrality adjustment of 1.0013 for FY 2009 to the previous cumulative FY 2008 adjustments of 0.9902, yielding a proposed adjustment of 0.9915, through FY 2009. For the Puerto Rico GAFs, we are proposing to apply a proposed incremental budget neutrality adjustment of 1.0009 for FY 2009 to the previous cumulative FY 2008 adjustment of 0.9955, yielding a proposed cumulative adjustment of 0.9965 (calculated with unrounded numbers) through FY 2009.

We then compared estimated aggregate capital Federal rate payments based on the FY 2008 DRG relative weights and the proposed FY 2009 GAFs to estimated aggregate capital Federal rate payments based on the cumulative effects of the proposed FY 2009 DRG relative weights and the proposed FY 2009 GAFs. The proposed incremental adjustment for proposed DRG classifications and proposed changes in relative weights is 0.9994 both nationally and for Puerto Rico. The proposed cumulative adjustments for DRG classifications and changes in relative weights and for proposed changes in the GAFs through FY 2009 are 0.9909 nationally and 0.9959 for Puerto Rico. The following table summarizes the adjustment factors for each fiscal year:

BILLING CODE 4120-01-P

[Federal Register graphic "ep30ap08.021" is not available. Please view the graphic in the PDF version of this document.]

BILLING CODE 4120-01-C

The methodology used to determine the recalibration and geographic (DRG/GAF) budget neutrality adjustment factor is similar to the methodology used in establishing budget neutrality adjustments under the PPS for operating costs. One difference is that, under the operating PPS, the budget neutrality adjustments for the effect of geographic reclassifications are determined separately from the effects of other changes in the hospital wage index and the DRG relative weights. Under the capital PPS, there is a single DRG/GAF budget neutrality adjustment factor (the national capital rate and the Puerto Rico capital rate are determined separately) for changes in the GAF (including geographic reclassification) and the DRG relative weights. In addition, there is no adjustment for the effects that geographic reclassification has on the other payment parameters, such as the payments for serving low-income patients or indirect medical education payments.

In the FY 2008 IPPS correction notice (72 FR 57636), we calculated a GAF/DRG budget neutrality factor of 0.9996 for FY 2008. For FY 2009, we are proposing to establish a GAF/DRG budget neutrality factor of 1.0007. The GAF/DRG budget neutrality factors are built permanently into the capital rates; that is, they are applied cumulatively in determining the capital Federal rate. This follows the requirement that estimated aggregate payments each year be no more or less than they would have been in the absence of the annual DRG reclassification and recalibration and changes in the GAFs. The incremental change in the proposed adjustment from FY 2008 to FY 2009 is 1.0007. The cumulative change in the proposed capital Federal rate due to this proposed adjustment is 0.9909 (the product of the incremental factors for FYs 1994 though 2008 and the proposed incremental factor of 1.0007 for FY 2009). (We note that averages of the incremental factors that were in effect during FYs 2004 and 2005, respectively, were used in the calculation of the proposed cumulative adjustment of 0.9909 for FY 2009.)

The proposed factor accounts for DRG reclassifications and recalibration and for changes in the GAFs. It also incorporates the effects on the proposed GAFs of FY 2009 geographic reclassification decisions made by the MGCRB compared to FY 2008 decisions. However, it does not account for changes in payments due to changes in the DSH and IME adjustment factors.

4. Exceptions Payment Adjustment Factor

Section 412.308(c)(3) of our regulations requires that the capital standard Federal rate be reduced by an adjustment factor equal to the estimated proportion of additional payments for both regular exceptions and special exceptions under § 412.348 relative to total capital PPS payments. In estimating the proportion of regular exception payments to total capital PPS payments during the transition period, we used the actuarial capital cost model originally developed for determining budget neutrality (described in Appendix B of the FY 2002 IPPS final rule (66 FR 40099)) to determine the exceptions payment adjustment factor, which was applied to both the Federal and hospital-specific capital rates.

An adjustment for regular exception payments is no longer necessary in determining the FY 2009 capital Federal rate because, in accordance with § 412.348(b), regular exception payments were only made for cost reporting periods beginning on or after October 1, 1991 and before October 1, 2001. Accordingly, as we explained in the FY 2002 IPPS final rule (66 FR 39949), in FY 2002 and subsequent fiscal years, no payments are made under the regular exceptions provision. However, in accordance with § 412.308(c), we still need to compute a budget neutrality adjustment for special exception payments under § 412.348(g). We describe our methodology for determining the exceptions adjustment used in calculating the FY 2008 capital Federal rate below.

Under the special exceptions provision specified at § 412.348(g)(1), eligible hospitals include SCHs, urban hospitals with at least 100 beds that have a disproportionate share percentage of at least 20.2 percent or qualify for DSH payments under § 412.106(c)(2), and hospitals with a combined Medicare and Medicaid inpatient utilization of at least 70 percent. An eligible hospital may receive special exceptions payments if it meets the following criteria: (1) A project need requirement as described at § 412.348(g)(2), which, in the case of certain urban hospitals, includes an excess capacity test as described at § 412.348(g)(4); (2) an age of assets test as described at § 412.348(g)(3); and (3) a project size requirement as described at § 412.348(g)(5).

Based on information compiled from our fiscal intermediaries, six hospitals have qualified for special exceptions payments under § 412.348(g). Because we have cost reports ending in FY 2005 for all of these hospitals, we calculated the adjustment based on actual cost experience. Using data from cost reports ending in FY 2005 from the December 2007 update of the HCRIS data, we divided the capital special exceptions payment amounts for the six hospitals that qualified for special exceptions by the total capital PPS payment amounts (including special exception payments) for all hospitals. Based on the data from cost reports ending in FY 2005, this ratio is rounded to 0.0002. We also computed the ratios for FY 2004 and FY 2003, which both round to 0.0003. Since the ratios are trending downward, we are proposing an adjustment of 0.0002. Because special exceptions are budget neutral, we are proposing to offset the proposed capital Federal rate by 0.02 percent for special exceptions payments for FY 2009. Therefore, the proposed exceptions adjustment factor is equal to 0.9998 (1-0.0002) to account for special exceptions payments in FY 2009.

In the FY 2008 IPPS final rule with comment period (72 FR 47430), we estimated that total (special) exceptions payments for FY 2008 would equal 0.03 percent of aggregate payments based on the capital Federal rate. Therefore, we applied an exceptions adjustment factor of 0.9997 (1 - 0.0003) to determine the FY 2008 capital Federal rate. As we stated above, we estimate that exceptions payments in FY 2009 would equal 0.02 percent of aggregate payments based on the proposed FY 2009 capital Federal rate. Therefore, we are proposing to apply an exceptions payment adjustment factor of 0.9998 to the proposed capital Federal rate for FY 2009. The proposed exceptions adjustment factor for FY 2009 is slightly lower than the factor used in determining the FY 2008 capital Federal rate in the FY 2008 IPPS final rule. The exceptions reduction factors are not built permanently into the capital rates; that is, the factors are not applied cumulatively in determining the capital Federal rate. Therefore, the net change in the proposed exceptions adjustment factor used in determining the proposed FY 2009 capital Federal rate is 1.0001 (0.9998/0.9997).

5. Proposed Capital Standard Federal Rate for FY 2009

In the FY 2008 IPPS final rule with comment period (72 FR 66888), we established a capital Federal rate of $426.14 for all hospitals for FY 2008. We are proposing to establish an update of 0.7 percent in determining the proposed FY 2009 capital Federal rate for all hospitals. However, under the statutory authority at section 1886(d)(3)(A)(vi) of the Act, and as specified in section 7 of Pub. L. 110-90, we are proposing an additional 0.9 percent reduction to the proposed standardized amounts for both capital and operating Federal payment rates in FY 2009. The proposed 0.9 percent reduction is based on our Actuary's analysis of the effect of changes in coding or classification of discharges that do not reflect real changes in case-mix in light of the adoption of the MS-DRGs. Although the proposed 0.9 percent reduction is outside the established process for developing the proposed capital Federal payment rate, it nevertheless is a factor in the final prospective payment rate to hospitals for capital-related costs. For that reason, the proposed national capital Federal payment rate proposed in this proposed rule was determined by applying the proposed 0.9 percent reduction. (As discussed below in section II.A.6. of this Addendum, we are not proposing to apply the proposed 0.9 percent reduction in developing the proposed FY 2009 Puerto Rico-specific capital rate.) As a result of the proposed 0.70 percent update and other proposed budget neutrality factors discussed above, we are proposing to establish a capital Federal rate of $421.29 for FY 2009. The proposed capital Federal rate for FY 2009 was calculated as follows:

• The proposed FY 2009 update factor is 1.0070, that is, the update is 0.70 percent.

• The proposed FY 2009 budget neutrality adjustment factor that is applied to the capital standard Federal payment rate for changes in the DRG relative weights and in the GAFs is 1.0007.

• The proposed FY 2009 outlier adjustment factor is 0.9427.

• The proposed FY 2009 (special) exceptions payment adjustment factor is 0.9998.

• The proposed FY 2009 reduction for improvements in documentation and coding under the MS-DRGs is 0.9 percent.

Because the proposed capital Federal rate has already been adjusted for differences in case-mix, wages, cost-of-living, indirect medical education costs, and payments to hospitals serving a disproportionate share of low-income patients, we are not proposing to make additional adjustments in the proposed capital standard Federal rate for these factors, other than the budget neutrality factor for changes in the DRG relative weights and the GAFs.

We are providing the following chart that shows how each of the proposed factors and adjustments for FY 2009 affected the computation of the proposed FY 2009 capital Federal rate in comparison to the FY 2008 capital Federal rate. The proposed FY 2009 update factor has the effect of increasing the proposed capital Federal rate by 0.70 percent compared to the FY 2008 capital Federal rate. The proposed GAF/DRG budget neutrality factor has the effect of increasing the proposed capital Federal rate by 0.07 percent. The proposed FY 2009 outlier adjustment factor has the effect of decreasing the proposed capital Federal rate by 1.01 percent compared to the FY 2008 capital Federal rate. The proposed FY 2009 exceptions payment adjustment factor has the effect of increasing the proposed capital Federal rate by 0.01 percent. The proposed adjustment for improvements in documentation and coding under the MS-DRGs has the effect of decreasing the proposed FY 2009 capital Federal rate by 0.9 percent as compared to the FY 2008 capital Federal rate. The combined effect of all the proposed changes decreases the proposed capital Federal rate by 1.14 percent compared to the FY 2008 capital Federal rate.

FY 2008 Proposed FY 20094 Change Percent change5
Update Factor1 1.0090 1.0070 1.0070 0.70
GAF/DRG Adjustment Factor1 0.9996 1.0007 1.0007 0.07
Outlier Adjustment Factor2 0.9523 0.9427 0.9899 -1.01
Exceptions Adjustment Factor2 0.9997 0.9998 1.0001 0.01
MS-DRG Coding and Documentation Improvements Adjustment Factor3 0.9940 0.9910 0.9910 -0.90
Capital Federal Rate $426.14 $421.29 0.9886 -1.14
1 The update factor and the GAF/DRG budget neutrality factors are built permanently into the capital rates. Thus, for example, the incremental change from FY 2008 to FY 2009 resulting from the application of the proposed 1.0007 GAF/DRG budget neutrality factor for FY 2009 is 1.0007.
2 The outlier reduction factor and the exceptions adjustment factor are not built permanently into the capital rates; that is, these factors are not applied cumulatively in determining the capital rates. Thus, for example, the net change resulting from the application of the proposed FY 2009 outlier adjustment factor is 0.9427/0.9523, or 0.9899.
3 Proposed adjustment to FY 2009 IPPS rates to account for documentation and coding improvements expected to result from the adoption of the MS-DRGs, as discussed above in section III.D. of the Addendum to this proposed rule.
4 Proposed factors for FY 2009, as discussed above in section III. of this Addendum.
5 Percent change of individual factors may not sum due to rounding.

6. Proposed Special Capital Rate for Puerto Rico Hospitals

Section 412.374 provides for the use of a blended payment system for payments to hospitals located in Puerto Rico under the PPS for acute care hospital inpatient capital-related costs. Accordingly, under the capital PPS, we compute a separate payment rate specific to hospitals located in Puerto Rico using the same methodology used to compute the national Federal rate for capital-related costs. Under the broad authority of section 1886(g) of the Act, as discussed in section V. of the preamble of this proposed rule, beginning with discharges occurring on or after October 1, 2004, capital payments to hospitals located in Puerto Rico are based on a blend of 25 percent of the Puerto Rico capital rate and 75 percent of the capital Federal rate. The Puerto Rico capital rate is derived from the costs of Puerto Rico hospitals only, while the capital Federal rate is derived from the costs of all acute care hospitals participating in the IPPS (including Puerto Rico).

To adjust hospitals' capital payments for geographic variations in capital costs, we apply a GAF to both portions of the blended capital rate. The GAF is calculated using the operating IPPS wage index, and varies depending on the labor market area or rural area in which the hospital is located. We use the Puerto Rico wage index to determine the GAF for the Puerto Rico part of the capital-blended rate and the national wage index to determine the GAF for the national part of the blended capital rate.

Because we implemented a separate GAF for Puerto Rico in FY 1998, we also apply separate budget neutrality adjustments for the national GAF and for the Puerto Rico GAF. However, we apply the same budget neutrality factor for DRG reclassifications and recalibration nationally and for Puerto Rico. As we stated above in section III.A.4. of this Addendum, for Puerto Rico, the proposed GAF budget neutrality factor is 1.0009, while the DRG adjustment is 0.9994, for a combined proposed cumulative adjustment of 1.0004.

In computing the payment for a particular Puerto Rico hospital, the Puerto Rico portion of the capital rate (25 percent) is multiplied by the Puerto Rico-specific GAF for the labor market area in which the hospital is located, and the national portion of the capital rate (75 percent) is multiplied by the national GAF for the labor market area in which the hospital is located (which is computed from national data for all hospitals in the United States and Puerto Rico). In FY 1998, we implemented a 17.78 percent reduction to the Puerto Rico capital rate as a result of Pub. L. 105-33. In FY 2003, a small part of that reduction was restored.

For FY 2008, before application of the GAF, the special capital rate for hospitals located in Puerto Rico was $201.67 for discharges occurring on or after October 1, 2007, through September 30, 2008 (72 FR 66888). However, as discussed in greater detail in section II.D. of the preamble of this proposed rule, we are revising this rate in a forthcoming correction notice that will be retroactive to October 1, 2007, to remove the application of the 0.6 percent documentation and coding adjustment for FY 2008, consistent with the correction to the Puerto Rico specific standardized amount for FY 2008. The statute gives broad authority to the Secretary under section 1886(g) of the Act, with respect to the development of and adjustments to a capital PPS. Although we would not be outside the authority of section 1886(g) of the Act in applying the documentation and coding adjustment to the Puerto Rico-specific portion of the capital payment rate, we have historically made changes to the capital PPS consistent with those changes made to the IPPS. Thus, we are removing the documentation and coding adjustment from the FY 2008 Puerto Rico-specific portion of the blended capital payment rate, consistent with its removal from the Puerto Rico-specific standardized amount under the IPPS for operating costs. Furthermore, we are not proposing to apply the 0.9 percent documentation and coding adjustment to the proposed FY 2009 Puerto Rico-specific portion of the blended capital payment. However, as also discussed in section II.D. of the preamble of this proposed rule, we may propose to apply such an adjustment to the Puerto Rico operating and capital rates in the future. With the changes we are proposing to make to the other factors used to determine the capital rate, the proposed FY 2009 special capital rate for hospitals in Puerto Rico is $197.19.

B. Calculation of the Proposed Inpatient Capital-Related Prospective Payments for FY 2009

Because the 10-year capital PPS transition period ended in FY 2001, all hospitals (except "new" hospitals under § 412.324(b) and under § 412.304(c)(2)) are paid based on 100 percent of the capital Federal rate in FY 2007. The applicable capital Federal rate was determined by making the following adjustments:

• For outliers, by dividing the capital standard Federal rate by the outlier reduction factor for that fiscal year; and

• For the payment adjustments applicable to the hospital, by multiplying the hospital's GAF, disproportionate share adjustment factor, and IME adjustment factor, when appropriate.

For purposes of calculating payments for each discharge during FY 2009, the capital standard Federal rate would be adjusted as follows: (Standard Federal Rate) × (DRG weight) × (GAF) × (COLA for hospitals located in Alaska and Hawaii) × (1 + Disproportionate Share Adjustment Factor + IME Adjustment Factor, if applicable). The result is the adjusted capital Federal rate. (As discussed above and in section V. of the preamble of this proposed rule, we eliminated the large urban add-on adjustment in existing regulations at § 412.316, beginning in FY 2008.)

Hospitals also may receive outlier payments for those cases that qualify under the thresholds established for each fiscal year. Section 412.312(c) provides for a single set of thresholds to identify outlier cases for both inpatient operating and inpatient capital-related payments. The proposed outlier thresholds for FY 2009 are in section II.A. of this Addendum. For FY 2009, a case qualifies as a cost outlier if the cost for the case plus the IME and DSH payments is greater than the prospective payment rate for the DRG plus the proposed fixed-loss amount of $21,025.

An eligible hospital may also qualify for a special exceptions payment under § 412.348(g) up through the 10th year beyond the end of the capital transition period if it meets the following criteria: (1) A project need requirement described at § 412.348(g)(2), which in the case of certain urban hospitals includes an excess capacity test as described at § 412.348(g)(4); and (2) a project size requirement as described at § 412.348(g)(5). Eligible hospitals include SCHs, urban hospitals with at least 100 beds that have a DSH patient percentage of at least 20.2 percent or qualify for DSH payments under § 412.106(c)(2), and hospitals that have a combined Medicare and Medicaid inpatient utilization of at least 70 percent. Under § 412.348(g)(8), the amount of a special exceptions payment is determined by comparing the cumulative payments made to the hospital under the capital PPS to the cumulative minimum payment level. This amount is offset by: (1) Any amount by which a hospital's cumulative capital payments exceed its cumulative minimum payment levels applicable under the regular exceptions process for cost reporting periods beginning during which the hospital has been subject to the capital PPS; and (2) any amount by which a hospital's current year operating and capital payments (excluding 75 percent of operating DSH payments) exceed its operating and capital costs. Under § 412.348(g)(6), the minimum payment level is 70 percent for all eligible hospitals.

During the transition period, new hospitals (as defined under § 412.300) were exempt from the capital IPPS for their first 2 years of operation and were paid 85 percent of their reasonable costs during that period. Effective with the third year of operation through the remainder of the transition period, under § 412.324(b), we paid the hospitals under the appropriate transition methodology (if the hold-harmless methodology were applicable, the hold-harmless payment for assets in use during the base period would extend for 8 years, even if the hold-harmless payments extend beyond the normal transition period).

Under § 412.304(c)(2), for cost reporting periods beginning on or after October 1, 2002, we pay a new hospital 85 percent of its reasonable costs during the first 2 years of operation unless it elects to receive payment based on 100 percent of the capital Federal rate. Effective with the third year of operation, we pay the hospital based on 100 percent of the capital Federal rate (that is, the same methodology used to pay all other hospitals subject to the capital PPS).

C. Capital Input Price Index

1. Background

Like the operating input price index, the capital input price index (CIPI) is a fixed-weight price index that measures the price changes associated with capital costs during a given year. The CIPI differs from the operating input price index in one important aspect-the CIPI reflects the vintage nature of capital, which is the acquisition and use of capital over time. Capital expenses in any given year are determined by the stock of capital in that year (that is, capital that remains on hand from all current and prior capital acquisitions). An index measuring capital price changes needs to reflect this vintage nature of capital. Therefore, the CIPI was developed to capture the vintage nature of capital by using a weighted-average of past capital purchase prices up to and including the current year.

We periodically update the base year for the operating and capital input prices to reflect the changing composition of inputs for operating and capital expenses. The CIPI was last rebased to FY 2002 in the FY 2006 IPPS final rule (70 FR 47387).

2. Forecast of the CIPI for FY 2009

Based on the latest forecast by Global Insight, Inc. (first quarter of 2008), we are forecasting the CIPI to increase 1.2 percent in FY 2009. This reflects a projected 1.9 percent increase in vintage-weighted depreciation prices (building and fixed equipment, and movable equipment), and a 2.9 percent increase in other capital expense prices in FY 2009, partially offset by 2.8 percent decline in vintage-weighted interest expenses in FY 2009. The weighted average of these three factors produces the 1.2 percent increase for the CIPI as a whole in FY 2009.

IV. Proposed Changes to Payment Rates for Excluded Hospitals and Hospital Units: Rate-of-Increase Percentages

Historically, hospitals and hospital units excluded from the prospective payment system received payment for inpatient hospital services they furnished on the basis of reasonable costs, subject to a rate-of-increase ceiling. An annual per discharge limit (the target amount as defined in § 413.40(a)) was set for each hospital or hospital unit based on the hospital's own cost experience in its base year. The target amount was multiplied by the Medicare discharges and applied as an aggregate upper limit (the ceiling as defined in § 413.40(a)) on total inpatient operating costs for a hospital's cost reporting period. Prior to October 1, 1997, these payment provisions applied consistently to all categories of excluded providers (rehabilitation hospitals and units (now referred to as IRFs), psychiatric hospitals and units (now referred to as IPFs), LTCHs, children's hospitals, and cancer hospitals).

Payment for services furnished in children's hospitals and cancer hospitals that are excluded from the IPPS continues to be subject to the rate-of-increase ceiling based on the hospital's own historical cost experience. (We note that, in accordance with § 403.752(a), RNHCIs are also subject to the rate-of-increase limits established under § 413.40 of the regulations.)

We are proposing that the FY 2009 rate-of-increase percentage for cancer and children's hospitals and RNHCIs is the percentage increase in the FY 2009 IPPS operating market basket, estimated to be 3.0 percent. Consistent with our historical approach, if more recent data are available for the final rule, we will use those data to calculate the IPPS operating market basket. For this proposed rule, we are proposing to calculate the IPPS operating market basket for FY 2009 using the most recent data available. For cancer and children's hospitals and RNHCIs, the proposed FY 2009 rate-of-increase percentage that is applied to FY 2008 target amounts in order to calculate the proposed FY 2009 target amounts is based on Global Insight, Inc.'s 2008 forecast of the IPPS operating market basket increase, in accordance with the applicable regulations at 42 CFR 413.40.

IRFs, IPFs, and LTCHs were previously paid under the reasonable cost methodology. However, the statute was amended to provide for the implementation of prospective payment systems for IRFs, IPFs, and LTCHs. In general, the prospective payment systems for IRFs, IPFs, and LTCHs provide transitioning periods of varying lengths of time during which a portion of the prospective payment is based on cost-based reimbursement rules under 42 CFR Part 413 (certain providers do not receive a transitioning period or may elect to bypass the transition as applicable under 42 CFR part 412, subparts N, O, and P.) We note that the various transitioning periods provided for under the IRF PPS, the IPF PPS, and the LTCH PPS have ended. For cost reporting periods beginning on or after October 1, 2002, all IRFs are paid 100 percent of the adjusted Federal rate under the IRF PPS. Therefore, for cost reporting periods beginning on or after October 1, 2002, no portion of an IRF PPS payment is subject to 42 CFR part 413. Similarly, for cost reporting periods beginning on or after October 1, 2006, all LTCHs are paid 100 percent of the adjusted Federal prospective payment rate under the LTCH PPS. Therefore, for cost reporting periods beginning on or after October 1, 2006, no portion of the LTCH PPS payment is subject to 42 CFR part 413. Likewise, for cost reporting periods beginning on or after January 1, 2008, all IPFs are paid 100 percent of the Federal per diem amount under the IPF PPS. Therefore, for cost reporting periods beginning on or after January 1, 2008, no portion of an IPF PPS payment is subject to 42 CFR part 413.

V. Tables

This section contains the tables referred to throughout the preamble to this proposed rule and in this Addendum. Tables 1A, 1B, 1C, 1D, 2, 3A, 3B, 4A, 4B, 4C, 4D, 4D-1, 4D-2, 4E, 4F, 4G, 4H, 4J, 5, 6A, 6B, 6C, 6D, 6E, 6F, 7A, 7B, 8A, 8B, 8C, 9A, 9C, 10, and 11 are presented below. The following tables discussed in section II. of the preamble of this proposed rule are available only through the Internet on the CMS Web site at: http://www.cms.hhs.gov/AcuteInpatientPPS/: Table 6G.-Additions to the CC Exclusions List; Table 6H.-Deletions from the CC Exclusions List; Table 6I.-Complete List of Complication and Comorbidity (CC) Exclusions; Table 6J.-Major Complication and Comorbidity (MCC) List; and Table 6K.-Complication and Comorbidity (CC).

The tables presented in this section of the Addendum are as follows:

Table 1A.-National Adjusted Operating Standardized Amounts, Labor/Nonlabor (69.7 Percent Labor Share/30.3 Percent Nonlabor Share If Wage Index Is Greater Than 1)

Table 1B.-National Adjusted Operating Standardized Amounts, Labor/Nonlabor (62 Percent Labor Share/38 Percent Nonlabor Share If Wage Index Is Less Than or Equal To 1)

Table 1C.-Adjusted Operating Standardized Amounts for Puerto Rico, Labor/Nonlabor

Table 1D.-Capital Standard Federal Payment Rate

Table 2.-Hospital Case-Mix Indexes for Discharges Occurring in Federal Fiscal Year 2007; Hospital Wage Indexes for Federal Fiscal Year 2009; Hospital Average Hourly Wages for Federal Fiscal Years 2007 (2003 Wage Data), 2008 (2004 Wage Data), and 2009 (2005 Wage Data); and 3-Year Average of Hospital Average Hourly Wages

Table 3A.-FY 2009 and 3-Year Average Hourly Wage for Urban Areas by CBSA

Table 3B.-FY 2009 and 3-Year Average Hourly Wage for Rural Areas by CBSA

Table 4A.-Wage Index and Capital Geographic Adjustment Factor (GAF) for Urban Areas by CBSA and by State-FY 2009

Table 4B.-Wage Index and Capital Geographic Adjustment Factor (GAF) for Rural Areas by CBSA and by State-FY 2009

Table 4C.-Wage Index and Capital Geographic Adjustment Factor (GAF) for Hospitals That Are Reclassified by CBSA and by State-FY 2009

Table 4D-1.-Rural Floor Budget Neutrality Factors-FY 2009

Table 4D-2.-Urban Areas with Hospitals Receiving the Statewide Rural Floor or Imputed Floor Wage Index-FY 2009

Table 4E.-Urban CBSAs and Constituent Counties-FY 2009

Table 4F.-Puerto Rico Wage Index and Capital Geographic Adjustment Factor (GAF) by CBSA-FY 2009

Table 4J.-Out-Migration Adjustment-FY 2009

Table 5.-List of Medicare Severity Diagnosis-Related Groups (MS-DRGs), Relative Weighting Factors, and Geometric and Arithmetic Mean Length of Stay

Table 6A.-New Diagnosis Codes

Table 6B.-New Procedure Codes

Table 6C.-Invalid Diagnosis Codes

Table 6D.-Invalid Procedure Codes

Table 6E.-Revised Diagnosis Code Titles

Table 6F.-Revised Procedure Code Titles

Table 7A.-Medicare Prospective Payment System Selected Percentile Lengths of Stay: FY 2007 MedPAR Update-December 2007 GROUPER V25.0 MS-DRGs

Table 7B.-Medicare Prospective Payment System Selected Percentile Lengths of Stay: FY 2007 MedPAR Update-December 2007 GROUPER V26.0 MS-DRGs

Table 8A.-Proposed Statewide Average Operating Cost-to-Charge Ratios- March 2008

Table 8B.-Proposed Statewide Average Capital Cost-to-Charge Ratios-March 2008

Table 8C.-Proposed Statewide Average Total Cost-to-Charge Ratios for LTCHs-March 2008

Table 9A.-Hospital Reclassifications and Redesignations-FY 2009

Table 9C.-Hospitals Redesignated as Rural under Section 1886(d)(8)(E) of the Act-FY 2009

Table 10.-Geometric Mean Plus the Lesser of .75 of the National Adjusted Operating Standardized Payment Amount (Increased to Reflect the Difference Between Costs and Charges) or .75 of One Standard Deviation of Mean Charges by Medicare Severity Diagnosis-Related Group (MS-DRG)-March 2008

Table 11.-Proposed FY 2009 MS-LTC-DRGs, Proposed Relative Weights, Proposed Geometric Average Length of Stay, and Proposed Short-Stay Outlier Threshold

Full update (3.0 percent) Labor-related Nonlabor-related Reduced update (1.0 percent) Labor-related Nonlabor-related
$3,553.98 $1,544.98 $3,484.97 $1,514.98

Full update (3.0 percent) Labor-related Nonlabor-related Reduced update (1.0 percent) Labor-related Nonlabor-related
$3,161.36 $1,937.60 $3,099.97 $1,899.98

Rates if wage index greater than 1 Labor Nonlabor Rates if wage index less than or equal to 1 Labor Nonlabor
National $3,553.98 $1,544.98 $3,161.36 $1,937.60
Puerto Rico 1,501.82 920.46 1,421.88 1,000.40

Rate
National $421.29
Puerto Rico 197.19

Provider No. Case-mix index2 FY 2009 wage index Average hourly wage FY 2007 Average hourly wage FY 2008 Average hourly wage FY 20091 Average hourly wage** (3 years)
010001 1.5513 0.8397 22.1989 23.2195 24.7672 23.3821
010005 1.1192 0.8636 23.6022 23.0203 25.7755 24.1406
010006 1.4819 0.7883 23.4975 23.7502 25.0258 24.0951
010007 1.0611 0.7647 19.9329 21.3492 22.0185 21.1334
010008 1.0242 0.7821 17.9533 22.0793 23.2562 20.8430
010009 0.9973 0.8636 23.5626 25.9011 25.8405 25.1048
010010 1.0945 0.8786 27.0385 22.8602 24.8375 24.7458
010011 1.6762 0.8786 27.6658 27.4668 27.1978 27.4380
010012 1.1633 0.9524 24.4059 25.5767 26.4968 25.4682
010015 1.0453 0.7693 22.3383 27.0806 23.6811 24.1695
010016 1.5794 0.8786 24.6488 26.8611 28.9705 26.8024
010018 1.4886 0.8786 23.7048 24.8974 26.9498 25.1709
010019 1.2556 0.7883 22.8766 23.3460 25.0154 23.7418
010021 1.2285 0.7677 19.7367 21.0624 21.7592 20.8458
010022 0.9940 0.9760 25.8404 27.4318 28.7520 27.3475
010023 1.7665 0.8192 25.4272 26.1739 27.0693 26.2901
010024 1.5997 0.8192 22.0819 25.0715 26.6617 24.5911
010025 1.2929 0.8495 22.7635 23.6186 23.8602 23.4229
010027 0.7391 0.7662 16.4682 17.0513 18.2507 17.2827
010029 1.5947 0.8495 23.9007 25.0468 24.3605 24.4407
010032 0.8805 0.7972 19.3311 18.5545 20.8446 19.6445
010033 2.1342 0.8786 27.4181 29.1471 29.2005 28.6046
010034 1.0166 0.8192 17.7457 19.1549 21.2713 19.3572
010035 1.2478 0.8786 24.2425 24.2746 26.5285 25.0065
010036 1.1526 0.7647 21.5796 24.2887 23.7923 23.2285
010038 1.3336 0.8054 23.7039 27.0752 28.9624 26.4786
010039 1.6454 0.8987 26.9919 28.6462 29.8012 28.4927
010040 1.6515 0.8052 24.3207 24.7657 25.9851 25.0414
010043 1.0854 0.8786 21.9774 23.9121 25.3624 23.7097
010044 1.0626 0.7647 22.5009 24.4276 23.4009 23.4233
010045 1.1529 0.7869 20.4927 23.1695 23.5160 22.3334
010046 1.5241 0.8052 23.4219 25.9105 25.4444 24.8777
010047 0.8836 0.7774 26.4851 19.7542 21.7347 22.0981
010049 1.1411 0.7662 21.7888 22.4248 23.1186 22.4564
010050 1.0831 0.8786 22.9620 24.4060 25.3663 24.2272
010051 0.8989 0.8695 18.7701 18.0305 20.0755 18.9088
010052 0.8813 0.8192 25.9233 36.3638 23.4990 28.7904
010054 1.1310 0.8636 23.3624 24.4810 25.4189 24.4485
010055 1.5957 0.8322 22.5396 22.4145 25.3295 23.4244
010056 1.5856 0.8786 23.7398 24.5754 25.7272 24.7305
010058 1.0206 0.8786 19.5092 17.0150 31.1856 21.2663
010059 1.0080 0.8636 23.0012 24.8199 27.8607 25.3457
010061 0.9842 0.8740 24.1185 25.2454 25.5878 24.9798
010062 1.0319 0.7718 21.4805 21.7112 22.9481 22.0341
010064 1.7124 0.8786 24.8155 27.6149 26.6313 26.3101
010065 1.5119 0.8786 23.0477 24.3346 24.5833 24.0058
010066 0.8885 0.7647 19.8692 25.4612 25.6055 23.6384
010068 *** * 22.7156 24.4145 * 23.5620
010069 0.9721 0.7647 23.1243 23.6272 27.3424 24.6217
010072 *** * 24.4989 * * 24.4989
010073 0.9451 0.7647 18.3963 19.0046 20.7832 19.3949
010078 1.6130 0.8054 23.5279 24.3828 25.2879 24.4148
010079 1.2409 0.8987 22.7337 22.3034 23.1015 22.7293
010083 1.1817 0.8115 22.4279 24.0036 25.0403 23.8754
010084 *** * 26.3238 26.5079 27.5054 26.7172
010085 1.3040 0.8636 24.2609 23.6280 24.0460 23.9691
010086 1.0270 0.7647 22.2096 21.5584 26.8993 23.3292
010087 2.2105 0.7809 22.4318 24.8320 26.2401 24.3812
010089 1.2944 0.8786 25.0811 26.2628 25.9704 25.7574
010090 1.7257 0.8030 26.0494 26.3957 25.6095 26.0158
010091 0.9075 0.7693 23.1310 22.5272 23.6554 23.1156
010092 1.4953 0.8695 26.6796 26.9959 28.5598 27.4270
010095 0.8389 0.8695 16.5250 17.0024 17.8242 17.1161
010097 0.7528 0.8192 19.4511 19.2481 18.4215 18.9973
010099 0.9928 0.7647 20.8383 20.6736 22.3677 21.2837
010100 1.7251 0.8115 23.8919 25.1460 25.4338 24.8850
010101 1.1737 0.8786 24.2575 25.0974 26.2731 25.2372
010102 0.9506 0.8192 25.6158 26.9859 26.6935 26.4289
010103 1.8628 0.8786 27.8272 28.9636 30.4015 29.0796
010104 1.8548 0.8786 27.6471 28.3126 30.4938 28.7438
010108 1.0595 0.8192 24.6740 25.4325 26.8882 25.7625
010109 0.9572 0.8098 17.6733 21.0449 21.9296 20.0804
010110 0.7382 0.7862 26.0038 19.8738 22.1164 22.5113
010112 0.9794 0.7647 17.1833 20.4027 21.3150 19.6839
010113 1.6320 0.7809 22.3282 24.7170 25.0689 24.0138
010114 1.4032 0.8786 25.6152 25.7090 25.3646 25.5596
010118 1.2125 0.8192 21.4630 22.7191 25.3678 23.1085
010120 1.0320 0.7647 20.9019 22.1868 22.8170 21.9915
010125 1.0385 0.8123 21.5123 22.8911 23.6542 22.7013
010126 1.1498 0.8192 23.9327 24.4957 25.7234 24.7205
010128 0.9062 0.7693 23.6647 24.9881 25.9417 24.9328
010129 1.0676 0.7781 22.1574 21.8502 24.4806 22.8945
010130 1.0051 0.8786 23.7528 24.5644 25.2775 24.5383
010131 1.3760 0.8987 26.4297 27.2707 28.0468 27.2971
010137 1.2318 0.8786 27.5782 28.5843 30.4347 28.8905
010138 0.6210 0.7713 16.7602 14.5551 15.0814 15.4264
010139 1.5846 0.8786 26.8726 28.1473 29.3543 28.1531
010143 1.2041 0.8636 26.2762 24.0674 25.0859 25.0921
010144 1.7285 0.7809 22.5133 22.3916 23.8581 22.9469
010145 1.4494 0.8695 24.5092 25.8293 27.3277 25.8981
010146 1.1251 0.8054 22.6586 22.6879 23.7803 23.0525
010148 0.8893 0.7647 23.9246 23.5714 25.0949 24.1955
010149 1.2271 0.8192 24.4805 25.4354 26.8895 25.7355
010150 0.9968 0.8192 23.6080 24.4098 25.0060 24.3378
010152 1.2632 0.7809 22.4075 23.7803 26.0777 24.1152
010157 1.1630 0.7883 23.3828 24.2206 27.1156 24.7415
010158 1.2536 0.7883 23.5533 25.5905 26.2350 25.0899
010162 *** * 33.8777 * * 33.8777
010163 *** * * 34.0325 * 34.0325
010164 1.2261 0.8786 * 23.2447 25.6659 24.4751
010165 *** * * 28.8040 * 28.8040
010166 *** * * 29.7256 * 29.7256
010167 1.6912 0.8786 * * * *
010168 1.3124 0.9061 * * * *
020001 1.7281 1.1884 35.4232 36.5298 38.1754 36.7192
020004 *** * 31.8004 * * 31.8004
020006 1.2847 1.1884 34.3752 37.0211 37.2838 36.2129
020008 1.2046 1.1884 36.1250 39.3432 40.6758 38.7262
020012 1.3619 1.1884 32.5975 33.9375 36.1891 34.2975
020014 1.0617 1.1884 29.4472 30.9722 30.6325 30.3727
020017 2.0201 1.1884 35.4119 35.8804 38.2137 36.5154
020018 0.9475 1.9292 * * * *
020019 0.9038 * * * * *
020024 1.1768 1.1884 29.5195 38.6934 39.9916 35.5845
020026 1.5400 1.9292 * * * *
020027 0.9585 1.9292 * * * *
030001 1.5351 1.0271 32.4791 33.4178 35.9045 33.8225
030002 2.1087 1.0271 30.2200 31.0818 32.9061 31.4265
030006 1.7187 0.9442 27.0599 27.7421 29.1218 28.0025
030007 1.4597 1.1305 31.1928 33.7213 35.5193 33.5056
030009 *** * 26.5408 * * 26.5408
030010 1.4417 0.9442 28.5684 30.6261 31.8606 30.4135
030011 1.5335 0.9442 28.1423 28.8203 30.2062 29.0981
030012 1.4301 1.0198 27.3895 29.1042 31.3041 29.3702
030013 1.5318 0.9903 27.0111 31.2815 31.9135 30.1305
030014 1.5815 1.0271 29.6582 29.8296 30.6276 30.0779
030016 1.2770 1.0271 29.1980 30.7896 31.1854 30.4653
030017 2.0581 1.0271 30.6007 34.4852 34.8458 33.3763
030018 1.3639 1.0271 29.4566 31.8056 31.7220 31.0137
030019 1.3016 1.0271 29.5921 30.1934 33.6528 31.0565
030022 1.8063 1.0271 30.5710 30.3746 35.0728 31.9469
030023 1.8138 1.1652 34.2142 35.8287 37.5481 35.8798
030024 2.1440 1.0271 31.9247 33.1797 35.6078 33.6344
030030 1.6952 1.0271 32.0994 34.4166 36.4747 34.2670
030033 1.3116 1.1305 28.7508 29.9383 32.0342 30.2702
030036 1.5415 1.0271 30.9834 33.0523 36.2020 33.6063
030037 1.9894 1.0271 31.2877 34.1079 35.1314 33.3937
030038 1.6433 1.0271 29.9314 31.7238 31.2906 31.0104
030040 *** * 27.5322 * * 27.5322
030043 1.2301 0.8857 26.5834 27.3856 28.3147 27.4531
030055 1.4731 1.0011 27.1473 27.1621 30.9311 28.4812
030060 1.1614 * 24.8373 * * 24.8373
030061 1.6370 1.0271 28.0696 28.1337 33.0826 29.7496
030062 1.2360 0.8857 26.6880 28.9587 29.9331 28.5898
030064 2.0334 0.9442 28.3853 29.8226 31.6603 30.0071
030065 1.6347 1.0271 29.5883 31.0817 31.4568 30.7651
030067 1.0057 0.9155 20.7591 27.4497 27.0766 25.0396
030068 1.1245 0.8857 23.1394 23.8792 26.0276 24.3896
030069 1.4761 1.1254 30.2224 29.7802 30.7696 30.2553
030071 1.0045 1.4448 * * * *
030073 1.1300 1.4448 * * * *
030074 0.9181 1.4448 * * * *
030077 0.8053 1.4448 * * * *
030078 1.1355 1.4448 * * * *
030080 *** * 27.1360 28.6568 30.7660 28.9576
030083 1.3493 1.0271 27.4983 33.5302 35.8488 32.0946
030084 1.0175 1.4448 * * * *
030085 1.6306 0.9442 26.8364 28.1388 29.0750 28.0469
030087 1.7040 1.0271 29.5962 31.2331 31.1070 30.6895
030088 1.3727 1.0271 27.8604 29.9758 30.5716 29.5054
030089 1.5952 1.0271 28.9068 30.1591 31.3148 30.1497
030092 1.5055 1.0271 31.7512 30.6343 30.4361 30.8516
030093 1.3209 1.0271 26.4430 27.8821 33.0699 29.2816
030094 1.5460 1.0271 31.5422 33.4050 34.2007 33.1194
030099 0.9137 0.8857 27.1402 26.9227 24.9115 26.3285
030100 2.0982 0.9442 31.5628 34.7532 35.0944 33.8057
030101 1.4909 1.1388 27.8302 30.6764 33.2110 30.6802
030102 2.4535 1.0271 31.6285 33.6247 36.9492 34.0941
030103 1.7698 1.0271 31.7322 32.2833 33.9387 32.6963
030105 2.3493 1.0271 31.2970 32.7449 33.9846 32.7833
030106 1.5634 1.0271 32.9840 36.4667 40.1625 36.8304
030107 1.9107 1.0271 35.6197 35.5386 35.4524 35.5298
030108 2.0613 1.0271 * 29.9395 34.8483 32.9293
030109 *** * 16.5906 * * 16.5906
030110 1.6838 1.0271 31.4852 29.7949 36.2124 32.4772
030111 1.0463 0.9442 * 33.3711 28.5133 30.2230
030112 2.0028 1.0271 * 36.6601 33.4776 34.6249
030113 0.9099 1.4448 * * * *
030114 1.4838 0.9442 * * 28.8439 28.8439
030115 1.4714 1.0271 * * 32.5857 32.5857
030117 1.2494 0.9817 * * * *
030118 1.1423 1.0198 * * * *
030119 1.2774 1.0271 * * * *
030120 0.8689 1.0271 * * * *
030121 1.0784 1.0271 * * * *
040001 1.0747 0.9131 22.9327 22.9948 24.4950 23.4592
040002 1.1735 0.7641 21.2020 25.0000 24.0479 23.3250
040004 1.6814 0.9131 27.1741 28.1117 29.2695 28.2056
040007 1.7434 0.8754 40.1291 29.1941 27.4839 32.0643
040010 1.4746 0.9131 24.2315 26.5287 28.2363 26.3909
040011 1.0296 0.7641 21.0967 22.2431 22.6320 22.0004
040014 1.3517 0.8650 26.4777 28.9855 34.8259 29.4945
040015 1.1207 0.7641 20.4279 20.1061 22.3145 20.9794
040016 1.7125 0.8754 25.8056 26.5911 26.4787 26.3029
040017 1.1221 0.8952 21.9147 23.8768 24.3768 23.3605
040018 1.1123 0.7843 24.0026 25.6751 26.2511 25.2931
040019 1.0410 0.8909 23.8706 24.9113 26.4915 25.0680
040020 1.6290 0.8909 22.6497 23.9470 26.1519 24.2422
040021 1.5502 0.8754 25.4046 26.1853 27.6779 26.3611
040022 1.4648 0.9131 29.5000 27.9902 30.0234 29.1589
040026 1.5430 0.9146 27.7931 29.5299 31.8579 29.7126
040027 1.5239 0.8477 21.4252 23.8220 25.7922 23.6373
040029 1.4258 0.8754 24.8409 25.1479 27.8865 25.9688
040036 1.6268 0.8754 27.6234 29.7150 30.4885 29.2730
040039 1.2296 0.8291 21.2712 21.4819 22.9798 21.9027
040041 1.1562 0.8650 23.7787 26.4964 26.4417 25.5529
040042 1.2893 0.9329 21.1716 19.8709 23.1648 21.3821
040047 1.0408 0.7758 22.4249 23.0358 23.3547 22.9631
040050 1.1948 0.7641 17.6906 18.5119 19.6944 18.6284
040051 0.9470 0.7641 21.3342 22.0394 22.1983 21.8575
040054 *** * 18.0509 19.5353 * 18.7591
040055 1.5598 0.7843 23.0448 24.9164 26.0132 24.6243
040062 1.6247 0.7843 23.8994 25.2303 25.6541 24.9287
040067 1.1145 0.7648 19.0471 18.9872 20.9688 19.6151
040069 1.0608 0.8909 24.8060 24.9996 23.3108 24.3661
040071 1.5798 0.8650 25.4680 25.2840 26.6629 25.8031
040072 1.1274 0.7641 22.4741 22.1058 22.9668 22.5262
040074 1.2633 0.8754 25.2699 26.2661 27.3878 26.2955
040076 0.9952 0.8650 23.5742 23.0954 24.7891 23.8273
040078 1.6712 0.8650 23.5915 26.1937 25.6870 25.0529
040080 1.0467 0.8291 24.1921 24.8760 26.5895 25.2945
040081 0.8888 0.7998 16.8437 17.2536 18.4756 17.5296
040084 1.2389 0.8754 27.7626 26.6449 28.1552 27.5095
040085 1.0085 0.8909 22.9916 25.7215 26.6972 25.1591
040088 1.6650 0.7789 22.4860 23.6276 24.7107 23.6212
040091 1.1951 0.8093 24.2398 23.1913 22.3295 23.2265
040100 *** * 21.3051 22.6131 24.5448 22.8466
040114 1.8332 0.8754 26.7581 27.7928 28.5682 27.7154
040118 1.5334 0.8291 26.0388 26.8908 26.5770 26.5251
040119 1.3884 0.8650 24.3680 24.2419 25.6769 24.7942
040126 *** * 15.6985 17.3715 * 16.4167
040132 *** * * 22.0054 21.8131 21.8928
040134 2.3449 0.8754 31.9325 32.2832 34.9636 33.0707
040137 1.3582 0.8754 25.9979 27.7360 27.7619 27.1679
040138 1.5085 0.9131 27.8584 28.3342 33.0048 29.8698
040141 0.7864 0.9131 26.1041 30.3475 33.8758 29.9321
040142 1.5543 0.9146 21.4222 23.8620 23.1293 22.9022
040143 *** * 37.1976 * * 37.1976
040144 *** * 21.4008 * * 21.4008
040145 1.7933 0.8291 * 24.4367 20.3865 22.2702
040146 *** * * 33.7876 * 33.7876
040147 1.7491 0.8754 * * 35.7643 35.7643
040148 1.3585 0.8754 * * * *
050002 1.4597 1.5288 35.5184 41.7336 43.1732 40.2432
050006 1.5912 1.2730 33.5751 37.1639 41.7694 37.1459
050007 1.4363 1.5025 43.4440 45.8773 46.3257 45.2428
050008 1.4460 1.4905 49.3167 46.8706 50.9532 49.0479
050009 1.6477 1.3974 43.0584 46.2186 49.7145 46.4654
050013 1.8267 1.3974 35.7591 43.5623 43.4884 40.8362
050014 1.2659 1.2710 36.0305 37.4135 39.4733 37.6850
050015 1.6268 * 32.2188 * * 32.2188
050016 1.3208 1.1925 24.5768 31.0653 34.4877 30.1759
050017 2.0225 1.2827 39.6653 42.2200 44.3892 42.1245
050018 1.2702 1.1916 23.3204 31.8310 43.5594 30.7984
050022 1.5850 1.1822 31.6467 33.0592 36.6332 33.8292
050024 1.1169 1.1822 29.4062 33.4334 33.5179 32.1616
050025 1.7936 1.1822 33.5466 32.7476 36.4068 34.2656
050026 1.5921 1.1822 31.5250 33.1277 35.0276 33.2678
050028 1.2946 1.1822 27.3826 28.5736 28.1194 28.0466
050030 1.2276 1.1822 27.2945 30.9014 33.5634 30.5981
050036 1.6000 1.1822 33.8000 36.0905 37.8493 35.9795
050038 1.6319 1.5766 44.2265 48.7483 55.2150 49.5117
050039 1.6727 1.1822 35.2630 36.6943 34.9232 35.5973
050040 1.3922 1.1916 35.8322 35.7054 38.1639 36.6252
050042 1.4804 1.2730 37.3760 40.3326 40.4361 39.4000
050043 1.6147 1.5288 45.4887 48.2283 50.5011 48.0790
050045 1.3307 1.1822 25.0150 27.0676 28.5930 26.9305
050046 1.1963 1.1822 26.1926 29.1125 31.8120 29.0132
050047 1.7553 1.4905 55.9367 45.1675 48.5921 49.7760
050054 1.1791 1.1822 21.3650 24.0338 27.1306 24.3249
050055 1.3418 1.4905 42.9516 44.2926 48.2759 45.1972
050056 1.4226 1.1916 30.6126 32.7693 34.7937 32.7247
050057 1.6897 1.1822 30.0236 31.7467 33.7545 31.8592
050058 1.6320 1.1916 33.1409 37.2538 39.1657 36.5431
050060 1.5084 1.1822 29.9762 32.0196 34.1151 31.9978
050063 1.4482 1.1916 34.0906 36.3085 36.6271 35.6915
050065 *** * 34.9110 38.2421 42.0052 38.4607
050067 1.2075 1.1963 38.8070 40.1393 41.8949 40.2601
050069 1.7361 1.1822 34.6353 35.3850 38.1313 36.1111
050070 1.3124 1.5025 47.4099 46.4009 49.3910 47.8284
050071 1.4512 1.5766 50.7602 49.6495 52.5202 51.0422
050072 1.4096 1.5278 49.4344 50.0343 51.9174 50.5640
050073 1.2488 1.5278 49.9730 49.0069 50.6478 49.8748
050075 1.3747 1.5288 54.4089 49.8290 51.5366 51.6907
050076 1.8168 1.5278 52.3788 50.2039 51.0338 51.1894
050077 1.5379 1.1822 34.8660 36.5384 37.4961 36.4378
050078 1.2512 1.1916 32.0133 30.4274 37.1909 33.1204
050079 1.5736 1.5278 47.3449 48.8994 48.2983 48.1333
050082 1.6600 1.1822 38.2878 37.8905 42.1694 39.4148
050084 1.5667 1.1954 35.5196 39.5748 41.0288 38.7442
050089 1.3670 1.1822 33.9593 36.4018 39.2412 36.5180
050090 1.2562 1.4879 33.8953 37.7421 41.5994 37.7203
050091 1.0354 1.1916 32.1301 37.1223 40.1032 36.4125
050093 1.5575 1.1822 36.9481 36.8486 37.7213 37.1762
050095 *** * * * 44.2364 44.2364
050096 1.2641 1.1916 34.9237 33.1322 33.3800 33.8096
050099 1.5398 1.1822 33.4174 32.0650 34.3480 33.2470
050100 1.8205 1.1822 31.4404 33.3959 34.2814 33.0478
050101 1.3210 1.5278 42.4589 47.9327 48.7447 46.4291
050102 1.3903 1.1822 32.0617 32.8434 33.2811 32.8150
050103 1.5437 1.1916 34.0935 35.6773 37.5528 35.8192
050104 1.4136 1.1916 32.3043 33.6204 37.1418 34.4090
050107 1.5287 1.1822 32.5846 33.5687 36.6966 34.2821
050108 1.8628 1.2827 38.8672 42.0131 43.0409 41.3295
050110 1.2335 1.1822 26.8408 28.0670 30.9036 28.6069
050111 1.1657 1.1916 28.7875 31.8766 31.9371 30.8306
050112 1.5363 1.1916 37.7281 38.9483 39.9904 38.9358
050113 1.1706 1.5025 39.4882 42.8884 46.3447 42.8008
050114 *** * 34.0309 35.7274 37.5895 35.8060
050115 1.4716 1.1822 28.8051 32.5257 33.8575 31.7873
050116 1.6387 1.1916 36.8825 37.6018 39.1213 37.9136
050117 *** * 34.2020 35.0531 * 34.3889
050118 1.2470 1.1963 39.9683 41.6701 41.8166 41.1955
050121 1.2657 1.1822 30.6105 34.6244 35.1123 33.4898
050122 1.6278 1.1954 33.9812 34.0259 36.8803 34.9559
050124 1.2976 1.1916 30.2522 29.9944 31.7666 30.6975
050125 1.4819 1.5766 44.9523 47.7578 53.6251 49.3187
050126 1.5255 1.1916 31.7619 32.6686 30.6587 31.6279
050127 1.2888 1.2827 32.0355 40.7610 42.5307 37.9357
050128 1.4865 1.1822 31.1308 33.4233 34.2327 32.9837
050129 1.8869 1.1822 34.7359 36.9887 40.7010 37.4287
050131 1.4641 1.5278 45.3152 47.5257 50.5592 48.0185
050132 1.4120 1.1916 35.9199 39.6807 39.5311 38.3266
050133 1.5874 1.2710 31.9527 33.1814 34.7446 33.5182
050135 1.0174 1.1916 25.1813 25.3209 25.4416 25.3286
050136 1.3870 1.4879 43.3747 46.6619 52.9752 47.9218
050137 1.5096 1.1916 39.1496 40.2457 45.3315 41.8810
050138 1.4788 1.1916 45.3727 40.6343 46.7946 44.1215
050139 1.3979 1.1916 37.8986 38.7385 44.3290 40.6568
050140 1.3188 1.1822 40.9725 39.4954 44.5658 41.7792
050144 *** * 33.6662 38.2424 40.4728 37.3677
050145 1.5409 1.4671 42.2921 48.0796 49.2634 46.7040
050146 1.8140 * * * * *
050148 1.0935 * 28.2305 * * 28.2305
050149 1.5423 1.1916 35.8821 37.3616 43.3419 39.0535
050150 1.2344 1.2710 33.6583 37.9946 43.5908 38.2550
050152 1.4480 1.4905 46.1553 51.6567 54.7138 50.9486
050153 1.4515 1.5766 42.8955 47.6374 50.4838 47.2422
050155 *** * 16.9516 16.7756 * 16.8520
050158 1.3682 1.1916 35.7805 39.9160 42.7838 39.6127
050159 1.2951 1.1822 32.5704 34.6915 35.0123 34.1437
050167 1.4830 1.1954 31.4798 34.0418 38.0704 34.4888
050168 1.5682 1.1822 37.9784 40.5973 40.8318 39.8615
050169 1.5146 1.1916 29.4693 31.4115 33.1105 31.4624
050173 1.3454 1.1822 29.0576 31.6717 32.3240 30.9921
050174 1.5492 1.4879 44.4199 48.1740 53.7062 48.9658
050175 *** * 33.3061 35.0152 * 34.1608
050177 *** * 24.0717 * * 24.0717
050179 1.1909 1.1963 30.4973 31.6651 34.6529 32.3080
050180 1.5822 1.5278 42.0358 45.7099 48.7392 45.6253
050188 1.5411 1.5766 41.0943 43.7381 45.8470 43.4416
050189 1.0400 1.4671 30.1155 28.7580 31.5787 30.2839
050191 1.5029 1.1916 37.7805 37.8756 42.0018 39.2858
050192 0.9799 1.1822 27.1400 27.8386 27.4599 27.4784
050193 1.2329 1.1822 33.9520 29.0623 36.7215 32.9051
050194 1.3496 1.5758 44.7107 49.0030 49.8490 47.9003
050195 1.5733 1.5288 48.8595 53.5583 57.6511 53.3853
050196 1.0787 1.1822 34.0956 32.8293 41.1280 35.9355
050197 1.9800 1.5758 50.0728 52.9998 55.2982 52.8587
050204 1.4038 1.1916 32.0121 35.3954 38.8654 35.4348
050205 1.3872 1.1916 29.3334 30.6322 30.6087 30.1774
050207 *** * 30.0062 31.3431 * 30.6661
050211 1.3077 1.5288 35.0515 35.0289 42.9220 37.8234
050214 *** * 25.4647 * * 25.4647
050215 *** * 48.8112 50.7578 * 49.8014
050219 1.3346 1.1916 26.4143 25.8378 26.7043 26.3093
050222 1.6635 1.1822 32.3882 33.7510 35.4673 33.9374
050224 1.6644 1.1822 32.5010 35.7280 37.2306 35.2444
050225 1.3992 1.1822 34.0836 35.1227 37.5227 35.6603
050226 1.5964 1.1822 32.4411 35.4597 36.5328 34.8249
050228 1.3082 1.4905 43.7939 47.1430 49.9023 46.9935
050230 1.5485 1.1822 34.0600 35.8490 38.8880 36.2981
050231 1.7120 1.1916 32.1813 33.7139 37.0216 34.3576
050232 1.7085 1.1925 26.3004 34.3242 35.5078 32.2261
050234 1.2780 1.1822 32.3726 34.8308 37.7096 34.9915
050235 1.4885 1.1916 30.5405 37.0858 39.1708 35.6922
050236 1.4514 1.1822 33.0686 32.6462 34.4239 33.3573
050238 1.5286 1.1916 33.3346 34.0823 35.1235 34.2447
050239 1.6781 1.1916 33.1148 35.9041 36.3232 35.1511
050240 *** * 36.1154 40.7427 * 38.4427
050242 1.3854 1.5758 46.4844 50.9882 53.7118 50.5362
050243 1.5755 1.1822 32.9385 36.1209 37.8510 35.6823
050245 1.3731 1.1822 27.3866 33.2556 34.5668 31.8473
050248 1.1239 1.4671 * 40.4941 46.0285 43.3497
050251 *** * 27.8452 * * 27.8452
050253 *** * 23.5381 * * 23.5381
050254 1.2803 1.2827 31.2386 33.0865 33.5043 32.6688
050256 *** * 29.6793 32.7159 32.6816 31.5748
050257 0.9389 1.1822 20.1829 24.0737 29.2635 24.4838
050261 1.2967 1.1822 29.2150 30.8704 33.7180 31.3396
050262 2.2067 1.1916 39.9946 41.4835 43.7672 41.7544
050264 1.3674 1.5288 47.7024 43.4181 48.0876 46.3588
050270 *** * 33.6855 36.0111 * 34.8609
050272 1.4019 1.1822 29.4671 30.9290 31.5894 30.7391
050276 1.1193 1.5278 41.1406 43.7943 47.2414 44.0832
050277 1.1820 1.1916 35.4443 35.0079 * 35.2189
050278 1.5456 1.1916 31.8712 34.3798 38.5649 35.0167
050279 1.1978 1.1822 29.7118 31.6738 32.1678 31.1945
050280 1.7360 1.2730 38.8341 41.3912 43.5214 41.2937
050281 1.4053 1.1916 29.4882 31.6639 31.0678 30.7699
050283 1.6153 1.5288 44.3122 43.6855 44.8602 44.2950
050289 1.6158 1.5025 44.2814 50.1762 52.0875 49.0216
050290 1.7575 1.1916 37.3563 40.6192 42.0066 39.9556
050291 1.9821 1.4879 38.4365 41.2100 43.2395 41.1200
050292 1.0615 1.1822 26.9786 27.3365 30.9112 28.4996
050295 1.4386 1.1822 34.7382 38.4256 39.5132 37.7732
050296 1.1373 1.5758 39.9842 42.5405 44.8105 42.4568
050298 1.2078 1.1839 30.2022 33.7864 33.6925 32.5818
050299 *** * 35.1249 32.3707 * 33.6024
050300 1.4161 1.1822 30.2874 33.6821 37.1244 33.7458
050301 1.2490 1.4497 35.9491 37.1103 36.3661 36.4668
050305 1.4137 1.5288 44.9681 48.5339 52.8531 48.7916
050308 1.5368 1.5766 43.7413 46.4180 49.0086 46.4303
050309 1.4523 1.2827 38.2659 40.1499 41.1612 39.8863
050312 *** * 36.8498 * * 36.8498
050313 1.2021 1.1954 35.0478 37.5024 37.8834 36.8450
050315 1.3141 1.1822 33.2038 32.5538 37.3526 34.4352
050320 1.2624 1.5288 45.7686 46.2071 50.6670 47.5834
050324 1.7781 1.1822 34.5503 36.3474 37.1854 36.0605
050325 1.1860 1.1855 31.3730 37.0441 34.0333 34.2474
050327 1.6676 1.1822 33.9507 35.9349 36.9523 35.6196
050329 1.2676 1.1822 23.2927 33.0390 36.7650 31.1927
050333 1.0488 1.1822 19.6352 18.6534 32.2010 21.9629
050334 1.5881 1.4671 43.9656 47.2968 50.9796 47.4795
050335 1.3834 1.1963 30.9928 34.7192 37.2324 34.3853
050336 1.2384 1.1954 30.4664 31.5480 33.0304 31.7345
050342 1.2489 1.1822 29.2244 30.4226 29.8368 29.8437
050348 1.7714 1.1822 31.5156 32.7107 33.5253 32.6280
050349 0.9688 1.1822 24.4863 25.4266 23.1089 24.2535
050350 1.4256 1.1916 31.0136 31.7908 34.0896 32.2951
050351 1.5307 1.1916 30.6599 33.3064 35.0010 33.0083
050352 1.3551 1.2827 36.7673 37.0807 38.6234 37.4921
050353 1.5204 1.1916 29.4215 30.4206 37.1683 32.2253
050357 1.5056 1.1822 32.6763 36.2089 38.9202 35.9956
050359 1.1869 1.1822 29.8345 31.3391 30.3963 30.5262
050360 1.5234 1.5278 47.4497 52.3811 53.4113 51.1213
050366 1.1511 1.1837 33.6714 37.1527 41.8302 37.3699
050367 1.4838 1.5278 38.6330 40.1904 40.0423 39.6594
050369 1.4765 1.1916 30.6439 32.2467 33.3330 32.1001
050373 1.4477 1.1916 35.1380 34.3737 37.6802 35.7093
050376 1.7774 1.1916 34.3539 35.2837 36.6487 35.4753
050378 1.0502 1.1916 37.9904 40.1923 42.0465 40.0787
050380 1.6776 1.5766 46.0276 49.4258 52.5752 49.4098
050382 1.4478 1.1916 30.4014 32.6683 32.9220 31.9903
050385 1.2993 1.4879 36.8107 36.4188 36.5610 36.5948
050390 1.1220 1.1822 27.3183 27.9359 33.0438 29.3100
050391 *** * 17.2141 * * 17.2141
050393 1.3848 1.1916 34.1743 35.6356 35.1855 35.0078
050394 1.6185 1.1822 27.4861 32.1894 32.1720 30.6682
050396 1.5625 1.1822 32.4918 37.3972 38.9901 36.2041
050397 0.8787 1.1822 28.3671 29.6825 31.1603 29.8101
050407 1.1900 1.4905 42.2748 44.6839 47.5560 44.8602
050411 1.3207 1.1916 38.8294 38.6328 44.7079 40.9918
050414 1.3194 1.2827 38.7585 41.8688 45.0472 42.0484
050417 1.3093 1.1822 32.9341 36.1222 37.0117 35.4225
050420 *** * 35.2869 39.9237 * 37.6935
050423 1.0114 1.1822 28.3768 31.9751 32.4104 31.1452
050424 1.9524 1.1822 34.5680 36.6091 37.5218 36.2762
050425 1.3696 1.2827 49.2245 46.6628 45.7794 47.0234
050426 1.4616 1.1822 33.2031 34.9855 37.6483 35.2291
050430 0.9394 1.1822 23.9045 24.5327 25.9363 24.7203
050432 *** * 33.1876 35.2416 * 34.2247
050433 *** * 21.3573 21.1287 23.0629 21.6609
050434 0.9988 1.1822 32.6255 33.7794 35.4799 33.9524
050435 1.1984 1.1822 30.6530 33.0372 35.7401 33.2043
050438 1.5503 1.1916 36.3026 36.2044 38.2823 36.9424
050441 1.9553 1.5766 44.5694 46.6160 49.2095 46.8421
050444 1.4083 1.2202 34.6313 37.6821 39.3915 37.5291
050447 2.2656 1.1822 26.7960 29.0780 27.1252 27.7351
050448 1.2948 1.1822 30.6201 32.7748 32.6666 31.9996
050454 1.9380 1.4905 38.5833 40.2811 43.3674 40.8320
050455 1.5610 1.1822 30.4606 34.5445 35.0200 33.3430
050456 *** * 21.6261 27.7659 27.9693 25.0702
050457 1.5970 1.4905 47.8947 50.0282 53.3144 50.4334
050464 1.7391 1.1963 38.3058 41.6235 42.6660 40.8465
050468 1.7714 1.1916 31.1111 35.7409 37.3361 34.8277
050469 *** * 30.6502 * * 30.6502
050470 *** * 27.8678 31.0466 32.5012 30.5202
050471 1.7119 1.1916 35.4768 36.8680 36.4887 36.2903
050476 1.4110 1.4497 38.7856 41.1042 40.5395 40.1623
050477 *** * 37.7668 40.1566 * 39.0877
050478 1.0325 1.1822 40.2558 41.1668 41.5592 41.0379
050481 1.5130 1.1916 36.1394 38.8650 42.8499 39.2898
050485 1.6505 1.1916 36.1488 34.6219 34.7050 35.1967
050488 1.4378 1.5288 42.6854 45.0630 47.1937 45.0874
050491 *** * 34.3598 * * 34.3598
050492 1.3241 1.1822 28.0826 30.7718 32.6577 30.4668
050494 1.4344 1.2710 38.1177 40.6384 42.3086 40.3782
050496 1.6970 1.5278 48.2468 51.6363 51.1433 50.4172
050498 1.3475 1.2827 37.1667 41.0350 42.2469 40.1486
050502 1.6482 1.1916 28.7046 31.8872 32.9773 31.1609
050503 1.5152 1.1822 34.0994 37.3605 37.7183 36.4438
050506 1.5249 1.1925 37.7420 39.8586 40.6497 39.4417
050510 1.3370 1.5278 52.5376 49.4533 51.3691 51.0324
050512 1.4990 1.5288 50.9264 48.8057 50.1599 49.9366
050515 1.3185 1.1822 38.9542 40.2957 41.0328 40.1925
050516 1.5093 1.2827 39.8161 43.0249 45.5247 42.8485
050517 1.2967 1.1822 20.0213 22.4096 29.3674 23.6394
050523 1.2869 1.5278 40.6535 43.4579 46.9830 43.8643
050526 1.1843 1.1822 28.1997 33.3964 35.5437 32.2787
050528 1.1507 1.1822 31.4941 36.2908 38.3022 35.4339
050531 1.0520 1.1916 27.1974 28.3348 28.4865 28.0127
050534 1.4315 1.1822 33.1666 36.6447 38.1859 36.0367
050535 *** * 34.6143 37.8174 * 36.2328
050537 1.4828 1.2827 34.9931 38.2145 40.1908 37.8814
050541 1.4378 1.5758 52.5908 48.0867 51.5270 50.6366
050543 0.7526 1.1822 29.4443 24.4913 32.8347 28.6007
050545 0.7226 1.1916 31.3080 35.3209 * 33.2475
050546 0.6945 1.1822 33.2245 36.5099 * 34.9356
050547 1.0205 1.4879 34.8401 33.8036 * 34.2850
050548 0.6180 1.1822 39.2234 41.1075 * 40.1570
050549 1.6510 1.1822 35.2792 38.3927 40.6759 38.1001
050550 *** * 30.9612 34.9476 39.2133 34.7849
050551 1.3452 1.1822 34.0467 37.2506 37.6198 36.3778
050552 0.9428 1.1916 33.0711 33.9810 35.3466 34.1389
050557 1.5993 1.1963 33.3654 35.7023 38.6871 35.9147
050561 1.4093 1.1916 38.0196 38.2543 39.1298 38.5223
050567 1.5110 1.1822 35.7063 37.6384 39.0084 37.5231
050568 1.2464 1.1822 25.2337 26.0908 26.7719 26.0576
050569 1.3207 * 31.6785 * * 31.6785
050570 1.5519 1.1822 34.5161 38.4373 40.6719 37.8603
050571 *** * 34.7627 39.0649 * 36.9575
050573 1.5662 1.1822 34.7279 35.2842 36.8535 35.6371
050575 1.3192 1.1916 25.1457 23.7990 22.1000 23.5654
050577 *** * 32.3744 * * 32.3744
050578 1.4310 1.1916 35.2390 31.3639 43.4883 36.9415
050579 *** * 42.5081 * * 42.5081
050580 1.1517 1.1822 31.5806 34.1531 35.0950 33.6230
050581 1.4139 1.1916 34.0136 37.7567 40.0883 37.3040
050583 1.6442 1.1822 34.5747 37.4450 40.5818 37.4769
050584 1.4508 1.1839 30.3434 30.7839 31.9887 31.0588
050585 *** * 22.2521 * * 22.2521
050586 1.3101 1.1822 26.4782 31.3513 31.1898 29.6927
050588 1.3759 1.1916 32.7556 37.7387 39.4229 36.6367
050589 1.2424 1.1822 34.5100 37.6886 37.2032 36.5093
050590 1.2814 1.2827 38.4971 41.7519 44.2900 41.5361
050591 *** * 30.6106 34.7133 * 32.5892
050592 *** * 27.3606 31.8053 32.2351 30.0884
050594 *** * 36.5256 42.0788 * 39.2148
050597 1.2983 1.1916 28.8294 31.5625 32.8964 31.1668
050599 1.8547 1.2827 32.7835 34.7187 36.6122 34.7394
050601 1.5329 1.1916 36.0572 39.7717 43.2367 39.7359
050603 1.4506 1.1822 34.0275 35.0279 35.4778 34.9101
050604 1.3664 1.5766 55.0821 49.4446 49.6225 50.8907
050608 1.2665 1.1822 30.4169 31.2909 30.7266 30.8122
050609 1.2511 1.1822 41.7208 39.7397 42.4128 41.2383
050613 *** * 42.8108 42.9930 * 42.8892
050615 *** * 35.9547 39.1299 * 37.5269
050616 1.4930 1.1822 37.7284 37.1200 40.8621 38.5549
050618 1.0232 1.1822 31.3182 33.1472 34.9156 33.1400
050624 1.3457 1.1916 33.9594 35.9346 39.2531 36.4371
050625 1.7610 1.1916 38.6591 41.0439 44.8446 41.6090
050633 1.2411 1.1925 36.8302 38.4916 40.7347 38.7394
050636 1.2748 1.1822 32.5576 33.0718 35.4525 33.7338
050641 1.3434 1.1916 39.6921 32.3586 32.0483 34.3171
050644 1.0499 1.1916 28.8237 30.7981 33.2746 30.9581
050660 1.7555 * * * * *
050662 0.7264 1.5766 33.2446 38.3017 * 35.5809
050663 1.4166 1.1916 27.7334 17.7035 17.8180 19.8971
050667 0.9359 1.3974 24.2771 25.9161 25.8444 25.2820
050668 1.2668 1.4905 56.6555 51.6049 52.6968 53.2587
050674 1.2833 1.2827 48.0893 47.0720 48.6658 47.9616
050677 1.3833 1.1916 38.5770 39.2161 40.7889 39.6370
050678 1.3254 1.1822 32.4473 33.7633 35.8378 34.1139
050680 1.2900 1.5278 38.2871 37.9856 39.0346 38.4541
050682 0.8353 1.1822 17.9077 22.2193 22.3883 20.9013
050684 1.1150 1.1822 27.5256 28.8378 33.5883 30.1544
050686 1.5945 1.1822 41.0188 39.7757 41.3815 40.7110
050688 1.2103 1.5766 44.1510 49.4062 53.2703 49.0705
050689 1.5822 1.5278 45.0951 48.8533 48.9898 47.6626
050690 1.3422 1.4879 50.9094 49.0226 51.7590 50.5850
050693 1.3899 1.1822 34.5797 39.6838 42.8232 38.9551
050694 1.0517 1.1822 30.7858 32.1065 34.8458 32.6630
050695 *** * 39.6004 49.0340 * 44.6756
050696 2.2640 1.1916 37.3837 39.8963 39.4330 38.9118
050697 1.1055 1.2730 16.6605 22.1441 26.7588 21.2675
050699 *** * 28.9083 21.5725 28.8973 26.4337
050701 1.3490 1.1822 31.9529 34.9876 37.2811 34.8704
050704 1.0435 1.1916 29.7740 31.6097 32.1995 31.2008
050707 *** * 35.7311 43.5555 44.0218 40.8918
050708 1.4932 1.1822 30.5860 31.8442 28.3051 30.2199
050709 1.4478 1.1822 26.8549 24.5621 29.5339 27.1486
050710 1.2058 1.1822 45.8022 44.2482 46.2957 45.4488
050713 *** * 21.1273 21.4825 * 21.2886
050714 1.4054 1.5818 31.9527 34.1542 42.9756 36.5738
050717 1.5439 1.1916 39.3227 38.8773 37.0867 38.4090
050718 *** * 25.5140 31.9622 * 28.5587
050720 0.9656 1.1822 29.4726 30.3595 32.1156 30.5944
050722 0.9138 1.1822 31.4867 33.7991 35.6698 33.7766
050723 1.3255 1.1916 38.5446 38.7140 41.1633 39.6081
050724 2.0000 1.1822 31.6910 35.2344 35.0980 34.1972
050725 0.8736 1.1916 24.3100 30.0580 28.8366 27.6830
050726 1.5371 1.1963 30.6479 28.6361 30.6054 29.9355
050727 1.3473 1.1916 33.9118 32.7783 33.0915 33.2499
050728 *** * 39.3581 41.8263 * 40.4993
050729 *** * 36.5432 38.1882 * 37.4033
050730 *** * 37.0629 39.2046 * 38.1210
050732 2.3278 1.1822 * 33.6831 34.3456 34.0196
050733 1.5906 1.2730 * 40.1517 40.6287 40.3877
050734 *** * * 31.2883 * 31.2883
050735 1.3963 1.1916 * * 36.6052 36.6052
050736 1.2104 1.1916 * * 41.8905 41.8905
050737 1.4996 1.1916 * * 38.0395 38.0395
050738 1.5052 1.1916 * * 43.9225 43.9225
050739 1.6284 1.1916 * * 57.2436 57.2436
050740 1.4538 1.1916 * * 54.0328 54.0328
050741 1.4520 1.1916 * * 51.1485 51.1485
050742 1.4454 1.1916 * * 39.0793 39.0793
050744 1.7412 1.1822 * * 48.4913 48.4913
050745 1.3450 1.1822 * * 42.5490 42.5490
050746 1.8196 1.1822 * * 43.1981 43.1981
050747 1.5410 1.1822 * * 44.5852 44.5852
050748 1.1344 1.1954 * * 42.9957 42.9957
050749 1.3856 1.1822 * * 28.1978 28.1978
050750 *** * * * 33.9880 33.9880
050751 2.9380 1.1916 * * 29.5465 29.5465
050752 1.4092 1.1916 * * 39.8004 39.8004
050753 1.6850 1.1916 * * * *
050754 1.1933 1.5025 * * * *
050755 1.3602 1.1916 * * * *
050757 1.5947 1.1822 * * * *
050758 1.3399 1.1822 * * * *
050759 2.1683 1.1822 * * * *
060001 1.5186 1.0070 29.6191 31.0018 32.4200 30.9988
060003 1.4098 1.0409 29.4809 31.3616 31.8621 30.9372
060004 1.1053 1.0561 32.4609 32.0095 34.8408 33.1185
060006 1.3131 0.9303 25.2139 27.2057 26.8067 26.4045
060008 1.2609 0.9303 23.0947 26.5175 27.2059 25.5276
060009 1.4736 1.0561 31.5210 32.4208 34.0129 32.6683
060010 1.5411 0.9734 27.1916 29.5304 30.6402 29.1093
060011 1.5219 1.0561 35.1573 32.1001 34.4158 33.8458
060012 1.5548 0.9738 27.3885 28.7724 29.4348 28.5090
060013 1.5942 0.9303 26.8675 27.9145 28.0786 27.6090
060014 1.8805 1.0561 31.0542 31.9389 33.0340 32.0056
060015 1.8679 1.0561 32.5285 32.2927 36.3270 33.6071
060016 1.1848 0.9303 26.5427 27.1430 28.3040 27.3080
060018 1.2897 0.9303 24.1086 25.3897 26.5770 25.3463
060020 1.5516 0.9303 24.5992 25.9147 26.7340 25.7382
060022 1.6011 0.9738 28.2944 29.3379 31.9353 29.8727
060023 1.6260 1.0409 29.5760 31.1556 32.7901 31.1705
060024 1.8688 1.0561 30.0279 31.5411 32.8183 31.5099
060027 1.5941 1.0409 29.6121 30.9212 31.6117 30.7134
060028 1.4266 1.0561 31.6900 32.1656 33.4942 32.4479
060030 1.4302 0.9734 27.8642 29.9513 31.2907 29.7046
060031 1.5357 1.0409 27.8345 29.3907 30.8385 29.3398
060032 1.4900 1.0561 31.0686 32.7383 34.6417 32.7827
060034 1.7145 1.0561 30.9359 32.1252 33.3625 32.1070
060036 1.0946 0.9303 20.3226 22.8256 20.9359 21.3443
060041 0.9254 0.9303 24.6142 25.9710 31.4722 27.2226
060043 0.9724 0.9303 18.2143 21.9955 23.3899 21.1620
060044 1.1929 0.9303 26.5611 24.8352 29.4060 26.8390
060049 1.4157 0.9581 29.3724 30.2192 32.1570 30.6358
060054 1.4812 0.9925 24.3389 25.0980 24.6714 24.6993
060064 1.7013 1.0561 32.3681 33.2428 37.2384 33.8162
060065 1.4081 1.0561 32.4735 33.8538 34.9177 33.7649
060071 1.1347 0.9303 27.6657 28.1762 31.5370 29.2648
060075 1.3842 0.9925 32.2545 37.6023 35.8069 35.2179
060076 1.2641 0.9303 26.5631 30.7808 31.6033 29.6210
060096 1.6188 1.0409 32.1310 37.8243 38.2230 36.0395
060100 1.7198 1.0561 32.6104 33.2145 33.5326 33.1192
060103 1.3654 1.0409 31.6314 32.9690 33.7519 32.8044
060104 1.4279 1.0561 32.4232 35.4409 37.1405 34.8954
060107 1.5071 1.0561 26.8388 28.0660 30.3986 28.4350
060112 1.6339 1.0561 34.9272 34.7116 35.1275 34.9373
060113 1.4241 1.0561 * 32.6073 35.2074 33.9039
060114 1.3878 1.0561 * 34.8536 35.3035 35.0938
060115 0.8560 0.9303 * * * *
060116 1.2796 1.0409 * * 33.1528 33.1528
060117 1.4396 0.9303 * * 28.3098 28.3098
060118 1.4247 0.9303 * * * *
060119 2.0319 0.9734 * * * *
070001 1.5932 1.2038 35.8958 37.0403 37.9403 36.9862
070002 1.8116 1.1897 33.4398 34.7636 36.4240 34.8862
070003 1.1297 1.1897 34.1352 35.6320 36.0505 35.2926
070004 1.1791 1.1897 29.4448 29.9557 31.2093 30.2307
070005 1.4770 1.2038 33.7813 34.9404 36.5469 35.0801
070006 1.3529 1.2391 37.9148 39.3935 41.2133 39.5140
070007 1.2875 1.1897 35.9617 36.2914 36.8054 36.3570
070008 1.2515 1.1897 28.5506 30.7305 35.4942 31.5216
070009 1.3430 1.1897 32.9299 35.5670 36.6355 34.9997
070010 1.6851 1.2391 35.3730 36.7227 38.6086 36.9439
070011 1.4127 1.1897 31.8987 31.6843 34.1325 32.5714
070012 1.4106 1.1897 29.4216 31.9345 33.2459 31.5134
070015 1.4333 1.2391 35.3385 37.3454 39.9225 37.5863
070016 1.4989 1.2038 31.4930 33.2391 34.1238 32.9404
070017 1.3644 1.2038 34.0490 35.6456 37.5821 35.7978
070018 1.3783 1.2391 39.7515 41.8460 42.4745 41.4021
070019 1.3857 1.2038 34.5125 33.7246 35.8591 34.6869
070020 1.2985 1.1897 33.6453 32.9714 35.6515 34.1183
070021 1.1854 1.1897 36.9241 38.5623 39.7761 38.4026
070022 1.6626 1.2038 39.0462 40.2283 41.4692 40.2883
070024 1.3628 1.1897 35.2323 34.7419 36.8976 35.6415
070025 1.7385 1.1897 32.4085 34.5887 36.1293 34.3741
070027 1.4463 1.1897 29.8513 30.4433 33.5960 31.3085
070028 1.5690 1.2391 35.1966 38.0855 43.1846 38.7150
070029 1.2883 1.1897 30.9299 31.0662 32.8478 31.6076
070031 1.2891 1.2038 30.1915 30.4054 30.5906 30.4009
070033 1.4498 1.2391 40.1594 41.7955 44.6692 42.2677
070034 1.4240 1.2391 38.3965 40.1685 42.4078 40.3330
070035 1.2479 1.1897 30.7440 32.2766 33.4024 32.1114
070036 1.6115 1.1897 38.3413 42.3391 43.6345 41.4903
070038 0.8866 1.2038 25.7914 35.8053 29.9492 29.4507
070039 0.9487 1.2038 36.1369 34.7219 32.7121 34.7190
070040 1.0777 1.1897 * * * *
080001 1.6391 1.0799 32.0105 33.5310 34.9490 33.5152
080002 *** * 29.6800 31.3391 33.0378 31.3601
080003 1.6226 1.0799 30.7697 34.3048 30.5113 31.8516
080004 1.5578 1.0645 30.1094 32.2443 34.3823 32.3013
080006 1.3096 1.0304 27.4749 28.8862 31.0299 29.2083
080007 1.4835 1.0909 30.1100 31.1645 33.4764 31.6259
090001 1.7487 1.1018 36.6577 38.3043 40.1629 38.3535
090003 1.2254 1.0670 31.0419 32.1960 32.8939 31.9877
090004 1.9209 1.1018 35.6964 37.3798 38.5646 37.2403
090005 1.4073 1.0670 33.0178 33.7448 35.2850 34.0306
090006 1.3917 1.0670 29.4912 31.3562 32.3448 31.0266
090008 1.2958 1.0670 32.0745 33.7471 36.6606 34.0292
090011 2.0065 1.1018 36.7579 38.0654 39.0086 37.9688
100001 1.4956 0.9092 26.4631 27.2809 27.8509 27.2111
100002 1.4292 1.0025 27.2350 28.7068 30.6650 28.8632
100006 1.6260 0.9189 29.1505 28.3673 28.9654 28.8205
100007 1.5846 0.9189 28.5702 29.0472 30.3800 29.3589
100008 1.6979 0.9865 29.1705 30.3392 32.1650 30.5829
100009 1.3613 0.9865 27.4424 27.8618 30.0468 28.3830
100012 1.6154 0.9502 28.4600 29.8353 30.8602 29.7781
100014 1.4551 0.9073 25.1524 27.4019 27.4048 26.6903
100015 1.2730 0.8993 26.0916 27.2483 28.6813 27.3086
100017 1.6234 0.9073 27.9654 28.2402 29.8685 28.7071
100018 1.6116 0.9820 30.2423 30.6545 32.8609 31.2755
100019 1.6071 0.9401 28.6630 30.3008 31.4521 30.1350
100020 *** * 27.1257 * * 27.1257
100022 1.6470 1.0025 32.8088 36.7912 36.3330 35.3146
100023 1.5384 0.9073 25.2652 25.4270 27.1008 26.0111
100024 1.2924 0.9865 29.1894 29.5423 29.8902 29.5369
100025 1.7145 0.8633 23.3843 26.7013 27.1652 25.7513
100026 1.5761 0.8633 23.4730 26.0147 27.3027 25.6436
100027 *** * 18.9432 * * 18.9432
100028 1.3554 0.9401 27.7497 27.5664 28.7776 28.0281
100029 1.2121 0.9865 28.8842 30.5382 31.5979 30.3873
100030 1.3539 0.9189 24.6314 25.3513 26.3096 25.4476
100032 1.6723 0.8993 26.8162 26.9275 27.8918 27.2236
100034 1.7942 0.9865 28.1280 27.2915 28.9362 28.1268
100035 1.6017 0.9757 29.4803 30.2382 32.5568 30.7182
100038 1.7177 1.0025 31.3403 31.6657 32.8363 31.9625
100039 1.5743 1.0025 28.2531 29.3699 29.0221 28.8790
100040 1.7008 0.9092 26.2429 27.2835 28.3342 27.2945
100043 1.4134 0.8993 26.4221 27.0054 26.8400 26.7591
100044 1.5389 0.9905 30.3659 33.1141 34.3895 32.6318
100045 1.3128 0.9073 29.7375 26.5413 25.5601 27.1971
100046 1.4584 0.8993 26.9469 26.7702 27.7856 27.1801
100047 1.6986 0.9648 26.7674 29.9729 31.4038 29.3525
100048 0.9293 0.8633 19.3226 20.2657 21.7684 20.4248
100049 1.2227 0.8715 24.0385 24.5571 27.6295 25.3718
100050 1.1486 0.9865 21.5101 25.3354 23.5194 23.4888
100051 1.3882 0.9189 28.0946 28.6225 30.1464 29.0839
100052 1.4592 0.8715 23.6796 23.4036 25.1096 24.0877
100053 1.3335 0.9865 28.5118 31.7415 31.9242 30.6741
100054 1.4058 0.8703 28.7646 30.5515 30.9825 30.1173
100055 1.4682 0.8993 25.6243 27.3826 29.6999 27.4746
100057 1.4366 0.9189 24.8010 26.3134 27.7025 26.3249
100061 1.5221 0.9865 31.4413 30.4528 31.9154 31.2647
100062 1.6289 0.8633 25.1280 25.9597 26.3043 25.8131
100063 1.2914 0.8993 25.5097 26.4139 27.0754 26.3647
100067 1.4240 0.8993 26.8628 27.4762 27.5486 27.3159
100068 1.6629 0.9073 26.1341 27.6576 27.6975 27.1712
100069 1.5199 0.8993 25.7450 27.2108 29.0462 27.3031
100070 1.6948 0.9757 26.8461 29.2005 29.1098 28.3496
100071 1.3016 0.8993 26.3768 25.3667 25.1867 25.6298
100072 1.3899 0.9073 25.7962 27.1889 27.6927 26.8986
100073 1.7604 1.0025 30.5845 29.4165 31.0379 30.3564
100075 1.5137 0.8993 25.7612 27.6534 26.7551 26.7473
100076 1.2093 0.9865 23.4551 24.0412 24.0262 23.8474
100077 1.3908 0.9648 30.6925 30.7564 27.9764 29.8150
100079 1.4454 * * * * *
100080 1.6170 1.0025 28.2188 29.5346 31.0487 29.6112
100081 0.9435 0.8633 16.9756 19.5711 19.7407 18.7147
100084 1.7063 0.9189 27.4947 32.7503 30.6285 30.2189
100086 1.3909 1.0025 28.5971 29.9072 31.3169 29.9261
100087 1.8447 0.9757 29.5823 30.5938 32.1290 30.7622
100088 1.5784 0.9092 26.7574 28.2825 29.5464 28.3236
100090 1.4708 0.9092 26.5703 27.6175 28.9548 27.7918
100092 1.5273 0.9401 27.8341 26.6315 28.6765 27.7162
100093 1.7183 0.8633 21.6438 22.5555 23.4836 22.5921
100099 1.0283 0.8715 25.8454 26.2395 28.0669 26.7407
100102 1.1035 0.8758 26.1015 27.8551 29.0373 27.7069
100105 1.5837 0.9741 29.9745 30.9915 30.8907 30.6081
100106 1.0497 0.8633 24.7650 24.8098 25.6284 25.0615
100107 1.1889 0.9502 27.4760 30.5764 31.2927 29.8950
100108 0.8653 0.8633 21.3540 22.6270 22.8139 22.2176
100109 1.2509 0.9073 25.5669 26.2446 26.7361 26.2234
100110 1.5739 0.9189 29.4788 29.5985 30.3729 29.8429
100113 1.9724 0.9427 28.0440 29.2429 30.5837 29.3004
100114 1.7025 0.9865 29.2862 30.2544 32.3934 30.6145
100117 1.2439 0.9092 27.7198 28.4928 30.0549 28.8365
100118 1.3879 0.8633 27.6438 27.0981 28.3179 27.7197
100121 1.1178 0.8715 26.2990 27.9353 24.9371 26.3668
100122 1.2316 0.8703 24.6285 26.7175 27.6162 26.3632
100124 1.1998 0.8633 24.0333 24.8880 26.2310 25.0380
100125 1.2235 0.9865 29.7750 31.7749 33.3469 31.6838
100126 1.3212 0.8993 29.6247 28.3213 28.9151 28.9566
100127 1.5761 0.8993 26.0923 27.4632 27.0669 26.8835
100128 2.1341 0.8993 29.2566 30.0324 30.3690 29.9099
100130 1.1458 1.0025 26.0268 28.3651 30.9735 28.5262
100131 1.4707 0.9865 27.8164 29.7647 30.9586 29.6460
100132 1.2889 0.8993 26.0526 27.8180 27.6613 27.2139
100134 0.8985 0.8633 20.7367 21.6544 22.9624 21.8248
100135 1.6390 0.8981 26.7030 29.1856 29.8423 28.5445
100137 1.3328 0.8715 24.8519 26.8391 28.2969 26.7255
100139 0.8641 0.9427 18.2197 21.1310 21.4420 20.1386
100140 1.1161 0.9092 26.1352 27.8352 28.5466 27.5007
100142 1.1395 0.8633 24.8853 25.6999 26.8978 25.8482
100150 1.2603 0.9865 26.8492 27.7740 29.3690 27.9646
100151 1.7355 0.9092 30.6447 29.7267 31.3820 30.5873
100154 1.6098 0.9865 28.2506 29.7332 31.3618 29.8234
100156 1.1428 0.9427 27.5706 28.3927 28.3041 28.1071
100157 1.5705 0.8993 29.7455 30.3086 30.3339 30.1497
100160 1.2508 0.9865 30.7454 30.6902 32.3113 31.2761
100161 1.5295 0.9189 28.0545 29.5673 30.8955 29.5189
100166 1.5059 0.9757 28.8685 30.1811 31.9053 30.2720
100167 1.2272 1.0025 30.2166 31.7813 32.4711 31.5289
100168 1.5608 1.0025 27.6739 27.0938 28.0517 27.6177
100172 *** * 20.7857 22.2183 20.5502 21.2381
100173 1.6082 0.8993 26.5436 28.6402 30.2470 28.5123
100175 0.9474 0.8633 23.9665 25.0913 26.1711 25.0707
100176 1.8223 1.0025 30.7087 33.3181 35.5821 33.1514
100177 1.3295 0.9401 28.0089 29.6284 31.0063 29.5570
100179 1.7392 0.9092 29.1111 29.2795 30.5213 29.6480
100180 1.5114 0.8993 29.9238 31.0099 31.5463 30.8513
100181 1.1566 0.9865 24.3708 23.9656 26.0656 24.7884
100183 1.2816 0.9865 29.0270 30.5042 32.9863 30.7987
100187 1.3637 0.9865 27.8144 30.7705 31.6639 30.0560
100189 1.3348 1.0025 28.8320 29.9376 30.5491 29.8033
100191 1.3365 0.8993 28.3710 29.4533 30.9183 29.5986
100200 1.3715 1.0025 28.7694 29.6400 29.0719 29.1618
100204 1.5799 0.9427 27.4763 27.2819 29.9311 28.2769
100206 1.2774 0.8993 27.0295 27.7551 28.8609 27.8936
100209 1.5193 0.9865 26.8473 28.5336 29.0435 28.1481
100210 1.5671 1.0025 29.8515 32.0830 32.4538 31.4634
100211 1.2490 0.8993 24.7533 26.2859 28.8303 26.5619
100212 1.4634 0.8633 26.1846 27.7960 29.2475 27.7618
100213 1.5367 0.9757 27.9283 29.5218 30.2251 29.2000
100217 1.3065 0.9741 27.3989 27.7683 30.3301 28.4907
100220 1.6181 0.9502 28.3868 29.3601 30.8265 29.5174
100223 1.5286 0.8703 25.0332 26.1115 27.6756 26.3160
100224 1.2624 1.0025 26.6446 28.0455 29.1992 27.9615
100225 1.3079 1.0025 28.5259 30.8782 32.6890 30.6971
100226 1.3028 0.9092 28.8165 28.8791 30.2828 29.3578
100228 1.3954 1.0025 28.1396 30.1635 31.0195 29.7490
100230 1.3499 1.0025 29.8493 31.9448 34.6099 32.1778
100231 1.7092 0.8633 25.7037 26.6773 28.3633 26.9108
100232 1.2640 0.9092 28.5537 28.3892 29.3783 28.7734
100234 1.3320 1.0025 27.4456 28.8835 29.7800 28.7289
100236 1.4357 0.9648 28.9955 28.3017 30.5701 29.2818
100237 1.8545 1.0025 31.7848 33.1536 33.9606 32.9295
100238 1.5484 0.8993 30.1094 31.4198 31.6331 31.0862
100239 1.3821 0.8993 28.6893 29.0650 30.3212 29.3632
100240 0.9591 0.9865 27.3523 29.7000 31.0943 29.4319
100242 1.5092 0.8633 25.6083 26.1988 27.8149 26.5486
100243 1.4703 0.8993 27.4534 28.3894 29.8294 28.5415
100244 1.4338 0.9502 26.6876 28.2881 29.8266 28.3031
100246 1.5457 0.9905 29.3310 30.1061 30.0261 29.8298
100248 1.5452 0.8993 28.8082 30.2133 32.4702 30.5161
100249 1.2896 0.8993 24.9876 26.4676 28.5107 26.7077
100252 1.1632 0.9741 27.8256 27.1639 29.1429 28.0419
100253 1.3893 1.0025 27.4927 28.7770 28.5597 28.3018
100254 1.4934 0.8981 26.1406 27.4900 28.5240 27.3995
100255 1.3025 0.8993 26.5571 27.3866 29.5157 27.8451
100256 1.7382 0.8993 30.3081 30.2093 33.3907 31.2430
100258 1.5591 1.0025 31.2203 33.8630 35.2197 33.4797
100259 1.2682 0.8993 27.4809 29.0612 29.9274 28.8444
100260 1.3830 0.9905 26.7129 28.2301 29.4885 28.1387
100264 1.4156 0.8993 26.8216 28.0370 30.1956 28.3177
100265 1.3296 0.8993 25.7432 26.3326 26.6920 26.2976
100266 1.3896 0.8633 23.0208 24.2517 25.6366 24.3555
100267 1.2811 0.9757 28.7259 28.9674 30.6033 29.4523
100268 1.1771 1.0025 29.0668 30.5750 33.6114 31.0650
100269 1.3742 1.0025 26.6047 27.8407 28.3722 27.6319
100271 2.0607 * * * * *
100275 1.3310 1.0025 26.8943 28.7797 31.0459 28.9926
100276 1.2874 1.0025 29.7606 30.5720 31.7050 30.6750
100277 1.5574 0.9865 20.4791 24.1122 25.5878 23.9890
100279 1.4040 0.9502 28.6383 29.2257 31.1921 29.7250
100281 1.3929 1.0025 29.6698 30.9131 32.8807 31.2127
100284 1.0632 0.9865 22.3134 25.2637 21.4401 22.7441
100285 1.2639 1.0025 * 41.9481 34.7963 39.4585
100286 1.5465 0.9820 28.3645 25.8085 26.5795 26.8126
100287 1.3877 1.0025 28.1051 29.7536 30.3059 29.3361
100288 1.7404 1.0025 28.7902 31.0506 32.9558 30.8729
100289 1.6231 1.0025 29.6376 31.9011 31.4701 31.0127
100290 1.2302 0.9215 27.1011 28.7111 29.7566 28.5282
100291 1.3483 0.9401 28.4722 28.1515 28.3762 28.3296
100292 1.3753 0.8633 26.7063 27.7644 28.5799 27.7205
100293 *** * 32.7963 * * 32.7963
100294 *** * 30.7557 * * 30.7557
100295 *** * 26.1983 * * 26.1983
100296 1.3271 0.9865 * 29.3870 31.1449 30.2840
100297 *** * * 32.1536 * 32.1536
100298 0.8450 0.8981 * 19.0297 21.9226 20.3569
100299 1.2918 0.9757 * 34.3697 31.6820 33.1821
100300 *** * * * 33.1669 33.1669
100302 1.1546 0.9189 * * * *
110001 1.3724 0.8740 26.4338 26.5640 27.4189 26.8009
110002 1.3136 0.9760 26.4715 26.2228 28.9001 27.2273
110003 1.3119 0.7840 22.7066 24.2097 25.0083 23.9366
110004 1.3686 0.8880 24.9978 25.1846 27.2513 25.7796
110005 1.2944 0.9760 28.1209 27.2826 29.5994 28.4189
110006 1.5596 0.9589 28.3839 * 32.3714 30.3778
110007 1.5907 0.8770 26.6396 26.3133 28.0665 27.0191
110008 1.3589 0.9760 29.2947 30.9757 31.8366 30.6980
110010 2.1741 0.9760 31.7185 33.2396 33.9818 32.9905
110011 1.2809 0.9760 28.0598 28.5892 30.3526 29.0303
110015 1.0815 0.9760 28.1274 28.8796 30.5004 29.2479
110016 1.2537 0.8495 22.7263 24.3563 25.9193 24.3226
110018 1.1989 0.9760 26.8016 30.1849 30.9429 29.3022
110020 1.2987 0.9760 28.3822 27.5559 29.4629 28.5809
110023 1.3269 0.9760 29.8061 29.3282 29.2001 29.4297
110024 1.4712 0.8943 27.0225 27.3357 28.5637 27.6412
110025 1.4799 1.0139 31.0703 30.2845 32.6731 31.3350
110026 1.0963 0.7840 21.8018 22.8820 24.3858 23.0082
110027 1.0459 0.7840 22.6058 25.5291 25.6536 24.4936
110028 1.7426 0.9604 30.4641 31.4568 32.8679 31.5933
110029 1.7563 0.9760 27.3618 29.2134 30.0367 28.8932
110030 1.3857 0.9760 29.6841 29.9531 32.0250 30.6320
110031 1.2793 0.9760 27.1989 29.5533 30.7447 29.1990
110032 1.2564 0.7840 23.2586 25.1896 24.4949 24.3026
110033 1.7263 0.9760 30.3415 32.4178 32.7019 31.8557
110034 1.7739 0.9604 27.2338 28.7915 29.6801 28.5541
110035 1.7859 0.9760 28.9408 30.1852 31.5705 30.2749
110036 1.8235 0.8943 26.6664 27.2280 28.4022 27.4638
110038 1.5488 0.8397 22.2720 22.9685 23.3659 22.8669
110039 1.3716 0.9604 26.3503 26.2485 28.4347 26.8945
110040 1.1123 0.9760 20.9487 23.9526 21.5761 22.1590
110041 1.2061 0.9760 24.8864 26.1948 27.6593 26.2845
110042 1.0795 0.9760 34.9954 33.4391 34.5117 34.3025
110043 1.7560 0.8943 27.8477 28.8551 30.3702 28.9989
110044 1.2146 0.7840 23.3039 24.3772 27.0418 24.8928
110045 1.0279 0.9760 24.4275 27.7619 28.2217 26.7950
110046 1.1453 0.9760 26.7464 * 28.6264 27.6790
110050 1.0857 0.8499 27.5985 27.0651 27.1525 27.2626
110051 1.1244 0.7840 20.1756 21.4898 22.1488 21.3080
110054 1.4223 0.9760 28.9254 29.4691 31.5780 30.0224
110059 1.1567 0.7840 23.2137 24.7838 24.9265 24.3029
110064 1.5836 0.9061 24.1219 26.9363 28.7283 26.5861
110069 1.3437 0.9618 26.2085 29.9098 30.6443 28.9853
110071 1.1205 0.7840 21.3963 21.2041 23.6494 22.1661
110073 1.0228 0.7840 18.5753 23.3571 23.0067 21.5478
110074 1.4894 0.9589 27.9190 31.0062 30.3996 29.7348
110075 1.3134 0.8841 23.7585 24.8244 26.1068 24.8944
110076 1.4843 0.9760 28.7871 29.4344 31.0636 29.7176
110078 1.9462 0.9760 29.9625 30.5196 31.1064 30.5424
110079 1.5678 0.9760 26.8412 27.3274 29.0882 27.7224
110080 *** * 18.4714 * * 18.4714
110082 1.9672 0.9760 30.8320 30.1072 31.1407 30.6976
110083 1.9525 0.9760 30.4287 34.0610 34.5768 33.0335
110086 1.2641 0.7840 21.6898 22.9959 23.4762 22.7087
110087 1.4285 0.9760 28.1633 31.0403 32.8007 30.7266
110089 1.1392 0.7840 23.9026 24.3327 26.0096 24.7677
110091 1.2915 0.9760 29.5337 27.0994 28.0609 28.1665
110092 1.1137 0.7840 20.8911 21.4168 22.8591 21.7047
110095 1.4622 0.8397 26.3075 28.0526 27.9005 27.4450
110100 0.9787 0.8630 16.2575 20.8201 20.0633 18.9182
110101 0.9836 0.7907 19.4257 21.0983 23.8601 21.3923
110104 1.2036 0.7840 20.3777 21.8966 22.2585 21.5748
110105 1.3643 0.7840 23.1405 23.4010 23.7738 23.4420
110107 1.9504 0.9815 28.9352 30.1027 31.5754 30.2370
110109 1.0213 0.7840 23.0376 21.6023 21.6011 22.0502
110111 1.1524 0.9604 25.1270 25.7084 27.2234 26.0060
110112 1.0413 0.8397 22.7672 26.4089 24.2924 24.5380
110113 0.9563 0.9604 21.3417 22.0793 22.0479 21.8312
110115 1.7706 0.9760 31.5074 32.7927 33.3880 32.5794
110121 1.0024 0.8397 26.2336 23.4571 24.5645 24.7827
110122 1.5445 0.8397 25.1934 25.4439 26.3052 25.6427
110124 1.0887 0.7840 22.9212 22.9571 24.8540 23.5883
110125 1.2577 0.9618 23.7834 24.7347 26.4991 24.9905
110128 1.2891 0.8841 25.7839 25.4190 24.5272 25.2129
110129 1.5763 0.9061 25.9625 30.0444 29.7304 28.5402
110130 0.9171 0.7840 19.1284 20.4349 21.7084 20.4154
110132 1.0348 0.7840 20.2502 21.2642 21.6033 21.0527
110135 1.2731 0.7840 22.5346 24.0945 25.1022 23.9470
110136 *** * 18.8212 * * 18.8212
110142 0.9807 0.8025 21.3935 21.6286 22.2156 21.7484
110143 1.4253 0.9760 28.6583 29.9139 30.9590 29.8777
110146 1.0832 0.9112 27.0987 29.0193 30.1159 28.7418
110149 *** * 28.4040 * * 28.4040
110150 1.2994 0.9760 25.3742 26.9884 27.7908 26.7261
110153 1.1210 0.9618 25.7467 29.3305 30.2424 28.4006
110161 1.5555 0.9760 30.4885 31.5001 31.9981 31.3389
110163 1.4520 0.8770 28.2169 27.7679 29.5674 28.5127
110164 1.7038 0.9815 28.8946 30.0145 31.2804 30.1111
110165 1.4333 0.9760 27.0977 28.7902 28.7898 28.2209
110168 1.7664 0.9760 28.5700 29.7774 30.8727 29.7602
110172 1.4736 0.9760 31.1234 31.3999 33.0426 31.8709
110177 1.9238 0.9604 28.8356 29.7079 30.5507 29.7260
110183 1.2868 0.9760 28.6208 28.3505 29.6606 28.9003
110184 1.2634 0.9760 28.3545 29.4071 30.2897 29.4131
110186 1.3171 0.9061 27.4925 28.2880 29.6479 28.4857
110187 1.2029 0.9760 25.2139 26.9638 31.0150 27.7895
110189 1.1025 0.9760 26.1418 26.2799 27.4200 26.6304
110190 1.0867 0.8081 23.3204 24.5224 29.4199 25.5710
110191 1.3278 0.9760 27.7760 30.9481 28.7481 29.1019
110192 1.4139 0.9760 28.8267 30.0843 31.6605 30.2562
110193 *** * 27.9161 * * 27.9161
110194 0.8957 0.7840 19.1920 21.0826 20.5257 20.2837
110198 1.3546 0.9760 31.0557 32.8171 34.0021 32.6125
110200 2.0256 0.9061 24.9236 27.2974 29.4610 27.3150
110201 1.4532 0.9815 31.0841 32.0967 33.4267 32.2165
110203 0.9588 0.9760 29.7888 32.3441 32.0585 31.3300
110205 1.1768 0.8347 22.0207 23.9738 26.1963 24.0311
110209 0.6196 0.7840 21.1534 21.2428 22.4539 21.6327
110212 1.2087 0.8163 * * * *
110214 *** * 37.1450 * * 37.1450
110215 1.3584 0.9760 27.5566 29.5238 30.1770 29.1787
110219 1.4002 0.9760 28.8814 32.2603 33.4462 31.6155
110220 *** * 37.5741 * * 37.5741
110221 *** * 28.0500 * * 28.0500
110222 *** * 35.6189 * * 35.6189
110223 *** * * 25.3071 * 25.3071
110224 *** * * 33.6464 * 33.6464
110225 1.2065 0.9760 * 29.5373 28.9757 29.2212
110226 1.1952 0.9760 * * 32.1814 32.1814
110228 0.8800 0.9760 * * * *
110229 1.2950 0.9760 * * * *
110230 1.3685 0.7840 * * * *
120001 1.7874 1.1608 34.1385 39.6348 39.0344 37.5738
120002 1.2448 1.1219 32.3784 34.1709 37.7249 34.7927
120004 1.2549 1.1608 30.0668 31.3555 32.5141 31.3602
120005 1.2949 1.1219 31.1985 33.6942 35.1716 33.3840
120006 1.2614 1.1608 31.6785 34.2231 35.7058 33.9086
120007 1.6360 1.1608 30.2473 30.8773 35.0167 31.9560
120010 1.9848 1.1608 29.5714 30.8526 34.3338 31.4351
120011 1.4966 1.1608 37.1792 39.1941 44.0519 40.3992
120014 1.3531 1.1219 30.3463 30.9839 34.2101 31.8841
120019 1.1710 1.1219 30.4257 33.0114 36.1586 33.2188
120022 1.8673 1.1608 29.9527 32.5326 34.9024 32.4610
120026 1.4190 1.1608 32.4566 34.2244 35.8383 34.2218
120027 1.3261 1.1608 28.7905 29.5825 31.8146 30.1238
120028 1.2595 1.1608 32.4847 34.0451 34.6327 33.7338
120029 *** * * 44.6382 * 44.6382
130002 1.4057 0.9100 24.7871 24.7266 24.3491 24.6130
130003 1.4692 0.9560 28.6158 28.6136 29.8774 29.0074
130006 1.7566 0.9290 27.2158 28.0048 28.8325 28.0328
130007 1.7298 0.9290 28.7246 30.4958 31.2250 30.1204
130013 1.3634 0.9290 30.9609 36.1570 33.8909 33.6903
130014 1.2442 0.9290 27.2543 27.5936 28.2815 27.7157
130018 1.7489 0.9327 27.3439 28.4041 30.2030 28.6009
130024 1.1981 0.8272 23.6212 24.8035 25.3184 24.5765
130025 1.2309 0.7597 21.1998 22.7962 23.8581 22.6625
130028 1.4347 0.9103 27.2195 28.4934 29.3360 28.3737
130049 1.5627 1.0315 27.3597 29.0185 29.7190 28.7360
130062 *** * 25.6467 29.1925 28.3416 27.9024
130063 1.4068 0.9290 26.0955 27.7607 27.7664 27.1825
130065 1.9441 0.9327 21.9792 30.4547 25.8977 26.3095
130066 2.0484 0.9504 * 28.9883 28.1483 28.5227
130067 2.5439 * * 21.3867 26.8243 23.8814
140001 1.1235 0.8797 22.3001 22.2003 23.2221 22.5895
140002 1.3464 0.8993 27.0165 27.4779 29.1084 27.9303
140007 1.4044 1.0334 30.7378 31.4024 32.4342 31.5521
140008 1.4402 1.0334 29.1767 31.8008 32.7592 31.2208
1400103 1.4980 1.0334 31.8806 40.1360 39.3702 36.3250
140B103 *** * * 40.1360 39.3702 39.7545
140011 1.2146 0.8428 23.8575 25.8864 26.2125 25.4083
140012 1.3120 1.0334 29.0336 31.8213 31.9498 30.8913
140013 1.4671 0.9043 23.9269 25.0951 26.4178 25.1250
140015 1.3506 0.8993 24.4687 24.6409 25.2491 24.8022
140018 1.3731 1.0334 26.3533 30.7398 31.5604 29.4466
140019 0.9139 0.8428 21.3438 22.3179 22.2899 21.9787
140026 1.1531 0.8743 25.9669 26.0493 28.1690 26.7518
140029 1.5837 1.0334 30.2688 36.7722 36.3824 34.4448
140030 1.5087 1.0334 30.2776 31.6822 32.1110 31.3500
140032 1.2668 0.8993 26.7310 27.5367 28.5229 27.5996
140033 *** * 27.9993 29.5256 31.4328 29.1997
140034 1.1683 0.8993 24.0470 24.4653 26.7233 25.0924
140040 1.2236 0.9043 23.2293 24.5589 28.4995 25.3375
140043 1.2647 0.8606 27.3469 29.8633 31.3736 29.5994
140046 1.4727 0.8993 24.7334 25.6230 25.7906 25.3934
140048 1.2788 1.0334 29.3877 30.6686 31.6262 30.5704
140049 1.5369 1.0334 29.0976 30.8617 32.0217 30.6556
140051 1.5614 1.0334 30.9696 32.1730 32.7506 31.9766
140052 1.3408 0.8993 25.9617 26.9907 26.7896 26.5759
140053 1.7853 0.9133 27.4518 28.4513 29.9472 28.5957
140054 1.4862 1.0334 33.1406 34.2378 34.5342 33.9734
140058 1.2320 0.8993 24.6058 25.2568 26.5660 25.4975
140059 1.0669 0.8993 22.6743 21.6230 22.8588 22.3764
140062 1.3719 1.0334 34.1230 36.8271 36.6461 35.8580
140063 1.4103 1.0334 28.6559 30.5465 31.1242 30.0979
140064 1.2191 0.9043 23.8639 25.7551 26.6231 25.4620
140065 1.4143 1.0334 30.1856 31.5510 32.4631 31.3610
140066 1.1167 0.8993 22.1524 22.0225 23.6295 22.6003
140067 1.8104 0.9043 28.3506 29.8982 30.6882 29.6686
140068 1.2321 1.0334 28.3938 26.7166 31.3440 28.7631
140075 1.2712 1.0334 26.2626 35.9507 33.6844 31.5469
140077 0.9374 0.8993 20.3999 21.6468 22.5061 21.5537
140080 1.4286 1.0334 28.8791 29.9067 30.3760 29.7135
140082 1.6302 1.0334 28.3429 31.0516 32.0539 30.4270
140083 0.9706 1.0334 26.8919 27.2189 26.1622 26.6852
140084 1.2689 1.0334 30.5036 30.7251 31.3281 30.8596
140088 1.8601 1.0334 30.5450 32.6866 34.0556 32.5121
140089 1.2292 0.8428 24.1066 24.9120 26.6942 25.2540
140091 1.7570 0.9353 27.8536 28.2095 29.4099 28.5130
140093 1.2251 0.9711 28.3298 28.6709 31.2955 29.5310
140094 1.0614 1.0334 27.3841 28.7647 28.8596 28.3324
140095 1.2067 1.0334 28.7617 29.7385 29.9452 29.4617
140100 1.4165 1.0334 41.3374 37.2961 37.3023 38.5940
140101 1.2742 1.0334 29.4081 28.9723 31.0048 29.8038
140103 1.1919 1.0334 23.6406 24.0926 25.3608 24.3942
140105 *** * 29.5274 29.6590 30.7135 29.8404
140110 1.1348 1.0334 28.6364 30.3432 31.3460 30.1323
140113 1.5825 0.9353 29.5452 30.2542 31.6124 30.5020
140114 1.5001 1.0334 28.2151 29.8316 31.1390 29.7616
140115 1.2630 1.0334 26.0383 25.4576 26.2578 25.9061
140116 1.3668 1.0341 34.5537 34.3876 34.1356 34.3550
140117 1.5097 1.0334 27.7201 30.9679 28.5785 29.0528
140118 1.4623 1.0334 32.5518 33.1987 33.6634 33.1346
140119 1.8095 1.0334 34.2118 32.2185 34.3896 33.5609
140120 1.3098 0.9043 23.9724 25.9275 26.2398 25.4006
140122 1.5055 1.0334 30.5653 30.2888 32.4728 31.1094
140124 1.2504 1.0334 35.7563 38.2191 38.8956 37.6290
140125 1.1586 0.8993 22.7571 26.5801 27.6333 25.6694
140127 1.6283 0.9520 25.6668 27.8363 29.3326 27.6412
140130 1.2280 1.0334 32.6209 32.5425 34.5053 33.2090
140133 1.4054 1.0334 31.0269 30.3259 32.8907 31.4186
140135 1.4168 0.8840 23.3196 24.6645 25.9046 24.6639
140137 1.0555 0.8993 23.4174 31.4349 * 26.5232
140143 1.1818 1.0334 27.4499 26.1126 27.0294 26.8354
140145 1.0941 0.8993 26.0875 25.2040 26.9326 26.0849
140147 1.0800 0.8428 21.0686 21.1817 22.1026 21.4534
140148 1.6364 0.9133 25.5677 27.0038 28.9453 27.2136
140150 1.6423 1.0334 52.0970 35.5951 45.8193 44.1226
140151 0.7986 1.0334 27.0312 26.0825 27.3539 26.8313
140152 *** * 30.2209 29.8647 32.2789 30.7789
140155 1.3176 1.0334 29.5734 32.7960 35.0804 32.3959
140158 1.3565 1.0334 27.3721 30.4445 32.1130 30.0627
140160 1.1748 0.9756 25.8684 27.6905 28.9023 27.4932
140161 1.1449 0.8596 25.2898 28.8266 28.8132 27.6822
140162 1.5506 0.9520 29.4121 32.1810 33.0967 31.5165
140164 1.7462 0.8993 24.6009 25.9726 27.3117 26.0022
140166 1.1830 0.8428 26.4800 26.2875 27.2398 26.6846
140167 1.1518 0.8428 22.8703 24.9904 24.2733 24.0635
140172 1.3856 1.0334 32.1220 33.0926 33.4586 32.9106
140174 1.5880 1.0334 30.5905 31.2231 34.2433 32.0655
140176 1.2311 1.0341 32.9794 32.6145 33.2116 32.9375
140177 0.9832 1.0334 26.4340 25.5725 26.0709 26.0349
140179 1.3098 1.0334 29.3657 30.2944 31.3599 30.3150
140180 1.1869 1.0334 27.8887 29.1352 29.7982 28.9361
140181 1.1559 1.0334 25.0226 27.6835 27.3815 26.6876
140182 1.4662 1.0334 30.1755 32.8972 26.4085 29.5346
140184 1.3087 0.8428 25.2327 26.6104 27.5837 26.4843
140185 1.4359 0.8993 25.2423 26.5398 27.9409 26.5570
140186 1.4967 1.0334 29.8022 30.7212 41.2521 33.4222
140187 1.5073 0.8993 24.8332 25.5873 26.9246 25.7702
140189 1.1619 0.8428 22.5965 24.7013 29.1349 25.4810
140191 1.3271 1.0334 28.5836 31.9943 29.7497 30.0468
140197 1.0759 1.0334 24.0463 24.9103 24.8700 24.5943
140200 1.5134 1.0334 28.8435 30.6641 31.3692 30.2724
140202 1.4541 1.0334 32.7915 32.9433 34.3762 33.4137
140206 1.2021 1.0334 29.7953 29.6275 31.1376 30.1671
140207 1.1245 1.0334 26.0535 28.2262 31.6793 28.4326
140208 1.6424 1.0334 29.5380 31.4035 26.1728 28.8260
140209 1.5750 0.9043 26.3230 29.7965 27.4032 27.7656
140210 1.0667 0.8428 20.6954 19.2053 22.2507 20.7150
140211 1.3317 1.0334 30.3286 31.4539 34.5893 32.1847
140213 1.2466 1.0334 31.6926 32.1031 33.3902 32.4246
140217 1.4736 1.0334 32.1277 32.9404 33.2151 32.8054
140223 1.4965 1.0334 31.7267 33.5083 34.6969 33.3189
140224 1.3728 1.0334 29.6181 31.2237 30.1050 30.3035
140228 1.4758 0.9862 27.9456 28.2855 28.7440 28.3351
140231 1.4738 1.0334 30.0236 34.8291 35.2199 33.3358
140233 1.6742 0.9862 29.7093 31.5168 32.3348 31.1982
140234 1.0951 0.8743 24.5476 25.7353 25.7647 25.3480
140239 1.5089 0.9862 31.1879 31.0918 33.7241 31.9840
140240 1.4543 1.0334 31.5637 32.7986 28.0966 30.7320
140242 1.5121 1.0334 34.6120 35.2351 36.6696 35.4606
140250 1.2451 1.0334 29.6305 31.2533 32.9392 31.3008
140251 1.3749 1.0334 28.0622 28.3598 29.5921 28.6552
140252 1.4509 1.0334 34.4268 35.8762 36.1503 35.4953
140258 1.5542 1.0334 34.2333 33.0093 34.5667 33.9309
140275 1.3633 0.8606 27.8186 28.5064 26.7377 27.6728
140276 1.9223 1.0334 31.6359 32.1048 32.7052 32.1538
140280 1.4877 0.8606 24.9401 26.6536 26.9815 26.2013
140281 1.7853 1.0334 33.3903 35.6589 37.5673 35.5869
140286 1.2031 1.0334 30.3237 32.0048 32.2227 31.5106
140288 1.4810 1.0334 31.5197 31.5944 32.5446 31.8981
140289 1.2801 0.8993 23.8452 25.6847 26.0851 25.2075
140290 1.3716 1.0334 31.8135 32.5247 35.9647 33.4767
140291 1.5227 1.0334 31.9052 33.8706 32.7857 32.8705
140292 1.1466 1.0334 28.5094 30.6917 32.4476 30.3851
140294 1.1034 0.8428 24.0750 26.1595 26.9772 25.8209
140300 1.1745 1.0334 35.1494 42.5240 37.1204 38.1961
140301 1.0712 1.0334 49.9507 39.4295 38.0581 40.7701
140303 2.1328 1.0334 29.6470 * 32.2920 30.8365
150001 1.1896 0.9827 28.9075 31.8089 32.9797 31.2747
150002 1.4747 1.0328 26.6222 27.6481 28.1057 27.6106
150003 1.5897 0.8960 26.7585 26.9771 29.0575 27.6017
150004 1.4569 1.0328 28.7336 30.9626 31.6781 30.3933
150005 1.2612 0.9827 29.5371 30.5367 31.6148 30.6086
150006 1.3702 0.9353 25.6265 27.1364 28.3389 27.0718
150007 1.4525 0.9254 29.4971 30.0500 31.0369 30.2270
150008 1.4479 1.0328 27.5703 27.0525 29.1473 27.9333
150009 1.4395 0.9238 25.4496 25.7616 26.1499 25.7891
150010 1.5221 0.9254 27.2272 28.4118 28.2599 27.9486
150011 1.3308 0.9707 25.3178 26.7686 27.7857 26.5785
150012 1.5537 0.9644 30.0348 31.2282 30.4819 30.5840
150015 1.3616 0.9320 28.0931 27.3811 30.1474 28.5072
150017 1.8267 0.9004 26.3973 26.3379 27.1249 26.6388
150018 1.5912 0.9353 27.3689 29.1137 30.0478 28.9018
150021 1.8098 0.9004 28.9196 30.0030 31.1140 30.0142
150022 1.0584 0.8637 23.1041 23.8971 26.8394 24.4351
150023 1.5869 0.9707 26.9095 27.7520 30.3560 28.3734
150024 1.4757 0.9827 28.1655 28.4170 30.6133 29.0364
150026 1.3515 0.9353 28.6517 30.4967 31.9378 30.4512
150029 1.3421 0.9644 28.7187 29.9307 29.7461 29.4587
150030 1.1963 0.9707 29.1493 29.3588 31.1964 29.9386
150033 1.4204 0.9827 28.6838 29.7744 33.1990 30.5371
150034 1.4624 1.0328 28.6429 28.0434 30.0027 28.9357
150035 1.5482 0.9320 26.9700 27.8904 29.2014 28.0374
150037 1.2521 0.9827 31.0935 29.0161 30.4623 30.1390
150038 1.1402 0.9827 29.3156 33.0112 31.9539 31.4556
150042 1.3656 0.8791 22.8786 25.1403 25.2440 24.4073
150044 1.4443 0.9238 25.2137 25.2685 25.9260 25.4830
150045 1.0453 0.9004 26.9818 27.5340 29.4308 27.9971
150046 1.5575 0.9130 24.5593 26.5876 27.6210 26.2766
150047 1.7059 0.9004 25.5194 25.8497 27.1835 26.1904
150048 1.4375 0.9583 27.1233 28.1525 29.5578 28.3255
150051 1.6111 0.9707 26.5655 28.9157 30.3742 28.6837
150056 1.9795 0.9827 28.8727 29.3500 30.5758 29.6152
150057 2.0656 0.9827 28.9529 30.3287 29.1268 29.4500
150058 1.6334 0.9644 29.1444 29.1255 31.7536 30.0001
150059 1.4852 0.9827 31.4987 31.3362 36.2553 33.0486
150061 1.1299 0.8479 21.3711 22.6746 23.2415 22.4414
150064 1.2404 0.8479 25.4987 28.7978 28.9419 27.8440
150065 1.2493 0.9707 27.9283 30.2053 30.8254 29.6617
150069 1.1831 0.9583 26.2028 26.0909 27.0720 26.4651
150072 1.1283 0.8584 21.2120 21.7644 23.0612 21.9963
150074 1.4309 0.9827 25.9321 28.5655 29.4124 28.0120
150075 1.1406 0.9004 25.1568 25.7245 26.5972 25.8595
150076 1.2974 0.9353 29.3249 30.1120 29.2703 29.5697
150082 1.5914 0.8525 28.3494 26.4544 28.1280 27.6224
150084 1.8344 0.9827 31.1720 33.1784 34.8522 33.0904
150086 1.2227 0.9583 25.1992 26.6745 27.2568 26.4089
150088 1.2980 0.9707 27.2103 29.1509 30.2378 28.8855
150089 1.5552 0.8479 24.7233 24.8045 26.7270 25.4200
150090 1.5584 1.0328 30.4835 30.6412 30.8754 30.6754
150091 1.1569 0.9004 30.4234 32.1627 33.0402 31.9030
150097 1.1855 0.9827 27.7468 29.1359 29.4776 28.7947
150100 1.6039 0.8525 25.7997 26.9724 27.6326 26.7725
150101 1.0840 0.9004 29.0301 30.5475 31.6018 30.3780
150102 1.0268 0.9320 25.7424 25.8742 25.4704 25.6892
150104 1.1443 0.9827 28.2552 28.7788 30.8970 29.3100
150109 1.5465 0.8960 25.3367 26.8464 28.7412 26.9892
150112 1.4960 0.9707 28.0068 29.8540 31.7711 29.8902
150113 1.2097 0.9707 24.7960 25.9814 26.9088 25.9097
150115 1.3474 0.8479 22.0747 22.5793 22.3560 22.3407
150125 1.5500 1.0328 27.6535 29.3596 31.2081 29.4320
150126 1.3476 1.0328 28.9454 29.4300 32.5356 30.2297
150128 1.4329 0.9827 28.7810 29.5008 31.1046 29.8290
150129 1.1906 0.9827 29.7398 31.4317 32.9621 31.3709
150132 *** * 27.6560 * * 27.6560
150133 1.2148 0.9353 25.1322 24.2538 23.0651 24.1076
150134 *** * 26.3249 21.6740 27.3963 24.7453
150146 1.1296 0.9547 29.5256 30.3343 31.8743 30.6315
150147 1.4431 1.0328 27.2339 26.1646 28.9248 27.6245
150149 0.9337 0.8525 23.7026 24.9629 25.3324 24.7398
150150 1.3583 0.9004 27.0542 26.7700 26.5963 26.7808
150153 2.3079 0.9827 32.1022 35.0617 37.3920 35.1885
150154 2.4814 0.9827 29.8514 29.8894 30.5758 30.1310
150155 *** * 45.0121 * * 45.0121
150156 *** * 25.9681 * * 25.9681
150157 1.7719 0.9827 * 32.3106 32.9148 32.6153
150158 1.2495 0.9827 * * 30.4337 30.4337
150159 *** * * * 27.5574 27.5574
150160 2.0971 0.9827 * * 28.6108 28.6108
150161 1.6006 0.9827 * * * *
150162 1.8254 0.9827 * * * *
150163 1.0174 0.9238 * * * *
150164 1.1402 0.9419 * * * *
150165 1.3537 0.9320 * * * *
150166 1.0260 0.9320 * * * *
160001 1.2035 0.8881 24.5108 25.7255 25.8676 25.3903
160005 1.2221 0.8709 23.1034 24.7755 24.8586 24.2778
160008 1.0503 0.8709 22.1402 22.4758 24.1271 22.9093
160013 1.1826 0.8888 24.0956 24.4099 25.5144 24.6765
160016 1.5621 0.8881 24.5338 27.1460 26.6516 26.0785
160024 1.5070 0.9460 27.4158 29.3756 32.4228 29.7117
160028 1.3546 0.9360 27.8535 30.0576 29.8324 29.2977
160029 1.5290 0.9337 28.7324 30.6687 32.2010 30.5406
160030 1.4497 0.9457 28.7786 30.9415 30.4757 30.0901
160032 1.0815 0.8944 25.4662 26.2935 28.5629 26.7834
160033 1.6123 0.8709 26.5315 27.2060 27.4787 27.0636
160040 1.3560 0.9248 25.9032 26.8110 28.2966 27.0153
160045 1.6650 0.8746 26.6463 27.5289 28.1662 27.4620
160047 1.3438 0.9360 26.0227 28.1280 29.4261 27.7499
160057 1.3696 0.9107 25.1272 25.6274 27.7953 26.1996
160058 1.9928 0.9337 28.4167 28.9924 29.8956 29.1104
160064 1.5613 0.9248 28.7668 28.4209 33.6067 30.2004
160067 1.3956 0.9248 24.8137 26.0243 26.7671 25.8721
160069 1.5119 0.8709 27.4473 27.6157 28.4064 27.8032
160079 1.4505 0.8746 24.7372 26.1618 28.5014 26.4591
160080 1.2258 0.8709 25.8252 27.2370 27.8729 26.9717
160082 1.7394 0.9460 27.4718 28.7831 31.7482 29.3428
160083 1.6319 0.9460 27.3004 28.3921 29.9472 28.5559
160089 1.2114 0.9107 23.2149 23.2888 23.9184 23.4747
160101 1.1157 0.9460 25.0503 25.4740 26.8503 25.8119
160104 1.6343 0.8709 28.1891 29.8126 27.0516 28.2560
160110 1.4968 0.9248 26.6633 28.8134 29.9071 28.6042
160112 1.2363 0.8709 24.7957 25.2886 26.1706 25.4488
160117 1.3763 0.8709 25.4659 27.3927 24.3309 25.6596
160122 1.1372 0.8709 23.9177 24.4996 25.3176 24.5888
160124 1.1221 0.8709 22.5482 24.3063 25.5031 24.1100
160146 1.4330 0.8745 22.6949 24.8485 25.1816 24.2135
160147 1.2223 0.8881 28.6303 29.8992 33.6376 30.7344
160153 1.6977 0.8745 29.9378 30.6173 30.4338 30.3298
160155 2.0066 0.8709 * * * *
170001 1.1220 0.8086 23.1260 23.8863 24.5932 23.8766
170006 1.3222 0.9351 24.2068 27.1033 28.3509 26.6135
170009 1.0785 0.9453 30.9025 29.6386 32.2817 30.9531
170010 1.2334 0.8086 23.9707 25.5573 28.1793 25.9458
170012 1.6303 0.8785 26.1367 27.1195 28.7852 27.3256
170013 1.7166 0.8785 25.2476 26.7124 28.3035 26.7042
170014 1.0389 0.9453 23.8135 24.2322 25.8151 24.6246
170016 1.5893 0.8873 25.8061 26.7536 28.6802 27.0793
170017 1.1359 0.8980 26.9657 27.2925 29.1445 27.8530
170020 1.5631 0.8785 23.2757 24.1149 25.0539 24.1602
170023 1.4632 0.8785 24.0561 23.9812 24.8758 24.3255
170027 1.4379 0.8086 23.1766 23.4037 24.1118 23.5721
170033 1.3317 0.8086 21.9709 24.1882 25.0393 23.6609
170039 0.9397 0.8980 26.9852 26.0952 23.5961 25.4102
170040 1.9332 0.9453 28.4458 30.2468 30.0807 29.6659
170049 1.5092 0.9453 25.2070 26.4086 31.8575 27.9185
170058 1.0992 0.8086 22.9210 26.5949 28.1316 25.7970
170068 1.2130 0.8885 23.0635 23.8812 23.8492 23.5912
170074 1.1942 0.8086 23.7829 23.0567 24.8855 23.9145
170075 0.8436 0.8086 19.7760 19.9351 21.1954 20.2943
170086 1.5732 0.8873 26.1362 26.3615 28.5234 27.0437
170094 0.9157 0.8086 21.5295 16.5136 17.1709 18.5438
170103 1.2784 0.8980 23.8042 24.2003 25.5653 24.5527
170104 1.4059 0.9453 26.2990 27.6211 29.5069 27.8074
170105 1.1156 0.8086 21.9606 22.7412 23.4317 22.7174
170109 1.0350 0.9453 23.1088 23.8515 29.0177 25.4500
170110 0.8962 0.8086 23.3260 23.9572 24.7910 24.0231
170114 0.5755 * * * * *
170120 1.3720 0.9351 22.0253 22.2805 23.5271 22.6059
170122 1.6975 0.8980 26.6605 28.7175 29.6314 28.2843
170123 1.6684 0.8980 27.6653 27.0843 28.7608 27.8479
170133 1.0196 0.9453 23.1226 25.2301 25.7108 24.7246
170137 1.3249 0.8086 24.7096 25.3395 26.8014 25.6444
170142 1.3711 0.8720 23.9527 24.6019 25.5550 24.7027
170145 1.0867 0.8086 23.2162 23.3967 25.3728 23.9852
170146 1.5002 0.9453 29.8858 29.0720 31.6994 30.2197
170147 *** * 22.4973 24.3268 21.4565 23.0046
170150 1.1410 0.8252 20.9448 19.6160 22.0251 20.8653
170166 1.0165 0.8086 21.0762 22.6968 24.1063 22.6638
170175 1.4832 0.8785 25.6281 26.7229 31.7582 28.0191
170176 1.5583 0.9453 27.2332 29.0735 30.1114 28.8494
170180 *** * 32.5010 * * 32.5010
170182 1.4504 0.9453 27.3503 28.9710 30.3781 28.8971
170183 1.9858 0.8980 25.8340 26.1890 27.7178 26.5683
170185 1.2572 0.9453 27.8139 28.1780 29.3202 28.5075
170186 2.5220 0.8980 32.8392 30.2613 30.7638 31.2790
170187 1.6421 0.8086 22.8493 24.1461 24.6391 23.8933
170188 1.9852 0.9453 30.6844 32.2573 33.7221 32.2678
170190 1.0158 0.8720 22.9540 26.2625 27.3023 25.5425
170191 1.8259 0.8086 22.1197 24.3813 26.0279 24.3247
170192 1.7639 0.8980 26.2724 27.7421 30.9200 28.4741
170193 1.3485 0.8785 20.6821 24.8531 24.4126 22.9315
170194 1.2331 0.9453 29.9014 27.6989 28.1972 28.5250
170195 2.4249 0.9453 30.1001 29.5947 29.1763 29.5492
170196 2.4635 0.8980 * 32.1832 29.9641 30.9601
170197 2.3250 0.8980 * * * *
170198 1.9320 0.8086 * * * *
180001 1.3069 0.9590 27.6917 29.7423 29.9655 29.1412
180002 1.0662 0.8062 25.7862 26.5488 27.3339 26.5496
180004 1.0759 0.7837 22.0797 20.8805 22.0615 21.6721
180005 1.1460 0.8767 24.9779 25.6159 27.4304 26.0705
180007 1.5443 0.8950 25.7042 27.1924 26.9425 26.6126
180009 1.7525 0.9127 26.4101 27.3228 28.7030 27.5584
180010 1.8312 0.8950 25.6153 27.7600 28.1667 27.1559
180011 1.6281 0.8756 25.5463 24.9909 25.0355 25.1733
180012 1.4715 0.9123 25.6000 26.7279 27.2829 26.5352
180013 1.5001 0.9276 23.7075 24.8125 26.8088 25.0983
180016 1.2868 0.9245 24.8408 24.7091 26.9522 25.4644
180017 1.3104 0.8230 21.8885 21.9715 25.4164 23.1027
180018 1.3551 0.7837 20.9857 23.3035 23.9155 22.7447
180019 1.1134 0.7837 24.0283 24.6279 27.6787 25.4951
180020 1.0616 0.7837 24.6953 25.9975 26.8856 25.8897
180021 0.9634 0.7837 20.7950 22.0740 22.3752 21.7644
180024 1.1593 0.9123 31.1159 26.3532 26.9538 28.0398
180025 1.2308 0.9245 22.6897 28.5935 28.4153 26.7267
180027 1.2008 0.8302 20.8303 21.7639 23.3873 21.9095
180029 1.4670 0.8756 25.6479 26.1528 26.3892 26.0660
180035 1.4807 0.9590 31.0794 32.8461 34.0348 32.7266
180036 1.3287 0.9127 25.2972 25.6959 30.2621 27.0558
180037 *** * 26.3132 27.8506 33.1874 29.1431
180038 1.5441 0.8764 26.0440 26.9752 28.2413 27.1328
180040 1.8313 0.9245 27.9979 28.5162 30.2450 28.9050
180043 1.1741 0.7978 20.9326 20.6439 24.0566 21.9172
180044 1.5998 0.8767 24.4569 25.8060 25.7978 25.3776
180045 1.3277 0.9590 27.4732 29.4127 29.9346 28.9840
180046 1.0026 0.8950 27.1034 27.0962 28.5552 27.5846
180048 1.3531 0.9123 23.9230 24.3696 24.6786 24.3395
180049 1.4067 0.8756 22.4769 24.3699 23.5737 23.4731
180050 1.1306 0.7919 26.3604 25.9557 26.7714 26.3675
180051 1.2266 0.8302 23.5299 24.3916 25.2356 24.4156
180053 0.9909 0.7837 21.3044 22.1921 23.0290 22.2290
180056 1.1314 0.8531 24.3074 24.5326 26.3959 25.0679
180064 1.2227 0.8151 17.1009 20.1799 21.9508 19.7362
180066 1.1136 0.9276 22.2713 23.7860 24.9530 23.6732
180067 1.9454 0.8950 26.0238 27.9852 29.6029 27.9902
180069 1.0930 0.8767 26.3701 26.6714 27.6777 26.8870
180070 1.1929 0.8077 20.6741 20.2189 21.3693 20.7657
180078 1.0594 0.8767 27.6806 28.2762 29.2125 28.3867
180079 1.1477 0.8096 20.2100 23.6005 24.9898 22.8630
180080 1.2693 0.7889 21.5818 23.7788 25.2996 23.5872
180087 1.2269 0.7837 20.8841 22.0302 22.1044 21.6767
180088 1.7069 0.9245 28.0916 28.6107 30.7936 29.1743
180092 1.1677 0.8950 23.7909 23.7866 25.2884 24.3103
180093 1.6170 0.8131 20.5807 21.4392 22.3324 21.4596
180095 1.0117 0.7837 17.9146 21.5639 21.2154 20.0750
180101 1.3146 0.8950 27.4506 28.1621 28.8758 28.2013
180102 1.5042 0.8302 21.0896 25.2343 27.3887 24.3942
180103 2.0473 0.8950 28.4583 28.1734 29.7626 28.8044
180104 1.5676 0.8302 25.6157 25.9689 27.1274 26.2415
180105 0.9511 0.7837 21.6002 23.1917 24.3659 23.0870
180106 0.8902 0.7837 20.2884 20.7220 21.2265 20.7447
180115 0.9040 0.7837 20.5539 20.3089 22.7088 21.1833
180116 1.1839 0.8320 23.5354 25.8927 26.8836 25.4592
180117 0.9408 0.7837 22.8469 24.7378 24.9567 24.2081
180124 1.3223 0.9276 24.8292 25.4664 27.1341 25.8362
180127 1.3584 0.9123 24.6774 26.3947 28.3610 26.4554
180128 0.9392 0.7837 22.6056 23.8144 23.7770 23.4109
180130 1.6779 0.9245 27.8900 29.1712 29.6725 28.9399
180132 1.4346 0.8756 24.5105 25.3789 29.0546 26.3805
180138 1.1879 0.9245 28.1901 28.6871 29.2584 28.7287
180139 1.0065 0.7837 23.3569 24.7575 26.2434 24.7763
180141 1.8666 0.9245 25.3357 27.5912 28.7307 27.2557
180143 1.6777 0.8950 28.1924 30.8734 28.2122 29.0557
180144 *** * 29.5052 * * 29.5052
180147 *** * * 31.1615 * 31.1615
180148 *** * * 30.1250 * 30.1250
180149 1.0087 0.7837 * * 16.4909 16.4909
180150 1.8775 0.9245 * * * *
190001 1.0903 0.7682 22.1394 22.1569 22.5328 22.2811
190002 1.5733 0.8438 23.3368 24.6984 25.9371 24.6300
190003 1.4214 0.8438 25.8294 26.7844 28.0895 26.9253
190004 1.5112 0.7870 25.3473 25.0803 24.6536 25.0228
190005 1.5223 0.9140 22.6029 24.2899 28.3303 24.2844
190006 1.2838 0.8438 22.7979 24.8836 25.2490 24.3632
190007 1.1753 0.7682 21.8205 23.1426 24.0527 23.0456
190008 1.7450 0.7870 24.6074 26.3638 27.2663 26.0087
190009 1.3606 0.8127 21.1005 24.0696 25.0269 23.3881
190011 1.0090 0.7961 21.4052 21.6991 21.9165 21.6827
190013 1.5563 0.7682 21.4573 23.7333 22.8372 22.6699
190014 1.2264 0.7682 22.7151 22.6405 24.5399 23.2756
190015 1.3070 0.9140 23.7789 25.1767 26.9572 25.3336
190017 1.4841 0.8438 24.5390 24.7537 25.5465 24.9732
190019 1.7201 0.8127 24.0468 25.4624 27.5462 25.7258
190020 1.2827 0.8142 22.1967 23.4602 24.2346 23.3365
190025 1.3344 0.7682 23.5007 24.5024 26.5944 24.8092
190026 1.6101 0.8127 23.7702 24.1556 25.3736 24.4572
190027 1.6236 0.7682 24.3006 26.7132 31.5026 27.4175
190034 1.2092 0.7871 20.7334 21.2130 22.9658 21.6044
190036 1.6604 0.9140 25.4164 25.6551 30.2172 26.9231
190037 *** * 19.4071 20.7271 28.0447 21.7538
190039 1.5115 0.9140 24.4386 25.4003 24.6075 24.8194
190040 1.4212 0.9140 28.6297 28.0169 28.2426 28.2870
190041 1.4648 0.8547 28.5376 28.0050 28.7683 28.4375
190044 1.2898 0.7943 20.9993 21.2604 22.2461 21.5123
190045 1.5439 0.9140 25.8238 27.1996 27.5854 26.9044
190046 1.4309 0.9140 23.8552 24.7370 * 24.2936
190050 1.1484 0.7726 21.0259 20.9142 22.7951 21.5828
190053 1.2074 0.7783 17.9788 18.5819 20.6282 19.0432
190054 1.3250 0.7767 23.1471 22.7011 23.5129 23.1218
190060 1.4709 0.7682 23.7393 22.6291 19.8899 21.9229
190064 1.6110 0.8142 23.1358 23.7298 26.9941 24.6370
190065 1.5904 0.8142 22.1880 23.1202 22.9847 22.7749
190078 1.0906 0.7869 22.2431 22.2346 25.6940 23.4396
190079 1.1812 0.9140 24.0985 23.8192 25.3327 24.4472
190081 0.8736 0.7682 20.0121 21.4510 20.4101 20.6028
190086 1.2760 0.7785 22.0610 22.2895 22.2837 22.2151
190088 1.1378 0.8547 23.8562 23.1638 24.7445 23.9122
190090 1.0338 0.7682 23.1241 24.3303 25.8607 24.3672
190098 1.7595 0.8547 25.6854 25.7449 27.5043 26.3126
190099 1.0153 0.7871 22.0610 23.2343 25.7481 23.6613
190102 1.5441 0.8438 27.3126 26.9700 28.3071 27.5010
190106 1.1415 0.8127 23.5376 26.6227 24.2755 24.7510
190111 1.6311 0.8547 25.5729 26.5722 27.3180 26.5044
190114 1.0602 0.7682 17.2678 19.1586 20.3639 18.9135
190115 1.2209 0.8547 28.2066 26.0797 26.0278 26.7727
190116 1.1880 0.7767 22.3710 23.4013 24.2156 23.3424
190118 0.9844 0.8547 22.8809 21.2580 22.6571 22.2425
190122 1.4015 0.8142 22.0072 22.2371 22.8671 22.4040
190124 *** * 26.0032 27.9484 28.6694 27.4838
190125 1.5711 0.7961 25.5463 24.8256 26.6254 25.6717
190128 1.0269 0.8142 28.3257 29.6682 31.1762 29.7845
190131 1.3325 0.8142 27.8465 28.6795 28.5938 28.3736
190133 0.9162 0.7784 18.2045 22.4311 23.9545 22.0666
190135 1.6174 0.9140 27.7540 30.5646 35.0524 30.2944
190140 0.9876 0.7717 18.9652 23.0485 23.6705 21.8176
190144 1.2672 0.8547 22.9181 23.7875 24.8858 23.8764
190145 0.9764 0.7772 19.9265 20.8579 21.3982 20.7221
190146 1.5575 0.9140 27.4824 28.7200 28.5963 28.2726
190151 0.9239 0.7682 18.7467 18.8391 20.6962 19.4061
190152 1.1740 0.9140 28.1334 30.8512 34.6485 30.9971
190158 *** * 26.4787 30.6450 21.9727 27.7355
190160 1.5637 0.7961 22.9325 24.7822 25.8632 24.4460
190161 1.0278 0.7682 22.6187 22.9035 23.8066 23.1213
190162 *** * 25.2953 * * 25.2953
190164 1.1308 0.8127 25.2560 26.6207 27.7247 26.5855
190167 1.2763 0.8438 26.4669 25.3283 27.1969 26.3225
190175 1.2783 0.9140 26.0547 27.4256 30.5928 28.0066
190176 1.7856 0.9140 25.8826 26.2596 * 26.0715
190177 1.6464 0.9140 27.7792 28.2751 29.7229 28.5969
190182 *** * 27.1682 29.8656 30.7038 29.2917
190183 1.2357 0.7870 22.6928 22.0119 23.3452 22.7038
190184 0.9592 0.7785 24.9476 24.1626 22.6137 23.9160
190185 *** * 25.6394 28.9759 36.7292 29.7365
190190 0.9248 0.7843 24.3327 26.7043 27.5056 26.1460
190191 1.3760 0.8438 24.1923 26.1628 26.9649 25.7635
190196 0.9701 0.8438 24.0385 25.8472 27.7801 25.9541
190197 *** * 25.8071 26.4825 28.7026 26.9781
190199 1.1052 0.8142 27.3304 32.0194 36.7076 31.6410
190200 *** * 28.8173 27.4781 * 28.3200
190201 1.2572 0.7682 25.1010 24.4563 26.8537 25.4868
190202 1.5245 0.8142 27.6084 29.6612 * 28.6936
190203 *** * 28.1832 29.9753 * 29.0343
190204 1.4475 0.9140 28.1033 30.5140 32.9125 30.3814
190205 1.6677 0.8438 26.6832 28.2484 30.1674 28.3935
190206 2.0426 0.9140 26.7401 29.2371 32.0163 29.3053
190208 0.8467 0.7682 28.7308 27.9908 24.9395 26.8779
190218 1.0293 0.8547 26.7262 28.1039 26.5243 27.0954
190236 1.4591 0.8547 24.7142 26.4614 26.9046 26.0708
190241 2.2461 0.7870 25.2123 25.7906 26.5307 25.8664
190242 1.1726 0.8142 24.8461 25.0035 26.9715 25.6625
190245 1.6582 0.7961 25.5751 26.7642 26.4147 26.2436
190246 1.8467 0.7843 * 22.7833 31.7133 27.5712
190247 *** * 32.7499 * * 32.7499
190248 *** * 23.2220 * * 23.2220
190249 1.7284 0.8142 20.0468 25.2523 27.0954 23.4238
190250 2.1126 0.9140 31.5101 33.3302 32.8347 32.5070
190251 1.3045 0.8142 21.4464 23.8389 25.1576 23.4538
190252 *** * 23.6924 * * 23.6924
190253 *** * 22.8060 23.8037 22.2212 23.0780
190254 *** * 32.9290 * * 32.9290
190255 0.7692 0.8438 22.2412 16.1593 23.8013 20.1015
190256 0.8038 0.9140 * 25.9577 25.9352 25.9454
190257 1.6689 0.7785 * 26.5505 22.7493 24.6724
190258 *** * 31.3715 26.1141 25.1970 27.3097
190259 2.0814 0.8438 * 26.5084 27.5500 27.0088
190260 *** * * 29.3947 33.6205 31.1711
190261 1.3897 0.7961 * 27.0441 25.4725 26.2680
190262 *** * * 30.3719 * 30.3719
190263 2.3211 0.8438 * 26.4202 29.7034 28.0032
190264 *** * * 26.5842 * 26.5842
190265 *** * * 22.6231 30.9242 27.1318
190266 2.3213 0.8142 * * 24.3790 24.3790
190267 1.3728 0.9140 * * 24.2777 24.2777
190268 1.6840 0.8438 * * 29.1407 29.1407
190270 1.8665 0.9140 * * * *
190272 1.2748 0.8438 * * 28.4541 28.4541
190273 1.7599 0.8142 * * * *
190274 1.6077 0.9140 * * * *
190275 1.3329 0.9140 * * * *
190276 0.8985 0.8547 * * * *
190277 0.8585 0.8069 * * * *
200001 1.3378 1.0115 25.2542 26.3045 28.1124 26.5658
200002 1.1591 0.8609 25.7212 27.1151 33.2665 28.3561
200008 1.3906 0.9927 27.7137 29.1836 29.3519 28.7769
200009 1.9207 0.9927 30.7510 32.5812 35.0717 32.7319
200018 1.3207 0.8609 23.5632 22.5027 24.6780 23.5929
200019 1.2779 0.9927 25.6649 27.7896 28.3393 27.2843
200020 1.3255 1.0007 32.6436 34.0916 34.5740 33.7902
200021 1.2204 0.9927 27.1381 29.2054 28.7597 28.4046
200024 1.6748 0.9644 27.5410 29.7817 30.9932 29.4721
200025 1.1710 0.9927 26.3124 28.5750 29.3588 28.1289
200031 1.3018 0.8609 21.2370 22.2151 23.7539 22.4062
200032 1.1782 0.9075 26.3322 26.8993 27.2259 26.8277
200033 1.8241 1.0115 29.3108 31.7007 33.6270 31.6171
200034 1.3255 0.9644 27.0582 27.0103 28.0397 27.3625
200037 1.1982 0.8609 24.1732 24.9418 26.7798 25.3841
200039 1.2970 0.9644 25.1179 26.6409 28.8029 26.8816
200040 1.2039 0.9927 25.9893 27.8053 25.5506 26.3685
200041 1.2079 0.8609 24.9670 26.6777 27.5049 26.3961
200050 1.2398 1.0115 27.6825 29.5033 30.1456 29.1592
200052 1.1153 0.8609 22.5159 24.4204 25.6220 24.1936
200063 1.1834 0.8609 25.8623 27.9748 28.2184 27.3991
210001 1.3549 0.9460 28.2858 29.3471 31.2328 29.6476
210002 1.9987 0.9981 32.3005 33.7388 36.0222 34.1104
210003 1.6222 1.0670 34.1109 30.7334 28.2547 30.8148
210004 1.4250 1.1018 33.6056 31.7132 33.9015 33.0686
210005 1.2610 1.1018 28.9554 29.5835 32.4052 30.3394
210006 1.0725 0.9981 25.9005 27.3620 27.9844 27.0796
210007 1.7994 0.9981 31.8767 30.7124 31.4098 31.3077
210008 1.4105 0.9981 24.3341 28.8850 31.8512 28.2947
210009 1.6490 0.9981 27.7900 30.2661 31.8249 29.9840
210011 1.3847 0.9981 30.8575 31.0966 30.7517 30.9025
210012 1.5973 0.9981 30.3078 31.1778 32.5280 31.3781
210013 1.1768 0.9981 28.5328 28.9917 32.1151 29.7726
210015 1.2997 0.9981 29.9261 32.2774 31.6875 31.3239
210016 1.6120 1.1018 32.3506 33.5493 35.3218 33.6933
210017 1.2904 0.8795 25.1890 26.8592 26.6187 26.2235
210018 1.2011 1.1018 29.5533 29.6521 31.5431 30.2539
210019 1.7205 0.9194 27.3731 28.7844 30.5458 28.9499
210022 1.4645 1.1018 35.4727 37.3092 36.1806 36.3038
210023 1.4878 1.0060 32.1812 33.0212 34.1635 33.1583
210024 1.8236 0.9981 30.6359 32.9434 34.5523 32.7596
210025 1.2388 0.8795 23.8552 24.8570 23.5138 24.0665
210027 1.4130 0.8795 24.6343 24.4821 25.2106 24.7916
210028 1.0692 0.9307 26.3469 26.7462 28.5196 27.2373
210029 1.2751 0.9981 31.0266 31.8539 32.9078 31.9592
210030 1.1883 0.8795 26.9763 32.2033 29.1777 29.4507
210032 1.1828 1.0645 27.0727 27.9359 29.2770 28.1114
210033 1.1640 0.9981 28.5534 29.2504 28.4332 28.7353
210034 1.2631 0.9981 30.2908 32.3827 33.0382 31.9423
210035 1.3018 1.0670 28.6484 27.3901 30.6664 28.8614
210037 1.2037 0.8795 27.3287 27.8394 28.8691 28.0163
210038 1.1889 0.9981 29.8121 32.3206 31.1537 31.0730
210039 1.1193 1.0670 30.4991 32.4139 35.1146 32.6902
210040 1.2216 0.9981 28.3559 29.2390 31.0827 29.5738
210043 1.3058 1.0060 26.6524 32.6961 29.2744 29.4113
210044 1.3653 0.9981 29.7339 30.3349 31.5436 30.5467
210045 0.9952 0.9194 14.2223 16.3724 19.6097 16.8133
210048 1.3768 0.9981 27.5043 26.0650 29.2439 27.5592
210049 1.2275 0.9981 26.0900 27.0161 28.5947 27.3346
210051 1.2948 1.0670 29.8892 29.5219 30.7936 30.0807
210054 1.2558 1.0670 27.4328 27.7607 28.6884 27.9549
210055 1.2394 1.0670 30.6941 31.4905 30.1989 30.7527
210056 1.3104 0.9981 30.0810 32.3518 32.7755 31.8047
210057 1.3542 1.1018 31.6787 32.8299 33.7244 32.7501
210058 1.1208 0.9981 31.0873 31.1988 32.0642 31.4531
210060 1.2448 1.0670 27.1764 29.9626 32.5116 29.9224
210061 1.2566 0.8983 23.1645 25.0253 26.6822 25.0230
220001 1.2273 1.1338 30.6070 31.2316 32.0820 31.3057
220002 1.3729 1.1338 32.4356 33.6649 35.9738 34.0706
220006 *** * 30.7673 33.6438 * 32.1319
220008 1.2887 1.1338 31.3385 34.7924 35.8651 34.0329
220010 1.2326 1.1338 30.7804 32.0925 33.7364 32.2148
220011 1.1369 1.1338 34.7655 36.5640 39.1211 36.8964
220012 1.4655 1.2672 37.8763 39.7564 41.7040 39.8247
220015 1.2984 1.0343 29.6315 32.4903 35.2353 32.4365
220016 1.1282 1.0343 30.4813 32.5863 33.1404 32.0656
220017 1.3194 1.1994 31.6170 33.3020 34.6550 33.1982
220019 1.0429 1.1338 24.4009 25.7855 26.3006 25.5037
220020 1.1312 1.1338 28.5288 30.8458 32.1503 30.5508
220024 1.2349 1.0343 28.7342 31.9491 32.8073 31.1791
220025 1.0377 1.1338 25.6478 30.4369 27.6958 27.7639
220028 *** * 31.7122 39.3089 * 35.2808
220029 1.1472 1.1338 30.6935 31.6363 32.6767 31.6963
220030 1.1059 1.0343 26.8849 28.1347 29.3701 28.1501
220031 1.5532 1.1994 36.8477 38.9433 39.4182 38.4392
220033 1.1976 1.1338 31.8249 32.3495 34.6977 33.0203
220035 1.4173 1.1338 31.4470 34.8739 36.1775 35.0964
220036 1.5119 1.1994 33.1436 35.9124 37.7268 35.6257
220046 1.4449 1.0445 30.4460 31.4510 33.8585 31.9500
220049 1.2309 1.1338 30.4740 32.4652 35.1108 32.7132
220050 1.0897 1.0343 28.3434 29.5194 30.3160 29.4110
220051 1.3081 1.0199 30.2552 30.1022 32.8672 31.0914
220052 1.1432 1.1994 32.4130 32.3532 34.9126 33.2019
220058 1.0116 1.1338 25.7247 27.8893 30.0325 27.9127
220060 1.1603 1.1994 32.5477 34.7336 36.8641 34.7665
220062 0.6341 1.1338 25.0766 25.4224 27.3304 25.9567
220063 1.2647 1.1338 30.2866 32.9283 32.2417 31.8295
220065 1.2613 1.0343 27.6009 30.1103 32.3793 30.0468
220066 1.3284 1.0343 27.8073 29.9736 * 28.8792
220067 1.2302 1.1994 30.2222 32.4019 33.9807 32.2180
220070 1.1429 1.1338 33.1299 34.2598 35.6244 34.3611
220071 1.8365 1.1994 36.5065 37.4087 40.0281 38.0115
220073 1.1896 1.1338 34.2989 36.0289 37.4224 35.9320
2200744 1.3507 1.1338 30.5607 31.4730 33.2051 31.7041
220B744 *** * * 31.4731 33.2051 32.3862
220075 1.5438 1.1994 30.9175 32.2957 33.3538 32.1942
220076 *** * 27.5148 * * 27.5148
220077 1.6655 1.0972 31.7325 34.0168 33.7563 33.1765
220080 1.1645 1.1338 29.9595 31.1268 33.1617 31.3799
220082 1.2899 1.1338 30.0611 30.8230 32.2105 31.0609
220083 1.0693 1.1994 34.5118 34.5969 35.2728 34.8205
220084 1.2134 1.1338 30.9527 31.6955 34.6254 32.3748
220086 1.7222 1.1994 34.2388 35.3451 36.2359 35.3173
220088 1.9446 1.1994 35.8255 34.7637 37.0808 35.9288
220089 *** * 32.6305 34.8205 * 33.7125
220090 1.2394 1.1338 32.9011 34.1963 35.8940 34.3697
220095 1.1576 1.1338 28.0673 30.8626 31.1619 30.0333
220098 1.1400 1.1338 30.5869 31.5403 30.6593 30.9378
220100 1.3072 1.1994 31.9859 34.6599 35.7276 34.1807
220101 1.2971 1.1338 35.3464 37.7809 36.0984 36.4336
220105 1.1814 1.1338 33.2625 34.4029 35.8155 34.5228
220108 1.1999 1.1994 32.6131 33.8854 35.6985 34.0752
220110 2.0011 1.1994 39.2167 40.7382 43.8401 41.3123
220111 1.2206 1.1994 33.6167 34.2498 35.6193 34.5167
220116 1.8714 1.1994 36.4149 38.8799 40.0952 38.4127
220119 1.1333 1.1994 30.9965 32.0863 33.7174 32.3365
220126 1.1806 1.1994 31.4882 32.6938 35.6250 33.2716
220133 *** * 29.4855 34.9182 * 32.1170
220135 1.3038 1.2672 36.0203 37.5189 38.7180 37.4435
220153 *** * * 19.8085 17.9600 18.7803
220154 *** * * 28.7898 * 28.7898
220162 1.5970 * * * * *
220163 1.6172 1.1338 34.4874 37.4968 39.4859 37.2285
220171 1.6935 1.1338 32.7414 35.9948 36.4545 35.0735
220174 1.1926 1.1338 30.0406 30.9503 32.9113 31.3266
220175 1.2681 * * * 34.1550 34.1550
220176 1.6474 1.1338 * * 31.4195 31.4195
230002 1.3237 1.0113 32.9010 32.7578 33.9675 33.2532
230003 1.2416 0.9455 27.5824 28.4716 28.9871 28.3360
230004 1.7110 1.0227 29.3934 31.5136 33.4620 31.5262
230005 1.2402 0.9337 25.8768 27.7463 29.0625 27.5854
230013 1.3836 1.0052 24.6511 27.2075 28.6417 26.7586
230015 1.1593 0.9159 26.2782 27.2541 28.9588 27.5253
230017 1.6518 1.0910 31.8821 32.5396 36.8018 33.8177
230019 1.6077 1.0052 32.3401 34.3213 35.1415 33.9317
230020 1.7476 1.0113 28.5646 29.5324 29.9072 29.3527
230021 1.5495 1.0365 26.5659 28.6169 29.5397 28.2368
230022 1.2686 0.9652 25.6683 30.1195 25.7829 27.0325
230024 1.6538 1.0113 32.1483 32.5892 34.5253 33.1061
230029 1.6160 1.0052 32.3538 32.3845 33.1460 32.6277
230030 1.2847 0.8864 23.8082 25.1100 24.9719 24.6466
230031 1.3571 0.9972 29.7232 30.0120 30.8859 30.2337
230034 1.3764 0.8864 24.4845 24.4141 29.1079 25.8635
230035 1.1994 0.9305 24.8822 25.6715 25.7083 25.4572
230036 1.4140 0.9472 29.3754 29.9642 31.0922 30.1636
230037 1.3059 1.0113 28.9244 28.5311 28.8529 28.7691
230038 1.7649 0.9455 28.2012 29.1263 30.1019 29.1994
230040 1.1794 0.9305 25.5154 26.3190 27.2835 26.3819
230041 1.5803 0.9472 27.8853 27.9569 30.3060 28.7057
230046 1.9162 1.0444 31.6235 32.2924 33.5285 32.5197
230047 1.4494 1.0052 31.1771 31.7075 32.0225 31.6475
230053 1.6700 1.0113 32.5711 32.1566 33.5420 32.7704
230054 1.8803 0.9412 25.7591 26.3251 28.1223 26.7475
230055 1.2587 0.8864 27.4349 28.4787 28.1872 28.0393
230058 1.1167 0.8864 25.9291 27.3156 27.9625 27.0813
230059 1.5346 0.9455 27.9091 28.5875 28.3586 28.2947
230060 1.2934 0.8864 28.2874 27.0288 28.7744 28.0391
230065 *** * 32.6255 * * 32.6255
230066 1.3058 1.0227 30.6184 30.2104 32.3459 31.0702
230069 1.1826 1.0810 30.2663 31.3406 31.9653 31.2223
230070 1.6502 0.9034 25.6778 26.8315 28.0349 26.8663
230071 0.9448 1.0052 28.3064 29.6728 28.2055 28.7253
230072 1.3622 0.9455 26.2838 27.4742 28.8006 27.5408
230075 1.3557 1.0086 28.2540 30.9525 32.1146 30.4322
230077 1.8799 1.0810 29.8538 30.5567 31.0097 30.4726
230078 1.1903 0.8864 25.6809 25.7232 27.0050 26.0991
230080 1.2607 0.9472 24.1573 24.5432 25.6193 24.7905
230081 1.2326 0.8864 24.7374 26.4337 27.8091 26.3288
230085 1.2326 1.0910 23.4959 25.4289 27.6459 25.5347
230089 1.3435 1.0113 31.0522 32.8450 32.2293 31.9436
230092 1.3964 1.0113 28.6829 29.3442 30.5399 29.5449
230093 1.2159 0.8922 25.5804 27.4463 27.0555 26.7238
230095 1.2754 0.9472 22.8681 25.1854 25.9196 24.6699
230096 1.1779 1.0365 30.6024 31.7399 27.7873 29.8976
230097 1.6913 0.9305 28.2526 29.8962 31.5152 29.8782
230099 1.2173 1.0113 29.0221 29.3720 28.7386 29.0351
230100 1.1914 0.8864 24.1881 25.2118 25.6583 25.0492
230101 1.1683 0.8864 25.4839 28.4372 28.8595 27.6204
2301045 1.5934 1.0113 32.4634 32.4125 34.0171 32.9570
230B045 *** * * * 34.0171 34.0171
230105 1.7842 0.9472 32.4583 30.5515 32.1103 31.7057
230106 1.2381 0.9455 25.3243 27.8584 30.0195 27.7687
230108 1.1549 0.8864 20.2539 24.4337 25.7463 23.4436
230110 1.2539 0.8864 27.0040 25.7196 27.0263 26.5809
230117 1.8415 1.0910 32.7994 33.0602 33.9148 33.2761
230118 1.0095 0.8864 23.6110 24.8890 24.8631 24.4400
230119 1.4381 1.0113 30.7488 31.9696 33.2026 32.0127
230121 1.2621 0.9652 26.4940 26.8361 27.7495 27.0478
230130 1.6817 1.0052 30.1608 31.2744 32.5589 31.3612
230132 1.5413 1.1258 32.3939 35.5304 38.2428 35.3551
230133 1.4288 0.8864 23.9442 25.0647 25.8516 24.9772
230135 1.3171 1.0113 25.9583 23.6005 31.5185 26.7530
230141 1.6173 1.1258 31.6152 33.2553 36.3094 33.7170
230142 1.2688 1.0113 27.8377 29.7417 29.9882 29.2232
230144 1.8275 1.0444 * * * *
230146 1.3735 1.0113 26.8156 27.2621 29.0197 27.7279
230151 1.3314 1.0052 27.4546 29.8366 28.6704 28.6311
230156 1.5950 1.0444 32.3755 33.9034 34.7840 33.7042
230165 1.5974 1.0113 29.6376 31.4242 32.2831 31.1343
230167 1.6088 0.9899 29.8071 31.0657 32.8063 31.2488
230174 1.3451 0.9455 30.0563 29.7488 31.2452 30.3405
230176 1.3115 1.0113 28.1498 28.9798 29.2664 28.8186
230180 1.1167 0.8864 26.0707 24.9696 24.6000 25.1971
230184 *** * 34.6295 * * 34.6295
230190 *** * 30.7875 33.8229 33.6707 32.7904
230193 1.3561 0.9972 25.1626 26.4728 28.4624 26.7218
230195 1.4319 1.0052 29.5656 30.9702 32.5528 31.0477
230197 1.6021 1.1258 32.0063 33.7128 34.8039 33.5209
230204 1.4349 1.0052 31.5615 32.2882 30.1956 31.3391
230207 1.2451 1.0052 25.4268 25.1983 26.8215 25.8117
230208 1.2210 0.9305 23.7523 24.3476 25.2472 24.4569
230212 1.0426 1.0444 31.9818 32.8567 33.4362 32.7601
230216 1.4778 0.9972 29.0147 29.2061 28.9567 29.0586
230217 1.4015 1.0086 30.1136 31.9732 33.0815 31.7828
230222 1.4250 0.9472 29.9341 30.6482 32.4389 30.9827
230223 1.3052 1.0052 28.6745 29.8430 31.9496 30.1361
230227 1.4799 1.0052 30.8218 33.6716 34.2728 32.7518
230230 1.4804 0.9899 29.8763 31.1712 31.4931 30.8595
230236 1.5428 0.9455 31.3110 30.8556 31.9088 31.3744
230239 1.3021 0.8864 21.0814 22.1579 23.5448 22.2557
230241 1.1943 0.9972 27.6106 28.5516 30.0233 28.7406
230244 1.4607 1.0113 29.6283 30.0405 32.1407 30.6177
230254 1.4847 1.0052 29.2653 29.5874 31.2379 30.0646
230257 0.9794 1.0052 29.6712 30.6372 30.0667 30.1067
230259 1.2691 1.0444 27.4217 27.5982 27.9557 27.6540
230264 2.0641 1.0052 22.7768 28.5416 29.2178 26.4132
230269 1.4701 1.0052 31.3226 31.3800 34.2667 32.3991
230270 1.3480 1.0113 28.5372 28.8173 29.2388 28.8712
230273 1.4692 1.0113 31.9862 31.5396 32.5706 32.0372
230275 0.5428 0.9034 23.8104 25.2133 22.3717 23.7470
230277 1.4612 1.0052 29.8372 31.4023 32.2518 31.1889
230279 0.5480 1.0810 27.2816 27.9726 26.8539 27.3521
230283 *** * 33.5531 * * 33.5531
230294 *** * 31.6195 * * 31.6195
230295 *** * 27.1298 * * 27.1298
230296 *** * * 34.2107 * 34.2107
230297 1.6971 1.0052 * * * *
230298 0.7864 1.0052 * * * *
230300 3.3739 1.0052 * * * *
230301 1.0374 1.0052 * * * *
240001 1.5531 1.0997 33.1499 34.7673 37.2179 35.0462
240002 1.8744 1.0519 31.6000 33.1051 34.6345 33.1529
240004 1.5878 1.0997 32.7010 32.5777 33.5085 32.9298
240006 1.2147 1.0982 31.0777 33.4777 32.8229 32.4953
240010 1.9657 1.0982 33.4668 32.7261 35.9102 34.0521
240014 1.0726 1.0997 29.8905 30.7519 33.4476 31.3959
240017 *** * 24.3596 * * 24.3596
240018 1.2598 0.9925 28.1432 29.4995 30.5632 29.4372
240019 1.0353 1.0519 33.7546 32.7052 34.2538 33.5836
240020 1.1144 1.0997 31.3874 33.2449 34.5686 33.0762
240022 1.0632 0.9120 26.1920 27.3137 28.5889 27.3645
240030 1.3950 1.0638 26.5508 27.1312 27.6584 27.1136
240036 1.6415 1.0997 32.7028 34.2980 37.2177 34.8308
240038 1.4964 1.0997 31.9891 33.0554 34.7330 33.2508
240040 1.0575 1.0519 27.5074 28.9009 30.0238 28.8059
240043 1.2453 0.9120 23.3489 24.0708 25.7420 24.4201
240044 1.0841 0.9745 25.0988 26.8681 28.5689 26.7906
240047 1.5230 1.0519 28.6406 29.7835 35.6742 31.1184
240050 1.0910 1.0997 27.5553 30.9805 33.7946 30.9171
240052 1.2031 0.9120 28.7206 29.4617 31.0917 29.7873
240053 1.5039 1.0997 31.4324 33.1148 34.4186 33.0264
240056 1.3585 1.0997 33.1728 34.0845 35.8580 34.4096
240057 1.7902 1.0997 30.7703 33.4713 34.8349 33.0717
240059 1.0937 1.0997 31.0911 32.4803 32.5938 32.0866
240061 1.8510 1.0982 33.1799 32.0828 34.6008 33.3406
240063 1.5799 1.0997 33.7895 35.2877 36.9798 35.4057
240064 1.1730 1.0401 34.3757 27.2407 29.9902 30.4614
240066 1.5245 1.0997 35.3441 36.0705 39.6582 37.0745
240069 1.1972 1.0997 29.3718 30.9719 31.1660 30.5144
240071 1.1037 1.0997 28.6950 31.7754 32.5442 30.9915
240075 1.1903 1.0638 27.5039 29.1171 30.3218 29.0129
240076 1.0213 1.0997 30.6936 33.1439 33.7939 32.5944
240078 1.6519 1.0997 32.5785 34.6118 36.1976 34.5440
240080 1.9537 1.0997 32.5725 34.8064 36.5363 34.6282
240084 1.1356 1.0519 26.5975 27.0995 29.0260 27.5332
240088 1.2998 1.0638 28.0603 29.1387 30.7223 29.3333
240093 1.4599 1.0997 27.2928 29.1717 30.4718 29.0677
240100 1.3409 0.9120 30.8391 31.5774 30.9460 31.1194
240101 1.1984 0.9120 25.6963 26.8849 28.5492 27.1176
240104 1.2063 1.0997 31.6511 35.0736 35.8816 34.3219
240106 1.6106 1.0997 30.5927 32.8156 33.9953 32.4894
240115 1.4822 1.0997 32.0107 33.5288 36.2755 33.9354
240117 1.1647 0.9647 24.5750 27.6950 29.0889 27.1230
240128 *** * 23.3334 * * 23.3334
240132 1.2651 1.0997 32.1233 34.6191 36.4224 34.2571
240141 1.1039 1.0997 31.4468 32.8689 34.2453 32.8961
240166 1.1593 0.9120 27.6987 26.5328 26.1726 26.6670
240187 1.2972 1.0997 27.8844 29.1582 30.9633 29.4012
240196 0.8466 1.0997 31.5965 34.3743 35.0319 33.6757
240206 0.9236 1.4448 * * * *
240207 1.2383 1.0997 32.5589 34.6792 36.4537 34.6384
240210 1.2823 1.0997 32.7123 34.4184 36.5922 34.6233
240211 1.0511 0.9932 22.5430 17.4044 16.6144 18.6322
240213 1.4161 1.0997 33.8680 35.7818 37.4575 35.7765
250001 1.9650 0.8095 23.5222 23.7773 24.3386 23.8768
250002 0.9549 0.7883 23.4063 25.4201 25.0335 24.6387
250004 1.7720 0.8909 24.7907 25.8722 24.8072 25.1647
250006 1.1563 0.8909 24.4282 25.9199 27.0493 25.8303
250007 1.2323 0.8898 24.8929 27.7665 29.3457 27.3747
250009 1.2588 0.8361 23.0352 23.4866 24.9100 23.8155
250010 1.0456 0.7653 21.4322 21.8665 22.7976 22.0351
250012 0.9464 0.9329 21.5540 23.4837 26.4108 23.6996
250015 1.1829 0.7653 22.0067 22.2803 22.3674 22.2133
250017 1.0987 0.7653 22.7660 33.6840 25.7397 26.7933
250018 0.8867 0.7653 17.1276 17.9025 19.1099 18.0552
250019 1.5607 0.8898 25.7376 26.2199 27.7207 26.5559
250020 1.0028 0.7653 22.1851 23.7245 23.1510 23.0478
250023 0.8728 0.8156 18.0108 18.5067 19.5072 18.7146
250025 1.1390 0.7653 22.5621 23.1738 23.0544 22.9290
250027 0.9541 0.7653 24.4937 26.9922 32.5430 27.8433
250031 1.3451 0.8095 24.8139 25.9189 26.7496 25.8093
250034 1.5368 0.8909 26.1887 26.7996 27.9267 26.9950
250035 0.8649 0.7653 20.1622 19.1038 20.5237 19.9107
250036 1.0485 0.8030 20.3625 19.7951 22.5661 20.8304
250038 0.9523 0.8095 22.2571 26.9621 30.7941 25.9485
250040 1.4898 0.8156 24.5962 27.3366 26.2250 26.0460
250042 1.2547 0.8909 25.6807 26.1190 27.4593 26.4125
250043 0.9847 0.7653 18.8979 20.8841 21.1254 20.3156
250044 1.0363 0.7883 24.0508 24.9199 26.1725 25.0759
250048 1.6491 0.8095 25.2092 24.7659 27.6318 25.8347
250049 0.8715 0.7653 19.1044 20.4775 24.2222 21.0940
250050 1.3084 0.7653 20.8084 21.1657 22.4407 21.4799
250051 0.8661 0.7653 14.3741 13.9532 14.1652 14.1687
250057 1.1739 0.7653 22.7601 24.3654 22.9665 23.3314
250058 1.2366 0.7653 19.2502 18.9970 19.6711 19.3080
250059 0.9358 0.7653 23.8997 26.7491 25.5976 25.3587
250060 0.8110 0.7653 28.1431 25.4779 27.0347 26.8919
250061 0.8867 0.7653 17.8267 18.7413 25.1493 20.4689
250067 1.0949 0.7653 23.1193 25.2189 23.8020 24.0644
250069 1.4416 0.8280 22.6353 22.4194 23.4494 22.8355
250072 1.6783 0.8095 25.8399 25.5337 27.5770 26.3178
250077 0.9717 0.7653 18.3735 19.0416 19.6329 19.0451
250078 1.5855 0.8156 22.1243 22.8430 23.9580 22.9829
250079 0.8932 0.7653 45.5166 43.0845 46.0338 44.8458
250081 1.3682 0.8280 23.9995 25.6808 24.8259 24.8305
250082 1.4127 0.8150 23.0287 23.5399 25.6206 24.1469
250084 1.2526 0.7653 19.6492 19.1604 19.5676 19.4638
250085 1.0182 0.7653 22.5513 24.2915 24.6743 23.8551
250093 1.1850 0.7653 23.0984 23.9128 26.4337 24.4984
250094 1.6982 0.8156 24.1422 24.7718 25.4215 24.7893
250095 1.0314 0.7653 21.7488 23.6140 25.9001 23.7842
250096 1.2042 0.8095 24.9187 26.3743 27.7270 26.3759
250097 1.4899 0.8146 21.8139 22.0211 22.7899 22.2472
250099 1.2725 0.8095 21.1269 21.5656 27.5739 23.2182
250100 1.5271 0.8280 25.6846 27.0286 27.5468 26.7620
250102 1.5947 0.8095 24.6652 25.4050 25.5308 25.2035
250104 1.4396 0.8280 23.4303 24.4311 25.3986 24.4448
250112 0.9616 0.7653 24.3069 26.3357 27.4138 26.0536
250117 1.1581 0.8156 22.2450 23.7337 24.5692 23.5009
250120 *** * 24.6370 26.6522 * 25.6905
250122 1.1272 0.7653 27.2795 27.4424 23.4884 26.0511
250123 1.3504 0.8898 26.6221 27.9058 29.8280 28.1116
250124 0.8367 0.8095 20.4394 20.5667 21.9411 20.9862
250125 1.3788 0.8898 27.5158 26.7687 32.7395 28.5834
250126 1.0192 0.9329 24.4126 25.0019 25.2582 24.9087
250127 0.8041 1.4448 * * * *
250128 0.9631 0.8099 17.7624 21.7882 23.5915 21.3639
250134 0.9291 0.8095 22.2167 21.0211 22.0830 21.7636
250136 1.0279 0.8095 22.9468 25.2241 27.1454 25.0260
250138 1.3091 0.8095 24.3018 25.2642 27.3114 25.5721
250141 1.4795 0.9329 28.5922 30.5112 33.4397 31.0006
250149 0.8769 0.7653 16.8796 17.2268 17.0956 17.0712
250151 0.5535 0.7653 18.8846 22.8238 * 19.4286
250152 0.8224 0.8095 26.9334 26.4559 28.5527 27.2309
250155 *** * 22.5728 * * 22.5728
250156 *** * * 16.8659 * 16.8659
250157 *** * * 29.6398 * 29.6398
250162 1.0520 0.8912 * * * *
260001 1.6886 0.9704 27.9230 29.5271 31.1839 29.5270
260004 0.9098 0.8470 20.3217 21.3629 24.1888 22.1072
260005 1.5296 0.8986 27.7855 27.9477 31.1215 28.9388
260006 1.4493 0.8470 30.3440 27.3754 33.7767 30.5981
260009 1.2153 0.9444 24.2360 25.7546 26.6670 25.5689
260011 1.5894 0.9038 25.6387 27.5762 31.2590 28.1581
260015 1.0293 0.8470 24.6139 25.0640 25.0244 24.8950
260017 1.3008 0.8736 23.5713 25.0461 26.2612 24.9757
260020 1.7335 0.8986 27.4730 29.3080 30.9576 29.2687
260021 1.3073 0.8986 29.3646 32.6735 19.4693 25.9620
260022 1.3246 0.8738 23.3393 24.8713 25.9379 24.7192
260023 1.3719 0.8986 24.3192 25.4314 25.5884 25.1233
260024 1.1889 0.8470 19.4952 19.2199 20.7131 19.8199
260025 1.3981 0.8986 22.2451 24.0358 24.5032 23.6143
260027 1.6154 0.9444 26.3590 29.3811 31.0217 28.7832
260032 1.8506 0.8986 25.6763 27.4857 28.7163 27.3241
260034 1.0142 0.9444 25.0573 27.1685 28.7725 27.0780
260040 1.7140 0.8470 24.3938 25.9074 27.2449 25.8128
260047 1.4348 0.8470 25.4978 26.6343 27.2646 26.4797
260048 1.1808 0.9444 27.6117 28.1515 29.6955 28.5297
260050 1.1398 1.0267 25.0506 26.2346 27.8050 26.4419
260052 1.3065 0.8986 26.0052 27.6360 29.6982 27.7827
260057 1.0872 0.9444 20.9639 21.5925 23.8167 22.1481
260059 1.2943 0.8547 22.6922 22.3885 24.9630 23.3714
260061 1.1720 0.8470 22.4766 22.8589 23.6708 22.9805
260062 1.2709 0.9444 28.1661 28.4975 29.6135 28.7754
260064 1.3641 0.8470 22.2395 23.3498 21.4934 22.3902
260065 1.7935 0.8470 27.1014 29.3564 27.9224 28.1492
260068 1.7301 0.8470 26.0295 27.3475 28.1227 27.1642
260070 0.9682 0.8470 24.6331 21.9701 25.2991 24.0399
260074 1.2162 0.8470 25.6218 28.0468 28.6203 27.4572
260077 1.6229 0.8986 26.7466 27.6624 28.7183 27.7262
260078 1.2711 0.8470 20.1983 21.1539 23.1780 21.5534
260080 1.0066 0.8470 17.9107 18.6070 18.6804 18.3878
260081 1.4925 0.8986 28.1182 29.1890 32.3581 29.9070
260085 1.5513 0.9444 26.6718 28.0306 29.6492 28.1046
260091 1.4867 0.8986 28.0537 28.5473 30.1154 28.9182
260094 1.6133 0.8470 24.1473 23.8654 25.1476 24.3842
260095 1.3868 0.9444 24.2698 27.6196 29.9069 27.0422
260096 1.5240 0.9444 29.7312 30.7267 32.9353 31.1666
260097 1.1896 0.8770 25.0624 25.5634 27.3117 26.0306
260102 0.9841 0.9444 27.2145 26.7624 30.7667 28.2426
260104 1.5825 0.8986 28.6247 28.0235 29.6366 28.7794
260105 1.8539 0.8986 29.8848 29.4766 32.4075 30.5702
260107 *** * 25.8177 27.9710 29.7754 27.7676
260108 1.8291 0.8986 26.6374 27.0758 28.5633 27.4377
260110 1.6476 0.8470 24.7656 26.6030 28.0368 26.5197
260113 1.1410 0.8470 21.2072 21.8884 23.0810 22.0233
260115 1.2609 0.8986 23.1396 24.6389 25.5643 24.4735
260116 1.0435 0.8470 21.3503 20.7479 22.5593 21.5340
260119 1.2922 0.8470 27.9769 31.5490 31.4981 30.2546
260137 1.7457 0.9704 24.3273 27.6592 31.4059 27.8364
260138 1.8944 0.9444 30.4410 30.6284 31.7554 30.9538
260141 1.8592 0.8470 24.1555 25.5663 26.6672 25.5210
260142 1.0838 0.8470 21.5923 21.7609 22.8201 22.0857
260147 0.9526 0.8470 21.4235 22.1928 22.9670 22.1968
260159 *** * 22.6276 23.9515 24.3018 23.5847
260160 1.0612 0.8470 23.8257 25.5096 26.6702 25.4076
260162 1.4383 0.8986 27.0236 28.4660 30.5739 28.7100
260163 1.2130 0.8557 21.6408 21.5566 23.8630 22.3617
260166 1.2356 0.9444 29.1225 28.5858 29.5234 29.0824
260175 1.1172 0.9444 25.1817 24.6064 25.7060 25.1720
260176 1.7557 0.8986 29.3034 31.1056 30.6112 30.3581
260177 1.2272 0.9444 27.0185 28.7942 29.0786 28.3077
260178 1.9689 0.8470 25.4782 27.1201 26.9886 26.5981
260179 1.5286 0.8986 26.6069 28.3234 29.6937 28.2012
260180 1.5853 0.8986 28.2931 29.3820 30.7313 29.4593
260183 1.6733 0.8986 27.5577 29.2684 31.4894 29.4549
260186 1.4640 0.8470 26.9797 28.8610 29.1853 28.3616
260190 1.2175 0.9444 27.9137 30.5343 30.8981 29.7909
260191 1.4412 0.8986 24.6973 26.3244 27.8627 26.3553
260193 1.2305 0.9444 26.8922 28.1060 29.5416 28.1851
260195 1.2498 0.8470 22.6870 24.0411 25.0275 23.9191
260198 *** * 28.0021 27.2555 27.9073 27.7138
260200 1.2908 0.8986 28.2453 27.4784 30.3290 28.7369
260207 1.1540 0.8470 22.6109 22.9579 23.6383 23.1705
260209 1.1532 0.9038 25.0098 25.0749 26.4196 25.5826
260210 1.3929 0.8986 26.8745 30.5975 36.4040 30.6935
260211 1.4262 0.9444 40.9821 35.9113 37.1525 38.3586
260213 *** * * 34.8953 * 34.8953
260214 1.2306 0.9444 * * 31.0153 31.0153
260216 1.3065 0.9444 * * * *
260218 0.8126 * * * * *
260219 1.3191 0.8986 * * * *
260220 2.3259 * * * * *
270002 1.1469 0.8640 24.0534 25.2907 28.3363 25.9060
270003 1.2563 0.8679 28.8700 29.1938 28.0533 28.6560
270004 1.6239 0.9045 26.1319 26.6779 28.5851 27.1552
270011 1.0779 * 22.7061 24.4696 * 23.5588
270012 1.5992 0.8679 25.2914 26.5854 28.0655 26.6761
270014 1.8067 0.8992 25.8231 27.4811 28.2567 27.1793
270017 1.3001 0.8909 26.5404 27.4150 29.3524 27.7689
270023 1.5599 0.8909 25.5682 26.3076 28.1878 26.6584
270032 1.0422 0.8640 20.3469 20.4330 21.6349 20.8153
270049 1.7681 0.9045 27.1634 28.6880 29.8869 28.6461
270051 1.5064 0.8909 26.5621 24.9371 29.3917 26.9486
270057 1.2964 0.8640 25.5811 27.1838 28.3612 27.1309
270074 0.8884 1.4448 * * * *
270081 1.0022 * 19.5612 20.0438 * 19.8033
270086 1.2443 0.8679 21.0808 20.7976 21.8997 21.2340
270087 1.3324 0.8640 25.9772 24.8022 24.9177 25.2095
280003 1.7687 0.9620 30.6124 30.1057 32.3760 30.9970
280009 1.8349 0.9336 27.0705 29.3634 28.1542 28.1942
280013 1.7183 0.9400 27.0250 27.9523 30.3102 28.4716
280020 1.6559 0.9620 27.3284 32.3896 29.4807 29.7217
280023 1.3206 0.9336 26.7980 29.5132 30.0701 28.7818
280030 1.9392 0.9400 29.5102 30.6991 31.8740 30.6841
280032 1.2928 0.9336 24.3995 24.7539 25.6529 24.9364
280040 1.5775 0.9400 28.7207 29.5276 30.7378 29.6445
280060 1.6610 0.9400 27.7496 30.3049 30.8594 29.5587
280061 1.4476 0.9223 26.0208 26.4824 28.9580 27.1706
280065 1.2542 0.9611 28.0581 28.0132 29.5456 28.5374
280077 1.3602 0.8841 27.0860 28.2206 29.9204 28.4615
280081 1.6812 0.9400 28.7464 31.1212 28.9675 29.5979
280105 1.2560 0.9400 27.8599 29.8488 30.0457 29.2896
280111 1.1718 0.8761 24.5617 27.4853 28.3536 26.8743
280119 0.8951 1.4448 * * * *
280123 0.9698 0.8884 15.4047 22.2185 20.2745 18.6147
280125 1.5858 0.8761 22.1345 23.2900 24.7453 23.4399
280127 1.8312 0.9620 29.3684 25.6806 26.5628 26.9797
280128 2.7488 0.9620 28.5422 28.8734 27.1001 28.1534
280129 2.0416 0.9400 * 27.8793 27.9490 27.9189
280130 1.3820 0.9400 * 29.8588 29.9628 29.9161
290001 1.7753 1.0476 36.3129 35.5113 33.3287 34.9942
290002 0.8657 0.9837 17.3876 23.9348 22.7349 20.8853
290003 1.7934 1.1666 30.3373 32.8182 34.6402 32.6118
290005 1.4648 1.1666 28.3366 31.7107 34.2346 31.0980
290006 1.0851 1.0476 31.7301 31.9838 33.1563 32.3337
290007 1.7274 1.1666 38.1938 39.7323 41.2361 39.7802
290008 1.2072 0.9824 27.3019 31.1116 33.2436 30.5242
290009 1.6426 1.0476 36.2724 32.3348 34.0900 34.1940
290012 1.3313 1.1666 32.3966 35.7988 38.5049 35.5355
290019 1.4604 1.0476 29.3650 30.5964 32.2793 30.8005
290020 1.0227 0.9824 23.2103 27.6277 27.2889 25.9788
290021 1.6689 1.1666 32.7894 36.7310 36.8695 35.4886
290022 1.7132 1.1666 29.9717 33.5330 38.8235 33.9036
290027 0.8931 0.9824 23.9959 23.9818 29.1114 25.2225
290032 1.4391 1.0476 31.6711 34.6589 36.9148 34.3264
290039 1.5440 1.1666 32.1423 34.9622 34.6334 33.9791
290041 1.4922 1.1666 34.2436 37.6077 38.4409 36.9258
290042 *** * * 22.4859 * 22.4859
290044 *** * 37.1662 * * 37.1662
290045 1.6567 1.1666 33.1512 34.4584 38.3841 35.4482
290046 1.4029 1.1666 * 38.7966 38.3084 38.5269
290047 1.4035 1.1666 * 33.4695 35.6348 34.5601
290049 1.3302 1.0476 * 26.0725 33.4248 30.0551
290051 1.8934 1.0027 * * 32.5253 32.5253
290052 1.1590 0.9824 * * * *
290053 1.5711 1.1666 * * * *
300001 1.4434 1.0807 29.2260 29.8145 31.0102 30.0651
300003 2.0357 1.0807 34.7900 37.0886 37.7215 36.5476
300005 1.3788 1.0807 27.8000 27.8431 28.7980 28.1664
300011 1.3319 1.0807 30.9403 31.8928 33.0771 31.9916
300012 1.3235 1.0807 30.4972 31.2655 33.0547 31.6597
300014 1.2318 1.0807 29.7667 29.1847 30.7717 29.9265
300017 1.2863 1.0807 29.9560 31.6699 33.4139 31.6768
300018 1.3172 1.0807 29.4270 31.7891 31.5012 30.9778
300019 1.2444 1.0807 27.5672 28.2287 28.3103 28.0672
300020 1.1991 1.0807 30.8491 30.9783 32.4635 31.4527
300023 1.4459 1.0807 31.0040 31.2726 32.3183 31.5692
300029 1.8204 1.0807 29.8117 31.4429 32.0012 31.1343
300034 1.8504 1.0807 30.7676 31.6880 33.5519 32.0214
310001 1.7571 1.2878 41.7460 39.3391 41.4917 40.8275
310002 1.7914 1.2693 37.9183 37.8652 37.9453 37.9105
310003 1.1900 1.2878 36.2346 39.0785 40.1509 38.5759
310005 1.3414 1.1440 32.1319 33.6311 34.7634 33.5607
310006 1.4339 1.2878 28.4771 28.7321 30.4276 29.2523
310008 1.3390 1.2878 32.6788 33.3172 34.3243 33.4553
310009 1.3656 1.2693 33.6940 33.6165 35.4592 34.2954
310010 1.2858 1.1313 33.9552 33.7009 36.0797 34.6164
310011 1.2607 1.1599 31.2907 34.3497 37.4820 34.3008
310012 1.5959 1.2878 38.3590 39.8568 41.9596 40.0664
310013 *** * 31.0447 35.6260 32.9465 33.1378
310014 1.8164 1.1221 30.0793 32.9016 36.5996 33.3018
310015 1.9106 1.2693 36.8818 39.2928 40.8200 39.0289
310016 1.3313 1.2878 35.6155 38.2740 41.0326 38.2707
310017 1.3644 1.2693 32.2434 35.7308 35.9780 34.6067
310018 1.1472 1.2693 30.3234 32.9704 32.6937 31.9526
310019 1.5510 1.2878 30.3518 30.6369 31.8909 30.9689
310020 1.5807 1.2878 33.5516 37.3372 38.4230 37.3143
310021 1.6495 1.1316 32.1929 31.6562 32.2042 32.0219
310022 1.3231 1.1221 30.4043 31.1951 32.8059 31.4436
310024 1.3886 1.1440 33.3415 33.8622 36.6897 34.6507
310025 1.4248 1.2878 34.3687 32.2630 32.1469 32.9318
310026 1.3243 1.2878 29.1588 30.1392 30.1294 29.8053
310027 1.4636 1.1440 29.7793 31.5967 34.6445 31.9780
310028 1.1907 1.1440 32.2977 33.9911 34.8312 33.7159
310029 1.7792 1.1221 32.9246 33.6695 35.2057 33.9510
310031 2.8606 1.1221 37.0668 39.3783 39.5882 38.6577
310032 1.3218 1.1221 30.7865 33.0258 35.2379 33.0201
310034 1.4121 1.1221 31.7012 32.7523 36.8586 33.7114
310037 1.4765 1.2878 38.5415 38.2865 40.4608 39.0092
310038 1.8931 1.2693 35.9190 36.3344 39.8671 37.3872
310039 1.2417 1.2693 31.4278 33.2100 32.6403 32.4242
310040 1.2573 1.2878 33.8535 37.7945 41.2219 37.4721
310041 1.3358 1.1221 32.8390 33.9799 35.1979 33.9784
310042 *** * 34.4986 * * 34.4986
310044 1.3493 1.1313 31.9678 33.7614 33.5843 33.0824
310045 1.6491 1.2878 36.7862 38.4424 39.2064 38.1273
310047 1.3458 1.1666 34.1520 37.3695 37.7198 36.4657
310048 1.3736 1.1316 32.9681 33.9506 34.5223 33.8353
310050 1.2457 1.2693 29.1732 32.3686 37.9191 32.9302
310051 1.4905 1.1440 35.0121 38.1174 39.7645 37.6891
310052 1.3237 1.1221 32.5778 33.5849 36.5463 34.2544
310054 1.4134 1.2693 34.4431 36.9095 38.2409 36.5602
310057 1.4334 1.1221 31.1268 31.8933 34.2018 32.3544
310058 1.0541 1.2878 27.1555 30.4080 30.4416 29.4040
310060 1.2546 1.1221 27.3415 27.8242 27.9121 27.7048
310061 1.2219 1.1221 31.6648 39.0538 33.5561 34.7375
310063 1.3448 1.1440 31.9247 33.8519 38.1450 34.4537
310064 1.5372 1.1666 35.7607 38.6310 39.4132 38.0057
310069 1.2581 1.1221 31.7642 34.4669 35.1354 33.8309
310070 1.4555 1.2693 34.3225 36.3279 36.9963 35.8869
310073 1.7821 1.1221 32.6733 34.2858 36.9226 34.6721
310074 1.4656 1.2878 40.3494 39.6196 39.0709 39.6558
310075 1.4250 1.1221 31.5226 32.5338 33.5226 32.5111
310076 1.6465 1.2693 38.0643 37.5163 38.1641 37.9202
310077 *** * 34.6085 * * 34.6085
310078 *** * 30.5761 * * 30.5761
310081 1.2620 1.1221 30.1561 31.0699 31.7950 31.0154
310083 1.3189 1.2693 30.3580 31.9151 28.3385 30.1096
310084 1.2659 1.1221 33.5941 32.6051 34.9604 33.7173
310086 1.2615 1.1221 29.5566 29.8794 30.9445 30.1377
310088 1.1243 1.1666 29.9929 30.3552 31.2420 30.5505
310090 1.2372 1.1440 32.8191 33.4615 33.9146 33.3953
310091 1.1327 1.1221 29.3969 31.9762 35.2892 32.2224
310092 1.4052 1.1313 29.7958 32.7054 32.8408 31.7803
310093 1.2201 1.2693 29.1288 30.2860 32.3840 30.5687
310096 1.9372 1.2693 34.1524 35.0707 34.2007 34.4697
310105 1.1572 1.2878 30.1069 32.5672 32.0252 31.5545
310108 1.4030 1.2693 33.0172 34.5866 36.2821 34.6390
310110 1.3096 1.1313 33.2246 33.4809 35.6793 34.1565
310111 1.2536 1.1221 31.8393 34.8284 36.0727 34.2677
310112 1.3277 1.1221 31.2372 32.2676 34.5315 32.6218
310113 1.2425 1.1221 31.0436 33.6771 35.0222 33.3347
310115 1.3224 1.1221 29.5320 31.9208 32.1173 31.2475
310116 1.2972 1.2878 29.2748 29.8144 27.5857 28.8828
310118 1.3587 1.2878 31.1803 31.2296 32.8252 31.7711
310119 1.8782 1.2693 43.1238 41.5702 41.2971 41.9830
310120 1.0851 1.1440 29.2535 33.3861 35.1643 32.4707
310122 *** * * 41.9029 * 41.9029
310123 *** * * 37.1022 * 37.1022
310124 *** * * 41.8827 * 41.8827
310125 *** * * 36.2186 * 36.2186
310126 *** * * * 34.3166 34.3166
320001 1.6823 0.9499 29.6182 30.0077 31.4174 30.3597
320002 1.5341 1.0587 32.0477 33.1342 34.1580 33.1619
320003 1.1298 1.0207 27.6222 31.4473 31.5768 30.3534
320004 1.3299 0.8858 24.7803 26.2073 28.2392 26.4283
320005 1.4214 0.9295 24.7543 28.7893 25.2152 26.1577
320006 1.2584 0.9295 26.9080 28.0964 28.5156 27.8949
320009 1.5798 0.9499 32.0116 27.8084 31.3279 30.3184
320011 1.1519 0.9300 25.6693 27.9522 28.9931 27.5536
320013 1.1126 1.0207 22.8283 30.5865 31.2869 27.7697
320014 1.0864 0.8858 27.2806 28.7089 30.4781 28.8685
320016 1.1842 0.8858 25.0835 27.1492 26.6374 26.3150
320017 1.2575 0.9499 31.6357 33.3496 30.5759 31.7120
320018 1.5461 0.8882 26.5109 25.9248 28.3438 26.9103
320019 1.4058 0.9499 27.8067 35.0217 28.6731 30.2204
320021 1.6185 0.9499 26.9918 28.8504 30.4499 28.7977
320022 1.1799 0.8858 23.9595 25.3707 27.5132 25.6817
320030 1.0361 0.8858 21.0378 24.4497 25.5246 23.7752
320033 1.2183 1.0207 31.7114 30.1471 30.1829 30.6567
320037 1.2261 0.9499 24.9657 25.2876 27.8969 26.0664
320038 1.2596 0.8858 21.7022 32.7192 31.6504 29.0042
320057 0.9342 1.4430 * * * *
320058 0.7891 1.4430 * * * *
320059 0.9914 1.4430 * * * *
320060 1.0159 1.4430 * * * *
320061 1.0245 1.4430 * * * *
320062 0.9174 1.4430 * * * *
320063 1.3932 0.9273 25.0031 26.0104 27.4933 26.1576
320065 1.3072 0.9273 27.3163 25.7945 26.9113 26.6843
320067 0.8947 0.8858 24.9865 24.7025 25.4100 25.0450
320069 1.0782 0.8858 22.4128 23.9863 25.3134 23.9141
320070 0.9255 1.4430 * * * *
320074 1.2421 0.9499 31.1333 28.4396 28.8072 29.1304
320079 1.2567 0.9499 26.1188 27.6877 31.5635 28.5357
320083 2.4454 0.9499 26.6921 29.5483 32.9443 29.7645
320084 0.9653 0.8858 17.5788 22.7706 24.2897 21.5109
320085 1.7562 0.8882 27.9944 27.4100 28.4513 27.9647
320086 1.4744 0.8858 * * * *
320087 1.3725 1.0587 * * * *
330002 1.5701 1.3043 30.9600 32.1956 34.7252 32.6020
330003 1.3545 0.8833 24.4326 25.2223 26.8348 25.5129
330004 1.3501 1.0709 28.0594 30.2236 30.3204 29.4839
330005 1.5906 0.9593 30.3200 31.5030 33.2828 31.7049
330006 1.2783 1.3043 33.6284 34.2001 36.3279 34.6900
330008 1.1757 0.9593 23.4429 25.2005 26.2131 24.9414
330009 1.3652 1.3043 36.2820 38.9166 41.3767 38.8011
330010 1.0125 0.8375 20.7476 19.7098 20.5800 20.3266
330011 1.3772 0.8721 25.1308 27.4747 26.8258 26.4851
330013 1.9475 0.8833 26.4578 26.8382 28.8015 27.3879
330014 1.3374 1.3043 42.1759 45.7619 46.3155 44.6761
330016 *** * 22.0493 23.0769 * 22.5738
330019 1.3063 1.3043 38.5368 39.7429 44.5627 40.8880
330023 1.5312 1.2855 35.9428 36.4736 37.5106 36.6960
330024 1.7996 1.3043 42.7691 43.2342 44.8034 43.6032
330025 1.0483 0.9593 21.2565 23.2424 24.2691 22.9268
330027 1.3943 1.2855 42.8000 45.1920 45.9531 44.5412
330028 1.5319 1.3043 36.6498 36.2901 38.0116 36.9910
330029 0.5241 0.9593 23.2039 24.0679 22.9321 23.3384
330030 1.1544 0.8911 24.6175 25.3454 25.5081 25.1586
330033 1.2323 0.8531 24.5510 24.8022 25.0205 24.7863
330036 1.2126 1.3043 29.1884 30.3757 30.4633 30.0049
330037 1.2293 0.8911 22.3689 21.9246 23.4904 22.5870
330041 1.3098 1.3043 37.4883 36.9934 37.1640 37.2203
330043 1.4593 1.2729 39.1643 38.8060 40.6059 39.5013
330044 1.3446 0.8721 26.5669 28.2293 28.2619 27.6916
330045 1.4086 1.2729 38.1269 40.0326 41.6537 39.9715
330046 1.3696 1.3043 50.3152 47.4975 52.2364 49.9699
330047 1.2132 0.8375 24.3932 24.9934 26.1791 25.2159
330049 1.4907 1.2694 29.8350 34.8585 34.9720 33.3441
330053 1.0857 0.8911 20.6272 21.8383 20.1297 20.8283
330055 1.5415 1.3043 41.5934 42.2007 44.2313 42.7264
330056 1.3947 1.3043 36.0136 38.8910 39.9628 38.2393
330057 1.6802 0.8833 26.4989 27.7121 30.1910 28.1436
330058 1.2665 0.8911 22.2524 22.6852 23.6285 22.8634
330059 1.5527 1.3043 41.7343 44.9162 45.3660 44.0375
330061 1.1594 1.3043 36.0587 37.8828 37.8620 37.2887
330064 1.2603 1.3043 38.0437 38.2332 41.5714 39.3164
330065 1.0618 0.9593 25.3043 24.4004 26.2272 25.3188
330066 1.2729 0.8833 29.1780 25.8174 27.2069 27.4291
330067 1.3961 1.2694 27.8900 29.2571 30.7516 29.2920
330072 1.3012 1.3043 37.8505 39.6996 41.4567 39.5848
330073 1.1090 0.8911 22.5592 23.4020 25.1380 23.7034
330074 1.1944 0.8911 22.6629 23.4576 23.1004 23.0807
330075 1.1190 0.9865 23.1592 24.2552 23.7516 23.7241
330078 1.4677 0.9593 25.8073 27.2870 27.6659 26.9471
330079 1.3733 0.8308 24.6054 24.9941 27.9464 25.8287
330080 1.1760 1.3043 39.1417 38.9405 40.2059 39.4431
330084 1.0851 0.8308 22.5573 25.6880 27.3430 25.1537
330085 1.1551 0.9471 25.3285 26.6235 27.1697 26.3813
330086 1.3189 1.3043 32.7675 35.5269 40.9743 36.5723
330088 1.0110 1.2729 34.0789 35.3871 35.9962 35.1584
330090 1.4588 0.9101 25.5351 26.8730 27.7287 26.7363
330091 1.3843 0.9593 25.9378 27.0040 28.3015 27.0881
330094 1.2631 0.9901 25.7116 26.9148 28.6203 27.1128
330096 1.1987 0.8308 22.7189 24.2422 24.7885 23.9177
330100 1.1185 1.3043 38.3333 39.6244 37.8618 38.6066
330101 1.8970 1.3043 40.1929 43.7944 45.5381 43.2279
330102 1.4096 0.9593 25.3879 26.6887 27.2523 26.4449
330103 1.2008 0.8351 22.8242 24.5585 25.4907 24.2904
330104 1.3423 1.3043 33.7537 35.1076 36.5857 35.1622
330106 1.6914 1.2855 43.8210 46.3657 48.2871 46.1844
330107 1.2407 1.2729 34.9047 35.7384 38.0246 36.2529
330108 1.1289 0.8347 23.2919 23.9368 25.3011 24.1893
330111 0.9674 0.9593 20.3473 40.4349 23.2125 25.3142
330115 1.1888 0.9865 25.2373 23.8235 24.3889 24.4744
330119 1.7304 1.3043 39.0528 42.2901 41.2326 40.8420
330125 1.7378 0.8911 27.2920 28.0584 29.4802 28.3192
330126 1.3038 1.2855 35.2257 36.5689 37.7797 36.5514
330127 1.3108 1.3043 45.3680 45.2993 45.2542 45.3069
330128 1.2304 1.3043 39.5197 41.7790 43.3424 41.5728
330132 1.1001 0.8439 21.0479 21.7648 22.1446 21.6691
330133 1.3704 1.3043 39.3837 38.5228 39.9011 39.2582
330135 1.2101 1.1586 27.9132 32.0525 33.2291 31.0896
330136 1.5320 0.9471 25.8531 26.6680 25.4193 25.9628
330140 1.7962 0.9865 27.6183 29.3461 31.1320 29.4083
330141 1.3202 1.2729 39.4701 39.3741 39.1699 39.3348
330144 0.9865 0.8362 22.9561 23.3874 24.9303 23.7658
330151 1.2083 0.8362 21.7665 19.7959 21.6335 21.0260
330152 1.3015 1.3043 37.6721 38.2079 39.5722 38.4999
330153 1.7175 0.8833 26.4386 28.4446 28.9924 27.9865
330154 1.6921 * * * * *
330157 1.3796 0.9471 26.5686 27.1432 29.7604 27.7881
330158 1.6713 1.3043 38.2033 41.7010 39.5913 39.8276
330159 1.3553 0.9865 28.2774 31.7835 33.8472 31.2089
330160 1.5503 1.3043 36.6208 37.1915 39.1048 37.6457
330162 1.3383 1.3043 34.9460 37.6226 38.7613 37.1390
330163 1.1132 0.9593 27.1933 28.3910 28.6229 28.0754
330164 1.4898 0.8911 27.7217 27.8746 29.8437 28.5199
330166 1.0613 0.8308 20.4680 20.7121 22.8498 21.3014
330167 1.6290 1.2855 36.7653 39.1251 39.1824 38.3281
330169 1.3998 1.3043 45.3774 46.4939 47.5367 46.4021
330171 *** * 30.4005 35.1577 * 32.5880
330175 1.1285 0.8568 23.8509 24.1005 26.7868 24.8937
330177 0.9936 0.8308 20.6338 22.9834 23.4294 22.3276
330180 1.1924 0.8833 24.3761 25.4170 26.8643 25.5779
330181 1.3033 1.2855 41.4104 43.0977 46.2154 43.5483
330182 2.2878 1.2855 40.9014 41.3033 42.7924 41.6641
330184 1.3645 1.3043 35.8102 39.0437 39.7213 38.2058
330185 1.2668 1.2729 36.3155 38.4002 39.6695 38.1531
330188 1.2402 0.9593 25.1153 27.5988 29.7302 27.4385
330189 1.2886 0.8833 22.3484 22.4383 25.8116 23.5448
330191 1.2850 0.8833 25.5656 26.4328 28.2938 26.8175
330193 1.4383 1.3043 39.9327 39.8910 40.0256 39.9494
330194 1.7941 1.3043 45.5639 46.8880 49.8845 47.4698
330195 1.7054 1.3043 39.7802 41.7885 43.3185 41.6774
330196 1.2884 1.3043 36.7178 38.2525 38.6925 37.9124
330197 1.1174 0.8308 26.8921 25.9872 26.5516 26.4718
330198 1.3922 1.2855 33.4930 34.8985 35.8688 34.8129
330199 1.1949 1.3043 38.6407 40.3948 39.4065 39.4834
330201 1.8000 1.3043 37.2064 42.6707 46.5096 42.1336
330202 1.4107 1.3043 37.4150 37.4158 38.7609 37.8756
330203 1.4153 0.9865 32.1207 34.0499 34.6499 33.6383
330204 1.4550 1.3043 39.6393 41.9953 39.5313 40.4252
330205 1.2337 1.1586 31.9510 33.9418 35.3766 33.7848
330208 1.1951 1.3043 32.1256 33.5287 37.1706 34.2436
330209 *** * 30.2038 * * 30.2038
330211 1.0836 0.8308 24.4470 25.8752 24.9417 25.1105
330213 1.0678 0.8308 24.4049 27.4890 28.5365 26.7727
330214 1.8791 1.3043 41.8719 42.1339 43.2434 42.4360
330215 1.2792 0.8721 23.7361 23.9583 26.3964 24.6837
330218 1.0910 0.9865 26.9638 26.9982 28.4109 27.4690
330219 1.7127 0.9593 29.8889 32.5658 33.2132 31.8655
330221 1.3708 1.3043 39.2080 40.0514 42.5461 40.6770
330222 1.2774 0.8833 25.8507 27.7198 28.7835 27.5072
330223 0.9707 0.8308 23.3669 26.1264 27.1959 25.6000
330224 1.3100 1.0709 27.9231 29.1738 30.4765 29.2021
330225 1.2228 1.2855 32.3585 35.7651 32.9013 33.6812
330226 1.4002 0.8911 24.5646 24.8471 26.3674 25.2746
330229 1.2244 0.8420 21.9356 23.0577 23.9230 22.9668
330230 1.0278 1.3043 37.1298 38.6569 39.3870 38.3808
330231 1.1135 1.3043 40.6697 44.9422 48.9002 44.9236
330232 1.2072 0.8833 26.3313 27.4639 27.9601 27.2541
330233 1.5357 1.3043 47.3497 52.7070 40.8517 46.1530
330234 2.3425 1.3043 48.2306 49.3219 49.8754 49.1340
330235 1.1520 0.9471 27.7031 29.4346 30.8007 29.3076
330236 1.5494 1.3043 40.2386 42.8981 42.6166 41.9558
330238 1.2738 0.8911 21.7435 21.8386 23.3946 22.3482
330239 1.2402 0.8420 22.3854 23.1885 24.6380 23.4006
330240 1.4609 1.3043 43.5753 40.5001 41.6117 41.8580
330241 1.8409 0.9865 30.2304 32.7683 32.9148 32.0133
330242 1.3112 1.3043 37.4870 36.9015 38.7839 37.7206
330245 1.7745 0.8721 26.1811 27.4326 28.6678 27.4605
330246 1.3715 1.2729 37.1611 35.7416 35.9559 36.2356
330247 1.1834 1.3043 35.4980 39.0219 41.3428 38.4848
330249 1.3392 0.9865 25.3246 24.6091 26.9847 25.6366
330250 1.3845 0.9216 27.1606 29.0080 29.6168 28.6244
330259 1.5072 1.2855 35.1514 36.4788 39.0189 36.8295
330261 1.2365 1.3043 33.7834 40.2579 38.0192 37.2335
330263 1.0140 0.8308 23.8738 24.1333 24.2125 24.0872
330264 1.3203 1.1586 30.4701 31.0557 32.1770 31.4635
330265 1.2419 0.8911 21.6477 23.9081 22.7426 22.7616
330267 1.3921 1.3043 32.8541 34.9885 35.3884 34.4218
330268 0.9313 0.8308 25.3567 23.8793 23.9129 24.3479
330270 2.0758 1.3043 57.3596 55.2136 52.3126 54.6691
330273 1.3499 1.3043 37.0157 35.9298 39.7849 37.6016
330276 1.1594 0.8344 24.3300 26.0935 27.0432 25.8320
330277 1.2068 0.9101 26.4535 30.9053 30.8138 29.1290
330279 1.6224 0.9593 27.4539 29.6385 31.2369 29.4467
330285 1.9771 0.8911 30.1928 31.1235 31.9305 31.0944
330286 1.3514 1.2729 35.5895 37.6040 38.8533 37.3699
330290 1.6233 1.3043 39.4690 40.6933 39.8010 39.9779
330304 1.3053 1.3043 36.2845 37.3537 39.4605 37.8134
330306 1.4567 1.3043 36.3552 38.7713 39.0391 38.0888
330307 1.3412 0.9561 29.2529 29.5885 30.8103 29.9028
330314 *** * 26.2719 28.1788 22.6868 26.0606
330316 1.2398 1.3043 34.8567 37.1766 37.9320 36.6690
330331 1.2869 1.2855 39.8402 41.2694 44.1690 41.7977
330332 1.3105 1.2855 35.1646 37.0111 38.6906 36.9311
330338 *** * 37.7497 * * 37.7497
330339 0.7634 0.8833 23.5786 24.3066 25.0041 24.2976
330340 1.2284 1.2729 37.9000 37.4161 38.4698 37.9265
330350 1.5260 1.3043 41.1339 44.4617 44.2368 43.3333
330353 1.2443 1.3043 45.9692 45.0977 46.0175 45.7015
330354 2.1246 * * * * *
330357 1.2886 1.3043 38.2286 40.3850 40.2097 39.5419
330372 1.2901 1.2855 36.1840 35.1297 37.0288 36.1053
330385 1.0504 1.3043 48.6175 49.0859 47.3989 48.3826
330386 1.3408 1.1461 29.9366 33.3216 32.9974 32.1005
330389 1.7338 1.3043 37.1862 39.6871 37.5883 38.1257
330390 1.2394 1.3043 36.3842 35.5562 38.7634 36.9285
330393 1.7385 1.2729 38.0619 39.2186 38.9295 38.7593
330394 1.6520 0.8721 27.3388 28.4597 28.8056 28.2126
330395 1.4204 1.3043 36.3921 37.5791 50.1276 40.5815
330396 1.3480 1.3043 37.4998 39.4904 39.1940 38.7397
330397 1.4094 1.3043 37.5682 41.4448 41.1659 39.9850
330399 1.1317 1.3043 34.7394 36.7626 39.8000 37.1071
330401 1.3519 1.2729 37.8559 40.4485 41.7804 40.0688
330403 0.9101 0.8911 25.5163 25.2937 28.7267 26.3688
330404 0.9366 1.3043 * * 36.1044 36.1044
330405 0.9452 1.3043 * * 35.2698 35.2698
330406 0.9450 0.8833 * * 28.2727 28.2727
330407 0.9449 0.8833 * * * *
340001 1.4870 0.9570 28.3988 29.5709 29.9082 29.3235
340002 1.7858 0.9192 28.4860 29.6622 30.7384 29.6332
340003 1.2344 0.8632 24.1602 26.0888 26.6393 25.6927
340004 1.4318 0.9096 26.6404 27.5283 27.9184 27.3734
340008 1.2672 0.9567 26.7443 27.7206 29.0639 27.8645
340010 1.3315 0.9557 27.2105 28.7544 29.5207 28.5197
340011 1.1738 0.8632 19.7441 22.0047 22.5138 21.4242
340012 1.2246 0.8632 23.2288 24.7576 24.9253 24.3215
340013 1.2360 0.9307 23.9492 26.3607 26.9137 25.7232
340014 1.6086 0.8984 27.4888 27.8384 29.5330 28.3119
340015 1.3956 0.9570 28.0585 28.3928 30.0958 28.8519
340016 1.3330 0.8632 25.6454 27.2365 27.9629 26.9654
340017 1.2759 0.9192 25.7780 27.5672 28.4845 27.2551
340020 1.1889 0.8788 26.4465 27.5473 28.3440 27.4399
340021 1.3379 0.9570 29.4864 29.3835 31.3610 30.1011
340023 1.3629 0.9307 26.4225 26.2716 27.6909 26.8311
340024 1.1349 0.8809 23.6638 26.4001 26.8984 25.6597
340025 1.2988 0.9192 23.5881 24.0101 25.2827 24.3044
340027 1.2181 0.9174 25.5973 26.3840 26.6506 26.2232
340028 1.5011 0.9923 28.0323 30.7591 31.9846 30.2233
340030 1.9766 0.9693 29.6630 30.4591 31.1985 30.4842
340032 1.4553 0.9570 26.5958 28.7636 29.2058 28.2291
340035 1.0979 0.8632 23.9669 24.6262 26.0827 24.8874
340036 1.3100 0.9685 27.2691 27.3860 29.0626 27.9422
340037 1.1218 0.8794 25.6262 29.0618 30.5346 28.5630
340038 1.2380 0.8885 22.4829 24.2111 26.2582 24.3742
340039 1.2806 0.9570 27.4457 27.8228 29.5042 28.2768
340040 1.9081 0.9346 27.6626 28.7434 30.1256 28.8796
340041 1.3315 0.8946 24.3595 26.8314 27.1270 26.1141
340042 1.2353 0.8632 25.0110 25.6349 27.0573 25.9214
340047 1.8051 0.8984 27.4022 28.4968 28.7600 28.2338
340049 1.7851 0.9693 30.6791 29.6826 31.5524 30.6567
340050 1.2008 0.9567 26.0365 27.5274 29.2266 27.6025
340051 1.1886 0.8794 23.9612 24.4561 25.4961 24.6507
340053 1.4900 0.9570 27.8577 28.9355 30.8320 29.2316
340055 1.2129 0.8946 26.0647 26.5752 29.0098 27.1555
340060 1.0621 0.9141 22.9097 25.1791 26.8366 24.9813
340061 1.7496 0.9693 27.0089 29.8574 31.2885 29.4140
340064 1.1205 0.8632 23.4233 23.9701 25.0796 24.1848
340068 1.2915 0.8632 22.6814 23.6757 24.7388 23.6999
340069 1.8414 0.9693 29.3439 31.4951 32.2147 31.0749
340070 1.2531 0.8984 25.3226 26.6546 27.7660 26.6186
340071 1.0621 0.9557 26.3921 27.9748 29.7321 28.0710
340072 1.1433 * 25.2493 24.1350 * 24.6895
340073 1.6527 0.9693 30.9849 31.6803 33.2859 32.0279
340075 1.2349 0.8946 25.1551 25.1438 26.8298 25.7432
340084 1.1236 0.9570 21.1363 23.1300 25.6868 23.2795
340085 1.1506 0.8882 26.5164 27.9572 29.1072 27.8491
340087 1.2341 0.8632 22.4287 25.4730 23.8343 23.9111
340090 1.3071 0.9685 26.4031 26.7428 28.3594 27.2234
340091 1.6022 0.9096 27.1285 28.8044 30.4345 28.8160
340096 1.2333 0.8882 24.9036 26.5438 26.5795 26.0408
340097 1.2431 0.8632 26.2228 29.8005 27.9788 27.9546
340098 1.4670 0.9570 28.2493 29.7180 31.3896 29.8226
340099 1.2912 0.8632 21.8564 23.9702 26.0062 24.0248
340104 0.7848 0.8794 16.1204 17.0165 19.9477 17.8305
340106 1.1406 0.8632 26.0892 26.1340 24.5134 25.5139
340107 1.1991 0.9068 24.1762 26.5626 27.3548 26.0750
340109 1.2448 0.8868 25.4464 26.6383 26.6462 26.2343
340113 1.9457 0.9570 28.5587 30.3841 32.3765 30.4662
340114 1.5304 0.9693 28.3222 28.1311 30.1188 28.8788
340115 1.6260 0.9693 26.7592 27.2781 28.0955 27.3861
340116 1.7476 0.8946 27.5881 29.3698 29.9425 28.9452
340119 1.2861 0.9570 25.6226 29.4470 27.2924 27.4283
340120 1.0708 0.8632 25.9134 25.5399 26.1449 25.8647
340121 1.0930 0.9087 23.1343 23.8854 25.1565 24.0798
340123 1.2779 0.9141 26.0637 28.5669 28.7125 27.7861
340124 *** * 22.2988 23.5480 25.7275 23.7126
340126 1.3283 0.9557 26.9866 28.2247 30.6880 28.6662
340127 1.1942 0.9693 26.4746 28.2161 28.8647 27.8604
340129 1.3110 0.9570 25.7976 26.7606 31.7833 27.9613
340130 1.3497 0.9570 26.1717 28.1594 29.5278 27.9862
340131 1.4690 0.9174 27.4750 28.8542 29.6545 28.6874
340132 1.2127 0.8632 23.5856 24.6162 25.3247 24.5295
340133 1.0197 0.8940 23.4678 24.8579 26.8831 25.1020
340137 *** * 22.1741 28.9672 27.0855 25.1884
340138 0.9092 0.9693 * * * *
340141 1.6729 0.9087 29.3878 29.3171 29.3351 29.3465
340142 1.2123 0.8632 26.6886 27.7555 28.2393 27.5936
340143 1.5447 0.8946 28.0082 27.9777 29.3839 28.4856
340144 1.2183 0.9570 26.1865 27.0150 27.6523 26.9370
340145 1.2148 0.9570 25.8459 26.7482 28.0628 26.9029
340147 1.3027 0.9557 26.9162 28.2626 29.6936 28.3096
340148 1.5007 0.8984 25.3660 25.8325 27.9119 26.4048
340151 1.2153 0.8684 22.7736 23.2158 24.5768 23.5273
340153 1.9232 0.9570 27.6509 28.5979 29.8260 28.7235
340155 1.4750 0.9693 30.3443 30.9501 31.7547 31.0367
340156 0.8722 1.4446 * * * *
340158 1.1294 0.9087 27.7816 27.6526 29.4088 28.3011
340159 1.2146 0.9693 24.2588 25.3108 28.1688 25.9712
340160 1.3520 0.8632 21.7923 23.4631 24.2003 23.1718
340166 1.3505 0.9570 27.1132 28.5395 29.9101 28.5234
340168 0.4196 0.9087 * * * *
340171 1.1184 0.9570 27.8539 27.4701 31.1928 28.9088
340173 1.3301 0.9693 28.3502 30.2815 30.9813 29.9351
340177 *** * 26.7155 * * 26.7155
340179 *** * 34.1895 * * 34.1895
340182 *** * 27.8071 * * 27.8071
340183 1.1992 0.9570 * * 30.1224 30.1224
350002 1.8113 0.7336 22.4307 23.5869 23.6039 23.2267
350003 1.2133 0.7336 23.9639 24.9975 24.5802 24.5236
350006 1.5637 0.7336 21.2726 22.4626 23.4334 22.3834
350009 1.0718 0.8212 23.8681 24.5737 23.9783 24.1447
350010 1.0699 * 20.1290 20.4198 * 20.2749
350011 1.9136 0.8212 23.8400 24.1135 26.0184 24.6622
350014 0.9542 * 19.1684 17.5837 * 18.3437
350015 1.5991 0.7336 20.9046 21.3342 22.9107 21.7900
350017 1.2273 0.7336 22.4359 21.6187 24.0965 22.7331
350019 1.6984 0.7709 23.2018 24.9615 24.9880 24.4055
350030 0.9524 0.7336 20.2722 22.5976 23.1013 22.0048
350063 0.9136 1.4365 * * * *
350064 0.7388 1.4365 * * * *
350070 1.7656 0.8212 25.2365 26.2454 26.2850 25.9334
360001 1.4815 0.9581 25.8669 28.8623 30.1018 28.2801
360002 1.2851 0.8723 24.5155 25.4859 25.2198 25.0794
360003 1.7681 0.9581 28.9672 30.7812 31.8948 30.5710
360006 1.8125 0.9869 30.1363 30.9806 31.8259 31.0038
360008 1.3172 0.8759 26.2632 27.5683 28.0182 27.2862
360009 1.5509 0.9299 25.0007 27.0618 28.2407 26.7836
360010 1.2398 0.8784 23.7825 24.7352 25.5935 24.7214
360011 1.2808 0.9657 27.6036 31.5587 29.9864 29.6800
360012 1.3492 0.9869 30.1416 31.0526 31.9806 31.0579
360013 1.0853 0.9299 27.0893 29.8412 30.2383 29.0666
360014 1.1225 0.9657 27.1017 27.0743 28.1800 27.4862
360016 1.4873 0.9581 27.8031 29.6298 30.2164 29.2161
360017 1.6193 0.9869 29.8525 31.7081 33.2491 31.6157
360019 1.3267 0.9266 26.9178 27.2997 28.3226 27.5252
360020 1.5825 0.9266 23.6400 25.6328 27.6681 25.6284
360025 1.4547 0.9267 27.4533 27.1546 28.4754 27.6992
360026 1.3750 0.9321 25.5379 25.2945 27.5409 26.1280
360027 1.5168 0.9266 27.4454 28.2923 29.6304 28.4671
360029 1.1810 0.9267 24.3216 26.4208 27.8825 26.2449
360032 1.2265 0.8582 25.0034 25.9916 27.2621 26.0956
360035 1.6390 0.9869 30.0172 31.3181 31.2432 30.8528
360036 1.1944 0.9266 27.8343 29.3514 29.9390 29.0664
360037 1.5004 0.9266 29.0046 30.0446 30.6535 29.8835
360038 1.5826 0.9581 25.4274 31.0611 31.3759 29.1457
360039 1.4590 0.9657 23.9783 24.7873 25.8206 24.8982
360040 1.2069 0.8969 24.8569 25.5337 26.7437 25.7182
360041 1.4496 0.9266 26.1522 26.6755 28.4427 27.1150
360044 1.1770 0.8709 21.5619 24.3840 24.7681 23.5345
360046 1.2150 0.9581 25.4673 26.2417 28.2956 26.6958
360048 1.8237 0.9267 29.3415 29.4378 30.0370 29.6170
360049 *** * 26.2222 * * 26.2222
360051 1.6897 0.9321 26.8501 28.1167 29.4411 28.1381
360052 1.5471 0.9321 26.2066 26.8806 28.4711 27.2049
360054 1.3413 0.8759 22.9359 24.8248 23.6593 23.7903
360055 1.4007 0.8931 27.3941 30.0143 31.4776 29.5863
360056 1.5488 0.9581 26.5318 30.3677 31.1802 29.4451
360058 1.1206 0.8582 23.8119 24.5003 25.9278 24.7681
360059 1.4695 0.9266 29.3624 30.6173 30.6279 30.2152
360062 1.5597 0.9869 31.7422 32.8893 32.8990 32.5514
360064 1.5123 0.8931 25.2336 27.7795 28.6078 27.1789
360065 1.2709 0.9266 28.0405 29.7155 31.5056 29.7621
360066 1.4332 0.9299 27.1436 29.7605 30.9636 29.2899
360068 1.8584 0.9267 26.2065 26.6933 28.6320 27.1929
360070 1.6693 0.8845 27.2389 27.8891 28.8717 27.9936
360071 1.1466 0.8617 23.4619 26.4081 25.7940 25.2133
360072 1.5262 0.9869 25.9589 27.2286 28.3666 27.2276
360074 1.2813 0.9267 25.8959 27.5328 27.9970 27.1581
360075 1.2013 0.9266 26.8925 26.1657 28.3916 27.1857
360076 1.5143 0.9581 28.1013 29.0148 29.2102 28.7968
360077 1.5018 0.9266 28.4449 28.0133 28.3010 28.2547
360078 1.2814 0.9266 25.7885 27.4689 27.3636 26.8573
360079 1.7270 0.9321 27.2437 30.1230 31.3114 29.5585
360080 1.1032 0.8582 21.4526 22.7020 21.8797 22.0297
360081 1.3032 0.9267 29.8366 29.5312 31.4274 30.2589
360082 1.3735 0.9266 29.2561 28.7925 30.5823 29.5279
360084 1.6319 0.8845 27.3917 28.5402 29.2435 28.4167
360085 2.0543 0.9869 31.5800 32.8502 33.1267 32.5905
360086 1.6514 0.9321 25.4218 27.3124 28.3559 27.0242
360087 1.4326 0.9266 29.6579 28.4185 28.6324 28.8850
360089 1.1327 0.8582 25.3465 25.5608 28.0769 26.2935
360090 1.4661 0.9267 29.0199 30.7530 29.2643 29.6802
360091 1.3415 0.9266 25.8657 27.6809 28.1671 27.2522
360092 1.2566 0.9869 25.4954 25.4055 28.0797 26.3112
360095 1.4803 0.9267 26.4635 29.3787 30.1514 28.6022
360096 1.1353 0.8582 25.9275 26.8653 27.9493 26.9250
360098 1.4304 0.9266 25.5973 26.6382 26.5824 26.3001
360100 1.3412 0.8845 25.4523 23.6167 25.8131 24.9650
360101 1.4779 0.9266 27.6030 29.7817 30.6609 29.3460
360107 1.1819 0.9267 24.6095 26.0534 26.8168 25.8586
360109 1.0429 0.8582 26.3131 30.1382 30.4624 28.9111
360112 1.8522 0.9267 30.5715 31.1356 32.4383 31.4039
360113 1.2805 0.9581 26.6556 30.2871 30.3893 29.0672
360115 1.3320 0.9266 25.9841 26.1821 26.8438 26.3395
360116 1.2122 0.9581 25.1717 26.4968 26.8619 26.2113
360118 1.4755 0.9295 27.3884 28.5643 29.9812 28.5726
360121 1.2872 0.9267 27.4442 28.3835 31.6755 29.0943
360123 1.4063 0.9266 27.1920 28.0334 28.5418 27.9298
360125 1.2052 0.8582 24.1388 25.9067 27.1761 25.6993
360130 1.5015 0.9266 25.6570 26.3986 28.1792 26.7600
360131 1.3679 0.8845 25.3719 26.6635 27.3408 26.4479
360132 1.3742 0.9581 27.7724 29.4070 29.8386 28.9945
360133 1.5965 0.9321 29.8684 31.7521 33.1791 31.6376
360134 1.7642 0.9581 27.7339 28.5141 29.9175 28.7663
360137 1.7064 0.9266 26.1250 27.6894 30.3093 28.0256
360141 1.6073 0.8931 29.7937 31.1778 31.9380 30.9580
360143 1.3047 0.9266 28.3057 26.9394 28.0681 27.7625
360144 1.3394 0.9266 28.2473 28.9177 29.6531 28.9566
360145 1.6504 0.9266 27.1908 28.1835 29.3247 28.2623
360147 1.2554 0.8582 25.5854 27.5548 29.2356 27.4482
360148 1.1785 0.8582 26.0837 26.3399 25.7446 26.0498
360150 1.3213 0.9266 25.1217 28.2561 27.8825 27.0949
360151 1.4719 0.8845 25.3780 26.5636 26.9664 26.3114
360152 1.5125 0.9869 29.9425 31.5377 33.3560 31.6190
360153 0.9954 0.8582 19.8499 20.2147 21.8404 20.6626
360155 1.4645 0.9266 26.9127 28.9521 28.8915 28.2820
360156 1.1512 0.8701 24.3281 25.0833 26.2253 25.2574
360159 1.3312 0.9657 29.1529 28.6174 29.0171 28.9284
360161 1.3364 0.8931 25.4433 27.0875 27.7406 26.7559
360163 1.8747 0.9581 28.9742 30.0724 31.2057 30.0774
360170 1.1878 0.9869 28.5474 29.5954 30.0025 29.4160
360172 1.3762 0.9266 27.5669 28.8283 30.2315 28.8817
360174 1.2862 0.9321 26.8586 28.3143 28.3749 27.8656
360175 1.2487 0.9657 28.1531 28.3054 29.7479 28.7375
360179 1.5492 0.9581 30.0311 29.8299 31.3518 30.4088
360180 2.3387 0.9266 29.6633 31.4342 32.0205 31.0895
360185 1.2624 0.8582 25.6800 26.1080 26.4201 26.0786
360187 1.4967 0.9321 24.9353 25.7600 27.3727 26.0387
360189 1.1420 0.9869 26.3756 27.5097 28.2736 27.4040
360192 1.3279 0.9266 26.4616 27.5991 29.1980 27.8031
360195 1.0799 0.9266 25.0922 27.6155 27.2619 26.6349
360197 1.1347 0.9657 28.7580 28.9207 28.5250 28.7314
360203 1.1898 0.8582 24.4433 25.3692 27.7551 25.8598
360210 1.2170 0.9869 28.2976 29.6476 31.8161 29.9477
360211 1.6076 0.8582 25.7053 26.5459 27.2721 26.4875
360212 1.3076 0.9266 25.6080 26.6976 28.5868 26.9659
360218 1.2246 0.9869 29.8662 30.0101 31.0690 30.3264
360230 1.5275 0.9266 28.8018 30.0661 30.5975 29.8409
360234 1.4185 0.9581 25.9360 31.0656 30.7904 29.2950
360236 1.3057 0.9581 25.6728 29.5321 29.9348 28.6891
360239 1.3536 0.9321 27.2939 30.7728 31.7919 29.9651
360241 *** * 23.0662 25.7290 25.8138 24.8236
360242 1.9535 * * * * *
360245 0.6344 0.9266 20.6504 20.3426 20.4587 20.4760
360247 0.4196 0.9869 19.3677 * * 19.3677
360253 2.2617 0.9581 33.2371 34.3347 34.6849 34.0994
360259 1.2301 0.9267 25.9878 27.2902 28.0868 27.1587
360261 1.5079 0.9118 22.3614 25.6332 26.6241 24.8458
360262 1.2975 0.9267 28.6995 30.1559 31.5616 30.2316
360263 1.9432 0.9299 25.1652 25.4864 28.1657 26.3875
360264 *** * 36.0754 * * 36.0754
360265 *** * 36.6265 * * 36.6265
360266 2.1538 0.9869 * 31.7565 29.8358 30.6488
360267 *** * * 34.0936 * 34.0936
360268 *** * * 34.0526 * 34.0526
360269 1.7035 0.9581 * 24.8552 25.5163 25.2427
360270 1.1268 0.8582 * * 28.8661 28.8661
360271 *** * * * 28.4331 28.4331
360272 *** * * * 38.0986 38.0986
360273 *** * * * 37.6617 37.6617
360274 1.5016 0.9321 * * * *
360276 1.1341 0.8931 * * * *
370001 1.6484 0.8652 26.0194 26.8884 28.4890 27.1483
370002 1.1271 0.8016 22.0476 23.6886 26.2488 23.9833
370004 1.1127 0.9349 26.7434 26.8521 28.2786 27.2955
370006 1.2372 0.8784 22.4802 23.9935 25.2294 23.8425
370007 1.0227 0.8016 19.4036 20.3706 21.1255 20.2911
370008 1.4408 0.8686 25.3352 26.6563 27.9923 26.6850
370011 1.0018 0.8686 21.9649 22.3391 23.1755 22.5131
370013 1.5415 0.8686 26.5364 27.2667 28.3486 27.4244
370014 1.0690 0.9291 25.9393 26.4488 28.8951 27.1129
370015 1.0296 0.8652 24.7547 25.5815 27.8050 26.1032
370016 1.5756 0.8686 26.7938 29.8284 30.4646 28.9272
370018 1.5016 0.8652 25.3573 24.6868 31.2325 27.0624
370019 1.1994 0.8016 22.0221 25.2814 26.7609 24.7201
370020 1.4065 0.8016 20.8723 22.7566 27.7807 23.6027
370022 1.1935 0.8016 24.6099 22.2289 26.4826 24.3184
370023 1.2804 0.8106 23.5170 24.0376 24.9575 24.1637
370025 1.3471 0.8652 23.9873 24.5547 24.8323 24.4542
370026 1.4489 0.8686 25.8428 25.5172 26.0190 25.7953
370028 1.9475 0.8686 27.8621 28.5619 29.9829 28.8114
370029 1.1365 0.8016 26.8508 28.5309 30.0133 28.4170
370030 1.0209 0.8652 24.1483 25.8212 26.0822 25.3421
370032 1.4768 0.8686 24.8626 26.2642 28.0726 26.3353
370034 1.2643 0.8016 19.5099 20.4106 23.2177 21.1222
370036 1.0929 0.8016 19.2318 19.8162 21.1549 20.1518
370037 1.6173 0.8686 24.9553 25.2350 26.8975 25.7110
370039 1.0375 0.8652 23.0254 23.5745 25.3412 23.9675
370040 0.9726 0.8016 22.8356 26.7395 19.7632 23.1713
370041 0.8769 0.8652 22.6731 22.9834 29.5069 24.8467
370047 1.4262 0.8686 24.1991 24.4766 27.8930 25.5715
370048 1.0294 0.8016 21.4543 22.0627 23.4845 22.3179
370049 1.3024 0.8686 23.8844 22.8755 24.2087 23.6440
370051 1.0519 0.8016 19.8329 19.3222 21.8711 20.3135
370054 1.2382 0.8016 22.4652 25.2142 23.4638 23.6682
370056 1.8723 0.8630 24.3986 25.5453 27.6169 25.8232
370057 1.0258 0.8652 19.8683 22.1337 23.1808 21.6643
370060 1.0456 0.8652 19.9025 23.3858 25.5560 22.9757
370065 1.0154 0.8112 21.2343 23.5815 24.0050 22.9087
370072 0.8329 0.8274 11.7942 13.0963 22.8589 14.5180
370078 1.5381 0.8652 27.8611 26.6972 30.4817 28.2974
370080 0.9489 0.8016 19.9595 22.4113 23.7218 22.0520
370083 0.9450 0.8067 19.2568 20.9878 21.9159 20.6845
370084 1.0056 0.8016 19.6230 20.7326 17.4201 19.1737
370089 1.4095 0.8016 20.6153 22.1523 22.0592 21.6429
370091 1.6019 0.8652 24.1438 25.8697 28.0464 26.0375
370093 1.6611 0.8686 26.0459 27.5356 26.7255 26.7691
370094 1.3751 0.8686 24.5555 26.5265 28.3484 26.4229
370097 1.2821 0.8630 26.3168 26.8138 28.0905 27.0817
370099 1.0542 0.8016 24.9971 26.7206 30.5425 27.4897
370100 0.9080 0.8116 17.9732 19.4002 20.6297 19.4038
370103 1.0407 0.8016 18.8933 19.4273 22.2665 20.0894
370105 2.0282 0.8686 26.7973 26.6399 30.5423 27.9853
370106 1.4171 0.8686 27.8979 28.5957 29.6782 28.7253
370112 0.9279 0.8016 16.0592 16.7888 19.0125 17.3058
370113 1.1274 0.8950 26.9720 26.4608 30.0045 27.8038
370114 1.5752 0.8652 23.0006 25.9841 27.3069 25.4424
370138 1.0937 0.8016 20.2528 22.1675 23.6337 21.8806
370139 0.9151 0.8016 19.4287 20.5156 21.0751 20.3636
370148 1.5372 0.8686 27.0904 28.1933 29.3428 28.2968
370149 1.3311 0.8686 23.3493 23.3423 23.0749 23.2542
370153 1.1065 0.8016 23.2778 24.1667 25.9232 24.4635
370156 1.0044 0.8137 25.2562 23.0104 22.7138 23.5680
370158 0.9394 0.8686 20.7641 21.5228 22.0059 21.4295
370166 0.8545 0.8652 25.1107 24.7251 26.3414 25.3950
370169 0.9454 0.8179 16.8252 16.6752 24.5386 19.7622
370170 0.9052 1.4446 * * * *
370171 0.9693 1.4446 * * * *
370172 0.8569 1.4704 * * * *
370173 0.9838 1.4446 * * * *
370174 0.9087 1.4446 * * * *
370176 1.3084 0.8652 24.7655 24.9650 26.6672 25.4759
370178 0.9114 0.8016 16.0179 16.0747 15.5266 15.8654
370180 1.1405 1.4446 * * * *
370183 0.9683 0.8652 24.7103 23.8419 30.3849 26.4222
370190 1.5039 0.8652 29.1568 34.6942 32.5630 32.3673
370192 1.9589 0.8686 27.6367 19.0638 19.1330 21.1807
370196 *** * 22.3498 20.8296 24.6968 22.8178
370199 0.9156 0.8686 23.3989 23.7412 23.9357 23.7085
370200 1.0572 0.8016 20.5175 21.7153 19.7049 20.6651
370201 1.7010 0.8686 23.8090 24.2364 25.5862 24.5320
370202 1.4934 0.8652 26.1132 25.7966 25.8246 25.9084
370203 1.9356 0.8686 22.8869 25.7770 30.3614 26.3098
370206 1.7577 0.8686 26.0353 27.5752 30.8129 28.1710
370210 2.1582 0.8652 23.3786 27.2111 25.7890 25.4309
370211 1.1931 0.8686 27.8737 28.6537 30.9637 29.3408
370212 1.8217 0.8686 19.1720 20.3495 20.0910 19.8981
370214 0.8902 0.8137 20.6217 21.0732 20.1491 20.5858
370215 2.3013 0.8686 31.5652 32.4087 32.0922 32.0514
370216 2.0050 0.8652 27.2429 25.8260 29.6639 27.5894
370217 *** * 26.8677 * * 26.8677
370218 1.9640 0.8652 * 30.3445 23.7493 26.4612
370219 *** * * * 41.4373 41.4373
370220 2.3081 0.8686 * * 21.3140 21.3140
370222 1.8753 0.8686 * * 26.9158 26.9158
370223 0.8701 0.8686 * * 24.0138 24.0138
370226 1.4674 0.8016 * * * *
370227 0.9326 0.8652 * * * *
370228 1.2387 0.8652 * * * *
380001 1.2850 1.1204 29.5842 32.0770 33.8473 31.8553
380002 1.2143 1.0298 30.3385 31.5246 32.6801 31.5496
380004 1.6454 1.1204 32.6901 34.5432 36.1178 34.4710
380005 1.4198 1.0298 30.9087 33.2849 33.5739 32.5875
380007 1.9643 1.1204 33.9601 35.1697 36.4198 35.2082
380009 2.0934 1.1204 32.4016 34.5635 36.5661 34.5647
380010 *** * 34.4208 * * 34.4208
380014 1.8838 1.1076 33.6078 33.1928 35.7074 34.1739
380017 1.7891 1.1204 34.2605 35.3734 37.0024 35.5661
380018 1.8551 1.0298 30.9923 31.8181 32.4859 31.7959
380020 1.4577 1.1157 29.6053 34.6183 35.7367 32.9979
380021 1.4597 1.1204 29.2164 32.6142 33.0611 31.5746
380022 1.3523 1.0572 30.1742 29.6224 30.9162 30.2422
380025 1.1973 1.1204 35.5084 36.4910 38.1479 36.7332
380027 1.3782 1.1157 26.4982 28.0247 31.4378 28.6431
380029 1.2617 1.0725 28.7994 29.4461 33.3348 30.6606
380033 1.7377 1.1157 33.4828 34.0094 36.0221 34.5420
380037 1.3322 1.1204 32.4033 32.7922 34.0301 33.1177
380038 1.2761 1.1204 34.5971 35.1105 35.0334 34.9145
380039 *** * 38.0989 * * 38.0989
380040 1.4621 1.0298 31.2286 32.9081 34.4710 32.9570
380047 1.8056 1.1043 31.0584 32.8188 35.8144 33.3095
380050 1.4231 1.0298 27.1814 29.7329 31.3064 29.4427
380051 1.7594 1.1204 30.8891 32.8545 34.6659 32.8426
380052 1.2624 1.0298 25.6085 28.6119 27.7647 27.2628
380056 1.1073 1.0725 27.7253 29.1686 31.0190 29.2586
380060 1.4994 1.1204 32.0101 33.8863 35.1087 33.6769
380061 1.6390 1.1204 32.3699 34.5230 35.7630 34.2152
380071 1.3775 1.1204 31.7761 31.0901 31.6798 31.5133
380075 1.3482 1.0298 33.8962 31.6884 34.0174 33.2050
380081 *** * 26.8149 * * 26.8149
380082 1.2966 1.1204 35.6708 35.7821 37.7239 36.4069
380089 1.3399 1.1204 34.6015 35.4850 36.9989 35.7198
380090 1.3418 1.1157 33.0990 35.5535 41.4499 36.7267
380091 1.4734 1.1204 39.9703 40.5066 38.4947 39.6719
380100 *** * * * 45.3849 45.3849
390001 1.5668 0.8342 23.6075 24.3251 25.4178 24.4575
390002 1.3393 0.8579 24.7867 25.0860 25.9811 25.2995
390003 1.2164 0.8342 23.3672 24.5099 26.2863 24.7251
390004 1.6088 0.9185 24.4068 25.2424 26.5037 25.3610
390006 1.9527 0.9185 26.8581 28.6926 30.9901 28.9685
390008 1.1400 0.8402 22.8042 22.6297 22.9409 22.7921
390009 1.8038 0.8708 26.7462 26.7234 28.7325 27.4264
390010 1.1889 0.8579 24.5785 24.8196 26.0951 25.1622
390011 *** * 21.4856 20.2291 * 20.8697
390012 1.1856 1.0992 30.7542 32.4856 34.1980 32.4294
390013 1.3619 0.9185 25.0037 26.2323 28.3024 26.5751
390016 1.2430 0.8559 23.2095 24.3488 26.1785 24.5413
390019 1.1210 0.9675 24.0538 25.7515 25.3173 24.9933
390022 *** * 30.3565 29.6308 * 29.9808
390023 1.2632 1.0992 35.4452 34.7787 36.2584 35.4918
390024 *** * 33.5186 38.8750 37.4780 36.5096
390025 0.4329 1.0992 19.1362 20.3878 * 19.7743
390026 1.3079 1.0992 31.8512 31.8309 36.0580 33.1365
390027 1.6538 1.0992 35.5692 39.2158 40.9084 38.5953
390028 1.5828 0.8579 27.1869 27.1451 29.6197 27.9531
390030 1.1870 0.8626 23.6063 24.6343 26.5661 24.9940
390031 1.2126 0.9204 26.2654 27.2033 26.1246 26.5387
390032 1.2693 0.8579 23.9466 24.5243 25.3739 24.6172
390035 1.1907 1.0992 28.4564 29.5417 27.2114 28.3541
390036 1.4853 0.8579 21.6358 24.4917 26.1934 24.0498
390037 1.4598 0.8579 25.4290 25.2296 27.0768 25.9180
390039 1.2528 0.8342 22.0208 23.2300 22.1517 22.4609
390041 1.3077 0.8579 22.9814 24.2257 25.1175 24.1286
390042 1.3624 0.8579 28.3633 28.0996 29.6193 28.7201
390043 1.1959 0.8342 23.2378 24.2087 24.3584 23.9394
390044 1.5562 1.0788 28.7758 29.4057 29.9946 29.4217
390045 1.4816 0.8342 23.9343 24.6495 25.8784 24.8306
390046 1.6617 0.9799 29.6574 30.5115 32.5260 30.9440
390048 1.1221 0.9185 28.5342 28.3152 28.4555 28.4340
390049 1.5809 0.9675 29.6121 30.7431 30.4709 30.2929
390050 2.0142 0.8579 27.2599 27.3481 29.6697 28.1208
390052 1.1476 0.8389 24.9510 25.1462 26.3688 25.5002
390054 *** * 24.4435 27.4805 27.5682 26.3435
390056 1.1124 0.8378 23.5077 23.5821 24.7026 23.9359
390057 1.3322 1.0992 29.7982 30.9198 31.0260 30.6011
390058 1.3063 0.9185 26.9546 27.7296 29.6597 28.1041
390061 1.5170 0.9799 29.1318 30.0597 30.9185 29.9889
390062 1.1231 0.8342 21.2999 21.0713 22.8844 21.7734
390063 1.8374 0.8708 26.4998 26.8381 28.3963 27.2925
390065 1.3159 1.1006 27.6249 29.5654 31.8827 29.7493
390066 1.3881 0.9185 25.9645 25.4407 29.0022 26.8307
390067 1.7872 0.9185 29.7234 30.6128 32.2862 30.8943
390068 1.3404 0.9799 26.7358 29.0962 29.6963 28.5413
390070 1.3523 1.0992 33.3185 34.4935 34.5477 34.1258
390071 1.0062 0.8342 24.6462 24.8467 26.3816 25.3085
390072 1.0663 0.8342 25.3029 26.2568 28.8131 26.7355
390073 1.6919 0.8342 25.7822 26.4083 27.0855 26.4996
390074 *** * 23.6500 25.4098 * 24.5222
390076 1.3189 1.0992 31.8500 32.7671 33.9877 32.8740
390079 1.8491 0.8560 22.5607 24.4452 26.0178 24.3375
390080 1.3943 1.0992 28.7063 29.2645 31.6193 29.8842
390081 1.2389 1.0992 31.7569 33.6247 36.4760 33.9941
390084 1.1285 0.8342 23.2039 24.3372 24.3181 23.9420
390086 1.5931 0.8342 23.5141 25.0992 24.7444 24.4724
390090 1.9186 0.8579 27.3528 27.0122 30.1231 28.1610
390091 1.1759 0.8559 21.7010 23.3562 23.2108 22.7618
390093 1.1913 0.8559 22.6082 22.6023 23.8837 23.0312
390095 1.1678 0.8342 22.6150 24.6290 25.3848 24.2111
390096 1.6015 1.0788 28.8258 28.6055 30.3896 29.2646
390097 1.2500 1.0992 26.1741 27.9858 28.1266 27.3784
390100 1.6431 0.9799 30.0132 30.0234 32.5896 30.9302
390101 1.2844 0.9666 23.1497 24.8377 27.3460 25.1596
390102 1.4773 0.8579 24.8369 24.4589 25.5321 24.9493
390103 *** * 20.5741 20.4446 * 20.5090
390104 1.1021 0.8342 19.2326 19.6630 20.4543 19.7621
390107 1.5861 0.8579 24.1159 24.6565 25.6775 24.8676
390108 1.1988 1.0992 27.8171 28.5928 34.3038 30.1995
390110 1.5950 0.8579 27.7311 25.3407 25.7142 26.1477
390111 2.1581 1.0992 34.2990 34.8756 38.6429 35.9670
390112 1.3266 0.8342 20.2380 21.5439 18.4179 19.9664
390113 1.3312 0.8559 23.3686 24.2593 24.8661 24.1707
390114 1.6377 0.8579 26.9620 27.9184 28.5319 27.8260
390115 1.4264 1.0992 29.6905 30.8063 32.5023 31.0518
390116 1.2605 1.0992 32.2513 33.2562 33.9272 33.1578
390117 1.1784 0.8344 20.7821 21.5038 22.2319 21.5356
390118 1.1738 0.8342 20.5614 21.8917 23.6529 22.0851
390119 1.2800 0.8342 23.0928 24.3245 25.3896 24.2630
390121 *** * 25.4826 * * 25.4826
390122 1.1069 0.8395 23.1866 23.3220 24.6425 23.7140
390123 1.1993 1.0992 32.4528 34.0062 35.1219 33.8960
390125 1.2499 0.8364 22.4033 22.8816 24.0182 23.1230
390127 1.3561 1.0992 31.9091 33.6557 33.1200 32.8957
390128 1.2331 0.8579 24.1628 24.1390 25.1844 24.5037
390130 1.1985 0.8342 23.0592 23.2504 30.3208 25.3350
390131 1.3570 0.8579 23.0577 23.5783 27.7127 24.8832
390132 1.4504 1.0992 29.6396 31.1168 30.0723 30.2692
390133 1.7609 0.9675 31.1083 32.9812 33.0697 32.4255
390136 *** * 23.9813 * * 23.9813
390137 1.4546 0.8342 24.2878 26.1457 26.9140 25.8031
390138 1.1966 0.9185 25.3410 27.4231 27.7549 26.8681
390139 1.3522 1.0992 34.1447 34.0836 36.4969 34.9221
390142 1.5286 1.0992 33.8224 34.5773 33.3491 33.9107
390145 1.5880 0.8579 24.6672 25.6980 26.9194 25.7780
390146 1.1823 0.8364 22.6752 25.1805 23.9869 23.9695
390147 1.3781 0.8579 26.8522 28.6606 29.0974 28.1881
390150 1.1119 0.8579 22.8228 22.7668 22.6473 22.7481
390151 1.3436 1.1006 29.9254 31.4067 31.8952 31.1171
390153 1.3705 1.0992 32.8234 33.2427 36.0259 34.1045
390154 1.2171 0.8342 22.8391 23.3559 23.9776 23.4008
390156 1.3593 1.0992 32.2688 32.8999 33.7034 32.9631
390157 1.3257 0.8579 21.5923 22.1112 23.0975 22.2734
390160 1.3326 0.8579 24.0208 22.9696 25.2027 24.0528
390162 1.5041 1.1449 35.5057 34.5809 35.1818 35.0918
390163 1.2454 0.8559 23.2055 22.8341 24.8747 23.6452
390164 2.1300 0.8579 26.3087 27.1950 29.7760 27.7684
390166 *** * 20.9272 23.3255 28.2160 23.9468
390168 1.4758 0.8579 26.1365 26.9816 27.3654 26.8304
390169 1.4118 0.8342 26.5514 26.2643 26.6049 26.4723
390173 1.2178 0.8342 23.9927 25.6455 27.6024 25.7719
390174 1.6824 1.0992 34.2069 34.8999 34.9029 34.6825
390176 1.1316 0.8579 23.9779 24.1247 12.3126 18.1769
390178 1.3247 0.8930 22.6006 23.1452 23.9151 23.2190
390179 1.4264 1.0992 28.0688 30.1219 31.5474 29.9836
390180 1.3926 1.0992 34.9832 35.5291 38.2969 36.3036
390181 *** * 25.9871 26.6021 27.8820 26.8191
390183 1.1452 0.8342 27.0122 27.8358 28.2196 27.6769
390184 1.0915 0.8579 22.7451 23.9736 23.9958 23.5369
390185 1.2586 0.9675 25.4256 27.1119 25.5306 25.9878
390189 1.1436 0.8342 22.6796 23.6215 23.4893 23.2864
390192 1.0388 0.8342 20.5459 23.6171 23.7948 22.6673
390194 1.2037 0.9675 27.5890 26.3152 23.7351 25.7636
390195 1.6565 1.0992 34.2980 34.5594 37.2471 35.3797
390196 1.6460 * * * * *
390197 1.4171 0.9675 26.8270 27.2455 28.1394 27.4100
390198 1.1294 0.8708 20.5979 20.4350 21.0850 20.7061
390199 1.1366 0.8342 22.3224 23.0046 24.5461 23.3008
390201 1.3518 0.9512 27.0054 27.3542 28.5649 27.6588
390203 1.5297 1.0992 29.4930 29.1370 30.7209 29.8038
390204 1.2911 1.0992 29.5251 30.7346 32.0218 30.7952
390211 1.2835 0.8930 25.1689 26.5052 27.7862 26.4993
390217 1.2278 0.8579 23.5879 24.1886 26.2690 24.6769
390219 1.3577 0.8579 25.4886 26.1196 26.3253 25.9698
390220 1.0888 1.0992 28.9128 30.7435 32.0869 30.6085
390222 1.2691 1.0992 30.9464 31.7361 32.3724 31.7085
390223 1.9836 1.0992 30.2523 34.3280 37.4105 33.8814
390225 1.1877 0.9799 27.5803 27.2555 26.3628 26.9591
390226 1.7135 1.0992 32.6658 32.6508 35.4653 33.6044
390228 1.3609 0.8579 23.9845 24.2242 25.5103 24.5893
390231 1.4014 1.0992 30.9339 32.8353 35.2285 33.0470
390233 1.3823 0.9666 25.6904 27.2597 28.3647 27.1364
390236 0.9818 0.8345 22.1144 23.1290 24.5566 23.2393
390237 1.5868 0.8342 27.4944 28.4337 29.0645 28.3719
390246 1.1777 * 25.1956 26.0179 * 25.6189
390256 1.9774 0.9185 28.0617 28.8970 28.5871 28.5302
390258 1.4533 1.0992 30.4142 31.7164 32.0531 31.4303
390263 1.5092 0.9675 28.5864 29.9850 31.7255 30.1997
390265 1.5374 0.8579 24.0675 25.0166 27.7776 25.6284
390266 1.1912 0.8930 20.8789 22.2228 23.0128 22.0423
390267 1.2760 0.8579 24.2428 24.8309 25.7553 24.9521
390268 1.4064 0.8810 25.6643 26.7342 28.4188 27.0040
390270 1.6183 0.8342 24.9510 26.5010 27.0286 26.2567
390272 0.6051 1.0992 * * 32.9893 32.9893
390278 0.6005 1.0992 26.6664 28.6323 28.8290 28.0560
390285 1.4914 1.0992 36.7163 37.6669 38.4678 37.6177
390286 1.2124 1.0992 29.5281 31.3393 31.7320 30.8704
390287 *** * 39.3176 42.2401 * 40.3959
390288 *** * 30.9701 * * 30.9701
390289 *** * 30.7583 * * 30.7583
390290 1.8004 1.0992 38.3776 41.1426 47.7624 42.2989
390302 0.8675 1.0992 * * * *
390303 *** * 27.5580 * * 27.5580
390304 1.2958 1.0992 30.4832 32.1633 33.4111 32.1082
390305 *** * * 29.3217 * 29.3217
390306 *** * * 40.3789 * 40.3789
390307 2.0387 0.8930 * 24.5393 22.9455 23.6860
390308 *** * * 36.1737 * 36.1737
390309 *** * * 37.8924 * 37.8924
390310 *** * * 44.3991 * 44.3991
390311 *** * * * 49.8990 49.8990
390312 1.2883 1.0992 * * 51.3342 51.3342
390313 1.1642 0.9204 * * * *
390314 1.9344 0.9675 * * * *
390315 1.6395 0.8579 * * * *
390316 1.6856 0.9518 * * * *
390318 0.8280 0.9675 * * * *
400001 1.3295 0.4404 13.9386 14.9151 15.4246 14.7738
400002 1.9377 0.4122 15.3833 12.9440 12.9793 13.6878
400003 1.3791 0.4122 13.9258 15.7906 14.6853 14.8161
400004 1.2115 0.4404 12.0923 12.5928 13.5193 12.7362
400005 1.2533 0.4404 10.3505 11.1152 11.7582 11.0789
400006 1.1625 0.4404 8.1841 8.1381 * 8.1610
400007 1.1605 0.4404 11.8203 12.0743 10.4935 11.4512
400009 0.9834 0.3137 9.3834 9.5114 10.1204 9.6757
400010 0.9051 0.3311 9.8132 10.7993 10.4202 10.3256
400011 1.1055 0.4404 9.6641 8.5503 9.4065 9.2136
400012 1.4864 0.4404 12.3362 10.1156 * 11.0797
400013 1.3650 0.4404 11.1414 11.4222 12.3068 11.6476
400014 1.3749 0.3896 10.5286 9.9395 12.3295 10.8952
400015 1.4718 0.4404 13.7043 22.2017 21.9216 18.9475
400016 1.4676 0.4404 16.6472 16.1931 17.9101 16.9079
400017 0.8958 0.4404 10.3123 9.9185 10.0587 10.0981
400018 1.1103 0.4404 11.9184 12.3942 13.1567 12.5002
400019 1.5158 0.4404 12.8380 14.7133 15.2358 14.0763
400021 1.3614 0.4648 14.4549 13.9217 14.9779 14.4495
400022 1.4439 0.4122 14.9089 15.3625 15.2119 15.1640
400024 0.8933 0.3896 10.8439 12.6226 13.7214 12.2509
400026 1.1373 0.3137 9.9262 7.1179 8.9063 8.4875
400028 1.1913 0.4122 11.3260 10.6711 9.6940 10.5465
400032 1.1451 0.4404 10.3736 10.7141 10.7841 10.6281
400044 1.4861 0.4122 14.6420 11.3551 12.1404 12.5283
400048 1.3035 0.3137 9.6416 9.6860 10.5172 9.9689
400061 2.2573 0.4404 18.1303 18.0093 17.4499 17.8500
400079 1.2280 0.3311 9.5296 10.4599 10.6123 10.2200
400087 1.3360 0.4404 11.0377 11.4162 12.0032 11.4590
400098 1.3491 0.4404 13.8034 13.7878 12.8752 13.4675
400102 1.1900 0.4404 10.5879 12.1761 12.1258 11.5565
400103 1.9297 0.3896 10.6971 11.7488 11.3309 11.2618
400104 1.2190 0.4404 11.4322 12.8404 12.6932 12.3296
400105 1.2578 0.4404 15.6626 16.9029 17.0458 16.5427
400106 1.1085 0.4404 13.4097 12.9272 14.8543 13.7089
400109 1.4302 0.4404 14.4386 14.8208 14.5707 14.6114
400110 1.2156 0.3358 11.1812 9.9278 10.8210 10.6067
400111 1.2130 0.3311 14.1718 10.2141 10.7888 11.5139
400112 1.2446 0.4404 10.1512 13.5177 11.2302 11.5795
400113 1.1764 0.4122 10.5305 10.9503 11.5947 11.0441
400114 1.1726 0.4404 10.1379 10.8913 11.6870 10.9257
400115 1.0815 0.4404 12.0713 9.6200 10.6805 10.8173
400117 1.1347 0.4404 9.5929 11.6258 12.1537 11.0019
400118 1.2649 0.4404 12.8692 12.7861 12.6196 12.7539
400120 1.3351 0.4404 13.4069 14.0817 14.5200 14.0199
400121 1.1129 0.4404 9.7427 9.1826 9.9712 9.6244
400122 1.8905 0.4404 8.9478 9.5814 10.0960 9.5553
400123 1.2353 0.3896 12.8317 12.5609 13.8597 13.0762
400124 2.6860 0.4404 17.2139 17.9140 19.1698 18.1028
400125 1.2073 0.4067 11.9787 13.5394 13.1075 12.8846
400126 1.2894 0.4648 14.1062 16.5726 * 15.3043
400127 2.0911 0.4404 17.8303 20.7775 * 19.5304
400128 1.0184 0.4404 * 12.3520 * 12.3520
410001 1.3144 1.1338 29.0877 30.0315 30.5848 29.9101
410004 1.3107 1.1338 29.4953 31.3023 35.2360 31.9950
410005 1.2724 1.1338 28.1141 31.4387 34.5807 31.2615
410006 1.3911 1.0669 30.1855 32.8456 33.5403 32.1894
410007 1.6113 1.1338 33.2896 32.0730 34.2549 33.1928
410008 1.3225 1.0669 30.9505 32.5889 33.5128 32.3511
410009 1.2374 1.0669 31.7300 32.8422 34.3405 32.9948
410010 1.1305 1.1338 32.0704 32.7379 34.8380 33.2523
410011 1.4882 1.1338 33.8781 30.1941 36.7639 33.5131
410012 1.5728 1.1338 33.6072 37.0299 35.5818 35.4055
410013 1.2045 1.1587 35.8075 41.0010 40.1823 38.9884
420002 1.5630 0.9561 29.5592 30.5111 31.2220 30.4468
420004 1.9671 0.9231 28.1455 28.9250 30.2325 29.1286
420005 1.1610 0.8609 25.0420 24.6968 26.5027 25.3750
420006 *** * 26.3293 27.7764 29.1383 27.7486
420007 1.6315 0.9294 26.8165 29.0901 28.9533 28.2944
420009 1.4114 0.9294 27.0147 29.9378 28.6625 28.5279
420010 1.1406 0.8609 25.1452 25.5710 26.5503 25.7612
420011 1.1778 0.9605 22.1787 25.5130 25.9543 24.5702
420015 1.3156 0.9605 24.1685 26.3499 27.4912 26.0287
420016 0.9672 0.8609 21.6266 22.5681 23.4313 22.5462
420018 1.8307 0.8984 25.6687 27.5563 29.0897 27.4853
420019 1.0990 0.8767 22.5489 25.4954 25.8113 24.4094
420020 1.3500 0.9231 28.4344 27.5000 29.2372 28.3934
420023 1.7169 0.9605 27.4589 28.9321 30.4471 28.9941
420026 1.8642 0.8984 27.8986 28.0647 29.5039 28.4725
420027 1.5767 0.9294 26.4472 28.5621 31.3772 28.7401
420030 1.3204 0.9231 27.8435 28.4433 30.3403 28.8720
420033 1.1839 0.9605 30.4162 31.1608 32.4244 31.3429
420036 1.2480 0.9557 23.8742 24.6505 26.3463 24.9665
420037 1.3390 0.9605 29.8321 30.9556 32.7083 31.1311
420038 1.2831 0.9605 24.6642 26.6435 27.1507 26.1466
420039 1.0529 0.9017 28.2220 26.5582 26.3100 26.9774
420043 1.1111 0.8766 24.0971 25.7951 25.8352 25.2415
420048 1.2885 0.8984 25.9610 26.9625 27.4313 26.8137
420049 1.2591 0.8683 26.0953 25.7060 28.0020 26.6253
420051 1.7106 0.8609 25.9056 26.4710 27.4172 26.6012
420053 1.2316 0.8644 23.2246 24.4793 25.5724 24.4361
420054 1.1106 0.8612 25.6779 25.6444 26.7888 26.0196
420055 1.0931 0.8609 24.0965 25.1738 25.3132 24.8604
420056 1.3487 0.8609 27.7250 28.4512 29.7763 28.7570
420057 1.2036 0.8609 24.9313 26.2489 25.6602 25.6193
420062 1.1026 0.9557 26.7467 25.9569 27.2249 26.6400
420064 1.2630 0.8683 24.3540 24.6507 25.0602 24.6890
420065 1.4161 0.9231 25.5483 26.8118 28.1872 26.8671
420066 0.9980 0.8609 25.1062 25.0932 * 25.0997
420067 1.3639 0.8827 25.8561 26.5658 27.7148 26.7379
420068 1.3759 0.9231 25.6857 27.7315 28.0296 27.1430
420069 1.2054 0.8609 22.3445 23.7494 24.4638 23.5595
420070 1.3136 0.8984 24.7899 27.5988 27.6406 26.7218
420071 1.4339 0.9294 25.2862 27.6371 28.1087 27.0462
420072 1.1634 0.8609 17.8019 21.6587 20.7707 19.9748
420073 1.3829 0.8984 25.5204 26.1120 28.2651 26.7147
420078 1.8607 0.9605 29.5135 30.9001 32.0165 30.8100
420079 1.5040 0.9231 27.5439 28.6374 30.5954 28.9420
420080 1.4321 0.8827 28.6060 31.5670 32.8693 30.8888
420082 1.5113 0.9597 31.2671 33.9874 34.8836 33.3515
420083 1.4528 0.9294 26.4932 28.9007 29.6565 28.4194
420085 1.5909 0.9074 27.8386 29.1127 29.9059 28.9688
420086 1.4584 0.8984 28.0485 27.9523 29.6321 28.5671
420087 1.8044 0.9231 25.4697 26.8409 28.4609 26.9052
420089 1.3777 0.9231 28.1855 29.5862 31.7347 29.8346
420091 1.4537 0.8609 26.0592 27.2520 27.9042 27.0840
420093 *** * 28.0765 33.0474 * 30.2237
420098 1.2041 0.8609 30.7532 27.1939 27.6701 28.2065
420099 *** * * 30.3089 * 30.3089
420100 *** * * * 29.2958 29.2958
420101 1.2049 0.8609 * * 33.1975 33.1975
420102 1.4677 0.9605 * * * *
430005 1.3356 0.8428 22.4111 23.8694 25.4368 23.9203
430008 1.1161 0.8963 24.4277 26.0873 27.2262 25.9003
430012 1.3044 0.9262 24.0326 25.2030 27.0179 25.4023
430013 1.2029 0.9262 25.9828 27.0427 28.4945 27.1837
430014 1.4127 0.8428 26.8752 27.9288 28.9278 27.9157
430015 1.1983 0.8428 23.6296 26.5787 28.0396 26.1008
430016 1.5975 0.9379 28.9376 32.8765 31.1313 30.9581
430027 1.7417 0.9379 26.6044 27.5759 29.2595 27.8481
430048 1.2671 0.8557 24.1969 25.1715 25.6411 25.0133
430060 0.9444 0.8428 13.2618 * * 13.2618
430064 0.9859 0.8428 18.3125 16.4916 17.7325 17.4427
430077 1.7222 0.9618 25.8572 27.2116 31.1926 28.0482
430081 0.9388 1.4448 * * * *
430082 0.8463 1.4448 * * * *
430083 0.8496 1.4448 * * * *
430084 0.9068 1.4448 * * * *
430085 0.8878 1.4448 * * * *
430089 1.8588 0.8783 22.3335 23.2467 24.9033 23.5426
430090 1.6017 0.9379 26.4862 29.0197 32.7369 29.5038
430091 2.2308 0.9502 25.1105 24.7274 26.7238 25.5162
430092 1.8871 0.8428 21.6478 21.9197 23.2508 22.2946
430093 1.3555 0.9502 27.5326 26.0232 24.7398 26.0952
430094 1.7381 0.8557 22.9091 23.2894 23.6605 23.3062
430095 2.4765 0.9379 31.3409 32.2326 32.5850 32.0536
430096 1.9114 0.8428 21.6713 24.6041 24.9608 23.8070
440001 1.1662 0.7999 21.2398 21.5755 25.4844 22.7818
440002 1.7208 0.8886 25.7434 26.3802 26.9121 26.3584
440003 1.3386 0.9445 28.4862 28.3557 26.0107 27.4326
440006 1.4409 0.9445 29.7146 31.5533 31.7373 31.0128
440007 0.9815 0.8176 19.9754 18.8273 22.7570 20.4815
440008 0.9673 0.8339 23.2126 27.3732 26.8850 25.9985
440009 1.1674 0.7957 23.9279 23.8148 24.4410 24.0653
440010 0.9494 0.7957 19.3669 19.6231 20.2498 19.7446
440011 1.3656 0.7957 23.6154 23.6698 24.8292 24.0419
440012 1.5047 0.7964 24.0169 23.7871 24.9243 24.2664
440015 1.8290 0.7957 25.0430 26.0601 27.1580 26.0995
440016 1.0436 0.8101 23.0350 24.5812 25.2515 24.2770
440017 1.7685 0.7964 25.0588 24.6707 26.1800 25.3213
440018 1.1100 0.7999 23.2107 25.0780 24.5898 24.3284
440019 1.6911 0.7957 25.3592 25.2230 26.2435 25.5920
440020 1.0903 0.8614 24.0995 24.7785 27.5620 25.4792
440024 1.1324 0.8717 23.9745 24.7705 26.2519 25.0623
440025 1.1246 0.8611 22.5407 22.6571 24.0274 23.0928
440026 *** * 28.0349 26.8153 28.4597 27.7725
440029 1.4650 0.9445 30.1204 31.2310 31.4630 30.9557
440030 1.2893 0.8013 23.7670 22.2607 22.3131 22.8053
440031 1.1356 0.7976 20.8964 22.6790 22.0708 21.8517
440032 1.1644 0.7957 19.7150 21.0380 23.8016 21.5383
440033 1.0637 0.7984 21.1087 22.7991 23.9790 22.5856
440034 1.6302 0.7957 24.6994 25.5061 25.9124 25.3762
440035 1.3910 0.9252 25.9613 26.2451 27.9203 26.6992
440039 2.1051 0.9445 29.8611 30.1790 30.1901 30.0895
440040 0.9210 0.7957 20.8637 20.8817 21.1282 20.9641
440046 1.3069 0.9445 27.9539 29.7377 30.7314 29.5270
440047 0.9617 0.8295 21.7892 22.8323 25.2156 23.3140
440048 1.8071 0.9305 29.4789 29.3187 30.6710 29.8250
440049 1.6747 0.9305 26.4772 28.8742 29.8603 28.4462
440050 1.2834 0.7964 24.4616 24.9694 26.3815 25.3086
440051 0.9337 0.8039 23.9253 23.4866 23.6554 23.6741
440052 1.0032 0.7957 22.8016 22.6128 24.4075 23.2437
440053 1.2712 0.9445 27.1197 27.8180 30.3887 28.4325
440054 1.0962 0.7957 23.5137 23.7931 21.9638 23.0467
440056 1.2127 0.7957 22.7820 23.2313 24.0623 23.3523
440057 1.1032 0.7978 16.6346 17.2176 19.3540 17.6957
440058 1.2003 0.7957 24.3522 26.0706 29.1174 26.6028
440059 1.4855 0.9252 28.3565 27.9467 29.4514 28.5989
440060 1.1325 0.8339 24.1024 25.0795 26.5869 25.2908
440061 1.1295 0.7957 23.9678 23.7360 25.4125 24.3711
440063 1.6197 0.7999 24.2566 23.9644 26.0741 24.7976
440064 0.9999 0.8857 23.7176 26.1246 26.7947 25.5515
440065 1.2421 0.9445 24.6169 25.8536 25.6096 25.3745
440067 1.1905 0.7957 24.4772 24.6553 26.0852 25.0966
440068 1.1835 0.8717 24.8146 26.1071 27.9066 26.2722
440070 1.0014 0.8066 20.0938 21.9166 23.2223 21.7288
440072 1.0393 0.8886 23.9563 25.7089 26.1643 25.2966
440073 1.4453 0.9252 26.3570 27.6154 27.5114 27.1567
440081 1.1673 0.8009 20.7125 20.7688 21.9671 21.1573
440082 1.9913 0.9445 30.6115 32.2479 32.8913 31.8790
440083 0.9577 0.7957 25.6099 23.6356 25.7074 24.9682
440084 1.1762 0.7982 18.6043 18.8699 19.8938 19.1297
440091 1.7581 0.8857 26.5687 28.1989 28.9678 27.9314
440102 1.0796 0.7957 20.7363 21.6762 22.1103 21.5215
440104 1.7788 0.8857 26.5741 27.9756 28.0888 27.5200
440105 0.9119 0.7999 22.9372 22.7962 23.7139 23.1599
440109 1.0139 0.8027 20.8924 21.4629 22.5885 21.7090
440110 1.1221 0.7957 20.9179 22.5929 23.6262 22.5559
440111 1.2820 0.9445 29.0975 28.8453 29.7446 29.2213
440115 0.9684 0.8295 23.1409 23.7107 24.9776 23.9354
440120 1.4947 0.7957 25.7161 24.7572 26.0604 25.5176
440125 1.6557 0.7957 22.8097 23.6328 24.0920 23.4915
440130 1.1217 0.7957 23.9955 25.1262 26.3188 25.1413
440131 1.1784 0.9305 25.6666 26.9649 28.3153 26.9308
440132 1.2291 0.7957 23.9410 24.0708 29.3371 25.7508
440133 1.7069 0.9445 29.2829 29.6093 32.5699 30.4215
440135 0.6898 0.7957 28.1925 27.7037 27.2084 27.7046
440137 1.0639 0.8695 22.2538 22.9547 24.6130 23.2371
440141 0.9917 0.7957 24.2406 24.9917 24.8736 24.6802
440144 1.2549 0.9252 23.9241 25.2293 26.3207 25.2055
440147 *** * 33.1756 34.8199 36.6955 34.8975
440148 1.1236 0.9252 23.9810 22.6188 28.0703 24.8107
440150 1.4307 0.9445 28.1012 29.4381 30.5491 29.3876
440151 1.1663 0.9252 27.1729 28.2203 28.6580 27.9977
440152 2.0008 0.9305 27.1877 28.4612 29.0563 28.2859
440153 1.0509 0.7964 23.6473 24.9388 23.3772 23.9591
440156 1.6421 0.8857 27.7309 28.5645 30.5139 28.9635
440159 1.4818 0.9305 26.9098 25.8289 27.2779 26.6811
440161 1.9267 0.9445 28.7074 29.9894 31.0647 29.9300
440162 *** * 27.6837 24.8705 24.6410 25.6902
440166 *** * 35.3064 * * 35.3064
440168 1.0456 0.9305 28.1215 29.4028 31.3312 29.7029
440173 1.4350 0.7957 23.1167 24.0621 23.1355 23.4173
440174 0.8828 0.8269 25.4829 26.2087 27.4573 26.4456
440175 1.0111 0.7957 24.4848 24.7869 26.7698 25.3295
440176 1.3339 0.7964 22.9631 23.7695 24.9405 23.9373
440180 1.3459 0.7984 24.9841 22.3070 24.3370 23.7701
440181 0.9020 0.8322 24.8857 25.9450 26.4759 25.8145
440182 0.9536 0.8101 24.3302 25.0111 24.9897 24.8044
440183 1.6228 0.9305 29.1982 30.6599 30.9900 30.2946
440184 1.1292 0.7999 24.5786 23.3970 26.9069 24.9779
440185 1.1883 0.8717 25.3817 26.7473 26.3958 26.1839
440186 0.9919 0.9445 27.3733 28.9124 28.2842 28.1940
440187 1.0974 0.7957 24.0723 25.8238 27.4029 25.7687
440189 1.4158 0.8452 28.2621 28.8974 30.5766 29.1873
440192 1.0765 0.9252 27.3917 29.6272 30.6519 29.2789
440193 1.3104 0.9445 24.3622 25.2124 25.9713 25.1845
440194 1.2925 0.9445 29.4706 30.8593 32.3002 30.9187
440197 1.3992 0.9445 29.4275 30.1184 31.4294 30.3064
440200 0.9829 0.9445 21.1860 23.8654 23.8295 22.9591
440203 *** * 23.7451 17.9041 * 20.6007
440217 1.3768 0.9305 28.8641 29.8888 31.6636 30.1328
440218 2.0116 0.9445 23.7257 18.7275 36.9244 25.9465
440222 1.0088 0.9305 28.4664 29.0062 30.5130 29.3485
440225 0.8097 0.7957 24.8328 27.8860 26.9656 26.4719
440226 1.5694 0.7957 26.5831 27.1348 28.3176 27.3318
440227 1.2974 0.9445 * 30.7785 31.9097 31.3743
440228 1.5738 0.9305 * 28.3687 29.5349 29.0087
450002 1.4448 0.8867 28.0936 28.8521 29.7157 28.8515
450005 1.2408 0.8595 24.4933 24.5405 27.3460 25.4548
450007 1.3344 0.8949 23.0026 23.9490 24.4625 23.8045
450008 1.3803 0.8855 24.4701 24.5965 24.4362 24.5017
450010 1.5960 0.9175 25.5503 25.5582 30.1022 27.0858
450011 1.6560 0.9193 26.7418 28.5329 29.9285 28.4349
450015 1.5911 0.9852 29.9193 29.4919 30.3151 29.9209
450018 1.5354 0.9925 30.2383 30.7852 31.3118 30.7838
450021 1.8903 0.9852 29.5658 31.3107 31.7338 30.8752
450023 1.4138 0.8153 25.4450 25.5346 25.1670 25.3821
450024 1.5693 0.8867 26.9113 28.2047 27.3787 27.5109
450028 1.5788 0.9226 29.1438 29.5792 29.5668 29.4314
450029 1.6143 0.8816 25.0602 26.9361 28.6442 26.7635
450031 1.4439 0.9852 29.0824 30.3542 29.2123 29.5392
450032 1.2547 0.8407 21.5084 25.5785 26.3146 24.2723
450033 1.5969 0.9226 29.2468 27.8680 29.7653 28.9230
450034 1.5308 0.8595 26.5313 27.6929 29.6291 28.1119
450035 1.5326 0.9925 28.0668 28.8049 30.3345 29.0806
450037 1.5845 0.8666 26.6207 28.3403 28.2594 27.7345
450039 1.5955 0.9852 26.7503 28.2081 29.8132 28.2727
450040 1.7553 0.8712 25.4734 26.8412 28.5453 26.9585
450042 1.7455 0.8703 26.6382 26.5429 27.6115 26.9555
450044 1.6959 0.9852 31.0381 29.4293 32.9897 31.1698
450046 1.5774 0.8494 24.8947 25.5903 27.2425 25.9770
450047 0.8561 0.9226 21.8824 23.8457 24.9663 23.5090
450051 1.9250 0.9852 28.8829 29.9038 30.3953 29.7565
450052 0.9850 0.8153 22.6448 23.0007 24.3959 23.3480
450054 1.7911 0.8855 27.5399 26.5599 30.2202 28.0403
450055 1.0449 0.8153 22.9245 23.6382 24.1423 23.5765
450056 1.6824 0.9521 28.3092 31.4971 32.0873 30.6432
450058 1.5743 0.8949 26.6926 26.9918 27.7297 27.1586
450059 1.2980 0.9024 26.8325 27.3856 28.5629 27.5865
450064 1.5113 0.9852 26.8355 28.2786 29.0474 28.0416
450068 2.0486 0.9925 29.5876 30.5001 32.0346 30.7379
450072 1.2155 0.9925 25.8619 27.1081 28.0902 27.0430
450073 0.8877 0.8153 26.9446 26.1567 22.2326 25.0645
450076 1.6904 * * * * *
450078 0.8999 0.8153 21.4716 20.0758 20.7809 20.7567
450079 1.6789 0.9852 30.2420 30.5968 36.8906 32.4452
450080 1.2493 0.8666 27.9191 26.2439 26.8091 27.0298
450082 1.1597 0.8153 23.9025 24.2018 25.5648 24.5569
450083 1.7529 0.8901 27.4955 32.6462 30.2031 29.9862
450085 1.0822 0.8153 24.3637 25.6440 26.3606 25.4425
450087 1.3998 0.9852 30.0095 31.2668 32.6536 31.3363
450090 1.2615 0.8803 21.3837 21.8839 22.7815 22.0412
450092 1.2126 0.8153 24.9917 26.2781 28.2267 26.4935
450096 *** * 26.5103 28.1902 * 27.3122
450097 1.4580 0.9925 29.0142 29.8734 31.9758 30.2412
450099 1.3019 0.8883 31.3495 31.7829 29.8469 30.9845
450101 1.6171 0.8703 25.4409 26.7457 28.4201 26.8726
450102 1.7083 0.8901 25.6318 26.4161 27.3343 26.4779
450104 1.1855 0.8949 24.6169 28.8063 27.7838 26.9841
450107 1.5806 0.8867 27.6064 27.8177 29.0310 28.1649
450108 1.1922 0.8949 21.6557 19.3245 22.4281 21.1092
450119 1.3181 0.9118 27.8027 31.1026 34.4129 30.7679
450121 *** * 29.1296 27.7472 * 28.4439
450123 1.3318 0.8595 24.9674 26.2469 24.0420 24.9404
450124 1.7511 0.9521 28.2571 30.9140 31.9772 30.4250
450126 1.3989 0.9925 29.3768 30.5540 32.0348 30.6758
450128 1.2318 0.9118 25.1122 26.3296 28.3156 26.5694
450130 1.1977 0.8949 24.3295 24.3842 26.9201 25.2414
450131 *** * 25.9494 * * 25.9494
450132 1.6322 0.9425 30.1620 31.9981 31.1340 31.0941
450133 1.5320 0.9283 28.4647 30.0648 30.9597 29.8077
450135 1.6395 0.9852 27.8983 30.1385 30.7885 29.6276
450137 1.6679 0.9852 31.4950 31.9644 35.7749 33.2271
450143 1.0277 0.9521 23.4592 23.6834 24.4333 23.8654
450144 1.0083 0.8712 26.2881 29.2987 31.1551 28.7443
450147 1.4564 0.8153 24.3562 24.7221 26.3019 25.1662
450148 1.2241 0.9852 27.0894 29.6777 30.0530 28.8673
450151 *** * 23.9558 26.2011 22.8759 24.2772
450152 1.2565 0.8855 23.3428 23.1056 24.3424 23.6074
450154 1.3302 0.8153 21.7237 22.9357 24.2578 22.9598
450155 1.1251 0.8153 21.7604 24.8052 24.8768 23.6641
450162 1.3269 0.8712 33.3285 32.9317 33.7803 33.3236
450163 1.0627 0.8207 24.1267 24.7857 27.0963 25.3188
450165 1.1447 0.8949 28.6490 29.1839 30.2222 29.3460
450176 1.4003 0.9118 23.1284 24.4338 25.8569 24.4742
450177 1.0905 0.8153 23.7624 24.4064 26.0891 24.7683
450178 0.9986 0.9283 27.8405 27.1184 28.5998 27.8381
450184 1.5684 0.9925 28.5399 29.5940 30.9705 29.6894
450187 1.2150 0.9925 28.3243 27.7374 29.2737 28.4472
450188 0.9254 0.8153 23.0595 23.2280 24.6816 23.6817
450191 1.1258 0.9521 26.5863 28.3937 31.1321 28.6333
450192 1.1180 0.8424 24.1186 26.4722 26.9874 25.8921
450193 2.0321 0.9925 34.4545 36.4793 37.1873 36.0649
450194 1.2632 0.8366 22.9605 24.3531 30.4368 25.7167
450196 1.4595 0.9852 24.0161 23.4577 25.4820 24.2962
450200 1.6042 0.8195 23.5012 25.6413 27.9825 25.4502
450201 0.9730 0.8153 23.2510 23.2800 22.5445 22.9956
450203 1.2116 0.9684 26.5237 27.8795 28.0968 27.5107
450209 1.8278 0.8997 27.5668 30.6146 31.9858 29.9981
450210 1.0215 0.8304 21.8722 22.5736 22.9049 22.4486
450211 1.3455 0.8666 28.4581 28.3770 28.8471 28.5692
450213 1.7959 0.8949 25.9169 26.8566 28.0289 26.9446
450214 1.2281 0.9925 27.4357 27.9913 28.2247 27.8829
450219 0.9660 0.8153 21.9207 23.9636 24.7267 23.5184
450221 1.1119 0.8153 19.3793 21.3721 20.7113 20.5035
450222 1.6824 0.9925 30.0314 30.3801 31.9231 30.7843
450224 1.3283 0.8901 26.8302 28.4382 28.7921 28.0121
450229 1.6525 0.8408 24.4450 25.1370 26.8016 25.3958
450231 1.6726 0.8997 27.1674 26.9783 27.0533 27.0671
450234 1.0198 0.8153 20.6889 20.4659 21.6802 21.1358
450235 1.0077 0.8153 23.5212 21.8967 23.8005 23.0639
450236 1.1319 0.8542 23.5426 22.9622 24.5926 23.6934
450237 1.6540 0.8949 25.7939 30.5885 31.2172 28.9557
450239 0.9770 0.8855 21.2586 19.1359 18.4232 19.4675
450241 1.0252 0.8153 20.8732 21.3641 28.4948 23.5112
450243 1.0024 0.8153 15.4510 17.2966 19.0176 17.2995
450253 0.9321 0.9925 24.2435 24.1056 22.9919 23.7733
450270 1.2113 0.8424 15.2190 19.8180 12.9994 15.5383
450271 1.2778 0.9684 22.7035 24.1269 23.9525 23.6286
450272 1.2096 0.9521 26.2576 27.0521 29.0903 27.4843
450280 1.4612 0.9852 29.9730 31.6575 34.9324 32.1866
450283 1.0893 0.9852 22.7938 24.1754 28.2079 24.8171
450289 1.4524 0.9925 32.2645 32.6533 32.6122 32.5225
450292 1.2808 0.9852 26.3242 26.8110 29.0226 27.3779
450293 0.8910 0.8153 23.6413 24.0827 24.1552 23.9551
450296 1.0439 0.9925 30.4324 31.5596 33.4528 31.7845
450299 1.5997 0.9193 27.5797 28.4171 29.4576 28.5044
450306 0.9802 0.8408 21.4558 22.9486 22.6822 22.3403
450315 2.4335 0.9852 37.1721 * 31.4204 33.9617
450324 1.5212 0.9852 25.1633 26.6093 27.9889 26.5490
450330 1.2552 0.9925 26.0771 27.1100 27.7403 26.9930
450340 1.4092 0.8600 25.0344 25.6791 30.5228 26.9242
450346 1.4343 0.8595 23.6072 23.8720 24.8416 24.1224
450347 1.2208 0.9925 28.7667 30.7825 28.5780 29.3911
450348 1.0018 0.8153 21.6787 21.0484 22.6822 21.8120
450351 1.2791 0.9684 26.5388 29.2560 29.9580 28.5841
450352 1.1062 0.9852 26.2281 27.2983 27.6466 27.0615
450353 *** * 27.0248 27.9576 * 27.5079
450358 1.9716 0.9925 31.4926 32.5922 33.9078 32.6875
450369 0.9268 0.8153 19.9148 22.8525 24.1950 22.2632
450370 1.2579 0.8388 25.5834 26.3235 29.0806 27.0009
450372 1.4550 0.9852 30.8886 29.5022 30.9328 30.4453
450373 0.9144 0.8153 24.8286 27.0726 27.4243 26.4835
450378 1.3092 0.9925 30.3883 32.2278 33.0566 31.9025
450379 1.4002 0.9852 33.7521 35.3807 35.0613 34.7094
450388 1.7004 0.8949 27.4328 27.8155 29.5360 28.2774
450389 1.1714 0.9852 25.6732 26.9638 26.8481 26.4861
450393 0.7662 0.9852 21.9347 * 39.0250 28.4483
450395 1.0730 0.9925 27.5189 26.7743 28.4265 27.6022
450399 0.8925 0.8153 20.3528 22.1731 20.6300 21.0332
450400 1.0684 0.8153 23.6358 26.2871 29.5008 26.1110
450403 1.3192 0.9852 29.0359 29.8643 31.7040 30.2580
450411 1.0061 0.8153 20.9372 21.5746 21.7875 21.4276
450418 *** * 28.4362 * * 28.4362
450419 1.3124 0.9852 31.9966 34.2427 34.9949 33.8163
450422 1.2786 0.9852 34.4331 31.3454 32.4640 32.6976
450424 1.3562 0.9925 28.2463 30.7228 29.8269 29.5962
450431 1.6067 0.9521 26.3263 27.3926 28.5263 27.4173
450438 1.1486 0.8388 27.8659 26.5223 27.7728 27.3852
450446 0.7131 0.9925 17.0691 17.2871 15.4631 16.6064
450447 1.3552 0.9852 25.4200 26.5238 28.3710 26.7880
450451 1.0753 0.8689 24.6201 26.5477 25.8824 25.6945
450460 0.9426 0.8206 22.4227 24.9870 25.2172 24.1531
450462 1.7253 0.9852 29.6069 30.1466 30.6488 30.1364
450465 1.1257 0.9925 26.2759 27.0835 28.1840 27.2041
450469 1.4624 0.9852 26.3262 26.3445 31.1333 27.8724
450475 1.1940 0.8666 23.0942 24.5176 24.7023 24.0834
450484 1.4990 0.8666 26.7242 28.3913 27.7774 27.6347
450488 1.1180 0.8666 22.3981 23.7985 24.9095 23.7092
450489 0.9839 0.8153 23.4806 25.2680 26.9542 25.1940
450497 0.9966 0.8528 22.0918 23.1860 23.0703 22.7799
450498 0.9829 0.8153 18.6563 20.2475 20.6876 19.8494
450508 1.4530 0.8666 28.4471 27.2850 29.1501 28.3018
450514 *** * 26.3704 27.3043 26.4002 26.6921
450518 1.4419 0.8595 28.1755 29.1322 27.5863 28.1826
450530 1.2667 0.9925 29.1349 29.9720 30.7727 29.9520
450537 1.5128 0.9852 27.7757 28.7448 30.9146 29.1361
450539 1.2202 0.8220 23.1829 24.2151 25.0188 24.1139
450547 0.9744 0.9852 23.7820 34.3349 25.4122 27.1653
450558 1.7678 0.8408 26.9407 28.0655 28.7729 27.9448
450563 1.5299 0.9852 30.8332 32.0507 32.6847 31.9164
450565 1.3270 0.9684 26.7942 28.1741 27.4760 27.4805
450571 1.6222 0.8600 25.2108 27.4605 26.5303 26.3740
450573 1.0770 0.8279 22.0797 22.1492 24.6744 22.9817
450578 0.9673 0.8153 22.5167 25.0498 25.2476 24.2617
450580 1.0515 0.8153 22.3886 23.9004 25.9872 23.9915
450584 1.0829 0.8153 20.5257 22.5204 23.6045 22.1623
450586 1.0201 0.8153 18.9107 20.6699 18.3294 19.3042
450587 1.2259 0.8153 23.1202 25.0174 25.9358 24.6518
450591 1.1895 0.9925 25.7031 27.1744 27.9847 26.9265
450596 1.1854 0.9684 27.4011 29.8462 31.6577 29.6788
450597 0.9963 0.8153 24.7853 24.2586 24.8439 24.6216
450604 1.3397 0.8153 24.4743 25.9133 29.1526 26.5819
450605 0.9810 0.8494 20.9276 23.9332 14.8030 19.8571
450610 1.5974 0.9925 27.7317 28.3713 30.5957 28.8793
450615 0.9986 0.8185 21.8442 24.1902 22.6324 22.8680
450617 1.5826 0.9925 28.0225 28.8323 30.2898 29.0536
450620 0.9635 0.8153 18.6183 20.3723 21.2530 20.0799
450630 1.5054 0.9925 29.1462 29.8431 31.7991 30.2292
450634 1.6203 0.9852 28.7312 30.3274 31.7983 30.2933
450638 1.5993 0.9925 30.6572 32.4911 33.3208 32.0988
450639 1.4598 0.9852 30.4019 32.6255 34.3727 32.4471
450641 0.9799 0.8528 19.4389 20.2483 21.7288 20.4546
450643 1.3367 0.8816 22.7355 24.4999 27.2517 24.7934
450644 1.5467 0.9925 29.7918 30.7815 31.6848 30.7914
450646 1.4527 0.8867 25.6313 26.8060 27.4611 26.6291
450647 1.8764 0.9852 30.6924 32.4236 34.0988 32.4013
450651 1.5358 0.9852 30.4484 31.9261 33.6467 32.0226
450653 1.1592 0.8153 25.2144 26.1756 26.5346 25.9882
450654 0.9049 0.8153 21.5002 22.5447 25.0736 23.0141
450656 1.4220 0.8666 25.5050 28.1493 29.7276 27.7366
450658 0.9793 0.8153 22.2293 24.7856 22.7086 23.2037
450659 1.4021 0.9925 31.5024 34.2380 34.2632 33.2709
450661 1.4614 0.9425 30.2610 30.0751 29.2361 29.8375
450662 1.6460 0.9226 29.0535 29.0532 30.9608 29.6825
450668 1.5414 0.8867 28.8635 30.6114 30.2059 29.8659
450669 1.2189 0.9852 27.9796 30.2374 32.1221 30.1382
450670 1.4361 0.9925 25.9638 26.4266 26.2942 26.2315
450672 1.8349 0.9852 30.1191 31.8420 33.0834 31.7654
450674 0.9478 0.9925 28.7101 29.8971 31.9284 30.1847
450675 1.4578 0.9852 28.9005 30.9562 32.6351 30.8652
450677 1.3166 0.9852 25.9555 27.2760 27.1594 26.8126
450678 1.4170 0.9852 31.1563 33.3386 33.5496 32.6557
450683 1.2015 0.9852 27.4925 21.1737 24.8430 24.2908
450684 1.2814 0.9925 29.3025 30.2139 31.2746 30.2639
450686 1.6149 0.8712 24.2331 25.8530 26.4851 25.5754
450688 1.2727 0.9852 26.8599 26.9897 29.4376 27.7076
450690 1.3408 0.8901 26.5528 26.1743 30.0569 27.4939
450694 1.1759 0.8153 23.9961 24.0031 27.0859 24.8819
450697 1.4748 0.8949 24.8667 26.4132 28.2983 26.4744
450698 0.9175 0.8280 20.0955 21.5742 23.3052 21.6138
450702 1.6153 0.8666 26.8384 26.3696 27.1300 26.7835
450709 1.4034 0.9925 26.8146 27.1077 31.3218 28.4257
450711 1.4823 0.9118 26.7472 27.5622 28.1016 27.5198
450713 1.5563 0.9521 28.8285 29.4980 30.4912 29.6225
450715 1.3146 0.9852 17.3991 17.0235 * 17.2098
450716 1.4070 0.9925 32.3960 33.7096 33.9898 33.3800
450718 1.4669 0.9521 27.3215 28.1560 29.7584 28.4466
450723 1.4494 0.9852 28.5103 30.1704 31.0456 29.9614
450730 1.3722 0.9852 31.3324 32.7293 32.8896 32.3004
450742 1.1754 0.9852 27.2023 30.0583 30.4185 29.2913
450743 1.4478 0.9852 28.3362 28.4736 29.5077 28.8191
450746 0.8780 0.8153 20.6343 22.7873 23.3483 22.2429
450747 1.1965 0.8901 23.8314 25.8175 28.3918 25.8472
450749 0.9371 0.8153 20.0487 22.1562 23.9271 21.9555
450751 *** * 18.7456 21.4223 * 20.1469
450754 0.9429 0.8153 22.1819 24.7797 22.8559 23.2191
450755 0.9660 0.8429 19.8988 22.2006 24.7427 22.1319
450758 *** * 28.7342 28.2803 28.3285 28.4884
450760 1.0061 0.8867 24.7489 25.1637 23.7138 24.5602
450766 2.0334 0.9852 30.8004 30.2341 31.2061 30.7524
450770 1.1706 0.9521 24.1647 24.3244 23.6084 24.0129
450771 1.7003 0.9852 30.7105 32.0500 32.4987 31.7652
450774 1.7600 0.9925 27.2080 25.7436 27.5052 26.8202
450775 1.3943 0.9925 28.1428 29.8230 31.6636 29.9048
450779 1.2842 0.9852 29.9674 31.8403 32.0748 31.3351
450780 2.5251 0.8949 26.7611 27.0084 28.5545 27.4508
450788 1.5291 0.8494 26.2840 28.3759 29.7646 28.1299
450795 1.1739 0.9925 25.2007 32.9803 43.8548 34.0292
450796 1.8173 0.8997 36.4073 37.6274 39.4710 37.9807
450797 1.2450 0.9925 24.8950 24.8598 26.0293 25.2371
450801 1.4989 0.8195 24.6328 23.6072 25.6368 24.6370
450803 1.2105 0.9925 28.9235 29.0106 28.7024 28.8861
450804 2.0345 0.9925 27.8775 29.1282 31.1869 29.4370
450808 1.8935 0.9521 21.9793 23.0312 29.6456 24.9240
450809 1.6551 0.9521 26.4223 27.3080 29.4671 27.7555
450811 1.7218 0.9118 27.2584 31.2208 31.7219 29.8931
450813 1.1338 0.8949 20.1710 22.9289 26.5793 23.2366
450820 1.4186 0.9925 31.4666 33.9030 34.7415 33.5465
450822 1.3260 0.9852 32.2968 32.2145 34.4032 32.9996
450824 2.6758 0.9521 31.2375 33.3653 31.8377 32.1641
450825 1.4768 0.9118 20.6457 25.1521 25.7993 23.7848
450827 1.4405 0.9175 23.7554 24.1984 24.3655 24.1145
450828 1.3774 0.8153 24.4740 24.8236 26.9546 25.5737
450829 *** * 20.6016 19.5842 * 20.0933
450830 1.0119 0.9283 28.5902 27.8005 28.4004 28.2670
450831 0.9180 0.9925 23.3880 23.9467 24.4124 23.8672
450832 1.3167 0.9925 26.5229 27.3290 28.1375 27.3874
450833 1.1878 0.9852 27.0133 27.9649 29.0241 28.0113
450834 1.6180 0.9193 20.9607 27.4844 26.7240 24.5166
450838 1.0772 0.8279 19.5754 18.9620 19.2941 19.2971
450839 0.9688 0.8153 25.8222 27.2199 27.5319 26.8415
450840 1.2996 0.9852 30.1743 32.2538 32.4135 31.6992
450841 1.9116 0.9226 20.9410 20.9424 24.4366 22.2249
450844 1.3797 0.9925 30.7887 33.7978 33.0727 32.7243
450845 1.8834 0.8867 29.4933 29.9265 28.5011 29.2842
450847 1.2564 0.9925 28.5548 29.7356 30.7409 29.7031
450848 1.2904 0.9925 29.5355 30.5546 31.1455 30.4213
450850 1.5769 0.9562 21.9266 31.9606 27.2645 26.5516
450851 2.3662 0.9852 32.6950 35.1102 32.8357 33.5034
450853 1.7353 0.9852 36.1169 37.1043 38.3572 37.3449
450854 *** * 27.1868 * * 27.1868
450855 1.6258 0.9226 30.8855 32.6916 30.7321 31.4205
450856 2.0970 0.8949 39.0865 37.7362 35.4977 37.3569
450857 *** * 30.4632 * * 30.4632
450860 1.8529 0.9925 24.0171 29.1075 33.3360 29.3070
450861 *** * 34.9290 * * 34.9290
450862 1.5594 0.9925 31.2224 31.8095 33.7932 32.2128
450863 *** * 24.8825 * * 24.8825
450864 2.1890 0.8901 23.3765 24.5049 25.3514 24.5415
450865 1.1032 0.9521 29.1763 29.9559 31.9179 30.4451
450866 *** * 15.2959 * * 15.2959
450867 1.1589 0.9521 28.2289 29.5879 31.4926 29.7806
450868 1.7418 0.9425 27.9579 25.3486 27.7398 27.0759
450869 2.1455 0.9118 22.6253 26.1616 28.7406 27.5500
450870 *** * 37.4364 * * 37.4364
450871 1.8768 0.9521 * 28.9150 32.3967 30.6337
450872 1.3756 0.9852 * 27.2833 31.7321 29.8421
450873 *** * * 14.8821 * 14.8821
450874 1.6738 0.9852 * 34.6083 35.6817 35.2071
450875 1.7360 0.8997 * 23.2763 23.2949 23.2862
450876 1.9264 0.8712 * 28.4343 30.3498 29.4575
450877 1.4979 0.8867 * 26.1867 29.2330 27.6968
450878 2.5641 0.8949 * 31.6750 33.6233 32.6691
450879 1.3352 0.8816 * 35.5672 36.4836 36.0727
450880 1.5477 0.9852 * 35.9572 32.6680 34.0899
450881 *** * * 24.5464 * 24.5464
450882 *** * * 26.6910 * 26.6910
450883 2.4793 0.9852 * 35.2646 37.1500 36.2387
450884 1.0281 0.8715 * 27.8213 23.5791 25.5501
450885 1.4517 0.9852 * 34.1148 36.0926 35.1477
450886 1.5017 0.9852 * * 30.1552 30.1552
450887 *** * * * 25.5574 25.5574
450888 1.7096 0.9708 * * 28.5970 28.5970
450889 1.5530 0.9852 * * 35.6125 35.6125
450890 1.8266 0.9852 * * 32.1973 32.1973
450891 1.4143 0.9852 * * 39.0842 39.0842
450892 *** * * * 39.5303 39.5303
450893 1.3909 0.9852 * * 36.2633 36.2633
450894 1.7932 0.9852 * * 25.9422 25.9422
450895 *** * * 18.4142 * 18.4142
460001 1.8307 0.9075 28.7150 30.0040 * 29.3648
460003 1.5382 0.9271 31.4135 32.3427 29.6430 31.1480
460004 1.7729 0.9271 28.2040 29.6342 29.8751 29.2534
460005 1.5237 0.9271 25.0239 26.0731 29.4163 26.8371
460006 1.4480 0.9271 27.1392 28.3678 28.9633 28.1485
460007 1.3341 0.9228 27.1308 28.0035 29.1171 28.1204
460008 1.3382 0.9271 29.5907 31.5485 27.6886 29.5829
460009 1.9760 0.9271 27.2885 28.3836 29.4687 28.4457
460010 2.0995 0.9271 29.0063 30.4606 30.9793 30.1575
460011 1.3236 0.8395 24.4402 24.9677 26.5474 25.3370
460013 1.3909 0.9075 27.7381 29.2731 29.7232 28.9118
460014 1.1488 0.9271 28.2647 29.5963 30.6427 29.4780
460015 1.3542 0.8827 27.2506 29.1318 28.7993 28.4031
460017 1.5067 0.8778 24.3030 26.1589 28.7101 26.4243
460018 0.8937 0.8395 22.0517 22.8028 22.0916 22.3156
460019 1.1962 0.8395 24.3756 23.2202 25.1607 24.2508
460020 0.9177 * 18.5159 * * 18.5159
460021 1.7949 1.1388 28.0291 29.5761 29.7373 29.2069
460023 1.2032 0.9075 26.9512 28.5884 28.9445 28.1975
460026 1.0634 0.9052 26.9295 27.9487 29.2757 28.0634
460030 1.1657 0.8395 23.5942 24.4218 26.8971 24.9667
460033 0.8711 0.8395 25.3422 26.6606 27.9090 26.6490
460035 0.9610 0.8395 20.6322 21.9115 23.8672 22.1202
460039 1.0970 0.8827 29.5651 30.4912 30.0656 30.0667
460041 1.3694 0.9271 26.4640 26.3807 26.7342 26.5286
460042 1.4973 0.9271 24.9454 26.8389 36.2868 28.7517
460043 0.9867 0.9075 28.2008 28.6668 29.5636 28.8137
460044 1.3270 0.9271 27.4928 28.7023 29.5056 28.5642
460047 1.6851 0.9271 28.2336 29.9990 30.9988 29.7618
460049 1.9801 0.9271 26.6702 28.4884 28.6251 27.9963
460051 1.4090 0.9271 27.0160 27.8841 28.1118 27.6918
460052 1.6516 0.9075 26.1629 27.1995 28.7433 27.4110
460054 1.6931 0.8827 24.9926 25.7870 26.3926 25.7328
460055 1.4742 0.9075 * * * *
470001 1.2668 0.9297 28.3017 29.7540 32.2867 30.1248
470003 1.8776 0.9275 28.1137 30.1973 30.0513 29.4645
470005 1.3533 0.9275 30.7872 33.1981 33.9946 32.7064
470011 1.1581 0.9275 28.1330 29.6269 30.8723 29.5547
470012 1.2088 0.9275 26.0225 27.0751 29.8242 27.6835
470024 1.1462 0.9275 27.0394 26.6351 27.3091 26.9932
490001 1.0923 0.8061 23.2174 24.0368 24.6876 23.9910
490002 1.0162 0.8061 20.8609 21.7092 24.0666 22.0939
490004 1.2931 0.9449 27.1676 27.5890 28.8643 27.8908
490005 1.5720 1.0669 29.8215 30.5349 31.4889 30.6457
490007 2.0360 0.8869 27.6572 29.3098 30.7391 29.2722
490009 1.9926 0.9728 30.4722 28.4642 31.4238 30.0808
490011 1.5707 0.8869 26.4766 27.4764 28.8762 27.6271
490012 1.0101 0.8061 21.0605 22.9922 21.8319 21.9360
490013 1.3744 0.9694 24.7521 25.5560 27.3086 25.8824
490017 1.5021 0.8869 25.8216 27.5902 29.6761 27.7176
490018 1.3622 0.9449 26.2510 27.2644 27.8664 27.1379
490019 1.1503 1.0669 25.9885 25.8264 29.8874 27.1451
490020 1.2876 0.9203 27.3142 29.3468 30.5993 29.0707
490021 1.4622 0.8646 25.7938 27.0641 28.1233 26.9966
490022 1.4112 1.0669 32.2676 30.1203 31.7964 31.3740
490023 1.3297 1.0669 30.3416 30.9920 32.6291 31.3336
490024 1.6994 0.8889 26.1125 27.9689 29.0379 27.6964
490027 1.1143 0.8061 24.0288 23.0017 24.3832 23.7446
490032 1.9515 0.9203 25.2654 28.5897 28.0097 27.3514
490033 1.0967 1.0669 31.2922 31.8282 30.9894 31.3730
490037 1.2781 0.8061 24.7711 25.2859 26.2942 25.4675
490038 1.2238 0.8061 21.8509 22.6504 24.0844 22.8205
490040 1.5127 1.1017 32.6564 34.1841 35.6796 34.1603
490041 1.5635 0.8869 26.0897 27.1613 29.1224 27.4587
490042 1.3157 0.8750 24.4650 25.7333 26.6055 25.6256
490043 1.3375 1.1017 33.7096 35.8872 36.5934 35.4348
490044 1.4493 0.8869 23.3527 23.3793 24.1751 23.6463
490045 1.3427 1.0669 32.0937 30.3772 32.8751 31.7663
490046 1.5416 0.8869 26.6517 27.9604 29.3861 28.0339
490048 1.4333 0.8646 26.2828 27.0620 28.0302 27.1308
490050 1.5231 1.0669 31.3885 32.2993 31.1346 31.5946
490052 1.6678 0.8869 23.5973 25.0046 25.1956 24.5749
490053 1.1871 0.8061 23.3315 23.8004 24.6193 23.9160
490057 1.6362 0.8869 26.6898 27.4918 29.0678 27.7786
490059 1.6585 0.9203 27.3611 30.8669 32.1008 30.0791
490060 1.0194 0.8061 23.6113 24.3192 25.7752 24.5807
490063 1.8759 1.1017 31.3619 31.6069 34.1154 32.3880
490066 1.3873 0.8869 27.8250 29.5917 31.4281 29.7032
490067 1.2870 0.9203 24.9021 25.9497 26.7787 25.8584
490069 1.5365 0.9203 27.3181 29.1527 30.1463 28.8658
490071 1.4069 0.9203 29.7186 31.7061 33.7101 31.7115
490073 *** * 33.1829 34.5774 46.4178 36.1085
490075 1.3188 0.8483 25.2022 25.7323 27.3411 26.0795
490077 1.4181 0.9728 26.6806 28.1506 31.0002 28.6185
490079 1.2674 0.8985 25.3103 25.2340 24.2052 24.9039
490084 1.1427 0.8248 24.9007 25.7657 26.3132 25.6727
490088 1.0983 0.8646 24.1471 25.0619 26.0270 25.0928
490089 1.1018 0.8889 24.9438 25.9902 27.4562 26.1612
490090 1.0545 0.8061 25.1157 25.5418 27.0746 25.9182
490092 1.0775 0.8061 23.3439 25.7405 27.5268 25.4745
490093 1.5429 0.8869 25.6531 26.7886 28.7103 27.0735
490094 0.9727 0.9203 28.2165 28.9155 29.7975 28.9991
490097 1.0690 0.9203 26.5322 27.1470 27.4607 27.0696
490098 1.2889 0.8061 23.2782 25.1625 26.7140 25.0883
490101 1.4144 1.1017 31.2377 32.3695 32.9490 32.2107
490104 0.7712 0.9203 * 17.0548 19.0055 18.0437
490105 0.8355 0.8061 25.5329 26.3827 * 25.9379
490106 0.7733 0.8061 23.8334 25.7352 26.2318 25.2383
490107 1.4215 1.1017 32.2672 33.5430 35.0239 33.6804
490108 1.0546 0.8646 22.9076 23.3204 25.1884 23.8173
490109 0.9060 0.8869 22.7854 24.2296 21.6710 22.7835
490110 1.3576 0.8307 24.2887 24.9861 26.3071 25.2068
490111 1.1082 0.8061 22.1476 22.7336 26.4282 23.6179
490112 1.7315 0.9203 27.1932 29.0816 31.2526 29.1894
490113 1.2911 1.0669 31.8177 32.4547 34.7813 33.0718
490114 1.1439 0.8061 22.5255 22.1387 23.0526 22.5829
490115 1.2011 0.8061 22.4058 23.5718 23.2109 23.0488
490116 1.1712 0.8061 24.2258 24.3853 25.0343 24.5470
490117 1.1002 0.8061 19.6398 18.1138 20.3031 19.3436
490118 1.6337 0.9203 27.6749 29.0569 31.2383 29.3451
490119 1.3013 0.8869 26.5756 27.8866 29.5203 28.0191
490120 1.4551 0.8869 25.8795 25.9610 27.1973 26.3518
490122 1.5919 1.1017 32.0743 33.3719 35.2212 33.5744
490123 1.1435 0.8061 24.3490 24.2254 24.5997 24.3927
490126 1.1732 0.8061 23.6690 24.0908 25.3282 24.3545
490127 1.1178 0.8061 21.3735 23.5161 23.1390 22.6004
490130 1.2203 0.8869 23.9982 25.3352 25.9771 25.1170
490134 0.8323 0.8061 * 33.2405 31.1474 32.1153
490135 0.7518 0.8889 * 25.9998 27.2771 26.6418
490136 1.4451 0.9203 * * 31.2889 31.2889
490138 1.9348 0.8646 * * * *
500001 1.6024 1.1562 31.1605 33.0901 37.5297 33.7723
500002 1.3750 1.0164 27.6400 29.1448 30.1855 29.0190
500003 1.3968 1.1377 30.6939 32.1262 32.7960 31.8089
500005 1.8014 1.1562 33.5117 35.0997 36.0900 34.9342
500007 1.3520 1.1377 29.2869 30.5263 31.0289 30.3229
500008 1.9737 1.1562 32.6052 33.5666 34.7787 33.6731
500011 1.3817 1.1562 31.4514 32.6223 38.3960 33.9417
500012 1.7799 1.0164 30.0509 33.8101 33.1661 32.2294
500014 1.6593 1.1562 36.1380 36.5833 37.2677 36.6858
500015 1.4000 1.1562 34.5877 37.5724 40.8644 37.5957
500016 1.6703 1.1377 31.4905 32.9177 34.2801 32.9164
500019 1.2524 1.0295 30.5594 31.6242 33.8866 32.0653
500021 1.3071 1.1377 30.7927 32.4702 33.5572 32.3511
500024 1.7453 1.1462 32.6171 36.1647 37.4510 35.4266
500025 1.9117 1.1562 37.7952 40.6369 44.7077 41.0323
500026 1.4550 1.1562 32.8369 34.5881 35.5055 34.3334
500027 1.4942 1.1562 34.6164 39.2906 42.4941 38.7477
500030 1.6959 1.1395 32.4426 34.9174 36.7964 34.7347
500031 1.2671 1.1297 32.8833 33.2391 34.1649 33.4481
500033 1.2468 1.0164 30.6292 31.8891 32.6732 31.7837
500036 1.3290 1.0164 28.7096 30.5938 31.9136 30.4918
500037 1.0577 1.0164 28.1056 31.2654 29.1752 29.5198
500039 1.5629 1.1377 32.2245 33.5606 34.5710 33.5071
500041 1.4344 1.1186 30.3627 34.2017 36.9240 33.8434
500044 1.8913 1.0514 29.0214 31.0936 32.0719 30.6373
500049 1.3698 1.0164 27.7170 29.8189 30.8120 29.5153
500050 1.5082 1.1186 32.6751 33.7713 35.7229 34.0820
500051 1.7917 1.1562 32.5764 34.7610 36.4745 34.6036
500052 1.4632 1.1562 * * * *
500053 1.2557 1.0164 28.2901 30.2811 28.5649 29.0318
500054 1.9737 1.0514 31.6595 32.5105 34.8088 32.9758
500058 1.6843 1.0164 30.7487 30.7034 32.6820 31.4274
500060 1.3541 1.1562 37.4869 38.7682 40.3002 38.8996
500064 1.8909 1.1562 31.6112 32.3581 34.7906 32.9459
500072 1.2605 1.0576 31.2000 32.5269 33.1128 32.3268
500077 1.4765 1.0514 31.6153 33.2223 34.3082 33.0354
500079 1.3733 1.1377 31.3280 32.5809 34.2468 32.6847
500084 1.2608 1.1562 30.2411 32.7883 33.3057 32.1164
500088 1.4739 1.1562 35.3770 36.7953 38.5166 36.8898
500108 1.6172 1.1377 31.8483 34.3872 35.8890 34.0321
500119 1.3809 1.0514 29.7028 31.2233 31.7102 30.8549
500124 1.4071 1.1562 32.3505 34.4790 36.3296 34.3958
500129 1.5755 1.1377 32.1102 34.4447 37.3169 34.6824
500134 0.5967 1.1562 27.2428 28.1374 28.9744 28.2246
500139 1.4903 1.1462 33.9739 34.6412 37.5682 35.2949
500141 1.2645 1.1562 31.3308 33.7532 34.2350 33.1511
500143 0.5889 1.1462 23.6766 25.3099 26.3882 25.1082
500148 1.2204 1.0164 26.4206 37.7830 24.6331 30.3555
500150 1.2775 1.1186 * * 34.7828 34.7828
510001 1.9319 0.8569 25.2973 25.8693 26.7901 26.0184
510002 1.2681 0.8732 23.8921 23.7270 24.8834 24.1721
510006 1.3528 0.8631 24.9627 24.8777 26.6403 25.4772
510007 1.6750 0.9107 24.7264 27.1149 28.5769 26.8115
510008 1.3363 0.9253 26.3554 27.5241 27.4687 27.1395
510012 0.9584 0.7759 18.8984 20.8455 22.9026 20.8292
510013 1.1635 0.7635 22.7882 22.8779 22.9605 22.8737
510018 1.0730 0.8398 22.4597 23.1043 23.7726 23.1223
510022 1.8098 0.8398 26.9511 26.8328 27.6095 27.1376
510023 1.2565 0.8011 20.6435 21.0940 23.1446 21.6346
510024 1.7530 0.8569 25.5634 26.6621 31.1308 27.8371
510026 0.9848 0.7635 17.9908 19.2025 17.8264 18.3206
510029 1.2995 0.8398 22.7104 24.0872 25.3908 24.0179
510030 1.1499 0.7635 24.3936 24.2007 25.5580 24.7270
510031 1.4626 0.8398 23.2624 24.0237 26.7854 24.6110
510033 1.5988 0.8028 22.6189 24.0796 24.2824 23.6905
510038 1.0704 0.7635 20.6565 20.9180 21.7526 21.1101
510039 1.3740 0.7635 19.8751 20.4719 21.3807 20.5901
510046 1.3781 0.7795 22.1712 22.2935 24.7175 23.0443
510047 1.2053 0.8569 27.1214 27.6859 28.8777 27.9077
510048 1.1872 0.7635 18.8576 22.7930 23.6384 21.5406
510050 1.5377 0.8569 21.0772 21.9009 23.5780 22.1906
510053 1.0938 0.7635 22.3318 21.5338 22.6278 22.1640
510055 1.5578 0.9107 28.4615 29.4111 30.7366 29.5844
510058 1.3382 0.8028 23.9015 25.3248 24.8750 24.7020
510059 *** * 22.1435 20.8847 21.9025 21.6378
510062 1.2241 0.8398 26.2296 26.7066 27.7962 26.9089
510067 1.0951 0.7635 25.0437 25.2130 25.2231 25.1585
510070 1.2034 0.8398 23.5639 23.9742 25.4968 24.3383
510071 1.2818 0.7795 23.4508 23.2954 23.4542 23.4003
510072 1.0733 0.7635 20.5146 19.4370 20.2379 20.0443
510077 1.0382 0.8748 24.5010 25.9515 27.1603 25.8349
510082 1.1006 0.7635 19.9081 20.3279 21.1654 20.4929
510085 1.2021 0.8398 26.3877 26.2617 26.8122 26.4911
510086 1.0879 0.7635 19.8735 19.2606 20.1963 19.7687
510090 *** * * * 39.0764 39.0764
520002 1.3026 0.9823 27.7705 29.0501 31.9053 29.6240
520004 1.4018 0.9796 27.6530 28.9857 30.9192 29.2469
520008 1.5695 1.0182 30.7553 33.8057 33.6749 32.7716
520009 1.6546 0.9511 27.4044 28.8591 29.6272 28.6360
520011 1.2826 0.9511 26.6268 28.0224 29.5006 28.0213
520013 1.4977 1.0976 29.0018 30.1834 32.1701 30.5206
520017 1.1201 0.9599 28.4699 29.3278 31.0517 29.6386
520019 1.3503 0.9511 28.6971 29.8640 30.2175 29.6442
520021 1.3207 1.0315 28.4182 29.1129 29.7788 29.1139
520027 1.4430 1.0182 31.4284 32.4137 33.5809 32.5077
520028 1.3966 1.1014 26.7260 28.0813 29.4683 28.3047
520030 1.6874 0.9823 29.4678 30.5724 31.6785 30.5738
520033 1.2248 0.9511 28.0662 29.0236 30.2616 29.1742
520034 1.2622 0.9511 26.1094 26.8886 28.1800 27.0611
520035 1.3586 0.9587 27.3276 28.1048 29.4053 28.2938
520037 1.7405 0.9823 30.1799 32.2144 31.6795 31.3757
520038 1.2048 1.0182 29.3134 29.6339 30.5249 29.8341
520040 *** * 29.1262 31.2038 35.9633 32.0420
520041 1.0813 1.1232 23.5495 25.3764 26.1572 25.0721
520044 1.3626 0.9587 27.3685 28.2382 28.6601 28.1191
520045 1.5915 0.9511 27.3336 29.2556 30.0840 28.8905
520048 1.5102 0.9511 26.8080 29.1870 30.1468 28.5889
520049 2.0434 0.9511 26.9851 28.0936 29.4223 28.1983
520051 1.5346 1.0182 31.9949 31.5974 32.4111 32.0738
520057 1.1885 0.9704 27.7528 29.1158 31.3292 29.4114
520059 1.3571 1.0026 29.5801 30.4491 31.1783 30.4093
520060 *** * 24.8638 * * 24.8638
520062 1.3331 1.0182 28.8510 32.8584 32.6992 31.5738
520063 1.1678 1.0182 29.0993 30.3391 31.5185 30.3770
520064 1.5219 1.0182 30.3225 31.5723 33.1248 31.5779
520066 1.4182 0.9824 29.2088 31.0644 31.6673 30.6304
520070 1.6950 0.9599 27.6771 28.2059 30.0451 28.7359
520071 1.2135 1.0026 30.0262 30.6930 31.5435 30.8053
520075 1.6946 0.9511 29.2920 30.1582 32.2755 30.5484
520076 1.2239 1.1014 27.3335 27.4423 26.8932 27.2252
520078 1.4666 1.0182 29.9837 31.6606 32.0179 31.1768
520083 1.7215 1.1232 30.8826 32.7728 34.7200 32.8276
520087 1.7126 0.9796 28.5810 30.5659 31.9747 30.3890
520088 1.3463 0.9523 30.7450 30.6657 30.7462 30.7187
520089 1.5744 1.1232 33.8793 33.4098 34.9331 34.0808
520091 1.2752 0.9511 25.4593 27.3442 28.7166 27.1741
520095 1.2282 0.9704 30.4216 32.0381 33.2399 31.9187
520096 1.3683 1.0026 27.8896 29.5985 28.5204 28.6435
520097 1.3252 0.9511 29.1479 29.9998 31.0204 30.0765
520098 2.0129 1.1232 32.5785 36.5776 38.0962 35.8078
520100 1.3329 0.9824 29.3243 29.9458 31.7748 30.3552
520102 1.1961 1.0026 29.1680 30.7990 31.5735 30.5379
520103 1.5575 1.0182 30.3165 32.6269 34.5620 32.5629
520107 1.3439 0.9523 28.9878 29.4178 30.0343 29.4887
520109 1.0451 0.9511 24.7228 25.0697 25.9723 25.2667
520113 1.2659 0.9511 31.4708 33.3475 33.3023 32.7086
520116 1.2564 1.0026 27.9688 30.2156 31.6687 29.9794
520132 *** * 25.0006 27.3431 * 26.0481
520136 1.6351 1.0182 30.6522 32.1479 32.3480 31.6992
520138 1.8898 1.0182 30.8016 31.6581 32.5653 31.6762
520139 1.3351 1.0182 28.8870 30.4903 31.7060 30.3322
520140 *** * 31.0043 31.1315 * 31.0699
520152 *** * 29.7308 * * 29.7308
520160 1.7768 0.9511 27.9548 29.5582 30.3037 29.2715
520170 1.4785 1.0182 30.4309 31.4710 31.7586 31.2272
520173 1.0888 * 29.2429 31.0599 * 30.1478
520177 1.5992 1.0182 31.4555 32.5714 33.1218 32.4064
520189 1.1684 1.0315 28.0014 29.0295 29.2212 28.7600
520193 1.7185 0.9511 27.8113 29.2007 29.4715 28.8651
520194 1.5801 1.0182 30.1668 31.4379 30.9993 30.8959
520195 0.6565 1.0182 36.3116 36.2900 41.6044 37.9667
520196 1.7736 0.9599 36.9266 31.1175 31.6125 32.7571
520197 *** * * 30.1917 * 30.1917
520198 1.3572 0.9511 * 28.5975 29.9781 29.2918
520199 2.0438 1.0182 * 36.5699 37.0103 36.7943
520202 1.6509 0.9823 * * * *
520203 2.9989 1.1232 * * * *
530002 1.1984 0.9223 28.3063 29.2069 29.2407 28.9305
530006 1.2359 0.9223 27.2421 29.2104 30.3704 28.9041
530008 1.1650 0.9223 24.0090 26.5180 30.5992 27.0161
530009 0.9602 0.9223 24.6719 26.0490 27.0529 25.9191
530010 1.2145 0.9223 25.9852 27.4121 28.5518 27.3468
530011 1.1265 0.9223 27.8772 27.8613 31.1309 28.8654
530012 1.7040 0.9618 26.9582 28.7524 30.6085 28.7888
530014 1.5582 0.9611 26.7156 28.5469 29.6709 28.4442
530015 1.1779 0.9327 29.8310 29.8306 33.4886 31.0902
530017 0.9134 0.9223 29.8503 31.1105 25.8172 28.8536
530025 1.2876 0.9223 24.4392 29.4346 28.8951 27.4712
530032 1.0528 0.9223 23.9004 24.6580 25.4254 24.6844
1 Based on salaries adjusted for occupational mix, according to the calculation in section III.D.2. of the preamble to this proposed rule.
2 The case-mix index is based on the billed DRGs in the FY 2007 MedPAR file. It is not transfer adjusted.
3 Provider 140010 is part of a multicampus provider (MCH) that is comprised of campuses that are located in two different CBSAs. The provider number with a "B" in the 4th position, 140B10, indicates the portion of the wage and hours of the MCH that is allocated to CBSA 29404; provider number 140010 indicates the portion of wages and hours of the MCH that is allocated to CBSA 16974.
4 Provider 220074 is part of a multicampus provider (MCH) that is comprised of campuses that are located in two different CBSAs. The provider number with a "B" in the 4th position, 220B74, indicates the portion of the wage and hours of the MCH that is allocated to CBSA 14484; provider number 220074 indicates the portion of wages and hours of the MCH that is allocated to CBSA 39300.
5 Provider 230104 is part of a multicampus provider (MCH) that is comprised of campuses that are located in two different CBSAs. The provider number with a "B" in the 4th position, 230B04, indicates the portion of the wage and hours of the MCH that is allocated to CBSA 47644; provider number 230104 indicates the portion of wages and hours of the MCH that is allocated to CBSA 19804.
*Denotes wage data not available for the provider for that year.
**Based on the sum of the salaries and hours computed for Federal FYs 2007, 2008, and 2009.
***Denotes MedPAR data not available for the provider for FY 2007.

CBSA code Urban area FY 2009 average hourly wage 3-Year average hourly wage
10180 Abilene, TX 27.1004 25.7723
10380 Aguadilla-Isabela-San Sebastián, PR 10.6709 10.7622
10420 Akron, OH 28.3319 26.9292
10500 Albany, GA 28.2617 27.2184
10580 Albany-Schenectady-Troy, NY 28.4655 27.2227
10740 Albuquerque, NM 30.6500 29.7201
10780 Alexandria, LA 26.1655 24.7913
10900 Allentown-Bethlehem-Easton, PA-NJ 31.2097 30.7425
11020 Altoona, PA 26.7060 25.9824
11100 Amarillo, TX 29.0008 28.2619
11180 Ames, IA 30.4757 30.0901
11260 Anchorage, AK 38.0798 36.6236
11300 Anderson, IN 28.7750 27.5948
11340 Anderson, SC 31.3772 28.7401
11460 Ann Arbor, MI 33.6572 32.6579
11500 Anniston-Oxford, AL 25.8029 24.6804
11540 Appleton, WI 30.0406 29.0241
11700 Asheville, NC 29.6273 28.5517
12020 Athens-Clarke County, GA 30.9008 29.8591
12060 Atlanta-Sandy Springs-Marietta, GA 31.4502 30.3269
12100 Atlantic City-Hammonton, NJ 38.0743 36.7794
12220 Auburn-Opelika, AL 24.3605 24.4407
12260 Augusta-Richmond County, GA-SC 30.9498 29.7603
12420 Austin-Round Rock, TX 30.6888 29.3079
12540 Bakersfield, CA 36.5786 34.6045
12580 Baltimore-Towson, MD 32.1655 30.9372
12620 Bangor, ME 32.5961 30.6397
12700 Barnstable Town, MA 40.8356 39.1326
12940 Baton Rouge, LA 26.2494 25.0384
12980 Battle Creek, MI 32.3508 30.7409
13020 Bay City, MI 30.3060 28.7057
13140 Beaumont-Port Arthur, TX 27.7045 26.7778
13380 Bellingham, WA 36.7964 34.7347
13460 Bend, OR 35.6036 33.2554
13644 Bethesda-Frederick-Gaithersburg, MD 33.9508 32.8571
13740 Billings, MT 29.1465 27.7805
13780 Binghamton, NY 28.1030 27.6136
13820 Birmingham-Hoover, AL 28.3138 27.3821
13900 Bismarck, ND 23.2350 22.4949
13980 Blacksburg-Christiansburg-Radford, VA 26.1759 25.2599
14020 Bloomington, IN 30.3742 28.6837
14060 Bloomington-Normal, IL 30.6807 29.0683
14260 Boise City-Nampa, ID 29.9365 29.1371
14484 Boston-Quincy, MA 38.6504 36.7387
14500 Boulder, CO 32.3079 31.3052
14540 Bowling Green, KY 26.8895 25.3106
14600 Bradenton-Sarasota-Venice, FL 31.5095 30.2345
14740 Bremerton-Silverdale, WA 34.5710 33.5071
14860 Bridgeport-Stamford-Norwalk, CT 42.0944 39.8678
15180 Brownsville-Harlingen, TX 29.7382 29.0319
15260 Brunswick, GA 32.6731 31.3350
15380 Buffalo-Niagara Falls, NY 30.9123 29.5833
15500 Burlington, NC 27.7660 26.6186
15540 Burlington-South Burlington, VT 29.6973 29.1460
15764 Cambridge-Newton-Framingham, MA 35.6990 34.3809
15804 Camden, NJ 34.1250 32.6476
15940 Canton-Massillon, OH 28.5297 27.6782
15980 Cape Coral-Fort Myers, FL 30.6869 29.4302
16180 Carson City, NV 32.3122 30.2124
16220 Casper, WY 30.6085 28.7888
16300 Cedar Rapids, IA 28.3050 27.0341
16580 Champaign-Urbana, IL 30.1432 29.1751
16620 Charleston, WV 27.1192 26.3071
16700 Charleston-North Charleston-Summerville, SC 29.7955 28.4097
16740 Charlotte-Gastonia-Concord, NC-SC 30.8456 29.4515
16820 Charlottesville, VA 31.3517 29.8273
16860 Chattanooga, TN-GA 28.6158 27.6439
16940 Cheyenne, WY 29.6709 28.4442
16974 Chicago-Naperville-Joliet, IL 33.3033 32.5973
17020 Chico, CA 35.0695 34.2761
17140 Cincinnati-Middletown, OH-KY-IN 30.9027 29.7285
17300 Clarksville, TN-KY 26.7544 25.7478
17420 Cleveland, TN 26.2909 25.3790
17460 Cleveland-Elyria-Mentor, OH 29.8896 28.9336
17660 Coeur d'Alene, ID 29.5998 28.7256
17780 College Station-Bryan, TX 29.6321 28.1756
17820 Colorado Springs, CO 31.4793 29.6470
17860 Columbia, MO 27.2133 26.2863
17900 Columbia, SC 28.9948 27.6672
17980 Columbus, GA-AL 29.2007 27.4844
18020 Columbus, IN 31.7711 29.8902
18140 Columbus, OH 31.8334 30.9635
18580 Corpus Christi, TX 27.3797 26.2260
18700 Corvallis, OR 35.7074 34.1739
19060 Cumberland, MD-WV 24.2686 24.3744
19124 Dallas-Plano-Irving, TX 31.7539 30.5827
19140 Dalton, GA 27.3868 26.8521
19180 Danville, IL 31.2955 29.5310
19260 Danville, VA 27.3411 26.0795
19340 Davenport-Moline-Rock Island, IA-IL 27.2010 26.8964
19380 Dayton, OH 30.0672 28.7100
19460 Decatur, AL 24.8584 24.2893
19500 Decatur, IL 26.3336 25.3091
19660 Deltona-Daytona Beach-Ormond Beach, FL 28.4632 27.8441
19740 Denver-Aurora, CO 34.1438 32.7970
19780 Des Moines-West Des Moines, IA 30.6173 28.7458
19804 Detroit-Livonia-Dearborn, MI 32.3846 31.4605
20020 Dothan, AL 24.8722 23.3546
20100 Dover, DE 34.3823 32.3013
20220 Dubuque, IA 26.5562 26.9190
20260 Duluth, MN-WI 33.8981 31.7842
20500 Durham, NC 31.2419 30.0944
20740 Eau Claire, WI 30.9902 29.6325
20764 Edison-New Brunswick, NJ 36.1487 34.5118
20940 El Centro, CA 29.1074 28.1129
21060 Elizabethtown, KY 27.2829 26.5352
21140 Elkhart-Goshen, IN 30.6988 29.4323
21300 Elmira, NY 26.8991 25.8564
21340 El Paso, TX 28.5812 28.1095
21500 Erie, PA 28.0896 26.9188
21660 Eugene-Springfield, OR 35.9675 34.2186
21780 Evansville, IN-KY 27.4904 26.7119
21820 Fairbanks, AK 36.1891 34.2975
21940 Fajardo, PR 13.1075 12.8846
22020 Fargo, ND-MN 26.0887 24.9864
22140 Farmington, NM 25.2152 26.1577
22180 Fayetteville, NC 31.9846 30.2233
22220 Fayetteville-Springdale-Rogers, AR-MO 29.4256 27.9239
22380 Flagstaff, AZ 37.5481 35.8798
22420 Flint, MI 36.2781 34.1503
22500 Florence, SC 27.3900 26.5639
22520 Florence-Muscle Shoals, AL 25.2619 24.0763
22540 Fond du Lac, WI 30.7462 30.7188
22660 Fort Collins-Loveland, CO 30.8219 29.2764
22744 Fort Lauderdale-Pompano Beach-Deerfield Beach, FL 31.6349 30.8485
22900 Fort Smith, AR-OK 25.2751 24.4937
23020 Fort Walton Beach-Crestview-Destin, FL 28.1059 26.8450
23060 Fort Wayne, IN 28.8955 28.1729
23104 Fort Worth-Arlington, TX 31.2137 29.8330
23420 Fresno, CA 35.7716 34.2816
23460 Gadsden, AL 25.7517 24.9688
23540 Gainesville, FL 30.4476 29.0940
23580 Gainesville, GA 30.0367 28.8932
23844 Gary, IN 30.0576 28.8628
24020 Glens Falls, NY 28.2938 26.8175
24140 Goldsboro, NC 29.5207 28.5197
24220 Grand Forks, ND-MN 24.9880 24.4055
24300 Grand Junction, CO 31.2200 29.9879
24340 Grand Rapids-Wyoming, MI 29.9037 29.1399
24500 Great Falls, MT 27.9340 26.5446
24540 Greeley, CO 32.4200 30.9988
24580 Green Bay, WI 30.6825 29.5078
24660 Greensboro-High Point, NC 29.4639 28.1363
24780 Greenville, NC 30.1256 28.8796
24860 Greenville-Mauldin-Easley, SC 31.0004 29.7649
25020 Guayama, PR 10.1106 09.6176
25060 Gulfport-Biloxi, MS 28.6731 27.0856
25180 Hagerstown-Martinsburg, MD-WV 29.8828 28.7638
25260 Hanford-Corcoran, CA 35.7293 33.4052
25420 Harrisburg-Carlisle, PA 29.4620 28.6481
25500 Harrisonburg, VA 28.8643 27.8908
25540 Hartford-West Hartford-East Hartford, CT 36.0188 34.1981
25620 Hattiesburg, MS 24.2839 23.4139
25860 Hickory-Lenoir-Morganton, NC 28.8353 27.7789
25980 1 Hinesville-Fort Stewart, GA
26100 Holland-Grand Haven, MI 29.3296 28.2605
26180 Honolulu, HI 37.4061 34.9722
26300 Hot Springs, AR 29.4741 27.9457
26380 Houma-Bayou Cane-Thibodaux, LA 25.3740 24.7942
26420 Houston-Sugar Land-Baytown, TX 31.9906 30.9869
26580 Huntington-Ashland, WV-KY-OH 29.4107 27.7644
26620 Huntsville, AL 28.9607 27.8624
26820 Idaho Falls, ID 29.3359 28.2699
26900 Indianapolis-Carmel, IN 31.6890 30.3105
26980 Iowa City, IA 30.2168 29.3116
27060 Ithaca, NY 30.8103 29.9028
27100 Jackson, MI 30.5399 29.5811
27140 Jackson, MS 25.9122 24.9687
27180 Jackson, TN 27.3080 26.6865
27260 Jacksonville, FL 29.3541 28.3904
27340 Jacksonville, NC 27.0573 25.9214
27500 Janesville, WI 31.7184 30.5036
27620 Jefferson City, MO 29.1505 27.2519
27740 Johnson City, TN 25.8452 24.5939
27780 Johnstown, PA 25.9505 24.9881
27860 Jonesboro, AR 26.0204 24.6491
27900 Joplin, MO 31.3014 28.6510
28020 Kalamazoo-Portage, MI 35.1589 33.2912
28100 Kankakee-Bradley, IL 38.7329 33.0300
28140 Kansas City, MO-KS 30.4624 29.0579
28420 Kennewick-Pasco-Richland, WA 31.3630 30.6561
28660 Killeen-Temple-Fort Hood, TX 28.5417 26.9557
28700 Kingsport-Bristol-Bristol, TN-VA 25.3719 24.5154
28740 Kingston, NY 30.3965 29.3492
28940 Knoxville, TN 25.4214 24.8943
29020 Kokomo, IN 29.8433 29.2845
29100 La Crosse, WI-MN 31.6291 30.0294
29140 Lafayette, IN 28.8946 27.2885
29180 Lafayette, LA 27.2063 25.9638
29340 Lake Charles, LA 24.4720 24.0434
29404 Lake County-Kenosha County, IL-WI 33.4390 32.6639
29420 Lake Havasu City-Kingman, AZ 31.6370 29.6383
29460 Lakeland-Winter Haven, FL 28.1459 27.5004
29540 Lancaster, PA 31.0576 30.0449
29620 Lansing-East Lansing, MI 31.9010 30.9914
29700 Laredo, TX 28.4147 26.3095
29740 Las Cruces, NM 28.3851 27.2925
29820 Las Vegas-Paradise, NV 37.5945 35.4889
29940 Lawrence, KS 26.8014 25.6444
30020 Lawton, OK 27.8148 26.3376
30140 Lebanon, PA 29.0022 26.8307
30300 Lewiston, ID-WA 29.8774 29.0074
30340 Lewiston-Auburn, ME 30.0517 28.7720
30460 Lexington-Fayette, KY 28.8431 27.8163
30620 Lima, OH 29.9606 28.3617
30700 Lincoln, NE 31.0009 30.3915
30780 Little Rock-North Little Rock-Conway, AR 28.2114 28.2530
30860 Logan, UT-ID 28.3537 27.8958
30980 Longview, TX 27.3041 26.9355
31020 Longview, WA 36.9240 33.8434
31084 Los Angeles-Long Beach-Glendale, CA 38.9626 36.6108
31140 Louisville-Jefferson County, KY-IN 29.7925 28.3269
31180 Lubbock, TX 28.0803 26.7835
31340 Lynchburg, VA 27.7933 26.6660
31420 Macon, GA 31.6291 30.3409
31460 Madera, CA 26.7719 26.0576
31540 Madison, WI 36.2618 34.3945
31700 Manchester-Nashua, NH 33.0542 31.4821
31900 Mansfield, OH 29.9812 28.5726
32420 Mayagüez, PR 12.5555 11.7170
32580 McAllen-Edinburg-Mission, TX 29.3886 27.9884
32780 Medford, OR 33.0786 32.3223
32820 Memphis, TN-MS-AR 30.0626 28.8798
32900 Merced, CA 39.1381 36.7035
33124 Miami-Miami Beach-Kendall, FL 31.8599 30.6911
33140 Michigan City-La Porte, IN 29.1570 27.7380
33260 Midland, TX 30.8197 29.6993
33340 Milwaukee-Waukesha-West Allis, WI 32.8741 31.8085
33460 Minneapolis-St. Paul-Bloomington, MN-WI 35.4391 33.7580
33540 Missoula, MT 28.2291 26.9683
33660 Mobile, AL 25.1640 24.3569
33700 Modesto, CA 39.1156 36.9865
33740 Monroe, LA 25.6673 24.6843
33780 Monroe, MI 28.7386 29.0350
33860 Montgomery, AL 26.3999 25.1056
34060 Morgantown, WV 27.8745 26.4870
34100 Morristown, TN 23.5598 23.4073
34580 Mount Vernon-Anacortes, WA 32.2055 31.3429
34620 Muncie, IN 26.7339 25.4260
34740 Muskegon-Norton Shores, MI 32.9571 31.3172
34820 Myrtle Beach-North Myrtle Beach-Conway, SC 28.0263 27.0772
34900 Napa, CA 45.2771 42.3405
34940 Naples-Marco Island, FL 31.7163 30.5323
34980 Nashville-Davidson-Murfreesboro-Franklin, TN 30.5185 29.8356
35004 Nassau-Suffolk, NY 41.0210 39.8184
35084 Newark-Union, NJ-PA 37.3360 36.1271
35300 New Haven-Milford, CT 38.1842 37.0168
35380 New Orleans-Metairie-Kenner, LA 29.4715 27.1340
35644 New York-White Plains-Wayne, NY-NJ 42.0303 40.8866
35660 Niles-Benton Harbor, MI 29.3085 28.0264
35980 Norwich-New London, CT 36.8468 36.0398
36084 Oakland-Fremont-Hayward, CA 49.9560 47.7941
36100 Ocala, FL 27.4049 26.5357
36140 Ocean City, NJ 37.4820 34.3008
36220 Odessa, TX 30.3782 30.3247
36260 Ogden-Clearfield, UT 29.7855 28.2615
36420 Oklahoma City, OK 27.9928 27.1135
36500 Olympia, WA 37.0153 34.9710
36540 Omaha-Council Bluffs, NE-IA 30.2913 29.2081
36740 Orlando-Kissimmee, FL 29.6766 28.9783
36780 Oshkosh-Neenah, WI 30.0761 28.8544
36980 Owensboro, KY 28.2413 27.1328
37100 Oxnard-Thousand Oaks-Ventura, CA 36.9286 35.1055
37340 Palm Bay-Melbourne-Titusville, FL 30.3622 29.2690
37380 2 Palm Coast, FL 28.3179 27.7197
37460 Panama City-Lynn Haven, FL 27.4719 25.9842
37620 Parkersburg-Marietta-Vienna, WV-OH 25.9281 25.2122
37700 Pascagoula, MS 25.8776 25.5012
37764 Peabody, MA 34.6216 32.8179
37860 Pensacola-Ferry Pass-Brent, FL 26.1506 24.9081
37900 Peoria, IL 29.1439 28.4392
37964 Philadelphia, PA 35.4610 33.9583
38060 Phoenix-Mesa-Scottsdale, AZ 33.0972 31.5810
38220 Pine Bluff, AR 26.6629 25.9270
38300 Pittsburgh, PA 27.6753 26.3759
38340 Pittsfield, MA 33.6590 31.7762
38540 Pocatello, ID 29.3360 28.3737
38660 Ponce, PR 13.2835 13.4725
38860 Portland-South Portland-Biddeford, ME 31.9890 30.7480
38900 Portland-Vancouver-Beaverton, OR-WA 36.1216 34.7569
38940 Port St. Lucie, FL 31.9898 30.8026
39100 Poughkeepsie-Newburgh-Middletown, NY 35.2679 33.9878
39140 Prescott, AZ 32.8634 30.9614
39300 Providence-New Bedford-Fall River, RI-MA 34.3817 33.0490
39340 Provo-Orem, UT 29.1600 28.8274
39380 Pueblo, CO 27.8188 26.8684
39460 Punta Gorda, FL 29.9874 29.4798
39540 Racine, WI 28.8930 28.8892
39580 Raleigh-Cary, NC 31.2156 30.0484
39660 Rapid City, SD 30.6204 27.7643
39740 Reading, PA 30.0875 29.3819
39820 Redding, CA 41.6249 39.4241
39900 Reno-Sparks, NV 33.7604 34.6330
40060 Richmond, VA 29.6609 28.3807
40140 Riverside-San Bernardino-Ontario, CA 36.2653 34.0181
40220 Roanoke, VA 28.6468 27.4630
40340 Rochester, MN 35.3899 33.7865
40380 Rochester, NY 28.7144 27.8099
40420 Rockford, IL 31.7824 30.6686
40484 Rockingham County-Strafford County, NH 31.9359 31.0988
40580 Rocky Mount, NC 29.2288 27.8751
40660 Rome, GA 31.2559 29.9017
40900 Sacramento-Arden-Arcade-Roseville, CA 41.9426 40.3835
40980 Saginaw-Saginaw Township North, MI 29.1128 28.2485
41060 St. Cloud, MN 37.2177 34.8308
41100 St. George, UT 29.7373 29.2069
41140 St. Joseph, MO-KS 33.7767 30.5981
41180 St. Louis, MO-IL 28.9842 27.8523
41420 Salem, OR 34.3369 32.4058
41500 Salinas, CA 47.9744 45.4050
41540 Salisbury, MD 29.6266 27.8982
41620 Salt Lake City, UT 29.8767 29.1422
41660 San Angelo, TX 27.7212 26.5502
41700 San Antonio, TX 28.8457 27.6665
41740 San Diego-Carlsbad-San Marcos, CA 36.2686 34.6834
41780 Sandusky, OH 28.4754 27.6992
41884 San Francisco-San Mateo-Redwood City, CA 48.5597 46.7826
41900 San Germán-Cabo Rojo, PR 14.9779 14.5348
41940 San Jose-Sunnyvale-Santa Clara, CA 51.2569 48.2592
41980 San Juan-Caguas-Guaynabo, PR 14.1930 13.8050
42020 San Luis Obispo-Paso Robles, CA 38.5623 36.3112
42044 Santa Ana-Anaheim-Irvine, CA 38.1247 35.9846
42060 Santa Barbara-Santa Maria-Goleta, CA 37.7124 35.1162
42100 Santa Cruz-Watsonville, CA 51.5525 48.3881
42140 Santa Fe, NM 34.1580 33.1619
42220 Santa Rosa-Petaluma, CA 49.2189 45.6081
42340 Savannah, GA 28.8176 27.8424
42540 Scranton-Wilkes-Barre, PA 26.5201 25.6648
42644 Seattle-Bellevue-Everett, WA 37.3352 35.3387
42680 Sebastian-Vero Beach, FL 30.7417 30.0442
43100 Sheboygan, WI 29.1159 28.0863
43300 Sherman-Denison, TX 29.9470 27.3065
43340 Shreveport-Bossier City, LA 27.5578 26.7863
43580 Sioux City, IA-NE-SD 28.3024 27.7781
43620 Sioux Falls, SD 30.2235 29.2197
43780 South Bend-Mishawaka, IN-MI 31.0993 30.1358
43900 Spartanburg, SC 29.1025 28.3525
44060 Spokane, WA 33.9523 32.3332
44100 Springfield, IL 29.4330 27.9091
44140 Springfield, MA 33.3312 31.8950
44180 Springfield, MO 27.3178 26.6919
44220 Springfield, OH 27.8315 26.5028
44300 State College, PA 28.4188 27.0040
44700 Stockton, CA 38.6087 36.4711
44940 Sumter, SC 27.6406 26.7218
45060 Syracuse, NY 31.7909 30.5763
45104 Tacoma, WA 35.9647 33.8969
45220 Tallahassee, FL 29.0061 27.8746
45300 Tampa-St. Petersburg-Clearwater, FL 28.9032 28.1723
45460 Terre Haute, IN 29.4437 27.6736
45500 Texarkana, TX-Texarkana, AR 26.4165 24.8363
45780 Toledo, OH 29.8934 28.9126
45820 Topeka, KS 28.5929 27.0599
45940 Trenton-Ewing, NJ 34.3697 33.3207
46060 Tucson, AZ 30.4264 29.2232
46140 Tulsa, OK 27.8831 26.3265
46220 Tuscaloosa, AL 28.0199 26.8295
46340 Tyler, TX 28.6912 27.8517
46540 Utica-Rome, NY 28.1040 27.1057
46660 Valdosta, GA 26.3052 25.6427
46700 Vallejo-Fairfield, CA 45.6926 44.8127
47020 Victoria, TX 25.6787 25.2869
47220 Vineland-Millville-Bridgeton, NJ 35.2379 33.0201
47260 Virginia Beach-Norfolk-Newport News, VA-NC 28.5838 27.2923
47300 Visalia-Porterville, CA 33.2020 31.5996
47380 Waco, TX 28.0515 26.9091
47580 Warner Robins, GA 30.5824 28.8902
47644 Warren-Troy-Farmington Hills, MI 32.1363 31.0932
47894 Washington-Arlington-Alexandria, DC-VA-MD-WV 34.3840 33.3639
47940 Waterloo-Cedar Falls, IA 28.0510 26.9028
48140 Wausau, WI 31.6785 30.5738
48260 Weirton-Steubenville, WV-OH 25.8721 24.7386
48300 Wenatchee, WA 30.3614 31.9688
48424 West Palm Beach-Boca Raton-Boynton Beach, FL 31.1027 29.7030
48540 Wheeling, WV-OH 22.6472 21.8074
48620 Wichita, KS 28.9395 27.7964
48660 Wichita Falls, TX 29.5744 26.8201
48700 Williamsport, PA 25.8784 24.8306
48864 Wilmington, DE-MD-NJ 34.0940 32.8588
48900 Wilmington, NC 29.1370 29.0123
49020 Winchester, VA-WV 31.4889 30.6457
49180 Winston-Salem, NC 29.0508 28.2246
49340 Worcester, MA 35.2688 34.2006
49420 Yakima, WA 32.0317 30.9552
49500 Yauco, PR 10.8210 10.6067
49620 York-Hanover, PA 31.1804 29.5691
49660 Youngstown-Warren-Boardman, OH-PA 28.8065 27.5854
49700 Yuba City, CA 34.7445 32.8688
49740 Yuma, AZ 31.9135 30.1305
1 This area has no average hourly wage because there are no short-term, acute care hospitals in the area.
2 This is a new CBSA for FY 2008. To calculate the 3-year average hourly wage for this new area, we included the hospitals' data from their previous geographic location for FY 2006 and FY 2007.

CBSA code Nonurban area FY 2009 average hourly wage 3-Year average hourly wage
01 Alabama 24.6411 23.6242
02 Alaska 38.4008 35.4138
03 Arizona 28.5407 27.4573
04 Arkansas 24.6204 23.3335
05 California 38.6569 35.9246
06 Colorado 30.0754 28.7842
07 Connecticut 36.4301 35.6330
08 Delaware 32.6029 30.8226
10 Florida 27.8797 26.8062
11 Georgia 25.2642 24.2873
12 Hawaii 36.0283 33.6508
13 Idaho 24.4380 24.1641
14 Illinois 27.1642 25.9705
15 Indiana 27.3432 26.4475
16 Iowa 28.1850 26.6791
17 Kansas 25.9806 24.8089
18 Kentucky 25.2536 24.2249
19 Louisiana 24.7667 23.6881
20 Maine 27.7429 26.2711
21 Maryland 28.3407 27.4609
22 Massachusetts
23 Michigan 28.5656 27.6632
24 Minnesota 29.3894 28.3126
25 Mississippi 24.6569 23.9273
26 Missouri 26.3804 25.2174
27 Montana 27.8425 26.4700
28 Nebraska 28.0119 26.9486
29 Nevada 31.6580 29.6483
30 New Hampshire 33.2526 32.8237
31 New Jersey1
32 New Mexico 28.5810 27.1089
33 New York 26.7717 25.8110
34 North Carolina 27.8184 26.7060
35 North Dakota 23.7299 22.7358
36 Ohio 27.6801 26.8138
37 Oklahoma 25.8341 24.3148
38 Oregon 33.1220 30.9016
39 Pennsylvania 26.9119 25.8178
40 Puerto Rico1
41 Rhode Island1
42 South Carolina 27.7889 26.8744
43 South Dakota 27.1581 25.8858
44 Tennessee 25.6634 24.6486
45 Texas 26.2796 25.3601
46 Utah 27.0526 25.6723
47 Vermont 32.0308 30.2935
49 Virginia 25.9700 24.9967
50 Washington 32.6127 31.5030
51 West Virginia 24.6596 23.6988
52 Wisconsin 30.7058 29.7224
53 Wyoming 29.7219 28.3175
1 All counties within the State or territory are classified as urban.

CBSA Code Urban area State Wage index GAF
10180 Abilene, TX TX 0.8408 0.8880
10380 Aguadilla-Isabela-San Sebastián, PR PR 0.3311 0.4691
10420 Akron, OH OH 0.8784 0.9150
10500 Albany, GA GA 0.8770 0.9140
10580 Albany-Schenectady-Troy, NY NY 0.8833 0.9185
10740 Albuquerque, NM NM 0.9499 0.9654
10780 Alexandria, LA LA 0.8127 0.8676
10900 Allentown-Bethlehem-Easton, PA-NJ NJ 1.1221 1.0821
10900 Allentown-Bethlehem-Easton, PA-NJ PA 0.9675 0.9776
11020 Altoona, PA PA 0.8342 0.8833
11100 Amarillo, TX TX 0.8997 0.9302
11180 Ames, IA IA 0.9417 0.9597
11260 Anchorage, AK AK 1.1884 1.1255
11300 Anderson, IN IN 0.8923 0.9249
11340 Anderson, SC SC 0.9721 0.9808
11460 Ann Arbor, MI MI 1.0444 1.0302
11500 Anniston-Oxford, AL AL 0.8007 0.8588
11540 Appleton, WI WI 0.9511 0.9662
11700 Asheville, NC NC 0.9192 0.9439
12020 Athens-Clarke County, GA GA 0.9589 0.9717
12060 Atlanta-Sandy Springs-Marietta, GA GA 0.9760 0.9835
12100 Atlantic City-Hammonton, NJ NJ 1.1666 1.1113
12220 Auburn-Opelika, AL AL 0.7647 0.8322
12260 Augusta-Richmond County, GA-SC GA 0.9604 0.9727
12260 Augusta-Richmond County, GA-SC SC 0.9589 0.9717
12420 Austin-Round Rock, TX TX 0.9521 0.9669
12540 Bakersfield, CA CA 1.1822 1.1214
12580 Baltimore-Towson, MD MD 0.9981 0.9987
12620 Bangor, ME ME 1.0115 1.0079
12700 Barnstable Town, MA MA 1.2672 1.1761
12940 Baton Rouge, LA LA 0.8142 0.8687
12980 Battle Creek, MI MI 1.0039 1.0027
13020 Bay City, MI MI 0.9472 0.9635
13140 Beaumont-Port Arthur, TX TX 0.8595 0.9015
13380 Bellingham, WA WA 1.1395 1.0935
13460 Bend, OR OR 1.1043 1.0703
13644 Bethesda-Frederick-Gaithersburg, MD MD 1.1018 1.0686
13740 Billings, MT MT 0.9045 0.9336
13780 Binghamton, NY NY 0.8721 0.9105
13820 Birmingham-Hoover, AL AL 0.8786 0.9152
13900 Bismarck, ND ND 0.7336 0.8088
13980 Blacksburg-Christiansburg-Radford, VA VA 0.8122 0.8672
14020 Bloomington, IN IN 0.9419 0.9598
14060 Bloomington-Normal, IL IL 0.9520 0.9669
14260 Boise City-Nampa, ID ID 0.9290 0.9508
14484 Boston-Quincy, MA MA 1.1994 1.1326
14500 Boulder, CO CO 0.9994 0.9996
14540 Bowling Green, KY KY 0.8344 0.8834
14600 Bradenton-Sarasota-Venice, FL FL 0.9757 0.9833
14740 Bremerton-Silverdale, WA WA 1.0706 1.0478
14860 Bridgeport-Stamford-Norwalk, CT CT 1.2591 1.1709
15180 Brownsville-Harlingen, TX TX 0.9226 0.9463
15260 Brunswick, GA GA 1.0139 1.0095
15380 Buffalo-Niagara Falls, NY NY 0.9593 0.9719
15500 Burlington, NC NC 0.8632 0.9042
15540 Burlington-South Burlington, VT VT 0.9275 0.9498
15764 Cambridge-Newton-Framingham, MA MA 1.1078 1.0726
15804 Camden, NJ NJ 1.1221 1.0821
15940 Canton-Massillon, OH OH 0.8845 0.9194
15980 Cape Coral-Fort Myers, FL FL 0.9502 0.9656
16180 Carson City, NV NV 1.0027 1.0018
16220 Casper, WY WY 0.9618 0.9737
16300 Cedar Rapids, IA IA 0.8746 0.9123
16580 Champaign-Urbana, IL IL 0.9353 0.9552
16620 Charleston, WV WV 0.8398 0.8873
16700 Charleston-North Charleston-Summerville, SC SC 0.9231 0.9467
16740 Charlotte-Gastonia-Concord, NC-SC NC 0.9570 0.9704
16740 Charlotte-Gastonia-Concord, NC-SC SC 0.9557 0.9694
16820 Charlottesville, VA VA 0.9728 0.9813
16860 Chattanooga, TN-GA GA 0.8880 0.9219
16860 Chattanooga, TN-GA TN 0.8857 0.9202
16940 Cheyenne, WY WY 0.9223 0.9461
16974 Chicago-Naperville-Joliet, IL IL 1.0334 1.0228
17020 Chico, CA CA 1.1822 1.1214
17140 Cincinnati-Middletown, OH-KY-IN IN 0.9583 0.9713
17140 Cincinnati-Middletown, OH-KY-IN KY 0.9590 0.9717
17140 Cincinnati-Middletown, OH-KY-IN OH 0.9581 0.9711
17300 Clarksville, TN-KY KY 0.8302 0.8804
17300 Clarksville, TN-KY TN 0.8280 0.8788
17420 Cleveland, TN TN 0.8137 0.8683
17460 Cleveland-Elyria-Mentor, OH OH 0.9266 0.9491
17660 Coeur d'Alene, ID ID 0.9185 0.9434
17780 College Station-Bryan, TX TX 0.9193 0.9440
17820 Colorado Springs, CO CO 0.9738 0.9820
17860 Columbia, MO MO 0.8470 0.8925
17900 Columbia, SC SC 0.8984 0.9293
17980 Columbus, GA-AL AL 0.9061 0.9347
17980 Columbus, GA-AL GA 0.9061 0.9347
18020 Columbus, IN IN 0.9852 0.9898
18140 Columbus, OH OH 0.9869 0.9910
18580 Corpus Christi, TX TX 0.8494 0.8942
18700 Corvallis, OR OR 1.1076 1.0725
19060 Cumberland, MD-WV MD 0.8795 0.9158
19060 Cumberland, MD-WV WV 0.7635 0.8313
19124 Dallas-Plano-Irving, TX TX 0.9852 0.9898
19140 Dalton, GA GA 0.8499 0.8946
19180 Danville, IL IL 0.9711 0.9801
19260 Danville, VA VA 0.8483 0.8935
19340 Davenport-Moline-Rock Island, IA-IL IL 0.8606 0.9023
19340 Davenport-Moline-Rock Island, IA-IL IA 0.8709 0.9097
19380 Dayton, OH OH 0.9321 0.9530
19460 Decatur, AL AL 0.7714 0.8372
19500 Decatur, IL IL 0.8428 0.8895
19660 Deltona-Daytona Beach-Ormond Beach, FL FL 0.8814 0.9172
19740 Denver-Aurora, CO CO 1.0561 1.0381
19780 Des Moines-West Des Moines, IA IA 0.9460 0.9627
19804 Detroit-Livonia-Dearborn, MI MI 1.0052 1.0036
20020 Dothan, AL AL 0.7718 0.8375
20100 Dover, DE DE 1.0669 1.0453
20220 Dubuque, IA IA 0.8709 0.9097
20260 Duluth, MN-WI MN 1.0519 1.0353
20260 Duluth, MN-WI WI 1.0499 1.0339
20500 Durham, NC NC 0.9693 0.9789
20740 Eau Claire, WI WI 0.9599 0.9724
20764 Edison-New Brunswick, NJ NJ 1.1221 1.0821
20940 El Centro, CA CA 1.1822 1.1214
21060 Elizabethtown, KY KY 0.8466 0.8922
21140 Elkhart-Goshen, IN IN 0.9547 0.9688
21300 Elmira, NY NY 0.8347 0.8836
21340 El Paso, TX TX 0.8867 0.9210
21500 Erie, PA PA 0.8708 0.9096
21660 Eugene-Springfield, OR OR 1.1157 1.0779
21780 Evansville, IN-KY IN 0.8525 0.8965
21780 Evansville, IN-KY KY 0.8531 0.8969
21820 Fairbanks, AK AK 1.1884 1.1255
21940 Fajardo, PR PR 0.4067 0.5400
22020 Fargo, ND-MN MN 0.9120 0.9389
22020 Fargo, ND-MN ND 0.8212 0.8738
22140 Farmington, NM NM 0.8858 0.9203
22180 Fayetteville, NC NC 0.9923 0.9947
22220 Fayetteville-Springdale-Rogers, AR-MO AR 0.9131 0.9396
22220 Fayetteville-Springdale-Rogers, AR-MO MO 0.9123 0.9391
22380 Flagstaff, AZ AZ 1.1652 1.1104
22420 Flint, MI MI 1.1258 1.0845
22500 Florence, SC SC 0.8609 0.9025
22520 Florence-Muscle Shoals, AL AL 0.7883 0.8497
22540 Fond du Lac, WI WI 0.9523 0.9671
22660 Fort Collins-Loveland, CO CO 0.9581 0.9711
22744 Fort Lauderdale-Pompano Beach-Deerfield Beach, FL FL 1.0025 1.0017
22900 Fort Smith, AR-OK AR 0.7843 0.8467
22900 Fort Smith, AR-OK OK 0.8016 0.8595
23020 Fort Walton Beach-Crestview-Destin, FL FL 0.8703 0.9093
23060 Fort Wayne, IN IN 0.9004 0.9307
23104 Fort Worth-Arlington, TX TX 0.9684 0.9783
23420 Fresno, CA CA 1.1822 1.1214
23460 Gadsden, AL AL 0.7991 0.8576
23540 Gainesville, FL FL 0.9427 0.9604
23580 Gainesville, GA GA 0.9321 0.9530
23844 Gary, IN IN 0.9320 0.9529
24020 Glens Falls, NY NY 0.8780 0.9148
24140 Goldsboro, NC NC 0.9159 0.9416
24220 Grand Forks, ND-MN MN 0.9120 0.9389
24220 Grand Forks, ND-MN ND 0.7709 0.8368
24300 Grand Junction, CO CO 0.9925 0.9949
24340 Grand Rapids-Wyoming, MI MI 0.9305 0.9519
24500 Great Falls, MT MT 0.8679 0.9075
24540 Greeley, CO CO 1.0028 1.0019
24580 Green Bay, WI WI 0.9511 0.9662
24660 Greensboro-High Point, NC NC 0.9141 0.9403
24780 Greenville, NC NC 0.9346 0.9547
24860 Greenville-Mauldin-Easley, SC SC 0.9605 0.9728
25020 Guayama, PR PR 0.3137 0.4521
25060 Gulfport-Biloxi, MS MS 0.8898 0.9232
25180 Hagerstown-Martinsburg, MD-WV MD 0.9273 0.9496
25180 Hagerstown-Martinsburg, MD-WV WV 0.9253 0.9482
25260 Hanford-Corcoran, CA CA 1.1822 1.1214
25420 Harrisburg-Carlisle, PA PA 0.9185 0.9434
25500 Harrisonburg, VA VA 0.8956 0.9273
25540 Hartford-West Hartford-East Hartford, CT CT 1.1897 1.1263
25620 Hattiesburg, MS MS 0.7653 0.8326
25860 Hickory-Lenoir-Morganton, NC NC 0.8946 0.9266
26100 Holland-Grand Haven, MI MI 0.9101 0.9375
26180 Honolulu, HI HI 1.1608 1.1075
26300 Hot Springs, AR AR 0.9146 0.9407
26380 Houma-Bayou Cane-Thibodaux, LA LA 0.7870 0.8487
26420 Houston-Sugar Land-Baytown, TX TX 0.9925 0.9949
26580 Huntington-Ashland, WV-KY-OH KY 0.9127 0.9394
26580 Huntington-Ashland, WV-KY-OH OH 0.9118 0.9387
26580 Huntington-Ashland, WV-KY-OH WV 0.9107 0.9380
26620 Huntsville, AL AL 0.8987 0.9295
26820 Idaho Falls, ID ID 0.9327 0.9534
26900 Indianapolis-Carmel, IN IN 0.9827 0.9881
26980 Iowa City, IA IA 0.9337 0.9541
27060 Ithaca, NY NY 0.9561 0.9697
27100 Jackson, MI MI 0.9477 0.9639
27140 Jackson, MS MS 0.8095 0.8653
27180 Jackson, TN TN 0.8452 0.8912
27260 Jacksonville, FL FL 0.9092 0.9369
27340 Jacksonville, NC NC 0.8632 0.9042
27500 Janesville, WI WI 0.9824 0.9879
27620 Jefferson City, MO MO 0.9038 0.9331
27740 Johnson City, TN TN 0.7999 0.8582
27780 Johnstown, PA PA 0.8342 0.8833
27860 Jonesboro, AR AR 0.8291 0.8796
27900 Joplin, MO MO 0.9704 0.9796
28020 Kalamazoo-Portage, MI MI 1.0910 1.0615
28100 Kankakee-Bradley, IL IL 1.2018 1.1341
28140 Kansas City, MO-KS KS 0.9453 0.9622
28140 Kansas City, MO-KS MO 0.9444 0.9616
28420 Kennewick-Pasco-Richland, WA WA 1.0164 1.0112
28660 Killeen-Temple-Fort Hood, TX TX 0.8855 0.9201
28700 Kingsport-Bristol-Bristol, TN-VA TN 0.7957 0.8551
28700 Kingsport-Bristol-Bristol, TN-VA VA 0.8061 0.8628
28740 Kingston, NY NY 0.9433 0.9608
28940 Knoxville, TN TN 0.7957 0.8551
29020 Kokomo, IN IN 0.9254 0.9483
29100 La Crosse, WI-MN MN 0.9815 0.9873
29100 La Crosse, WI-MN WI 0.9796 0.9860
29140 Lafayette, IN IN 0.8960 0.9276
29180 Lafayette, LA LA 0.8438 0.8902
29340 Lake Charles, LA LA 0.7682 0.8348
29404 Lake County-Kenosha County, IL-WI IL 1.0376 1.0256
29404 Lake County-Kenosha County, IL-WI WI 1.0357 1.0243
29420 Lake Havasu City-Kingman, AZ AZ 0.9817 0.9874
29460 Lakeland-Winter Haven, FL FL 0.8715 0.9101
29540 Lancaster, PA PA 0.9799 0.9862
29620 Lansing-East Lansing, MI MI 0.9899 0.9931
29700 Laredo, TX TX 0.8816 0.9173
29740 Las Cruces, NM NM 0.8858 0.9203
29820 Las Vegas-Paradise, NV NV 1.1666 1.1113
29940 Lawrence, KS KS 0.8317 0.8814
30020 Lawton, OK OK 0.8630 0.9040
30140 Lebanon, PA PA 0.8991 0.9298
30300 Lewiston, ID-WA ID 0.9271 0.9495
30300 Lewiston, ID-WA WA 1.0164 1.0112
30340 Lewiston-Auburn, ME ME 0.9326 0.9533
30460 Lexington-Fayette, KY KY 0.8950 0.9268
30620 Lima, OH OH 0.9299 0.9514
30700 Lincoln, NE NE 0.9620 0.9738
30780 Little Rock-North Little Rock-Conway, AR AR 0.8754 0.9129
30860 Logan, UT-ID ID 0.8827 0.9181
30860 Logan, UT-ID UT 0.8827 0.9181
30980 Longview, TX TX 0.8666 0.9066
31020 Longview, WA WA 1.1434 1.0961
31084 Los Angeles-Long Beach-Glendale, CA CA 1.1916 1.1275
31140 Louisville-Jefferson County, KY-IN IN 0.9238 0.9472
31140 Louisville-Jefferson County, KY-IN KY 0.9245 0.9477
31180 Lubbock, TX TX 0.8712 0.9099
31340 Lynchburg, VA VA 0.8646 0.9052
31420 Macon, GA GA 0.9815 0.9873
31460 Madera, CA CA 1.1822 1.1214
31540 Madison, WI WI 1.1232 1.0828
31700 Manchester-Nashua, NH NH 1.0807 1.0546
31900 Mansfield, OH OH 0.9295 0.9512
32420 Mayagüez, PR PR 0.3896 0.5244
32580 McAllen-Edinburg-Mission, TX TX 0.9118 0.9387
32780 Medford, OR OR 1.0298 1.0203
32820 Memphis, TN-MS-AR AR 0.9329 0.9535
32820 Memphis, TN-MS-AR MS 0.9329 0.9535
32820 Memphis, TN-MS-AR TN 0.9305 0.9519
32900 Merced, CA CA 1.1969 1.1310
33124 Miami-Miami Beach-Kendall, FL FL 0.9865 0.9907
33140 Michigan City-La Porte, IN IN 0.9041 0.9333
33260 Midland, TX TX 0.9562 0.9698
33340 Milwaukee-Waukesha-West Allis, WI WI 1.0182 1.0124
33460 Minneapolis-St. Paul-Bloomington, MN-WI MN 1.0997 1.0672
33460 Minneapolis-St. Paul-Bloomington, MN-WI WI 1.0976 1.0659
33540 Missoula, MT MT 0.8909 0.9239
33660 Mobile, AL AL 0.7809 0.8442
33700 Modesto, CA CA 1.1963 1.1306
33740 Monroe, LA LA 0.7961 0.8554
33780 Monroe, MI MI 0.8918 0.9246
33860 Montgomery, AL AL 0.8192 0.8723
34060 Morgantown, WV WV 0.8631 0.9041
34100 Morristown, TN TN 0.7957 0.8551
34580 Mount Vernon-Anacortes, WA WA 1.0164 1.0112
34620 Muncie, IN IN 0.8479 0.8932
34740 Muskegon-Norton Shores, MI MI 1.0227 1.0155
34820 Myrtle Beach-North Myrtle Beach-Conway, SC SC 0.8683 0.9078
34900 Napa, CA CA 1.3847 1.2497
34940 Naples-Marco Island, FL FL 0.9820 0.9876
34980 Nashville-Davidson-Murfreesboro-Franklin, TN TN 0.9445 0.9617
35004 Nassau-Suffolk, NY NY 1.2729 1.1797
35084 Newark-Union, NJ-PA NJ 1.1440 1.0965
35084 Newark-Union, NJ-PA PA 1.1574 1.1053
35300 New Haven-Milford, CT CT 1.1897 1.1263
35380 New Orleans-Metairie-Kenner, LA LA 0.9140 0.9403
35644 New York-White Plains-Wayne, NY-NJ NJ 1.2878 1.1891
35644 New York-White Plains-Wayne, NY-NJ NY 1.3043 1.1995
35660 Niles-Benton Harbor, MI MI 0.9095 0.9371
35980 Norwich-New London, CT CT 1.1897 1.1263
36084 Oakland-Fremont-Hayward, CA CA 1.5278 1.3367
36100 Ocala, FL FL 0.8633 0.9042
36140 Ocean City, NJ NJ 1.1484 1.0994
36220 Odessa, TX TX 0.9425 0.9603
36260 Ogden-Clearfield, UT UT 0.9243 0.9475
36420 Oklahoma City, OK OK 0.8686 0.9080
36500 Olympia, WA WA 1.1462 1.0979
36540 Omaha-Council Bluffs, NE-IA IA 0.9360 0.9557
36540 Omaha-Council Bluffs, NE-IA NE 0.9400 0.9585
36740 Orlando-Kissimmee, FL FL 0.9189 0.9437
36780 Oshkosh-Neenah, WI WI 0.9511 0.9662
36980 Owensboro, KY KY 0.8764 0.9136
37100 Oxnard-Thousand Oaks-Ventura, CA CA 1.1822 1.1214
37340 Palm Bay-Melbourne-Titusville, FL FL 0.9401 0.9586
37380 Palm Coast, FL FL 0.8769 0.9140
37460 Panama City-Lynn Haven, FL FL 0.8633 0.9042
37620 Parkersburg-Marietta-Vienna, WV-OH OH 0.8582 0.9006
37620 Parkersburg-Marietta-Vienna, WV-OH WV 0.8028 0.8603
37700 Pascagoula, MS MS 0.8030 0.8605
37764 Peabody, MA MA 1.0744 1.0504
37860 Pensacola-Ferry Pass-Brent, FL FL 0.8633 0.9042
37900 Peoria, IL IL 0.9043 0.9334
37964 Philadelphia, PA PA 1.0992 1.0669
38060 Phoenix-Mesa-Scottsdale, AZ AZ 1.0271 1.0185
38220 Pine Bluff, AR AR 0.8274 0.8783
38300 Pittsburgh, PA PA 0.8579 0.9004
38340 Pittsfield, MA MA 1.0445 1.0303
38540 Pocatello, ID ID 0.9103 0.9377
38660 Ponce, PR PR 0.4122 0.5450
38860 Portland-South Portland-Biddeford, ME ME 0.9927 0.9950
38900 Portland-Vancouver-Beaverton, OR-WA OR 1.1204 1.0810
38900 Portland-Vancouver-Beaverton, OR-WA WA 1.1186 1.0798
38940 Port St. Lucie, FL FL 0.9905 0.9935
39100 Poughkeepsie-Newburgh-Middletown, NY NY 1.0944 1.0637
39140 Prescott, AZ AZ 1.0198 1.0135
39300 Providence-New Bedford-Fall River, RI-MA MA 1.0669 1.0453
39300 Providence-New Bedford-Fall River, RI-MA RI 1.0669 1.0453
39340 Provo-Orem, UT UT 0.9052 0.9341
39380 Pueblo, CO CO 0.9303 0.9517
39460 Punta Gorda, FL FL 0.9286 0.9505
39540 Racine, WI WI 0.9511 0.9662
39580 Raleigh-Cary, NC NC 0.9685 0.9783
39660 Rapid City, SD SD 0.9502 0.9656
39740 Reading, PA PA 0.9327 0.9534
39820 Redding, CA CA 1.2730 1.1797
39900 Reno-Sparks, NV NV 1.0476 1.0324
40060 Richmond, VA VA 0.9203 0.9447
40140 Riverside-San Bernardino-Ontario, CA CA 1.1822 1.1214
40220 Roanoke, VA VA 0.8889 0.9225
40340 Rochester, MN MN 1.0982 1.0662
40380 Rochester, NY NY 0.8911 0.9241
40420 Rockford, IL IL 0.9862 0.9905
40484 Rockingham County-Strafford County, NH NH 1.0807 1.0546
40580 Rocky Mount, NC NC 0.9068 0.9352
40660 Rome, GA GA 0.9699 0.9793
40900 Sacramento-Arden-Arcade-Roseville, CA CA 1.2827 1.1859
40980 Saginaw-Saginaw Township North, MI MI 0.9034 0.9328
41060 St. Cloud, MN MN 1.1549 1.1036
41100 St. George, UT UT 0.9228 0.9465
41140 St. Joseph, MO-KS KS 1.0481 1.0327
41140 St. Joseph, MO-KS MO 1.0472 1.0321
41180 St. Louis, MO-IL IL 0.8993 0.9299
41180 St. Louis, MO-IL MO 0.8986 0.9294
41420 Salem, OR OR 1.0650 1.0441
41500 Salinas, CA CA 1.4671 1.3001
41540 Salisbury, MD MD 0.9194 0.9441
41620 Salt Lake City, UT UT 0.9271 0.9495
41660 San Angelo, TX TX 0.8600 0.9019
41700 San Antonio, TX TX 0.8949 0.9268
41740 San Diego-Carlsbad-San Marcos, CA CA 1.1822 1.1214
41780 Sandusky, OH OH 0.8828 0.9182
41884 San Francisco-San Mateo-Redwood City, CA CA 1.4879 1.3127
41900 San Germán-Cabo Rojo, PR PR 0.4648 0.5918
41940 San Jose-Sunnyvale-Santa Clara, CA CA 1.5758 1.3654
41980 San Juan-Caguas-Guaynabo, PR PR 0.4404 0.5703
42020 San Luis Obispo-Paso Robles, CA CA 1.1822 1.1214
42044 Santa Ana-Anaheim-Irvine, CA CA 1.1822 1.1214
42060 Santa Barbara-Santa Maria-Goleta, CA CA 1.1822 1.1214
42100 Santa Cruz-Watsonville, CA CA 1.5766 1.3658
42140 Santa Fe, NM NM 1.0587 1.0398
42220 Santa Rosa-Petaluma, CA CA 1.5052 1.3232
42340 Savannah, GA GA 0.8943 0.9264
42540 Scranton-Wilkes-Barre, PA PA 0.8342 0.8833
42644 Seattle-Bellevue-Everett, WA WA 1.1562 1.1045
42680 Sebastian-Vero Beach, FL FL 0.9519 0.9668
43100 Sheboygan, WI WI 0.9511 0.9662
43300 Sherman-Denison, TX TX 0.9291 0.9509
43340 Shreveport-Bossier City, LA LA 0.8547 0.8981
43580 Sioux City, IA-NE-SD IA 0.8745 0.9123
43580 Sioux City, IA-NE-SD NE 0.8783 0.9150
43580 Sioux City, IA-NE-SD SD 0.8783 0.9150
43620 Sioux Falls, SD SD 0.9379 0.9570
43780 South Bend-Mishawaka, IN-MI IN 0.9644 0.9755
43780 South Bend-Mishawaka, IN-MI MI 0.9651 0.9760
43900 Spartanburg, SC SC 0.9017 0.9316
44060 Spokane, WA WA 1.0514 1.0349
44100 Springfield, IL IL 0.9133 0.9398
44140 Springfield, MA MA 1.0343 1.0234
44180 Springfield, MO MO 0.8470 0.8925
44220 Springfield, OH OH 0.8629 0.9040
44300 State College, PA PA 0.8810 0.9169
44700 Stockton, CA CA 1.1822 1.1214
44940 Sumter, SC SC 0.8609 0.9025
45060 Syracuse, NY NY 0.9865 0.9907
45104 Tacoma, WA WA 1.1137 1.0765
45220 Tallahassee, FL FL 0.8981 0.9290
45300 Tampa-St. Petersburg-Clearwater, FL FL 0.8993 0.9299
45460 Terre Haute, IN IN 0.9130 0.9396
45500 Texarkana, TX-Texarkana, AR AR 0.8197 0.8727
45500 Texarkana, TX-Texarkana, AR TX 0.8195 0.8726
45780 Toledo, OH OH 0.9267 0.9492
45820 Topeka, KS KS 0.8873 0.9214
45940 Trenton-Ewing, NJ NJ 1.1221 1.0821
46060 Tucson, AZ AZ 0.9442 0.9614
46140 Tulsa, OK OK 0.8652 0.9056
46220 Tuscaloosa, AL AL 0.8695 0.9087
46340 Tyler, TX TX 0.8901 0.9234
46540 Utica-Rome, NY NY 0.8721 0.9105
46660 Valdosta, GA GA 0.8163 0.8702
46700 Vallejo-Fairfield, CA CA 1.3974 1.2575
47020 Victoria, TX TX 0.8153 0.8695
47220 Vineland-Millville-Bridgeton, NJ NJ 1.1221 1.0821
47260 Virginia Beach-Norfolk-Newport News, VA NC 0.8868 0.9210
47260 Virginia Beach-Norfolk-Newport News, VA VA 0.8869 0.9211
47300 Visalia-Porterville, CA CA 1.1822 1.1214
47380 Waco, TX TX 0.8703 0.9093
47580 Warner Robins, GA GA 0.9490 0.9648
47644 Warren-Troy-Farmington-Hills, MI MI 0.9972 0.9981
47894 Washington-Arlington-Alexandria, DC-VA-MD-WV DC 1.0670 1.0454
47894 Washington-Arlington-Alexandria DC-VA-MD-WV MD 1.0670 1.0454
47894 Washington-Arlington-Alexandria DC-VA-MD-WV VA 1.0669 1.0453
47894 Washington-Arlington-Alexandria DC-VA-MD-WV WV 1.0647 1.0439
47940 Waterloo-Cedar Falls, IA IA 0.9248 0.9479
48140 Wausau, WI WI 0.9823 0.9878
48260 Weirton-Steubenville, WV-OH OH 0.8582 0.9006
48260 Weirton-Steubenville, WV-OH WV 0.8011 0.8591
48300 Wenatchee, WA WA 1.0164 1.0112
48424 West Palm Beach-Boca Raton-Boynton Beach, FL FL 0.9631 0.9746
48540 Wheeling, WV-OH OH 0.8582 0.9006
48540 Wheeling, WV-OH WV 0.7635 0.8313
48620 Wichita, KS KS 0.8980 0.9290
48660 Wichita Falls, TX TX 0.9175 0.9427
48700 Williamsport, PA PA 0.8342 0.8833
48864 Wilmington, DE-MD-NJ DE 1.0645 1.0437
48864 Wilmington, DE-MD-NJ MD 1.0645 1.0437
48864 Wilmington, DE-MD-NJ NJ 1.1221 1.0821
48900 Wilmington, NC NC 0.9087 0.9365
49020 Winchester, VA-WV VA 0.9771 0.9843
49020 Winchester, VA-WV WV 0.9751 0.9829
49180 Winston-Salem, NC NC 0.9096 0.9372
49340 Worcester, MA MA 1.0945 1.0638
49420 Yakima, WA WA 1.0164 1.0112
49500 Yauco, PR PR 0.3358 0.4737
49620 York-Hanover, PA PA 0.9666 0.9770
49660 Youngstown-Warren-Boardman, OH-PA OH 0.8931 0.9255
49660 Youngstown-Warren-Boardman, OH-PA PA 0.8930 0.9254
49700 Yuba City, CA CA 1.1822 1.1214
49740 Yuma, AZ AZ 0.9903 0.9933

CBSA code Rural area State Wage index GAF
01 Alabama AL 0.7647 0.8322
02 Alaska AK 1.1884 1.1255
03 Arizona AZ 0.8857 0.9202
04 Arkansas AR 0.7641 0.8317
05 California CA 1.1822 1.1214
06 Colorado CO 0.9303 0.9517
07 Connecticut CT 1.1897 1.1263
08 Delaware DE 1.0252 1.0172
10 Florida FL 0.8633 0.9042
11 Georgia GA 0.7840 0.8465
12 Hawaii HI 1.1219 1.0820
13 Idaho ID 0.7597 0.8284
14 Illinois IL 0.8428 0.8895
15 Indiana IN 0.8479 0.8932
16 Iowa IA 0.8709 0.9097
17 Kansas KS 0.8086 0.8646
18 Kentucky KY 0.7837 0.8463
19 Louisiana LA 0.7682 0.8348
20 Maine ME 0.8609 0.9025
21 Maryland MD 0.8795 0.9158
22 Massachusetts MA 1.0199 1.0136
23 Michigan MI 0.8864 0.9207
24 Minnesota MN 0.9120 0.9389
25 Mississippi MS 0.7653 0.8326
26 Missouri MO 0.8470 0.8925
27 Montana MT 0.8640 0.9047
28 Nebraska NE 0.8761 0.9134
29 Nevada NV 0.9824 0.9879
30 New Hampshire NH 1.0807 1.0546
31 New Jersey1 NJ 1.1221 1.0821
32 New Mexico NM 0.8858 0.9203
33 New York NY 0.8308 0.8808
34 North Carolina NC 0.8632 0.9042
35 North Dakota ND 0.7336 0.8088
36 Ohio OH 0.8582 0.9006
37 Oklahoma OK 0.8016 0.8595
38 Oregon OR 1.0298 1.0203
39 Pennsylvania PA 0.8342 0.8833
40 Puerto Rico1 PR
41 Rhode Island1 RI
42 South Carolina SC 0.8609 0.9025
43 South Dakota SD 0.8428 0.8895
44 Tennessee TN 0.7957 0.8551
45 Texas TX 0.8153 0.8695
46 Utah UT 0.8395 0.8871
47 Vermont VT 0.9275 0.9498
49 Virginia VA 0.8061 0.8628
50 Washington WA 1.0164 1.0112
51 West Virginia WV 0.7635 0.8313
52 Wisconsin WI 0.9511 0.9662
53 Wyoming WY 0.9223 0.9461
1 All counties in the State or Territory are classified as urban. The New Jersey floor is imputed as specified in § 412.64(h)(4) and discussed in the FY 2005 IPPS final rule (69 FR 49109) and in section III.B.2 of the preamble of this proposed rule.

CBSA code Area State Wage index GAF
10420 Akron, OH OH 0.8784 0.9150
10500 Albany, GA AL 0.8397 0.8872
10500 Albany, GA GA 0.8397 0.8872
10580 Albany-Schenectady-Troy, NY NY 0.8833 0.9185
10740 Albuquerque, NM NM 0.9295 0.9512
10780 Alexandria, LA LA 0.8127 0.8676
10900 Allentown-Bethlehem-Easton, PA-NJ PA 0.9675 0.9776
11100 Amarillo, TX KS 0.8885 0.9222
11100 Amarillo, TX TX 0.8883 0.9221
11180 Ames, IA IA 0.8881 0.9219
11260 Anchorage, AK AK 1.1884 1.1255
11460 Ann Arbor, MI MI 1.0113 1.0077
12060 Atlanta-Sandy Springs-Marietta, GA AL 0.9760 0.9835
12060 Atlanta-Sandy Springs-Marietta, GA GA 0.9760 0.9835
12420 Austin-Round Rock, TX TX 0.9521 0.9669
12620 Bangor, ME ME 1.0115 1.0079
12940 Baton Rouge, LA MS 0.8146 0.8690
13020 Bay City, MI MI 0.9472 0.9635
13644 Bethesda-Frederick-Gaithersburg, MD DC 1.1018 1.0686
13644 Bethesda-Frederick-Gaithersburg, MD PA 1.1006 1.0678
13644 Bethesda-Frederick-Gaithersburg, MD VA 1.1017 1.0686
13780 Binghamton, NY PA 0.8560 0.8990
13820 Birmingham-Hoover, AL AL 0.8786 0.9152
13900 Bismarck, ND ND 0.7336 0.8088
13980 Blacksburg-Christiansburg-Radford, VA WV 0.7795 0.8432
14020 Bloomington, IN IN 0.8791 0.9155
14260 Boise City-Nampa, ID ID 0.9100 0.9375
14260 Boise City-Nampa, ID NV 0.9824 0.9879
14484 Boston-Quincy, MA MA 1.1338 1.0898
14484 Boston-Quincy, MA RI 1.1338 1.0898
14600 Bradenton-Sarasota-Venice, FL FL 0.9648 0.9758
14740 Bremerton-Silverdale, WA WA 1.0576 1.0391
14860 Bridgeport-Stamford-Norwalk, CT NY 1.2694 1.1775
15380 Buffalo-Niagara Falls, NY NY 0.9593 0.9719
15540 Burlington-South Burlington, VT NY 0.9216 0.9456
15764 Cambridge-Newton-Framingham, MA NH 1.0807 1.0546
16180 Carson City, NV NV 0.9837 0.9888
16220 Casper, WY SD 0.9618 0.9737
16580 Champaign-Urbana, IL IL 0.8840 0.9190
16620 Charleston, WV WV 0.8398 0.8873
16700 Charleston-North Charleston-Summerville, SC SC 0.9231 0.9467
16740 Charlotte-Gastonia-Concord, NC-SC NC 0.9570 0.9704
16740 Charlotte-Gastonia-Concord, NC-SC SC 0.9557 0.9694
16820 Charlottesville, VA VA 0.9449 0.9619
16860 Chattanooga, TN-GA AL 0.8740 0.9119
16860 Chattanooga, TN-GA GA 0.8740 0.9119
16860 Chattanooga, TN-GA TN 0.8717 0.9103
16974 Chicago-Naperville-Joliet, IL IL 1.0334 1.0228
16974 Chicago-Naperville-Joliet, IL IN 1.0328 1.0223
16974 Chicago-Naperville-Joliet, IL WI 1.0315 1.0215
17140 Cincinnati-Middletown, OH-KY-IN IN 0.9583 0.9713
17140 Cincinnati-Middletown, OH-KY-IN OH 0.9581 0.9711
17300 Clarksville, TN-KY KY 0.8302 0.8804
17460 Cleveland-Elyria-Mentor, OH OH 0.9266 0.9491
17660 Coeur d'Alene, ID MT 0.8992 0.9298
17820 Colorado Springs, CO CO 0.9738 0.9820
17860 Columbia, MO MO 0.8470 0.8925
17900 Columbia, SC SC 0.8984 0.9293
17980 Columbus, GA-AL AL 0.8495 0.8943
17980 Columbus, GA-AL GA 0.8495 0.8943
18140 Columbus, OH OH 0.9657 0.9764
18700 Corvallis, OR OR 1.0572 1.0388
19124 Dallas-Plano-Irving, TX TX 0.9852 0.9898
19340 Davenport-Moline-Rock Island, IA-IL IL 0.8606 0.9023
19340 Davenport-Moline-Rock Island, IA-IL IA 0.8709 0.9097
19380 Dayton, OH OH 0.9321 0.9530
19740 Denver-Aurora, CO CO 1.0409 1.0278
19804 Detroit-Livonia-Dearborn, MI MI 1.0052 1.0036
20100 Dover, DE DE 1.0304 1.0207
20260 Duluth, MN-WI MN 1.0401 1.0273
20500 Durham, NC NC 0.9693 0.9789
20500 Durham, NC VA 0.9694 0.9789
20764 Edison-New Brunswick, NJ NJ 1.1221 1.0821
21060 Elizabethtown, KY KY 0.8230 0.8751
21140 Elkhart-Goshen, IN IN 0.9547 0.9688
21500 Erie, PA NY 0.8420 0.8889
21660 Eugene-Springfield, OR OR 1.1157 1.0779
21780 Evansville, IN-KY IN 0.8479 0.8932
21780 Evansville, IN-KY KY 0.8131 0.8679
22020 Fargo, ND-MN ND 0.8212 0.8738
22020 Fargo, ND-MN SD 0.8428 0.8895
22180 Fayetteville, NC NC 0.9567 0.9701
22220 Fayetteville-Springdale-Rogers, AR-MO AR 0.8952 0.9270
22220 Fayetteville-Springdale-Rogers, AR-MO OK 0.8950 0.9268
22380 Flagstaff, AZ AZ 1.1305 1.0876
22420 Flint, MI MI 1.0810 1.0548
22520 Florence-Muscle Shoals, AL AL 0.7883 0.8497
22520 Florence-Muscle Shoals, AL MS 0.7883 0.8497
22540 Fond du Lac, WI WI 0.9523 0.9671
22660 Fort Collins-Loveland, CO CO 0.9581 0.9711
22744 Ft Lauderdale-Pompano Beach-Deerfield Beach, FL FL 1.0025 1.0017
23020 Fort Walton Beach-Crestview-Destin, FL FL 0.8633 0.9042
23060 Fort Wayne, IN IN 0.9004 0.9307
23104 Fort Worth-Arlington, TX TX 0.9684 0.9783
23540 Gainesville, FL FL 0.9427 0.9604
23844 Gary, IN IN 0.9320 0.9529
24300 Grand Junction, CO CO 0.9925 0.9949
24340 Grand Rapids-Wyoming, MI MI 0.9305 0.9519
24500 Great Falls, MT MT 0.8679 0.9075
24540 Greeley, CO NE 0.9611 0.9732
24540 Greeley, CO WY 0.9611 0.9732
24580 Green Bay, WI MI 0.9412 0.9594
24580 Green Bay, WI WI 0.9511 0.9662
24660 Greensboro-High Point, NC NC 0.8984 0.9293
24660 Greensboro-High Point, NC VA 0.8985 0.9293
24780 Greenville, NC NC 0.9174 0.9427
24860 Greenville-Mauldin-Easley, SC NC 0.9307 0.9520
24860 Greenville-Mauldin-Easley, SC SC 0.9294 0.9511
25060 Gulfport-Biloxi, MS MS 0.8156 0.8697
25420 Harrisburg-Carlisle, PA PA 0.9185 0.9434
25540 Hartford-West Hartford-East Hartford, CT CT 1.1897 1.1263
25540 Hartford-West Hartford-East Hartford, CT MA 1.0972 1.0656
25860 Hickory-Lenoir-Morganton, NC NC 0.8794 0.9158
26180 Honolulu, HI HI 1.1608 1.1075
26420 Houston-Sugar Land-Baytown, TX TX 0.9925 0.9949
26580 Huntington-Ashland, WV-KY-OH KY 0.8767 0.9138
26580 Huntington-Ashland, WV-KY-OH OH 0.8759 0.9133
26580 Huntington-Ashland, WV-KY-OH WV 0.8748 0.9125
26620 Huntsville, AL AL 0.8636 0.9045
26620 Huntsville, AL TN 0.8614 0.9029
26820 Idaho Falls, ID ID 0.9327 0.9534
26820 Idaho Falls, ID WY 0.9327 0.9534
26900 Indianapolis-Carmel, IN IN 0.9707 0.9798
26980 Iowa City, IA IA 0.9107 0.9380
27060 Ithaca, NY NY 0.9101 0.9375
27140 Jackson, MS MS 0.8095 0.8653
27180 Jackson, TN MS 0.8361 0.8846
27180 Jackson, TN TN 0.8339 0.8830
27260 Jacksonville, FL FL 0.9092 0.9369
27260 Jacksonville, FL GA 0.9112 0.9383
27620 Jefferson City, MO MO 0.8736 0.9116
27780 Johnstown, PA PA 0.8342 0.8833
27860 Jonesboro, AR AR 0.8291 0.8796
27860 Jonesboro, AR MO 0.8470 0.8925
27900 Joplin, MO KS 0.9351 0.9551
27900 Joplin, MO OK 0.9349 0.9549
28020 Kalamazoo-Portage, MI MI 1.0365 1.0249
28140 Kansas City, MO-KS MO 0.9444 0.9616
28420 Kennewick-Pasco-Richland, WA ID 0.9560 0.9697
28420 Kennewick-Pasco-Richland, WA WA 1.0164 1.0112
28700 Kingsport-Bristol-Bristol, TN-VA KY 0.7919 0.8523
28700 Kingsport-Bristol-Bristol, TN-VA TN 0.7957 0.8551
28940 Knoxville, TN KY 0.7889 0.8501
28940 Knoxville, TN TN 0.7957 0.8551
29180 Lafayette, LA LA 0.8438 0.8902
29460 Lakeland-Winter Haven, FL FL 0.8715 0.9101
29540 Lancaster, PA PA 0.9799 0.9862
29620 Lansing-East Lansing, MI MI 0.9652 0.9760
29820 Las Vegas-Paradise, NV AZ 1.1388 1.0931
29820 Las Vegas-Paradise, NV UT 1.1388 1.0931
30460 Lexington-Fayette, KY KY 0.8756 0.9130
30620 Lima, OH OH 0.9299 0.9514
30700 Lincoln, NE NE 0.9336 0.9540
30780 Little Rock-North Little Rock-Conway, AR AR 0.8650 0.9055
30860 Logan, UT-ID UT 0.8827 0.9181
30980 Longview, TX TX 0.8666 0.9066
31084 Los Angeles-Long Beach-Glendale, CA CA 1.1822 1.1214
31140 Louisville-Jefferson County, KY-IN KY 0.9123 0.9391
31340 Lynchburg, VA VA 0.8646 0.9052
31420 Macon, GA GA 0.9618 0.9737
31540 Madison, WI WI 1.1014 1.0684
31700 Manchester-Nashua, NH NH 1.0807 1.0546
32780 Medford, OR OR 1.0298 1.0203
32820 Memphis, TN-MS-AR AR 0.8909 0.9239
32820 Memphis, TN-MS-AR MS 0.8909 0.9239
32820 Memphis, TN-MS-AR TN 0.8886 0.9223
33124 Miami-Miami Beach-Kendall, FL FL 0.9865 0.9907
33340 Milwaukee-Waukesha-West Allis, WI WI 1.0026 1.0018
33460 Minneapolis-St. Paul-Bloomington, MN-WI MN 1.0997 1.0672
33460 Minneapolis-St. Paul-Bloomington, MN-WI WI 1.0976 1.0659
33540 Missoula, MT MT 0.8909 0.9239
33700 Modesto, CA CA 1.1963 1.1306
33740 Monroe, LA AR 0.7789 0.8427
33740 Monroe, LA LA 0.7785 0.8424
33860 Montgomery, AL AL 0.8192 0.8723
34060 Morgantown, WV WV 0.8631 0.9041
34740 Muskegon-Norton Shores, MI MI 0.9455 0.9623
34820 Myrtle Beach-North Myrtle Beach-Conway, SC NC 0.8632 0.9042
34820 Myrtle Beach-North Myrtle Beach-Conway, SC SC 0.8609 0.9025
34980 Nashville-Davidson-Murfreesboro-Franklin, TN KY 0.9276 0.9498
34980 Nashville-Davidson-Murfreesboro-Franklin, TN TN 0.9252 0.9482
35004 Nassau-Suffolk, NY CT 1.2038 1.1354
35084 Newark-Union, NJ-PA NJ 1.1316 1.0884
35084 Newark-Union, NJ-PA NY 1.1461 1.0979
35084 Newark-Union, NJ-PA PA 1.1449 1.0971
35300 New Haven-Milford, CT CT 1.1897 1.1263
35380 New Orleans-Metairie-Kenner, LA LA 0.9140 0.9403
35644 New York-White Plains-Wayne, NY-NJ CT 1.2391 1.1581
35644 New York-White Plains-Wayne, NY-NJ NJ 1.2693 1.1774
35644 New York-White Plains-Wayne, NY-NJ NY 1.2855 1.1877
35980 Norwich-New London, CT RI 1.1587 1.1061
36084 Oakland-Fremont-Hayward, CA CA 1.5278 1.3367
36140 Ocean City, NJ DE 1.0909 1.0614
36220 Odessa, TX NM 0.9273 0.9496
36220 Odessa, TX TX 0.9283 0.9503
36420 Oklahoma City, OK OK 0.8686 0.9080
36500 Olympia, WA WA 1.1297 1.0871
36740 Orlando-Kissimmee, FL FL 0.9073 0.9356
37460 Panama City-Lynn Haven, FL AL 0.8322 0.8818
37700 Pascagoula, MS AL 0.8030 0.8605
37764 Peabody, MA NH 1.0807 1.0546
37860 Pensacola-Ferry Pass-Brent, FL AL 0.8115 0.8667
37900 Peoria, IL IL 0.9043 0.9334
37964 Philadelphia, PA DE 1.0799 1.0540
37964 Philadelphia, PA NJ 1.1221 1.0821
37964 Philadelphia, PA PA 1.0788 1.0533
38220 Pine Bluff, AR MS 0.8150 0.8693
38300 Pittsburgh, PA OH 0.8582 0.9006
38300 Pittsburgh, PA PA 0.8579 0.9004
38300 Pittsburgh, PA WV 0.8569 0.8996
38340 Pittsfield, MA NY 0.9901 0.9932
38340 Pittsfield, MA VT 0.9275 0.9498
38860 Portland-South Portland-Biddeford, ME ME 0.9644 0.9755
38900 Portland-Vancouver-Beaverton, OR-WA OR 1.1204 1.0810
38900 Portland-Vancouver-Beaverton, OR-WA WA 1.1186 1.0798
38940 Port St. Lucie, FL FL 0.9741 0.9822
39100 Poughkeepsie-Newburgh-Middletown, NY NY 1.0709 1.0480
39140 Prescott, AZ AZ 1.0011 1.0008
39340 Provo-Orem, UT UT 0.9052 0.9341
39580 Raleigh-Cary, NC NC 0.9557 0.9694
39740 Reading, PA PA 0.9204 0.9448
39820 Redding, CA CA 1.2730 1.1797
39900 Reno-Sparks, NV NV 1.0476 1.0324
40060 Richmond, VA VA 0.9203 0.9447
40140 Riverside-San Bernardino-Ontario, CA AZ 1.1254 1.0843
40220 Roanoke, VA VA 0.8750 0.9126
40220 Roanoke, VA WV 0.8732 0.9113
40380 Rochester, NY NY 0.8911 0.9241
40420 Rockford, IL IL 0.9756 0.9832
40484 Rockingham County-Strafford County, NH ME 1.0007 1.0005
40660 Rome, GA AL 0.9524 0.9672
40900 Sacramento-Arden-Arcade-Roseville, CA CA 1.2710 1.1785
40980 Saginaw-Saginaw Township North, MI MI 0.8864 0.9207
41060 St. Cloud, MN MN 1.0638 1.0433
41100 St. George, UT UT 0.9228 0.9465
41140 St. Joseph, MO-KS MO 1.0267 1.0182
41180 St. Louis, MO-IL IL 0.8993 0.9299
41180 St. Louis, MO-IL MO 0.8986 0.9294
41620 Salt Lake City, UT UT 0.9271 0.9495
41700 San Antonio, TX TX 0.8949 0.9268
41884 San Francisco-San Mateo-Redwood City, CA CA 1.4879 1.3127
41940 San Jose-Sunnyvale-Santa Clara, CA CA 1.5758 1.3654
42044 Santa Ana-Anaheim-Irvine, CA CA 1.1822 1.1214
42100 Santa Cruz-Watsonville, CA CA 1.5766 1.3658
42140 Santa Fe, NM NM 1.0207 1.0141
42220 Santa Rosa-Petaluma, CA CA 1.4497 1.2896
42340 Savannah, GA GA 0.8841 0.9191
42340 Savannah, GA SC 0.8827 0.9181
42644 Seattle-Bellevue-Everett, WA WA 1.1377 1.0924
43300 Sherman-Denison, TX OK 0.9291 0.9509
43340 Shreveport-Bossier City, LA LA 0.8547 0.8981
43580 Sioux City, IA-NE-SD NE 0.8761 0.9134
43620 Sioux Falls, SD SD 0.9262 0.9489
43780 South Bend-Mishawaka, IN-MI IN 0.9353 0.9552
43900 Spartanburg, SC SC 0.9017 0.9316
44060 Spokane, WA ID 1.0315 1.0215
44180 Springfield, MO AR 0.8477 0.8930
44180 Springfield, MO MO 0.8470 0.8925
44940 Sumter, SC SC 0.8609 0.9025
45060 Syracuse, NY NY 0.9471 0.9635
45220 Tallahassee, FL GA 0.8397 0.8872
45300 Tampa-St. Petersburg-Clearwater, FL FL 0.8993 0.9299
45500 Texarkana, TX-Texarkana, AR AR 0.8093 0.8651
45780 Toledo, OH OH 0.9267 0.9492
45820 Topeka, KS KS 0.8720 0.9105
46140 Tulsa, OK OK 0.8652 0.9056
46220 Tuscaloosa, AL MS 0.8280 0.8788
46340 Tyler, TX TX 0.8901 0.9234
46700 Vallejo-Fairfield, CA CA 1.3974 1.2575
47260 Virginia Beach-Norfolk-Newport News, VA NC 0.8868 0.9210
47644 Warren-Troy-Farmington-Hills, MI MI 0.9972 0.9981
47894 Washington-Arlington-Alexandria, DC-VA VA 1.0669 1.0453
47940 Waterloo-Cedar Falls, IA IA 0.9248 0.9479
48140 Wausau, WI WI 0.9823 0.9878
48620 Wichita, KS KS 0.8785 0.9151
48620 Wichita, KS OK 0.8784 0.9150
48700 Williamsport, PA PA 0.8342 0.8833
48864 Wilmington, DE-MD-NJ DE 1.0645 1.0437
48864 Wilmington, DE-MD-NJ NJ 1.1221 1.0821
48900 Wilmington, NC SC 0.9074 0.9356
49180 Winston-Salem, NC NC 0.9096 0.9372
49340 Worcester, MA NH 1.0807 1.0546
49660 Youngstown-Warren-Boardman, OH-PA OH 0.8582 0.9006
49660 Youngstown-Warren-Boardman, OH-PA PA 0.8559 0.8989
04 Arkansas LA 0.7682 0.8348
05 California CA 1.1822 1.1214
10 Florida FL 0.8633 0.9042
14 Illinois IL 0.8428 0.8895
14 Illinois KY 0.8320 0.8817
14 Illinois MO 0.8470 0.8925
16 Iowa MO 0.8738 0.9118
17 Kansas KS 0.8086 0.8646
22 Massachusetts MA 1.0199 1.0136
23 Michigan MI 0.8864 0.9207
25 Mississippi MS 0.7653 0.8326
26 Missouri MO 0.8470 0.8925
30 New Hampshire VT 0.9297 0.9513
33 New York NY 0.8308 0.8808
34 North Carolina TN 0.8611 0.9027
36 Ohio OH 0.8582 0.9006
37 Oklahoma OK 0.8016 0.8595
38 Oregon OR 1.0298 1.0203
39 Pennsylvania NY 0.8351 0.8839
39 Pennsylvania PA 0.8342 0.8833
44 Tennessee KY 0.7978 0.8567
44 Tennessee TN 0.7957 0.8551
45 Texas TX 0.8153 0.8695
49 Virginia KY 0.8062 0.8628
49 Virginia VA 0.8061 0.8628
50 Washington WA 1.0164 1.0112
53 Wyoming NE 0.9223 0.9461

State Rural floor budget neutrality ajustment factor
Alabama 1.00000
Alaska 0.99734
Arizona 1.00000
Arkansas 1.00000
California 0.98552
Colorado 0.99683
Connecticut 0.96390
Delaware 1.00000
Washington, DC 1.00000
Florida 0.99781
Georgia 1.00000
Hawaii 1.00000
Idaho 1.00000
Illinois 0.99993
Indiana 0.99928
Iowa 0.99572
Kansas 1.00000
Kentucky 1.00000
Louisiana 0.99945
Maine 1.00000
Maryland
Massachusetts 1.00000
Michigan 1.00000
Minnesota 1.00000
Mississippi 1.00000
Missouri 0.99910
Montana 1.00000
Nebraska 1.00000
Nevada 1.00000
New Hampshire 0.97787
New Jersey 0.98738
New Mexico 0.99875
New York 1.00000
North Carolina 0.99983
North Dakota 0.99424
Ohio 0.99906
Oklahoma 0.99983
Oregon 0.99955
Pennsylvania 0.99895
Puerto Rico 1.00000
Rhode Island 1.00000
South Carolina 0.99840
South Dakota 1.00000
Tennessee 0.99741
Texas 0.99980
Utah 1.00000
Vermont 0.90100
Virginia 0.99991
Washington 0.99791
West Virginia 0.99782
Wisconsin 0.99809
Wyoming 1.00000
* Maryland hospitals, under section 1814(b)(3) of the Act, are waived from the IPPS ratesetting. Therefore, the rural floor budget neutrality adjustment does not apply.
** The rural floor budget neutrality factor for New Jersey is based on an imputed floor (see Table 4B).

CBSA code Urban area State * Rural or imputed floor wage index
10900 Allentown-Bethlehem-Easton, PA-NJ NJ 1.1221
11020 Altoona, PA PA 0.8342
11260 Anchorage, AK AK 1.1884
11540 Appleton, WI WI 0.9511
12220 Auburn-Opelika, AL AL 0.7647
12540 Bakersfield, CA CA 1.1822
13900 Bismarck, ND ND 0.7336
15500 Burlington, NC NC 0.8632
15540 Burlington-South Burlington, VT VT 0.9275
15804 Camden, NJ NJ 1.1221
16940 Cheyenne, WY WY 0.9223
17020 Chico, CA CA 1.1822
17860 Columbia, MO MO 0.8470
19060 Cumberland, MD-WV MD 0.8795
19060 Cumberland, MD-WV WV 0.7635
19340 Davenport-Moline-Rock Island, IA-IL IA 0.8709
19500 Decatur, IL IL 0.8428
20220 Dubuque, IA IA 0.8709
20764 Edison-New Brunswick, NJ NJ 1.1221
20940 El Centro, CA CA 1.1822
21820 Fairbanks, AK AK 1.1884
22020 Fargo, ND-MN MN 0.9120
22140 Farmington, NM NM 0.8858
22500 Florence, SC SC 0.8609
22900 Fort Smith, AR-OK OK 0.8016
23420 Fresno, CA CA 1.1822
24220 Grand Forks, ND-MN MN 0.9120
24580 Green Bay, WI WI 0.9511
25260 Hanford-Corcoran, CA CA 1.1822
25540 Hartford-West Hartford-East Hartford, CT CT 1.1897
25620 Hattiesburg, MS MS 0.7653
27340 Jacksonville, NC NC 0.8632
27780 Johnstown, PA PA 0.8342
28420 Kennewick-Pasco-Richland, WA WA 1.0164
28700 Kingsport-Bristol-Bristol, TN-VA TN 0.7957
28700 Kingsport-Bristol-Bristol, TN-VA VA 0.8061
28940 Knoxville, TN TN 0.7957
29340 Lake Charles, LA LA 0.7682
29740 Las Cruces, NM NM 0.8858
30300 Lewiston, ID-WA WA 1.0164
31460 Madera, CA CA 1.1822
31700 Manchester-Nashua, NH NH 1.0807
32780 Medford, OR OR 1.0298
34100 Morristown, TN TN 0.7957
34580 Mount Vernon-Anacortes, WA WA 1.0164
34620 Muncie, IN IN 0.8479
35300 New Haven-Milford, CT CT 1.1897
35980 Norwich-New London, CT CT 1.1897
36100 Ocala, FL FL 0.8633
36780 Oshkosh-Neenah, WI WI 0.9511
37100 Oxnard-Thousand Oaks-Ventura, CA CA 1.1822
37460 Panama City-Lynn Haven, FL FL 0.8633
37620 Parkersburg-Marietta-Vienna, WV-OH OH 0.8582
37860 Pensacola-Ferry Pass-Brent, FL FL 0.8633
39380 Pueblo, CO CO 0.9303
39540 Racine, WI WI 0.9511
40140 Riverside-San Bernardino-Ontario, CA CA 1.1822
40484 Rockingham County-Strafford County, NH NH 1.0807
41740 San Diego-Carlsbad-San Marcos, CA CA 1.1822
42020 San Luis Obispo-Paso Robles, CA CA 1.1822
42044 Santa Ana-Anaheim-Irvine, CA CA 1.1822
42060 Santa Barbara-Santa Maria-Goleta, CA CA 1.1822
42540 Scranton-Wilkes-Barre, PA PA 0.8342
43100 Sheboygan, WI WI 0.9511
44180 Springfield, MO MO 0.8470
44700 Stockton, CA CA 1.1822
44940 Sumter, SC SC 0.8609
45940 Trenton-Ewing, NJ NJ 1.1221
47020 Victoria, TX TX 0.8153
47220 Vineland-Millville-Bridgeton, NJ NJ 1.1221
47300 Visalia-Porterville, CA CA 1.1822
48260 Weirton-Steubenville, WV-OH OH 0.8582
48300 Wenatchee, WA WA 1.0164
48540 Wheeling, WV-OH OH 0.8582
48540 Wheeling, WV-OH WV 0.7635
48700 Williamsport, PA PA 0.8342
48864 Wilmington, DE-MD-NJ NJ 1.1221
49420 Yakima, WA WA 1.0164
49700 Yuba City, CA CA 1.1822

CBSA code Urban area (constituent counties)
10180 Abilene, TX
Callahan County, TX
Jones County, TX
Taylor County, TX
10380 Aguadilla-Isabela-San Sebastián, PR
Aguada Municipio, PR
Aguadilla Municipio, PR
Añasco Municipio, PR
Isabela Municipio, PR
Lares Municipio, PR
Moca Municipio, PR
Rincón Municipio, PR
San Sebastián Municipio, PR
10420 Akron, OH
Portage County, OH
Summit County, OH
10500 Albany, GA
Baker County, GA
Dougherty County, GA
Lee County, GA
Terrell County, GA
Worth County, GA
10580 Albany-Schenectady-Troy, NY
Albany County, NY
Rensselaer County, NY
Saratoga County, NY
Schenectady County, NY
Schoharie County, NY
10740 Albuquerque, NM
Bernalillo County, NM
Sandoval County, NM
Torrance County, NM
Valencia County, NM
10780 Alexandria, LA
Grant Parish, LA
Rapides Parish, LA
10900 Allentown-Bethlehem-Easton, PA-NJ
Warren County, NJ
Carbon County, PA
Lehigh County, PA
Northampton County, PA
11020 Altoona, PA
Blair County, PA
11100 Amarillo, TX
Armstrong County, TX
Carson County, TX
Potter County, TX
Randall County, TX
11180 Ames, IA
Story County, IA
11260 Anchorage, AK
Anchorage Municipality, AK
Matanuska-SusitnaBorough, AK
11300 Anderson, IN
Madison County, IN
11340 Anderson, SC
Anderson County, SC
11460 Ann Arbor, MI
Washtenaw County, MI
11500 Anniston-Oxford, AL
Calhoun County, AL
11540 Appleton, WI
Calumet County, WI
Outagamie County, WI
11700 Asheville, NC
Buncombe County, NC
Haywood County, NC
Henderson County, NC
Madison County, NC
12020 Athens-Clarke County, GA
Clarke County, GA
Madison County, GA
Oconee County, GA
Oglethorpe County, GA
12060 1 Atlanta-Sandy Springs-Marietta, GA
Barrow County, GA
Bartow County, GA
Butts County, GA
Carroll County, GA
Cherokee County, GA
Clayton County, GA
Cobb County, GA
Coweta County, GA
Dawson County, GA
DeKalb County, GA
Douglas County, GA
Fayette County, GA
Forsyth County, GA
Fulton County, GA
Gwinnett County, GA
Haralson County, GA
Heard County, GA
Henry County, GA
Jasper County, GA
Lamar County, GA
Meriwether County, GA
Newton County, GA
Paulding County, GA
Pickens County, GA
Pike County, GA
Rockdale County, GA
Spalding County, GA
Walton County, GA
12100 Atlantic City-Hammonton, NJ
Atlantic County, NJ
Hammonton County, NJ
12220 Auburn-Opelika, AL
Lee County, AL
12260 Augusta-Richmond County, GA-SC
Burke County, GA
Columbia County, GA
McDuffie County, GA
Richmond County, GA
Aiken County, SC
Edgefield County, SC
12420 1 Austin-Round Rock, TX
Bastrop County, TX
Caldwell County, TX
Hays County, TX
Travis County, TX
Williamson County, TX
12540 Bakersfield, CA
Kern County, CA
12580 1 Baltimore-Towson, MD
Anne Arundel County, MD
Baltimore County, MD
Carroll County, MD
Harford County, MD
Howard County, MD
Queen Anne's County, MD
Baltimore City, MD
12620 Bangor, ME
Penobscot County, ME
12700 Barnstable Town, MA
Barnstable County, MA
12940 Baton Rouge, LA
Ascension Parish, LA
East Baton Rouge Parish, LA
East Feliciana Parish, LA
Iberville Parish, LA
Livingston Parish, LA
Pointe Coupee Parish, LA
St. Helena Parish, LA
West Baton Rouge Parish, LA
West Feliciana Parish, LA
12980 Battle Creek, MI
Calhoun County, MI
13020 Bay City, MI
Bay County, MI
13140 Beaumont-Port Arthur, TX
Hardin County, TX
Jefferson County, TX
Orange County, TX
13380 Bellingham, WA
Whatcom County, WA
13460 Bend, OR
Deschutes County, OR
13644 1 Bethesda-Frederick-Gaithersburg, MD
Frederick County, MD
Montgomery County, MD
13740 Billings, MT
Carbon County, MT
Yellowstone County, MT
13780 Binghamton, NY
Broome County, NY
Tioga County, NY
13820 1 Birmingham-Hoover, AL
Bibb County, AL
Blount County, AL
Chilton County, AL
Jefferson County, AL
St. Clair County, AL
Shelby County, AL
Walker County, AL
13900 Bismarck, ND
Burleigh County, ND
Morton County, ND
13980 Blacksburg-Christiansburg-Radford, VA
Giles County, VA
Montgomery County, VA
Pulaski County, VA
Radford City, VA
14020 Bloomington, IN
Greene County, IN
Monroe County, IN
Owen County, IN
14060 Bloomington-Normal, IL
McLean County, IL
14260 Boise City-Nampa, ID
Ada County, ID
Boise County, ID
Canyon County, ID
Gem County, ID
Owyhee County, ID
14484 1 Boston-Quincy, MA
Norfolk County, MA
Plymouth County, MA
Suffolk County, MA
14500 Boulder, CO
Boulder County, CO
14540 Bowling Green, KY
Edmonson County, KY
Warren County, KY
14600 Bradenton-Sarasota-Venice, FL
Bradenton County, FL
Manatee County, FL
Sarasota County, FL
14740 Bremerton-Silverdale, WA
Kitsap County, WA
14860 Bridgeport-Stamford-Norwalk, CT
Fairfield County, CT
15180 Brownsville-Harlingen, TX
Cameron County, TX
15260 Brunswick, GA
Brantley County, GA
Glynn County, GA
McIntosh County, GA
15380 1 Buffalo-Niagara Falls, NY
Erie County, NY
Niagara County, NY
15500 Burlington, NC
Alamance County, NC
15540 Burlington-South Burlington, VT
Chittenden County, VT
Franklin County, VT
Grand Isle County, VT
15764 1 Cambridge-Newton-Framingham, MA
Middlesex County, MA
15804 1 Camden, NJ
Burlington County, NJ
Camden County, NJ
Gloucester County, NJ
15940 Canton-Massillon, OH
Carroll County, OH
Stark County, OH
15980 Cape Coral-Fort Myers, FL
Lee County, FL
16180 Carson City, NV
Carson City, NV
16220 Casper, WY
Natrona County, WY
16300 Cedar Rapids, IA
Benton County, IA
Jones County, IA
Linn County, IA
16580 Champaign-Urbana, IL
Champaign County, IL
Ford County, IL
Piatt County, IL
16620 Charleston, WV
Boone County, WV
Clay County, WV
Kanawha County, WV
Lincoln County, WV
Putnam County, WV
16700 Charleston-North Charleston-Summerville, SC
Berkeley County, SC
Charleston County, SC
Dorchester County, SC
Summerville County, SC
16740 1 Charlotte-Gastonia-Concord, NC-SC
Anson County, NC
Cabarrus County, NC
Gaston County, NC
Mecklenburg County, NC
Union County, NC
York County, SC
16820 Charlottesville, VA
Albemarle County, VA
Fluvanna County, VA
Greene County, VA
Nelson County, VA
Charlottesville City, VA
16860 Chattanooga, TN-GA
Catoosa County, GA
Dade County, GA
Walker County, GA
Hamilton County, TN
Marion County, TN
Sequatchie County, TN
16940 Cheyenne, WY
Laramie County, WY
16974 1 Chicago-Naperville-Joliet, IL
Cook County, IL
DeKalb County, IL
DuPage County, IL
Grundy County, IL
Kane County, IL
Kendall County, IL
McHenry County, IL
Will County, IL
17020 Chico, CA
Butte County, CA
17140 1 Cincinnati-Middletown, OH-KY-IN
Dearborn County, IN
Franklin County, IN
Ohio County, IN
Boone County, KY
Bracken County, KY
Campbell County, KY
Gallatin County, KY
Grant County, KY
Kenton County, KY
Pendleton County, KY
Brown County, OH
Butler County, OH
Clermont County, OH
Hamilton County, OH
Warren County, OH
17300 Clarksville, TN-KY
Christian County, KY
Trigg County, KY
Montgomery County, TN
Stewart County, TN
17420 Cleveland, TN
Bradley County, TN
Polk County, TN
17460 1 Cleveland-Elyria-Mentor, OH
Cuyahoga County, OH
Geauga County, OH
Lake County, OH
Lorain County, OH
Medina County, OH
17660 Coeur d'Alene, ID
Kootenai County, ID
17780 College Station-Bryan, TX
Brazos County, TX
Burleson County, TX
Robertson County, TX
17820 Colorado Springs, CO
El Paso County, CO
Teller County, CO
17860 Columbia, MO
Boone County, MO
Howard County, MO
17900 Columbia, SC
Calhoun County, SC
Fairfield County, SC
Kershaw County, SC
Lexington County, SC
Richland County, SC
Saluda County, SC
17980 Columbus, GA-AL
Russell County, AL
Chattahoochee County, GA
Harris County, GA
Marion County, GA
Muscogee County, GA
18020 Columbus, IN
Bartholomew County, IN
18140 1 Columbus, OH
Delaware County, OH
Fairfield County, OH
Franklin County, OH
Licking County, OH
Madison County, OH
Morrow County, OH
Pickaway County, OH
Union County, OH
18580 Corpus Christi, TX
Aransas County, TX
Nueces County, TX
San Patricio County, TX
18700 Corvallis, OR
Benton County, OR
19060 Cumberland, MD-WV
Allegany County, MD
Mineral County, WV
19124 1 Dallas-Plano-Irving, TX
Collin County, TX
Dallas County, TX
Delta County, TX
Denton County, TX
Ellis County, TX
Hunt County, TX
Kaufman County, TX
Rockwall County, TX
19140 Dalton, GA
Murray County, GA
Whitfield County, GA
19180 Danville, IL
Vermilion County, IL
19260 Danville, VA
Pittsylvania County, VA
Danville City, VA
19340 Davenport-Moline-Rock Island, IA-IL
Henry County, IL
Mercer County, IL
Rock Island County, IL
Scott County, IA
19380 Dayton, OH
Greene County, OH
Miami County, OH
Montgomery County, OH
Preble County, OH
19460 Decatur, AL
Lawrence County, AL
Morgan County, AL
19500 Decatur, IL
Macon County, IL
19660 Deltona-Daytona Beach-Ormond Beach, FL
Volusia County, FL
19740 1 Denver-Aurora, CO
Adams County, CO
Arapahoe County, CO
Broomfield County, CO
Clear Creek County, CO
Denver County, CO
Douglas County, CO
Elbert County, CO
Gilpin County, CO
Jefferson County, CO
Park County, CO
19780 Des Moines-West Des Moines, IA
Dallas County, IA
Guthrie County, IA
Madison County, IA
Polk County, IA
Warren County, IA
19804 1 Detroit-Livonia-Dearborn, MI
Wayne County, MI
20020 Dothan, AL
Geneva County, AL
Henry County, AL
Houston County, AL
20100 Dover, DE
Kent County, DE
20220 Dubuque, IA
Dubuque County, IA
20260 Duluth, MN-WI
Carlton County, MN
St. Louis County, MN
Douglas County, WI
20500 Durham, NC
Chatham County, NC
Durham County, NC
Orange County, NC
Person County, NC
20740 Eau Claire, WI
Chippewa County, WI
Eau Claire County, WI
20764 1 Edison-New Brunswick, NJ
Middlesex County, NJ
Monmouth County, NJ
New Brunswick County, NJ
Ocean County, NJ
Somerset County, NJ
20940 El Centro, CA
Imperial County, CA
21060 Elizabethtown, KY
Hardin County, KY
Larue County, KY
21140 Elkhart-Goshen, IN
Elkhart County, IN
21300 Elmira, NY
Chemung County, NY
21340 El Paso, TX
El Paso County, TX
21500 Erie, PA
Erie County, PA
21660 Eugene-Springfield, OR
Lane County, OR
21780 Evansville, IN-KY
Gibson County, IN
Posey County, IN
Vanderburgh County, IN
Warrick County, IN
Henderson County, KY
Webster County, KY
21820 Fairbanks, AK
Fairbanks North Star Borough, AK
21940 Fajardo, PR
Ceiba Municipio, PR
Fajardo Municipio, PR
Luquillo Municipio, PR
22020 Fargo, ND-MN
Clay County, MN
Cass County, ND
22140 Farmington, NM
San Juan County, NM
22180 Fayetteville, NC
Cumberland County, NC
Hoke County, NC
22220 Fayetteville-Springdale-Rogers, AR-MO
Benton County, AR
Madison County, AR
Washington County, AR
McDonald County, MO
22380 Flagstaff, AZ
Coconino County, AZ
22420 Flint, MI
Genesee County, MI
22500 Florence, SC
Darlington County, SC
Florence County, SC
22520 Florence-Muscle Shoals, AL
Colbert County, AL
Lauderdale County, AL
22540 Fond du Lac, WI
Fond du Lac County, WI
22660 Fort Collins-Loveland, CO
Larimer County, CO
22744 1 Fort Lauderdale-Pompano Beach-Deerfield Beach, FL
Broward County, FL
22900 Fort Smith, AR-OK
Crawford County, AR
Franklin County, AR
Sebastian County, AR
Le Flore County, OK
Sequoyah County, OK
23020 Fort Walton Beach-Crestview-Destin, FL
Okaloosa County, FL
23060 Fort Wayne, IN
Allen County, IN
Wells County, IN
Whitley County, IN
23104 1 Fort Worth-Arlington, TX
Johnson County, TX
Parker County, TX
Tarrant County, TX
Wise County, TX
23420 Fresno, CA
Fresno County, CA
23460 Gadsden, AL
Etowah County, AL
23540 Gainesville, FL
Alachua County, FL
Gilchrist County, FL
23580 Gainesville, GA
Hall County, GA
23844 Gary, IN
Jasper County, IN
Lake County, IN
Newton County, IN
Porter County, IN
24020 Glens Falls, NY
Warren County, NY
Washington County, NY
24140 Goldsboro, NC
Wayne County, NC
24220 Grand Forks, ND-MN
Polk County, MN
Grand Forks County, ND
24300 Grand Junction, CO
Mesa County, CO
24340 Grand Rapids-Wyoming, MI
Barry County, MI
Ionia County, MI
Kent County, MI
Newaygo County, MI
24500 Great Falls, MT
Cascade County, MT
24540 Greeley, CO
Weld County, CO
24580 Green Bay, WI
Brown County, WI
Kewaunee County, WI
Oconto County, WI
24660 Greensboro-High Point, NC
Guilford County, NC
Randolph County, NC
Rockingham County, NC
24780 Greenville, NC
Greene County, NC
Pitt County, NC
24860 Greenville-Mauldin-Easley, SC
Greenville County, SC
Laurens County, SC
Pickens County, SC
25020 Guayama, PR
Arroyo Municipio, PR
Guayama Municipio, PR
Patillas Municipio, PR
25060 Gulfport-Biloxi, MS
Hancock County, MS
Harrison County, MS
Stone County, MS
25180 Hagerstown-Martinsburg, MD-WV
Washington County, MD
Berkeley County, WV
Morgan County, WV
25260 Hanford-Corcoran, CA
Kings County, CA
25420 Harrisburg-Carlisle, PA
Cumberland County, PA
Dauphin County, PA
Perry County, PA
25500 Harrisonburg, VA
Rockingham County, VA
Harrisonburg City, VA
25540 1 Hartford-West Hartford-East Hartford, CT
Hartford County, CT
Middlesex County, CT
Tolland County, CT
25620 Hattiesburg, MS
Forrest County, MS
Lamar County, MS
Perry County, MS
25860 Hickory-Lenoir-Morganton, NC
Alexander County, NC
Burke County, NC
Caldwell County, NC
Catawba County, NC
25980 Hinesville-Fort Stewart, GA
Liberty County, GA
Long County, GA
26100 Holland-Grand Haven, MI
Ottawa County, MI
26180 Honolulu, HI
Honolulu County, HI
26300 Hot Springs, AR
Garland County, AR
26380 Houma-Bayou Cane-Thibodaux, LA
Lafourche Parish, LA
Terrebonne Parish, LA
26420 1 Houston-Sugar Land-Baytown, TX
Austin County, TX
Brazoria County, TX
Chambers County, TX
Fort Bend County, TX
Galveston County, TX
Harris County, TX
Liberty County, TX
Montgomery County, TX
San Jacinto County, TX
Waller County, TX
26580 Huntington-Ashland, WV-KY-OH
Boyd County, KY
Greenup County, KY
Lawrence County, OH
Cabell County, WV
Wayne County, WV
26620 Huntsville, AL
Limestone County, AL
Madison County, AL
26820 Idaho Falls, ID
Bonneville County, ID
Jefferson County, ID
26900 1 Indianapolis-Carmel, IN
Boone County, IN
Brown County, IN
Hamilton County, IN
Hancock County, IN
Hendricks County, IN
Johnson County, IN
Marion County, IN
Morgan County, IN
Putnam County, IN
Shelby County, IN
26980 Iowa City, IA
Johnson County, IA
Washington County, IA
27060 Ithaca, NY
Tompkins County, NY
27100 Jackson, MI
Jackson County, MI
27140 Jackson, MS
Copiah County, MS
Hinds County, MS
Madison County, MS
Rankin County, MS
Simpson County, MS
27180 Jackson, TN
Chester County, TN
Madison County, TN
27260 1 Jacksonville, FL
Baker County, FL
Clay County, FL
Duval County, FL
Nassau County, FL
St. Johns County, FL
27340 Jacksonville, NC
Onslow County, NC
27500 Janesville, WI
Rock County, WI
27620 Jefferson City, MO
Callaway County, MO
Cole County, MO
Moniteau County, MO
Osage County, MO
27740 Johnson City, TN
Carter County, TN
Unicoi County, TN
Washington County, TN
27780 Johnstown, PA
Cambria County, PA
27860 Jonesboro, AR
Craighead County, AR
Poinsett County, AR
27900 Joplin, MO
Jasper County, MO
Newton County, MO
28020 Kalamazoo-Portage, MI
Kalamazoo County, MI
Van Buren County, MI
28100 Kankakee-Bradley, IL
Kankakee County, IL
28140 1 Kansas City, MO-KS
Franklin County, KS
Johnson County, KS
Leavenworth County, KS
Linn County, KS
Miami County, KS
Wyandotte County, KS
Bates County, MO
Caldwell County, MO
Cass County, MO
Clay County, MO
Clinton County, MO
Jackson County, MO
Lafayette County, MO
Platte County, MO
Ray County, MO
28420 Kennewick-Pasco-Richland, WA
Benton County, WA
Franklin County, WA
28660 Killeen-Temple-Fort Hood, TX
Bell County, TX
Coryell County, TX
Lampasas County, TX
28700 Kingsport-Bristol-Bristol, TN-VA
Hawkins County, TN
Sullivan County, TN
Bristol City, VA
Scott County, VA
Washington County, VA
28740 Kingston, NY
Ulster County, NY
28940 Knoxville, TN
Anderson County, TN
Blount County, TN
Knox County, TN
Loudon County, TN
Union County, TN
29020 Kokomo, IN
Howard County, IN
Tipton County, IN
29100 La Crosse, WI-MN
Houston County, MN
La Crosse County, WI
29140 Lafayette, IN
Benton County, IN
Carroll County, IN
Tippecanoe County, IN
29180 Lafayette, LA
Lafayette Parish, LA
St. Martin Parish, LA
29340 Lake Charles, LA
Calcasieu Parish, LA
Cameron Parish, LA
29404 Lake County-Kenosha County, IL-WI
Lake County, IL
Kenosha County, WI
29420 Lake Havasu City-Kingman, AZ
Mohave County, AZ
29460 Lakeland-Winter Haven, FL
Polk County, FL
Winter Haven County, FL
29540 Lancaster, PA
Lancaster County, PA
29620 Lansing-East Lansing, MI
Clinton County, MI
Eaton County, MI
Ingham County, MI
29700 Laredo, TX
Webb County, TX
29740 Las Cruces, NM
Dona Ana County, NM
29820 1 Las Vegas-Paradise, NV
Clark County, NV
29940 Lawrence, KS
Douglas County, KS
30020 Lawton, OK
Comanche County, OK
30140 Lebanon, PA
Lebanon County, PA
30300 Lewiston, ID-WA
Nez Perce County, ID
Asotin County, WA
30340 Lewiston-Auburn, ME
Androscoggin County, ME
30460 Lexington-Fayette, KY
Bourbon County, KY
Clark County, KY
Fayette County, KY
Jessamine County, KY
Scott County, KY
Woodford County, KY
30620 Lima, OH
Allen County, OH
30700 Lincoln, NE
Lancaster County, NE
Seward County, NE
30780 Little Rock-North Little Rock-Conway, AR
Faulkner County, AR
Grant County, AR
Lonoke County, AR
Perry County, AR
Pulaski County, AR
Saline County, AR
30860 Logan, UT-ID
Franklin County, ID
Cache County, UT
30980 Longview, TX
Gregg County, TX
Rusk County, TX
Upshur County, TX
31020 Longview, WA
Cowlitz County, WA
31084 1 Los Angeles-Long Beach-Glendale, CA
Los Angeles County, CA
31140 1 Louisville-Jefferson County, KY-IN
Clark County, IN
Floyd County, IN
Harrison County, IN
Washington County, IN
Bullitt County, KY
Henry County, KY
Jefferson County, KY
Meade County, KY
Nelson County, KY
Oldham County, KY
Shelby County, KY
Spencer County, KY
Trimble County, KY
31180 Lubbock, TX
Crosby County, TX
Lubbock County, TX
31340 Lynchburg, VA
Amherst County, VA
Appomattox County, VA
Bedford County, VA
Campbell County, VA
Bedford City, VA
Lynchburg City, VA
31420 Macon, GA
Bibb County, GA
Crawford County, GA
Jones County, GA
Monroe County, GA
Twiggs County, GA
31460 Madera, CA
Madera County, CA
31540 Madison, WI
Columbia County, WI
Dane County, WI
Iowa County, WI
31700 Manchester-Nashua, NH
Hillsborough County, NH
31900 Mansfield, OH
Richland County, OH
32420 Mayagüez, PR
Hormigueros Municipio, PR
Mayagüez Municipio, PR
32580 McAllen-Edinburg-Mission, TX
Hidalgo County, TX
32780 Medford, OR
Jackson County, OR
32820 1 Memphis, TN-MS-AR
Crittenden County, AR
DeSoto County, MS
Marshall County, MS
Tate County, MS
Tunica County, MS
Fayette County, TN
Shelby County, TN
Tipton County, TN
32900 Merced, CA
Merced County, CA
33124 1 Miami-Miami Beach-Kendall, FL
Miami-Dade County, FL
33140 Michigan City-La Porte, IN
LaPorte County, IN
33260 Midland, TX
Midland County, TX
33340 1 Milwaukee-Waukesha-West Allis, WI
Milwaukee County, WI
Ozaukee County, WI
Washington County, WI
Waukesha County, WI
33460 1 Minneapolis-St. Paul-Bloomington, MN-WI
Anoka County, MN
Carver County, MN
Chisago County, MN
Dakota County, MN
Hennepin County, MN
Isanti County, MN
Ramsey County, MN
Scott County, MN
Sherburne County, MN
Washington County, MN
Wright County, MN
Pierce County, WI
St. Croix County, WI
33540 Missoula, MT
Missoula County, MT
33660 Mobile, AL
Mobile County, AL
33700 Modesto, CA
Stanislaus County, CA
33740 Monroe, LA
Ouachita Parish, LA
Union Parish, LA
33780 Monroe, MI
Monroe County, MI
33860 Montgomery, AL
Autauga County, AL
Elmore County, AL
Lowndes County, AL
Montgomery County, AL
34060 Morgantown, WV
Monongalia County, WV
Preston County, WV
34100 Morristown, TN
Grainger County, TN
Hamblen County, TN
Jefferson County, TN
34580 Mount Vernon-Anacortes, WA
Skagit County, WA
34620 Muncie, IN
Delaware County, IN
34740 Muskegon-Norton Shores, MI
Muskegon County, MI
34820 Myrtle Beach-North Myrtle Beach-Conway, SC
Horry County, SC
34900 Napa, CA
Napa County, CA
34940 Naples-Marco Island, FL
Collier County, FL
34980 1 Nashville-Davidson-Murfreesboro-Franklin, TN
Cannon County, TN
Cheatham County, TN
Davidson County, TN
Dickson County, TN
Hickman County, TN
Macon County, TN
Robertson County, TN
Rutherford County, TN
Smith County, TN
Sumner County, TN
Trousdale County, TN
Williamson County, TN
Wilson County, TN
35004 1 Nassau-Suffolk, NY
Nassau County, NY
Suffolk County, NY
35084 1 Newark-Union, NJ-PA
Essex County, NJ
Hunterdon County, NJ
Morris County, NJ
Sussex County, NJ
Union County, NJ
Pike County, PA
35300 New Haven-Milford, CT
New Haven County, CT
35380 1 New Orleans-Metairie-Kenner, LA
Jefferson Parish, LA
Orleans Parish, LA
Plaquemines Parish, LA
St. Bernard Parish, LA
St. Charles Parish, LA
St. John the Baptist Parish, LA
St. Tammany Parish, LA
35644 1 New York-White Plains-Wayne, NY-NJ
Bergen County, NJ
Hudson County, NJ
Passaic County, NJ
Bronx County, NY
Kings County, NY
New York County, NY
Putnam County, NY
Queens County, NY
Richmond County, NY
Rockland County, NY
Westchester County, NY
35660 Niles-Benton Harbor, MI
Berrien County, MI
35980 Norwich-New London, CT
New London County, CT
36084 1 Oakland-Fremont-Hayward, CA
Alameda County, CA
Contra Costa County, CA
36100 Ocala, FL
Marion County, FL
36140 Ocean City, NJ
Cape May County, NJ
36220 Odessa, TX
Ector County, TX
36260 Ogden-Clearfield, UT
Davis County, UT
Morgan County, UT
Weber County, UT
36420 1 Oklahoma City, OK
Canadian County, OK
Cleveland County, OK
Grady County, OK
Lincoln County, OK
Logan County, OK
McClain County, OK
Oklahoma County, OK
36500 Olympia, WA
Thurston County, WA
36540 Omaha-Council Bluffs, NE-IA
Harrison County, IA
Mills County, IA
Pottawattamie County, IA
Cass County, NE
Douglas County, NE
Sarpy County, NE
Saunders County, NE
Washington County, NE
36740 1 Orlando-Kissimmee, FL
Lake County, FL
Orange County, FL
Osceola County, FL
Seminole County, FL
36780 Oshkosh-Neenah, WI
Winnebago County, WI
36980 Owensboro, KY
Daviess County, KY
Hancock County, KY
McLean County, KY
37100 Oxnard-Thousand Oaks-Ventura, CA
Ventura County, CA
37340 Palm Bay-Melbourne-Titusville, FL
Brevard County, FL
37380 Palm Coast, FL
Flager County, FL
37460 Panama City-Lynn Haven, FL
Bay County, FL
37620 Parkersburg-Marietta-Vienna, WV-OH
Washington County, OH
Pleasants County, WV
Wirt County, WV
Wood County, WV
37700 Pascagoula, MS
George County, MS
Jackson County, MS
37764 Peabody, MA
Essex County, MA
37860 Pensacola-Ferry Pass-Brent, FL
Escambia County, FL
Santa Rosa County, FL
37900 Peoria, IL
Marshall County, IL
Peoria County, IL
Stark County, IL
Tazewell County, IL
Woodford County, IL
37964 1 Philadelphia, PA
Bucks County, PA
Chester County, PA
Delaware County, PA
Montgomery County, PA
Philadelphia County, PA
38060 1 Phoenix-Mesa-Scottsdale, AZ
Maricopa County, AZ
Pinal County, AZ
38220 Pine Bluff, AR
Cleveland County, AR
Jefferson County, AR
Lincoln County, AR
38300 1 Pittsburgh, PA
Allegheny County, PA
Armstrong County, PA
Beaver County, PA
Butler County, PA
Fayette County, PA
Washington County, PA
Westmoreland County, PA
38340 Pittsfield, MA
Berkshire County, MA
38540 Pocatello, ID
Bannock County, ID
Power County, ID
38660 Ponce, PR
Juana Díaz Municipio, PR
Ponce Municipio, PR
Villalba Municipio, PR
38860 Portland-South Portland-Biddeford, ME
Cumberland County, ME
Sagadahoc County, ME
York County, ME
38900 1 Portland-Vancouver-Beaverton, OR-WA
Clackamas County, OR
Columbia County, OR
Multnomah County, OR
Washington County, OR
Yamhill County, OR
Clark County, WA
Skamania County, WA
38940 Port St. Lucie, FL
Martin County, FL
St. Lucie County, FL
39100 Poughkeepsie-Newburgh-Middletown, NY
Dutchess County, NY
Orange County, NY
39140 Prescott, AZ
Yavapai County, AZ
39300 1 Providence-New Bedford-Fall River, RI-MA
Bristol County, MA
Bristol County, RI
Kent County, RI
Newport County, RI
Providence County, RI
Washington County, RI
39340 Provo-Orem, UT
Juab County, UT
Utah County, UT
39380 Pueblo, CO
Pueblo County, CO
39460 Punta Gorda, FL
Charlotte County, FL
39540 Racine, WI
Racine County, WI
39580 Raleigh-Cary, NC
Franklin County, NC
Johnston County, NC
Wake County, NC
39660 Rapid City, SD
Meade County, SD
Pennington County, SD
39740 Reading, PA
Berks County, PA
39820 Redding, CA
Shasta County, CA
39900 Reno-Sparks, NV
Storey County, NV
Washoe County, NV
40060 1 Richmond, VA
Amelia County, VA
Caroline County, VA
Charles City County, VA
Chesterfield County, VA
Cumberland County, VA
Dinwiddie County, VA
Goochland County, VA
Hanover County, VA
Henrico County, VA
King and Queen County, VA
King William County, VA
Louisa County, VA
New Kent County, VA
Powhatan County, VA
Prince George County, VA
Sussex County, VA
Colonial Heights City, VA
Hopewell City, VA
Petersburg City, VA
Richmond City, VA
40140 1 Riverside-San Bernardino-Ontario, CA
Riverside County, CA
San Bernardino County, CA
40220 Roanoke, VA
Botetourt County, VA
Craig County, VA
Franklin County, VA
Roanoke County, VA
Roanoke City, VA
Salem City, VA
40340 Rochester, MN
Dodge County, MN
Olmsted County, MN
Wabasha County, MN
40380 1 Rochester, NY
Livingston County, NY
Monroe County, NY
Ontario County, NY
Orleans County, NY
Wayne County, NY
40420 Rockford, IL
Boone County, IL
Winnebago County, IL
40484 Rockingham County-Strafford County, NH
Rockingham County, NH
Strafford County, NH
40580 Rocky Mount, NC
Edgecombe County, NC
Nash County, NC
40660 Rome, GA
Floyd County, GA
40900 1 Sacramento-Arden-Arcade-Roseville, CA
El Dorado County, CA
Placer County, CA
Sacramento County, CA
Yolo County, CA
40980 Saginaw-Saginaw Township North, MI
Saginaw County, MI
41060 St. Cloud, MN
Benton County, MN
Stearns County, MN
41100 St. George, UT
Washington County, UT
41140 St. Joseph, MO-KS
Doniphan County, KS
Andrew County, MO
Buchanan County, MO
DeKalb County, MO
41180 1 St. Louis, MO-IL
Bond County, IL
Calhoun County, IL
Clinton County, IL
Jersey County, IL
Macoupin County, IL
Madison County, IL
Monroe County, IL
St. Clair County, IL
Crawford County, MO
Franklin County, MO
Jefferson County, MO
Lincoln County, MO
St. Charles County, MO
St. Louis County, MO
Warren County, MO
Washington County, MO
St. Louis City, MO
41420 Salem, OR
Marion County, OR
Polk County, OR
41500 Salinas, CA
Monterey County, CA
41540 Salisbury, MD
Somerset County, MD
Wicomico County, MD
41620 Salt Lake City, UT
Salt Lake County, UT
Summit County, UT
Tooele County, UT
41660 San Angelo, TX
Irion County, TX
Tom Green County, TX
41700 1 San Antonio, TX
Atascosa County, TX
Bandera County, TX
Bexar County, TX
Comal County, TX
Guadalupe County, TX
Kendall County, TX
Medina County, TX
Wilson County, TX
41740 1 San Diego-Carlsbad-San Marcos, CA
San Diego County, CA
41780 Sandusky, OH
Erie County, OH
41884 1 San Francisco-San Mateo-Redwood City, CA
Marin County, CA
San Francisco County, CA
San Mateo County, CA
41900 San Germán-Cabo Rojo, PR
Cabo Rojo Municipio, PR
Lajas Municipio, PR
Sabana Grande Municipio, PR
San Germán Municipio, PR
41940 1 San Jose-Sunnyvale-Santa Clara, CA
San Benito County, CA
Santa Clara County, CA
41980 1 San Juan-Caguas-Guaynabo, PR
Aguas Buenas Municipio, PR
Aibonito Municipio, PR
Arecibo Municipio, PR
Barceloneta Municipio, PR
Barranquitas Municipio, PR
Bayamón Municipio, PR
Caguas Municipio, PR
Camuy Municipio, PR
Canóvanas Municipio, PR
Carolina Municipio, PR
Cataño Municipio, PR
Cayey Municipio, PR
Ciales Municipio, PR
Cidra Municipio, PR
Comerío Municipio, PR
Corozal Municipio, PR
Dorado Municipio, PR
Florida Municipio, PR
Guaynabo Municipio, PR
Gurabo Municipio, PR
Hatillo Municipio, PR
Humacao Municipio, PR
Juncos Municipio, PR
Las Piedras Municipio, PR
Loíza Municipio, PR
Manatí Municipio, PR
Maunabo Municipio, PR
Morovis Municipio, PR
Naguabo Municipio, PR
Naranjito Municipio, PR
Orocovis Municipio, PR
Quebradillas Municipio, PR
Río Grande Municipio, PR
San Juan Municipio, PR
San Lorenzo Municipio, PR
Toa Alta Municipio, PR
Toa Baja Municipio, PR
Trujillo Alto Municipio, PR
Vega Alta Municipio, PR
Vega Baja Municipio, PR
Yabucoa Municipio, PR
42020 San Luis Obispo-Paso Robles, CA
San Luis Obispo County, CA
42044 1 Santa Ana-Anaheim-Irvine, CA
Orange County, CA
42060 Santa Barbara-Santa Maria-Goleta, CA
Santa Barbara County, CA
42100 Santa Cruz-Watsonville, CA
Santa Cruz County, CA
42140 Santa Fe, NM
Santa Fe County, NM
42220 Santa Rosa-Petaluma, CA
Sonoma County, CA
42340 Savannah, GA
Bryan County, GA
Chatham County, GA
Effingham County, GA
42540 Scranton-Wilkes-Barre, PA
Lackawanna County, PA
Luzerne County, PA
Wyoming County, PA
42644 1 Seattle-Bellevue-Everett, WA
King County, WA
Snohomish County, WA
42680 Sebastian-Vero Beach, FL
Indian River County, FL
43100 Sheboygan, WI
Sheboygan County, WI
43300 Sherman-Denison, TX
Grayson County, TX
43340 Shreveport-Bossier City, LA
Bossier Parish, LA
Caddo Parish, LA
De Soto Parish, LA
43580 Sioux City, IA-NE-SD
Woodbury County, IA
Dakota County, NE
Dixon County, NE
Union County, SD
43620 Sioux Falls, SD
Lincoln County, SD
McCook County, SD
Minnehaha County, SD
Turner County, SD
43780 South Bend-Mishawaka, IN-MI
St. Joseph County, IN
Cass County, MI
43900 Spartanburg, SC
Spartanburg County, SC
44060 Spokane, WA
Spokane County, WA
44100 Springfield, IL
Menard County, IL
Sangamon County, IL
44140 Springfield, MA
Franklin County, MA
Hampden County, MA
Hampshire County, MA
44180 Springfield, MO
Christian County, MO
Dallas County, MO
Greene County, MO
Polk County, MO
Webster County, MO
44220 Springfield, OH
Clark County, OH
44300 State College, PA
Centre County, PA
44700 Stockton, CA
San Joaquin County, CA
44940 Sumter, SC
Sumter County, SC
45060 Syracuse, NY
Madison County, NY
Onondaga County, NY
Oswego County, NY
45104 Tacoma, WA
Pierce County, WA
45220 Tallahassee, FL
Gadsden County, FL
Jefferson County, FL
Leon County, FL
Wakulla County, FL
45300 1 Tampa-St. Petersburg-Clearwater, FL
Hernando County, FL
Hillsborough County, FL
Pasco County, FL
Pinellas County, FL
45460 Terre Haute, IN
Clay County, IN
Sullivan County, IN
Vermillion County, IN
Vigo County, IN
45500 Texarkana, TX-Texarkana, AR
Miller County, AR
Bowie County, TX
45780 Toledo, OH
Fulton County, OH
Lucas County, OH
Ottawa County, OH
Wood County, OH
45820 Topeka, KS
Jackson County, KS
Jefferson County, KS
Osage County, KS
Shawnee County, KS
Wabaunsee County, KS
45940 Trenton-Ewing, NJ
Mercer County, NJ
46060 Tucson, AZ
Pima County, AZ
46140 Tulsa, OK
Creek County, OK
Okmulgee County, OK
Osage County, OK
Pawnee County, OK
Rogers County, OK
Tulsa County, OK
Wagoner County, OK
46220 Tuscaloosa, AL
Greene County, AL
Hale County, AL
Tuscaloosa County, AL
46340 Tyler, TX
Smith County, TX
46540 Utica-Rome, NY
Herkimer County, NY
Oneida County, NY
46660 Valdosta, GA
Brooks County, GA
Echols County, GA
Lanier County, GA
Lowndes County, GA
46700 Vallejo-Fairfield, CA
Solano County, CA
47020 Victoria, TX
Calhoun County, TX
Goliad County, TX
Victoria County, TX
47220 Vineland-Millville-Bridgeton, NJ
Cumberland County, NJ
47260 1 Virginia Beach-Norfolk-Newport News, VA-NC
Currituck County, NC
Gloucester County, VA
Isle of Wight County, VA
James City County, VA
Mathews County, VA
Surry County, VA
York County, VA
Chesapeake City, VA
Hampton City, VA
Newport News City, VA
Norfolk City, VA
Poquoson City, VA
Portsmouth City, VA
Suffolk City, VA
Virginia Beach City, VA
Williamsburg City, VA
47300 Visalia-Porterville, CA
Tulare County, CA
47380 Waco, TX
McLennan County, TX
47580 Warner Robins, GA
Houston County, GA
47644 1 Warren-Troy-Farmington Hills, MI
Lapeer County, MI
Livingston County, MI
Macomb County, MI
Oakland County, MI
St. Clair County, MI
47894 1 Washington-Arlington-Alexandria, DC-VA-MD-WV
District of Columbia, DC
Calvert County, MD
Charles County, MD
Prince George's County, MD
Arlington County, VA
Clarke County, VA
Fairfax County, VA
Fauquier County, VA
Loudoun County, VA
Prince William County, VA
Spotsylvania County, VA
Stafford County, VA
Warren County, VA
Alexandria City, VA
Fairfax City, VA
Falls Church City, VA
Fredericksburg City, VA
Manassas City, VA
Manassas Park City, VA
Jefferson County, WV
47940 Waterloo-Cedar Falls, IA
Black Hawk County, IA
Bremer County, IA
Grundy County, IA
48140 Wausau, WI
Marathon County, WI
48260 Weirton-Steubenville, WV-OH
Jefferson County, OH
Brooke County, WV
Hancock County, WV
48300 Wenatchee, WA
Chelan County, WA
Douglas County, WA
48424 1 West Palm Beach-Boca Raton-Boynton Beach, FL
Palm Beach County, FL
48540 Wheeling, WV-OH
Belmont County, OH
Marshall County, WV
Ohio County, WV
48620 Wichita, KS
Butler County, KS
Harvey County, KS
Sedgwick County, KS
Sumner County, KS
48660 Wichita Falls, TX
Archer County, TX
Clay County, TX
Wichita County, TX
48700 Williamsport, PA
Lycoming County, PA
48864 Wilmington, DE-MD-NJ
New Castle County, DE
Cecil County, MD
Salem County, NJ
48900 Wilmington, NC
Brunswick County, NC
New Hanover County, NC
Pender County, NC
49020 Winchester, VA-WV
Frederick County, VA
Winchester City, VA
Hampshire County, WV
49180 Winston-Salem, NC
Davie County, NC
Forsyth County, NC
Stokes County, NC
Yadkin County, NC
49340 Worcester, MA
Worcester County, MA
49420 Yakima, WA
Yakima County, WA
49500 Yauco, PR
Guánica Municipio, PR
Guayanilla Municipio, PR
Peñuelas Municipio, PR
Yauco Municipio, PR
49620 York-Hanover, PA
York County, PA
49660 Youngstown-Warren-Boardman, OH-PA
Mahoning County, OH
Trumbull County, OH
Mercer County, PA
49700 Yuba City, CA
Sutter County, CA
Yuba County, CA
49740 Yuma, AZ
Yuma County, AZ
1 Large urban area.

CBSA code Area Wage index GAF Wage index-reclassified hospitals GAF-reclassified hospitals
10380 Aguadilla-Isabela-San Sebastián, PR 0.7845 0.8469
21940 Fajardo, PR 0.9572 0.9705
25020 Guayama, PR 0.7472 0.8191
32420 Mayagüez, PR 0.9236 0.9470
38660 Ponce, PR 0.9757 0.9833
41900 San Germán-Cabo Rojo, PR 1.0864 1.0584
41980 San Juan-Caguas-Guaynabo, PR 1.0348 1.0237
49500 Yauco, PR 0.7969 0.8560

The following list represents all hospitals that are eligible to have their wage index increased by the out-migration adjustment listed in this table. Hospitals cannot receive the out-migration adjustment if they are reclassified under section 1886(d)(10) of the Act or redesignated under section 1886(d)(8)(B) of the Act. Hospitals that have already been reclassified under section 1886(d)(10) of the Act or redesignated under section 1886(d)(8)(B) of the Act are designated with an asterisk. We will automatically assume that hospitals that have already been reclassified under section 1886(d)(10) of the Act or redesignated under section 1886(d)(8)(B) of the Act wish to retain their reclassification/redesignation status and waive the application of the out-migration adjustment. Section 1886(d)(10) hospitals that wish to receive the out-migration adjustment, rather than their reclassification, should follow the termination/withdrawal procedures specified in 42 CFR 412.273 and section III.I.3. of the preamble of this proposed rule. Otherwise, they will be deemed to have waived the out-migration adjustment. Hospitals redesignated under section 1886(d)(8)(B) of the Act will be deemed to have waived the out-migration adjustment, unless they explicitly notify CMS that they elected to receive the out-migration adjustment instead within 45 days from the publication of this proposed rule. These notifications should be sent to the following address: Centers for Medicare and Medicaid Services, Center for Medicare Management, Attn.: Wage Index Adjustment Waivers, Division of Acute Care, Room C4-08-06, 7500 Security Boulevard, Baltimore, MD 21244-1850.

Provider No. Reclassified for FY 2009 Out-migration adjustment Qualifying county name County code
010005 * 0.0296 MARSHALL 01470
010008 0.0174 CRENSHAW 01200
010009 * 0.0092 MORGAN 01510
010010 * 0.0296 MARSHALL 01470
010012 * 0.0186 DE KALB 01240
010015 0.0046 CLARKE 01120
010021 0.0030 DALE 01220
010022 * 0.1128 CHEROKEE 01090
010025 * 0.0235 CHAMBERS 01080
010027 0.0015 COFFEE 01150
010029 * 0.0289 LEE 01400
010032 0.0325 RANDOLPH 01550
010035 * 0.0254 CULLMAN 01210
010038 0.0047 CALHOUN 01070
010040 0.0061 ETOWAH 01270
010045 0.0222 FAYETTE 01280
010046 0.0061 ETOWAH 01270
010047 0.0127 BUTLER 01060
010049 0.0015 COFFEE 01150
010052 * 0.0103 TALLAPOOSA 01610
010054 * 0.0092 MORGAN 01510
010059 * 0.0069 LAWRENCE 01390
010061 * 0.0542 JACKSON 01350
010065 * 0.0103 TALLAPOOSA 01610
010078 0.0047 CALHOUN 01070
010083 * 0.0134 BALDWIN 01010
010085 * 0.0092 MORGAN 01510
010091 0.0046 CLARKE 01120
010100 * 0.0134 BALDWIN 01010
010101 * 0.0211 TALLADEGA 01600
010109 0.0451 PICKENS 01530
010110 0.0215 BULLOCK 01050
010125 0.0476 WINSTON 01660
010128 0.0046 CLARKE 01120
010129 0.0134 BALDWIN 01010
010138 0.0066 SUMTER 01590
010143 * 0.0254 CULLMAN 01210
010146 0.0047 CALHOUN 01070
010150 * 0.0127 BUTLER 01060
010158 * 0.0023 FRANKLIN 01290
010164 * 0.0211 TALLADEGA 01600
030067 0.0298 LAPAZ 03055
040014 * 0.0199 WHITE 04720
040019 * 0.0258 ST. FRANCIS 04610
040039 * 0.0172 GREENE 04270
040047 0.0117 RANDOLPH 04600
040067 0.0007 COLUMBIA 04130
040071 * 0.0149 JEFFERSON 04340
040076 * 0.1000 HOT SPRING 04290
040081 0.0357 PIKE 04540
050002 0.0010 ALAMEDA 05000
050007 0.0146 SAN MATEO 05510
050008 0.0026 SAN FRANCISCO 05480
050009 * 0.0180 NAPA 05380
050013 * 0.0180 NAPA 05380
050014 * 0.0139 AMADOR 05020
050016 0.0103 SAN LUIS OBISPO 05500
050042 * 0.0162 TEHAMA 05620
050043 0.0010 ALAMEDA 05000
050047 0.0026 SAN FRANCISCO 05480
050055 0.0026 SAN FRANCISCO 05480
050069 * 0.0020 ORANGE 05400
050070 0.0146 SAN MATEO 05510
050073 * 0.0171 SOLANO 05580
050075 0.0010 ALAMEDA 05000
050076 * 0.0026 SAN FRANCISCO 05480
050084 0.0132 SAN JOAQUIN 05490
050089 * 0.0017 SAN BERNARDINO 05460
050090 * 0.0058 SONOMA 05590
050099 * 0.0017 SAN BERNARDINO 05460
050101 * 0.0171 SOLANO 05580
050113 0.0146 SAN MATEO 05510
050118 * 0.0132 SAN JOAQUIN 05490
050122 0.0132 SAN JOAQUIN 05490
050129 * 0.0017 SAN BERNARDINO 05460
050133 * 0.0178 YUBA 05680
050136 * 0.0058 SONOMA 05590
050140 * 0.0017 SAN BERNARDINO 05460
050150 * 0.0342 NEVADA 05390
050152 0.0026 SAN FRANCISCO 05480
050167 0.0132 SAN JOAQUIN 05490
050168 * 0.0020 ORANGE 05400
050173 * 0.0020 ORANGE 05400
050174 * 0.0058 SONOMA 05590
050193 * 0.0020 ORANGE 05400
050194 * 0.0052 SANTA CRUZ 05540
050195 0.0010 ALAMEDA 05000
050197 * 0.0146 SAN MATEO 05510
050211 0.0010 ALAMEDA 05000
050224 * 0.0020 ORANGE 05400
050226 * 0.0020 ORANGE 05400
050228 0.0026 SAN FRANCISCO 05480
050230 * 0.0020 ORANGE 05400
050232 0.0103 SAN LUIS OBISPO 05500
050242 * 0.0052 SANTA CRUZ 05540
050245 * 0.0017 SAN BERNARDINO 05460
050264 0.0010 ALAMEDA 05000
050272 * 0.0017 SAN BERNARDINO 05460
050279 * 0.0017 SAN BERNARDINO 05460
050283 0.0010 ALAMEDA 05000
050289 0.0146 SAN MATEO 05510
050291 * 0.0058 SONOMA 05590
050298 0.0017 SAN BERNARDINO 05460
050300 * 0.0017 SAN BERNARDINO 05460
050305 0.0010 ALAMEDA 05000
050313 0.0132 SAN JOAQUIN 05490
050320 0.0010 ALAMEDA 05000
050325 0.0033 TUOLUMNE 05650
050327 * 0.0017 SAN BERNARDINO 05460
050335 * 0.0033 TUOLUMNE 05650
050336 0.0132 SAN JOAQUIN 05490
050348 * 0.0020 ORANGE 05400
050366 0.0015 CALAVERAS 05040
050367 * 0.0171 SOLANO 05580
050385 * 0.0058 SONOMA 05590
050407 0.0026 SAN FRANCISCO 05480
050426 * 0.0020 ORANGE 05400
050444 0.0233 MERCED 05340
050454 0.0026 SAN FRANCISCO 05480
050457 0.0026 SAN FRANCISCO 05480
050476 * 0.0278 LAKE 05160
050488 0.0010 ALAMEDA 05000
050494 * 0.0342 NEVADA 05390
050506 0.0103 SAN LUIS OBISPO 05500
050512 0.0010 ALAMEDA 05000
050517 * 0.0017 SAN BERNARDINO 05460
050526 * 0.0020 ORANGE 05400
050528 * 0.0233 MERCED 05340
050541 * 0.0146 SAN MATEO 05510
050543 * 0.0020 ORANGE 05400
050547 * 0.0058 SONOMA 05590
050548 * 0.0020 ORANGE 05400
050551 * 0.0020 ORANGE 05400
050567 * 0.0020 ORANGE 05400
050570 * 0.0020 ORANGE 05400
050580 * 0.0020 ORANGE 05400
050584 0.0017 SAN BERNARDINO 05460
050586 * 0.0017 SAN BERNARDINO 05460
050589 * 0.0020 ORANGE 05400
050603 * 0.0020 ORANGE 05400
050609 * 0.0020 ORANGE 05400
050618 * 0.0017 SAN BERNARDINO 05460
050633 0.0103 SAN LUIS OBISPO 05500
050667 * 0.0180 NAPA 05380
050668 0.0026 SAN FRANCISCO 05480
050678 * 0.0020 ORANGE 05400
050680 * 0.0171 SOLANO 05580
050690 * 0.0058 SONOMA 05590
050693 * 0.0020 ORANGE 05400
050714 0.0052 SANTA CRUZ 05540
050720 * 0.0020 ORANGE 05400
050744 * 0.0020 ORANGE 05400
050745 * 0.0020 ORANGE 05400
050746 * 0.0020 ORANGE 05400
050747 * 0.0020 ORANGE 05400
050748 0.0132 SAN JOAQUIN 05490
050754 0.0146 SAN MATEO 05510
050758 * 0.0017 SAN BERNARDINO 05460
060001 0.0042 WELD 06610
060003 * 0.0069 BOULDER 06060
060010 0.0153 LARIMER 06340
060027 * 0.0069 BOULDER 06060
060030 0.0153 LARIMER 06340
060103 * 0.0069 BOULDER 06060
060116 * 0.0069 BOULDER 06060
060119 0.0153 LARIMER 06340
070006 * 0.0045 FAIRFIELD 07000
070010 * 0.0045 FAIRFIELD 07000
070018 * 0.0045 FAIRFIELD 07000
070028 * 0.0045 FAIRFIELD 07000
070033 * 0.0045 FAIRFIELD 07000
070034 * 0.0045 FAIRFIELD 07000
080001 * 0.0063 NEW CASTLE 08010
080003 * 0.0063 NEW CASTLE 08010
100014 * 0.0047 VOLUSIA 10630
100017 * 0.0047 VOLUSIA 10630
100045 * 0.0047 VOLUSIA 10630
100047 * 0.0028 CHARLOTTE 10070
100068 * 0.0047 VOLUSIA 10630
100072 * 0.0047 VOLUSIA 10630
100077 * 0.0028 CHARLOTTE 10070
100081 * 0.0022 WALTON 10650
100102 0.0125 COLUMBIA 10110
100118 * 0.0177 FLAGLER 10170
100156 * 0.0125 COLUMBIA 10110
100232 * 0.0054 PUTNAM 10530
100236 * 0.0028 CHARLOTTE 10070
100252 * 0.0151 OKEECHOBEE 10460
100290 0.0582 SUMTER 10590
100292 * 0.0022 WALTON 10650
110023 * 0.0416 GORDON 11500
110029 * 0.0052 HALL 11550
110040 * 0.1455 JACKSON 11610
110041 * 0.0623 HABERSHAM 11540
110100 0.0790 JEFFERSON 11620
110101 0.0067 COOK 11311
110142 0.0185 EVANS 11441
110146 * 0.0805 CAMDEN 11170
110150 * 0.0227 BALDWIN 11030
110187 * 0.0643 LUMPKIN 11701
110189 * 0.0066 FANNIN 11450
110190 0.0241 MACON 11710
110205 0.0507 GILMER 11471
130003 * 0.0235 NEZ PERCE 13340
130024 0.0675 BONNER 13080
130049 * 0.0319 KOOTENAI 13270
130066 0.0319 KOOTENAI 13270
130067 * 0.0725 BINGHAM 13050
140001 0.0369 FULTON 14370
140026 0.0315 LA SALLE 14580
140043 * 0.0056 WHITESIDE 14988
140058 * 0.0126 MORGAN 14770
140110 * 0.0315 LA SALLE 14580
140116 0.0007 MC HENRY 14640
140160 * 0.0332 STEPHENSON 14970
140161 0.0168 LIVINGSTON 14610
140167 * 0.0632 IROQUOIS 14460
140176 0.0007 MC HENRY 14640
140234 0.0315 LA SALLE 14580
150006 * 0.0113 LA PORTE 15450
150015 * 0.0113 LA PORTE 15450
150022 0.0158 MONTGOMERY 15530
150030 * 0.0192 HENRY 15320
150072 0.0105 CASS 15080
150076 * 0.0215 MARSHALL 15490
150088 * 0.0111 MADISON 15470
150091 * 0.0050 HUNTINGTON 15340
150102 * 0.0108 STARKE 15740
150113 * 0.0111 MADISON 15470
150133 * 0.0193 KOSCIUSKO 15420
150146 * 0.0319 NOBLE 15560
160013 0.0179 MUSCATINE 16690
160030 0.0040 STORY 16840
160032 0.0235 JASPER 16490
160080 * 0.0066 CLINTON 16220
170137 * 0.0336 DOUGLAS 17220
170150 0.0166 COWLEY 17170
180012 * 0.0080 HARDIN 18460
180017 * 0.0035 BARREN 18040
180049 * 0.0488 MADISON 18750
180064 0.0314 MONTGOMERY 18860
180066 * 0.0439 LOGAN 18700
180070 0.0240 GRAYSON 18420
180079 0.0259 HARRISON 18480
190003 * 0.0085 IBERIA 19220
190015 * 0.0243 TANGIPAHOA 19520
190017 * 0.0187 ST. LANDRY 19480
190034 0.0189 VERMILION 19560
190044 0.0261 ACADIA 19000
190050 0.0044 BEAUREGARD 19050
190053 0.0101 JEFFERSON DAVIS 19260
190054 0.0085 IBERIA 19220
190078 0.0187 ST. LANDRY 19480
190086 * 0.0061 LINCOLN 19300
190088 * 0.0387 WEBSTER 19590
190099 0.0189 AVOYELLES 19040
190106 * 0.0102 ALLEN 19010
190116 0.0085 MOREHOUSE 19330
190133 0.0102 ALLEN 19010
190140 0.0035 FRANKLIN 19200
190144 * 0.0387 WEBSTER 19590
190145 0.0090 LA SALLE 19290
190184 * 0.0161 CALDWELL 19100
190190 0.0161 CALDWELL 19100
190191 * 0.0187 ST. LANDRY 19480
190246 0.0161 CALDWELL 19100
190257 * 0.0061 LINCOLN 19300
190277 0.0387 WEBSTER 19590
200024 * 0.0094 ANDROSCOGGIN 20000
200032 0.0466 OXFORD 20080
200034 * 0.0094 ANDROSCOGGIN 20000
200050 * 0.0227 HANCOCK 20040
210001 0.0187 WASHINGTON 21210
210023 0.0079 ANNE ARUNDEL 21010
210028 0.0512 ST. MARYS 21180
210043 0.0079 ANNE ARUNDEL 21010
210061 0.0188 WORCESTER 21230
220001 * 0.0067 WORCESTER 22170
220002 * 0.0271 MIDDLESEX 22090
220010 * 0.0355 ESSEX 22040
220011 * 0.0271 MIDDLESEX 22090
220019 * 0.0067 WORCESTER 22170
220025 * 0.0067 WORCESTER 22170
220029 * 0.0355 ESSEX 22040
220033 * 0.0355 ESSEX 22040
220035 * 0.0355 ESSEX 22040
220049 * 0.0271 MIDDLESEX 22090
220058 * 0.0067 WORCESTER 22170
220062 * 0.0067 WORCESTER 22170
220063 * 0.0271 MIDDLESEX 22090
220070 * 0.0271 MIDDLESEX 22090
220080 * 0.0355 ESSEX 22040
220082 * 0.0271 MIDDLESEX 22090
220084 * 0.0271 MIDDLESEX 22090
220090 * 0.0067 WORCESTER 22170
220095 * 0.0067 WORCESTER 22170
220098 * 0.0271 MIDDLESEX 22090
220101 * 0.0271 MIDDLESEX 22090
220105 * 0.0271 MIDDLESEX 22090
220163 * 0.0067 WORCESTER 22170
220171 * 0.0271 MIDDLESEX 22090
220174 * 0.0355 ESSEX 22040
220176 * 0.0067 WORCESTER 22170
230003 * 0.0220 OTTAWA 23690
230005 0.0473 LENAWEE 23450
230013 * 0.0025 OAKLAND 23620
230015 0.0295 ST. JOSEPH 23740
230019 * 0.0025 OAKLAND 23620
230021 * 0.0101 BERRIEN 23100
230022 * 0.0212 BRANCH 23110
230029 * 0.0025 OAKLAND 23620
230035 * 0.0095 MONTCALM 23580
230037 * 0.0210 HILLSDALE 23290
230047 * 0.0021 MACOMB 23490
230069 * 0.0210 LIVINGSTON 23460
230071 * 0.0025 OAKLAND 23620
230072 * 0.0220 OTTAWA 23690
230075 0.0047 CALHOUN 23120
230078 * 0.0101 BERRIEN 23100
230092 * 0.0223 JACKSON 23370
230093 0.0058 MECOSTA 23530
230096 * 0.0295 ST. JOSEPH 23740
230099 * 0.0231 MONROE 23570
230121 * 0.0678 SHIAWASSEE 23770
230130 * 0.0025 OAKLAND 23620
230151 * 0.0025 OAKLAND 23620
230174 * 0.0220 OTTAWA 23690
230195 * 0.0021 MACOMB 23490
230204 * 0.0021 MACOMB 23490
230207 * 0.0025 OAKLAND 23620
230208 * 0.0095 MONTCALM 23580
230217 0.0047 CALHOUN 23120
230222 * 0.0035 MIDLAND 23550
230223 * 0.0025 OAKLAND 23620
230227 * 0.0021 MACOMB 23490
230254 * 0.0025 OAKLAND 23620
230257 * 0.0021 MACOMB 23490
230264 * 0.0021 MACOMB 23490
230269 * 0.0025 OAKLAND 23620
230277 * 0.0025 OAKLAND 23620
230279 * 0.0210 LIVINGSTON 23460
230301 * 0.0025 OAKLAND 23620
240018 0.0805 GOODHUE 24240
240044 0.0625 WINONA 24840
240064 * 0.0134 ITASCA 24300
240069 * 0.0267 STEELE 24730
240071 * 0.0385 RICE 24650
240117 0.0527 MOWER 24490
240211 0.0812 PINE 24570
250023 * 0.0541 PEARL RIVER 25540
250040 * 0.0021 JACKSON 25290
250117 * 0.0541 PEARL RIVER 25540
250128 0.0446 PANOLA 25530
250162 0.0014 HANCOCK 25220
260059 0.0077 LACLEDE 26520
260064 * 0.0089 AUDRAIN 26030
260097 0.0300 JOHNSON 26500
260116 * 0.0087 ST. FRANCOIS 26930
260163 0.0087 ST. FRANCOIS 26930
280077 0.0080 DODGE 28260
280123 0.0123 GAGE 28330
290002 * 0.0277 LYON 29090
300011 * 0.0069 HILLSBOROUGH 30050
300012 * 0.0069 HILLSBOROUGH 30050
300017 * 0.0102 ROCKINGHAM 30070
300020 * 0.0069 HILLSBOROUGH 30050
300023 * 0.0102 ROCKINGHAM 30070
300029 * 0.0102 ROCKINGHAM 30070
300034 * 0.0069 HILLSBOROUGH 30050
310002 * 0.0268 ESSEX 31200
310009 * 0.0268 ESSEX 31200
310010 0.0092 MERCER 31260
310011 0.0115 CAPE MAY 31180
310015 * 0.0203 MORRIS 31300
310017 * 0.0203 MORRIS 31300
310018 * 0.0268 ESSEX 31200
310021 * 0.0092 MERCER 31260
310031 * 0.0153 BURLINGTON 31150
310038 * 0.0209 MIDDLESEX 31270
310039 * 0.0209 MIDDLESEX 31270
310044 0.0092 MERCER 31260
310050 * 0.0203 MORRIS 31300
310054 * 0.0268 ESSEX 31200
310057 * 0.0153 BURLINGTON 31150
310061 * 0.0153 BURLINGTON 31150
310069 * 0.0096 SALEM 31340
310070 * 0.0209 MIDDLESEX 31270
310076 * 0.0268 ESSEX 31200
310083 * 0.0268 ESSEX 31200
310091 * 0.0096 SALEM 31340
310092 0.0092 MERCER 31260
310093 * 0.0268 ESSEX 31200
310096 * 0.0268 ESSEX 31200
310108 * 0.0209 MIDDLESEX 31270
310110 0.0092 MERCER 31260
310119 * 0.0268 ESSEX 31200
320003 * 0.0629 SAN MIGUEL 32230
320011 0.0442 RIO ARRIBA 32190
320018 0.0024 DONA ANA 32060
320085 0.0024 DONA ANA 32060
330004 * 0.0633 ULSTER 33740
330008 * 0.0126 WYOMING 33900
330010 0.0067 MONTGOMERY 33380
330027 * 0.0123 NASSAU 33400
330033 0.0223 CHENANGO 33080
330047 0.0067 MONTGOMERY 33380
330073 * 0.0151 GENESEE 33290
330094 * 0.0503 COLUMBIA 33200
330103 * 0.0131 CATTARAUGUS 33040
330106 * 0.0123 NASSAU 33400
330126 * 0.0642 ORANGE 33540
330132 0.0131 CATTARAUGUS 33040
330135 0.0642 ORANGE 33540
330144 0.0054 STEUBEN 33690
330151 0.0054 STEUBEN 33690
330167 * 0.0123 NASSAU 33400
330175 0.0260 CORTLAND 33210
330181 * 0.0123 NASSAU 33400
330182 * 0.0123 NASSAU 33400
330191 * 0.0017 WARREN 33750
330198 * 0.0123 NASSAU 33400
330205 0.0642 ORANGE 33540
330224 * 0.0633 ULSTER 33740
330225 * 0.0123 NASSAU 33400
330235 * 0.0306 CAYUGA 33050
330259 * 0.0123 NASSAU 33400
330264 0.0642 ORANGE 33540
330276 0.0036 FULTON 33280
330277 * 0.0054 STEUBEN 33690
330331 * 0.0123 NASSAU 33400
330332 * 0.0123 NASSAU 33400
330372 * 0.0123 NASSAU 33400
330386 * 0.0745 SULLIVAN 33710
340020 0.0156 LEE 34520
340021 * 0.0162 CLEVELAND 34220
340024 0.0177 SAMPSON 34810
340027 * 0.0128 LENOIR 34530
340037 0.0162 CLEVELAND 34220
340038 0.0253 BEAUFORT 34060
340039 * 0.0101 IREDELL 34480
340068 * 0.0087 COLUMBUS 34230
340069 * 0.0015 WAKE 34910
340070 * 0.0395 ALAMANCE 34000
340071 * 0.0226 HARNETT 34420
340073 * 0.0015 WAKE 34910
340085 0.0250 DAVIDSON 34280
340096 0.0250 DAVIDSON 34280
340104 0.0162 CLEVELAND 34220
340114 * 0.0015 WAKE 34910
340126 * 0.0100 WILSON 34970
340129 * 0.0101 IREDELL 34480
340133 0.0308 MARTIN 34580
340138 * 0.0015 WAKE 34910
340144 * 0.0101 IREDELL 34480
340145 * 0.0336 LINCOLN 34540
340151 0.0052 HALIFAX 34410
340173 * 0.0015 WAKE 34910
360002 0.0141 ASHLAND 36020
360010 * 0.0074 TUSCARAWAS 36800
360013 * 0.0135 SHELBY 36760
360025 * 0.0077 ERIE 36220
360036 * 0.0126 WAYNE 36860
360040 0.0387 KNOX 36430
360044 0.0127 DARKE 36190
360065 * 0.0075 HURON 36400
360071 0.0035 VAN WERT 36820
360086 * 0.0186 CLARK 36110
360096 * 0.0071 COLUMBIANA 36140
360107 * 0.0119 SANDUSKY 36730
360125 * 0.0133 ASHTABULA 36030
360156 0.0119 SANDUSKY 36730
360175 * 0.0183 CLINTON 36130
360185 * 0.0071 COLUMBIANA 36140
360187 * 0.0186 CLARK 36110
360245 * 0.0133 ASHTABULA 36030
370014 * 0.0361 BRYAN 37060
370015 * 0.0366 MAYES 37480
370023 0.0090 STEPHENS 37680
370065 0.0096 CRAIG 37170
370072 0.0258 LATIMER 37380
370083 0.0051 PUSHMATAHA 37630
370100 0.0100 CHOCTAW 37110
370149 * 0.0302 POTTAWATOMIE 37620
370156 0.0121 GARVIN 37240
370169 0.0163 MCINTOSH 37450
370172 0.0258 LATIMER 37380
370214 0.0121 GARVIN 37240
380022 * 0.0067 LINN 38210
380029 0.0075 MARION 38230
380051 * 0.0075 MARION 38230
380056 0.0075 MARION 38230
390008 0.0060 LAWRENCE 39450
390016 * 0.0060 LAWRENCE 39450
390030 0.0284 SCHUYLKILL 39650
390031 * 0.0284 SCHUYLKILL 39650
390044 * 0.0191 BERKS 39110
390052 0.0047 CLEARFIELD 39230
390056 0.0036 HUNTINGDON 39380
390065 * 0.0532 ADAMS 39000
390066 * 0.0372 LEBANON 39460
390079 * 0.0003 BRADFORD 39130
390086 * 0.0047 CLEARFIELD 39230
390096 * 0.0191 BERKS 39110
390110 * 0.0003 CAMBRIA 39160
390113 * 0.0053 CRAWFORD 39260
390117 0.0002 BEDFORD 39100
390122 0.0053 CRAWFORD 39260
390125 0.0022 WAYNE 39760
390130 * 0.0003 CAMBRIA 39160
390138 * 0.0218 FRANKLIN 39350
390146 0.0022 WARREN 39740
390150 * 0.0031 GREENE 39370
390151 * 0.0218 FRANKLIN 39350
390162 * 0.0200 NORTHAMPTON 39590
390183 * 0.0284 SCHUYLKILL 39650
390201 0.1170 MONROE 39550
390236 0.0003 BRADFORD 39130
390313 * 0.0284 SCHUYLKILL 39650
390316 0.0191 BERKS 39110
420002 0.0004 YORK 42450
420007 * 0.0027 SPARTANBURG 42410
420009 * 0.0113 OCONEE 42360
420019 0.0158 CHESTER 42110
420020 * 0.0007 GEORGETOWN 42210
420027 * 0.0108 ANDERSON 42030
420030 * 0.0069 COLLETON 42140
420036 * 0.0064 LANCASTER 42280
420039 * 0.0153 UNION 42430
420043 0.0157 CHEROKEE 42100
420053 0.0035 NEWBERRY 42350
420054 0.0003 MARLBORO 42340
420062 * 0.0109 CHESTERFIELD 42120
420068 * 0.0027 ORANGEBURG 42370
420069 * 0.0052 CLARENDON 42130
420070 * 0.0052 SUMTER 42420
420082 0.0008 AIKEN 42010
420083 * 0.0027 SPARTANBURG 42410
420098 * 0.0007 GEORGETOWN 42210
430008 0.0535 BROOKINGS 43050
430048 0.0129 LAWRENCE 43400
430094 0.0129 LAWRENCE 43400
440007 0.0219 COFFEE 44150
440008 * 0.0449 HENDERSON 44380
440012 0.0007 SULLIVAN 44810
440016 0.0144 CARROLL 44080
440017 0.0007 SULLIVAN 44810
440024 * 0.0230 BRADLEY 44050
440025 * 0.0007 GREENE 44290
440030 0.0056 HAMBLEN 44310
440031 0.0019 ROANE 44720
440033 0.0027 CAMPBELL 44060
440035 * 0.0301 MONTGOMERY 44620
440047 0.0338 GIBSON 44260
440050 0.0007 GREENE 44290
440051 0.0082 MC NAIRY 44540
440057 0.0021 CLAIBORNE 44120
440060 * 0.0338 GIBSON 44260
440067 * 0.0056 HAMBLEN 44310
440070 0.0109 DECATUR 44190
440081 0.0052 SEVIER 44770
440084 0.0025 MONROE 44610
440109 0.0070 HARDIN 44350
440115 0.0338 GIBSON 44260
440137 0.0738 BEDFORD 44010
440144 * 0.0219 COFFEE 44150
440148 * 0.0296 DE KALB 44200
440153 0.0007 COCKE 44140
440174 0.0312 HAYWOOD 44370
440176 0.0007 SULLIVAN 44810
440180 0.0027 CAMPBELL 44060
440181 0.0365 HARDEMAN 44340
440182 0.0144 CARROLL 44080
440185 * 0.0230 BRADLEY 44050
450032 0.0254 HARRISON 45620
450039 * 0.0024 TARRANT 45910
450052 * 0.0276 BOSQUE 45160
450059 0.0075 COMAL 45320
450064 * 0.0024 TARRANT 45910
450087 * 0.0024 TARRANT 45910
450090 0.0650 COOKE 45340
450099 * 0.0145 GRAY 45563
450135 * 0.0024 TARRANT 45910
450137 * 0.0024 TARRANT 45910
450144 0.0559 ANDREWS 45010
450163 0.0054 KLEBERG 45743
450192 0.0271 HILL 45651
450194 0.0213 CHEROKEE 45281
450210 0.0151 PANOLA 45842
450224 * 0.0195 WOOD 45974
450236 0.0389 HOPKINS 45654
450270 0.0271 HILL 45651
450283 * 0.0653 VAN ZANDT 45947
450324 * 0.0132 GRAYSON 45564
450347 * 0.0370 WALKER 45949
450348 * 0.0059 FALLS 45500
450370 0.0235 COLORADO 45312
450389 * 0.0618 HENDERSON 45640
450393 * 0.0132 GRAYSON 45564
450395 * 0.0441 POLK 45850
450419 * 0.0024 TARRANT 45910
450438 0.0235 COLORADO 45312
450451 0.0536 SOMERVELL 45893
450460 0.0053 TYLER 45942
450469 * 0.0132 GRAYSON 45564
450497 0.0375 MONTAGUE 45800
450539 0.0067 HALE 45582
450547 * 0.0195 WOOD 45974
450563 * 0.0024 TARRANT 45910
450565 * 0.0486 PALO PINTO 45841
450573 0.0126 JASPER 45690
450596 * 0.0743 HOOD 45653
450615 0.0032 CASS 45260
450639 * 0.0024 TARRANT 45910
450641 0.0375 MONTAGUE 45800
450672 * 0.0024 TARRANT 45910
450675 * 0.0024 TARRANT 45910
450677 * 0.0024 TARRANT 45910
450698 0.0127 LAMB 45751
450747 * 0.0126 ANDERSON 45000
450755 0.0276 HOCKLEY 45652
450770 * 0.0182 MILAM 45795
450779 * 0.0024 TARRANT 45910
450813 * 0.0126 ANDERSON 45000
450838 0.0126 JASPER 45690
450872 * 0.0024 TARRANT 45910
450880 * 0.0024 TARRANT 45910
450884 0.0049 UPSHUR 45943
450886 * 0.0024 TARRANT 45910
450888 0.0024 TARRANT 45910
460001 0.0023 UTAH 46240
460013 0.0023 UTAH 46240
460017 0.0383 BOX ELDER 46010
460023 0.0023 UTAH 46240
460039 * 0.0383 BOX ELDER 46010
460043 0.0023 UTAH 46240
460052 0.0023 UTAH 46240
460055 0.0023 UTAH 46240
490019 * 0.1088 CULPEPER 49230
490084 0.0187 ESSEX 49280
490110 0.0185 MONTGOMERY 49600
500003 * 0.0166 SKAGIT 50280
500007 * 0.0166 SKAGIT 50280
500019 0.0131 LEWIS 50200
500039 * 0.0094 KITSAP 50170
500041 * 0.0020 COWLITZ 50070
510012 0.0124 MASON 51260
510018 * 0.0188 JACKSON 51170
510047 * 0.0269 MARION 51240
510077 * 0.0021 MINGO 51290
520028 * 0.0286 GREEN 52220
520035 0.0076 SHEBOYGAN 52580
520044 0.0076 SHEBOYGAN 52580
520057 0.0193 SAUK 52550
520059 * 0.0195 RACINE 52500
520071 * 0.0161 JEFFERSON 52270
520076 * 0.0146 DODGE 52130
520095 0.0193 SAUK 52550
520096 * 0.0195 RACINE 52500
520102 * 0.0242 WALWORTH 52630
520116 * 0.0161 JEFFERSON 52270
670015 0.0024 TARRANT 45910
670023 0.0024 TARRANT 45910

MS-DRG FY 2009 proposed rule post-acute DRG FY 2009 proposed rule special pay DRG MDC Type MS-DRG title Weights Geometric mean LOS Arithmetic mean LOS
001 No No PRE SURG Heart transplant or implant of heart assist system w MCC 23.4061 29.1 40.2
002 No No PRE SURG Heart transplant or implant of heart assist system w/o MCC 12.8956 18.4 24.7
003 Yes No PRE SURG ECMO or trach w MV 96+ hrs or PDX exc face, mouth neck w maj O.R 18.3635 32.5 39.6
004 Yes No PRE SURG Trach w MV 96+ hrs or PDX exc face, mouth neck w/o maj O.R. 11.1684 23.5 28.8
005 No No PRE SURG Liver transplant w MCC or intestinal transplant 10.7436 15.9 21.2
006 No No PRE SURG Liver transplant w/o MCC 4.8292 8.9 10.2
007 No No PRE SURG Lung transplant 9.7325 15.9 19.7
008 No No PRE SURG Simultaneous pancreas/kidney transplant 4.8917 10.1 11.9
009 No No PRE SURG Bone marrow transplant 6.6398 18.2 21.9
010 No No PRE SURG Pancreas transplant 3.7508 9.1 10.8
011 No No PRE SURG Tracheostomy for face,mouth neck diagnoses w MCC 4.8900 13.1 16.7
012 No No PRE SURG Tracheostomy for face,mouth neck diagnoses w CC 3.0563 8.9 10.7
013 No No PRE SURG Tracheostomy for face,mouth neck diagnoses w/o CC/MCC 1.9057 5.9 6.9
020 No No 01 SURG Intracranial vascular procedures w PDX hemorrhage w MCC 8.3276 14.8 18.4
021 No No 01 SURG Intracranial vascular procedures w PDX hemorrhage w CC 6.3534 13.7 15.4
022 No No 01 SURG Intracranial vascular procedures w PDX hemorrhage w/o CC/MCC 4.2072 7.6 9.4
023 No No 01 SURG Cranio w major dev impl/acute complex CNS PDX w MCC or chemo implant 5.0763 8.9 12.7
024 No No 01 SURG Cranio w major dev impl/acute complex CNS PDX w/o MCC 3.4757 6.3 9.0
025 Yes No 01 SURG Craniotomy endovascular intracranial procedures w MCC 5.0324 9.9 13.0
026 Yes No 01 SURG Craniotomy endovascular intracranial procedures w CC 3.0107 6.5 8.2
027 Yes No 01 SURG Craniotomy endovascular intracranial procedures w/o CC/MCC 2.1083 3.5 4.5
028 Yes Yes 01 SURG Spinal procedures w MCC 5.1853 10.7 14.3
029 Yes Yes 01 SURG Spinal procedures w CC or spinal neurostimulators 2.7949 5.1 7.1
030 Yes Yes 01 SURG Spinal procedures w/o CC/MCC 1.5395 2.8 3.7
031 Yes No 01 SURG Ventricular shunt procedures w MCC 4.3899 9.4 13.1
032 Yes No 01 SURG Ventricular shunt procedures w CC 1.9471 4.0 6.0
033 Yes No 01 SURG Ventricular shunt procedures w/o CC/MCC 1.3334 2.3 3.0
034 No No 01 SURG Carotid artery stent procedure w MCC 3.2182 4.6 7.2
035 No No 01 SURG Carotid artery stent procedure w CC 2.0258 2.1 3.3
036 No No 01 SURG Carotid artery stent procedure w/o CC/MCC 1.5706 1.3 1.6
037 No No 01 SURG Extracranial procedures w MCC 3.0208 5.9 8.5
038 No No 01 SURG Extracranial procedures w CC 1.5585 2.5 3.8
039 No No 01 SURG Extracranial procedures w/o CC/MCC 1.0057 1.5 1.8
040 Yes Yes 01 SURG Periph/cranial nerve other nerv syst proc w MCC 3.9691 9.7 13.3
041 Yes Yes 01 SURG Periph/cranial nerve other nerv syst proc w CC or periph neurostim 2.1517 5.3 7.2
042 Yes Yes 01 SURG Periph/cranial nerve other nerv syst proc w/o CC/MCC 1.6771 2.5 3.6
052 No No 01 MED Spinal disorders injuries w CC/MCC 1.6271 4.9 6.7
053 No No 01 MED Spinal disorders injuries w/o CC/MCC 0.8617 3.2 4.0
054 Yes No 01 MED Nervous system neoplasms w MCC 1.5844 5.2 7.0
055 Yes No 01 MED Nervous system neoplasms w/o MCC 1.0781 3.8 5.1
056 Yes No 01 MED Degenerative nervous system disorders w MCC 1.6311 5.7 7.8
057 Yes No 01 MED Degenerative nervous system disorders w/o MCC 0.8755 3.9 5.0
058 No No 01 MED Multiple sclerosis cerebellar ataxia w MCC 1.5373 5.7 7.6
059 No No 01 MED Multiple sclerosis cerebellar ataxia w CC 0.9404 4.2 5.1
060 No No 01 MED Multiple sclerosis cerebellar ataxia w/o CC/MCC 0.6978 3.4 4.0
061 No No 01 MED Acute ischemic stroke w use of thrombolytic agent w MCC 2.8759 6.8 8.9
062 No No 01 MED Acute ischemic stroke w use of thrombolytic agent w CC 1.9505 5.3 6.3
063 No No 01 MED Acute ischemic stroke w use of thrombolytic agent w/o CC/MCC 1.5168 3.9 4.5
064 Yes No 01 MED Intracranial hemorrhage or cerebral infarction w MCC 1.8446 5.5 7.5
065 Yes No 01 MED Intracranial hemorrhage or cerebral infarction w CC 1.1748 4.3 5.2
066 Yes No 01 MED Intracranial hemorrhage or cerebral infarction w/o CC/MCC 0.8426 3.1 3.7
067 No No 01 MED Nonspecific cva precerebral occlusion w/o infarct w MCC 1.3899 4.4 5.8
068 No No 01 MED Nonspecific cva precerebral occlusion w/o infarct w/o MCC 0.8449 2.7 3.4
069 No No 01 MED Transient ischemia 0.7143 2.4 3.0
070 Yes No 01 MED Nonspecific cerebrovascular disorders w MCC 1.8241 6.0 7.9
071 Yes No 01 MED Nonspecific cerebrovascular disorders w CC 1.1307 4.4 5.6
072 Yes No 01 MED Nonspecific cerebrovascular disorders w/o CC/MCC 0.7629 2.8 3.5
073 No No 01 MED Cranial peripheral nerve disorders w MCC 1.3037 4.7 6.2
074 No No 01 MED Cranial peripheral nerve disorders w/o MCC 0.8406 3.4 4.3
075 No No 01 MED Viral meningitis w CC/MCC 1.6738 5.7 7.3
076 No No 01 MED Viral meningitis w/o CC/MCC 0.8544 3.4 4.1
077 No No 01 MED Hypertensive encephalopathy w MCC 1.6225 5.2 6.7
078 No No 01 MED Hypertensive encephalopathy w CC 1.0050 3.6 4.4
079 No No 01 MED Hypertensive encephalopathy w/o CC/MCC 0.7377 2.8 3.4
080 No No 01 MED Nontraumatic stupor coma w MCC 1.1007 3.8 5.1
081 No No 01 MED Nontraumatic stupor coma w/o MCC 0.7094 2.7 3.5
082 No No 01 MED Traumatic stupor coma, coma 1 hr w MCC 2.0177 3.7 6.4
083 No No 01 MED Traumatic stupor coma, coma 1 hr w CC 1.3027 3.7 5.0
084 No No 01 MED Traumatic stupor coma, coma 1 hr w/o CC/MCC 0.8720 2.4 3.1
085 Yes No 01 MED Traumatic stupor coma, coma 1 hr w MCC 2.0942 5.5 7.6
086 Yes No 01 MED Traumatic stupor coma, coma 1 hr w CC 1.2049 3.9 5.0
087 Yes No 01 MED Traumatic stupor coma, coma 1 hr w/o CC/MCC 0.8008 2.6 3.3
088 No No 01 MED Concussion w MCC 1.5774 4.2 5.9
089 No No 01 MED Concussion w CC 0.9162 3.0 3.8
090 No No 01 MED Concussion w/o CC/MCC 0.6736 2.0 2.5
091 Yes No 01 MED Other disorders of nervous system w MCC 1.5641 4.6 6.4
092 Yes No 01 MED Other disorders of nervous system w CC 0.9195 3.5 4.5
093 Yes No 01 MED Other disorders of nervous system w/o CC/MCC 0.6753 2.6 3.2
094 No No 01 MED Bacterial tuberculous infections of nervous system w MCC 3.3477 9.2 11.9
095 No No 01 MED Bacterial tuberculous infections of nervous system w CC 2.1934 6.9 8.6
096 No No 01 MED Bacterial tuberculous infections of nervous system w/o CC/MCC 1.8297 5.0 6.2
097 No No 01 MED Non-bacterial infect of nervous sys exc viral meningitis w MCC 3.2101 9.9 12.6
098 No No 01 MED Non-bacterial infect of nervous sys exc viral meningitis w CC 1.8564 6.8 8.4
099 No No 01 MED Non-bacterial infect of nervous sys exc viral meningitis w/o CC/MCC 1.2533 4.6 5.9
100 Yes No 01 MED Seizures w MCC 1.5064 4.7 6.4
101 Yes No 01 MED Seizures w/o MCC 0.7594 2.9 3.7
102 No No 01 MED Headaches w MCC 0.9594 3.3 4.5
103 No No 01 MED Headaches w/o MCC 0.6224 2.5 3.1
113 No No 02 SURG Orbital procedures w CC/MCC 1.5656 3.8 5.6
114 No No 02 SURG Orbital procedures w/o CC/MCC 0.8313 1.9 2.6
115 No No 02 SURG Extraocular procedures except orbit 1.0625 3.3 4.3
116 No No 02 SURG Intraocular procedures w CC/MCC 1.1338 2.6 4.1
117 No No 02 SURG Intraocular procedures w/o CC/MCC 0.6699 1.6 2.2
121 No No 02 MED Acute major eye infections w CC/MCC 0.9556 4.4 5.5
122 No No 02 MED Acute major eye infections w/o CC/MCC 0.6127 3.4 4.0
123 No No 02 MED Neurological eye disorders 0.6840 2.3 2.9
124 No No 02 MED Other disorders of the eye w MCC 1.0620 3.9 5.3
125 No No 02 MED Other disorders of the eye w/o MCC 0.6660 2.8 3.5
129 No No 03 SURG Major head neck procedures w CC/MCC or major device 2.0147 3.7 5.2
130 No No 03 SURG Major head neck procedures w/o CC/MCC 1.1588 2.4 2.9
131 No No 03 SURG Cranial/facial procedures w CC/MCC 1.9768 4.0 5.7
132 No No 03 SURG Cranial/facial procedures w/o CC/MCC 1.1041 2.1 2.7
133 No No 03 SURG Other ear, nose, mouth throat O.R. procedures w CC/MCC 1.5491 3.6 5.3
134 No No 03 SURG Other ear, nose, mouth throat O.R. procedures w/o CC/MCC 0.8243 1.7 2.2
135 No No 03 SURG Sinus mastoid procedures w CC/MCC 1.6842 3.8 5.8
136 No No 03 SURG Sinus mastoid procedures w/o CC/MCC 0.9023 1.7 2.3
137 No No 03 SURG Mouth procedures w CC/MCC 1.2668 3.8 5.4
138 No No 03 SURG Mouth procedures w/o CC/MCC 0.7368 1.9 2.5
139 No No 03 SURG Salivary gland procedures 0.8176 1.4 1.8
146 No No 03 MED Ear, nose, mouth throat malignancy w MCC 2.0489 6.7 9.4
147 No No 03 MED Ear, nose, mouth throat malignancy w CC 1.2486 4.3 6.1
148 No No 03 MED Ear, nose, mouth throat malignancy w/o CC/MCC 0.8181 2.7 3.8
149 No No 03 MED Dysequilibrium 0.6086 2.2 2.7
150 No No 03 MED Epistaxis w MCC 1.2243 3.7 5.2
151 No No 03 MED Epistaxis w/o MCC 0.6018 2.3 2.9
152 No No 03 MED Otitis media URI w MCC 0.8976 3.4 4.5
153 No No 03 MED Otitis media URI w/o MCC 0.5948 2.6 3.2
154 No No 03 MED Other ear, nose, mouth throat diagnoses w MCC 1.3768 4.6 6.3
155 No No 03 MED Other ear, nose, mouth throat diagnoses w CC 0.8779 3.5 4.4
156 No No 03 MED Other ear, nose, mouth throat diagnoses w/o CC/MCC 0.6306 2.5 3.2
157 No No 03 MED Dental oral diseases w MCC 1.4793 4.7 6.7
158 No No 03 MED Dental oral diseases w CC 0.8615 3.4 4.5
159 No No 03 MED Dental oral diseases w/o CC/MCC 0.5952 2.4 3.1
163 Yes No 04 SURG Major chest procedures w MCC 4.9951 12.2 14.9
164 Yes No 04 SURG Major chest procedures w CC 2.5982 6.7 8.1
165 Yes No 04 SURG Major chest procedures w/o CC/MCC 1.8086 4.3 5.1
166 Yes No 04 SURG Other resp system O.R. procedures w MCC 3.6865 10.0 12.9
167 Yes No 04 SURG Other resp system O.R. procedures w CC 2.0256 6.3 8.0
168 Yes No 04 SURG Other resp system O.R. procedures w/o CC/MCC 1.3443 3.9 5.3
175 Yes No 04 MED Pulmonary embolism w MCC 1.5777 6.0 7.3
176 Yes No 04 MED Pulmonary embolism w/o MCC 1.0696 4.6 5.3
177 Yes No 04 MED Respiratory infections inflammations w MCC 2.0391 7.2 9.1
178 Yes No 04 MED Respiratory infections inflammations w CC 1.4979 6.0 7.4
179 Yes No 04 MED Respiratory infections inflammations w/o CC/MCC 1.0409 4.6 5.6
180 No No 04 MED Respiratory neoplasms w MCC 1.6938 6.0 7.9
181 No No 04 MED Respiratory neoplasms w CC 1.2293 4.5 5.9
182 No No 04 MED Respiratory neoplasms w/o CC/MCC 0.8712 3.2 4.2
183 No No 04 MED Major chest trauma w MCC 1.5304 5.8 7.2
184 No No 04 MED Major chest trauma w CC 0.9405 3.8 4.6
185 No No 04 MED Major chest trauma w/o CC/MCC 0.6755 2.9 3.4
186 Yes No 04 MED Pleural effusion w MCC 1.6200 5.7 7.4
187 Yes No 04 MED Pleural effusion w CC 1.0940 4.1 5.3
188 Yes No 04 MED Pleural effusion w/o CC/MCC 0.8121 3.1 4.0
189 No No 04 MED Pulmonary edema respiratory failure 1.3473 4.8 6.1
190 Yes No 04 MED Chronic obstructive pulmonary disease w MCC 1.3004 5.0 6.3
191 Yes No 04 MED Chronic obstructive pulmonary disease w CC 0.9734 4.1 5.0
192 Yes No 04 MED Chronic obstructive pulmonary disease w/o CC/MCC 0.7239 3.3 4.0
193 Yes No 04 MED Simple pneumonia pleurisy w MCC 1.4303 5.4 6.8
194 Yes No 04 MED Simple pneumonia pleurisy w CC 1.0041 4.4 5.3
195 Yes No 04 MED Simple pneumonia pleurisy w/o CC/MCC 0.7301 3.5 4.1
196 Yes No 04 MED Interstitial lung disease w MCC 1.6006 5.9 7.4
197 Yes No 04 MED Interstitial lung disease w CC 1.0973 4.4 5.4
198 Yes No 04 MED Interstitial lung disease w/o CC/MCC 0.8158 3.3 4.1
199 No No 04 MED Pneumothorax w MCC 1.7383 6.4 8.3
200 No No 04 MED Pneumothorax w CC 1.0118 3.9 5.1
201 No No 04 MED Pneumothorax w/o CC/MCC 0.7399 3.1 4.1
202 No No 04 MED Bronchitis asthma w CC/MCC 0.8135 3.5 4.4
203 No No 04 MED Bronchitis asthma w/o CC/MCC 0.5938 2.8 3.4
204 No No 04 MED Respiratory signs symptoms 0.6533 2.2 2.9
205 Yes No 04 MED Other respiratory system diagnoses w MCC 1.2427 4.0 5.5
206 Yes No 04 MED Other respiratory system diagnoses w/o MCC 0.7266 2.7 3.4
207 Yes No 04 MED Respiratory system diagnosis w ventilator support 96+ hours 5.1153 12.8 15.1
208 No No 04 MED Respiratory system diagnosis w ventilator support 96 hours 2.1827 5.2 7.2
215 No No 05 SURG Other heart assist system implant 12.3351 7.8 14.2
216 Yes No 05 SURG Cardiac valve oth maj cardiothoracic proc w card cath w MCC 1..1072 15.7 18.4
217 Yes No 05 SURG Cardiac valve oth maj cardiothoracic proc w card cath w CC 7.0028 10.9 12.3
218 Yes No 05 SURG Cardiac valve oth maj cardiothoracic proc w card cath w/o CC/MCC 5.4355 8.4 9.1
219 Yes Yes 05 SURG Cardiac valve oth maj cardiothoracic proc w/o card cath w MCC 8.0764 11.5 14.0
220 Yes Yes 05 SURG Cardiac valve oth maj cardiothoracic proc w/o card cath w CC 5.3066 7.7 8.6
221 Yes Yes 05 SURG Cardiac valve oth maj cardiothoracic proc w/o card cath w/o CC/MCC 4.4089 6.0 6.4
222 No No 05 SURG Cardiac defib implant w cardiac cath w AMI/HF/shock w MCC 8.6586 10.7 13.1
223 No No 05 SURG Cardiac defib implant w cardiac cath w AMI/HF/shock w/o MCC 6.3035 4.6 6.3
224 No No 05 SURG Cardiac defib implant w cardiac cath w/o AMI/HF/shock w MCC 7.9767 9.2 11.4
225 No No 05 SURG Cardiac defib implant w cardiac cath w/o AMI/HF/shock w/o MCC 5.9123 4.5 5.6
226 No No 05 SURG Cardiac defibrillator implant w/o cardiac cath w MCC 6.7278 6.2 9.3
227 No No 05 SURG Cardiac defibrillator implant w/o cardiac cath w/o MCC 5.0145 1.8 2.8
228 Yes No 05 SURG Other cardiothoracic procedures w MCC 7.8191 12.1 14.7
229 Yes No 05 SURG Other cardiothoracic procedures w CC 5.0358 7.9 9.1
230 Yes No 05 SURG Other cardiothoracic procedures w/o CC/MCC 4.0677 5.6 6.5
231 No No 05 SURG Coronary bypass w PTCA w MCC 7.6801 11.2 13.3
232 No No 05 SURG Coronary bypass w PTCA w/o MCC 5.5460 8.3 9.2
233 Yes No 05 SURG Coronary bypass w cardiac cath w MCC 7.0378 12.4 14.2
234 Yes No 05 SURG Coronary bypass w cardiac cath w/o MCC 4.6193 8.3 8.9
235 Yes No 05 SURG Coronary bypass w/o cardiac cath w MCC 5.6992 9.5 11.2
236 Yes No 05 SURG Coronary bypass w/o cardiac cath w/o MCC 3.6122 6.1 6.6
237 No No 05 SURG Major cardiovasc procedures w MCC or thoracic aortic aneurysm repair 5.0881 7.5 10.8
238 No No 05 SURG Major cardiovasc procedures w/o MCC 2.8962 3.2 4.6
239 Yes No 05 SURG Amputation for circ sys disorders exc upper limb toe w MCC 4.4798 12.0 15.3
240 Yes No 05 SURG Amputation for circ sys disorders exc upper limb toe w CC 2.6706 8.3 10.4
241 Yes No 05 SURG Amputation for circ sys disorders exc upper limb toe w/o CC/MCC 1.5740 5.6 6.8
242 Yes No 05 SURG Permanent cardiac pacemaker implant w MCC 3.7041 6.7 8.8
243 Yes No 05 SURG Permanent cardiac pacemaker implant w CC 2.5934 3.8 5.1
244 Yes No 05 SURG Permanent cardiac pacemaker implant w/o CC/MCC 2.0098 2.2 2.9
245 No No 05 SURG AICD generator procedures 4.0022 2.1 3.2
246 No No 05 SURG Perc cardiovasc proc w drug-eluting stent w MCC or 4+ vessels/stents 3.1498 3.6 5.3
247 No No 05 SURG Perc cardiovasc proc w drug-eluting stent w/o MCC 1.9134 1.7 2.2
248 No No 05 SURG Perc cardiovasc proc w non-drug-eluting stent w MCC or 4+ ves/stents 2.8065 4.2 6.0
249 No No 05 SURG Perc cardiovasc proc w non-drug-eluting stent w/o MCC 1.6397 1.9 2.5
250 No No 05 SURG Perc cardiovasc proc w/o coronary artery stent w MCC 2.9923 5.4 7.8
251 No No 05 SURG Perc cardiovasc proc w/o coronary artery stent w/o MCC 1.6023 2.1 2.8
252 No No 05 SURG Other vascular procedures w MCC 2.9526 5.5 8.5
253 No No 05 SURG Other vascular procedures w CC 2.2593 4.2 6.0
254 No No 05 SURG Other vascular procedures w/o CC/MCC 1.5485 2.0 2.7
255 Yes No 05 SURG Upper limb toe amputation for circ system disorders w MCC 2.4040 7.1 9.7
256 Yes No 05 SURG Upper limb toe amputation for circ system disorders w CC 1.5895 5.8 7.5
257 Yes No 05 SURG Upper limb toe amputation for circ system disorders w/o CC/MCC 1.0216 3.6 4.8
258 No No 05 SURG Cardiac pacemaker device replacement w MCC 2.8434 5.4 7.4
259 No No 05 SURG Cardiac pacemaker device replacement w/o MCC 1.6944 2.0 2.8
260 No No 05 SURG Cardiac pacemaker revision except device replacement w MCC 3.4221 8.1 11.2
261 No No 05 SURG Cardiac pacemaker revision except device replacement w CC 1.4398 3.0 4.2
262 No No 05 SURG Cardiac pacemaker revision except device replacement w/o CC/MCC 1.0173 2.0 2.6
263 No No 05 SURG Vein ligation stripping 1.5392 3.4 5.4
264 Yes No 05 SURG Other circulatory system O.R. procedures 2.5265 5.8 8.9
265 No No 05 SURG AICD lead procedures 2.2140 2.2 3.5
280 Yes No 05 MED Acute myocardial infarction, discharged alive w MCC 1.9395 5.8 7.3
281 Yes No 05 MED Acute myocardial infarction, discharged alive w CC 1.2210 3.9 4.8
282 Yes No 05 MED Acute myocardial infarction, discharged alive w/o CC/MCC 0.8698 2.6 3.2
283 No No 05 MED Acute myocardial infarction, expired w MCC 1.6979 3.4 5.5
284 No No 05 MED Acute myocardial infarction, expired w CC 0.9130 2.2 3.2
285 No No 05 MED Acute myocardial infarction, expired w/o CC/MCC 0.6059 1.7 2.2
286 No No 05 MED Circulatory disorders except AMI, w card cath w MCC 1.9745 5.2 6.9
287 No No 05 MED Circulatory disorders except AMI, w card cath w/o MCC 1.0225 2.4 3.1
288 Yes No 05 MED Acute subacute endocarditis w MCC 3.0720 9.2 11.8
289 Yes No 05 MED Acute subacute endocarditis w CC 1.9524 7.0 8.7
290 Yes No 05 MED Acute subacute endocarditis w/o CC/MCC 1.4507 5.2 6.5
291 Yes No 05 MED Heart failure shock w MCC 1.4576 5.0 6.5
292 Yes No 05 MED Heart failure shock w CC 1.0053 4.1 5.0
293 Yes No 05 MED Heart failure shock w/o CC/MCC 0.7205 3.1 3.7
294 No No 05 MED Deep vein thrombophlebitis w CC/MCC 0.9564 4.6 5.5
295 No No 05 MED Deep vein thrombophlebitis w/o CC/MCC 0.6347 3.7 4.3
296 No No 05 MED Cardiac arrest, unexplained w MCC 1.1910 1.9 3.0
297 No No 05 MED Cardiac arrest, unexplained w CC 0.6502 1.4 1.8
298 No No 05 MED Cardiac arrest, unexplained w/o CC/MCC 0.4438 1.1 1.3
299 Yes No 05 MED Peripheral vascular disorders w MCC 1.4326 5.0 6.7
300 Yes No 05 MED Peripheral vascular disorders w CC 0.9245 4.1 5.0
301 Yes No 05 MED Peripheral vascular disorders w/o CC/MCC 0.6580 3.0 3.7
302 No No 05 MED Atherosclerosis w MCC 1.0307 3.2 4.4
303 No No 05 MED Atherosclerosis w/o MCC 0.5666 2.0 2.5
304 No No 05 MED Hypertension w MCC 1.0808 3.9 5.2
305 No No 05 MED Hypertension w/o MCC 0.5900 2.3 2.9
306 No No 05 MED Cardiac congenital valvular disorders w MCC 1.5655 4.4 6.3
307 No No 05 MED Cardiac congenital valvular disorders w/o MCC 0.7476 2.7 3.4
308 No No 05 MED Cardiac arrhythmia conduction disorders w MCC 1.2981 4.1 5.5
309 No No 05 MED Cardiac arrhythmia conduction disorders w CC 0.8320 3.1 3.9
310 No No 05 MED Cardiac arrhythmia conduction disorders w/o CC/MCC 0.5829 2.3 2.8
311 No No 05 MED Angina pectoris 0.4969 1.9 2.3
312 No No 05 MED Syncope collapse 0.7082 2.5 3.1
313 No No 05 MED Chest pain 0.5312 1.7 2.1
314 Yes No 05 MED Other circulatory system diagnoses w MCC 1.7517 5.0 7.0
315 Yes No 05 MED Other circulatory system diagnoses w CC 0.9922 3.5 4.6
316 Yes No 05 MED Other circulatory system diagnoses w/o CC/MCC 0.6513 2.4 3.0
326 Yes No 06 SURG Stomach, esophageal duodenal proc w MCC 5.8025 13.2 17.1
327 Yes No 06 SURG Stomach, esophageal duodenal proc w CC 2.8389 7.8 10.1
328 Yes No 06 SURG Stomach, esophageal duodenal proc w/o CC/MCC 1.4576 3.2 4.4
329 Yes No 06 SURG Major small large bowel procedures w MCC 5.1793 12.8 16.0
330 Yes No 06 SURG Major small large bowel procedures w CC 2.5644 8.3 9.7
331 Yes No 06 SURG Major small large bowel procedures w/o CC/MCC 1.6250 5.2 5.9
332 Yes No 06 SURG Rectal resection w MCC 4.5358 12.0 14.3
333 Yes No 06 SURG Rectal resection w CC 2.4487 7.7 8.8
334 Yes No 06 SURG Rectal resection w/o CC/MCC 1.6247 4.7 5.5
335 Yes No 06 SURG Peritoneal adhesiolysis w MCC 4.0903 11.6 14.1
336 Yes No 06 SURG Peritoneal adhesiolysis w CC 2.2387 7.5 9.1
337 Yes No 06 SURG Peritoneal adhesiolysis w/o CC/MCC 1.4519 4.4 5.6
338 No No 06 SURG Appendectomy w complicated principal diag w MCC 3.1787 8.8 10.7
339 No No 06 SURG Appendectomy w complicated principal diag w CC 1.8625 6.0 7.0
340 No No 06 SURG Appendectomy w complicated principal diag w/o CC/MCC 1.2267 3.5 4.2
341 No No 06 SURG Appendectomy w/o complicated principal diag w MCC 2.1659 5.3 7.1
342 No No 06 SURG Appendectomy w/o complicated principal diag w CC 1.3154 3.2 4.1
343 No No 06 SURG Appendectomy w/o complicated principal diag w/o CC/MCC 0.9067 1.8 2.2
344 No No 06 SURG Minor small large bowel procedures w MCC 3.0822 9.2 11.8
345 No No 06 SURG Minor small large bowel procedures w CC 1.6391 6.2 7.2
346 No No 06 SURG Minor small large bowel procedures w/o CC/MCC 1.1869 4.4 4.9
347 No No 06 SURG Anal stomal procedures w MCC 2.1823 6.4 8.8
348 No No 06 SURG Anal stomal procedures w CC 1.2860 4.4 5.7
349 No No 06 SURG Anal stomal procedures w/o CC/MCC 0.7681 2.4 3.1
350 No No 06 SURG Inguinal femoral hernia procedures w MCC 2.2486 5.8 8.0
351 No No 06 SURG Inguinal femoral hernia procedures w CC 1.2638 3.4 4.6
352 No No 06 SURG Inguinal femoral hernia procedures w/o CC/MCC 0.8131 2.0 2.5
353 No No 06 SURG Hernia procedures except inguinal femoral w MCC 2.4935 6.4 8.4
354 No No 06 SURG Hernia procedures except inguinal femoral w CC 1.4046 4.0 5.1
355 No No 06 SURG Hernia procedures except inguinal femoral w/o CC/MCC 0.9675 2.4 2.9
356 Yes No 06 SURG Other digestive system O.R. procedures w MCC 3.8574 9.5 12.9
357 Yes No 06 SURG Other digestive system O.R. procedures w CC 2.1703 6.2 8.1
358 Yes No 06 SURG Other digestive system O.R. procedures w/o CC/MCC 1.3493 3.3 4.5
368 No No 06 MED Major esophageal disorders w MCC 1.6184 5.1 6.6
369 No No 06 MED Major esophageal disorders w CC 1.0703 3.8 4.7
370 No No 06 MED Major esophageal disorders w/o CC/MCC 0.7835 2.8 3.4
371 Yes No 06 MED Major gastrointestinal disorders peritoneal infections w MCC 1.9062 6.7 8.7
372 Yes No 06 MED Major gastrointestinal disorders peritoneal infections w CC 1.3025 5.6 6.9
373 Yes No 06 MED Major gastrointestinal disorders peritoneal infections w/o CC/MCC 0.8646 4.2 4.9
374 Yes No 06 MED Digestive malignancy w MCC 1.9057 6.3 8.6
375 Yes No 06 MED Digestive malignancy w CC 1.2523 4.6 6.0
376 Yes No 06 MED Digestive malignancy w/o CC/MCC 0.8820 3.2 4.2
377 Yes No 06 MED G.I. hemorrhage w MCC 1.6069 4.9 6.4
378 Yes No 06 MED G.I. hemorrhage w CC 1.0048 3.7 4.4
379 Yes No 06 MED G.I. hemorrhage w/o CC/MCC 0.7567 2.9 3.4
380 Yes No 06 MED Complicated peptic ulcer w MCC 1.7995 5.6 7.3
381 Yes No 06 MED Complicated peptic ulcer w CC 1.1138 4.2 5.2
382 Yes No 06 MED Complicated peptic ulcer w/o CC/MCC 0.8208 3.1 3.7
383 No No 06 MED Uncomplicated peptic ulcer w MCC 1.1789 4.4 5.5
384 No No 06 MED Uncomplicated peptic ulcer w/o MCC 0.7818 3.1 3.7
385 No No 06 MED Inflammatory bowel disease w MCC 1.8541 6.5 8.8
386 No No 06 MED Inflammatory bowel disease w CC 1.0601 4.5 5.7
387 No No 06 MED Inflammatory bowel disease w/o CC/MCC 0.7746 3.5 4.3
388 Yes No 06 MED G.I. obstruction w MCC 1.5392 5.5 7.3
389 Yes No 06 MED G.I. obstruction w CC 0.9244 4.0 5.0
390 Yes No 06 MED G.I. obstruction w/o CC/MCC 0.6333 3.0 3.6
391 No No 06 MED Esophagitis, gastroent misc digest disorders w MCC 1.0810 3.9 5.2
392 No No 06 MED Esophagitis, gastroent misc digest disorders w/o MCC 0.6685 2.8 3.5
393 No No 06 MED Other digestive system diagnoses w MCC 1.5367 4.9 6.9
394 No No 06 MED Other digestive system diagnoses w CC 0.9489 3.8 4.8
395 No No 06 MED Other digestive system diagnoses w/o CC/MCC 0.6745 2.6 3.3
405 Yes No 07 SURG Pancreas, liver shunt procedures w MCC 5.6481 12.4 17.0
406 Yes No 07 SURG Pancreas, liver shunt procedures w CC 2.7895 7.0 9.2
407 Yes No 07 SURG Pancreas, liver shunt procedures w/o CC/MCC 1.8411 4.2 5.5
408 No No 07 SURG Biliary tract proc except only cholecyst w or w/o c.d.e. w MCC 4.2539 12.1 15.0
409 No No 07 SURG Biliary tract proc except only cholecyst w or w/o c.d.e. w CC 2.5819 8.3 9.8
410 No No 07 SURG Biliary tract proc except only cholecyst w or w/o c.d.e. w/o CC/MCC 1.6374 5.4 6.5
411 No No 07 SURG Cholecystectomy w c.d.e. w MCC 3.7602 10.4 12.4
412 No No 07 SURG Cholecystectomy w c.d.e. w CC 2.3633 7.5 8.6
413 No No 07 SURG Cholecystectomy w c.d.e. w/o CC/MCC 1.6896 5.0 5.9
414 Yes No 07 SURG Cholecystectomy except by laparoscope w/o c.d.e. w MCC 3.5777 9.7 11.7
415 Yes No 07 SURG Cholecystectomy except by laparoscope w/o c.d.e. w CC 2.0372 6.5 7.6
416 Yes No 07 SURG Cholecystectomy except by laparoscope w/o c.d.e. w/o CC/MCC 1.3290 4.1 4.8
417 No No 07 SURG Laparoscopic cholecystectomy w/o c.d.e. w MCC 2.4851 6.5 8.4
418 No No 07 SURG Laparoscopic cholecystectomy w/o c.d.e. w CC 1.6541 4.5 5.6
419 No No 07 SURG Laparoscopic cholecystectomy w/o c.d.e. w/o CC/MCC 1.1296 2.5 3.2
420 No No 07 SURG Hepatobiliary diagnostic procedures w MCC 4.0976 9.9 13.7
421 No No 07 SURG Hepatobiliary diagnostic procedures w CC 1.8978 5.6 7.7
422 No No 07 SURG Hepatobiliary diagnostic procedures w/o CC/MCC 1.2275 3.2 4.4
423 No No 07 SURG Other hepatobiliary or pancreas O.R. procedures w MCC 4.5535 11.8 15.9
424 No No 07 SURG Other hepatobiliary or pancreas O.R. procedures w CC 2.5159 7.9 10.4
425 No No 07 SURG Other hepatobiliary or pancreas O.R. procedures w/o CC/MCC 1.3760 4.0 5.4
432 No No 07 MED Cirrhosis alcoholic hepatitis w MCC 1.6776 5.2 7.0
433 No No 07 MED Cirrhosis alcoholic hepatitis w CC 0.9378 3.8 4.9
434 No No 07 MED Cirrhosis alcoholic hepatitis w/o CC/MCC 0.6551 2.9 3.7
435 No No 07 MED Malignancy of hepatobiliary system or pancreas w MCC 1.7117 5.7 7.6
436 No No 07 MED Malignancy of hepatobiliary system or pancreas w CC 1.1892 4.5 5.8
437 No No 07 MED Malignancy of hepatobiliary system or pancreas w/o CC/MCC 0.9506 3.2 4.3
438 No No 07 MED Disorders of pancreas except malignancy w MCC 1.6992 5.5 7.5
439 No No 07 MED Disorders of pancreas except malignancy w CC 1.0223 4.2 5.3
440 No No 07 MED Disorders of pancreas except malignancy w/o CC/MCC 0.6963 3.2 3.8
441 Yes No 07 MED Disorders of liver except malig, cirr, alc hepa w MCC 1.6580 5.1 7.0
442 Yes No 07 MED Disorders of liver except malig, cirr, alc hepa w CC 0.9825 3.9 5.1
443 Yes No 07 MED Disorders of liver except malig, cirr, alc hepa w/o CC/MCC 0.6945 3.0 3.8
444 No No 07 MED Disorders of the biliary tract w MCC 1.5579 5.0 6.6
445 No No 07 MED Disorders of the biliary tract w CC 1.0375 3.8 4.7
446 No No 07 MED Disorders of the biliary tract w/o CC/MCC 0.7225 2.6 3.3
453 No No 08 SURG Combined anterior/posterior spinal fusion w MCC 9.8724 12.0 15.7
454 No No 08 SURG Combined anterior/posterior spinal fusion w CC 7.0370 6.5 8.0
455 No No 08 SURG Combined anterior/posterior spinal fusion w/o CC/MCC 5.1744 3.7 4.4
456 No No 08 SURG Spinal fus exc cerv w spinal curv/malig/infec or 9+ fus w MCC 8.5225 11.6 14.7
457 No No 08 SURG Spinal fus exc cerv w spinal curv/malig/infec or 9+ fus w CC 5.6672 6.2 7.5
458 No No 08 SURG Spinal fus exc cerv w spinal curv/malig/infec or 9+ fus w/o CC/MCC 4.7056 4.0 4.5
459 Yes No 08 SURG Spinal fusion except cervical w MCC 5.9847 7.6 9.4
460 Yes No 08 SURG Spinal fusion except cervical w/o MCC 3.5746 3.6 4.2
461 No No 08 SURG Bilateral or multiple major joint procs of lower extremity w MCC 4.5636 6.8 8.4
462 No No 08 SURG Bilateral or multiple major joint procs of lower extremity w/o MCC 3.1564 3.9 4.2
463 Yes No 08 SURG Wnd debrid skn grft exc hand, for musculo-conn tiss dis w MCC 4.6669 12.0 16.6
464 Yes No 08 SURG Wnd debrid skn grft exc hand, for musculo-conn tiss dis w CC 2.6117 7.7 10.2
465 Yes No 08 SURG Wnd debrid skn grft exc hand, for musculo-conn tiss dis w/o CC/MCC 1.4955 4.4 5.9
466 Yes No 08 SURG Revision of hip or knee replacement w MCC 4.5564 7.4 9.2
467 Yes No 08 SURG Revision of hip or knee replacement w CC 3.0720 4.8 5.5
468 Yes No 08 SURG Revision of hip or knee replacement w/o CC/MCC 2.4597 3.6 3.9
469 Yes No 08 SURG Major joint replacement or reattachment of lower extremity w MCC 3.2979 6.9 8.2
470 Yes No 08 SURG Major joint replacement or reattachment of lower extremity w/o MCC 2.0144 3.6 3.9
471 No No 08 SURG Cervical spinal fusion w MCC 4.4277 7.0 9.8
472 No No 08 SURG Cervical spinal fusion w CC 2.6200 2.8 4.1
473 No No 08 SURG Cervical spinal fusion w/o CC/MCC 1.9213 1.6 2.0
474 Yes No 08 SURG Amputation for musculoskeletal sys conn tissue dis w MCC 3.4435 9.5 12.6
475 Yes No 08 SURG Amputation for musculoskeletal sys conn tissue dis w CC 1.9768 6.5 8.4
476 Yes No 08 SURG Amputation for musculoskeletal sys conn tissue dis w/o CC/MCC 1.1001 3.7 4.8
477 Yes Yes 08 SURG Biopsies of musculoskeletal system connective tissue w MCC 3.2545 8.9 11.9
478 Yes Yes 08 SURG Biopsies of musculoskeletal system connective tissue w CC 2.1266 4.6 6.6
479 Yes Yes 08 SURG Biopsies of musculoskeletal system connective tissue w/o CC/MCC 1.4779 1.9 2.8
480 Yes Yes 08 SURG Hip femur procedures except major joint w MCC 2.9050 7.8 9.3
481 Yes Yes 08 SURG Hip femur procedures except major joint w CC 1.8204 5.4 5.9
482 Yes Yes 08 SURG Hip femur procedures except major joint w/o CC/MCC 1.4976 4.5 4.8
483 Yes No 08 SURG Major joint limb reattachment proc of upper extremity w CC/MCC 2.2601 3.4 4.2
484 Yes No 08 SURG Major joint limb reattachment proc of upper extremity w/o CC/MCC 1.7535 2.1 2.4
485 No No 08 SURG Knee procedures w pdx of infection w MCC 3.3033 9.8 12.1
486 No No 08 SURG Knee procedures w pdx of infection w CC 2.1664 6.8 8.0
487 No No 08 SURG Knee procedures w pdx of infection w/o CC/MCC 1.5507 4.9 5.7
488 Yes No 08 SURG Knee procedures w/o pdx of infection w CC/MCC 1.6836 4.1 5.2
489 Yes No 08 SURG Knee procedures w/o pdx of infection w/o CC/MCC 1.1604 2.6 3.0
490 No No 08 SURG Back neck proc exc spinal fusion w CC/MCC or disc device/neurostim 1.7221 3.0 4.3
491 No No 08 SURG Back neck proc exc spinal fusion w/o CC/MCC 0.9413 1.8 2.2
492 Yes Yes 08 SURG Lower extrem humer proc except hip,foot,femur w MCC 2.7705 6.8 8.5
493 Yes Yes 08 SURG Lower extrem humer proc except hip,foot,femur w CC 1.7631 4.3 5.3
494 Yes Yes 08 SURG Lower extrem humer proc except hip,foot,femur w/o CC/MCC 1.2385 2.8 3.4
495 Yes No 08 SURG Local excision removal int fix devices exc hip femur w MCC 3.1782 8.1 11.0
496 Yes No 08 SURG Local excision removal int fix devices exc hip femur w CC 1.7775 4.6 6.0
497 Yes No 08 SURG Local excision removal int fix devices exc hip femur w/o CC/MCC 1.1277 2.3 3.0
498 No No 08 SURG Local excision removal int fix devices of hip femur w CC/MCC 2.0274 5.5 7.9
499 No No 08 SURG Local excision removal int fix devices of hip femur w/o CC/MCC 0.9097 2.3 3.0
500 Yes Yes 08 SURG Soft tissue procedures w MCC 2.8423 7.8 10.8
501 Yes Yes 08 SURG Soft tissue procedures w CC 1.4718 4.5 6.0
502 Yes Yes 08 SURG Soft tissue procedures w/o CC/MCC 0.9585 2.3 2.9
503 No No 08 SURG Foot procedures w MCC 2.3059 7.2 9.5
504 No No 08 SURG Foot procedures w CC 1.4725 5.1 6.5
505 No No 08 SURG Foot procedures w/o CC/MCC 0.9882 2.6 3.4
506 No No 08 SURG Major thumb or joint procedures 1.0286 2.5 3.4
507 No No 08 SURG Major shoulder or elbow joint procedures w CC/MCC 1.7188 3.7 5.1
508 No No 08 SURG Major shoulder or elbow joint procedures w/o CC/MCC 1.1156 1.7 2.1
509 No No 08 SURG Arthroscopy 1.1762 2.0 3.1
510 Yes No 08 SURG Shoulder,elbow or forearm proc, exc major joint proc w MCC 1.9973 4.9 6.4
511 Yes No 08 SURG Shoulder,elbow or forearm proc, exc major joint proc w CC 1.3434 3.2 4.0
512 Yes No 08 SURG Shoulder,elbow or forearm proc, exc major joint proc w/o CC/MCC 0.9533 1.8 2.2
513 No No 08 SURG Hand or wrist proc, except major thumb or joint proc w CC/MCC 1.2813 3.6 5.0
514 No No 08 SURG Hand or wrist proc, except major thumb or joint proc w/o CC/MCC 0.8067 2.1 2.8
515 Yes Yes 08 SURG Other musculoskelet sys conn tiss O.R. proc w MCC 3.0601 7.9 10.4
516 Yes Yes 08 SURG Other musculoskelet sys conn tiss O.R. proc w CC 1.8073 4.5 6.0
517 Yes Yes 08 SURG Other musculoskelet sys conn tiss O.R. proc w/o CC/MCC 1.3326 2.1 3.0
533 Yes No 08 MED Fractures of femur w MCC 1.4207 4.8 6.7
534 Yes No 08 MED Fractures of femur w/o MCC 0.7318 3.3 4.0
535 Yes No 08 MED Fractures of hip pelvis w MCC 1.3327 4.8 6.2
536 Yes No 08 MED Fractures of hip pelvis w/o MCC 0.6934 3.4 3.9
537 No No 08 MED Sprains, strains, dislocations of hip, pelvis thigh w CC/MCC 0.8871 3.6 4.5
538 No No 08 MED Sprains, strains, dislocations of hip, pelvis thigh w/o CC/MCC 0.5787 2.7 3.2
539 Yes No 08 MED Osteomyelitis w MCC 2.0097 7.5 9.7
540 Yes No 08 MED Osteomyelitis w CC 1.3457 5.7 7.1
541 Yes No 08 MED Osteomyelitis w/o CC/MCC 0.9285 4.2 5.4
542 Yes No 08 MED Pathological fractures musculoskelet conn tiss malig w MCC 1.8953 6.7 8.8
543 Yes No 08 MED Pathological fractures musculoskelet conn tiss malig w CC 1.1263 4.8 5.9
544 Yes No 08 MED Pathological fractures musculoskelet conn tiss malig w/o CC/MCC 0.7672 3.7 4.4
545 Yes No 08 MED Connective tissue disorders w MCC 2.3477 6.5 9.1
546 Yes No 08 MED Connective tissue disorders w CC 1.0951 4.4 5.5
547 Yes No 08 MED Connective tissue disorders w/o CC/MCC 0.7224 3.1 3.8
548 No No 08 MED Septic arthritis w MCC 1.8776 6.7 8.9
549 No No 08 MED Septic arthritis w CC 1.1590 5.1 6.4
550 No No 08 MED Septic arthritis w/o CC/MCC 0.8006 3.7 4.5
551 Yes No 08 MED Medical back problems w MCC 1.5261 5.4 7.1
552 Yes No 08 MED Medical back problems w/o MCC 0.7623 3.4 4.1
553 No No 08 MED Bone diseases arthropathies w MCC 1.0978 4.7 6.0
554 No No 08 MED Bone diseases arthropathies w/o MCC 0.6305 3.0 3.7
555 No No 08 MED Signs symptoms of musculoskeletal system conn tissue w MCC 1.0014 3.6 4.8
556 No No 08 MED Signs symptoms of musculoskeletal system conn tissue w/o MCC 0.5738 2.5 3.1
557 Yes No 08 MED Tendonitis, myositis bursitis w MCC 1.4264 5.2 6.6
558 Yes No 08 MED Tendonitis, myositis bursitis w/o MCC 0.8009 3.5 4.3
559 Yes No 08 MED Aftercare, musculoskeletal system connective tissue w MCC 1.7085 5.3 7.6
560 Yes No 08 MED Aftercare, musculoskeletal system connective tissue w CC 0.9491 3.6 4.7
561 Yes No 08 MED Aftercare, musculoskeletal system connective tissue w/o CC/MCC 0.5794 2.1 2.8
562 Yes No 08 MED Fx, sprn, strn disl except femur, hip, pelvis thigh w MCC 1.3933 4.9 6.4
563 Yes No 08 MED Fx, sprn, strn disl except femur, hip, pelvis thigh w/o MCC 0.6749 3.1 3.7
564 No No 08 MED Other musculoskeletal sys connective tissue diagnoses w MCC 1.4053 5.2 7.0
565 No No 08 MED Other musculoskeletal sys connective tissue diagnoses w CC 0.8848 3.9 5.0
566 No No 08 MED Other musculoskeletal sys connective tissue diagnoses w/o CC/MCC 0.6673 3.0 3.7
573 Yes No 09 SURG Skin graft /or debrid for skn ulcer or cellulitis w MCC 3.1703 9.6 13.1
574 Yes No 09 SURG Skin graft /or debrid for skn ulcer or cellulitis w CC 1.9362 7.1 9.3
575 Yes No 09 SURG Skin graft /or debrid for skn ulcer or cellulitis w/o CC/MCC 1.1176 4.7 5.9
576 No No 09 SURG Skin graft /or debrid exc for skin ulcer or cellulitis w MCC 3.4522 8.4 13.0
577 No No 09 SURG Skin graft /or debrid exc for skin ulcer or cellulitis w CC 1.5788 4.2 6.1
578 No No 09 SURG Skin graft /or debrid exc for skin ulcer or cellulitis w/o CC/MCC 0.9803 2.4 3.3
579 Yes No 09 SURG Other skin, subcut tiss breast proc w MCC 2.7821 7.8 10.7
580 Yes No 09 SURG Other skin, subcut tiss breast proc w CC 1.4093 3.7 5.5
581 Yes No 09 SURG Other skin, subcut tiss breast proc w/o CC/MCC 0.8606 1.9 2.6
582 No No 09 SURG Mastectomy for malignancy w CC/MCC 0.9682 2.1 2.8
583 No No 09 SURG Mastectomy for malignancy w/o CC/MCC 0.7498 1.6 1.8
584 No No 09 SURG Breast biopsy, local excision other breast procedures w CC/MCC 1.4344 4.0 6.0
585 No No 09 SURG Breast biopsy, local excision other breast procedures w/o CC/MCC 0.7995 1.7 2.2
592 Yes No 09 MED Skin ulcers w MCC 1.7469 6.6 8.9
593 Yes No 09 MED Skin ulcers w CC 1.1021 5.2 6.4
594 Yes No 09 MED Skin ulcers w/o CC/MCC 0.7871 4.1 5.1
595 No No 09 MED Major skin disorders w MCC 1.8159 6.2 8.3
596 No No 09 MED Major skin disorders w/o MCC 0.8200 3.8 4.8
597 No No 09 MED Malignant breast disorders w MCC 1.6001 5.9 8.2
598 No No 09 MED Malignant breast disorders w CC 1.0812 4.3 5.7
599 No No 09 MED Malignant breast disorders w/o CC/MCC 0.7309 2.7 3.7
600 No No 09 MED Non-malignant breast disorders w CC/MCC 0.9433 4.1 5.1
601 No No 09 MED Non-malignant breast disorders w/o CC/MCC 0.6539 3.1 3.9
602 Yes No 09 MED Cellulitis w MCC 1.3980 5.5 7.0
603 Yes No 09 MED Cellulitis w/o MCC 0.7988 3.9 4.7
604 No No 09 MED Trauma to the skin, subcut tiss breast w MCC 1.1875 4.3 5.7
605 No No 09 MED Trauma to the skin, subcut tiss breast w/o MCC 0.6739 2.8 3.5
606 No No 09 MED Minor skin disorders w MCC 1.2415 4.4 6.3
607 No No 09 MED Minor skin disorders w/o MCC 0.6434 2.9 3.8
614 No No 10 SURG Adrenal pituitary procedures w CC/MCC 2.5046 5.1 7.0
615 No No 10 SURG Adrenal pituitary procedures w/o CC/MCC 1.3782 2.7 3.2
616 Yes No 10 SURG Amputat of lower limb for endocrine, nutrit, metabol dis w MCC 4.6284 13.3 16.9
617 Yes No 10 SURG Amputat of lower limb for endocrine, nutrit, metabol dis w CC 2.0940 7.0 8.8
618 Yes No 10 SURG Amputat of lower limb for endocrine, nutrit, metabol dis w/o CC/MCC 1.3234 5.1 6.4
619 No No 10 SURG O.R. procedures for obesity w MCC 3.3383 5.2 8.2
620 No No 10 SURG O.R. procedures for obesity w CC 1.8739 2.9 3.7
621 No No 10 SURG O.R. procedures for obesity w/o CC/MCC 1.4269 1.9 2.2
622 Yes No 10 SURG Skin grafts wound debrid for endoc, nutrit metab dis w MCC 3.1268 9.4 13.2
623 Yes No 10 SURG Skin grafts wound debrid for endoc, nutrit metab dis w CC 1.8728 6.7 8.6
624 Yes No 10 SURG Skin grafts wound debrid for endoc, nutrit metab dis w/o CC/MCC 1.0877 4.8 6.0
625 No No 10 SURG Thyroid, parathyroid thyroglossal procedures w MCC 2.1260 4.7 7.1
626 No No 10 SURG Thyroid, parathyroid thyroglossal procedures w CC 1.1284 2.1 3.1
627 No No 10 SURG Thyroid, parathyroid thyroglossal procedures w/o CC/MCC 0.7378 1.3 1.5
628 Yes No 10 SURG Other endocrine, nutrit metab O.R. proc w MCC 3.2732 7.5 11.2
629 Yes No 10 SURG Other endocrine, nutrit metab O.R. proc w CC 2.2931 6.9 8.7
630 Yes No 10 SURG Other endocrine, nutrit metab O.R. proc w/o CC/MCC 1.5069 4.0 5.5
637 Yes No 10 MED Diabetes w MCC 1.3538 4.5 6.1
638 Yes No 10 MED Diabetes w CC 0.8135 3.4 4.3
639 Yes No 10 MED Diabetes w/o CC/MCC 0.5577 2.5 3.0
640 Yes No 10 MED Nutritional misc metabolic disorders w MCC 1.1105 3.9 5.4
641 Yes No 10 MED Nutritional misc metabolic disorders w/o MCC 0.6798 3.1 3.8
642 No No 10 MED Inborn errors of metabolism 1.0169 3.7 5.2
643 Yes No 10 MED Endocrine disorders w MCC 1.6408 5.8 7.6
644 Yes No 10 MED Endocrine disorders w CC 1.0437 4.4 5.5
645 Yes No 10 MED Endocrine disorders w/o CC/MCC 0.7164 3.1 3.9
652 No No 11 SURG Kidney transplant 2.9787 6.6 7.8
653 Yes No 11 SURG Major bladder procedures w MCC 5.8091 13.6 16.9
654 Yes No 11 SURG Major bladder procedures w CC 2.9531 8.7 9.9
655 Yes No 11 SURG Major bladder procedures w/o CC/MCC 2.0241 5.7 6.5
656 No No 11 SURG Kidney ureter procedures for neoplasm w MCC 3.2762 8.0 10.1
657 No No 11 SURG Kidney ureter procedures for neoplasm w CC 1.8655 5.0 6.0
658 No No 11 SURG Kidney ureter procedures for neoplasm w/o CC/MCC 1.3790 3.3 3.7
659 Yes No 11 SURG Kidney ureter procedures for non-neoplasm w MCC 3.3225 8.0 11.2
660 Yes No 11 SURG Kidney ureter procedures for non-neoplasm w CC 1.8913 4.8 6.5
661 Yes No 11 SURG Kidney ureter procedures for non-neoplasm w/o CC/MCC 1.2600 2.6 3.3
662 No No 11 SURG Minor bladder procedures w MCC 2.7078 7.4 10.3
663 No No 11 SURG Minor bladder procedures w CC 1.4443 3.7 5.3
664 No No 11 SURG Minor bladder procedures w/o CC/MCC 0.9940 1.6 2.1
665 No No 11 SURG Prostatectomy w MCC 2.5635 8.2 11.1
666 No No 11 SURG Prostatectomy w CC 1.5553 4.3 6.4
667 No No 11 SURG Prostatectomy w/o CC/MCC 0.8259 2.1 2.9
668 No No 11 SURG Transurethral procedures w MCC 2.2348 6.2 8.5
669 No No 11 SURG Transurethral procedures w CC 1.2049 3.1 4.4
670 No No 11 SURG Transurethral procedures w/o CC/MCC 0.7672 1.9 2.5
671 No No 11 SURG Urethral procedures w CC/MCC 1.4136 4.1 5.9
672 No No 11 SURG Urethral procedures w/o CC/MCC 0.7962 1.9 2.5
673 No No 11 SURG Other kidney urinary tract procedures w MCC 2.7645 5.8 9.7
674 No No 11 SURG Other kidney urinary tract procedures w CC 2.1527 4.6 7.2
675 No No 11 SURG Other kidney urinary tract procedures w/o CC/MCC 1.3137 1.5 2.1
682 Yes No 11 MED Renal failure w MCC 1.6374 5.2 7.2
683 Yes No 11 MED Renal failure w CC 1.1270 4.5 5.7
684 Yes No 11 MED Renal failure w/o CC/MCC 0.7278 3.2 3.9
685 No No 11 MED Admit for renal dialysis 0.8578 2.5 3.5
686 No No 11 MED Kidney urinary tract neoplasms w MCC 1.6240 5.6 7.6
687 No No 11 MED Kidney urinary tract neoplasms w CC 1.0719 4.1 5.4
688 No No 11 MED Kidney urinary tract neoplasms w/o CC/MCC 0.6816 2.5 3.3
689 Yes No 11 MED Kidney urinary tract infections w MCC 1.2271 4.9 6.2
690 Yes No 11 MED Kidney urinary tract infections w/o MCC 0.7559 3.5 4.2
691 No No 11 MED Urinary stones w esw lithotripsy w CC/MCC 1.4503 2.9 4.0
692 No No 11 MED Urinary stones w esw lithotripsy w/o CC/MCC 1.1528 1.9 2.4
693 No No 11 MED Urinary stones w/o esw lithotripsy w MCC 1.1915 3.6 4.8
694 No No 11 MED Urinary stones w/o esw lithotripsy w/o MCC 0.6573 2.0 2.6
695 No No 11 MED Kidney urinary tract signs symptoms w MCC 1.1723 4.2 5.5
696 No No 11 MED Kidney urinary tract signs symptoms w/o MCC 0.6308 2.6 3.3
697 No No 11 MED Urethral stricture 0.6938 2.4 3.1
698 Yes No 11 MED Other kidney urinary tract diagnoses w MCC 1.4719 5.0 6.7
699 Yes No 11 MED Other kidney urinary tract diagnoses w CC 0.9700 3.7 4.8
700 Yes No 11 MED Other kidney urinary tract diagnoses w/o CC/MCC 0.6813 2.8 3.6
707 No No 12 SURG Major male pelvic procedures w CC/MCC 1.6265 3.4 4.4
708 No No 12 SURG Major male pelvic procedures w/o CC/MCC 1.1839 1.8 2.1
709 No No 12 SURG Penis procedures w CC/MCC 1.8803 3.8 6.5
710 No No 12 SURG Penis procedures w/o CC/MCC 1.2586 1.4 1.8
711 No No 12 SURG Testes procedures w CC/MCC 2.0318 5.5 8.2
712 No No 12 SURG Testes procedures w/o CC/MCC 0.8077 2.2 3.0
713 No No 12 SURG Transurethral prostatectomy w CC/MCC 1.1188 2.9 4.2
714 No No 12 SURG Transurethral prostatectomy w/o CC/MCC 0.6333 1.7 1.9
715 No No 12 SURG Other male reproductive system O.R. proc for malignancy w CC/MCC 1.7120 3.9 6.3
716 No No 12 SURG Other male reproductive system O.R. proc for malignancy w/o CC/MCC 0.9713 1.2 1.4
717 No No 12 SURG Other male reproductive system O.R. proc exc malignancy w CC/MCC 1.8091 5.1 7.2
718 No No 12 SURG Other male reproductive system O.R. proc exc malignancy w/o CC/MCC 0.7849 2.2 2.8
722 No No 12 MED Malignancy, male reproductive system w MCC 1.5588 5.7 7.6
723 No No 12 MED Malignancy, male reproductive system w CC 0.9901 4.1 5.3
724 No No 12 MED Malignancy, male reproductive system w/o CC/MCC 0.6006 2.4 3.2
725 No No 12 MED Benign prostatic hypertrophy w MCC 1.0462 4.2 5.5
726 No No 12 MED Benign prostatic hypertrophy w/o MCC 0.6675 2.7 3.5
727 No No 12 MED Inflammation of the male reproductive system w MCC 1.3016 5.0 6.4
728 No No 12 MED Inflammation of the male reproductive system w/o MCC 0.6911 3.3 4.0
729 No No 12 MED Other male reproductive system diagnoses w CC/MCC 1.0993 4.0 5.6
730 No No 12 MED Other male reproductive system diagnoses w/o CC/MCC 0.5963 2.4 3.1
734 No No 13 SURG Pelvic evisceration, rad hysterectomy rad vulvectomy w CC/MCC 2.3505 6.0 8.0
735 No No 13 SURG Pelvic evisceration, rad hysterectomy rad vulvectomy w/o CC/MCC 1.1311 2.9 3.4
736 No No 13 SURG Uterine adnexa proc for ovarian or adnexal malignancy w MCC 4.1736 11.2 13.8
737 No No 13 SURG Uterine adnexa proc for ovarian or adnexal malignancy w CC 1.9577 6.0 7.2
738 No No 13 SURG Uterine adnexa proc for ovarian or adnexal malignancy w/o CC/MCC 1.1577 3.5 3.9
739 No No 13 SURG Uterine, adnexa proc for non-ovarian/adnexal malig w MCC 3.0131 7.8 10.2
740 No No 13 SURG Uterine, adnexa proc for non-ovarian/adnexal malig w CC 1.4661 4.3 5.2
741 No No 13 SURG Uterine, adnexa proc for non-ovarian/adnexal malig w/o CC/MCC 1.0021 2.7 3.0
742 No No 13 SURG Uterine adnexa proc for non-malignancy w CC/MCC 1.3433 3.5 4.5
743 No No 13 SURG Uterine adnexa proc for non-malignancy w/o CC/MCC 0.8469 2.0 2.3
744 No No 13 SURG DC, conization, laparoscopy tubal interruption w CC/MCC 1.3918 4.1 5.8
745 No No 13 SURG DC, conization, laparoscopy tubal interruption w/o CC/MCC 0.7460 2.1 2.6
746 No No 13 SURG Vagina, cervix vulva procedures w CC/MCC 1.2662 3.0 4.2
747 No No 13 SURG Vagina, cervix vulva procedures w/o CC/MCC 0.8403 1.6 1.9
748 No No 13 SURG Female reproductive system reconstructive procedures 0.8193 1.5 1.7
749 No No 13 SURG Other female reproductive system O.R. procedures w CC/MCC 2.4919 6.7 9.3
750 No No 13 SURG Other female reproductive system O.R. procedures w/o CC/MCC 0.9660 2.5 3.1
754 No No 13 MED Malignancy, female reproductive system w MCC 1.7520 6.2 8.3
755 No No 13 MED Malignancy, female reproductive system w CC 1.0769 4.3 5.7
756 No No 13 MED Malignancy, female reproductive system w/o CC/MCC 0.6327 2.5 3.1
757 No No 13 MED Infections, female reproductive system w MCC 1.5775 6.5 8.1
758 No No 13 MED Infections, female reproductive system w CC 1.0621 4.9 6.1
759 No No 13 MED Infections, female reproductive system w/o CC/MCC 0.7646 3.6 4.5
760 No No 13 MED Menstrual other female reproductive system disorders w CC/MCC 0.7917 3.0 4.0
761 No No 13 MED Menstrual other female reproductive system disorders w/o CC/MCC 0.5008 1.9 2.4
765 No No 14 SURG Cesarean section w CC/MCC 1.0606 4.0 5.0
766 No No 14 SURG Cesarean section w/o CC/MCC 0.7486 3.0 3.2
767 No No 14 SURG Vaginal delivery w sterilization /or DC 0.9741 2.6 3.4
768 No No 14 SURG Vaginal delivery w O.R. proc except steril /or DC 1.7321 0.0 0.0
769 No No 14 SURG Postpartum post abortion diagnoses w O.R. procedure 1.2935 3.2 4.6
770 No No 14 SURG Abortion w DC, aspiration curettage or hysterotomy 0.6677 1.6 2.2
774 No No 14 MED Vaginal delivery w complicating diagnoses 0.6571 2.6 3.2
775 No No 14 MED Vaginal delivery w/o complicating diagnoses 0.4830 2.0 2.2
776 No No 14 MED Postpartum post abortion diagnoses w/o O.R. procedure 0.6192 2.5 3.3
777 No No 14 MED Ectopic pregnancy 0.7721 1.9 2.2
778 No No 14 MED Threatened abortion 0.4373 2.0 3.0
779 No No 14 MED Abortion w/o DC 0.4871 1.6 2.1
780 No No 14 MED False labor 0.1962 1.3 1.5
781 No No 14 MED Other antepartum diagnoses w medical complications 0.6154 2.6 3.8
782 No No 14 MED Other antepartum diagnoses w/o medical complications 0.3926 1.7 2.5
789 No No 15 MED Neonates, died or transferred to another acute care facility 1.4227 0.0 0.0
790 No No 15 MED Extreme immaturity or respiratory distress syndrome, neonate 4.6916 0.0 0.0
791 No No 15 MED Prematurity w major problems 3.2042 0.0 0.0
792 No No 15 MED Prematurity w/o major problems 1.9334 0.0 0.0
793 No No 15 MED Full term neonate w major problems 3.2914 0.0 0.0
794 No No 15 MED Neonate w other significant problems 1.1650 0.0 0.0
795 No No 15 MED Normal newborn 0.1577 0.0 0.0
799 No No 16 SURG Splenectomy w MCC 4.7602 10.8 14.1
800 No No 16 SURG Splenectomy w CC 2.5819 6.2 7.9
801 No No 16 SURG Splenectomy w/o CC/MCC 1.6484 3.8 4.9
802 No No 16 SURG Other O.R. proc of the blood blood forming organs w MCC 3.3539 8.9 12.2
803 No No 16 SURG Other O.R. proc of the blood blood forming organs w CC 1.7689 4.7 6.7
804 No No 16 SURG Other O.R. proc of the blood blood forming organs w/o CC/MCC 1.0613 2.5 3.4
808 No No 16 MED Major hematol/immun diag exc sickle cell crisis coagul w MCC 1.9850 6.3 8.2
809 No No 16 MED Major hematol/immun diag exc sickle cell crisis coagul w CC 1.1737 4.2 5.3
810 No No 16 MED Major hematol/immun diag exc sickle cell crisis coagul w/o CC/MCC 0.8957 3.2 4.0
811 No No 16 MED Red blood cell disorders w MCC 1.2742 4.0 5.7
812 No No 16 MED Red blood cell disorders w/o MCC 0.7629 2.8 3.7
813 No No 16 MED Coagulation disorders 1.3556 3.7 5.1
814 No No 16 MED Reticuloendothelial immunity disorders w MCC 1.4932 5.0 6.7
815 No No 16 MED Reticuloendothelial immunity disorders w CC 0.9973 3.8 5.0
816 No No 16 MED Reticuloendothelial immunity disorders w/o CC/MCC 0.6989 2.8 3.5
820 No No 17 SURG Lymphoma leukemia w major O.R. procedure w MCC 5.6401 13.3 17.7
821 No No 17 SURG Lymphoma leukemia w major O.R. procedure w CC 2.2489 5.5 7.9
822 No No 17 SURG Lymphoma leukemia w major O.R. procedure w/o CC/MCC 1.2399 2.6 3.5
823 No No 17 SURG Lymphoma non-acute leukemia w other O.R. proc w MCC 4.0990 12.1 15.4
824 No No 17 SURG Lymphoma non-acute leukemia w other O.R. proc w CC 2.1791 6.6 8.7
825 No No 17 SURG Lymphoma non-acute leukemia w other O.R. proc w/o CC/MCC 1.2059 3.0 4.3
826 No No 17 SURG Myeloprolif disord or poorly diff neopl w maj O.R. proc w MCC 4.6385 11.1 15.0
827 No No 17 SURG Myeloprolif disord or poorly diff neopl w maj O.R. proc w CC 2.2759 5.9 8.0
828 No No 17 SURG Myeloprolif disord or poorly diff neopl w maj O.R. proc w/o CC/MCC 1.3050 3.0 3.8
829 No No 17 SURG Myeloprolif disord or poorly diff neopl w other O.R. proc w CC/MCC 2.8972 7.0 10.7
830 No No 17 SURG Myeloprolif disord or poorly diff neopl w other O.R. proc w/o CC/MCC 1.0802 2.5 3.7
834 No No 17 MED Acute leukemia w/o major O.R. procedure w MCC 4.5854 9.5 15.5
835 No No 17 MED Acute leukemia w/o major O.R. procedure w CC 2.5840 6.2 10.4
836 No No 17 MED Acute leukemia w/o major O.R. procedure w/o CC/MCC 1.2085 3.4 5.2
837 No No 17 MED Chemo w acute leukemia as sdx or w high dose chemo agent w MCC 6.4047 17.6 23.1
838 No No 17 MED Chemo w acute leukemia as sdx w CC or high dose chemo agent 2.9669 7.9 12.3
839 No No 17 MED Chemo w acute leukemia as sdx w/o CC/MCC 1.4181 5.0 6.4
840 Yes No 17 MED Lymphoma non-acute leukemia w MCC 2.6031 7.7 10.4
841 Yes No 17 MED Lymphoma non-acute leukemia w CC 1.5529 5.2 6.9
842 Yes No 17 MED Lymphoma non-acute leukemia w/o CC/MCC 1.0261 3.4 4.6
843 No No 17 MED Other myeloprolif dis or poorly diff neopl diag w MCC 1.8203 6.1 8.5
844 No No 17 MED Other myeloprolif dis or poorly diff neopl diag w CC 1.2030 4.6 6.1
845 No No 17 MED Other myeloprolif dis or poorly diff neopl diag w/o CC/MCC 0.8143 3.3 4.3
846 No No 17 MED Chemotherapy w/o acute leukemia as secondary diagnosis w MCC 2.1299 5.8 8.4
847 No No 17 MED Chemotherapy w/o acute leukemia as secondary diagnosis w CC 0.9436 2.7 3.4
848 No No 17 MED Chemotherapy w/o acute leukemia as secondary diagnosis w/o CC/MCC 0.7995 2.5 3.1
849 No No 17 MED Radiotherapy 1.2021 4.4 6.0
853 Yes No 18 SURG Infectious parasitic diseases w O.R. procedure w MCC 5.4286 12.7 16.7
854 Yes No 18 SURG Infectious parasitic diseases w O.R. procedure w CC 2.9171 9.1 11.1
855 Yes No 18 SURG Infectious parasitic diseases w O.R. procedure w/o CC/MCC 1.8093 5.6 7.0
856 Yes No 18 SURG Postoperative or post-traumatic infections w O.R. proc w MCC 4.7315 11.5 15.4
857 Yes No 18 SURG Postoperative or post-traumatic infections w O.R. proc w CC 2.0472 6.6 8.5
858 Yes No 18 SURG Postoperative or post-traumatic infections w O.R. proc w/o CC/MCC 1.3563 4.5 5.7
862 Yes No 18 MED Postoperative post-traumatic infections w MCC 1.9123 6.1 8.2
863 Yes No 18 MED Postoperative post-traumatic infections w/o MCC 0.9575 4.2 5.2
864 No No 18 MED Fever of unknown origin 0.8224 3.2 4.1
865 No No 18 MED Viral illness w MCC 1.4950 4.7 6.7
866 No No 18 MED Viral illness w/o MCC 0.6673 2.8 3.5
867 Yes No 18 MED Other infectious parasitic diseases diagnoses w MCC 2.3423 7.0 9.6
868 Yes No 18 MED Other infectious parasitic diseases diagnoses w CC 1.0761 4.5 5.8
869 Yes No 18 MED Other infectious parasitic diseases diagnoses w/o CC/MCC 0.7628 3.5 4.3
870 Yes No 18 MED Septicemia or severe sepsis w MV 96+ hours 5.7422 12.9 15.5
871 Yes No 18 MED Septicemia or severe sepsis w/o MV 96+ hours w MCC 1.8211 5.5 7.5
872 Yes No 18 MED Septicemia or severe sepsis w/o MV 96+ hours w/o MCC 1.1188 4.7 5.7
876 No No 19 SURG O.R. procedure w principal diagnoses of mental illness 2.4279 7.8 11.9
880 No No 19 MED Acute adjustment reaction psychosocial dysfunction 0.5867 2.4 3.2
881 No No 19 MED Depressive neuroses 0.5784 3.1 4.2
882 No No 19 MED Neuroses except depressive 0.6086 3.1 4.4
883 No No 19 MED Disorders of personality impulse control 1.0102 4.4 7.4
884 Yes No 19 MED Organic disturbances mental retardation 0.8923 4.1 5.5
885 No No 19 MED Psychoses 0.8380 5.5 7.6
886 No No 19 MED Behavioral developmental disorders 0.7479 4.0 6.1
887 No No 19 MED Other mental disorder diagnoses 0.7275 3.0 4.6
894 No No 20 MED Alcohol/drug abuse or dependence, left ama 0.3842 2.1 3.0
895 No No 20 MED Alcohol/drug abuse or dependence w rehabilitation therapy 0.8727 8.1 10.5
896 Yes No 20 MED Alcohol/drug abuse or dependence w/o rehabilitation therapy w MCC 1.3787 4.8 6.6
897 Yes No 20 MED Alcohol/drug abuse or dependence w/o rehabilitation therapy w/o MCC 0.6152 3.3 4.1
901 No No 21 SURG Wound debridements for injuries w MCC 3.8708 9.9 15.1
902 No No 21 SURG Wound debridements for injuries w CC 1.6889 5.5 7.7
903 No No 21 SURG Wound debridements for injuries w/o CC/MCC 0.9976 3.4 4.6
904 No No 21 SURG Skin grafts for injuries w CC/MCC 2.9204 7.0 11.2
905 No No 21 SURG Skin grafts for injuries w/o CC/MCC 1.1156 3.4 4.7
906 No No 21 SURG Hand procedures for injuries 0.9941 2.1 3.1
907 Yes No 21 SURG Other O.R. procedures for injuries w MCC 3.6871 8.0 11.6
908 Yes No 21 SURG Other O.R. procedures for injuries w CC 1.9162 4.9 6.8
909 Yes No 21 SURG Other O.R. procedures for injuries w/o CC/MCC 1.1372 2.7 3.6
913 No No 21 MED Traumatic injury w MCC 1.2246 4.2 5.7
914 No No 21 MED Traumatic injury w/o MCC 0.6625 2.7 3.4
915 No No 21 MED Allergic reactions w MCC 1.2354 3.3 4.7
916 No No 21 MED Allergic reactions w/o MCC 0.4409 1.7 2.1
917 Yes No 21 MED Poisoning toxic effects of drugs w MCC 1.4143 3.7 5.2
918 Yes No 21 MED Poisoning toxic effects of drugs w/o MCC 0.5809 2.1 2.7
919 No No 21 MED Complications of treatment w MCC 1.5200 4.5 6.4
920 No No 21 MED Complications of treatment w CC 0.9220 3.3 4.4
921 No No 21 MED Complications of treatment w/o CC/MCC 0.6097 2.3 3.0
922 No No 21 MED Other injury, poisoning toxic effect diag w MCC 1.3580 4.1 6.0
923 No No 21 MED Other injury, poisoning toxic effect diag w/o MCC 0.6142 2.4 3.2
927 No No 22 SURG Extensive burns or full thickness burns w MV 96+ hrs w skin graft 14.0060 23.4 31.1
928 No No 22 SURG Full thickness burn w skin graft or inhal inj w CC/MCC 5.0621 11.7 16.0
929 No No 22 SURG Full thickness burn w skin graft or inhal inj w/o CC/MCC 2.1574 5.3 7.7
933 No No 22 MED Extensive burns or full thickness burns w MV 96+ hrs w/o skin graft 2.1246 2.3 4.3
934 No No 22 MED Full thickness burn w/o skin grft or inhal inj 1.2949 4.4 6.2
935 No No 22 MED Non-extensive burns 1.2209 3.6 5.4
939 No No 23 SURG O.R. proc w diagnoses of other contact w health services w MCC 2.6570 6.6 10.1
940 No No 23 SURG O.R. proc w diagnoses of other contact w health services w CC 1.6379 3.6 5.4
941 No No 23 SURG O.R. proc w diagnoses of other contact w health services w/o CC/MCC 1.0782 2.1 2.7
945 Yes No 23 MED Rehabilitation w CC/MCC 1.2869 8.6 10.5
946 Yes No 23 MED Rehabilitation w/o CC/MCC 1.0861 6.9 7.9
947 Yes No 23 MED Signs symptoms w MCC 1.0525 3.8 5.0
948 Yes No 23 MED Signs symptoms w/o MCC 0.6473 2.8 3.5
949 No No 23 MED Aftercare w CC/MCC 0.7925 2.6 4.1
950 No No 23 MED Aftercare w/o CC/MCC 0.5548 2.4 3.5
951 No No 23 MED Other factors influencing health status 0.7442 2.2 4.7
955 No No 24 SURG Craniotomy for multiple significant trauma 5.0969 8.6 12.3
956 Yes No 24 SURG Limb reattachment, hip femur proc for multiple significant trauma 3.5263 7.6 9.3
957 No No 24 SURG Other O.R. procedures for multiple significant trauma w MCC 6.0787 10.2 14.9
958 No No 24 SURG Other O.R. procedures for multiple significant trauma w CC 3.6129 8.0 10.4
959 No No 24 SURG Other O.R. procedures for multiple significant trauma w/o CC/MCC 2.3808 4.9 6.3
963 No No 24 MED Other multiple significant trauma w MCC 2.8713 6.7 9.5
964 No No 24 MED Other multiple significant trauma w CC 1.6024 4.9 6.2
965 No No 24 MED Other multiple significant trauma w/o CC/MCC 0.9832 3.4 4.1
969 No No 25 SURG HIV w extensive O.R. procedure w MCC 5.3749 12.9 18.8
970 No No 25 SURG HIV w extensive O.R. procedure w/o MCC 2.4892 6.5 9.8
974 No No 25 MED HIV w major related condition w MCC 2.5595 7.3 10.4
975 No No 25 MED HIV w major related condition w CC 1.3571 5.3 7.0
976 No No 25 MED HIV w major related condition w/o CC/MCC 0.8910 3.8 4.9
977 No No 25 MED HIV w or w/o other related condition 1.0965 3.9 5.3
981 Yes No SURG Extensive O.R. procedure unrelated to principal diagnosis w MCC 5.0175 11.7 15.1
982 Yes No SURG Extensive O.R. procedure unrelated to principal diagnosis w CC 3.0780 7.5 9.7
983 Yes No SURG Extensive O.R. procedure unrelated to principal diagnosis w/o CC/MCC 1.9959 3.9 5.4
984 No No SURG Prostatic O.R. procedure unrelated to principal diagnosis w MCC 3.3256 11.8 14.6
985 No No SURG Prostatic O.R. procedure unrelated to principal diagnosis w CC 2.2113 7.3 9.7
986 No No SURG Prostatic O.R. procedure unrelated to principal diagnosis w/o CC/MCC 1.2767 3.5 5.3
987 Yes No SURG Non-extensive O.R. proc unrelated to principal diagnosis w MCC 3.4336 9.8 13.0
988 Yes No SURG Non-extensive O.R. proc unrelated to principal diagnosis w CC 1.8752 5.8 7.8
989 Yes No SURG Non-extensive O.R. proc unrelated to principal diagnosis w/o CC/MCC 1.1032 2.9 4.1
998 No No ** Principal diagnosis invalid as discharge diagnosis 0.0000 0.0 0.0
999 No No ** Ungroupable 0.0000 0.0 0.0
MS-DRGs 998 and 999 contain cases that could not be assigned to valid DRGs.
Note: If there is no value in either the geometric mean length of stay or the arithmetic mean length of stay columns, the volume of cases is insufficient to obtain a meaningful computation of these statistics.

Diagnosis code Description CC MDC MS-DRG
046.11 Variant Creutzfeldt-Jakob disease CC 01 056, 057
046.19 Other and unspecified Creutzfeldt-Jakob disease CC 01 056, 057
046.71 Gerstmann-Sträussler-Scheinker syndrome CC 01 056, 057
25 974, 975, 976
046.72 Fatal familial insomnia CC 01 056, 057
25 974, 975, 976
046.79 Other and unspecified prion disease of central nervous system CC 01 056, 057
25 974, 975, 976
051.01 Cowpox N 18 865, 866
051.02 Vaccinia not from vaccination N 18 865, 866
059.00 Orthopoxvirus infection, unspecified N 18 865, 866
059.01 Monkeypox CC 18 865, 866
059.09 Other orthopoxvirus infections N 18 865, 866
059.10 Parapoxvirus infection, unspecified N 18 865, 866
059.11 Bovine stomatitis N 18 865, 866
059.12 Sealpox N 18 865, 866
059.19 Other parapoxvirus infections N 18 865, 866
059.21 Tanapox CC 18 865, 866
059.22 Yaba monkey tumor virus N 18 865, 866
059.29 Yatapoxvirus infection, unspecified N 18 865, 866
059.8 Other poxvirus infections N 18 865, 866
059.9 Poxvirus infections, unspecified N 18 865, 866
078.12 Plantar wart N 09 606, 607
136.21 Specific infection due to acanthamoeba N 18 867, 868, 869
136.29 Other specific infections by free-living amebae CC 18 867, 868, 869
199.2 Malignant neoplasm associated with transplant organ CC 17 843, 844, 845
203.02 Multiple myeloma, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
203.12 Plasma cell leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
203.82 Other immunoproliferative neoplasms, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
204.02 Acute lymphoid leukemia, in relapse CC 17 820, 821, 822, 834, 835, 836, 8371 , 8381 , 8391
204.12 Chronic lymphoid leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
204.22 Subacute lymphoid leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
204.82 Other lymphoid leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
204.92 Unspecified lymphoid leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
205.02 Acute myeloid leukemia, in relapse CC 17 820, 821, 822, 834, 835, 836, 8371 , 8381 , 8391
205.12 Chronic myeloid leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
205.22 Subacute myeloid leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
205.32 Myeloid sarcoma, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
205.82 Other myeloid leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
205.92 Unspecified myeloid leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
206.02 Acute monocytic leukemia, in relapse CC 17 820, 821, 822, 834, 835, 836, 8371 , 8381 , 8391
206.12 Chronic monocytic leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
206.22 Subacute monocytic leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
206.82 Other monocytic leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
206.92 Unspecified monocytic leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
207.02 Acute erythremia and erythroleukemia, in relapse CC 17 820, 821, 822, 834, 835, 836, 8371 , 8381 , 8391
207.12 Chronic erythremia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
207.22 Megakaryocytic leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
207.82 Other specified leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
208.02 Acute leukemia of unspecified cell type, in relapse CC 17 820, 821, 822, 834, 835, 836, 8371 , 8381 , 8391
208.12 Chronic leukemia of unspecified cell type, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
208.22 Subacute leukemia of unspecified cell type, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
208.82 Other leukemia of unspecified cell type, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
208.92 Unspecified leukemia, in relapse CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
209.00 Malignant carcinoid tumor of the small intestine, unspecified portion CC 06 374, 375, 376
209.01 Malignant carcinoid tumor of the duodenum CC 06 374, 375, 376
209.02 Malignant carcinoid tumor of the jejunum CC 06 374, 375, 376
209.03 Malignant carcinoid tumor of the ileum CC 06 374, 375, 376
209.10 Malignant carcinoid tumor of the large intestine, unspecified portion CC 06 374, 375, 376
209.11 Malignant carcinoid tumor of the appendix CC 06 338, 339, 340, 374, 375, 376
209.12 Malignant carcinoid tumor of the cecum CC 06 374, 375, 376
209.13 Malignant carcinoid tumor of the ascending colon CC 06 374, 375, 376
209.14 Malignant carcinoid tumor of the transverse colon CC 06 374, 375, 376
209.15 Malignant carcinoid tumor of the descending colon CC 06 374, 375, 376
209.16 Malignant carcinoid tumor of the sigmoid colon CC 06 374, 375, 376
209.17 Malignant carcinoid tumor of the rectum CC 06 374, 375, 376
209.20 Malignant carcinoid tumor of unknown primary site CC 17 843, 844, 845
209.21 Malignant carcinoid tumor of the bronchus and lung CC 04 180, 181, 182
209.22 Malignant carcinoid tumor of the thymus CC 17 843, 844, 845
209.23 Malignant carcinoid tumor of the stomach CC 06 374, 375, 376
209.24 Malignant carcinoid tumor of the kidney CC 11 656, 657, 658, 686, 687, 688
209.25 Malignant carcinoid tumor of foregut, not otherwise specified CC 06 374, 375, 376
209.26 Malignant carcinoid tumor of midgut, not otherwise specified CC 06 374, 375, 376
209.27 Malignant carcinoid tumor of hindgut, not otherwise specified CC 06 374, 375, 376
209.29 Malignant carcinoid tumor of other sites CC 17 843, 844, 845
209.30 Malignant poorly differentiated neuroendocrine carcinoma, any site CC 17 843, 844, 845
209.40 Benign carcinoid tumor of the small intestine, unspecified portion N 06 393, 394, 395
209.41 Benign carcinoid tumor of the duodenum N 06 393, 394, 395
209.42 Benign carcinoid tumor of the jejunum N 06 393, 394, 395
209.43 Benign carcinoid tumor of the ileum N 06 393, 394, 395
209.50 Benign carcinoid tumor of the large intestine, unspecified portion N 06 393, 394, 395
209.51 Benign carcinoid tumor of the appendix N 06 393, 394, 395
209.52 Benign carcinoid tumor of the cecum N 06 393, 394, 395
209.53 Benign carcinoid tumor of the ascending colon N 06 393, 394, 395
209.54 Benign carcinoid tumor of the transverse colon N 06 393, 394, 395
209.55 Benign carcinoid tumor of the descending colon N 06 393, 394, 395
209.56 Benign carcinoid tumor of the sigmoid colon N 06 393, 394, 395
209.57 Benign carcinoid tumor of the rectum N 06 393, 394, 395
209.60 Benign carcinoid tumor of unknown primary site N 17 843, 844, 845
209.61 Benign carcinoid tumor of the bronchus and lung N 04 180, 181, 182
209.62 Benign carcinoid tumor of the thymus N 16 814, 815, 816
209.63 Benign carcinoid tumor of the stomach N 06 393, 394, 395
209.64 Benign carcinoid tumor of the kidney N 11 656, 657, 658, 686, 687, 688
209.65 Benign carcinoid tumor of foregut, not otherwise specified N 06 393, 394, 395
209.66 Benign carcinoid tumor of midgut, not otherwise specified N 06 393, 394, 395
209.67 Benign carcinoid tumor of hindgut, not otherwise specified N 06 393, 394, 395
209.69 Benign carcinoid tumor of other sites N 17 843, 844, 845
238.77 Post-transplant lymphoproliferative disorder (PTLD) CC 21 919, 920, 921
249.00 Secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified N PRE 10 008, 010 637, 638, 639
249.01 Secondary diabetes mellitus without mention of complication, uncontrolled N PRE 10 008, 010 637, 638, 639
249.10 Secondary diabetes mellitus with ketoacidosis, not stated as uncontrolled, or unspecified MCC PRE 10 008, 010 637, 638, 639
249.11 Secondary diabetes mellitus with ketoacidosis, uncontrolled MCC PRE 10 008, 010 637, 638, 639,
249.20 Secondary diabetes mellitus with hyperosmolarity, not stated as uncontrolled, or unspecified MCC PRE 10 008, 010 637, 638, 639
249.21 Secondary diabetes mellitus with hyperosmolarity, uncontrolled MCC PRE 10 008, 010 637, 638, 639
249.30 Secondary diabetes mellitus with other coma, not stated as uncontrolled, or unspecified MCC PRE 10 008, 010 637, 638, 639
249.31 Secondary diabetes mellitus with other coma, uncontrolled MCC PRE 10 008, 010 637, 638, 639
249.40 Secondary diabetes mellitus with renal manifestations, not stated as uncontrolled, or unspecified N PRE 11 008, 010 698, 699, 700
249.41 Secondary diabetes mellitus with renal manifestations, uncontrolled N PRE 11 008, 010 698, 699, 700
249.50 Secondary diabetes mellitus with ophthalmic manifestations, not stated as uncontrolled, or unspecified N PRE 02 008, 010 124, 125
249.51 Secondary diabetes mellitus with ophthalmic manifestations, uncontrolled N PRE 02 008, 010 124, 125
249.60 Secondary diabetes mellitus with neurological manifestations, not stated as uncontrolled, or unspecified N PRE 01 008, 010 073, 074
249.61 Secondary diabetes mellitus with neurological manifestations, uncontrolled N PRE 01 008, 010 073, 074
249.70 Secondary diabetes mellitus with peripheral circulatory disorders, not stated as uncontrolled, or unspecified N PRE 05 008, 010 299, 300, 301
249.71 Secondary diabetes mellitus with peripheral circulatory disorders, uncontrolled N PRE 05 008, 010 299, 300, 301
249.80 Secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified N PRE 10 008, 010 637, 638, 639
249.81 Secondary diabetes mellitus with other specified manifestations, uncontrolled N PRE 10 008, 010 637, 638, 639
249.90 Secondary diabetes mellitus with unspecified complication, not stated as uncontrolled, or unspecified N PRE 10 008, 010 637, 638, 639
249.91 Secondary diabetes mellitus with unspecified complication, uncontrolled N PRE 10 008, 010 637, 638, 639
259.50 Androgen insensitivity, unspecified N 10 643, 644, 645
259.51 Androgen insensitivity syndrome N 10 643, 644, 645
259.52 Partial androgen insensitivity N 10 643, 644, 645
275.5 Hungry bone syndrome N 10 640, 641
279.50 Graft-versus-host disease, unspecified CC 16 808, 809, 810
279.51 Acute graft-versus-host disease CC 16 808, 809, 810
279.52 Chronic graft-versus-host disease CC 16 808, 809, 810
279.53 Acute on chronic graft-versus-host disease CC 16 808, 809, 810
289.84 Heparin-induced thrombocytopenia (HIT) N 15 7912 , 7932
16 813
25 977
337.00 Idiopathic peripheral autonomic neuropathy, unspecified N 01 073, 074
337.01 Carotid sinus syndrome N 01 073, 074
337.09 Other idiopathic peripheral autonomic neuropathy N 01 073, 074
339.00 Cluster headache syndrome, unspecified N 01 102, 103
339.01 Episodic cluster headache N 01 102, 103
339.02 Chronic cluster headache N 01 102, 103
339.03 Episodic paroxysmal hemicrania N 01 102, 103
339.04 Chronic paroxysmal hemicrania N 01 102, 103
339.05 Short lasting unilateral neuralgiform headache with conjunctival injection and tearing N 01 102, 103
339.09 Other trigeminal autonomic cephalgias N 01 102, 103
339.10 Tension type headache, unspecified N 01 102, 103
339.11 Episodic tension type headache N 01 102, 103
339.12 Chronic tension type headache N 01 102, 103
339.20 Post-traumatic headache, unspecified N 01 102, 103
339.21 Acute post-traumatic headache N 01 102, 103
339.22 Chronic post-traumatic headache N 01 102, 103
339.3 Drug induced headache, not elsewhere classified N 01 102, 103
339.41 Hemicrania continua N 01 102, 103
339.42 New daily persistent headache N 01 102, 103
339.43 Primary thunderclap headache N 01 102, 103
339.44 Other complicated headache syndrome N 01 102, 103
339.81 Hypnic headache N 01 102, 103
339.82 Headache associated with sexual activity N 01 102, 103
339.83 Primary cough headache N 01 102, 103
339.84 Primary exertional headache N 01 102, 103
339.85 Primary stabbing headache N 01 102, 103
339.89 Other headache syndromes N 01 102, 103
346.02 Migraine with aura, without mention of intractable migraine with status migrainosus N 01 102, 103
346.03 Migraine with aura, with intractable migraine, so stated, with status migrainosus N 01 102, 103
346.12 Migraine without aura, without mention of intractable migraine with status migrainosus N 01 102, 103
346.13 Migraine without aura, with intractable migraine, so stated, with status migrainosus N 01 102, 103
346.22 Variants of migraine, not elsewhere classified, without mention of intractable migraine with status migrainosus N 01 102, 103
346.23 Variants of migraine, not elsewhere classified, with intractable migraine, so stated, with status migrainosus N 01 102, 103
346.30 Hemiplegic migraine, without mention of intractable migraine without mention of status migrainosus N 01 102, 103
346.31 Hemiplegic migraine, with intractable migraine, so stated, without mention of status migrainosus N 01 102, 103
346.32 Hemiplegic migraine, without mention of intractable migraine with status migrainosus N 01 102, 103
346.33 Hemiplegic migraine, with intractable migraine, so stated, with status migrainosus N 01 102, 103
346.40 Menstrual migraine, without mention of intractable migraine without mention of status migrainosus N 01 102, 103
346.41 Menstrual migraine, with intractable migraine, so stated, without mention of status migrainosus N 01 102, 103
346.42 Menstrual migraine, without mention of intractable migraine with status migrainosus N 01 102, 103
346.43 Menstrual migraine, with intractable migraine, so stated, with status migrainosus N 01 102, 103
346.50 Persistent migraine aura without cerebral infarction, without mention of intractable migraine without mention of status migrainosus N 01 102, 103
346.51 Persistent migraine aura without cerebral infarction, with intractable migraine, so stated, without mention of status migrainosus N 01 102, 103
346.52 Persistent migraine aura without cerebral infarction, without mention of intractable migraine with status migrainosus N 01 102, 103
346.53 Persistent migraine aura without cerebral infarction, with intractable migraine, so stated, with status migrainosus N 01 102, 103
346.60 Persistent migraine aura with cerebral infarction, without mention of intractable migraine without mention of status migrainosus CC 01 102, 103
346.61 Persistent migraine aura with cerebral infarction, with intractable migraine, so stated, without mention of status migrainosus CC 01 102, 103
346.62 Persistent migraine aura with cerebral infarction, without mention of intractable migraine with status migrainosus CC 01 102, 103
346.63 Persistent migraine aura with cerebral infarction, with intractable migraine, so stated, with status migrainosus CC 01 102, 103
346.70 Chronic migraine without aura, without mention of intractable migraine without mention of status migrainosus N 01 102, 103
346.71 Chronic migraine without aura, with intractable migraine, so stated, without mention of status migrainosus N 01 102, 103
346.72 Chronic migraine without aura, without mention of intractable migraine with status migrainosus N 01 102, 103
346.73 Chronic migraine without aura, with intractable migraine, so stated, with status migrainosus N 01 102, 103
346.82 Other forms of migraine, without mention of intractable migraine with status migrainosus N 01 102, 103
346.83 Other forms of migraine, with intractable migraine, so stated, with status migrainosus N 01 102, 103
362.20 Retinopathy of prematurity, unspecified N 02 124, 125
362.22 Retinopathy of prematurity, stage 0 N 02 124, 125
362.23 Retinopathy of prematurity, stage 1 N 02 124, 125
362.24 Retinopathy of prematurity, stage 2 N 02 124, 125
362.25 Retinopathy of prematurity, stage 3 N 02 124, 125
362.26 Retinopathy of prematurity, stage 4 N 02 124, 125
362.27 Retinopathy of prematurity, stage 5 N 02 124, 125
364.82 Plateau iris syndrome N 02 124, 125
372.34 Pingueculitis N 02 124, 125
414.3 Coronary atherosclerosis due to lipid rich plaque N 05 302, 303
511.81 Malignant pleural effusion CC 04 180, 181, 182
511.89 Other specified forms of effusion, except tuberculous CC 04 186, 187, 188
15 7912 , 7932
569.44 Dysplasia of anus N 06 393, 394, 395
571.42 Autoimmune hepatitis N 07 441, 442, 443
599.70 Hematuria, unspecified N 11 695, 696
15 7912 , 7932
599.71 Gross hematuria N 11 695, 696
15 7912 , 7932
599.72 Microscopic hematuria N 11 695, 696
15 7912 , 7932
611.81 Ptosis of breast N 09 600, 601
611.82 Hypoplasia of breast N 09 600, 601
611.83 Capsular contracture of breast implant N 09 600, 601
611.89 Other specified disorders of breast N 09 600, 601
612.0 Deformity of reconstructed breast N 09 600, 601
612.1 Disproportion of reconstructed breast N 09 600, 601
625.70 Vulvodynia, unspecified N 13 742, 743, 760, 761
625.71 Vulvar vestibulitis N 13 742, 743, 757, 758, 759
625.79 Other vulvodynia N 13 742, 743, 760, 761
649.70 Cervical shortening, unspecified as to episode of care or not applicable CC 14 998
649.71 Cervical shortening, delivered, with or without mention of antepartum condition CC 14 765, 766, 767, 768, 774, 775
649.73 Cervical shortening, antepartum condition or complication CC 14 781, 782
678.00 Fetal hematologic conditions, unspecified as to episode of care or not applicable N 14 998
678.01 Fetal hematologic conditions, delivered, with or without mention of antepartum condition N 14 765, 766, 767, 768, 774, 775
678.03 Fetal hematologic conditions, antepartum condition or complication N 14 781, 782
678.10 Fetal conjoined twins, unspecified as to episode of care or not applicable N 14 998
678.11 Fetal conjoined twins, delivered, with or without mention of antepartum condition N 14 765, 766, 767, 768, 774, 775
678.13 Fetal conjoined twins, antepartum condition or complication N 14 781, 782
679.00 Maternal complications from in utero procedure, unspecified as to episode of care or not applicable N 14 765, 766, 767, 768, 774, 775
679.01 Maternal complications from in utero procedure, delivered, with or without mention of antepartum condition N 14 765, 766, 767, 768, 774
679.02 Maternal complications from in utero procedure, delivered, with mention of postpartum complication N 14 765, 766, 767, 768, 774
679.03 Maternal complications from in utero procedure, antepartum condition or complication N 14 781, 782
679.04 Maternal complications from in utero procedure, postpartum condition or complication N 14 769, 776
679.10 Fetal complications from in utero procedures, unspecified as to episode of care or not applicable N 14 998
679.11 Fetal complications from in utero procedures, delivered, with or without mention of antepartum condition N 14 765, 766, 767, 768, 774, 775
679.12 Fetal complications from in utero procedures, delivered, with mention of postpartum complication N 14 765, 766, 767, 768, 774, 775
679.13 Fetal complications from in utero procedures, antepartum condition or complication N 14 781, 782
679.14 Fetal complications from in utero procedures, postpartum condition or complication N 14 769, 776
695.10 Erythema multiforme, unspecified N 09 595, 596
695.11 Erythema multiforme minor N 09 595, 596
695.12 Erythema multiforme major CC 09 595, 596
695.13 Stevens-Johnson syndrome CC 09 595, 596
695.14 Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome CC 09 595, 596
695.15 Toxic epidermal necrolysis CC 09 595, 596
695.19 Other erythema multiforme N 09 595, 596
695.50 Exfoliation due to erythematous condition involving less than 10 percent of body surface N 09 606, 607
695.51 Exfoliation due to erythematous condition involving 10-19 percent of body surface N 09 606, 607
695.52 Exfoliation due to erythematous condition involving 20-29 percent of body surface N 09 606, 607
695.53 Exfoliation due to erythematous condition involving 30-39 percent of body surface CC 09 606, 607
695.54 Exfoliation due to erythematous condition involving 40-49 percent of body surface CC 09 606, 607
695.55 Exfoliation due to erythematous condition involving 50-59 percent of body surface CC 09 606, 607
695.56 Exfoliation due to erythematous condition involving 60-69 percent of body surface CC 09 606, 607
695.57 Exfoliation due to erythematous condition involving 70-79 percent of body surface CC 09 606, 607
695.58 Exfoliation due to erythematous condition involving 80-89 percent of body surface CC 09 606, 607
695.59 Exfoliation due to erythematous condition involving 90 percent or more of body surface CC 09 606, 607
707.20 Pressure ulcer, unspecified stage N 09 573, 574, 575, 592, 593, 594
707.21 Pressure ulcer, stage I N 09 573, 574, 575, 592, 593, 594
707.22 Pressure ulcer, stage II N 09 573, 574, 575, 592, 593, 594
707.23 Pressure ulcer, stage III MCC3 09 573, 574, 575, 592, 593, 594
707.24 Pressure ulcer, stage IV MCC3 09 573, 574, 575, 592, 593, 594
729.90 Disorders of soft tissue, unspecified N 08 555, 556
729.91 Post-traumatic seroma N 08 555, 556
729.92 Nontraumatic hematoma of soft tissue N 08 555, 556
729.99 Other disorders of soft tissue N 08 555, 556
760.61 Newborn affected by amniocentesis N 15 794
760.62 Newborn affected by other in utero procedure N 15 794
760.63 Newborn affected by other surgical operations on mother during pregnancy N 15 794
760.64 Newborn affected by previous surgical procedure on mother not associated with pregnancy N 15 794
777.50 Necrotizing enterocolitis in newborn, unspecified MCC 15 7914 , 7934
777.51 Stage I necrotizing enterocolitis in newborn MCC 15 7914 , 7934
777.52 Stage II necrotizing enterocolitis in newborn MCC 15 7914 , 7934
777.53 Stage III necrotizing enterocolitis in newborn MCC 15 7914 , 7934
780.72 Functional quadriplegia MCC 01 052, 053
788.91 Functional urinary incontinence N 11 695, 696
788.99 Other symptoms involving urinary system N 11 695, 696
795.07 Satisfactory cervical smear but lacking transformation zone N 13 742, 743, 760, 761
795.10 Abnormal glandular Papanicolaou smear of vagina N 13 742, 743, 760, 761
795.11 Papanicolaou smear of vagina with atypical squamous cells of undetermined significance (ASC-US) N 13 742, 743, 760, 761
795.12 Papanicolaou smear of vagina with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H) N 13 742, 743, 760, 761
795.13 Papanicolaou smear of vagina with low grade squamous intraepithelial lesion (LGSIL) N 13 742, 743, 760, 761
795.14 Papanicolaou smear of vagina with high grade squamous intraepithelial lesion (HGSIL) N 13 742, 743, 760, 761
795.15 Vaginal high risk human papillomavirus (HPV) DNA test positive N 13 742, 743, 760, 761
795.16 Papanicolaou smear of vagina with cytologic evidence of malignancy N 13 742, 743, 760, 761
795.18 Unsatisfactory vaginal cytology smear N 13 742, 743, 760, 761
795.19 Other abnormal Papanicolaou smear of vagina and vaginal HPV N 13 742, 743, 760, 761
796.70 Abnormal glandular Papanicolaou smear of anus N 06 393, 394, 395
796.71 Papanicolaou smear of anus with atypical squamous cells of undetermined significance (ASC-US) N 06 393, 394, 395
796.72 Papanicolaou smear of anus with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H) N 06 393, 394, 395
796.73 Papanicolaou smear of anus with low grade squamous intraepithelial lesion (LGSIL) N 06 393, 394, 395
796.74 Papanicolaou smear of anus with high grade squamous intraepithelial lesion (HGSIL) N 06 393, 394, 395
796.75 Anal high risk human papillomavirus (HPV) DNA test positive N 06 393, 394, 395
796.76 Papanicolaou smear of anus with cytologic evidence of malignancy N 06 393, 394, 395
796.77 Satisfactory anal smear but lacking transformation zone N 06 393, 394, 395
796.78 Unsatisfactory anal cytology smear N 06 393, 394, 395
796.79 Other abnormal Papanicolaou smear of anus and anal HPV N 06 393, 394, 395
997.31 Ventilator associated pneumonia CC 04 205, 206
15 7912 , 7932
997.39 Other respiratory complications CC 04 205, 206
15 7912 , 7932
998.30 Disruption of wound, unspecified CC 21 919, 920, 921
998.33 Disruption of traumatic wound repair CC 21 919, 920, 921
999.81 Extravasation of vesicant chemotherapy CC 05 314, 315, 316
15 7912 , 7932
999.82 Extravasation of other vesicant agent CC 05 314, 315, 316
15 7912 , 7932
999.88 Other infusion reaction N 05 314, 315, 316
15 7912 , 7932
999.89 Other transfusion reaction N 15 7912 , 7932
16 811, 812
V07.51 Prophylactic use of selective estrogen receptor modulators (SERMs) N 23 951
V07.52 Prophylactic use of aromatase inhibitors N 23 951
V07.59 Prophylactic use of other agents affecting estrogen receptors and estrogen levels N 23 951
V13.51 Personal history of pathologic fracture N 23 951
V13.52 Personal history of stress fracture N 23 951
V13.59 Personal history of other musculoskeletal disorders N 23 951
V15.21 Personal history of undergoing in utero procedure during pregnancy N 23 951
V15.22 Personal history of undergoing in utero procedure while a fetus N 23 951
V15.29 Personal history of surgery to other organs N 23 951
V15.51 Personal history of traumatic fracture N 23 951
V15.59 Personal history of other injury N 23 951
V23.85 Pregnancy resulting from assisted reproductive technology N 14 998
V23.86 Pregnancy with history of in utero procedure during previous pregnancy N 14 998
V28.81 Encounter for fetal anatomic survey N 23 951
V28.82 Encounter for screening for risk of pre-term labor N 23 951
V28.89 Other specified antenatal screening N 23 951
V45.11 Renal dialysis status N 23 951
V45.12 Noncompliance with renal dialysis N 23 951
V45.87 Transplanted organ removal status N 23 951
V46.3 Wheelchair dependence N 23 951
V51.0 Encounter for breast reconstruction following mastectomy N 09 606, 607
V51.8 Other aftercare involving the use of plastic surgery N 09 606, 607
V87.01 Contact with and (suspected) exposure to arsenic N 23 951
V87.09 Contact with and (suspected) exposure to other hazardous metals N 23 951
V87.11 Contact with and (suspected) exposure to aromatic amines N 23 951
V87.12 Contact with and (suspected) exposure to benzene N 23 951
V87.19 Contact with and (suspected) exposure to other hazardous aromatic compounds N 23 951
V87.2 Contact with and (suspected) exposure to other potentially hazardous chemicals N 23 951
V87.31 Contact with and (suspected) exposure to mold N 23 951
V87.39 Contact with and (suspected) exposure to other potentially hazardous substances N 23 951
V87.41 Personal history of antineoplastic chemotherapy N 23 949, 950
V87.42 Personal history of monoclonal drug therapy N 23 949, 950
V87.49 Personal history of other drug therapy N 23 949, 950
V88.01 Acquired absence of both cervix and uterus N 13 742, 743, 760, 761
V88.02 Acquired absence of uterus with remaining cervical stump N 13 742, 743, 760, 761
V88.03 Acquired absence of cervix with remaining uterus N 13 742, 743, 760, 761
V89.01 Suspected problem with amniotic cavity and membrane not found N 23 951
V89.02 Suspected placental problem not found N 23 951
V89.03 Suspected fetal anomaly not found N 23 951
V89.04 Suspected problem with fetal growth not found N 23 951
V89.05 Suspected cervical shortening not found N 23 951
V89.09 Other suspected maternal and fetal condition not found N 23 951
1 Secondary diagnosis of acute leukemia
2 Secondary diagnosis of major problem.
3 The pressure ulcer site specific codes (707.00-707.09) will be non-CCs. The pressure ulcer stage III and IV codes will be classified as MCCs.
4 Principal or secondary diagnosis of major problem.

Procedure code Description O.R. MDC MS-DRG
00.49 SuperSaturated oxygen therapy N.
00.58 Insertion of intra-aneurysm sac pressure monitoring device (intraoperative) N.
00.59 Intravascular pressure measurement of coronary arteries N.
00.67 Intravascular pressure measurement of intrathoracic arteries N.
00.68 Intravascular pressure measurement of peripheral arteries N.
00.69 Intravascular pressure measurement, other specified and unspecified vessels N.
17.11 Laparoscopic repair of direct inguinal hernia with graft or prosthesis Y 06 350, 351, 352
17.12 Laparoscopic repair of indirect inguinal hernia with graft or prosthesis Y 06 350, 351, 352
17.13 Laparoscopic repair of inguinal hernia with graft or prosthesis, not otherwise specified Y 06 350, 351, 352
17.21 Laparoscopic bilateral repair of direct inguinal hernia with graft or prosthesis Y 06 350, 351, 352
17.22 Laparoscopic bilateral repair of indirect inguinal hernia with graft or prosthesis Y 06 350, 351, 352
17.23 Laparoscopic bilateral repair of inguinal hernia, one direct and one indirect, with graft or prosthesis Y 06 350, 351, 352
17.24 Laparoscopic bilateral repair of inguinal hernia with graft or prosthesis, not otherwise specified Y 06 350, 351, 352
17.31 Laparoscopic multiple segmental resection of large intestine Y 06 329, 330, 331
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
17.32 Laparoscopic cecectomy Y 05 264
06 329, 330, 331
21 907, 908, 909
24 957, 958, 959
17.33 Laparoscopic right hemicolectomy Y 05 264
06 329, 330, 331
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
17.34 Laparoscopic resection of transverse colon Y 05 264
06 329, 330, 331
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
17.35 Laparoscopic left hemicolectomy Y 05 264
06 329, 330, 331
10 628, 629, 630
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
17.36 Laparoscopic sigmoidectomy Y 06 329, 330, 331
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
17.39 Other laparoscopic partial excision of large intestine Y 05 264
06 329, 330, 331
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
37.36 Excision or destruction of left atrial appendage (LAA) N.
37.55 Removal of internal biventricular heart replacement system Y PRE 001, 002
05 237, 238
38.23 Intravascular spectroscopy N.
45.81 Laparoscopic total intra-abdominal colectomy Y 05 264
06 329, 330, 331
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
45.82 Open total intra-abdominal colectomy Y 05 264
06 329, 330, 331
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
45.83 Other and unspecified total intra-abdominal colectomy Y 05 264
06 329, 330, 331
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
48.40 Pull-through resection of rectum, not otherwise specified Y 06 332, 333, 334
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
48.42 Laparoscopic pull-through resection of rectum Y 06 332, 333, 334
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
48.43 Open pull-through resection of rectum Y 06 332, 333, 334
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
48.50 Abdominoperineal resection of the rectum, not otherwise specified Y 06 332, 333, 334
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
48.51 Laparoscopic abdominoperineal resection of the rectum Y 06 332, 333, 334
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
48.52 Open abdominoperineal resection of the rectum Y 06 332, 333, 334
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
48.59 Other abdominoperineal resection of the rectum Y 06 332, 333, 334
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
53.42 Laparoscopic repair of umbilical hernia with graft or prosthesis Y 06 353, 354, 355
53.43 Other laparoscopic umbilical herniorrhaphy Y 06 353, 354, 355
21 907, 908, 909
24 957, 958, 959
53.62 Laparoscopic incisional hernia repair with graft or prosthesis Y 06 353, 354, 355
21 907, 908, 909
24 957, 958, 959
53.63 Other laparoscopic repair of other hernia of anterior abdominal wall with graft or prosthesis Y 06 353, 354, 355
53.71 Laparoscopic repair of diaphragmatic hernia, abdominal approach Y 04 163, 164, 165
06 326, 327, 328
21 907, 908, 909
24 957, 958, 959
53.72 Other and open repair of diaphragmatic hernia, abdominal approach Y 04 163, 164, 165
06 326, 327, 328
21 907, 908, 909
24 957, 958, 959
53.75 Repair of diaphragmatic hernia, abdominal approach, not otherwise specified Y 04 163, 164, 165
06 326, 327, 328
21 907, 908, 909
24 957, 958, 959
53.83 Laparoscopic repair of diaphragmatic hernia, with thoracic approach Y 04 163, 164, 165
06 326, 327, 328
21 907, 908, 909
24 957, 958, 959
53.84 Other and open repair of diaphragmatic hernia, with thoracic approach Y 04 163, 164, 165
06 326, 327, 328
21 907, 908, 909
24 957, 958, 959
80.53 Repair of the anulus fibrosus with graft or prosthesis Y 01 028, 029, 030
08 490, 491
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
80.54 Other and unspecified repair of the anulus fibrosus Y 01 028, 029, 030
08 490, 491
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959

Diagnosis code Description CC MDC MS-DRG
046.1 Jakob-Creutzfeldt disease CC 01 056, 057
051.0 Cowpox N 18 865, 866
136.2 Specific infections by free-living amebae MCC 18 867, 868, 869
259.5 Androgen insensitivity syndrome N 10 643, 644, 645
337.0 Idiopathic peripheral autonomic neuropathy CC 01 073, 074
511.8 Other specified forms of pleural effusion, except tuberculous MCC 04 186, 187, 188
15 7911 , 7931
599.7 Hematuria N 11 695, 696
15 7911 , 7931
611.8 Other specified disorders of breast N 09 600, 601
695.1 Erythema multiforme CC 09 595, 596
729.9 Other and unspecified disorders of soft tissue N 08 555, 556
760.6 Surgical operation on mother N 15 794
777.5 Necrotizing enterocolitis in fetus or newborn MCC 15 7912 , 7932
788.9 Other symptoms involving urinary system N 11 695, 696
795.1 Nonspecific abnormal Papanicolaou smear of other site N 04 180, 181, 182
997.3 Respiratory complications CC 04 205, 206
15 7911 , 7931
999.8 Other transfusion reaction CC 15 7911 , 7931
16 811, 812
V13.5 Personal history of other musculoskeletal disorders N 23 951
V15.2 Personal history of surgery to other major organs N 23 951
V15.5 Personal history of injury N 23 951
V28.8 Encounter for other specified antenatal screening N 23 951
V45.1 Renal dialysis status N 23 951
V51 Aftercare involving the use of plastic surgery N 09 606, 607
1 Principal or secondary diagnosis of major problem.
2 Principal or secondary diagnosis of major problem.

Procedure code Description O.R. MDC MS-DRG
45.8 Total intra-abdominal colectomy Y 05 264
06 329, 330, 331
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
48.5 Abdominoperineal resection of rectum Y 06 332, 333, 334
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
53.7 Repair of diaphragmatic hernia, abdominal approach Y 04 163, 164, 165
06 326, 327, 328
21 907, 908, 909
24 957, 958, 959

Diagnosis code Description CC MDC MS-DRG
203.00 Multiple myeloma, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
203.10 Plasma cell leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
203.80 Other immunoproliferative neoplasms, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
204.00 Acute lymphoid leukemia, without mention of having achieved remission CC 17 820, 821, 822, 834, 835, 836, 8371 , 8381 , 8391
204.10 Chronic lymphoid leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
204.20 Subacute lymphoid leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
204.80 Other lymphoid leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
204.90 Unspecified lymphoid leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
205.00 Acute myeloid leukemia, without mention of having achieved remission CC 17 820, 821, 822, 834, 835, 836, 8371 , 8381 , 8391
205.10 Chronic myeloid leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
205.20 Subacute myeloid leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
205.30 Myeloid sarcoma, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
205.80 Other myeloid leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
205.90 Unspecified myeloid leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
206.00 Acute monocytic leukemia, without mention of having achieved remission CC 17 820, 821, 822, 834, 835, 836, 8371 , 8381 , 8391
206.10 Chronic monocytic leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
206.20 Subacute monocytic leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
206.80 Other monocytic leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
206.90 Unspecified monocytic leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
207.00 Acute erythremia and erythroleukemia, without mention of having achieved remission CC 17 820, 821, 822, 834, 835, 836, 8371 , 8381 , 8391
207.10 Chronic erythremia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
207.20 Megakaryocytic leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
207.80 Other specified leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
208.00 Acute leukemia of unspecified cell type, without mention of having achieved remission CC 17 820, 821, 822, 834, 835, 836, 8371 , 8381 , 8391
208.10 Chronic leukemia of unspecified cell type, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
208.20 Subacute leukemia of unspecified cell type, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
208.80 Other leukemia of unspecified cell type, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
208.90 Unspecified leukemia, without mention of having achieved remission CC 17 820, 821, 822, 823, 824, 825, 840, 841, 842
346.00 Migraine with aura, without mention of intractable migraine without mention of status migrainosus N 01 102, 103
346.01 Migraine with aura, with intractable migraine, so stated, without mention of status migrainosus N 01 102, 103
346.10 Migraine without aura, without mention of intractable migraine without mention of status migrainosus N 01 102, 103
346.11 Migraine without aura, with intractable migraine, so stated, without mention of status migrainosus N 01 102, 103
346.20 Variants of migraine, not elsewhere classified, without mention of intractable migraine without mention of status migrainosus N 01 102, 103
346.21 Variants of migraine, not elsewhere classified, with intractable migraine, so stated, without mention of status migrainosus N 01 102, 103
346.80 Other forms of migraine, without mention of intractable migraine without mention of status migrainosus N 01 102, 103
346.81 Other forms of migraine, with intractable migraine, so stated, without mention of status migrainosus N 01 102, 103
386.00 Ménière's disease, unspecified N 03 149
386.01 Active Ménière's disease, cochleovestibular N 03 149
386.02 Active Ménière's disease, cochlear N 03 149
386.03 Active Ménière's disease, vestibular N 03 149
386.04 Inactive Ménière's disease N 03 149
707.00 Pressure ulcer, unspecified site N2 09 573, 574, 575, 592, 593, 594
707.01 Pressure ulcer, elbow N2 09 573, 574, 575, 592, 593, 594
707.02 Pressure ulcer, upper back N2 09 573, 574, 575, 592, 593, 594
707.03 Pressure ulcer, lower back N2 09 573, 574, 575, 592, 593, 594
707.04 Pressure ulcer, hip N2 09 573, 574, 575, 592, 593, 594
707.05 Pressure ulcer, buttock N2 09 573, 574, 575, 592, 593, 594
707.06 Pressure ulcer, ankle N2 09 573, 574, 575, 592, 593, 594
707.07 Pressure ulcer, heel N2 09 573, 574, 575, 592, 593, 594
707.09 Pressure ulcer, other site N2 09 573, 574, 575, 592, 593, 594
776.9 Unspecified hematological disorder specific to newborn N 15 794
795.08 Unsatisfactory cervical cytology smear N 13 742, 743, 760, 761
998.31 Disruption of internal operation (surgical) wound CC 21 919, 920, 921
V28.3 Encounter for routine screening for malformation using ultrasonics N 23 951
V45.71 Acquired absence of breast and nipple N 23 951
1 Secondary diagnosis of acute leukemia.
2 The pressure ulcer site specific codes (707.00-707.09) will be non-CCs. The pressure ulcer stage III and IV codes will be classified as MCCs.

Procedure code Description O.R. MDC MS-DRG
37.52 Implantation of internal biventricular heart replacement system Y PRE 0011 , 0021
37.53 Replacement or repair of thoracic unit of (total) replacement heart system Y 05 215
37.54 Replacement or repair of other implantable component of (total) replacement heart system Y 05 215
45.71 Open and other multiple segmental resection of large intestine Y 06 329, 330, 331
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
45.72 Open and other cecectomy Y 05 264
06 329, 330, 331
21 907, 908, 909
24 957, 958, 959
45.73 Open and other right hemicolectomy Y 05 264
06 329, 330, 331
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
45.74 Open and other resection of transverse colon Y 05 264
06 329, 330, 331
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
45.75 Open and other left hemicolectomy Y 05 264
06 329, 330, 331
10 628, 629, 630
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
45.76 Open and other sigmoidectomy Y 06 329, 330, 331
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
45.79 Other and unspecified partial excision of large intestine Y 05 264
06 329, 330, 331
17 820, 821, 822, 826, 827, 828
21 907, 908, 909
24 957, 958, 959
53.01 Other and open repair of direct inguinal hernia Y 06 350, 351, 352
53.02 Other and open repair of indirect inguinal hernia Y 06 350, 351, 352
53.03 Other and open repair of direct inguinal hernia with graft or prosthesis Y 06 350, 351, 352
53.04 Other and open repair of indirect inguinal hernia with graft or prosthesis Y 06 350, 351, 352
53.11 Other and open bilateral repair of direct inguinal hernia Y 06 350, 351, 352
53.12 Other and open bilateral repair of indirect inguinal hernia Y 06 350, 351, 352
53.13 Other and open bilateral repair of inguinal hernia, one direct and one indirect Y 06 350, 351, 352
53.14 Other and open bilateral repair of direct inguinal hernia with graft or prosthesis Y 06 350, 351, 352
53.15 Other and open bilateral repair of indirect inguinal hernia with graft or prosthesis Y 06 350, 351, 352
53.16 Other and open bilateral repair of inguinal hernia, one direct and one indirect, with graft or prosthesis Y 06 350, 351, 352
53.41 Other and open repair of umbilical hernia with graft or prosthesis Y 06 353, 354, 355
53.49 Other open umbilical herniorrhaphy Y 06 353, 354, 355
21 907, 908, 909
24 957, 958, 959
53.61 Other open incisional hernia repair with graft or prosthesis Y 06 353, 354, 355
21 907, 908, 909
24 957, 958, 959
53.69 Other and open repair of other hernia of anterior abdominal wall with graft or prosthesis Y 06 353, 354, 355
81.65 Percutaneous vertebroplasty Y 08 515, 516, 517
21 907, 908, 909
24 957, 958, 959
81.66 Percutaneous vertebral augmentation Y 08 515, 516, 517
21 907, 908, 909
24 957, 958, 959
1 Note MS-DRG change.

MS-DRG Number of discharges Arithmetic mean LOS 10th percentile 25th percentile 50th percentile 75th percentile 90th percentile
1 655 40.2107 12 17 31 51 83
2 287 24.7456 9 12 17 28 48
3 23,205 39.6406 16 22 32 48 68
4 21,267 28.8412 11 17 24 35 49
5 635 21.1717 7 10 15 26 42
6 229 10.2576 6 7 9 12 17
7 356 19.6517 8 10 15 22 38
8 483 11.9337 6 7 9 13 20
9 1,346 21.9725 8 16 20 25 35
10 163 10.7791 6 7 8 11 19
11 1,264 16.7302 6 9 13 20 30
12 1,907 10.6754 4 6 9 13 18
13 1,268 6.9267 3 4 6 8 11
20 885 18.3525 6 10 17 24 32
21 530 15.4472 8 11 14 19 25
22 212 9.3726 2 6 9 12 15
23 3,730 12.6794 2 5 10 17 25
24 2,092 9.0263 1 4 8 12 18
25 8,697 13.0331 4 6 10 17 25
26 11,781 8.2206 2 4 7 11 15
27 13,695 4.5403 1 2 4 6 9
28 1,666 14.3055 4 7 11 18 27
29 3,070 7.1091 1 3 6 9 14
30 3,398 3.7310 1 1 3 5 7
31 1,024 13.1377 3 6 10 18 27
32 2,780 5.9781 1 2 4 8 14
33 3,623 3.0395 1 1 2 4 6
34 765 7.2261 1 2 5 9 15
35 2,239 3.2823 1 1 2 4 8
36 6,947 1.5949 1 1 1 2 3
37 4,841 8.5478 2 3 7 11 17
38 14,146 3.7666 1 1 2 5 9
39 51,927 1.8278 1 1 1 2 3
40 4,766 13.3479 3 6 10 17 25
41 7,573 7.2006 1 3 6 9 14
42 4,859 3.6300 1 1 2 5 8
52 1,163 6.7395 2 3 5 8 14
53 587 4.0102 1 2 3 5 7
54 5,240 6.9504 2 3 5 9 14
55 16,289 5.0708 1 2 4 6 10
56 8,250 7.7668 2 3 6 9 14
57 47,224 4.9743 2 3 4 6 9
58 736 7.5978 2 4 6 9 15
59 2,752 5.1432 2 3 4 6 9
60 4,068 3.9668 2 2 4 5 7
61 1,586 8.9426 2 4 7 11 17
62 2,464 6.2683 3 4 5 8 11
63 1,323 4.5110 2 3 4 6 8
64 55,734 7.4669 2 3 6 10 15
65 105,000 5.2179 2 3 4 6 9
66 89,325 3.7141 1 2 3 5 7
67 1,397 5.8232 2 3 5 7 11
68 11,402 3.4467 1 2 3 4 6
69 101,817 2.9920 1 2 2 4 5
70 7,341 7.8574 2 4 6 10 15
71 9,526 5.5568 2 3 4 7 10
72 5,739 3.5389 1 2 3 4 7
73 9,223 6.2394 2 3 5 8 12
74 31,500 4.3070 1 2 3 5 8
75 1,238 7.3021 2 4 6 9 14
76 873 4.1340 2 2 4 5 7
77 1,211 6.6821 2 3 5 9 12
78 1,405 4.4157 2 2 4 6 8
79 931 3.3845 1 2 3 4 6
80 1,861 5.1016 1 2 4 6 10
81 7,124 3.5267 1 2 3 4 6
82 1,757 6.4087 1 1 4 9 15
83 2,049 4.9551 1 2 4 7 10
84 2,769 3.1268 1 1 2 4 6
85 5,879 7.6399 2 3 6 10 15
86 11,469 5.0021 1 3 4 6 9
87 12,958 3.2740 1 2 3 4 6
88 711 5.8748 1 3 4 7 12
89 2,733 3.7603 1 2 3 5 7
90 3,089 2.5494 1 1 2 3 5
91 7,605 6.3657 2 3 5 8 13
92 16,265 4.4647 1 2 4 6 8
93 16,121 3.2188 1 2 3 4 6
94 1,473 11.8547 4 6 10 15 22
95 1,030 8.6359 3 5 7 11 15
96 757 6.1744 2 4 6 8 11
97 1,192 12.6023 4 7 11 16 23
98 1,005 8.3522 3 5 7 10 15
99 641 5.8752 2 3 5 8 11
100 16,989 6.3526 2 3 5 8 12
101 56,991 3.6950 1 2 3 5 7
102 1,080 4.5306 1 2 3 6 9
103 13,735 3.1270 1 2 2 4 6
113 525 5.5981 1 2 4 8 12
114 555 2.6090 1 1 2 3 5
115 1,046 4.3222 1 2 4 5 7
116 546 4.0678 1 1 2 5 8
117 996 2.1596 1 1 1 2 3
121 542 5.4576 2 3 4 7 10
122 617 4.0454 2 2 3 5 7
123 2,785 2.8747 1 2 2 4 5
124 749 5.2697 1 2 4 7 10
125 4,661 3.5134 1 2 3 4 7
129 1,353 5.1803 1 2 4 6 11
130 1,073 2.9385 1 1 2 4 6
131 929 5.7492 1 2 4 8 12
132 886 2.6501 1 1 2 3 5
133 1,981 5.3296 1 2 4 7 11
134 3,362 2.2329 1 1 1 3 4
135 352 5.8295 1 2 4 8 12
136 472 2.3305 1 1 1 3 5
137 773 5.4062 1 2 4 7 11
138 886 2.5237 1 1 2 3 5
139 1,490 1.8456 1 1 1 2 3
146 674 9.4466 2 4 7 12 19
147 1,364 6.1320 1 2 4 8 12
148 847 3.8040 1 1 3 5 8
149 38,817 2.7185 1 1 2 3 5
150 949 5.1981 1 2 4 6 10
151 6,810 2.8921 1 1 2 4 5
152 1,726 4.4571 1 2 3 5 8
153 11,433 3.2168 1 2 3 4 6
154 1,899 6.3381 2 3 5 8 12
155 4,471 4.4187 1 2 4 6 8
156 4,819 3.1731 1 2 3 4 6
157 1,044 6.6542 1 3 5 8 14
158 3,219 4.5281 1 2 3 6 9
159 2,355 3.0522 1 1 2 4 6
163 13,614 14.9476 5 8 13 19 27
164 17,887 8.0977 3 5 7 10 15
165 13,805 5.1442 2 3 5 6 9
166 20,549 12.9161 4 7 10 16 24
167 20,520 7.9756 2 4 7 10 15
168 5,467 5.2532 1 2 4 7 10
175 12,682 7.2650 3 4 6 9 12
176 41,338 5.3283 2 3 5 7 9
177 63,750 9.1032 3 5 7 12 17
178 70,831 7.3794 3 4 6 9 13
179 26,087 5.5654 2 3 5 7 10
180 22,324 7.9001 2 4 6 10 15
181 30,220 5.9078 2 3 5 8 11
182 5,446 4.1761 1 2 3 5 8
183 1,856 7.2338 2 4 6 9 13
184 4,320 4.5829 2 3 4 6 8
185 2,506 3.4066 1 2 3 4 6
186 9,239 7.4006 2 4 6 9 14
187 10,028 5.3216 2 3 4 7 10
188 5,014 3.9928 1 2 3 5 8
189 113,067 6.1459 2 3 5 8 11
190 58,781 6.2972 2 3 5 8 12
191 118,162 5.0156 2 3 4 6 9
192 184,764 3.9705 1 2 3 5 7
193 87,315 6.7517 2 4 6 8 12
194 253,950 5.2660 2 3 4 7 9
195 133,231 4.0792 2 2 4 5 7
196 5,388 7.3537 3 4 6 9 14
197 6,796 5.3899 2 3 4 7 10
198 4,616 4.0804 1 2 3 5 7
199 3,208 8.3030 2 4 7 11 16
200 8,382 5.0894 1 2 4 7 10
201 3,467 4.0580 1 2 3 5 8
202 29,252 4.3530 1 2 4 5 8
203 36,870 3.3859 1 2 3 4 6
204 25,669 2.8746 1 1 2 4 5
205 5,848 5.5050 1 2 4 7 10
206 21,532 3.4393 1 2 3 4 6
207 39,505 15.0709 6 9 13 18 25
208 76,444 7.2241 1 3 6 10 14
215 141 14.1844 1 3 9 17 31
216 8,616 18.3713 8 11 16 23 31
217 7,236 12.3046 6 8 11 15 20
218 2,554 9.0568 5 6 8 11 14
219 10,525 13.9944 6 8 11 17 26
220 13,928 8.5619 5 6 7 10 14
221 7,032 6.4428 4 5 6 7 10
222 2,771 13.0949 5 7 11 17 23
223 5,080 6.2701 1 3 5 8 12
224 1,911 11.3673 4 6 9 14 21
225 5,076 5.6420 2 3 5 7 10
226 7,064 9.3342 1 3 7 12 19
227 42,807 2.8263 1 1 1 3 7
228 2,974 14.7078 6 8 13 18 26
229 3,596 9.1096 4 6 8 11 15
230 1,566 6.4757 3 4 6 8 11
231 1,446 13.3811 6 8 11 17 24
232 1,515 9.1868 5 7 8 11 14
233 16,254 14.1787 7 9 12 17 24
234 34,309 8.9262 5 6 8 11 13
235 9,629 11.2185 5 7 9 14 20
236 30,065 6.6177 4 5 6 8 10
237 22,384 10.8073 2 5 9 14 21
238 42,226 4.6444 1 2 3 6 9
239 13,307 15.3499 5 8 12 19 29
240 11,658 10.3695 3 5 8 13 19
241 2,680 6.7634 3 4 6 8 12
242 17,519 8.7738 3 4 7 11 17
243 36,074 5.0924 1 2 4 7 10
244 62,706 2.9268 1 1 2 4 6
245 5,887 3.3061 1 1 2 4 7
246 28,818 5.3370 1 2 4 7 12
247 188,884 2.1674 1 1 1 3 4
248 13,847 5.9831 1 2 4 8 12
249 69,978 2.4966 1 1 2 3 5
250 6,762 7.7798 1 3 6 10 16
251 41,707 2.8343 1 1 2 4 6
252 45,567 8.5378 1 3 6 11 18
253 44,910 6.0144 1 2 5 8 13
254 53,360 2.7299 1 1 2 3 6
255 2,521 9.6942 2 4 8 12 18
256 3,425 7.4762 2 4 6 9 13
257 705 4.8482 1 2 4 7 10
258 686 7.3761 2 3 6 9 14
259 7,302 2.8020 1 1 2 4 6
260 1,549 11.2214 3 5 8 14 22
261 3,522 4.2127 1 1 3 6 9
262 3,531 2.5902 1 1 2 3 6
263 652 5.4126 1 1 3 7 13
264 28,273 8.8998 1 3 6 11 19
280 63,593 7.3381 2 4 6 9 13
281 53,704 4.8075 2 3 4 6 9
282 54,305 3.2480 1 2 3 4 6
283 14,888 5.4547 1 1 3 7 13
284 4,139 3.2341 1 1 2 4 7
285 2,803 2.2112 1 1 1 3 5
286 23,695 6.9333 2 3 5 9 14
287 158,158 3.1457 1 1 2 4 6
288 2,953 11.7541 4 6 9 14 22
289 1,357 8.6610 3 5 7 11 15
290 473 6.4947 2 4 5 8 11
291 187,597 6.4926 2 3 5 8 12
292 204,514 4.9936 2 3 4 6 9
293 196,441 3.6816 1 2 3 5 6
294 1,415 5.5611 2 3 5 7 9
295 1,343 4.3291 2 3 4 6 7
296 1,917 3.0303 1 1 1 3 7
297 791 1.8217 1 1 1 2 3
298 602 1.3040 1 1 1 1 2
299 17,750 6.6518 2 3 5 8 12
300 44,551 5.0493 2 3 4 6 9
301 36,994 3.6992 1 2 3 5 7
302 7,587 4.3756 1 2 3 5 8
303 70,544 2.5315 1 1 2 3 5
304 2,086 5.1942 1 2 4 7 10
305 35,079 2.8628 1 1 2 4 5
306 1,515 6.2964 1 3 4 8 12
307 6,344 3.4455 1 2 3 4 6
308 35,699 5.5438 1 2 4 7 11
309 79,311 3.9373 1 2 3 5 7
310 158,556 2.7530 1 1 2 4 5
311 21,034 2.3089 1 1 2 3 4
312 165,835 3.1053 1 2 2 4 6
313 211,391 2.1067 1 1 2 3 4
314 61,613 7.0205 2 3 5 9 14
315 29,960 4.6041 1 2 4 6 9
316 17,966 2.9978 1 1 2 4 6
326 11,226 17.1201 6 9 14 21 32
327 10,457 10.0519 3 5 8 13 18
328 8,865 4.3610 1 2 3 6 9
329 48,110 15.9561 6 9 13 20 29
330 63,624 9.7138 4 6 8 12 17
331 28,171 5.8793 3 4 5 7 9
332 1,823 14.3489 6 8 12 18 25
333 5,922 8.8349 4 6 8 10 15
334 3,719 5.5052 2 4 5 7 9
335 7,182 14.0778 5 8 12 18 25
336 12,448 9.0917 3 5 8 11 16
337 8,570 5.5883 1 3 5 8 10
338 1,501 10.7082 4 6 9 13 19
339 3,163 7.0452 3 4 6 9 12
340 3,558 4.1521 2 2 4 5 7
341 878 7.1287 2 3 5 9 14
342 2,544 4.1395 1 2 3 5 8
343 6,975 2.1792 1 1 2 3 4
344 936 11.7575 4 6 9 15 22
345 2,914 7.2447 3 4 6 9 12
346 2,759 4.9467 2 3 5 6 8
347 1,625 8.8166 2 4 7 11 17
348 4,164 5.7366 2 3 5 7 11
349 5,155 3.0795 1 1 2 4 6
350 1,756 7.9897 2 3 6 10 16
351 4,287 4.5573 1 2 4 6 9
352 8,183 2.4793 1 1 2 3 5
353 3,165 8.4051 2 4 7 11 16
354 8,420 5.0816 2 3 4 6 9
355 15,316 2.8995 1 1 2 4 5
356 8,335 12.9146 3 6 10 16 25
357 7,801 8.1406 2 4 6 10 16
358 2,477 4.4719 1 2 4 6 9
368 3,566 6.5979 2 3 5 8 13
369 5,248 4.7487 2 3 4 6 9
370 3,554 3.3995 1 2 3 4 6
371 24,371 8.7488 3 4 7 11 17
372 27,061 6.8532 3 4 6 8 12
373 15,249 4.9382 2 3 4 6 8
374 9,039 8.5759 2 4 7 11 16
375 18,945 6.0287 2 3 5 8 12
376 4,279 4.1837 1 2 3 5 8
377 51,556 6.3806 2 3 5 8 12
378 110,340 4.4472 2 3 4 5 8
379 92,136 3.4088 1 2 3 4 6
380 3,020 7.2738 2 3 6 9 14
381 5,293 5.1734 2 3 4 6 9
382 4,492 3.6814 1 2 3 5 7
383 1,223 5.5200 2 3 4 7 10
384 8,080 3.7490 1 2 3 5 7
385 1,996 8.8191 3 4 6 11 18
386 7,126 5.6996 2 3 5 7 10
387 5,033 4.2935 1 2 4 5 8
388 18,540 7.3159 2 3 6 9 14
389 45,795 5.0160 2 3 4 6 9
390 46,426 3.5522 1 2 3 4 6
391 44,299 5.2367 1 2 4 6 10
392 282,071 3.4889 1 2 3 4 6
393 23,253 6.8917 2 3 5 8 14
394 45,853 4.8196 1 2 4 6 9
395 24,740 3.3344 1 2 3 4 6
405 3,963 17.0056 5 8 13 21 34
406 5,300 9.1566 2 5 7 11 18
407 2,115 5.4851 1 3 5 7 10
408 1,548 14.9961 6 8 12 18 28
409 1,737 9.8290 4 6 8 12 18
410 598 6.5033 2 4 6 8 11
411 956 12.4069 5 7 10 15 22
412 955 8.5696 4 6 8 11 14
413 756 5.9272 2 4 5 7 10
414 5,241 11.7296 5 7 10 14 21
415 6,127 7.6236 3 5 7 9 13
416 5,328 4.8281 2 3 4 6 8
417 16,444 8.3803 3 4 7 10 16
418 27,075 5.6341 2 3 5 7 10
419 35,887 3.1911 1 1 3 4 6
420 766 13.6606 3 6 10 17 26
421 1,054 7.6879 2 3 6 10 16
422 327 4.3609 1 2 4 6 8
423 1,542 15.8599 4 7 12 20 32
424 894 10.4172 3 5 8 14 20
425 125 5.3760 1 2 4 7 10
432 15,140 6.9542 2 3 5 9 14
433 9,672 4.8719 1 2 4 6 9
434 877 3.6933 1 2 3 5 6
435 12,111 7.5614 2 3 6 10 15
436 13,158 5.8396 2 3 5 8 11
437 3,887 4.2529 1 2 3 6 8
438 14,063 7.5128 2 3 5 9 15
439 24,364 5.3275 2 3 4 7 10
440 25,670 3.8103 1 2 3 5 7
441 13,335 7.0467 2 3 5 9 14
442 14,144 5.1103 2 2 4 6 9
443 6,544 3.7796 1 2 3 5 7
444 12,898 6.6243 2 3 5 8 13
445 16,794 4.7264 1 2 4 6 9
446 15,932 3.2658 1 2 3 4 6
453 948 15.6561 5 7 12 19 29
454 1,771 8.0237 3 4 6 10 14
455 1,969 4.4307 1 3 4 5 7
456 946 14.7061 5 7 11 19 28
457 2,413 7.4836 3 4 6 9 13
458 1,609 4.5438 2 3 4 6 7
459 3,508 9.4478 4 5 7 11 17
460 51,883 4.2180 2 3 4 5 7
461 1,018 8.4342 3 5 6 9 14
462 13,194 4.2178 3 3 4 5 6
463 5,054 16.5693 5 7 12 20 33
464 5,839 10.2197 3 5 8 12 20
465 2,398 5.8661 1 3 5 7 11
466 4,072 9.1717 3 5 7 11 16
467 14,331 5.4882 3 3 4 6 9
468 21,133 3.9306 2 3 3 4 6
469 30,532 8.2006 3 5 7 10 14
470 405,204 3.9281 3 3 3 4 6
471 2,283 9.7946 2 4 7 13 20
472 6,954 4.0913 1 1 3 5 9
473 22,875 1.9623 1 1 1 2 4
474 2,918 12.6453 4 6 10 15 24
475 3,277 8.3946 3 4 7 11 15
476 1,589 4.7885 1 2 4 6 9
477 2,582 11.8548 3 6 9 15 22
478 8,562 6.6119 1 3 6 9 13
479 11,424 2.8188 1 1 1 4 7
480 26,724 9.2958 4 5 8 11 16
481 72,123 5.9291 3 4 5 7 9
482 48,111 4.8427 3 4 4 6 7
483 7,100 4.2093 2 2 3 5 8
484 17,842 2.4311 1 2 2 3 4
485 1,183 12.1116 4 6 10 15 22
486 2,186 8.0425 3 5 7 10 14
487 1,312 5.6715 3 3 5 7 9
488 2,495 5.2236 2 3 4 6 10
489 5,763 3.0465 1 2 3 4 5
490 22,971 4.3437 1 1 3 5 9
491 52,406 2.2104 1 1 2 3 4
492 5,217 8.5338 3 5 7 11 15
493 16,900 5.2509 2 3 4 6 9
494 29,166 3.3992 1 2 3 4 6
495 1,970 10.9609 3 5 8 14 21
496 5,555 5.9802 2 3 5 7 11
497 6,632 3.0054 1 1 2 4 6
498 1,163 7.8865 2 3 6 10 16
499 1,110 2.9757 1 1 2 4 6
500 1,503 10.8283 3 5 8 14 21
501 3,873 5.9700 2 3 5 8 12
502 6,452 2.9416 1 1 2 4 6
503 833 9.4586 3 5 7 11 17
504 2,162 6.4510 2 3 6 8 12
505 3,004 3.3832 1 2 3 4 6
506 810 3.4074 1 1 2 4 7
507 836 5.1459 1 2 4 6 10
508 2,481 2.0512 1 1 1 2 3
509 627 3.1100 1 1 2 3 7
510 973 6.4070 2 3 5 8 12
511 3,926 3.9758 1 2 3 5 7
512 10,961 2.1581 1 1 2 3 4
513 1,052 5.0266 1 2 4 6 10
514 1,006 2.8191 1 1 2 3 6
515 3,818 10.4445 3 5 8 13 20
516 11,280 5.9870 1 3 5 8 11
517 17,523 3.0079 1 1 2 4 7
533 822 6.6861 2 3 5 8 12
534 3,392 4.0292 1 2 3 5 7
535 6,990 6.2365 2 3 5 8 12
536 33,661 3.9328 2 3 3 5 7
537 665 4.4722 2 3 4 5 8
538 1,056 3.2197 1 2 3 4 6
539 3,417 9.7085 3 5 8 12 17
540 4,016 7.1257 3 4 6 8 13
541 1,618 5.3745 2 3 4 7 9
542 5,709 8.7758 3 4 7 11 17
543 17,012 5.9463 2 3 5 7 11
544 10,798 4.4077 2 3 4 5 8
545 4,079 9.0924 2 4 6 11 19
546 5,577 5.5338 2 3 4 7 10
547 4,533 3.8083 1 2 3 5 7
548 580 8.9379 3 4 7 11 17
549 1,110 6.3874 2 3 5 8 12
550 858 4.4545 2 2 4 6 8
551 10,066 7.1058 2 3 6 9 14
552 85,179 4.1225 1 2 3 5 7
553 3,076 5.9620 2 3 5 7 11
554 19,173 3.6913 1 2 3 5 7
555 2,013 4.8405 1 2 4 6 9
556 18,639 3.1089 1 2 3 4 6
557 3,646 6.6100 2 3 5 8 12
558 15,089 4.2586 2 2 4 5 7
559 1,815 7.5444 2 3 6 9 15
560 4,319 4.7217 1 2 4 6 9
561 7,107 2.7680 1 1 2 3 5
562 5,458 6.3674 2 3 5 8 12
563 36,267 3.7016 1 2 3 4 6
564 1,661 6.9934 2 3 5 9 13
565 3,311 4.9795 2 3 4 6 9
566 2,624 3.6825 1 2 3 5 7
573 5,477 13.0933 4 6 9 16 26
574 11,123 9.3248 3 5 7 11 17
575 5,462 5.8521 2 3 5 7 11
576 547 12.9506 2 4 9 17 28
577 2,228 6.1104 1 2 4 8 13
578 3,054 3.3062 1 1 2 4 7
579 3,511 10.6830 3 5 8 14 21
580 10,711 5.5084 1 2 4 7 12
581 12,142 2.6146 1 1 2 3 6
582 5,337 2.8943 1 1 2 3 5
583 8,748 1.8056 1 1 1 2 3
584 668 5.9850 1 2 4 8 13
585 1,469 2.2321 1 1 1 2 4
592 4,178 8.8712 3 4 7 10 16
593 12,304 6.4415 2 3 5 8 11
594 2,751 5.0593 2 3 4 6 9
595 1,112 8.3327 2 4 6 10 16
596 5,308 4.7600 1 2 4 6 8
597 458 8.2009 2 3 6 10 16
598 1,400 5.7243 2 3 4 7 11
599 306 3.7320 1 1 3 4 6
600 682 5.0513 2 3 4 7 9
601 884 3.8541 1 2 3 5 7
602 22,088 7.0278 2 4 6 9 13
603 130,121 4.7073 2 3 4 6 8
604 2,660 5.6590 1 3 4 7 11
605 22,097 3.4622 1 2 3 4 6
606 1,350 6.3422 1 3 4 7 12
607 7,168 3.7913 1 2 3 5 7
614 1,457 7.0336 2 3 5 8 14
615 1,546 3.1572 1 2 3 4 5
616 1,091 16.9432 6 9 13 20 31
617 6,718 8.7904 3 5 7 11 15
618 258 6.3605 2 3 6 8 11
619 696 8.2011 2 3 5 9 18
620 2,186 3.6780 1 2 3 4 7
621 7,848 2.1617 1 1 2 3 4
622 1,112 13.1574 3 6 9 16 24
623 3,077 8.5707 3 4 7 10 15
624 383 6.0261 2 3 5 7 10
625 1,274 7.0879 1 2 5 9 15
626 2,538 3.1233 1 1 2 3 7
627 14,026 1.5172 1 1 1 2 2
628 3,366 11.1851 2 4 8 14 23
629 4,160 8.7418 3 5 7 11 16
630 534 5.5281 1 2 4 7 11
637 17,104 6.0581 2 3 5 7 12
638 42,581 4.2659 1 2 3 5 8
639 38,312 3.0382 1 2 2 4 5
640 60,806 5.4332 1 2 4 7 11
641 201,324 3.8256 1 2 3 5 7
642 1,492 5.1810 1 2 4 6 9
643 5,176 7.6103 2 4 6 9 14
644 11,788 5.4597 2 3 4 7 10
645 8,179 3.8912 1 2 3 5 7
652 10,067 7.7888 4 5 6 9 13
653 1,697 16.8981 7 9 13 21 31
654 3,452 9.8624 5 7 8 11 16
655 1,633 6.5150 3 5 7 8 10
656 3,918 10.1146 4 5 8 12 19
657 7,422 5.9603 3 4 5 7 10
658 8,271 3.7356 2 2 3 5 6
659 4,658 11.2003 3 5 8 14 22
660 7,594 6.5146 2 3 5 8 13
661 4,260 3.2758 1 2 3 4 6
662 949 10.2740 2 4 8 14 20
663 2,054 5.2639 1 2 4 7 11
664 4,390 2.1223 1 1 1 2 4
665 654 11.0627 3 5 9 14 21
666 2,092 6.3595 1 2 4 9 14
667 3,616 2.8695 1 1 2 3 6
668 3,833 8.5265 2 4 7 11 16
669 12,746 4.4236 1 2 3 6 9
670 11,687 2.5131 1 1 2 3 5
671 808 5.9468 1 2 4 8 12
672 943 2.5302 1 1 2 3 5
673 12,542 9.7323 1 3 7 13 21
674 11,715 7.1905 1 2 5 9 15
675 7,824 2.0675 1 1 1 2 4
682 82,091 7.1569 2 3 5 9 14
683 132,320 5.6544 2 3 5 7 10
684 44,932 3.8913 1 2 3 5 7
685 2,331 3.4822 1 1 2 4 7
686 1,597 7.5717 2 3 6 9 15
687 3,261 5.3502 1 3 4 7 10
688 1,073 3.2591 1 1 2 4 6
689 55,995 6.2004 2 3 5 8 11
690 198,101 4.2356 2 2 4 5 7
691 821 3.9586 1 2 3 5 8
692 491 2.3992 1 1 2 3 5
693 2,429 4.8345 1 2 4 6 10
694 18,000 2.5778 1 1 2 3 5
695 975 5.5251 1 3 4 7 11
696 10,518 3.2901 1 2 3 4 6
697 592 3.1115 1 1 2 4 6
698 23,320 6.6546 2 3 5 8 13
699 24,207 4.8302 1 2 4 6 9
700 12,279 3.5497 1 2 3 4 7
707 5,979 4.4131 1 2 3 5 8
708 18,063 2.1475 1 1 2 3 4
709 762 6.5341 1 2 4 8 15
710 1,831 1.7739 1 1 1 2 3
711 790 8.1684 1 3 6 10 16
712 705 3.0496 1 1 2 4 7
713 10,252 4.1916 1 2 3 5 9
714 28,797 1.9430 1 1 2 2 3
715 531 6.2806 1 2 4 8 13
716 1,273 1.4289 1 1 1 1 2
717 703 7.2319 2 3 5 9 14
718 589 2.7640 1 1 2 3 5
722 745 7.5852 2 3 6 10 14
723 1,949 5.2678 1 3 4 7 10
724 578 3.1522 1 1 2 4 6
725 755 5.5007 2 3 4 7 10
726 3,716 3.4739 1 2 3 4 6
727 1,294 6.3995 2 3 5 8 12
728 6,158 4.0404 1 2 3 5 7
729 591 5.5736 1 2 4 7 10
730 471 3.0786 1 1 2 4 6
734 1,362 7.9941 3 4 6 9 15
735 1,130 3.3602 1 2 3 4 5
736 854 13.7752 5 7 11 17 25
737 3,293 7.1786 3 4 6 8 13
738 863 3.8714 2 3 3 5 6
739 1,013 10.1955 3 5 8 12 20
740 4,326 5.2305 2 3 4 6 9
741 6,014 2.9940 1 2 3 4 5
742 10,950 4.5175 2 2 3 5 8
743 32,325 2.2608 1 2 2 3 3
744 1,520 5.8355 1 2 4 7 12
745 1,694 2.5738 1 1 2 3 5
746 2,634 4.2134 1 2 3 5 8
747 10,409 1.8856 1 1 2 2 3
748 19,857 1.7358 1 1 1 2 3
749 982 9.3401 2 4 7 12 19
750 435 3.1103 1 1 2 4 6
754 978 8.3395 2 4 7 11 16
755 2,933 5.6870 2 3 4 7 11
756 677 3.1359 1 1 2 4 6
757 1,393 8.1436 3 4 6 10 16
758 1,605 6.0536 2 3 5 7 11
759 1,239 4.4722 2 2 4 5 8
760 1,700 3.9594 1 2 3 5 8
761 1,749 2.4351 1 1 2 3 5
765 2,754 5.0359 2 3 4 5 7
766 2,686 3.1601 2 2 3 4 4
767 132 3.3712 2 2 2 3 5
768 6 3.5000 1 2 3 6 6
769 98 4.6224 1 2 3 6 11
770 202 2.2277 1 1 1 2 5
774 1,506 3.1886 2 2 2 3 5
775 5,768 2.2394 1 2 2 3 3
776 511 3.3112 1 2 2 4 7
777 206 2.2136 1 1 2 3 4
778 474 3.0127 1 1 2 3 5
779 110 2.1182 1 1 1 2 3
780 40 1.4500 1 1 1 1 3
781 3,017 3.7630 1 1 2 4 7
782 171 2.4971 1 1 1 2 4
790 1 25.0000 125 125 125 125 125
799 566 14.0583 5 7 11 18 26
800 705 7.8610 3 4 6 9 15
801 557 4.9336 2 2 4 6 9
802 765 12.2706 3 5 9 15 25
803 1,070 6.6738 1 3 5 8 14
804 987 3.4215 1 1 3 4 6
808 6,088 8.2467 3 4 6 10 16
809 12,869 5.3247 2 3 4 7 10
810 2,786 4.0337 1 2 3 5 7
811 21,404 5.6912 1 2 4 7 11
812 89,951 3.7401 1 2 3 5 7
813 14,232 5.1669 1 2 4 6 10
814 1,554 6.7368 2 3 5 8 13
815 3,297 4.9706 1 2 4 6 9
816 2,147 3.5198 1 2 3 4 7
820 1,299 17.7229 5 8 14 23 34
821 2,474 7.8646 1 3 6 10 16
822 1,893 3.5288 1 1 3 4 7
823 2,178 15.4385 5 8 12 20 29
824 2,974 8.7492 2 4 7 11 17
825 1,748 4.3084 1 1 3 6 9
826 524 15.0401 4 7 11 19 29
827 1,254 7.9793 2 4 6 10 16
828 799 3.7722 1 2 3 5 7
829 1,171 10.6576 2 4 7 13 22
830 521 3.7179 1 1 2 4 8
834 4,028 15.4615 2 4 10 23 36
835 2,703 10.4351 2 3 6 12 28
836 1,622 5.1843 1 2 3 6 10
837 1,043 23.1419 5 10 23 31 42
838 1,320 12.2629 3 4 6 21 29
839 1,467 6.4104 3 4 5 6 10
840 9,659 10.4408 3 5 8 13 21
841 10,035 6.9221 2 3 5 9 13
842 5,310 4.5563 1 2 4 6 9
843 1,350 8.5222 2 4 6 10 17
844 2,412 6.0987 2 3 5 8 12
845 804 4.3022 1 2 3 6 8
846 2,113 8.4179 2 3 5 10 18
847 23,862 3.3508 1 2 3 4 6
848 1,723 3.1294 1 1 3 4 5
849 1,477 5.9709 2 3 5 6 12
853 34,852 16.6669 5 8 13 21 30
854 6,643 11.1072 4 6 9 14 20
855 459 7.0261 2 4 6 9 13
856 5,892 15.3839 4 7 12 19 30
857 9,614 8.4628 3 4 7 10 16
858 3,246 5.6741 2 3 5 7 10
862 7,929 8.1778 2 4 6 10 16
863 21,420 5.1976 2 3 4 7 9
864 18,946 4.0639 1 2 3 5 7
865 1,705 6.7009 2 3 4 8 14
866 8,182 3.5351 1 2 3 4 7
867 5,062 9.6254 2 4 7 12 19
868 2,641 5.7819 2 3 4 7 11
869 1,103 4.3128 2 2 4 5 7
870 21,199 15.4758 6 9 13 19 27
871 216,384 7.4839 2 3 6 10 14
872 90,892 5.7138 2 3 5 7 10
876 857 11.9498 2 5 9 14 24
880 9,282 3.1518 1 1 2 4 6
881 4,623 4.1888 1 2 3 5 8
882 1,556 4.4274 1 2 3 6 9
883 757 7.3725 1 2 4 8 15
884 19,006 5.4936 2 3 4 6 10
885 80,806 7.6211 2 3 6 9 14
886 404 6.0767 1 2 4 7 12
887 393 4.6209 1 2 3 5 8
894 4,369 2.9528 1 1 2 3 4
895 6,958 10.4997 3 4 6 7 9
896 5,490 6.6087 2 3 5 8 13
897 36,053 4.0582 1 2 3 5 6
901 924 15.0693 3 6 10 18 30
902 2,031 7.7371 2 3 6 9 16
903 1,500 4.5680 1 2 4 6 9
904 1,047 11.2178 2 4 7 13 23
905 811 4.6523 1 2 4 6 8
906 712 3.1657 1 1 2 4 6
907 8,462 11.6494 2 5 8 14 23
908 8,319 6.7682 2 3 5 8 13
909 5,447 3.6367 1 1 3 5 7
913 804 5.6629 1 3 4 7 12
914 6,609 3.4330 1 2 3 4 6
915 1,078 4.7356 1 2 3 6 9
916 5,508 2.1044 1 1 2 3 4
917 15,775 5.1645 1 2 4 6 11
918 35,653 2.7260 1 1 2 3 5
919 11,089 6.3723 2 3 5 8 13
920 13,970 4.3608 1 2 3 5 8
921 9,423 2.9687 1 1 2 4 6
922 1,047 5.9933 1 2 4 7 12
923 3,952 3.2338 1 1 2 4 6
927 211 31.1374 7 15 26 41 60
928 818 15.9694 4 7 12 21 31
929 438 7.6872 1 3 6 10 16
933 139 4.3453 1 1 1 4 8
934 659 6.1988 1 3 5 8 12
935 2,201 5.4330 1 2 4 7 11
939 671 10.0611 2 4 7 13 20
940 1,320 5.4220 1 2 4 7 12
941 1,707 2.7299 1 1 2 3 5
945 6,244 10.4947 4 6 8 12 15
946 3,055 7.8628 3 5 6 7 8
947 9,715 5.0101 1 2 4 6 10
948 47,722 3.4806 1 2 3 4 6
949 632 4.1092 1 1 2 4 6
950 387 3.4858 1 1 2 4 5
951 940 4.6436 1 1 2 3 6
955 443 12.2822 2 5 10 16 26
956 3,975 9.2896 4 5 7 11 17
957 1,311 14.8795 2 7 12 19 28
958 1,146 10.4031 3 6 8 13 19
959 286 6.2413 2 3 5 8 11
963 1,586 9.5214 2 4 8 13 19
964 2,573 6.2274 2 3 5 8 11
965 1,071 4.1391 1 2 3 5 7
969 639 18.8279 4 8 14 22 36
970 136 9.8309 2 3 7 12 17
974 5,920 10.3723 2 4 8 13 21
975 4,674 7.0148 2 3 5 9 13
976 2,617 4.9308 2 2 4 6 8
977 4,565 5.2931 1 2 4 6 10
981 25,479 15.1488 5 8 12 19 28
982 18,329 9.7455 3 5 8 12 18
983 6,112 5.3613 1 2 4 7 11
984 671 14.6811 5 8 13 18 25
985 903 9.6512 2 5 8 13 18
986 731 5.3338 1 2 3 7 12
987 8,240 13.0089 4 6 10 16 24
988 11,583 7.8090 2 3 6 10 15
989 5,796 4.1046 1 1 3 6 9
11,387,276

MS-DRG Number of discharges Arithmetic mean LOS 10th percentile 25th percentile 50th percentile 75th percentile 90th percentile
1 655 40.2107 12 17 31 51 83
2 287 24.7456 9 12 17 28 48
3 23,205 39.6406 16 22 32 48 68
4 21,267 28.8412 11 17 24 35 49
5 635 21.1717 7 10 15 26 42
6 229 10.2576 6 7 9 12 17
7 356 19.6517 8 10 15 22 38
8 483 11.9337 6 7 9 13 20
9 1,346 21.9725 8 16 20 25 35
10 163 10.7791 6 7 8 11 19
11 1,264 16.7302 6 9 13 20 30
12 1,907 10.6754 4 6 9 13 18
13 1,268 6.9267 3 4 6 8 11
20 885 18.3525 6 10 17 24 32
21 530 15.4472 8 11 14 19 25
22 212 9.3726 2 6 9 12 15
23 3,730 12.6794 2 5 10 17 25
24 2,092 9.0263 1 4 8 12 18
25 8,697 13.0331 4 6 10 17 25
26 11,781 8.2206 2 4 7 11 15
27 13,695 4.5403 1 2 4 6 9
28 1,666 14.3055 4 7 11 18 27
29 3,070 7.1091 1 3 6 9 14
30 3,398 3.7310 1 1 3 5 7
31 1,024 13.1377 3 6 10 18 27
32 2,780 5.9781 1 2 4 8 14
33 3,623 3.0395 1 1 2 4 6
34 765 7.2261 1 2 5 9 15
35 2,239 3.2823 1 1 2 4 8
36 6,947 1.5949 1 1 1 2 3
37 4,841 8.5478 2 3 7 11 17
38 14,146 3.7666 1 1 2 5 9
39 51,927 1.8278 1 1 1 2 3
40 4,765 13.3490 3 6 10 17 25
41 7,573 7.2006 1 3 6 9 14
42 4,859 3.6300 1 1 2 5 8
52 1,163 6.7395 2 3 5 8 14
53 587 4.0102 1 2 3 5 7
54 5,240 6.9504 2 3 5 9 14
55 16,289 5.0708 1 2 4 6 10
56 8,250 7.7668 2 3 6 9 14
57 47,224 4.9743 2 3 4 6 9
58 736 7.5978 2 4 6 9 15
59 2,752 5.1432 2 3 4 6 9
60 4,068 3.9668 2 2 4 5 7
61 1,586 8.9426 2 4 7 11 17
62 2,464 6.2683 3 4 5 8 11
63 1,323 4.5110 2 3 4 6 8
64 55,734 7.4669 2 3 6 10 15
65 105,000 5.2179 2 3 4 6 9
66 89,325 3.7141 1 2 3 5 7
67 1,397 5.8232 2 3 5 7 11
68 11,402 3.4467 1 2 3 4 6
69 101,817 2.9920 1 2 2 4 5
70 7,341 7.8574 2 4 6 10 15
71 9,526 5.5568 2 3 4 7 10
72 5,739 3.5389 1 2 3 4 7
73 9,223 6.2394 2 3 5 8 12
74 31,500 4.3070 1 2 3 5 8
75 1,238 7.3021 2 4 6 9 14
76 873 4.1340 2 2 4 5 7
77 1,211 6.6821 2 3 5 9 12
78 1,405 4.4157 2 2 4 6 8
79 931 3.3845 1 2 3 4 6
80 1,861 5.1016 1 2 4 6 10
81 7,124 3.5267 1 2 3 4 6
82 1,757 6.4087 1 1 4 9 15
83 2,049 4.9551 1 2 4 7 10
84 2,769 3.1268 1 1 2 4 6
85 5,879 7.6399 2 3 6 10 15
86 11,468 5.0024 1 3 4 6 9
87 12,958 3.2740 1 2 3 4 6
88 711 5.8748 1 3 4 7 12
89 2,733 3.7603 1 2 3 5 7
90 3,089 2.5494 1 1 2 3 5
91 7,605 6.3657 2 3 5 8 13
92 16,265 4.4647 1 2 4 6 8
93 16,121 3.2188 1 2 3 4 6
94 1,473 11.8547 4 6 10 15 22
95 1,030 8.6359 3 5 7 11 15
96 757 6.1744 2 4 6 8 11
97 1,192 12.6023 4 7 11 16 23
98 1,005 8.3522 3 5 7 10 15
99 641 5.8752 2 3 5 8 11
100 16,989 6.3526 2 3 5 8 12
101 56,991 3.6950 1 2 3 5 7
102 1,080 4.5306 1 2 3 6 9
103 13,735 3.1270 1 2 2 4 6
113 525 5.5981 1 2 4 8 12
114 555 2.6090 1 1 2 3 5
115 1,046 4.3222 1 2 4 5 7
116 546 4.0678 1 1 2 5 8
117 996 2.1596 1 1 1 2 3
121 542 5.4576 2 3 4 7 10
122 617 4.0454 2 2 3 5 7
123 2,785 2.8747 1 2 2 4 5
124 749 5.2697 1 2 4 7 10
125 4,661 3.5134 1 2 3 4 7
129 1,353 5.1803 1 2 4 6 11
130 1,073 2.9385 1 1 2 4 6
131 929 5.7492 1 2 4 8 12
132 886 2.6501 1 1 2 3 5
133 1,981 5.3296 1 2 4 7 11
134 3,362 2.2329 1 1 1 3 4
135 352 5.8295 1 2 4 8 12
136 472 2.3305 1 1 1 3 5
137 773 5.4062 1 2 4 7 11
138 886 2.5237 1 1 2 3 5
139 1,490 1.8456 1 1 1 2 3
146 674 9.4466 2 4 7 12 19
147 1,364 6.1320 1 2 4 8 12
148 847 3.8040 1 1 3 5 8
149 38,817 2.7185 1 1 2 3 5
150 949 5.1981 1 2 4 6 10
151 6,810 2.8921 1 1 2 4 5
152 1,726 4.4571 1 2 3 5 8
153 11,433 3.2168 1 2 3 4 6
154 1,899 6.3381 2 3 5 8 12
155 4,471 4.4187 1 2 4 6 8
156 4,819 3.1731 1 2 3 4 6
157 1,044 6.6542 1 3 5 8 14
158 3,219 4.5281 1 2 3 6 9
159 2,355 3.0522 1 1 2 4 6
163 13,614 14.9476 5 8 13 19 27
164 17,887 8.0977 3 5 7 10 15
165 13,805 5.1442 2 3 5 6 9
166 20,549 12.9161 4 7 10 16 24
167 20,520 7.9756 2 4 7 10 15
168 5,467 5.2532 1 2 4 7 10
175 12,682 7.2650 3 4 6 9 12
176 41,338 5.3283 2 3 5 7 9
177 63,750 9.1032 3 5 7 12 17
178 70,831 7.3794 3 4 6 9 13
179 26,087 5.5654 2 3 5 7 10
180 22,324 7.9001 2 4 6 10 15
181 30,220 5.9078 2 3 5 8 11
182 5,446 4.1761 1 2 3 5 8
183 1,856 7.2338 2 4 6 9 13
184 4,320 4.5829 2 3 4 6 8
185 2,506 3.4066 1 2 3 4 6
186 9,239 7.4006 2 4 6 9 14
187 10,028 5.3216 2 3 4 7 10
188 5,014 3.9928 1 2 3 5 8
189 113,067 6.1459 2 3 5 8 11
190 58,781 6.2972 2 3 5 8 12
191 118,162 5.0156 2 3 4 6 9
192 184,764 3.9705 1 2 3 5 7
193 87,315 6.7517 2 4 6 8 12
194 253,950 5.2660 2 3 4 7 9
195 133,231 4.0792 2 2 4 5 7
196 5,388 7.3537 3 4 6 9 14
197 6,796 5.3899 2 3 4 7 10
198 4,616 4.0804 1 2 3 5 7
199 3,208 8.3030 2 4 7 11 16
200 8,382 5.0894 1 2 4 7 10
201 3,467 4.0580 1 2 3 5 8
202 29,252 4.3530 1 2 4 5 8
203 36,870 3.3859 1 2 3 4 6
204 25,669 2.8746 1 1 2 4 5
205 5,848 5.5050 1 2 4 7 10
206 21,532 3.4393 1 2 3 4 6
207 39,505 15.0709 6 9 13 18 25
208 76,444 7.2241 1 3 6 10 14
215 141 14.1844 1 3 9 17 31
216 8,616 18.3713 8 11 16 23 31
217 7,236 12.3046 6 8 11 15 20
218 2,554 9.0568 5 6 8 11 14
219 10,525 13.9944 6 8 11 17 26
220 13,928 8.5619 5 6 7 10 14
221 7,032 6.4428 4 5 6 7 10
222 2,771 13.0949 5 7 11 17 23
223 5,080 6.2701 1 3 5 8 12
224 1,911 11.3673 4 6 9 14 21
225 5,076 5.6420 2 3 5 7 10
226 7,064 9.3342 1 3 7 12 19
227 42,807 2.8263 1 1 1 3 7
228 2,974 14.7078 6 8 13 18 26
229 3,596 9.1096 4 6 8 11 15
230 1,566 6.4757 3 4 6 8 11
231 1,446 13.3811 6 8 11 17 24
232 1,515 9.1868 5 7 8 11 14
233 16,254 14.1787 7 9 12 17 24
234 34,309 8.9262 5 6 8 11 13
235 9,629 11.2185 5 7 9 14 20
236 30,065 6.6177 4 5 6 8 10
237 22,384 10.8073 2 5 9 14 21
238 42,226 4.6444 1 2 3 6 9
239 13,307 15.3499 5 8 12 19 29
240 11,658 10.3695 3 5 8 13 19
241 2,680 6.7634 3 4 6 8 12
242 17,519 8.7738 3 4 7 11 17
243 36,074 5.0924 1 2 4 7 10
244 62,706 2.9268 1 1 2 4 6
245 3,930 3.2237 1 1 2 4 7
246 28,818 5.3370 1 2 4 7 12
247 188,884 2.1674 1 1 1 3 4
248 13,847 5.9831 1 2 4 8 12
249 69,978 2.4966 1 1 2 3 5
250 6,762 7.7798 1 3 6 10 16
251 41,707 2.8343 1 1 2 4 6
252 45,567 8.5378 1 3 6 11 18
253 44,910 6.0144 1 2 5 8 13
254 53,360 2.7299 1 1 2 3 6
255 2,521 9.6942 2 4 8 12 18
256 3,425 7.4762 2 4 6 9 13
257 705 4.8482 1 2 4 7 10
258 686 7.3761 2 3 6 9 14
259 7,302 2.8020 1 1 2 4 6
260 1,549 11.2214 3 5 8 14 22
261 3,522 4.2127 1 1 3 6 9
262 3,531 2.5902 1 1 2 3 6
263 652 5.4126 1 1 3 7 13
264 28,273 8.8998 1 3 6 11 19
265 1,957 3.4716 1 1 2 4 8
280 63,593 7.3381 2 4 6 9 13
281 53,704 4.8075 2 3 4 6 9
282 54,305 3.2480 1 2 3 4 6
283 14,888 5.4547 1 1 3 7 13
284 4,139 3.2341 1 1 2 4 7
285 2,803 2.2112 1 1 1 3 5
286 23,695 6.9333 2 3 5 9 14
287 158,158 3.1457 1 1 2 4 6
288 2,953 11.7541 4 6 9 14 22
289 1,357 8.6610 3 5 7 11 15
290 473 6.4947 2 4 5 8 11
291 187,597 6.4926 2 3 5 8 12
292 204,514 4.9936 2 3 4 6 9
293 196,441 3.6816 1 2 3 5 6
294 1,415 5.5611 2 3 5 7 9
295 1,343 4.3291 2 3 4 6 7
296 1,917 3.0303 1 1 1 3 7
297 791 1.8217 1 1 1 2 3
298 602 1.3040 1 1 1 1 2
299 17,750 6.6518 2 3 5 8 12
300 44,551 5.0493 2 3 4 6 9
301 36,994 3.6992 1 2 3 5 7
302 7,587 4.3756 1 2 3 5 8
303 70,544 2.5315 1 1 2 3 5
304 2,086 5.1942 1 2 4 7 10
305 35,079 2.8628 1 1 2 4 5
306 1,515 6.2964 1 3 4 8 12
307 6,344 3.4455 1 2 3 4 6
308 35,699 5.5438 1 2 4 7 11
309 79,311 3.9373 1 2 3 5 7
310 158,556 2.7530 1 1 2 4 5
311 21,034 2.3089 1 1 2 3 4
312 165,835 3.1053 1 2 2 4 6
313 211,391 2.1067 1 1 2 3 4
314 61,613 7.0205 2 3 5 9 14
315 29,960 4.6041 1 2 4 6 9
316 17,966 2.9978 1 1 2 4 6
326 11,226 17.1201 6 9 14 21 32
327 10,457 10.0519 3 5 8 13 18
328 8,865 4.3610 1 2 3 6 9
329 48,110 15.9561 6 9 13 20 29
330 63,624 9.7138 4 6 8 12 17
331 28,171 5.8793 3 4 5 7 9
332 1,823 14.3489 6 8 12 18 25
333 5,922 8.8349 4 6 8 10 15
334 3,719 5.5052 2 4 5 7 9
335 7,182 14.0778 5 8 12 18 25
336 12,448 9.0917 3 5 8 11 16
337 8,570 5.5883 1 3 5 8 10
338 1,501 10.7082 4 6 9 13 19
339 3,163 7.0452 3 4 6 9 12
340 3,558 4.1521 2 2 4 5 7
341 878 7.1287 2 3 5 9 14
342 2,544 4.1395 1 2 3 5 8
343 6,975 2.1792 1 1 2 3 4
344 936 11.7575 4 6 9 15 22
345 2,914 7.2447 3 4 6 9 12
346 2,759 4.9467 2 3 5 6 8
347 1,625 8.8166 2 4 7 11 17
348 4,164 5.7366 2 3 5 7 11
349 5,155 3.0795 1 1 2 4 6
350 1,756 7.9897 2 3 6 10 16
351 4,287 4.5573 1 2 4 6 9
352 8,183 2.4793 1 1 2 3 5
353 3,165 8.4051 2 4 7 11 16
354 8,420 5.0816 2 3 4 6 9
355 15,316 2.8995 1 1 2 4 5
356 8,334 12.9144 3 6 10 16 25
357 7,801 8.1406 2 4 6 10 16
358 2,477 4.4719 1 2 4 6 9
368 3,566 6.5979 2 3 5 8 13
369 5,248 4.7487 2 3 4 6 9
370 3,554 3.3995 1 2 3 4 6
371 24,371 8.7488 3 4 7 11 17
372 27,061 6.8532 3 4 6 8 12
373 15,249 4.9382 2 3 4 6 8
374 9,039 8.5759 2 4 7 11 16
375 18,945 6.0287 2 3 5 8 12
376 4,279 4.1837 1 2 3 5 8
377 51,556 6.3806 2 3 5 8 12
378 110,340 4.4472 2 3 4 5 8
379 92,136 3.4088 1 2 3 4 6
380 3,020 7.2738 2 3 6 9 14
381 5,293 5.1734 2 3 4 6 9
382 4,492 3.6814 1 2 3 5 7
383 1,223 5.5200 2 3 4 7 10
384 8,080 3.7490 1 2 3 5 7
385 1,996 8.8191 3 4 6 11 18
386 7,126 5.6996 2 3 5 7 10
387 5,033 4.2935 1 2 4 5 8
388 18,540 7.3159 2 3 6 9 14
389 45,795 5.0160 2 3 4 6 9
390 46,426 3.5522 1 2 3 4 6
391 44,299 5.2367 1 2 4 6 10
392 282,071 3.4889 1 2 3 4 6
393 23,253 6.8917 2 3 5 8 14
394 45,853 4.8196 1 2 4 6 9
395 24,740 3.3344 1 2 3 4 6
405 3,963 17.0056 5 8 13 21 34
406 5,300 9.1566 2 5 7 11 18
407 2,115 5.4851 1 3 5 7 10
408 1,548 14.9961 6 8 12 18 28
409 1,737 9.8290 4 6 8 12 18
410 598 6.5033 2 4 6 8 11
411 956 12.4069 5 7 10 15 22
412 955 8.5696 4 6 8 11 14
413 756 5.9272 2 4 5 7 10
414 5,241 11.7296 5 7 10 14 21
415 6,127 7.6236 3 5 7 9 13
416 5,328 4.8281 2 3 4 6 8
417 16,444 8.3803 3 4 7 10 16
418 27,075 5.6341 2 3 5 7 10
419 35,887 3.1911 1 1 3 4 6
420 766 13.6606 3 6 10 17 26
421 1,054 7.6879 2 3 6 10 16
422 327 4.3609 1 2 4 6 8
423 1,542 15.8599 4 7 12 20 32
424 894 10.4172 3 5 8 14 20
425 125 5.3760 1 2 4 7 10
432 15,140 6.9542 2 3 5 9 14
433 9,672 4.8719 1 2 4 6 9
434 877 3.6933 1 2 3 5 6
435 12,111 7.5614 2 3 6 10 15
436 13,158 5.8396 2 3 5 8 11
437 3,887 4.2529 1 2 3 6 8
438 14,063 7.5128 2 3 5 9 15
439 24,364 5.3275 2 3 4 7 10
440 25,670 3.8103 1 2 3 5 7
441 13,335 7.0467 2 3 5 9 14
442 14,144 5.1103 2 2 4 6 9
443 6,544 3.7796 1 2 3 5 7
444 12,898 6.6243 2 3 5 8 13
445 16,794 4.7264 1 2 4 6 9
446 15,932 3.2658 1 2 3 4 6
453 948 15.6561 5 7 12 19 29
454 1,771 8.0237 3 4 6 10 14
455 1,969 4.4307 1 3 4 5 7
456 946 14.7061 5 7 11 19 28
457 2,413 7.4836 3 4 6 9 13
458 1,609 4.5438 2 3 4 6 7
459 3,508 9.4478 4 5 7 11 17
460 51,883 4.2180 2 3 4 5 7
461 1,018 8.4342 3 5 6 9 14
462 13,194 4.2178 3 3 4 5 6
463 5,052 16.5713 5 7 12 20 33
464 5,838 10.2205 3 5 8 12 20
465 2,398 5.8661 1 3 5 7 11
466 4,072 9.1717 3 5 7 11 16
467 14,331 5.4882 3 3 4 6 9
468 21,133 3.9306 2 3 3 4 6
469 30,531 8.2004 3 5 7 10 14
470 405,204 3.9281 3 3 3 4 6
471 2,283 9.7946 2 4 7 13 20
472 6,954 4.0913 1 1 3 5 9
473 22,875 1.9623 1 1 1 2 4
474 2,918 12.6453 4 6 10 15 24
475 3,277 8.3946 3 4 7 11 15
476 1,589 4.7885 1 2 4 6 9
477 2,582 11.8548 3 6 9 15 22
478 8,562 6.6119 1 3 6 9 13
479 11,424 2.8188 1 1 1 4 7
480 26,724 9.2958 4 5 8 11 16
481 72,123 5.9291 3 4 5 7 9
482 48,111 4.8427 3 4 4 6 7
483 7,100 4.2093 2 2 3 5 8
484 17,842 2.4311 1 2 2 3 4
485 1,183 12.1116 4 6 10 15 22
486 2,186 8.0425 3 5 7 10 14
487 1,312 5.6715 3 3 5 7 9
488 2,495 5.2236 2 3 4 6 10
489 5,763 3.0465 1 2 3 4 5
490 22,971 4.3437 1 1 3 5 9
491 52,406 2.2104 1 1 2 3 4
492 5,216 8.5299 3 5 7 11 15
493 16,899 5.2510 2 3 4 6 9
494 29,166 3.3992 1 2 3 4 6
495 1,970 10.9609 3 5 8 14 21
496 5,555 5.9802 2 3 5 7 11
497 6,632 3.0054 1 1 2 4 6
498 1,163 7.8865 2 3 6 10 16
499 1,110 2.9757 1 1 2 4 6
500 1,502 10.8309 3 5 8 14 21
501 3,872 5.9698 2 3 5 8 12
502 6,452 2.9416 1 1 2 4 6
503 833 9.4586 3 5 7 11 17
504 2,162 6.4510 2 3 6 8 12
505 3,004 3.3832 1 2 3 4 6
506 810 3.4074 1 1 2 4 7
507 836 5.1459 1 2 4 6 10
508 2,481 2.0512 1 1 1 2 3
509 627 3.1100 1 1 2 3 7
510 973 6.4070 2 3 5 8 12
511 3,926 3.9758 1 2 3 5 7
512 10,961 2.1581 1 1 2 3 4
513 1,052 5.0266 1 2 4 6 10
514 1,006 2.8191 1 1 2 3 6
515 3,818 10.4445 3 5 8 13 20
516 11,280 5.9870 1 3 5 8 11
517 17,523 3.0079 1 1 2 4 7
533 822 6.6861 2 3 5 8 12
534 3,392 4.0292 1 2 3 5 7
535 6,990 6.2365 2 3 5 8 12
536 33,661 3.9328 2 3 3 5 7
537 665 4.4722 2 3 4 5 8
538 1,056 3.2197 1 2 3 4 6
539 3,417 9.7085 3 5 8 12 17
540 4,016 7.1257 3 4 6 8 13
541 1,618 5.3745 2 3 4 7 9
542 5,709 8.7758 3 4 7 11 17
543 17,012 5.9463 2 3 5 7 11
544 10,798 4.4077 2 3 4 5 8
545 4,079 9.0924 2 4 6 11 19
546 5,577 5.5338 2 3 4 7 10
547 4,533 3.8083 1 2 3 5 7
548 580 8.9379 3 4 7 11 17
549 1,110 6.3874 2 3 5 8 12
550 858 4.4545 2 2 4 6 8
551 10,066 7.1058 2 3 6 9 14
552 85,179 4.1225 1 2 3 5 7
553 3,076 5.9620 2 3 5 7 11
554 19,173 3.6913 1 2 3 5 7
555 2,013 4.8405 1 2 4 6 9
556 18,639 3.1089 1 2 3 4 6
557 3,646 6.6100 2 3 5 8 12
558 15,089 4.2586 2 2 4 5 7
559 1,815 7.5444 2 3 6 9 15
560 4,319 4.7217 1 2 4 6 9
561 7,107 2.7680 1 1 2 3 5
562 5,458 6.3674 2 3 5 8 12
563 36,267 3.7016 1 2 3 4 6
564 1,661 6.9934 2 3 5 9 13
565 3,311 4.9795 2 3 4 6 9
566 2,624 3.6825 1 2 3 5 7
573 5,477 13.0933 4 6 9 16 26
574 11,123 9.3248 3 5 7 11 17
575 5,462 5.8521 2 3 5 7 11
576 547 12.9506 2 4 9 17 28
577 2,228 6.1104 1 2 4 8 13
578 3,054 3.3062 1 1 2 4 7
579 3,511 10.6830 3 5 8 14 21
580 10,711 5.5084 1 2 4 7 12
581 12,142 2.6146 1 1 2 3 6
582 5,337 2.8943 1 1 2 3 5
583 8,748 1.8056 1 1 1 2 3
584 668 5.9850 1 2 4 8 13
585 1,469 2.2321 1 1 1 2 4
592 4,178 8.8712 3 4 7 10 16
593 12,304 6.4415 2 3 5 8 11
594 2,751 5.0593 2 3 4 6 9
595 1,112 8.3327 2 4 6 10 16
596 5,308 4.7600 1 2 4 6 8
597 458 8.2009 2 3 6 10 16
598 1,400 5.7243 2 3 4 7 11
599 306 3.7320 1 1 3 4 6
600 682 5.0513 2 3 4 7 9
601 884 3.8541 1 2 3 5 7
602 22,088 7.0278 2 4 6 9 13
603 130,121 4.7073 2 3 4 6 8
604 2,660 5.6590 1 3 4 7 11
605 22,097 3.4622 1 2 3 4 6
606 1,350 6.3422 1 3 4 7 12
607 7,168 3.7913 1 2 3 5 7
614 1,457 7.0336 2 3 5 8 14
615 1,546 3.1572 1 2 3 4 5
616 1,091 16.9432 6 9 13 20 31
617 6,718 8.7904 3 5 7 11 15
618 258 6.3605 2 3 6 8 11
619 696 8.2011 2 3 5 9 18
620 2,186 3.6780 1 2 3 4 7
621 7,848 2.1617 1 1 2 3 4
622 1,112 13.1574 3 6 9 16 24
623 3,077 8.5707 3 4 7 10 15
624 383 6.0261 2 3 5 7 10
625 1,274 7.0879 1 2 5 9 15
626 2,538 3.1233 1 1 2 3 7
627 14,026 1.5172 1 1 1 2 2
628 3,366 11.1851 2 4 8 14 23
629 4,160 8.7418 3 5 7 11 16
630 534 5.5281 1 2 4 7 11
637 17,104 6.0581 2 3 5 7 12
638 42,581 4.2659 1 2 3 5 8
639 38,312 3.0382 1 2 2 4 5
640 60,806 5.4332 1 2 4 7 11
641 201,324 3.8256 1 2 3 5 7
642 1,492 5.1810 1 2 4 6 9
643 5,176 7.6103 2 4 6 9 14
644 11,788 5.4597 2 3 4 7 10
645 8,179 3.8912 1 2 3 5 7
652 10,067 7.7888 4 5 6 9 13
653 1,697 16.8981 7 9 13 21 31
654 3,452 9.8624 5 7 8 11 16
655 1,633 6.5150 3 5 7 8 10
656 3,918 10.1146 4 5 8 12 19
657 7,422 5.9603 3 4 5 7 10
658 8,271 3.7356 2 2 3 5 6
659 4,658 11.2003 3 5 8 14 22
660 7,594 6.5146 2 3 5 8 13
661 4,260 3.2758 1 2 3 4 6
662 949 10.2740 2 4 8 14 20
663 2,054 5.2639 1 2 4 7 11
664 4,390 2.1223 1 1 1 2 4
665 654 11.0627 3 5 9 14 21
666 2,092 6.3595 1 2 4 9 14
667 3,616 2.8695 1 1 2 3 6
668 3,833 8.5265 2 4 7 11 16
669 12,746 4.4236 1 2 3 6 9
670 11,687 2.5131 1 1 2 3 5
671 808 5.9468 1 2 4 8 12
672 943 2.5302 1 1 2 3 5
673 12,542 9.7323 1 3 7 13 21
674 11,715 7.1905 1 2 5 9 15
675 7,824 2.0675 1 1 1 2 4
682 82,091 7.1569 2 3 5 9 14
683 132,320 5.6544 2 3 5 7 10
684 44,932 3.8913 1 2 3 5 7
685 2,331 3.4822 1 1 2 4 7
686 1,597 7.5717 2 3 6 9 15
687 3,261 5.3502 1 3 4 7 10
688 1,073 3.2591 1 1 2 4 6
689 55,995 6.2004 2 3 5 8 11
690 198,101 4.2356 2 2 4 5 7
691 821 3.9586 1 2 3 5 8
692 491 2.3992 1 1 2 3 5
693 2,429 4.8345 1 2 4 6 10
694 18,000 2.5778 1 1 2 3 5
695 975 5.5251 1 3 4 7 11
696 10,518 3.2901 1 2 3 4 6
697 592 3.1115 1 1 2 4 6
698 23,320 6.6546 2 3 5 8 13
699 24,207 4.8302 1 2 4 6 9
700 12,279 3.5497 1 2 3 4 7
707 5,979 4.4131 1 2 3 5 8
708 18,063 2.1475 1 1 2 3 4
709 762 6.5341 1 2 4 8 15
710 1,831 1.7739 1 1 1 2 3
711 790 8.1684 1 3 6 10 16
712 705 3.0496 1 1 2 4 7
713 10,252 4.1916 1 2 3 5 9
714 28,797 1.9430 1 1 2 2 3
715 531 6.2806 1 2 4 8 13
716 1,273 1.4289 1 1 1 1 2
717 703 7.2319 2 3 5 9 14
718 589 2.7640 1 1 2 3 5
722 745 7.5852 2 3 6 10 14
723 1,949 5.2678 1 3 4 7 10
724 578 3.1522 1 1 2 4 6
725 755 5.5007 2 3 4 7 10
726 3,716 3.4739 1 2 3 4 6
727 1,294 6.3995 2 3 5 8 12
728 6,158 4.0404 1 2 3 5 7
729 591 5.5736 1 2 4 7 10
730 471 3.0786 1 1 2 4 6
734 1,362 7.9941 3 4 6 9 15
735 1,130 3.3602 1 2 3 4 5
736 854 13.7752 5 7 11 17 25
737 3,293 7.1786 3 4 6 8 13
738 863 3.8714 2 3 3 5 6
739 1,013 10.1955 3 5 8 12 20
740 4,326 5.2305 2 3 4 6 9
741 6,014 2.9940 1 2 3 4 5
742 10,950 4.5175 2 2 3 5 8
743 32,325 2.2608 1 2 2 3 3
744 1,520 5.8355 1 2 4 7 12
745 1,694 2.5738 1 1 2 3 5
746 2,634 4.2134 1 2 3 5 8
747 10,409 1.8856 1 1 2 2 3
748 19,857 1.7358 1 1 1 2 3
749 982 9.3401 2 4 7 12 19
750 435 3.1103 1 1 2 4 6
754 978 8.3395 2 4 7 11 16
755 2,933 5.6870 2 3 4 7 11
756 677 3.1359 1 1 2 4 6
757 1,393 8.1436 3 4 6 10 16
758 1,605 6.0536 2 3 5 7 11
759 1,239 4.4722 2 2 4 5 8
760 1,700 3.9594 1 2 3 5 8
761 1,749 2.4351 1 1 2 3 5
765 2,754 5.0359 2 3 4 5 7
766 2,686 3.1601 2 2 3 4 4
767 132 3.3712 2 2 2 3 5
768 6 3.5000 1 2 3 6 6
769 98 4.6224 1 2 3 6 11
770 202 2.2277 1 1 1 2 5
774 1,506 3.1886 2 2 2 3 5
775 5,768 2.2394 1 2 2 3 3
776 511 3.3112 1 2 2 4 7
777 206 2.2136 1 1 2 3 4
778 474 3.0127 1 1 2 3 5
779 110 2.1182 1 1 1 2 3
780 40 1.4500 1 1 1 1 3
781 3,017 3.7630 1 1 2 4 7
782 171 2.4971 1 1 1 2 4
790 1 25.0000 125 125 125 125 125
799 566 14.0583 5 7 11 18 26
800 705 7.8610 3 4 6 9 15
801 557 4.9336 2 2 4 6 9
802 765 12.2706 3 5 9 15 25
803 1,070 6.6738 1 3 5 8 14
804 987 3.4215 1 1 3 4 6
808 6,088 8.2467 3 4 6 10 16
809 12,869 5.3247 2 3 4 7 10
810 2,786 4.0337 1 2 3 5 7
811 21,404 5.6912 1 2 4 7 11
812 89,951 3.7401 1 2 3 5 7
813 14,232 5.1669 1 2 4 6 10
814 1,554 6.7368 2 3 5 8 13
815 3,297 4.9706 1 2 4 6 9
816 2,147 3.5198 1 2 3 4 7
820 1,299 17.7229 5 8 14 23 34
821 2,474 7.8646 1 3 6 10 16
822 1,893 3.5288 1 1 3 4 7
823 2,178 15.4385 5 8 12 20 29
824 2,974 8.7492 2 4 7 11 17
825 1,748 4.3084 1 1 3 6 9
826 524 15.0401 4 7 11 19 29
827 1,254 7.9793 2 4 6 10 16
828 799 3.7722 1 2 3 5 7
829 1,171 10.6576 2 4 7 13 22
830 521 3.7179 1 1 2 4 8
834 4,028 15.4615 2 4 10 23 36
835 2,703 10.4351 2 3 6 12 28
836 1,622 5.1843 1 2 3 6 10
837 1,043 23.1419 5 10 23 31 42
838 1,320 12.2629 3 4 6 21 29
839 1,467 6.4104 3 4 5 6 10
840 9,659 10.4408 3 5 8 13 21
841 10,035 6.9221 2 3 5 9 13
842 5,310 4.5563 1 2 4 6 9
843 1,350 8.5222 2 4 6 10 17
844 2,412 6.0987 2 3 5 8 12
845 804 4.3022 1 2 3 6 8
846 2,113 8.4179 2 3 5 10 18
847 23,862 3.3508 1 2 3 4 6
848 1,723 3.1294 1 1 3 4 5
849 1,477 5.9709 2 3 5 6 12
853 34,852 16.6669 5 8 13 21 30
854 6,643 11.1072 4 6 9 14 20
855 459 7.0261 2 4 6 9 13
856 5,892 15.3839 4 7 12 19 30
857 9,614 8.4628 3 4 7 10 16
858 3,246 5.6741 2 3 5 7 10
862 7,929 8.1778 2 4 6 10 16
863 21,420 5.1976 2 3 4 7 9
864 18,946 4.0639 1 2 3 5 7
865 1,705 6.7009 2 3 4 8 14
866 8,182 3.5351 1 2 3 4 7
867 5,062 9.6254 2 4 7 12 19
868 2,641 5.7819 2 3 4 7 11
869 1,103 4.3128 2 2 4 5 7
870 21,199 15.4758 6 9 13 19 27
871 216,384 7.4839 2 3 6 10 14
872 90,892 5.7138 2 3 5 7 10
876 857 11.9498 2 5 9 14 24
880 9,282 3.1518 1 1 2 4 6
881 4,623 4.1888 1 2 3 5 8
882 1,556 4.4274 1 2 3 6 9
883 757 7.3725 1 2 4 8 15
884 19,006 5.4936 2 3 4 6 10
885 80,806 7.6211 2 3 6 9 14
886 404 6.0767 1 2 4 7 12
887 393 4.6209 1 2 3 5 8
894 4,369 2.9528 1 1 2 3 4
895 6,958 10.4997 3 4 6 7 9
896 5,490 6.6087 2 3 5 8 13
897 36,053 4.0582 1 2 3 5 6
901 924 15.0693 3 6 10 18 30
902 2,031 7.7371 2 3 6 9 16
903 1,500 4.5680 1 2 4 6 9
904 1,046 11.2237 2 4 7 13 23
905 811 4.6523 1 2 4 6 8
906 710 3.1451 1 1 2 4 6
907 8,461 11.6506 2 5 8 14 23
908 8,319 6.7682 2 3 5 8 13
909 5,447 3.6367 1 1 3 5 7
913 804 5.6629 1 3 4 7 12
914 6,609 3.4330 1 2 3 4 6
915 1,078 4.7356 1 2 3 6 9
916 5,508 2.1044 1 1 2 3 4
917 15,775 5.1645 1 2 4 6 11
918 35,653 2.7260 1 1 2 3 5
919 11,089 6.3723 2 3 5 8 13
920 13,970 4.3608 1 2 3 5 8
921 9,423 2.9687 1 1 2 4 6
922 1,047 5.9933 1 2 4 7 12
923 3,952 3.2338 1 1 2 4 6
927 211 31.1374 7 15 26 41 60
928 818 15.9694 4 7 12 21 31
929 438 7.6872 1 3 6 10 16
933 139 4.3453 1 1 1 4 8
934 659 6.1988 1 3 5 8 12
935 2,201 5.4330 1 2 4 7 11
939 671 10.0611 2 4 7 13 20
940 1,320 5.4220 1 2 4 7 12
941 1,707 2.7299 1 1 2 3 5
945 6,244 10.4947 4 6 8 12 15
946 3,055 7.8628 3 5 6 7 8
947 9,715 5.0101 1 2 4 6 10
948 47,722 3.4806 1 2 3 4 6
949 632 4.1092 1 1 2 4 6
950 387 3.4858 1 1 2 4 5
951 940 4.6436 1 1 2 3 6
955 444 12.2658 2 5 10 16 26
956 3,976 9.2912 4 5 7 11 17
957 1,318 14.8566 2 7 12 19 28
958 1,147 10.4080 3 6 8 13 19
959 291 6.2921 2 3 5 8 11
963 1,586 9.5214 2 4 8 13 19
964 2,573 6.2274 2 3 5 8 11
965 1,072 4.1371 1 2 3 5 7
969 639 18.8279 4 8 14 22 36
970 136 9.8309 2 3 7 12 17
974 5,920 10.3723 2 4 8 13 21
975 4,674 7.0148 2 3 5 9 13
976 2,617 4.9308 2 2 4 6 8
977 4,565 5.2931 1 2 4 6 10
981 25,478 15.1488 5 8 12 19 28
982 18,329 9.7455 3 5 8 12 18
983 6,112 5.3613 1 2 4 7 11
984 671 14.6811 5 8 13 18 25
985 903 9.6512 2 5 8 13 18
986 731 5.3338 1 2 3 7 12
987 8,240 13.0089 4 6 10 16 24
988 11,583 7.8090 2 3 6 10 15
989 5,796 4.1046 1 1 3 6 9
11,387,276

State Urban Rural
Alabama 0.261 0.33
Alaska 0.401 0.745
Arizona 0.288 0.418
Arkansas 0.32 0.368
California 0.225 0.303
Colorado 0.281 0.437
Connecticut 0.399 0.528
Delaware 0.495 0.513
District of Columbia * 0.345
Florida 0.238 0.281
Georgia 0.329 0.39
Hawaii 0.382 0.453
Idaho 0.468 0.534
Illinois 0.305 0.395
Indiana 0.39 0.466
Iowa 0.357 0.444
Kansas 0.288 0.424
Kentucky 0.37 0.371
Louisiana 0.299 0.353
Maine 0.498 0.462
Maryland 0.726 0.793
Massachusetts * 0.471
Michigan 0.364 0.462
Minnesota 0.391 0.53
Mississippi 0.302 0.355
Missouri 0.33 0.399
Montana 0.422 0.465
Nebraska 0.335 0.46
Nevada 0.22 0.478
New Hampshire 0.457 0.427
New Jersey * 0.178
New Mexico 0.377 0.36
New York 0.346 0.522
North Carolina 0.402 0.396
North Dakota 0.428 0.457
Ohio 0.338 0.522
Oklahoma 0.293 0.383
Oregon 0.452 0.415
Pennsylvania 0.267 0.413
Puerto Rico * 0.474
Rhode Island * 0.388
South Carolina 0.284 0.301
South Dakota 0.335 0.43
Tennessee 0.297 0.371
Texas 0.257 0.342
Utah 0.414 0.572
Vermont 0.543 0.619
Virginia 0.358 0.357
Washington 0.385 0.443
West Virginia 0.471 0.462
Wisconsin 0.425 0.458
Wyoming 0.431 0.562
* All counties in the State or Territory are classified as urban, with the exception of Massachusetts, which has areas designated as rural. However, no short-term acute care IPPS hospitals are located in those areas as of March 2008.

State Ratio
Alabama 0.024
Alaska 0.036
Arizona 0.023
Arkansas 0.025
California 0.015
Colorado 0.028
Connecticut 0.028
Delaware 0.035
District of Columbia 0.022
Florida 0.022
Georgia 0.028
Hawaii 0.03
Idaho 0.038
Illinois 0.026
Indiana 0.037
Iowa 0.028
Kansas 0.03
Kentucky 0.029
Louisiana 0.026
Maine 0.03
Maryland 0.058
Massachusetts 0.031
Michigan 0.03
Minnesota 0.028
Mississippi 0.027
Missouri 0.029
Montana 0.034
Nebraska 0.039
Nevada 0.021
New Hampshire 0.032
New Jersey 0.013
New Mexico 0.032
New York 0.026
North Carolina 0.032
North Dakota 0.037
Ohio 0.028
Oklahoma 0.026
Oregon 0.031
Pennsylvania 0.022
Puerto Rico 0.042
Rhode Island 0.02
South Carolina 0.024
South Dakota 0.032
Tennessee 0.03
Texas 0.026
Utah 0.032
Vermont 0.045
Virginia 0.036
Washington 0.03
West Virginia 0.034
Wisconsin 0.037
Wyoming 0.044

State Urban Rural
Alabama 0.279 0.36
Alaska 0.432 0.806
Arizona 0.311 0.448
Arkansas 0.343 0.401
California 0.238 0.322
Colorado 0.307 0.479
Connecticut 0.426 0.576
Delaware 0.529 0.551
District of Columbia * 0.368
Florida 0.259 0.311
Georgia 0.355 0.424
Hawaii 0.411 0.487
Idaho 0.506 0.576
Illinois 0.33 0.427
Indiana 0.426 0.507
Iowa 0.381 0.483
Kansas 0.314 0.463
Kentucky 0.398 0.401
Louisiana 0.325 0.38
Maine 0.529 0.49
Maryland *** 0.34 0.434
Massachusetts ** 0.502
Michigan 0.393 0.497
Minnesota 0.418 0.569
Mississippi 0.328 0.384
Missouri 0.357 0.438
Montana 0.453 0.505
Nebraska 0.371 0.505
Nevada 0.24 0.539
New Hampshire 0.489 0.459
New Jersey ** 0.19
New Mexico 0.408 0.394
New York 0.372 0.558
North Carolina 0.434 0.431
North Dakota 0.461 0.505
Ohio 0.365 0.563
Oklahoma 0.318 0.414
Oregon 0.484 0.444
Pennsylvania 0.287 0.443
Puerto Rico ** 0.514
Rhode Island ** 0.408
South Carolina 0.308 0.327
South Dakota 0.365 0.466
Tennessee 0.326 0.406
Texas 0.282 0.374
Utah 0.445 0.622
Vermont 0.594 0.657
Virginia 0.393 0.398
Washington 0.414 0.473
West Virginia 0.505 0.496
Wisconsin 0.462 0.497
Wyoming 0.467 0.616
* All counties in the State or Territory are classified as urban, with the exception of Massachusetts, which has areas designated as rural. However, no short-term acute care IPPS hospitals or LTCHs are located in those areas as of March 2008.
** National average IPPS total cost-to-charge ratios, as discussed in section VI.E. of this proposed rule.

Provider No. Geographic CBSA Reclassified CBSA LUGAR
010001 20020 10500
010005 01 26620
010009 19460 26620
010010 01 13820
010012 01 40660
010022 01 12060
010025 01 17980
010029 12220 17980
010035 01 13820
010052 01 33860
010054 19460 26620
010055 20020 37460
010059 19460 26620
010061 01 16860
010065 01 13820
010083 01 37860
010085 19460 26620
010090 33660 37700
010100 01 37860
010101 01 13820
010102 01 33860
010118 01 33860
010126 01 33860
010143 01 26620
010150 01 33860
010158 01 22520
010164 01 13820
020008 02 11260
030007 39140 22380 LUGAR
030033 03 22380
030055 29420 39140
030069 29420 40140
030101 29420 29820
040014 04 30780
040017 04 22220
040019 04 32820
040020 27860 32820
040027 04 44180
040039 04 27860
040041 04 30780
040069 04 32820
040071 38220 30780
040076 04 30780 LUGAR
040078 26300 30780
040080 04 27860
040085 04 32820
040088 04 33740
040091 04 45500
040119 04 30780
050006 05 39820
050009 34900 46700
050013 34900 46700
050014 05 40900
050022 40140 42044
050038 41940 42100
050042 05 39820
050046 37100 31084
050054 40140 42044
050069 42044 31084
050071 41940 42100
050073 46700 36084
050076 41884 36084
050082 37100 31084
050089 40140 31084
050090 42220 41884
050099 40140 31084
050101 46700 36084
050102 40140 42044
050118 44700 33700
050125 41940 42100
050129 40140 31084
050131 41884 36084
050133 49700 40900
050136 42220 41884
050140 40140 31084
050150 05 40900
050153 41940 42100
050159 37100 31084
050168 42044 31084
050173 42044 31084
050174 42220 41884
050188 41940 42100
050193 42044 31084
050194 42100 41940
050197 41884 41940
050224 42044 31084
050226 42044 31084
050230 42044 31084
050236 37100 31084
050242 42100 41940
050243 40140 42044
050245 40140 31084
050272 40140 31084
050279 40140 31084
050291 42220 41884
050292 40140 42044
050300 40140 31084
050301 05 42220
050308 41940 42100
050327 40140 31084
050329 40140 42044
050335 05 33700
050348 42044 31084
050360 41884 36084
050367 46700 36084
050380 41940 42100
050385 42220 41884
050390 40140 42044
050394 37100 31084
050423 40140 42044
050426 42044 31084
050441 41940 42100
050476 05 42220
050494 05 40900
050510 41884 36084
050517 40140 31084
050526 42044 31084
050534 40140 42044
050541 41884 41940
050543 42044 31084
050547 42220 41884
050548 42044 31084
050549 37100 31084
050551 42044 31084
050567 42044 31084
050570 42044 31084
050573 40140 42044
050580 42044 31084
050586 40140 31084
050589 42044 31084
050603 42044 31084
050604 41940 42100
050609 42044 31084
050616 37100 31084
050662 41940 42100
050667 34900 46700
050678 42044 31084
050680 46700 36084
050684 40140 42044
050686 40140 42044
050688 41940 42100
050690 42220 41884
050693 42044 31084
050694 40140 42044
050701 40140 42044
050709 40140 31084
050720 42044 31084
050744 42044 31084
050745 42044 31084
050746 42044 31084
050747 42044 31084
050749 37100 31084
050758 40140 31084
060003 14500 19740
060012 39380 17820
060023 24300 19740
060027 14500 19740
060031 17820 19740
060049 06 22660
060075 06 24300
060096 06 19740
060103 14500 19740
060116 14500 19740
070001 35300 35004
070003 07 25540 LUGAR
070004 07 25540
070005 35300 35004
070006 14860 35644
070010 14860 35644
070011 07 25540
070015 07 35644
070016 35300 35004
070017 35300 35004
070018 14860 35644
070019 35300 35004
070022 35300 35004
070028 14860 35644
070031 35300 35004
070033 14860 35644
070034 14860 35644
070036 25540 35300
070038 35300 35004
070039 35300 35004
080001 48864 37964
080003 48864 37964
080004 20100 48864
080006 08 20100
080007 08 36140
090001 47894 13644
090004 47894 13644
090011 47894 13644
100002 48424 22744
100014 19660 36740
100017 19660 36740
100022 33124 22744
100023 10 36740
100024 10 33124
100045 19660 36740
100047 39460 14600
100049 10 29460
100068 19660 36740
100072 19660 36740
100077 39460 14600
100080 48424 22744
100081 10 23020 LUGAR
100105 42680 38940
100109 10 36740
100130 48424 22744
100139 10 23540 LUGAR
100150 10 33124
100156 10 23540
100157 29460 45300
100160 10 33124
100168 48424 22744
100176 48424 22744
100217 42680 38940
100232 10 27260
100234 48424 22744
100236 39460 14600
100249 10 45300
100252 10 38940
100253 48424 22744
100258 48424 22744
100268 48424 22744
100269 48424 22744
100275 48424 22744
100287 48424 22744
100288 48424 22744
100292 10 23020 LUGAR
110001 19140 16860
110002 11 12060
110016 11 17980
110023 11 12060
110029 23580 12060
110038 11 45220
110040 11 12060 LUGAR
110041 11 12060
110054 40660 12060
110069 47580 31420
110075 11 42340
110095 11 10500
110112 11 10500
110121 11 45220
110122 46660 45220
110125 11 31420
110128 11 42340
110146 11 27260
110150 11 12060
110153 47580 31420
110168 40660 12060
110187 11 12060 LUGAR
110189 11 12060
120028 12 26180
130002 13 14260
130003 30300 28420
130049 17660 44060
130067 13 26820 LUGAR
140012 14 16974
140015 14 41180
140032 14 41180
140034 14 41180
140040 14 37900
140043 14 19340
140046 14 41180
140058 14 41180
140064 14 37900
140084 29404 16974
140100 29404 16974
140110 14 16974
140130 29404 16974
140135 19500 16580
140143 14 16974
140155 28100 16974
140160 14 40420
140164 14 41180
140186 28100 16974
140202 29404 16974
140291 29404 16974
150002 23844 16974
150004 23844 16974
150006 33140 43780
150008 23844 16974
150011 15 26900
150015 33140 23844
150018 21140 43780
150023 45460 26900
150026 21140 43780
150030 15 26900 LUGAR
150034 23844 16974
150042 15 14020
150045 15 23060
150048 15 17140
150051 14020 26900
150065 15 26900
150069 15 17140
150076 15 43780
150088 11300 26900
150090 23844 16974
150091 15 23060
150102 15 23844 LUGAR
150112 18020 26900
150113 11300 26900
150115 15 21780
150125 23844 16974
150126 23844 16974
150133 15 43780
150146 15 21140
150147 23844 16974
160001 16 11180
160016 16 11180
160057 16 26980
160064 16 47940
160080 16 19340
160089 16 26980
160147 16 11180
170006 17 27900
170012 17 48620
170013 17 48620
170020 17 48620
170023 17 48620
170068 17 11100
170120 17 27900
170142 17 45820
170175 17 48620
170190 17 45820
170193 17 48620
180002 18 49
180005 18 26580
180011 18 30460
180012 21060 31140
180013 14540 34980
180017 18 21060
180024 18 31140
180027 18 17300
180029 18 30460
180043 18 44
180044 18 26580
180048 18 31140
180049 18 30460
180050 18 28700
180066 18 34980
180069 18 26580
180078 18 26580
180080 18 28940
180093 18 21780
180102 18 17300
180104 18 17300
180116 18 14
180124 14540 34980
180127 18 31140
180132 18 30460
190003 19 29180
190015 19 35380
190017 19 29180
190086 19 33740
190088 19 43340
190106 19 10780
190144 19 43340
190164 19 10780
190167 19 29180
190184 19 33740
190191 19 29180
190208 19 04
190218 19 43340
190257 19 33740
200020 38860 40484
200024 30340 38860
200034 30340 38860
200039 20 38860
200050 20 12620
220001 49340 14484
220002 15764 14484
220008 39300 14484
220010 37764 14484
220011 15764 14484
220019 49340 14484
220020 39300 14484
220025 49340 14484
220029 37764 14484
220033 37764 14484
220035 37764 14484
220049 15764 14484
220058 49340 14484
220062 49340 14484
220063 15764 14484
220070 15764 14484
220073 39300 14484
220074 39300 14484
220077 44140 25540
220080 37764 14484
220082 15764 14484
220084 15764 14484
220090 49340 14484
220095 49340 14484
220098 15764 14484
220101 15764 14484
220105 15764 14484
220163 49340 14484
220171 15764 14484
220174 37764 14484
220175 15764 14484
220176 49340 14484
230002 19804 11460
230003 26100 34740
230013 47644 19804
230019 47644 19804
230020 19804 11460
230021 35660 28020
230022 23 29620
230024 19804 11460
230029 47644 19804
230030 23 40980
230035 23 24340 LUGAR
230036 23 13020
230037 23 11460
230038 24340 34740
230047 47644 19804
230053 19804 11460
230054 23 24580
230059 24340 34740
230069 47644 22420
230071 47644 19804
230072 26100 34740
230077 40980 22420
230080 23 13020
230089 19804 11460
230092 27100 11460
230095 23 13020
230096 23 28020
230097 23 24340
230099 33780 11460
230104 19804 11460
23B104 47644 19804
230105 23 13020
230106 24340 34740
230119 19804 11460
230121 23 29620 LUGAR
230130 47644 19804
230135 19804 11460
230142 19804 11460
230146 19804 11460
230151 47644 19804
230165 19804 11460
230174 26100 34740
230176 19804 11460
230195 47644 19804
230204 47644 19804
230207 47644 19804
230208 23 24340 LUGAR
230222 23 13020
230223 47644 19804
230227 47644 19804
230236 24340 34740
230244 19804 11460
230254 47644 19804
230257 47644 19804
230264 47644 19804
230269 47644 19804
230270 19804 11460
230273 19804 11460
230277 47644 19804
230279 47644 22420
230301 47644 19804
240030 24 41060
240036 41060 33460
240064 24 20260
240069 24 33460
240071 24 33460
240075 24 41060
240088 24 41060
240093 24 33460
240187 24 33460
250002 25 22520
250004 25 32820
250006 25 32820
250009 25 27180
250023 25 25060 LUGAR
250031 25 27140
250034 25 32820
250040 37700 25060
250042 25 32820
250044 25 22520
250069 25 46220
250078 25620 25060
250081 25 46220
250082 25 38220
250094 25620 25060
250097 25 12940
250099 25 27140
250100 25 46220
250104 25 46220
250117 25 25060 LUGAR
260009 26 28140
260015 26 27860
260017 26 27620
260022 26 16
260025 26 41180
260050 26 41140
260064 26 17860
260074 26 17860
260094 26 44180
260110 26 44180
260113 26 14
260116 26 14
260119 26 27860
260175 26 28140
260183 26 41180
260186 26 44180
270003 27 24500
270014 33540 17660
270017 27 33540
270051 27 33540
280009 28 30700
280023 28 30700
280032 28 30700
280061 28 53
280065 28 24540
280125 28 43580
290002 29 16180 LUGAR
290006 29 39900
290008 29 14260
290019 16180 39900
300001 30 31700
300011 31700 49340
300012 31700 49340
300017 40484 37764
300019 30 15764
300020 31700 49340
300023 40484 37764
300029 40484 37764
300034 31700 49340
310002 35084 35644
310009 35084 35644
310014 15804 37964
310015 35084 35644
310017 35084 35644
310018 35084 35644
310021 45940 35084
310022 15804 37964
310029 15804 37964
310031 15804 20764
310032 47220 48864
310038 20764 35644
310039 20764 35644
310048 20764 35084
310050 35084 35644
310054 35084 35644
310070 20764 35644
310076 35084 35644
310081 15804 37964
310083 35084 35644
310086 15804 37964
310093 35084 35644
310096 35084 35644
310108 20764 35644
310119 35084 35644
320003 32 42140
320005 22140 10740
320006 32 10740
320013 32 42140
320033 32 42140 LUGAR
320063 32 36220
320065 32 36220
330004 28740 39100
330008 33 15380 LUGAR
330023 39100 35644
330027 35004 35644
330049 39100 14860
330067 39100 14860
330073 33 40380 LUGAR
330085 33 45060
330090 21300 27060
330094 33 38340
330103 33 39
330106 35004 35644
330126 39100 35644
330136 33 45060
330157 33 45060
330167 35004 35644
330181 35004 35644
330182 35004 35644
330191 24020 10580
330198 35004 35644
330224 28740 39100
330225 35004 35644
330229 33 21500
330235 33 45060 LUGAR
330239 33 21500
330250 33 15540
330259 35004 35644
330277 33 27060
330331 35004 35644
330332 35004 35644
330372 35004 35644
330386 33 35084
340004 24660 49180
340008 34 22180
340010 24140 39580
340013 34 24860
340014 49180 24660
340015 34 16740
340021 34 16740
340023 11700 24860
340027 34 24780
340039 34 16740
340047 49180 24660
340050 34 22180
340051 34 25860
340068 34 34820
340069 39580 20500
340070 15500 24660
340071 34 39580 LUGAR
340073 39580 20500
340091 24660 49180
340109 34 47260
340114 39580 20500
340115 34 20500
340126 34 39580
340127 34 20500 LUGAR
340129 34 16740
340131 34 24780
340138 39580 20500
340144 34 16740
340145 34 16740 LUGAR
340147 40580 39580
340148 49180 24660
340173 39580 20500
350003 35 13900
350006 35 13900
350009 35 22020
360008 36 26580
360010 36 10420
360011 36 18140
360013 36 30620
360014 36 18140
360019 10420 17460
360020 10420 17460
360025 41780 45780
360027 10420 17460
360036 36 17460
360039 36 18140
360054 36 26580
360065 36 17460
360078 10420 17460
360086 44220 19380
360095 36 45780
360096 36 49660 LUGAR
360107 36 45780
360121 36 45780
360150 10420 17460
360159 36 18140
360175 36 18140
360185 36 49660 LUGAR
360187 44220 19380
360197 36 18140
360211 48260 38300
360245 36 17460 LUGAR
360253 19380 17140
370004 37 27900
370006 37 48620
370014 37 43300
370015 37 46140
370016 37 36420
370018 37 46140
370025 37 46140
370026 37 36420
370030 37 46140
370047 37 36420
370049 37 36420
370113 37 22220
370149 37 36420
380001 38 38900
380022 38 18700 LUGAR
380027 38 21660
380050 38 32780
380051 41420 38900
380090 38 21660
390006 39 25420
390013 39 25420
390016 39 49660
390031 39 39740 LUGAR
390044 39740 37964
390046 49620 29540
390048 39 25420
390065 39 13644
390066 30140 25420
390071 39 48700 LUGAR
390079 39 13780
390086 39 27780
390091 39 49660
390093 39 49660
390096 39740 37964
390110 27780 38300
390113 39 49660
390138 39 25420
390150 39 38300 LUGAR
390151 39 13644
390162 10900 35084
390163 38300 49660
390185 42540 10900
390313 39 39740 LUGAR
410001 39300 14484
410004 39300 14484
410005 39300 14484
410007 39300 14484
410010 39300 14484
410011 39300 14484
410012 39300 14484
410013 39300 35980
420007 43900 24860
420009 42 24860 LUGAR
420020 42 16700
420027 11340 24860
420030 42 16700
420036 42 16740
420039 42 43900 LUGAR
420062 42 16740
420067 42 42340
420068 42 16700
420069 42 44940 LUGAR
420070 44940 17900
420071 42 24860
420080 42 42340
420083 43900 24860
420085 34820 48900
420098 42 34820
430012 43 43620
430013 43 43620
430014 43 22020
430077 39660 16220
440002 27180 32820
440008 44 27180
440020 44 26620
440024 17420 16860
440025 44 34
440035 17300 34980
440056 34100 28940
440059 44 34980
440060 44 27180
440067 34100 28700
440068 44 16860
440072 44 32820
440073 44 34980
440144 44 34980
440148 44 34980
440151 44 34980
440185 17420 16860
440192 44 34980
450007 45 41700
450039 23104 19124
450064 23104 19124
450080 45 30980
450087 23104 19124
450099 45 11100
450133 33260 36220
450135 23104 19124
450137 23104 19124
450148 23104 19124
450178 45 36220
450187 45 26420
450196 45 19124
450211 45 30980
450214 45 26420
450224 45 46340
450283 45 19124 LUGAR
450324 43300 19124
450347 45 26420
450351 45 23104
450389 45 19124 LUGAR
450393 43300 19124
450395 45 26420
450419 23104 19124
450447 45 19124
450465 45 26420
450469 43300 19124
450484 45 30980
450508 45 30980
450547 45 19124
450563 23104 19124
450565 45 23104
450596 45 23104
450639 23104 19124
450656 45 30980
450672 23104 19124
450675 23104 19124
450677 23104 19124
450747 45 46340
450770 45 12420 LUGAR
450779 23104 19124
450813 45 41700
450830 45 36220
450872 23104 19124
450880 23104 19124
450886 23104 19124
460004 36260 41620
460005 36260 41620
460007 46 41100
460021 41100 29820
460026 46 39340
460039 46 30860
460041 36260 41620
460042 36260 41620
470001 47 30
470012 47 38340
490004 25500 16820
490005 49020 47894
490013 49 20500
490018 49 16820
490019 49 47894
490040 47894 13644
490042 13980 40220
490043 47894 13644
490048 40220 31340
490063 47894 13644
490079 49 24660
490097 49 40060
490101 47894 13644
490107 47894 13644
490122 47894 13644
500002 50 28420
500003 34580 42644
500007 34580 42644
500016 48300 42644
500021 45104 42644
500031 50 36500
500039 14740 42644
500041 31020 38900
500072 50 14740
500079 45104 42644
500108 45104 42644
500129 45104 42644
510001 34060 38300
510002 51 40220
510006 51 34060
510018 51 16620 LUGAR
510024 34060 38300
510046 51 13980
510047 51 38300
510050 48540 38300
510062 51 16620
510070 51 16620
510071 51 13980
510077 51 26580
520002 52 48140
520013 20740 33460
520021 29404 16974
520028 52 31540 LUGAR
520037 52 48140
520059 39540 33340
520071 52 33340 LUGAR
520076 52 31540
520096 39540 33340
520102 52 33340 LUGAR
520107 52 22540
520113 52 24580
520116 52 33340 LUGAR
520189 29404 16974
530014 16940 24540
530015 53 26820

Provider No. Geographic CBSA Redesignated rural area
050192 23420 05
050528 32900 05
050618 40140 05
100048 37860 10
100118 37380 10
100134 27260 10
140167 14 14
170137 29940 17
220051 38340 22
230078 35660 23
250017 25 25
260006 41140 26
260047 27620 26
260195 44180 26
330268 10580 33
360125 36 36
370054 36420 37
380040 13460 38
390130 27780 39
390183 39 39
440135 34980 44
450052 45 45
450078 10180 45
450243 10180 45
450348 45 45
490116 13980 49
500148 48300 50

MS-DRG Number of cases Threshold
1 655 $345,754
2 287 202,892
3 23,338 258,756
4 21,431 156,815
5 634 172,190
6 228 95,919
7 356 167,452
8 482 96,343
9 1,345 104,341
10 163 77,500
11 1,266 77,654
12 1,909 55,617
13 1,274 39,624
20 887 149,490
21 532 115,973
22 212 81,500
23 3,741 88,473
24 2,103 62,851
25 8,713 82,504
26 11,796 56,523
27 13,711 44,491
28 1,670 80,242
29 3,085 50,231
30 3,425 32,616
31 1,024 67,618
32 2,785 38,809
33 3,621 31,322
34 764 60,605
35 2,238 44,518
36 6,915 38,592
37 4,842 55,045
38 14,152 35,529
39 51,945 25,865
40 4,769 62,151
41 7,588 41,971
42 4,869 36,094
52 1,167 32,407
53 593 22,313
54 5,257 31,973
55 16,334 26,860
56 8,269 29,873
57 47,422 19,707
58 742 29,625
59 2,761 22,941
60 4,080 17,346
61 1,591 55,734
62 2,466 44,297
63 1,327 38,685
64 55,842 35,590
65 105,150 28,434
66 89,467 21,616
67 1,406 31,006
68 11,458 23,218
69 102,005 18,938
70 7,347 34,967
71 9,531 27,718
72 5,746 20,092
73 9,230 28,411
74 31,583 21,471
75 1,240 35,756
76 874 23,183
77 1,214 34,334
78 1,405 25,703
79 931 19,435
80 1,870 26,205
81 7,158 17,937
82 1,764 36,630
83 2,056 30,149
84 2,784 22,390
85 5,896 37,019
86 11,488 27,925
87 13,005 19,836
88 712 31,870
89 2,740 23,572
90 3,094 17,953
91 7,628 30,627
92 16,286 22,388
93 16,162 17,182
94 1,476 57,294
95 1,034 44,072
96 761 37,723
97 1,195 56,725
98 1,007 38,018
99 642 30,539
100 17,058 30,273
101 57,248 19,211
102 1,086 24,512
103 13,854 16,849
113 527 33,475
114 562 20,755
115 1,060 26,332
116 566 26,098
117 1,140 16,472
121 549 22,487
122 623 14,246
123 2,789 18,857
124 753 25,197
125 4,693 16,936
129 1,359 40,771
130 1,074 29,912
131 933 39,603
132 889 28,315
133 1,988 32,709
134 3,379 21,267
135 353 36,814
136 474 24,169
137 775 29,030
138 891 18,731
139 1,498 20,992
146 680 36,795
147 1,369 27,392
148 860 20,935
149 38,942 16,006
150 955 25,517
151 6,839 13,767
152 1,735 21,825
153 11,517 15,282
154 1,906 28,847
155 4,498 21,959
156 4,851 16,219
157 1,048 29,382
158 3,229 21,572
159 2,376 15,149
163 13,622 83,366
164 17,895 50,966
165 13,816 40,520
166 20,575 60,767
167 20,538 42,190
168 5,478 32,296
175 12,686 34,823
176 41,375 26,341
177 63,876 38,177
178 71,036 31,805
179 26,205 25,015
180 22,369 34,979
181 30,299 28,647
182 5,485 22,812
183 1,858 32,624
184 4,329 23,386
185 2,521 16,595
186 9,254 33,122
187 10,047 27,117
188 5,031 20,564
189 113,197 30,640
190 58,935 28,961
191 118,443 24,100
192 185,468 18,078
193 87,659 30,876
194 254,760 24,785
195 134,022 18,110
196 5,396 32,914
197 6,822 27,198
198 4,650 20,752
199 3,215 34,978
200 8,396 25,022
201 3,475 17,803
202 29,397 20,216
203 37,161 14,886
204 25,777 17,542
205 5,872 27,528
206 21,625 18,717
207 39,614 87,097
208 76,655 43,557
215 143 173,781
216 8,640 168,323
217 7,240 124,423
218 2,557 104,181
219 10,538 136,802
220 13,938 99,436
221 7,039 87,477
222 2,772 156,334
223 5,081 119,825
224 1,912 145,014
225 5,074 113,498
226 7,067 118,743
227 42,758 93,475
228 2,975 132,326
229 3,599 95,382
230 1,568 80,590
231 1,445 149,264
232 1,516 114,499
233 16,267 125,690
234 34,348 93,360
235 9,634 99,860
236 30,093 73,812
237 22,441 88,481
238 42,307 57,831
239 13,331 62,725
240 11,688 43,263
241 2,679 32,205
242 17,530 66,838
243 36,091 52,897
244 62,665 44,466
245 3,943 73,686
246 28,838 67,069
247 188,816 48,746
248 13,859 60,786
249 70,027 44,038
250 6,790 59,714
251 41,777 41,857
252 45,667 51,697
253 44,988 46,446
254 53,543 37,335
255 2,525 40,724
256 3,453 31,694
257 707 23,510
258 688 53,299
259 7,314 38,081
260 1,553 56,280
261 3,525 31,484
262 3,531 25,624
263 656 30,621
264 28,327 41,945
265 1,959 42,694
280 63,744 37,477
281 53,825 29,595
282 54,438 22,672
283 14,927 32,787
284 4,145 24,166
285 2,811 16,215
286 23,714 42,608
287 158,325 29,592
288 2,964 50,314
289 1,357 37,277
290 480 31,429
291 188,057 30,477
292 205,085 23,997
293 197,247 17,506
294 1,417 22,037
295 1,346 14,125
296 1,917 28,779
297 793 17,798
298 603 12,266
299 17,830 29,028
300 44,700 21,461
301 37,174 15,572
302 7,607 24,792
303 70,815 14,928
304 2,098 25,698
305 35,311 15,266
306 1,521 29,058
307 6,371 18,574
308 35,795 28,398
309 79,510 20,681
310 158,993 14,833
311 21,229 13,279
312 166,359 18,189
313 212,358 14,841
314 61,733 32,156
315 30,052 24,173
316 18,076 16,573
326 11,247 90,510
327 10,467 52,332
328 8,878 34,042
329 48,192 83,718
330 63,720 49,785
331 28,246 37,251
332 1,828 76,442
333 5,926 48,536
334 3,736 36,301
335 7,186 70,724
336 12,464 45,785
337 8,586 34,468
338 1,501 60,013
339 3,167 42,250
340 3,566 31,529
341 882 45,033
342 2,548 33,808
343 6,990 24,135
344 933 54,766
345 2,919 36,119
346 2,766 28,030
347 1,628 40,240
348 4,174 30,100
349 5,178 19,260
350 1,760 42,667
351 4,293 30,824
352 8,211 20,507
353 3,172 47,221
354 8,433 33,349
355 15,386 23,911
356 8,357 61,777
357 7,827 42,844
358 2,484 32,598
368 3,570 34,021
369 5,250 26,848
370 3,562 20,098
371 24,424 34,233
372 27,117 28,743
373 15,293 20,505
374 9,082 35,802
375 19,032 28,329
376 4,321 22,907
377 51,664 32,372
378 110,502 24,239
379 92,325 18,668
380 3,027 35,357
381 5,304 27,876
382 4,499 21,070
383 1,227 29,549
384 8,101 21,207
385 1,998 34,976
386 7,139 26,903
387 5,041 20,238
388 18,589 31,113
389 45,899 23,260
390 46,538 16,397
391 44,419 26,016
392 282,973 17,753
393 23,327 30,889
394 45,966 23,957
395 24,872 17,482
405 3,972 86,374
406 5,304 52,360
407 2,120 39,348
408 1,549 71,677
409 1,737 50,663
410 601 36,877
411 957 69,221
412 961 51,066
413 760 39,922
414 5,248 62,853
415 6,133 43,331
416 5,338 32,604
417 16,454 49,649
418 27,098 39,258
419 35,942 29,790
420 768 66,342
421 1,057 39,447
422 331 31,257
423 1,545 71,874
424 897 47,509
425 126 32,981
432 15,201 33,045
433 9,723 23,926
434 898 17,085
435 12,164 34,878
436 13,203 28,443
437 3,911 25,366
438 14,096 33,587
439 24,418 26,852
440 25,766 18,781
441 13,382 31,516
442 14,214 24,098
443 6,593 17,782
444 12,947 33,108
445 16,870 27,464
446 16,037 19,832
453 950 165,424
454 1,778 121,032
455 1,988 93,297
456 947 144,023
457 2,416 98,535
458 1,617 82,249
459 3,516 97,638
460 52,310 66,514
461 1,018 82,048
462 13,179 63,047
463 5,060 60,604
464 5,853 43,476
465 2,416 31,714
466 4,073 74,467
467 14,326 57,869
468 21,140 49,618
469 30,544 59,370
470 405,849 44,493
471 2,288 77,861
472 7,009 52,304
473 23,109 42,971
474 2,925 51,927
475 3,287 37,186
476 1,595 25,620
477 2,589 58,272
478 8,575 45,067
479 11,457 35,879
480 26,755 53,624
481 72,188 40,303
482 48,187 34,632
483 7,107 47,684
484 17,896 40,860
485 1,183 60,074
486 2,189 44,942
487 1,312 36,049
488 2,501 35,530
489 5,791 27,889
490 23,080 37,310
491 52,938 23,744
492 5,221 51,439
493 16,933 38,816
494 29,231 29,960
495 1,974 52,628
496 5,569 37,148
497 6,672 28,169
498 1,167 38,115
499 1,113 22,378
500 1,503 47,316
501 3,878 32,847
502 6,482 23,489
503 833 42,531
504 2,172 32,702
505 3,036 24,287
506 815 25,704
507 838 37,099
508 2,506 27,713
509 627 28,236
510 974 40,828
511 3,932 32,904
512 11,002 23,803
513 1,053 30,121
514 1,014 20,124
515 3,820 54,024
516 11,287 39,608
517 17,603 32,537
533 825 27,647
534 3,414 16,259
535 7,007 27,756
536 33,727 15,479
537 667 21,443
538 1,059 13,756
539 3,448 35,081
540 4,046 28,706
541 1,658 21,628
542 5,723 34,804
543 17,041 26,766
544 10,817 18,081
545 4,093 36,357
546 5,587 26,110
547 4,571 17,948
548 585 33,933
549 1,120 26,761
550 865 18,763
551 10,077 30,882
552 85,429 18,705
553 3,084 25,449
554 19,284 15,035
555 2,025 23,819
556 18,715 14,407
557 3,658 29,996
558 15,153 19,455
559 1,816 30,350
560 4,334 21,234
561 7,125 13,644
562 5,476 28,172
563 36,406 15,527
564 1,667 28,585
565 3,334 21,320
566 2,646 16,029
573 5,490 45,601
574 11,156 34,288
575 5,477 25,545
576 549 51,383
577 2,233 32,911
578 3,065 24,256
579 3,521 45,095
580 10,746 31,153
581 12,188 22,362
582 5,347 24,362
583 8,780 19,177
584 670 31,432
585 1,499 20,658
592 4,197 31,149
593 12,368 23,904
594 2,786 17,143
595 1,119 31,375
596 5,334 19,449
597 465 30,971
598 1,413 25,450
599 321 18,124
600 686 22,523
601 893 15,565
602 22,195 28,410
603 130,827 18,332
604 2,679 26,853
605 22,207 16,438
606 1,358 25,667
607 7,223 15,152
614 1,460 47,701
615 1,550 34,632
616 1,091 65,719
617 6,743 38,652
618 262 29,334
619 696 56,060
620 2,183 41,545
621 7,840 34,898
622 1,113 43,197
623 3,081 34,355
624 387 24,651
625 1,276 41,939
626 2,544 28,873
627 14,040 19,271
628 3,371 53,828
629 4,183 42,434
630 539 33,189
637 17,173 28,050
638 42,846 19,293
639 38,599 13,546
640 61,027 25,018
641 202,068 16,467
642 1,522 23,787
643 5,194 31,972
644 11,834 25,437
645 8,221 17,977
652 10,083 61,353
653 1,697 89,458
654 3,458 56,337
655 1,633 42,874
656 3,922 58,696
657 7,428 41,203
658 8,291 33,644
659 4,668 53,703
660 7,609 38,883
661 4,273 31,713
662 952 45,713
663 2,064 31,902
664 4,406 24,778
665 656 47,408
666 2,094 32,797
667 3,632 20,211
668 3,838 42,144
669 12,767 30,048
670 11,721 19,264
671 809 31,091
672 945 19,988
673 12,591 45,199
674 11,735 41,821
675 7,841 34,014
682 82,356 31,292
683 132,588 26,544
684 45,085 17,817
685 2,328 19,847
686 1,603 31,947
687 3,266 26,251
688 1,084 18,135
689 56,256 27,047
690 198,999 18,127
691 819 33,914
692 492 26,929
693 2,431 28,697
694 18,046 18,013
695 981 25,865
696 10,563 15,132
697 594 17,528
698 23,391 29,470
699 24,279 23,424
700 12,340 16,877
707 5,984 37,222
708 18,084 30,416
709 765 35,528
710 1,845 29,560
711 792 37,675
712 710 20,316
713 10,272 26,996
714 28,875 15,559
715 532 36,052
716 1,275 29,420
717 705 34,114
718 589 19,293
722 754 30,816
723 1,970 24,740
724 586 15,657
725 759 24,606
726 3,733 16,368
727 1,300 27,843
728 6,194 17,130
729 592 25,442
730 471 14,723
734 1,364 44,272
735 1,133 28,372
736 856 73,117
737 3,302 41,614
738 866 28,882
739 1,015 53,269
740 4,338 34,448
741 6,033 24,839
742 10,977 31,971
743 32,430 21,234
744 1,527 30,774
745 1,700 20,207
746 2,643 30,028
747 10,434 21,235
748 19,915 20,564
749 982 45,119
750 437 24,771
754 986 33,562
755 2,954 25,879
756 687 16,172
757 1,398 32,870
758 1,612 26,363
759 1,244 19,100
760 1,708 19,562
761 1,773 13,249
765 2,773 20,365
766 2,692 13,836
767 133 18,724
769 98 28,990
770 203 16,249
774 1,517 12,327
775 5,784 8,750
776 513 15,047
777 209 20,244
778 475 8,942
779 112 11,223
780 41 3,917
781 3,040 13,218
782 175 8,623
799 566 82,467
800 705 50,685
801 556 37,382
802 764 53,613
803 1,071 36,134
804 995 27,223
808 6,092 37,130
809 12,879 27,509
810 2,801 22,786
811 21,482 26,846
812 90,369 18,397
813 14,238 27,095
814 1,564 30,406
815 3,315 25,805
816 2,154 18,432
820 1,301 89,835
821 2,478 43,777
822 1,894 30,581
823 2,182 69,584
824 2,976 44,341
825 1,756 30,652
826 524 76,715
827 1,256 44,122
828 802 32,076
829 1,175 47,921
830 524 28,158
834 4,031 58,295
835 2,707 37,287
836 1,623 25,573
837 1,044 96,925
838 1,321 47,431
839 1,466 30,443
840 9,683 43,346
841 10,060 32,240
842 5,341 25,445
843 1,354 34,538
844 2,414 27,673
845 811 21,496
846 2,117 38,966
847 23,925 26,844
848 1,725 23,146
849 1,478 29,110
853 34,961 80,838
854 6,662 52,593
855 459 38,661
856 5,904 65,124
857 9,631 37,513
858 3,258 30,272
862 7,955 34,329
863 21,482 22,129
864 19,034 20,781
865 1,707 29,217
866 8,201 17,149
867 5,076 38,916
868 2,659 25,425
869 1,139 18,507
870 21,356 94,830
871 216,894 35,333
872 91,026 27,030
876 860 42,167
880 9,304 15,133
881 4,658 12,046
882 1,558 12,634
883 758 17,971
884 19,126 19,197
885 81,314 15,242
886 407 13,905
887 399 16,694
894 4,798 7,599
895 10,278 12,773
896 5,570 26,933
897 38,298 13,086
901 926 54,456
902 2,036 33,188
903 1,508 23,579
904 1,047 43,056
905 812 26,185
906 716 24,257
907 8,469 56,134
908 8,340 36,960
909 5,470 27,977
913 807 27,237
914 6,655 16,360
915 1,080 26,134
916 5,527 10,518
917 15,818 29,720
918 35,758 14,390
919 11,106 30,394
920 14,005 22,313
921 9,462 14,923
922 1,055 28,288
923 3,976 15,419
927 213 182,484
928 819 65,145
929 440 37,218
933 145 31,568
934 663 24,756
935 2,220 22,937
939 673 46,257
940 1,322 33,961
941 1,720 26,932
945 6,687 20,290
946 4,359 15,730
947 9,751 24,756
948 47,916 15,920
949 682 18,328
950 420 12,682
951 951 15,279
955 449 87,860
956 3,984 57,503
957 1,325 101,860
958 1,156 67,071
959 295 47,759
963 1,592 50,127
964 2,581 34,357
965 1,077 25,020
969 644 78,213
970 138 45,746
974 5,952 41,989
975 4,710 29,607
976 2,654 22,430
977 4,633 25,054
981 25,506 78,693
982 18,355 55,049
983 6,144 40,105
984 671 59,501
985 904 42,990
986 732 29,607
987 8,256 55,744
988 11,611 37,995
989 5,817 27,744
999 26 15,387
1 Cases taken from the FY 2007 MedPAR file; MS-DRGs are from GROUPER Version 26.0.

Proposed MS-LTC-DRG Proposed base MS-LTC-DRG Proposed MS-LTC-DRG title FY 2007 LTCH cases Proposed relative weight Proposed geometric average length of stay Proposed short-stay outlier (SSO) threshold1
1 1 Heart transplant or implant of heart assist system w MCC 0 0.0000 0.0 0.0
2 1 Heart transplant or implant of heart assist system w/o MCC 0 0.0000 0.0 0.0
3 3 ECMO or trach w MV 96+ hrs or PDX exc face, mouth neck w maj O.R. 286 4.5889 66.5 55.4
4 4 Trach w MV 96+ hrs or PDX exc face, mouth neck w/o maj O.R. 1,201 2.9992 44.4 37.0
5 5 Liver transplant w MCC or intestinal transplant 0 0.0000 0.0 0.0
6 5 Liver transplant w/o MCC 0 0.0000 0.0 0.0
7 7 Lung transplant 0 0.0000 0.0 0.0
8 8 Simultaneous pancreas/kidney transplant 0 0.0000 0.0 0.0
9 9 Bone marrow transplant 0 1.2617 31.5 26.3
10 10 Pancreas transplant 0 0.0000 0.0 0.0
11 11 Tracheostomy for face, mouth neck diagnoses w MCC 1 1.7509 37.9 31.6
12 11 Tracheostomy for face, mouth neck diagnoses w CC 1 1.7509 37.9 31.6
13 11 Tracheostomy for face, mouth neck diagnoses w/o CC/MCC 0 1.7509 37.9 31.6
20 20 Intracranial vascular procedures w PDX hemorrhage w MCC 0 1.7509 37.9 31.6
21 20 Intracranial vascular procedures w PDX hemorrhage w CC 0 1.7509 37.9 31.6
22 20 Intracranial vascular procedures w PDX hemorrhage w/o CC/MCC 0 1.7509 37.9 31.6
23 23 Craniotomy w major device implant or acute complex CNS PDX w MCC* 2 1.2617 31.5 26.3
24 23 Craniotomy w major device implant or acute complex CNS PDX w/o MCC* 1 1.2617 31.5 26.3
25 25 Craniotomy endovascular intracranial procedures w MCC 1 1.7509 37.9 31.6
26 25 Craniotomy endovascular intracranial procedures w CC 3 1.7509 37.9 31.6
27 25 Craniotomy endovascular intracranial procedures w/o CC/MCC 1 0.8596 25.2 21.0
28 28 Spinal procedures w MCC 11 1.2617 31.5 26.3
29 28 Spinal procedures w CC 9 1.2617 31.5 26.3
30 28 Spinal procedures w/o CC/MCC 1 1.2617 31.5 26.3
31 31 Ventricular shunt procedures w MCC 5 1.7509 37.9 31.6
32 31 Ventricular shunt procedures w CC 1 1.7509 37.9 31.6
33 31 Ventricular shunt procedures w/o CC/MCC 0 1.7509 37.9 31.6
34 34 Carotid artery stent procedure w MCC 0 1.2617 31.5 26.3
35 34 Carotid artery stent procedurew CC 0 1.2617 31.5 26.3
36 34 Carotid artery stent procedure w/o CC/MCC 0 1.2617 31.5 26.3
37 37 Extracranial procedures w MCC 7 1.2617 31.5 26.3
38 37 Extracranial procedures w CC* 6 1.2617 31.5 26.3
39 37 Extracranial procedures w/o CC/MCC 0 1.2617 31.5 26.3
40 40 Periph cranial nerve other nerv syst proc w MCC 143 1.2451 34.8 29.0
41 40 Periph cranial nerve other nerv syst proc w CC 87 1.0890 34.5 28.8
42 40 Periph cranial nerve other nerv syst proc w/o CC/MCC* 6 1.0890 34.5 28.8
52 52 Spinal disorders injuries w CC/MCC 83 0.9943 31.3 26.1
53 52 Spinal disorders injuries w/o CC/MCC 7 0.8596 25.2 21.0
54 54 Nervous system neoplasms w MCC 31 1.0109 26.7 22.3
55 54 Nervous system neoplasms w/o MCC 50 0.6542 21.6 18.0
56 56 Degenerative nervous system disorders w MCC 1,180 0.8022 25.3 21.1
57 56 Degenerative nervous system disorders w/o MCC 1,945 0.6033 24.0 20.0
58 58 Multiple sclerosis cerebellar ataxia w MCC 19 0.8596 25.2 21.0
59 58 Multiple sclerosis cerebellar ataxia w CC 23 0.6327 21.6 18.0
60 58 Multiple sclerosis cerebellar ataxia w/o CC/MCC 10 0.6327 21.6 18.0
61 61 Acute ischemic stroke w use of thrombolytic agent w MCC 0 0.8823 23.5 19.6
62 61 Acute ischemic stroke w use of thrombolytic agent w CC 0 0.5770 22.8 19.0
63 61 Acute ischemic stroke w use of thrombolytic agent w/o CC/MCC 0 0.4824 19.6 16.3
64 64 Intracranial hemorrhage or cerebral infarction w MCC 107 0.7831 24.5 20.4
65 64 Intracranial hemorrhage or cerebral infarction w CC 67 0.6217 24.0 20.0
66 64 Intracranial hemorrhage or cerebral infarction w/o CC/MCC 24 0.4824 19.6 16.3
67 67 Nonspecific cva precerebral occlusion w/o infarct w MCC 4 0.4824 19.6 16.3
68 67 Nonspecific cva precerebral occlusion w/o infarct w/o MCC 4 0.4824 19.6 16.3
69 69 Transient ischemia 13 0.4824 19.6 16.3
70 70 Nonspecific cerebrovascular disorders w MCC 87 0.8823 23.5 19.6
71 70 Nonspecific cerebrovascular disorders w CC 52 0.5770 22.8 19.0
72 70 Nonspecific cerebrovascular disorders w/o CC/MCC 8 0.4824 19.6 16.3
73 73 Cranial peripheral nerve disorders w MCC 116 0.8910 24.6 20.5
74 73 Cranial peripheral nerve disorders w/o MCC 173 0.6057 23.1 19.3
75 75 Viral meningitis w CC/MCC 15 0.6327 21.6 18.0
76 75 Viral meningitis w/o CC/MCC 0 0.6327 21.6 18.0
77 77 Hypertensive encephalopathy w MCC 4 1.2617 31.5 26.3
78 77 Hypertensive encephalopathy w CC 1 0.6327 21.6 18.0
79 77 Hypertensive encephalopathy w/o CC/MCC 1 0.4824 19.6 16.3
80 80 Nontraumatic stupor coma w MCC 47 0.7859 29.2 24.3
81 80 Nontraumatic stupor coma w/o MCC 110 0.7028 28.2 23.5
82 82 Traumatic stupor coma, coma 1 hr w MCC 9 0.8596 25.2 21.0
83 82 Traumatic stupor coma, coma 1 hr w CC 12 0.6327 21.6 18.0
84 82 Traumatic stupor coma, coma 1 hr w/o CC/MCC 3 0.6327 21.6 18.0
85 85 Traumatic stupor coma, coma 1 hr w MCC 78 0.8652 26.1 21.8
86 85 Traumatic stupor coma, coma 1 hr w CC 81 0.6630 24.1 20.1
87 85 Traumatic stupor coma, coma 1 hr w/o CC/MCC 15 0.4824 19.6 16.3
88 88 Concussion w MCC 0 0.4824 19.6 16.3
89 88 Concussion w CC 1 0.4824 19.6 16.3
90 88 Concussion w/o CC/MCC 0 0.4824 19.6 16.3
91 91 Other disorders of nervous system w MCC 218 0.9248 25.9 21.6
92 91 Other disorders of nervous system w CC 138 0.6661 25.0 20.8
93 91 Other disorders of nervous system w/o CC/MCC 43 0.6046 22.0 18.3
94 94 Bacterial tuberculous infections of nervous system w MCC 203 1.0466 29.2 24.3
95 94 Bacterial tuberculous infections of nervous system w CC 106 0.9763 28.9 24.1
96 94 Bacterial tuberculous infections of nervous system w/o CC/MCC 31 0.7559 27.6 23.0
97 97 Non-bacterial infect of nervous sys exc viral meningitis w MCC 48 1.0415 26.0 21.7
98 97 Non-bacterial infect of nervous sys exc viral meningitis w CC 22 0.8596 25.2 21.0
99 97 Non-bacterial infect of nervous sys exc viral meningitis w/o CC/MCC 6 0.6327 21.6 18.0
100 100 Seizures w MCC 47 0.6380 21.8 18.2
101 100 Seizures w/o MCC 55 0.6132 25.4 21.2
102 102 Headaches w MCC 9 0.6327 21.6 18.0
103 102 Headaches w/o MCC 4 0.6327 21.6 18.0
113 113 Orbital procedures w CC/MCC 1 0.8596 25.2 21.0
114 113 Orbital procedures w/o CC/MCC 0 0.8596 25.2 21.0
115 115 Extraocular procedures except orbit 0 0.4824 19.6 16.3
116 116 Intraocular procedures w CC/MCC 1 0.8596 25.2 21.0
117 116 Intraocular procedures w/o CC/MCC 0 0.4824 19.6 16.3
121 121 Acute major eye infections w CC/MCC 10 0.6327 21.6 18.0
122 121 Acute major eye infections w/o CC/MCC 1 0.6327 21.6 18.0
123 123 Neurological eye disorders 0 0.4824 19.6 16.3
124 124 Other disorders of the eye w MCC 2 0.6327 21.6 18.0
125 124 Other disorders of the eye w/o MCC 8 0.4824 19.6 16.3
129 129 Major head neck procedures w CC/MCC or major device 0 1.3344 30.2 25.2
130 129 Major head neck procedures w/o CC/MCC 0 0.4824 19.6 16.3
131 131 Cranial/facial procedures w CC/MCC 0 1.7509 37.9 31.6
132 131 Cranial/facial procedures w/o CC/MCC 1 1.7509 37.9 31.6
133 133 Other ear, nose, mouth throat O.R. procedures w CC/MCC 10 1.2617 31.5 26.3
134 133 Other ear, nose, mouth throat O.R. procedures w/o CC/MCC 0 1.2617 31.5 26.3
135 135 Sinus mastoid procedures w CC/MCC 2 0.4824 19.6 16.3
136 135 Sinus mastoid procedures w/o CC/MCC* 1 0.4824 19.6 16.3
137 137 Mouth procedures w CC/MCC 1 1.7509 37.9 31.6
138 137 Mouth procedures w/o CC/MCC 0 1.7509 37.9 31.6
139 139 Salivary gland procedures 0 1.7509 37.9 31.6
146 146 Ear, nose, mouth throat malignancy w MCC 40 1.3344 30.2 25.2
147 146 Ear, nose, mouth throat malignancy w CC 26 0.9930 22.4 18.7
148 146 Ear, nose, mouth throat malignancy w/o CC/MCC 6 0.4824 19.6 16.3
149 149 Dysequilibrium 11 0.4824 19.6 16.3
150 150 Epistaxis w MCC 0 0.8596 25.2 21.0
151 150 Epistaxis w/o MCC 0 0.6327 21.6 18.0
152 152 Otitis media URI w MCC 9 0.8596 25.2 21.0
153 152 Otitis media URI w/o MCC 23 0.6327 21.6 18.0
154 154 Nasal trauma deformity w MCC 50 0.7707 22.0 18.3
155 154 Nasal trauma deformity w CC 47 0.7011 21.1 17.6
156 154 Nasal trauma deformity w/o CC/MCC 13 0.6327 21.6 18.0
157 157 Dental Oral Diseases w MCC 12 0.6327 21.6 18.0
158 157 Dental Oral Diseases w CC 21 0.6327 21.6 18.0
159 157 Dental Oral Diseases w/o CC/MCC 5 0.4824 19.6 16.3
163 163 Major chest procedures w MCC 45 2.5063 33.5 27.9
164 163 Major chest procedures w CC 6 1.2617 31.5 26.3
165 163 Major chest procedures w/o CC/MCC 1 0.8596 25.2 21.0
166 166 Other resp system O.R. procedures w MCC 1,506 2.4992 41.8 34.8
167 166 Other resp system O.R. procedures w CC 211 1.8587 36.2 30.2
168 166 Other resp system O.R. procedures w/o CC/MCC 8 0.8596 25.2 21.0
175 175 Pulmonary embolism w MCC 128 0.6640 21.9 18.3
176 175 Pulmonary embolism w/o MCC 139 0.5479 20.0 16.7
177 177 Respiratory infections inflammations w MCC 3,181 0.8784 22.8 19.0
178 177 Respiratory infections inflammations w CC 2,334 0.7414 22.1 18.4
179 177 Respiratory infections inflammations w/o CC/MCC 394 0.6225 19.4 16.2
180 180 Respiratory neoplasms w MCC 149 0.7975 20.9 17.4
181 180 Respiratory neoplasms w CC 109 0.6255 18.7 15.6
182 180 Respiratory neoplasms w/o CC/MCC* 11 0.6255 18.7 15.6
183 183 Major chest trauma w MCC 1 0.4824 19.6 16.3
184 183 Major chest trauma w CC 2 0.4824 19.6 16.3
185 183 Major chest trauma w/o CC/MCC 1 0.4824 19.6 16.3
186 186 Pleural effusion w MCC 121 0.7576 20.5 17.1
187 186 Pleural effusion w CC 60 0.6176 20.5 17.1
188 186 Pleural effusion w/o CC/MCC* 15 0.6176 20.5 17.1
189 189 Pulmonary edema respiratory failure 6,586 0.9608 23.9 19.9
190 190 Chronic obstructive pulmonary disease w MCC 1,652 0.7477 20.5 17.1
191 190 Chronic obstructive pulmonary disease w CC 1,343 0.6220 19.4 16.2
192 190 Chronic obstructive pulmonary disease w/o CC/MCC 764 0.5358 17.3 14.4
193 193 Simple pneumonia pleurisy w MCC 1,805 0.7698 21.6 18.0
194 193 Simple pneumonia pleurisy w CC 2,026 0.6368 20.1 16.8
195 193 Simple pneumonia pleurisy w/o CC/MCC 382 0.5374 17.4 14.5
196 196 Interstitial lung disease w MCC 110 0.7122 20.1 16.8
197 196 Interstitial lung disease w CC 85 0.5716 17.6 14.7
198 196 Interstitial lung disease w/o CC/MCC 40 0.5059 15.9 13.3
199 199 Pneumothorax w MCC 49 0.7639 21.8 18.2
200 199 Pneumothorax w CC 32 0.5906 17.8 14.8
201 199 Pneumothorax w/o CC/MCC 5 0.4824 19.6 16.3
202 202 Bronchitis asthma w CC/MCC 88 0.6509 19.6 16.3
203 202 Bronchitis asthma w/o CC/MCC 21 0.6327 21.6 18.0
204 204 Respiratory signs symptoms 233 0.8315 22.8 19.0
205 205 Other respiratory system diagnoses w MCC 324 0.8236 22.3 18.6
206 205 Other respiratory system diagnoses w/o MCC 171 0.7182 21.5 17.9
207 207 Respiratory system diagnosis w ventilator support 96+ hours 13,186 2.0793 34.5 28.8
208 208 Respiratory system diagnosis w ventilator support 96 hours 1,452 1.1752 23.6 19.7
215 215 Other heart assist system implant 0 0.8596 25.2 21.0
216 216 Cardiac valve oth maj cardiothoracic proc w card cath w MMCC 0 1.2617 31.5 26.3
217 216 Cardiac valve oth maj cardiothoracic proc w card cath w MCC 0 0.8596 25.2 21.0
218 216 Cardiac valve oth maj cardiothoracic proc w card cath w/o CC/MMCC 0 0.8596 25.2 21.0
219 219 Cardiac valve oth maj cardiothoracic proc w/o card cath w MMCC 0 1.2617 31.5 26.3
220 219 Cardiac valve oth maj cardiothoracic proc w/o card cath w MCC 0 0.8596 25.2 21.0
221 219 Cardiac valve oth maj cardiothoracic proc w/o card cath w/o CC/MCC 0 0.8596 25.2 21.0
222 222 Cardiac defib implant w cardiac cath w AMI/HF/shock w MMCC 0 1.7509 37.9 31.6
223 222 Cardiac defib implant w cardiac cath w AMI/HF/shock w/o MMCC 0 1.7509 37.9 31.6
224 224 Cardiac defib implant w cardiac cath w/o AMI/HF/shock w MMCC 0 1.7509 37.9 31.6
225 224 Cardiac defib implant w cardiac cath w/o AMI/HF/shock w/o MMCC 0 1.7509 37.9 31.6
226 226 Cardiac defibrillator implant w/o cardiac cath w MMCC 11 1.7509 37.9 31.6
227 226 Cardiac defibrillator implant w/o cardiac cath w/o MMCC 9 1.7509 37.9 31.6
228 228 Other cardiothoracic procedures w MMCC 0 1.4637 33.3 27.8
229 228 Other cardiothoracic procedures w MCC 0 1.2121 28.9 24.1
230 228 Other cardiothoracic procedures w/o CC/MMCC 0 0.6327 21.6 18.0
231 231 Coronary bypass w PTCA w MMCC 0 1.2617 31.5 26.3
232 231 Coronary bypass w PTCA w/o MMCC 0 0.8596 25.2 21.0
233 233 Coronary bypass w cardiac cath w MMCC 0 1.2617 31.5 26.3
234 233 Coronary bypass w cardiac cath w/o MMCC 0 0.8596 25.2 21.0
235 235 Coronary bypass w/o cardiac cath w MMCC 0 1.2617 31.5 26.3
236 235 Coronary bypass w/o cardiac cath w/o MMCC 0 0.8596 25.2 21.0
237 237 Major cardiovascular procedures w MMCC 7 1.2617 31.5 26.3
238 237 Major cardiovascular procedures w/o MMCC 2 0.8596 25.2 21.0
239 239 Amputation for circ sys disorders exc upper limb toe w MMCC 163 1.5067 36.6 30.5
240 239 Amputation for circ sys disorders exc upper limb toe w MCC 83 1.1559 34.1 28.4
241 239 Amputation for circ sys disorders exc upper limb toe w/o CC/MMCC 10 0.8596 25.2 21.0
242 242 Permanent cardiac pacemaker implant w MCC* 12 1.7509 37.9 31.6
243 242 Permanent cardiac pacemaker implant w MCC 5 1.7509 37.9 31.6
244 242 Permanent cardiac pacemaker implant w/o CC/MMCC 1 1.7509 37.9 31.6
245 245 AICD generator procedures 0 1.7509 37.9 31.6
246 246 Percutaneous cardiovascular proc w drug-eluting stent w MMCC 3 1.2617 31.5 26.3
247 246 Percutaneous cardiovascular proc w drug-eluting stent w/o MMCC 1 1.2617 31.5 26.3
248 248 Percutaneous cardiovasc proc w non-drug-eluting stent w MMCC 2 1.2617 31.5 26.3
249 248 Percutaneous cardiovasc proc w non-drug-eluting stent w/o MCC* 1 1.2617 31.5 26.3
250 250 Perc cardiovasc proc w/o coronary artery stent or AMI w MMCC 3 1.7509 37.9 31.6
251 250 Perc cardiovasc proc w/o coronary artery stent or AMI w/o MMCC 0 1.7509 37.9 31.6
252 252 Other vascular procedures w MMCC 134 1.4637 33.3 27.8
253 252 Other vascular procedures w MCC 51 1.2121 28.9 24.1
254 252 Other vascular procedures w/o CC/MMCC 3 0.6327 21.6 18.0
255 255 Upper limb toe amputation for circ system disorders w MMCC 61 1.2589 33.8 28.2
256 255 Upper limb toe amputation for circ system disorders w MCC 42 0.9416 30.0 25.0
257 255 Upper limb toe amputation for circ system disorders w/o CC/MMCC 1 0.4824 19.6 16.3
258 258 Cardiac pacemaker device replacement w MMCC 0 1.2617 31.5 26.3
259 258 Cardiac pacemaker device replacement w/o MMCC 1 1.2617 31.5 26.3
260 260 Cardiac pacemaker revision except device replacement w MMCC 2 1.2617 31.5 26.3
261 260 Cardiac pacemaker revision except device replacement w CC* 1 0.8596 25.2 21.0
262 260 Cardiac pacemaker revision except device replacement w/o CC/MCC* 1 0.8596 25.2 21.0
263 263 Vein ligation stripping 3 0.4824 19.6 16.3
264 264 Other circulatory system O.R. procedures 608 1.0954 31.1 25.9
265 265 AICD lead procedures 0 1.2617 31.5 26.3
280 280 Circulatory disorders w AMI, discharged alive w MMCC 259 0.7832 23.0 19.2
281 280 Circulatory disorders w AMI, discharged alive w MCC 110 0.5772 20.6 17.2
282 280 Circulatory disorders w AMI, discharged alive w/o CC/MMCC 35 0.5060 19.9 16.6
283 283 Circulatory disorders w AMI, expired w MMCC 56 0.7924 16.1 13.4
284 283 Circulatory disorders w AMI, expired w CC* 17 0.7924 16.1 13.4
285 283 Circulatory disorders w AMI, expired w/o CC/MMCC 0 0.7924 16.1 13.4
286 286 Circulatory disorders except AMI, w card cath w MMCC 8 1.2617 31.5 26.3
287 286 Circulatory disorders except AMI, w card cath w/o MMCC 9 0.8596 25.2 21.0
288 288 Acute subacute endocarditis w MMCC 594 1.0060 26.1 21.8
289 288 Acute subacute endocarditis w MCC 217 0.7920 26.1 21.8
290 288 Acute subacute endocarditis w/o CC/MMCC 48 0.6873 24.3 20.3
291 291 Heart failure shock w MMCC 1,728 0.7727 21.9 18.3
292 291 Heart failure shock w MCC 901 0.6294 21.2 17.7
293 291 Heart failure shock w/o CC/MMCC 362 0.5168 18.8 15.7
294 294 Deep vein thrombophlebitis w CC/MMCC 6 0.6327 21.6 18.0
295 294 Deep vein thrombophlebitis w/o CC/MMCC 0 0.6327 21.6 18.0
296 296 Cardiac arrest, unexplained w MMCC 0 0.7924 16.1 13.4
297 296 Cardiac arrest, unexplained w MCC 0 0.7924 16.1 13.4
298 296 Cardiac arrest, unexplained w/o CC/MMCC 0 0.7924 16.1 13.4
299 299 Peripheral vascular disorders w MMCC 587 0.7804 23.4 19.5
300 299 Peripheral vascular disorders w MCC 751 0.5847 22.0 18.3
301 299 Peripheral vascular disorders w/o CC/MMCC 78 0.5385 20.3 16.9
302 302 Atherosclerosis w MMCC 59 0.7597 21.8 18.2
303 302 Atherosclerosis w/o MMCC 61 0.5692 20.1 16.8
304 304 Hypertension w MMCC 6 0.4824 19.6 16.3
305 304 Hypertension w/o MMCC 15 0.4824 19.6 16.3
306 306 Cardiac congenital valvular disorders w MMCC 59 0.8224 22.7 18.9
307 306 Cardiac congenital valvular disorders w/o MMCC 38 0.7367 22.9 19.1
308 308 Cardiac arrhythmia conduction disorders w MMCC 96 0.8384 25.0 20.8
309 308 Cardiac arrhythmia conduction disorders w MCC 107 0.5679 20.8 17.3
310 308 Cardiac arrhythmia conduction disorders w/o CC/MCC 36 0.4590 19.4 16.2
311 311 Angina pectoris 7 0.4824 19.6 16.3
312 312 Syncope collapse 58 0.5083 19.7 16.4
313 313 Chest pain 6 0.4824 19.6 16.3
314 314 Other circulatory system diagnoses w MMCC 1,305 0.8758 22.9 19.1
315 314 Other circulatory system diagnoses w MCC 285 0.6575 21.0 17.5
316 314 Other circulatory system diagnoses w/o CC/MMCC 72 0.6026 21.0 17.5
326 326 Stomach, esophageal duodenal proc w MMCC 19 1.7509 37.9 31.6
327 326 Stomach, esophageal duodenal proc w MCC 3 1.2617 31.5 26.3
328 326 Stomach, esophageal duodenal proc w/o CC/MCC* 1 1.2617 31.5 26.3
329 329 Major small large bowel procedures w MMCC 31 2.2757 41.8 34.8
330 329 Major small large bowel procedures w MCC 12 1.7509 37.9 31.6
331 329 Major small large bowel procedures w/o CC/MMCC 1 1.7509 37.9 31.6
332 332 Rectal resection w MMCC 0 1.6757 34.2 28.5
333 332 Rectal resection w MCC 0 1.1606 30.0 25.0
334 332 Rectal resection w/o CC/MMCC 0 1.1606 30.0 25.0
335 335 Peritoneal adhesiolysis w MMCC 6 1.7509 37.9 31.6
336 335 Peritoneal adhesiolysis w MCC 0 1.7509 37.9 31.6
337 335 Peritoneal adhesiolysis w/o CC/MMCC 0 1.7509 37.9 31.6
338 338 Appendectomy w complicated principal diag w MMCC 0 0.9726 25.1 20.9
339 338 Appendectomy w complicated principal diag w MCC 0 0.7768 23.2 19.3
340 338 Appendectomy w complicated principal diag w/o CC/MMCC 0 0.5958 19.6 16.3
341 341 Appendectomy w/o complicated principal diag w MMCC 0 0.9726 25.1 20.9
342 341 Appendectomy w/o complicated principal diag w MCC 0 0.7768 23.2 19.3
343 341 Appendectomy w/o complicated principal diag w/o CC/MMCC 0 0.5958 19.6 16.3
344 344 Minor small large bowel procedures w MMCC 5 1.7509 37.9 31.6
345 344 Minor small large bowel procedures w MCC 0 1.7509 37.9 31.6
346 344 Minor small large bowel procedures w/o CC/MMCC 0 1.7509 37.9 31.6
347 347 Anal stomal procedures w MMCC 3 1.7509 37.9 31.6
348 347 Anal stomal procedures w MCC 3 1.2617 31.5 26.3
349 347 Anal stomal procedures w/o CC/MMCC 0 1.2617 31.5 26.3
350 350 Inguinal femoral hernia procedures w MMCC 0 1.2617 31.5 26.3
351 350 Inguinal femoral hernia procedures w MCC 0 1.2617 31.5 26.3
352 350 Inguinal femoral hernia procedures w/o CC/MMCC 0 1.2617 31.5 26.3
353 353 Hernia procedures except inguinal femoral w MMCC 1 1.7509 37.9 31.6
354 353 Hernia procedures except inguinal femoral w MCC 1 0.6327 21.6 18.0
355 353 Hernia procedures except inguinal femoral w/o CC/MMCC 0 0.6327 21.6 18.0
356 356 Other digestive system O.R. procedures w MMCC 141 1.6757 34.2 28.5
357 356 Other digestive system O.R. procedures w MCC 36 1.1606 30.0 25.0
358 356 Other digestive system O.R. procedures w/o CC/MCC* 4 1.1606 30.0 25.0
368 368 Major esophageal disorders w MMCC 26 0.9161 21.1 17.6
369 368 Major esophageal disorders w MCC 14 0.8596 25.2 21.0
370 368 Major esophageal disorders w/o CC/MMCC 4 0.8596 25.2 21.0
371 371 Major gastrointestinal disorders peritoneal infections w MMCC 722 0.9726 25.1 20.9
372 371 Major gastrointestinal disorders peritoneal infections w MCC 350 0.7768 23.2 19.3
373 371 Major gastrointestinal disorders peritoneal infections w/o CC/MCC 68 0.5958 19.6 16.3
374 374 Digestive malignancy w MMCC 96 0.9011 21.5 17.9
375 374 Digestive malignancy w MCC 90 0.7804 23.4 19.5
376 374 Digestive malignancy w/o CC/MMCC 3 0.6327 21.6 18.0
377 377 G.I. hemorrhage w MMCC 90 0.8200 23.8 19.8
378 377 G.I. hemorrhage w MCC 53 0.6902 23.8 19.8
379 377 G.I. hemorrhage w/o CC/MMCC 18 0.6327 21.6 18.0
380 380 Complicated peptic ulcer w MMCC 22 0.8596 25.2 21.0
381 380 Complicated peptic ulcer w MCC 17 0.6327 21.6 18.0
382 380 Complicated peptic ulcer w/o CC/MMCC 5 0.4824 19.6 16.3
383 383 Uncomplicated peptic ulcer w MMCC 0 0.8596 25.2 21.0
384 383 Uncomplicated peptic ulcer w/o MMCC 7 0.8596 25.2 21.0
385 385 Inflammatory bowel disease w MMCC 36 0.8076 23.3 19.4
386 385 Inflammatory bowel disease w MCC 37 0.7126 23.1 19.3
387 385 Inflammatory bowel disease w/o CC/MMCC 5 0.4824 19.6 16.3
388 388 G.I. obstruction w MMCC 213 0.9486 22.5 18.8
389 388 G.I. obstruction w MCC 97 0.7302 20.9 17.4
390 388 G.I. obstruction w/o CC/MMCC 17 0.6327 21.6 18.0
391 391 Esophagitis, gastroent misc digest disorders w MMCC 255 0.7914 21.9 18.3
392 391 Esophagitis, gastroent misc digest disorders w/o MMCC 292 0.6568 21.0 17.5
393 393 Other digestive system diagnoses w MMCC 779 1.0684 25.7 21.4
394 393 Other digestive system diagnoses w MCC 449 0.7872 22.6 18.8
395 393 Other digestive system diagnoses w/o CC/MMCC 33 0.5783 22.1 18.4
405 405 Pancreas, liver shunt procedures w MMCC 10 1.2617 31.5 26.3
406 405 Pancreas, liver shunt procedures w CC* 2 1.2617 31.5 26.3
407 405 Pancreas, liver shunt procedures w/o CC/MMCC 0 1.2617 31.5 26.3
408 408 Biliary tract proc except only cholecyst w or w/o c.d.e. w MMCC 0 0.6327 21.6 18.0
409 408 Biliary tract proc except only cholecyst w or w/o c.d.e. w MCC 1 0.6327 21.6 18.0
410 408 Biliary tract proc except only cholecyst w or w/o c.d.e. w/o CC/MMCC 0 0.6327 21.6 18.0
411 411 Cholecystectomy w c.d.e. w MMCC 1 1.7509 37.9 31.6
412 411 Cholecystectomy w c.d.e. w MCC 0 1.7509 37.9 31.6
413 411 Cholecystectomy w c.d.e. w/o CC/MMCC 0 1.7509 37.9 31.6
414 414 Cholecystectomy except by laparoscope w/o c.d.e. w MMCC 2 1.7509 37.9 31.6
415 414 Cholecystectomy except by laparoscope w/o c.d.e. w MCC 3 1.7509 37.9 31.6
416 414 Cholecystectomy except by laparoscope w/o c.d.e. w/o CC/MMCC 0 1.7509 37.9 31.6
417 417 Laparoscopic cholecystectomy w/o c.d.e. w MCC* 11 1.7509 37.9 31.6
418 417 Laparoscopic cholecystectomy w/o c.d.e. w MCC 5 1.7509 37.9 31.6
419 417 Laparoscopic cholecystectomy w/o c.d.e. w/o CC/MMCC 0 1.7509 37.9 31.6
420 420 Hepatobiliary diagnostic procedures w MMCC 0 0.8596 25.2 21.0
421 420 Hepatobiliary diagnostic procedures w MCC 0 0.8596 25.2 21.0
422 420 Hepatobiliary diagnostic procedures w/o CC/MMCC 0 0.8596 25.2 21.0
423 423 Other hepatobiliary or pancreas O.R. procedures w MMCC 23 1.7509 37.9 31.6
424 423 Other hepatobiliary or pancreas O.R. procedures w MCC 2 0.8596 25.2 21.0
425 423 Other hepatobiliary or pancreas O.R. procedures w/o CC/MMCC 0 0.8596 25.2 21.0
432 432 Cirrhosis alcoholic hepatitis w MMCC 73 0.6977 20.9 17.4
433 432 Cirrhosis alcoholic hepatitis w MCC 24 0.6327 21.6 18.0
434 432 Cirrhosis alcoholic hepatitis w/o CC/MMCC 0 0.6327 21.6 18.0
435 435 Malignancy of hepatobiliary system or pancreas w MMCC 53 0.8340 22.0 18.3
436 435 Malignancy of hepatobiliary system or pancreas w MCC 26 0.4904 17.2 14.3
437 435 Malignancy of hepatobiliary system or pancreas w/o CC/MMCC 4 0.4824 19.6 16.3
438 438 Disorders of pancreas except malignancy w MMCC 243 1.0807 23.5 19.6
439 438 Disorders of pancreas except malignancy w MCC 144 0.7533 22.0 18.3
440 438 Disorders of pancreas except malignancy w/o CC/MMCC 24 0.6327 21.6 18.0
441 441 Disorders of liver except malig,cirr,alc hepa w MMCC 123 0.8206 23.1 19.3
442 441 Disorders of liver except malig,cirr,alc hepa w MCC 62 0.7145 21.7 18.1
443 441 Disorders of liver except malig,cirr,alc hepa w/o CC/MMCC 14 0.4824 19.6 16.3
444 444 Disorders of the biliary tract w MMCC 104 0.8334 22.7 18.9
445 444 Disorders of the biliary tract w MCC 35 0.6140 20.7 17.3
446 444 Disorders of the biliary tract w/o CC/MCC* 8 0.6140 20.7 17.3
453 453 Combined anterior/posterior spinal fusion w MMCC 0 1.7509 37.9 31.6
454 453 Combined anterior/posterior spinal fusion w MCC 0 1.7509 37.9 31.6
455 453 Combined anterior/posterior spinal fusion w/o CC/MMCC 0 1.7509 37.9 31.6
456 456 Spinal fusion exc cerv w spinal curv, malig or 9+ fusions w MMCC 1 1.7509 37.9 31.6
457 456 Spinal fusion exc cerv w spinal curv, malig or 9+ fusions w MCC 3 1.7509 37.9 31.6
458 456 Spinal fusion exc cerv w spinal curv, malig or 9+ fusions w/o CC/MMCC 0 1.7509 37.9 31.6
459 459 Spinal fusion except cervical w MMCC 1 1.7509 37.9 31.6
460 459 Spinal fusion except cervical w/o MMCC 0 1.7509 37.9 31.6
461 461 Bilateral or multiple major joint procs of lower extremity w MMCC 0 1.7509 37.9 31.6
462 461 Bilateral or multiple major joint procs of lower extremity w/o MMCC 0 0.8596 25.2 21.0
463 463 Wnd debrid skn grft exc hand, for musculo-conn tiss dis w MMCC 526 1.4126 38.7 32.3
464 463 Wnd debrid skn grft exc hand, for musculo-conn tiss dis w MCC 311 1.0643 34.0 28.3
465 463 Wnd debrid skn grft exc hand, for musculo-conn tiss dis w/o CC/MCC 61 0.9863 34.0 28.3
466 466 Revision of hip or knee replacement w MMCC 3 1.2617 31.5 26.3
467 466 Revision of hip or knee replacement w MCC 4 1.2617 31.5 26.3
468 466 Revision of hip or knee replacement w/o CC/MMCC 1 0.4824 19.6 16.3
469 469 Major joint replacement or reattachment of lower extremity w MCC* 3 1.7509 37.9 31.6
470 469 Major joint replacement or reattachment of lower extremity w/o MMCC 3 1.7509 37.9 31.6
471 471 Cervical spinal fusion w MMCC 2 0.8596 25.2 21.0
472 471 Cervical spinal fusion w MCC 1 0.8596 25.2 21.0
473 471 Cervical spinal fusion w/o CC/MMCC 0 0.8596 25.2 21.0
474 474 Amputation for musculoskeletal sys conn tissue dis w MMCC 91 1.5642 38.4 32.0
475 474 Amputation for musculoskeletal sys conn tissue dis w MCC 67 1.1116 33.9 28.3
476 474 Amputation for musculoskeletal sys conn tissue dis w/o CC/MMCC 4 0.8596 25.2 21.0
477 477 Biopsies of musculoskeletal system connective tissue w MMCC 22 1.7509 37.9 31.6
478 477 Biopsies of musculoskeletal system connective tissue w MCC 12 1.2617 31.5 26.3
479 477 Biopsies of musculoskeletal system connective tissue w/o CC/MMCC 0 1.2617 31.5 26.3
480 480 Hip femur procedures except major joint w MMCC 21 1.7509 37.9 31.6
481 480 Hip femur procedures except major joint w MCC 11 1.2617 31.5 26.3
482 480 Hip femur procedures except major joint w/o CC/MMCC 2 0.8596 25.2 21.0
483 483 Major joint limb reattachment proc of upper extremity w CC/MMCC 0 1.7509 37.9 31.6
484 483 Major joint limb reattachment proc of upper extremity w/o CC/MMCC 0 0.8596 25.2 21.0
485 485 Knee procedures w pdx of infection w MMCC 10 1.2617 31.5 26.3
486 485 Knee procedures w pdx of infection w MCC 10 1.2617 31.5 26.3
487 485 Knee procedures w pdx of infection w/o CC/MCC* 2 1.2617 31.5 26.3
488 488 Knee procedures w/o pdx of infection w CC/MMCC 1 1.7509 37.9 31.6
489 488 Knee procedures w/o pdx of infection w/o CC/MMCC 1 0.6327 21.6 18.0
490 490 Back neck procedures except spinal fusion w CC/MCC or disc devices 8 1.2617 31.5 26.3
491 490 Back neck procedures except spinal fusion w/o CC/MMCC 0 1.2617 31.5 26.3
492 492 Lower extrem humer proc except hip, foot, femur w MMCC 10 1.2617 31.5 26.3
493 492 Lower extrem humer proc except hip, foot, femur w MCC 10 1.2617 31.5 26.3
494 492 Lower extrem humer proc except hip, foot, femur w/o CC/MMCC 1 0.8596 25.2 21.0
495 495 Local excision removal int fix devices exc hip femur w MMCC 42 1.2616 36.9 30.8
496 495 Local excision removal int fix devices exc hip femur w CC* 20 1.2616 36.9 30.8
497 495 Local excision removal int fix devices exc hip femur w/o CC/MCC* 5 1.2616 36.9 30.8
498 498 Local excision removal int fix devices of hip femur w CC/MCC 9 1.7509 37.9 31.6
499 498 Local excision removal int fix devices of hip femur w/o CC/MCC 0 1.7509 37.9 31.6
500 500 Soft tissue procedures w MMCC 68 1.3427 36.7 30.6
501 500 Soft tissue procedures w MCC 28 1.0746 33.3 27.8
502 500 Soft tissue procedures w/o CC/MMCC 4 0.8596 25.2 21.0
503 503 Foot procedures w MMCC 15 1.2617 31.5 26.3
504 503 Foot procedures w MCC 22 0.8596 25.2 21.0
505 503 Foot procedures w/o CC/MMCC 3 0.8596 25.2 21.0
506 506 Major thumb or joint procedures 0 1.2617 31.5 26.3
507 507 Major shoulder or elbow joint procedures w CC/MMCC 1 1.7509 37.9 31.6
508 507 Major shoulder or elbow joint procedures w/o CC/MMCC 0 1.7509 37.9 31.6
509 509 Arthroscopy 0 0.8596 25.2 21.0
510 510 Shoulder, elbow or forearm proc, exc major joint proc w MCC* 1 0.8596 25.2 21.0
511 510 Shoulder, elbow or forearm proc, exc major joint proc w CC* 2 0.8596 25.2 21.0
512 510 Shoulder, elbow or forearm proc, exc major joint proc w/o CC/MCC 0 0.8596 25.2 21.0
513 513 Hand or wrist proc, except major thumb or joint proc w CC/MMCC 6 1.2617 31.5 26.3
514 513 Hand or wrist proc, except major thumb or joint proc w/o CC/MCC* 1 1.2617 31.5 26.3
515 515 Other musculoskelet sys conn tiss O.R. proc w MMCC 60 1.3728 31.5 26.3
516 515 Other musculoskelet sys conn tiss O.R. proc w MCC 27 0.9133 28.0 23.3
517 515 Other musculoskelet sys conn tiss O.R. proc w/o CC/MMCC 0 0.9133 28.0 23.3
533 533 Fractures of femur w MMCC 3 0.6327 21.6 18.0
534 533 Fractures of femur w/o MMCC 6 0.6327 21.6 18.0
535 535 Fractures of hip pelvis w MMCC 16 0.8596 25.2 21.0
536 535 Fractures of hip pelvis w/o MMCC 25 0.6130 26.9 22.4
537 537 Sprains, strains, dislocations of hip, pelvis thigh w CC/MMCC 1 0.4824 19.6 16.3
538 537 Sprains, strains, dislocations of hip, pelvis thigh w/o CC/MCC 0 0.4824 19.6 16.3
539 539 Osteomyelitis w MMCC 1,317 0.9928 30.2 25.2
540 539 Osteomyelitis w MCC 848 0.7632 27.6 23.0
541 539 Osteomyelitis w/o CC/MMCC 227 0.6901 27.1 22.6
542 542 Pathological fractures musculoskelet conn tiss malig w MMCC 23 0.8596 25.2 21.0
543 542 Pathological fractures musculoskelet conn tiss malig w MCC 42 0.5682 20.5 17.1
544 542 Pathological fractures musculoskelet conn tiss malig w/o CC/MMCC 17 0.4824 19.6 16.3
545 545 Connective tissue disorders w MMCC 50 0.9093 23.5 19.6
546 545 Connective tissue disorders w MCC 38 0.8478 25.5 21.3
547 545 Connective tissue disorders w/o CC/MMCC 5 0.4824 19.6 16.3
548 548 Septic arthritis w MMCC 172 0.8843 26.1 21.8
549 548 Septic arthritis w MCC 200 0.7080 26.9 22.4
550 548 Septic arthritis w/o CC/MMCC 73 0.6067 24.2 20.2
551 551 Medical back problems w MMCC 83 0.8867 26.5 22.1
552 551 Medical back problems w/o MMCC 156 0.6146 24.2 20.2
553 553 Bone diseases arthropathies w MMCC 15 0.6327 21.6 18.0
554 553 Bone diseases arthropathies w/o MMCC 59 0.5022 21.3 17.8
555 555 Signs symptoms of musculoskeletal system conn tissue w MMCC 3 0.8596 25.2 21.0
556 555 Signs symptoms of musculoskeletal system conn tissue w/o MCC 8 0.4824 19.6 16.3
557 557 Tendonitis, myositis bursitis w MMCC 84 0.8284 24.6 20.5
558 557 Tendonitis, myositis bursitis w/o MMCC 134 0.6519 23.0 19.2
559 559 Aftercare, musculoskeletal system connective tissue w MMCC 1,368 0.8146 26.1 21.8
560 559 Aftercare, musculoskeletal system connective tissue w MCC 1,613 0.6469 24.7 20.6
561 559 Aftercare, musculoskeletal system connective tissue w/o CC/MMCC 730 0.5579 22.8 19.0
562 562 Fx, sprn, strn disl except femur, hip, pelvis thigh w MMCC 5 0.8596 25.2 21.0
563 562 Fx, sprn, strn disl except femur, hip, pelvis thigh w/o MMCC 9 0.4824 19.6 16.3
564 564 Other musculoskeletal sys connective tissue diagnoses w MMCC 307 0.8803 24.2 20.2
565 564 Other musculoskeletal sys connective tissue diagnoses w MCC 199 0.6473 22.7 18.9
566 564 Other musculoskeletal sys connective tissue diagnoses w/o CC/MMCC 60 0.6236 22.5 18.8
573 573 Skin graft /or debrid for skn ulcer or cellulitis w MMCC 1,814 1.3944 38.2 31.8
574 573 Skin graft /or debrid for skn ulcer or cellulitis w MCC 1,761 1.0779 36.0 30.0
575 573 Skin graft /or debrid for skn ulcer or cellulitis w/o CC/MMCC 200 0.9033 30.1 25.1
576 576 Skin graft /or debrid exc for skin ulcer or cellulitis w MMCC 27 1.7840 37.6 31.3
577 576 Skin graft /or debrid exc for skin ulcer or cellulitis w MCC 28 0.8093 27.3 22.8
578 576 Skin graft /or debrid exc for skin ulcer or cellulitis w/o CC/MMCC 11 0.6327 21.6 18.0
579 579 Other skin, subcut tiss breast proc w MMCC 476 1.3648 36.5 30.4
580 579 Other skin, subcut tiss breast proc w MCC 398 1.0585 33.5 27.9
581 579 Other skin, subcut tiss breast proc w/o CC/MMCC 34 0.8032 30.1 25.1
582 582 Mastectomy for malignancy w CC/MMCC 1 1.7509 37.9 31.6
583 582 Mastectomy for malignancy w/o CC/MMCC 0 1.7509 37.9 31.6
584 584 Breast biopsy, local excision other breast procedures w CC/MMCC 2 0.6327 21.6 18.0
585 584 Breast biopsy, local excision other breast procedures w/o CC/MMCC 0 0.6327 21.6 18.0
592 592 Skin ulcers w MMCC 3,044 0.9490 27.0 22.5
593 592 Skin ulcers w MCC 2,805 0.7171 26.1 21.8
594 592 Skin ulcers w/o CC/MMCC 435 0.6109 24.8 20.7
595 595 Major skin disorders w MMCC 28 0.8138 25.3 21.1
596 595 Major skin disorders w/o MMCC 39 0.6547 22.4 18.7
597 597 Malignant breast disorders w MMCC 7 1.2617 31.5 26.3
598 597 Malignant breast disorders w MCC 7 0.8596 25.2 21.0
599 597 Malignant breast disorders w/o CC/MCC* 1 0.8596 25.2 21.0
600 600 Non-malignant breast disorders w CC/MMCC 17 0.8596 25.2 21.0
601 600 Non-malignant breast disorders w/o CC/MMCC 6 0.4824 19.6 16.3
602 602 Cellulitis w MMCC 829 0.6963 21.7 18.1
603 602 Cellulitis w/o MMCC 1,634 0.5333 19.9 16.6
604 604 Trauma to the skin, subcut tiss breast w MMCC 29 0.8236 24.4 20.3
605 604 Trauma to the skin, subcut tiss breast w/o MMCC 53 0.6053 23.8 19.8
606 606 Minor skin disorders w MMCC 63 0.8273 24.5 20.4
607 606 Minor skin disorders w/o MMCC 93 0.5599 20.7 17.3
614 614 Adrenal pituitary procedures w CC/MMCC 0 1.0449 32.5 27.1
615 614 Adrenal pituitary procedures w/o CC/MMCC 0 0.8596 25.2 21.0
616 616 Amputat of lower limb for endocrine, nutrit, metabol dis w MMCC 70 1.4804 38.4 32.0
617 616 Amputat of lower limb for endocrine, nutrit, metabol dis w MCC 132 1.1478 33.1 27.6
618 616 Amputat of lower limb for endocrine, nutrit, metabol dis w/o CC/MMCC 2 0.4824 19.6 16.3
619 619 O.R. procedures for obesity w MMCC 1 1.7509 37.9 31.6
620 619 O.R. procedures for obesity w MCC 0 1.7509 37.9 31.6
621 619 O.R. procedures for obesity w/o CC/MMCC 0 1.7509 37.9 31.6
622 622 Skin grafts wound debrid for endoc, nutrit metab dis w MCC 171 1.2978 35.7 29.8
623 622 Skin grafts wound debrid for endoc, nutrit metab dis w MCC 357 1.0065 30.9 25.8
624 622 Skin grafts wound debrid for endoc, nutrit metab dis w/o CC/MMCC 21 0.6327 21.6 18.0
625 625 Thyroid, parathyroid thyroglossal procedures w MMCC 1 1.2617 31.5 26.3
626 625 Thyroid, parathyroid thyroglossal procedures w MCC 1 0.8596 25.2 21.0
627 625 Thyroid, parathyroid thyroglossal procedures w/o CC/MMCC 0 0.8596 25.2 21.0
628 628 Other endocrine, nutrit metab O.R. proc w MMCC 48 1.3769 32.3 26.9
629 628 Other endocrine, nutrit metab O.R. proc w MCC 110 1.0449 32.5 27.1
630 628 Other endocrine, nutrit metab O.R. proc w/o CC/MMCC 2 0.8596 25.2 21.0
637 637 Diabetes w MMCC 421 0.9264 26.6 22.2
638 637 Diabetes w MCC 1,052 0.6950 24.5 20.4
639 637 Diabetes w/o CC/MMCC 71 0.5777 20.8 17.3
640 640 Nutritional misc metabolic disorders w MMCC 638 0.8424 23.1 19.3
641 640 Nutritional misc metabolic disorders w/o MMCC 548 0.6217 21.5 17.9
642 642 Inborn errors of metabolism 5 0.4824 19.6 16.3
643 643 Endocrine disorders w MMCC 30 0.6833 24.0 20.0
644 643 Endocrine disorders w MCC 28 0.5393 21.1 17.6
645 643 Endocrine disorders w/o CC/MCC 1 0.4824 19.6 16.3
652 652 Kidney transplant 0 0.0000 0.0 0.0
653 653 Major bladder procedures w MCC 2 1.7509 37.9 31.6
654 653 Major bladder procedures w MCC 0 1.7509 37.9 31.6
655 653 Major bladder procedures w/o CC/MMCC 0 1.7509 37.9 31.6
656 656 Kidney ureter procedures for neoplasm w MMCC 1 1.7509 37.9 31.6
657 656 Kidney ureter procedures forneoplasm w MCC 0 1.7509 37.9 31.6
658 656 Kidney ureter procedures for neoplasm w/o CC/MMCC 0 1.7509 37.9 31.6
659 659 Kidney ureter procedures for non-neoplasm w MMCC 6 1.2617 31.5 26.3
660 659 Kidney ureter procedures for non-neoplasm w MCC 6 1.2617 31.5 26.3
661 659 Kidney ureter procedures for non-neoplasm w/o CC/MMCC 1 0.6327 21.6 18.0
662 662 Minor bladder procedures w MMCC 2 1.7509 37.9 31.6
663 662 Minor bladder procedures w MCC 2 0.6327 21.6 18.0
664 662 Minor bladder procedures w/o CC/MCC 0 0.6327 21.6 18.0
665 665 Prostatectomy w MCC* 2 0.8596 25.2 21.0
666 665 Prostatectomy w CC* 1 0.8596 25.2 21.0
667 665 Prostatectomy w/o CC/MMCC 0 0.8596 25.2 21.0
668 668 Transurethral procedures w MMCC 4 0.8596 25.2 21.0
669 668 Transurethral procedures w MCC 3 0.6327 21.6 18.0
670 668 Transurethral procedures w/o CC/MMCC 0 0.6327 21.6 18.0
671 671 Urethral procedures w CC/MMCC 1 0.6327 21.6 18.0
672 671 Urethral procedures w/o CC/MMCC 0 0.6327 21.6 18.0
673 673 Other kidney urinary tract procedures w MMCC 227 1.4418 33.8 28.2
674 673 Other kidney urinary tract procedures w MCC 67 1.1430 29.1 24.3
675 673 Other kidney urinary tract procedures w/o CC/MMCC 0 1.1430 29.1 24.3
682 682 Renal failure w MMCC 1,458 0.8945 23.8 19.8
683 682 Renal failure w MCC 713 0.7478 22.8 19.0
684 682 Renal failure w/o CC/MMCC 91 0.6647 20.6 17.2
685 685 Admit for renal dialysis 32 0.8341 25.1 20.9
686 686 Kidney urinary tract neoplasms w MMCC 15 0.8596 25.2 21.0
687 686 Kidney urinary tract neoplasms w MCC 18 0.8596 25.2 21.0
688 686 Kidney urinary tract neoplasms w/o CC/MMCC 3 0.6327 21.6 18.0
689 689 Kidney urinary tract infections w MMCC 868 0.6712 22.6 18.8
690 689 Kidney urinary tract infections w/o MMCC 782 0.5266 20.5 17.1
691 691 Urinary stones w esw lithotripsy w CC/MMCC 0 0.4824 19.6 16.3
692 691 Urinary stones w esw lithotripsy w/o CC/MMCC 0 0.4824 19.6 16.3
693 693 Urinary stones w/o esw lithotripsy w MMCC 3 0.8596 25.2 21.0
694 693 Urinary stones w/ot esw lithotripsy w/o MMCC 5 0.4824 19.6 16.3
695 695 Kidney urinary tract signs symptoms w MMCC 4 1.2617 31.5 26.3
696 695 Kidney urinary tract signs symptoms w/o MMCC 7 0.6327 21.6 18.0
697 697 Urethral stricture 0 0.6327 21.6 18.0
698 698 Other kidney urinary tract diagnoses w MMCC 285 0.9527 23.5 19.6
699 698 Other kidney urinary tract diagnoses w MCC 142 0.6606 22.0 18.3
700 698 Other kidney urinary tract diagnoses w/o CC/MMCC 33 0.5695 21.1 17.6
707 707 Major male pelvic procedures w CC/MMCC 0 1.2617 31.5 26.3
708 707 Major male pelvic procedures w/o CC/MMCC 0 0.6327 21.6 18.0
709 709 Penis procedures w CC/MMCC 15 1.7509 37.9 31.6
710 709 Penis procedures w/o CC/MMCC 0 1.7509 37.9 31.6
711 711 Testes procedures w CC/MMCC 6 1.2617 31.5 26.3
712 711 Testes procedures w/o CC/MMCC 0 1.2617 31.5 26.3
713 713 Transurethral prostatectomy w CC/MMCC 2 1.7509 37.9 31.6
714 713 Transurethral prostatectomy w/o CC/MMCC 0 1.7509 37.9 31.6
715 715 Other male reproductive system O.R. proc for malignancy w CC/MMCC 0 1.2617 31.5 26.3
716 715 Other male reproductive system O.R. proc for malignancy w/o CC/MMCC 0 1.2617 31.5 26.3
717 717 Other male reproductive system O.R. proc exc malignancy w CC/MMCC 11 1.2617 31.5 26.3
718 717 Other male reproductive system O.R. proc exc malignancy w/o CC/MMCC 0 1.2617 31.5 26.3
722 722 Malignancy, male reproductive system w MMCC 15 0.6327 21.6 18.0
723 722 Malignancy, male reproductive system w MCC 15 0.4824 19.6 16.3
724 722 Malignancy, male reproductive system w/o CC/MMCC 0 0.4824 19.6 16.3
725 725 Benign prostatic hypertrophy w MMCC 1 0.8596 25.2 21.0
726 725 Benign prostatic hypertrophy w/o MMCC 2 0.4824 19.6 16.3
727 727 Inflammation of the male reproductive system w MMCC 27 0.7907 23.1 19.3
728 727 Inflammation of the male reproductive system w/o MMCC 51 0.5259 20.4 17.0
729 729 Other male reproductive system diagnoses w CC/MMCC 49 0.8878 26.2 21.8
730 729 Other male reproductive system diagnoses w/o CC/MMCC 8 0.4824 19.6 16.3
734 734 Pelvic evisceration, rad hysterectomy rad vulvectomy w CC/MMCC 0 1.2617 31.5 26.3
735 734 Pelvic evisceration, rad hysterectomy rad vulvectomy w/o CC/MMCC 0 1.2617 31.5 26.3
736 736 Uterine adnexa proc for ovarian or adnexal malignancy w MMCC 0 1.2617 31.5 26.3
737 736 Uterine adnexa proc for ovarian or adnexal malignancy w MCC 0 0.8596 25.2 21.0
738 736 Uterine adnexa proc for ovarian or adnexal malignancy w/o CC/MMCC 0 0.4824 19.6 16.3
739 739 Uterine,adnexa proc for non-ovarian/adnexal malig w MMCC 1 1.2617 31.5 26.3
740 739 Uterine,adnexa proc for non-ovarian/adnexal malig w MCC 0 1.2617 31.5 26.3
741 739 Uterine,adnexa proc for non-ovarian/adnexal malig w/o CC/MMCC 0 1.2617 31.5 26.3
742 742 Uterine adnexa proc for non-malignancy w CC/MMCC 0 0.8596 25.2 21.0
743 742 Uterine adnexa proc for non-malignancy w/o CC/MMCC 0 0.4824 19.6 16.3
744 744 DC, conization, laparascopy tubal interruption w CC/MMCC 1 0.8596 25.2 21.0
745 744 DC, conization, laparascopy tubal interruption w/o CC/MMCC 0 0.8596 25.2 21.0
746 746 Vagina, cervix vulva procedures w CC/MMCC 1 1.7509 37.9 31.6
747 746 Vagina, cervix vulva procedures w/o CC/MMCC 0 1.7509 37.9 31.6
748 748 Female reproductive system reconstructive procedures 0 1.2617 31.5 26.3
749 749 Other female reproductive system O.R. procedures w CC/MMCC 4 1.2617 31.5 26.3
750 749 Other female reproductive system O.R. procedures w/o CC/MMCC 0 1.2617 31.5 26.3
754 754 Malignancy, female reproductive system w MMCC 22 1.2617 31.5 26.3
755 754 Malignancy, female reproductive system w MCC 21 0.8596 25.2 21.0
756 754 Malignancy, female reproductive system w/o CC/MMCC 1 0.4824 19.6 16.3
757 757 Infections, female reproductive system w MCC* 52 0.7580 23.7 19.8
758 757 Infections, female reproductive system w CC* 27 0.7580 23.7 19.8
759 757 Infections, female reproductive system w/o CC/MCC* 5 0.7580 23.7 19.8
760 760 Menstrual other female reproductive system disorders w CC/MMCC 0 0.8596 25.2 21.0
761 760 Menstrual other female reproductive system disorders w/o CC/MMCC 0 0.8596 25.2 21.0
765 765 Cesarean section w CC/MMCC 0 0.8596 25.2 21.0
766 765 Cesarean section w/o CC/MMCC 0 0.8596 25.2 21.0
767 767 Vaginal delivery w sterilization /or DC 0 0.8596 25.2 21.0
768 768 Vaginal delivery w O.R. proc except steril /or DC 0 0.8596 25.2 21.0
769 769 Postpartum post abortion diagnoses w O.R. procedure 0 0.8596 25.2 21.0
770 770 Abortion w DC, aspiration curettage or hysterotomy 0 0.8596 25.2 21.0
774 774 Vaginal delivery w complicating diagnoses 0 0.8596 25.2 21.0
775 775 Vaginal delivery w/o complicating diagnoses 0 0.8596 25.2 21.0
776 776 Postpartum post abortion diagnoses w/o O.R. procedure 0 0.8596 25.2 21.0
777 777 Ectopic pregnancy 0 0.8596 25.2 21.0
778 778 Threatened abortion 0 0.7580 23.7 19.8
779 779 Abortion w/o DC 0 0.7580 23.7 19.8
780 780 False labor 0 0.7580 23.7 19.8
781 781 Other antepartum diagnoses w medical complications 1 0.4824 19.6 16.3
782 782 Other antepartum diagnoses w/o medical complications 0 0.4824 19.6 16.3
789 789 Neonates, died or transferred to another acute care facility 0 0.4824 19.6 16.3
790 790 Extreme immaturity or respiratory distress syndrome, neonate 0 0.4824 19.6 16.3
791 791 Prematurity w major problems 0 0.4824 19.6 16.3
792 792 Prematurity w/o major problems 0 0.4824 19.6 16.3
793 793 Full term neonate w major problems 0 0.4824 19.6 16.3
794 794 Neonate w other significant problems 0 0.4824 19.6 16.3
795 795 Normal newborn 0 0.4824 19.6 16.3
799 799 Splenectomy w MCC 0 0.8596 25.2 21.0
800 799 Splenectomy w CC 1 0.8596 25.2 21.0
801 799 Splenectomy w/o CC/MMCC 0 0.8596 25.2 21.0
802 802 Other O.R. proc of the blood blood forming organs w MMCC 4 1.2617 31.5 26.3
803 802 Other O.R. proc of the blood blood forming organs w MCC 0 1.2617 31.5 26.3
804 802 Other O.R. proc of the blood blood forming organs w/o CC/MMCC 0 1.2617 31.5 26.3
808 808 Major hematol/immun diag exc sickle cell crisis coagul w MMCC 17 1.2617 31.5 26.3
809 808 Major hematol/immun diag exc sickle cell crisis coagul w MCC 11 0.8596 25.2 21.0
810 808 Major hematol/immun diag exc sickle cell crisis coagul w/o CC/MMCC 1 0.4824 19.6 16.3
811 811 Red blood cell disorders w MMCC 43 0.7905 22.8 19.0
812 811 Red blood cell disorders w/o MMCC 58 0.5349 20.4 17.0
813 813 Coagulation disorders 55 0.8402 23.2 19.3
814 814 Reticuloendothelial immunity disorders w MMCC 16 0.8596 25.2 21.0
815 814 Reticuloendothelial immunity disorders w MCC 7 0.6327 21.6 18.0
816 814 Reticuloendothelial immunity disorders w/o CC/MMCC 1 0.4824 19.6 16.3
820 820 Lymphoma leukemia w major O.R. procedure w MMCC 0 1.2617 31.5 26.3
821 820 Lymphoma leukemia w major O.R. procedure w MCC 0 0.8596 25.2 21.0
822 820 Lymphoma leukemia w major O.R. procedure w/o CC/MMCC 0 0.8596 25.2 21.0
823 823 Lymphoma non-acute leukemia w other O.R. proc w MMCC 11 1.2617 31.5 26.3
824 823 Lymphoma non-acute leukemia w other O.R. proc w MCC 4 0.8596 25.2 21.0
825 823 Lymphoma non-acute leukemia w other O.R. proc w/o CC/MMCC 0 0.8596 25.2 21.0
826 826 Myeloprolif disord or poorly diff neopl w maj O.R. proc w MMCC 1 1.7509 37.9 31.6
827 826 Myeloprolif disord or poorly diff neopl w maj O.R. proc w MCC 1 1.7509 37.9 31.6
828 826 Myeloprolif disord or poorly diff neopl w maj O.R. proc w/o CC/MMCC 0 1.7509 37.9 31.6
829 829 Myeloprolif disord or poorly diff neopl w other O.R. proc w CC/MMCC 7 1.7509 37.9 31.6
830 829 Myeloprolif disord or poorly diff neopl w other O.R. proc w/o CC/MMCC 0 1.7509 37.9 31.6
834 834 Acute leukemia w/o major O.R. procedure w MMCC 14 0.8596 25.2 21.0
835 834 Acute leukemia w/o major O.R. procedure w CC* 14 0.8596 25.2 21.0
836 834 Acute leukemia w/o major O.R. procedure w/o CC/MCC* 2 0.8596 25.2 21.0
837 837 Chemo w acute leukemia as sdx or w high dose chemo agent w MMCC 0 1.7509 37.9 31.6
838 837 Chemo w acute leukemia as sdx or w high dose chemo agent w MCC 0 1.7509 37.9 31.6
839 837 Chemo w acute leukemia as sdx or w high dose chemo agent w/o CC/MMCC 0 1.7509 37.9 31.6
840 840 Lymphoma non-acute leukemia w MMCC 133 0.9227 23.1 19.3
841 840 Lymphoma non-acute leukemia w MCC 63 0.7247 19.7 16.4
842 840 Lymphoma non-acute leukemia w/o CC/MMCC 7 0.6327 21.6 18.0
843 843 Other myeloprolif dis or poorly diff neopl diag w MMCC 20 0.8596 25.2 21.0
844 843 Other myeloprolif dis or poorly diff neopl diag w MCC 11 0.6327 21.6 18.0
845 843 Other myeloprolif dis or poorly diff neopl diag w/o CC/MMCC 3 0.6327 21.6 18.0
846 846 Chemotherapy w/o acute leukemia as secondary diagnosis w MMCC 49 1.4778 30.0 25.0
847 846 Chemotherapy w/o acute leukemia as secondary diagnosis w MCC 43 1.0877 23.8 19.8
848 846 Chemotherapy w/o acute leukemia as secondary diagnosis w/o CC/MMCC 0 1.0877 23.8 19.8
849 849 Radiotherapy 141 0.7949 21.6 18.0
853 853 Infectious parasitic diseases w O.R. procedure w MMCC 837 1.7864 37.3 31.1
854 853 Infectious parasitic diseases w O.R. procedure w MCC 104 1.1703 33.0 27.5
855 853 Infectious parasitic diseases w O.R. procedure w/o CC/MCC* 5 1.1703 33.0 27.5
856 856 Postoperative or post-traumatic infections w O.R. proc w MMCC 301 1.5591 36.7 30.6
857 856 Postoperative or post-traumatic infections w O.R. proc w MCC 213 1.0707 32.6 27.2
858 856 Postoperative or post-traumatic infections w O.R. proc w/o CC/MMCC 32 0.8943 26.8 22.3
862 862 Postoperative post-traumatic infections w MMCC 1,163 0.9629 25.3 21.1
863 862 Postoperative post-traumatic infections w/o MMCC 1,231 0.7018 23.8 19.8
864 864 Fever of unknown origin 11 0.4824 19.6 16.3
865 865 Viral illness w MMCC 36 0.7998 22.2 18.5
866 865 Viral illness w/o MMCC 14 0.6327 21.6 18.0
867 867 Other infectious parasitic diseases diagnoses w MMCC 357 1.1296 23.4 19.5
868 867 Other infectious parasitic diseases diagnoses w MCC 86 0.7458 22.6 18.8
869 867 Other infectious parasitic diseases diagnoses w/o CC/MMCC 7 0.4824 19.6 16.3
870 870 Septicemia w MV 96+ hours 894 2.2127 33.0 27.5
871 871 Septicemia w/o MV 96+ hours w MMCC 4,507 0.8713 23.4 19.5
872 871 Septicemia w/o MV 96+ hours w/o MMCC 1,608 0.6584 21.8 18.2
876 876 O.R. procedure w principal diagnoses of mental illness 12 0.6327 21.6 18.0
880 880 Acute adjustment reaction psychosocial dysfunction 11 0.4824 19.6 16.3
881 881 Depressive neuroses 14 0.6327 21.6 18.0
882 882 Neuroses except depressive 16 0.4824 19.6 16.3
883 883 Disorders of personality impulse control 12 0.8596 25.2 21.0
884 884 Organic disturbances mental retardation 146 0.5159 25.4 21.2
885 885 Psychoses 1,218 0.4206 23.9 19.9
886 886 Behavioral developmental disorders 18 0.4824 19.6 16.3
887 887 Other mental disorder diagnoses 0 0.6327 21.6 18.0
894 894 Alcohol/drug abuse or dependence, left ama 0 0.6327 21.6 18.0
895 895 Alcohol/drug abuse or dependence w rehabilitation therapy 2 0.4824 19.6 16.3
896 896 Alcohol/drug abuse or dependence w/o rehabilitation therapy w MMCC 7 1.2617 31.5 26.3
897 896 Alcohol/drug abuse or dependence w/o rehabilitation therapy w/o MMCC 17 0.4824 19.6 16.3
901 901 Wound debridements for injuries w MMCC 217 1.5251 35.9 29.9
902 901 Wound debridements for injuries w MCC 129 1.0552 30.1 25.1
903 901 Wound debridements for injuries w/o CC/MMCC 23 0.8596 25.2 21.0
904 904 Skin grafts for injuries w CC/MMCC 78 1.3404 35.6 29.7
905 904 Skin grafts for injuries w/o CC/MMCC 6 0.8596 25.2 21.0
906 906 Hand procedures for injuries 1 1.7509 37.9 31.6
907 907 Other O.R. procedures for injuries w MMCC 91 1.6273 37.5 31.3
908 907 Other O.R. procedures for injuries w MCC 63 1.1167 34.0 28.3
909 907 Other O.R. procedures for injuries w/o CC/MCC* 6 1.1167 34.0 28.3
913 913 Traumatic injury w MMCC 37 0.7480 24.8 20.7
914 913 Traumatic injury w/o MMCC 66 0.6073 21.8 18.2
915 915 Allergic reactions w MMCC 0 0.4824 19.6 16.3
916 915 Allergic reactions w/o MMCC 0 0.4824 19.6 16.3
917 917 Poisoning toxic effects of drugs w MMCC 8 0.4824 19.6 16.3
918 917 Poisoning toxic effects of drugs w/o MMCC 9 0.4824 19.6 16.3
919 919 Complications of treatment w MMCC 1,235 1.0924 26.9 22.4
920 919 Complications of treatment w MCC 841 0.8582 26.0 21.7
921 919 Complications of treatment w/o CC/MMCC 117 0.6163 20.1 16.8
922 922 Other injury, poisoning toxic effect diag w MMCC 7 0.8596 25.2 21.0
923 922 Other injury, poisoning toxic effect diag w/o MMCC 11 0.6327 21.6 18.0
927 927 Extensive burns or full thickness burns w MV 96+ hrs w skin graft 1 1.7509 37.9 31.6
928 928 Full thickness burn w skin graft or inhal inj w CC/MMCC 9 1.2617 31.5 26.3
929 928 Full thickness burn w skin graft or inhal inj w/o CC/MMCC 2 0.6327 21.6 18.0
933 933 Extensive burns or full thickness burns w MV 96+ hrs w/o skin graft 10 1.2617 31.5 26.3
934 934 Full thickness burn w/o skin grft or inhal inj 40 0.7755 24.2 20.2
935 935 Non-extensive burns 46 0.7815 24.5 20.4
939 939 O.R. proc w diagnoses of other contact w health services w MCC 267 1.3463 34.1 28.4
940 939 O.R. proc w diagnoses of other contact w health services w MCC 135 0.9993 30.6 25.5
941 939 O.R. proc w diagnoses of other contact w health services w/o CC/MMCC 15 0.8596 25.2 21.0
945 945 Rehabilitation w CC/MMCC 2,220 0.6154 22.1 18.4
946 945 Rehabilitation w/o CC/MMCC 428 0.4311 18.9 15.8
947 947 Signs symptoms w MMCC 57 0.6548 22.2 18.5
948 947 Signs symptoms w/o MMCC 69 0.5737 22.2 18.5
949 949 Aftercare w CC/MMCC 3,802 0.7034 22.5 18.8
950 949 Aftercare w/o CC/MMCC 546 0.5002 19.2 16.0
951 951 Other factors influencing health status 28 1.2726 27.0 22.5
955 955 Craniotomy for multiple significant trauma 0 1.7509 37.9 31.6
956 956 Limb reattachment, hip femur proc for multiple significant trauma 0 0.8596 25.2 21.0
957 957 Other O.R. procedures for multiple significant trauma w MMCC 1 1.2617 31.5 26.3
958 957 Other O.R. procedures for multiple significant trauma w MCC 1 0.4824 19.6 16.3
959 957 Other O.R. procedures for multiple significant trauma w/o CC/MMCC 0 0.4824 19.6 16.3
963 963 Other multiple significant trauma w MMCC 15 0.8596 25.2 21.0
964 963 Other multiple significant trauma w MCC 5 0.6327 21.6 18.0
965 963 Other multiple significant trauma w/o CC/MMCC 3 0.4824 19.6 16.3
969 969 HIV w extensive O.R. procedure w MMCC 13 1.2617 31.5 26.3
970 969 HIV w extensive O.R. procedure w/o MCC* 3 1.2617 31.5 26.3
974 974 HIV w major related condition w MMCC 196 1.0056 21.9 18.3
975 974 HIV w major related condition w MCC 85 0.6433 18.3 15.3
976 974 HIV w major related condition w/o CC/MMCC 16 0.6327 21.6 18.0
977 977 HIV w or w/o other related condition 45 0.6975 19.0 15.8
981 981 Extensive O.R. procedure unrelated to principal diagnosis w MMCC 1,143 2.3516 43.1 35.9
982 981 Extensive O.R. procedure unrelated to principal diagnosis w MCC 290 1.4645 35.2 29.3
983 981 Extensive O.R. procedure unrelated to principal diagnosis w/o CC/MMCC 26 1.1662 31.9 26.6
984 984 Prostatic O.R. procedure unrelated to principal diagnosis w MMCC 16 1.2617 31.5 26.3
985 984 Prostatic O.R. procedure unrelated to principal diagnosis w MCC 9 1.2617 31.5 26.3
986 984 Prostatic O.R. procedure unrelated to principal diagnosis w/o CC/MMCC 0 1.2617 31.5 26.3
987 987 Non-extensive O.R. proc unrelated to principal diagnosis w MMCC 419 1.7561 36.4 30.3
988 987 Non-extensive O.R. proc unrelated to principal diagnosis w MCC 218 1.1596 33.9 28.3
989 987 Non-extensive O.R. proc unrelated to principal diagnosis w/o CC/MMCC 10 0.8596 25.2 21.0
998 998 Ungroupable 0 0.0000 0.0 0.0
999 999 Principal diagnosis invalid as discharge diagnosis 0 0.0000 0.0 0.0
1 The proposed SSO Threshold is calculated as 56 th of the geometric average length of stay of the proposed MS-LTC-DRG (as specified at § 412.529 in conjunction with § 412.503).
* In determining the proposed MS-LTC-DRG relative weights, these proposed MS-LTC-DRGs were adjusted for nonmonotonicity as discussed in section II.I.4. (step 6) of the preamble of this proposed rule.

Appendix A-Regulatory Impact Analysis

I. Overall Impact

We have examined the impacts of this proposed rule as required by Executive Order 12866 (September 1993, Regulatory Planning and Review) and the Regulatory Flexibility Act (RFA) (September 19, 1980, Pub. L. 96-354), section 1102(b) of the Social Security Act, the Unfunded Mandates Reform Act of 1995 (Pub. L. 104-4), Executive Order 13132 on Federalism, and the Congressional Review Act (5 U.S.C. 804(2)).

Executive Order 12866 (as amended by Executive Order 13258) directs agencies to assess all costs and benefits of available regulatory alternatives and, if regulation is necessary, to select regulatory approaches that maximize net benefits (including potential economic, environmental, public health and safety effects, distributive impacts, and equity). A regulatory impact analysis (RIA) must be prepared for major rules with economically significant effects ($100 million or more in any 1 year).

We have determined that this proposed rule is a major rule as defined in 5 U.S.C. 804(2). We estimate that the proposed changes for FY 2009 operating and capital payments would redistribute in excess of $100 million among different types of inpatient cases. The market basket update to the IPPS rates required by the statute, in conjunction with other payment changes in this proposed rule, would result in an approximate $4 billion increase in FY 2009 operating and capital payments. Our impact estimate includes the -0.9 percent adjustment for documentation and coding changes to the IPPS standardized amounts and capital Federal rates for FY 2009 in accordance with section 7 of Pub. L. 110-90. For purposes of the impact analysis, we also assume an additional 1.8 percent increase in case-mix between FY 2008 and FY 2009 because we believe the adoption of the MS-DRGs will result in case-mix growth due to documentation and coding changes that do not reflect real changes in patient severity of illness. The estimates of IPPS operating payments do not reflect any changes in hospital admissions or real case-mix intensity, which would also affect overall payment changes.

The RFA requires agencies to analyze options for regulatory relief of small businesses. For purposes of the RFA, small entities include small businesses, nonprofit organizations, and small government jurisdictions. Most hospitals and most other providers and suppliers are considered to be small entities, either by being nonprofit organizations or by meeting the Small Business Administration definition of a small business (having revenues of $31.5 million or less in any 1 year). (For details on the latest standards for heath care providers, we refer readers to page 33 of the Table of Small Business Size Standards at the Small Business Administration Web site at: http://www.sba.gov/services/contractingopportunities/sizestandardstopics/tableofsize/index.html. ) For purposes of the RFA, all hospitals and other providers and suppliers are considered to be small entities. Individuals and States are not included in the definition of a small entity. We believe that this proposed rule would have a significant impact on small entities as explained in this Appendix. Because we acknowledge that many of the affected entities are small entities, the analysis discussed throughout the preamble of this proposed rule constitutes our initial regulatory flexibility analysis. Therefore, we are soliciting comments on our estimates and analysis of the impact of the proposed rule on those small entities.

In addition, section 1102(b) of the Act requires us to prepare a regulatory impact analysis for any proposed or final rule that may have a significant impact on the operations of a substantial number of small rural hospitals. This analysis must conform to the provisions of section 603 of the RFA. With the exception of hospitals located in certain New England counties, for purposes of section 1102(b) of the Act, we now define a small rural hospital as a hospital that is located outside of an urban area and has fewer than 100 beds. Section 601(g) of the Social Security Amendments of 1983 (Pub. L. 98-21) designated hospitals in certain New England counties as belonging to the adjacent urban area. Thus, for purposes of the IPPS, we continue to classify these hospitals as urban hospitals.

Section 202 of the Unfunded Mandates Reform Act of 1995 (Pub. L. 104-4) also requires that agencies assess anticipated costs and benefits before issuing any rule whose mandates require spending in any 1 year of $100 million in 1995 dollars, updated annually for inflation. That threshold level is currently approximately $130 million. This proposed rule will not mandate any requirements for State, local, or tribal governments, nor will it affect private sector costs.

Executive Order 13132 establishes certain requirements that an agency must meet when it promulgates a proposed rule (and subsequent final rule) that imposes substantial direct requirement costs on State and local governments, preempts State law, or otherwise has Federalism implications. As stated above, this proposed rule would not have a substantial effect on State and local governments.

The following analysis, in conjunction with the remainder of this document, demonstrates that this proposed rule is consistent with the regulatory philosophy and principles identified in Executive Order 12866, the RFA, and section 1102(b) of the Act. The proposed rule would affect payments to a substantial number of small rural hospitals, as well as other classes of hospitals, and the effects on some hospitals may be significant.

II. Objectives

The primary objective of the IPPS is to create incentives for hospitals to operate efficiently and minimize unnecessary costs while at the same time ensuring that payments are sufficient to adequately compensate hospitals for their legitimate costs. In addition, we share national goals of preserving the Medicare Hospital Insurance Trust Fund.

We believe the proposed changes in this proposed rule would further each of these goals while maintaining the financial viability of the hospital industry and ensuring access to high quality health care for Medicare beneficiaries. We expect that these proposed changes would ensure that the outcomes of this payment system are reasonable and equitable while avoiding or minimizing unintended adverse consequences.

III. Limitations of Our Analysis

The following quantitative analysis presents the projected effects of our proposed policy changes, as well as statutory changes effective for FY 2009, on various hospital groups. We estimate the effects of individual proposed policy changes by estimating payments per case while holding all other payment policies constant. We use the best data available, but, generally, we do not attempt to make adjustments for future changes in such variables as admissions, lengths of stay, or case-mix. However, in the FY 2008 IPPS final rule, we indicated that we believe that implementation of the MS-DRGs would lead to increases in case-mix that do not reflect actual increases in patients' severity of illness as a result of more comprehensive documentation and coding. As explained in section II.D. of the preamble of this proposed rule, the FY 2008 IPPS final rule with comment period established a documentation and coding adjustment of -1.2 percent for FY 2008, -1.8 percent for FY 2009, and -1.8 percent for FY 2010 to maintain budget neutrality for the transition to the MS DRGs. Subsequently, Congress enacted Pub. L. 110-90. Section 7 of Public L. 110-90 reduced the IPPS documentation and coding adjustment from -1.2 percent to -0.6 percent for FY 2008 and from -1.8 percent to -0.9 percent for FY 2009. Following enactment of Pub. L. 110-90, we revised the FY 2008 standardized amounts (as well as other affected payment factors and thresholds) to reflect the -0.6 percent FY 2008 documentation and coding adjustment. The proposed FY 2009 IPPS national standardized amount included in this proposed rule reflects the documentation and coding adjustment of -0.9 percent for FY 2009. While we have adopted the statutorily mandated documentation and coding adjustments for payment purposes, we continue to believe that an increase in case-mix of 1.8 percent between FY 2008 and FY 2009 is likely as a result of the adoption of the MS DRGs. The impacts shown below illustrate the impact of the FY 2009 IPPS changes on hospital operating payments, including the -0.9 percent FY 2009 documentation and coding adjustment to the IPPS national standardized amounts, both prior to and following the expected 1.8 percent growth in case-mix between FY 2008 and FY 2009. As we have done in the previous rules, we are soliciting comments and information about the anticipated effects of the proposed changes on hospitals and our methodology for estimating them.

IV. Hospitals Included in and Excluded From the IPPS

The prospective payment systems for hospital inpatient operating and capital-related costs encompass most general short-term, acute care hospitals that participate in the Medicare program. There were 35 Indian Health Service hospitals in our database, which we excluded from the analysis due to the special characteristics of the prospective payment methodology for these hospitals. Among other short-term, acute care hospitals, only the 46 such hospitals in Maryland remain excluded from the IPPS under the waiver at section 1814(b)(3) of the Act.

As of March 2008, there are 3,528 IPPS hospitals to be included in our analysis. This represents about 58 percent of all Medicare-participating hospitals. The majority of this impact analysis focuses on this set of hospitals. There are also approximately 1,311 CAHs. These small, limited service hospitals are paid on the basis of reasonable costs rather than under the IPPS. There are also 1,219 specialty hospitals and 2,291 specialty units that are excluded from the IPPS. These specialty hospitals include IPFs, IRFs, LTCHs, RNHCIs, children's hospitals, and cancer hospitals. Changes in payments for IPFs and IRFs are made through other separate rulemaking. Payment impacts for these specialty hospitals and units are not included in this proposed rule. There is also a separate rule to update and make changes to the LTCH PPS for its current July 1 through June 30 rate year (RY). However, we have traditionally used the IPPS rule to update the LTCH patient classifications and relative weights because the LTCH PPS uses the same DRGs as the IPPS, resulting in the LTCH relative weights being reclassified and recalibrated according to the same schedule as the IPPS (that is, for each Federal fiscal year). The impacts of our policy changes on LTCHs, where applicable, are discussed below. (We note that, as discussed in section II.I. of the preamble of this proposed rule, in the RY 2009 LTCH PPS proposed rule 73 FR 5351 through 5352), we proposed to move the annual LTCH PPS RY update (currently effective July 1) to be effective October 1 through September 30 (the Federal fiscal year) each year beginning October 1, 2009. Under this proposal, RY 2009 would be extended 3 months, such that RY 2009 would be the 15-month period of July 1, 2008 through September 30, 2009.)

V. Effects on Excluded Hospitals and Hospital Units

As of March 2008, there were 1,219 hospitals excluded from the IPPS. Of these 1,219 hospitals, 314 IPFs, 78 children's hospitals, 11 cancer hospitals, and 19 RNHCIs are either being paid on a reasonable cost basis or have a portion of the PPS payment based on reasonable cost principles subject to the rate-of-increase ceiling under § 413.40. The remaining providers, 221 IRFs, 394 LTCHs, and 182 IPFs, are paid 100 percent of the Federal prospective rate under the IRF PPS and the LTCH PPS, respectively, or 100 percent of the Federal per diem amount under the IPF PPS. As stated above, IRFs and IPFs are not affected by this proposed rule. The impacts of the changes to LTCHs are discussed separately below. In addition, there are 1,319 IPFs co-located in hospitals otherwise subject to the IPPS, 788 of which are paid on a blend of the IPF PPS per diem payment and the reasonable cost-based payment. The remaining 531 IPF units are paid 100 percent of the Federal amount under the IPF PPS. There are 972 IRFs (paid under the IRF PPS) co-located in hospitals otherwise subject to the IPPS.

In the past, hospitals and units excluded from the IPPS have been paid based on their reasonable costs subject to limits as established by the Tax Equity and Fiscal Responsibility Act of 1982 (TEFRA). Hospitals that continue to be paid fully on a reasonable cost basis are subject to TEFRA limits for FY 2009. For these hospitals (cancer and children's hospitals), consistent with section 1886(b)(3)(B)(ii) of the Act, we are proposing an update that is the percentage increase in the FY 2009 IPPS operating market basket, which is estimated to be 3.0 percent, based on Global Insights, Inc.'s 2008 first quarter forecast of the IPPS operating market basket increase. In addition, in accordance with § 403.752(a) of the regulations, RNHCIs are paid under § 413.40, which also uses section 1886(b)(3)(B)(ii) of the Act to update target amounts by the rate-of-increase percentage. For RNHCIs, the proposed update is the percentage increase in the FY 2009 IPPS operating market basket increase, which is estimated to be 3.0 percent, based on Global Insight, Inc.'s 2008 first quarter forecast of the IPPS operating market basket increase.

The final rule implementing the IPF PPS (69 FR 66922) established a 3-year transition to the IPF PPS during which some providers received a blend of the IPF PPS per diem payment and the TEFRA reasonable cost-based payment. This transitional period for a blended payment amount for IPFs ended for cost reporting periods that began on or after January 1, 2008. Because the reasonable cost-based amount is zero percent for cost reporting periods beginning during CY 2008, no IPF will have a portion of its PPS payment that is based in part on reasonable cost subject to the rate-of-increase ceiling during FY 2009. Thus, there is no longer a need for an update factor for IPFs' TEFRA target amount for FY 2009 and thereafter.

The impact on excluded hospitals and hospital units of the proposed update in the rate-of-increase limit depends on the cumulative cost increases experienced by each excluded hospital or unit since its applicable base period. For excluded hospitals and units that have maintained their cost increases at a level below the rate-of-increase limits since their base period, the major effect is on the level of incentive payments these hospitals and hospital units receive. Conversely, for excluded hospitals and hospital units with per-case cost increases above the cumulative update in their rate-of-increase limits, the major effect is the amount of excess costs that will not be reimbursed.

We note that, under § 413.40(d)(3), an excluded hospital or unit whose costs exceed 110 percent of its rate-of-increase limit receives its rate-of-increase limit plus 50 percent of the difference between its reasonable costs and 110 percent of the limit, not to exceed 110 percent of its limit. In addition, under the various provisions set forth in § 413.40, certain excluded hospitals and hospital units can obtain payment adjustments for justifiable increases in operating costs that exceed the limit.

VI. Quantitative Effects of the Proposed Policy Changes Under the IPPS for Operating Costs

A. Basis and Methodology of Estimates

In this proposed rule, we are announcing proposed policy changes and payment rate updates for the IPPS for operating costs. Changes to the capital payments are discussed in section VIII. of this Appendix.

Based on the overall percentage change in payments per case estimated using our payment simulation model, we estimate that total FY 2009 operating payments will increase 4.1 percent compared to FY 2008, largely due to the statutorily mandated update to the IPPS rates. This amount also reflects the -0.9 percent FY 2009 documentation and coding adjustment to the IPPS national standardized amounts and our assumption of an additional 1.8 percent increase in case-mix between FY 2008 and FY 2009 as a result of improvements in documentation and coding that do not represent real increases in underlying resource demands and patient acuity due to the adoption of the MS-DRGs. The impacts do not illustrate changes in hospital admissions or real case-mix intensity, which will also affect overall payment changes.

We have prepared separate impact analyses of the changes to each system. This section deals with changes to the operating prospective payment system. Our payment simulation model relies on the most recent available data to enable us to estimate the impacts on payments per case of certain changes in this proposed rule. However, there are other changes for which we do not have data available that would allow us to estimate the payment impacts using this model. For those changes, we have attempted to predict the payment impacts based upon our experience and other more limited data.

The data used in developing the quantitative analyses of changes in payments per case presented below are taken from the FY 2007 MedPAR file and the most current Provider-Specific File that is used for payment purposes. Although the analyses of the changes to the operating PPS do not incorporate cost data, data from the most recently available hospital cost report were used to categorize hospitals. Our analysis has several qualifications. First, in this analysis, we do not make adjustments for future changes in such variables as admissions, lengths of stay, or underlying growth in real case-mix. Second, due to the interdependent nature of the IPPS payment components, it is very difficult to precisely quantify the impact associated with each change. Third, we use various sources for the data used to categorize hospitals in the tables. In some cases, particularly the number of beds, there is a fair degree of variation in the data from different sources. We have attempted to construct these variables with the best available source overall. However, for individual hospitals, some miscategorizations are possible.

Using cases from the FY 2007 MedPAR file, we simulated payments under the operating IPPS given various combinations of payment parameters. Any short-term, acute care hospitals not paid under the IPPS (Indian Health Service hospitals and hospitals in Maryland) were excluded from the simulations. The impact of payments under the capital IPPS, or the impact of payments for costs other than inpatient operating costs, are not analyzed in this section. Estimated payment impacts of FY 2009 changes to the capital IPPS are discussed in section VIII. of this Appendix.

The changes discussed separately below are the following:

• The effects of the annual reclassification of diagnoses and procedures, full implementation of the MS-DRG system and 100 percent cost-based DRG relative weights,

• The effects of the changes in hospitals' wage index values reflecting wage data from hospitals' cost reporting periods beginning during FY 2005, compared to the FY 2004 wage data.

• The effects of the recalibration of the DRG relative weights as required by section 1886(d)(4)(C) of the Act, including the wage and recalibration budget neutrality factors.

• The effects of geographic reclassifications by the MGCRB that will be effective in FY 2009.

• The effects of the proposal to apply the rural floor budget neutrality adjustment at the State level, redistributing payments within the State, rather than adjusting payments to hospitals in other States.

• The effects of the proposal to apply the imputed rural floor budget neutrality adjustment to the wage index at the State-level, rather than applying it to the standardized amount at the national level.

• The effects of section 505 of Pub. L. 108-173, which provides for an increase in a hospital's wage index if the hospital qualifies by meeting a threshold percentage of residents of the county where the hospital is located who commute to work at hospitals in counties with higher wage indexes.

• The effect of the budget neutrality adjustment being made for the adoption of the MS-DRGs under section 1886(d)(3)(A)(iv) of the Act for the change in aggregate payments that is a result of changes in the coding or classification of discharges that do not reflect real changes in case-mix.

• The total estimated change in payments based on the proposed FY 2009 policies relative to payments based on FY 2008 policies.

To illustrate the impacts of the proposed FY 2009 changes, our analysis begins with a FY 2008 baseline simulation model using: the proposed FY 2009 update of 3.0 percent; the FY 2008 DRG GROUPER (Version 25.0); the most current CBSA designations for hospitals based on OMB's MSA definitions; the FY 2008 wage index; and no MGCRB reclassifications. Outlier payments are set at 5.1 percent of total operating DRG and outlier payments.

Section 1886(b)(3)(B)(viii) of the Act, as added by section 5001(a) of Pub. L. 109-171, provides that for FY 2007 and subsequent years, the update factor will be reduced by 2.0 percentage points for any hospital that does not submit quality data in a form and manner and at a time specified by the Secretary. At the time this impact was prepared, 186 providers did not receive the full market basket rate-of-increase for FY 2008 because they failed the quality data submission process. For purposes of the simulations shown below, we modeled the proposed payment changes for FY 2009 using a reduced update for these 186 hospitals. However, we do not have enough information to determine which hospitals will not receive the full market basket rate-of-increase for FY 2009 at this time.

Each policy change, statutorily or otherwise, is then added incrementally to this baseline, finally arriving at an FY 2009 model incorporating all of the proposed changes. This simulation allows us to isolate the effects of each proposed change.

Our final comparison illustrates the proposed percent change in payments per case from FY 2008 to FY 2009. Three factors not discussed separately have significant impacts here. The first is the update to the standardized amount. In accordance with section 1886(b)(3)(B)(i) of the Act, we are updating the standardized amounts for FY 2009 using the most recently forecasted hospital market basket increase for FY 2009 of 3.0 percent. (Hospitals that fail to comply with the quality data submission requirements to receive the full update will receive an update reduced by 2.0 percentage points to 1.0 percent.) Under section 1886(b)(3)(B)(iv) of the Act, the updates to the hospital-specific amounts for SCHs and for MDHs are also equal to the market basket increase, or 3.0 percent.

A second significant factor that affects the proposed changes in hospitals' payments per case from FY 2008 to FY 2009 is the change in a hospital's geographic reclassification status from one year to the next. That is, payments may be reduced for hospitals reclassified in FY 2008 that are no longer reclassified in FY 2009. Conversely, payments may increase for hospitals not reclassified in FY 2008 that are reclassified in FY 2009. Particularly with the expiration of section 508 of Pub. L. 108-173, the reclassification provision, these impacts can be quite substantial, so if a relatively small number of hospitals in a particular category lose their reclassification status, the percentage change in payments for the category may be below the national mean.

A third significant factor is that we currently estimate that actual outlier payments during FY 2008 will be 4.8 percent of total DRG payments. When the FY 2008 final rule was published, we projected FY 2008 outlier payments would be 5.1 percent of total DRG plus outlier payments; the average standardized amounts were offset correspondingly. The effects of the lower than expected outlier payments during FY 2009 (as discussed in the Addendum to this proposed rule) are reflected in the analyses below comparing our current estimates of FY 2008 payments per case to estimated FY 2009 payments per case (with outlier payments projected to equal 5.1 percent of total DRG payments).

B. Analysis of Table I

Table I displays the results of our analysis of the proposed changes for FY 2009. The table categorizes hospitals by various geographic and special payment consideration groups to illustrate the varying impacts on different types of hospitals. The top row of the table shows the overall impact on the 3,528 hospitals included in the analysis.

The next four rows of Table I contain hospitals categorized according to their geographic location: all urban, which is further divided into large urban and other urban; and rural. There are 2,542 hospitals located in urban areas included in our analysis. Among these, there are 1,402 hospitals located in large urban areas (populations over 1 million), and 1,140 hospitals in other urban areas (populations of 1 million or fewer). In addition, there are 986 hospitals in rural areas. The next two groupings are by bed-size categories, shown separately for urban and rural hospitals. The final groupings by geographic location are by census divisions, also shown separately for urban and rural hospitals.

The second part of Table I shows hospital groups based on hospitals' FY 2009 payment classifications, including any reclassifications under section 1886(d)(10) of the Act. For example, the rows labeled urban, large urban, other urban, and rural show that the number of hospitals paid based on these categorizations after consideration of geographic reclassifications (including reclassifications under section 1886(d)(8)(B) and section 1886(d)(8)(E) of the Act that have implications for capital payments) are 2,584, 1,424, 1,160 and 944, respectively.

The next three groupings examine the impacts of the proposed changes on hospitals grouped by whether or not they have GME residency programs (teaching hospitals that receive an IME adjustment) or receive DSH payments, or some combination of these two adjustments. There are 2,485 nonteaching hospitals in our analysis, 805 teaching hospitals with fewer than 100 residents, and 238 teaching hospitals with 100 or more residents.

In the DSH categories, hospitals are grouped according to their DSH payment status, and whether they are considered urban or rural for DSH purposes. The next category groups together hospitals considered urban after geographic reclassification, in terms of whether they receive the IME adjustment, the DSH adjustment, both, or neither.

The next five rows examine the impacts of the proposed changes on rural hospitals by special payment groups (SCHs, RRCs, and MDHs). There were 197 RRCs, 355 SCHs, 156 MDHs, 102 hospitals that are both SCHs and RRCs, and 12 hospitals that are both an MDH and an RRC.

The next series of groupings are based on the type of ownership and the hospital's Medicare utilization expressed as a percent of total patient days. These data were taken from the FY 2005 Medicare cost reports.

The next two groupings concern the geographic reclassification status of hospitals. The first grouping displays all urban hospitals that were reclassified by the MGCRB for FY 2009. The second grouping shows the MGCRB rural reclassifications. The final category shows the impact of the proposed policy changes on the 20 cardiac specialty hospitals in our analysis.

Number of hospitals1 Proposed FY 2009 cost based DRG Weights MS-DRG changes2 Proposed FY 2009 wage data3 Proposed FY 2009 DRG, rel. wts. and wage index changes4 FY 2009 MGCRB Reclassifications5 Application of proposed rural floor and imputed rural floor, including proposed within state budget neutrality6 Proposed FY 2009 out-migration adjustment7 All proposed FY 2009 changes w/CMI adjustment prior to estimated CMI growth8 All proposed FY 2009 changes w/CMI adjustment and estimated CMI growth9
(1) (2) (3) (4) (5) (6) (7) (8) (9)
All Hospitals 3,528 0.1 -0.1 0 0 0 0 2.3 4.1
By Geographic Location:
Urban hospitals 2,542 0.2 -0.1 0.1 -0.2 0 0 2.4 4.2
Large urban areas 1,402 0.5 -0.1 0.3 -0.4 -0.1 0 2.6 4.4
Other urban areas 1,140 0 0 -0.1 -0.1 0.1 0 2.2 3.9
Rural hospitals 986 -1 0 -1.1 2.1 -0.1 0.1 1.5 3.3
Bed Size (Urban):
0-99 beds 643 -0.7 -0.1 -0.8 -0.4 0.1 0 1.6 3.4
100-199 beds 829 0.1 0 0 -0.1 0.1 0 2.2 4
200-299 beds 483 0.2 0 0.2 -0.2 -0.1 0 2.4 4.2
300-499 beds 411 0.3 0 0.3 -0.2 0 0 2.6 4.3
500 or more beds 176 0.5 -0.3 0.1 -0.3 0 0 2.5 4.3
Bed Size (Rural):
0-49 beds 338 -2.3 0.1 -2.3 0.6 0 0.2 0.7 2.5
50-99 beds 373 -1.2 0 -1.3 1.1 -0.1 0.2 1.2 3
100-149 beds 166 -0.9 0.1 -0.8 2.5 0 0.1 1.5 3.3
150-199 beds 67 -0.6 -0.1 -0.8 3 -0.1 0 2 3.8
200 or more beds 42 -0.3 -0.1 -0.4 3.2 -0.1 0 2.1 3.9
Urban by Region:
New England 121 0 0 -0.1 0.5 0.1 0 1.2 3
Middle Atlantic 348 0 -0.5 -0.5 0.1 0 0 1.2 3
South Atlantic 385 0.4 -0.3 0.1 -0.4 0 0 2.7 4.4
East North Central 394 0.5 -0.5 -0.1 -0.4 0 0 2.4 4.1
East South Central 163 -0.1 -0.2 -0.2 -0.2 0 0 2.4 4.2
West North Central 157 -0.1 0.2 0.1 -0.7 0 0 2.8 4.5
West South Central 371 0.4 0 0.3 -0.6 0 0 2.9 4.7
Mountain 157 0.3 0.1 0.5 -0.2 0 0 3.2 5
Pacific 393 0.4 0.9 1.2 -0.2 0 0 3.4 5.2
Puerto Rico 53 -0.2 -0.7 -0.9 -0.7 0 0 1.4 3.2
Rural by Region:
New England 23 -0.8 -0.4 -1.3 2.4 -0.9 0 0.6 2.3
Middle Atlantic 70 -0.9 -0.1 -1.1 2 0 0.1 1.3 3.1
South Atlantic 172 -0.6 -0.1 -0.7 2.2 0 0.1 1.9 3.7
East North Central 121 -0.9 -0.3 -1.3 1.6 0 0.1 1.4 3.2
East South Central 176 -1.3 -0.1 -1.4 2.7 0 0.1 1.6 3.4
West North Central 113 -0.9 0.1 -0.8 1.7 0 0.1 1.6 3.4
West South Central 200 -1.7 0.5 -1.3 2.5 0 0.1 1.3 3.1
Mountain 75 -0.9 0 -1 0.5 0 0.1 1.2 3.1
Pacific 36 -0.7 0.6 -0.2 1.8 -0.3 0 1.8 3.6
By Payment Classification:
Urban hospitals 2,584 0.2 -0.1 0.1 -0.2 0 0 2.4 4.2
Large urban areas 1,424 0.4 -0.1 0.3 -0.4 -0.1 0 2.6 4.4
Other urban areas 1,160 0 0 -0.1 0 0.1 0 2.2 3.9
Rural areas 944 -1 0 -1.1 2 -0.1 0.1 1.5 3.3
Teaching Status:
Nonteaching 2,485 -0.2 0 -0.2 0.3 0 0 2.2 4
Fewer than 100 residents 805 0.2 0 0.1 -0.2 0 0 2.4 4.2
100 or more residents 238 0.5 -0.3 0.2 -0.3 0 0 2.5 4.2
Urban DSH:
Non-DSH 838 -0.3 -0.2 -0.4 -0.1 0 0 1.8 3.6
100 or more beds 1,534 0.4 -0.1 0.3 -0.3 0 0 2.6 4.3
Less than 100 beds 354 -0.7 0 -0.8 0 0 0 1.6 3.4
Rural DSH:
SCH 389 -1.5 0 -1.5 0.4 0 0.1 1.5 3.3
RRC 206 -0.6 0 -0.6 3.4 -0.1 0 1.9 3.7
100 or more beds 39 -0.8 0 -0.9 1.3 0 0.4 1.3 3.1
Less than 100 beds 168 -1.7 0 -1.8 1.3 0 0.3 0.6 2.4
Urban teaching and DSH:
Both teaching and DSH 811 0.4 -0.1 0.3 -0.4 0 0 2.5 4.3
Teaching and no DSH 172 -0.1 -0.2 -0.3 0 0 0 1.8 3.6
No teaching and DSH 1,077 0.2 0 0.2 0 0.1 0 2.5 4.3
No teaching and no DSH 524 -0.2 -0.2 -0.4 -0.3 0 0 1.9 3.7
Special Hospital Types:
RRC 197 -0.4 -0.1 -0.4 3.2 0 0 2.3 4.1
SCH 355 -1.3 0.1 -1.3 0.4 0 0.1 1.2 3
MDH 156 -1.8 0.1 -1.8 0.5 0 0.2 2 3.8
SCH and RRC 102 -0.5 0.1 -0.5 1.7 0 0 2.2 4.1
MDH and RRC 12 -1.3 0.1 -1.3 0.9 -0.3 0 1 2.8
Type of Ownership:
Voluntary 2,027 0.1 -0.1 0 0 0 0 2.3 4
Proprietary 827 0 0 -0.1 0 -0.1 0 2.4 4.1
Government 587 0.1 -0.1 0 0.1 0.1 0 2.6 4.4
Medicare Utilization as a Percent of Inpatient Days:
0-25 255 0.8 -0.1 0.7 -0.4 -0.2 0 3.2 4.9
25-50 1,350 0.3 0 0.3 -0.3 0 0 2.7 4.4
50-65 1,431 -0.1 -0.2 -0.3 0.4 0.1 0 1.9 3.7
Over 65 392 -0.8 -0.2 -1 0.5 0 0.1 1.2 3
FY 2009 Reclassifications by the Medicare Geographic Classification Review Board:
All Reclassified Hospitals 805 0 0 0 2 -0.1 0 2.1 3.8
Non-Reclassified Hospitals 2,723 0.2 -0.1 0 -0.7 0 0 2.4 4.2
Urban Hospitals Reclassified 445 0.2 0 0.2 1.5 -0.2 0 2.1 3.9
Urban Nonreclassified, FY 2009 2,075 0.3 -0.1 0.1 -0.7 0.1 0 2.5 4.3
All Rural Hospitals Reclassified Full Year FY 2009 360 -0.7 0 -0.7 3.3 -0 0 1.8 3.7
Rural Nonreclassified Hospitals Full Year FY 2009 565 -1.5 -0 -1.6 -0.4 -0.1 0.3 1 2.8
All Section 401 Reclassified Hospitals 29 -1.3 -0.2 -1.6 0.6 0 0 1.6 3.5
Other Reclassified Hospitals (Section 1886(d)(8)(B)) 61 -1 -0.2 -1.3 3.2 -0.2 0.1 1 2.8
Specialty Hospitals
Cardiac specialty Hospitals 20 -2.2 -0.1 -2.4 -0.7 0.1 0 0 1.8
1 Because data necessary to classify some hospitals by category were missing, the total number of hospitals in each category may not equal the national total. Discharge data are from FY 2007, and hospital cost report data are from reporting periods beginning in FY 2006 and FY 2005.
2 This column displays the payment impact of the changes to the V26 GROUPER and the recalibration of the DRG weights based on FY 2007 MedPAR data in accordance with section 1886(d)(4)(C)(iii) of the Act.
3 This column displays the payment impact of updating the wage index data to the FY 2005 cost report data.
4 This column displays the combined payment impact of the changes in column 2 and column 3 and the budget neutrality factors for DRG and wage index changes in accordance with section 1886(d)(4)(C)(iii) of the Act and section 1886(d)(3)(E) of the Act.
5 Shown here are the effects of geographic reclassifications by the Medicare Geographic Classification Review Board (MGCRB). The effects demonstrate the FY 2009 payment impact of going from no reclassifications to the reclassifications scheduled to be in effect for FY 2008. Reclassification for prior years has no bearing on the payment impacts shown here. This column reflects the geographic budget neutrality factor of 0.992333.
6 This column displays the effects of the rural floor and the imputed rural floor, including the proposal to apply the budget neutrality adjustment within State.
7 This column displays the impact of section 505 of Pub. L. 108-173, which provides for an increase in a hospital's wage index if the hospital qualifies by meeting a threshold percentage of residents of the county where the hospital is located who commute to work at hospitals in counties with higher wage indexes.
8 This column shows changes in payments from FY 2008 to FY 2009, including the proposed FY 2009 -0.9 percent documentation and coding adjustment, but not the projected 1.8 percent increase in case-mix expected to occur in FY 2009 due to improvements in documentation and coding. It incorporates all of the changes displayed in Columns 4, 5, 6, 7 (the changes displayed in Columns 2 and 3 are included in Column 4). It also reflects the impact of the FY 2009 update, and changes in hospitals' reclassification status in FY 2009 compared to FY 2008.
9 This column shows changes in payments from FY 2008 to FY 2009 including the proposed FY 2009 -0.9 percent documentation and coding adjustment and the projected 1.8 percent increase in case-mix expected to occur in FY 2009 due to improvements in documentation and coding. It incorporates all of the changes displayed in Columns 4, 5, 6, 7, 8 (the changes displayed in Columns 2 and 3 are included in Column 4). It also reflects the impact of the FY 2008 update, and changes in hospitals' reclassification status in FY 2009 compared to FY 2008. The sum of these impacts may be different from the percentage changes shown here due to rounding and interactive effects.

C. Effects of the Proposed Changes to the MS-DRG Reclassifications and Relative Cost-Based Weights (Column 2)

In Column 2 of Table I, we present the effects of the DRG reclassifications, as discussed in section II. of the preamble to this proposed rule. Section 1886(d)(4)(C)(i) of the Act requires us annually to make appropriate classification changes in order to reflect changes in treatment patterns, technology, and any other factors that may change the relative use of hospital resources.

As discussed in the preamble of this proposed rule, the FY2009 DRG relative weights will be 100 percent cost-based and 100 percent MS-DRGs, thus completing our three year transition to cost-based relative weights and our two year transition to MS-DRGs. For FY 2009, the MS-DRGs are calculated using the FY2007 MedPAR data grouped to the Version 26.0 (FY2009) DRGs. The proposed methods of calculating the relative weights and the reclassification changes to the GROUPER are described in more detail in section II.H. of the preamble to this proposed rule. In previous years, this column would also reflect the effects of the recalibration budget neutrality factor that is applied to the hospital-specific rates and the Puerto Rico-specific standardized amount. However, for this proposed rule, we show the effects of the recalibration budget neutrality factor of 0.998700 in column 4. We note that, consistent with section 1886(d)(4)(C)(iii) of the Act, we are applying a budget neutrality factor to the national standardized amounts to ensure that the overall payment impact of the DRG changes (combined with the wage index changes) is budget neutral. This proposed wage and recalibration budget neutrality factor of 0.99525 is applied to payments in Column 4 and not Column 2.

The proposed changes to the relative weights and DRGs shown in column 2 are prior to any offset for budget neutrality. The "All Hospitals" line indicates that proposed changes in this column will increase payments by 0.1 percent. However, as stated earlier, the proposed changes shown in this column are combined with revisions to the wage index, and the budget neutrality adjustments made for these changes are shown in column 4. Thus, the impact after accounting only for budget neutrality for proposed changes to the DRG relative weights and classification is somewhat lower than the figures shown in this column (approximately 0.1 percent).

D. Effects of Proposed Wage Index Changes (Column 3)

Section 1886(d)(3)(E) of the Act requires that, beginning October 1, 1993, we annually update the wage data used to calculate the wage index. In accordance with this requirement, the wage index for FY 2009 is based on data submitted for hospital cost reporting periods beginning on or after October 1, 2004 and before October 1, 2005. The estimated impact of the proposed wage data on hospital payments is isolated in Column 3 by holding the other payment parameters constant in this simulation. That is, Column 3 shows the percentage changes in payments when going from a model using the FY 2008 wage index, based on FY 2004 wage data and having a 100-percent occupational mix adjustment applied, to a model using the FY 2009 pre-reclassification wage index, also having a 100-percent occupational mix adjustment applied, based on FY 2005 wage data (while holding other payment parameters such as use of the version 26.0 DRG grouper constant). The wage data collected on the FY 2005 cost report include overhead costs for contract labor that were not collected on FY 2004 and earlier cost reports. The impacts below incorporate the effects of the FY 2005 wage data collected on hospital cost reports, including additional overhead costs for contract labor compared to the wage data from FY 2004 cost reports that were used to calculate the FY 2008 wage index.

Column 3 shows the impacts of updating the wage data using FY 2004 cost reports. Overall, the new wage data will lead to a -0.1 percent change for all hospitals before application of the wage and DRG recalibration budget neutrality adjustment shown in column 4. Thus, the figures in this column are approximately 0.1 below what they otherwise would be if they also illustrated a budget neutrality adjustment solely for changes to the wage index. Among the regions, the largest increase is in the urban Pacific region, which experiences a 0.9 percent increase before applying an adjustment for budget neutrality. The largest decline from updating the wage data is seen in Puerto Rico (0.7 percent decrease).

In looking at the wage data itself, the national average hourly wage increased 4.2 percent compared to FY 2008. Therefore, the only manner in which to maintain or exceed the previous year's wage index was to match or exceed the national 4.2 percent increase in average hourly wage. Of the 3,457 hospitals with wage data for both FYs 2008 and 2009, 1,707, or 49.4 percent, experienced an average hourly wage increase of 4.2 percent or more.

The following chart compares the shifts in wage index values for hospitals for FY 2009 relative to FY 2008. Among urban hospitals, 32 will experience an increase of more than 5 percent and less than 10 percent and 5 will experience an increase of more than 10 percent. Among rural hospitals, none will experience an increase of more than 5 percent and less than 10 percent, and none will experience an increase of more than 10 percent. However, 972 rural hospitals will experience increases or decreases of less than 5 percent, while 2,420 urban hospitals will experience increases or decreases of less than 5 percent. Eighteen urban hospitals will experience decreases in their wage index values of more than 5 percent and less than 10 percent. Ten urban hospitals will experience decreases in their wage index values of greater than 10 percent. No rural hospitals will experience decreases of more than 5 percent. These figures reflect changes in the wage index which is an adjustment to either 69.7 percent or 62 percent of a hospital's standardized amount depending upon whether its wage index is greater than 1.0 or less than or equal to 1.0. Therefore, these figures are illustrating a somewhat larger change in the wage index than would occur to the hospital's total payment.

The following chart shows the projected impact for urban and rural hospitals.

Percentage change in area wage index values Number of hospitals Urban Rural
Increase more than 10 percent 5 0
Increase more than 5 percent and less than 10 percent 32 0
Increase or decrease less than 5 percent 2,420 972
Decrease more than 5 percent and less than 10 percent 18 0
Decrease more than 10 percent 10 0

E. Combined Effects of Proposed MS-DRG and Wage Index Changes (Column 4)

Section 1886(d)(4)(C)(iii) of the Act requires that changes to MS-DRG reclassifications and the relative weights cannot increase or decrease aggregate payments. In addition, section 1886(d)(3)(E) of the Act specifies that any updates or adjustments to the wage index are to be budget neutral. As noted in the Addendum to this proposed rule, in determining the budget neutrality factor, we equated simulated aggregate payments for FY 2008 and FY 2009 using the FY 2007 Medicare utilization data after applying the changes to the DRG relative weights and the wage index.

We computed a wage and MS-DRG recalibration budget neutrality factor of 0.999525 (which is applied to the national standardized amounts) and a recalibration budget neutrality factor 0.998700 (which is applied to the hospital-specific rates and the Puerto Rico-specific standardized amount). The 0.0 percent impact for all hospitals demonstrates that the proposed MS-DRG and wage changes, in combination with the budget neutrality factor, are budget neutral. In Table I, the combined overall impacts of the effects of both the MS-DRG reclassifications and the updated wage index are shown in Column 4. The estimated changes shown in this column reflect the combined effects of the changes in Columns 2 and 3 and the budget neutrality factors discussed previously.

We estimate that the combined impact of the proposed changes to the relative weights and DRGs and the updated wage data with budget neutrality applied will increase payments to hospitals located in large urban areas (populations over 1 million) by approximately 0.3. These proposed changes would generally increase payments to hospitals in all urban areas (0.1 percent) and large teaching hospitals (0.2 percent). Rural hospitals will generally experience a decrease in payments (-1.1 percent). Among the rural hospital categories, rural hospitals with less than 50 beds will experience the greatest decline in payment (-2.3 percent) primarily due to the changes to MS-DRGs and the relative cost weights.

F. Effects of MGCRB Reclassifications (Column 5)

Our impact analysis to this point has assumed hospitals are paid on the basis of their actual geographic location (with the exception of ongoing policies that provide that certain hospitals receive payments on other bases than where they are geographically located). The proposed changes in Column 5 reflect the per case payment impact of moving from this baseline to a simulation incorporating the MGCRB decisions for FY 2009 which affect hospitals' wage index area assignments.

By February 28 of each year, the MGCRB makes reclassification determinations that will be effective for the next fiscal year, which begins on October 1. The MGCRB may approve a hospital's reclassification request for the purpose of using another area's wage index value. Hospitals may appeal denials of MGCRB decisions to the CMS Administrator. Further, hospitals have 45 days from publication of the IPPS rule in the Federal Register to decide whether to withdraw or terminate an approved geographic reclassification for the following year. This column reflects all MGCRB decisions, Administrator appeals and decisions of hospitals for FY 2009 geographic reclassifications.

The overall effect of geographic reclassification is required by section 1886(d)(8)(D) of the Act to be budget neutral. Therefore, we are proposing to apply an adjustment of 0.992333 to ensure that the effects of the section 1886(d)(10) reclassifications are budget neutral. (See section II.A. of the Addendum to this proposed rule.) Geographic reclassification generally benefits hospitals in rural areas. We estimate that geographic reclassification will increase payments to rural hospitals by an average of 2.1 percent.

G. Effects of the Proposed Rural Floor and Imputed Rural Floor, Including the Proposed Application of Budget Neutrality at the State Level (Column 6)

As discussed in section III.B. of the preamble of this FY 2009 proposed rule, section 4410 of Pub. L. 105-33 established the rural floor by requiring that the wage index for a hospital in any urban area cannot be less than the area wage index determined for the state's rural area. In FY 2008, we changed how we applied budget neutrality to the rural floor. Rather than applying a budget neutrality adjustment to the standardized amount, a uniform budget neutrality adjustment is applied to the wage index. For FY 2009, we are proposing to apply the rural floor budget neutrality adjustment at the State level, which would redistribute payments within the State rather than across all other providers within the Nation.

Furthermore, the FY 2005 IPPS final rule (69 FR 49109) established a temporary imputed rural floor for all urban States from FY 2005 to FY 2007. The rural floor requires that an urban wage index cannot be lower than the wage index for any rural hospital in that State. Therefore, an imputed rural floor was established for States that do not have rural areas or rural IPPS hospitals. In the FY 2008 IPPS final rule with comment period (72 FR 47321), we finalized our rule to extend the imputed rural floor for 1 additional year. In this proposed rule, we are proposing to extend the imputed rural floor for an additional 3 years through FY 2011. Furthermore, consistent with our proposal to apply the rural floor budget neutrality adjustment at the State level, we are proposing to apply the imputed rural floor budget neutrality adjustment to the wage index at the State level.

Column 6 shows the projected impact of the rural floor and the imputed rural floor, including the proposed application of the budget neutrality adjustment at the State level. The column compares the post-reclassification FY 2009 wage index of providers before the rural floor adjustment and the post-reclassification FY 2009 wage index of providers with the rural floor and imputed rural floor adjustment. Only urban hospitals can benefit from the rural floor provision. Because the provision is budget neutral, in prior years, all other hospitals (that is, all rural hospitals and those urban hospitals to which the adjustment is not made) had experienced a decrease in payments due to the budget neutrality adjustment applied nationally. However, under this proposal, States that have no hospitals receiving a rural floor wage index would no longer have a negative budget neutrality adjustment applied to their wage indices. Conversely, all hospitals in States with hospitals receiving a rural floor would have their wage indices downwardly adjusted to achieve budget neutrality within the State.

We project that, in aggregate, rural hospitals will experience a 0.1 percent decrease in payments. We project hospitals located in other urban areas (populations of 1 million or fewer) will experience a 0.1 percent increase in payments because the rural floor adjustment applies to urban hospitals. Rural New England hospitals can expect the greatest decrease in payment by 0.9 percent because hospitals in Vermont will receive a rural floor budget neutrality adjustment of 0.901 or a reduction of approximately 10 percent, and hospitals in Connecticut will receive a rural floor budget neutrality adjustment of 0.9639 or a reduction of approximately 4 percent. New Jersey, which is the only State that benefits from the imputed rural floor, is expected to receive a rural floor budget neutrality adjustment of 0.987838 or a reduction of approximately 1.2 percent.

The table that appears in section III B.2.b. of the preamble of this proposed rule shows how payments would change, at the State level, if we moved from our current policy of applying rural floor budget neutrality at the national level to our proposed policy to apply the rural floor budget neutrality within the State. The table shows that, under our current policy of applying budget neutrality at the national level, States that do not have any hospitals receiving the rural floor wage index would expect a decrease in payments because, in order to maintain budget neutrality nationally, these hospitals have to pay for the hospitals in other States that do receive a rural floor. For example, States such as Arizona, New York, and Rhode Island, which do not have hospitals receiving a rural floor, would expect to lose 0.2 percent in payments under a national rural floor budget neutrality adjustment. However, under our proposed policy to apply rural floor budget neutrality within each State, States that do not have hospitals receiving a floor would see an increase in payments (compared with our current policy of applying budget neutrality at the national level) because they would no longer have their wage indexes adjusted to maintain budget neutrality. However, all hospitals in States with hospitals receiving a rural floor would expect a decrease in their payments in order to achieve budget neutrality within their States (that is, the wage indices for hospitals in that State would be decreased in order to make the additional payments to hospitals in that State receiving the rural floor). Therefore, compared with our current policy of applying budget neutrality at the national level, States such as Arizona, New York, and Rhode Island could expect payment increases of 0.3 percent under a rural floor budget neutrality applied at the State level, while States such as California and Connecticut, which have several hospitals that benefit from the rural floor, could expect decreases in payments by 0.8 percent and 2.2 percent, respectively.

H. Effects of the Proposed Wage Index Adjustment for Out-Migration (Column 7)

Section 1886(d)(13) of the Act, as added by section 505 of Pub. L. 108-173, provides for an increase in the wage index for hospitals located in certain counties that have a relatively high percentage of hospital employees who reside in the county, but work in a different area with a higher wage index. Hospitals located in counties that qualify for the payment adjustment are to receive an increase in the wage index that is equal to a weighted average of the difference between the wage index of the resident county, post-reclassification and the higher wage index work area(s), weighted by the overall percentage of workers who are employed in an area with a higher wage index. With the out-migration adjustment, rural providers will experience a 0.1 percent increase in payments in FY 2009 relative to no adjustment at all. We included these additional payments to providers in the impact table shown above, and we estimate the impact of these providers receiving the out-migration increase to be approximately $20 million.

I. Effects of All Proposed Changes With CMI Adjustment Prior to Estimated Growth (Column 8)

Column 8 compares our estimate of payments per case between FY 2008 and FY 2009 with all changes reflected in this proposed rule for FY 2009, including a -0.9 percent documentation and coding adjustment to the FY 2009 national standardized amounts to account for anticipated improvements in documentation and coding that are expected to increase case-mix. We generally apply an adjustment to the DRGs to ensure budget neutrality assuming constant utilization. However, in the FY 2008 IPPS final rule with comment period, we indicated that we believe that the adoption of MS-DRGs would lead to increases in case-mix as a result of improved documentation and coding. In the FY 2008 IPPS final rule with comment period, we had finalized a policy to apply a documentation and coding adjustment to the standardized amount of -1.2 percent for FY 2008, -1.8 percent for FY 2009, and -1.8 percent for FY 2010 to offset the expected increase in case-mix and achieve budget neutrality. However, in compliance with section 7 of Pub. L. 110-90, we reduced the documentation and coding adjustment to -0.6 percent for FY 2008. In accordance with section 7 of Pub. L.110-90, for FY 2009, we are applying a documentation and coding adjustment of -0.9 percent to the FY 2009 national standardized amounts (in addition to the -0.6 percent adjustment made for FY 2008). We are not proposing to apply the documentation and coding adjustment to the FY 2009 hospital-specific rates and the FY 2009 Puerto Rico-specific standardized amount. However, we continue to believe that case-mix growth of an additional 1.8 percent compared to FY 2008 is likely to occur across all hospitals as a result of improvements in documentation and coding.

Column 8 illustrates the total payment change for FY 2009 compared to FY 2008, taking into account the -0.9 percent FY 2009 documentation and coding adjustment but not the projected 1.8 percent case-mix increase itself. Therefore, this column illustrates a total payment change that is less than what is anticipated to occur.

J. Effects of All Proposed Changes With CMI Adjustment and Estimated Growth (Column 9)

Column 9 compares our estimate of payments per case between FY 2008 and FY 2009, incorporating all changes reflected in this proposed rule for FY 2009 (including statutory changes). This column includes the FY 2009 documentation and coding adjustment of -0.9 percent and the projected 1.8 percent increase in case-mix from improved documentation and coding (with the 1.8 percent case-mix increase assumed to occur equally across all hospitals).

Column 9 reflects the impact of all FY 2009 changes relative to FY 2008, including those shown in Columns 2 through 7. The average increase for all hospitals is approximately 4.1 percent. This increase includes the effects of the 3.0 percent market basket update. It also reflects the 0.3 percentage point difference between the projected outlier payments in FY 2008 (5.1 percent of total DRG payments) and the current estimate of the percentage of actual outlier payments in FY 2008 (4.8 percent), as described in the introduction to this Appendix and the Addendum to this proposed rule. As a result, payments are projected to be 0.3 percentage points lower in FY 2008 than originally estimated, resulting in a 0.3 percentage point greater increase for FY 2009 than would otherwise occur. In addition, the impact of expiration of section 508 of Pub. L. 108-173 reclassification accounts for a 0.1 percent decrease in estimated payments. There might also be interactive effects among the various factors comprising the payment system that we are not able to isolate. For these reasons, the values in Column 9 may not equal the product of the percentage changes described above.

The overall change in payments per case for hospitals in FY 2009 is proposed to increase by 4.1 percent. Hospitals in urban areas will experience an estimated 4.2 percent increase in payments per case compared to FY 2008. Hospitals in large urban areas will experience an estimated 4.4 percent increase and hospitals in other urban areas will experience an estimated 3.9 percent increase in payments per case in FY 2008. Hospital payments per case in rural areas are estimated to increase 3.3 percent. The increases that are larger than the national average for larger urban areas and smaller than the national average for other urban and rural areas are largely attributed to the differential impact of adopting MS-DRGs.

Among urban census divisions, the largest estimated payment increases will be 5.2 percent in the Pacific region (generally attributed to MS-DRGs and wage data) and 5.0 percent in the Mountain region (mostly due to MS-DRGs). The smallest urban increase is estimated at 3.0 percent in the Middle Atlantic and New England regions.

Among the rural regions in Column 9, the providers in the New England region experience the smallest increase in payments (2.3 percent) primarily due to the State-specific rural floor budget neutrality adjustment. The South Atlantic and Pacific regions will have the highest increases among rural regions, with 3.7 percent and 3.6 percent estimated increases, respectively. Again, increases in rural areas are generally less than the national average due to the adoption of MS-DRGs.

Among special categories of rural hospitals in Column 9, the SCH and RRC providers will receive an estimated increase in payments of 4.1 percent, and the MDH and RRCs will experience an estimated increase in payments by 2.8 percent.

Urban hospitals reclassified for FY 2009 are anticipated to receive an increase of 3.9 percent, while urban hospitals that are not reclassified for FY 2009 are expected to receive an increase of 4.3 percent. Rural hospitals reclassifying for FY 2009 are anticipated to receive a 3.7 percent payment increase and rural hospitals that are not reclassifying are estimated to receive a payment increase of 2.8 percent.

K. Effects of Policy on Payment Adjustments for Low-Volume Hospitals

For FY 2009, we are continuing to apply the volume adjustment criteria we specified in the FY 2005 IPPS final rule (69 FR 49099). We expect that three providers will receive the low-volume adjustment for FY 2009. We estimate the impact of these providers receiving the additional 25-percent payment increase to be approximately $2,300.

L. Impact Analysis of Table II

Table II presents the projected impact of the proposed changes for FY 2009 for urban and rural hospitals and for the different categories of hospitals shown in Table I. It compares the estimated payments per case for FY 2008 with the proposed average estimated payments per case for FY 2009, as calculated under our models. Thus, this table presents, in terms of the average dollar amounts paid per discharge, the combined effects of the proposed changes presented in Table I. The proposed percentage changes shown in the last column of Table II equal the proposed percentage changes in average payments from Column 9 of Table I.

Number of hospitals Average FY 2008 payment per case1 Average proposed FY 2009 payment per case1 All proposed FY 2009 changes
(1) (2) (3) (4)
All hospitals 3,528 $9,144 $9,519 4.1
By Geographic Location:
Urban hospitals 2,542 9,571 9,972 4.2
Large urban areas (populations over 1 million) 1,402 10,045 10,484 4.4
Other urban areas (populations of 1 million or fewer) 1,140 9,000 9,355 3.9
Rural hospitals 986 6,683 6,905 3.3
Bed Size (Urban):
0-99 beds 643 7,283 7,533 3.4
100-199 beds 829 8,103 8,428 4
200-299 beds 483 8,985 9,363 4.2
300-499 beds 411 10,046 10,482 4.3
500 or more beds 176 11,875 12,382 4.3
Bed Size (Rural):
0-49 beds 338 5,509 5,644 2.5
50-99 beds 373 6,097 6,279 3
100-149 beds 166 6,660 6,884 3.4
150-199 beds 67 7,467 7,752 3.8
200 or more beds 42 8,361 8,686 3.9
Urban by Region:
New England 121 9,935 10,230 3
Middle Atlantic 348 10,440 10,752 3
South Atlantic 385 9,025 9,427 4.5
East North Central 394 9,065 9,440 4.1
East South Central 163 8,681 9,044 4.2
West North Central 157 9,140 9,555 4.5
West South Central 371 9,043 9,466 4.7
Mountain 157 9,571 10,051 5
Pacific 393 11,614 12,219 5.2
Puerto Rico 53 4,706 4,857 3.2
Rural by Region:
New England 23 9,051 9,263 2.3
Middle Atlantic 70 6,912 7,124 3.1
South Atlantic 172 6,529 6,773 3.7
East North Central 121 6,872 7,093 3.2
East South Central 176 6,263 6,474 3.4
West North Central 113 6,886 7,119 3.4
West South Central 200 6,088 6,276 3.1
Mountain 75 6,802 7,010 3.1
Pacific 36 8,162 8,455 3.6
By Payment Classification:
Urban hospitals 2,584 9,549 9,948 4.2
Large urban areas (populations over 1 million) 1,424 10,026 10,464 4.4
Other urban areas (populations of 1 million or fewer) 1,160 8,975 9,328 3.9
Rural areas 944 6,716 6,941 3.3
Teaching Status:
Non-teaching 2,485 7,716 8,023 4
Fewer than 100 Residents 805 9,193 9,577 4.2
100 or more Residents 238 13,392 13,951 4.2
Urban DSH:
Non-DSH 838 8,118 8,409 3.6
100 or more beds 1,534 10,062 10,498 4.3
Less than 100 beds 354 6,792 7,022 3.4
Rural DSH:
SCH 389 6,093 6,293 3.3
RRC 206 7,465 7,740 3.7
100 or more beds 39 6,110 6,299 3.1
Less than 100 beds 168 5,451 5,580 2.4
Urban teaching and DSH:
Both teaching and DSH 811 10,986 11,457 4.3
Teaching and no DSH 172 8,885 9,201 3.6
No teaching and DSH 1,077 8,283 8,644 4.4
No teaching and no DSH 524 7,796 8,083 3.7
Rural Hospital Types:
RRC 197 7,783 8,100 4.1
SCH 355 6,564 6,764 3
MDH 156 5,757 5,975 3.8
SCH and RRC 102 7,901 8,223 4.1
MDH and RRC 12 7,303 7,510 2.8
Type of Ownership:
Voluntary 2,027 9,252 9,625 4
Proprietary 827 8,424 8,772 4.1
Government 587 9,440 9,853 4.4
Medicare Utilization as a Percent of Inpatient Days:
0-25 255 13,112 13,751 4.9
25-50 1,350 10,344 10,801 4.4
50-65 1,431 7,950 8,245 3.7
Over 65 392 7,033 7,245 3
Hospitals Reclassified by the Medicare Geographic Classification Review Board:
FY 2009 Reclassifications:
All Reclassified Hospitals FY 2009 805 8,803 9,141 3.8
All Non-Reclassified Hospitals FY 2009 2,723 9,264 9,651 4.2
Urban Reclassified Hospitals FY 2009: 445 9,547 9,921 3.9
Urban Non-reclassified Hospitals FY 2009: 2,075 9,586 9,994 4.3
Rural Reclassified Hospitals FY 2009: 360 7,240 7,505 3.7
Rural Nonreclassified Hospitals FY 2009: 565 5,870 6,033 2.8
All Section 401 Reclassified Hospitals: 29 7,555 7,816 3.5
Other Reclassified Hospitals (Section 1886(d)(8)(B)) 61 6,534 6,716 2.8
Specialty Hospitals:
Cardiac Specialty Hospitals 20 10,894 11,085 1.8
1 These payment amounts per case do not reflect any estimates of annual case-mix increase.

VII. Effects of Other Proposed Policy Changes

In addition to those policy changes discussed above that we are able to model using our IPPS payment simulation model, we are proposing to make various other changes in this proposed rule. Generally, we have limited or no specific data available with which to estimate the impacts of these proposed changes. Our estimates of the likely impacts associated with these other proposed changes are discussed below.

A. Effects of Proposed Policy on HACs, Including Infections

In section II.F. of the preamble of this proposed rule, we discuss our implementation of section 5001(c) of Pub. L. 109-171, which requires the Secretary to identify conditions that (1) are high cost, high volume, or both, (2) result in the assignment of a case to a MS-DRG that has a higher payment when present as a secondary diagnosis, and (3) could reasonably have been prevented through application of evidence-based guidelines. For discharges occurring on or after October 1, 2008, hospitals will not receive additional payment for cases in which one of the selected conditions was not present on admission. That is, the case will be paid as though the secondary diagnosis was not present. However, the statute also requires the Secretary to continue counting the condition as a secondary diagnosis that results in a higher IPPS payment when doing the budget neutrality calculations for MS-DRG reclassifications and recalibration. Therefore, we do our budget neutrality calculations as though the payment provision did not apply but Medicare will make a lower payment to the hospital for the specific case that includes the secondary diagnosis. Thus, the provision will result in cost savings to the Medicare program.

We note that the provision will only apply when one or more of the selected conditions are the only secondary diagnosis or diagnoses present on the claim that will lead to higher payment. Therefore, if at least one nonselected secondary diagnosis that leads to the same higher payment is on the claim, the case will continue to be assigned to the higher paying DRG and there will be no savings to Medicare from the case. Medicare beneficiaries will generally have multiple secondary diagnoses during a hospital stay, such that beneficiaries having one MCC or CC will frequently have additional conditions that also will generate higher payment. Therefore, in only a small percentage of the cases will the beneficiary have only one secondary diagnosis that would lead to higher payment.

The section 5001(c) payment provision will go into effect on October 1, 2008. Our savings estimate for the next 5 fiscal years from this provision has changed from our savings estimate published in the FY 2008 IPPS final rule with comment period because of the potential addition to the list of selected HACs for FY 2009 of the nine conditions considered in section II.F. of this proposed rule. We had estimated a savings of $20 million per year from this provision for the eight conditions we originally selected in the FY 2008 IPPS final rule with comment period (72 FR 48168). We now estimate that this provision will save $50 million per year for the first 3 years beginning October 1, 2008. Beginning in FY 2012, we estimate a savings of $60 million per year as a result of this provision. Our savings estimates for the next 5 fiscal years are shown below:

Year Savings (in millions)
FY 2009 $50
FY 2010 50
FY 2011 50
FY 2012 60
FY 2013 60

B. Effects of Proposed MS-LTC-DRG Reclassifications and Relative Weights for LTCHs

In section II.I. of the preamble to this proposed rule, we discuss the proposed MS-LTC-DRGs (proposed Version 26.0 of the GROUPER) and development of the proposed relative weights for use under the LTCH PPS for FY 2009. We also discuss that when we adopted the new severity adjusted MS-LTC-DRG patient classification system under the LTCH PPS in the FY 2008 IPPS final rule with comment, we implemented a 2-year transition, in which the MS-LTC-DRG relative weights for FY 2009 would be based completely on the MS-LTC-DRG patient classification system (and no longer based in part on the former LTC-DRG patient classification system). Consistent with the requirement at § 412.517 established in the RY 2008 LTCH PPS final rule (72 FR 26880 through 26884), the proposed annual update to the classification and relative weights under the LTCH PPS for RY 2009 was done in a budget neutral manner, such that estimated aggregate LTCH PPS payments would be unaffected; that is, they would be neither greater than nor less than the estimated aggregate LTCH PPS payments that would have been made without the MS-LTC-DRG classification and relative weight changes. To achieve budget neutrality under § 412.517, in determining the proposed FY 2009 MS-LTC-DRG relative weights, we applied a factor of 1.038266 in the first step of the budget neutrality process (normalization), and we applied a budget neutrality factor of 0.9965 after normalization (see section II.I.4. (step 7) of the preamble of this proposed rule). These proposed factors that were applied to maintain budget neutrality were based on the most recent available LTCH claims data (FY 2007 MedPAR files) for the 387 LTCHs in our database. Consistent with the budget neutrality requirement under § 412.517, we estimate that with the proposed changes to the MS-LTC-DRG classifications and relative weights for FY 2009, there would be no change in aggregate LTCH PPS payments. In applying the budget neutrality adjustment described above, we assumed constant utilization.

C. Effects of Proposed Policy Change Relating to New Medical Service and Technology Add-On Payments

In section II.J. of the preamble to this proposed rule, we discuss proposed add-on payments for new medical services and technologies. As explained in that section, add-on payments for new technology under section 1886(d)(5)(K) of the Act are not required to be budget neutral. As discussed in section II.J.4. of this proposed rule, we have yet to determine whether any of the four applications we received will meet the criteria for new technology add-on payments for FY 2009. Consequently, it is premature to estimate the potential payment impact in FY 2009 of any potential new technology add-on payments for FY 2009. There are no technologies receiving new technology add-on payment in FY 2008. Therefore, at this time, we estimate that Medicare's new technology add-on payments would remain unchanged in FY 2009 compared to FY 2008. If any of the four applicants are found to be eligible for new technology add-on payments for FY 2009 in the final rule, we would discuss the estimated payment impact for FY 2009 in that final rule.

D. Effects of Proposed Policy Regarding Postacute Care Transfers to Home Health Services

In section IV.A. of the preamble to this proposed rule, we noted that, under current regulations, the postacute care transfer policy applies to acute care discharges for which home health care (for a related condition) begins within 3 days of the discharge from an acute care hospital where the patient was discharged from the hospital prior to the geometric mean length of stay for a "qualified" MS-DRG. In that section, we discussed the reasons why we believe that the 3-day timeframe is no longer an appropriate threshold under the postacute care transfer policy. We discussed our rationale for extending the timeframe from within 3 days to within 7 days. Accordingly, we proposed to revise the timeframe in our regulations to within 7 days of discharge to home under a written plan for the provision of home health services, effective with discharges occurring on or after October 1, 2008.

To estimate the impact of this proposal, we used acute care hospital claims from the FY 2005 MedPAR file and searched for claims with a discharge destination code of "01" (Discharged to Home or Self-Care (Routine Discharge)) or "06" (Discharged/Transferred to Home under Care of Organized Home Health Service Organization in Anticipation of Covered Skilled Care). We then matched the acute care hospital MedPAR claims with HHA final action claims for 2005, using beneficiary identification numbers. We then compared the hospital discharge date with the home health admission date and determined a distribution by the difference in these two dates. We found that, for those patients for whom home health services began within 60 days of hospital discharge, in 6.7 percent of the cases, the services began on days 4 through day 7 after the acute care hospital discharge. We estimate that applying the proposed change to the hospital postacute care transfer policy would reduce Medicare payments to acute care inpatient hospitals by approximately $330 million over 5 years. For FY 2009, we estimate that Medicare payments would be reduced by approximately $50 million.

E. Effects of Proposed Requirements for Hospital Reporting of Quality Data for Annual Hospital Payment Update

In section IV.B. of the preamble of this proposed rule, we discuss the requirements for hospitals to report quality data in order for hospitals to receive the full annual hospital payment update for FY 2009 and FY 2010. There are an estimated 186 hospitals in this analysis that may not receive the full market basket update for FY 2009. Most of these hospitals are either small rural or small urban hospitals. However, at this time, information is not available to determine the hospitals that do not meet the requirements for the full hospital market increase for FY 2009.

We also note that, for the FY 2009 payment update, hospitals must pass our validation requirement of a minimum of 80 percent reliability, based upon our chart-audit validation process, for the four quarters of data from FY 2007. These data were due to the QIO Clinical Warehouse by May 15, 2007 (fourth quarter CY 2006 discharges), August 15, 2007 (first quarter CY 2007 discharges), November 15, 2007 (second quarter CY 2007 discharges), and February 15, 2008 (third quarter CY 2007 discharges). We have continued our efforts to ensure that QIOs provide assistance to all hospitals that wish to submit data. In the preamble of this proposed rule, we are proposing to provide additional validation criteria to ensure that the quality data being sent to CMS are accurate. The requirement of 5 charts per hospital will result in approximately 21,500 charts per quarter total submitted to the agency. We reimburse hospitals for the cost of sending charts to the Clinical Data Abstraction Center (CDAC) at the rate of 12 cents per page for copying and approximately $4.00 per chart for postage. Our experience shows that the average chart received at the CDAC is approximately 150 pages. Thus, the agency will have expenditures of approximately $597,600 per quarter to collect the charts. Given that we reimburse for the data collection effort, we believe that a requirement for five charts per hospital per quarter represents a minimal burden to the participating hospital.

F. Effects of Proposed Policy Change to Methodology for Computing Core Staffing Factors for Volume Decrease Adjustment for SCHs and MDHs

In section IV.D. of the preamble of this proposed rule, we discuss a change to the methodology we would use to compute the average nursing staff factors (nursing hours per patient days) for the volume decrease adjustment for SCHs and MDHs. If certain requirements are met, this adjustment may be made if the hospital's total discharges decrease by more than 5 percent from one cost reporting period to the next. We do not believe this proposed change would have any significant impact on Medicare payments to these hospitals.

G. Effects of Proposed Clarification of Policy for Collection of Risk Adjustment Data From MA Organizations

In section IV.H. of the preamble of this proposed rule, we discuss our proposed revision of our regulations to clarify that CMS has the authority to require MA organizations to submit encounter data for each item and service provided to an MA plan enrollee. The proposed revision also would clarify that CMS will determine the formats for submitting encounter data, which may be more abbreviated than those used for the Medicare fee-for-service claims data submission process. At this time, we have not yet determined an approach for submission of the encounter data. Therefore, we are not in a position to determine the extent to which the cost impact of submitting encounter data would differ from the current costs to MA organizations of submitting risk adjustment data.

H. Effects of Proposed Policy Changes Relating to Hospital Emergency Services Under EMTALA

In section IV.I. of the preamble of this proposed rule, we are proposing to clarify our policy regarding the applicability of EMTALA to hospital inpatients. We are proposing to amend the regulations to state that when an individual covered by EMTALA was admitted as an inpatient and remains unstabilized with an emergency medical condition, a receiving hospital with specialized capabilities has an EMTALA obligation to accept that individual, assuming that the transfer of the individual is an appropriate transfer and the participating hospital with specialized capabilities has the capacity to treat the individual. In addition, we are proposing two changes relating to the requirements for on-call physicians in hospital emergency departments. We are proposing to delete the provision relating to maintaining a list of on-call physicians from the regulations referring to EMTALA at § 489.24(j)(1) because a provision addressing the on-call physician list is already included in the regulations relating to provider agreements at § 489.20(r)(2). We are proposing to incorporate the language of § 489.24(j)(1) as replacement language for the existing § 489.20(r)(2) and amend the regulatory language to make it more consistent with the statutory language found at section 1866(a)(1)(I)(iii) of the Act, which refers to hospital CoPs and the requirement to maintain an on-call list. These proposed changes would make the regulations consistent with the statutory basis for maintaining an on-call list. In addition, we are proposing to amend our regulations to provide that hospitals may comply with the on-call list requirement by participating in a formal community call plan so long as the plan includes a number of elements that are specified in the preamble to the proposed rule. Lastly, we are proposing to make a technical change to the regulations to conform them to the statutory language found in the Pandemic and All-Hazards Preparedness Act. These proposals do not include any substantive new requirements. Although hospitals choosing to participate in a community call arrangement will be required to devise a formal community call plan, such a plan would increase a hospital's flexibility in meeting its on-call requirements. We are estimating no impact on Medicare expenditures and no significant impact on hospitals with emergency departments.

I. Effects of Implementation of Rural Community Hospital Demonstration Program

In section IV.K. of the preamble to this proposed rule, we discuss our implementation of section 410A of Pub. L. 108-173 that required the Secretary to establish a demonstration that will modify reimbursement for inpatient services for up to 15 small rural hospitals. Section 410A(c)(2) requires that "in conducting the demonstration program under this section, the Secretary shall ensure that the aggregate payments made by the Secretary do not exceed the amount which the Secretary would have paid if the demonstration program under this section was not implemented." There are currently nine hospitals participating in the demonstration. We are currently conducting a solicitation for up to six additional hospitals to participate in the demonstration program.

As discussed in section IV.K. of the preamble to this proposed rule, we are satisfying this requirement by adjusting national IPPS rates by a factor that is sufficient to account for the added costs of this demonstration. We estimate that the average additional annual payment for FY 2009 that would be made to each participating hospital under the demonstration would be approximately $2,134,123. We based this estimate on the recent historical experience of the difference between inpatient cost and payment for hospitals that are participating in the demonstration. As an estimate for the 15 hospitals that may participate, the total annual impact of the demonstration program for FY 2009 is projected to be $32,011,849. (In the final rule, we should know the exact number of hospitals participating in the demonstration program and would revise our estimates accordingly.) The adjustment factor to the Federal rate used in calculating Medicare inpatient prospective payments as a result of the demonstration is 0.999903.

J. Effects of Proposed Policy Changes Relating to Payments to Hospitals-Within-Hospitals

In section VI.F. of the preamble of this proposed rule, we discuss our proposed policy change to allow a HwH that cannot meet the criteria in regulations for a separate governing body solely because it is a State hospital occupying space with another State hospital or located on the same campus as another State hospital and both hospitals are under the same governing authority, or the governing authority of a third entity that controls both State hospitals, to nevertheless qualify for an exclusion from the IPPS if the hospital meets other applicable criteria for HwHs in the regulations and the specified proposed criteria in this proposed rule. We are only aware of one hospital that would be allowed qualify for exclusion from the IPPS under the proposed criteria and to expand its bed size under the proposed provisions. Because any expansion would occur at some point in the future, we are unable to quantify the impact of this proposed change.

K. Effects of Proposed Policy Changes Relating to Requirements for Disclosure of Physician Ownership in Hospitals

In section VII. of the preamble of this proposed rule, we discuss our proposals concerning (1) the definition of a physician-owned hospital; (2) the requirement that physician-owned hospitals disclose the ownership to patients; and (3) the requirement that all hospitals and CAHs must furnish written notice to their patients at the beginning of their hospital stay or outpatient visit if a physician is not present in the hospital 24 hours per day, 7 days per week, and that the notice must indicate how the hospital will meet the medical needs of any patient who develops an emergency medical condition at a time when there is no physician present in the hospital. The definition and the above requirements were implemented in the FY 2008 IPPS final rule with comment period (72 FR 47387 and 47391).

In this proposed rule, we are proposing to revise the definition of a physician-owned hospital at § 489.3 to include hospitals that have an ownership or investment interests by a physician and/or by an immediate family member of a physician. (The existing definition refers to an ownership or investment interest by a physician only, and not to an ownership or investment interest by an immediate family member.) We are also proposing to except from the definition of physician-owned hospital those hospitals that do not have at least one physician owner/investor or immediate family member owner/investor who refers patients to the hospital. We believe that the proposed changes to the definition of physician-owned hospital would result in no more than a de minimis increase in the number of hospitals that are subject to the disclosure requirements applicable to physician-owned hospitals. We believe that there would be very few hospitals that would now meet the definition of physician-owned hospital, if we adopt our proposal to include immediate family members within the group of owners or investors that cause a hospital to be considered physician-owned, that did not already meet the definition. That is, we believe there are very few hospitals for which an immediate family member of a physician, but not the physician himself or herself, or any other physician, has an ownership or investment interest. Moreover, to the extent that such hospitals exist, that is, hospitals that have no physician owner/investors but which have owners/investors who are immediate family members of one or more physicians, such hospitals would not be subject to the disclosure requirement if we adopt our proposed exception to the definition of a physician-owned hospital for those hospitals that do not have at least one referring physician whose immediate family member is an owner/investor. Also, if we adopt this proposed exception to the definition of physician-owned hospital, the number of hospitals that now are subject to the disclosure requirement may be reduced slightly as we understand that there are some hospitals that have no referring physician owner/investors but rather have physician owner/investors who have retired from the practice of medicine. Thus, if both our proposed changes to the definition of physician-owned hospital are adopted, the net result may be no change, or a minimal increase or decrease in the number of hospitals that are subject to the disclosure requirement. Finally, if our proposal to change the definition of physician-owned hospital is adopted to encompass immediate family members, some hospitals that already meet the definition based on the presence of physician owner/investors may have to amend their list of physician owner/investors to add immediate family members, which we believe would be a minimal burden.

We are proposing to clarify that the list of the hospital's owners or investors who are physicians or immediate family members of physicians must be provided to the patient at the time the request for the list is made by or on behalf of the patient. We note that hospitals are already currently required to furnish the list of physician owners or investors and, thus, we believe that the impact of stipulating a timeframe for furnishing the list is negligible.

We are proposing to require all hospitals to require that all physician owners who also are members of the hospital's medical staff to agree, as a condition of continued medical staff membership or admitting privileges, to disclose, in writing, to all patients they refer to the hospital any ownership or investment interest that is held by themselves or by an immediate family member (as defined in § 411.351). Disclosure would be required at the time the referral is made. Both hospitals and physicians would participate in the disclosure process. We believe this proposal would have a small effect on physician-owned hospitals to the extent that it may require them to change their bylaws or make similar changes.

We do not anticipate that our proposals in section VII. of the preamble of this proposed rule would have a significant economic impact on a substantial number of physicians, other health care providers and suppliers, or the Medicare or Medicaid programs and their beneficiaries. Specifically, we believe that this proposed rule would affect mostly hospitals, physicians, and beneficiaries. The proposed changes concerning both the definition of a physician-owned hospital and the disclosure of physician ownership in hospitals are consistent with the physician self-referral statute and regulations as well as the current practices of most hospitals. Thus, our proposed requirement that the list of physician owners be provided to the patient at the time the request for the list is made by or on behalf of the patient would present a negligible economic impact on the hospital. Similarly, the cost borne by individual physicians to implement these provisions would be limited to a one-time cost associated with developing a disclosure notice that would be shared with patients at the time the referral is made in addition to the negligible time associated with providing the list to the patient and maintaining a copy of the notice in the patient's medical record.

We are also proposing to provide authority for CMS to terminate the Medicare provider agreement of any hospital that fails to furnish the required written notice that a physician is not available 24 hours per day, 7 days per week and to describe how the hospital will meet the medical needs of any patient who develops an emergency medical condition at a time when there is no physician present in the hospital. We believe that the cost borne by hospitals to implement this proposal would be limited to a one-time cost associated with completing minor revisions to the hospital's policies and procedures to comply with the requirements of its Medicare provider agreement. Most hospitals have standard procedures to satisfy CMS by correcting deficiencies (such as the failure to furnish notice of physician ownership in the hospital to patients) before action is taken by CMS to terminate the Medicare provider agreement.

Overall, we believe that beneficiaries would be positively impacted by these provisions. Specifically, disclosure of physician ownership or investment interests equips patients to make informed decisions about where they elect to receive care. Our proposals make no significant changes that have the potential to impede patient access to health care facilities and services. In fact, we believe that our proposals would help minimize anti-competitive behavior that can affect the decision as to where a beneficiary receives health care services and possibly the quality of the services furnished.

L. Effects of Proposed Changes Relating to Physician Self-Referral Provisions

In section VIII. of the preamble of this proposed rule, we discuss our proposals pertaining to physician self-referral provisions, including: stand in the shoes, period of disallowance, and reporting of financial relationships between hospitals and physicians. We do not anticipate that our proposals would have a significant impact on physicians, other health care providers and suppliers, or the Medicare or Medicaid programs and their beneficiaries.

With respect to the proposals to modify the physician "stand in the shoes" provisions, we do not anticipate that entities that include one or more physician organizations would find it necessary to restructure their organizational relationships. We believe that if either of our alternative approaches is adopted, compliance with the "stand in the shoes" provisions would be made easier by simplifying the required analysis of arrangements in which a physician organization is interposed between the referring physician and the entity furnishing DHS. In addition to our proposals concerning the physician "stand in the shoes" provisions, we are making an entity "stand in the shoes" proposal, whereby an entity that furnishes DHS would be deemed to stand in the shoes of an organization in which it has a 100-percent ownership interest and would be deemed to have the same compensation arrangements with the same parties and on the same terms as does the organization that it owns. We believe that the entity stand in the shoes proposal may result in more financial relationships between entities and physicians being subject to the physician self-referral provisions, but we are unable to quantify at this time the possible increase or determine the effect of the proposal on the referral patterns or organization structures of DHS entities and their wholly-owned organizations. Rather, we welcome public comments on these issues.

Our proposal pertaining to the period of disallowance is a codification of what we believe is existing law and reflects what we believe most entities furnishing DHS are already following. Therefore, we do not anticipate a significant economic impact on the industry.

M. Effects of Proposed Changes Relating to Reporting of Financial Relationships Between Hospitals and Physicians

As discussed in section IX. of the preamble to this proposed rule, we are proposing to require that 500 hospitals furnish information concerning their financial relationships with their physicians. The financial relationships include ownership and investment interests and compensation arrangements. We are proposing that this information be submitted in a collection of information instrument that CMS has developed-the "DFRR," which is included in Appendix C to this proposed rule. We are unable to quantify the number of physicians who have ownership and investment interests and compensation arrangements with hospitals. Even if we assume that the 500 hospitals have a substantial number of financial relationships with physicians, we believe that, in general, the economic impact on these hospitals would not be substantial. Because we are proposing that the DFRR be completed by hospitals and that the physician information requested in the DFRR will be on file at the hospital, we believe there should be negligible, if any, impact upon physicians or other health care providers or suppliers. Specifically, we believe that the cost to complete the DFRR for each hospital would be approximately $1,550, and the total cost burden for the industry would be approximately $775,000.

We expect that this proposed rule may result in savings to the Medicare program by minimizing anti-competitive business arrangements as well as financial incentives that encourage overutilization. In addition, to the extent that we determine that any arrangements are noncompliant with the physician self-referral statute and regulations, there may be monies returned to the Medicare Trust Fund. We cannot gauge with any certainty the extent of these savings to the Medicare program at this time. Finally, we do not anticipate any financial burden on beneficiaries or impact on beneficiary access to medically necessary services because the completion of the DFRR would be conducted by hospitals.

VIII. Effects of Proposed Changes in the Capital IPPS

A. General Considerations

Fiscal year (FY) 2001 was the last year of the 10-year transition period established to phase in the PPS for hospital capital-related costs. During the transition period, hospitals were paid under one of two payment methodologies: fully prospective or hold harmless. Under the fully prospective methodology, hospitals were paid a blend of the capital Federal rate and their hospital-specific rate (see § 412.340). Under the hold-harmless methodology, unless a hospital elected payment based on 100 percent of the capital Federal rate, hospitals were paid 85 percent of reasonable costs for old capital costs (100 percent for SCHs) plus an amount for new capital costs based on a proportion of the capital Federal rate (see § 412.344). As we state in section V. of the preamble of this proposed rule, with the 10-year transition period ending with hospital cost reporting periods beginning on or after October 1, 2001 (FY 2002), beginning in FY 2002 capital prospective payment system payments for most hospitals are based solely on the capital Federal rate. Therefore, we no longer include information on obligated capital costs or projections of old capital costs and new capital costs, which were factors needed to calculate payments during the transition period, for our impact analysis.

The basic methodology for determining a capital PPS payment is set forth at § 412.312. The basic methodology for calculating capital IPPS payments in FY 2009 would be as follows:(Standard Federal Rate) × (DRG weight) × (GAF) × (COLA for hospitals located in Alaska and Hawaii) × (1 + Disproportionate Share Adjustment Factor + IME Adjustment Factor, if applicable).

We note that, in accordance with § 412.322(c), the IME adjustment factor for FY 2009 is equal to half of the current adjustment, as discussed in section V.B.2. of the preamble of this proposed rule. In addition, hospitals may also receive outlier payments for those cases that qualify under the threshold established for each fiscal year.

The data used in developing the impact analysis presented below are taken from the December 2007 update of the FY 2007 MedPAR file and the December 2007 update of the Provider-Specific File that is used for payment purposes. Although the analyses of the proposed changes to the capital prospective payment system do not incorporate cost data, we used the December 2007 update of the most recently available hospital cost report data (FYs 2005 and 2006) to categorize hospitals. Our analysis has several qualifications. We use the best data available and make assumptions about case-mix and beneficiary enrollment as described below. In addition, as discussed in section III. of the Addendum to this proposed rule, as we established for FY 2008, we are proposing to adjust the national capital rate to account for improvements in documentation and coding under the MS-DRGs in FY 2009. (As discussed in section III.A.6. of the Addendum to this proposed rule, we are not proposing to adjust the Puerto Rico specific capital rate to account for improvements in documentation and coding under theMS-DRGs in FY 2009.) Furthermore, due to the interdependent nature of the IPPS, it is very difficult to precisely quantify the impact associated with each proposed change. In addition, we draw upon various sources for the data used to categorize hospitals in the tables. In some cases (for instance, the number of beds), there is a fair degree of variation in the data from different sources. We have attempted to construct these variables with the best available sources overall. However, for individual hospitals, some miscategorizations are possible.

Using cases from the December 2007 update of the FY 2007 MedPAR file, we simulated payments under the capital PPS for FY 2008 and FY 2009 for a comparison of total payments per case. Any short-term, acute care hospitals not paid under the general IPPS (Indian Health Service hospitals and hospitals in Maryland) are excluded from the simulations.

As we explain in section III.A. of the Addendum to this proposed rule, payments are no longer made under the regular exceptions provision under §§ 412.348(b) through (e). Therefore, we no longer use the actuarial capital cost model (described in Appendix B of the August 1, 2001 proposed rule (66 FR 40099)). We modeled payments for each hospital by multiplying the capital Federal rate by the GAF and the hospital's case-mix. We then added estimated payments for indirect medical education (which are reduced by 50 percent in FY 2009 in accordance with § 412.322(c), as discussed in section V.B.2. of the preamble of this proposed rule), disproportionate share, and outliers, if applicable. For purposes of this impact analysis, the model includes the following assumptions:

• We estimate that the Medicare case-mix index will increase by 1.0 percent in both FYs 2008 and 2009. (We note that this does not reflect the expected growth in case-mix due to improvement in documentation and coding under the MS-DRGs, as discussed below.)

• We estimate that the Medicare discharges will be 13.2 million in FY 2008 and 13.3 million in FY 2009 for an approximately 0.4 percent increase from FY 2008 to FY 2009.

• The capital Federal rate was updated beginning in FY 1996 by an analytical framework that considers changes in the prices associated with capital-related costs and adjustments to account for forecast error, changes in the case-mix index, allowable changes in intensity, and other factors. As discussed in section VIII. of the preamble and section III.A.2.1. of the Addendum to this proposed rule, the proposed FY-2009 update is 0.7 percent.

• In addition to the proposed FY 2009 update factor, the proposed FY 2009 capital Federal rate was calculated based on a proposed GAF/DRG budget neutrality factor of 1.0007, a proposed outlier adjustment factor of 0.9427, and a proposed exceptions adjustment factor of 0.9998.

• For FY 2009, as discussed in section III.A. of the Addendum to this proposed rule, the proposed FY 2009 national capital rate was further adjusted by a factor to account for anticipated improvements in documentation and coding that are expected to increase case-mix under theMS-DRGs. In the FY 2008 IPPS final rule with comment period (72 FR 47186), we established adjustments to the IPPS rates based on the Office of the Actuary projected case-mix growth resulting from improved documentation and coding of 1.2 percent for FY 2008, 1.8 percent for FY 2009, and 1.8 percent for FY 2010. However, we reduced the documentation and coding adjustment to -0.6 percent for FY 2008, and for FY 2009, we are proposing to apply an adjustment of 0.9 percent, consistent with section 7 of Pub. L. 110-90. As noted above and as discussed in section III.A.6. of the Addendum to this proposed rule, we are not proposing to adjust the Puerto Rico-specific capital rate to account for improvements in documentation and coding under the MS-DRGs in FY 2009.

B. Results

We used the actuarial model described above to estimate the potential impact of our proposed changes for FY 2009 on total capital payments per case, using a universe of 3,528 hospitals. As described above, the individual hospital payment parameters are taken from the best available data, including the December 2007 update of the FY 2007 MedPAR file, the December 2007 update to the PSF, and the most recent cost report data from the December 2007 update of HCRIS. In Table III, we present a comparison of total payments per case for FY 2008 compared to proposed FY 2009 based on the proposed FY 2009 payment policies. Column 2 shows estimates of payments per case under our model for FY 2008. Column 3 shows estimates of payments per case under our model for FY 2009. Column 4 shows the total percentage change in payments from FY 2008 to FY 2009. The change represented in Column 4 includes the proposed 0.7 percent update to the capital Federal rate, other changes in the adjustments to the capital Federal rate (for example, the 50 percent reduction to the teaching adjustment for FY 2009), and the additional 0.9 percent reduction to the national capital rate to account for improvements in documentation and coding (or other changes in coding that do not reflect real changes in case-mix) for implementation of the MS-DRGs. Consistent with the impact analysis for the proposed policy changes under the IPPS for operating costs in section VI. of this Appendix, for purposes of this impact analysis, we also assume a 1.8 percent increase in case-mix growth for FY 2009, as determined by the Office of the Actuary, because we believe the adoption of theMS-DRG will result in case-mix growth due to documentation and coding changes that do not reflect real changes in patient severity of illness. The comparisons are provided by: (1) Geographic location; (2) region; and(3) payment classification.

The simulation results show that, on average, capital payments per case in FY 2009 can be expected to remain about the same as capital payments per case in FY 2008. The proposed capital rate for FY 2009 would decrease 1.14 percent as compared to the FY 2008 capital rate, and the proposed changes to the GAFs are expected to result in a slight decrease (0.3 percent) in capital payments. In addition, the 50 percent reduction to the teaching adjustment in FY 2009 will also result in a decrease in capital payments from FY 2008 as compared to FY 2009. Countering these factors is the projected case-mix growth as a result of improved documentation and coding (discussed above) as well as an estimated increase in outlier payments in FY 2008 as compared to FY 2009. The net result of these changes is an estimated 0.0 percent change in capital payments per discharge from FY 2008 to FY 2009 for all hospitals (as shown below in Table III).

The results of our comparisons by geographic location and by region are consistent with the results we expected with the decrease to the teaching adjustment in FY 2009 (§ 412.522(c)). The geographic comparison shows that all urban hospitals are expected to experience no change in capital IPPS payments per case in FY 2009 as compared to FY 2008, while hospitals in large urban areas are expected to experience a slight decrease (0.3 percent) in capital IPPS payments per case in FY 2009 as compared to FY 2008. Capital IPPS payments per case for rural hospitals are expected to increase 0.5 percent. These differences in payments per case by geographic location are mostly due to the decrease in the teaching adjustment. Because teaching hospitals generally tend to be located in urban or large urban areas, we would expect that the 50 percent decrease in the teaching adjustment for FY 2009 would have a more significant impact on hospitals in those areas than those hospitals located in rural areas.

Most regions are estimated to experience an increase in total capital payments per case from FY 2008 to FY 2009. These increases vary by region and range from a 1.9 percent increase in the Pacific urban and West South Central urban regions to a 0.1 percent increase in the East North Central urban region. Two urban regions are projected to experience a relatively larger decrease in capital payments, with the difference mostly due to proposed changes in the GAFs and the 50 percent reduction in the teaching adjustment for FY 2009: -2.7 percent in the Middle Atlantic urban region and -3.6 percent in the New England urban region. The East North Central urban region is also expected to experience a decrease of 0.1 percent in capital payments in FY 2009 as compared to FY 2008, mostly due to proposed changes in the GAFs. There are two rural regions that expected to experience a decrease in total capital payments per case: A -4.5 percent decrease in the New England rural region and a -1.0 percent decrease in the Middle Atlantic rural region. Again, for these two rural regions, the projected decrease in capital payments is mostly due to proposed changes in the GAF, as well as a smaller than average increase in changes payments due to the adoption of the MS-DRGs.

By type of ownership, voluntary and government hospitals are estimated to experience a decrease of 0.2 percent and 0.8 percent, respectively. The projected decrease in capital payments per case is primarily due to the 50 percent teaching adjustment reduction for FY 2009. Proprietary hospitals are estimated to experience an increase in capital payments per case of 1.6 percent. This estimated increase in capital payments is mostly due to a smaller than average decrease in payments resulting from the 50 percent teaching adjustment reduction for FY 2009.

Section 1886(d)(10) of the Act established the MGCRB. Before FY 2005, hospitals could apply to the MGCRB for reclassification for purposes of the standardized amount, wage index, or both. Section 401(c) of Pub. L. 108-173 equalized the standardized amounts under the operating IPPS. Therefore, beginning in FY 2005, there is no longer reclassification for the purposes of the standardized amounts; however, hospitals still may apply for reclassification for purposes of the wage index for FY 2009. Reclassification for wage index purposes also affects the GAFs because that factor is constructed from the hospital wage index.

To present the effects of the hospitals being reclassified for FY 2009, we show the average capital payments per case for reclassified hospitals for FY 2008. Urban reclassified hospitals are expected to have the largest decrease in capital payments of 0.4 percent, while rural reclassified hospitals are expected to have the largest increase in capital payments of 1.0 percent. Urban nonreclassified hospitals are not expected to experience any change in capital payment from FY 2008 to FY 2009, while rural nonreclassified hospitals are expected to experience a slight decrease in capital payments of 0.3 percent. The projected changes in capital payments for rural hospitals are mainly due to the proposed changes to the GAF (including the proposal to apply the rural floor budget neutrality at a State level). The projected changes in capital payments for urban hospitals are mainly due to the 50 percent reduction in the teaching adjustment in FY 2009.

Number of hospitals Average FY 2008 payments/case Average FY 2009 payments/case Change
By Geographic Location:
All hospitals 3,528 757 757 0.0
Large urban areas (populations over 1 million) 1,402 834 831 -0.3
Other urban areas (populations of 1 million or fewer) 1,140 752 754 0.3
Rural areas 986 528 531 0.5
Urban hospitals 2,542 796 796 0.0
0-99 beds 643 632 642 1.6
100-199 beds 829 684 692 1.1
200-299 beds 483 752 758 0.8
300-499 beds 411 829 827 -0.3
500 or more beds 176 973 957 -1.7
Rural hospitals 986 528 531 0.5
0-49 beds 338 429 427 -0.5
50-99 beds 373 485 487 0.4
100-149 beds 166 532 537 1.0
150-199 beds 67 586 595 1.4
200 or more beds 42 652 652 0.0
By Region:
Urban by Region 2,542 796 796 0.0
New England 121 835 805 -3.6
Middle Atlantic 348 858 835 -2.7
South Atlantic 385 755 763 1.1
East North Central 394 777 770 -0.9
East South Central 163 719 727 1.2
West North Central 157 777 779 0.2
West South Central 371 747 761 1.9
Mountain 157 807 822 1.8
Pacific 393 925 943 1.9
Puerto Rico 53 367 368 0.3
Rural by Region 986 528 531 0.5
New England 23 706 675 -4.5
Middle Atlantic 70 543 537 -1.0
South Atlantic 172 516 524 1.5
East North Central 121 555 555 0.1
East South Central 176 480 484 0.9
West North Central 113 560 567 1.1
West South Central 200 479 483 0.8
Mountain 75 533 539 1.2
Pacific 36 650 660 1.6
By Payment Classification:
All hospitals 3,528 757 757 0.0
Large urban areas (populations over 1 million) 1,424 832 830 -0.3
Other urban areas (populations of 1 million or fewer) 1,160 750 752 0.3
Rural areas 944 528 531 0.6
Teaching Status:
Non-teaching 2,484 643 657 2.1
Fewer than 100 Residents 805 765 769 0.5
100 or more Residents 238 1,085 1,037 -4.4
Urban DSH:
100 or more beds 1,534 823 820 -0.3
Less than 100 beds 354 567 573 1.2
Rural DSH:
Sole Community (SCH/EACH) 389 467 469 0.4
Referral Center (RRC/EACH) 206 584 589 0.8
Other Rural:
100 or more beds 39 489 493 0.8
Less than 100 beds 168 438 438 0.1
Urban teaching and DSH:
Both teaching and DSH 811 896 881 -1.6
Teaching and no DSH 172 784 777 -0.8
No teaching and DSH 1,077 683 700 2.5
No teaching and no DSH 524 702 716 2.0
Rural Hospital Types:
Non special status hospitals 2,459 800 799 -0.1
RRC/EACH 63 700 714 2.0
SCH/EACH 36 654 659 0.8
Medicare-dependent hospitals (MDH) 11 457 456 -0.2
SCH, RRC and EACH 15 751 776 3.4
Hospitals Reclassified by the Medicare Geographic Classification Review Board:
FY 2009 Reclassifications:
All Urban Reclassified 445 802 799 -0.4
All Urban Non-Reclassified 2,075 796 796 0.0
All Rural Reclassified 360 573 579 1.0
All Rural Non-Reclassified 565 459 458 -0.3
Other Reclassified Hospitals (Section 1886(d)(8)(B)) 54 535 538 0.5
Type of Ownership:
Voluntary 2,027 770 769 -0.2
Proprietary 827 699 710 1.6
Government 587 752 746 -0.8
Medicare Utilization as a Percent of Inpatient Days:
0-25 255 998 971 -2.8
25-50 1,350 847 843 -0.5
50-65 1,431 671 677 0.9
Over 65 392 598 601 0.5

IX. Alternatives Considered

This proposed rule contains a range of proposed policies. The preamble of this proposed rule provides descriptions of the statutory provisions that are addressed, identifies those proposed policies when discretion has been exercised, and presents rationale for our decisions and, where relevant, alternatives that were considered.

X. Overall Conclusion

The changes we are proposing in this proposed rule will affect all classes of hospitals. Some hospitals are expected to experience significant gains and others less significant gains, but overall hospitals are projected to experience positive updates in IPPS payments in FY 2009. Table I of section VI. of this Appendix demonstrates the estimated distributional impact of the IPPS budget neutrality requirements for proposed MS-DRG and wage index changes, and for the wage index reclassifications under the MGCRB. Table I also shows an overall increase of 4.1 percent in operating payments. We estimate operating payments to increase by $3.96 billion. This accounts for the projected savings associated with the postacute care transfer policy proposal and the HACs policy, which each have an estimated savings of $50 million. In addition, this estimate includes the hospital reporting of quality data program costs ($2.39 million) and all proposed operating payment policies as described in section VII. of this Appendix. Capital payments are estimated to increase by 0.0 percent per case, as shown in Table III of section VIII. of this Appendix. Therefore, we project that the increase in capital payments in FY 2009 compared to FY 2008 is negligible ($6 million). The proposed operating and capital payments should result in a net increase of $3.967 billion to IPPS providers. The discussions presented in the previous pages, in combination with the rest of this proposed rule, constitute a regulatory impact analysis.

XI. Accounting Statement

As required by OMB Circular A-4 (available at http://www.whitehousegov/omb/circulars/a004/a-4.pdf), in Table IV below, we have prepared an accounting statement showing the classification of the expenditures associated with the provisions of this proposed rule. This table provides our best estimate of the increase in Medicare payments to providers as a result of the proposed changes to the IPPS presented in this proposed rule. All expenditures are classified as transfers to Medicare providers.

Category Transfers
Annualized Monetized Transfers $3.967 Billion.
From Whom to Whom Federal Government to IPPS Medicare Providers.
Total $3.967 Billion.

XII. Executive Order 12866

In accordance with the provisions of Executive Order 12866, the Office of Management and Budget reviewed this proposed rule.

Appendix B: Recommendation of Update Factors for Operating Cost Rates of Payment for Inpatient Hospital Services

I. Background

Section 1886(e)(4)(A) of the Act requires that the Secretary, taking into consideration the recommendations of the MedPAC, recommend update factors for inpatient hospital services for each fiscal year that take into account the amounts necessary for the efficient and effective delivery of medically appropriate and necessary care and high quality care. Under section 1886(e)(5)(B) of the Act, we are required to publish update factors recommended by the Secretary in the proposed and final IPPS rules, respectively. Accordingly, this Appendix provides the recommendations for the update factors for the IPPS national standardized amount, the Puerto Rico-specific standardized amount, the hospital-specific rates for SCHs and MDHs, and the rate-of-increase limits for hospitals and hospital units excluded from the IPPS, as well as LTCHS, IPFs, and IRFs. We also discuss our response to MedPAC's recommended update factors for inpatient hospital services.

II. Inpatient Hospital Update for FY 2009

Section 1886(b)(3)(B)(i)(XX) of the Act, as amended by section 5001(a) of Pub. L. 109-171, sets the FY 2009 percentage increase in the operating cost standardized amount equal to the rate-of-increase in the hospital market basket for IPPS hospitals in all areas, subject to the hospital submitting quality information under rules established by the Secretary in accordance with 1886(b)(3)(B)(viii) of the Act. For hospitals that do not provide these data, the update is equal to the market basket percentage increase less 2.0 percentage points. Consistent with current law, based on Global Insight, Inc.'s first quarter 2008 forecast of the FY 2009 market basket increase, we are estimating that the FY 2009 update to the standardized amount will be 3.0 percent (that is, the current estimate of the market basket rate-of-increase) for hospitals in all areas, provided the hospital submits quality data in accordance with our rules. For hospitals that do not submit quality data, we are estimating that the update to the standardized amount will be 1.0 percent (that is, the current estimate of the market basket rate-of-increase minus 2.0 percentage points).

Section 1886(d)(9)(C)(1) of the Act is the basis for determining the percentage increase to the Puerto Rico-specific standardized amount. For FY 2009, we are applying the full rate-of-increase in the hospital market basket for IPPS hospitals to the Puerto Rico-specific standardized amount. Therefore, the update to the Puerto Rico-specific standardized amount is estimated to be 3.0 percent.

Section 1886(b)(3)(B)(iv) of the Act sets the FY 2009 percentage increase in the hospital-specific rates applicable to SCHs and MDHs equal to the rate set forth in section 1886(b)(3)(B)(i) of the Act (that is, the same update factor as for all other hospitals subject to the IPPS, or the rate-of-increase in the market basket). Therefore, the update to the hospital-specific rates applicable to SCHs and MDHs is estimated to be 3.0 or 1.0 percent, depending upon whether the hospital submits quality data.

Section 1886(b)(3)(B)(ii) of the Act is used for purposes of determining the percentage increase in the rate-of-increase limits for children's and cancer hospitals. Section 1886(b)(3)(B)(ii) of the Act sets the percentage increase in the rate-of-increase limits equal to the market basket percentage increase. In accordance with § 403.752(a) of the regulations, RNHCIs are paid under § 413.40, which also uses section 1886(b)(3)(B)(ii) of the Act to update the percentage increase in the rate-of-increase limits. Section 1886(j)(3)(C) of the Act addresses the increase factor for the Federal prospective payment rate of IRFs. Section 123 of Pub. L. 106-113, as amended by section 307(b) of Pub. L. 106-554, provides the statutory authority for updating payment rates under the LTCH PPS. As discussed below, for cost reporting periods beginning on or after October 1, 2006, LTCHs that are not defined as new under § 412.23(e)(4), and that had not elected to be paid under 100 percent of the Federal rate are paid 100 percent of the adjusted Federal PPS rate. Therefore, because no portion of LTCHs' prospective payments will be based on reasonable cost concepts for cost reporting periods beginning on or after October 1, 2006, we are not proposing a rate-of-increase percentage to the reasonable cost portion for FY 2009 for LTCHs to be used under § 413.40. In addition, section 124 of Pub. L. 106-113 provides the statutory authority for updating all aspects of the payment rates for IPFs. Under this broad authority, IPFs that are not defined as new under § 412.426(c) are paid under a blended methodology for cost reporting periods beginning on or after January 1, 2005, and before January 1, 2008. For cost reporting periods beginning on or after January 1, 2008, existing IPFs are paid based on 100 percent of the Federal per diem rate. Therefore, because no portion of the existing IPFs prospective payments will be based on reasonable cost concepts for cost reporting periods beginning on or after January 1, 2008, we are not proposing a rate-of-increase percentage to the reasonable cost portion for FY 2009 for IPFs to be used under § 412.426(c). New IPFs are paid based on 100 percent of the Federal per diem payment amount.

Currently, children's hospitals, cancer hospitals, and RNHCIs are the remaining three types of hospitals still reimbursed under the reasonable cost methodology. We are providing our current estimate of the FY 2009 IPPS operating market basket percentage increase (3.0 percent) to update the target limits for children's hospitals, cancer hospitals, and RNHCIs.

Effective for cost reporting periods beginning on or after October 1, 2002, LTCHs have been paid under the LTCH PPS. Additionally, for cost reporting periods beginning on or after October 1, 2006, no portion of a LTCH's PPS payments can be based on reasonable cost concepts. Consequently, there is no need to propose to update the target limit under § 413.40 effective October 1, 2008, for LTCHs.

In the RY 2009 LTCH PPS proposed rule (73 FR 5361 through 5362), we proposed an update of 2.6 percent to the LTCH PPS Federal rate for RY 2009, which is based on a proposed market basket increase of 3.5 percent and a proposed adjustment of 0.9 percent to account for the increase in case-mix in a prior year that resulted from changes in coding practices rather than an increase in patient severity. The proposed market basket of 3.5 percent used in determining this proposed update factor is based on our proposal in the LTCH proposed rule to extend the LTCH RY 2009 by 3 months (a total of 15 months instead of 12 months) through September 30, 2009. (A full discussion of the reasons for this proposed extension of RY 2009 can be found in the RY 2009 LTCH PPS proposed rule (73 FR 5351 through 5353).) However, if we were not proposing to extend the 2009 LTCH PPS rate year by 3 months, we would have proposed a market basket update of 3.1 percent for a 12-month RY 2009 offset by the proposed adjustment of 0.9 percent to account for the increase in case-mix in a prior year that resulted from changes in coding practices rather than an increase in patient severity.

Effective for cost reporting periods beginning on or after January 1, 2005, IPFs are paid under the IPF PPS. IPF PPS payments are based on a Federal per diem rate that is derived from the sum of the average routine operating, ancillary, and capital costs for each patient day of psychiatric care in an IPF, adjusted for budget neutrality. For cost reporting periods beginning on or after January 1, 2005, and before January 1, 2008, existing IPFs (those not defined as "new" under § 412.426(c)) are paid based on a blend of the reasonable cost-based PPS payments and the Federal per diem base rate. For cost reporting periods beginning on or after January 1, 2008, existing IPFs are paid based on 100 percent of the Federal per diem rate. Consequently, there is no need to propose to update the target limit under § 412.426(c) effective October 1, 2008, for IPFs.

IRFs are paid under the IRF PPS for cost reporting periods beginning on or after January 1, 2002. For cost reporting periods beginning on or after October 1, 2002 (FY 2003), and thereafter, the Federal prospective payments to IRFs are based on 100 percent of the adjusted Federal IRF prospective payment amount, updated annually (69 FR 45721). Section 1886(j)(3)(C) of the Act, as amended by section 115 of Pub. L. 110-173 sets the FY 2009 IRF PPS update factor equal to 0 percent. Thus, we are not applying an update (market basket) to the IRF PPS rates for FY 2009.

III. Secretary's Recommendation

MedPAC is recommending an inpatient hospital update equal to the market basket rate of increase for FY 2009. MedPAC's rationale for this update recommendation is described in more detail below. Based on the FY 2009 President's Budget, we are recommending an update to the standardized amount of 0 percent. We are recommending that this same update factor apply to SCHs and MDHs.

Section 1886(d)(9)(C)(1) of the Act is the basis for determining the percentage increase to the Puerto Rico-specific standardized amount. For FY 2009, we are applying the full rate-of-increase in the hospital market basket for IPPS hospitals to the Puerto Rico-specific standardized amount. Therefore, the update to the Puerto Rico-specific standardized amount is estimated to be 3.0 percent.

In addition to making a recommendation for IPPS hospitals, in accordance with section 1886(e)(4)(A) of the Act, we are also recommending update factors for all other types of hospitals. Consistent with the President's Budget, we are recommending an update based on the IPPS market basket increase for children's hospitals, cancer hospitals, and RNHCIs of 0 percent. As mentioned above, for cost reporting periods beginning on or after January 1, 2008, existing IPFs are paid based on 100 percent of the Federal per diem rate (and are no longer paid a blend of the reasonable cost-based PPS payments and the Federal per diem base rate). Consequently, we are no longer recommending an update factor for the portion of the payment that is based on reasonable costs. Consistent with the President's Budget, based on Global Insight, Inc.'s first quarter 2008 forecast of the RPL market basket increase, we are recommending an update to the IPF PPS Federal rate for RY 2009 of 3.2 percent for the Federal per diem payment amount.

In the RY 2009 LTCH PPS proposed rule (73 FR 5361 through 5362), we proposed an update of 2.6 percent to the LTCH PPS Federal rate for RY 2009, which is based on a proposed market basket increase of 3.5 percent and a proposed adjustment of 0.9 percent to account for the increase in case-mix in a prior year that resulted from changes in coding practices rather than an increase in patient severity. The proposed market basket of 3.5 percent used in determining this proposed update factor is based on our proposal in the LTCH proposed rule to extend the LTCH RY 2009 by 3 months (a total of 15 months instead of 12 months) through September 30, 2009. (A full discussion on the reasons for this proposed extension of RY 2009 can be found in the RY 2009 LTCH PPS proposed rule (73 FR 5351 through 5353).) However, if we were not proposing to extend the 2009 LTCH PPS rate year by 3 months, we would have proposed a market basket update for a 12 month RY 2009 of 3.1 percent in determining the proposed update factor for RY 2009 offset by the proposed adjustment of 0.9 percent to account for the increase in case-mix in a prior year that resulted from changes in coding practices rather than an increase in patient severity.

Finally, consistent with the President's FY 2009 Budget, we are recommending a zero percent update to the IRF PPS Federal rate for FY 2009. This recommendation is consistent with the zero percent increase factor specified in section 1886(j)(3)(C) of the Act, as amended by section 115 of Pub. L. 110-173.

IV. MedPAC Recommendation for Assessing Payment Adequacy and Updating Payments in Traditional Medicare

In its March 2008 Report to Congress, MedPAC assessed the adequacy of current payments and costs, and the relationship between payments and an appropriate cost base, utilizing an established methodology used by MedPAC in the past several years.

MedPAC recommended an update to the hospital inpatient rates equal to the increase in the hospital market basket in FY 2009, concurrent with implementation of a quality incentive program. Similar to last year, MedPAC also recommended that CMS put pressure on hospitals to control their costs rather than accommodate the current rate of cost growth, which is, in part, caused by a lack of pressure from private payers.

MedPAC noted that indicators of payment adequacy are almost uniformly positive. MedPAC expects Medicare margins to remain low in 2008. At the same time though, MedPAC's analysis finds that hospitals with low non-Medicare profit margins have below average standardized costs and most of these facilities have positive overall Medicare margins.

Response: Similar to our response last year, we agree with MedPAC that hospitals should control costs rather than accommodate the current rate of growth. An update equal to less than the market basket will motivate hospitals to control their costs, consistent with MedPAC's recommendation. As MedPAC noted, the lack of financial pressure at certain hospitals can lead to higher costs and in turn bring down the overall Medicare margin for the industry.

As discussed in section II of the preamble of this proposed rule, CMS implemented the MS-DRGs in FY 2008 to better account for severity of illness under the IPPS, and is basing the DRG weights on costs rather than charges. We continue to believe that these refinements will better match Medicare payment of the cost of care and provide incentives for hospitals to be more efficient in controlling costs.

We note that, because the operating and capital prospective payment systems remain separate, we are proposing to continue to use separate updates for operating and capital payments. The proposed update to the capital rate is discussed in section III of the Addendum to this proposed rule.

Appendix C-Disclosure of Financial Relationship Report (DFRR) Form

Disclosure of Financial Relationship Report (DFRR)

Requirement

Completion of the Disclosure of Financial Relationship Report (DFRR or Report) is required under section 1877(f) of the Social Security Act. The Report must be completed, certified by the appropriate officer of the hospital, and received by CMS within 60 days of the date that appears on the cover letter or e-mail transmission. Pursuant to 42 CFR 411.361(f), failure to timely submit the requested information concerning an entity's ownership, investment, and compensation arrangements may result in civil monetary penalties of up to $10,000 for each day beyond the deadline established for disclosure.

Please be advised that the results from the DFRR may be shared with other Federal agencies and with Congressional committees, as permitted or mandated by law. We intend to protect from public disclosure, to the fullest extent permitted by Exemptions 4 and 6 of the Freedom of Information Act, 5 U.S.C. 552(b)(4) and (6), any confidential business information and any individual-specific information collected. We note that CMS is prevented by the Trade Secrets Act, 18 U.S.C. 1905, from releasing confidential business information, except as authorized by law.

Information collected from each hospital will be analyzed separately to determine whether the financial relationships are in compliance with the physician self-referral laws and implementing regulations. At this time, we do not plan to aggregate data.

Exception to Mandatory Reporting

An entity that furnishes 20 or fewer Part A and/or Part B services during a calendar year is excepted from this reporting requirement pursuant to 42 CFR 411.361(b). If you believe that the hospital qualifies for this exception:

• The Chief Executive Officer, Chief Financial Officer, or a comparable officer of the Hospital must certify in writing that the hospital furnishes 20 or fewer Part A and/or Part B services during a calendar year.

• The certification statement must read as follows: "I, (insert name), hereby certify that, to the best of my knowledge and belief, (insert name of Hospital) furnishes 20 or fewer Part A and/or Part B services during a calendar year. Therefore the hospital is relying on the exception in 42 CFR 411.361(b) and will not be reporting financial relationship data concerning the facility." The certification statement must be signed and dated, and include the title of the signatory.

• If the hospital or entity qualifies for the exception at 42 CFR 411.361(b), please mail the original and one copy of the signed certification statement to: Physician Self-Referral, Centers for Medicare Medicaid Services, 7500 Security Boulevard, Mailstop C4-25-02, Baltimore, Maryland 21244-1850. In addition, we request, but do not require, that you e-mail a PDF or other electronically scanned version of the document to HOSPITALDISCLOSURE@cms.hhs.gov . In the subject line, please include the title "Exception to Disclosure Report."

General Instructions for DFRR

• The requested disclosures on Worksheets 1 through 6 pertain only to hospitals with physician ownership or investment. For purposes of this Report, ownership is synonymous with investment.

• For any question pertaining to the financial relationship between a physician and the Hospital or entity or individual, "physician" shall include each immediate family member of the physician, as defined in 42 CFR 411.351.

• The terms, "physician-owner" and "physician-investor" are used interchangeably throughout this report.

• Please provide the physician's last name, first name, and Medicare National Provider Identifier (NPI). Only for those physicians who have not yet received an NPI, may the physician's Unique Physician Identification Number (UPIN) be submitted instead. We will not accept a hospital created identifier (for example, Physician 1, Physician 2, etc.).

• Where supporting documentation or an explanation is requested, please include the name of the physician-owner or physician-investor, and his/her NPI.

• Supplemental documents should be provided only when specifically requested on a worksheet. Supporting documentation should be organized and clearly labeled to reference the relevant worksheet. Please include only information that responds to the question asked; extraneous information should not be included. For example, if only a few pages of a large document are responsive to a question, please only submit those relevant pages.

• If a particular question does not apply to the hospital, please type "N/A."

• If sufficient rows are not provided, please save the Excel spreadsheet, insert the necessary number of additional rows, and print a copy of the revised Excel spreadsheet.

• Upon completion of the entire DFRR, please verify all information presented (including the totals for the respective fields or columns) and return an original and one copy to: Physician Self-Referral, Centers for Medicare Medicaid Services, 7500 Security Boulevard, Mailstop C4-25-02, Baltimore, Maryland 21244-1850. CMS also requests, but does not require, that a PDF or other electronically scanned version of the DFRR and accompanying documentation be sent to HOSPITALDISCLOSURE@cms.hhs.gov .

• Please enter all date fields in the following format: MM/DD/YY. For example, "March 31, 2006" must be entered as follows: 03/31/06.

Report Contents

The attached report consists of the following spreadsheets:

• Cover Sheet-(Certification Page)

• Worksheet 1-Hospital Characteristics

• Worksheet 2-Direct Ownership in Hospital

• Worksheet 3-Indirect Ownership in Hospital

• Worksheet 4-Payments Made to Hospital by Direct Owners

• Worksheet 5-Payments Made to Hospital by Indirect Owners

• Worksheet 6-Investment Reconciliation

• Worksheet 7-Compensation Arrangements-Rentals, Personal Service Arrangements, and Recruitment (See 42 CFR 411.357)

• Worksheet 8-Other Types of Compensation Arrangements (See 42 CFR 411.357)

Key Terms

1. Additional Purchases: Stocks purchased after initial or starting investment. Report the total cost and number of additional shares of stock purchased.

2. Assessments: Any cost or fee required and paid by any investor of the hospital. These fees usually do not involve any basis or change in the owner's investment in the facility.

3. Back-up Guarantee: Physician-owner's risk of loss or liability related to the ownership of his or her stock is guaranteed by another entity. If the borrower has problems in repayment, the payment is guaranteed by a third party.

4. Basis of Stock/Shares: The cost of the stock at the end of the cost reporting period(s) ending in 2006.

5. Capital Calls: Each investor is asked/required to put additional capital in the company. Depending on the structure of the call, if no additional shares are issued, the basis (cost) of the investor's stock will increase, or if additional shares are issued, the number of the investor's shares will increase.

6. Compilation of Financial Statements: A compilation presents information in the form of financial statements that are the representation of management without expressing assurances.

7. Direct Ownership or Investment Interest: Direct ownership or investment interest is defined at 42 CFR 411.354(a)(2).

8. Disproportionate Guarantee by Physician Investor: Physician investor's risk of loss or liability related to the ownership of his/her stock is guaranteed by the corporate investor in a disproportionate percentage to the percentage of stock owned by that physician investor (i.e.: Physician investor owns 40% of the stock of a hospital, but assumes risk of loss or liability equal to 20%.)

9. Fair Market Value: Fair market value is defined at 42 CFR 411.351.

10. Hospital: Hospital is synonymous with operating entity (that is, the corporation or legal entity through which the hospital operates).

11. Immediate family member: An immediate family member means: Husband or wife; birth or adoptive parent, child, or sibling; stepparent, stepchild, stepbrother, or stepsister; father-in-law, mother-in-law, son-in-law, daughter-in-law, brother-in-law, sister-in-law; grandparent or grandchild; and spouse of a grandparent or grandchild. 42 CFR 411.351.

12. Indirect Ownership or Investment Interest: An indirect ownership or investment interest is defined at 42 CFR 411.354(b)(5).

13. Internally prepared: Internally prepared financial statements are prepared by employees of the hospital, and are used mostly to monitor the hospital's performance.

14. Loan Guarantees: A situation when the borrower's liability is collateralized by a third party.

15. NPI: Medicare National Provider Identifier.

16. Other Capital Assessments: Report only if shares of stock are involved. Fees assessed should not be reported.

17. Relinquishments or Sales: For each share of stock that is sold during the cost reporting period(s) in 2006, report the dollar amount of the sale and the number of shares sold.

18. Reporting Period: The reporting period refers to any cost reporting period(s) ending in 2006.

19. Return of Capital Dividends: A distribution that is not paid out of the earnings and profits of the company. This distribution reduces the basis of the stock.

20. Review of Financial Statements: A review of financial statements is an engagement that results in an accountant's opinion that expresses less assurance than that of a certified audit, but more than a compilation. Typically this involves limited auditing, testing, analytical procedures, and/or inquiries.

21. Stock/share: These terms are used interchangeably throughout the worksheets.

22. Stock Dividends: Stock dividends are distributions made by a corporation of its own stock.

Worksheet 1-Hospital Characteristics

• Please include month, date, and year for the beginning and end of your cost reporting period(s).

Worksheet 2-Direct Ownership in Hospital

• Identify the class of stock (if applicable) and list all owners of that class within the same grouping on the Worksheet.

• If the direct owner is the physician, enter "Self" in Column B.

• If the direct owner is not the physician, please write the individual's name in Column A and in Column B indicate his/her relationship to the physician and give the physician's name.

• The basis of the stock/shares is the cost of the stock at the end of the cost reporting period(s) ending in 2006. This amount should equal Worksheet 6, Column B, Line 18.

• One hundred percent of ownership should be identified for each individual class of stock.

Worksheet 3-Indirect Ownership in Hospital

• Report only indirect ownership interests of physicians and immediate family members on this Worksheet.

• In Column A, identify each entity with ownership in the hospital and identify the type of entity in Column B. The entity's percentage of direct ownership should be listed in Column C.

• List each investor-owner of the group entity in Column D. Indicate if the investor-owner is a physician. If the investor-owner is an immediate family member, please indicate the relationship to, and name of the physician to whom the investor-owner is related.

• Column E should indicate each investor-owner's percentage ownership in the entity at the end of the cost reporting period(s) in 2006, with the number of shares owned (if applicable) listed in Column F. Each type of share owned (if applicable) should be listed individually with the type of stock labeled in Column G.

• To calculate the percent of indirect ownership in Column H for each investor-owner of the entity, multiply the percentage in Column C by the percentage in Column E.

Worksheet 4-Payments Made to Hospital by Direct Owners

• Report only payments to the hospital by direct physician-owners and immediate family member owners on this Worksheet.

• Complete one line for each payment made by a physician-owner related to his or her investment interest, including, but not limited to: Initial investments, assessments, capital calls, and loan guarantees. If necessary, please insert additional lines.

• In Column B, indicate "Self" if the physician is the direct owner. If the direct owner is not the physician, please list the direct owner's name in Column A and in Column B, indicate the immediate family member's relationship to the physician and give the physician's name.

• Do not group payments under one physician name, but rather use a separate line for each type of payment made by a physician.

Worksheet 5-Payments Made to Hospital by Indirect Owners

• Report only payments made by indirect physician-owners and immediate family member owners on this Worksheet.

• Complete one line for each payment made by an entity related to an investment interest, including, but not limited to: Initial investments, assessments, capital calls, and loan guarantees. If necessary, please insert additional lines.

• List the name of the indirect ownership entity in Column A. In Column B, list the names of individuals that compose that entity, placing only one person per line and indicating his or her status, i.e. "Self" for physician, or "IFM" for immediate family member.

• For immediate family members, enter the relationship to and name of, the physician family member in Column C.

• Do not group payments under one entity name, but rather use a separate line for each type of payment made by an entity.

Worksheet 6-Investment Reconciliation

• Please complete a separate Worksheet for each physician-owner or immediate family member owner.

• Please provide the owner's Social Security Number (SSN) or NPI as appropriate.

• If a physician owns more than one class of stock/equity, a separate worksheet must be completed for each class of stock/equity.

• Line 10, Column A-The begin date must be the start of the cost reporting period(s) that end(s) in 2006. That is, for a cost reporting period of July 1, 2005 to June 30, 2006, the begin date is 07/01/05.

• Line 10, Columns B, C, and D must reflect the physician-owner's total investment for the class of stock/equity described, as of the beginning of the period being evaluated (all cost period(s) ending in 2006).

• Lines 11 through 17, Columns B, C, and D must reflect any and all changes to the physician-owner's stock/equity during the period being evaluated, so that line 18 reflects the owner's total investment at the end of the period.

• Line 17 must reflect all other capital assessments that occurred during the cost reporting period(s) ending in 2006.

• Line 18, Column A-The end date must be the end date of the cost reporting period(s) that end(s) in 2006. That is, for a cost reporting period of July 1, 2005 to June 30, 2006, the end date is 06/30/06.

• Line 18, Column B-The amount entered here should be equal to the amount listed on Worksheet 2, Column C for each class of stock for each physician owner.

Worksheet 7-Compensation Arrangements-Rentals, Personal Service Arrangements, and Recruitment (See 42 CFR 411.357)

• For all physicians who had one or more of the compensation arrangements listed in columns A through D list the physician's complete name in the first column, the physician's NPI, and insert either a Y or N as to whether the physician is an owner/investor of the hospital. In addition, please insert the applicable number of compensation arrangements in each respective column.

• For those compensation arrangements listed in columns A through D, include not just those that you believe fit within an exception in 42 CFR 411.357, but those that are implicated by the referenced exception.

• The information requested in columns A and B must include compensation arrangements that occur in either direction (i.e., rentals to/from physicians).

• Please indicate in the appropriate column the number of compensation arrangements that pertain to the physician for the reporting period(s) ending in 2006.

• Note that each Column A-D that is filled in with a number requires the submission of supporting documentation for each compensation arrangement. With the exception of uniform personal service arrangements, please submit a copy of the written agreement(s) that were in effect during the reporting period(s) ending in 2006.

Personal Service Arrangements (PSA-Column C)

? For each physician listed, please indicate the number of PSAs in effect for the cost reporting period(s) ending in 2006.

? In the next column indicate if the physician used a uniform PSA prepared by the hospital. We consider a PSA to be uniform if all of the elements present in the arrangements are materially the same. Only one copy of the uniform PSA should be included in the supplemental materials. The one copy will satisfy the supporting documentation requirement for all physicians who entered into a uniform PSA with the hospital.

? Indicate whether or not the hospital has a signed copy of this agreement on file for this physician in the next sub-column with a Y or N.

? If the physician had a non-uniform PSA in effect for the cost reporting period(s) ending in 2006, please indicate this on the Worksheet and provide a copy of the PSA with the supplemental materials for this Worksheet.

Worksheet 8-Other Types of Compensation Arrangements (See 42 CFR 411.357)

• This Worksheet addresses other compensation arrangements exceptions that are found at 42 CFR 411.357.

• Please note that you may be required to furnish an explanation or additional documentation depending on the answer to each question.

• Submit only the information that is necessary to answer the question by removing extraneous documentation where possible.

Questions

Questions regarding these instructions may be directed to: DFRR-Questions@cms.hhs.gov .

BILLING CODE 4120-01-P

[Federal Register graphic "EP30AP08.022" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.023" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.024" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.025" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.026" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.027" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.028" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.029" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.030" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.031" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.032" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.033" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.035" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "EP30AP08.036" is not available. Please view the graphic in the PDF version of this document.]

[FR Doc. 08-1135 Filed 4-14-08; 9:19 am]

BILLING CODE 4120-01-C